Citrus Sinensis ID: 005621

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------
Protein Sequence
MAKKLKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNSSLLEKVSNWSSAGDDADNISSICRVGS
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHccccccccEEEEcccccccccccEEEEEcEEEccccEEEcccccccEEEEEEEcccccccccccccEEEEEEEEEEEEEEcccccccccEEEEEEccccccccccccccEEcccccccccccccEEEEEEEccccccccccccccEEEEcccccccccccccccccccccEEEEccccccEEEEEEEEccccEEEEEEEEccccccccccEEEEcccccccccEEEEEEcccccccEEEEEEcccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHEEEEEcccccccccccccccccEEcHHHHHHHHccccccccccccccEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHcccccccccccEEEEcccEEEEEEEEcccccccHHccccccccccHHHHHHHHHHHHHHHHHHccccEEEEEEcccccccEEEccccccccccccccccccccccccccEEEccccccccccccccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHcccccEEEcccccccccccEEEccEEEEccccEEEEEccccccEEEEEEcccEEEccccccccEEEEEEEEEEEEEcccccccccEEEEEEEcccccccccHHHHcEEEEcccccccccEEEEEEEEccccccccccccccEEEEEccccccccccccEEccccccEEEEEEccccEEEEEEcccccEEEEEEEccccccccEEEEEEEccHHHccccEEEEEEEEEccccccccEEEEEEEccccccccccHHcccccccccccHHHEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHcccccccccccccccEEEEcEccccccEEEEEEEccccHccHHHHHHHHHHHHHcHHHHHHHHHHHHcccccEEEEEEccccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEEcccccccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccHHHHHEHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MAKKLKFFLVLFIFLanpvfsqqeEFFFSGfrdaannnnmslnGAAEIEKNGKLMLTNTTLRVLghafysspikfknstrnskslsfSTCFAFAIVPeytalgghgfaftisaskelpgtlpsqylgllnssdlgnltnhIFAVefdtvkdfefgdindnhvgidinslrsnasepaayfLENSTKQVLNLKSGEVIQAWIDydssknhlevrlapssvkprspilsfdvdlspivketmyvgfssstgllassHYILGWsfnmsgdakslsldslpslpgpkekhlgLIVGVTVSAFFVMFLAIAVGCYLVKkirnadvlesweldvgphrfsYEELKKATrgfrdkellgfggfgrvykgtlpstntQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCrrrgdlllvydfmpngsldkclFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLldselngrlgdfglaklyergtnpsttrvvgtlgylapeltrtgkpttssdvYAFGALLLEVVcgrrpiepkalpeelILVDWVWDRWKAGAILEvvdprlngefneieALDVVKLglmcsndaaeaRPTMRQVVRYlegevplpqavaapdacdgkkektsgggagvdgpefedfvysypnssllekvsnwssagddadnissicrvgs
Flexible Loop (DISEMBL)
MAKKLKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRlapssvkprspilsFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLesweldvgphRFSYEelkkatrgfrdkeLLGFGGFgrvykgtlpstntqvAVKRVsneskqglrefaseissigrlrhrNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKlyergtnpsttrvvGTLGYLApeltrtgkpttssDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEvvdprlngefNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNSSLLEKVSnwssagddadnissicrvgs
Low Complexity Region (SEG)
MAkklkfflvlfiflANPVfsqqeefffsGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYlgllnssdlgnlTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKslsldslpslpGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNSSLLEKVSNWSSAGDDADNISSICRVGS
Disordered region (IsUnstruct)
****LKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNST**SKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRL*********PILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMS********************HLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVA**************FASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPL****************************FEDFVYSYP*****************************
Disordered Region (DISOPRED)
**KKLKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMS***********PSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS*********FASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP*ALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAA*******************************************************C****
Disordered Region (DISEMBL)
MAKKLKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPD**************GVDGPEFEDFVYSYPNSSLLEKVSNWSSAGDDADNISSICRVGS
Disordered Region (DISPRO)
MAKKLKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEF*DF**********************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAKKLKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNSSLLEKVSNWSSAGDDADNISSICRVGS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	687	2.2.26 [Sep-21-2011]
Q9M2S4	684	L-type lectin-domain cont	yes	no	0.941	0.945	0.634	0.0
Q9M345	677	L-type lectin-domain cont	no	no	0.914	0.927	0.521	0.0
O80939	675	L-type lectin-domain cont	no	no	0.850	0.865	0.538	1e-178
Q9SZD5	669	L-type lectin-domain cont	no	no	0.870	0.893	0.510	1e-172
O81291	669	L-type lectin-domain cont	no	no	0.895	0.919	0.494	1e-172
O81292	674	L-type lectin-domain cont	no	no	0.871	0.888	0.500	1e-169
O04534	666	Putative L-type lectin-do	no	no	0.887	0.915	0.471	1e-167
Q9FIF1	674	Probable L-type lectin-do	no	no	0.879	0.896	0.501	1e-159
Q96285	661	L-type lectin-domain cont	no	no	0.839	0.872	0.498	1e-158
Q9M1G4	674	Probable L-type lectin-do	no	no	0.857	0.873	0.468	1e-156

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  830 bits (2143), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/663 (63%), Positives = 512/663 (77%), Gaps = 16/663 (2%)

Query: 19  VFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNS 78
           V S  ++F F GF+ A+ N  ++LNG AEI   G + LT  T RV+GHAFYS PI+FK  
Sbjct: 19  VSSLIQDFSFIGFKKASPN--LTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRFKPI 76

Query: 79  TRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLT 138
             N ++LSFST FA A+VPE+  LGGHG AF I+ + +L G+LPSQYLGLLNSS + N +
Sbjct: 77  GVN-RALSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLNSSRV-NFS 134

Query: 139 NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQ 198
           +H FAVEFDTV+D EF DINDNHVGIDINS+ S+ S PA YFL NSTK+ L L  G VIQ
Sbjct: 135 SHFFAVEFDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTKKELFLDGGRVIQ 194

Query: 199 AWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYIL 258
           AWIDYDS+K  L+V+L+P S KP+  +LS+DVDLS ++ + MYVGFS+STGLLASSHYIL
Sbjct: 195 AWIDYDSNKKRLDVKLSPFSEKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYIL 254

Query: 259 GWSFNMSGDAKSLSLDSLPSLPGP----KEKHLGLIVGVTVSAFFVMF-LAIAVGCYLVK 313
           GW+FNMSG+A SLSL SLP +P      K+K   LI+GV++    ++F + +A   ++V+
Sbjct: 255 GWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAASLFVVR 314

Query: 314 KIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAV 373
           K+++ D +E WELD GPHRFSY ELKKAT GF DKELLG GGFG+VYKG LP ++  VAV
Sbjct: 315 KVKDEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAV 374

Query: 374 KRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD 433
           KR+S+ES+QG+REF SE+SSIG LRHRNLVQLLGWCRRR DLLLVYDFMPNGSLD  LFD
Sbjct: 375 KRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFD 434

Query: 434 EQ-KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA 492
           E  + ILTW+QR++IIKGVASGLLYLHE WEQTVIHRDIKA NVLLDSE+NGR+GDFGLA
Sbjct: 435 ENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLA 494

Query: 493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP 552
           KLYE G++P  TRVVGT GYLAPELT++GK TTS+DVYAFGA+LLEV CGRRPIE  ALP
Sbjct: 495 KLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALP 554

Query: 553 EELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           EEL++VDWVW RW++G I +VVD RLNGEF+E E + V+KLGL+CSN++ E RPTMRQVV
Sbjct: 555 EELVMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVV 614

Query: 613 RYLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFV-----YSYPNSSLLEKVS 667
            YLE + P P+ V APD  D          +G  G EFEDFV     YS PN +    + 
Sbjct: 615 MYLEKQFPSPEVVPAPDFLDANDSMCLDERSGSAG-EFEDFVDSARFYSGPNETTTSSIF 673

Query: 668 NWS 670
           ++S
Sbjct: 674 SFS 676

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  641 bits (1653), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/639 (52%), Positives = 442/639 (69%), Gaps = 11/639 (1%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTR 80
           SQ   F ++GF     +  +SL G A +  NG L LTNT+++  GHAF +  I+FK+S +
Sbjct: 22  SQNLNFTYNGFHPPLTD--ISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRFKDS-Q 78

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
           N    SFST F FAI  +   L GHG AF ++ +  LP  LPSQY+GL N S+ GN TNH
Sbjct: 79  NGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNISNNGNDTNH 138

Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           IFAVEFDT++  EFGD NDNHVGID+N LRS     A Y  ++   Q L+L S + IQ W
Sbjct: 139 IFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDDHDKFQNLSLISRKRIQVW 198

Query: 201 IDYDSSKNHLEVRLAP-SSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILG 259
           IDYD+  + ++V +AP  S KPR P++S+  DLS I+ E MYVGFSS+TG + S H+++G
Sbjct: 199 IDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSATGSVLSEHFLVG 258

Query: 260 WSFNMSGDAKSLSLDSLPSLPG--PKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVK-KIR 316
           WSF ++G+A  LSL  LP LP   P+       +G+ + +  ++F  I +  Y+V+ K +
Sbjct: 259 WSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLISLSLIFSIIFLAFYIVRRKKK 318

Query: 317 NADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV 376
             + L+ WE + G +RF ++EL  AT+GF++K+LLG GGFGRVY+G LP+T  +VAVKRV
Sbjct: 319 YEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKRV 378

Query: 377 SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQK 436
           S++SKQG++EF +EI SIGR+ HRNLV LLG+CRRRG+LLLVYD+MPNGSLDK L++  +
Sbjct: 379 SHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPE 438

Query: 437 AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE 496
             L W+QR  IIKGVASGL YLHEEWEQ VIHRD+KA NVLLD++ NGRLGDFGLA+LY+
Sbjct: 439 TTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYD 498

Query: 497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE-PKALPEEL 555
            G++P TT VVGTLGYLAPE +RTG+ TT++DVYAFGA LLEVV GRRPIE   A  +  
Sbjct: 499 HGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTF 558

Query: 556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVV-KLGLMCSNDAAEARPTMRQVVRY 614
           +LV+WV+  W  G I+E  DP+L     ++E +++V KLGL+CS+    ARP+MRQV++Y
Sbjct: 559 LLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQY 618

Query: 615 LEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDF 653
           L G++ LP+    P           GG  G  G    DF
Sbjct: 619 LRGDMALPE--LTPLDLSAGSVMNLGGRDGFSGIAMTDF 655

Required during pollen development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  626 bits (1615), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 318/590 (53%), Positives = 416/590 (70%), Gaps = 6/590 (1%)

Query: 39  NMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPE 98
           ++S+ G   +  NG L LTNTT++  GHAFY+ PI+FK+S   + S SFST F FAI  +
Sbjct: 38  DLSIQGITTVTPNGLLKLTNTTVQKTGHAFYTKPIRFKDSPNGTVS-SFSTSFVFAIHSQ 96

Query: 99  YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDIN 158
              L GHG AF ++ +  LP   PSQY+GL N ++ GN TNH+FAVE DT+   EF D N
Sbjct: 97  IAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNGNETNHVFAVELDTILSTEFNDTN 156

Query: 159 DNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAP-S 217
           DNHVGIDINSL+S  S PA Y+ E    + L L S + +Q W+DYD   N ++V +AP +
Sbjct: 157 DNHVGIDINSLKSVQSSPAGYWDEKGQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFN 216

Query: 218 SVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLP 277
             KP  P+++   DLS ++ + MYVGFSS+TG + S HYILGWSF ++  A  L+L  LP
Sbjct: 217 EDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVLSEHYILGWSFGLNEKAPPLALSRLP 276

Query: 278 SLPG--PKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRN-ADVLESWELDVGPHRFS 334
            LP   PK       +G+ + + F++F  I + CY+V++ R  A+ LE WE + G +RF 
Sbjct: 277 KLPRFEPKRISEFYKIGMPLISLFLIFSFIFLVCYIVRRRRKFAEELEEWEKEFGKNRFR 336

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSI 394
           +++L  AT+GF++K LLG GGFG VYKG +P T  ++AVKRVS+ES+QG++EF +EI SI
Sbjct: 337 FKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSI 396

Query: 395 GRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
           GR+ HRNLV LLG+CRRRG+LLLVYD+MPNGSLDK L++  +  L W+QR ++I GVASG
Sbjct: 397 GRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIKVILGVASG 456

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           L YLHEEWEQ VIHRD+KA NVLLD ELNGRLGDFGLA+LY+ G++P TT VVGTLGYLA
Sbjct: 457 LFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLA 516

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE-PKALPEELILVDWVWDRWKAGAILEV 573
           PE TRTG+ T ++DV+AFGA LLEV CGRRPIE  +   E  +LVDWV+  W  G IL  
Sbjct: 517 PEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAA 576

Query: 574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQ 623
            DP +  E +E E   V+KLGL+CS+    ARP+MRQV+ YL G+  LP+
Sbjct: 577 KDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPE 626

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1

 Score =  605 bits (1559), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 315/617 (51%), Positives = 428/617 (69%), Gaps = 19/617 (3%)

Query: 16  ANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKF 75
           +N   SQ EE  F GF     +N+    G A     G + LTN++    GH FY+SP++F
Sbjct: 16  SNKALSQSEEGEF-GFNGYLYDNS----GIAITNSKGLMKLTNSSEFSYGHVFYNSPVRF 70

Query: 76  KNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLG 135
           KNS   + S SFST F FAIV    AL GHG AF IS +K LP +  SQYLGL N ++ G
Sbjct: 71  KNSPNGTVS-SFSTTFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLFNLTNNG 129

Query: 136 NLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENS-TKQVLNLKSG 194
           + +NHI AVEFDT ++ EF D+++NHVGIDINSL S  +  A Y+ ++  T + + L + 
Sbjct: 130 DPSNHIVAVEFDTFQNQEFDDMDNNHVGIDINSLSSEKASTAGYYEDDDGTFKNIRLINQ 189

Query: 195 EVIQAWIDYDSSKNHLEVRLAPSSV-KPRSPILSFDVDLSPIVKETMYVGFSSSTGLLAS 253
           + IQAWI+YDSS+  L V + P  + KP+ P+LS   DLSP + ++MYVGF+S+TG L S
Sbjct: 190 KPIQAWIEYDSSRRQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRS 249

Query: 254 SHYILGWSFNMSGDAKSLSLDSLPSLPGPK-----EKHLGLIVGVTVSAFFVMFLAIAVG 308
           SHYILGW+F ++G A ++ +  LP LP        +K L + + +T  A  V FL I+  
Sbjct: 250 SHYILGWTFKLNGTASNIDISRLPKLPRDSRSTSVKKILAISLSLTSLAILV-FLTISYM 308

Query: 309 CYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTN 368
            +L +K +  +VLE WE+  GPHRF+Y++L  AT+GFR+ ELLG GGFG+VYKGTL ++N
Sbjct: 309 LFLKRK-KLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSN 367

Query: 369 TQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLD 428
             +AVK+VS++S+QG+REF +EI++IGRLRH NLV+LLG+CRR+G+L LVYD MP GSLD
Sbjct: 368 MDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLD 427

Query: 429 KCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGD 488
           K L+ + +  L W QR++IIK VASGL YLH +W Q +IHRDIK  NVLLD  +NG+LGD
Sbjct: 428 KFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGD 487

Query: 489 FGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
           FGLAKL E G +P T+ V GT GY++PEL+RTGK +TSSDV+AFG L+LE+ CGRRP+ P
Sbjct: 488 FGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLP 547

Query: 549 KA-LPEELILVDWVWDRWKAGAILEVVDPRL--NGEFNEIEALDVVKLGLMCSNDAAEAR 605
           +A  P E++L DWV D W+   IL+VVD R+  + ++ E +   V+KLGL CS+  A  R
Sbjct: 548 RASSPSEMVLTDWVLDCWE-DDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVR 606

Query: 606 PTMRQVVRYLEGEVPLP 622
           P+M  V+++L+G   LP
Sbjct: 607 PSMSSVIQFLDGVAQLP 623

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1

 Score =  604 bits (1557), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 311/629 (49%), Positives = 424/629 (67%), Gaps = 14/629 (2%)

Query: 3   KKLKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLR 62
           K    F + F + +    SQ  +F ++GFR    +  +S+ G A I  NG L LTNTT++
Sbjct: 5   KLFTIFFLSFFWQSLKSSSQIIDFTYNGFRPPPTD--ISILGIATITPNGLLKLTNTTMQ 62

Query: 63  VLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLP 122
             GHAFY+ PI+FK+S   + S SFST F FAI  +      HG AF I+ +  LP   P
Sbjct: 63  STGHAFYTKPIRFKDSPNGTVS-SFSTTFVFAIHSQIPI--AHGMAFVIAPNPRLPFGSP 119

Query: 123 SQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLE 182
            QYLGL N ++ GN+ NH+FAVE DT+ + EF D N+NHVGIDINSL S  S PA Y+ E
Sbjct: 120 LQYLGLFNVTNNGNVRNHVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYWDE 179

Query: 183 NSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAP-SSVKPRSPILSFDVDLSPIVKETMY 241
           N     L L S + +Q W+D+D   + ++V +AP   VKPR P++S   DLS ++ + M+
Sbjct: 180 NDQFHNLTLISSKRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMF 239

Query: 242 VGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLPGPKEK-------HLGLIVGVT 294
           VGFSS+TG + S  ++LGWSF ++G+A+ L+L  LP LP    K       +   +  ++
Sbjct: 240 VGFSSATGNIVSEIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLIS 299

Query: 295 VSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFG 354
           +     + +   V   + ++ + A+ +E WE + G +R  +++L  AT+GF+DK +LG G
Sbjct: 300 LLLIPFLLIIFLVRFIMKRRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSG 359

Query: 355 GFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD 414
           GFG VYKG +P T  ++AVKRVSNES+QGL+EF +EI SIG++ HRNLV L+G+CRRR +
Sbjct: 360 GFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDE 419

Query: 415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAG 474
           LLLVYD+MPNGSLDK L++  +  L W+QR+++I GVAS L YLHEEWEQ VIHRD+KA 
Sbjct: 420 LLLVYDYMPNGSLDKYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKAS 479

Query: 475 NVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGA 534
           NVLLD+ELNGRLGDFGLA+L + G++P TTRVVGT GYLAP+  RTG+ TT++DV+AFG 
Sbjct: 480 NVLLDAELNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGV 539

Query: 535 LLLEVVCGRRPIEPKALP-EELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKL 593
           LLLEV CGRRPIE      E ++LVDWV+  W    IL+  DP L  E+++ E   V+KL
Sbjct: 540 LLLEVACGRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKL 599

Query: 594 GLMCSNDAAEARPTMRQVVRYLEGEVPLP 622
           GL+CS+    ARPTMRQV++YL G+  LP
Sbjct: 600 GLLCSHSDPLARPTMRQVLQYLRGDAMLP 628

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  597 bits (1538), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 307/613 (50%), Positives = 411/613 (67%), Gaps = 14/613 (2%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTR 80
           SQ   F ++ F     N  +S+ G A +  NG L LT+ T+   GHAFY+ PI+FK+S  
Sbjct: 24  SQSLNFTYNSFHRPPTN--ISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKDSPN 81

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
           ++ S SFST F   I      + GHG AF I+ +  L   + SQYLGL +S++ GN TNH
Sbjct: 82  DTVS-SFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNNGNDTNH 140

Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVEFDT+ + EF D NDNHVGI+INSL S  S    Y+ E +    L L S + +Q W
Sbjct: 141 ILAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYWDEINQFNNLTLISRKRMQVW 200

Query: 201 IDYDSSKNHLEVRLAP-SSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILG 259
           +DYD   N ++V +AP   VKPR  ++S   DLS +  + MY+GFS++TG + S H++ G
Sbjct: 201 VDYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLSEHFVFG 260

Query: 260 WSFNMSGD-AKSLSLDSLPSLP--GPK------EKHLGLIVGVTVSAFFVMFLAIAVGCY 310
           WSF + G  A  L+L  +P  P  GP       +  + L   + +   FV+ L   V   
Sbjct: 261 WSFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVSLIFLVRFI 320

Query: 311 LVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQ 370
           + ++ + A+  E WE + G +R  +++L  AT+GF+DK+LLG GGFGRVY+G +P+T  +
Sbjct: 321 VRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKE 380

Query: 371 VAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKC 430
           +AVKRVSNES+QGL+EF +EI SIGR+ HRNLV LLG+CRRR +LLLVYD+MPNGSLDK 
Sbjct: 381 IAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKY 440

Query: 431 LFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG 490
           L+D  +  L W+QR+ +I GVASGL YLHEEWEQ VIHRDIKA NVLLD+E NGRLGDFG
Sbjct: 441 LYDCPEVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFG 500

Query: 491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKA 550
           LA+L + G++P TTRVVGT GYLAP+  RTG+ TT++DV+AFG LLLEV CGRRPIE + 
Sbjct: 501 LARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEI 560

Query: 551 LPEE-LILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMR 609
             +E ++LVD V+  W  G IL+  DP L   +++ E   V+KLGL+CS+   + RPTMR
Sbjct: 561 ESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMR 620

Query: 610 QVVRYLEGEVPLP 622
           QV++YL G+  LP
Sbjct: 621 QVLQYLRGDATLP 633

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04534|LRK51_ARATH Putative L-type lectin-domain containing receptor kinase V.1 OS=Arabidopsis thaliana GN=LECRK51 PE=3 SV=1

 Score =  588 bits (1516), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 291/617 (47%), Positives = 408/617 (66%), Gaps = 7/617 (1%)

Query: 39  NMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPE 98
           NM  +G+A I  NG + LTN+T +  G  FY+  ++FKNS   + S SFST F F+I   
Sbjct: 33  NMYTSGSAYINNNGLIRLTNSTPQTTGQVFYNDQLRFKNSVNGTVS-SFSTTFVFSIEFH 91

Query: 99  YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDIN 158
               GG+G AF I  +++L  T P+ YLGL N S++G+  NHI AVE DT  D +F D +
Sbjct: 92  NGIYGGYGIAFVICPTRDLSPTFPTTYLGLFNRSNMGDPKNHIVAVELDTKVDQQFEDKD 151

Query: 159 DNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSS 218
            NHVGIDIN+L S+    A Y+++N T + L L SG+ +Q WI+YDS +  + V L P  
Sbjct: 152 ANHVGIDINTLVSDTVALAGYYMDNGTFRSLLLNSGQPMQIWIEYDSKQKQINVTLHPLY 211

Query: 219 V-KPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLP 277
           V KP+ P+LS + DLSP + E MYVGF+S+TG L +SHYILGW+F M+G    +    LP
Sbjct: 212 VPKPKIPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFKMNGTTPDIDPSRLP 271

Query: 278 SLPGPKEKHLG-----LIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHR 332
            +P   +  +      L + +TVS   ++ +        +K+ +  +VLE WE+  GPHR
Sbjct: 272 KIPRYNQPWIQSPNGILTISLTVSGVIILIILSLSLWLFLKRKKLLEVLEDWEVQFGPHR 331

Query: 333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEIS 392
           F++++L  AT+GF+D E+LG GGFG+VYKGTLP +N ++AVK VS++S+QG+REF +EI+
Sbjct: 332 FAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMREFIAEIA 391

Query: 393 SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVA 452
           +IGRLRH NLV+L G+CR +G+L LVYD M  GSLDK L+ +Q   L W QR++IIK VA
Sbjct: 392 TIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYHQQTGNLDWSQRFKIIKDVA 451

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           SGL YLH++W Q +IHRDIK  N+LLD+ +N +LGDFGLAKL + GT+P T+ V GTLGY
Sbjct: 452 SGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQTSHVAGTLGY 511

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           ++PEL+RTGK +T SDV+AFG ++LE+ CGR+PI P+A   E++L DWV + W+   I++
Sbjct: 512 ISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVLTDWVLECWENEDIMQ 571

Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPDACD 632
           V+D ++  E+ E +A  V+KLGL CS+  A  RP M  V++ L+    LP  +       
Sbjct: 572 VLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQLLDSVAQLPHNLLDIVQTR 631

Query: 633 GKKEKTSGGGAGVDGPE 649
                T   G   D PE
Sbjct: 632 EVHRGTEISGEAADSPE 648

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1

 Score =  561 bits (1445), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 318/634 (50%), Positives = 420/634 (66%), Gaps = 30/634 (4%)

Query: 7   FFLVLFIFLANPVFSQQ-EEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLG 65
           F+L++ I +   VF+Q+ + F +  FR+A    ++ L+G A    +G L LTN T    G
Sbjct: 10  FWLIIGIHVTFLVFAQEGDHFVYYDFRNA----DLELDGMANTN-HGPLHLTNNTNTGTG 64

Query: 66  HAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKEL--PGTLPS 123
           HAFY+ PIKF  S+ +S S S      FAI P   +  GHG AF +S +K+L   G+  S
Sbjct: 65  HAFYNIPIKFTASSLSSFSFSTEF--VFAIFPLQKSTYGHGMAFVVSPTKDLRSNGSANS 122

Query: 124 QYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLEN 183
             LG+ N ++      HIFAVE DT ++ E  D   N VGIDINS+ S  S  A+YF   
Sbjct: 123 N-LGIFNRANDNKTATHIFAVELDTNQNSESFDKGGNDVGIDINSIVSVESADASYFNAR 181

Query: 184 STKQV-LNLKSGEVIQAWIDYDSSKNHLEVRLAP------------SSVKPRSPILSFDV 230
             K + L L SG+ I  WIDYD  +  L V LAP            S +KP+ P+LS  +
Sbjct: 182 KGKNISLPLASGKSILVWIDYDGIEKVLNVTLAPVQTPKPDSPYFSSFIKPKVPLLSRSI 241

Query: 231 DLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLP-GPKEKHLGL 289
           +LS I  ETMYVGFS STG + S+ YILGWSF   G A+SL +  L + P  PK   L  
Sbjct: 242 NLSEIFTETMYVGFSGSTGSIKSNQYILGWSFKQGGKAESLDISRLSNPPPSPKRFPLKE 301

Query: 290 IVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKE 349
           ++G T+S   + FL +    YL KK + A+VLE WE +  P R+S+  L KAT+GFR+ +
Sbjct: 302 VLGATIST--IAFLTLGGIVYLYKKKKYAEVLEQWEKEYSPQRYSFRILYKATKGFRENQ 359

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           LLG GGFG+VYKG LPS  TQ+AVKRV ++++QG++++ +EI+S+GRLRH+NLV LLG+C
Sbjct: 360 LLGAGGFGKVYKGILPS-GTQIAVKRVYHDAEQGMKQYVAEIASMGRLRHKNLVHLLGYC 418

Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQK-AILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
           RR+G+LLLVYD+MPNGSLD  LF + K   LTW QR  IIKGVAS LLYLHEEWEQ V+H
Sbjct: 419 RRKGELLLVYDYMPNGSLDDYLFHKNKLKDLTWSQRVNIIKGVASALLYLHEEWEQVVLH 478

Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RDIKA N+LLD++LNG+LGDFGLA+ ++RG N   TRVVGT+GY+APELT  G  TT +D
Sbjct: 479 RDIKASNILLDADLNGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTD 538

Query: 529 VYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEAL 588
           VYAFGA +LEVVCGRRP++P A  E++ILV WV    K  A+ + VD +L  +F   EA 
Sbjct: 539 VYAFGAFILEVVCGRRPVDPDAPREQVILVKWVASCGKRDALTDTVDSKLI-DFKVEEAK 597

Query: 589 DVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLP 622
            ++KLG++CS    E RP+MRQ+++YLEG V +P
Sbjct: 598 LLLKLGMLCSQINPENRPSMRQILQYLEGNVSVP 631

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96285|LRK55_ARATH L-type lectin-domain containing receptor kinase V.5 OS=Arabidopsis thaliana GN=LECRK55 PE=1 SV=1

 Score =  557 bits (1436), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 294/590 (49%), Positives = 396/590 (67%), Gaps = 13/590 (2%)

Query: 43  NGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTAL 102
            G+  I  NG   LTNTT    G AF +  ++ KNS+    S SFS  F FAIVPE+   
Sbjct: 30  QGSVGIGFNGYFTLTNTTKHTFGQAFENEHVEIKNSSTGVIS-SFSVNFFFAIVPEHNQQ 88

Query: 103 GGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHV 162
           G HG  F IS ++ LPG    QYLG+ N ++ G  +N++ A+E D  KD EFGDI+DNHV
Sbjct: 89  GSHGMTFVISPTRGLPGASSDQYLGIFNKTNNGKASNNVIAIELDIHKDEEFGDIDDNHV 148

Query: 163 GIDINSLRSNASEPAAYFLE-NSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSS--V 219
           GI+IN LRS AS  A Y+ + + + + L+L S EV++  I Y      L V L P+   V
Sbjct: 149 GININGLRSVASASAGYYDDKDGSFKKLSLISREVMRLSIVYSQPDQQLNVTLFPAEIPV 208

Query: 220 KPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSL 279
            P  P+LS + DLSP + E MY+GF++STG + + HY++GW  N   +   L L S+P L
Sbjct: 209 PPLKPLLSLNRDLSPYLLEKMYLGFTASTGSVGAIHYLMGWLVNGVIEYPRLEL-SIPVL 267

Query: 280 PG-PKEK----HLGLIVGVTVSAFFVMFLAIAVG-CYLVKKIRNADVLESWELDVGPHRF 333
           P  PK+        L V +TVS F   F+A  +G  + ++  +  +VLE WE+  GPHRF
Sbjct: 268 PPYPKKTSNRTKTVLAVCLTVSVF-AAFVASWIGFVFYLRHKKVKEVLEEWEIQYGPHRF 326

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISS 393
           +Y+EL  AT+GF++K+LLG GGFG+VYKGTLP ++ ++AVKR S++S+QG+ EF +EIS+
Sbjct: 327 AYKELFNATKGFKEKQLLGKGGFGQVYKGTLPGSDAEIAVKRTSHDSRQGMSEFLAEIST 386

Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVA 452
           IGRLRH NLV+LLG+CR + +L LVYD+MPNGSLDK L   E +  LTWEQR+RIIK VA
Sbjct: 387 IGRLRHPNLVRLLGYCRHKENLYLVYDYMPNGSLDKYLNRSENQERLTWEQRFRIIKDVA 446

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           + LL+LH+EW Q +IHRDIK  NVL+D+E+N RLGDFGLAKLY++G +P T++V GT GY
Sbjct: 447 TALLHLHQEWVQVIIHRDIKPANVLIDNEMNARLGDFGLAKLYDQGFDPETSKVAGTFGY 506

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           +APE  RTG+ TTS+DVYAFG ++LEVVCGRR IE +A   E  LVDW+ + W+ G I +
Sbjct: 507 IAPEFLRTGRATTSTDVYAFGLVMLEVVCGRRIIERRAAENEEYLVDWILELWENGKIFD 566

Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLP 622
             +  +  E N  +   V+KLG++CS+ AA  RP M  V+R L G   LP
Sbjct: 567 AAEESIRQEQNRGQVELVLKLGVLCSHQAASIRPAMSVVMRILNGVSQLP 616

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M1G4|LRK15_ARATH Probable L-type lectin-domain containing receptor kinase I.5 OS=Arabidopsis thaliana GN=LECRK15 PE=2 SV=2

 Score =  552 bits (1422), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 286/610 (46%), Positives = 403/610 (66%), Gaps = 21/610 (3%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTR 80
           S+   F F+GF      +N++L+G+A +  NG L L   +   +GHAF   PI F +S  
Sbjct: 23  SKDTSFVFNGF----GQSNLALDGSATLLPNGLLQLAKDSQHQMGHAFIKKPIDFSSS-- 76

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
             K LSFST F  A+VP+    GGHG  F IS + +     P++Y+G+ N+S  G+ ++H
Sbjct: 77  --KPLSFSTHFVCALVPKPGFEGGHGITFVISPTVDFTRAQPTRYMGIFNASTNGSPSSH 134

Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQA 199
           +FAVE DTV++ +F + N+NH+GID+N+  S  S PA+YF + + K V +NL SG+ IQ 
Sbjct: 135 LFAVELDTVRNPDFRETNNNHIGIDVNNPISVESAPASYFSKTAQKNVSINLSSGKPIQV 194

Query: 200 WIDYDSSKNHLEVRLAP-SSVKPRSPILSFDVDLSPIV-KETMYVGFSSSTGLLASSHYI 257
           W+DY    N L V +AP  + KP  P+LS  ++LS I  +  ++VGF+++TG   S HY+
Sbjct: 195 WVDYHG--NVLNVSVAPLEAEKPSLPLLSRSMNLSEIFSRRRLFVGFAAATGTSISYHYL 252

Query: 258 LGWSFNMSGD-AKSLSLDSLPSLPGPKEKH----LGLIVGVTVSAFFVMFLAIAVGCYLV 312
           LGWSF+ + + ++ L    LP +P P+ +H      LI+ + V    ++ +A+  G Y  
Sbjct: 253 LGWSFSTNRELSQLLDFSKLPQVPRPRAEHKKVQFALIIALPV-ILAIVVMAVLAGVYYH 311

Query: 313 KKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVA 372
           +K + A+V E WE   G HRFSY+ L  AT+GF     LG GGFG VY+G LP  N  VA
Sbjct: 312 RKKKYAEVSEPWEKKYGTHRFSYKSLYIATKGFHKDRFLGRGGFGEVYRGDLP-LNKTVA 370

Query: 373 VKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF 432
           VKRVS++ +QG+++F +E+ S+  L+HRNLV LLG+CRR+G+LLLV ++MPNGSLD+ LF
Sbjct: 371 VKRVSHDGEQGMKQFVAEVVSMKSLKHRNLVPLLGYCRRKGELLLVSEYMPNGSLDQHLF 430

Query: 433 DEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA 492
           D+Q  +L+W QR+ I+KG+AS L YLH E EQ V+HRDIKA NV+LD+ELNGRLGDFG+A
Sbjct: 431 DDQSPVLSWSQRFVILKGIASALFYLHTEAEQVVLHRDIKASNVMLDAELNGRLGDFGMA 490

Query: 493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP 552
           + ++ G N +TT  VGT+GY+APEL   G  +T +DVYAFG  LLEV CGR+P+E     
Sbjct: 491 RFHDHGGNAATTAAVGTVGYMAPELITMGA-STITDVYAFGVFLLEVACGRKPVEFGVQV 549

Query: 553 EELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           E+  L+ WV + WK  ++L+  DPRL  EF   E   V+KLGL+C+N   E+RP M QVV
Sbjct: 550 EKRFLIKWVCECWKKDSLLDAKDPRLGEEFVPEEVELVMKLGLLCTNIVPESRPAMGQVV 609

Query: 613 RYLEGEVPLP 622
            YL G +PLP
Sbjct: 610 LYLSGNLPLP 619

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	687
255566440	743	kinase, putative [Ricinus communis] gi|2	0.947	0.876	0.756	0.0
225449434	679	PREDICTED: L-type lectin-domain containi	0.978	0.989	0.707	0.0
224109482	685	predicted protein [Populus trichocarpa]	0.951	0.954	0.720	0.0
449439978	683	PREDICTED: L-type lectin-domain containi	0.946	0.951	0.652	0.0
224101021	653	predicted protein [Populus trichocarpa]	0.924	0.972	0.678	0.0
356567976	674	PREDICTED: L-type lectin-domain containi	0.944	0.962	0.655	0.0
255584540	683	kinase, putative [Ricinus communis] gi|2	0.950	0.956	0.662	0.0
356523179	673	PREDICTED: L-type lectin-domain containi	0.921	0.940	0.662	0.0
356537938	676	PREDICTED: L-type lectin-domain containi	0.896	0.911	0.686	0.0
356506714	719	PREDICTED: L-type lectin-domain containi	0.931	0.890	0.635	0.0

>gi|255566440|ref|XP_002524205.1| kinase, putative [Ricinus communis] gi|223536482|gb|EEF38129.1| kinase, putative [Ricinus communis]

 Score =  993 bits (2568), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 500/661 (75%), Positives = 565/661 (85%), Gaps = 10/661 (1%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTR 80
           +  EE F  GF  A NN  MSL   AEIE NG L LTN T R+ GHAFYS+ I+FKNS+ 
Sbjct: 23  THVEEIFSDGFSHAGNN--MSLYDGAEIENNGVLRLTNNTQRLKGHAFYSNLIQFKNSS- 79

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
           N K+ SFST FAFAIVPEY  LGGHGFAFTIS SK+L G+LPSQYLGLLN+SD+GN +NH
Sbjct: 80  NGKAFSFSTSFAFAIVPEYLKLGGHGFAFTISTSKQLQGSLPSQYLGLLNASDIGNFSNH 139

Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVEFDTV+DFEFGDINDNHVGIDINSL+SN S PAAYFL+NST+Q L+L+S +VIQAW
Sbjct: 140 ILAVEFDTVQDFEFGDINDNHVGIDINSLQSNKSAPAAYFLDNSTRQNLSLQSNKVIQAW 199

Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           IDYDS KN +EVRL+P SVKPR PILSF VDLSP +K+ MYVGFSSSTGLLAS+HYILGW
Sbjct: 200 IDYDSIKNLVEVRLSPFSVKPRLPILSFGVDLSPFLKDYMYVGFSSSTGLLASTHYILGW 259

Query: 261 SFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADV 320
           +F+++G AKSLSL SLP+LPGPK+ H  LI  VT+SA  ++ LA+AV  YL++KI+NADV
Sbjct: 260 TFSVNGVAKSLSLSSLPTLPGPKKDHTLLIAAVTISAVVIIILAVAVSFYLIRKIQNADV 319

Query: 321 LESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES 380
           +E WE DVGPHRFSY ELKKAT+GFRDKELLGFGGFG+VYKGTLP++ T+VAVKR+S+ES
Sbjct: 320 IEEWEFDVGPHRFSYRELKKATKGFRDKELLGFGGFGKVYKGTLPNS-TEVAVKRISHES 378

Query: 381 KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILT 440
           KQG+REFASEI+SIGRLRHRNLVQLLGWCRRR DLLLVYDFMPNGSLDK LFDE   IL 
Sbjct: 379 KQGVREFASEIASIGRLRHRNLVQLLGWCRRRVDLLLVYDFMPNGSLDKYLFDEPPTILN 438

Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN 500
           WEQR+ IIKGVASGLLYLHE WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG+N
Sbjct: 439 WEQRFNIIKGVASGLLYLHEGWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGSN 498

Query: 501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW 560
           PSTTRVVGTLGYLAPELTRTGKPT SSDV+AFGALLLEVVCGRRPIEPKALPEELILVDW
Sbjct: 499 PSTTRVVGTLGYLAPELTRTGKPTASSDVFAFGALLLEVVCGRRPIEPKALPEELILVDW 558

Query: 561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP 620
           VWD+W++GAILEVVDPRLNGEF+E+EA+ V+KLGL+CSN++   RP MRQVV YL+GEV 
Sbjct: 559 VWDKWRSGAILEVVDPRLNGEFDELEAVVVLKLGLICSNNSPNMRPAMRQVVSYLQGEVA 618

Query: 621 LPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNSSLLEKVSNWSSAGDDADNIS 680
           LP+ V APDA D KK      G G  G EFED+V+SYP SS  EK S WSS GD  D+I 
Sbjct: 619 LPEMVTAPDAYDKKK------GEGTSGVEFEDYVHSYPLSSNFEKGSTWSSVGDYGDDIE 672

Query: 681 S 681
           +
Sbjct: 673 A 673

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225449434|ref|XP_002278015.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4 [Vitis vinifera]

 Score =  981 bits (2535), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 482/681 (70%), Positives = 564/681 (82%), Gaps = 9/681 (1%)

Query: 1   MAKKLKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT 60
           MA+ LK F V   FL+NPV SQ +EFF+  F  A NN  +SLNG A+IEKNG L LTN  
Sbjct: 1   MAEALKLFWVFVFFLSNPVLSQLDEFFYDSFHGAGNN--LSLNGVAKIEKNGMLRLTNDV 58

Query: 61  LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGT 120
            R  G  FY SPI+FKNS+   K+ SFST FAFAIVP+Y  LGGHG AF I+++KELPG 
Sbjct: 59  ARWFGRGFYPSPIRFKNSS-GGKAFSFSTAFAFAIVPQYPTLGGHGLAFAITSTKELPGA 117

Query: 121 LPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYF 180
           LP QYLGLLN++D GN TNH+FAVEFDTV+DFEF DI+DNHVGID+NS+ S AS  A+YF
Sbjct: 118 LPRQYLGLLNATDNGNSTNHVFAVEFDTVQDFEFNDISDNHVGIDLNSMTSYASANASYF 177

Query: 181 LENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETM 240
            +NSTK+ LNLK G+ IQAWIDYD  ++ L V L+P S KP SPILS  V+LS I+KE M
Sbjct: 178 SDNSTKEYLNLKGGKTIQAWIDYDGQRDQLNVFLSPHSTKPTSPILSCGVNLSSILKEFM 237

Query: 241 YVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFV 300
           YVGFS+STGLLASSHY+LGW F M+G A+SL L SLP LPGPK  +  LI+GV+V+A  +
Sbjct: 238 YVGFSASTGLLASSHYVLGWRFKMNGVAESLDLSSLPKLPGPKRNNTPLIIGVSVAATSM 297

Query: 301 MFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVY 360
           +  A+A+  YL++KI+NADV+E+WELD+GPHRFSY+ELKKATRGFRDKEL+GFGGFG+VY
Sbjct: 298 IVFAVALAFYLIRKIKNADVIEAWELDIGPHRFSYQELKKATRGFRDKELIGFGGFGKVY 357

Query: 361 KGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD 420
           KGTL ++NTQVAVKR+S+ESKQG+REF SEI+SIGRLRHRNLVQLLGWCRRRGDLLLVYD
Sbjct: 358 KGTLRNSNTQVAVKRISHESKQGMREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLVYD 417

Query: 421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS 480
           +MPNGSLDK LFD  K+ L+WEQR++IIKGVASGLLYLHEEWEQTVIHRDIKAGN+LLDS
Sbjct: 418 YMPNGSLDKYLFDTSKSTLSWEQRFKIIKGVASGLLYLHEEWEQTVIHRDIKAGNILLDS 477

Query: 481 ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           ELNGRLGDFGLAKLYE G+NPSTTRVVGTLGYLAPELTRTGKPT SSDV+AFGALLLEVV
Sbjct: 478 ELNGRLGDFGLAKLYEHGSNPSTTRVVGTLGYLAPELTRTGKPTRSSDVFAFGALLLEVV 537

Query: 541 CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSND 600
           CGRRP+E KALPEELILVDWVW+RW+ GAIL+VVDPRL GE++E+E + V+KLGLMCSN+
Sbjct: 538 CGRRPVEAKALPEELILVDWVWERWREGAILDVVDPRLKGEYDEVEVVVVLKLGLMCSNN 597

Query: 601 AAEARPTMRQVVRYLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNS 660
           +   RP+MRQV+RYLEGEV LP+ ++APDA D K      G       EFED+V+SYP S
Sbjct: 598 SPAVRPSMRQVLRYLEGEVALPEELSAPDAYDKKGGGAGDGF------EFEDYVHSYPAS 651

Query: 661 SLLEKVSNWSSAGDDADNISS 681
           S  EKVS WSSA DD D  SS
Sbjct: 652 SCFEKVSTWSSAVDDVDVESS 672

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224109482|ref|XP_002315211.1| predicted protein [Populus trichocarpa] gi|222864251|gb|EEF01382.1| predicted protein [Populus trichocarpa]

 Score =  936 bits (2420), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 477/662 (72%), Positives = 542/662 (81%), Gaps = 8/662 (1%)

Query: 16  ANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKF 75
            +PVFSQ ++ +F GF    +N  MSLNGAA IEKNG L LTN T   +GHAFYSSP+KF
Sbjct: 12  TSPVFSQLDDLYFPGFNHVTSN--MSLNGAAVIEKNGILRLTNNTQHTVGHAFYSSPVKF 69

Query: 76  KNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLG 135
           KNS+ N KS SFST FAF IVPE   + GHGFAFTIS SKELPG LP+QYLGLLN++D G
Sbjct: 70  KNSS-NGKSFSFSTAFAFTIVPENPRIRGHGFAFTISTSKELPGALPNQYLGLLNATDSG 128

Query: 136 NLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGE 195
           N +NH+FAVEFDTVKD++  DINDNHVGIDINS+ SN S PAA FL NST + LNL SG 
Sbjct: 129 NFSNHLFAVEFDTVKDYDLHDINDNHVGIDINSVISNKSVPAASFLVNSTTKDLNLCSGR 188

Query: 196 VIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSH 255
            IQAW+DYDS KN LEVRL+  S +P SPILS  +DLSP+ K+ MYVGFSSSTGLL S+H
Sbjct: 189 PIQAWVDYDSIKNLLEVRLSSFSKRPVSPILSCKIDLSPLFKDYMYVGFSSSTGLLTSTH 248

Query: 256 YILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKI 315
           YILGWSF+M G+AKSLSL SLPSLPG K  H GLI+GV+  A F++ L +A   YL +K+
Sbjct: 249 YILGWSFSMKGEAKSLSLPSLPSLPGHKMNHTGLILGVSTLATFLIILIVATTFYLSRKM 308

Query: 316 RNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKR 375
           + ADV E+WELD+GPHRFSY+ELKKAT+ FRD+ELLGFGGFG+VYKGTLP++NT++AVKR
Sbjct: 309 KKADVTEAWELDIGPHRFSYQELKKATKNFRDEELLGFGGFGKVYKGTLPNSNTEIAVKR 368

Query: 376 VSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ 435
           + +ES QGL+EF +EI SIGRLRHRNLV+LLGWCR++GDLLLVYDFM NGSLDK LFD  
Sbjct: 369 ICHESTQGLKEFLTEIDSIGRLRHRNLVRLLGWCRQQGDLLLVYDFMANGSLDKYLFDNP 428

Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
           K IL WEQR  IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY
Sbjct: 429 KTILKWEQRLNIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 488

Query: 496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL 555
           +R +NP TT+VVGTLGYLAPELTRTGKPTTSSDV+AFGALLLEVVCGR+PIEPKALPEEL
Sbjct: 489 DRNSNPITTKVVGTLGYLAPELTRTGKPTTSSDVFAFGALLLEVVCGRKPIEPKALPEEL 548

Query: 556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           ILVD VWDRWK+GAIL+VVDPRLNGEFNE EA+ V+KLGLMCSN+A  ARP MRQV R+L
Sbjct: 549 ILVDLVWDRWKSGAILDVVDPRLNGEFNEHEAVLVLKLGLMCSNNAPNARPPMRQVARFL 608

Query: 616 EGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNSSLLEKVSNWSSAGDD 675
           EGEV LP  VAAP+A DGK        A     E  D  +SYP SS LEKVS WS  GD 
Sbjct: 609 EGEVALPALVAAPNAYDGKNVN-----ANKVRRELVDHKHSYPVSSNLEKVSTWSFDGDY 663

Query: 676 AD 677
            D
Sbjct: 664 GD 665

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439978|ref|XP_004137762.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Cucumis sativus] gi|449524894|ref|XP_004169456.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Cucumis sativus]

 Score =  895 bits (2314), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/667 (65%), Positives = 538/667 (80%), Gaps = 17/667 (2%)

Query: 16  ANPVFSQQEEFFFSGFRD-AANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIK 74
           A P  SQQ   +FSGF+D AA   N++L   A+IE+NG L LTN T R+ GHAFYSSP++
Sbjct: 16  AAPAASQQ--LYFSGFQDDAAVAANLTLTDIAKIEQNGILKLTNDTSRLQGHAFYSSPVR 73

Query: 75  FKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDL 134
           FKNS+ + K  SFST F  A+VPEY  LGGHG AFTI+ SK L G LPSQYLGLLN+ D+
Sbjct: 74  FKNSS-DGKVFSFSTAFVIAVVPEYPTLGGHGLAFTIAPSKNLRG-LPSQYLGLLNAKDV 131

Query: 135 GNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENS-TKQVLNLKS 193
           GN TNH+FAVEFDTV+DFEF DINDNHVGI++N + SN S  A+YF+++  TKQ L LKS
Sbjct: 132 GNFTNHLFAVEFDTVQDFEFADINDNHVGINLNHMISNVSTTASYFVDDGPTKQNLTLKS 191

Query: 194 GEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLAS 253
           G  IQAW+DYDSS N L V L+PSS KP+ PILSF+VDLSPI+ E MYVGFS+STGLLAS
Sbjct: 192 GRPIQAWVDYDSSVNSLTVALSPSSTKPKKPILSFNVDLSPILDEFMYVGFSASTGLLAS 251

Query: 254 SHYILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVK 313
           SHY+LGWSF+M+G A+SL L SLPS+PGPK+KH    +G++V+A  ++ +AI V   ++ 
Sbjct: 252 SHYVLGWSFSMNGQARSLDLSSLPSVPGPKKKHTAFTIGISVAAVLIVIIAICVAVLIIW 311

Query: 314 KIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAV 373
           KI+NAD++E+WE ++GPHR+SY+ELKKAT+ FRDKELLG GGFG+VYKGTLP++  QVAV
Sbjct: 312 KIKNADIIEAWEHEIGPHRYSYKELKKATKRFRDKELLGRGGFGKVYKGTLPNSKIQVAV 371

Query: 374 KRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD 433
           KR+S+ESKQGLREF SEI+SIGRLRHRNLVQLLGWCRRRGDLLLVYDFM NGSLD  +FD
Sbjct: 372 KRISHESKQGLREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLVYDFMANGSLDNYIFD 431

Query: 434 EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK 493
           +    L+W+QR+ IIKGVASGLLYLHE +EQ VIHRD+KA NVLLDSE+NG+LGDFGLA+
Sbjct: 432 DPDVNLSWQQRFGIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEMNGKLGDFGLAR 491

Query: 494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           LYE G NPSTTRVVGTLGYLAPEL RTGK TTSSDVYAFGALLLEV CGRRPI+PK+  E
Sbjct: 492 LYEHGANPSTTRVVGTLGYLAPELPRTGKATTSSDVYAFGALLLEVACGRRPIDPKSSSE 551

Query: 554 ELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
           EL+LVDWVW+ ++ G +L+V+DP+L G+FN +EA+ ++KLGL CSND+A ARP+MRQVVR
Sbjct: 552 ELVLVDWVWENYREGKLLDVMDPKLKGDFNVVEAMMILKLGLFCSNDSAAARPSMRQVVR 611

Query: 614 YLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNSSLLEKVSNWSSAG 673
           +LEGE+ +P+ ++AP   +G          G +G  F+DFV S+ +SS   K S++SS G
Sbjct: 612 FLEGEMGVPEEISAPKVMEG----------GRNGEGFDDFVNSFASSS-FNKFSSYSSTG 660

Query: 674 DDADNIS 680
           +   ++S
Sbjct: 661 NKDMDMS 667

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224101021|ref|XP_002312109.1| predicted protein [Populus trichocarpa] gi|222851929|gb|EEE89476.1| predicted protein [Populus trichocarpa]

 Score =  889 bits (2296), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/646 (67%), Positives = 522/646 (80%), Gaps = 11/646 (1%)

Query: 17  NPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFK 76
           N V +Q ++ +F GF      NNMSLNGAAEIEKNG L LTN +  +LGHAFYS  IKFK
Sbjct: 18  NHVLTQLDDLYFQGFNHV--RNNMSLNGAAEIEKNGLLSLTNNSKSILGHAFYSHQIKFK 75

Query: 77  NSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGN 136
           NST N K+ SFST F FA+VP+Y  LGGHG AFT+S S ELPG  P +YLGLLN++  G+
Sbjct: 76  NST-NGKAFSFSTAFVFAVVPKYPNLGGHGLAFTLSTSNELPGAFPRKYLGLLNTTVAGS 134

Query: 137 LTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEV 196
            + HIF+VEFDT KD++F DINDNHVG++INS+ SN S PAAYFL NS K+ L+L SG  
Sbjct: 135 FSYHIFSVEFDTHKDYDFFDINDNHVGVNINSMISNKSVPAAYFLLNSEKEELDLTSGNP 194

Query: 197 IQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHY 256
           IQAW+DYDS KN LEVRL+PSS KP  PILS D+DLS I+ ++MYVGFSSSTG+L S+HY
Sbjct: 195 IQAWVDYDSVKNQLEVRLSPSSTKPIYPILSIDIDLSSILNDSMYVGFSSSTGMLTSTHY 254

Query: 257 ILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIR 316
           +LGWSF+++G+AKS S+ SLPSLP  K+  + ++     S F V+ L IAV  YLV+KI+
Sbjct: 255 VLGWSFSVNGEAKSFSMSSLPSLPETKDLLVLVVCVSVGSTF-VIILGIAVSFYLVRKIK 313

Query: 317 NADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV 376
           +AD++E WEL VGP RFSY+EL++ATRGFR+KELLGFGGFG+VYKGTLP+  T +AVKR 
Sbjct: 314 DADMIEGWELQVGPRRFSYQELREATRGFREKELLGFGGFGKVYKGTLPNCGTPIAVKRF 373

Query: 377 SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQK 436
            +ESKQGLREF++EI+SIGRLRH+NLV+LLGW R RG+LLLVYDFMPNGSLDK +F+E K
Sbjct: 374 CHESKQGLREFSTEIASIGRLRHKNLVRLLGWSRLRGELLLVYDFMPNGSLDKYIFEEPK 433

Query: 437 AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE 496
            IL WEQR++I+K VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE
Sbjct: 434 TILKWEQRFKIVKDVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE 493

Query: 497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELI 556
           RG+NP TT+VVGTLGYLAPELT+TGKPTTSSDV        EV+CGRRPIEPKALPEELI
Sbjct: 494 RGSNPITTKVVGTLGYLAPELTKTGKPTTSSDVLPL-VHFAEVICGRRPIEPKALPEELI 552

Query: 557 LVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
           LVDWVWD+WK+GAIL+VVDPRLNGEF+E EA+ ++KLGLMCSN    ARP MR++VRYLE
Sbjct: 553 LVDWVWDKWKSGAILDVVDPRLNGEFDETEAVLLLKLGLMCSNYVPRARPLMRKIVRYLE 612

Query: 617 GEVPLPQAVAAPDACDGKKEKTSGGGAGVD-GPEFEDFVYSYPNSS 661
           GEV LP+ VAAPD  DG+        A  D G E +D +Y YP S+
Sbjct: 613 GEVALPELVAAPDVYDGEN-----ADANTDSGDECKDHMYFYPQST 653

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567976|ref|XP_003552190.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  884 bits (2285), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 442/674 (65%), Positives = 533/674 (79%), Gaps = 25/674 (3%)

Query: 1   MAKKLKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT 60
           MA  LK  L L + L  PV  Q ++  ++GF+D   +N +++NG A+IE NG L LTN +
Sbjct: 1   MATLLKI-LSLTVLLLIPVSCQVDQLLYAGFKDVGASN-LTMNGVAKIEHNGILKLTNDS 58

Query: 61  LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGT 120
            R++GHAFY SP + KNST + K LSFS+ FA AIVPEY  LGGHG AFTI+ SK+L   
Sbjct: 59  SRLMGHAFYPSPFQLKNST-SGKVLSFSSSFALAIVPEYPKLGGHGLAFTIATSKDLKA- 116

Query: 121 LPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYF 180
           LPSQYLGLLNSSD GN++NHIFAVEFDTV+DFEFGDINDNHVGIDINS++SNAS      
Sbjct: 117 LPSQYLGLLNSSDNGNISNHIFAVEFDTVQDFEFGDINDNHVGIDINSMQSNASA----- 171

Query: 181 LENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETM 240
             N +   L LKSG+ I AW+DYDS  N + V L+P+S KP++P+L+F+VDLSP+  + M
Sbjct: 172 --NVSLVGLTLKSGKPILAWVDYDSQLNLISVALSPNSSKPKTPLLTFNVDLSPVFHDIM 229

Query: 241 YVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFV 300
           YVGFS+STGLLASSHYILGWSF ++G A  L L SLP LP PK+K   LI+GV+VS F +
Sbjct: 230 YVGFSASTGLLASSHYILGWSFKINGPAPPLDLSSLPQLPQPKKKQTSLIIGVSVSVFVI 289

Query: 301 MFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVY 360
           + LAI++G Y  +KI+NADV+E+WEL++GPHR+SY+ELKKATRGF+DKELLG GGFGRVY
Sbjct: 290 VLLAISIGIYFYRKIKNADVIEAWELEIGPHRYSYQELKKATRGFKDKELLGQGGFGRVY 349

Query: 361 KGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD 420
           KGTLP++  QVAVKRVS+ESKQGLREF SEI+SIGRLRHRNLVQLLGWCRRRGDLLLVYD
Sbjct: 350 KGTLPNSKIQVAVKRVSHESKQGLREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLVYD 409

Query: 421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS 480
           FM NGSLDK LFDE K IL WE R++IIKGVAS LLYLHE +EQ VIHRD+KA NVLLD 
Sbjct: 410 FMANGSLDKYLFDEPKIILNWEHRFKIIKGVASALLYLHEGYEQVVIHRDVKASNVLLDF 469

Query: 481 ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           ELNGRLGDFGLA+LYE G NPSTTRVVGTLGYLAPEL RTGK TTSSDV+AFGALLLEV 
Sbjct: 470 ELNGRLGDFGLARLYEHGANPSTTRVVGTLGYLAPELPRTGKATTSSDVFAFGALLLEVA 529

Query: 541 CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSND 600
           CGRRPIEPKALPEEL+LVDWVW+++K G IL++VDP+LN  F+E E + V+KLGLMCSND
Sbjct: 530 CGRRPIEPKALPEELVLVDWVWEKYKQGRILDLVDPKLNVYFDEKEVIVVLKLGLMCSND 589

Query: 601 AAEARPTMRQVVRYLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNS 660
               RP+MRQVVRYL+GEV +P+ +  P    G      G         F++F++S  +S
Sbjct: 590 VPVTRPSMRQVVRYLDGEVEVPEDLKKP----GDISHHEG---------FDEFLHSLASS 636

Query: 661 SLLEKVSNWSSAGD 674
           S  +K+S+ S+ G+
Sbjct: 637 S-FDKMSSGSNFGN 649

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255584540|ref|XP_002532997.1| kinase, putative [Ricinus communis] gi|223527226|gb|EEF29389.1| kinase, putative [Ricinus communis]

 Score =  884 bits (2283), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 440/664 (66%), Positives = 528/664 (79%), Gaps = 11/664 (1%)

Query: 1   MAKKLKFFLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT 60
           MA   +F  VL +F++ PV  Q  E ++ GF+   +  N+SL G AEI+KNG + LTN T
Sbjct: 1   MAYVFRFVYVL-LFISIPVSCQLNELYYPGFKHV-DTVNISLTGVAEIQKNGIIRLTNET 58

Query: 61  LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGT 120
            R++G AFY+SP +FKNS+ N K+ SFST FA AI PEY  LGGHG AFTISASK+L G 
Sbjct: 59  SRLMGQAFYASPFQFKNSS-NGKAFSFSTSFALAIFPEYKKLGGHGLAFTISASKDLKG- 116

Query: 121 LPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYF 180
           LPSQYLGLLN+SDLGN TNH+ AVEFDTV+DFEFGDINDNHVGIDIN+L+SNAS  AAY+
Sbjct: 117 LPSQYLGLLNASDLGNFTNHLLAVEFDTVQDFEFGDINDNHVGIDINNLKSNASAAAAYY 176

Query: 181 LENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETM 240
           + +++KQ LNLK+G+ IQ WIDYDS +N L V ++P+S KPR PILSF +DLS I +E M
Sbjct: 177 INDTSKQDLNLKTGKPIQVWIDYDSIQNLLNVTISPTSEKPRLPILSFPIDLSQIFEEYM 236

Query: 241 YVGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLP-GPKEKHLGLIVGVTVSAFF 299
           YVGFS+STGLLASSHYILGWSF M G A++L L SLPSLP GPK KH GL + V V + F
Sbjct: 237 YVGFSASTGLLASSHYILGWSFKMDGQARALDLSSLPSLPRGPKTKHTGLTIAVIVPSVF 296

Query: 300 VMFLAIAVGC-YLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGR 358
           +  +A+++   Y+++KIRNADV+E WEL++GPHR+SY+ELKKAT+GF  KELLG GGFG+
Sbjct: 297 LAIIALSLAIFYVIRKIRNADVIEDWELEIGPHRYSYQELKKATKGFSGKELLGQGGFGQ 356

Query: 359 VYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV 418
           VYKG LP +  QVAVKR+SNES QGLREF SEI+S+GRLRHRNLVQLLGWCRRR D LLV
Sbjct: 357 VYKGILPDSKVQVAVKRISNESNQGLREFVSEIASVGRLRHRNLVQLLGWCRRRDDFLLV 416

Query: 419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL 478
           YD+M NGSLD  LFDE K IL WEQR++IIK VASGLLYLHE +EQ VIHRD+KA NVLL
Sbjct: 417 YDYMANGSLDNFLFDEPKIILNWEQRFKIIKDVASGLLYLHEGYEQVVIHRDVKASNVLL 476

Query: 479 DSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLE 538
           DSEL GRLGDFGLA+LYE G+NP TTRVVGTLGYLAPE+ RTGK T  SDVYAFGALLLE
Sbjct: 477 DSELTGRLGDFGLARLYEHGSNPGTTRVVGTLGYLAPEMPRTGKATACSDVYAFGALLLE 536

Query: 539 VVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCS 598
           V CGRRPIEPKA PEE++LVDWVW+ +K G +L+VVD RLNGE+NE E + V+ LGLMCS
Sbjct: 537 VACGRRPIEPKASPEEMVLVDWVWEMFKQGRVLDVVDSRLNGEYNEGEMMMVLTLGLMCS 596

Query: 599 NDAAEARPTMRQVVRYLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYP 658
           N+A  ARP+MRQVV+YL+GEV +P+ + AP          SGG  G+ G  F+D V S+ 
Sbjct: 597 NNAPMARPSMRQVVKYLDGEVGMPENLIAPHG----HGIGSGGAKGI-GEGFDDLVNSFA 651

Query: 659 NSSL 662
           +SS 
Sbjct: 652 SSSF 655

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523179|ref|XP_003530219.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  870 bits (2248), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/657 (66%), Positives = 526/657 (80%), Gaps = 24/657 (3%)

Query: 18  PVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKN 77
           PV  Q ++  +SGF+D   +N +++NG   IE+NG L LTN + R +GHAFY SP + KN
Sbjct: 17  PVSCQVDQVLYSGFKDVGASN-LTMNGVTTIERNGILKLTNESSRSIGHAFYPSPFQLKN 75

Query: 78  STRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNL 137
           ST + K+LSFS+ FAFAIVPEY  LGGHG AFTI+ SK+L   LP+QYLGLLNSSD GN 
Sbjct: 76  ST-SGKALSFSSSFAFAIVPEYPKLGGHGLAFTIATSKDLKA-LPNQYLGLLNSSDNGNF 133

Query: 138 TNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVI 197
           +NHIFAVEFDTV+DFEFGDINDNHVGIDINS++SN S        N +   L LKSG+ I
Sbjct: 134 SNHIFAVEFDTVQDFEFGDINDNHVGIDINSMQSNTSA-------NVSLVGLTLKSGKPI 186

Query: 198 QAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYI 257
            AW+DYDS  N + V L+P+S KP++P+L+F+VDLSP+  +TMYVGFS+STGLLASSHYI
Sbjct: 187 LAWVDYDSRLNLISVALSPNSSKPKTPLLTFNVDLSPVFHDTMYVGFSASTGLLASSHYI 246

Query: 258 LGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRN 317
           LGWSF ++G A  L L SLP LP PK+K   LI+GV+VS   ++ LAI++G Y  +KI+N
Sbjct: 247 LGWSFKINGPAPPLDLSSLPQLPKPKKKQTSLIIGVSVSVVVIVLLAISIGIYFYRKIKN 306

Query: 318 ADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS 377
           ADV+E+WEL++GPHR+SY+ELKKATRGF+DKELLG GGFGRVYKGTLP++  QVAVKRVS
Sbjct: 307 ADVIEAWELEIGPHRYSYQELKKATRGFKDKELLGQGGFGRVYKGTLPNSKIQVAVKRVS 366

Query: 378 NESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKA 437
           +ESKQGLREF SEI+SIGRLRHRNLVQLLGWCRR+GDLLLVYDFM NGSLDK LFDE K 
Sbjct: 367 HESKQGLREFVSEIASIGRLRHRNLVQLLGWCRRQGDLLLVYDFMANGSLDKYLFDEPKI 426

Query: 438 ILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER 497
           IL WE R++IIKGVAS L+YLHE +EQ VIHRD+KA NVLLD ELNGRLGDFGLA+LYE 
Sbjct: 427 ILNWEHRFKIIKGVASALMYLHEGYEQVVIHRDVKASNVLLDFELNGRLGDFGLARLYEH 486

Query: 498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELIL 557
           G NPSTTRVVGTLGYLAPEL RTGK TTSSDV+AFGALLLEVVCGRRPIEPKALPEE++L
Sbjct: 487 GANPSTTRVVGTLGYLAPELPRTGKATTSSDVFAFGALLLEVVCGRRPIEPKALPEEMVL 546

Query: 558 VDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG 617
           VDWVW+++K G IL+VVDP+LNG F+E E + V+KLGLMCSND   ARP+MRQVVRYL+G
Sbjct: 547 VDWVWEKYKQGRILDVVDPKLNGHFDEKEVMVVLKLGLMCSNDVPAARPSMRQVVRYLDG 606

Query: 618 EVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNSSLLEKVSNWSSAGD 674
           EV +P+ +  P A    +              FE+F++S  +SS  +K+S+ S+ G+
Sbjct: 607 EVEVPEDLKKPGAVSHHE-------------GFEEFLHSLASSS-FDKMSSGSNFGN 649

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356537938|ref|XP_003537463.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  862 bits (2226), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 427/622 (68%), Positives = 517/622 (83%), Gaps = 6/622 (0%)

Query: 10  VLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFY 69
           V+ I + N   SQQEEFFF+GF  AA++N ++LNG A IE  G L LTN T RV+GHAFY
Sbjct: 15  VMTIMVTNLAKSQQEEFFFNGFGGAASSN-ITLNGGAVIEHRGILRLTNDTQRVIGHAFY 73

Query: 70  SSPIKFKNSTRN-SKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGL 128
            +PI+FK+  +N +K  SFST FAFAI+P++  LGGHGFAFTIS S+ L    PSQYLGL
Sbjct: 74  PTPIQFKHRNKNATKVFSFSTAFAFAIIPQHPKLGGHGFAFTISRSRSLEDAYPSQYLGL 133

Query: 129 LNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV 188
           LN +D+GN +NH+FAVEFDTV+DFEFGDIN NHVGI++N+L SN S  AA+F   + KQ 
Sbjct: 134 LNPNDVGNFSNHLFAVEFDTVQDFEFGDINGNHVGINLNNLASNKSVEAAFFTSTNNKQK 193

Query: 189 LNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSST 248
           LNLKSGEV QAW+DYDS KN+LEVRL+ +S KP SPILS+ VDLS I++++MYVGFSSST
Sbjct: 194 LNLKSGEVTQAWVDYDSLKNNLEVRLSTTSSKPTSPILSYKVDLSQIIQDSMYVGFSSST 253

Query: 249 GLLASSHYILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFL-AIAV 307
           GLL+SSHYILGWSF ++GDAK+LSL +LPSL    +    LI  +++S      L A A+
Sbjct: 254 GLLSSSHYILGWSFKINGDAKTLSLKNLPSLSASSKPQKRLIFALSLSLIIPTVLAATAL 313

Query: 308 GCY--LVKKIRNADVLESWELD-VGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTL 364
            CY  L++K+RN++V+E+WE++ VGPHRF Y+EL KAT+GF+DK L+GFGGFGRVYKG L
Sbjct: 314 ACYYFLLRKMRNSEVIEAWEMEVVGPHRFPYKELHKATKGFKDKNLIGFGGFGRVYKGVL 373

Query: 365 PSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN 424
           P +N +VAVKRVSNESKQG++EF SEIS+IGRLRHRNLVQLLGWCR++ DLLLVYDFM N
Sbjct: 374 PKSNIEVAVKRVSNESKQGMQEFVSEISTIGRLRHRNLVQLLGWCRKQNDLLLVYDFMRN 433

Query: 425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG 484
           GSLDK LF++ K IL+WEQR++IIKGVASGL+YLHEEWEQTVIHRD+KAGNVLLD+++NG
Sbjct: 434 GSLDKYLFEQPKRILSWEQRFKIIKGVASGLVYLHEEWEQTVIHRDVKAGNVLLDNQMNG 493

Query: 485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRR 544
           RLGDFGLAKLYE G+NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGAL+LEV+CGRR
Sbjct: 494 RLGDFGLAKLYEHGSNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALVLEVLCGRR 553

Query: 545 PIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEA 604
           PIE KALPEEL+LV+WVW+RW+ G +L VVDPRL G F+E EAL VVK+GL CS +A E 
Sbjct: 554 PIEVKALPEELVLVEWVWERWRVGNVLAVVDPRLGGVFDEEEALLVVKVGLSCSAEAPEE 613

Query: 605 RPTMRQVVRYLEGEVPLPQAVA 626
           RP+MRQVVRYLE EV  P+ + 
Sbjct: 614 RPSMRQVVRYLEREVAPPEVLV 635

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356506714|ref|XP_003522121.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  852 bits (2200), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 418/658 (63%), Positives = 526/658 (79%), Gaps = 18/658 (2%)

Query: 8   FLVLFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHA 67
           FL L +FL  PV SQQ + F++GF+    +NNM+L+G AEIE NG L LTN + +V+GHA
Sbjct: 41  FLSLLVFLLIPVSSQQNQLFYAGFK-GLKSNNMTLDGVAEIEPNGVLKLTNDSSKVMGHA 99

Query: 68  FYSSPIKFKNSTRN-SKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYL 126
           FY +P +FKNS+   +K+ SFS+ FA AIVPE+  LGGHG AF I+ +KEL    PSQYL
Sbjct: 100 FYPTPFRFKNSSGGGNKAFSFSSSFALAIVPEFPKLGGHGLAFAIAPTKELKAH-PSQYL 158

Query: 127 GLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFL--ENS 184
           GLL+S+ +GN +NH+FAVEFDT KDFEFGDI+DNHVGIDINSL S AS  A Y+   E+S
Sbjct: 159 GLLDSTGIGNFSNHLFAVEFDTAKDFEFGDIDDNHVGIDINSLSSIASASAGYYSGDEDS 218

Query: 185 TKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGF 244
           TKQ + L+SG  I AW+DYD++++ + V ++ SS KP+ P+LS+ VDLSPI ++ MYVGF
Sbjct: 219 TKQNVTLQSGVPILAWVDYDAAQSVVHVTISASSTKPKRPLLSYHVDLSPIFEDLMYVGF 278

Query: 245 SSSTGLLASSHYILGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIVGVTVSAFFVMFLA 304
           S+STG+LASSHYILGWSF ++G A  L L SLP LPGPK+KH  LI+GV+ S  F++  A
Sbjct: 279 SASTGMLASSHYILGWSFKINGPALPLDLSSLPQLPGPKKKHTSLIIGVSASVVFLVLCA 338

Query: 305 IAVGCYLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTL 364
           + +G Y+ ++ +NADV+E+WEL++GPHR+SY+ELKKAT+GF+DK LLG GGFG VYKGTL
Sbjct: 339 VLLGIYMYRRYKNADVIEAWELEIGPHRYSYQELKKATKGFKDKGLLGQGGFGSVYKGTL 398

Query: 365 PSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN 424
           P++NTQVAVKR+S++S QGLREF SEI+SIGRLRHRNLVQLLGWCRRRGDLLLVYDFM N
Sbjct: 399 PNSNTQVAVKRISHDSNQGLREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLVYDFMEN 458

Query: 425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG 484
           GSLDK LFDE + +L+WEQR+++IK VAS LLYLHE +EQ VIHRD+KA NVLLD ELNG
Sbjct: 459 GSLDKYLFDEPEIVLSWEQRFKVIKDVASALLYLHEGYEQVVIHRDVKASNVLLDGELNG 518

Query: 485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRR 544
           RLGDFGLA+LYE GTNPSTTRVVGTLGYLAPE+ RTGK T SSDV+AFGALLLEV CG R
Sbjct: 519 RLGDFGLARLYEHGTNPSTTRVVGTLGYLAPEVPRTGKATPSSDVFAFGALLLEVACGLR 578

Query: 545 PIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEA 604
           P+EPKA+PE+++LVD VW+++K G+IL++VDP+LNG FNE E L V+KLGL+CSN +  A
Sbjct: 579 PLEPKAMPEDMVLVDCVWNKFKQGSILDLVDPKLNGVFNEREMLMVLKLGLLCSNSSPTA 638

Query: 605 RPTMRQVVRYLEGEVPLPQAVAAPDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNSSL 662
           RP+MRQVVR+LEGEV +P  +  P           G G   +G  F++F++S  +SS 
Sbjct: 639 RPSMRQVVRFLEGEVGVPDELKKP-----------GEGGYQEG--FDEFLHSLESSSF 683

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	687
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.925	0.929	0.615	5.1e-209
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.909	0.925	0.501	1.4e-160
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.890	0.903	0.507	9.6e-160
TAIR|locus:2119936	669	AT4G29050 [Arabidopsis thalian	0.838	0.860	0.503	6.9e-150
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.855	0.878	0.496	1.8e-149
TAIR|locus:2133229	674	LPK1 "lectin-like protein kina	0.847	0.863	0.493	1.5e-147
TAIR|locus:2020608	666	AT1G70110 [Arabidopsis thalian	0.889	0.917	0.461	1.5e-145
TAIR|locus:2168509	674	AT5G59260 [Arabidopsis thalian	0.841	0.857	0.507	1.4e-144
TAIR|locus:2097493	661	HLECRK "lectin-receptor kinase	0.835	0.868	0.490	3.5e-139
TAIR|locus:2043909	658	AT2G43700 [Arabidopsis thalian	0.847	0.884	0.467	6.7e-136

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 2021 (716.5 bits), Expect = 5.1e-209, P = 5.1e-209
 Identities = 401/652 (61%), Positives = 488/652 (74%)

Query:    30 GFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFST 89
             GF+ A+ N  ++LNG AEI   G + LT  T RV+GHAFYS PI+FK    N ++LSFST
Sbjct:    30 GFKKASPN--LTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRFKPIGVN-RALSFST 86

Query:    90 CFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTV 149
              FA A+VPE+  LGGHG AF I+ + +L G+LPSQY            ++H FAVEFDTV
Sbjct:    87 SFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLNSSRVNF-SSHFFAVEFDTV 145

Query:   150 KDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNH 209
             +D EF DINDNHVGIDINS+ S+ S PA YFL NSTK+ L L  G VIQAWIDYDS+K  
Sbjct:   146 RDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTKKELFLDGGRVIQAWIDYDSNKKR 205

Query:   210 LEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAK 269
             L+V+L+P S KP+  +LS+DVDLS ++ + MYVGFS+STGLLASSHYILGW+FNMSG+A 
Sbjct:   206 LDVKLSPFSEKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNFNMSGEAF 265

Query:   270 XXXXXXX----XXXXGPKEKHLGLIVGVTVSAFFVMF-LAIAVGCYLVKKIRNADVLESW 324
                              K+K   LI+GV++    ++F + +A   ++V+K+++ D +E W
Sbjct:   266 SLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAASLFVVRKVKDEDRVEEW 325

Query:   325 ELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL 384
             ELD GPHRFSY ELKKAT GF DKELLG GGFG+VYKG LP ++  VAVKR+S+ES+QG+
Sbjct:   326 ELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGV 385

Query:   385 REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ-KAILTWEQ 443
             REF SE+SSIG LRHRNLVQLLGWCRRR DLLLVYDFMPNGSLD  LFDE  + ILTW+Q
Sbjct:   386 REFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILTWKQ 445

Query:   444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
             R++IIKGVASGLLYLHE WEQTVIHRDIKA NVLLDSE+NGR+GDFGLAKLYE G++P  
Sbjct:   446 RFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGA 505

Query:   504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWD 563
             TRVVGT GYLAPELT++GK TTS+DVYAFGA+LLEV CGRRPIE  ALPEEL++VDWVW 
Sbjct:   506 TRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELVMVDWVWS 565

Query:   564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQ 623
             RW++G I +VVD RLNGEF+E E + V+KLGL+CSN++ E RPTMRQVV YLE + P P+
Sbjct:   566 RWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEKQFPSPE 625

Query:   624 AVAAPDACDGKKEKTSGGGAGVDGPEFEDFV-----YSYPNSSLLEKVSNWS 670
              V APD  D          +G  G EFEDFV     YS PN +    + ++S
Sbjct:   626 VVPAPDFLDANDSMCLDERSGSAG-EFEDFVDSARFYSGPNETTTSSIFSFS 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1564 (555.6 bits), Expect = 1.4e-160, P = 1.4e-160
 Identities = 322/642 (50%), Positives = 424/642 (66%)

Query:    39 NMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPE 98
             ++S+ G   +  NG L LTNTT++  GHAFY+ PI+FK+S   + S SFST F FAI  +
Sbjct:    38 DLSIQGITTVTPNGLLKLTNTTVQKTGHAFYTKPIRFKDSPNGTVS-SFSTSFVFAIHSQ 96

Query:    99 YTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEFGDIN 158
                L GHG AF ++ +  LP   PSQY            TNH+FAVE DT+   EF D N
Sbjct:    97 IAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNGNETNHVFAVELDTILSTEFNDTN 156

Query:   159 DNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAP-S 217
             DNHVGIDINSL+S  S PA Y+ E    + L L S + +Q W+DYD   N ++V +AP +
Sbjct:   157 DNHVGIDINSLKSVQSSPAGYWDEKGQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFN 216

Query:   218 SVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKXXXXXXXX 277
               KP  P+++   DLS ++ + MYVGFSS+TG + S HYILGWSF ++  A         
Sbjct:   217 EDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVLSEHYILGWSFGLNEKAPPLALSRLP 276

Query:   278 XXXGPKEKHLGLI--VGVTVSAFFVMFLAIAVGCYLVKKIRN-ADVLESWELDVGPHRFS 334
                  + K +     +G+ + + F++F  I + CY+V++ R  A+ LE WE + G +RF 
Sbjct:   277 KLPRFEPKRISEFYKIGMPLISLFLIFSFIFLVCYIVRRRRKFAEELEEWEKEFGKNRFR 336

Query:   335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSI 394
             +++L  AT+GF++K LLG GGFG VYKG +P T  ++AVKRVS+ES+QG++EF +EI SI
Sbjct:   337 FKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSI 396

Query:   395 GRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
             GR+ HRNLV LLG+CRRRG+LLLVYD+MPNGSLDK L++  +  L W+QR ++I GVASG
Sbjct:   397 GRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIKVILGVASG 456

Query:   455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
             L YLHEEWEQ VIHRD+KA NVLLD ELNGRLGDFGLA+LY+ G++P TT VVGTLGYLA
Sbjct:   457 LFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLA 516

Query:   515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE-PKALPEELILVDWVWDRWKAGAILEV 573
             PE TRTG+ T ++DV+AFGA LLEV CGRRPIE  +   E  +LVDWV+  W  G IL  
Sbjct:   517 PEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAA 576

Query:   574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPDACDG 633
              DP +  E +E E   V+KLGL+CS+    ARP+MRQV+ YL G+  LP+   +P    G
Sbjct:   577 KDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPEL--SPLDLSG 634

Query:   634 KKEKTSGGGAGV-DGPEFEDFVYSYPNSSLLEKVSNWSSAGD 674
                  SG   GV DG  F +   SY +SS+ +  +  SS  D
Sbjct:   635 -----SGMMFGVHDG--FSELGMSY-SSSVFKGFTGGSSIAD 668

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 1556 (552.8 bits), Expect = 9.6e-160, P = 9.6e-160
 Identities = 315/621 (50%), Positives = 422/621 (67%)

Query:    39 NMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPE 98
             ++SL G A +  NG L LTNT+++  GHAF +  I+FK+S +N    SFST F FAI  +
Sbjct:    38 DISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRFKDS-QNGNVSSFSTTFVFAIHSQ 96

Query:    99 YTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEFGDIN 158
                L GHG AF ++ +  LP  LPSQY            TNHIFAVEFDT++  EFGD N
Sbjct:    97 IPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNISNNGNDTNHIFAVEFDTIQSSEFGDPN 156

Query:   159 DNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAP-S 217
             DNHVGID+N LRS     A Y  ++   Q L+L S + IQ WIDYD+  + ++V +AP  
Sbjct:   157 DNHVGIDLNGLRSANYSTAGYRDDHDKFQNLSLISRKRIQVWIDYDNRSHRIDVTVAPFD 216

Query:   218 SVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKXXXXXXXX 277
             S KPR P++S+  DLS I+ E MYVGFSS+TG + S H+++GWSF ++G+A         
Sbjct:   217 SDKPRKPLVSYVRDLSSILLEDMYVGFSSATGSVLSEHFLVGWSFRLNGEAPMLSLSKLP 276

Query:   278 XXXGPKEKHLGLI--VGVTVSAFFVMFLAIAVGCYLVK-KIRNADVLESWELDVGPHRFS 334
                  + + +     +G+ + +  ++F  I +  Y+V+ K +  + L+ WE + G +RF 
Sbjct:   277 KLPRFEPRRISEFYKIGMPLISLSLIFSIIFLAFYIVRRKKKYEEELDDWETEFGKNRFR 336

Query:   335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSI 394
             ++EL  AT+GF++K+LLG GGFGRVY+G LP+T  +VAVKRVS++SKQG++EF +EI SI
Sbjct:   337 FKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSI 396

Query:   395 GRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
             GR+ HRNLV LLG+CRRRG+LLLVYD+MPNGSLDK L++  +  L W+QR  IIKGVASG
Sbjct:   397 GRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPETTLDWKQRSTIIKGVASG 456

Query:   455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
             L YLHEEWEQ VIHRD+KA NVLLD++ NGRLGDFGLA+LY+ G++P TT VVGTLGYLA
Sbjct:   457 LFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLA 516

Query:   515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE-PKALPEELILVDWVWDRWKAGAILEV 573
             PE +RTG+ TT++DVYAFGA LLEVV GRRPIE   A  +  +LV+WV+  W  G I+E 
Sbjct:   517 PEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEA 576

Query:   574 VDPRLNGEFNEIEALDVV-KLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPDACD 632
              DP+L     ++E +++V KLGL+CS+    ARP+MRQV++YL G++ LP+     D   
Sbjct:   577 KDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGDMALPELTPL-DLSA 635

Query:   633 GKKEKTSGGGAGVDGPEFEDF 653
             G      GG  G  G    DF
Sbjct:   636 GSVMNL-GGRDGFSGIAMTDF 655

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)]

 Score = 1463 (520.1 bits), Expect = 6.9e-150, P = 6.9e-150
 Identities = 297/590 (50%), Positives = 402/590 (68%)

Query:    43 NGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTAL 102
             +G A     G + LTN++    GH FY+SP++FKNS   + S SFST F FAIV    AL
Sbjct:    38 SGIAITNSKGLMKLTNSSEFSYGHVFYNSPVRFKNSPNGTVS-SFSTTFVFAIVSNVNAL 96

Query:   103 GGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEFGDINDNHV 162
              GHG AF IS +K LP +  SQY            +NHI AVEFDT ++ EF D+++NHV
Sbjct:    97 DGHGLAFVISPTKGLPYSSSSQYLGLFNLTNNGDPSNHIVAVEFDTFQNQEFDDMDNNHV 156

Query:   163 GIDINSLRSNASEPAAYFLENS-TKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSV-K 220
             GIDINSL S  +  A Y+ ++  T + + L + + IQAWI+YDSS+  L V + P  + K
Sbjct:   157 GIDINSLSSEKASTAGYYEDDDGTFKNIRLINQKPIQAWIEYDSSRRQLNVTIHPIHLPK 216

Query:   221 PRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKXXXXXXX---- 276
             P+ P+LS   DLSP + ++MYVGF+S+TG L SSHYILGW+F ++G A            
Sbjct:   217 PKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRSSHYILGWTFKLNGTASNIDISRLPKLP 276

Query:   277 -XXXXGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFSY 335
                     +K L + + +T  A  V FL I+   +L +K +  +VLE WE+  GPHRF+Y
Sbjct:   277 RDSRSTSVKKILAISLSLTSLAILV-FLTISYMLFLKRK-KLMEVLEDWEVQFGPHRFAY 334

Query:   336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIG 395
             ++L  AT+GFR+ ELLG GGFG+VYKGTL ++N  +AVK+VS++S+QG+REF +EI++IG
Sbjct:   335 KDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIG 394

Query:   396 RLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGL 455
             RLRH NLV+LLG+CRR+G+L LVYD MP GSLDK L+ + +  L W QR++IIK VASGL
Sbjct:   395 RLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQSLDWSQRFKIIKDVASGL 454

Query:   456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
              YLH +W Q +IHRDIK  NVLLD  +NG+LGDFGLAKL E G +P T+ V GT GY++P
Sbjct:   455 CYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISP 514

Query:   516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKAL-PEELILVDWVWDRWKAGAILEVV 574
             EL+RTGK +TSSDV+AFG L+LE+ CGRRP+ P+A  P E++L DWV D W+   IL+VV
Sbjct:   515 ELSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSPSEMVLTDWVLDCWEDD-ILQVV 573

Query:   575 DPRL--NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLP 622
             D R+  + ++ E +   V+KLGL CS+  A  RP+M  V+++L+G   LP
Sbjct:   574 DERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSSVIQFLDGVAQLP 623

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 1459 (518.7 bits), Expect = 1.8e-149, P = 1.8e-149
 Identities = 299/602 (49%), Positives = 399/602 (66%)

Query:    30 GFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFST 89
             GFR    +  +S+ G A I  NG L LTNTT++  GHAFY+ PI+FK+S   + S SFST
Sbjct:    32 GFRPPPTD--ISILGIATITPNGLLKLTNTTMQSTGHAFYTKPIRFKDSPNGTVS-SFST 88

Query:    90 CFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTV 149
              F FAI  +      HG AF I+ +  LP   P QY             NH+FAVE DT+
Sbjct:    89 TFVFAIHSQIPI--AHGMAFVIAPNPRLPFGSPLQYLGLFNVTNNGNVRNHVFAVELDTI 146

Query:   150 KDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNH 209
              + EF D N+NHVGIDINSL S  S PA Y+ EN     L L S + +Q W+D+D   + 
Sbjct:   147 MNIEFNDTNNNHVGIDINSLNSVKSSPAGYWDENDQFHNLTLISSKRMQVWVDFDGPTHL 206

Query:   210 LEVRLAP-SSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDA 268
             ++V +AP   VKPR P++S   DLS ++ + M+VGFSS+TG + S  ++LGWSF ++G+A
Sbjct:   207 IDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVGFSSATGNIVSEIFVLGWSFGVNGEA 266

Query:   269 KXXXXXXXXXX----XGPKEKHLGLIVGVT-VSAFFVMFLAIA-VGCYLVKKIRN-ADVL 321
             +                P   +      V  +S   + FL I  +  +++K+ R  A+ +
Sbjct:   267 QPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLIPFLLIIFLVRFIMKRRRKFAEEV 326

Query:   322 ESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK 381
             E WE + G +R  +++L  AT+GF+DK +LG GGFG VYKG +P T  ++AVKRVSNES+
Sbjct:   327 EDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIAVKRVSNESR 386

Query:   382 QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTW 441
             QGL+EF +EI SIG++ HRNLV L+G+CRRR +LLLVYD+MPNGSLDK L++  +  L W
Sbjct:   387 QGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPEVTLDW 446

Query:   442 EQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP 501
             +QR+++I GVAS L YLHEEWEQ VIHRD+KA NVLLD+ELNGRLGDFGLA+L + G++P
Sbjct:   447 KQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHGSDP 506

Query:   502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE-PKALPEELILVDW 560
              TTRVVGT GYLAP+  RTG+ TT++DV+AFG LLLEV CGRRPIE      E ++LVDW
Sbjct:   507 QTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGERVVLVDW 566

Query:   561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP 620
             V+  W    IL+  DP L  E+++ E   V+KLGL+CS+    ARPTMRQV++YL G+  
Sbjct:   567 VFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLRGDAM 626

Query:   621 LP 622
             LP
Sbjct:   627 LP 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1441 (512.3 bits), Expect = 1.5e-147, P = 1.5e-147
 Identities = 294/596 (49%), Positives = 391/596 (65%)

Query:    39 NMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPE 98
             N+S+ G A +  NG L LT+ T+   GHAFY+ PI+FK+S  ++ S SFST F   I   
Sbjct:    40 NISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKDSPNDTVS-SFSTTFVIGIYSG 98

Query:    99 YTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEFGDIN 158
                + GHG AF I+ +  L   + SQY            TNHI AVEFDT+ + EF D N
Sbjct:    99 IPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNNGNDTNHILAVEFDTIMNPEFDDTN 158

Query:   159 DNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAP-S 217
             DNHVGI+INSL S  S    Y+ E +    L L S + +Q W+DYD   N ++V +AP  
Sbjct:   159 DNHVGININSLTSVKSSLVGYWDEINQFNNLTLISRKRMQVWVDYDDRTNQIDVTMAPFG 218

Query:   218 SVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAK---XXXXX 274
              VKPR  ++S   DLS +  + MY+GFS++TG + S H++ GWSF + G           
Sbjct:   219 EVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLSEHFVFGWSFMVKGKTAPPLTLSKV 278

Query:   275 XXXXXXGPK------EKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRN-ADVLESWELD 327
                   GP       +  + L   + +   FV+ L   V  ++V++ R  A+  E WE +
Sbjct:   279 PKFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVSLIFLVR-FIVRRRRKFAEEFEDWETE 337

Query:   328 VGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF 387
              G +R  +++L  AT+GF+DK+LLG GGFGRVY+G +P+T  ++AVKRVSNES+QGL+EF
Sbjct:   338 FGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKRVSNESRQGLKEF 397

Query:   388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRI 447
              +EI SIGR+ HRNLV LLG+CRRR +LLLVYD+MPNGSLDK L+D  +  L W+QR+ +
Sbjct:   398 VAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPEVTLDWKQRFNV 457

Query:   448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
             I GVASGL YLHEEWEQ VIHRDIKA NVLLD+E NGRLGDFGLA+L + G++P TTRVV
Sbjct:   458 IIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVV 517

Query:   508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE-LILVDWVWDRWK 566
             GT GYLAP+  RTG+ TT++DV+AFG LLLEV CGRRPIE +   +E ++LVD V+  W 
Sbjct:   518 GTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVLLVDSVFGFWI 577

Query:   567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLP 622
              G IL+  DP L   +++ E   V+KLGL+CS+   + RPTMRQV++YL G+  LP
Sbjct:   578 EGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLRGDATLP 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009625 "response to insect" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1422 (505.6 bits), Expect = 1.5e-145, P = 1.5e-145
 Identities = 286/620 (46%), Positives = 403/620 (65%)

Query:    37 NNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV 96
             + NM  +G+A I  NG + LTN+T +  G  FY+  ++FKNS   + S SFST F F+I 
Sbjct:    31 SGNMYTSGSAYINNNGLIRLTNSTPQTTGQVFYNDQLRFKNSVNGTVS-SFSTTFVFSIE 89

Query:    97 PEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEFGD 156
                   GG+G AF I  +++L  T P+ Y             NHI AVE DT  D +F D
Sbjct:    90 FHNGIYGGYGIAFVICPTRDLSPTFPTTYLGLFNRSNMGDPKNHIVAVELDTKVDQQFED 149

Query:   157 INDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAP 216
              + NHVGIDIN+L S+    A Y+++N T + L L SG+ +Q WI+YDS +  + V L P
Sbjct:   150 KDANHVGIDINTLVSDTVALAGYYMDNGTFRSLLLNSGQPMQIWIEYDSKQKQINVTLHP 209

Query:   217 SSV-KPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSG---DAKXXX 272
               V KP+ P+LS + DLSP + E MYVGF+S+TG L +SHYILGW+F M+G   D     
Sbjct:   210 LYVPKPKIPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFKMNGTTPDIDPSR 269

Query:   273 XXXXXXXXGPK-EKHLGLI-VGVTVSAFFVMF-LAIAVGCYLVKKIRNADVLESWELDVG 329
                      P  +   G++ + +TVS   ++  L++++  +L +K +  +VLE WE+  G
Sbjct:   270 LPKIPRYNQPWIQSPNGILTISLTVSGVIILIILSLSLWLFLKRK-KLLEVLEDWEVQFG 328

Query:   330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS 389
             PHRF++++L  AT+GF+D E+LG GGFG+VYKGTLP +N ++AVK VS++S+QG+REF +
Sbjct:   329 PHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMREFIA 388

Query:   390 EISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIK 449
             EI++IGRLRH NLV+L G+CR +G+L LVYD M  GSLDK L+ +Q   L W QR++IIK
Sbjct:   389 EIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYHQQTGNLDWSQRFKIIK 448

Query:   450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT 509
              VASGL YLH++W Q +IHRDIK  N+LLD+ +N +LGDFGLAKL + GT+P T+ V GT
Sbjct:   449 DVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQTSHVAGT 508

Query:   510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA 569
             LGY++PEL+RTGK +T SDV+AFG ++LE+ CGR+PI P+A   E++L DWV + W+   
Sbjct:   509 LGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVLTDWVLECWENED 568

Query:   570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPD 629
             I++V+D ++  E+ E +A  V+KLGL CS+  A  RP M  V++ L+    LP  +    
Sbjct:   569 IMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQLLDSVAQLPHNLLDIV 628

Query:   630 ACDGKKEKTSGGGAGVDGPE 649
                     T   G   D PE
Sbjct:   629 QTREVHRGTEISGEAADSPE 648

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)]

 Score = 1413 (502.5 bits), Expect = 1.4e-144, P = 1.4e-144
 Identities = 306/603 (50%), Positives = 394/603 (65%)

Query:    37 NNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV 96
             N ++ L+G A    +G L LTN T    GHAFY+ PIKF  S+ +S   SFST F FAI 
Sbjct:    37 NADLELDGMANTN-HGPLHLTNNTNTGTGHAFYNIPIKFTASSLSS--FSFSTEFVFAIF 93

Query:    97 PEYTALGGHGFAFTISASKELP--GTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEF 154
             P   +  GHG AF +S +K+L   G+  S              T HIFAVE DT ++ E 
Sbjct:    94 PLQKSTYGHGMAFVVSPTKDLRSNGSANSNLGIFNRANDNKTAT-HIFAVELDTNQNSES 152

Query:   155 GDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQAWIDYDSSKNHLEVR 213
              D   N VGIDINS+ S  S  A+YF     K + L L SG+ I  WIDYD  +  L V 
Sbjct:   153 FDKGGNDVGIDINSIVSVESADASYFNARKGKNISLPLASGKSILVWIDYDGIEKVLNVT 212

Query:   214 LAP------------SSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWS 261
             LAP            S +KP+ P+LS  ++LS I  ETMYVGFS STG + S+ YILGWS
Sbjct:   213 LAPVQTPKPDSPYFSSFIKPKVPLLSRSINLSEIFTETMYVGFSGSTGSIKSNQYILGWS 272

Query:   262 FNMSGDAKXXXXXXXXXXX-GPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADV 320
             F   G A+             PK   L  ++G T+S   + FL +    YL KK + A+V
Sbjct:   273 FKQGGKAESLDISRLSNPPPSPKRFPLKEVLGATIST--IAFLTLGGIVYLYKKKKYAEV 330

Query:   321 LESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES 380
             LE WE +  P R+S+  L KAT+GFR+ +LLG GGFG+VYKG LPS  TQ+AVKRV +++
Sbjct:   331 LEQWEKEYSPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILPS-GTQIAVKRVYHDA 389

Query:   381 KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-L 439
             +QG++++ +EI+S+GRLRH+NLV LLG+CRR+G+LLLVYD+MPNGSLD  LF + K   L
Sbjct:   390 EQGMKQYVAEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLDDYLFHKNKLKDL 449

Query:   440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
             TW QR  IIKGVAS LLYLHEEWEQ V+HRDIKA N+LLD++LNG+LGDFGLA+ ++RG 
Sbjct:   450 TWSQRVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGKLGDFGLARFHDRGV 509

Query:   500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD 559
             N   TRVVGT+GY+APELT  G  TT +DVYAFGA +LEVVCGRRP++P A  E++ILV 
Sbjct:   510 NLEATRVVGTIGYMAPELTAMGVTTTCTDVYAFGAFILEVVCGRRPVDPDAPREQVILVK 569

Query:   560 WVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
             WV    K  A+ + VD +L  +F   EA  ++KLG++CS    E RP+MRQ+++YLEG V
Sbjct:   570 WVASCGKRDALTDTVDSKLI-DFKVEEAKLLLKLGMLCSQINPENRPSMRQILQYLEGNV 628

Query:   620 PLP 622
              +P
Sbjct:   629 SVP 631

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2097493 HLECRK "lectin-receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1362 (484.5 bits), Expect = 3.5e-139, P = 3.5e-139
 Identities = 290/591 (49%), Positives = 384/591 (64%)

Query:    44 GAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALG 103
             G+  I  NG   LTNTT    G AF +  ++ KNS+    S SFS  F FAIVPE+   G
Sbjct:    31 GSVGIGFNGYFTLTNTTKHTFGQAFENEHVEIKNSSTGVIS-SFSVNFFFAIVPEHNQQG 89

Query:   104 GHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEFGDINDNHVG 163
              HG  F IS ++ LPG    QY            +N++ A+E D  KD EFGDI+DNHVG
Sbjct:    90 SHGMTFVISPTRGLPGASSDQYLGIFNKTNNGKASNNVIAIELDIHKDEEFGDIDDNHVG 149

Query:   164 IDINSLRSNASEPAAYF--LENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSS--V 219
             I+IN LRS AS  A Y+   + S K+ L+L S EV++  I Y      L V L P+   V
Sbjct:   150 ININGLRSVASASAGYYDDKDGSFKK-LSLISREVMRLSIVYSQPDQQLNVTLFPAEIPV 208

Query:   220 KPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKXXXXXXXXXX 279
              P  P+LS + DLSP + E MY+GF++STG + + HY++GW  N   +            
Sbjct:   209 PPLKPLLSLNRDLSPYLLEKMYLGFTASTGSVGAIHYLMGWLVNGVIEYPRLELSIPVLP 268

Query:   280 XGPKEKH----LGLIVGVTVSAFFVMFLAIAVGC--YLV-KKIRNADVLESWELDVGPHR 332
               PK+        L V +TVS F   F+A  +G   YL  KK++  +VLE WE+  GPHR
Sbjct:   269 PYPKKTSNRTKTVLAVCLTVSVF-AAFVASWIGFVFYLRHKKVK--EVLEEWEIQYGPHR 325

Query:   333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEIS 392
             F+Y+EL  AT+GF++K+LLG GGFG+VYKGTLP ++ ++AVKR S++S+QG+ EF +EIS
Sbjct:   326 FAYKELFNATKGFKEKQLLGKGGFGQVYKGTLPGSDAEIAVKRTSHDSRQGMSEFLAEIS 385

Query:   393 SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF-DEQKAILTWEQRYRIIKGV 451
             +IGRLRH NLV+LLG+CR + +L LVYD+MPNGSLDK L   E +  LTWEQR+RIIK V
Sbjct:   386 TIGRLRHPNLVRLLGYCRHKENLYLVYDYMPNGSLDKYLNRSENQERLTWEQRFRIIKDV 445

Query:   452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG 511
             A+ LL+LH+EW Q +IHRDIK  NVL+D+E+N RLGDFGLAKLY++G +P T++V GT G
Sbjct:   446 ATALLHLHQEWVQVIIHRDIKPANVLIDNEMNARLGDFGLAKLYDQGFDPETSKVAGTFG 505

Query:   512 YLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL 571
             Y+APE  RTG+ TTS+DVYAFG ++LEVVCGRR IE +A   E  LVDW+ + W+ G I 
Sbjct:   506 YIAPEFLRTGRATTSTDVYAFGLVMLEVVCGRRIIERRAAENEEYLVDWILELWENGKIF 565

Query:   572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLP 622
             +  +  +  E N  +   V+KLG++CS+ AA  RP M  V+R L G   LP
Sbjct:   566 DAAEESIRQEQNRGQVELVLKLGVLCSHQAASIRPAMSVVMRILNGVSQLP 616

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0090333 "regulation of stomatal closure" evidence=IMP

GO:1900425 "negative regulation of defense response to bacterium" evidence=IMP

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

TAIR|locus:2043909 AT2G43700 [Arabidopsis thaliana (taxid:3702)]

 Score = 1331 (473.6 bits), Expect = 6.7e-136, P = 6.7e-136
 Identities = 278/595 (46%), Positives = 376/595 (63%)

Query:    36 NNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI 95
             +   + + G+A   K G   LT+T     G AF    + FKNS  N    SFS  F FAI
Sbjct:    23 SRGKLVMQGSAGFFK-GYRTLTSTKKHAYGQAFEDEIVPFKNSA-NDTVTSFSVTFFFAI 80

Query:    96 VPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEFG 155
              PE    G HG AF IS ++ + G    QY            +NH+ AVE D  KD EFG
Sbjct:    81 APEDKHKGAHGMAFVISPTRGITGASADQYLGIFNKANNGDSSNHVIAVELDINKDEEFG 140

Query:   156 DINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLA 215
             DINDNHVGI+IN +RS    PA Y+ +    + L+L SG +++  I Y   +  L V L+
Sbjct:   141 DINDNHVGININGMRSIKFAPAGYYDQEGQFKDLSLISGSLLRVTILYSQMEKQLNVTLS 200

Query:   216 -PSSVK-PRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKXXXX 273
              P     P  P+LS + DLSP + E MYVGFS+STG + + HY+L W  +   D      
Sbjct:   201 SPEEAYYPNKPLLSLNQDLSPYILENMYVGFSASTGSVRAMHYMLSWFVHGGVDVPNLDL 260

Query:   274 XXXXXXXGPKEKHLGLIVGVTVSAFFVMFLAI---AVGCYLVKKIRNA-DVLESWELDVG 329
                     PKEK L   + +  S   V+F+A+   A+  +  ++ +   +VLE WE+  G
Sbjct:   261 GIPTFPPYPKEKSLVYRIVLVTSLALVLFVALVASALSIFFYRRHKKVKEVLEEWEIQCG 320

Query:   330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS 389
             PHRF+Y+EL KAT+GF  K+LLG GGFG+V+KGTLP ++ ++AVKR+S++SKQG++EF +
Sbjct:   321 PHRFAYKELFKATKGF--KQLLGKGGFGQVFKGTLPGSDAEIAVKRISHDSKQGMQEFLA 378

Query:   390 EISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE-QKAILTWEQRYRII 448
             EIS+IGRLRH+NLV+L G+CR + +L LVYDFMPNGSLDK L+    +  LTW QR++II
Sbjct:   379 EISTIGRLRHQNLVRLQGYCRYKEELYLVYDFMPNGSLDKYLYHRANQEQLTWNQRFKII 438

Query:   449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG 508
             K +AS L YLH EW Q VIHRDIK  NVL+D ++N RLGDFGLAKLY++G +P T+RV G
Sbjct:   439 KDIASALCYLHHEWVQVVIHRDIKPANVLIDHQMNARLGDFGLAKLYDQGYDPQTSRVAG 498

Query:   509 TLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG 568
             T  Y+APEL R+G+ TT +DVYAFG  +LEV CGRR IE +   +E++L +W    W+ G
Sbjct:   499 TFWYIAPELIRSGRATTGTDVYAFGLFMLEVSCGRRLIERRTASDEVVLAEWTLKCWENG 558

Query:   569 AILEVVDPRLNGEFNEIEALDVV-KLGLMCSNDAAEARPTMRQVVRYLEGEVPLP 622
              ILE V+  +  E N  E L++V KLG++CS+ A   RP M +VV+ L G++ LP
Sbjct:   559 DILEAVNDGIRHEDNR-EQLELVLKLGVLCSHQAVAIRPDMSKVVQILGGDLQLP 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9M2S4	LRKS4_ARATH	2, ., 7, ., 1, 1, ., 1	0.6349	0.9417	0.9459	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00018441001 SubName- Full=Chromosome chr13 scaffold_17, whole genome shotgun sequence; (679 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	687
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	1e-101
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	1e-96
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-49
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-45
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-30
cd01951	223	cd01951, lectin_L-type, legume lectins	5e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-26
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-26
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-24
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-20
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-20
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-19
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-19
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-18
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.003

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score =  308 bits (791), Expect = e-101
 Identities = 123/245 (50%), Positives = 158/245 (64%), Gaps = 13/245 (5%)

Query: 25  EFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRV--LGHAFYSSPIKFKNSTRNS 82
            F F+GF    + +N++L G A I  NG L LTN T     +G A YS P++  +ST   
Sbjct: 2   SFNFNGFSS--DQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDST-TG 58

Query: 83  KSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIF 142
           K  SFST F+F+I P   +LGG G AF ++ +  LP      YLGL NSS+ GN +NHI 
Sbjct: 59  KVASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIV 118

Query: 143 AVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWID 202
           AVEFDT ++ EFGD +DNHVGID+NSL    S  A Y+ ++  K    LKSG+ +QAWID
Sbjct: 119 AVEFDTFQNPEFGDPDDNHVGIDVNSLV---SVKAGYWDDDGGK----LKSGKPMQAWID 171

Query: 203 YDSSKNHLEVRLAPSSV-KPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWS 261
           YDSS   L V LA S V KP+ P+LS+ VDLS ++ E +YVGFS+STGLL   HYIL WS
Sbjct: 172 YDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWS 231

Query: 262 FNMSG 266
           F+ +G
Sbjct: 232 FSSNG 236

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score =  297 bits (762), Expect = 1e-96
 Identities = 116/240 (48%), Positives = 147/240 (61%), Gaps = 13/240 (5%)

Query: 25  EFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKS 84
            F ++GF   +N +N++L G A +  NG L LTN T    G A YS PI+  +S+   K 
Sbjct: 4   SFNYNGF---SNVSNLTLQGDATVLPNGLLQLTNVTNNSAGRALYSKPIRLWDSS-TGKV 59

Query: 85  LSFSTCFAFAIVPE-YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFA 143
            SFST F FAI     +  GG G AF ++ S   PG     YLGL NSS+ GN +NHI A
Sbjct: 60  ASFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGNSSNHIVA 119

Query: 144 VEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDY 203
           VEFDT  + EF DI+DNHVGID+NS+ S ASE A       +   L+L SG+ IQ WIDY
Sbjct: 120 VEFDTFLNPEFNDIDDNHVGIDVNSIISVASESA-------SFVPLDLNSGKPIQVWIDY 172

Query: 204 DSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFN 263
           D S   L V LA  + KP+ P+LS  VDLS ++ E +YVGFS+STG    SHY+L WSF+
Sbjct: 173 DGSSKRLSVTLAYPN-KPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESHYVLSWSFS 231

Length = 231

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  187 bits (478), Expect = 9e-55
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 9/204 (4%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRNL 402
           +     LG G FG VYK     T   VAVK +   +E  +  +    EI  + RL H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V+L+     +  L LV ++   G L    +  +   L+ ++  +I   +  GL YLH   
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFD--YLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +IHRD+K  N+LLD     ++ DFGLAK     ++ S T  VGT  Y+APE+   G 
Sbjct: 119 ---IIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGN 174

Query: 523 P-TTSSDVYAFGALLLEVVCGRRP 545
                 DV++ G +L E++ G+ P
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  174 bits (443), Expect = 2e-50
 Identities = 84/231 (36%), Positives = 113/231 (48%), Gaps = 27/231 (11%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLGWC 409
           LG GGFG VY      T  +VA+K +  E    L E    EI  + +L H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHR 469
                L LV ++   GSL   L  E +  L+ ++  RI+  +  GL YLH      +IHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 470 DIKAGNVLLDSELNGR--LGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGKPTTS 526
           D+K  N+LLDS+ NG+  L DFGL+KL     +   T  VGT  Y+APE L   G  +  
Sbjct: 117 DLKPENILLDSD-NGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEK 174

Query: 527 SDVYAFGALLLEVVCGRRPIEPKALPE--ELILVDWVWD---RWKAGAILE 572
           SD+++ G +L E            LPE  +LI      D   R  A  ILE
Sbjct: 175 SDIWSLGVILYE------------LPELKDLIRKMLQKDPEKRPSAKEILE 213

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  171 bits (435), Expect = 9e-49
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 18/207 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLV 403
           +   E LG G FG+VY      T   VA+K +  +  +  RE    EI  + +L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYL 458
           +L         L LV ++   G L   L       E +A          ++ + S L YL
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-------FYLRQILSALEYL 113

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H    + ++HRD+K  N+LLD + + +L DFGLA+  + G   +T   VGT  Y+APE+ 
Sbjct: 114 HS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT--FVGTPEYMAPEVL 168

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                  + D+++ G +L E++ G+ P
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  164 bits (418), Expect = 3e-46
 Identities = 82/279 (29%), Positives = 125/279 (44%), Gaps = 35/279 (12%)

Query: 348 KELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNL 402
            + LG G FG VYKGTL         +VAVK +  + S+Q + EF  E   + +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V+LLG C     L++V ++MP G L   L   +   L+          +A G+ YL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT--NPSTTRVVGTLGYLAPELTRT 520
            +  IHRD+ A N L+   L  ++ DFGL++             ++   + ++APE  + 
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKE 178

Query: 521 GKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN 579
           GK T+ SDV++FG LL E+   G  P    +  E                +LE +     
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE----------------VLEYLK---K 219

Query: 580 GEFNEIEAL---DVVKLGLMCSNDAAEARPTMRQVVRYL 615
           G           ++ KL L C  +  E RPT  ++V  L
Sbjct: 220 GYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  161 bits (410), Expect = 5e-45
 Identities = 83/285 (29%), Positives = 131/285 (45%), Gaps = 40/285 (14%)

Query: 349 ELLGFGGFGRVYKGTL---PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLVQ 404
           + LG G FG VYKG L       T+VAVK +  + S++  ++F  E   + +L H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCL-------FDEQKAILTWEQRYRIIKGVASGLLY 457
           LLG C     L LV ++M  G L   L          +K+ L+ +        +A G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG-----Y 512
           L     +  +HRD+ A N L+  +L  ++ DFGL+    R           T G     +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLS----RDVYDDDYYRKKTGGKLPIRW 173

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAIL 571
           +APE  + G  T+ SDV++FG LL E+   G  P    +  EE++  +++    + G  L
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEVL--EYL----RKGYRL 226

Query: 572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
               P    +       ++ +L L C     E RPT  ++V  LE
Sbjct: 227 P--KPEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  158 bits (403), Expect = 3e-44
 Identities = 80/280 (28%), Positives = 122/280 (43%), Gaps = 38/280 (13%)

Query: 348 KELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNL 402
            + LG G FG VYKG L         +VAVK +  + S+Q + EF  E   + +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V+LLG C     L +V ++M  G L   L   +  + +          +A G+ YL    
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL-SLSDLLSFALQIARGMEYLE--- 119

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG---YLAPELTR 519
            +  IHRD+ A N L+   L  ++ DFGL++           R  G      ++APE  +
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD---DYYRKRGGKLPIRWMAPESLK 176

Query: 520 TGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL 578
            GK T+ SDV++FG LL E+   G +P         +   +          +LE +    
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQP------YPGMSNEE----------VLEYLK--- 217

Query: 579 NGEFNEIEAL---DVVKLGLMCSNDAAEARPTMRQVVRYL 615
           NG           ++  L L C  +  E RPT  ++V  L
Sbjct: 218 NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  157 bits (399), Expect = 1e-43
 Identities = 87/278 (31%), Positives = 130/278 (46%), Gaps = 35/278 (12%)

Query: 349 ELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLV 403
           + LG G FG VYKGTL      T T+VAVK +    S++   EF  E S + +L H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +LLG C +   L +V ++MP G L   L  +    LT +   ++   +A G+ YL     
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL-----APELT 518
           +  +HRD+ A N L+   L  ++ DFGL+    R             G L     APE  
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLS----RDIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 519 RTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR 577
           + GK T+ SDV++FG LL E+   G +P    +  E   +++ +    + G        R
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLELL----EDG-------YR 222

Query: 578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           L     E    ++ +L L C     E RPT  ++V  L
Sbjct: 223 L--PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (364), Expect = 1e-38
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           ELLG G FG VY      T   +AVK   +S +S++ L     EI  +  L+H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 407 GWCR-RRGDLLLVY-DFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLH 459
           G  R    + L ++ +++  GSL   L       E        ++Y   + +  GL YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKY--TRQILEGLAYLH 118

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLAPELT 518
                 ++HRDIK  N+L+DS+   +L DFG AK          T  V GT  ++APE+ 
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           R  +   ++D+++ G  ++E+  G+ P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  128 bits (325), Expect = 2e-33
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 6/201 (2%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           F   E +G GGFG VYK     T  +VA+K +  ESK+   +  +EI  + + +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             G   ++ +L +V +F   GSL   L       LT  Q   + K +  GL YLH     
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH---SN 117

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
            +IHRDIKA N+LL S+   +L DFGL+         +   +VGT  ++APE+       
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT--KARNTMVGTPYWMAPEVINGKPYD 175

Query: 525 TSSDVYAFGALLLEVVCGRRP 545
             +D+++ G   +E+  G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 2e-33
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQL 405
            +L+G G FG VYKG    T   VA+K++S E   ++ L+    EI  +  L+H N+V+ 
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           +G       L ++ ++  NGSL + +     F E          Y  +  V  GL YLHE
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-----VY--VYQVLQGLAYLHE 117

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
              Q VIHRDIKA N+L   +   +L DFG+A       +     VVGT  ++APE+   
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEM 173

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRP 545
              +T+SD+++ G  ++E++ G  P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 1e-31
 Identities = 73/199 (36%), Positives = 103/199 (51%), Gaps = 11/199 (5%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
              +G G FG V  G       +VAVK + ++S    + F +E S +  LRH NLVQLLG
Sbjct: 11  GATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
              +   L +V ++M  GSL   L    +A++T  Q+      V  G+ YL    E+  +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HRD+ A NVL+  +L  ++ DFGLAK   +G +     V  T    APE  R  K +T S
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKS 180

Query: 528 DVYAFGALLLEVVC-GRRP 545
           DV++FG LL E+   GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  120 bits (303), Expect = 1e-30
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 8/217 (3%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           F  +  LG G FG V++G L     +VA+K + ++     ++F  E+ ++ RLRH++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L   C     + ++ + M  GSL   L   +  +L       +   VA G+ YL    EQ
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQ 123

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLY-ERGTNPSTTRVVGTLGYLAPELTRTGKP 523
             IHRD+ A N+L+  +L  ++ DFGLA+L  E     S  ++     + APE    G  
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 524 TTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVD 559
           +T SDV++FG LL E+   G+ P       E    + 
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173886 cd01951, lectin_L-type, legume lectins

 Score =  117 bits (296), Expect = 5e-30
 Identities = 70/238 (29%), Positives = 90/238 (37%), Gaps = 19/238 (7%)

Query: 27  FFSGFRDAANNNNMSLNG-AAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSL 85
                    N +N  LNG A     +G L LT  T    G A+Y +PI            
Sbjct: 3   LNFSNFSNNNQSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLSKD------- 55

Query: 86  SFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVE 145
            F+T F F +       G  G AF +               G       G + N   AVE
Sbjct: 56  -FTTTFKFYL-GTKGTNGADGIAFVLQNDPAGALGGG----GGGGGLGYGGIGN-SVAVE 108

Query: 146 FDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDS 205
           FDT K+ +  D N NH+ ID+N    N +  A      S         G      I YD 
Sbjct: 109 FDTYKNDDNNDPNGNHISIDVN---GNGNNTALATSLGSASLPNGTGLGNEHTVRITYDP 165

Query: 206 SKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFN 263
           + N L V L   S    S  ++  VDL  +     Y GF++STG L + H IL WSF 
Sbjct: 166 TTNTLTVYLDNGS-TLTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFT 222

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  118 bits (298), Expect = 9e-30
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 12/215 (5%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFA-SEISSIGRLRHRNL 402
           +   + +G G FG+VY     S      +K +  +   +  RE A +E+  + +L H N+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIK---GVASGLLYLH 459
           ++       +G L +V ++   G L +    +QK         +I+     +   L YLH
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQ-KIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
               + ++HRDIK  N+ L S    +LGDFG++K+    T      VVGT  YL+PEL +
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYYLSPELCQ 176

Query: 520 TGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
             KP    SD+++ G +L E+   + P E + L E
Sbjct: 177 -NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (298), Expect = 4e-29
 Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 28/287 (9%)

Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS---NESKQGLREFASEISSIGRLRH- 399
            +R    LG G FG VY          VA+K ++       + +  F  EI  +  L H 
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLY 457
            N+V+L  + +  G L LV +++  GSL+  L  +  +K  L+  +   I+  + S L Y
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELN-GRLGDFGLAKLYERGTNPSTTR-----VVGTLG 511
           LH    + +IHRDIK  N+LLD +    +L DFGLAKL     + S+        VGT G
Sbjct: 117 LH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173

Query: 512 YLAPEL---TRTGKPTTSSDVYAFGALLLEVVCGRRPIE-PKALPEELILVDWVWDRWKA 567
           Y+APE+         ++SSD+++ G  L E++ G  P E  K        +  + +    
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL--- 230

Query: 568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY 614
                 +   L+    E+ +     L         + R +    + +
Sbjct: 231 --PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275

Length = 384

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 2e-28
 Identities = 69/205 (33%), Positives = 114/205 (55%), Gaps = 14/205 (6%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQ---VAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           +++G G FG V +G L     +   VA+K +   S    R +F +E S +G+  H N+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L G   +   ++++ ++M NGSLDK L  E     T  Q   +++G+ASG+ YL    E 
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYLS---EM 125

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG---TLGYLAPELTRTG 521
             +HRD+ A N+L++S L  ++ DFGL++  E      TT+  G    + + APE     
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--GGKIPIRWTAPEAIAYR 183

Query: 522 KPTTSSDVYAFGALLLEVVC-GRRP 545
           K T++SDV++FG ++ EV+  G RP
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 9e-28
 Identities = 69/208 (33%), Positives = 108/208 (51%), Gaps = 25/208 (12%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGL-REFASEISSIGRLRHRNLVQLLGW 408
           +G G +G+VYK     T   VA+K++  E+ K+G       EI  + +LRH N+V+L   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 409 C--RRRGDLLLVYDFMP---NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
              + +G + +V+++M     G     L D  +   T  Q    +K +  GL YLH    
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQYLHS--- 118

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE-RGTNPSTTRVVGTLGYLAPEL----T 518
             ++HRDIK  N+L++++   +L DFGLA+ Y  R +   T RV+ TL Y  PEL    T
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGAT 177

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           R G      D+++ G +L E+  G +PI
Sbjct: 178 RYG---PEVDMWSVGCILAELFLG-KPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (282), Expect = 1e-27
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 14/216 (6%)

Query: 351 LGFGGFGRVYKGTL--PSTNT--QVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQL 405
           LG G FG+V          NT  QVAVK +++   +Q   +F  EI  +  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 406 LGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            G C + G   L L+ +++P+GSL   L    +  +  ++       +  G+ YL     
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYLGS--- 127

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG--YLAPELTRTG 521
           Q  IHRD+ A N+L++SE   ++ DFGLAK+     +    +  G     + APE  RT 
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 522 KPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELI 556
           K +++SDV++FG  L E+   G     P A    +I
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI 223

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 1e-26
 Identities = 73/205 (35%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG---LREFASEISSIGRLRHRNLVQ 404
           +  LG G FG V+ GT   T T+VAVK +    K G      F  E   + +LRH  LVQ
Sbjct: 11  ERKLGAGQFGEVWMGTWNGT-TKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQ 65

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L   C     + +V ++M  GSL   L   +   L   Q   +   +A G+ YL     +
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---R 122

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT---LGYLAPELTRTG 521
             IHRD+ A N+L+   L  ++ DFGLA+L E   +  T R  G    + + APE    G
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIE--DDEYTAR-EGAKFPIKWTAPEAANYG 179

Query: 522 KPTTSSDVYAFGALLLEVVC-GRRP 545
           + T  SDV++FG LL E+V  GR P
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 1e-26
 Identities = 72/223 (32%), Positives = 107/223 (47%), Gaps = 20/223 (8%)

Query: 324 WELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG 383
           WE+D    R S + L+K          LG G FG V++G L +  T VAVK +   +   
Sbjct: 1   WEID----RTSIQLLRK----------LGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMD- 44

Query: 384 LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ 443
            ++F +E   + +LRH  L+QL   C     + +V + M  GSL + L       L   Q
Sbjct: 45  PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQ 104

Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
              +   VASG+ YL     Q  IHRD+ A NVL+      ++ DFGLA++ +     + 
Sbjct: 105 LIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161

Query: 504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
                 + + APE     + +  SDV++FG LL E+V  GR P
Sbjct: 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  108 bits (272), Expect = 2e-26
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 23/208 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVS-----NESKQGLREFASEISSIGRLRHRNLV 403
           ELLG G FG VY+G         AVK VS        ++ +++   EI+ + +L+H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYL 458
           Q LG  R   +L +  + +P GSL K L     F E    L   Q       +  GL YL
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-------ILLGLEYL 118

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-L 517
           H+   +  +HRDIK  N+L+D+    +L DFG+AK              G+  ++APE +
Sbjct: 119 HD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVI 173

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            + G    ++D+++ G  +LE+  G+ P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  107 bits (269), Expect = 5e-26
 Identities = 68/207 (32%), Positives = 119/207 (57%), Gaps = 13/207 (6%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQ---VAVKRV-SNESKQGLREFASEISSIGRLRHRNLV 403
           +E++G G FG V +G L     +   VA+K + S  +++  R+F SE S +G+  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            L G   +   ++++ +FM NG+LD  L  +     T  Q   +++G+A+G+ YL    E
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLS---E 124

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT-NPSTTRVVG---TLGYLAPELTR 519
              +HRD+ A N+L++S L  ++ DFGL++  E  T +P+ T  +G    + + APE   
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 520 TGKPTTSSDVYAFGALLLEVVC-GRRP 545
             K T++SDV+++G ++ EV+  G RP
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  106 bits (265), Expect = 2e-25
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 14/213 (6%)

Query: 347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           ++ +LG G +G VY     ST  ++A+K +     + ++    EI+    L+HRN+VQ L
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRII-KGVASGLLYLHEEWEQT 465
           G     G   +  + +P GSL   L  +   +   EQ      K +  GL YLH   +  
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQ 128

Query: 466 VIHRDIKAGNVLLDSELNG--RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           ++HRDIK  NVL+++  +G  ++ DFG +K    G NP T    GTL Y+APE+   G  
Sbjct: 129 IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 524 --TTSSDVYAFGALLLEVVCGRRPI----EPKA 550
                +D+++ G  ++E+  G+ P     EP+A
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQA 219

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (266), Expect = 2e-25
 Identities = 62/205 (30%), Positives = 107/205 (52%), Gaps = 14/205 (6%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNL 402
           +++ E +G G  G VYK T  +T  +VA+K  R+  ++K+ +    +EI  +   +H N+
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNI 77

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V          +L +V ++M  GSL   +  +    +   Q   + + V  GL YLH   
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGLEYLHS-- 134

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
            Q VIHRDIK+ N+LL  + + +L DFG  A+L +  +  ++  VVGT  ++APE+ +  
Sbjct: 135 -QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIK-R 190

Query: 522 KP-TTSSDVYAFGALLLEVVCGRRP 545
           K      D+++ G + +E+  G  P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  105 bits (263), Expect = 3e-25
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 6/205 (2%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRNL 402
           F     +G G FG V+K    +     A+K++  S  +++   E   E   + +L    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           ++       +G L +V ++  NG L K L  ++   L  +Q +R    +  GL +LH   
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-- 119

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + ++HRDIK+ N+ LD+  N ++GD G+AKL    TN + T +VGT  YL+PEL     
Sbjct: 120 -KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKP 177

Query: 523 PTTSSDVYAFGALLLEVVCGRRPIE 547
               SDV+A G +L E   G+ P +
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  104 bits (261), Expect = 7e-25
 Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 22/269 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLV 403
               ++LG G  G VYK     T    A+K++  +  ++  ++   E+ ++       +V
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY--RIIKGVASGLLYLHEE 461
           +  G   + G++ +V ++M  GSL     D  K +    +     I + +  GL YLH +
Sbjct: 63  KCYGAFYKEGEISIVLEYMDGGSLA----DLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
             + +IHRDIK  N+L++S+   ++ DFG++K+ E   +   T  VGT+ Y++PE  +  
Sbjct: 119 --RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERIQGE 175

Query: 522 KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE 581
             + ++D+++ G  LLE   G+ P  P   P    L+          AI +   P L  E
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---------AICDGPPPSLPAE 226

Query: 582 FNEIEALDVVKLGLMCSNDAAEARPTMRQ 610
               E  D +     C     + RP+  +
Sbjct: 227 EFSPEFRDFIS---ACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  103 bits (260), Expect = 9e-25
 Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           F   E LG G +G VYK     T   VA+K V  E    L+E   EIS + +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 405 LLGWCRRRGDLLLVYDFMPNGSL-------DKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
             G   +  DL +V ++   GS+       +K L +E+ A         I+     GL Y
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA--------ILYQTLKGLEY 114

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
           LH       IHRDIKAGN+LL+ E   +L DFG++      T      V+GT  ++APE+
Sbjct: 115 LHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT-DTMAKRNTVIGTPFWMAPEV 170

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            +       +D+++ G   +E+  G+ P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  104 bits (260), Expect = 1e-24
 Identities = 68/218 (31%), Positives = 114/218 (52%), Gaps = 34/218 (15%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRV----------SNESKQGLREFASEISSIGRLR 398
           EL+G G +GRVY     +T   +AVK+V           +  K  ++   SEI ++  L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVAS 453
           H N+VQ LG+      L +  +++P GS+  CL     F+EQ      EQ       V  
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ-------VLE 119

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK----LYERGTNPSTTRVVGT 509
           GL YLH    + ++HRD+KA N+L+D++   ++ DFG++K    +Y+   N     + G+
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD---NDQNMSMQGS 173

Query: 510 LGYLAPELTRTGKPTTSS--DVYAFGALLLEVVCGRRP 545
           + ++APE+  +     S+  D+++ G ++LE+  GRRP
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  103 bits (259), Expect = 1e-24
 Identities = 64/205 (31%), Positives = 115/205 (56%), Gaps = 11/205 (5%)

Query: 348 KELLGFGGFGRVYKGTLP---STNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLV 403
           ++++G G FG V++G L         VA+K +     +  R +F SE S +G+  H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L G   +    +++ ++M NG+LDK L D      ++ Q   +++G+A+G+ YL    +
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYLS---D 125

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG--YLAPELTRTG 521
              +HRD+ A N+L++S L  ++ DFGL+++ E     + T   G +   + APE     
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 522 KPTTSSDVYAFGALLLEVVC-GRRP 545
           K T++SDV++FG ++ EV+  G RP
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  102 bits (257), Expect = 2e-24
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 11/210 (5%)

Query: 352 GFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGW 408
           G G FG+V       T    A+K ++ +    K  +R   +E   +  L H  LV L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
            +   ++ LV D +  G L   L   QK   + EQ    I  +   L YLH    + +IH
Sbjct: 69  FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLALEYLHS---KGIIH 123

Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RDIK  N+LLD + +  + DF +A      T   TT   GT GY+APE+      + + D
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCRQGYSVAVD 181

Query: 529 VYAFGALLLEVVCGRRPIEPKAL-PEELIL 557
            ++ G    E + G+RP    +    + I 
Sbjct: 182 WWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  102 bits (256), Expect = 3e-24
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 7/208 (3%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V K     T   +AVK +  E  + ++ +   E+  + +     +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHR 469
              GD+ +  ++M  GSLDK L + Q  I       +I   V  GL YLHE+    +IHR
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPE-RILGKIAVAVLKGLTYLHEK--HKIIHR 125

Query: 470 DIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDV 529
           D+K  N+L++S    +L DFG++    +  N      VGT  Y+APE  +    +  SD+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDI 182

Query: 530 YAFGALLLEVVCGRRPIEPKALPEELIL 557
           ++ G  L+E+  GR P  P+  P + I 
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIF 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 4e-24
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 12/201 (5%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG+VYK     T    A K +  ES++ L +F  EI  +   +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               L ++ +F   G+LD  +  E +  LT  Q   + + +   L +LH      VIHRD
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128

Query: 471 IKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGYLAPEL--TRTGKPT--- 524
           +KAGN+LL  + + +L DFG+ AK         T   +GT  ++APE+    T K     
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186

Query: 525 TSSDVYAFGALLLEVVCGRRP 545
             +D+++ G  L+E+     P
Sbjct: 187 YKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (256), Expect = 4e-24
 Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 37/225 (16%)

Query: 348 KELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRN 401
           K  LG G FG+V+ G             VAVK +   +    R+ F  E   +   +H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL------------FDEQKAILTWEQRYRIIK 449
           +V+  G C      ++V+++M +G L+K L             D     LT  Q  +I  
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTT---R 505
            +ASG++YL     Q  +HRD+   N L+  +L  ++GDFG+++ +Y       TT   R
Sbjct: 130 QIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-------TTDYYR 179

Query: 506 VVGT----LGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           V G     + ++ PE     K TT SDV++FG +L E+   G++P
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 5e-24
 Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 42/283 (14%)

Query: 345 FRDKELLGFGGFGRVYKG--TLPSTNTQ--VAVKRVSNES-KQGLREFASEISSIGRLRH 399
               ++LG G FG VYKG         +  VA+K +  E+  +  +E   E   +  + H
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ-----KAILTWEQRYRIIKGVASG 454
            ++V+LLG C     + L+   MP G L   + + +     + +L W  +      +A G
Sbjct: 69  PHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKG 121

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG---TLG 511
           + YL E   + ++HRD+ A NVL+ +  + ++ DFGLAKL +           G    + 
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK--EYHAEGGKVPIK 176

Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAI 570
           ++A E       T  SDV+++G  + E++  G +P E     E       + D  + G  
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGER 229

Query: 571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
           L    P        I  +DV  + + C    AE+RPT ++++ 
Sbjct: 230 LP--QP-------PICTIDVYMVLVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 1e-23
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 31/213 (14%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQG-----LREFASEISSIGRLR 398
           +   E LG G +G VYK     T   VA+K++  +  ++G     LRE    IS +  L+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELK 56

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPN---GSLDKCLFD----EQKAILTWEQRYRIIKGV 451
           H N+V+LL        L LV+++        LDK          K+I+     Y++++G+
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIM-----YQLLRGL 111

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG 511
           A    Y H      ++HRD+K  N+L++ +   +L DFGLA+ +       T  VV TL 
Sbjct: 112 A----YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLW 163

Query: 512 YLAPE-LTRTGKPTTSSDVYAFGALLLEVVCGR 543
           Y APE L  +   +T+ D+++ G +  E++ G+
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 59/192 (30%), Positives = 96/192 (50%), Gaps = 4/192 (2%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C R     ++ +FM  G+L   L +  +  +       +   ++S + YL    ++  I
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HRD+ A N L+      ++ DFGL++L    T  +       + + APE     K +  S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 528 DVYAFGALLLEV 539
           DV+AFG LL E+
Sbjct: 187 DVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (251), Expect = 1e-23
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 17/205 (8%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G FG+VY      T   +AVK  R+ +   + ++E A E+  +  L+H NLV+  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              R  + +  ++   G+L++ L  E   IL           +  GL YLH      ++H
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHS---HGIVH 122

Query: 469 RDIKAGNVLLDSELNG--RLGDFGLAKLYERGTNPSTTRV---VGTLGYLAPELTRTGKP 523
           RDIK  N+ LD   NG  +LGDFG A   +  T      V    GT  Y+APE+   GK 
Sbjct: 123 RDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 524 T---TSSDVYAFGALLLEVVCGRRP 545
                ++D+++ G ++LE+  G+RP
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  100 bits (250), Expect = 2e-23
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 25/212 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVS------NESKQGLREFASEISSIGRLRHRNL 402
           + LG G F   Y+     T T +AVK+V+      +E ++ +     EI  + RL H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE---QKAILTWEQRYRIIKGVASGLLYLH 459
           +++LG         L  ++M  GS+   L      ++A++         + +  GL YLH
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLH 120

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLA-KLYERGTNPS--TTRVVGTLGYL 513
           E     +IHRD+K  N+L+DS   G   R+ DFG A +L  +GT       +++GT+ ++
Sbjct: 121 E---NQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           APE+ R  +   S DV++ G +++E+   + P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 76/256 (29%), Positives = 120/256 (46%), Gaps = 35/256 (13%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           E +G G FG VYKG L   NT+VAVK   +     L+  F  E   + +  H N+V+L+G
Sbjct: 1   EKIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C ++  + +V + +P GSL   L  ++K  LT ++  ++    A+G+ YL     +  I
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCI 115

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERG--TNPSTTRVVGTLGYLAPELTRTGKPTT 525
           HRD+ A N L+      ++ DFG+++  E G  T     + +  + + APE    G+ T+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIKWTAPEALNYGRYTS 174

Query: 526 SSDVYAFGALLLEVVCG-------------RRPIE-------PKALPEE---LILVDWVW 562
            SDV+++G LL E                 R  IE       P+  PEE   L+L  W +
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY 234

Query: 563 D---RWKAGAILEVVD 575
           D   R     I   + 
Sbjct: 235 DPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 98.5 bits (245), Expect = 5e-23
 Identities = 72/218 (33%), Positives = 113/218 (51%), Gaps = 17/218 (7%)

Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR 396
            L+K T G    E++G G FG V +G    T  +VAVK +  +     + F  E + + +
Sbjct: 4   NLQKLTLG----EIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTA--QAFLEETAVMTK 55

Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           L H+NLV+LLG     G L +V + M  G+L   L    +A+++  Q  +    VA G+ 
Sbjct: 56  LHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YL     + ++HRD+ A N+L+  +   ++ DFGLA++   G + S   V  T    APE
Sbjct: 115 YLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APE 167

Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPE 553
             +  K ++ SDV+++G LL EV   GR P    +L E
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  104 bits (260), Expect = 5e-23
 Identities = 85/335 (25%), Positives = 155/335 (46%), Gaps = 30/335 (8%)

Query: 295 VSAFFVMFLAIAVGCYLVKKIRNADVLE---------SWELDVGPHRFSYE-ELKKATRG 344
           ++     FL +A+  +    IR  + LE         +WEL     + S    +      
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSS 691

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
            +++ ++  G  G  YKG       Q  VK +++ +        SEI+ +G+L+H N+V+
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVK 747

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L+G CR      L+++++   +L + L +     L+WE+R +I  G+A  L +LH     
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
            V+  ++    +++D +    L      +L   G   + T+   +  Y+APE TR  K  
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPE-TRETKDI 855

Query: 525 TS-SDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP--RLNGE 581
           T  SD+Y FG +L+E++ G+ P + +      I V+W    +    +   +DP  R +  
Sbjct: 856 TEKSDIYGFGLILIELLTGKSPADAEFGVHGSI-VEWARYCYSDCHLDMWIDPSIRGDVS 914

Query: 582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
            N+ E ++V+ L L C+     ARP    V++ LE
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 98.8 bits (247), Expect = 7e-23
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 46/233 (19%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-------NESKQGLREFASEISSIGRL 397
           F+  +++G G F  V       TN + A+K +         + K    E       + RL
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV----LTRL 58

Query: 398 -RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGV 451
             H  +++L    +   +L  V ++ PNG L + +      DE+        R+     +
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT------RF-YAAEI 111

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV----- 506
              L YLH    + +IHRD+K  N+LLD +++ ++ DFG AK+ +  ++P + +      
Sbjct: 112 LLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 507 --------------VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
                         VGT  Y++PEL        SSD++A G ++ +++ G+ P
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 34/213 (15%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVS------NESKQGLREFASEISSIGRLRHRNLVQ 404
           +G G +G VYK     T   VA+K++          K  LRE    I  +  L H N+++
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE----IKLLKELNHPNIIK 62

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ--------KAILTWEQRYRIIKGVASGLL 456
           LL   R +GDL LV++FM +  L K + D Q        K+ L     Y++++G+A    
Sbjct: 63  LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYL-----YQLLQGLA---- 112

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      ++HRD+K  N+L+++E   +L DFGLA+ +        T  V T  Y APE
Sbjct: 113 FCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPE 168

Query: 517 -LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
            L      +T  D+++ G +  E++  RRP+ P
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELL-SRRPLFP 200

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 15/201 (7%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSI-GRLRHRNLVQLLG 407
           LG G FG+V       T    A+K  +     K+   E      +I  R+ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 408 WC--RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L LV ++ P G L   L   ++   + E+R R     +   L YLH     
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFS-EERARFYAAEIVLALEYLHS---L 112

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
            +I+RD+K  N+LLD++ + +L DFGLAK         T    GT  YLAPE+       
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFCGTPEYLAPEVLLGKGYG 171

Query: 525 TSSDVYAFGALLLEVVCGRRP 545
            + D ++ G LL E++ G+ P
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 96.2 bits (239), Expect = 3e-22
 Identities = 63/191 (32%), Positives = 101/191 (52%), Gaps = 6/191 (3%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLG 407
           ELLG G FG V+KGTL    T VAVK    +  Q L+ +F SE   + +  H N+V+L+G
Sbjct: 1   ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C +R  + +V + +P G     L  ++K  L  +Q  +     A+G+ YL     +  I
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLES---KNCI 115

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HRD+ A N L+      ++ DFG+++  + G   S+      + + APE    G+ ++ S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 528 DVYAFGALLLE 538
           DV+++G LL E
Sbjct: 176 DVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 96.9 bits (241), Expect = 3e-22
 Identities = 68/206 (33%), Positives = 113/206 (54%), Gaps = 13/206 (6%)

Query: 348 KELLGFGGFGRVYKG--TLPST-NTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNL 402
           ++++G G FG V  G   LP      VA+K  +     KQ  R+F SE S +G+  H N+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNI 67

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L G   +   +++V ++M NGSLD  L  +     T  Q   +++G+ASG+ YL    
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGIASGMKYLS--- 123

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG--YLAPELTRT 520
           +   +HRD+ A N+L++S L  ++ DFGL+++ E     + T   G +   + APE    
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 521 GKPTTSSDVYAFGALLLEVVC-GRRP 545
            K T++SDV+++G ++ EV+  G RP
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 71/224 (31%), Positives = 111/224 (49%), Gaps = 31/224 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV-----SNESKQGLREFASEISSIGRLRH 399
           +R  +LLG G FGRVY      T  ++AVK+V     S E+K+ +     EI  +  L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVAS 453
             +VQ  G  R    L +  ++MP GS+     D+ KA       +T +   +I++GV  
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTRKYTRQILEGVE- 118

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK----LYERGTNPSTTRVVGT 509
              YLH      ++HRDIK  N+L DS  N +LGDFG +K    +   GT   +  V GT
Sbjct: 119 ---YLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGT 170

Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP---IEPKA 550
             +++PE+         +DV++ G  ++E++  + P    E  A
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 96.5 bits (240), Expect = 5e-22
 Identities = 74/232 (31%), Positives = 107/232 (46%), Gaps = 32/232 (13%)

Query: 343 RGFRDKELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRL 397
           R  +   +LG G FG+V    Y      T   VAVK +  E  Q     +  EI+ +  L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63

Query: 398 RHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGL 455
            H N+V+  G C  +G   L L+ +++P GSL   L    K  L   Q     + +  G+
Sbjct: 64  YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGM 120

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LY----ERGTNPSTTR 505
            YLH    Q  IHRD+ A NVLLD++   ++GDFGLAK       Y    E G +P    
Sbjct: 121 AYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP---- 173

Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP-IEPKALPEELI 556
               + + A E  +  K + +SDV++FG  L E++        P    EE+I
Sbjct: 174 ----VFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 95.5 bits (238), Expect = 6e-22
 Identities = 75/278 (26%), Positives = 115/278 (41%), Gaps = 34/278 (12%)

Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           + LG G FG V +G   ++      VAVK + ++     + +F  E + +  L H NL++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L G       L++V +  P GSL   L  +                +A+G+ YL     +
Sbjct: 61  LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---K 116

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTT--RVVGTLGYLAPELTRTG 521
             IHRD+ A N+LL S+   ++GDFGL + L +   +        V    + APE  RT 
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTR 175

Query: 522 KPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP---R 577
             + +SDV+ FG  L E+   G  P                W       IL+ +D    R
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP----------------WAGLSGSQILKKIDKEGER 219

Query: 578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           L  E  E    D+  + L C       RPT   +  +L
Sbjct: 220 L--ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 14/201 (6%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
            ++G G +G V K    +T   VA+K  + S + +   +    E+  + +LRH N+V L 
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
              RR+G L LV++++    L+  L +     L  +     I  +   + Y H      +
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHS---HNI 121

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL----TRTGK 522
           IHRDIK  N+L+      +L DFG A+          T  V T  Y APEL    T  GK
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181

Query: 523 PTTSSDVYAFGALLLEVVCGR 543
           P    DV+A G ++ E++ G 
Sbjct: 182 PV---DVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 95.1 bits (237), Expect = 7e-22
 Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 351 LGFGGFGRVYKGTLPSTNTQ---VAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V KG     + +   VAVK +  E    G +EF  E S + +L H  +V+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQ----KAILTWEQRYRIIKGVASGLLYLHEEW 462
           G C+    L+LV +  P G L K L   +      +     +      VA G+ YL    
Sbjct: 63  GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES-- 113

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRT 520
            +  +HRD+ A NVLL +    ++ DFG+++    G++       G   L + APE    
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 521 GKPTTSSDVYAFGALLLEVVC-GRRP 545
           GK ++ SDV+++G  L E    G +P
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 76/268 (28%), Positives = 122/268 (45%), Gaps = 27/268 (10%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ G        VA+K +  E      +F  E   + +L H NLVQL G C 
Sbjct: 12  LGSGQFGVVHLGKWRG-KIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           ++  + +V ++M NG L   L  E+K  L  E    +   V   + YL        IHRD
Sbjct: 70  KQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 471 IKAGNVLLDSELNGRLGDFGLAK--LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           + A N L+  +   ++ DFGLA+  L ++ T+   T+    + +  PE+    + ++ SD
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSRFSSKSD 183

Query: 529 VYAFGALLLEV-VCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEA 587
           V++FG L+ EV   G+ P E  +  E       V +   AG  L    P+L       E 
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAGYRLY--RPKLAPT----EV 230

Query: 588 LDVVKLGLMCSNDAAEARPTMRQVVRYL 615
             ++     C ++  E RP  ++++  L
Sbjct: 231 YTIMYS---CWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 26/222 (11%)

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLREFAS 389
           YE L          E +G G FG V K    S    +  K      ++ + KQ L    S
Sbjct: 2   YEVL----------ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VS 48

Query: 390 EISSIGRLRHRNLVQLLGWC--RRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQRY 445
           E++ +  L+H N+V+       R    L +V ++   G L + +    +++  +  E  +
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108

Query: 446 RIIKGVASGLLYLH--EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
           RI+  +   L   H   +   TV+HRD+K  N+ LD+  N +LGDFGLAK+    ++ + 
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           T  VGT  Y++PE          SD+++ G L+ E +C   P
Sbjct: 169 T-YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE-LCALSP 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)

Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+ N S +   EF +E S +      ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLD----KCLFDEQKA----ILTWEQRYRIIKGVASGLL 456
           LLG        L+V + M  G L         + +        T ++  ++   +A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL     +  +HRD+ A N ++  +L  ++GDFG+ + +YE        + +  + ++AP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVV 540
           E  + G  TT SDV++FG +L E+ 
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 24/212 (11%)

Query: 349 ELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNL 402
           E LG G FG+VYKG L       + T VA+K +   ++  ++ EF  E   +  L+H N+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLF--------------DEQKAILTWEQRYRII 448
           V LLG C +     ++++++ +G L + L               +  K+ L       I 
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL-YERGTNPSTTRVV 507
             +A+G+ YL        +HRD+ A N L+   L  ++ DFGL++  Y        ++ +
Sbjct: 131 IQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
             + ++ PE    GK TT SD+++FG +L E+
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 7/204 (3%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG V+ G       +VA+K +  E      +F  E   + +L H  LVQL G C 
Sbjct: 12  IGSGQFGLVWLGYW-LEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
            R  + LV++FM +G L   L   Q+   + E    +   V  G+ YL       VIHRD
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L+      ++ DFG+ +        S+T     + + +PE+    K ++ SDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 531 AFGALLLEVVC-GRRPIEPKALPE 553
           +FG L+ EV   G+ P E ++  E
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSE 209

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 36/215 (16%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRLRHRNLVQ 404
           +G G +G VY+    ++   VA+K+V  ++++       LRE    I+ +  LRH N+V+
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLRHPNIVE 70

Query: 405 LL----GWCRRRGDLLLVYDFMPNGSLDKC------LFDEQKAILTWEQRYRIIKGVASG 454
           L     G  +    + LV ++        C      L D      +  Q   ++  +  G
Sbjct: 71  LKEVVVG--KHLDSIFLVMEY--------CEQDLASLLDNMPTPFSESQVKCLMLQLLRG 120

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           L YLHE +   +IHRD+K  N+LL  +   ++ DFGLA+ Y     P T +VV TL Y A
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRA 176

Query: 515 PE-LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
           PE L      TT+ D++A G +L E++   +P+ P
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLP 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 75/241 (31%), Positives = 110/241 (45%), Gaps = 47/241 (19%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQG-----LREF 387
            YE L K          LG G FG VYK     T   VA+K++   + K G     LRE 
Sbjct: 9   DYEILGK----------LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE- 57

Query: 388 ASEISSIGRLRHRNLVQLL--------GWCRRRGDLLLVYDFMPNGSLDKC-LFDEQKAI 438
              I  + +L+H N+V L+           R+RG + +V  +M +   D   L +     
Sbjct: 58  ---IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH---DLSGLLENPSVK 111

Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE-- 496
           LT  Q    +  +  G+ YLHE     ++HRDIKA N+L+D++   ++ DFGLA+ Y+  
Sbjct: 112 LTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Query: 497 -----RGTNPST---TRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIE 547
                 G    T   T +V T  Y  PEL    +  TT+ D++  G +  E+   RRPI 
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF-TRRPIL 227

Query: 548 P 548
            
Sbjct: 228 Q 228

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 66/196 (33%), Positives = 96/196 (48%), Gaps = 7/196 (3%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT  + NT+VAVK +          F  E   + +LRH  LVQL     
Sbjct: 14  LGNGQFGEVWMGTW-NGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L D +   L       +   VA+G+ Y+        IHRD
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           +++ N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+V  GR P
Sbjct: 188 SFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 20/208 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLV 403
           F   E +G G FG VYK     TN  VA+K +   E++  + +   EI  + + R   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 404 QLLGWCRRRGDLLLVYDFMPNGS----LDKCLFDEQK-AILTWEQRYRIIKGVASGLLYL 458
           +  G   +   L ++ ++   GS    L     DE   A         I++ V  GL YL
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF--------ILREVLLGLEYL 114

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPEL 517
           HE   +  IHRDIKA N+LL  E + +L DFG++ +L    +  +T   VGT  ++APE+
Sbjct: 115 HE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEV 169

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            +       +D+++ G   +E+  G  P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.0 bits (228), Expect = 9e-21
 Identities = 77/266 (28%), Positives = 114/266 (42%), Gaps = 21/266 (7%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 14  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 531 AFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDV 590
           +FG LL E+    R   P  +  E      V D+ + G  +    P      ++      
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMP-CPPECPESLHD------ 234

Query: 591 VKLGLMCSNDAAEARPTMRQVVRYLE 616
             L   C     E RPT   +  +LE
Sbjct: 235 --LMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 80/279 (28%), Positives = 131/279 (46%), Gaps = 35/279 (12%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRV----SNE--SKQGLREFASEISSIGRLRHRNL 402
           E+LG G +G VY G L +    +AVK+V    SN   +++   +   E+  +  L+H N+
Sbjct: 6   EVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           VQ LG C     + +  +F+P GS+   L  F      +  +   +I+ GVA    YLH 
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLH- 119

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVV----GTLGYLAP 515
                V+HRDIK  NV+L      +L DFG A +L   G + + + ++    GT  ++AP
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD 575
           E+         SD+++ G  + E+  G+ P         L  +D +   +  GA   ++ 
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPP---------LASMDRLAAMFYIGAHRGLM- 227

Query: 576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY 614
           PRL   F+   A+D V     C       RP+  Q++R+
Sbjct: 228 PRLPDSFSA-AAIDFVT---SCLTRDQHERPSALQLLRH 262

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 60/193 (31%), Positives = 89/193 (46%), Gaps = 12/193 (6%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G +G VYK    +T   VA+K +  E          EIS +   RH N+V   G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           RR  L +V ++   GSL   ++   +  L+  Q   + +    GL YLH   E   IHRD
Sbjct: 71  RRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRD 126

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELT---RTGKPTT 525
           IK  N+LL  + + +L DFG++      T     R   +GT  ++APE+    R G    
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAPEVAAVERKGGYDG 183

Query: 526 SSDVYAFGALLLE 538
             D++A G   +E
Sbjct: 184 KCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 81/275 (29%), Positives = 126/275 (45%), Gaps = 39/275 (14%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG- 407
           + +G G FG V  G       +VAVK + N++    + F +E S + +LRH NLVQLLG 
Sbjct: 12  QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
               +G L +V ++M  GSL   L    +++L  +   +    V   + YL        +
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFV 124

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HRD+ A NVL+  +   ++ DFGL K  E  +   T ++   + + APE  R  K +T S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKS 180

Query: 528 DVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIE 586
           DV++FG LL E+   GR P     L +                    V PR+   + +++
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKD--------------------VVPRVEKGY-KMD 219

Query: 587 ALD-----VVKLGLMCSNDAAEARPTMRQVVRYLE 616
           A D     V  +   C +  A  RP+  Q+   LE
Sbjct: 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 35/226 (15%)

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQG-----LREFA 388
           YEEL            +G G +G VYK    +T   VA+K+V    S++G     LRE A
Sbjct: 1   YEEL----------AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA 50

Query: 389 SEISSIGRLRHRNLVQLL----GWCRRRG-DLLLVYDFMP---NGSLDKCLFDEQKAILT 440
             +  +    H N+V+LL    G    R   L LV++ +       L KC     K  L 
Sbjct: 51  L-LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC----PKPGLP 105

Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN 500
            E    +++ +  G+ +LH      ++HRD+K  N+L+ S+   ++ DFGLA++Y     
Sbjct: 106 PETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF--E 160

Query: 501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
            + T VV TL Y APE+       T  D+++ G +  E+   RRP+
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPL 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 23/210 (10%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLG 407
           E++G G    VY       N +VA+KR+  E  Q  + E   E+ ++ +  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 408 WCRRRGDLLLVYDFMPNGSL--------DKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
                 +L LV  ++  GSL         +   DE   I T      ++K V  GL YLH
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDE-AIIAT------VLKEVLKGLEYLH 119

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTR--VVGTLGYLAPE 516
                  IHRDIKAGN+LL  + + ++ DFG+ A L + G      R   VGT  ++APE
Sbjct: 120 S---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 517 LTRTGKPTTS-SDVYAFGALLLEVVCGRRP 545
           +          +D+++FG   +E+  G  P
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 18/212 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV-----SNESKQGLREFASEISSIGRLRH 399
           +R  +LLG G FGRVY      T  ++A K+V     S E+ + +     EI  +  L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 400 RNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKA--ILTWEQRYRIIKGVASGL 455
             +VQ  G  R R +  L +  ++MP GS+     D+ KA   LT     +  + +  G+
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGM 119

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST--TRVVGTLGYL 513
            YLH      ++HRDIK  N+L DS  N +LGDFG +K  +      T    V GT  ++
Sbjct: 120 SYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +PE+         +DV++ G  ++E++  + P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 32/209 (15%)

Query: 349 ELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           + LG G FG V    Y     +T   VAVK++ + + + LR+F  EI  +  L+H N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 405 LLGWCRRRG--DLLLVYDFMPNGSLDKCL------FDEQKAILTWEQRYRIIKGVASGLL 456
             G C   G  +L LV +++P GSL   L       D +K +L   Q   I KG+     
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ---ICKGME---- 122

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL------YERGTNPSTTRVVGTL 510
           YL     +  +HRD+   N+L++SE   ++GDFGL K+      Y +   P  + +    
Sbjct: 123 YLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF--- 176

Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEV 539
            + APE     K + +SDV++FG +L E+
Sbjct: 177 -WYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.7 bits (225), Expect = 3e-20
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 13/209 (6%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE---FASEISSIGRLRHRNLVQL 405
           + LG G FG V+ G   + +T+VA+K +    KQG      F +E + + +L+H  LV+L
Sbjct: 12  KKLGAGQFGEVWMG-YYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRL 66

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
                +   + ++ ++M NGSL   L   +   LT  +   +   +A G+ ++     + 
Sbjct: 67  YAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KN 122

Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTT 525
            IHRD++A N+L+   L  ++ DFGLA+L E     +       + + APE    G  T 
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 526 SSDVYAFGALLLEVVC-GRRPIEPKALPE 553
            SDV++FG LL E+V  GR P      PE
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPE 211

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 44/204 (21%)

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFA-SEI 391
           YE+L K          +G G FG V+K     T   VA+K+V   NE K+G    A  EI
Sbjct: 14  YEKLAK----------IGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREI 62

Query: 392 SSIGRLRHRNLVQLLGWCRR--------RGDLLLVYDFMPNGSLDKC------LFDEQKA 437
             +  L+H N+V L+  CR         +G   LV++F        C      L   +  
Sbjct: 63  KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF--------CEHDLAGLLSNKNV 114

Query: 438 ILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER 497
             T  +  +++K + +GL Y+H      ++HRD+KA N+L+  +   +L DFGLA+ +  
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSL 171

Query: 498 GTNPS----TTRVVGTLGYLAPEL 517
             N      T RVV TL Y  PEL
Sbjct: 172 SKNSKPNRYTNRVV-TLWYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 17/208 (8%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE---FAS--EISSIGRLRHRNLV 403
           + LG G +  VYK     T   VA+K++    ++  ++   F +  EI  +  L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            LL     + ++ LV++FM    L+K +  ++  +LT       +     GL YLH  W 
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEK-VIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW- 122

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL---TRT 520
             ++HRD+K  N+L+ S+   +L DFGLA+ +       T +VV T  Y APEL    R 
Sbjct: 123 --ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGAR- 178

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEP 548
                  D+++ G +  E +  R P  P
Sbjct: 179 -HYGVGVDMWSVGCIFAE-LLLRVPFLP 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 7e-20
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 26/209 (12%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS--------EISSIGRL-RHRN 401
           LG G FG VY      T   VA+K++        ++F S        E+ S+ +L  H N
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR-IIKGVASGLLYLHE 460
           +V+L    R   +L  V+++M  G+L + L  ++K     E   R II  +  GL ++H+
Sbjct: 60  IVKLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTR 519
                  HRD+K  N+L+      ++ DFGLA+  E  + P  T  V T  Y APE L R
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLR 172

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
           +   ++  D++A G ++ E+    RP+ P
Sbjct: 173 STSYSSPVDIWALGCIMAELYTL-RPLFP 200

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 89.8 bits (223), Expect = 8e-20
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKR-VSNESKQGLREFA-SEISSIGRLRHRNLVQLL 406
            L+G G +G V K     T   VA+K+ + +E  + +++ A  EI  + +LRH NLV L+
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI--LTWEQRYRIIKGVASGLLYLHEEWEQ 464
              RR+  L LV++F+ +  LD    D +K    L   +  + +  +  G+ + H     
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCH---SH 119

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL----TRT 520
            +IHRDIK  N+L+      +L DFG A+          T  V T  Y APEL    T+ 
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKY 178

Query: 521 GKPTTSSDVYAFGALLLEVVCG 542
           G+     D++A G L+ E++ G
Sbjct: 179 GRAV---DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 22/214 (10%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV-----SNESKQGLREFASEISSIGRLRH 399
           +R  +LLG G FG VY      T  ++AVK+V     S E+ + +     EI  +  LRH
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 400 RNLVQLLGWCR--RRGDLLLVYDFMPNGSLDKCLFDEQKA--ILTWEQRYRIIKGVASGL 455
             +VQ  G  R      L +  ++MP GS+     D+ KA   LT     R  + +  G+
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQGV 119

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK----LYERGTNPSTTRVVGTLG 511
            YLH      ++HRDIK  N+L DS  N +LGDFG +K    +   GT   +  V GT  
Sbjct: 120 SYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPY 174

Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +++PE+         +DV++    ++E++  + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 22/205 (10%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLG 407
           LG GGFG V    + +T    A K++  +    ++G +   +E   + ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 408 WCRRRGDLLLVYDFMPNGSL-------DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
               + DL LV   M  G L        +  F E +AI    Q       +  GL +LH+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-------IICGLEHLHQ 113

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
                +++RD+K  NVLLD   N R+ D GLA   + G         GT GY+APE+ + 
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--KGRAGTPGYMAPEVLQG 168

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRP 545
                S D +A G  L E++ GR P
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 351 LGFGGFGR--VYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG   +Y+ T    ++ V  K V  +  S++  R+  +EI  +  L+H N++   
Sbjct: 8   LGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 407 GWCRRRGDLLLVYDFMPNGSL-------DKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
                   LL+  ++   G+L          LF+E+  +    Q       + S + Y+H
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-------IVSAVSYIH 118

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
           +     ++HRDIK  N+ L      +LGDFG++K+     + + T VVGT  Y++PEL +
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQ 174

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
             K    SD++A G +L E++  +R  +      
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG+VYK     T    A K +  +S++ L ++  EI  +    H N+V+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
              +L ++ +F   G++D  + + ++  LT  Q   + K     L YLH   E  +IHRD
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYLH---ENKIIHRD 128

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL----TRTGKPTT- 525
           +KAGN+L   + + +L DFG++    R T       +GT  ++APE+    T   +P   
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187

Query: 526 SSDVYAFGALLLEVVCGRRPIEP 548
            +DV++ G  L+E+      IEP
Sbjct: 188 KADVWSLGITLIEMA----QIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 20/219 (9%)

Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRN 401
            F+  + LG G +G VYK    S N   A+K V   + S++   +  +EI  +  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 402 LVQ-----LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKA--ILTWEQRYRIIKGVASG 454
           ++      L G  +    L +V ++ P G L K +   +K   ++  ++ +RI   +  G
Sbjct: 61  IISYKEAFLDG-NK----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           L  LHE   Q ++HRD+K+ N+LL +    ++GD G++K+            +GT  Y+A
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMA 169

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           PE+ +    +  SD+++ G LL E+     P E +++ +
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 27/215 (12%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES-----KQGLREFASEISSIGRLRHRNLVQL 405
           LG G  G V K  L +T    A+K ++ +      KQ LRE     S     +   +V+ 
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC----KSPYIVKY 64

Query: 406 LGWC--RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY------RIIKGVASGLLY 457
            G         + +  ++   GSLD       K +     R       +I + V  GL Y
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIY----KKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
           LH    + +IHRDIK  N+LL  +   +L DFG++   E   + + T   GT  Y+APE 
Sbjct: 121 LHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGT-FTGTSFYMAPER 174

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP 552
            +    + +SDV++ G  LLEV   R P  P+  P
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 27/213 (12%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQV--AVKRVSN-ESKQGLREFASEISSIGRL-RHRNLV 403
           ++++G G FG+V K  +     ++  A+KR+    SK   R+FA E+  + +L  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCL-------FDEQKAI-------LTWEQRYRIIK 449
            LLG C  RG L L  ++ P+G+L   L        D   AI       L+ +Q      
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT 509
            VA G+ YL    ++  IHRD+ A N+L+      ++ DFGL+    RG      + +G 
Sbjct: 132 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGR 184

Query: 510 LG--YLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           L   ++A E       TT+SDV+++G LL E+V
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 67/213 (31%), Positives = 110/213 (51%), Gaps = 27/213 (12%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFA-SEISSIGRLRHRNLVQL--- 405
           +G G +G+VYK     T   VA+K+V  ++ K+G    A  EI  + +L HRN+V L   
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74

Query: 406 -------LGWCRRRGDLLLVYDFMPN---GSLDKCLFDEQKAILTWEQRYRIIKGVASGL 455
                  L + + +G   LV+++M +   G L+  L    +     +     +K +  GL
Sbjct: 75  VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE-----DHIKSFMKQLLEGL 129

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLA 514
            Y H+   +  +HRDIK  N+LL+++   +L DFGLA+LY    + P T +V+ TL Y  
Sbjct: 130 NYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRP 185

Query: 515 PELTRTGKPTTSS-DVYAFGALLLEVVCGRRPI 546
           PEL    +    + DV++ G +L E+   ++PI
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 28/207 (13%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVS-------NESKQGLREFASEISSIGRLRHRNLV 403
           LG GGFGRV    + S N   A+K V         + +    E   EI       H  +V
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSE--KEILEE--CNHPFIV 56

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
           +L    + +  + ++ ++   G L     D+ LFDE  A      R+  I  V     YL
Sbjct: 57  KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA------RF-YIACVVLAFEYL 109

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H    + +I+RD+K  N+LLDS    +L DFG AK  + G    T    GT  Y+APE+ 
Sbjct: 110 HN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEII 164

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                  S D ++ G LL E++ GR P
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG+VYK     T    A K +  +S++ L ++  EI  +    H  +V+LLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
             G L ++ +F P G++D  + +  +  LT  Q   I + +   L YLH      +IHRD
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLH---SMKIIHRD 135

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE--LTRTGKPTT--- 525
           +KAGNVLL  + + +L DFG++    + T       +GT  ++APE  +  T K T    
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVK-TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194

Query: 526 SSDVYAFGALLLEVVCGRRPIEP 548
            +D+++ G  L+E+      IEP
Sbjct: 195 KADIWSLGITLIEMA----QIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 19/210 (9%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---------KQGLREFASEISSIGRLRHR 400
           L+G G FG VY G   S+   +AVK+V   S         +  L   A EI+ +  L+H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           N+VQ LG       L +  +++P GS+   L +   A      R   ++ +  GL YLH 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVR-NFVRQILKGLNYLHN 124

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER-----GTNPSTTRVVGTLGYLAP 515
              + +IHRDIK  N+L+D++   ++ DFG++K  E       TN +   + G++ ++AP
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           E+ +    T  +D+++ G L++E++ G+ P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 87.2 bits (216), Expect = 7e-19
 Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 34/215 (15%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLV 403
           F+  E LG G +  VYKG   +T   VA+K +  ++++G    A  EIS +  L+H N+V
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 404 QLLGWCRRRGDLLLVYDFMPN------------GSLDKCLFDEQKAILTWEQRYRIIKGV 451
           +L         L+LV+++M              G+LD                Y+++KG+
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALD--------PNTVKSFTYQLLKGI 113

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG 511
           A    + HE     V+HRD+K  N+L++     +L DFGLA+ +    N  +  VV TL 
Sbjct: 114 A----FCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLW 165

Query: 512 YLAPEL---TRTGKPTTSSDVYAFGALLLEVVCGR 543
           Y AP++   +RT   +TS D+++ G ++ E++ GR
Sbjct: 166 YRAPDVLLGSRT--YSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 351 LGFGGFGRVYKGT---LPSTNT--QVAVK-RVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G            QVAVK    + S+Q   +F  E   + +  H+N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
           L+G    R    ++ + M  G L   L +     E+ + LT +      + VA G  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK------LYERGTNPSTTRVVGTL 510
              E   IHRDI A N LL  +  GR   + DFG+A+       Y +G      R +  +
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG-----GRAMLPI 185

Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEV 539
            ++ PE    G  T+ +DV++FG LL E+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 27/213 (12%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQV--AVKRVSN-ESKQGLREFASEISSIGRL-RHRNLV 403
           ++++G G FG+V +  +     ++  A+K +    S+   R+FA E+  + +L  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSL------------DKCLFDEQ--KAILTWEQRYRIIK 449
            LLG C  RG L +  ++ P G+L            D     E    + LT +Q  +   
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT 509
            VA+G+ YL E   +  IHRD+ A NVL+   L  ++ DFGL+    RG      + +G 
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYVKKTMGR 179

Query: 510 LG--YLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           L   ++A E       TT SDV++FG LL E+V
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 79/302 (26%), Positives = 127/302 (42%), Gaps = 64/302 (21%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQ-----VAVKRV-SNESKQGLREFASEIS---SIGRLRH 399
           + LG G FG+V K      +       VAVK +  + +++ L +  SE+     IG+  H
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 75

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSL----------------DKCLFDEQKAILTWEQ 443
           +N++ LLG C + G L +V ++  +G+L                D     E+   LT + 
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET--LTQKD 133

Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYER 497
                  VA G+ +L     +  IHRD+ A NVL+  +   ++ DFGLA+       Y +
Sbjct: 134 LVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 498 GTNPSTTRVVGTLGY--LAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEE 554
            TN       G L    +APE       T  SDV++FG LL E+   G  P     + E 
Sbjct: 191 TTN-------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242

Query: 555 LILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY 614
                 ++   K G     ++   N         ++  L   C ++    RPT +Q+V  
Sbjct: 243 ------LFKLLKEG---YRMEKPQNC------TQELYHLMRDCWHEVPSQRPTFKQLVED 287

Query: 615 LE 616
           L+
Sbjct: 288 LD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 22/214 (10%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV-----SNESKQGLREFASEISSIGRLRH 399
           +R  +LLG G FGRVY      T  ++AVK+V     S E+ + +     EI  +  L H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 400 RNLVQLLGWCR--RRGDLLLVYDFMPNGSLDKCLFDEQKA--ILTWEQRYRIIKGVASGL 455
             +VQ  G  R      L +  + MP GS+     D+ K+   LT     +  + +  G+
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEGV 119

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE----RGTNPSTTRVVGTLG 511
            YLH      ++HRDIK  N+L DS  N +LGDFG +K  +     GT   +  V GT  
Sbjct: 120 SYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPY 174

Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +++PE+         +D+++ G  ++E++  + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 72/222 (32%), Positives = 104/222 (46%), Gaps = 36/222 (16%)

Query: 350 LLGFGGFGRVYKGTL-----PSTNTQ-VAVKRVSNESK-QGLREFASEISSIGRLRHRNL 402
            LG G FG VY+GT      P +    VAVK +   +  Q  +EF  E   +    H N+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQK-----AILTWEQRYRIIKGVASGLLY 457
           V+LLG C       ++ + M  G L   L D +       +LT ++   I   VA G +Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 458 LHEEWEQT-VIHRDIKAGNVLLDSELNGR-----LGDFGLAK-LYE------RGTNPSTT 504
           L    EQ   IHRD+ A N L+  +         +GDFGLA+ +Y+       G      
Sbjct: 122 L----EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           R      ++APE    GK TT SDV++FG L+ E++  G++P
Sbjct: 178 R------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG------LREFASEISSIGRLRHRNLVQ 404
           +G G  G V+K     T   VA+K+V+    +G      LRE    I ++   +H  +V+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVK 63

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           LL         +LV ++MP   L + L DE++  L   Q    ++ +  G+ Y+H     
Sbjct: 64  LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMHAN--- 118

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP- 523
            ++HRD+K  N+L+ ++   ++ DFGLA+L+        +  V T  Y APEL   G   
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL-YGARK 177

Query: 524 -TTSSDVYAFGALLLEVVCGR 543
                D++A G +  E++ G 
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 27/212 (12%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQV--AVKRVSN-ESKQGLREFASEISSIGRL-RHRNLVQ 404
           +++G G FG+V K  +     ++  A+KR+    SK   R+FA E+  + +L  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 405 LLGWCRRRGDLLLVYDFMPNGSL------------DKCLFDEQ--KAILTWEQRYRIIKG 450
           LLG C  RG L L  ++ P+G+L            D          + L+ +Q       
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL 510
           VA G+ YL +   +  IHRD+ A N+L+      ++ DFGL+    RG      + +G L
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRL 173

Query: 511 G--YLAPELTRTGKPTTSSDVYAFGALLLEVV 540
              ++A E       TT+SDV+++G LL E+V
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 70/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ G   + +T+VAVK +   +   ++ F  E + +  L+H  LV+L     
Sbjct: 14  LGAGQFGEVWMGYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           +   + ++ ++M  GSL   L  ++   +   +       +A G+ Y+     +  IHRD
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRD 128

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A NVL+   L  ++ DFGLA++ E     +       + + APE    G  T  SDV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 531 AFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALD 589
           +FG LL E+V  G+ P    +  + +  +   +             PR+  E    E  D
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-----------PRM--ENCPDELYD 235

Query: 590 VVKLGLMCSNDAAEARPT 607
           ++K    C  + AE RPT
Sbjct: 236 IMK---TCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 18/209 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-LREFASEISSIGRLRH---R 400
           ++  EL+G G +G VY+G    T   VA+K ++ ++    + +   E++ + +LR     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 401 NLVQLLGWCRRRG-DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR--IIKGVASGLLY 457
           N+ +  G    +G  L ++ ++   GS+ + L           ++Y   II+ V   L Y
Sbjct: 63  NITKYYG-SYLKGPRLWIIMEYAEGGSV-RTLMKAGPI----AEKYISVIIREVLVALKY 116

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
           +H+     VIHRDIKA N+L+ +  N +L DFG+A L  + ++  +T  VGT  ++APE+
Sbjct: 117 IHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEV 172

Query: 518 TRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
              GK   T +D+++ G  + E+  G  P
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 17/207 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL---REFASEISSIGRLRHRN 401
           F D   +G G FG VY      TN  VA+K++S   KQ     ++   E+  + +LRH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
            ++  G   R     LV ++    + D  + +  K  L   +   I  G   GL YLH  
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIAAICHGALQGLAYLHS- 133

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT- 520
                IHRDIKAGN+LL      +L DFG A L     +P+ +  VGT  ++APE+    
Sbjct: 134 --HERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS-FVGTPYWMAPEVILAM 186

Query: 521 --GKPTTSSDVYAFGALLLEVVCGRRP 545
             G+     DV++ G   +E+   R+P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELA-ERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 35/231 (15%)

Query: 345 FRDKELLGFGGFGRV----------YKGTLPSTNTQ----VAVKRV-SNESKQGLREFAS 389
            R KE LG G FG V          + G            VAVK + ++ +K    +F  
Sbjct: 7   LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK 66

Query: 390 EISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI----------- 438
           EI  + RL++ N+++LLG C     L ++ ++M NG L++  F  Q+ I           
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ--FLSQREIESTFTHANNIP 124

Query: 439 -LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYE 496
            ++      +   +ASG+ YL        +HRD+   N L+ +    ++ DFG+++ LY 
Sbjct: 125 SVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV--VCGRRP 545
                   R V  + ++A E    GK TT+SDV+AFG  L E+  +C  +P
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 23/266 (8%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ G   +   +VA+K + NE      +F  E   + +L H  LVQL G C 
Sbjct: 12  LGSGQFGVVHLGKWRAQ-IKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           ++  L +V +FM NG L   L  +++  L+ +    + + V  G+ YL      + IHRD
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRD 125

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L+ S    ++ DFG+ +        S++     + +  PE+    K ++ SDV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185

Query: 531 AFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALD 589
           +FG L+ EV   G+ P E K+  E + ++         G  L    P+L        ++ 
Sbjct: 186 SFGVLMWEVFTEGKMPFEKKSNYEVVEMI-------SRGFRL--YRPKL-------ASMT 229

Query: 590 VVKLGLMCSNDAAEARPTMRQVVRYL 615
           V ++   C ++  E RPT  +++R +
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 85.3 bits (212), Expect = 5e-18
 Identities = 69/226 (30%), Positives = 109/226 (48%), Gaps = 41/226 (18%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIGRLR 398
           +   + +G G +G V       T  +VA+K++SN      ++K+ LRE    I  +  LR
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE----IKLLRHLR 57

Query: 399 HRNLVQLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----YRIIK 449
           H N++ LL   R        D+ +V + M    L K +   Q   LT +      Y+I++
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP--LTDDHIQYFLYQILR 114

Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST------ 503
           G    L YLH      VIHRD+K  N+L++S  + ++ DFGLA    RG +P        
Sbjct: 115 G----LKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLA----RGVDPDEDEKGFL 163

Query: 504 TRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           T  V T  Y APEL  +    T + D+++ G +  E++  R+P+ P
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFP 208

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)

Query: 348 KELLGFGGFGRVYKG---TLPSTNTQ--VAVKRVSNESKQGLREFASEISSIGRLRHRNL 402
           K  LG G FG+V+      L  T  +  VAVK + + +    ++F  E   +  L+H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDK----------CLFDEQ----KAILTWEQRYRII 448
           V+  G C     L++V+++M +G L+K           L D Q    K  L   Q   I 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             +ASG++YL     Q  +HRD+   N L+ + L  ++GDFG+++ +Y           +
Sbjct: 130 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
             + ++ PE     K TT SDV++FG +L E+   G++P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 26/221 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS--EISSIGRLRHRNLVQLL 406
           + +G G FG++Y     S +    +K +         + AS  E+  + +++H N+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 407 GWCRRRGDLLLVYDFMPNGSLDK-------CLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
              +  G L +V ++   G L K        LF E + IL+W         ++ GL ++H
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSW------FVQISLGLKHIH 118

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           +   + ++HRDIK+ N+ L    NG   +LGDFG+A+        + T  VGT  YL+PE
Sbjct: 119 D---RKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPE 172

Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELIL 557
           + +       +D+++ G +L E+   + P E   L  +L+L
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-HQLVL 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 23/215 (10%)

Query: 351 LGFGGFGRVY----KGTLP-STNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQL 405
           LG G FG+V+       LP      VAVK +   S+   ++F  E   +  L+H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCL---------FDEQKAI----LTWEQRYRIIKGVA 452
            G C     LL+V+++M +G L++ L             + +    LT  Q   I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLG 511
           SG++YL        +HRD+   N L+   L  ++GDFG+++ +Y         R +  + 
Sbjct: 133 SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           ++ PE     K TT SD+++FG +L E+   G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 83.6 bits (206), Expect = 8e-18
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 6/206 (2%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +   +      F  E   + +LRH  LV L     
Sbjct: 14  LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V +FM  GSL   L +     L   Q   +   +A G+ Y+        IHRD
Sbjct: 72  EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 531 AFGALLLEVVCGRRPIEPKALPEELI 556
           +FG LL E+V   R   P  +  E++
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVL 213

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 83.4 bits (206), Expect = 8e-18
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 23/210 (10%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQ---VAVK--RVSNESKQGLREFASEISSIGRLRHRNL 402
           + +LG G FG + +G L   + +   VA+   R     KQ  R F +E  ++G+  H N+
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNI 68

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V+L G   R   +++V ++M NG+LD  L  + +  L   Q   ++ G+ASG+ YL    
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMKYLS--- 124

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG------YLAPE 516
           E   +H+ + A  VL++S+L  ++  F       R     +  +  T+       + APE
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVLWAAPE 178

Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
             +    +++SDV++FG ++ EV+  G RP
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 83.4 bits (206), Expect = 9e-18
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 351 LGFGGFGRVYKGTLPS--TNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           +G G FG+V  G + S  T  QV VK +  + S Q   +F  E      L+H NL+Q LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKA-ILTWEQR--YRIIKGVASGLLYLHEEWEQ 464
            C      LLV +F P G L   L   +KA ++T +     R+   +A GLL+LH   + 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKL-YERGTNPSTTRVVGTLGYLAPELTR---- 519
             IH D+   N LL ++L  ++GD+GL+   Y+     +  ++   L ++APEL      
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 520 ---TGKPTTSSDVYAFGALLLEV 539
                  T  S+V++ G  + E+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 58/192 (30%), Positives = 99/192 (51%), Gaps = 6/192 (3%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLG 407
           E +G G FG V+ G L + NT VAVK         L+ +F  E   + +  H N+V+L+G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C ++  + +V + +  G     L  E    L  ++  ++++  A+G+ YL     +  I
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCI 116

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT-LGYLAPELTRTGKPTTS 526
           HRD+ A N L+  +   ++ DFG+++  E G   ST  +    + + APE    G+ ++ 
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 527 SDVYAFGALLLE 538
           SDV++FG LL E
Sbjct: 177 SDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 351 LGFGGFGRVYKGTLPS--TNTQVAVKRV---SNESKQGLREFASEISSIGRLRHRNLVQL 405
           +G G FG+V  G      +  +V VK +   +   +Q L  F  E+     L H N++Q 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVLQC 60

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR---YRIIKGVASGLLYLHEEW 462
           LG C      LLV +F P G L   L   +  +    Q+    R+   VASGLL+LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELT--- 518
           +   IH D+   N  L ++L+ ++GD+GLA + Y      +       L +LAPEL    
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 519 ----RTGKPTTSSDVYAFGALLLEV 539
                    T  S++++ G  + E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 76/266 (28%), Positives = 119/266 (44%), Gaps = 29/266 (10%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V  G        VA+K +  E      EF  E   + +L H  LVQL G C 
Sbjct: 12  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           ++  + +V ++M NG L   L +  K      Q   + K V  G+ YL     +  IHRD
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT---LGYLAPELTRTGKPTTSS 527
           + A N L+D +   ++ DFGL++      +   T  VG+   + +  PE+    K ++ S
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 528 DVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIE 586
           DV+AFG L+ EV   G+ P                ++R+     +E V   L      + 
Sbjct: 183 DVWAFGVLMWEVYSLGKMP----------------YERFNNSETVEKVSQGLRLYRPHLA 226

Query: 587 ALDVVKLGLMCSNDAAEARPTMRQVV 612
           +  V  +   C ++ AE RPT +Q++
Sbjct: 227 SEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 32/238 (13%)

Query: 333 FSYEELKKATRGFRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSNES-KQGLREF 387
               EL+K        +LLG G FG V+KG  +P   S    VA+K + + S +Q  +E 
Sbjct: 4   LKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI 56

Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-----LTWE 442
              + ++G L H  +V+LLG C     L LV    P GSL   +   + ++     L W 
Sbjct: 57  TDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC 115

Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNP 501
            +      +A G+ YL E     ++HR++ A N+LL S+   ++ DFG+A  LY      
Sbjct: 116 VQ------IAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166

Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP---IEPKALPEEL 555
             +     + ++A E    G+ T  SDV+++G  + E++  G  P   + P  +P+ L
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 47/300 (15%)

Query: 348 KELLGFGGFGRVY------------KGTLPSTN----TQVAVKRV-SNESKQGLREFASE 390
            E LG G FG V+            K    + N      VAVK +  + S     +F  E
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69

Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------------ 438
           +  + RL   N+ +LLG C     L ++ ++M NG L++ L   QK +            
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL---QKHVAETSGLACNSKS 126

Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYER 497
           L++     +   +ASG+ YL        +HRD+   N L+      ++ DFG+++ LY  
Sbjct: 127 LSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183

Query: 498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV--VCGRRPIEPKALPEEL 555
                  R    + ++A E    GK TT SDV+AFG  L E+  +C  +P E   L ++ 
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE--HLTDQQ 241

Query: 556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           ++ +        G  + +  P    +       D+ +L L C     E RPT R++  +L
Sbjct: 242 VIENAGHFFRDDGRQIYLPRPPNCPK-------DIYELMLECWRRDEEDRPTFREIHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 9/211 (4%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS--NESKQGLRE-FASEISSIGRLR 398
              F+ ++ +G G F  VYK         VA+K+V          R+    EI  + +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQRYRIIKGVASGLL 456
           H N+++ L       +L +V +    G L + +  F +QK ++     ++    + S L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           ++H    + ++HRDIK  NV + +    +LGD GL + +   T  + + +VGT  Y++PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE 176

Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
                     SD+++ G LL E+   + P  
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 22/215 (10%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
           FR   +LG GGFG V    + +T    A K++  +    ++G     +E   + ++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLD-------KCLFDEQKAILTWEQRYRIIKGVASG 454
           +V L      +  L LV   M  G L        +  F+E +A+    +       +  G
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-------ICCG 114

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           L  LH+E    +++RD+K  N+LLD   + R+ D GLA     G   +    VGT+GY+A
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMA 169

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPK 549
           PE+ +  + T S D +A G LL E++ G+ P + +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 26/220 (11%)

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKR-VSNESKQGLREFA-SEIS 392
           YE+L K          +G G +G V+K     T   VA+K+ V +E    +++ A  EI 
Sbjct: 3   YEKLSK----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR 52

Query: 393 SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVA 452
            + +L+H NLV L+   RR+  L LV+++  +  L++   ++    +      +II    
Sbjct: 53  MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTL 110

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
             + + H+      IHRD+K  N+L+  +   +L DFG A++   G     T  V T  Y
Sbjct: 111 QAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWY 166

Query: 513 LAPEL----TRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
            APEL    T+ G P    DV+A G +  E++ G +P+ P
Sbjct: 167 RAPELLVGDTQYGPPV---DVWAIGCVFAELLTG-QPLWP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 10/203 (4%)

Query: 348 KELLGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLV 403
              +G G FG VY+G   S       VAVK   N +   +RE F  E   + +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L+G       + +V +  P G L   L    K  L           +++ L YL     
Sbjct: 71  KLIGVITEN-PVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLES--- 125

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  +HRDI A NVL+ S    +LGDFGL++  E  +    ++    + ++APE     + 
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 524 TTSSDVYAFGALLLEVVC-GRRP 545
           T++SDV+ FG  + E++  G +P
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 81.6 bits (201), Expect = 4e-17
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 7/204 (3%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+  T  + +T+VAVK +   S   +  F +E + +  L+H  LV+L     
Sbjct: 14  LGAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           +   + ++ +FM  GSL   L  ++ +     +       +A G+ ++ +   +  IHRD
Sbjct: 72  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 127

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+ + L  ++ DFGLA++ E     +       + + APE    G  T  SDV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187

Query: 531 AFGALLLEVVC-GRRPIEPKALPE 553
           +FG LL+E+V  GR P    + PE
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPE 211

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.9 bits (202), Expect = 5e-17
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 16/211 (7%)

Query: 339 KKATRGFRDKELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQG-LREFASEISS 393
           K+  +  RD   LG G FG+V    Y     +T  QVAVK +  ES    + +   EI  
Sbjct: 3   KRFLKRIRD---LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 59

Query: 394 IGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV 451
           +  L H N+V+  G C   G   + L+ +F+P+GSL + L    K  +  +Q+ +    +
Sbjct: 60  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQI 118

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGT 509
             G+ YL     +  +HRD+ A NVL++SE   ++GDFGL K  E      T +  +   
Sbjct: 119 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175

Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           + + APE     K   +SDV++FG  L E++
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 81.7 bits (201), Expect = 6e-17
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 21/216 (9%)

Query: 348 KELLGFGGFGRV-----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL 402
           K  LG G FG+V     Y          VAVK + + S    ++F  E   +  L+H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLF-----------DEQKAILTWEQRYRIIKGV 451
           V+  G C     L++V+++M +G L+K L              + A LT  Q   I + +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL 510
           A+G++YL     Q  +HRD+   N L+   L  ++GDFG+++ +Y           +  +
Sbjct: 130 AAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
            ++ PE     K TT SDV++ G +L E+   G++P
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 81.0 bits (200), Expect = 8e-17
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 23/207 (11%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLG 407
           LG GGFG V    + +T    A K+++ +    ++G      E   + ++  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 408 WCRRRGDLLLVYDFMPNGSL---------DKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
             + + DL LV   M  G L         +   F E +A     Q       + SGL +L
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ-------IISGLEHL 113

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H+   + +I+RD+K  NVLLD++ N R+ D GLA   + G +  T    GT G++APEL 
Sbjct: 114 HQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELL 169

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +  +   S D +A G  L E++  R P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 80.9 bits (200), Expect = 9e-17
 Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 22/222 (9%)

Query: 333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV-SNESKQGLREFASEI 391
           F+ E+LK       D   +G G FG V K     + T +AVKR+ S   ++  +    ++
Sbjct: 1   FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53

Query: 392 SSIGRLRH-RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKC---LFDEQKAILTWEQRYRI 447
             + R      +V+  G   R GD  +  + M + SLDK    +++  K+++  E   +I
Sbjct: 54  DVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKI 112

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRV 506
                  L YL EE +  +IHRD+K  N+LLD   N +L DFG++ +L +   + + TR 
Sbjct: 113 AVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRD 167

Query: 507 VGTLGYLAPE-LTRTGKP--TTSSDVYAFGALLLEVVCGRRP 545
            G   Y+APE +  + +      SDV++ G  L EV  G+ P
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 78/278 (28%), Positives = 122/278 (43%), Gaps = 38/278 (13%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVS---NESKQGLREFASEISSIGRLRHRNLVQLLG 407
           LG G +G VYK     T   +A+K +    +ESK    +   E+  + +     +V   G
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK--FNQIIMELDILHKAVSPYIVDFYG 66

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI--LTWEQRYRIIKGVASGLLYLHEEWEQT 465
                G + +  ++M  GSLDK L+    A   +  +   RI   V  GL +L EE    
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG---TNPSTTRVVGTLGYLAPELTRTGK 522
           +IHRD+K  NVL++     +L DFG++         TN      +G   Y+APE  ++G 
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN------IGCQSYMAPERIKSGG 177

Query: 523 P------TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP 576
           P      T  SDV++ G  +LE+  GR P  P+                +  AI++   P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA---------QLSAIVDGDPP 228

Query: 577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY 614
            L   +++ +A D V     C N     RPT  Q++ +
Sbjct: 229 TLPSGYSD-DAQDFVAK---CLNKIPNRRPTYAQLLEH 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.5 bits (209), Expect = 1e-16
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 24/203 (11%)

Query: 367 TNTQVAVKRVSNESKQGLREFA---SEISSIGRLRHRNLVQLL--GWCRRRGDLLL--VY 419
           T  +VA+K +  ++ +   + A    E +   RL H N+V LL  G        LL  V+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVF 58

Query: 420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL- 478
           +++P  +L + L  +    L   +  R++  V   L   H    Q ++HRD+K  N+++ 
Sbjct: 59  EYVPGRTLREVLAAD--GALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVS 113

Query: 479 --DSELNGRLGDFGLAKL------YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
                 + ++ DFG+  L       +  T   TT V+GT  Y APE  R    T +SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 531 AFGALLLEVVCGRRPIEPKALPE 553
           A+G + LE + G+R ++  ++ E
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.8 bits (202), Expect = 1e-16
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 27/224 (12%)

Query: 330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV-SNESKQGLREFA 388
               S  EL++  R       +G G  G VYK     T    A+K +  N      R+  
Sbjct: 68  SAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQIC 120

Query: 389 SEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY--R 446
            EI  +  + H N+V+        G++ ++ +FM  GSL      E   I   ++++   
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL------EGTHI--ADEQFLAD 172

Query: 447 IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV 506
           + + + SG+ YLH    + ++HRDIK  N+L++S  N ++ DFG++++  +  +P  +  
Sbjct: 173 VARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228

Query: 507 VGTLGYLAPELTRT----GK-PTTSSDVYAFGALLLEVVCGRRP 545
           VGT+ Y++PE   T    G     + D+++ G  +LE   GR P
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 11/215 (5%)

Query: 351 LGFGGFGRVYKGT--LPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLG 407
           LG G FG V KG   +      VA+K + NE+++ +R E   E   + +L +  +V+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C     L+LV +    G L+K L  ++  I T      ++  V+ G+ YL     +  +
Sbjct: 63  VCEAEA-LMLVMEMASGGPLNKFLSGKKDEI-TVSNVVELMHQVSMGMKYLEG---KNFV 117

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGKPTT 525
           HRD+ A NVLL ++   ++ DFGL+K      +    R  G   L + APE     K ++
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 526 SSDVYAFGALLLEVVC-GRRPIEPKALPEELILVD 559
            SDV+++G  + E    G++P +    PE +  ++
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE 212

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 25/207 (12%)

Query: 354 GGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS---EISSIGRLRHRNLVQLLGWCR 410
           G +GRV+     ST    A+K +         +      E   + + +   +V+L    +
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 411 RRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
            + +L LV +++P G L   L      DE  A +        I  +   L YLH      
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI-------YIAEIVLALEYLHS---NG 113

Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAK--LYERGTNPS-----TTRVVGTLGYLAPELT 518
           +IHRD+K  N+L+DS  + +L DFGL+K  L  R  N +       R+VGT  Y+APE+ 
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                + + D ++ G +L E + G  P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 31/214 (14%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFA-SEISSIGRLRHRNLVQLL 406
           E +G G +G VYK     T   VA+K++  E+  +G+   A  EIS +  L H N+V+LL
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 407 GWCRRRGDLLLVYDFM-----------PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGL 455
                   L LV++F+           P   LD  L    K+ L     Y++++G+A   
Sbjct: 65  DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSYL-----YQLLQGIA--- 113

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
            Y H      V+HRD+K  N+L+D E   +L DFGLA+ +       T  VV TL Y AP
Sbjct: 114 -YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 168

Query: 516 ELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           E+    +  +T  D+++ G +  E +  RRP+ P
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAE-MVNRRPLFP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.3 bits (200), Expect = 1e-16
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 16/208 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG---LREFASEISSIGRLRHRN 401
           F D   +G G FG VY      TN  VA+K++S   KQ     ++   E+  + R++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
            ++  G   R     LV ++    + D  L +  K  L   +   I  G   GL YLH  
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHS- 143

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT- 520
               +IHRDIKAGN+LL      +L DFG A +     +P+ +  VGT  ++APE+    
Sbjct: 144 --HNMIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS-FVGTPYWMAPEVILAM 196

Query: 521 --GKPTTSSDVYAFGALLLEVVCGRRPI 546
             G+     DV++ G   +E+   + P+
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 349 ELLGFGGFGRVYKGTLPSTNT---QVAVK--RVSNESKQGLREFASEISSIGRLRHRNLV 403
           ++LG G FG V +G L   +    +VAVK  ++   +   + EF SE + +    H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 404 QLLGWCRRRGDL------LLVYDFMPNGSLDKCLF----DEQKAILTWEQRYRIIKGVAS 453
           +L+G C     L      +++  FM +G L   L           L  +   + +  +A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT-LGY 512
           G+ YL     +  IHRD+ A N +L  ++   + DFGL+K    G      R+    + +
Sbjct: 125 GMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEV 539
           +A E       T+ SDV+AFG  + E+
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 82/297 (27%), Positives = 128/297 (43%), Gaps = 51/297 (17%)

Query: 351 LGFGGFGRVYKGT------LPSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLV 403
           LG G FG+V K T           T VAVK +  N S   LR+  SE + + ++ H +++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTT-VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSL----------------------DKCLFDEQKAILTW 441
           +L G C + G LLL+ ++   GSL                         L +  +  LT 
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 442 EQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTN 500
                    ++ G+ YL E     ++HRD+ A NVL+      ++ DFGL++ +YE  + 
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVD 559
              ++    + ++A E       TT SDV++FG LL E+V  G  P  P   PE L    
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIAPERL---- 238

Query: 560 WVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
             ++  K G  +E  +       N  E   +  L L C     + RPT   + + LE
Sbjct: 239 --FNLLKTGYRMERPE-------NCSEE--MYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 32/213 (15%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNLVQLL 406
           E +G G +G VYKG    T   VA+K++  ES+ +G+   A  EIS +  L+H N+V L 
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 407 GWCRRRGDLLLVYDFM------------PNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
               +   L L+++F+                +D  L    K+ L     Y+I++G+   
Sbjct: 66  DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELV---KSYL-----YQILQGI--- 114

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
            L+ H    + V+HRD+K  N+L+D++   +L DFGLA+ +       T  VV TL Y A
Sbjct: 115 -LFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRA 169

Query: 515 PE-LTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           PE L  + + +T  D+++ G +  E+   ++P+
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 18/208 (8%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNLVQLL 406
           E +G G +G VYK     TN  +A+K++  E + +G+   A  EIS +  ++H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLHEEW 462
                   L LV+++     LD  L     +   + +  R+IK     +  G+ Y H   
Sbjct: 68  DVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS-- 120

Query: 463 EQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
              V+HRD+K  N+L+D   N  +L DFGLA+ +       T  VV TL Y APE+    
Sbjct: 121 -HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGS 178

Query: 522 KP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           +  +T  D+++ G +  E+V  ++P+ P
Sbjct: 179 RHYSTPVDIWSVGCIFAEMV-NQKPLFP 205

Length = 294

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG---LREFASEISSIGRLRHRN 401
           F D   +G G FG VY       +  VA+K++S   KQ     ++   E+  + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
            +Q  G   R     LV ++    + D  L +  K  L   +   +  G   GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 133

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT- 520
               +IHRD+KAGN+LL      +LGDFG A +      P+    VGT  ++APE+    
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANX-FVGTPYWMAPEVILAM 186

Query: 521 --GKPTTSSDVYAFGALLLEVVCGRRPI 546
             G+     DV++ G   +E+   + P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 78.8 bits (194), Expect = 4e-16
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 8/198 (4%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLG 407
           LG GGFG V    + +T    A K++  +    K G +    E   + ++    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
               +  L LV   M  G L   +++  +  L  E+       +  G+L+LH      ++
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           +RD+K  NVLLD + N RL D GLA   + G   + T+  GT GY+APE+ +    +   
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 528 DVYAFGALLLEVVCGRRP 545
           D +A G  + E+V GR P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 29/200 (14%)

Query: 354 GGFGRVYKGTLPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRLRHRNLVQL-- 405
           G +G VY+     T   VA+K++  E ++       LRE    I+ + +L+H N+V +  
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLRE----INILLKLQHPNIVTVKE 71

Query: 406 --LGWCRRRGDLLLVYDFMPNGSLD-KCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +G       + +V +++ +   D K L +  K      +   ++  + SG+ +LH+ W
Sbjct: 72  VVVG--SNLDKIYMVMEYVEH---DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTG 521
              ++HRD+K  N+LL++    ++ DFGLA+ Y     P T  VV TL Y APE L    
Sbjct: 127 ---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGAK 182

Query: 522 KPTTSSDVYA----FGALLL 537
           + +T+ D+++    F  LL 
Sbjct: 183 EYSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 34/214 (15%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVS--------------NESKQGLREFASEISSIG 395
           +LG G FG+V    L  T+   AVK +                E +         + ++ 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKR---------VLALA 52

Query: 396 RLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASG 454
             +H  L QL    + +  L  V +++  G L   +F  Q++    E R R     +  G
Sbjct: 53  G-KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLG 108

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYL 513
           L +LHE   + +I+RD+K  NVLLDSE + ++ DFG+ K  E      TT    GT  Y+
Sbjct: 109 LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYI 163

Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
           APE+        + D +A G LL E++ G+ P E
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 79.1 bits (196), Expect = 4e-16
 Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE----SKQGLREFASEISSIGRLRHR 400
           F   + LG G FGRV       +    A+K +S       KQ +    +E   +  +RH 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHP 61

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGS----LDKC-LFDEQKAILTWEQRYRIIKGVASGL 455
            LV L G  +   +L LV +++P G     L K   F E  A     Q       V   L
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ-------VVLAL 114

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
            YLH      +++RD+K  N+LLDS+   ++ DFG AK  +  T   T  + GT  YLAP
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT--LCGTPEYLAP 167

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           E+  +     + D +A G L+ E++ G  P
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 10/207 (4%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLG 407
           ++G G FG V+     +    V +K++  E  +K       +E   +  L H N+++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
                  L++V ++ P G+L + +     ++L  +    I+      LL LH    + ++
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT---ILHFFVQILLALHHVHTKLIL 123

Query: 468 HRDIKAGNVLLDSELN-GRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP-TT 525
           HRD+K  N+LLD      ++GDFG++K     +      VVGT  Y++PEL   GKP   
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCE-GKPYNQ 180

Query: 526 SSDVYAFGALLLEVVCGRRPIEPKALP 552
            SD++A G +L E+   +R  E   LP
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLP 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.7 bits (194), Expect = 5e-16
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 8/196 (4%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V K     T T +A K V   +K  +R +   E+  +   R   +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHR 469
               ++ +  +FM  GSLD+    ++   +  E   +I   V  GL YL+      ++HR
Sbjct: 73  LNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHR 128

Query: 470 DIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDV 529
           DIK  N+L++S    +L DFG++       N      VGT  Y++PE  + GK T  SDV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYTVKSDV 185

Query: 530 YAFGALLLEVVCGRRP 545
           ++ G  ++E+  G+ P
Sbjct: 186 WSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 24/215 (11%)

Query: 346 RDKELLGFGGFGRVYKG----TLPSTNTQ-VAVKRVSNESKQGLRE-FASEISSIGRLRH 399
           R  E LG   FG+VYKG    T P   TQ VA+K + ++++  LRE F  E     RL+H
Sbjct: 8   RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF-----------DEQKAI---LTWEQRY 445
            N+V LLG   +   L +++ +  +  L + L            D+ K +   L      
Sbjct: 68  PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTT 504
            I+  +A+G+ +L       V+H+D+   NVL+  +LN ++ D GL + +Y         
Sbjct: 128 HIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184

Query: 505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
             +  + +++PE    GK +  SD++++G +L EV
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 78.7 bits (194), Expect = 6e-16
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 351 LGFGGFGRVYKGT---LPSTNT--QVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLV 403
           LG G FG+V + T   L  ++   +VAVK +   +    RE   SE+  +  L  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            LLG C   G +L++ ++   G L   L  ++++ LT E        VA G+ +L     
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS--- 159

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN---PSTTRVVGTLGYLAPELTRT 520
           +  IHRD+ A NVLL      ++ DFGLA+     +N       R+   + ++APE    
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIFN 217

Query: 521 GKPTTSSDVYAFGALLLEV 539
              T  SDV+++G LL E+
Sbjct: 218 CVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 17/207 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ---GLREFASEISSIGRLRHRN 401
           F     +G G FG VY  T   TN  VAVK++S   KQ     ++   E+  + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
            ++  G   +     LV ++    + D  L +  K  L   +   I  G   GL YLH  
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHS- 139

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT- 520
               +IHRDIKAGN+LL      +L DFG A      ++P+ +  VGT  ++APE+    
Sbjct: 140 --HNMIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS-FVGTPYWMAPEVILAM 192

Query: 521 --GKPTTSSDVYAFGALLLEVVCGRRP 545
             G+     DV++ G   +E+   R+P
Sbjct: 193 DEGQYDGKVDVWSLGITCIELA-ERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 11/208 (5%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFA-SEISSIGRLRHRN 401
           F+  E +G G +G VYK     T   VA+K  R+  E+ +G+   A  EIS +  L H N
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPN 60

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +V+LL        L LV++F+ +  L K +     + +        +  +  GL + H  
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS- 118

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
               V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE+    
Sbjct: 119 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 175

Query: 522 K-PTTSSDVYAFGALLLEVVCGRRPIEP 548
           K  +T+ D+++ G +  E+V  RR + P
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT-RRALFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 78.0 bits (192), Expect = 8e-16
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           +G G FGRV++   P        T VAVK +  E S     +F  E + +    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCL--------------------FDEQKAILTWEQR 444
           LLG C     + L++++M  G L++ L                           L+  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPST 503
             I K VA+G+ YL    E+  +HRD+   N L+   +  ++ DFGL+  +Y      ++
Sbjct: 133 LCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                 + ++ PE     + TT SDV+A+G +L E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 41/226 (18%)

Query: 349 ELLGF---GGFGRVYKGTL--PSTNTQVAVKRVSNESKQGLREFASEISSIGRLR---HR 400
           E+ G    G +GRVYK          + A+K+   + +Q      S    I  LR   H 
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62

Query: 401 NLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR-----------I 447
           N+V L+       D  + L++D+  +             I+ + ++ +           +
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEHDLW---------QIIKFHRQAKRVSIPPSMVKSL 113

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR----LGDFGLAKLYERGTNPST 503
           +  + +G+ YLH  W   V+HRD+K  N+L+  E   R    +GD GLA+L+     P  
Sbjct: 114 LWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 504 T--RVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGRRPI 546
               VV T+ Y APEL    +  T + D++A G +  E++    PI
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 78.8 bits (195), Expect = 1e-15
 Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 32/215 (14%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV----SNESK-QGLREFASEISSIGRLR-HRNLVQ 404
           LG G +G V+K     T   VA+K++     N +  Q  R F  EI  +  L  H N+V+
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTF-REIMFLQELGDHPNIVK 71

Query: 405 LLGWCRRRG--DLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----YRIIKGVASGLLYL 458
           LL   +     D+ LV+++M    L   +   +  IL    +    Y+++K +     Y+
Sbjct: 72  LLNVIKAENDKDIYLVFEYMET-DLHAVI---RANILEDVHKRYIMYQLLKALK----YI 123

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK----LYERGTNPSTTRVVGTLGYLA 514
           H      VIHRD+K  N+LL+S+   +L DFGLA+    L E   NP  T  V T  Y A
Sbjct: 124 HS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 515 PE-LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
           PE L  + + T   D+++ G +L E++ G +P+ P
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFP 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 78.4 bits (193), Expect = 1e-15
 Identities = 81/240 (33%), Positives = 114/240 (47%), Gaps = 28/240 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASE-------ISSIGRLRHRN 401
            +LG G FG+V    L  +    AVK +  +    L++   E       I S+ R  H  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLAR-NHPF 57

Query: 402 LVQLLGWCRRRGD-LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLH 459
           L QL   C +  D L  V +F+  G L   +F  QK+    E R R     + S L++LH
Sbjct: 58  LTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLH 113

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELT 518
           +   + +I+RD+K  NVLLD E + +L DFG+ K  E   N  TT    GT  Y+APE+ 
Sbjct: 114 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEIL 168

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE--ELILVDWV----WDRWKAGAILE 572
           +      S D +A G LL E++CG  P E +   +  E IL D V    W    A  IL+
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILK 228

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 45/227 (19%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-----GLREFASEISSIGRLRH 399
           +++   +G G +G V   T   T  +VA+K++S    Q      LRE    I  + R +H
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLRE----IKILRRFKH 62

Query: 400 RNLVQLLGWCRRRG-----DLLLVYDFMPNGSLDKCLFDEQKAILTWEQR---------- 444
            N++ +L   R        D+ +V + M          D  K I T  Q           
Sbjct: 63  ENIIGILDIIRPPSFESFNDVYIVQELMET--------DLYKLIKT--QHLSNDHIQYFL 112

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST- 503
           Y+I++G    L Y+H      V+HRD+K  N+LL++  + ++ DFGLA++ +   + +  
Sbjct: 113 YQILRG----LKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 504 -TRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
            T  V T  Y APE+    K  T + D+++ G +L E++   RP+ P
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 24/215 (11%)

Query: 346 RDKELLGFGGFGRVYKG--TLPSTNTQ--VAVKRVSN-ESKQGLREFASEISSIGRLRHR 400
           R  E LG   FG++YKG   LP  +    VA+K + +  + Q   EF  E S +  L H 
Sbjct: 8   RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDK------------CLFDEQ---KAILTWEQRY 445
           N+V LLG   +   + ++++++  G L +            C  DE    K+ L      
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTT 504
            I   +A+G+ YL   +    +H+D+ A N+L+  +L+ ++ D GL++ +Y         
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
           + +  + ++ PE    GK ++ SD+++FG +L E+
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 40/235 (17%)

Query: 348 KELLGFGGFGRVY------KGTLPSTN----------TQVAVKRV-SNESKQGLREFASE 390
           KE LG G FG V+         LP+              VAVK +  + +K    +F  E
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69

Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------------FD 433
           +  + RL+  N+++LLG C     L ++ ++M NG L++ L                   
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129

Query: 434 EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK 493
                +++     +   +ASG+ YL        +HRD+   N L+   L  ++ DFG+++
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Query: 494 -LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV--VCGRRP 545
            LY         R V  + ++A E    GK TT+SDV+AFG  L E+  +C  +P
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 37/220 (16%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES------KQGLREFASEISSIGRLRHRNL 402
           E +G G +G V       +  +VA+K++ +        K+ LRE    +  +   +H N+
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE----LKILRHFKHDNI 66

Query: 403 VQLLGWCRRRG----DLLLVYDFMPNGSLDKCLFDEQKAILTWEQ----RYRIIKGVASG 454
           + +    R  G    D+ +V D M +  L   +  +Q   LT E      Y++++G    
Sbjct: 67  IAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQP--LTEEHIRYFLYQLLRG---- 119

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-----TTRVVGT 509
           L Y+H      VIHRD+K  N+L++ +   R+GDFG+A+     ++P+      T  V T
Sbjct: 120 LKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS--SSPTEHKYFMTEYVAT 174

Query: 510 LGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEP 548
             Y APEL  +  + TT+ D+++ G +  E++ GRR + P
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP 213

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 11/197 (5%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLVQLLGWC 409
           +G G  G V   T  ST  QVAVK++ +  KQ  RE   +E+  +   +H N+V++    
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHR 469
               +L +V +F+  G+L   +   +   +  EQ   +   V   L +LH    Q VIHR
Sbjct: 86  LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHA---QGVIHR 139

Query: 470 DIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           DIK+ ++LL S+   +L DFG  A++ +    P    +VGT  ++APE+       T  D
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVD 197

Query: 529 VYAFGALLLEVVCGRRP 545
           +++ G +++E+V G  P
Sbjct: 198 IWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 71/257 (27%), Positives = 109/257 (42%), Gaps = 35/257 (13%)

Query: 354 GGFGRVYKGTLPSTNTQVAVK---RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           G FG VY     ST    A+K   +    +K  +    +E + +        V  L +  
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 411 RRGD-LLLVYDFMPNG---SLDKCL--FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           +  D L LV +++  G   SL K L    E      W ++Y  I  V  G+  LH+   +
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKTLGGLPED-----WAKQY--IAEVVLGVEDLHQ---R 116

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
            +IHRDIK  N+L+D   + +L DFGL++           + VGT  YLAPE        
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGTPDYLAPETILGVGDD 171

Query: 525 TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE 584
             SD ++ G ++ E + G  P   +         D V+D   +  I     P    EF  
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAET-------PDAVFDNILSRRINW---PEEVKEFCS 221

Query: 585 IEALDVVKLGLMCSNDA 601
            EA+D++   L+C + A
Sbjct: 222 PEAVDLIN-RLLCMDPA 237

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 18/206 (8%)

Query: 349 ELLGFGGFGRVYK-GTLPSTNTQVAVKRVS----------NESKQGLREFASEISSIG-R 396
           E LG G FG VYK     +    +A+K ++           E  + + +  SE++ I  +
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQRYRIIKGVASG 454
           LRH N+V+          L +V D +    L +      E+K   T E+ + I   +   
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           L YLH+E  + ++HRD+   N++L  +    + DFGLAK  ++      T VVGT+ Y  
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVV 540
           PE+ +       +DV+AFG +L ++ 
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 24/214 (11%)

Query: 344 GFRDKELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLR 398
                +LL  G FGR++ G L    P    +V VK V + + +  +     E   +  L 
Sbjct: 7   RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66

Query: 399 HRNLVQLLGWCRRRGDLLLV-YDFMPNGSLD----KC-LFDEQKAI-LTWEQRYRIIKGV 451
           H+N++ +L  C   G+   V Y +M  G+L     +C L +      L+ +Q   +   +
Sbjct: 67  HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT-- 509
           A G+ YLH+   + VIH+DI A N ++D EL  ++ D  L+    R   P     +G   
Sbjct: 127 ACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALS----RDLFPMDYHCLGDNE 179

Query: 510 ---LGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
              + ++A E     + +++SDV++FG LL E++
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.9 bits (186), Expect = 4e-15
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 18/207 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLV 403
           F   E +G G FG V+KG    T   VA+K +   E++  + +   EI+ + +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCL----FDEQKAILTWEQRYRIIKGVASGLLYLH 459
           +  G   +   L ++ +++  GS    L    FDE        Q   ++K +  GL YLH
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF-------QIATMLKEILKGLDYLH 118

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELT 518
            E +   IHRDIKA NVLL  + + +L DFG+A +L +  T       VGT  ++APE+ 
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVI 173

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +     + +D+++ G   +E+  G  P
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 32/197 (16%)

Query: 338 LKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL 397
           L   T  F   E++G G +G+VYK     T   VA+K + +  +    E   E + + + 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59

Query: 398 -RHRNLVQLLGWCRRRGD------LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR---- 446
             H N+    G   ++        L LV +    GS+     D  K +    +R +    
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT----DLVKGLRKKGKRLKEEWI 115

Query: 447 --IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-----KLYERGT 499
             I++    GL YLHE     VIHRDIK  N+LL      +L DFG++      L  R T
Sbjct: 116 AYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172

Query: 500 NPSTTRVVGTLGYLAPE 516
                  +GT  ++APE
Sbjct: 173 ------FIGTPYWMAPE 183

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.9 bits (186), Expect = 4e-15
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 8/202 (3%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLV 403
           F   E +G G FG V+KG    T   VA+K +   E++  + +   EI+ + +     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +  G   +   L ++ +++  GS    L   +   L   Q   I++ +  GL YLH E +
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
              IHRDIKA NVLL      +L DFG+A      T       VGT  ++APE+ +    
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
            + +D+++ G   +E+  G  P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 8/208 (3%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
           FR   +LG GGFG V    + +T    A KR+  +    ++G     +E   + ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +V L      +  L LV   M  G L   +++        E+       +  GL  LH E
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
                ++RD+K  N+LLD   + R+ D GLA     G   S    VGT+GY+APE+    
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNNQ 176

Query: 522 KPTTSSDVYAFGALLLEVVCGRRPIEPK 549
           + T S D +  G L+ E++ G+ P   +
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
           FR   +LG GGFG V    + +T    A K++  +    ++G     +E   + ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-------FDEQKAILTWEQRYRIIKGVASG 454
           +V L      +  L LV   M  G L   +       FDEQ+AI    +       +  G
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-------LCCG 114

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYL 513
           L  L  E    +++RD+K  N+LLD   + R+ D GLA     G    T R  VGT+GY+
Sbjct: 115 LEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRVGTVGYM 168

Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           APE+    K T S D +  G L+ E++ G+ P
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 9/206 (4%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS---NESKQGLREFASEISSIGRLRHRN 401
           F+ ++ +G G F  VY+ T       VA+K+V        +  ++   EI  + +L H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQRYRIIKGVASGLLYLH 459
           +++ L       +L +V +    G L + +  F +QK ++     ++    + S + ++H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
               + V+HRDIK  NV + +    +LGD GL + +   T  + + +VGT  Y++PE   
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIH 179

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                  SD+++ G LL E+   + P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 16/208 (7%)

Query: 343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRN 401
             F   E +G G FG VYKG    T   VA+K +   E++  + +   EI+ + +     
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLLYL 458
           + +  G   +   L ++ +++  GS    L     E+  I T      I++ +  GL YL
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYL 117

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPEL 517
           H E +   IHRDIKA NVLL  + + +L DFG+A +L +  T       VGT  ++APE+
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEV 172

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            +       +D+++ G   +E+  G  P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)

Query: 343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRN 401
           + +   E +G G  G VY     +T  +VA+K++ N  +Q  +E   +EI  +   +H N
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPN 77

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           +V  L       +L +V +++  GSL     + C+ + Q A +  E            L 
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALE 129

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGYLAP 515
           +LH      VIHRDIK+ N+LL  + + +L DFG  A++    +  ST  +VGT  ++AP
Sbjct: 130 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 184

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           E+          D+++ G + +E+V G  P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 31/225 (13%)

Query: 349 ELLGFGGFGRVYKGT-LPSTNT---QVAVKRVSNESK--QGLREFASEISSIGRLRHRNL 402
           ++LG G FG VYKG  +P   T    VA+K + NE+   +   EF  E   +  + H +L
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-----LTWEQRYRIIKGVASGLLY 457
           V+LLG C     + LV   MP+G L   + + +  I     L W  +      +A G++Y
Sbjct: 72  VRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 124

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYLA 514
           L E   + ++HRD+ A NVL+ S  + ++ DFGLA+L    E+  N    ++   + ++A
Sbjct: 125 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMA 179

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVC-GRRP---IEPKALPEEL 555
            E     K T  SDV+++G  + E++  G +P   I  + +P+ L
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 13/202 (6%)

Query: 351 LGFGGFGRVYKGTLPSTNTQ--VAVKRVSNESK-QGLR-EFASEISSIGRLRHRNLVQLL 406
           LG G FG V KG      ++  VAVK + N++    L+ E   E + + +L +  +V+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G C      +LV +    G L+K  F ++   +T +    ++  V+ G+ YL E      
Sbjct: 63  GICEAE-SWMLVMELAELGPLNK--FLQKNKHVTEKNITELVHQVSMGMKYLEE---TNF 116

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGKPT 524
           +HRD+ A NVLL ++   ++ DFGL+K      N    +  G   + + APE     K +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 525 TSSDVYAFGALLLEVVC-GRRP 545
           + SDV++FG L+ E    G++P
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 9/206 (4%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGLREFASEISSIGRLRHRN 401
           FR ++ +G G F  VY+ T       VA+K+V        +   +   EI  + +L H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQRYRIIKGVASGLLYLH 459
           +++         +L +V +    G L + +  F +QK ++  +  ++    + S L ++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
               + V+HRDIK  NV + +    +LGD GL + +   T  + + +VGT  Y++PE   
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIH 179

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                  SD+++ G LL E+   + P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 14/202 (6%)

Query: 354 GGFGRVYKGTL--PSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRR 411
           G  G V+  T        +V VK V+     G +    EI  +  + HR ++ L+   R 
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRW 157

Query: 412 RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDI 471
           +  + +V   MP    D   + ++   L  EQ   I + +   L YLH    + +IHRD+
Sbjct: 158 KSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDV 211

Query: 472 KAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           K  N+ LD   N  LGDFG A KL      P      GTL   +PEL         +D++
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIW 271

Query: 531 AFGALLLEVVCGRRPIEPKALP 552
           + G +L E+      +  K + 
Sbjct: 272 SAGLVLFEMSVKNVTLFGKQVK 293

Length = 392

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 46/242 (19%)

Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQ 404
            ++G G FG VY GTL  ++      AVK ++     + + +F  E   +    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-------VASGLL 456
           LLG C    G  L+V  +M +G L        +  +  E     +K        VA G+ 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDL--------RNFIRSETHNPTVKDLIGFGLQVAKGME 112

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYL 513
           YL     +  +HRD+ A N +LD     ++ DFGLA+ +Y++            L   ++
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE 553
           A E  +T K TT SDV++FG LL E++                     GRR ++P+  P+
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD 229

Query: 554 EL 555
            L
Sbjct: 230 PL 231

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 15/209 (7%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLVQLLGWC 409
           LG G +  VYKG    T+  VA+K +  E ++G    A  E+S +  L+H N+V L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 410 RRRGDLLLVYDFMPNGSLDKCL---FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                L LV+++     LDK L    D+    +        +  +  GL Y H    + V
Sbjct: 74  HTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKV 125

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGKPTT 525
           +HRD+K  N+L++     +L DFGLA+     T   +  VV TL Y  P+ L  +   +T
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184

Query: 526 SSDVYAFGALLLEVVCGRRPIEPKALPEE 554
             D++  G +  E+  G RP+ P +  EE
Sbjct: 185 QIDMWGVGCIFYEMSTG-RPLFPGSTVEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 30/212 (14%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFA-SEISSIGRLRHRNLVQLLG 407
           ++G G +G V K     T   VA+K+  + E  + ++E    E+  +  L+  N+V+L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 408 WCRRRGDLLLVYDF-----------MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
             RRRG L LV+++           MPNG       ++ ++ +     Y++IK +     
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP----EKVRSYI-----YQLIKAI----- 113

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
             H   +  ++HRDIK  N+L+      +L DFG A+    G+N + T  V T  Y +PE
Sbjct: 114 --HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
           L        + D+++ G +L E+  G +P+ P
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDG-QPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
           FR   +LG GGFG V    + +T    A K++  +    ++G     +E   + ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-------FDEQKAILTWEQRYRIIKGVASG 454
           +V L      +  L LV   M  G L   +       FDE++A+    +       +  G
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-------ITCG 114

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           L  LH E    +++RD+K  N+LLD   + R+ D GLA     G      RV GT+GY+A
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRV-GTVGYMA 169

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           PE+ +  + T S D +  G L+ E++ G+ P
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLVQLLG 407
           E LG G +  V+KG    T   VA+K +  E ++G    A  E+S +  L+H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL---FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
                  L LV+++     LDK L    D+   I++       +  +  GL Y H    +
Sbjct: 72  IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---R 123

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGKP 523
            V+HRD+K  N+L++     +L DFGLA+     T   +  VV TL Y  P+ L  + + 
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182

Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALPEE 554
           +T  D++  G +  E+  G RP+ P +  E+
Sbjct: 183 STQIDMWGVGCIFFEMASG-RPLFPGSTVED 212

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 25/221 (11%)

Query: 333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQG-LRE 386
           F    L++ T        LG G FG V+             T V VK +     +    E
Sbjct: 2   FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE 54

Query: 387 FASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-------L 439
           F  E+    +L H+N+V+LLG CR      ++ ++   G L + L   +          L
Sbjct: 55  FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114

Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERG 498
           + +Q+  +   +A G+ +L        +HRD+ A N L+ S+   ++    L+K +Y   
Sbjct: 115 STKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171

Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                  ++  L +LAPE  +    +T SDV++FG L+ EV
Sbjct: 172 YYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 76/287 (26%), Positives = 130/287 (45%), Gaps = 31/287 (10%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V K     +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHR 469
              G++ +  + M  GSLD+ L + ++  +  E   ++   V  GL YL E+    ++HR
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREK--HQIMHR 128

Query: 470 DIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           D+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  SD
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSD 184

Query: 529 VYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEAL 588
           +++ G  L+E+  GR PI P    E    ++ ++ R           P ++GE  E  ++
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGR-----------PVVDGEEGEPHSI 229

Query: 589 DVVKL--GLMCSNDAAEARPTMR--QVVRYLEGEVP--LPQAVAAPD 629
                  G   S    ++RP M   +++ Y+  E P  LP  V  PD
Sbjct: 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPD 276

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 24/210 (11%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIGRLRHRNLVQ 404
           +G G +G V       TN +VA+K+++N      ++K+ LRE    I  +  L H N++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE----IKLLRHLDHENVIA 68

Query: 405 LLGW----CRRR-GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
           +        R    D+ +VY+ M +  L + +   Q   L+ +     +  +  GL Y+H
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIH 125

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LT 518
                 V+HRD+K  N+LL++  + ++ DFGLA+          T  V T  Y APE L 
Sbjct: 126 S---ANVLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLL 181

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
              + TT+ DV++ G +  E++ GR+P+ P
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELL-GRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR------LRHRNLV 403
           +LG G FG+V    L  TN   A+K +  +    L +   E + + R        H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLT 59

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
            L    + +  L  V +++  G L         FDE +A     +       +  GL +L
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE-------IICGLQFL 112

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H++    +I+RD+K  NVLLD + + ++ DFG+ K    G   ++T   GT  Y+APE+ 
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEIL 168

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +  K   S D ++FG LL E++ G+ P
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 13/211 (6%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V+K +   +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEWEQTVIH 468
              G++ +  + M  GSLD+ L   +KA    EQ   ++   V  GL YL E+    ++H
Sbjct: 73  YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 127

Query: 469 RDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           RD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  S
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQS 183

Query: 528 DVYAFGALLLEVVCGRRPIEPKALPE-ELIL 557
           D+++ G  L+E+  GR PI P    E EL+ 
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 7/195 (3%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G  G V   T   T  QVAVK++    +Q      +E+  +    H N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
              +L +V +F+  G+L   +   +   +  EQ   +   V   L YLH    Q VIHRD
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHN---QGVIHRD 143

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           IK+ ++LL S+   +L DFG      +   P    +VGT  ++APE+       T  D++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 531 AFGALLLEVVCGRRP 545
           + G +++E++ G  P
Sbjct: 203 SLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR------LRHRNL 402
           ++LG G FG+V    L  T+   A+K +  +    L++   + +   +       +H  L
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFL 58

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEE 461
             L    + +  L  V +++  G L   +F  Q++    E R R     V   L++LH  
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHR- 114

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELTR 519
               VI+RD+K  N+LLD+E + +L DFG+ K    G     +TT   GT  Y+APE+ +
Sbjct: 115 --HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRPIE 547
             +   S D +A G L+ E++ G+ P E
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 67/225 (29%), Positives = 100/225 (44%), Gaps = 49/225 (21%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRV-----SNESKQGLREFASEISSIGRLRHR--- 400
           E LG G +G V K     T T +AVKR+     S E K+ L +   +IS    +R     
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDL--DIS----MRSVDCP 60

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKC---LFDEQKAILTWEQRYRIIKGVASGLLY 457
             V   G   R GD+ +  + M + SLDK    ++D+   I   +   +I   +   L Y
Sbjct: 61  YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPE-DILGKIAVSIVKALEY 118

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG--------LAKLYERGTNPSTTRVVGT 509
           LH +   +VIHRD+K  NVL++     +L DFG        +AK  + G  P        
Sbjct: 119 LHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP-------- 168

Query: 510 LGYLAPELTRTGKPTTS-------SDVYAFGALLLEVVCGRRPIE 547
             Y+APE      P  +       SDV++ G  ++E+  GR P +
Sbjct: 169 --YMAPERI---NPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 11/197 (5%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G  G V       +  QVAVK +    +Q      +E+  +   +H+N+V++     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
              +L ++ +F+  G+L   +    +  L  EQ   + + V   L YLH    Q VIHRD
Sbjct: 89  VGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHS---QGVIHRD 142

Query: 471 IKAGNVLLDSELNGR--LGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           IK+ ++LL   L+GR  L DFG      +   P    +VGT  ++APE+       T  D
Sbjct: 143 IKSDSILL--TLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 529 VYAFGALLLEVVCGRRP 545
           +++ G +++E+V G  P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 32/227 (14%)

Query: 348 KELLGFGGFGRVY----KGTL------------PSTNTQVAVKRVSNESKQGLR-EFASE 390
           KE LG G FG V+    +G               +    VAVK +  ++ +  R +F  E
Sbjct: 10  KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL---------FDEQKAILTW 441
           I  + RL+  N+++LL  C     L ++ ++M NG L++ L                +++
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 442 EQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTN 500
                +   +ASG+ YL        +HRD+   N L+      ++ DFG+++ LY     
Sbjct: 130 STLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186

Query: 501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV--CGRRP 545
               R V  + +++ E    GK TT+SDV+AFG  L E++  C  +P
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 7/192 (3%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVS--NESKQGLREFASEISSIGRLRHRNLVQLL-G 407
           +G G +G V      +   Q  +K+++  N S++  +    E   + +L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
           W    G L +V  F   G L   L +++  +L   Q       +A  L YLHE+    ++
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HIL 124

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HRD+K  NV L      ++GD G+A++ E   + ++T ++GT  Y++PEL         S
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYNYKS 183

Query: 528 DVYAFGALLLEV 539
           DV+A G  + E+
Sbjct: 184 DVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLF----DEQ----KAILTWEQRYRIIKGVASGLL 456
           LLG   +    L++ + M  G L   L     + +    +A  + ++  ++   +A G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 134 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 12/207 (5%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLV 403
           F     LG G  G V K     +   +A K +  E K  +R +   E+  +       +V
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEW 462
              G     G++ +  + M  GSLD+ L   +KA    E    +I   V  GL YL E+ 
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLREK- 118

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTG 521
              ++HRD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +  
Sbjct: 119 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGT 173

Query: 522 KPTTSSDVYAFGALLLEVVCGRRPIEP 548
             T  SD+++ G  L+E+  GR PI P
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGRYPIPP 200

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 72.7 bits (178), Expect = 8e-14
 Identities = 86/334 (25%), Positives = 139/334 (41%), Gaps = 71/334 (21%)

Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+    VAVK + ++ + + L +  SE+  +  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL----------------DKCLFDEQKAILTWEQRY 445
           ++ LLG C + G L ++ ++   G+L                D C   E++  LT++   
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ--LTFKDLV 137

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGT 499
                VA G+ YL     Q  IHRD+ A NVL+  +   ++ DFGLA+       Y++ T
Sbjct: 138 SCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD 559
           N         + ++APE       T  SDV++FG LL E+            P   I V+
Sbjct: 195 NGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEI------FTLGGSPYPGIPVE 243

Query: 560 WVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV------- 612
            ++   K G        R++   N    L ++     C +     RPT +Q+V       
Sbjct: 244 ELFKLLKEGH-------RMDKPANCTHELYMIM--RECWHAVPSQRPTFKQLVEDLDRVL 294

Query: 613 ------RYLEGEVPLPQAVAAPDACDGKKEKTSG 640
                  YL+  VP  Q   +P   D     +SG
Sbjct: 295 TVTSTDEYLDLSVPFEQ--YSPGCPDSPSSCSSG 326

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 16/207 (7%)

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEIS 392
           Y ++KK          +G G FG+           Q  +K +  S  S +   E   E++
Sbjct: 2   YVKVKK----------IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVA 51

Query: 393 SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVA 452
            +  ++H N+VQ        G+L +V D+   G L K   + Q+ +L  E +  I+    
Sbjct: 52  VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYK-KINAQRGVLFPEDQ--ILDWFV 108

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
              L L    ++ ++HRDIK+ N+ L  +   +LGDFG+A++       + T  +GT  Y
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYY 167

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEV 539
           L+PE+         SD++A G +L E+
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 71.7 bits (175), Expect = 9e-14
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 17/214 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLV 403
           F   EL+G G +G+VYKG    T  Q+A  +V + +     E   EI+ + +   HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 404 QLLGWCRRRG------DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
              G   ++        L LV +F   GS+   + + +   L  E    I + +  GL +
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
           LH+     VIHRDIK  NVLL      +L DFG++   +R      T  +GT  ++APE+
Sbjct: 127 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 182

Query: 518 TRTGK-PTTS----SDVYAFGALLLEVVCGRRPI 546
               + P  +    SD+++ G   +E+  G  P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 22/206 (10%)

Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLRE---FASEISSIGRLRHRNL 402
           LG G FG VY+G           T+VAVK V NES   LRE   F +E S +      ++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESAS-LRERIEFLNEASVMKGFTCHHV 71

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLD---KCLFDEQ-----KAILTWEQRYRIIKGVASG 454
           V+LLG   +    L+V + M +G L    + L  E      +   T ++  ++   +A G
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           + YL+    +  +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + ++
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 514 APELTRTGKPTTSSDVYAFGALLLEV 539
           APE  + G  TTSSD+++FG +L E+
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 24/208 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR----LRHRN--L 402
           ++LG G FG+V    L       AVK +  +    L +   E + + +    L   N  L
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFL 58

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
             L    + +  L  V +F+  G L     DK  FD  +A     +       +  GL +
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAE-------IVCGLQF 111

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
           LH +    +I+RD+K  NV+LD + + ++ DFG+ K    G N ++T   GT  Y+APE+
Sbjct: 112 LHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEI 167

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            +  K T S D ++FG LL E++ G+ P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.7 bits (175), Expect = 2e-13
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 25/214 (11%)

Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRL 397
           KK TR     E +G G  G V+     +T  +VA+K++ N  KQ  +E   +EI  +  L
Sbjct: 19  KKYTR----YEKIGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKEL 73

Query: 398 RHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVA 452
           ++ N+V  L       +L +V +++  GSL     + C+ + Q A +  E          
Sbjct: 74  KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE--------CL 125

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLG 511
             L +LH      VIHRDIK+ NVLL  + + +L DFG  A++    +  ST  +VGT  
Sbjct: 126 QALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180

Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           ++APE+          D+++ G + +E+V G  P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 19/218 (8%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFA-SEI 391
            YE+L+K          +G G +G V+K     T+  VA+KRV  ++  +G+   A  EI
Sbjct: 1   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 50

Query: 392 SSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV 451
             +  L+H+N+V+L         L LV+++  +  L K  FD     +  E     +  +
Sbjct: 51  CLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKK-YFDSCNGDIDPEIVKSFMFQL 108

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG 511
             GL + H      V+HRD+K  N+L++     +L DFGLA+ +       +  VV TL 
Sbjct: 109 LKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLW 164

Query: 512 YLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           Y  P++    K  +TS D+++ G +  E+    RP+ P
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 20/216 (9%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLVQLLGWC 409
           LG G +  V+KG    T   VA+K +  E ++G    A  E+S +  L+H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 410 RRRGDLLLVYDFMPNG---SLDKC--LFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
                L LV++++ +     LD C  L       +   Q  R       GL Y H+   +
Sbjct: 73  HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR-------GLSYCHK---R 122

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGKP 523
            ++HRD+K  N+L++ +   +L DFGLA+     T   +  VV TL Y  P+ L  + + 
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181

Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKA-LPEELILV 558
           +T  D++  G +L E+  G RP+ P + + EEL L+
Sbjct: 182 STPIDMWGVGCILYEMATG-RPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 16/204 (7%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES----KQGLREFASEISSIGRLRHRNLVQ 404
           +++G G FG+V      S  +  AVK +  ++    K+     A     +  L+H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWE 463
           L    +    L  V D++  G L    F  Q+     E R R     VAS + YLH    
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS--- 114

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELTRTG 521
             +I+RD+K  N+LLDS+ +  L DFGL K    G  P  +T+   GT  YLAPE+ R  
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLRKE 171

Query: 522 KPTTSSDVYAFGALLLEVVCGRRP 545
               + D +  GA+L E++ G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 43/221 (19%)

Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDK-----------------CLFDEQKAILTWEQR 444
           ++ LLG C + G L ++ ++   G+L +                  + +EQ   L+++  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ---LSFKDL 142

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERG 498
                 VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+       Y++ 
Sbjct: 143 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
           TN         + ++APE       T  SDV++FG LL E+
Sbjct: 200 TNGRL-----PVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 18/203 (8%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISS-----IGRLRHRNLVQL 405
           +G G FG+V      +     AVK +  ++    +E    I +     +  ++H  LV L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVGL 61

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V D++  G L    F  Q+     E R R     +AS L YLH     
Sbjct: 62  HYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---L 115

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            +I+RD+K  N+LLDS+ +  L DFGL K    G   S  T+   GT  YLAPE+ R   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
              + D +  GA+L E++ G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 21/211 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKR------VSNESKQGLREFASEISSIGRLR 398
           FR   +LG G FG+V       T    A+K       ++ +  + L        +    R
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASG 454
           H  LV L    +    +  V ++   G L       +F E +A+      Y     V  G
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-----Y--AACVVLG 113

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           L YLHE     +++RD+K  N+LLD+E   ++ DFGL K    G    T+   GT  +LA
Sbjct: 114 LQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLA 169

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           PE+      T + D +  G L+ E++ G  P
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 37/218 (16%)

Query: 351 LGFGGFGRVYKG-------TLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V +        + P     VAVK +  N + + L +  SE+  +  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           FD  K     L+++     
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+       Y++ +N 
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 197 RL-----PVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 13/199 (6%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL-REFASEISSIGRLRHRNLVQLL 406
           +E+LG G  G VYK     T   +AVK +  +    L ++  SE+  + +     ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + +  +FM  GSLD       + +L      RI   V  GL YL   W   +
Sbjct: 66  GAFFVENRISICTEFMDGGSLD-VYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKI 116

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRD+K  N+L+++    +L DFG++    +  N      VGT  Y+APE     +    
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 527 SDVYAFGALLLEVVCGRRP 545
           SDV++ G   +E+  GR P
Sbjct: 174 SDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 7/195 (3%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G  G V   T+ S+   VAVK++    +Q      +E+  +   +H N+V++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
              +L +V +F+  G+L   +   +   +  EQ   +   V   L  LH    Q VIHRD
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHA---QGVIHRD 141

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           IK+ ++LL  +   +L DFG      +   P    +VGT  ++APEL          D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 531 AFGALLLEVVCGRRP 545
           + G +++E+V G  P
Sbjct: 201 SLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 47/230 (20%)

Query: 346 RDK----ELLGFGGFGRVYKGTL-------PSTNTQVAVKRVS-NESKQGLREFASEISS 393
           RDK    + LG G FG+V            P     VAVK +  + +++ L +  SE+  
Sbjct: 14  RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73

Query: 394 IGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF-----------------DEQ 435
           +  + +H+N++ LLG C + G L ++ ++   G+L + L                  DEQ
Sbjct: 74  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-- 493
              +T++        VA G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+  
Sbjct: 134 ---MTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 494 ----LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                Y++ TN         + ++APE       T  SDV++FG L+ E+
Sbjct: 188 NNIDYYKKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 51/152 (33%), Positives = 77/152 (50%), Gaps = 12/152 (7%)

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLY 457
           H  LV L    +    L  V +++  G L   +F  Q+     E+  R     ++  L Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAP 515
           LHE   + +I+RD+K  NVLLDSE + +L D+G+ K    G  P  +T+   GT  Y+AP
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAP 165

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
           E+ R      S D +A G L+ E++ GR P +
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 19/211 (9%)

Query: 351 LGFGGFGRVYKGTLPSTNT--QVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V +G L   ++  +VAVK  +++  ++  + +F SE   +    H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 407 GWCRRRGDL------LLVYDFMPNGSLDKCLF----DEQKAILTWEQRYRIIKGVASGLL 456
           G C +  +       +++  FM +G L   L      +    L  +   + +  +ASG+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT-LGYLAP 515
           YL     ++ IHRD+ A N +L+  +N  + DFGL+K    G      R+    + ++A 
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           E       TT SDV++FG  + E+   G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 46/136 (33%), Positives = 72/136 (52%), Gaps = 12/136 (8%)

Query: 415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQTVIHRDIKA 473
           L  V +F+  G L   +F  Q+     E+  R     ++  L +LHE   + +I+RD+K 
Sbjct: 71  LFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKL 124

Query: 474 GNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYA 531
            NVLLD+E + +L D+G+ K    G  P  +T+   GT  Y+APE+ R      S D +A
Sbjct: 125 DNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181

Query: 532 FGALLLEVVCGRRPIE 547
            G L+ E++ GR P +
Sbjct: 182 LGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 13/202 (6%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E+R R     + S L YLH    +
Sbjct: 61  KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS---R 114

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELTRTGKP 523
            V++RDIK  N++LD + + ++ DFGL K  E  ++ +T +   GT  YLAPE+      
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
             + D +  G ++ E++CGR P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 17/210 (8%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLG 407
           E++G G +G+VYKG    T  Q+A  +V + ++    E   EI+ + +   HRN+    G
Sbjct: 22  EVVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 408 WCRRRG------DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
              ++        L LV +F   GS+   + + +   L  +    I + +  GL +LH  
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA- 139

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
               VIHRDIK  NVLL      +L DFG++   +R      T  +GT  ++APE+    
Sbjct: 140 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 196

Query: 522 KPTTS-----SDVYAFGALLLEVVCGRRPI 546
           +   +     SD+++ G   +E+  G  P+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 38/98 (38%), Positives = 57/98 (58%), Gaps = 6/98 (6%)

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGT 509
           +A GL +LH    + +I+RD+K  NV+LD+E + ++ DFG+ K  E      TTR   GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164

Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
             Y+APE+        S D +AFG LL E++ G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 58/223 (26%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIGRLRHRNLVQ 404
           +G+G FG V+  T P    +VA+K++ N        K+  RE    +  +   +H N++ 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRE----LKMLCFFKHDNVLS 63

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDE------------QKAILTWEQR-------- 444
            L             D +    +D   F+E             K I++  Q         
Sbjct: 64  AL-------------DILQPPHID--PFEEIYVVTELMQSDLHKIIVS-PQPLSSDHVKV 107

Query: 445 --YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS 502
             Y+I++G    L YLH      ++HRDIK GN+L++S    ++ DFGLA++ E   +  
Sbjct: 108 FLYQILRG----LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH 160

Query: 503 TTRVVGTLGYLAPELTRTGKP--TTSSDVYAFGALLLEVVCGR 543
            T+ V T  Y APE+   G    T++ D+++ G +  E++  R
Sbjct: 161 MTQEVVTQYYRAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 49/201 (24%), Positives = 95/201 (47%), Gaps = 9/201 (4%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           ++G G FGR       +++ + A+K +   +S   + +   E   + +++H N+V     
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
               G L +V ++   G L + +  ++  +   +   +    +  G+ ++HE   + V+H
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLH 123

Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST--TRVVGTLGYLAPELTRTGKPTTS 526
           RDIK+ N+ L      +LGDFG A+L    T+P       VGT  Y+ PE+         
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLL---TSPGAYACTYVGTPYYVPPEIWENMPYNNK 180

Query: 527 SDVYAFGALLLEVVCGRRPIE 547
           SD+++ G +L E+   + P +
Sbjct: 181 SDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLR-EFASEISSIGRLR---HRNLVQL 405
           +G G +G VYK   P +   VA+K V  ++ + GL      E++ + RL    H N+V+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 406 LGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           +  C      R   + LV++ + +  L   L       L  E    +++    GL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
                ++HRD+K  N+L+ S    +L DFGLA++Y      + T VV TL Y APE+   
Sbjct: 127 ---NCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAPEVLLQ 181

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPI 546
               T  D+++ G +  E+   R+P+
Sbjct: 182 STYATPVDMWSVGCIFAEMF-RRKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 28/217 (12%)

Query: 350 LLGFGGFGRVYKGTLPSTN---TQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQ 404
           +LG G FG V +  L S +    +VAVK +  +  S   + EF  E + +    H N+++
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 405 LLGWC---RRRGDL---LLVYDFMPNGSLDKCLF----DEQKAILTWEQRYRIIKGVASG 454
           L+G     R +G L   +++  FM +G L   L      E+   L  +   R +  +ASG
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL-----YERGTNPSTTRVVGT 509
           + YL     +  IHRD+ A N +L+  +   + DFGL+K      Y R    S   V   
Sbjct: 126 MEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV--- 179

Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
             +LA E       TT SDV+AFG  + E++  G+ P
Sbjct: 180 -KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ--LLGW 408
           +G G FG+VY+     T    A+K +S +     +E A  I        RN++   LL  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG------ERNILVRTLLDE 54

Query: 409 C----------RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
                      +   DL LV D+M  G L    +  QK     E R +    +A  +L L
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFSEDRAKFY--IAELVLAL 109

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               +  +++RD+K  N+LLD+  +  L DFGL+K      N +T    GT  YLAPE+ 
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVL 168

Query: 519 RTGKPTTSS-DVYAFGALLLEVVCGRRP 545
              K  T   D ++ G L+ E+ CG  P
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 54/192 (28%), Positives = 84/192 (43%), Gaps = 9/192 (4%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G +G VYK    +T    A+K +  E  +       EI  +   +H N+V   G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           RR  L +  +F   GSL           L+  Q   + +    GL YLH + +   +HRD
Sbjct: 77  RRDKLWICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRD 131

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT---RTGKPTTSS 527
           IK  N+LL    + +L DFG++      T       +GT  ++APE+    R G      
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQIT-ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190

Query: 528 DVYAFGALLLEV 539
           D++A G   +E+
Sbjct: 191 DIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 27/231 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR------LRHRNL 402
           ++LG G FG+V+   L  TN   A+K +  +    L +   E + + +        H  L
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFL 58

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSL----DKC-LFDEQKAILTWEQRYRIIKGVASGLLY 457
             L    + + +L  V +++  G L      C  FD  +A     +       +  GL +
Sbjct: 59  THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE-------IICGLQF 111

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
           LH    + +++RD+K  N+LLD++ + ++ DFG+ K    G +  T    GT  Y+APE+
Sbjct: 112 LH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFCGTPDYIAPEI 167

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRP---IEPKALPEELILVDWVWDRW 565
               K  TS D ++FG LL E++ G+ P    + + L + + + +  + RW
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRW 218

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 65/284 (22%), Positives = 115/284 (40%), Gaps = 47/284 (16%)

Query: 351 LGFGGFGRVYKGTL---PSTNTQVAVKRVSNESK---QGLR---EFASEISSIGRLRHRN 401
           LG G F  +YKG L      +     + VS   K      R    F    S + +L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           LV+L G C R  +++ V +++  G LD  L   +K  ++   +  + K +AS L YL + 
Sbjct: 63  LVKLYGVCVRDENIM-VEEYVKFGPLDVFL-HREKNNVSLHWKLDVAKQLASALHYLED- 119

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY-------LA 514
             + ++H ++   N+L+      R G       + + ++P     V +          +A
Sbjct: 120 --KKLVHGNVCGKNILV-----ARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIA 172

Query: 515 PELTRTG--KPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAIL 571
           PE  R G    T ++D ++FG  LLE+   G  P+   +  E+          ++    L
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQDQHRL 225

Query: 572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            + D             ++  L   C       RP+ R ++R L
Sbjct: 226 PMPDCA-----------ELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 9/134 (6%)

Query: 415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQTVIHRDIKA 473
           L L+ D++  G L   L+  +      E   R+    +   L +LH+     +I+RDIK 
Sbjct: 80  LHLILDYVNGGELFTHLYQREHFT---ESEVRVYIAEIVLALDHLHQ---LGIIYRDIKL 133

Query: 474 GNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS--DVYA 531
            N+LLDSE +  L DFGL+K +            GT+ Y+APE+ R G        D ++
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193

Query: 532 FGALLLEVVCGRRP 545
            G L  E++ G  P
Sbjct: 194 LGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 36/222 (16%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIG-------------R 396
           LG G +G+V K     T   VA+K+V   E    + +    +   G              
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           ++H N++ L+        + LV D M    L K +  ++K  LT  Q   I+  + +GL 
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV--DRKIRLTESQVKCILLQILNGLN 133

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---------ERGTNPS----- 502
            LH+ +    +HRD+   N+ ++S+   ++ DFGLA+ Y          +          
Sbjct: 134 VLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190

Query: 503 TTRVVGTLGYLAPELTR-TGKPTTSSDVYAFGALLLEVVCGR 543
           T++VV TL Y APEL     K   + D+++ G +  E++ G+
Sbjct: 191 TSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 39/98 (39%), Positives = 58/98 (59%), Gaps = 6/98 (6%)

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGT 509
           +A GL +LH    + +I+RD+K  NV+LDSE + ++ DFG+ K  E   +  TT+   GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164

Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
             Y+APE+        S D +AFG LL E++ G+ P E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 29/219 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           + D   LG G  G V+       + +VAVK++     Q ++    EI  I RL H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 405 L---LGWCRRR-----GDLL---LVYDFMPNGSLDKCLFDEQKAILTWEQR---YRIIKG 450
           +   LG          G L     VY        D     EQ  +     R   Y++++G
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRG 126

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKL----YERGTNPSTTR 505
               L Y+H      V+HRD+K  NV +++E L  ++GDFGLA++    Y      S   
Sbjct: 127 ----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179

Query: 506 VVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           V  T  Y +P L  +    T + D++A G +  E++ G+
Sbjct: 180 V--TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)

Query: 351 LGFGGFGRVYKG-TLPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRLRHRNLV 403
           +G G +G+V+K   L +    VA+KRV  ++ +       +RE A  +  +    H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 67

Query: 404 QLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
           +L   C      R   L LV++ + +  L   L    +  +  E    ++  +  GL +L
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H      V+HRD+K  N+L+ S    +L DFGLA++Y      + T VV TL Y APE+ 
Sbjct: 127 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVL 181

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRPI 546
                 T  D+++ G +  E+   R+P+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMF-RRKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 32/213 (15%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK---RVSN--ESKQGLREFASEISSIGRLRHR--N 401
             +G G  G+VYK     T   +AVK   R  N  E+K+ L +       +    H    
Sbjct: 21  GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL-----DVVLKSHDCPY 75

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQK----AILTWEQRYRIIKGVASGLLY 457
           +V+  G+     D+ +  + M    LDK L   Q      IL      ++   +   L Y
Sbjct: 76  IVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILG-----KMTVAIVKALHY 129

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPE 516
           L E+    VIHRD+K  N+LLD+  N +L DFG++ +L +       TR  G   Y+APE
Sbjct: 130 LKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPE 184

Query: 517 LTRTGKPTTS----SDVYAFGALLLEVVCGRRP 545
                 P       +DV++ G  L+E+  G+ P
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 66.6 bits (162), Expect = 2e-11
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 20/176 (11%)

Query: 374 KRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR---------RRGDLLLVYDFMPN 424
           KRV   S+  + +  +EI ++GRL H N++++    R         ++ D  L Y FM +
Sbjct: 198 KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDL-YSFMYD 255

Query: 425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG 484
            +     FD +   L  + R  I+K +   + Y+H+   + +IHRDIK  N+ L+ +   
Sbjct: 256 EA-----FDWKDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKI 306

Query: 485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
            LGDFG A  +E+         VGT+   +PE+         +D+++ G +LL+++
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 13/216 (6%)

Query: 349 ELLGFGGFGRVY---KGTLPSTNTQVAVK---RVSNESKQGLREFASEISSIGRLRHRNL 402
           ++LG G FG+V+   K T P      A+K   + + + +  +R    E   +  + H  +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFI 60

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V+L    +  G L L+ DF+  G L   L  E   + T E     +  +A  L +LH   
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS-- 116

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+LLD E + +L DFGL+K              GT+ Y+APE+     
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRG 174

Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
            T S+D ++FG L+ E++ G  P + K   E + ++
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 45/136 (33%), Positives = 73/136 (53%), Gaps = 12/136 (8%)

Query: 415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQTVIHRDIKA 473
           L LV +++  G L   +F  Q+     E+  R     +   L +LHE   + +I+RD+K 
Sbjct: 71  LFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKL 124

Query: 474 GNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYA 531
            NVLLD++ + +L D+G+ K    G  P  +T+   GT  Y+APE+ R  +   S D +A
Sbjct: 125 DNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181

Query: 532 FGALLLEVVCGRRPIE 547
            G L+ E++ GR P +
Sbjct: 182 LGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 54/226 (23%)

Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIGRLR-H 399
           LG G +G V       T       VA+K+++N       +K+ LRE    +  +   R H
Sbjct: 8   LGQGAYGIVCSARNAETSE--EETVAIKKITNVFSKKILAKRALRE----LKLLRHFRGH 61

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE-----QKAILTWEQR---------- 444
           +N+  L        D+ +V+    N      L++E        I+   Q           
Sbjct: 62  KNITCLY-------DMDIVFPGNFNELY---LYEELMEADLHQIIRSGQPLTDAHFQSFI 111

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG---TNP 501
           Y+I+     GL Y+H      V+HRD+K GN+L++++   ++ DFGLA+ +         
Sbjct: 112 YQIL----CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164

Query: 502 STTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPI 546
             T  V T  Y APE+  + +  T + DV++ G +L E++ GR+P+
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.0 bits (161), Expect = 3e-11
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 1/100 (1%)

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYL 513
           LL +H    + +IHRDIK+ N+LL S    +LGDFG +K+Y    +    R   GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           APE+ R    +  +D+++ G LL E++  +RP + + + E
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE 252

Length = 496

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 20/212 (9%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEIS 392
           SYE+L+K          LG G +  VYKG        VA+K +  + ++G    A  E S
Sbjct: 6   SYEKLEK----------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS 55

Query: 393 SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF-DEQKAILTWEQRYRIIKGV 451
            +  L+H N+V L      +  L LV++++     D C + D+    L  E     +  +
Sbjct: 56  LLKGLKHANIVLLHDIIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQL 112

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG 511
             GL Y+H+ +   ++HRD+K  N+L+      +L DFGLA+     ++  +  VV TL 
Sbjct: 113 LRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLW 168

Query: 512 YLAPE-LTRTGKPTTSSDVYAFGALLLEVVCG 542
           Y  P+ L  + + +T  D++  G + +E++ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 46/221 (20%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIG-----RL-- 397
           +++   +G G +G+V       T  +VA+K++S       R F S I +       RL  
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLK 69

Query: 398 --RHRNLVQLLG-WCRRRG-----DLLLVYDFMPN--GSLDKC--LFDEQKAILTWEQRY 445
              H N++ LL  +          D+ LV   M     ++ KC  L D+    L     Y
Sbjct: 70  HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLV----Y 125

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL--DSELNGRLGDFGLAKLYERGTNPST 503
           +I++G    L Y+H      +IHRD+K  N+ +  D EL  ++ DFGLA    R T+   
Sbjct: 126 QILRG----LKYIHS---AGIIHRDLKPSNIAVNEDCEL--KILDFGLA----RHTDDEM 172

Query: 504 TRVVGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVVCGR 543
           T  V T  Y APE +        + D+++ G ++ E++ G+
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 37/98 (37%), Positives = 58/98 (59%), Gaps = 6/98 (6%)

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGT 509
           ++ GL +LH    + +I+RD+K  NV+LDSE + ++ DFG+ K  E   +  TTR   GT
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGT 164

Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
             Y+APE+        S D +A+G LL E++ G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 49/206 (23%), Positives = 96/206 (46%), Gaps = 17/206 (8%)

Query: 349 ELLGFGGFGRVYKGTLPST-------NTQVAVKRVSNESKQGLREFASEISSIGRLRHRN 401
           E LG G F +++KG             T+V +K +    +     F    S + +L H++
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-LTWEQRYRIIKGVASGLLYLHE 460
           LV   G C    + ++V +++  GSLD  L   +  I ++W  +  + K +A  L +L  
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE- 117

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR---VVGTLGYLAPEL 517
             ++ + H ++ A NVLL  E + + G+    KL + G + +      ++  + ++ PE 
Sbjct: 118 --DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175

Query: 518 TRTGKP-TTSSDVYAFGALLLEVVCG 542
               +  + ++D ++FG  L E+  G
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 76/283 (26%), Positives = 129/283 (45%), Gaps = 44/283 (15%)

Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSNE-SKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 69  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL E   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 124 YLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWM 178

Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P +   +P   I            +ILE
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEI-----------SSILE 225

Query: 573 VVDPRLNGEF---NEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
                  GE      I  +DV  + + C    A++RP  R+++
Sbjct: 226 ------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.5 bits (157), Expect = 5e-11
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 40/218 (18%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES----KQGLREFASEISSIGRLRHR 400
           F   E LG G FGRV       T    A+K +        KQ ++  A E S +  L H 
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHP 78

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSL------------DKCLFDEQKAILTWEQRYRII 448
            +V ++   +    +  + +F+  G L            D   F   + +L +E      
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE------ 132

Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
                   YLH    + +I+RD+K  N+LLD++ + ++ DFG AK + +R     T  + 
Sbjct: 133 --------YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLC 176

Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           GT  YLAPE+ ++     + D +  G LL E + G  P
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      ++    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               + +  L  V +++  G L    F   +  +  E R R     + S L YLH     
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHS---G 114

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELTRTGKP 523
            +++RD+K  N++LD + + ++ DFGL K  E  T+ +T +   GT  YLAPE+      
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
             + D +  G ++ E++CGR P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.6 bits (154), Expect = 6e-11
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 23/213 (10%)

Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR 398
           KK TR     E +G G  G VY     +T  +VA+K+++ + +       +EI  +   +
Sbjct: 19  KKYTR----FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK 74

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVAS 453
           + N+V  L       +L +V +++  GSL     + C+ + Q A +  E           
Sbjct: 75  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQ 126

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGY 512
            L +LH      VIHRDIK+ N+LL  + + +L DFG  A++    +  ST  +VGT  +
Sbjct: 127 ALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 181

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+          D+++ G + +E+V G  P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE---FASEISSIGRLRHRN 401
               + +G G FGRV+      +    A+K ++      L++     +E   +  + H  
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           +++L      +  L ++ +++P G L   L     F     +    +       +   L 
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE-------IVCALE 115

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YLH    + +++RD+K  N+LLD E + +L DFG AK L +R     T  + GT  YLAP
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAP 167

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           E+ ++     + D +A G L+ E++ G  P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 28/217 (12%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEIS 392
           +Y++L K          LG G +  VYKG    T   VA+K +  E ++G    A  E S
Sbjct: 6   TYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREAS 55

Query: 393 SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG---SLDKC--LFDEQKAILTWEQRYRI 447
            +  L+H N+V L      +  L LV++++       +D C          L   Q  R 
Sbjct: 56  LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR- 114

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
                 GL Y H   ++ V+HRD+K  N+L+      +L DFGLA+     +   +  VV
Sbjct: 115 ------GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV 165

Query: 508 GTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVVCGR 543
            TL Y  P+ L  + + +TS D++  G +  E+  GR
Sbjct: 166 -TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 12/202 (5%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E R R     + S L YLH E   
Sbjct: 61  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN- 116

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELTRTGKP 523
            V++RD+K  N++LD + + ++ DFGL K  E   + +T +   GT  YLAPE+      
Sbjct: 117 -VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY 173

Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
             + D +  G ++ E++CGR P
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE------SKQGLREFASEISSIG 395
           T  + D + +G G FG V       T   VA+K++         +K+  RE    +  + 
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE----LKLLK 64

Query: 396 RLRHRNLVQLLG-WCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGV 451
            LRH N++ L   +     D+  V + +    L + L     E++ I  +   Y+I++G 
Sbjct: 65  HLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYF--LYQILRG- 120

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG 511
              L Y+H      V+HRD+K  N+L++   + ++ DFGLA++ +    P  T  V T  
Sbjct: 121 ---LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVSTRY 170

Query: 512 YLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEP 548
           Y APE+  T  K     D+++ G +  E++ G +P+ P
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFP 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 64/204 (31%), Positives = 91/204 (44%), Gaps = 16/204 (7%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE----FASEISSIGRLRHRNLVQ 404
           +++G G FG+V            AVK +  +     +E     A     +  ++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRI-IKGVASGLLYLHEEWE 463
           L    +    L  V DF+  G L    F  Q+     E R R     +AS L YLH    
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS--- 114

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTG 521
             +++RD+K  N+LLDS+ +  L DFGL K    G   S  TT   GT  YLAPE+ R  
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 522 KPTTSSDVYAFGALLLEVVCGRRP 545
               + D +  GA+L E++ G  P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 34/215 (15%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS----EISSIGRLRHR 400
           +RD + +G G +G V       T  +VA+K++    +  L  FA     E+  +  ++H 
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL--FAKRAYRELRLLKHMKHE 74

Query: 401 NLVQLLGW------CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR-----YRIIK 449
           N++ LL          R  D  LV  FM    L K +  E+ +    E R     Y+++K
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLS----EDRIQFLVYQMLK 129

Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT 509
           G    L Y+H      +IHRD+K GN+ ++ +   ++ DFGLA    R T+   T  V T
Sbjct: 130 G----LKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA----RQTDSEMTGYVVT 178

Query: 510 LGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGR 543
             Y APE+       T + D+++ G ++ E++ G+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 12/200 (6%)

Query: 346 RDKELL---GFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL 402
            D EL+   G G +G VYK     T    AVK +  E          EI  +   +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V   G    R  L +  ++   GSL           L+  Q   + +    GL YLH + 
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT---R 519
           +   +HRDIK  N+LL    + +L DFG+A      T       +GT  ++APE+    +
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAKIT-ATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 520 TGKPTTSSDVYAFGALLLEV 539
            G      D++A G   +E+
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 12/210 (5%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGR-LRHRNLVQ 404
           +++G G FG+V      +     AVK +  ++   K+  +   SE + + + ++H  LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWE 463
           L    +    L  V D++  G L    +  Q+     E R R     +AS L YLH    
Sbjct: 61  LHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLHS--- 114

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
             +++RD+K  N+LLDS+ +  L DFGL K      N +T+   GT  YLAPE+      
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
             + D +  GA+L E++ G  P   +   E
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 25/226 (11%)

Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRV-SNESKQGLREFASEISSIGRLRH 399
            +  ++LG G FG VYKG  +P   +    VA+K +  N S +  +E   E   +  +  
Sbjct: 9   LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
             + +LLG C     + LV   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 69  PYVCRLLGICLT-STVQLVTQLMPYG----CLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL E     ++HRD+ A NVL+ S  + ++ DFGLA+L    E   +    +V   + ++
Sbjct: 124 YLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWM 178

Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRP---IEPKALPEEL 555
           A E     + T  SDV+++G  + E++  G +P   I  + +P+ L
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 36/224 (16%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIGRLR 398
           ++ +E++G G +G V       T  +VA+K++++      ++ + LRE    I  +  LR
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILRE----IKLLRLLR 57

Query: 399 HRNLVQ----LLGWCRRR-GDLLLVYDFMPNGSLDKCLFDEQKAI-----LTWEQRYRII 448
           H ++V+    +L   RR   D+ +V++ M +        D  + I     LT E     +
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELMES--------DLHQVIKANDDLTPEHHQFFL 109

Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST--TRV 506
             +   L Y+H      V HRD+K  N+L +++   ++ DFGLA++    T  +   T  
Sbjct: 110 YQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166

Query: 507 VGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRRPIEP 548
           V T  Y APEL  +   K T + D+++ G +  EV+ G +P+ P
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFP 209

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 25/218 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
           F  K L+G G FG V      +T    A+K +      +++ +  F  E   +       
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL------FDEQKAILTWEQRYRIIKGVASGL 455
           + QL    + + +L LV ++ P G L   L      FDE  A     Q Y     +A  +
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA-----QFY-----LAELV 112

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           L +H   +   +HRDIK  NVL+D   + +L DFG A         ++   VGT  Y+AP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172

Query: 516 ELTRT----GKPT--TSSDVYAFGALLLEVVCGRRPIE 547
           E+  T    GK T     D ++ G +  E++ GR P  
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 28/235 (11%)

Query: 330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS 389
                 E L   T  +   E +G G +G+VYK T     +  AVK + +       E  +
Sbjct: 9   SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEA 67

Query: 390 EISSIGRL-RHRNLVQLLGWCRRR-----GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ 443
           E + +  L  H N+V+  G   +      G L LV +    GS+ + +    K +L   Q
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQ 123

Query: 444 RYR------IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYE 496
           R        I+ G   GL +LH      +IHRD+K  N+LL +E   +L DFG+ A+L  
Sbjct: 124 RLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Query: 497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSS-----DVYAFGALLLEVVCGRRPI 546
                +T+  VGT  ++APE+    +    S     DV++ G   +E+  G  P+
Sbjct: 181 TRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 15/218 (6%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E R R     + S L YLH     
Sbjct: 61  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALGYLHS---C 114

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELTRTGKP 523
            V++RD+K  N++LD + + ++ DFGL K  E  ++ +T +   GT  YLAPE+      
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALPE--ELILVD 559
             + D +  G ++ E++CGR P   +   +  ELIL++
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 60.9 bits (147), Expect = 4e-10
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR 398
           KK TR     E +G G  G VY     +T  +VA+++++ + +       +EI  +   +
Sbjct: 20  KKYTR----FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVAS 453
           + N+V  L       +L +V +++  GSL     + C+ + Q A +  E           
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQ 127

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGY 512
            L +LH      VIHRDIK+ N+LL  + + +L DFG  A++    +  S   +VGT  +
Sbjct: 128 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYW 182

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+          D+++ G + +E++ G  P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 9/206 (4%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLG 407
           +G G FG+V +     T    A+K +      S+  +    +E + + ++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
             +    L LV  F+  G L   L  E +  L+  + Y      A  L  L    +  VI
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFY-----TAELLCALENLHKFNVI 115

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           +RD+K  N+LLD + +  L DFGL KL  +  + + T   GT  YLAPEL      T + 
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTKAV 174

Query: 528 DVYAFGALLLEVVCGRRPIEPKALPE 553
           D +  G LL E++ G  P   + + E
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENVNE 200

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 11/211 (5%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLVQLLG 407
           E LG G +  VYKG        VA+K +S ++++G+   A  E S +  L+H N+V L  
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
               +  L  V+++M +  L + +      +  +  R  + + +  GL Y+H    Q ++
Sbjct: 71  IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIHG---QHIL 125

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGKPTTS 526
           HRD+K  N+L+      +L DFGLA+     +   ++ VV TL Y  P+ L      +++
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184

Query: 527 SDVYAFGALLLEVVCGRRPIEP--KALPEEL 555
            D++  G + +E++ G +P  P    + E+L
Sbjct: 185 LDIWGAGCIFIEMLQG-QPAFPGVSDVFEQL 214

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASE--ISSIGRLRHRNLVQ 404
           ++G GGFG VY      T    A+K +  +    KQG     +E  + S+        + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 405 LLGWCRRRGD-LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            + +     D L  + D M  G L   L   Q  + + ++       +  GL ++H  + 
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHNRF- 117

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
             V++RD+K  N+LLD   + R+ D GLA  + +   P  +  VGT GY+APE+ + G  
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEVLQKGTA 172

Query: 524 -TTSSDVYAFGALLLEVVCGRRP 545
             +S+D ++ G +L +++ G  P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLG 407
           +G GG+G+V+      T   VA+KR+          +R   +E   +   +   LV+LL 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
             +    L L  +++P G   + L +    +     R+ + +   + +  LHE      I
Sbjct: 69  AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEA-VDALHE---LGYI 123

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HRD+K  N L+D+  + +L DFGL+K    G       VVG+  Y+APE+ R      + 
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDFTV 179

Query: 528 DVYAFGALLLEVVCGRRP 545
           D ++ G +L E +CG  P
Sbjct: 180 DYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 16/207 (7%)

Query: 349 ELLGFGGFGRVY---KGTLPSTNTQVAVKRVSN----ESKQGLREFASEISSIGRLRHRN 401
           ++LG G +G+V+   K T   T    A+K +      +  + +    +E + +  +R   
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 402 -LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLH 459
            LV L    +    L L+ D++  G +   L+         E   R   G +   L +LH
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILALEHLH 122

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
           +     +++RDIK  N+LLDSE +  L DFGL+K +       T    GT+ Y+APE+ R
Sbjct: 123 K---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179

Query: 520 T-GKPTTSSDVYAFGALLLEVVCGRRP 545
             G    + D ++ G L+ E++ G  P
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 57/238 (23%), Positives = 89/238 (37%), Gaps = 58/238 (24%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNE----SKQGL-----REFASEISSIGRLRHR 400
           ++G G FG V+      T    A+K +         Q       R+  ++  S       
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS------P 61

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGL 455
            +V+L    +    L LV ++MP G L      K +F E        + Y     +A  +
Sbjct: 62  WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-----ETARFY-----IAELV 111

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-----------LYERGTNPSTT 504
           L L    +   IHRDIK  N+L+D++ + +L DFGL K           L +        
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 505 R-----------------VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
                              VGT  Y+APE+ R        D ++ G +L E++ G  P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 351 LGFGGFGRVYKGTL--PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           +G G FG+V    +   +   +V VK + +N S +   EF  +      L+H N++Q LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR-------YRIIKGVASGLLYLHE 460
            C      LLV+++   G L   L  EQ     W +R        R+   +A+G+ ++H 
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQ-----WHRRNSQLLLLQRMACEIAAGVTHMH- 116

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTR 519
             +   +H D+   N  L S+L  ++GD+G+    Y+     +       L +LAPEL  
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174

Query: 520 -------TGKPTTSSDVYAFGALLLEVV-CGRRP 545
                  T + T  S+V+A G  L E+     +P
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 35/213 (16%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLL 406
           ++G GGFG VY      T    A+K +  +    KQG    A        L  R ++ L+
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLA--------LNERIMLSLV 51

Query: 407 --GWC----------RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VAS 453
             G C               L  + D M  G L   L   Q  + + E   R     +  
Sbjct: 52  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFS-EAEMRFYAAEIIL 108

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL 513
           GL ++H  +   V++RD+K  N+LLD   + R+ D GLA  + +   P  +  VGT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYM 162

Query: 514 APELTRTGKPTTSS-DVYAFGALLLEVVCGRRP 545
           APE+ + G    SS D ++ G +L +++ G  P
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 6e-09
 Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 15/198 (7%)

Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
           G+   + L  G  GRV+  T P     V +K     +         E   +  + H +++
Sbjct: 67  GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVI 120

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLF-DEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           ++           +V   +P+ S D   +  ++   L  +Q   I K +  GL YLH   
Sbjct: 121 RMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA-- 175

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            Q +IHRD+K  N+ ++      +GD G A+       P+   + GT+   APE+    K
Sbjct: 176 -QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVETNAPEVLARDK 232

Query: 523 PTTSSDVYAFGALLLEVV 540
             + +D+++ G +L E++
Sbjct: 233 YNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 73/285 (25%), Positives = 129/285 (45%), Gaps = 46/285 (16%)

Query: 349 ELLGFGGFGRVYKGTL--------PSTNTQVAVKRVSNESKQGLRE----FASEISSIGR 396
           E LG G   ++Y G L           + +  +K +        R+    F    S + +
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKA-ILTWEQRYRIIKGVASGL 455
           + H+++V L G C R  + ++V +F+  G LD  LF  +K+ +LT   ++++ K +AS L
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASAL 118

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLYERG---TNPSTTRVVGTLG 511
            YL    ++ ++H ++   N+LL  E ++G  G F   KL + G   T  S    V  + 
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQECVERIP 173

Query: 512 YLAPELTRTGKP-TTSSDVYAFGALLLEVVC--GRRPIEPKALPEELILVDWVWDRWKAG 568
           ++APE     K  + ++D ++FG  L E +C  G  P++ K L E+        +R+  G
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWE-ICYNGEIPLKDKTLAEK--------ERFYEG 224

Query: 569 AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
             + +V P            ++  L   C N     RP  R ++R
Sbjct: 225 QCM-LVTPSCK---------ELADLMTHCMNYDPNQRPFFRAIMR 259

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 9/134 (6%)

Query: 415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQTVIHRDIKA 473
           L L+ D++  G L   L   ++     EQ  +I  G +   L +LH+     +I+RDIK 
Sbjct: 80  LHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLHK---LGIIYRDIKL 133

Query: 474 GNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP--TTSSDVYA 531
            N+LLDS  +  L DFGL+K +            GT+ Y+AP++ R G      + D ++
Sbjct: 134 ENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWS 193

Query: 532 FGALLLEVVCGRRP 545
            G L+ E++ G  P
Sbjct: 194 MGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.6 bits (142), Expect = 9e-09
 Identities = 62/239 (25%), Positives = 95/239 (39%), Gaps = 60/239 (25%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGLREFASEISSIGRLRHRNLVQLL 406
           L+G GG G VY    P  + +VA+K++     E+    + F  E      L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 407 GWCRRRGDLLLVYDFMP----------------NGSLDKCLFDEQKAILTWEQRYRIIKG 450
             C   GD   VY  MP                  SL K L  E+ ++  +     I   
Sbjct: 69  SICSD-GDP--VYYTMPYIEGYTLKSLLKSVWQKESLSKEL-AEKTSVGAF---LSIFHK 121

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG-----DFGLAK------------ 493
           + + + Y+H    + V+HRD+K  N+LL     G  G     D+G A             
Sbjct: 122 ICATIEYVHS---KGVLHRDLKPDNILL-----GLFGEVVILDWGAAIFKKLEEEDLLDI 173

Query: 494 -------LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   Y   T P   ++VGT  Y+APE       + S+D+YA G +L +++    P
Sbjct: 174 DVDERNICYSSMTIPG--KIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 14/166 (8%)

Query: 389 SEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR---- 444
           SE+  +    H  +V+     +    LLL+ ++   G L+K +    K  L +++     
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 445 --YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS 502
             Y+I+       L L E   + ++HRD+K+ N+ L      +LGDFG +K Y    +  
Sbjct: 174 LFYQIV-------LALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 503 T-TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
             +   GT  YLAPEL    + +  +D+++ G +L E++   RP +
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272

Length = 478

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 19/208 (9%)

Query: 348 KELLGFGGFGRVY---KGTLPSTNTQVAVKRVSN----ESKQGLREFASEISSIGRLRHR 400
            ++LG GG+G+V+   K T   T    A+K +       +++      +E + +  ++H 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
            +V L+   +  G L L+ +++  G L   L  E++ I   +     +  ++  L +LH+
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK--LYERGTNPSTTRVVGTLGYLAPE-L 517
              Q +I+RD+K  N+LLD++ + +L DFGL K  ++E      T    GT+ Y+APE L
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE---GTVTHTFCGTIEYMAPEIL 172

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            R+G    + D ++ GAL+ +++ G  P
Sbjct: 173 MRSGH-GKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 24/204 (11%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHRNLVQLLG- 407
           +G G +G V       T  +VAVK++S   +S    +    E+  +  ++H N++ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 408 -----WCRRRGDLLLVYDFMPN--GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
                      D+ LV   M     ++ KC    QK  LT +    +I  +  GL Y+H 
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK--LTDDHVQFLIYQILRGLKYIHS 138

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
                +IHRD+K  N+ ++ +   ++ DFGLA    R T+   T  V T  Y APE+   
Sbjct: 139 ---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLN 191

Query: 521 GKP-TTSSDVYAFGALLLEVVCGR 543
                 + D+++ G ++ E++ GR
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 7/109 (6%)

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG-LAKLYERGTNPSTTRVVGT 509
           +A  +L +H   +   +HRDIK  NVLLD   + RL DFG   K+ + GT  S+   VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-AVGT 166

Query: 510 LGYLAPELTRT-----GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
             Y++PE+ +      GK     D ++ G  + E++ G  P   ++L E
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHRNLVQLL-- 406
           +G G +G V          +VAVK++S   +S    R    E+  +  ++H N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 407 ----GWCRRRGDLLLVYDFMPN--GSLDKC--LFDEQKAILTWEQRYRIIKGVASGLLYL 458
                      ++ LV + M     ++ KC  L DE    L     Y++++G    L Y+
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI----YQLLRG----LKYI 134

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H      +IHRD+K  NV ++ +   R+ DFGLA    R  +   T  V T  Y APE+ 
Sbjct: 135 HS---AGIIHRDLKPSNVAVNEDCELRILDFGLA----RQADDEMTGYVATRWYRAPEIM 187

Query: 519 RTGKPTTSS-DVYAFGALLLEVVCGR 543
                   + D+++ G ++ E++ G+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 29/88 (32%), Positives = 54/88 (61%), Gaps = 5/88 (5%)

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL 513
           G+ Y+H+   + ++HRD+KA N+ L + L  ++GDFG+++L     + +TT   GT  Y+
Sbjct: 118 GVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT-FTGTPYYM 172

Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC 541
           +PE  +     + SD+++ G +L E+ C
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.3 bits (131), Expect = 8e-08
 Identities = 41/137 (29%), Positives = 65/137 (47%), Gaps = 17/137 (12%)

Query: 352 GFGGFGRVYKGTLPSTNTQVAVKRVS--NESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
            F     V+      TNT VAVK+++  + SK+ L+    EI +  +L+H N++  +   
Sbjct: 9   CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 410 RRRGDLLLVYDFMPNGS---LDKCLFDE---QKAILTWEQRYRIIKGVASGLLYLHEEWE 463
               +L +V   M  GS   L K  F E   + AI      + I+K V + L Y+H +  
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI-----AF-ILKDVLNALDYIHSK-- 120

Query: 464 QTVIHRDIKAGNVLLDS 480
              IHR +KA ++LL  
Sbjct: 121 -GFIHRSVKASHILLSG 136

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 45/234 (19%)

Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA 388
           F  EE+ K        +   + +G G +G V       T  +VA+K++S       R F 
Sbjct: 1   FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-------RPFQ 53

Query: 389 SEI------SSIGRLRHRNLVQLLGWCRRRG---------DLLLVYDFMPNGSLDKCLFD 433
           SEI        +  L+H     ++G               D  LV  +M          D
Sbjct: 54  SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT--------D 105

Query: 434 EQKAI---LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG 490
            QK +   L+ ++   ++  +  GL Y+H      +IHRD+K GN+ ++ +   ++ DFG
Sbjct: 106 LQKIMGHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFG 162

Query: 491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           LA    R  +   T  V T  Y APE+         + D+++ G ++ E++ G+
Sbjct: 163 LA----RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 22/232 (9%)

Query: 335 YEELKKATRGFRDK-------ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLR 385
           YE++ +  R  + K       +++G G FG V      S+    A+K +S     K+   
Sbjct: 28  YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87

Query: 386 EFASEISSIGRLRHRN-LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR 444
            F  E   I    +   +VQL    +    L +V ++MP G L   L         W + 
Sbjct: 88  AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF 146

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPST 503
           Y      A  +L L       +IHRD+K  N+LLD   + +L DFG   K+ E G     
Sbjct: 147 Y-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201

Query: 504 TRVVGTLGYLAPELTRT----GKPTTSSDVYAFGALLLEVVCGRRPIEPKAL 551
           T  VGT  Y++PE+ ++    G      D ++ G  L E++ G  P    +L
Sbjct: 202 T-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 19/217 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRN- 401
           F   +++G G FG V      S+    A+K +S     K+    F  E   I  + H N 
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANS 102

Query: 402 --LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
             +VQL    +    L +V ++MP G L   L         W + Y     V   L  +H
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFY--TAEVVLALDAIH 159

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELT 518
                  IHRD+K  N+LLD   + +L DFG   K+   G     T  VGT  Y++PE+ 
Sbjct: 160 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVL 215

Query: 519 RT----GKPTTSSDVYAFGALLLEVVCGRRPIEPKAL 551
           ++    G      D ++ G  L E++ G  P    +L
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 35/206 (16%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLR-HRNLVQLLG 407
           +G G F  V K     T    A+K +    +S + +     EI ++ RL  H N+++L+ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65

Query: 408 --WCRRRGDLLLV--------YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
             + R+ G L LV        Y+ +      K    E++ + ++   Y+++K     L +
Sbjct: 66  VLFDRKTGRLALVFELMDMNLYELIKG---RKRPLPEKR-VKSY--MYQLLKS----LDH 115

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAPE 516
           +H      + HRDIK  N+L+  ++  +L DFG  + +Y +   P  T  + T  Y APE
Sbjct: 116 MHR---NGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSK---PPYTEYISTRWYRAPE 168

Query: 517 --LTRTGKPTTSSDVYAFGALLLEVV 540
             LT  G      D++A G +  E++
Sbjct: 169 CLLT-DGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 65/248 (26%), Positives = 96/248 (38%), Gaps = 66/248 (26%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-------NESKQGLREFASEISSIGRL 397
           F+  +LLG G  GRV+   L  T    A+K +        N+ K+ L E   EI +   L
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTE--QEILA--TL 58

Query: 398 RHRNLVQLLGWCRRRGDLLLVYDFMPNGSL--------DKCLFDEQKAILTWEQRYRIIK 449
            H  L  L    +    L LV D+ P G L         KCL +E            + +
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE------------VAR 106

Query: 450 GVAS----GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL----------- 494
             A+     L YLH      +++RD+K  N+LL    +  L DF L+K            
Sbjct: 107 FYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Query: 495 YERGTN--------------PSTTR---VVGTLGYLAPELTRTGKPTTSSDVYAFGALLL 537
             +G+                 + R    VGT  Y+APE+       ++ D +  G LL 
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223

Query: 538 EVVCGRRP 545
           E++ G  P
Sbjct: 224 EMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 7/93 (7%)

Query: 467 IHRDIKAGNVLLDSELNGRLGDFG-LAKLYERGTNPSTTRVVGTLGYLAPELTR-----T 520
           +HRDIK  NVLLD   + RL DFG   +L   GT  S    VGT  Y++PE+ +      
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-AVGTPDYISPEILQAMEDGK 182

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           G+     D ++ G  + E++ G  P   ++L E
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 53.2 bits (127), Expect = 4e-07
 Identities = 70/258 (27%), Positives = 110/258 (42%), Gaps = 60/258 (23%)

Query: 327 DVGPHRFS-YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR 385
           D G  R + YE +KK          +G G FG V+      T      K +S    +GL+
Sbjct: 6   DDGESRLNEYEVIKK----------IGNGRFGEVFLVKHKRTQEFFCWKAIS---YRGLK 52

Query: 386 E-----FASEISSIGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLD----KC--LF 432
           E        E++ +  L+H+N+V+ +     + +  L ++ +F   G L     KC  +F
Sbjct: 53  EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112

Query: 433 D--EQKAILTWEQRYRIIKGVASGLLYLHEEWE----QTVIHRDIKAGNVLLDS------ 480
              E+ AI+       I + +   L Y H   +    + V+HRD+K  N+ L +      
Sbjct: 113 GKIEEHAIVD------ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166

Query: 481 -------ELNGR----LGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT--RTGKPTTSS 527
                   LNGR    +GDFGL+K    G        VGT  Y +PEL    T      S
Sbjct: 167 KITAQANNLNGRPIAKIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKS 224

Query: 528 DVYAFGALLLEVVCGRRP 545
           D++A G ++ E+  G+ P
Sbjct: 225 DMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLG 407
           E +G G +G+V+K  L   N   A  ++ +       E  +E + +  L  H N+V+  G
Sbjct: 24  ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82

Query: 408 WCRRR----GD-LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR------IIKGVASGLL 456
              ++    GD L LV +    GS+     D  K  L   +R        I+     GL 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGYLAP 515
           +LH       IHRD+K  N+LL +E   +L DFG+ A+L       +T+  VGT  ++AP
Sbjct: 139 HLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAP 193

Query: 516 ELTRTGKPTTSS-----DVYAFGALLLEVVCGRRPI 546
           E+    +   S+     DV++ G   +E+  G  P+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 12/174 (6%)

Query: 387 FASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR 446
           F    S + ++ H +L  + G C R  + ++V +F+ +G LD CL  E+  +     +  
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPV-AWKIT 121

Query: 447 IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG---TNPST 503
           + + +AS L YL    ++ ++H ++ A N+LL + L    G     KL + G   T  S 
Sbjct: 122 VAQQLASALSYLE---DKNLVHGNVCAKNILL-ARLGLAEGTSPFIKLSDPGVSFTALSR 177

Query: 504 TRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVC--GRRPIEPKALPEE 554
              V  + ++APE    G   +T++D ++FG  LLE +C  G  P++ +   E+
Sbjct: 178 EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE-ICFDGEVPLKERTPSEK 230

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 7/93 (7%)

Query: 467 IHRDIKAGNVLLDSELNGRLGDFG-LAKLYERGTNPSTTRVVGTLGYLAPELTRT----- 520
           +HRDIK  N+L+D   + RL DFG   KL E GT  S+   VGT  Y++PE+ +      
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEDGK 182

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           GK     D ++ G  + E++ G  P   ++L E
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 351 LGFGGFGRVYKGTLPSTN-TQVAVKRVSN----ESKQGLREFASEISSIGRLRHRNLVQL 405
           LG G FGRV   T  + +   VA+KR       + KQ    F SE   +  + H   V L
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV--ASGLLYLHEEWE 463
            G  +    L LV +F+  G        E    L   +R+    G   A+ ++ + E  +
Sbjct: 97  YGSFKDESYLYLVLEFVIGG--------EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ 148

Query: 464 Q-TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +++RD+K  N+LLD +   ++ DFG AK+ +      T  + GT  Y+APE+     
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVG 204

Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
              ++D +  G  + E++ G  P
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.3 bits (123), Expect = 9e-07
 Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 50/191 (26%)

Query: 414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKA 473
           +L  V D++P G +   L   +  I   +     I  +   +  +H+      IHRDIK 
Sbjct: 75  NLYFVMDYIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKP 129

Query: 474 GNVLLDSELNGRLGDFGL---------AKLYERGTNPST--------------------- 503
            N+L+D + + +L DFGL         +K Y++G +                        
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLE 189

Query: 504 -------TRV-----VGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVVCGRRP-IEPK 549
                   R      VGT  Y+APE L RTG  T   D ++ G +L E++ G+ P +   
Sbjct: 190 RRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLADT 248

Query: 550 ALPEELILVDW 560
               +L +++W
Sbjct: 249 PAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 50.2 bits (121), Expect = 1e-06
 Identities = 44/135 (32%), Positives = 69/135 (51%), Gaps = 15/135 (11%)

Query: 416 LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKA 473
           +L+ D++ +G L    FD  +++  L+  +  +II+ +   L  LH+     +IH DIK 
Sbjct: 85  VLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKL 137

Query: 474 GNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAF 532
            NVL D   +   L D+GL K+   GT PS     GTL Y +PE  +      S D +A 
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKI--IGT-PSCYD--GTLDYFSPEKIKGHNYDVSFDWWAV 192

Query: 533 GALLLEVVCGRRPIE 547
           G L  E++ G+ P +
Sbjct: 193 GVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 28/210 (13%)

Query: 351 LGFGGFGRVYKGTLP--STNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLVQLLG 407
           +G G +G VYK        +   A+K++      G+   A  EI+ +  L+H N++ L  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEG---TGISMSACREIALLRELKHPNVISLQK 65

Query: 408 WCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY-------- 457
                 D  + L++D+  +       F   +A    ++  ++ +G+   LLY        
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKF--HRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSE--LNGR--LGDFGLAKLYERGTNP--STTRVVGTLG 511
           LH  W   V+HRD+K  N+L+  E    GR  + D G A+L+     P      VV T  
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 512 YLAPELTRTGKPTTSS-DVYAFGALLLEVV 540
           Y APEL    +  T + D++A G +  E++
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 30/211 (14%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFA-SEISSIGRLRHRN-LVQL 405
           E +G G +G+VYK    +T   VA+K+   E  ++G+   A  EIS +  L     +V+L
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 406 LGWCRRRGD-----LLLVYDFMPNGSLDKCLFD---------EQKAILTWEQRYRIIKGV 451
           L             L LV++++ +  L K +             K I ++   Y+++KGV
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF--MYQLLKGV 123

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTL 510
           A    + H+     V+HRD+K  N+L+D +    ++ D GL + +       T  +V TL
Sbjct: 124 A----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TL 175

Query: 511 GYLAPE-LTRTGKPTTSSDVYAFGALLLEVV 540
            Y APE L  +   +T  D+++ G +  E+ 
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 45/129 (34%), Positives = 61/129 (47%), Gaps = 28/129 (21%)

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK---------LYERGTNPSTTR 505
           L YLH      ++HRD+K  N+L+ S  + +L DFGL+K         LYE G     TR
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE-GHIEKDTR 169

Query: 506 ------VVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPE 553
                 V GT  Y+APE+      GKP    D +A G +L E + G  P     P+ L  
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPV---DWWAMGIILYEFLVGCVPFFGDTPEELFG 226

Query: 554 ELILVDWVW 562
           ++I  D  W
Sbjct: 227 QVISDDIEW 235

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 61/267 (22%), Positives = 107/267 (40%), Gaps = 57/267 (21%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRN 401
           F   + LG G FG V       T    A+K +  +    +  +    +E   +    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +V+L    + + +L  V D++P G +   L   +  I   +     I  +   +  +H+ 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFPEDLARFYIAELTCAVESVHK- 119

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGL---------AKLYERGT------------- 499
                IHRDIK  N+L+D + + +L DFGL         +K Y+ G              
Sbjct: 120 --MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 500 -NPSTTR-----------------------VVGTLGYLAPE-LTRTGKPTTSSDVYAFGA 534
            +P+  R                       +VGT  Y+APE L RTG  T   D ++ G 
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGV 236

Query: 535 LLLEVVCGRRP-IEPKALPEELILVDW 560
           +L E++ G+ P +    L  ++ +++W
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 27/213 (12%)

Query: 352 GFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           GF     VY      T T V V+   + N +++ L+   +E+      RH N++      
Sbjct: 9   GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF 68

Query: 410 RRRGDLLLVYDFMPNGS---LDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
                L ++  FM  GS   L K  F E   +A++       I+ G   GL YLH+    
Sbjct: 69  TTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQ---N 120

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV--------GTLGYLAPE 516
             IHR+IKA ++L+  +  G +   GL+ LY    N    +VV          L +L+PE
Sbjct: 121 GYIHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178

Query: 517 LTRTGKP--TTSSDVYAFGALLLEVVCGRRPIE 547
           L R         SD+Y+ G    E+  GR P +
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)

Query: 351 LGFGGFGRVYKGTLP--STNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLVQLLG 407
           +G G +G VYK          + A+K++      G+   A  EI+ +  L+H N++ L  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEG---TGISMSACREIALLRELKHPNVIALQK 65

Query: 408 WCRRRGD--LLLVYDFMPNGSLDKCLF------DEQKAILTWEQRYRIIKGVASGLLYLH 459
                 D  + L++D+  +       F      +++   L       ++  +  G+ YLH
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR----LGDFGLAKLYERGTNP--STTRVVGTLGYL 513
             W   V+HRD+K  N+L+  E   R    + D G A+L+     P      VV T  Y 
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 514 APELTRTGKPTTSS-DVYAFGALLLEVV 540
           APEL    +  T + D++A G +  E++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 53/220 (24%), Positives = 104/220 (47%), Gaps = 30/220 (13%)

Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR 398
           +   + ++   ++G G FG VY+     T+ +VA+K+V  + +   R    E+  +  L 
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLN 117

Query: 399 HRNLVQLLGW----CRRRGD----LLLVYDFMPNGSLDKCLFDEQK------AILTWEQR 444
           H N++ L  +    C ++ +    L +V +F+P  ++ K +    +        L     
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYS 176

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPST 503
           Y++ + +A    Y+H ++   + HRD+K  N+L+D   +  +L DFG AK    G    +
Sbjct: 177 YQLCRALA----YIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR--S 227

Query: 504 TRVVGTLGYLAPELTR-TGKPTTSSDVYAFGALLLEVVCG 542
              + +  Y APEL       TT  D+++ G ++ E++ G
Sbjct: 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 18/180 (10%)

Query: 371 VAVKRVSN--ESKQGLREFASEISSIGRLRHRNLVQLLG------WCRRRGDLLLVYDFM 422
           VAVK++S   +++   +    E+  +  + H+N++ LL             D+ LV + M
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL 482
            + +L + +  E    L  E+   ++  +  G+ +LH      +IHRD+K  N+++ S+ 
Sbjct: 109 -DANLCQVIHME----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC 160

Query: 483 NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCG 542
             ++ DFGLA+     TN   T  V T  Y APE+        + D+++ G ++ E+V G
Sbjct: 161 TLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 61/265 (23%), Positives = 106/265 (40%), Gaps = 65/265 (24%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLG 407
           LG G FG V       T+   A+K +  +   ++  +    +E   +    +  +V+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             + + +L  V D++P G +   L     F E  A      R+ I    A   L +    
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA------RFYI----AELTLAIESVH 118

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGL---------AKLYERGTN-------PS---- 502
           +   IHRDIK  N+L+D + + +L DFGL         +K Y++G++       PS    
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 503 --------------------------TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALL 536
                                        +VGT  Y+APE+      T   D ++ G +L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 537 LEVVCGRRP-IEPKALPEELILVDW 560
            E++ G+ P + P     +L +++W
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 44/182 (24%), Positives = 86/182 (47%), Gaps = 18/182 (9%)

Query: 370 QVAVKRVSN--ESKQGLREFASEISSIGRLRHRNLVQLLG------WCRRRGDLLLVYDF 421
            VA+K++S   +++   +    E+  +  + H+N++ LL             D+ +V + 
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE 481
           M     D  L    +  L  E+   ++  +  G+ +LH      +IHRD+K  N+++ S+
Sbjct: 111 M-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSD 162

Query: 482 LNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC 541
              ++ DFGLA+    GT+   T  V T  Y APE+        + D+++ G ++ E++ 
Sbjct: 163 CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220

Query: 542 GR 543
           G 
Sbjct: 221 GG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 37/98 (37%), Positives = 53/98 (54%), Gaps = 12/98 (12%)

Query: 448 IKGVASGLL----YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG--TNP 501
           +  VA  LL    Y+H E    +IHRDIK  NVL++   +  LGDFG A  + RG  + P
Sbjct: 262 VTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTP 317

Query: 502 STTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLE 538
               + GT+   APE+   G P T S D+++ G ++ E
Sbjct: 318 FHYGIAGTVDTNAPEVL-AGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 20/204 (9%)

Query: 419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL 478
           Y    +  +   L D+    LT          VA G+ +L     +  +HRD+ A NVLL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270

Query: 479 DSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLL 537
                 ++ DFGLA+     +N  S       + ++APE       TT SDV+++G LL 
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330

Query: 538 EVVCGRRPIEPKALPEELILVDWV-WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLM 596
           E+            P   ++VD   +++ K+G  +   D             +V  + + 
Sbjct: 331 EI------FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQ---------EVYDIMVK 375

Query: 597 CSNDAAEARPTMRQVVRYLEGEVP 620
           C N   E RP+   +   +E  +P
Sbjct: 376 CWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.9 bits (116), Expect = 5e-06
 Identities = 54/225 (24%), Positives = 105/225 (46%), Gaps = 24/225 (10%)

Query: 324 WELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESK 381
           + ++VG   F+   LK+    +++ + +G G  G V        +  VA+K++S   +++
Sbjct: 4   YSVEVGDSTFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ 57

Query: 382 QGLREFASEISSIGRLRHRNLVQLLG------WCRRRGDLLLVYDFMPNGSLDKCLFDEQ 435
              +    E+  +  + H+N++ LL             D+ LV + M     D  L    
Sbjct: 58  THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVI 112

Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
           +  L  E+   ++  +  G+ +LH      +IHRD+K  N+++ S+   ++ DFGLA+  
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 167

Query: 496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
             GT+   T  V T  Y APE+        + D+++ G ++ E+V
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.7 bits (116), Expect = 7e-06
 Identities = 35/100 (35%), Positives = 50/100 (50%), Gaps = 11/100 (11%)

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT- 509
           VA G+ +L     +  IHRD+ A NVLL      ++ DFGLA+      N S   V G  
Sbjct: 221 VAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIM---NDSNYVVKGNA 274

Query: 510 ---LGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
              + ++APE       T  SDV+++G LL E+   G+ P
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 9e-06
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 18/149 (12%)

Query: 354 GGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           G FG+VY G   + +   AVK V      +K  + +  +E  ++   +   +V L    +
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 411 RRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
              ++ LV +++  G +   L     FDE+ A+       + I  VA  L YLH      
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV-------KYISEVALALDYLHR---HG 124

Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
           +IHRD+K  N+L+ +E + +L DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 13/222 (5%)

Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSI 394
           +L+     +   +++G G FG V      ST    A+K +S     K+    F  E   I
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 395 GRLRHRN-LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
               +   +VQL    +    L +V ++MP G L   L         W + Y      A 
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFY-----TAE 150

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL 513
            +L L        IHRD+K  N+LLD   + +L DFG      +         VGT  Y+
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210

Query: 514 APELTRT----GKPTTSSDVYAFGALLLEVVCGRRPIEPKAL 551
           +PE+ ++    G      D ++ G  L E++ G  P    +L
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 49/170 (28%), Positives = 73/170 (42%), Gaps = 26/170 (15%)

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGT 509
           VA G+ +L     +  IHRD+ A N+LL      ++ DFGLA+ +Y+   +P   R    
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYK---DPDYVRKGSA 236

Query: 510 ---LGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRW 565
              L ++APE       TT SDV++FG LL E+   G  P     + EE         R 
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC------QRL 290

Query: 566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           K G  +            E    ++ ++ L C     + RPT   +V  L
Sbjct: 291 KDGTRMRA---------PENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 42/170 (24%), Positives = 66/170 (38%), Gaps = 46/170 (27%)

Query: 415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQ-RYRIIKGVASGLLYLHEEWEQTVIHRDIKA 473
           L L+ +++P G +   L   +K   T E+ R+ I    A  +L +    +   IHRDIK 
Sbjct: 76  LYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYI----AETILAIDSIHKLGYIHRDIKP 129

Query: 474 GNVLLDSELNGRLGDFGLAK---------LYER------GTNPSTTR------------- 505
            N+LLD++ + +L DFGL            Y                             
Sbjct: 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWK 189

Query: 506 ---------VVGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
                     VGT  Y+APE   +TG      D ++ G ++ E++ G  P
Sbjct: 190 RNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 43/166 (25%), Positives = 68/166 (40%), Gaps = 39/166 (23%)

Query: 414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKA 473
           +L L+ +F+P G +   L   +K  LT E+    I   A  +L +    +   IHRDIK 
Sbjct: 75  NLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI---AETVLAIDSIHQLGFIHRDIKP 129

Query: 474 GNVLLDSELNGRLGDFGL----------------------------------AKLYERGT 499
            N+LLDS+ + +L DFGL                                  A+ ++R  
Sbjct: 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189

Query: 500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
                  VGT  Y+APE+          D ++ G ++ E++ G  P
Sbjct: 190 RQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGT 509
           VA G+ +L     +  IHRD+ A N+LL      ++ DFGLA+ +Y+   +P   R    
Sbjct: 182 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYK---DPDYVRKGDA 235

Query: 510 ---LGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              L ++APE       TT SDV++FG LL E+
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 10/111 (9%)

Query: 433 DEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA 492
           D  K +LT E        VA G+ +L     +  IHRD+ A N+LL      ++ DFGLA
Sbjct: 170 DLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLA 226

Query: 493 K-LYERGTNPSTTRVVGT---LGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
           + +Y+   +P   R       L ++APE       T  SDV++FG LL E+
Sbjct: 227 RDIYK---DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 39/199 (19%), Positives = 88/199 (44%), Gaps = 19/199 (9%)

Query: 358 RVYKGTLPSTNTQVAV---KRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD 414
            +YKG     N +V +   K+     K  +    +EI ++ R+   N++++ G+     D
Sbjct: 35  SIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92

Query: 415 LL----LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
            L    L+ ++   G L + L  E+   L+++ +  +      GL  L++   +   +++
Sbjct: 93  DLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148

Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT--GKPTTSSD 528
           + + + L+      ++   GL K+    ++P    V   + Y + ++      + T   D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKIL---SSPPFKNV-NFMVYFSYKMLNDIFSEYTIKDD 204

Query: 529 VYAFGALLLEVVCGRRPIE 547
           +Y+ G +L E+  G+ P E
Sbjct: 205 IYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN-PSTTRVVGT 509
           VA+G+ +L     +  +HRD+ A NVL+      ++ DFGLA+   R +N  S       
Sbjct: 248 VANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
           L ++APE       TT SDV++FG LL E+
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 39/166 (23%)

Query: 414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKA 473
           +L L+ +F+P G +   L   +K  L+ E     I      +  +H+      IHRDIK 
Sbjct: 75  NLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKP 129

Query: 474 GNVLLDSELNGRLGDFGL----------------------------------AKLYERGT 499
            N+LLD++ + +L DFGL                                  A+ +++  
Sbjct: 130 DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNR 189

Query: 500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
                  VGT  Y+APE+          D ++ G ++ E++ G  P
Sbjct: 190 RQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 48/189 (25%), Positives = 89/189 (47%), Gaps = 26/189 (13%)

Query: 367 TNTQVAVKRVS------NESKQGLREFASEISSIGRLRHRNLVQLLG-WCRRRG-----D 414
           T   VA+K++S        +K+  RE       +  + H+N++ LL  +  ++      D
Sbjct: 40  TGQNVAIKKLSRPFQNVTHAKRAYRELVL----MKLVNHKNIIGLLNVFTPQKSLEEFQD 95

Query: 415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAG 474
           + LV + M     D  L    +  L  E+   ++  +  G+ +LH      +IHRD+K  
Sbjct: 96  VYLVMELM-----DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 147

Query: 475 NVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGA 534
           N+++ S+   ++ DFGLA+    GT+   T  V T  Y APE+        + D+++ G 
Sbjct: 148 NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205

Query: 535 LLLEVVCGR 543
           ++ E++ G 
Sbjct: 206 IMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 30/97 (30%), Positives = 44/97 (45%), Gaps = 3/97 (3%)

Query: 447 IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV 506
           I + V   + YLHE     +IHRDIKA N+ ++   +  LGDFG A              
Sbjct: 187 IERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243

Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGR 543
            GT+   APEL        + D+++ G +L E+    
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 26/174 (14%)

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT- 509
           VA G+ +L     +  IHRD+ A N+LL      ++ DFGLA+      N S   V G  
Sbjct: 223 VAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI---RNDSNYVVKGNA 276

Query: 510 ---LGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRW 565
              + ++APE       T  SDV+++G LL E+   G  P     +P +      + + +
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY--PGMPVDSKFYKMIKEGY 334

Query: 566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           +           L+ E    E  D++K    C +     RPT +Q+V+ +E ++
Sbjct: 335 RM----------LSPECAPSEMYDIMK---SCWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 31/125 (24%), Positives = 44/125 (35%), Gaps = 46/125 (36%)

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLA-------------KLYER--GTNPSTTR------ 505
           IHRDIK  N+L+D   + +L DFGL+             KL +     N    R      
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 506 -------------------------VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
                                     VGT  Y+APE+          D ++ GA++ E +
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242

Query: 541 CGRRP 545
            G  P
Sbjct: 243 IGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 39/167 (23%), Positives = 67/167 (40%), Gaps = 28/167 (16%)

Query: 349 ELLGFGGFGRVYKGTLPSTN--TQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           +L+G GGFG VY+    S +     AV ++ N   + +     E      +   + + L 
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETI---VMETLVYNNIYDIDKIAL- 73

Query: 407 GWCRRRG-DLLLVYDFMPNGSLDKC-----------LFDEQKAILTWEQRY------RII 448
            W      D L +  +   GS  +C           L +  K I    +         I+
Sbjct: 74  -WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIM 132

Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
           K + + L Y+H   E  + H DIK  N+++D    G + D+G+A  +
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	687
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd06899	236	lectin_legume_LecRK_Arcelin_ConA legume lectins, l	100.0
PF00139	236	Lectin_legB: Legume lectin domain; InterPro: IPR00	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd01951	223	lectin_L-type legume lectins. The L-type (legume-t	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
cd07308	218	lectin_leg-like legume-like lectins: ERGIC-53, ERG	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
PRK10345	210	hypothetical protein; Provisional	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
smart00090	237	RIO RIO-like kinase.	99.72
cd06901	248	lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr	99.72
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
cd06902	225	lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
PF03388	229	Lectin_leg-like: Legume-like lectin family; InterP	99.42
cd06903	215	lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem	99.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.32
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.27
KOG1243	690	consensus Protein kinase [General function predict	99.22
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.15
KOG3839	351	consensus Lectin VIP36, involved in the transport	99.12
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.1
KOG3087	229	consensus Serine/threonine protein kinase [General	99.07
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.04
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.01
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.87
KOG3838	497	consensus Mannose lectin ERGIC-53, involved in gly	98.79
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.75
cd06900	255	lectin_VcfQ VcfQ bacterial pilus biogenesis protei	98.63
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.5
PRK09902	216	hypothetical protein; Provisional	98.5
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.47
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.38
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.37
COG4248	637	Uncharacterized protein with protein kinase and he	98.36
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.28
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.27
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.2
PF01636	239	APH: Phosphotransferase enzyme family This family	98.17
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.12
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.05
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.03
PLN02876	822	acyl-CoA dehydrogenase	97.94
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.88
PRK10593	297	hypothetical protein; Provisional	97.81
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.71
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.69
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.6
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.57
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.52
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.51
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.47
PRK05231	319	homoserine kinase; Provisional	97.47
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.37
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.18
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.16
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.84
PLN02236	344	choline kinase	96.76
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.65
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.61
PLN02756	418	S-methyl-5-thioribose kinase	96.5
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.45
PRK12396	409	5-methylribose kinase; Reviewed	96.41
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.07
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.02
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.0
COG2334	331	Putative homoserine kinase type II (protein kinase	95.92
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.74

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-57  Score=484.55  Aligned_cols=290  Identities=50%  Similarity=0.830  Sum_probs=258.4

Q ss_pred             CCCccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeee
Q 005621          329 GPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW  408 (687)
Q Consensus       329 ~~~~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~  408 (687)
                      ..+.|+|+|++.||++|+..++||+|+||.||+|.+.+ ++.||||++.....+..++|..|+.++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            46779999999999999999999999999999999954 58999998877654315669999999999999999999999


Q ss_pred             eecCC-eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEc
Q 005621          409 CRRRG-DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       409 ~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~  487 (687)
                      |.+.+ +.+||||||++|+|.++|+......++|.+|++|+.++|+||+|||+.+.++|+||||||+|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99999 59999999999999999987544389999999999999999999999998899999999999999999999999


Q ss_pred             ccccceeccC-CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 005621          488 DFGLAKLYER-GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK  566 (687)
Q Consensus       488 DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~  566 (687)
                      |||+|+.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||++|.+.........+++|++..+.
T Consensus       220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999976543 22211111 799999999999999999999999999999999999999987765566669999999999


Q ss_pred             ccccccccCCcCC-CCCCH-HHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          567 AGAILEVVDPRLN-GEFNE-IEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       567 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      ++.+.+++||++. ..++. .+..++..++.+|++.+|++||+|.||+++|+....
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            9999999999997 66665 688889999999999999999999999999966543

>cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

Probab=100.00  E-value=9e-54  Score=430.84  Aligned_cols=232  Identities=51%  Similarity=0.814  Sum_probs=208.9

Q ss_pred             cceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC--CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCC
Q 005621           24 EEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT--LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTA  101 (687)
Q Consensus        24 ~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~--~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~  101 (687)
                      ++|+|++|..+  .++|+++|+|.+..+|.|+||++.  .+++|||+|++||+||++. ++.++||+|+|+|.|.++...
T Consensus         1 ~~f~f~~f~~~--~~~l~l~G~A~~~~~~~i~LT~~~~~~~~~G~v~y~~pi~l~~~~-~~~~~sFst~F~F~i~~~~~~   77 (236)
T cd06899           1 LSFNFNGFSSD--QSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDST-TGKVASFSTSFSFSITPPNPS   77 (236)
T ss_pred             CceecCCCCCC--CCCEEEecceEcCCCCeEEecCCCCCCcceEEEEeCCCEEeecCC-CCCceeEEEEEEEEEEcCCCC
Confidence            36999999875  368999999999768999999998  8999999999999999987 789999999999999987667


Q ss_pred             CCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccccccccc
Q 005621          102 LGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFL  181 (687)
Q Consensus       102 ~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~~  181 (687)
                      .+||||||+|+|....+.+..|++|||++..+.+++.+++|||||||++|.+++||++||||||+|++.|..+..+..  
T Consensus        78 ~~gdGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~--  155 (236)
T cd06899          78 LGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDD--  155 (236)
T ss_pred             CCCCeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeecccc--
Confidence            889999999999876665789999999998877778899999999999999989999999999999998877654421  


Q ss_pred             ccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCC-CCCCcceeeeecCCccccccceeeeeccCCcccceeEEEEe
Q 005621          182 ENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSV-KPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW  260 (687)
Q Consensus       182 ~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~-~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sW  260 (687)
                           ....+.+|+.++|||+||+.+++|+|+|.+.+. +|..|+|+..+||+++|+++||||||||||...|.|+|++|
T Consensus       156 -----~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~sW  230 (236)
T cd06899         156 -----DGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSW  230 (236)
T ss_pred             -----ccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEEE
Confidence                 134478999999999999999999999998876 89999999999999999999999999999999999999999


Q ss_pred             eeccC
Q 005621          261 SFNMS  265 (687)
Q Consensus       261 sf~~~  265 (687)
                      +|++.
T Consensus       231 sF~s~  235 (236)
T cd06899         231 SFSSN  235 (236)
T ss_pred             EEEcC
Confidence            99863

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin

>PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported

Probab=100.00  E-value=1.9e-52  Score=422.56  Aligned_cols=232  Identities=45%  Similarity=0.740  Sum_probs=205.4

Q ss_pred             cceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCC-CeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeec--CC
Q 005621           24 EEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL-RVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPE--YT  100 (687)
Q Consensus        24 ~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~-~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~--~~  100 (687)
                      .+|+|++|..   .++++++|+|.+..+|.|+||+... +++|||+|++||+|||+. ++.++||+|+|+|.|...  ..
T Consensus         2 ~~F~~~~F~~---~~~~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~d~~-~~~~~sF~t~F~f~i~~~~~~~   77 (236)
T PF00139_consen    2 VSFSFPSFSN---SSNLTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLWDST-TGNVASFSTSFSFSITNGPGSS   77 (236)
T ss_dssp             EEEEESSBTT---GTTEEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESBETT-TTEBEEEEEEEEEEEEESSSSS
T ss_pred             ceEEcCCCCC---CCceEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEeCCC-CcceeeeeeEEEEEEeccCCCC
Confidence            5799999933   2799999999996689999999887 999999999999999988 788999999999999643  56


Q ss_pred             CCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccccccc
Q 005621          101 ALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYF  180 (687)
Q Consensus       101 ~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~  180 (687)
                      ..+||||||||+|....+.+..|++||+++..+.+.+.++.|||||||++|.+++||++||||||+|++.|..+.+++++
T Consensus        78 ~~~~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~~~~  157 (236)
T PF00139_consen   78 NNGGDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASAGYY  157 (236)
T ss_dssp             SS-BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE----
T ss_pred             ccCCCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCccccccccccc
Confidence            77899999999999877777899999999887777678999999999999999999999999999999999888776544


Q ss_pred             cccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcccceeEEEEe
Q 005621          181 LENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW  260 (687)
Q Consensus       181 ~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sW  260 (687)
                          .....++.+|+.++|||+||+..++|+|++.....+|..|+|+..+||+.+|+++||||||||||...|.|.|++|
T Consensus       158 ----~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW  233 (236)
T PF00139_consen  158 ----SSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNSSKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSW  233 (236)
T ss_dssp             ----EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETTTTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEE
T ss_pred             ----ccccccccCCcEEEEEEEEcCCccEEEEEEecccCCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEE
Confidence                3346788999999999999999999999999886689999999999999999999999999999999999999999


Q ss_pred             eec
Q 005621          261 SFN  263 (687)
Q Consensus       261 sf~  263 (687)
                      +|+
T Consensus       234 ~F~  236 (236)
T PF00139_consen  234 SFS  236 (236)
T ss_dssp             EEE
T ss_pred             EeC
Confidence            995

Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B ....

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-47  Score=402.22  Aligned_cols=251  Identities=36%  Similarity=0.534  Sum_probs=210.4

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeE-EEEEEecCcchh--hHHHHHHHHHHHhhhcCCCceeeeeeeecCC-eeEEEEecCC
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQ-VAVKRVSNESKQ--GLREFASEISSIGRLRHRNLVQLLGWCRRRG-DLLLVYDFMP  423 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey~~  423 (687)
                      .+.||+|+||+||+|.+.  |+. ||||++......  ..++|.+|+.+|++++|||||+++|+|.+.. .+++|||||+
T Consensus        46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            445999999999999994  555 999999865322  2569999999999999999999999999887 7999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCe-EEeeccCCCcEEeccCC-cEEEcccccceeccCCCCC
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT-VIHRDIKAGNVLLDSEL-NGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~~~~  501 (687)
                      +|+|.++|+...+..+++..+++|+.|||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            9999999977656789999999999999999999999   66 99999999999999997 99999999998765432 2


Q ss_pred             ceeeeecCCCCCchhhcc--CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          502 STTRVVGTLGYLAPELTR--TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~--~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      ..+...||+.|||||++.  ...++.|+||||||++||||+||+.||.......   ....            ++....+
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~~------------v~~~~~R  264 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VASA------------VVVGGLR  264 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHHH------------HHhcCCC
Confidence            233368999999999999  5699999999999999999999999998876411   1111            1112222


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ..++..+...+..++.+||+.||+.||++.+++..|+...
T Consensus       265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence            3333445668899999999999999999999999998653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=378.42  Aligned_cols=256  Identities=26%  Similarity=0.389  Sum_probs=215.7

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCR  410 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  410 (687)
                      .++..||+.       .+.||+|..|+|||+.++.+++.+|+|.+.... ....+++.+|++++++.+||+||.+||.|.
T Consensus        75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            456666664       578999999999999999999999999996553 445688999999999999999999999999


Q ss_pred             cCC-eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccc
Q 005621          411 RRG-DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDF  489 (687)
Q Consensus       411 ~~~-~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF  489 (687)
                      ..+ +..|+||||++|||++.+...  +++++...-+|+.+|++||.|||+  .++||||||||+|||++..|++|||||
T Consensus       148 ~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDF  223 (364)
T KOG0581|consen  148 SNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDF  223 (364)
T ss_pred             eCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccc
Confidence            988 599999999999999998433  679999999999999999999996  399999999999999999999999999


Q ss_pred             ccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCC--cchhhHHHHHHHHhcc
Q 005621          490 GLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKAL--PEELILVDWVWDRWKA  567 (687)
Q Consensus       490 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~--~~~~~~~~~v~~~~~~  567 (687)
                      |.++.+...   .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.....  .....+.+++.     
T Consensus       224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-----  295 (364)
T KOG0581|consen  224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-----  295 (364)
T ss_pred             cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-----
Confidence            999876554   33457899999999999999999999999999999999999999987522  22222332221     


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       568 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                          .-.-|++...   ....+++.++..||+.||.+||+++|+++
T Consensus       296 ----~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  296 ----DEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ----cCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                1122344433   24448899999999999999999999997

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=397.75  Aligned_cols=253  Identities=32%  Similarity=0.473  Sum_probs=215.9

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      ...+.||+|.||.||.|.+. ....||+|.+.... ...+.|.+|+++|++|+|+|||+++|+|...+.++||||||+.|
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            34678999999999999994 34589999987652 23478999999999999999999999999998999999999999


Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceee
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR  505 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  505 (687)
                      +|.+||....+..+...+.+.++.|||+||+||++   +++|||||.++||||+++..+||+|||||+....+.......
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~  363 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG  363 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence            99999987677789999999999999999999999   999999999999999999999999999999655544433333


Q ss_pred             eecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ..-+..|+|||.+..++++.|||||||||+||||+| |+.|+......+..                +.++...+-..+.
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~----------------~~le~GyRlp~P~  427 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL----------------ELLERGYRLPRPE  427 (468)
T ss_pred             CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH----------------HHHhccCcCCCCC
Confidence            344779999999999999999999999999999999 88888876643322                2233333444556


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .++..+.+|+..||+.+|++|||++.+...|+...
T Consensus       428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            67779999999999999999999999999887643

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-45  Score=387.82  Aligned_cols=248  Identities=27%  Similarity=0.458  Sum_probs=214.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .+|...++||+|||+++|++++..+|+.||+|++.+..   ....+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            57899999999999999999998999999999997742   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |+|++++|.+++.  +...+++.++..++.||+.||.|||+   ++|+|||||..|+||++++++||+|||||..+....
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999884  56789999999999999999999999   999999999999999999999999999999887554


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      ... .+.+||+.|+|||++.....+..+||||+|||||-|++|++||+.....+...       .++.   .+..     
T Consensus       173 Erk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~-------~Ik~---~~Y~-----  236 (592)
T KOG0575|consen  173 ERK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN-------KIKL---NEYS-----  236 (592)
T ss_pred             ccc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH-------HHHh---cCcc-----
Confidence            433 45799999999999999999999999999999999999999999875433221       1111   1111     


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        ++........+|+..+|+++|.+|||+.+|+.
T Consensus       237 --~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 --MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             --cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              12233346789999999999999999999997

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=367.14  Aligned_cols=205  Identities=27%  Similarity=0.505  Sum_probs=185.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ..+|...+.||.|.|++||+|+++.++..||||.+.+.  .+...+....|+.+|+.++|||||++++++...+.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35788888899999999999999999999999999877  5666677899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC------CcEEEcccccce
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE------LNGRLGDFGLAK  493 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~------~~~kl~DFGla~  493 (687)
                      |||.||+|.+|++.  .+.+++.....++.|||.||++||+   ++||||||||.||||+..      -.+||+|||+||
T Consensus        89 EyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999954  4579999999999999999999999   999999999999999765      458999999999


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcc
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE  553 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~  553 (687)
                      .+....  ...+.+|++-|||||++..++|+.|+|+||+|++||++++|+.||+.....+
T Consensus       164 ~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  164 FLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             hCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            886443  3345799999999999999999999999999999999999999998766543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-45  Score=357.28  Aligned_cols=259  Identities=25%  Similarity=0.377  Sum_probs=214.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeee-eecCCe-eEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGW-CRRRGD-LLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~-~~~~~~-~~lV  418 (687)
                      .+|.+.++||.|.||+|||++...+|..+|.|.++-.  .....++...|+.+|++|+|||||+++++ +.+.++ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3577788999999999999999999999999998754  34556788999999999999999999994 444444 8999


Q ss_pred             EecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccC-eEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          419 YDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ-TVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ||||..|+|.+.+..  .+++.+++..+++++.|++.||..+|+.+.+ -|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999854  5567899999999999999999999986543 3999999999999999999999999999988


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      +.... -....+||+.||+||.+.+..|+.||||||+||++|||+.-+.||.++...       -+.+++.+|+..    
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~-------~L~~KI~qgd~~----  246 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL-------SLCKKIEQGDYP----  246 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH-------HHHHHHHcCCCC----
Confidence            65443 234578999999999999999999999999999999999999999987421       123334444221    


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                       +   -.++....++..|+..|+..||+.||+...+++.+..
T Consensus       247 -~---~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  247 -P---LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -C---CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence             1   1225566789999999999999999996666665544

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7e-45  Score=393.43  Aligned_cols=275  Identities=28%  Similarity=0.486  Sum_probs=233.8

Q ss_pred             CccCHHHHHHHhcCc---------ccceeeeeeCeEEEEEEEeCCCC---eEEEEEEecCcc-hhhHHHHHHHHHHHhhh
Q 005621          331 HRFSYEELKKATRGF---------RDKELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNES-KQGLREFASEISSIGRL  397 (687)
Q Consensus       331 ~~~~~~el~~at~~f---------~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l  397 (687)
                      ..++||+-.+|.+.|         .+.++||.|.||.||+|.++..+   ..||||.++... .....+|+.|+.||.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            357888877776655         35689999999999999997655   469999998764 45568999999999999


Q ss_pred             cCCCceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEE
Q 005621          398 RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL  477 (687)
Q Consensus       398 ~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  477 (687)
                      +||||++|.|+....+..+||+|||+||+|+.||+.+.. .+++.|..-++++||.||.||.+   .++|||||.++|||
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNIL  763 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNIL  763 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhee
Confidence            999999999999999999999999999999999987664 59999999999999999999998   99999999999999


Q ss_pred             eccCCcEEEcccccceeccCCCCCceeeeec--CCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcch
Q 005621          478 LDSELNGRLGDFGLAKLYERGTNPSTTRVVG--TLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEE  554 (687)
Q Consensus       478 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~  554 (687)
                      ++.+..+|++||||+|.++.+.....+...|  +.+|.|||.+..++++.+|||||||+||||.++ |.+||=.....+.
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV  843 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV  843 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence            9999999999999999886665433333333  579999999999999999999999999999888 9999876654322


Q ss_pred             hhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCCCCCC
Q 005621          555 LILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAV  625 (687)
Q Consensus       555 ~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~  625 (687)
                      .                ..++...+-..+.+++..|.+|++.||+.|..+||.+.||+..|++...-|...
T Consensus       844 I----------------kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  844 I----------------KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             H----------------HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence            2                223334444556678889999999999999999999999999999987666543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-44  Score=362.66  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=208.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-------hHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-------GLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      .+.|...+.||+|+||.|-+|..+.+|+.||||++++....       ......+|+++|++|+|||||+++++++..+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            45678889999999999999999999999999999765211       12335699999999999999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC---CcEEEccccc
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE---LNGRLGDFGL  491 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGl  491 (687)
                      .|||||||+||.|.+.+-.  ++.+.+..-..++.|++.|+.|||+   +||+||||||+|||+..+   ..+||+|||+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             eEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999998843  4457777888999999999999999   999999999999999766   6789999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCCC---CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGK---PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG  568 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~  568 (687)
                      |+....  ..-+.+.+||+.|.|||++.++.   +..+.|+||+|||||-+++|..||.....+..      +.+.+..|
T Consensus       326 AK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQI~~G  397 (475)
T KOG0615|consen  326 AKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQILKG  397 (475)
T ss_pred             hhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHHHhcC
Confidence            997653  34456689999999999998754   33478999999999999999999987654321      11222233


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          569 AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       569 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +...      .........++.++|+.++|..||++||++.|+++
T Consensus       398 ~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  398 RYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            3211      11233445668899999999999999999999997

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.2e-44  Score=393.32  Aligned_cols=260  Identities=29%  Similarity=0.466  Sum_probs=221.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      +.+....+.||+|+||+||+|+...     ....||||.++..... ..++|++|+++++.++|||||+|+|.|.+++.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            3455667889999999999998743     3357999999887655 788999999999999999999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchh------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQ------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                      +||+|||..|+|.+||....            ..+|+..+.+.|+.|||.||.||-+   +.+|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence            99999999999999995321            2348999999999999999999998   99999999999999999999


Q ss_pred             EEEcccccceeccCCCCCc-eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 005621          484 GRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWV  561 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v  561 (687)
                      +||+||||+|..-...... ...-.-+.+|||||.+..++++.+||||||||||||+++ |+.|+.+....+       |
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------V  714 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------V  714 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------H
Confidence            9999999999654333322 213344789999999999999999999999999999999 999998876543       4


Q ss_pred             HHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          562 WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       562 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      .+.+++|+++         ..++.++.++.+|+..||+..|++||+++||-..|+....
T Consensus       715 Ie~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  715 IECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            4555666654         3456677799999999999999999999999999987543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-42  Score=346.17  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=210.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .+.|+..++||+|+||+||+++.+++++.+|+|++++..   ....+...+|..+|.+++||.||+++-.|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467899999999999999999999999999999998763   34567788999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      +||+.||.|..+|  ++.+.+++..+.-++..|+.||.|||+   ++||||||||+|||||++|.++|+||||++..-..
T Consensus       104 ld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            9999999999999  455679999999999999999999999   99999999999999999999999999999854332


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                       ...+.+.+||+.|||||++.+..++..+|.||+|+++|||++|..||.......       ..+.+..+++        
T Consensus       179 -~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k~--------  242 (357)
T KOG0598|consen  179 -GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGKL--------  242 (357)
T ss_pred             -CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCcC--------
Confidence             233445899999999999999999999999999999999999999998765322       1222222221        


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCC----CHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARP----TMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~  613 (687)
                       ...+.....+.++++...+..+|++|.    ++.+|.+
T Consensus       243 -~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  243 -PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             -CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence             111122233678899999999999995    4555443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-42  Score=361.96  Aligned_cols=273  Identities=28%  Similarity=0.451  Sum_probs=218.1

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWC  409 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~  409 (687)
                      +.+.++++.-.+.+...+.||+|.||+||+|.+-+   .||||+++..  ..+..+.|+.|+.++++-+|.||+-+.|||
T Consensus       381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             CccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence            34445666666677788999999999999999944   5999999765  345678999999999999999999999999


Q ss_pred             ecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccc
Q 005621          410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDF  489 (687)
Q Consensus       410 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF  489 (687)
                      ..... .||+.+|+|.+|+.+|+..+ ..+...+.++|++|||+||.|||.   ++|||||||+.||||.+++.+||+||
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecc
Confidence            98877 99999999999999998765 468999999999999999999999   99999999999999999999999999


Q ss_pred             ccceeccCC-CCCceeeeecCCCCCchhhccC---CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 005621          490 GLAKLYERG-TNPSTTRVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       490 Gla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      ||+..-..- .........|...|||||+++.   ..|++.+||||||+|+|||+||..||. ....+...+        
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIif--------  603 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIF--------  603 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEE--------
Confidence            999643221 1122233457789999999975   368999999999999999999999998 333332211        


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC-CCCC
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP-LPQA  624 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~-~~~~  624 (687)
                      .-|+-.-..|..   .....+..++.+|+..||..++++||.+.+|+..|+...+ +|..
T Consensus       604 mVGrG~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki  660 (678)
T KOG0193|consen  604 MVGRGYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKI  660 (678)
T ss_pred             EecccccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccc
Confidence            111111111111   1223455688999999999999999999999998887665 4443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-41  Score=348.88  Aligned_cols=264  Identities=27%  Similarity=0.373  Sum_probs=211.7

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--CeeEEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDLLLVY  419 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~  419 (687)
                      .|+..++||+|.||.||+|++..+|+.||+|+++.+.  .....-..+|+.+|++|+||||++|.+...+.  +.+|||+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            4556678999999999999999999999999998764  33445567999999999999999999988776  7899999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |||+. +|.-++.. ..-.++..++..+++|++.||.|+|+   ++|+|||||.+|||||.+|.+||+|||||+.+....
T Consensus       198 eYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  198 EYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             ecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            99976 78777743 23469999999999999999999999   999999999999999999999999999999888777


Q ss_pred             CCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH-----hcccccc--
Q 005621          500 NPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR-----WKAGAIL--  571 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~-----~~~~~~~--  571 (687)
                      ....+..+-|..|.|||++.+ ..|+.+.|+||.||||.||++|+..+.+....+....+-.+...     |...++.  
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence            666777888999999999987 47999999999999999999999999887765544333222111     1111111  


Q ss_pred             cccCC------cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDP------RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+.+      ++... -.......++|+..+|..||.+|.|+.++++
T Consensus       353 ~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            11111      11111 0112336788999999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=346.78  Aligned_cols=255  Identities=29%  Similarity=0.428  Sum_probs=207.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC--eeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG--DLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~E  420 (687)
                      .++...+.||+|.||+||++....+|...|||.+........+.+.+|+.+|++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45667889999999999999998889999999987764444677899999999999999999999754444  6999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-CCcEEEcccccceeccC--
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-ELNGRLGDFGLAKLYER--  497 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~--  497 (687)
                      |+++|+|.+++..... .+++..+.+.++||++||.|||+   ++|+||||||+|||++. ++.+||+|||++.....  
T Consensus        97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999966554 79999999999999999999998   99999999999999999 79999999999987653  


Q ss_pred             CCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      ..........||+.|||||++..+ ....++|||||||++.||+||+.||....     ...+++.......     .-|
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~-----~~P  242 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGRED-----SLP  242 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccC-----CCC
Confidence            122233457899999999999964 34459999999999999999999998641     1112222211111     112


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                          .++...+.+..+++.+|+..+|++|||+.++++..
T Consensus       243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                34444555788999999999999999999999853

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.6e-41  Score=330.16  Aligned_cols=264  Identities=23%  Similarity=0.322  Sum_probs=208.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hh-HHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QG-LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      +.|+...++|+|+||.|||++++.+|+.||||++-.... .. .+-.++|+++|++++|+|+|.|+.+|..+..++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            357778899999999999999999999999999866533 33 3456899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      ||+.--|++ |... ...++.+.+.+++.|++.|+.|+|+   ++++||||||+||||+.++.+||||||.||.+.. ..
T Consensus        82 ~~dhTvL~e-Le~~-p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg  155 (396)
T KOG0593|consen   82 YCDHTVLHE-LERY-PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG  155 (396)
T ss_pred             ecchHHHHH-HHhc-cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence            997754444 4332 3348889999999999999999999   9999999999999999999999999999998764 22


Q ss_pred             CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------hccccc-
Q 005621          501 PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR--------WKAGAI-  570 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~--------~~~~~~-  570 (687)
                      ...+..+.|..|.|||.+.+ .+|....||||+||++.||++|..-|.+...-+...++......        +..... 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            33455678999999999987 68999999999999999999999988877665555444332211        111111 


Q ss_pred             ccccCCc------CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 LEVVDPR------LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 ~~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+.-|.      +...++. ...-+++++..|++.||++|++-+|++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111111      1111221 1225789999999999999999999885

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.7e-41  Score=357.86  Aligned_cols=261  Identities=30%  Similarity=0.434  Sum_probs=206.3

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCC
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRG  413 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  413 (687)
                      ..++|...++||+|+||.||+|.+.     ..++.||||++.... ....+.+..|+.++.++ +||||++++++|...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3467899999999999999999752     335679999987543 33456789999999999 8999999999887644


Q ss_pred             -eeEEEEecCCCCCchhhhhchh---------------------------------------------------------
Q 005621          414 -DLLLVYDFMPNGSLDKCLFDEQ---------------------------------------------------------  435 (687)
Q Consensus       414 -~~~lV~Ey~~~gsL~~~L~~~~---------------------------------------------------------  435 (687)
                       .+++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             6899999999999999985421                                                         


Q ss_pred             ---hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC-CceeeeecCCC
Q 005621          436 ---KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLG  511 (687)
Q Consensus       436 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~  511 (687)
                         ...+++..+.+++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....... .......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               1347888999999999999999998   9999999999999999999999999999986533221 11222345788


Q ss_pred             CCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHH
Q 005621          512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDV  590 (687)
Q Consensus       512 y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  590 (687)
                      |+|||++.+..++.++|||||||++|||++ |..||......+.      .......+..     ++.    +......+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~-----~~~----~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTR-----MRA----PENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCC-----CCC----CCCCCHHH
Confidence            999999999999999999999999999997 9999976543221      1111222211     111    12233468


Q ss_pred             HHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          591 VKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       591 ~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .+++.+||+.+|++||++.++++.|+...
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            89999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-41  Score=353.99  Aligned_cols=252  Identities=26%  Similarity=0.390  Sum_probs=214.8

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      .|...++||+|+.|.||.+....+++.||||++........+-..+|+.+|+..+|+|||++++.+...+++|+|||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            46667789999999999999999999999999988766666778899999999999999999999998999999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +|+|.+.+   ....+++.++..|++++++||+|||.   ++|+|||||.+|||++.++++||+|||++..+..... ..
T Consensus       354 ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR  426 (550)
T KOG0578|consen  354 GGSLTDVV---TKTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR  426 (550)
T ss_pred             CCchhhhh---hcccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence            99999988   34459999999999999999999998   9999999999999999999999999999988766554 33


Q ss_pred             eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN  583 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~  583 (687)
                      ...+||+.|||||++....|.+|.||||||++++||+-|..||-...+-....++      -..|        ......+
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------a~ng--------~P~lk~~  492 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG--------TPKLKNP  492 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------hhcC--------CCCcCCc
Confidence            4468999999999999999999999999999999999999999764432222111      1111        1112233


Q ss_pred             HHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHh
Q 005621          584 EIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLE  616 (687)
Q Consensus       584 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~  616 (687)
                      +.....+.+++.+||+.|+++||++.|+++  +|+
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence            444557899999999999999999999998  553

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=338.08  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=214.1

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ..+.|+..+.||.|..++||+|.....++.||||++..+. ....+.+.+|+..|+.++||||++++..|..+.++|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            3467889999999999999999999899999999998663 334688999999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      .||.+||+.+.++..-...+++..+..|++++++||.|||.   +|.||||||+.||||+++|.+||+|||.+..+....
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999999977656669999999999999999999999   999999999999999999999999999876543332


Q ss_pred             CCce---eeeecCCCCCchhhccC--CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          500 NPST---TRVVGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       500 ~~~~---~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      .+..   ...+||++|||||++..  ..|+.|+||||||+..+||.+|..||....+-+..      ...++. ......
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tLqn-~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTLQN-DPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHhcC-CCCCcc
Confidence            2221   45689999999999644  46999999999999999999999999876543221      111211 111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      -..+..+-.......+.+++..|++.||++|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111122222223347889999999999999999999996

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=380.90  Aligned_cols=258  Identities=30%  Similarity=0.468  Sum_probs=212.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCC-----eEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTN-----TQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      .+....+.||+|.||.||.|...+..     ..||||.+.+. +.+...+|++|..+|++++|||||+++|.|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            34456789999999999999985432     34999998876 4566789999999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchh-----hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          417 LVYDFMPNGSLDKCLFDEQ-----KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                      |++|||++|+|..||++.+     ...|+..+.+.++.|||+|+.||++   +++|||||.++|+||++...+||+||||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999997642     3468999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          492 AKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       492 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      |+.+..... .......-+..|||||.+..+.++.|+|||||||+|||++| |..||......+...  .+    ...| 
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--~~----~~gg-  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--DV----LEGG-  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH--HH----HhCC-
Confidence            994433322 22222234579999999999999999999999999999999 888887765433221  11    1222 


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                             ||  +.+..++..+.+++..||+.+|++||+++.|++.+..+.
T Consensus       922 -------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  922 -------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             -------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence                   22  234456668999999999999999999999999877654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=354.08  Aligned_cols=239  Identities=28%  Similarity=0.467  Sum_probs=202.6

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCC
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGS  426 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs  426 (687)
                      .++.||.|+.|.||+|++  .++.||||+++.-.       ..+++-|++|+||||+.+.|+|...-.+|||||||+.|.
T Consensus       128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhccCcccceeeeec--cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            467899999999999999  57899999875432       357899999999999999999999999999999999999


Q ss_pred             chhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeee
Q 005621          427 LDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV  506 (687)
Q Consensus       427 L~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  506 (687)
                      |.+.|+  ..++++......|..+||.||.|||.   +.|||||||+-||||..+..+||+|||.++.+..-  .....+
T Consensus       199 L~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF  271 (904)
T KOG4721|consen  199 LYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF  271 (904)
T ss_pred             HHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence            999994  44578889999999999999999999   99999999999999999999999999999866432  223347


Q ss_pred             ecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHH
Q 005621          507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIE  586 (687)
Q Consensus       507 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~  586 (687)
                      +||..|||||++++...++|.||||||||||||+||..||..-+....      +|         .+=...|.-..+..+
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------Iw---------GVGsNsL~LpvPstc  336 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IW---------GVGSNSLHLPVPSTC  336 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EE---------eccCCcccccCcccC
Confidence            899999999999999999999999999999999999999976443211      01         111122333445556


Q ss_pred             HHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          587 ALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       587 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      +..+.-|+..||+..|..||++++|+..|+
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            667888999999999999999999999886

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=352.70  Aligned_cols=252  Identities=24%  Similarity=0.424  Sum_probs=211.0

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc----ch-hhHHHHHHHHHHHhhhc-CCCceeeeeeeecCC
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE----SK-QGLREFASEISSIGRLR-HRNLVQLLGWCRRRG  413 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~  413 (687)
                      ...++|...+.||+|.||+|++|.+..+++.||+|++...    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567899999999999999999999999999999987664    11 23456668999999999 999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-CcEEEcccccc
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLA  492 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla  492 (687)
                      .+++||||+.+|+|.+++..  .+++.+.++.+++.|++.|++|||+   ++|+||||||+|||++.+ +++||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999954  5679999999999999999999999   999999999999999999 99999999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccCCC-CC-CccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRTGK-PT-TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      .... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......       +...+..+..
T Consensus       169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki~~~~~  240 (370)
T KOG0583|consen  169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKIRKGEF  240 (370)
T ss_pred             cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHHhcCCc
Confidence            9774 2233445678999999999999876 75 78999999999999999999999844321       1111222211


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                            .+...+.   ..++..|+.+|+.++|.+|+++.+|++
T Consensus       241 ------~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  241 ------KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ------cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                  1111111   457899999999999999999999995

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=350.51  Aligned_cols=265  Identities=23%  Similarity=0.321  Sum_probs=215.3

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHH--HHHHHHHHhhhc-CCCceeeeeeeecCC-eeE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE--FASEISSIGRLR-HRNLVQLLGWCRRRG-DLL  416 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~  416 (687)
                      .-++|...++||.|.||.||+|+.+.++..||||++++.-.. +++  =++|++.|++|+ ||||++|.+.+.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            346788899999999999999999999999999999765332 233  368999999998 999999999998888 999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +|||||+ .+|.+++.++ +..+++.++..|+.||++||+|+|.   +|+.|||+||+|||+..+..+||+||||||...
T Consensus        87 fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   87 FVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence            9999994 5999998776 7789999999999999999999998   999999999999999999999999999999664


Q ss_pred             CCCCCceeeeecCCCCCchhhc-cCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc----
Q 005621          497 RGTNPSTTRVVGTLGYLAPELT-RTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL----  571 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~----  571 (687)
                        ..+..+..+-|..|.|||++ +.+.|+.+.|||++|||++|+.+-+.-|.+...-++..-+.-|..........    
T Consensus       162 --SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  162 --SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             --cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence              34556667889999999986 56789999999999999999999998888776555444433332222221111    


Q ss_pred             --cccCCcC--------CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          572 --EVVDPRL--------NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       572 --~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                        ..+.-++        ..-.+. ...++.+++.+|++.||++|||+.|.+++
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence              1111111        111122 55688999999999999999999999984

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=358.36  Aligned_cols=258  Identities=30%  Similarity=0.398  Sum_probs=209.8

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCe---E-EEEEEecC---cchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNT---Q-VAVKRVSN---ESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~---~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ...++||+|+||.||+|.++..+.   . ||||....   ..+....+|+.|+++|++++|||||++||++.....+++|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            345899999999999999865422   3 89999885   3467788999999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      ||+|+||+|++||.+... .++..++++++.+.|.||+|||+   ++++||||.++|+|++.++.+||+||||++.-..-
T Consensus       240 mEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY  315 (474)
T ss_pred             EEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence            999999999999966543 69999999999999999999999   99999999999999999999999999998854311


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      ... .....-+.+|+|||.+..+.++.++|||||||++||+.+ |..||.+....+       +.....        ...
T Consensus       316 ~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~kI~--------~~~  379 (474)
T KOG0194|consen  316 VMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAKIV--------KNG  379 (474)
T ss_pred             eec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHHHH--------hcC
Confidence            111 111134679999999999999999999999999999999 888988765421       111110        111


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCCCC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQ  623 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~  623 (687)
                      .+...+...+..+..++..||..+|++||+|.++.+.|+.......
T Consensus       380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            1222233445577888889999999999999999999987665444

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9e-40  Score=341.52  Aligned_cols=252  Identities=26%  Similarity=0.354  Sum_probs=206.0

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .|+..+.||+|+||+||++.+..+++.||+|.+....   ......+.+|+.++++++|+|++++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999998899999999987543   2233567899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++|+|.+++.......+++.++..++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            9999999988865445568999999999999999999998   999999999999999999999999999998754322 


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                       ......||..|+|||++.+..++.++|||||||++|||++|+.||..........   .+.......          ..
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~----------~~  222 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKED----------QE  222 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhcc----------cc
Confidence             2233568999999999999999999999999999999999999998654322111   111111110          01


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                      .++......+.+|+.+||+.||++||+     +.++++
T Consensus       223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            122223347889999999999999997     788886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.8e-39  Score=339.08  Aligned_cols=258  Identities=17%  Similarity=0.279  Sum_probs=205.0

Q ss_pred             CccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh---hHHHHHHHHHHHhhhcCCCceeeee
Q 005621          331 HRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ---GLREFASEISSIGRLRHRNLVQLLG  407 (687)
Q Consensus       331 ~~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~  407 (687)
                      ..+.++++.     ......||+|++|.||+|.+  +|+.||||+++.....   ..+.|.+|+.++++++||||+++++
T Consensus        13 ~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988         13 KCIESDDID-----KYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             eecCHHHcC-----CCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            344555552     23346799999999999998  6899999998765332   2577889999999999999999999


Q ss_pred             eeec----CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          408 WCRR----RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       408 ~~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                      ++.+    ....++||||+++|+|.+++..  ...+++....+++.|++.||.|||+  ..+++||||||+||++++++.
T Consensus        86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~  161 (283)
T PHA02988         86 FIIDIVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYK  161 (283)
T ss_pred             eEEecccCCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCc
Confidence            9876    3578999999999999999954  3468999999999999999999997  247889999999999999999


Q ss_pred             EEEcccccceeccCCCCCceeeeecCCCCCchhhccC--CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 005621          484 GRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV  561 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v  561 (687)
                      +||+|||+++......    ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+.   ...+
T Consensus       162 ~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~~i  234 (283)
T PHA02988        162 LKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YDLI  234 (283)
T ss_pred             EEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HHHH
Confidence            9999999998653321    23467899999999976  6899999999999999999999999986542211   1111


Q ss_pred             HHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          562 WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       562 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                         ...+     ..+.    .+......+.+++.+||+.||++||++.++++.|+..
T Consensus       235 ---~~~~-----~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        235 ---INKN-----NSLK----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             ---HhcC-----CCCC----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence               1111     0111    1222345788999999999999999999999998753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.7e-39  Score=392.81  Aligned_cols=263  Identities=27%  Similarity=0.503  Sum_probs=219.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .+.|...++||+|+||.||+|++..++..||||++......    ...|++.+++++||||++++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            35677888999999999999999888999999998654322    13468899999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++|+|.++++     .++|.++.+|+.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||.+......   
T Consensus       765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            99999999993     38999999999999999999997666899999999999999999888875 6665433211   


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC-
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG-  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~-  580 (687)
                        ....|+..|+|||++.+..++.++|||||||++|||+||+.|++.... .....++|++..+........+|+.+.. 
T Consensus       836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCC
Confidence              123678999999999999999999999999999999999999964332 3345667777666665566667777644 


Q ss_pred             -CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          581 -EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       581 -~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                       ..+..+..++.+++.+||+.+|++||+|+||++.|+...+
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence             3445667788999999999999999999999999987654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.8e-40  Score=316.44  Aligned_cols=265  Identities=26%  Similarity=0.346  Sum_probs=210.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh--hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ--GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .+|...++||+|.||.||+|++..+|+.||||+++.....  ......+|++.|+.++|+||+.++++|...+.+-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677889999999999999999999999999999765322  23567899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      ||+. +|+..++++ ...++..++..++.++++||+|||+   +.|+||||||.|+|+++++.+||+|||+|+.+.....
T Consensus        82 fm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             eccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9964 898888654 4579999999999999999999999   9999999999999999999999999999998876544


Q ss_pred             CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc---------
Q 005621          501 PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI---------  570 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~---------  570 (687)
                      ... ..+-|..|.|||.+.+ +.|+...||||.||++.||+.|.+-|.+...-+....+-.+.........         
T Consensus       157 ~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 IQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             ccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            333 3377999999999876 57999999999999999999988766665543333222111111111111         


Q ss_pred             ---ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          571 ---LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       571 ---~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                         .....+.+..-++ ....++++|+..++..||.+|+++.|++++
T Consensus       236 ~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence               1111122222222 234467999999999999999999999973

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-40  Score=342.99  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=210.8

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  416 (687)
                      -.++|...+.||.|.|++|++|+.+.+++.+|||++.+.-   ....+-...|-.+|.+| .||.|++|+-.|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3457788899999999999999999999999999997652   22234456788899999 8999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +|+||++||+|.++|.  +.+.+++.-...++.+|+.||+|||+   +|||||||||+|||||+||++||.|||.|+.+.
T Consensus       151 FvLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999999994  44679999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCCC----------c--eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 005621          497 RGTNP----------S--TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       497 ~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      .....          .  ...++||..|.+||++..+..+..+|+|+|||+||+|+.|++||.....-  ..+.     .
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--liFq-----k  298 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--LIFQ-----K  298 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--HHHH-----H
Confidence            32211          1  14589999999999999999999999999999999999999999876531  1111     1


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      +      ..++-.+...++    +.+.+|+.+.|..||.+|++..||.+.
T Consensus       299 I------~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  299 I------QALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             H------HHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence            1      112223333333    578899999999999999999999873

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-39  Score=336.97  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=206.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeC---CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLP---STNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++|+..+.||+|+||.||+|.+.   ..+..||+|.++... ......|.+|+..+++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999874   345789999987653 3345678999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++... ...+++.+++.++.|++.||+|||+   ++++||||||+|||++.++.+|++|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999998543 3468999999999999999999998   9999999999999999999999999998764322


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      ..........++..|+|||++.+..++.++|||||||++||+++ |+.||......+   ..+    ....+..     .
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~----~~~~~~~-----~  227 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK----AVEDGFR-----L  227 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH----HHHCCCC-----C
Confidence            21111112335678999999999999999999999999999875 999997654321   111    1111111     1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                          ..+...+..+.+++.+||+.+|++||++.+|.+.|.+.
T Consensus       228 ----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 ----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                11223344788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-40  Score=339.09  Aligned_cols=250  Identities=34%  Similarity=0.559  Sum_probs=196.8

Q ss_pred             cceeeeeeCeEEEEEEEeC----CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          347 DKELLGFGGFGRVYKGTLP----STNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ..+.||.|.||.||+|.+.    ..+..|+||.++... ....++|.+|++.+++++||||++++|+|...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999996    345789999996643 34578999999999999999999999999988889999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++|+|.++|.......+++.++.+|+.||+.||.|||+   .+++|+||+++||++++++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            999999999977655679999999999999999999998   89999999999999999999999999999876322111


Q ss_pred             -ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          502 -STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       502 -~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       ..........|+|||.+....++.++||||||+++|||++ |+.|+......+   +    .....++....       
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~----~~~~~~~~~~~-------  225 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---I----IEKLKQGQRLP-------  225 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---H----HHHHHTTEETT-------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc---c----cccccccccce-------
Confidence             1122356778999999999889999999999999999999 778876553211   1    11112222211       


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                        .+......+.+++.+||+.+|++||++.++++.|
T Consensus       226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              1122334788999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.6e-39  Score=341.09  Aligned_cols=263  Identities=25%  Similarity=0.391  Sum_probs=204.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCC----------------CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceee
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPS----------------TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQL  405 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  405 (687)
                      ++|...++||+|+||.||++.+..                .+..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999998632                34579999987653 3345679999999999999999999


Q ss_pred             eeeeecCCeeEEEEecCCCCCchhhhhchh-----------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEe
Q 005621          406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ-----------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH  468 (687)
Q Consensus       406 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  468 (687)
                      ++++.+.+..++||||+++|+|.+++....                 ...+++.++++++.||+.||.|||+   .+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            999999999999999999999999884321                 1247889999999999999999998   89999


Q ss_pred             eccCCCcEEeccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh--CCCC
Q 005621          469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC--GRRP  545 (687)
Q Consensus       469 rDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt--G~~p  545 (687)
                      |||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999865433221 1222345788999999998899999999999999999987  5567


Q ss_pred             CCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          546 IEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       546 ~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      |......+   ....+.+.+..... ..     ....+..++..+.+++.+||+.+|++||++.+|.+.|++
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRDQGR-QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhhccc-cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            66543221   12222222211110 00     001112233478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=340.11  Aligned_cols=273  Identities=30%  Similarity=0.421  Sum_probs=204.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhh--hcCCCceeeeeeeecCC----eeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR--LRHRNLVQLLGWCRRRG----DLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~  416 (687)
                      ......++||+|+||.||||++  .++.||||++....+   +.|.+|-++.+.  ++|+||+++++.-+...    +++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            4455678899999999999999  569999999976544   456666666555  58999999999876655    899


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccc------cCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW------EQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                      ||+||.++|+|.+||   ....++|....+|+..+++||+|||++.      +++|+|||||++||||..|+++.|+|||
T Consensus       285 LVt~fh~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EEeeeccCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999999   4457999999999999999999999863      5679999999999999999999999999


Q ss_pred             cceeccCCCCCc-eeeeecCCCCCchhhccCCC-C-----CCccceehhhHHHHHHHhCCCCCCCCCC-cchhhHHHHHH
Q 005621          491 LAKLYERGTNPS-TTRVVGTLGYLAPELTRTGK-P-----TTSSDVYAFGALLLEVVCGRRPIEPKAL-PEELILVDWVW  562 (687)
Q Consensus       491 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~-----~~~sDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~v~  562 (687)
                      ||..+....... ....+||.+|||||++.+.. +     -.+.||||+|.|||||++...-++.... +...-+...+.
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            999887655432 33478999999999997642 2     2368999999999999997665542111 11111111111


Q ss_pred             HHhc-----ccccccccCCcCCCCCCHH-HHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCCCC
Q 005621          563 DRWK-----AGAILEVVDPRLNGEFNEI-EALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQ  623 (687)
Q Consensus       563 ~~~~-----~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~  623 (687)
                      ....     +-.+.+...|.++..+... -+..+.+.+..||..||+.|.|+.=|.+++.....+.+
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            1110     0011222334443333222 34467899999999999999999999888877654443

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-39  Score=354.07  Aligned_cols=259  Identities=27%  Similarity=0.368  Sum_probs=205.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEe-----CCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  414 (687)
                      .++|+..+.||+|+||+||+|++     ..++..||||+++... ....+.+.+|+.+++.+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788899999999999999974     3346689999987543 33456788999999999 89999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchh-----------------------------------------------------------
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQ-----------------------------------------------------------  435 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~-----------------------------------------------------------  435 (687)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999885421                                                           


Q ss_pred             --------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          436 --------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       436 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                                    ...+++..+.+++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          1247899999999999999999998   99999999999999999999999999999865433221


Q ss_pred             c-eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          502 S-TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       502 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      . .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......  ....+    +..+..         
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~---------  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGYR---------  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCcc---------
Confidence            1 112335678999999999999999999999999999998 888886543321  11111    111110         


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ...+...+.++.+++.+||+.||++||++.||++.|++.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            011111234788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.7e-40  Score=346.45  Aligned_cols=247  Identities=29%  Similarity=0.421  Sum_probs=212.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|...+.||+|.||+||||+.+.+.+.||+|.+.+..  ....+...+|++++++++||||+.++++|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            47888899999999999999999999999999998764  3456788999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+.| +|..+|  .+.+.++++++..|+.++..||.|||+   .+|+|||+||.|||++..+.+|+||||+|+.+..+. 
T Consensus        82 ~a~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-  154 (808)
T KOG0597|consen   82 YAVG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-  154 (808)
T ss_pred             hhhh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence            9977 999999  556679999999999999999999999   999999999999999999999999999999876543 


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                      ...+.+.||+.|||||+..++.|+..+|+||+||++||+.+|++||.....   ..+++.    +.       -||.   
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si---~~Lv~~----I~-------~d~v---  217 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI---TQLVKS----IL-------KDPV---  217 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH---HHHHHH----Hh-------cCCC---
Confidence            334567899999999999999999999999999999999999999975432   112211    11       1111   


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .++......+..++...+..||.+|.+..+++.
T Consensus       218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            122344557888999999999999999999986

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=345.70  Aligned_cols=254  Identities=25%  Similarity=0.346  Sum_probs=207.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||.||+|++..+++.||||++....   ......+..|++++.+++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999998889999999997642   234567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++.  ....+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            9999999999984  34568999999999999999999998   9999999999999999999999999999986533  


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+   . .+.  ....  .+.. 
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i---~-~~~--~~~~--~~~~-  222 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL---K-YWK--ETLQ--RPVY-  222 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH---H-hcc--cccc--CCCC-
Confidence              223457899999999999999999999999999999999999999765432211110   0 000  0000  0110 


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ..........+.+++.+||+.+|++||++.++++.
T Consensus       223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00001223468899999999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2e-39  Score=334.43  Aligned_cols=256  Identities=28%  Similarity=0.416  Sum_probs=210.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      .+|...+.||+|++|.||+|.+...++.||+|++.... ....++.+|++++++++|||++++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778899999999999999998889999999987543 34567899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.......+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            99999999966555578999999999999999999998   899999999999999999999999999998664432222


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......+       .++....+         ....
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~~~~  225 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKG---------YRME  225 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCC---------CCCC
Confidence            222234668999999999999999999999999999998 888987543211       11111111         1112


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            2222345788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.4e-39  Score=338.13  Aligned_cols=266  Identities=23%  Similarity=0.291  Sum_probs=207.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..+.||+|+||+||+++++.+++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999999889999999987542  2335678899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |++++.|..+.  .....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLE--EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            99988776543  223468999999999999999999998   9999999999999999999999999999987654333


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHH---------HHhcccccc
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVW---------DRWKAGAIL  571 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~---------~~~~~~~~~  571 (687)
                      .......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.........         .........
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            33344578999999999998889999999999999999999999998654322221111110         000000000


Q ss_pred             cccCCcCCC------CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLNG------EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....+....      .+.......+.+++.+||+.||++||+++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            110011100      011123346899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd01951 lectin_L-type legume lectins

Probab=100.00  E-value=1.9e-38  Score=318.68  Aligned_cols=204  Identities=32%  Similarity=0.417  Sum_probs=171.4

Q ss_pred             CCeEEeeceEEcc-CCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCC
Q 005621           38 NNMSLNGAAEIEK-NGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKE  116 (687)
Q Consensus        38 ~~l~~~g~a~~~~-~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~  116 (687)
                      .++.++|+|.+.. ++.|+||++..+++||++|++||++|        ++|+|+|+|.|.... ..+||||||+|+|...
T Consensus        14 ~~~~~~G~A~~~~~~~~l~Lt~~~~~~~G~~~~~~~i~~~--------~~F~~~F~f~i~~~~-~~~gdG~aF~l~~~~~   84 (223)
T cd01951          14 SNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS--------KDFTTTFKFYLGTKG-TNGADGIAFVLQNDPA   84 (223)
T ss_pred             hhcEEcccEEecCCCCEEEECCCCCCcEEEEEECCcEecc--------CCEEEEEEEEEeCCC-CCCCCcEEEEEecCCC
Confidence            5899999999975 78999999999999999999999997        379999999998764 5689999999999876


Q ss_pred             CCCCCCC--ccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccc--ccccccccccccccccccC
Q 005621          117 LPGTLPS--QYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNA--SEPAAYFLENSTKQVLNLK  192 (687)
Q Consensus       117 ~~~~~~g--~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~--~~~~~~~~~~~~~~~~~~~  192 (687)
                      .+.+.++  ++||+       ...++.+||||||++|.+++||+.||||||+|+..+..  ..+..+.     ..+....
T Consensus        85 ~~~~~~g~~~~lG~-------~~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~-----~~~~~~~  152 (223)
T cd01951          85 GALGGGGGGGGLGY-------GGIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSA-----SLPNGTG  152 (223)
T ss_pred             CccccCCCCCccCc-------cccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCccccccccee-----eCCCccC
Confidence            5555555  78887       34568999999999999888999999999999987641  1111111     0112222


Q ss_pred             CCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcccceeEEEEeeec
Q 005621          193 SGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFN  263 (687)
Q Consensus       193 ~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sWsf~  263 (687)
                      +|+.++|||+||+.+++|+|+|..... |..+.++.++||+..++++||||||||||...|.|.|++|+|+
T Consensus       153 ~g~~~~v~I~Y~~~~~~L~v~l~~~~~-~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~  222 (223)
T cd01951         153 LGNEHTVRITYDPTTNTLTVYLDNGST-LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFT  222 (223)
T ss_pred             CCCEEEEEEEEeCCCCEEEEEECCCCc-cccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEec
Confidence            399999999999999999999987653 6778899999999999999999999999999999999999996

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=348.74  Aligned_cols=254  Identities=27%  Similarity=0.395  Sum_probs=219.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      .+....++||-|.||.||.|.|++-...||||.++.+.- ..++|+.|+.+|+.++|||+|+|+|+|..+-.+|||+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            445667899999999999999998889999999976543 4689999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      .+|+|.+||+...+..++.-..+.++.||+.||.||..   +++|||||.++|+|+.++..+||+||||+|++..+....
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            99999999988777778888899999999999999998   999999999999999999999999999999886655433


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....-+..|.|||-+....++.|+|||+|||+||||.| |..||.+-+..       .|+.++         ....+.+
T Consensus       423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------qVY~LL---------EkgyRM~  486 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYGLL---------EKGYRMD  486 (1157)
T ss_pred             ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------HHHHHH---------hcccccc
Confidence            322334678999999999999999999999999999999 88887664422       233333         3334445


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      -++.|+..+.+|++.||+.+|.+||+++|+-+.++
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            56677789999999999999999999999998775

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4e-39  Score=343.77  Aligned_cols=245  Identities=24%  Similarity=0.310  Sum_probs=204.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888999999999999999999899999999987542   233567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        98 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            99999999999853  4468899999999999999999998   99999999999999999999999999999865432 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+       ..+....+..      .+.
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~------~~p  235 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRL------KFP  235 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCc------CCC
Confidence               223578999999999999999999999999999999999999997543211       1111222211      111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                      ..    ....+.+++.+||+.||++||+     ++++++
T Consensus       236 ~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        236 NW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            11    2336789999999999999997     678775

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.1e-39  Score=342.85  Aligned_cols=242  Identities=24%  Similarity=0.309  Sum_probs=200.1

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      +.||+|+||.||+++...+++.||+|++....   .....++..|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999899999999987642   334567789999999999999999999999999999999999999


Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceee
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR  505 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  505 (687)
                      +|.+++..  ...+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~  154 (323)
T cd05571          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT  154 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence            99998843  4578999999999999999999998   99999999999999999999999999998753221 122334


Q ss_pred             eecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHH
Q 005621          506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEI  585 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~  585 (687)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..    .....+      +..+.    ..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~----~~~~~~------~~~~p----~~  217 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF----ELILME------EIRFP----RT  217 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HH----HHHHcC------CCCCC----CC
Confidence            679999999999999999999999999999999999999997643211   11    111111      11122    22


Q ss_pred             HHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          586 EALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       586 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ....+.+++.+||+.||++||     ++.++++
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            334688999999999999999     7999886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=345.62  Aligned_cols=264  Identities=28%  Similarity=0.409  Sum_probs=215.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .+...+.++||+|.||.|.++... .+..||||.++.... ....+|.+|+++|.+|+||||++|+|.|...+.+++|+|
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            345567899999999999999984 369999999998754 445899999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      ||++|+|.+||.......+.-....+|+.||+.||+||.+   .++|||||.++|+|++.++++||+|||++|.+-.+..
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999999977654445667778899999999999999   9999999999999999999999999999996544433


Q ss_pred             -CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh--CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          501 -PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC--GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       501 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                       ....+.+-+.+|||||.+..++++.+||||+||+.+||+++  ...||+....+.   .++-....+..+....     
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~-----  764 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQV-----  764 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcce-----
Confidence             33345566889999999999999999999999999999864  788987665322   2222222222111111     


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                       -...+..++..+.+++++||..+-++||+++++...|++.
T Consensus       765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence             1122344566899999999999999999999999998764

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.4e-39  Score=351.46  Aligned_cols=259  Identities=27%  Similarity=0.409  Sum_probs=205.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  414 (687)
                      .++|...+.||+|+||.||+|++..     ++..||+|++.... ......+.+|+.+++.+ +|+||++++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            3478889999999999999998643     33579999997653 33356788999999999 89999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchh-----------------------------------------------------------
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQ-----------------------------------------------------------  435 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~-----------------------------------------------------------  435 (687)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999885421                                                           


Q ss_pred             ---------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc-eee
Q 005621          436 ---------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTR  505 (687)
Q Consensus       436 ---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~  505 (687)
                               ...+++.++++++.||+.||.|||+   ++|+||||||+|||+++++.+||+|||+++......... ...
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                     1247889999999999999999998   999999999999999999999999999998654332211 112


Q ss_pred             eecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.........      ......+     ..+.    .+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~------~~~~~~~-----~~~~----~~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF------YKMVKRG-----YQMS----RPD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH------HHHHHcc-----cCcc----CCC
Confidence            235678999999998899999999999999999997 99998765432211      1111111     0111    111


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ..+.++.+++.+||+.+|++||++.+|++.|++.
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1234788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.8e-39  Score=330.96  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=208.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|+..++||+|++|.||+|... ++..||+|.+..... ..+.+..|+.++++++|+||+++++.+...+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            57888999999999999999975 567799998865432 3578899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.......+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.........
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            99999999976555678999999999999999999998   999999999999999999999999999998765433222


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....++..|+|||++..+.++.++||||||+++|||++ |+.||.......   ...++    ..+.     ...... 
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~-----~~~~~~-  227 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL----QRGY-----RMPRME-  227 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCC-----CCCCCC-
Confidence            223345678999999998899999999999999999998 999986543211   11111    1111     011111 


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                         ..+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       228 ---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         228 ---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               123468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=339.26  Aligned_cols=246  Identities=23%  Similarity=0.288  Sum_probs=204.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|.+..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999998889999999986542   233466889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            99999999999843  4468999999999999999999998   99999999999999999999999999999865332 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+       ..+....+.      .   
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~------~---  215 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGK------L---  215 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------c---
Confidence               223568999999999998889999999999999999999999997654221       111111111      1   


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVRY  614 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~  614 (687)
                       .++......+.+++.+||+.||.+||+     +.++++.
T Consensus       216 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 -EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             111222346889999999999999995     8887763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=338.64  Aligned_cols=249  Identities=29%  Similarity=0.448  Sum_probs=214.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ..|+..++||+|.||.||||.+..+++.||+|++..+. ....++..+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45677789999999999999999999999999998764 44567889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      |.+|++.+.|.  ....+.+..+.-|+++++.||.|||.   ++.+|||||+.|||+..++.+||+|||.+-.+......
T Consensus        93 ~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   93 CGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             hcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999999993  34445888888899999999999999   99999999999999999999999999999877655544


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      . .+++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.....+            +.+-..|.|.+.
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~~  234 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDGD  234 (467)
T ss_pred             c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCccccc
Confidence            4 568999999999999988999999999999999999999999987765332221            122334555554


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +..    .+.+++..|++.+|+.||++.++++
T Consensus       235 ~S~----~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  235 FSP----PFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cCH----HHHHHHHHHhhcCcccCcCHHHHhh
Confidence            443    6889999999999999999999986

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.4e-39  Score=334.70  Aligned_cols=256  Identities=28%  Similarity=0.460  Sum_probs=208.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCC-----eEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTN-----TQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ++|+..+.||+|+||.||+|.+...+     ..||+|.+.... .....+|.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            36778899999999999999986544     679999987543 334567899999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhh--------------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC
Q 005621          417 LVYDFMPNGSLDKCLFDEQK--------------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL  482 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~  482 (687)
                      ++|||+++++|.+++.....              ..+++.+++.++.|++.||.|||+   .+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence            99999999999999854311              458899999999999999999998   8999999999999999999


Q ss_pred             cEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 005621          483 NGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDW  560 (687)
Q Consensus       483 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~  560 (687)
                      .+||+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||......+   .   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~---  235 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---V---  235 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---
Confidence            999999999986533221 22233456789999999998899999999999999999998 999987654321   1   


Q ss_pred             HHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       561 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                       .+.+..+..         ...+...+.++.+|+.+||+.+|++||++.+|++.|+.
T Consensus       236 -~~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 -IEMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             111112111         11223344578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.7e-39  Score=334.11  Aligned_cols=256  Identities=29%  Similarity=0.451  Sum_probs=213.2

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ...+|...++||.|++|.||+|.+.. +..+|+|.+.........++..|+.+++.++|||++++++++...+..++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34568889999999999999999976 88999999987766566789999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++.......+++.++.+++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999977666679999999999999999999998   8999999999999999999999999999986543222


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      . .....++..|+|||.+..+.++.++||||||+++++|++ |+.||......+.   ...+.    .+         ..
T Consensus       160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~~----~~---------~~  222 (261)
T cd05148         160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQIT----AG---------YR  222 (261)
T ss_pred             c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHHH----hC---------Cc
Confidence            1 122345678999999998899999999999999999998 8999876542211   11111    11         11


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ...+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            11122334478899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=337.37  Aligned_cols=240  Identities=25%  Similarity=0.298  Sum_probs=196.7

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      ||+|+||.||+|.+..+++.||+|++...   .......+..|+.++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999888999999998754   233456788999999999999999999999999999999999999999


Q ss_pred             hhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeee
Q 005621          428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV  507 (687)
Q Consensus       428 ~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  507 (687)
                      .+++..  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... .......
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  154 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC  154 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence            999854  4468999999999999999999998   999999999999999999999999999997543222 2233457


Q ss_pred             cCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHH
Q 005621          508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEA  587 (687)
Q Consensus       508 gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  587 (687)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .. +....+.      ..    ++....
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~-~~~~~~~------~~----~~~~~~  217 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MY-RKILQEP------LR----FPDGFD  217 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HH-HHHHcCC------CC----CCCcCC
Confidence            9999999999999999999999999999999999999997643211      11 1111111      11    122223


Q ss_pred             HHHHHHHHhccccCcCcCCC---HHHHHH
Q 005621          588 LDVVKLGLMCSNDAAEARPT---MRQVVR  613 (687)
Q Consensus       588 ~~l~~l~~~Cl~~dP~~RPs---~~evl~  613 (687)
                      ..+.+++.+||+.||++||+   +.++++
T Consensus       218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            46789999999999999986   455554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2e-38  Score=338.77  Aligned_cols=263  Identities=24%  Similarity=0.318  Sum_probs=206.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      -++|+..+.||+|+||.||++++..++..+|+|.+.... .....++.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367899999999999999999999899999999987653 3345679999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            9999999999843  3468999999999999999999997  2469999999999999999999999999997653322 


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc-----------
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA-----------  569 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~-----------  569 (687)
                        .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+......+.           
T Consensus       159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhcccccccccCCccccCccc
Confidence              2334689999999999998999999999999999999999999965432111   000000000000           


Q ss_pred             ----------------------ccc-ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          570 ----------------------ILE-VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       570 ----------------------~~~-~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                                            ..+ ................++.+++.+||+.||++||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                  000 000000000011233478899999999999999999999873

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=314.82  Aligned_cols=237  Identities=25%  Similarity=0.355  Sum_probs=205.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||.|.||+|.+++.+.+|..+|+|++++...   ...+...+|..+|+.+.||.++++++.|.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            467788999999999999999999999999999987643   33456788999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||++||.|..+|+  +.+++++..+.-++.||+.||+|||+   ..|++|||||+|||||.+|.+||.|||.|+....  
T Consensus       124 eyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--  196 (355)
T ss_pred             eccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence            9999999999994  44579999999999999999999999   9999999999999999999999999999997643  


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                        .+.+.+||+.|+|||++..+.++.++|.|||||++|||+.|..||......       .+.+++.++++         
T Consensus       197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~v---------  258 (355)
T KOG0616|consen  197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGKV---------  258 (355)
T ss_pred             --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCcc---------
Confidence              366789999999999999999999999999999999999999999987652       12333333332         


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEAR  605 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~R  605 (687)
                       .++.....++.+|+...++.|-.+|
T Consensus       259 -~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 -KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence             1233333477888889999998888

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-39  Score=343.34  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=213.7

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      -|+..+.||+|+-|.|-+|++..+|+.+|||++.+..   ......+.+|+-+|+.+.|||++++|+.++++.++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            3566788999999999999999999999999997762   2234567899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++|-|.++|  -.++++++.++.+++.||+.|+.|+|.   .+|+||||||+|+|||..+++||+|||+|-....+. 
T Consensus        93 yv~gGELFdyl--v~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-  166 (786)
T KOG0588|consen   93 YVPGGELFDYL--VRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-  166 (786)
T ss_pred             ecCCchhHHHH--HhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence            99999999999  456789999999999999999999999   999999999999999999999999999998654433 


Q ss_pred             CceeeeecCCCCCchhhccCCCCC-CccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPT-TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       ...+-+|.+.|.+||++.+.+|. .++||||+|||||.|+||+.||+++..       +-+..+.+.|..         
T Consensus       167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G~f---------  229 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRGVF---------  229 (786)
T ss_pred             -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCcc---------
Confidence             33456899999999999998875 589999999999999999999996543       222233334432         


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCCC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVP  620 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~  620 (687)
                       +.+.....++.+|+.+|+..||++|.|++||++  +|.+-..
T Consensus       230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence             122333447889999999999999999999998  4555433

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=328.09  Aligned_cols=255  Identities=29%  Similarity=0.413  Sum_probs=207.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|+..+.||+|++|.||+|.+. .++.||+|.++... ...+++.+|+.++++++|||++++++++...+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            456888999999999999999975 45789999987643 2356789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++.++.+++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            999999999966544568999999999999999999998   89999999999999999999999999999876533222


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                      .......+..|+|||++.+..++.++||||||+++|||++ |+.||.......       +......+.         ..
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~---------~~  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGY---------RM  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC---------CC
Confidence            1111223458999999998899999999999999999999 998987543211       111111110         01


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ..+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1112234578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.6e-38  Score=337.42  Aligned_cols=243  Identities=23%  Similarity=0.308  Sum_probs=200.0

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      +.||+|+||.||++....+++.||+|++....   .....++..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999998899999999997642   334567889999999999999999999999999999999999999


Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceee
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR  505 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  505 (687)
                      +|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~  154 (328)
T cd05593          81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT  154 (328)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence            99988843  3468999999999999999999998   999999999999999999999999999987532221 22234


Q ss_pred             eecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHH
Q 005621          506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEI  585 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~  585 (687)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+..       +....+      +..+...    
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-------~~~~~~------~~~~p~~----  217 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILME------DIKFPRT----  217 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-------HHhccC------CccCCCC----
Confidence            57999999999999889999999999999999999999999764422111       111111      1112222    


Q ss_pred             HHHHHHHHHHhccccCcCcCC-----CHHHHHHH
Q 005621          586 EALDVVKLGLMCSNDAAEARP-----TMRQVVRY  614 (687)
Q Consensus       586 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  614 (687)
                      ...++.+++.+||+.||++||     ++.++++.
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            234678999999999999997     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.2e-38  Score=337.29  Aligned_cols=242  Identities=25%  Similarity=0.311  Sum_probs=198.9

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      +.||+|+||.||++....++..||+|++....   ......+..|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999998899999999987642   334567788999999999999999999999999999999999999


Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceee
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR  505 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  505 (687)
                      +|..++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~  154 (323)
T cd05595          81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT  154 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence            99988843  3468999999999999999999998   999999999999999999999999999987532211 12233


Q ss_pred             eecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHH
Q 005621          506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEI  585 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~  585 (687)
                      ..||+.|+|||++.++.++.++|||||||++|||++|+.||.........       .....+      +..+...    
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-------~~~~~~------~~~~p~~----  217 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILME------EIRFPRT----  217 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcC------CCCCCCC----
Confidence            56899999999999999999999999999999999999999765432111       111111      1112222    


Q ss_pred             HHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          586 EALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       586 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ....+.+++.+||+.||++||     ++.++++
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            234678999999999999998     8888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-38  Score=332.37  Aligned_cols=262  Identities=24%  Similarity=0.304  Sum_probs=198.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCC-CCeEEEEEEecCcc--hhhHHHHHHHHHHHhhh---cCCCceeeeeeee-----c
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPS-TNTQVAVKRVSNES--KQGLREFASEISSIGRL---RHRNLVQLLGWCR-----R  411 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~  411 (687)
                      ++|+..+.||+|+||+||+|++.. +++.||+|++....  ......+.+|+.+++.+   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            478899999999999999999853 46889999886542  22234556677777665   6999999999885     3


Q ss_pred             CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                      ...+++||||++ ++|.+++.......+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 689998866555568999999999999999999998   9999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc---cc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK---AG  568 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~---~~  568 (687)
                      ++.....  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+...   .+.+...   ..
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~---~i~~~~~~~~~~  231 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLPGEE  231 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHHhCCCChh
Confidence            9865433  22334568999999999988899999999999999999999999998754322211   1111100   00


Q ss_pred             ccc-------cccCCcCCC---CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          569 AIL-------EVVDPRLNG---EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       569 ~~~-------~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ...       ....+.-..   .........+.+++.+||+.||++||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000       000000000   000112346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.2e-38  Score=327.10  Aligned_cols=251  Identities=29%  Similarity=0.465  Sum_probs=202.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||+|+||.||++.+. .+..+|+|.+.... ....++..|+.++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            45778899999999999999985 45689999876443 23467889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++|+|.+++.... ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++.........
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999886433 358999999999999999999998   999999999999999999999999999998653322222


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+   ....+.    .+..  ...+     
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~----~~~~--~~~~-----  223 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMIS----RGFR--LYRP-----  223 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCC--CCCC-----
Confidence            222345678999999998889999999999999999999 899987654321   111111    1110  0111     


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                        ......+.+++.+||+.+|++||++.++++.|
T Consensus       224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              11234688999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=343.35  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=206.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||+||+|.+..+++.||||++....   ......+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999998889999999987642   234567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999543  578999999999999999999998   999999999999999999999999999998654432


Q ss_pred             ----------------------------CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCC
Q 005621          500 ----------------------------NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKAL  551 (687)
Q Consensus       500 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~  551 (687)
                                                  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                        1122335689999999999999999999999999999999999999987653


Q ss_pred             cchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC-HHHHHHH
Q 005621          552 PEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT-MRQVVRY  614 (687)
Q Consensus       552 ~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~  614 (687)
                      .+..      .........   .  .+...  ......+.+++.+|++ +|++||+ +.++++.
T Consensus       236 ~~~~------~~i~~~~~~---~--~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QETY------NKIINWKES---L--RFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHH------HHHhccCCc---c--cCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            2111      111100000   0  01000  0123468889999997 9999999 9999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-38  Score=327.00  Aligned_cols=256  Identities=29%  Similarity=0.451  Sum_probs=207.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|+..+.||+|+||+||+|.++..   ...||||.+.... .....+|.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5688899999999999999998643   4579999987653 33456789999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++.... ..+++.++++++.|++.||.|||+   .+|+||||||+||++++++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999985433 368999999999999999999998   99999999999999999999999999999876522


Q ss_pred             CCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          499 TNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       499 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+   ..+    ....+..      
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~----~~~~~~~------  226 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIK----AVEDGYR------  226 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHH----HHHcCCC------
Confidence            211 1112234678999999998899999999999999999998 999986543221   111    1111100      


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                         ...+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       227 ---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 ---LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               011122334788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.7e-39  Score=336.93  Aligned_cols=253  Identities=23%  Similarity=0.310  Sum_probs=208.7

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ..++|..++.||+|+||.||+++-+.+|..+|+|++++..   ....+..+.|-.+|...++|+||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            3568999999999999999999999999999999998874   4556778899999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+|||++..+|.  ..+.|++..+...+.+++.|+.-||+   .|+|||||||+|+|||..|.+||+||||+.-+..
T Consensus       219 iMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            999999999999994  45679999999999999999999998   9999999999999999999999999999853311


Q ss_pred             ---------------CC-------CC-----ce-------------------eeeecCCCCCchhhccCCCCCCccceeh
Q 005621          498 ---------------GT-------NP-----ST-------------------TRVVGTLGYLAPELTRTGKPTTSSDVYA  531 (687)
Q Consensus       498 ---------------~~-------~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~sDV~S  531 (687)
                                     ..       ..     ..                   ...+||+.|||||++.+..|+..+|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                           00       00     00                   1246999999999999999999999999


Q ss_pred             hhHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC---
Q 005621          532 FGALLLEVVCGRRPIEPKALPEEL-ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT---  607 (687)
Q Consensus       532 ~Gvvl~elltG~~p~~~~~~~~~~-~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---  607 (687)
                      +|||+|||+.|.+||....+.+.. .++.|-..              +...-......+..+|+.+|+. ||++|.-   
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            999999999999999988765432 22333211              1111111222578899999999 9999986   


Q ss_pred             HHHHHH
Q 005621          608 MRQVVR  613 (687)
Q Consensus       608 ~~evl~  613 (687)
                      +.||.+
T Consensus       439 ~~EIK~  444 (550)
T KOG0605|consen  439 AEEIKK  444 (550)
T ss_pred             HHHHhc
Confidence            555554

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.9e-38  Score=332.11  Aligned_cols=265  Identities=23%  Similarity=0.340  Sum_probs=203.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|...++||.|+||.||+|....++..||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999998899999999987543 22345678999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++ +|.+++... ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        85 ~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          85 LDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            975 898887433 3357899999999999999999998   9999999999999999999999999999986533221 


Q ss_pred             ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH-----hcc----cccc
Q 005621          502 STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR-----WKA----GAIL  571 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~-----~~~----~~~~  571 (687)
                      ......++..|+|||++.+ ..++.++||||+||++|||++|+.||......+...........     +..    ....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2233467899999999865 56899999999999999999999999776543322211110000     000    0000


Q ss_pred             cccCCcCCCC----CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLNGE----FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....+.....    .......++.+++.+|++.||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0111111000    00112346789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-38  Score=339.37  Aligned_cols=247  Identities=23%  Similarity=0.296  Sum_probs=203.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCC-eEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTN-TQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++|...+.||+|+||.||+|.+...+ ..||+|++....   ....+.+..|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            356889999999999999999875544 689999986542   2345678899999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++..  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       109 v~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            9999999999999853  3468999999999999999999998   9999999999999999999999999999986543


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ..+....+..      .
T Consensus       184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~------~  246 (340)
T PTZ00426        184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGII------Y  246 (340)
T ss_pred             C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC------C
Confidence            2    234579999999999998889999999999999999999999997654211       1111111111      1


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVRY  614 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  614 (687)
                      +...    ....+.+++.+|++.+|++|+     +++++++.
T Consensus       247 ~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 FPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1112    233678899999999999995     89988863

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.1e-38  Score=322.53  Aligned_cols=251  Identities=28%  Similarity=0.432  Sum_probs=209.1

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|...+.||+|++|.||+|++..+++.|++|.+...  ......++..|++++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477789999999999999999889999999998643  344567889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++.++++++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            999999999976555679999999999999999999998   89999999999999999999999999999866543222


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                       .....|+..|+|||+..+..++.++|+||||+++|||++|+.||......   ....    ....+..     +    .
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~~~-----~----~  220 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALIL----KIIRGVF-----P----P  220 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCCC-----C----C
Confidence             23346889999999999999999999999999999999999999765421   1111    1111111     1    1


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .+......+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            122334478999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-38  Score=354.22  Aligned_cols=251  Identities=22%  Similarity=0.280  Sum_probs=206.5

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCC-CeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPST-NTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      .|...+.||+|++|.||+|....+ +..||+|.+..........+..|+.+++.++||||+++++++...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            488899999999999999998776 7889999876665555567888999999999999999999999999999999999


Q ss_pred             CCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          423 PNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       423 ~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      ++|+|.++|...  ...++++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988542  23468999999999999999999998   9999999999999999999999999999987654322


Q ss_pred             -CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          501 -PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       501 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .... ...+..    +    
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~-~~~~~~----~----  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQ-VLYGKY----D----  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhCCC----C----
Confidence             12334579999999999999999999999999999999999999997543211      1111 111111    0    


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       .++......+.+++.+||+.+|++||++.++++
T Consensus       290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             111122346889999999999999999999874

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-38  Score=336.27  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=204.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCe----EEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNT----QVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .+|+..+.||+|+||.||+|++..++.    .||+|++.... ....+++..|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468899999999999999999765554    48999987543 34567889999999999999999999999764 5789


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      |+||+++|+|.+++... ...+++..+++++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus        86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence            99999999999998643 3358899999999999999999998   9999999999999999999999999999987654


Q ss_pred             CCCCce-eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNPST-TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ...... ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+   +    .+....+...    
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~----  230 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGERL----  230 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHhCCCCC----
Confidence            332211 11234678999999999999999999999999999998 999987543211   1    1111111100    


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                           ..+..+...+.+++.+||+.+|++||++.++++.|....
T Consensus       231 -----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         231 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                 111122346889999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-38  Score=345.84  Aligned_cols=260  Identities=27%  Similarity=0.409  Sum_probs=207.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCC-----CeEEEEEEecCcch-hhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPST-----NTQVAVKRVSNESK-QGLREFASEISSIGRLR-HRNLVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~  414 (687)
                      .++|...++||+|+||.||+|++...     +..||||++..... ...+.+..|+++++++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            56788899999999999999987432     34799999976433 33467899999999996 9999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchh-----------------------------------------------------------
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQ-----------------------------------------------------------  435 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~-----------------------------------------------------------  435 (687)
                      .+|||||+++|+|.++|....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999885421                                                           


Q ss_pred             -----------------------------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc
Q 005621          436 -----------------------------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS  480 (687)
Q Consensus       436 -----------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~  480 (687)
                                                         ...+++.++.+++.|++.||.|||+   .+|+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence                                               1247888999999999999999998   99999999999999999


Q ss_pred             CCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHH
Q 005621          481 ELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILV  558 (687)
Q Consensus       481 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~  558 (687)
                      ++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||........    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~----  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence            99999999999986543222 11223356788999999998899999999999999999997 9899875432211    


Q ss_pred             HHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          559 DWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       559 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                        .......+.     .+    ..+......+.+++.+||+.+|++||++.+|.+.|+...
T Consensus       349 --~~~~~~~~~-----~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         349 --FYNKIKSGY-----RM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --HHHHHhcCC-----CC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence              111111111     01    112233457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-38  Score=327.03  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=205.8

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      +|+..++||+|+||+||++.+..+++.||+|++....   ......+.+|+.++++++||||+++++++...+.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999998889999999987542   2223567889999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            9999999998865545569999999999999999999998   8999999999999999999999999999987543222


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                        .....|+..|+|||++.+..++.++||||||+++|||++|+.||.........   +.+......          ...
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~----------~~~  222 (285)
T cd05605         158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKE----------DQE  222 (285)
T ss_pred             --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhh----------ccc
Confidence              22346899999999999889999999999999999999999999865432111   111111111          011


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      .++......+.+++.+||+.||++||     ++.++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            12223344688999999999999999     8888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-39  Score=308.56  Aligned_cols=250  Identities=26%  Similarity=0.361  Sum_probs=215.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|+..+.||+|.||.||.|+.+.++-.||+|++.++.-   +...++.+|+++.+.|+||||+++|+|+.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            3578899999999999999999999999999999977632   2356889999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      +||.++|.|...|.......+++.....++.|+|.||.|+|.   ++|+||||||+|+|++.++..||+|||.+....  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            999999999999987777789999999999999999999999   999999999999999999999999999987543  


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                       .....+.+||..|.|||...+...+...|+|++|++.||++.|.+||+.....+..       +.+.   -.+..+   
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY-------krI~---k~~~~~---  241 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY-------KRIR---KVDLKF---  241 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH-------HHHH---HccccC---
Confidence             22344578999999999999999999999999999999999999999876632211       1111   112222   


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                          +......+.+++.+|+..+|.+|.+..|+++.
T Consensus       242 ----p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  242 ----PSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                23334478899999999999999999999874

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-38  Score=338.09  Aligned_cols=268  Identities=24%  Similarity=0.349  Sum_probs=200.6

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----CeeE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----GDLL  416 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~  416 (687)
                      +|+..++||+|+||.||+|++..+++.||||++...  ......++.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            578899999999999999999889999999998753  223446788999999999999999999987543     3579


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +||||+. ++|.+++..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 688888843  3468999999999999999999998   999999999999999999999999999998543


Q ss_pred             CCCC--CceeeeecCCCCCchhhccC--CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHH
Q 005621          497 RGTN--PSTTRVVGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV--------WDR  564 (687)
Q Consensus       497 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v--------~~~  564 (687)
                      ....  .......||..|+|||++.+  ..++.++|||||||++|||++|+.||...........+...        ...
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2221  11233578999999999876  67899999999999999999999999765432111100000        000


Q ss_pred             hcccc---cccccCCcCCCCCC---HHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          565 WKAGA---ILEVVDPRLNGEFN---EIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       565 ~~~~~---~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      +....   ....+.+.....+.   ......+.+++.+||+.+|++||++.|+++  ++++
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence            00000   00001110000000   011236789999999999999999999997  3444

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-38  Score=344.59  Aligned_cols=255  Identities=21%  Similarity=0.240  Sum_probs=205.0

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ..++|+..++||+|+||.||++++..+++.||+|++....   ......+..|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4568999999999999999999999899999999986532   2334567889999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++..   ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       121 v~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         121 VMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999998843   358888999999999999999998   9999999999999999999999999999987644


Q ss_pred             CCCCceeeeecCCCCCchhhccCC----CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTG----KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ..........||+.|+|||++.+.    .++.++|||||||++|||++|+.||........       ...+..+..   
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~~---  264 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------YSKIMDHKN---  264 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-------HHHHHcCCC---
Confidence            332223345799999999998653    478899999999999999999999986543211       111111100   


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCc--CCCHHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEA--RPTMRQVVRY  614 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  614 (687)
                       ......  .......+.+++.+|++.+|++  ||++.++++.
T Consensus       265 -~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 -SLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -cCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             000111  1112347788999999999988  9999999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.9e-38  Score=336.24  Aligned_cols=253  Identities=22%  Similarity=0.261  Sum_probs=205.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||+||++....+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999999899999999997643   234567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999999998543 2469999999999999999999998   999999999999999999999999999998765443


Q ss_pred             CCceeeeecCCCCCchhhcc------CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          500 NPSTTRVVGTLGYLAPELTR------TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ........||+.|+|||++.      ...++.++|||||||++|||++|+.||........      .............
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~  230 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRFLKF  230 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCccCC
Confidence            33333457899999999986      45678999999999999999999999976543211      1111111111111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .       ........+.+++..|++ +|++||++.++++
T Consensus       231 ~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         231 P-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             C-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0       011123467888999998 9999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.6e-38  Score=341.81  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=199.3

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .|...+.||+|+||+||+|++..+++.||||++....   ......+..|++++++++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788999999999999999999999999999997542   3345678999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++|+|.+++..  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            9999999999853  3468899999999999999999998   9999999999999999999999999999764311000


Q ss_pred             ----------------------------------------------CceeeeecCCCCCchhhccCCCCCCccceehhhH
Q 005621          501 ----------------------------------------------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGA  534 (687)
Q Consensus       501 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gv  534 (687)
                                                                    .......||..|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0012346999999999999888999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHh--ccccCcCcCCCHHHHH
Q 005621          535 LLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLM--CSNDAAEARPTMRQVV  612 (687)
Q Consensus       535 vl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~evl  612 (687)
                      ++|||++|+.||......+...      .........     ....  ......++.+++.+  |+..+|..||++.+++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~------~i~~~~~~~-----~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQL------KVINWENTL-----HIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHH------HHHcccccc-----CCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            9999999999998654322111      000000000     0100  00112356666665  6667777799999999


Q ss_pred             H
Q 005621          613 R  613 (687)
Q Consensus       613 ~  613 (687)
                      +
T Consensus       304 ~  304 (381)
T cd05626         304 A  304 (381)
T ss_pred             c
Confidence            7

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-38  Score=340.25  Aligned_cols=248  Identities=24%  Similarity=0.377  Sum_probs=196.8

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      +|...++||+|+||+||+|++..+++.||||++.... .....++.+|++++++++|+||+++++++...+.+++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3455688999999999999998889999999986543 334567899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+..      ...+..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus       155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  224 (353)
T PLN00034        155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P  224 (353)
T ss_pred             CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence            999987543      35667788999999999999998   9999999999999999999999999999987643322 2


Q ss_pred             eeeeecCCCCCchhhccC-----CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          503 TTRVVGTLGYLAPELTRT-----GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .....||..|+|||++..     ...+.++|||||||++|||++|+.||......+...+...+    ...     ..+ 
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~-----~~~-  294 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----CMS-----QPP-  294 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hcc-----CCC-
Confidence            233578999999998753     23456899999999999999999999844332211111100    000     001 


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                         .........+.+++.+||+.+|++||++.|+++.
T Consensus       295 ---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 ---EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1122233478899999999999999999999983

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.9e-38  Score=334.19  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=201.9

Q ss_pred             CcccceeeeeeCeEEEEEEEeC---CCCeEEEEEEecCcc----hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCee
Q 005621          344 GFRDKELLGFGGFGRVYKGTLP---STNTQVAVKRVSNES----KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  415 (687)
                      +|+..+.||+|+||.||+++..   .+++.||+|++.+..    ....+.+..|+.+++++ +||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999999864   467899999987532    22345678899999999 599999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus        81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            999999999999999853  3468999999999999999999998   99999999999999999999999999999865


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ............||..|+|||++.+. .++.++|||||||++|||++|+.||..........   .+......      .
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~------~  226 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILK------C  226 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhc------C
Confidence            44433334456799999999999865 47889999999999999999999997543322111   11111111      1


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ++.+...+    ...+.+++.+||+.||++||     +++++++
T Consensus       227 ~~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 DPPFPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            22222222    33678899999999999999     6777775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.9e-38  Score=324.17  Aligned_cols=253  Identities=30%  Similarity=0.456  Sum_probs=204.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|+..++||+|++|.||+|.+. .+..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            46788899999999999999885 466799999876433 3467899999999999999999999885 45689999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.......+++.++.+++.|++.||.|||+   .+++||||||+||++++++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            99999999976555568999999999999999999998   899999999999999999999999999998764433222


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....++..|+|||++.+..++.++||||||+++|||++ |..||......+   ..+.    +..+         ....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----~~~~---------~~~~  223 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ----VERG---------YRMP  223 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcC---------CCCC
Confidence            222345678999999988899999999999999999999 888886543211   1111    1111         1111


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      .+......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            222334478999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=341.06  Aligned_cols=252  Identities=22%  Similarity=0.283  Sum_probs=201.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|++..+++.||||++....   ......+..|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999999899999999997542   234466788999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999999854  3468999999999999999999998   999999999999999999999999999987543211


Q ss_pred             CC-------------------------------------ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhC
Q 005621          500 NP-------------------------------------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCG  542 (687)
Q Consensus       500 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG  542 (687)
                      ..                                     .....+||+.|+|||++....++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                     01124689999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC---HHHHHH
Q 005621          543 RRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT---MRQVVR  613 (687)
Q Consensus       543 ~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~  613 (687)
                      ..||......+..   .   ......       ..+...........+.+++.+|+. +|.+|++   +.++++
T Consensus       236 ~~Pf~~~~~~~~~---~---~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         236 YPPFCSDNPQETY---R---KIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCHHHHH---H---HHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999765432111   1   111000       000000000122367788888886 8999998   888887

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3e-38  Score=330.90  Aligned_cols=259  Identities=27%  Similarity=0.441  Sum_probs=210.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|...+.||+|+||.||+|...     .++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999853     2456799999887766666789999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          418 VYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                      ||||+++++|.+++....              ...+++.++++++.||+.||+|||+   ++|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence            999999999999985422              2348999999999999999999998   99999999999999999999


Q ss_pred             EEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 005621          484 GRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWV  561 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v  561 (687)
                      +||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||+| |+.||......+       +
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence            99999999976543221 11223456788999999999999999999999999999999 999987654322       1


Q ss_pred             HHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          562 WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       562 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      .+....+...+         .+...+..+.+++.+||+.+|++||++.+|+++|+....
T Consensus       235 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            11122222111         111233478899999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.5e-38  Score=341.72  Aligned_cols=258  Identities=21%  Similarity=0.239  Sum_probs=203.7

Q ss_pred             HHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          338 LKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       338 l~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      +....++|+..+.||+|+||.||++.+..+++.+|+|++.+..   ......+.+|+.+++.++||||+++++++...+.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3444578999999999999999999999889999999986532   2234567889999999999999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++||||+++|+|.+++..   ..+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            9999999999999998843   358899999999999999999998   9999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCC----CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTG----KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      .............||+.|+|||++.+.    .++.++|||||||++|||++|+.||.........      .........
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~~  265 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKNS  265 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCcc
Confidence            644332223346799999999998754    3788999999999999999999999765432111      111110000


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCc--CCCHHHHHHH
Q 005621          571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEA--RPTMRQVVRY  614 (687)
Q Consensus       571 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  614 (687)
                      .     .+.  ........+.+++..|+..++.+  ||++.|+++.
T Consensus       266 ~-----~~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 L-----NFP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             c-----CCC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            0     011  01112345778888898755544  8999999884

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.2e-38  Score=324.66  Aligned_cols=254  Identities=30%  Similarity=0.434  Sum_probs=205.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|+..++||+|+||.||+|++..+ ..||+|++..... ..+++..|++++++++||||+++++.+.+ ...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            35688999999999999999998654 5699999875432 34678999999999999999999998754 567999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++|+|.+++.......+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999999965545568999999999999999999998   99999999999999999999999999999876543322


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                      ......++..|+|||+..+..++.++||||||+++|||++ |..||......+.       ......+.         ..
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-------~~~~~~~~---------~~  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGY---------RM  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-------HHHHhcCC---------CC
Confidence            2223346778999999988899999999999999999999 7888865542211       11111110         01


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ......+..+.+++.+|++.+|++||++.+++++|+.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            1122344578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-38  Score=328.43  Aligned_cols=256  Identities=26%  Similarity=0.438  Sum_probs=207.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ++|...+.||+|+||.||+|.+..     .+..||||.+...... ..+.+.+|++++++++|||++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            467888999999999999998743     3578999998766444 4678999999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchh------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          417 LVYDFMPNGSLDKCLFDEQ------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      +||||+++++|.+++....            ...+++.++..++.|++.||.|||+   ++++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence            9999999999999995431            2458899999999999999999998   899999999999999999999


Q ss_pred             EEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 005621          485 RLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVW  562 (687)
Q Consensus       485 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~  562 (687)
                      ||+|||+++....... .......++..|+|||++.++.++.++||||||+++|||++ |..||......+   ..+.  
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~--  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIEC--  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH--
Confidence            9999999976433221 11223345788999999999999999999999999999998 999987654322   1111  


Q ss_pred             HHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       563 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                        ...+...         ..+......+.+++.+||+.+|++||++.||++.|++
T Consensus       237 --~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         237 --ITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --HHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              1122111         1111233478899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.9e-38  Score=333.81  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=200.5

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ++||+|+||.||++.+..+++.||+|+++...   ....+.+..|..++.++ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999899999999997642   23345678899999998 799999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|.+++..  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~  154 (329)
T cd05588          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTS  154 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccc
Confidence            999988843  3569999999999999999999998   99999999999999999999999999998742211 12233


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE--ELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~--~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||+.....+  .....++..+....+.      ..+...+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~p~~~  228 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRIPRSL  228 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCCCCCC
Confidence            4579999999999999999999999999999999999999997433221  1112233333332221      1122222


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCC------HHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPT------MRQVVR  613 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~  613 (687)
                          ...+.+++.+||+.||.+||+      ++++++
T Consensus       229 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         229 ----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                336789999999999999997      677765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.2e-38  Score=333.66  Aligned_cols=249  Identities=25%  Similarity=0.337  Sum_probs=199.1

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||+||++.+..+++.||+|++....   ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999899999999997642   23445677899888877 899999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|..++..  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (329)
T cd05618          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS  154 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence            999988743  3569999999999999999999998   999999999999999999999999999987532211 2223


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE--ELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~--~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.......  .....+++.+....+..      .    +
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~----~  224 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R----I  224 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C----C
Confidence            4578999999999999999999999999999999999999996422111  11122333333222111      1    1


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCC------HHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPT------MRQVVR  613 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~  613 (687)
                      +......+.+++.+||+.||++||+      +.++++
T Consensus       225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            2223346789999999999999998      467654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.9e-38  Score=322.15  Aligned_cols=259  Identities=24%  Similarity=0.350  Sum_probs=210.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||.||+|+...+++.||||.+...   ......++.+|++++++++|||++++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5788999999999999999999888999999987642   2344567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          420 DFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||+++++|.+++...  ....+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999888532  23458899999999999999999998   9999999999999999999999999999986543


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      ... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||........ ...    ......     ..+.
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~----~~~~~~-----~~~~  227 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLC----QKIEQC-----DYPP  227 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHH----HHHhcC-----CCCC
Confidence            221 12234678899999999988899999999999999999999999865433211 111    111111     1111


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                         .........+.+++.+||+.+|++||++.+|++.|++.
T Consensus       228 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 ---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence               11223345788999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.1e-37  Score=333.38  Aligned_cols=202  Identities=26%  Similarity=0.399  Sum_probs=178.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|+..++||+|+||.||++.+..++..+|+|++.... .....++.+|++++++++||||++++++|...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999998889999999987653 3345678999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          84 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            9999999999853  3468899999999999999999997  2479999999999999999999999999987553221 


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKA  550 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~  550 (687)
                        .....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence              223468999999999998889999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.1e-38  Score=340.95  Aligned_cols=259  Identities=22%  Similarity=0.202  Sum_probs=199.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      .+|...+.||+|+||.||++.+..+++.||+|....      ..+.+|++++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            579999999999999999999999999999997532      34678999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      . ++|..++..  ...+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.........
T Consensus       166 ~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        166 K-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             C-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            5 688888743  3468999999999999999999998   899999999999999999999999999997543322223


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcc----hhhHHHHHHHHhccc----------
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE----ELILVDWVWDRWKAG----------  568 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~----~~~~~~~v~~~~~~~----------  568 (687)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+.......    .......+.......          
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            334579999999999999899999999999999999999998875432110    000011111110000          


Q ss_pred             cccc---------ccCCcCCCCCC--HHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          569 AILE---------VVDPRLNGEFN--EIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       569 ~~~~---------~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+.+         ...+.....+.  ...+.++.+|+.+||+.||++|||+.|+++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000         00000010110  123446889999999999999999999996

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7e-38  Score=338.83  Aligned_cols=203  Identities=26%  Similarity=0.376  Sum_probs=178.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||++....+++.||+|++....   ......+..|+.++.+++||||+++++.+.+...+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999998889999999997642   233456788999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++.++..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999999853  4569999999999999999999998   999999999999999999999999999987543211


Q ss_pred             C----------------------------------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCC
Q 005621          500 N----------------------------------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP  545 (687)
Q Consensus       500 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p  545 (687)
                      .                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                  001235799999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 005621          546 IEPKA  550 (687)
Q Consensus       546 ~~~~~  550 (687)
                      |....
T Consensus       236 f~~~~  240 (363)
T cd05628         236 FCSET  240 (363)
T ss_pred             CCCCC
Confidence            97654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=336.48  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=216.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe-eEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD-LLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~  419 (687)
                      ++|...+++|+|+||.++..+++.+++.+++|.+....  ....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999999999999999987653  3334467899999999999999999999988888 99999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      +|++||+|.+.+...+...++++++.+|+.|++.|+.|||+   ..|+|||||+.|||++.+..+||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            99999999999987777789999999999999999999998   999999999999999999999999999999876554


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       ......+||+.||.||.+.+..|..|+|||||||++|||++-+++|...+...   ++..+         .+    ...
T Consensus       161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki---------~~----~~~  223 (426)
T KOG0589|consen  161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKI---------NR----GLY  223 (426)
T ss_pred             -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHH---------hh----ccC
Confidence             23445789999999999999999999999999999999999999998776432   11111         11    111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ...+.....++..++..|++.+|+.||++.+++..
T Consensus       224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            23344445588999999999999999999999974

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.7e-38  Score=327.55  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=205.2

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      ++++|+..+.||+|+||.||+|.+..     .+..||+|++.... .....++.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            56789999999999999999998642     35679999986543 3345678999999999999999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchh--------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEE
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQ--------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL  486 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl  486 (687)
                      .++||||+++++|.+++....        ...+++.+++.++.|++.||.|||+   .+++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999985422        2246888999999999999999998   89999999999999999999999


Q ss_pred             cccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 005621          487 GDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       487 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      +|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ |..||......+   ..+.    
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~----  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRF----  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----
Confidence            999998755332221 1112345778999999998899999999999999999999 688886543221   1111    


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ...+...         ..+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            1111111         1112233468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-37  Score=330.84  Aligned_cols=238  Identities=26%  Similarity=0.331  Sum_probs=190.7

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHH-HHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEIS-SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ++||+|+||+||+|++..+++.||+|++....   .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999899999999987542   222344555554 67889999999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      ++|..++..  ...+++.++..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (321)
T cd05603          81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS  154 (321)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence            999888843  3468899999999999999999998   999999999999999999999999999987532211 2233


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   .    .+....+.          ..++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~----~~~i~~~~----------~~~~~  217 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---M----YDNILHKP----------LQLPG  217 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---H----HHHHhcCC----------CCCCC
Confidence            4578999999999998899999999999999999999999997654211   1    11111111          01122


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMR  609 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~  609 (687)
                      .....+.+++.+|++.+|.+||+..
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         218 GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCHHHHHHHHHHccCCHhhcCCCC
Confidence            2334688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.1e-38  Score=333.60  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=199.0

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      +.||+|+||.||++.+..+++.||+|++....   .....++..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999998899999999997642   334567788999999999999999999999999999999999999


Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceee
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR  505 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  505 (687)
                      +|.+++..  ...+++.++..++.||+.||.|||+  ..+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~  155 (325)
T cd05594          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT  155 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence            99988843  3468999999999999999999996  2699999999999999999999999999987532221 12233


Q ss_pred             eecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHH
Q 005621          506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEI  585 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~  585 (687)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........       .....+      ...+...+   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-------~~i~~~------~~~~p~~~---  219 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILME------EIRFPRTL---  219 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-------HHHhcC------CCCCCCCC---
Confidence            56999999999999999999999999999999999999999765432111       111111      11122222   


Q ss_pred             HHHHHHHHHHhccccCcCcCC-----CHHHHHHH
Q 005621          586 EALDVVKLGLMCSNDAAEARP-----TMRQVVRY  614 (687)
Q Consensus       586 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  614 (687)
                       ...+.+++.+||+.||++|+     ++.++++.
T Consensus       220 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         220 -SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence             33678899999999999996     89999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.9e-38  Score=323.76  Aligned_cols=252  Identities=29%  Similarity=0.428  Sum_probs=202.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||+|++|+||+|.+.. +..+|+|.+..... ...+|.+|+.++++++||||+++++++......++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            457788999999999999998853 45699998875432 3467899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.... ..+++.++++++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||+++.........
T Consensus        82 ~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          82 SNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999985433 268999999999999999999998   999999999999999999999999999988654332211


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+   ..+    ....+..     +    .
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~----~~~~~~~-----~----~  221 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE----KVSQGLR-----L----Y  221 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH----HHhcCCC-----C----C
Confidence            112235678999999998889999999999999999999 999987544321   111    1111111     0    0


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      .+......+.+++.+||+.+|++||++.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11112347889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.6e-38  Score=329.50  Aligned_cols=261  Identities=28%  Similarity=0.414  Sum_probs=209.3

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCC-----CeEEEEEEecCc-chhhHHHHHHHHHHHhhh-cCCCceeeeeeeec
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPST-----NTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRNLVQLLGWCRR  411 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  411 (687)
                      +...++|+..+.||+|+||.||++.....     ...+|+|.+... ......++.+|+.++.++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            34456788899999999999999997543     378999998764 334456788999999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCCchhhhhch--------------hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEE
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDE--------------QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL  477 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  477 (687)
                      .+..+++|||+++|+|.+++...              ....+++..+++++.|++.||.|||+   .+|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEE
Confidence            99999999999999999998532              23468999999999999999999998   99999999999999


Q ss_pred             eccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchh
Q 005621          478 LDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEEL  555 (687)
Q Consensus       478 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  555 (687)
                      ++.++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+. 
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-  243 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-  243 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH-
Confidence            999999999999999865433211 1122335678999999998899999999999999999998 8888865443221 


Q ss_pred             hHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       556 ~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                            .+....+.         ....+......+.+++.+||+.+|++|||+.++++.|+..
T Consensus       244 ------~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 ------FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             ------HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                  11111111         1111222334788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=322.07  Aligned_cols=250  Identities=24%  Similarity=0.381  Sum_probs=213.7

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ...+|+..+.||+|.||.|-+|.....|+.||||.++++.   .+++-.+.+|+++|+.|+||||++++.+|+..+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            3467888899999999999999998899999999998763   4556678899999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||..+|.|++|+.  +.+.|++.+...+++||.+|+.|+|.   ++++|||||.+|||||.|+++||+||||+.++..
T Consensus       131 vMEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  131 VMEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999994  45679999999999999999999998   9999999999999999999999999999987754


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      ..  -.++++|.+-|.+||++.+..| .+..|-|||||+||-|+.|..||++.+..   .+    .+.+..|...+    
T Consensus       206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l----vrQIs~GaYrE----  272 (668)
T KOG0611|consen  206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL----VRQISRGAYRE----  272 (668)
T ss_pred             cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH----HHHhhcccccC----
Confidence            33  3456899999999999999877 46899999999999999999999986531   11    12223333222    


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                             +..+....-|++|||..+|++|-|+.+|....
T Consensus       273 -------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  273 -------PETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                   12223577899999999999999999999854

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.7e-38  Score=332.45  Aligned_cols=242  Identities=24%  Similarity=0.361  Sum_probs=194.4

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||.||+|.+..+++.||+|+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999998889999999987642   22344556677777654 899999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|.+++..  ...+++.++..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~  154 (316)
T cd05592          81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS  154 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence            999988843  3468999999999999999999998   999999999999999999999999999998643322 2233


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+       +.......      .+.+    +.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~------~~~~----~~  217 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILND------RPHF----PR  217 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC------CCCC----CC
Confidence            4578999999999999899999999999999999999999997654211       11111110      1111    22


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHH-HHHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMR-QVVR  613 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~  613 (687)
                      .....+.+++.+||+.+|++||++. ++++
T Consensus       218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            2234678899999999999999876 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.5e-38  Score=337.54  Aligned_cols=260  Identities=28%  Similarity=0.425  Sum_probs=205.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecC-C
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRR-G  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~  413 (687)
                      .++|+..+.||+|+||.||+|.+..     +++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            3578899999999999999997533     34789999987543 33456788899999999 899999999988654 5


Q ss_pred             eeEEEEecCCCCCchhhhhchh----------------------------------------------------------
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQ----------------------------------------------------------  435 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~----------------------------------------------------------  435 (687)
                      .++++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6889999999999999885321                                                          


Q ss_pred             -hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC-CceeeeecCCCCC
Q 005621          436 -KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYL  513 (687)
Q Consensus       436 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~  513 (687)
                       ...++|.++.+++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..... .......++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             1368999999999999999999998   9999999999999999999999999999986543222 1122345677899


Q ss_pred             chhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHH
Q 005621          514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVK  592 (687)
Q Consensus       514 aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  592 (687)
                      |||++.+..++.++|||||||++|||++ |..||......+.      .......+..         ...+.....++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTR---------MRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCC---------CCCCccCCHHHHH
Confidence            9999999999999999999999999998 9999876433221      1111111111         0111222347889


Q ss_pred             HHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          593 LGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       593 l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ++.+||+.+|++||++.||++.|+...
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.5e-38  Score=328.42  Aligned_cols=258  Identities=27%  Similarity=0.429  Sum_probs=209.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|...+.||+|+||+||++...     .++..+|+|.+..........+..|++++++++|||++++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888999999999999999852     3456799999987766667789999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchh-----------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEE
Q 005621          418 VYDFMPNGSLDKCLFDEQ-----------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL  486 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl  486 (687)
                      ||||+++++|.+++....           ...+++.+++.++.|++.||+|||+   ++++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence            999999999999985321           2358999999999999999999998   99999999999999999999999


Q ss_pred             cccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 005621          487 GDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       487 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      +|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+       ....
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence            99999985533221 11122345778999999998899999999999999999998 888886554321       1111


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ...+...     .....    ....+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       235 i~~~~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         235 ITQGRVL-----QRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHcCCcC-----CCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            2222211     11112    2346899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=327.72  Aligned_cols=257  Identities=26%  Similarity=0.373  Sum_probs=208.5

Q ss_pred             HHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--------------hhHHHHHHHHHHHhhhcCCCce
Q 005621          338 LKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--------------QGLREFASEISSIGRLRHRNLV  403 (687)
Q Consensus       338 l~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv  403 (687)
                      -.+..++|+..+.||+|.||.|-+|....+++.||||++.+...              ...++..+|+.+|++++|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            34556789999999999999999999999999999999865421              1235788999999999999999


Q ss_pred             eeeeeeecC--CeeEEEEecCCCCCchhhhhchhhcc-CCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc
Q 005621          404 QLLGWCRRR--GDLLLVYDFMPNGSLDKCLFDEQKAI-LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS  480 (687)
Q Consensus       404 ~l~~~~~~~--~~~~lV~Ey~~~gsL~~~L~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~  480 (687)
                      +|+.+..+.  +.+|||+|||..|.+...-   .... ++..+++++++++..||+|||.   ++|+||||||+|+||++
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcC
Confidence            999998765  5799999999988876433   3444 9999999999999999999999   99999999999999999


Q ss_pred             CCcEEEcccccceeccCCCC----CceeeeecCCCCCchhhccCCC----CCCccceehhhHHHHHHHhCCCCCCCCCCc
Q 005621          481 ELNGRLGDFGLAKLYERGTN----PSTTRVVGTLGYLAPELTRTGK----PTTSSDVYAFGALLLEVVCGRRPIEPKALP  552 (687)
Q Consensus       481 ~~~~kl~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~S~Gvvl~elltG~~p~~~~~~~  552 (687)
                      ++++||+|||.+..+..+..    ......+||+.|+|||...++.    .+.+.||||+||.||.|+.|+.||-....-
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            99999999999987643322    2233468999999999987743    456889999999999999999999865421


Q ss_pred             chhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          553 EELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       553 ~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                      +   +-            ..++...|.....+++.+++.+|++++|+.||++|.+..+|....
T Consensus       326 ~---l~------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  326 E---LF------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             H---HH------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            1   11            123333443333334566889999999999999999999998754

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5e-38  Score=321.63  Aligned_cols=248  Identities=27%  Similarity=0.415  Sum_probs=200.1

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      +.||+|+||.||+|++..+++.+|+|.+.... ......+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999998889999999876543 34456799999999999999999999999999999999999999999


Q ss_pred             hhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce-eee
Q 005621          428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRV  506 (687)
Q Consensus       428 ~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~  506 (687)
                      .+++... ...+++.+++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++........... ...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            9998543 3458999999999999999999998   8999999999999999999999999999875433221111 111


Q ss_pred             ecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHH
Q 005621          507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEI  585 (687)
Q Consensus       507 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~  585 (687)
                      ..+..|+|||.+.++.++.++||||||+++|||++ |..|+........       ......         ......+..
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~---------~~~~~~~~~  220 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQ---------GVRLPCPEL  220 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHc---------CCCCCCccc
Confidence            23457999999999999999999999999999998 8888865432111       111111         111122223


Q ss_pred             HHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          586 EALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       586 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      .+..+.+++.+|++.+|++||++.++++.|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.1e-38  Score=333.02  Aligned_cols=247  Identities=23%  Similarity=0.305  Sum_probs=199.9

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCC-CceeeeeeeecCCeeEEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHR-NLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~  419 (687)
                      +|+..+.||+|+||.||+|++..+++.||||++....   ....+.+..|.+++..++|+ +|+++++++...+.+++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999998889999999987642   33456788899999999765 5888999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            99999999998843  3468999999999999999999998   999999999999999999999999999987432211


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       .......||..|+|||++.+..++.++|||||||++|||++|+.||......+.   .    ......      .+.+ 
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~----~~i~~~------~~~~-  220 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---F----QSIMEH------NVSY-  220 (324)
T ss_pred             -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H----HHHHcC------CCCC-
Confidence             223345799999999999999999999999999999999999999976542111   1    111111      1111 


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCH-----HHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTM-----RQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  613 (687)
                         +......+.+++.+||+.+|++||+.     .++.+
T Consensus       221 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         221 ---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             ---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               12223467899999999999999976     56554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-37  Score=330.25  Aligned_cols=242  Identities=24%  Similarity=0.355  Sum_probs=196.7

Q ss_pred             eeeeeeCeEEEEEEEeC---CCCeEEEEEEecCcc----hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          349 ELLGFGGFGRVYKGTLP---STNTQVAVKRVSNES----KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +.||+|+||.||++...   ..++.||+|++....    ......+..|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999863   467899999987542    22345678899999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.  ....+.+..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  155 (323)
T cd05584          82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T  155 (323)
T ss_pred             CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence            99999999884  34568889999999999999999998   999999999999999999999999999987543222 2


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........       ......+.      ..+   
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-------~~~~~~~~------~~~---  219 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-------IDKILKGK------LNL---  219 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCC------CCC---
Confidence            22335789999999999988899999999999999999999999976543211       11111111      111   


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                       +......+.+++.+||+.+|++||     ++.++++
T Consensus       220 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         220 -PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence             122234688999999999999999     7888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=348.78  Aligned_cols=257  Identities=23%  Similarity=0.287  Sum_probs=212.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeee-eec------CC
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGW-CRR------RG  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~------~~  413 (687)
                      ..++++.+.|.+|||+.||.|++...+..+|+|++-.......+...+|+++|++|+ |||||.+++. ...      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            345667899999999999999998777999999988778888999999999999997 9999999993 211      23


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      +.+|.||||+||.|-+++..+....|++.++++|+.++++|+++||. +.++|||||||-+||||..+++.||||||.|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            78999999999999999987666679999999999999999999996 56789999999999999999999999999997


Q ss_pred             eccCCCCC-c-------eeeeecCCCCCchhhc---cCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 005621          494 LYERGTNP-S-------TTRVVGTLGYLAPELT---RTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVW  562 (687)
Q Consensus       494 ~~~~~~~~-~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~  562 (687)
                      ..-..... .       .-...-|+.|+|||.+   .+...++|+|||+|||+||-|+....||+....           
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------  263 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------  263 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence            43222210 0       0012358999999976   466899999999999999999999999987632           


Q ss_pred             HHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       563 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                              +.+++....-.-.......+.+||..||+++|++||++-||+..+.++
T Consensus       264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                    122333332222245666899999999999999999999999987654

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-38  Score=322.81  Aligned_cols=250  Identities=27%  Similarity=0.416  Sum_probs=201.3

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      +|+..+.||+|++|.||+|.+. .+..+|+|++..... ...++.+|++++++++||||+++++++...+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4778889999999999999985 466899999865432 23578889999999999999999999999999999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +++|.+++.... ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++..........
T Consensus        83 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          83 NGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999999986433 368999999999999999999998   8999999999999999999999999999986543222111


Q ss_pred             eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ..    ....+     ...    ..
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----~~~~~-----~~~----~~  222 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VE----SVSAG-----YRL----YR  222 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HH----HHHcC-----CcC----CC
Confidence            11223467999999998899999999999999999999 8888875432211   11    11111     111    11


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                      +...+..+.+++.+||+.+|++||++.++++.|
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            122344789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.2e-38  Score=332.95  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=196.5

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHH---hhhcCCCceeeeeeeecCCeeEEE
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSI---GRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      |+..+.||+|+||.||+|.+..+++.||||++....   ....+.+..|.+++   ++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999998889999999997542   22334566665554   567899999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|..++.   ...+++.++..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            99999999998874   3469999999999999999999998   99999999999999999999999999998743221


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      . .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.   .    ..+..+.      +..
T Consensus       155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~----~~i~~~~------~~~  220 (324)
T cd05589         155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---F----DSIVNDE------VRY  220 (324)
T ss_pred             C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHhCC------CCC
Confidence            1 222345789999999999999999999999999999999999999976542211   1    1111111      111


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ...    ....+.+++.+||+.||++||     ++.++++
T Consensus       221 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         221 PRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            112    234678999999999999999     5666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-37  Score=339.67  Aligned_cols=251  Identities=22%  Similarity=0.308  Sum_probs=196.7

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      +|...++||+|+||+||+|+...+++.||+|++....   ......+.+|+.++++++||||+++++.+.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999999899999999987542   3345678899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC-
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT-  499 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~-  499 (687)
                      |+++|+|.+++..  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            9999999999853  3468899999999999999999998   899999999999999999999999999975321000 


Q ss_pred             ---------------------------------------------CCceeeeecCCCCCchhhccCCCCCCccceehhhH
Q 005621          500 ---------------------------------------------NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGA  534 (687)
Q Consensus       500 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gv  534 (687)
                                                                   ........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00011246899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC---HHHH
Q 005621          535 LLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT---MRQV  611 (687)
Q Consensus       535 vl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ev  611 (687)
                      ++|||++|+.||......+...      .....       ...+...........+.+++.+|+ .+|++|++   +.++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~------~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQM------KVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHH------HHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            9999999999998654321110      10000       000100001111224556666654 49999997   7777


Q ss_pred             HH
Q 005621          612 VR  613 (687)
Q Consensus       612 l~  613 (687)
                      ++
T Consensus       303 ~~  304 (382)
T cd05625         303 KA  304 (382)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=320.16  Aligned_cols=252  Identities=27%  Similarity=0.412  Sum_probs=205.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-----hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-----KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|...+.||+|++|.||++....+++.+|+|.+....     ....+.+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999998889999999886432     2234578899999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      |+||+++++|.+++..  ...+++..+.+++.|++.||.|||+   .+++||||+|+||++++++.++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            9999999999998843  3468899999999999999999998   9999999999999999999999999999976543


Q ss_pred             CCCCce--eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNPST--TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ......  ....|+..|+|||.+.+..++.++||||||+++|||++|+.||.........      .....         
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~---------  221 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIAT---------  221 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhc---------
Confidence            222111  2345788999999999988999999999999999999999998754321111      11000         


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .......+......+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            001112222334478899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.5e-38  Score=326.35  Aligned_cols=256  Identities=25%  Similarity=0.418  Sum_probs=204.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeC----CCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLP----STNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|+..+.||+|+||+||+|.+.    ..+..+|+|.+... ......++.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            45778899999999999999852    34578999998754 34445788999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchh---------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC
Q 005621          418 VYDFMPNGSLDKCLFDEQ---------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL  482 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~  482 (687)
                      ||||+++++|.+++....               ...+++.+.+.++.|++.||.|||+   ++++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence            999999999999985321               2358899999999999999999998   8999999999999999999


Q ss_pred             cEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 005621          483 NGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDW  560 (687)
Q Consensus       483 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~  560 (687)
                      .+||+|||+++....... .......++..|+|||++.++.++.++||||||+++|||++ |..||......   ...  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~--  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVI--  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence            999999999986533221 11222345678999999988889999999999999999998 88888654321   111  


Q ss_pred             HHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       561 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                        +....+...         ..+......+.+++.+||+.+|++||++.+|.+.|..
T Consensus       237 --~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 --EMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              111111111         1112233478899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.8e-38  Score=325.73  Aligned_cols=257  Identities=27%  Similarity=0.403  Sum_probs=205.5

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      .+++|...+.||+|++|.||+|.+..     .+..||+|.+.... ......|..|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45678999999999999999999976     67889999887543 3345678999999999999999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhh-----ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC---cEEE
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQK-----AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL---NGRL  486 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl  486 (687)
                      .++||||+++++|.+++.....     ..+++.++++++.||+.||.|||+   .+++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999854321     258999999999999999999998   8999999999999998764   5899


Q ss_pred             cccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 005621          487 GDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       487 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      +|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||......+.   .+    .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~----~  233 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME----F  233 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----H
Confidence            999999865322211 1112233568999999999999999999999999999997 9999876543221   11    1


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      ....         .....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       234 ~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111         011112222347889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.5e-37  Score=335.20  Aligned_cols=261  Identities=22%  Similarity=0.251  Sum_probs=206.4

Q ss_pred             HHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeec
Q 005621          335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRR  411 (687)
Q Consensus       335 ~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  411 (687)
                      ..++....++|+..+.||+|+||.||++.+..+++.+|+|++....   ....+.+.+|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4556666789999999999999999999999999999999986532   2334567889999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                      .+..++||||+++|+|.+++..   ..++...+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            9999999999999999998843   358888999999999999999998   9999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCC----CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTG----KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      ++..............||+.|+|||++...    .++.++|||||||++|||++|+.||........      .......
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~  262 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNH  262 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcC
Confidence            987654333233446799999999998753    378899999999999999999999986543111      1111111


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCc--CCCHHHHHHH
Q 005621          568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEA--RPTMRQVVRY  614 (687)
Q Consensus       568 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  614 (687)
                      .......+       .......+.+++.+|+...+.+  ||++.++++.
T Consensus       263 ~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         263 KNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            11111110       1122336778899999844443  7899999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.8e-38  Score=322.52  Aligned_cols=257  Identities=28%  Similarity=0.461  Sum_probs=206.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCC---eEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++|+..+.||+|++|.||+|.++.++   ..+|+|.+.... ....+++..|++++++++|||++++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356788899999999999999986544   379999987653 3445678999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++++|.+++... ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999998543 3468999999999999999999998   8999999999999999999999999999986643


Q ss_pred             CCCCcee--eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          498 GTNPSTT--RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       498 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      .......  ....+..|+|||++..+.++.++||||||+++|||++ |+.||......+   .    ......+.     
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~----~~~i~~~~-----  227 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---V----MKAINDGF-----  227 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H----HHHHhcCC-----
Confidence            3221111  1123457999999998889999999999999999998 999986543211   1    11111110     


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                          ...........+.+++.+||+.+|++||++.+|++.|++.
T Consensus       228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                1111122344788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.6e-38  Score=325.46  Aligned_cols=256  Identities=28%  Similarity=0.438  Sum_probs=203.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCe----EEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNT----QVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|+..+.||+|+||+||+|.+..+++    .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            457778899999999999999866655    47888876443 3345678889999999999999999998864 45789


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ++||+++|+|.+++... ...+++..+..|+.||+.||.|||+   ++++||||||+||++++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999999999543 3468999999999999999999998   8999999999999999999999999999986543


Q ss_pred             CCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||.......   ..+    .+..+...  ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~--~~  232 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPD----LLEKGERL--AQ  232 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCCcC--CC
Confidence            322 12223456789999999998999999999999999999998 999987654321   111    11122111  11


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      +       ..+...+.+++.+||+.+|++||++.|+++.|....
T Consensus       233 ~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         233 P-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             C-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1       112336788999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.7e-38  Score=331.96  Aligned_cols=242  Identities=23%  Similarity=0.315  Sum_probs=197.4

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ++||+|+||.||+|++..+++.||+|++....   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999998889999999987642   23445677899988876 799999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|..++..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~  154 (321)
T cd05591          81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT  154 (321)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence            999988843  3468999999999999999999998   999999999999999999999999999987543222 2223


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+.   .    +....+.      ..    ++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~----~~i~~~~------~~----~p~  217 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---F----ESILHDD------VL----YPV  217 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---H----HHHHcCC------CC----CCC
Confidence            45789999999999998999999999999999999999999986543211   1    1111111      01    111


Q ss_pred             HHHHHHHHHHHhccccCcCcCC-------CHHHHHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARP-------TMRQVVR  613 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~  613 (687)
                      .....+.+++.+||+.+|++||       ++.++++
T Consensus       218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            1234678999999999999999       7888875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.2e-38  Score=352.11  Aligned_cols=259  Identities=23%  Similarity=0.323  Sum_probs=209.1

Q ss_pred             HHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC
Q 005621          336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG  413 (687)
Q Consensus       336 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  413 (687)
                      ++.+...++|...+.||+|+||+||+|.+..+++.||||++...  .......+.+|+..+..++|+|+++++..+...+
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            34455568999999999999999999999889999999998654  3444567889999999999999999988765332


Q ss_pred             --------eeEEEEecCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          414 --------DLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       414 --------~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                              .+++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCC
Confidence                    368999999999999998543  23468999999999999999999998   99999999999999999999


Q ss_pred             EEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 005621          484 GRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVW  562 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~  562 (687)
                      +||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .+.
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~  255 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMH  255 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHH
Confidence            99999999986543222 22234579999999999999999999999999999999999999997643211      111


Q ss_pred             HHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       563 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       ....+..    + .+    +......+.+++.+||+.+|++||++.++++
T Consensus       256 -~~~~~~~----~-~~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        256 -KTLAGRY----D-PL----PPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             -HHhcCCC----C-CC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence             1111111    1 11    2223347889999999999999999999986

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.9e-37  Score=327.63  Aligned_cols=247  Identities=24%  Similarity=0.316  Sum_probs=199.5

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      +|...+.||+|+||.||+|.+..+++.||+|++.+..   ....+.+..|..++..+ +|++|+++++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999998889999999987642   22345567788888777 5899999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            99999999988843  3468999999999999999999998   999999999999999999999999999997543211


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..    .+....      .   
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~----~i~~~~------~---  218 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ----SIMEHN------V---  218 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCC------C---
Confidence             12234578999999999999999999999999999999999999997654211   111    111111      1   


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCH-----HHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTM-----RQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  613 (687)
                       .++.....++.+++.+|++.+|++|++.     .++.+
T Consensus       219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         219 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             -CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence             1122233477899999999999999984     56654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.2e-38  Score=340.90  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=199.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||.||+++...+++.||||++....   ......+.+|++++++++||||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999999899999999986542   223466889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  .+.+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            99999999999854  3468899999999999999999998   999999999999999999999999999975321000


Q ss_pred             ------------------------------------------CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHH
Q 005621          500 ------------------------------------------NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLL  537 (687)
Q Consensus       500 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~  537 (687)
                                                                ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                      00011347999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCC---CHHHHHHH
Q 005621          538 EVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARP---TMRQVVRY  614 (687)
Q Consensus       538 elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~  614 (687)
                      ||++|+.||......+...      ......       ..+...........+.+++.+|+ .+|.+|+   ++.++++.
T Consensus       236 ell~G~~Pf~~~~~~~~~~------~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAETQL------KVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHH------HHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999998755322111      100000       00000001112235566777765 4999999   88998863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=338.94  Aligned_cols=253  Identities=22%  Similarity=0.279  Sum_probs=199.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||+||++....+++.||||++....   ....+++..|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999999999999999986542   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999853  3568999999999999999999998   999999999999999999999999999996432100


Q ss_pred             C------------C----------------------------------ceeeeecCCCCCchhhccCCCCCCccceehhh
Q 005621          500 N------------P----------------------------------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFG  533 (687)
Q Consensus       500 ~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~G  533 (687)
                      .            .                                  ......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0            0                                  00124699999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcC---CCHHH
Q 005621          534 ALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEAR---PTMRQ  610 (687)
Q Consensus       534 vvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~e  610 (687)
                      |++|||++|+.||......+..      ...........     +...  ......+.+++.+|++ +|.+|   +++.+
T Consensus       236 vil~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~-----~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETY------RKIINWRETLY-----FPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHH------HHHHccCCccC-----CCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            9999999999999765432111      01110000000     1000  0122367788889997 66665   69999


Q ss_pred             HHHH
Q 005621          611 VVRY  614 (687)
Q Consensus       611 vl~~  614 (687)
                      +++.
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-37  Score=320.36  Aligned_cols=254  Identities=28%  Similarity=0.441  Sum_probs=206.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|...++||+|+||.||+|... +++.||+|.+..... ...++.+|+.++++++|+|++++++++. .+..+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            356888999999999999999975 567899999875443 3467899999999999999999999874 4578999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++.++..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999999876555678999999999999999999998   99999999999999999999999999999876533222


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                      ......++..|+|||++....++.++||||||+++|||++ |+.||......+.   ..    .+..+..     .    
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~~-----~----  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ----NLERGYR-----M----  222 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH----HHHcCCC-----C----
Confidence            2223345778999999998889999999999999999999 9999976543221   11    1111110     1    


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ..+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1111223478999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.4e-37  Score=326.07  Aligned_cols=264  Identities=20%  Similarity=0.261  Sum_probs=201.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|...+.||+|+||+||+|+...+++.||||++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4679999999999999999999988899999999875432 233467889999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |++ ++|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            995 6787777433 3458899999999999999999998   999999999999999999999999999997543222 


Q ss_pred             CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc---cc-----
Q 005621          501 PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA---IL-----  571 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~---~~-----  571 (687)
                      .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||........  ..+.+........   ..     
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhc
Confidence            12223467899999999865 4578899999999999999999999986533211  1111111110000   00     


Q ss_pred             cccCC-cCCCCCCH---------HHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDP-RLNGEFNE---------IEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~-~l~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ...++ ......+.         .....+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000 00000000         01235778999999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.2e-37  Score=330.08  Aligned_cols=249  Identities=23%  Similarity=0.309  Sum_probs=200.5

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ++||+|+||+||++.+..+++.||+|++....   ....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999899999999997642   23456688899999888 699999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|..++..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (327)
T cd05617          81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS  154 (327)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence            999988843  3469999999999999999999998   999999999999999999999999999987532211 2233


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||............+++.+......      .++    +.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~----p~  224 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRI----PR  224 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCC----CC
Confidence            46799999999999999999999999999999999999999975433222222333333332211      111    12


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCH------HHHHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTM------RQVVR  613 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~  613 (687)
                      .....+.+++.+||+.||++||++      .++++
T Consensus       225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  259 (327)
T cd05617         225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS  259 (327)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence            223467889999999999999984      56654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.7e-38  Score=325.88  Aligned_cols=263  Identities=25%  Similarity=0.369  Sum_probs=203.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEe----CCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeec--CCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRR--RGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~  416 (687)
                      ++|+..+.||+|+||.||++..    ..++..||+|++........+.+..|++++++++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4678889999999999999984    34678999999987776677889999999999999999999998754  34689


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +||||+++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            999999999999998543 2458999999999999999999998   999999999999999999999999999998764


Q ss_pred             CCCCCc--eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcch---------hhHHHHHHHHh
Q 005621          497 RGTNPS--TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE---------LILVDWVWDRW  565 (687)
Q Consensus       497 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~~~~~v~~~~  565 (687)
                      ......  .....++..|+|||++.+..++.++||||||+++|||++|..|+........         ........+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            332211  1112234569999999988999999999999999999998876543221000         00000011111


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                               ........+...+..+.+++.+||+.+|++|||+.+|++.|+..
T Consensus       240 ---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         240 ---------KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ---------hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                     11111111122334788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-37  Score=319.88  Aligned_cols=253  Identities=30%  Similarity=0.447  Sum_probs=203.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||+|++|.||+|.+..+ ..+|+|++..... ..+.+.+|+.++++++|||++++++++. .+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4678889999999999999998654 4699998765432 3467889999999999999999999885 45689999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            99999999976555568999999999999999999998   899999999999999999999999999998764433222


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....++..|+|||...+..++.++||||||+++|||++ |+.||......+   ..++.    ..+.     .+    .
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~-----~~----~  223 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV----ERGY-----RM----P  223 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCC-----CC----C
Confidence            222345678999999998899999999999999999999 888987643221   11111    1110     01    1


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      .+...+..+.+++.+||+.+|++||++.+|+++|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            122234578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-37  Score=327.80  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=207.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEe-----CCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  414 (687)
                      .++|...+.||+|+||.||++.+     ...+..||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            35788999999999999999975     2345689999987653 33456789999999999 79999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++||||+++|+|.+++.......+++.++..++.|++.||.|||+   ++++|+||||+||+++.++.+|++|||+++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            9999999999999999965444458999999999999999999998   8999999999999999999999999999986


Q ss_pred             ccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          495 YERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       495 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      ....... ......++..|+|||.+.++.++.++|||||||++|||++ |..||......+..  ...    ...+.   
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~----~~~~~---  261 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKL----IKEGY---  261 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHH----HHcCC---
Confidence            5433211 1112345678999999999999999999999999999998 99998765432211  111    11111   


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                            ....+......+.+++.+||+.+|++||++.|+++.|++.
T Consensus       262 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 ------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  1111112234788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-37  Score=320.12  Aligned_cols=255  Identities=24%  Similarity=0.335  Sum_probs=204.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|+..+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            56888999999999999999998889999999997665555567889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++..  ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........ .
T Consensus        89 ~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~  162 (267)
T cd06646          89 GGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K  162 (267)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence            99999998843  3468999999999999999999998   9999999999999999999999999999986643221 1


Q ss_pred             eeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          503 TTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      .....|+..|+|||.+.   ...++.++|||||||++|||++|+.|+......+....       .....   ...+...
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~---~~~~~~~  232 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSN---FQPPKLK  232 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCC---CCCCCCc
Confidence            22346889999999874   34578899999999999999999999864432111100       00000   0111111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                      .  .......+.+++.+||+.+|++||++.++++.|
T Consensus       233 ~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 D--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0  111234788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.2e-38  Score=332.01  Aligned_cols=242  Identities=25%  Similarity=0.368  Sum_probs=197.0

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||+||+|.++.+++.||||++....   ....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999998889999999987542   23456677888888876 699999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|.+++..  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (320)
T cd05590          81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS  154 (320)
T ss_pred             chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence            999988843  3468999999999999999999998   999999999999999999999999999987542221 2233


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+       +.+.+..+..      .    ++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~------~----~~~  217 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV------V----YPT  217 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC------C----CCC
Confidence            4578999999999999899999999999999999999999997654321       1111111111      1    111


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCH------HHHHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTM------RQVVR  613 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~  613 (687)
                      .....+.+++.+||+.||++||++      +++++
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~  252 (320)
T cd05590         218 WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR  252 (320)
T ss_pred             CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence            223467899999999999999998      56654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-37  Score=324.90  Aligned_cols=267  Identities=28%  Similarity=0.383  Sum_probs=203.5

Q ss_pred             cccceeeeeeCeEEEEEEEe----CCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--CeeEE
Q 005621          345 FRDKELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDLLL  417 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  417 (687)
                      |...+.||+|+||+||++..    ..+++.||+|.+.... ......|.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988653    3467789999987653 23456788999999999999999999988654  45899


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++++|.+++..   ..+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        86 v~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          86 IMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            9999999999999843   359999999999999999999998   8999999999999999999999999999986643


Q ss_pred             CCCCc--eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNPS--TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      .....  .....++..|+|||.+....++.++||||||+++|||++|+.|+........ ....+...........+.++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhh
Confidence            22211  1122356679999999988999999999999999999999999865432110 00000000000111111122


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .......+...+..+.+++.+||+.+|++||++++|++.|+..
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            2222222333445789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-37  Score=320.39  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=202.8

Q ss_pred             cccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe-----
Q 005621          345 FRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD-----  414 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  414 (687)
                      |...+.||+|+||.||+|.+..+   +..||+|+++...  .....++..|++.++.++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            46678999999999999998643   3789999987542  3445789999999999999999999998866554     


Q ss_pred             -eEEEEecCCCCCchhhhhch----hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccc
Q 005621          415 -LLLVYDFMPNGSLDKCLFDE----QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDF  489 (687)
Q Consensus       415 -~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF  489 (687)
                       .++++||+++|+|..++...    ....+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999988543    22468999999999999999999998   89999999999999999999999999


Q ss_pred             ccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          490 GLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       490 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      |+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+   ..+++    ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----RH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----Hc
Confidence            999866433221 1122235678999999988899999999999999999999 888886543221   11211    11


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       568 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      +..     +..    +......+.+++.+||+.||++||++.|+++.|+..
T Consensus       231 ~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNR-----LKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC-----CCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111     111    122344789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-37  Score=309.62  Aligned_cols=262  Identities=22%  Similarity=0.276  Sum_probs=206.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-h-HHHHHHHHHHHhhhcCCCceeeeeeee--cCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-G-LREFASEISSIGRLRHRNLVQLLGWCR--RRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV  418 (687)
                      ++|..+++|++|.||.||+|+++.+++.||+|+++.+... + --.-++|+.+|.+++|||||.+-.+..  +-+.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4577788999999999999999999999999999765422 1 224578999999999999999998765  34579999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      ||||+. +|...+.... .++...++.-++.|+++|++|||.   .-|+|||||++|+|++..|.+||+||||||.++..
T Consensus       156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            999966 7888775443 578999999999999999999999   89999999999999999999999999999988765


Q ss_pred             CCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc---cc----
Q 005621          499 TNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG---AI----  570 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~---~~----  570 (687)
                      . ...+..+-|..|.|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+....+....   +.+.+...   ..    
T Consensus       231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~---If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK---IFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH---HHHHhCCCccccCCCcc
Confidence            4 34556778999999999887 4699999999999999999999999887765443332   22222110   00    


Q ss_pred             -cc---------ccCCcCCCCCCHH-HHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 -LE---------VVDPRLNGEFNEI-EALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 -~~---------~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       ..         .....++..|... ....-.+|+...+..||.+|.|+.|.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             00         0111122223222 2345678899999999999999999987

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.2e-37  Score=317.08  Aligned_cols=259  Identities=24%  Similarity=0.386  Sum_probs=211.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|++|.||+|....+++.||+|.++..   .....+++.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5789999999999999999999888999999988642   2334568899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          420 DFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       420 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||+++++|.+++..  .....+++.++..++.+++.||.|||+   .+++||||+|+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998854  234568999999999999999999998   9999999999999999999999999999986543


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......    ..+. .+....+..     +.
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~-----~~  227 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEKCDY-----PP  227 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHH-HhhhhcCCC-----CC
Confidence            322 123346888999999999888999999999999999999999998654421    1111 111111111     11


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      +.   .......+.+++.+||+.+|++||++.+|+++|++.
T Consensus       228 ~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11   113344788999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.9e-38  Score=323.41  Aligned_cols=255  Identities=27%  Similarity=0.388  Sum_probs=204.3

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecC-----
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRR-----  412 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-----  412 (687)
                      +.+++.|+..+.||+|+||.||+|....+++.||+|++.... ....++..|+.+++++ +|||++++++++...     
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            346778999999999999999999998899999999987543 2346788899999998 799999999998653     


Q ss_pred             -CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          413 -GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       413 -~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                       ..+++||||+++++|.+++.......+++..+..++.|++.||.|||+   ++|+||||||+||++++++.+||+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence             468999999999999999966555678999999999999999999998   8999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK  566 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~  566 (687)
                      ++....... ......|+..|+|||++.     ...++.++|||||||++|||++|+.||..........      ....
T Consensus       158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~~~  230 (272)
T cd06637         158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIPR  230 (272)
T ss_pred             ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHhc
Confidence            986543222 223456899999999986     3457889999999999999999999996543211111      0000


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       567 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       .     ..+.+.   .......+.+++.+||+.+|.+||++.++++
T Consensus       231 -~-----~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 -N-----PAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -C-----CCCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             0     011111   1112346889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-37  Score=323.69  Aligned_cols=246  Identities=26%  Similarity=0.354  Sum_probs=199.0

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      ||+|+||+||++.+..+++.||+|++....   ....+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999998899999999987542   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceee
Q 005621          428 DKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR  505 (687)
Q Consensus       428 ~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  505 (687)
                      ..++..  .....+++.++..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988753  234568999999999999999999998   9999999999999999999999999999986543322 2233


Q ss_pred             eecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHH
Q 005621          506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEI  585 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~  585 (687)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||..........   .+....        ....  ..++..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~--------~~~~--~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRI--------LNDS--VTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---HHHHhh--------cccC--CCCccc
Confidence            568999999999999999999999999999999999999997654321110   011110        0110  112223


Q ss_pred             HHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          586 EALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       586 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ....+.+++.+||+.+|++||     +++++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            344788999999999999999     6777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-37  Score=319.27  Aligned_cols=259  Identities=25%  Similarity=0.383  Sum_probs=210.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|++|.||++....+++.+|||.+...   ......++.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999999888999999987653   2334568889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          420 DFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       420 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||+++++|.+++..  .....+++.+++.++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998853  223468999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      ... ......|+..|+|||++.+..++.++||||||+++|||++|..||........ ...    ...     .....+.
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~-----~~~~~~~  227 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC----KKI-----EQCDYPP  227 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh----hhh-----hcCCCCC
Confidence            322 12234688999999999988899999999999999999999999875432211 111    111     1111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      +.   .......+.+++.+||+.+|++||||.+|++.+++.
T Consensus       228 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 LP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11   122344788999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-37  Score=317.13  Aligned_cols=253  Identities=30%  Similarity=0.469  Sum_probs=204.9

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhH--HHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL--REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      |+..+.||+|+||+||++....+++.+|+|++........  .....|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678999999999999999999999999999987754332  23456999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.  ....+++.++..++.|+++||.+||+   .+++||||||+||+++.++.++|+|||.+.... .....
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN  154 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred             cccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence            9999999995  45678999999999999999999999   999999999999999999999999999998642 22233


Q ss_pred             eeeeecCCCCCchhhcc-CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTR-TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....++..|+|||++. +..++.++||||+|+++|+|++|..|+..................    .....    ..  
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~~----~~--  224 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR----PLPSS----SQ--  224 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT----HHHHH----TT--
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc----ccccc----cc--
Confidence            34467899999999998 888999999999999999999999999876222222111111110    00000    00  


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ........+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00001157899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-37  Score=337.66  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=202.1

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC-----eeE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG-----DLL  416 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  416 (687)
                      +|+..+.||+|+||.||++.+..+++.||||++...  .....+++.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999999888999999998653  2334567889999999999999999999998776     789


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +|+||+. ++|.+++..  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999996 578777733  3468999999999999999999998   999999999999999999999999999998754


Q ss_pred             CCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc-----
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI-----  570 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~-----  570 (687)
                      ...........++..|+|||++.+. .++.++|||||||++|||++|+.||...........+   .+.......     
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~~~~  231 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEAMRS  231 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHHHHH
Confidence            4333333345678999999998764 5789999999999999999999999765532221111   110000000     


Q ss_pred             ----------ccccCCc-CC--CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 ----------LEVVDPR-LN--GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 ----------~~~~d~~-l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                                .....+. ..  ..........+.+++.+||+.||++||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                      0000000 00  0111122346889999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.6e-37  Score=319.08  Aligned_cols=246  Identities=28%  Similarity=0.404  Sum_probs=197.4

Q ss_pred             eeeeeCeEEEEEEEe--CCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          350 LLGFGGFGRVYKGTL--PSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       350 ~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      .||+|+||.||+|.+  ..++..+|+|++....  ....+++..|+.++++++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999975  4567889999986543  334578899999999999999999999886 45679999999999


Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc--e
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--T  503 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~--~  503 (687)
                      +|.+++..  ...+++..+.+++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++.........  .
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            99999843  3468999999999999999999998   999999999999999999999999999998764433211  1


Q ss_pred             eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||......+   ..+.    ...+..         ...
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----i~~~~~---------~~~  219 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQM----IESGER---------MEC  219 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHCCCC---------CCC
Confidence            12234578999999988889999999999999999998 999997643211   1111    111111         112


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      +...+..+.+++.+||+.+|++||++.+|.+.|++
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            22234478899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-37  Score=323.90  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=205.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|...++||+|+||.||++...     .++..+|+|.+..........+..|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999999742     3467899999887766667889999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhh-------------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          418 VYDFMPNGSLDKCLFDEQK-------------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~-------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      +|||+++++|.+++.....             ..+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence            9999999999999854321             358999999999999999999998   999999999999999999999


Q ss_pred             EEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 005621          485 RLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVW  562 (687)
Q Consensus       485 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~  562 (687)
                      ||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+..   .   
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~---  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---E---  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---H---
Confidence            9999999976533221 11122345678999999998999999999999999999998 88898654432211   1   


Q ss_pred             HHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       563 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                       ....+..     .    ..+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       236 -~~~~~~~-----~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 -CITQGRE-----L----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HHHcCcc-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             1111110     1    111122346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.8e-37  Score=327.64  Aligned_cols=242  Identities=24%  Similarity=0.377  Sum_probs=195.8

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||+||+|++..+++.||||+++...   ......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999998889999999987642   23345567788888764 899999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|.+++..  ...+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (316)
T cd05619          81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC  154 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence            999998843  3468999999999999999999998   999999999999999999999999999987532221 2233


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+   +    .+....+      .+....    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~----~~~i~~~------~~~~~~----  217 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---L----FQSIRMD------NPCYPR----  217 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhC------CCCCCc----
Confidence            4578999999999999899999999999999999999999997654211   1    1111111      111111    


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHH-HHHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMR-QVVR  613 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~  613 (687)
                      .....+.+++.+||+.+|++||++. ++.+
T Consensus       218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         218 WLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            2234678899999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3e-37  Score=328.48  Aligned_cols=238  Identities=26%  Similarity=0.338  Sum_probs=191.7

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHH-HHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEIS-SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||+||+|++..+++.||+|++....   .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999899999999987542   222344555554 56778999999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|.+++..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (323)
T cd05575          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS  154 (323)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence            999998843  4468999999999999999999998   99999999999999999999999999998753221 12233


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+       ..+....+.      ..+....  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~------~~~~~~~--  219 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILNKP------LRLKPNI--  219 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCC------CCCCCCC--
Confidence            4578999999999999999999999999999999999999997654211       111111111      1112222  


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMR  609 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~  609 (687)
                        ...+.+++.+|++.+|++||+++
T Consensus       220 --~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         220 --SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CHHHHHHHHHHhhcCHHhCCCCC
Confidence              34688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-37  Score=327.17  Aligned_cols=257  Identities=30%  Similarity=0.446  Sum_probs=204.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCe--EEEEEEecCc-chhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNT--QVAVKRVSNE-SKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|+..+.||+|+||.||+|.++.++.  .+++|.++.. .....+.+..|+++++++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999999876654  4788888753 334457789999999999 799999999999999999999


Q ss_pred             EecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          419 YDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      +||+++++|.+++....              ...+++.++..++.|++.||+|||+   ++|+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            99999999999985422              1358899999999999999999998   999999999999999999999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      ||+|||++.......  .......+..|+|||++.+..++.++|||||||++|||++ |..||......+.       .+
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-------~~  229 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-------YE  229 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HH
Confidence            999999986432211  1111223567999999998889999999999999999997 9999976543211       11


Q ss_pred             HhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       564 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      ....+         .....+......+.+++.+||+.+|.+||++.++++.|+....
T Consensus       230 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         230 KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11111         1111122233478899999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-38  Score=336.79  Aligned_cols=246  Identities=25%  Similarity=0.361  Sum_probs=209.2

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCe
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  414 (687)
                      ....++|...++||+|.||+|+++..+.+++.+|||.+++..   +...+..+.|.+++... +||.+++++.++..+++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            344578999999999999999999999999999999998873   45567788899888887 59999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      +++||||+.||++..+.   ..+.+++..+.-++..|+.||+|||+   ++|||||||.+|||||.+|.+||+||||++.
T Consensus       444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence            99999999999954433   44679999999999999999999999   9999999999999999999999999999985


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      -- .....+.+++||+.|||||++.+..|+.+.|.|||||+||||+.|..||.+++.++...-       +.      ..
T Consensus       518 ~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds-------I~------~d  583 (694)
T KOG0694|consen  518 GM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS-------IV------ND  583 (694)
T ss_pred             cC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------Hh------cC
Confidence            32 223456779999999999999999999999999999999999999999998775432211       11      01


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTM  608 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  608 (687)
                      |+    .++.....+.+.|+.+.+..+|++|.-+
T Consensus       584 ~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 EV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            22    2344455578899999999999999987

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=318.21  Aligned_cols=250  Identities=33%  Similarity=0.470  Sum_probs=207.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|+..+.||+|++|.||+|..  .++.||+|.+..... ..+++.+|+.++++++|+|++++++++......++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            35678889999999999999998  478999999977654 567899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            999999999965554579999999999999999999998   9999999999999999999999999999986532221 


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                         ...++..|+|||++.++.++.++||||||+++|||++ |+.||......+   +    ......+.         ..
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~~---------~~  218 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPHVEKGY---------RM  218 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhcCC---------CC
Confidence               2334678999999998899999999999999999998 999987553211   1    11111110         01


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ..+...+..+.+++.+||+.+|++||++.+++++|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            1112223478899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.4e-37  Score=317.16  Aligned_cols=251  Identities=20%  Similarity=0.334  Sum_probs=207.2

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      +|...+.||+|+||.||++++..++..+|+|.+... .....+++..|+.++++++|+|++++++.+...+.+++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            477889999999999999999989999999998643 3345577889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.......+++..+..++.|++.||.|||+   ++|+|+||||+||++++++.++++|||+++....... .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            99999998865555568999999999999999999998   9999999999999999999999999999986643221 2


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||........      ... ...+...         ..
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~---------~~  220 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILK-VCQGSYK---------PL  220 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHH-HhcCCCC---------CC
Confidence            2235688999999999988899999999999999999999999976432111      111 1111111         11


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      +......+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            12223467899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=322.59  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=206.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCC-----CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPST-----NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      .++|...+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+.+++.++|||++++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            35788899999999999999998643     3789999987553 34456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchh--------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQ--------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~  487 (687)
                      ++||||+++++|.+++....        ...+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence            99999999999999985422        2347899999999999999999998   999999999999999999999999


Q ss_pred             ccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHh
Q 005621          488 DFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       488 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      |||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+   ..++    .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~----~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKF----V  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHH----H
Confidence            9999986543321 12233456789999999998899999999999999999998 888987544321   1111    1


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      ..+...     .....    .+..+.+++.+||+.+|++||++.++++.|+
T Consensus       235 ~~~~~~-----~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 IDGGHL-----DLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             hcCCCC-----CCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111111     11112    2447889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.4e-37  Score=325.64  Aligned_cols=257  Identities=29%  Similarity=0.414  Sum_probs=204.9

Q ss_pred             CcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      +|...+.||+|+||.||+|+...     ....+++|.+.... .....++..|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46778899999999999998743     23579999887553 3345788999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhch----------------------hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCc
Q 005621          418 VYDFMPNGSLDKCLFDE----------------------QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGN  475 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~----------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  475 (687)
                      ++||+++++|.+++...                      ....+++.+++.++.|++.||.|||+   .+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            99999999999987432                      12358899999999999999999998   999999999999


Q ss_pred             EEeccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcc
Q 005621          476 VLLDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPE  553 (687)
Q Consensus       476 Ill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~  553 (687)
                      ||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999999999865332211 1222345678999999988889999999999999999999 999986543211


Q ss_pred             hhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          554 ELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       554 ~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                             +++....+.         ....+......+.+++.+||+.+|++||++.++++.|++..
T Consensus       238 -------~~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 -------LFNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             -------HHHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                   122221111         11111223347889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-37  Score=327.49  Aligned_cols=256  Identities=21%  Similarity=0.244  Sum_probs=199.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||++....+++.||+|++.+.   .....+.+.+|..++..++|+||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4688999999999999999999988999999998753   2233456889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++... ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999998532 3468999999999999999999998   999999999999999999999999999997654433


Q ss_pred             CCceeeeecCCCCCchhhccC-----CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          500 NPSTTRVVGTLGYLAPELTRT-----GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ........||+.|+|||++..     +.++.++|||||||++|||++|+.||......+.      ............. 
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~-  229 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQF-  229 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCcccC-
Confidence            333333569999999999863     4578899999999999999999999976543211      1111111110110 


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhcccc--CcCcCCCHHHHHHH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSND--AAEARPTMRQVVRY  614 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~  614 (687)
                       +.....    ....+.+++.+|+..  ++..||++.++++.
T Consensus       230 -~~~~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 -PPDVTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -CCccCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             000111    233566777776654  44448899999874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-37  Score=329.49  Aligned_cols=242  Identities=25%  Similarity=0.354  Sum_probs=197.9

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||+||+|.+..+++.||||++....   ......+..|.+++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999998889999999997642   23345677899999888 799999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|..++..  ...+++.++..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||+++...... ....
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (318)
T cd05570          81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS  154 (318)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence            999988843  3469999999999999999999998   999999999999999999999999999987532211 1223


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||.......       +......+.      ..    ++.
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~------~~----~~~  217 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDE------VR----YPR  217 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCC------CC----CCC
Confidence            4578999999999999999999999999999999999999997544211       111111111      11    112


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCH-----HHHHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTM-----RQVVR  613 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  613 (687)
                      .....+.+++.+||+.||++||++     .++++
T Consensus       218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            223468899999999999999999     88875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-37  Score=320.61  Aligned_cols=255  Identities=26%  Similarity=0.397  Sum_probs=200.8

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCe--EEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC------Ce
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNT--QVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR------GD  414 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~  414 (687)
                      |...++||+|+||.||+|++...+.  .+|+|.++..  .....+.+..|+.++++++||||++++++|...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3456889999999999999876654  6999988654  344567889999999999999999999987432      25


Q ss_pred             eEEEEecCCCCCchhhhhch----hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          415 LLLVYDFMPNGSLDKCLFDE----QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                      .+++|||+++|+|.+++...    ....+++..+..++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432    23458999999999999999999998   999999999999999999999999999


Q ss_pred             cceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccc
Q 005621          491 LAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAG  568 (687)
Q Consensus       491 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~  568 (687)
                      +++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+       ..+....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcC
Confidence            99866433221 1122345678999999999999999999999999999999 788886543211       11222222


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          569 AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       569 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ....     .    +......+.+++.+||+.+|++||++.++++.|+..
T Consensus       231 ~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 NRLK-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            2111     1    112234688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.6e-37  Score=320.49  Aligned_cols=246  Identities=26%  Similarity=0.339  Sum_probs=197.5

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      ||+|+||.||++..+.+++.+|+|++....   ......+..|++++++++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999998899999999986532   12234556799999999999999999999999999999999999999


Q ss_pred             hhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeee
Q 005621          428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV  507 (687)
Q Consensus       428 ~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  507 (687)
                      .+++.......+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            998866555568999999999999999999998   999999999999999999999999999998654322  223356


Q ss_pred             cCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHH
Q 005621          508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEA  587 (687)
Q Consensus       508 gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  587 (687)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||........  ..+...... ...    +.. ...    ...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~----~~~-~~~----~~~  223 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL-EDE----VKF-EHQ----NFT  223 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh-ccc----ccc-ccc----cCC
Confidence            89999999999988899999999999999999999999975432111  111111111 111    000 001    123


Q ss_pred             HHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          588 LDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       588 ~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .++.+++.+||+.+|++||+++|+++
T Consensus       224 ~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         224 EESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHHHHHHHHhccCHhhCCCCccchh
Confidence            36789999999999999999977664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.7e-37  Score=326.79  Aligned_cols=241  Identities=24%  Similarity=0.346  Sum_probs=195.2

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ++||+|+||.||+|+++.+++.||+|+++...   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999899999999997642   22345567788888764 899999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|..++..  ...+++.++..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS  154 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence            999998843  3568999999999999999999998   999999999999999999999999999987432221 2233


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+       ..+....+      .+.+..    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~------~~~~~~----  217 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVD------TPHYPR----  217 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC------CCCCCC----
Confidence            4678999999999999999999999999999999999999997654211       11111111      111111    


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHH-HHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMR-QVV  612 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~-evl  612 (687)
                      ....++.+++.+||+.||++||++. +++
T Consensus       218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1234678899999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-37  Score=318.55  Aligned_cols=255  Identities=31%  Similarity=0.463  Sum_probs=208.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|...+.||+|++|.||+|.+. +++.+|||.+..... ..+++.+|+.++++++|+|++++++++......++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            467889999999999999999985 457899999875433 346789999999999999999999999998999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++.++..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+++........
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            999999999976555679999999999999999999998   89999999999999999999999999999876542222


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ..+.    ...+         ...
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~----~~~~---------~~~  223 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ----VERG---------YRM  223 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcC---------CCC
Confidence            2222334678999999998899999999999999999999 999986543211   1111    1111         000


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ..+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1111123478899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.8e-37  Score=322.92  Aligned_cols=264  Identities=25%  Similarity=0.371  Sum_probs=207.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCC----------------eEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCcee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTN----------------TQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQ  404 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~  404 (687)
                      .++|+..+.||+|+||.||++.+...+                ..||+|++.... ....+++.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            457889999999999999999875433                568999987653 345678899999999999999999


Q ss_pred             eeeeeecCCeeEEEEecCCCCCchhhhhchh---------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCc
Q 005621          405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ---------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGN  475 (687)
Q Consensus       405 l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  475 (687)
                      +++++...+..++||||+++++|.+++....         ...+++..++.++.|++.||.|||+   .+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence            9999999999999999999999999985432         1268999999999999999999998   999999999999


Q ss_pred             EEeccCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh--CCCCCCCCCCc
Q 005621          476 VLLDSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC--GRRPIEPKALP  552 (687)
Q Consensus       476 Ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt--G~~p~~~~~~~  552 (687)
                      |+++.++.++|+|||+++....... .......++..|+|||++.++.++.++||||||+++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986533221 11223456778999999998899999999999999999998  66777654321


Q ss_pred             chhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          553 EELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       553 ~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      .   ....+...+........      ...+...+.++.+++.+||+.+|++||++.||++.|++
T Consensus       241 ~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 Q---VIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             H---HHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            1   12222222211111110      11112233478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.8e-37  Score=323.59  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=206.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||+|++|.||+|....+++.||+|.+..........+..|+.+++.++|||++++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999998889999999988765555678899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.   ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........ .
T Consensus       100 ~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~  172 (296)
T cd06654         100 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (296)
T ss_pred             CCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence            9999999883   3358999999999999999999998   9999999999999999999999999999876533221 1


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.........      ......+      .+.+  ..
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~------~~~~--~~  238 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNG------TPEL--QN  238 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCC------CCCC--CC
Confidence            22346889999999999888999999999999999999999999765432111      1111111      0111  11


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +......+.+++.+||..+|++||++.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            1223346788999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-38  Score=300.63  Aligned_cols=263  Identities=25%  Similarity=0.294  Sum_probs=212.7

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----Cee
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----GDL  415 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  415 (687)
                      ..++|++.++||+|||.-||+++...+++.+|+|++.....++.+..++|++..++++|||++++++++..+     .+.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            347899999999999999999998889999999999988888889999999999999999999999987543     358


Q ss_pred             EEEEecCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          416 LLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ||+++|...|+|.+.+...  ++..+++.+.++|+.+|++||.+||+. .++++||||||.||++.+.+.+++.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999998543  344799999999999999999999982 3459999999999999999999999999987


Q ss_pred             eccCCCCCc--------eeeeecCCCCCchhhccC---CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 005621          494 LYERGTNPS--------TTRVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVW  562 (687)
Q Consensus       494 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~  562 (687)
                      ...-.....        ......|..|.|||.+.-   ...++++|||||||+||+|+.|..||+....           
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----------  246 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----------  246 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence            543211110        112345889999999863   4678899999999999999999999976432           


Q ss_pred             HHhcccccc-cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          563 DRWKAGAIL-EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       563 ~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                         +.|.+. .+..+.+.-.-.....+.+.+++.+|++.||.+||++.+++..++..
T Consensus       247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence               112221 12222222222222456899999999999999999999999988764

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.3e-37  Score=326.21  Aligned_cols=256  Identities=21%  Similarity=0.232  Sum_probs=200.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||+||++++..+++.||+|++....   ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999999889999999987532   223456788999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999543 3468999999999999999999998   999999999999999999999999999998665433


Q ss_pred             CCceeeeecCCCCCchhhccC-----CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          500 NPSTTRVVGTLGYLAPELTRT-----GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ........||+.|+|||++.+     +.++.++|||||||++|||++|+.||......+.      ..........    
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~----  226 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEER----  226 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCc----
Confidence            323334579999999999875     5678899999999999999999999976543211      1111111000    


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCc--CCCHHHHHHH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEA--RPTMRQVVRY  614 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  614 (687)
                       ..+.... ......+.+++.+|++..+++  |++++++++.
T Consensus       227 -~~~p~~~-~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 -FQFPSHI-TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -ccCCCcc-ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence             0011111 112346778888888865544  5688888763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.5e-37  Score=317.74  Aligned_cols=259  Identities=26%  Similarity=0.435  Sum_probs=208.5

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      |++.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++|+||+++++++...+..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            45667788888899999999999999998888999999988776666788999999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccC--CHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-CCcEEEcccccce
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAIL--TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-ELNGRLGDFGLAK  493 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~  493 (687)
                      +|+||+++++|.+++.... ..+  ++..+..++.||+.||.|||+   .+|+||||||+||+++. ++.+||+|||++.
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999999986432 234  788899999999999999998   99999999999999986 6789999999997


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCC--CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGK--PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ...... .......|+..|+|||++....  ++.++||||||+++|||++|+.||..........   +.....      
T Consensus       158 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~------  227 (268)
T cd06624         158 RLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMF------  227 (268)
T ss_pred             ecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhh------
Confidence            654322 1222345789999999986643  7889999999999999999999986543211110   000000      


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                       ...+    .++.....++.+++.+||+.+|++||++.|+++.
T Consensus       228 -~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 -KIHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -ccCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence             0111    2222334478899999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4e-37  Score=321.61  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=204.1

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      |+..+.||+|+||+||++.+..+++.||+|.+....   ......+..|+.++++++|+|++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999999999999999986542   22335677899999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++.++..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            999999999865545568999999999999999999998   9999999999999999999999999999976543222 


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                       .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..................         ........
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~~~~~~~  227 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---------VQEEYSEK  227 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---------hhhhcCcc
Confidence             12346899999999999999999999999999999999999999865432111111100000         00111112


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                          ....+.+++..||+.||++||+     +.|+++
T Consensus       228 ----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         228 ----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                2336789999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-37  Score=325.14  Aligned_cols=255  Identities=26%  Similarity=0.398  Sum_probs=203.5

Q ss_pred             CcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .|+..+.||+|+||.||+|.+..     .+..||+|++...... ....+..|+.++++++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46677889999999999998753     2578999999765433 34678899999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhch--------------hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          418 VYDFMPNGSLDKCLFDE--------------QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                      ++||+++++|.+++...              ....+++..+.+++.|++.||.|||+   ++|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence            99999999999998421              12358899999999999999999998   99999999999999999999


Q ss_pred             EEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 005621          484 GRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWV  561 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v  561 (687)
                      +||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..||......+   ..   
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~---  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VI---  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---
Confidence            99999999886533221 11222345779999999988899999999999999999998 878876543211   11   


Q ss_pred             HHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          562 WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       562 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                       +....+...         ..+...+..+.+++..||+.+|++||++.+|++.|+.
T Consensus       237 -~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 -EMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             111121111         1122334468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.2e-37  Score=318.93  Aligned_cols=252  Identities=23%  Similarity=0.313  Sum_probs=201.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|...++||+|+||.||+|.+..+++.||+|++... ......++..|++++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577889999999999999999888999999998654 334456789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|..+.      .+++..+..++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||++.......  
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            9999997543      47888899999999999999998   999999999999999999999999999998654322  


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                       .....|+..|+|||++.+..++.++||||||+++|||++|+.||.............-..+.....     ..+.+.. 
T Consensus       150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-  222 (279)
T cd06619         150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVLPV-  222 (279)
T ss_pred             -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCCCC-
Confidence             223568999999999998899999999999999999999999997643222111000001111110     1111111 


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                        .....++.+++.+|++.+|++||+++++++.
T Consensus       223 --~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         223 --GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              1122367899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.3e-37  Score=315.08  Aligned_cols=247  Identities=29%  Similarity=0.446  Sum_probs=199.9

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      ++||+|+||.||+|... ++..+|+|++..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36999999999999975 578999999876543 3345788999999999999999999999999999999999999999


Q ss_pred             hhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeee
Q 005621          428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV  507 (687)
Q Consensus       428 ~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  507 (687)
                      .+++... ...+++.++..++.|++.+|.|||+   ++++||||||+||+++.++.+||+|||+++..............
T Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          80 LSFLRKK-KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            9988543 3458999999999999999999998   99999999999999999999999999999765433222222234


Q ss_pred             cCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHH
Q 005621          508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIE  586 (687)
Q Consensus       508 gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~  586 (687)
                      ++..|+|||++.++.++.++||||||+++||+++ |..||........       ......+.         ....+...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-------~~~~~~~~---------~~~~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-------REQVEKGY---------RMSCPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHHcCC---------CCCCCCCC
Confidence            4678999999998899999999999999999998 9999875533211       11111111         01111223


Q ss_pred             HHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          587 ALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       587 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      +..+.+++.+|++.+|++||++.++++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.2e-37  Score=326.54  Aligned_cols=255  Identities=29%  Similarity=0.438  Sum_probs=202.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCe--EEEEEEecCc-chhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNT--QVAVKRVSNE-SKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|+..+.||+|+||.||+|.+..++.  .+|+|.+... ......++.+|++++.++ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            467888999999999999999876664  4678877653 334556888999999999 899999999999999999999


Q ss_pred             EecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          419 YDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      |||+++++|.+++....              ...+++.+++.++.|++.||+|||+   ++++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence            99999999999985432              2358899999999999999999998   999999999999999999999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      ||+|||+++.....  .......++..|+|||++.+..++.++|||||||++|||+| |..||......+.   .+    
T Consensus       164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----  234 (303)
T cd05088         164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YE----  234 (303)
T ss_pred             EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HH----
Confidence            99999998643211  11112234678999999988889999999999999999998 9999875443211   11    


Q ss_pred             HhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       564 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ....+         .....+......+.+++.+||+.+|++||++.++++.|+..
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         235 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111         00011111234678999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=319.00  Aligned_cols=268  Identities=26%  Similarity=0.368  Sum_probs=205.9

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhh--hcCCCceeeeeeeecCC---
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR--LRHRNLVQLLGWCRRRG---  413 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~---  413 (687)
                      +...++....+.||+|.||.||+|.+  .|+.||||++......   .+.+|.++.+.  |+|+||+.+++.-...+   
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            34556788889999999999999999  5789999999765443   34455555554  69999999998765433   


Q ss_pred             -eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhccc-----ccCeEEeeccCCCcEEeccCCcEEEc
Q 005621          414 -DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE-----WEQTVIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       414 -~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDlk~~NIll~~~~~~kl~  487 (687)
                       ++|||++|.++|||.|||.   ...++.+..++++..+|.||++||.+     .++.|.|||||+.|||+..++.+.|+
T Consensus       282 TQLwLvTdYHe~GSL~DyL~---r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLN---RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEEEeeecccCCcHHHHHh---hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence             6899999999999999994   35799999999999999999999975     36789999999999999999999999


Q ss_pred             ccccceeccCCCC---CceeeeecCCCCCchhhccCCC----C--CCccceehhhHHHHHHHhC----------CCCCCC
Q 005621          488 DFGLAKLYERGTN---PSTTRVVGTLGYLAPELTRTGK----P--TTSSDVYAFGALLLEVVCG----------RRPIEP  548 (687)
Q Consensus       488 DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDV~S~Gvvl~elltG----------~~p~~~  548 (687)
                      |+|||-..+....   ......+||.+|||||++...-    +  -..+||||||+|+||+...          +.||.+
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            9999987765533   2344578999999999986532    1  2368999999999999762          346654


Q ss_pred             CCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH-HHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          549 KALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE-IEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       549 ~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      ..+.+..      .+.+++--..+.+.|.+...+.. +....+.+|+..||..+|..|.|+-.|.+.|.+...
T Consensus       439 ~Vp~DPs------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  439 VVPSDPS------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCCC------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            4332211      01111112233445555544433 456678899999999999999999999999987654

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=330.72  Aligned_cols=251  Identities=29%  Similarity=0.503  Sum_probs=213.0

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCch
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLD  428 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~  428 (687)
                      -+||+|.||+||.|++..+...+|||.+.....+..+.+.+|+.+.++|+|+|||+++|.|.+++.+-|.||.+|||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            37999999999999999999999999998777777788999999999999999999999999999999999999999999


Q ss_pred             hhhhchhhccC--CHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-CCcEEEcccccceeccCCCCCceee
Q 005621          429 KCLFDEQKAIL--TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-ELNGRLGDFGLAKLYERGTNPSTTR  505 (687)
Q Consensus       429 ~~L~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~  505 (687)
                      ++|... -+++  ++...--..+||++||.|||+   ..|||||||-+|||++. .|.+||+|||.++.+. +..+.+.+
T Consensus       661 sLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TET  735 (1226)
T KOG4279|consen  661 SLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTET  735 (1226)
T ss_pred             HHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhc-cCCccccc
Confidence            999542 3455  677788899999999999999   99999999999999975 4889999999988653 45567778


Q ss_pred             eecCCCCCchhhccCC--CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCC
Q 005621          506 VVGTLGYLAPELTRTG--KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN  583 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~  583 (687)
                      +.||..|||||++..+  .|..++|||||||.+.||.||++||.....+....+        +-|-      -...+.++
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--------kVGm------yKvHP~iP  801 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--------KVGM------YKVHPPIP  801 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--------hhcc------eecCCCCc
Confidence            8999999999999765  588999999999999999999999987665432211        1111      01224556


Q ss_pred             HHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          584 EIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       584 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                      ++...++..++++|+.++|.+||+++++++  +|+..
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            777778899999999999999999999997  56543

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-37  Score=315.98  Aligned_cols=248  Identities=29%  Similarity=0.456  Sum_probs=199.8

Q ss_pred             eeeeeeCeEEEEEEEeCCCC---eEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ++||+|+||.||+|.+...+   ..+|+|.+..... ...+++..|+.++++++|||++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999875544   7899999876543 34568899999999999999999999876 4568999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce-
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-  503 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~-  503 (687)
                      ++|.+++...  ..+++..+..++.|++.||.|||.   .+++||||||+|||++.++.+||+|||+++.......... 
T Consensus        80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            9999999543  368999999999999999999998   8999999999999999999999999999987644332211 


Q ss_pred             -eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          504 -TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       504 -~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                       ....++..|+|||.+.+..++.++||||||+++|||++ |..||......   .+..++.    .+...         .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~~~~---------~  218 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SGERL---------P  218 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCCcC---------C
Confidence             11234568999999998999999999999999999998 99998765432   1222221    11110         1


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1122334788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.3e-37  Score=315.86  Aligned_cols=254  Identities=27%  Similarity=0.451  Sum_probs=206.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|+..+.||+|+||.||++.+. .+..+|+|.+.... ...+.+.+|++++++++|+|++++++.+.. ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            467889999999999999999874 45679999887543 335678999999999999999999999887 778999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999999976555678999999999999999999998   89999999999999999999999999999866443322


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                      ......++..|+|||++..+.++.++|+||||+++||+++ |+.||.......   +..+    ...+...         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----~~~~~~~---------  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA----LERGYRM---------  222 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HhCCCCC---------
Confidence            2223345678999999998889999999999999999999 898987543221   1111    1111111         


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      .........+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1112223468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-37  Score=330.19  Aligned_cols=239  Identities=26%  Similarity=0.327  Sum_probs=194.1

Q ss_pred             eeeeeeCeEEEEEEEe---CCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCC
Q 005621          349 ELLGFGGFGRVYKGTL---PSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      +.||+|+||.||++..   ..+++.||+|++.....  .....+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999876   34678999999976432  234567789999999999999999999999999999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~  155 (318)
T cd05582          82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA  155 (318)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence            9999998843  3468999999999999999999998   999999999999999999999999999998653322 223


Q ss_pred             eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN  583 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~  583 (687)
                      ....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+   ...   ... ...      ..    ++
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~---~i~-~~~------~~----~p  218 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMT---MIL-KAK------LG----MP  218 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHH---HHH-cCC------CC----CC
Confidence            34578999999999998889999999999999999999999997643211   111   111 111      01    11


Q ss_pred             HHHHHHHHHHHHhccccCcCcCCCHHH
Q 005621          584 EIEALDVVKLGLMCSNDAAEARPTMRQ  610 (687)
Q Consensus       584 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e  610 (687)
                      ......+.+++.+||+.||++||++.+
T Consensus       219 ~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         219 QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            222346789999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-37  Score=338.79  Aligned_cols=261  Identities=27%  Similarity=0.407  Sum_probs=206.7

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhc-CCCceeeeeeeecC
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNESK-QGLREFASEISSIGRLR-HRNLVQLLGWCRRR  412 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~  412 (687)
                      ...++|...++||+|+||.||+|++.     ..+..||||++..... ...+.+..|++++.++. ||||++++++|...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34456778899999999999999864     2456899999976533 33457889999999997 99999999999999


Q ss_pred             CeeEEEEecCCCCCchhhhhchh---------------------------------------------------------
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQ---------------------------------------------------------  435 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~---------------------------------------------------------  435 (687)
                      +..++||||+++|+|.++++...                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999986421                                                         


Q ss_pred             ---------------------------------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcE
Q 005621          436 ---------------------------------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNV  476 (687)
Q Consensus       436 ---------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  476 (687)
                                                             ...+++.++.+++.|++.||.|||+   ++++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence                                                   1246788899999999999999998   9999999999999


Q ss_pred             EeccCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcch
Q 005621          477 LLDSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEE  554 (687)
Q Consensus       477 ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~  554 (687)
                      |+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            999999999999999986533221 11223356789999999998889999999999999999998 8889865432221


Q ss_pred             hhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          555 LILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       555 ~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                            .......+.         ....+......+.+++.+||+.+|++||++++|++.|+..
T Consensus       351 ------~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         351 ------FYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ------HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  111111111         1111222334788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-37  Score=323.67  Aligned_cols=262  Identities=26%  Similarity=0.399  Sum_probs=203.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCC--------------CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeee
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPST--------------NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLG  407 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~  407 (687)
                      ++|+..+.||+|+||.||++.....              ...||+|.++... .....+|.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5788999999999999999987432              2359999987653 344567999999999999999999999


Q ss_pred             eeecCCeeEEEEecCCCCCchhhhhchh----------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEE
Q 005621          408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQ----------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL  477 (687)
Q Consensus       408 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  477 (687)
                      ++...+..++||||+++++|.+++....          ...+++..+++++.|++.||+|||+   .+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence            9999999999999999999999985321          1247899999999999999999998   99999999999999


Q ss_pred             eccCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh--CCCCCCCCCCcch
Q 005621          478 LDSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC--GRRPIEPKALPEE  554 (687)
Q Consensus       478 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt--G~~p~~~~~~~~~  554 (687)
                      ++.++.+||+|||+++....... .......++..|+|||++.++.++.++||||||++++||++  |..||......+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999976533221 11222345678999999998899999999999999999998  5567765443221


Q ss_pred             hhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          555 LILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       555 ~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                         .....+.+.....      ......+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       242 ---~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 ---IENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               1111111111000      0000111112347899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.9e-37  Score=319.74  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=203.3

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      |+..+.||+|+||+||+|.+..+++.+|+|.+....   ......+..|++++++++|+|++++++.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999999899999999986542   22334578899999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            999999998865555579999999999999999999998   999999999999999999999999999997654322  


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      ......|+..|+|||++.+..++.++|+||||+++|||++|+.||...........   +......+      .+..   
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~------~~~~---  224 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLET------EEVY---  224 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhcc------cccc---
Confidence            22334689999999999988999999999999999999999999976543221111   11111111      0111   


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                       .......+.+++..|++.+|++||+     +.++++
T Consensus       225 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 -SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             1122336788999999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.8e-37  Score=320.37  Aligned_cols=259  Identities=26%  Similarity=0.404  Sum_probs=205.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCe----EEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNT----QVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .+|...++||+|+||+||+|++..+++    .||+|++.... .....++.+|+.+++.++|||+++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            567888999999999999999765555    58999987543 34457788999999999999999999999754 5789


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ++||+++|+|.+++... ...+++.+++.++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+++....
T Consensus        86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999998543 3468999999999999999999998   9999999999999999999999999999987643


Q ss_pred             CCCCc-eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNPS-TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ..... .....++..|+|||...+..++.++||||||+++|||++ |..||.......   +..+    +..+...    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~----  230 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL----LEKGERL----  230 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCcC----
Confidence            22211 111234678999999998899999999999999999998 889986543211   1111    1111110    


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLP  622 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  622 (687)
                           ..+......+.+++.+||+.||++||++.++++.|+.....|
T Consensus       231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                 111123347889999999999999999999999988765433

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.8e-37  Score=318.47  Aligned_cols=256  Identities=29%  Similarity=0.465  Sum_probs=205.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCe---EEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNT---QVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ..|+..+.||+|+||.||+|.+..++.   .||||.+... ......+|..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            347788999999999999999876553   6999998765 344567899999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++... ...+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999998543 3468999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CCCce-e-eee--cCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          499 TNPST-T-RVV--GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       499 ~~~~~-~-~~~--gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ..... . ...  .+..|+|||++.+..++.++||||||+++||+++ |..||......   ...+++..    .     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~----~-----  227 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQ----D-----  227 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc----C-----
Confidence            22111 1 111  2457999999999999999999999999999886 99998764422   11222211    0     


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ...    ..+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       228 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 YRL----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            000    11122334678999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.2e-37  Score=315.63  Aligned_cols=247  Identities=27%  Similarity=0.391  Sum_probs=197.4

Q ss_pred             eeeeeCeEEEEEEEeC--CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCC
Q 005621          350 LLGFGGFGRVYKGTLP--STNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGS  426 (687)
Q Consensus       350 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs  426 (687)
                      .||+|+||.||+|.+.  ..+..||+|++.... ....+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999874  445679999987654 334567899999999999999999999886 457899999999999


Q ss_pred             chhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc--ee
Q 005621          427 LDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TT  504 (687)
Q Consensus       427 L~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~--~~  504 (687)
                      |.+++... ...+++.++++++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++.........  ..
T Consensus        81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99998543 3468999999999999999999998   899999999999999999999999999998654332211  11


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCC
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN  583 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~  583 (687)
                      ...++..|+|||.+....++.++||||||+++|||++ |..||......+.       ......+.         ....+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~---------~~~~~  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-------MSFIEQGK---------RLDCP  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHHCCC---------CCCCC
Confidence            1223578999999988889999999999999999996 9999976543211       11111111         11222


Q ss_pred             HHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          584 EIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       584 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ..+..++.+++.+||+.+|++||++.+|.+.|+.
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            3334578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.9e-37  Score=315.25  Aligned_cols=248  Identities=31%  Similarity=0.442  Sum_probs=201.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeee-cCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR-RRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~Ey  421 (687)
                      ++|...+.||+|++|.||++..  .+..+|+|.+....  ..+.+..|+.++++++|+|++++++++. ..+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            4678889999999999999987  47889999986543  2467889999999999999999999764 45678999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++..+++++.|++.||+|||+   ++++||||||+||++++++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999999966555568999999999999999999998   999999999999999999999999999987543322  


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                        ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+   +..++    ..+.         ..
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~----~~~~---------~~  218 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGY---------KM  218 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcCC---------CC
Confidence              12234568999999998899999999999999999998 998886543211   11111    1110         11


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            1122234478899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=313.27  Aligned_cols=270  Identities=25%  Similarity=0.346  Sum_probs=209.3

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEec--CcchhhHHHHHHHHHHHhhhcCCCceeeeeeeec-----CC
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS--NESKQGLREFASEISSIGRLRHRNLVQLLGWCRR-----RG  413 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~  413 (687)
                      ....|...+.||+|+||.|..+.++.+|+.||||++.  .......++-.+|+++|+.++|+||+.+++.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3455666789999999999999999999999999997  3455567888999999999999999999998754     45


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..|+|+|+| ..+|.+.++  .+..|+.....-++.|+++||.|+|+   .+|+||||||+|++++.+...||+||||||
T Consensus       100 DvYiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eeEEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccccee
Confidence            789999999 668888884  33459999999999999999999999   999999999999999999999999999999


Q ss_pred             eccCCC-CCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------H
Q 005621          494 LYERGT-NPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVW--------D  563 (687)
Q Consensus       494 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~--------~  563 (687)
                      ..+... ....+..+.|..|.|||++.. ..|+.+.||||.||++.||++|+.-|.+...-....++-.+.        .
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            876432 223456778999999998754 689999999999999999999999997765433332221111        1


Q ss_pred             Hhccccccccc---CC----cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          564 RWKAGAILEVV---DP----RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       564 ~~~~~~~~~~~---d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      .+...+....+   .+    .+...++ ......++|+.+||..||.+|+|++|.++  +|+.
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~  315 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP  315 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence            11110000000   00    0011111 12236789999999999999999999997  4544

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.2e-37  Score=325.15  Aligned_cols=269  Identities=23%  Similarity=0.353  Sum_probs=204.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|...+.||+|+||+||+|+++.+++.||+|++..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            568899999999999999999988899999999875432 2335678899999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++ +|.+++... ...+++.++..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++....... 
T Consensus        86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            975 888877443 3458899999999999999999998   9999999999999999999999999999976433221 


Q ss_pred             ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhccccc-c
Q 005621          502 STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV--------WDRWKAGAI-L  571 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v--------~~~~~~~~~-~  571 (687)
                      ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+........        |..+..... .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            1223467899999998865 46889999999999999999999999776543332222111        110000000 0


Q ss_pred             cccCCcCCC----CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          572 EVVDPRLNG----EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       572 ~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ..-.+....    ........++.+++.+|++.||++|||+.|+++  +++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  291 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS  291 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence            000000000    000112346789999999999999999999997  4444

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-37  Score=318.36  Aligned_cols=249  Identities=30%  Similarity=0.456  Sum_probs=198.0

Q ss_pred             eeeeeeCeEEEEEEEeCCCCe--EEEEEEecCc-chhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNT--QVAVKRVSNE-SKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||.||+|++..++.  .+++|.+... .....+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999977664  5788888754 344556889999999999 899999999999999999999999999


Q ss_pred             CCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          425 GSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       425 gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                      |+|.+++....              ...+++.++..++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999985432              1347899999999999999999998   999999999999999999999999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      +++......  .......+..|+|||++....++.++||||||+++|||++ |..||......+.       .+....+ 
T Consensus       158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~-  227 (270)
T cd05047         158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------YEKLPQG-  227 (270)
T ss_pred             Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-------HHHHhCC-
Confidence            986332111  1111233567999999988899999999999999999997 9999865432111       1111111 


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                              ...+.+......+.+++.+||+.+|.+||++.++++.|+..
T Consensus       228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                    01111112334688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-36  Score=320.41  Aligned_cols=259  Identities=24%  Similarity=0.355  Sum_probs=210.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||+|++|.||+|....+++.||+|.+........+.+..|+.+++.++|+|++++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            67889999999999999999998889999999997665555677889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.   ...+++.++..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++........ .
T Consensus        99 ~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~  171 (297)
T cd06656          99 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (297)
T ss_pred             CCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence            9999999883   3458999999999999999999998   8999999999999999999999999999976543322 1


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........      ....+      .+.+  ..
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~------~~~~--~~  237 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPEL--QN  237 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC------CCCC--CC
Confidence            2234688899999999988899999999999999999999999976443211100      00000      0111  11


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCCCCC
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVPLP  622 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~~  622 (687)
                      +......+.+++.+||+.+|++||++.++++  +++...+.+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence            2223346788999999999999999999998  555444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.5e-37  Score=313.16  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=205.7

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeec-CCeeEEEEe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRR-RGDLLLVYD  420 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E  420 (687)
                      +|+..+.||+|++|.||++.++.+++.+|+|++....  ....+.+..|++++++++|+|++++++.+.. ...+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5788999999999999999998889999999986542  3445678899999999999999999998764 446899999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++.......+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            9999999999976555578999999999999999999998   8999999999999999999999999999987643222


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                       ......+++.|+|||++.+..++.++||||||++++||++|+.||......      .+.... ..+..     +    
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~-~~~~~-----~----  220 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRI-IEGKL-----P----  220 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-HhcCC-----C----
Confidence             223456889999999999999999999999999999999999998754321      111111 11111     1    


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ..+......+.+++.+|++.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1122233478899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.6e-37  Score=322.23  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=205.8

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG  413 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  413 (687)
                      ...++|+..++||+|+||.||+|..+.     .+..||+|.+.... .....++.+|+.++++++||||+++++++.+.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            346789999999999999999997642     34589999886543 233456889999999999999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchh--------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEE
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQ--------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR  485 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k  485 (687)
                      ..++||||+++|+|.+++....        ...+++..+.+++.|++.||.|||+   ++|+||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999995422        1345778889999999999999998   9999999999999999999999


Q ss_pred             EcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 005621          486 LGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       486 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      |+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||......+   ..+    
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~----  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK----  232 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----
Confidence            999999986533221 11222345678999999998899999999999999999999 788886543211   111    


Q ss_pred             HhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       564 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ....+..     +..    +......+.+++.+|++.+|++||++.++++.|++..
T Consensus       233 ~~~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         233 FVMDGGY-----LDQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1111111     111    1122347899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.9e-37  Score=320.16  Aligned_cols=261  Identities=24%  Similarity=0.320  Sum_probs=197.4

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhh---cCCCceeeeeeeec-----CC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRL---RHRNLVQLLGWCRR-----RG  413 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~  413 (687)
                      +|+..+.||+|+||+||+|.+..+++.||+|.+.....  .....+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            57888999999999999999998999999999875422  1223456677777665   79999999998754     34


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++||||++ ++|.+++.......+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5899999997 488888865444568999999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc---ccc
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA---GAI  570 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~---~~~  570 (687)
                      ......  ......||..|+|||++.+..++.++|||||||++|||++|+.||......+...   .+......   ...
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~  231 (288)
T cd07863         157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG---KIFDLIGLPPEDDW  231 (288)
T ss_pred             cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH---HHHHHhCCCChhhC
Confidence            654322  2233568899999999998899999999999999999999999997654322111   11111000   000


Q ss_pred             c-------cccCCcCC---CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 L-------EVVDPRLN---GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 ~-------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .       ....+...   ..........+.+++.+|++.||++||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0       00000000   0111122346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-37  Score=329.47  Aligned_cols=241  Identities=26%  Similarity=0.312  Sum_probs=193.0

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHH-HHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEIS-SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||+||+|+...+++.+|+|++....   .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999899999999987542   233345556654 46778999999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|..++.  ....+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (325)
T cd05604          81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT  154 (325)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence            99998884  34568999999999999999999998   999999999999999999999999999987532211 2233


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+.       .+....+.      ..+...   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-------~~~~~~~~------~~~~~~---  218 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-------YDNILHKP------LVLRPG---  218 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-------HHHHHcCC------ccCCCC---
Confidence            45799999999999999999999999999999999999999976543211       11111111      111111   


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHHHHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMRQVV  612 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl  612 (687)
                       ....+.+++.+|++.+|++||++++.+
T Consensus       219 -~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         219 -ASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             -CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence             233677899999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.4e-37  Score=325.99  Aligned_cols=242  Identities=24%  Similarity=0.302  Sum_probs=196.0

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~  419 (687)
                      +|+..+.||+|+||+||+|.++.+++.||+|++....   ....+.+..|..++..+. |++|+++++++...+.+++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999999899999999987642   233456788999988885 577888999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++.++..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            99999999998843  3569999999999999999999998   999999999999999999999999999987532221


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....    ...+.      .   
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~----i~~~~------~---  218 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQS----IMEHN------V---  218 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhCC------C---
Confidence             12233568999999999999899999999999999999999999997654211   1111    11111      1   


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTM  608 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  608 (687)
                       .++......+.+++.+||+.+|.+|++.
T Consensus       219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             1112223467889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-37  Score=314.99  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=205.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC-----eeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG-----DLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l  417 (687)
                      -.|...+++|.|.||.||+|....+++.||||+.-.+.+..    ..|+++|++++|||||+|+-++....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35677899999999999999999999999999986554321    36899999999999999999885432     4579


Q ss_pred             EEecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-CcEEEccccccee
Q 005621          418 VYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKL  494 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla~~  494 (687)
                      ||||||. +|.+.++.  ..+..++...+.-+..||.+||.|||+   .+|+||||||.|+|+|.+ +.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999975 89988854  234567888888899999999999999   999999999999999987 9999999999998


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc--
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL--  571 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~--  571 (687)
                      +..+....  ....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+....+....+-.+........+.  
T Consensus       176 L~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  176 LVKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            87665443  3456889999999887 579999999999999999999999998876555444433332222222111  


Q ss_pred             -----cccCCcCCCC-----CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 -----EVVDPRLNGE-----FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 -----~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                           +...|.+...     +......+.++++.++++.+|.+|.++.|++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                 1122222211     23334558899999999999999999999986

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.5e-37  Score=317.01  Aligned_cols=256  Identities=29%  Similarity=0.460  Sum_probs=205.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .+|+..+.||+|+||.||+|.+..+   +..+|+|.+.... ....+.+..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            5678889999999999999987533   3479999987543 33456889999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++.... ..+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999995432 468999999999999999999998   99999999999999999999999999999876443


Q ss_pred             CCCcee--eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          499 TNPSTT--RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       499 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ......  ...++..|+|||++.++.++.++||||||+++||+++ |..||......+   ....+    ..+.     .
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~-----~  227 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EEGY-----R  227 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hCCC-----c
Confidence            221111  1223568999999998899999999999999999887 999987654321   11111    1110     0


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .    ......+..+.+++.+|++.+|++||+|.++++.|+..
T Consensus       228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            1    11112234678999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.8e-37  Score=324.64  Aligned_cols=261  Identities=27%  Similarity=0.400  Sum_probs=207.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeC-------CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecC
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLP-------STNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRR  412 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  412 (687)
                      ..+|...+.||+|+||.||+|+..       ..+..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888899999999999999752       234579999987543 34567889999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                      +..++||||+++|+|.+++....              ...+++.++..++.||+.||.|||+   .+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence            99999999999999999996432              2357899999999999999999998   899999999999999


Q ss_pred             ccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhh
Q 005621          479 DSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELI  556 (687)
Q Consensus       479 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  556 (687)
                      +.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..|+......+   
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---  247 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  247 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence            99999999999999876433221 1222345678999999998889999999999999999998 777875443211   


Q ss_pred             HHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCC
Q 005621          557 LVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPL  621 (687)
Q Consensus       557 ~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  621 (687)
                          ..+....+..         ...+......+.+++.+||+.+|++||++.++++.|++...+
T Consensus       248 ----~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         248 ----LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ----HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                1111211111         011122345788999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-37  Score=317.41  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=206.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|+..+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.++++++|+|++++++++.+...+++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999998899999999987653 44456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++...   .+++.++..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            9999999998432   78999999999999999999998   8999999999999999999999999999987654322 


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      ......++..|+|||++.+..++.++||||||+++|||++|+.||........      .. ....+     ..+.+...
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~-~~~~~-----~~~~~~~~  221 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LF-LIPKN-----NPPSLEGN  221 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HH-Hhhhc-----CCCCCccc
Confidence            22335688899999999998899999999999999999999999976442111      11 11111     11111111


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         .....+.+++.+||+.+|++||+++++++
T Consensus       222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               03346888999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-36  Score=321.19  Aligned_cols=259  Identities=24%  Similarity=0.323  Sum_probs=204.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|+..+.||+|+||.||++.+..++..+|+|.+.... .....++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999998889999999987653 33456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++..  ...+++..+..++.|++.||.|||+  ..+++||||||+||+++.++.+||+|||++.......  
T Consensus        81 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            999999999854  3568999999999999999999997  2589999999999999999999999999987543221  


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc-----------
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI-----------  570 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~-----------  570 (687)
                       .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........   ..+..........           
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccCCC
Confidence             2235688999999999888899999999999999999999999865432111   1100000000000           


Q ss_pred             ----------------ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          571 ----------------LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       571 ----------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                                      .....+.+..   ......+.+++.+||+.+|++||++.+|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                            0000011100   1123468899999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.9e-37  Score=340.77  Aligned_cols=267  Identities=21%  Similarity=0.299  Sum_probs=198.6

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--------
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRR--------  412 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------  412 (687)
                      ..++|...++||+|+||.||+|.+..+++.||||++....    ....+|+.++++++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999998889999999886542    2234699999999999999999876321        


Q ss_pred             CeeEEEEecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-cEEEccc
Q 005621          413 GDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-NGRLGDF  489 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DF  489 (687)
                      ..+++||||+++ +|.+++..  .....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999975 67776643  234568999999999999999999998   9999999999999999764 6999999


Q ss_pred             ccceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc
Q 005621          490 GLAKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG  568 (687)
Q Consensus       490 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~  568 (687)
                      |+++.+.....  .....||+.|+|||++.+ ..++.++|||||||++|||++|..||......+.......+.......
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            99986643322  223468999999999865 468999999999999999999999998765433221111110000000


Q ss_pred             -------ccccc-----cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          569 -------AILEV-----VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       569 -------~~~~~-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                             ...+.     ....+...++...+.++.+|+.+||+.+|.+||++.|+++  +++.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence                   00000     0011111122223457889999999999999999999996  4443

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.2e-37  Score=327.63  Aligned_cols=242  Identities=25%  Similarity=0.290  Sum_probs=192.3

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHH-HHHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEI-SSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||+||+|++..+++.||+|++....   .....++..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999999889999999987542   12233444444 456778999999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|.+++..  ...+.+..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~  154 (325)
T cd05602          81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS  154 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence            999998843  3457888899999999999999998   999999999999999999999999999997532221 2233


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   .+.+    ....      ..+...   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i----~~~~------~~~~~~---  218 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNI----LNKP------LQLKPN---  218 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHH----HhCC------cCCCCC---
Confidence            45799999999999999999999999999999999999999976543211   1111    1111      011112   


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       ....+.+++.+|++.+|.+||++.+.+.
T Consensus       219 -~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         219 -ITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             -CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence             2336788999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.5e-37  Score=332.14  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||++....+++.||+|++....   ......+..|+.++.+++||||+++++.+.+.+.+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999999899999999987542   334567888999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999999843  4568999999999999999999998   999999999999999999999999999987542211


Q ss_pred             C----------------------------------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCC
Q 005621          500 N----------------------------------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP  545 (687)
Q Consensus       500 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p  545 (687)
                      .                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                  001234799999999999999999999999999999999999999


Q ss_pred             CCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC---HHHHHH
Q 005621          546 IEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT---MRQVVR  613 (687)
Q Consensus       546 ~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~  613 (687)
                      |..........      ..........     .....  .....+.+++.+|+ .+|++|++   +.++++
T Consensus       236 f~~~~~~~~~~------~i~~~~~~~~-----~p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         236 FCSETPQETYR------KVMNWKETLV-----FPPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCHHHHHH------HHHcCCCcee-----cCCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            98655322111      1110000000     01110  11235667777766 49999985   566665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-37  Score=312.74  Aligned_cols=249  Identities=32%  Similarity=0.486  Sum_probs=205.5

Q ss_pred             eeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPST---NTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||.||+|.....   +..|++|.+...... ..+++..|++.++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999765   889999999876543 367889999999999999999999999999999999999999


Q ss_pred             CCchhhhhchh-------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          425 GSLDKCLFDEQ-------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       425 gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ++|.+++....       ...+++.++.+++.|++.||.|||+   ++++||||||+||+++.++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999996542       3579999999999999999999998   9999999999999999999999999999987654


Q ss_pred             CCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ... .......++..|+|||.+....++.++||||||++++||++ |..||......+       +.+....+..     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~-----  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYR-----  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence            321 12233457889999999998899999999999999999999 689987663211       1111111111     


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                          ...+.....++.+++.+||+.+|++||++.++++.|+
T Consensus       226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                1112222457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-36  Score=311.20  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=209.3

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|+..+.||.|+||.||.++...+++.+++|.+...  .....+++.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578899999999999999999889999999987654  344567889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            999999999965545578999999999999999999998   8999999999999999999999999999987644332 


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      ......|+..|+|||++.+..++.++||||||+++|||++|+.||......+.      +... ..+....         
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~-~~~~~~~---------  220 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKI-VQGNYTP---------  220 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHH-HcCCCCC---------
Confidence            22335689999999999888889999999999999999999999976443211      1111 1111111         


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                      ........+.+++.+||+.+|++||++.++++.+
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            1122334688999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=329.58  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=214.1

Q ss_pred             CcccceeeeeeCeEEEEEEEeCC----CCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPS----TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .....++||.|.||.||+|+...    ..-.||||..+.+ .....+.|++|..+|++++||||++|+|.|.+ ...|||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            34456799999999999998732    2235999998874 44557889999999999999999999999975 478999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      ||.++-|.|..||..+ +..|+......++.||+.||+|||+   ..+|||||..+|||+.+.--+||+||||+|.++..
T Consensus       469 mEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  469 MELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            9999999999999654 3468999999999999999999999   99999999999999999999999999999998877


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .....+...-+..|||||.+.-++++.+||||.|||++||++. |.+||..-...+..                ..++..
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----------------~~iEnG  608 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----------------GHIENG  608 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE----------------EEecCC
Confidence            7666555566789999999999999999999999999999987 99999876543321                122222


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      -+...++.|+..+..|+.+||..+|.+||.+.|+...|..
T Consensus       609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence            3344566777799999999999999999999999887653

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-36  Score=319.43  Aligned_cols=257  Identities=24%  Similarity=0.376  Sum_probs=209.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||.|++|.||+|.+..+++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46889999999999999999998899999999987665555678889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.   ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........ .
T Consensus        99 ~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  171 (296)
T cd06655          99 AGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K  171 (296)
T ss_pred             CCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence            9999999883   3468999999999999999999998   9999999999999999999999999999876543222 1


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........   +.   ..+ .     +.+  ..
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~---~~~-~-----~~~--~~  237 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA---TNG-T-----PEL--QN  237 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---hcC-C-----ccc--CC
Confidence            2234688899999999988899999999999999999999999976543221110   00   000 0     001  01


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCCC
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVP  620 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~  620 (687)
                      +......+.+++.+||+.+|++||++.++++  +++...+
T Consensus       238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            1122336788999999999999999999997  4554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.4e-37  Score=324.71  Aligned_cols=259  Identities=27%  Similarity=0.401  Sum_probs=205.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC-------CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecC
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS-------TNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRR  412 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  412 (687)
                      .++|...+.||+|+||.||++.+..       ....+|+|.+.... .....++..|+.+++++ +||||++++++|...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3578999999999999999998643       23569999997653 34456788999999999 799999999999999


Q ss_pred             CeeEEEEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                      +..++||||+++|+|.+++....              ...+++.++++++.|++.||+|||+   .+++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence            99999999999999999996432              1358999999999999999999998   999999999999999


Q ss_pred             ccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhh
Q 005621          479 DSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELI  556 (687)
Q Consensus       479 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  556 (687)
                      +.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+   
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence            99999999999999765432211 1112234568999999998889999999999999999998 888886543211   


Q ss_pred             HHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          557 LVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       557 ~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                          +......+..         .+.+......+.+++.+||+.+|++||++.+|++.|+...
T Consensus       251 ----~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         251 ----LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             ----HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                1111111111         1112223447889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.7e-37  Score=320.00  Aligned_cols=257  Identities=27%  Similarity=0.445  Sum_probs=205.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      .++|+..+.||+|+||.||++.+..     ++..||+|++.... .....++.+|+.++++++|||++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            4678899999999999999998743     56789999987653 34456799999999999999999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchh--------------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQ--------------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGN  475 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  475 (687)
                      ++||||+++|+|.+++....                    ...+++.+++.++.|++.||.|||+   .+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            99999999999999995321                    1347889999999999999999998   999999999999


Q ss_pred             EEeccCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcc
Q 005621          476 VLLDSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPE  553 (687)
Q Consensus       476 Ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~  553 (687)
                      |+++.++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875533221 11112234678999999998899999999999999999998 888886543211


Q ss_pred             hhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          554 ELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       554 ~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                            . ......+....         .+......+.+++.+||+.+|++||++.|+++.|++
T Consensus       241 ------~-~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 ------V-IYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ------H-HHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                  1 11122222111         112233478899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1e-36  Score=351.30  Aligned_cols=259  Identities=20%  Similarity=0.287  Sum_probs=204.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..++||+|+||.||+|.+..+++.||+|++....   ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999998889999999987542   233567999999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhch---------hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          420 DFMPNGSLDKCLFDE---------QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                      ||+++|+|.+++...         ....+++..+++++.||+.||+|||+   ++|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988531         12346778889999999999999998   899999999999999999999999999


Q ss_pred             cceeccCCCC-----------------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcc
Q 005621          491 LAKLYERGTN-----------------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE  553 (687)
Q Consensus       491 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~  553 (687)
                      +++.......                 .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                 01123469999999999999999999999999999999999999997643211


Q ss_pred             hhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCC-CHHHHHHHHhcC
Q 005621          554 ELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARP-TMRQVVRYLEGE  618 (687)
Q Consensus       554 ~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~  618 (687)
                      ..      ..    ...   .++.-... ....+..+.+++.+|++.||++|| +++++++.|+..
T Consensus       239 i~------~~----~~i---~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 IS------YR----DVI---LSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             hh------hh----hhc---cChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            10      00    000   01100000 012234678899999999999996 566676666553

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-36  Score=319.73  Aligned_cols=263  Identities=26%  Similarity=0.396  Sum_probs=203.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeC----------------CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceee
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLP----------------STNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQL  405 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  405 (687)
                      ++|+..+.||+|+||.||++...                .++..+|+|++.... .....++..|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56889999999999999998643                234579999987653 3445789999999999999999999


Q ss_pred             eeeeecCCeeEEEEecCCCCCchhhhhchh---------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcE
Q 005621          406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ---------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNV  476 (687)
Q Consensus       406 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  476 (687)
                      ++++...+..++||||+++++|.+++....         ...+++.++.+++.|++.||+|||+   .+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence            999999999999999999999999985432         1247888999999999999999998   8999999999999


Q ss_pred             EeccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh--CCCCCCCCCCcc
Q 005621          477 LLDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC--GRRPIEPKALPE  553 (687)
Q Consensus       477 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt--G~~p~~~~~~~~  553 (687)
                      |++.++.+||+|||+++.+...... ......++..|++||....+.++.++|||||||++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            9999999999999999865332211 1222344678999999888899999999999999999998  677876543322


Q ss_pred             hhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          554 ELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       554 ~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ..   ....+.+..... ....+     .+..++..+.+++.+||+.+|++||++.+|++.|++
T Consensus       242 ~~---~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 VI---ENTGEFFRDQGR-QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HH---HHHHHHHhhccc-cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11   111111111100 00001     111233578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.6e-37  Score=318.60  Aligned_cols=263  Identities=26%  Similarity=0.383  Sum_probs=206.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCC----CCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeec--CCee
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPS----TNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRR--RGDL  415 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  415 (687)
                      +.|...+.||+|+||.||+|.+..    ++..+|||++...... ..++|..|++++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            356677899999999999998743    3788999999866543 56789999999999999999999999987  5578


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++++|.+++.... ..+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            99999999999999995433 359999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchh--------hHHHHHHHHh
Q 005621          496 ERGTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL--------ILVDWVWDRW  565 (687)
Q Consensus       496 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~--------~~~~~v~~~~  565 (687)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........        .......+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            532221  111223456799999999889999999999999999999999998653321100        0011111111


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .         .......+..+...+.+++.+||+.+|++||++.||+++|+..
T Consensus       240 ~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 K---------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             H---------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1         1111111222335788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.5e-36  Score=324.41  Aligned_cols=256  Identities=20%  Similarity=0.228  Sum_probs=199.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...++||+|+||+||++.++.+++.+|+|++.+..   ......+..|+.++..++|+||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999999889999999986532   223345788999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999999542 3468999999999999999999998   999999999999999999999999999997654333


Q ss_pred             CCceeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          500 NPSTTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ........||+.|+|||++.     ...++.++|||||||++|||++|+.||......+.      ..........    
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~----  226 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKER----  226 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCcc----
Confidence            22333457999999999986     34688999999999999999999999976543221      1111111000    


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcC--cCCCHHHHHHH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAE--ARPTMRQVVRY  614 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPs~~evl~~  614 (687)
                       ..... ........+.+++.+|+..+++  .|+++.++++.
T Consensus       227 -~~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 -FQFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -ccCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             00100 0111234677788887755444  47899999874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.4e-37  Score=317.80  Aligned_cols=259  Identities=25%  Similarity=0.340  Sum_probs=206.8

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCC----CCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeec-CCe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPS----TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRR-RGD  414 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  414 (687)
                      ..++|...+.||+|+||.||+|.+..    .+..|++|++... .......+.+|+.++++++|||++++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35688899999999999999999865    2578999988754 33445778899999999999999999998766 567


Q ss_pred             eEEEEecCCCCCchhhhhchhh------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcc
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQK------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGD  488 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  488 (687)
                      .++++||+++++|.+++.....      ..+++.+++.++.|++.||.|||+   .+++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence            8999999999999999854322      468999999999999999999998   9999999999999999999999999


Q ss_pred             cccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhc
Q 005621          489 FGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWK  566 (687)
Q Consensus       489 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~  566 (687)
                      ||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+   +..++    .
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL----K  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH----H
Confidence            9999865332211 1112345678999999998889999999999999999999 999997643211   11111    1


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       567 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .+.     ....    ....+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       234 ~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         234 DGY-----RLAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             cCC-----CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111     0011    112234688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-36  Score=322.67  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=204.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeC-------CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLP-------STNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRG  413 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  413 (687)
                      ++|...+.||+|+||.||+++..       .....+|+|++.... .....++..|+.+++++ +||||++++++|...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57788999999999999999753       234579999987543 34467789999999999 6999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD  479 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  479 (687)
                      ..++||||+++|+|.+++....              ...+++.++.+++.|++.||.|||+   ++++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence            9999999999999999995432              2358999999999999999999998   9999999999999999


Q ss_pred             cCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhH
Q 005621          480 SELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELIL  557 (687)
Q Consensus       480 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~  557 (687)
                      .++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |..||......+    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----  244 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----  244 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            9999999999999865432211 1112234567999999998899999999999999999999 888886543211    


Q ss_pred             HHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          558 VDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       558 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                         +.+....+...         ..+......+.+++.+||+.+|++||++.++++.|++..
T Consensus       245 ---~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         245 ---LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             ---HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence               11111111111         111222346889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7e-37  Score=317.99  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=204.0

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+..|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566778999999999999998889999999987543 344567899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.   ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++........ .
T Consensus        85 ~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06642          85 GGGSALDLLK---PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence            9999999884   3468999999999999999999998   9999999999999999999999999999976543221 1


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....|+..|+|||++.+..++.++||||||+++|||++|+.|+.........      .. ...     ...+    ..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~~~-----~~~~----~~  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FL-IPK-----NSPP----TL  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hh-hhc-----CCCC----CC
Confidence            22346788999999999888999999999999999999999998754321110      00 000     0111    12


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .......+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            22334578899999999999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-36  Score=312.04  Aligned_cols=249  Identities=26%  Similarity=0.441  Sum_probs=202.5

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---------hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---------QGLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      +|...+.||+|++|.||+|.+..+++.+|+|.+.....         ...+.+..|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            46678899999999999999988889999998865321         123568899999999999999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++||||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||+++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            9999999999999999943  3568899999999999999999998   8999999999999999999999999999986


Q ss_pred             ccCCCC-----CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          495 YERGTN-----PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       495 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      ......     .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.........      ...     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~-----  224 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------FKI-----  224 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------HHH-----
Confidence            643211     1112245788999999999888999999999999999999999999764321110      000     


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       .....+.+.    ......+.+++.+||+.+|++||++.+|++
T Consensus       225 -~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 -GENASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -hccCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             011122222    223347889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-36  Score=311.95  Aligned_cols=249  Identities=29%  Similarity=0.422  Sum_probs=201.8

Q ss_pred             eeeeeeCeEEEEEEEeCC-CC--eEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPS-TN--TQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ++||+|++|.||+|.+.. .+  ..||||.+..... ...+++..|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999854 23  3699999987765 567789999999999999999999999988 889999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC--c
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--S  502 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~--~  502 (687)
                      ++|.+++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            999999965443568999999999999999999998   99999999999999999999999999999876442221  1


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.   ....   ...+.       .+  .
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~---~~~~~-------~~--~  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKI---DKEGE-------RL--E  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---HhcCC-------cC--C
Confidence            112456789999999998899999999999999999999 9999865432211   1111   11110       00  1


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      .+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11123347889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=332.91  Aligned_cols=248  Identities=27%  Similarity=0.377  Sum_probs=210.0

Q ss_pred             cceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          347 DKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ..++||+|.||.|++|.|...   -..||||.++..... ...+|++|+.+|.+|+|||+++|||...+ ..+.||||++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            457899999999999999643   246999999877544 67899999999999999999999999987 7889999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      +.|+|.+.|++..+..+-......++.|||.||.||.+   +++|||||..+|+||-....+||+||||.|.+..+...-
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            99999999988667788899999999999999999999   999999999999999999999999999999886654422


Q ss_pred             ee--eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          503 TT--RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       503 ~~--~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      ..  ...-+..|+|||.++.++++.+||||+|||.+|||+| |..||-+....                .+++.+|..-+
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~~er  333 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDAGER  333 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhcccccc
Confidence            11  1223568999999999999999999999999999999 78888765432                12333443333


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      -.-++.|.+++.+++..||..+|++||++..|.+.
T Consensus       334 LpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            34466788899999999999999999999999853

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.8e-37  Score=328.54  Aligned_cols=260  Identities=29%  Similarity=0.432  Sum_probs=202.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecC-C
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRR-G  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~  413 (687)
                      .++|+..+.||+|+||.||+|.+.     .+++.||||+++... ......+..|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            357889999999999999999842     356789999997643 33456788999999999 689999999988654 4


Q ss_pred             eeEEEEecCCCCCchhhhhchh----------------------------------------------------------
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQ----------------------------------------------------------  435 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~----------------------------------------------------------  435 (687)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6799999999999999885321                                                          


Q ss_pred             -------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC-Cceeeee
Q 005621          436 -------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN-PSTTRVV  507 (687)
Q Consensus       436 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~  507 (687)
                             ...+++.++.+++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||+++....... .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   1247888999999999999999998   9999999999999999999999999999986532211 1111234


Q ss_pred             cCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHH
Q 005621          508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIE  586 (687)
Q Consensus       508 gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~  586 (687)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||.........      ......+...     ...    ...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~~~~-----~~~----~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRM-----RAP----DYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH------HHHHhccCCC-----CCC----CCC
Confidence            5678999999998899999999999999999997 88888654332111      1111111111     111    112


Q ss_pred             HHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          587 ALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       587 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ...+.+++.+||+.+|++||++.+|++.|+...
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            236889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=310.68  Aligned_cols=257  Identities=26%  Similarity=0.306  Sum_probs=214.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      +.|+..+.||+|.-|+||++.+.+++..+|+|++.+..   +....+...|-+||+.++||.++.||+.++..+..|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            34566788999999999999999989999999998764   445667788999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC--
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER--  497 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~--  497 (687)
                      |||+||+|..+++.+..+.+++..+.-++..++.||+|||.   .|||+|||||+||||-++|.+-|+||.|+.....  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            99999999999988888899999999999999999999998   9999999999999999999999999998754310  


Q ss_pred             -------------------------------C-CC---------------------CceeeeecCCCCCchhhccCCCCC
Q 005621          498 -------------------------------G-TN---------------------PSTTRVVGTLGYLAPELTRTGKPT  524 (687)
Q Consensus       498 -------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~  524 (687)
                                                     . ..                     .....++||-.|+|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           0 00                     011235799999999999999999


Q ss_pred             CccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCc
Q 005621          525 TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEA  604 (687)
Q Consensus       525 ~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~  604 (687)
                      .+.|.|+|||++|||+.|..||.+....+....               ++-..+.-.........+.+||++.|..||++
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N---------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN---------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH---------------HhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence            999999999999999999999998876544321               11222211111234457899999999999999


Q ss_pred             CCC----HHHHHH--HHhc
Q 005621          605 RPT----MRQVVR--YLEG  617 (687)
Q Consensus       605 RPs----~~evl~--~L~~  617 (687)
                      |..    +.||-+  ++++
T Consensus       379 Rlg~~rGA~eIK~HpFF~g  397 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRHPFFEG  397 (459)
T ss_pred             hhccccchHHhhcCccccC
Confidence            998    778776  4444

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.7e-36  Score=310.52  Aligned_cols=252  Identities=32%  Similarity=0.498  Sum_probs=204.9

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCC----eEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTN----TQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      |...+.||.|+||.||++++...+    ..||+|.+...... ..+.+..|+..+++++|+|++++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            345688999999999999997665    88999999766443 5678999999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++.......+++.++..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999965443338999999999999999999998   899999999999999999999999999998765442


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      ........++..|+|||.+.+..++.++||||+|++++||++ |+.||.......   ..    +....+...       
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~~-------  223 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VL----EYLKKGYRL-------  223 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCCCC-------
Confidence            222212336789999999988889999999999999999998 788876533211   11    111111111       


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                        ..+...+..+.+++.+|++.+|++||++.|+++.|
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 --PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              11112344788999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-36  Score=313.37  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=204.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||+|+||.||+|++..+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46778889999999999999998889999999988765555667889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++..  .+.+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....... ..
T Consensus        89 ~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~  162 (267)
T cd06645          89 GGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK  162 (267)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence            99999998843  4468999999999999999999998   899999999999999999999999999987654322 22


Q ss_pred             eeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          503 TTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      .....|+..|+|||++.   .+.++.++|||||||++|||++|+.|+...........      . .....   ..+...
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~------~-~~~~~---~~~~~~  232 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------M-TKSNF---QPPKLK  232 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh------h-hccCC---CCCccc
Confidence            23356899999999974   45688999999999999999999999865443221110      0 00110   011111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..  ......+.+++.+|++.+|++||++.+|++
T Consensus       233 ~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 DK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            10  011235788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.4e-36  Score=311.47  Aligned_cols=253  Identities=28%  Similarity=0.396  Sum_probs=194.1

Q ss_pred             eeeeeeCeEEEEEEEeCC--CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          349 ELLGFGGFGRVYKGTLPS--TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      +.||+|+||.||+|.+..  .+..+|+|.++... .....++.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998643  34679999987653 334457889999999999999999999999999999999999999


Q ss_pred             Cchhhhhchh---hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC-
Q 005621          426 SLDKCLFDEQ---KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP-  501 (687)
Q Consensus       426 sL~~~L~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-  501 (687)
                      +|.+++....   ....++..+.+++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999996432   2246778888999999999999998   99999999999999999999999999998754322211 


Q ss_pred             ceeeeecCCCCCchhhccCC-------CCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          502 STTRVVGTLGYLAPELTRTG-------KPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||......+...   ..    ..+.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~----~~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YT----VREQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HH----hhcccCCC
Confidence            11234567889999998642       35789999999999999996 999997544322111   10    11111222


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      .++.+....    ...+.+++..|| .+|++||++.+|++.|.
T Consensus       231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            233332222    235777889998 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.3e-37  Score=318.35  Aligned_cols=263  Identities=27%  Similarity=0.359  Sum_probs=203.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEe----CCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--Cee
Q 005621          343 RGFRDKELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDL  415 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  415 (687)
                      +.|...+.||+|+||.||++.+    ..++..||+|.+.... ......+.+|+.++++++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467889999999999999985    3457889999987553 33456789999999999999999999998775  568


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++++|.+++... ...+++.++..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            9999999999999998543 2358999999999999999999998   99999999999999999999999999999866


Q ss_pred             cCCCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCc--------chhhHHHHHHHHh
Q 005621          496 ERGTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP--------EELILVDWVWDRW  565 (687)
Q Consensus       496 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~--------~~~~~~~~v~~~~  565 (687)
                      ......  ......++..|+|||++.+..++.++||||||+++|||++++.|.......        .............
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            433221  112345677899999998888999999999999999999987764332110        0000011111111


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ..+..         ...+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       240 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111         111122345789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-36  Score=316.93  Aligned_cols=262  Identities=26%  Similarity=0.383  Sum_probs=209.9

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCR  410 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~  410 (687)
                      +.++.++....+.|+..+.||+|+||.||+|.+...++.+|+|++..... ...++..|+.++.++ +|+|++++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            35677777888999999999999999999999988899999999866433 345688899999998 7999999999885


Q ss_pred             c------CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          411 R------RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       411 ~------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      .      ...++++|||+++|+|.+++.......+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCE
Confidence            3      4578999999999999999866555568899999999999999999998   999999999999999999999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD  559 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~  559 (687)
                      +|+|||++........ ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||...........  
T Consensus       161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--  237 (282)
T cd06636         161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--  237 (282)
T ss_pred             EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence            9999999876533221 223356889999999876     34678899999999999999999999975432211110  


Q ss_pred             HHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          560 WVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       560 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                                ......+.+.   .......+.+++.+||+.+|.+||++.|+++
T Consensus       238 ----------~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 ----------IPRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ----------HhhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                      0000111111   1122347889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-36  Score=312.15  Aligned_cols=252  Identities=29%  Similarity=0.485  Sum_probs=202.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      .+|+..+.||+|+||.||+|.+. .+..+|+|.+..... ...+|..|++++++++|||++++++++......++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            45777899999999999999985 367899998865432 2357889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.........
T Consensus        82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          82 EHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            999999988543 2458999999999999999999998   899999999999999999999999999998654322211


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....++.+|+|||++.++.++.++||||||+++|||++ |+.||......+   ..   . ....+  .....+..   
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~---~-~~~~~--~~~~~~~~---  225 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VV---E-TINAG--FRLYKPRL---  225 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HH---H-HHhCC--CCCCCCCC---
Confidence            122235678999999998899999999999999999998 899987543211   11   1 11111  01111211   


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                          ....+.+++.+||+.+|++||++.++++.|+
T Consensus       226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                2347889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.2e-36  Score=313.17  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=206.8

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ......+..|+.++++++|||++++++++.+.+..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4667788999999999999998889999999987543 445678899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.   ...+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus        85 ~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06640          85 GGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence            9999999884   3468999999999999999999998   9999999999999999999999999999986543321 2


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....++..|+|||++.+..++.++|+||||+++|||++|..|+..........                .+........
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~~~~~~  221 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----------------LIPKNNPPTL  221 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----------------hhhcCCCCCC
Confidence            233467889999999998889999999999999999999999987654221110                0011111223


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ....+..+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            34456678899999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.7e-36  Score=311.64  Aligned_cols=250  Identities=26%  Similarity=0.418  Sum_probs=198.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-----hhhHHHHHHHHHHHhhhcCCCceeeeeeeec--CCee
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-----KQGLREFASEISSIGRLRHRNLVQLLGWCRR--RGDL  415 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  415 (687)
                      .+|...+.||+|+||.||+|.+..++..||+|++....     ......+.+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999998889999999886432     2334678899999999999999999998865  3578


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++++||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            999999999999999843  3458999999999999999999998   89999999999999999999999999999765


Q ss_pred             cCCCC--CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          496 ERGTN--PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       496 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      .....  .......++..|+|||++.+..++.++||||||+++|||++|+.||.........      .....     ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~-----~~  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIAT-----QP  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhc-----CC
Confidence            33211  1122345788999999999888999999999999999999999999754322111      11110     11


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+.    ++......+.+++ +||..+|++||+++||++
T Consensus       226 ~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1122    2222233455565 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.1e-36  Score=309.00  Aligned_cols=250  Identities=22%  Similarity=0.385  Sum_probs=206.9

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|+..+.||+|+||.+|++....+++.||+|++...  .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            578899999999999999999888999999998653  233456889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.......+++.++++++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            999999998865444568999999999999999999998   8999999999999999999999999999986543221 


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      ......|+..|+|||++.++..+.++|+||||++++||++|+.||......+      .+.... .+..     +.    
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~~~-----~~----  220 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKII-RGSY-----PP----  220 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHh-cCCC-----CC----
Confidence            1223467889999999999899999999999999999999999987543221      111111 1111     11    


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+......+.+++.+||+.+|++||++.+|++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            12223447889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.8e-36  Score=327.42  Aligned_cols=263  Identities=21%  Similarity=0.262  Sum_probs=199.8

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC-----
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG-----  413 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----  413 (687)
                      ..++|...+.||+|+||.||++.+..+++.||||++...  ......++.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999999888999999998654  2334567889999999999999999999886443     


Q ss_pred             -eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccc
Q 005621          414 -DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA  492 (687)
Q Consensus       414 -~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla  492 (687)
                       ..++||||+++ +|.+.+.    ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             57999999965 5665552    347889999999999999999998   99999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhh------------HHH-
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELI------------LVD-  559 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~------------~~~-  559 (687)
                      +.....  .......||..|+|||++.+..++.++|||||||++|||++|+.||......+...            ... 
T Consensus       171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            754322  12233578999999999999999999999999999999999999998654221100            000 


Q ss_pred             ---HHHHHhccccc------ccccCCcC---CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          560 ---WVWDRWKAGAI------LEVVDPRL---NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       560 ---~v~~~~~~~~~------~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         .+.........      .+......   ...........+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence               00000000000      00000000   00011122346789999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.9e-36  Score=310.18  Aligned_cols=250  Identities=28%  Similarity=0.396  Sum_probs=206.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|+..+.||+|++|.||+|....++..+++|.+.....  .+++.+|++++++++|||++++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578889999999999999999988889999999876533  678999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++........ .
T Consensus        81 ~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (256)
T cd06612          81 GAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K  155 (256)
T ss_pred             CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence            999999988432 3568999999999999999999998   8999999999999999999999999999986544321 2


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....++..|+|||++.+..++.++||||||+++|||++|+.|+...........       ..     ....+.+  ..
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~-----~~~~~~~--~~  221 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IP-----NKPPPTL--SD  221 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hc-----cCCCCCC--Cc
Confidence            2334578899999999988999999999999999999999999876433211100       00     0000111  11


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +......+.+++.+||+.+|++||++.||++
T Consensus       222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            2223347889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4e-36  Score=313.16  Aligned_cols=251  Identities=26%  Similarity=0.372  Sum_probs=202.6

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      |+..+.||+|+||.||+|.+..++..+++|.+........+.+..|+++++.++|||++++++++...+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            45677899999999999999888999999999776666678899999999999999999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      ++|..++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........ ...
T Consensus        87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~  161 (282)
T cd06643          87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD  161 (282)
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence            9999887542 3468999999999999999999998   9999999999999999999999999999875432221 222


Q ss_pred             eeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          505 RVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      ...++..|+|||++.     ...++.++|||||||++|||++|+.||......+.  ..    ... ...     .+.+ 
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~----~~~-~~~-----~~~~-  228 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LL----KIA-KSE-----PPTL-  228 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HH----HHh-hcC-----CCCC-
Confidence            346889999999984     34577899999999999999999999876432111  11    110 000     0111 


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                       ..+......+.+++.+||+.+|++||++.++++.
T Consensus       229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0111123468899999999999999999998863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-36  Score=314.46  Aligned_cols=250  Identities=31%  Similarity=0.474  Sum_probs=199.2

Q ss_pred             eeeeeeCeEEEEEEEeCCCC------eEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          349 ELLGFGGFGRVYKGTLPSTN------TQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +.||+|+||.||+|++....      +.+|+|.+.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36999999999999985433      679999886543 34456889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchh-----hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-----cEEEccccc
Q 005621          422 MPNGSLDKCLFDEQ-----KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-----NGRLGDFGL  491 (687)
Q Consensus       422 ~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-----~~kl~DFGl  491 (687)
                      +++++|.+++....     ...+++.+++.++.|++.||.|||+   .+++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996532     2347899999999999999999998   8999999999999999887     899999999


Q ss_pred             ceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          492 AKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       492 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      ++....... .......++..|+|||++.++.++.++||||||+++|||++ |+.||......+   ....+    ..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcCC
Confidence            975533221 11122345678999999999999999999999999999998 999986543211   11111    1111


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                               ....+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                     111122234578899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.8e-36  Score=313.59  Aligned_cols=255  Identities=25%  Similarity=0.355  Sum_probs=204.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|...++||+|+||.||+|.+...   ...||||...... ....+.+.+|+.++++++|||++++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4577889999999999999987543   3469999887654 4556789999999999999999999999875 457899


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++... ...+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            9999999999999543 2358999999999999999999998   99999999999999999999999999999866443


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .........++..|+|||.+....++.++||||||+++|||++ |..||......+..   .++    ..+..     ..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~----~~~~~-----~~  228 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI----ENGER-----LP  228 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----HcCCc-----CC
Confidence            2222222334568999999988889999999999999999986 99999765432211   111    11111     11


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .    +...+..+.+++.+|+..+|++||++.++++.|+..
T Consensus       229 ~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         229 M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1    122334788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.1e-37  Score=341.46  Aligned_cols=271  Identities=23%  Similarity=0.289  Sum_probs=200.3

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC------CCceeeeeeee
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH------RNLVQLLGWCR  410 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~  410 (687)
                      ++...+++|+..++||+|+||+||+|.+...++.||||+++.... ...++..|+.++++++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            344456889999999999999999999988899999999965422 23445667777777754      45889999886


Q ss_pred             cC-CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-------
Q 005621          411 RR-GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-------  482 (687)
Q Consensus       411 ~~-~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-------  482 (687)
                      .. +.+++|||++ +++|.+++..  .+.+++.++..|+.||+.||.|||+  +.+|+||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccc
Confidence            54 5789999988 7788888843  3569999999999999999999996  25999999999999998765       


Q ss_pred             ---------cEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcc
Q 005621          483 ---------NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE  553 (687)
Q Consensus       483 ---------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~  553 (687)
                               .+||+|||++....    .......||..|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             ccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                     49999999886432    12334679999999999999999999999999999999999999998755433


Q ss_pred             hhhHHHHHHH-----------------Hhcc-cccccccCCc----CC---CCCCHHHHHHHHHHHHhccccCcCcCCCH
Q 005621          554 ELILVDWVWD-----------------RWKA-GAILEVVDPR----LN---GEFNEIEALDVVKLGLMCSNDAAEARPTM  608 (687)
Q Consensus       554 ~~~~~~~v~~-----------------~~~~-~~~~~~~d~~----l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  608 (687)
                      ....+.....                 .+.. +.+....++.    +.   ..........+++|+.+||+.||++||++
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            2222211100                 0000 0000000000    00   00001123457899999999999999999


Q ss_pred             HHHHH--HHhc
Q 005621          609 RQVVR--YLEG  617 (687)
Q Consensus       609 ~evl~--~L~~  617 (687)
                      +|+++  ++.+
T Consensus       433 ~e~L~Hp~~~~  443 (467)
T PTZ00284        433 RQMTTHPYVLK  443 (467)
T ss_pred             HHHhcCccccc
Confidence            99998  5554

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-36  Score=333.14  Aligned_cols=262  Identities=23%  Similarity=0.244  Sum_probs=199.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ..+|...+.||+|+||.||++.+...++.||||....      ..+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999999998899999996432      3456899999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      + .++|.+++... ...+++.+++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       242 ~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        242 Y-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             c-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            9 47888887543 2369999999999999999999998   99999999999999999999999999999865433221


Q ss_pred             -ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCC-cc----hhhHHHHHHHHhcc-cccccc-
Q 005621          502 -STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKAL-PE----ELILVDWVWDRWKA-GAILEV-  573 (687)
Q Consensus       502 -~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~~----~~~~~~~v~~~~~~-~~~~~~-  573 (687)
                       ......||..|+|||++.+..++.++|||||||++|||++|..|+..... +.    ...+...+.+.... ...... 
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence             22235699999999999999999999999999999999998876543221 11    11111111110000 000000 


Q ss_pred             ---------------cCCcC-CCCCCH--HHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          574 ---------------VDPRL-NGEFNE--IEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       574 ---------------~d~~l-~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                                     ..+.. ...+..  .....+.+|+.+||+.||++|||+.|+++.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                           00000 000000  112357889999999999999999999974

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-36  Score=312.07  Aligned_cols=241  Identities=25%  Similarity=0.420  Sum_probs=191.5

Q ss_pred             eeeeeeCeEEEEEEEeCC------------CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          349 ELLGFGGFGRVYKGTLPS------------TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      +.||+|+||.||+|+...            ....|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998632            22368999987766666678899999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc-------EEEccc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN-------GRLGDF  489 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-------~kl~DF  489 (687)
                      +||||+++++|..++... ...+++..+++++.||+.||+|||+   ++|+||||||+|||++.++.       +|++||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999887533 3468999999999999999999998   99999999999999987664       899999


Q ss_pred             ccceeccCCCCCceeeeecCCCCCchhhcc-CCCCCCccceehhhHHHHHHH-hCCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          490 GLAKLYERGTNPSTTRVVGTLGYLAPELTR-TGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       490 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      |++......     ....++..|+|||++. +..++.++|||||||++|||+ +|..|+......+..    ..   . .
T Consensus       157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~---~-~  223 (262)
T cd05077         157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RF---Y-E  223 (262)
T ss_pred             CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HH---H-h
Confidence            998754321     2245788999999987 467899999999999999998 477777654322111    00   0 1


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       568 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      +..      .....    ....+.+|+.+||+.||++||++.+|++.|+
T Consensus       224 ~~~------~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 GQC------MLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             cCc------cCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            100      01111    1246789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=309.62  Aligned_cols=254  Identities=26%  Similarity=0.366  Sum_probs=208.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||.|++|.||+|....+++.+++|.+........+.+.+|++++++++|||++++++++...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999998888999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++... ...+++.++..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||++........ .
T Consensus        83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  157 (262)
T cd06613          83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K  157 (262)
T ss_pred             CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence            999999988543 2468999999999999999999998   9999999999999999999999999999876543221 1


Q ss_pred             eeeeecCCCCCchhhccCC---CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          503 TTRVVGTLGYLAPELTRTG---KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~---~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      .....++..|+|||.+...   .++.++||||||+++|||++|+.|+...........       ....   ....+.+ 
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~---~~~~~~~-  226 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKS---NFPPPKL-  226 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhc---cCCCccc-
Confidence            2234678899999998776   889999999999999999999999976543221110       0000   0001111 


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       .........+.+++.+||+.+|.+||++.+|+.
T Consensus       227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             112233457889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-36  Score=313.62  Aligned_cols=256  Identities=26%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ++|+..+.||+|+||.||+|+.+.     ..+.|++|.+...... ..+++..|++++++++|+|++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            568889999999999999999743     3467999988765443 4678999999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhh-------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccc
Q 005621          417 LVYDFMPNGSLDKCLFDEQK-------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDF  489 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~-------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF  489 (687)
                      +||||+++|+|.+++.....       ..+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999964431       258999999999999999999998   89999999999999999999999999


Q ss_pred             ccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccc
Q 005621          490 GLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAG  568 (687)
Q Consensus       490 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~  568 (687)
                      |+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||.......   ..    .....+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~----~~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VL----NRLQAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HH----HHHHcC
Confidence            9987543322222233456778999999988889999999999999999999 778886433211   11    111111


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          569 AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       569 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      ....        ......+..+.+++.+||+.+|++||++.++++.|.
T Consensus       235 ~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1110        111122347889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=309.33  Aligned_cols=247  Identities=30%  Similarity=0.468  Sum_probs=200.2

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      ++||+|++|.||++.+.. ++.||+|++...... ...++.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            469999999999999976 899999998765433 567899999999999999999999999999999999999999999


Q ss_pred             hhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce-eee
Q 005621          428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRV  506 (687)
Q Consensus       428 ~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~  506 (687)
                      .+++... ...+++..+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||+++.......... ...
T Consensus        80 ~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          80 LTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9998543 2358899999999999999999998   8999999999999999999999999999986542221111 112


Q ss_pred             ecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHH
Q 005621          507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEI  585 (687)
Q Consensus       507 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~  585 (687)
                      .++..|+|||.+.++.++.++|+||||+++|||++ |..||.........   .    ....+         .....+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~---~----~~~~~---------~~~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---E----RIESG---------YRMPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH---H----HHhcC---------CCCCCCcc
Confidence            33567999999998899999999999999999999 78888655432111   1    11111         01111223


Q ss_pred             HHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          586 EALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       586 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      .+..+.+++.+|++.+|++||++.|+++.|+
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3447889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.6e-36  Score=315.20  Aligned_cols=252  Identities=26%  Similarity=0.377  Sum_probs=205.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      +.|+..++||+|+||.||+|.+..+++.+++|.+........+++..|+.++++++|||++++++.+...+..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888999999999999999998889999999998777777788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|..++... ...+++..+..++.|++.+|.|||+   .+++||||||+||+++.++++||+|||++....... ..
T Consensus        92 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~  166 (292)
T cd06644          92 PGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR  166 (292)
T ss_pred             CCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence            999998877543 3468999999999999999999998   999999999999999999999999999987543322 12


Q ss_pred             eeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          503 TTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .....++..|+|||++.     ...++.++|||||||++|||++|+.|+........      +... ...     ..+.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~-~~~-----~~~~  234 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKI-AKS-----EPPT  234 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHH-hcC-----CCcc
Confidence            23356888999999984     34568899999999999999999999876442111      1111 111     0111


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +  ..+......+.+++.+||+.+|++||++.++++
T Consensus       235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 L--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             C--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1  011122346788999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-36  Score=316.32  Aligned_cols=263  Identities=23%  Similarity=0.320  Sum_probs=207.2

Q ss_pred             cCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeee-
Q 005621          333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCR-  410 (687)
Q Consensus       333 ~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~-  410 (687)
                      +.++.+..+.++|+..+.||+|+||.||++.+..+++.+|+|++..... ...++.+|+.+++++ +|||++++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            4456667788999999999999999999999988899999998865322 235678899999999 6999999999874 


Q ss_pred             ----cCCeeEEEEecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          411 ----RRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       411 ----~~~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                          ..+..++||||+++++|.+++..  .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence                34568999999999999998753  223468899999999999999999998   899999999999999999999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccC-----CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT-----GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD  559 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~  559 (687)
                      ||+|||+++....... ......|+..|+|||++..     ..++.++|||||||++|||++|+.|+..........   
T Consensus       164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~---  239 (286)
T cd06638         164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF---  239 (286)
T ss_pred             EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh---
Confidence            9999999986543221 2223468999999999753     457889999999999999999999987654321110   


Q ss_pred             HHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          560 WVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       560 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                         . .....     .+.+.  .+......+.+++.+||+.+|++||++.|+++.
T Consensus       240 ---~-~~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 ---K-IPRNP-----PPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ---h-ccccC-----CCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence               0 00110     01110  011122368899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-36  Score=323.60  Aligned_cols=258  Identities=28%  Similarity=0.405  Sum_probs=205.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCC-------CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPS-------TNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRG  413 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  413 (687)
                      .+|...+.||+|+||.||++.+..       .+..||+|.+.... ....+++.+|+.+++++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468889999999999999998632       22469999887543 34467899999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD  479 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  479 (687)
                      ..+++|||+++|+|.+++....              ...+++.+++.++.|++.||.|||+   ++++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence            9999999999999999985421              2358899999999999999999998   9999999999999999


Q ss_pred             cCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhH
Q 005621          480 SELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELIL  557 (687)
Q Consensus       480 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~  557 (687)
                      .++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  244 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  244 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence            9999999999999865432211 1122234567999999999999999999999999999998 888886543211    


Q ss_pred             HHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          558 VDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       558 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                        + ......+..         .+.+......+.+++.+||+.+|++||++.++++.|+...
T Consensus       245 --~-~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         245 --L-FKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             --H-HHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence              1 111111111         1111223347889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.1e-37  Score=315.70  Aligned_cols=241  Identities=23%  Similarity=0.392  Sum_probs=192.3

Q ss_pred             eeeeeeCeEEEEEEEeCCCCe-------EEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          349 ELLGFGGFGRVYKGTLPSTNT-------QVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +.||+|+||.||+|.....+.       .+|+|.+........+++.+|+.+++.++|||++++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998855443       4889988766666667889999999999999999999999998999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc--------EEEcccccce
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN--------GRLGDFGLAK  493 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--------~kl~DFGla~  493 (687)
                      +++|+|.+++.... ..+++..+++++.||+.||.|||+   ++|+||||||+||+++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999986543 368999999999999999999998   99999999999999987765        5899999886


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGR-RPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ....     .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+..........       ....    
T Consensus       157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~----  220 (258)
T cd05078         157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED----  220 (258)
T ss_pred             ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc----
Confidence            5432     123457889999999986 45789999999999999999995 5544332211110       0000    


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                         ...+    +.....++.+++.+||+.+|++||+++++++.|+
T Consensus       221 ---~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ---RHQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---cccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               0111    1112246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.2e-36  Score=308.75  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=208.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|+..+.||.|++|+||+|....++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999998889999999987543 33567899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhh-ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          422 MPNGSLDKCLFDEQK-AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      +++++|.+++..... ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999965332 568999999999999999999998   9999999999999999999999999999876544332


Q ss_pred             C---ceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          501 P---STTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       501 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      .   ......|+..|+|||++... .++.++|+||||+++|||++|+.||......+.  ..+    ....      ..+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~~------~~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQN------DPP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----HhcC------CCC
Confidence            2   22335688999999998877 789999999999999999999999976543221  111    1111      111


Q ss_pred             cCCCCC-CHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          577 RLNGEF-NEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       577 ~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+.... .......+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111111 1123457889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-36  Score=315.84  Aligned_cols=265  Identities=25%  Similarity=0.321  Sum_probs=199.9

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|+..+.||+|++|.||+|+...+++.||+|++....  ....+.+.+|+.++++++|||++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999998889999999986542  22346788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchh-hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          422 MPNGSLDKCLFDEQ-KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       422 ~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      ++ ++|.+++.... ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 68888875432 3568999999999999999999998   9999999999999999999999999999976543221


Q ss_pred             CceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHH-HH-------HHHHhcc-ccc
Q 005621          501 PSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV-DW-------VWDRWKA-GAI  570 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~-~~-------v~~~~~~-~~~  570 (687)
                       ......++..|+|||++.+. .++.++||||||+++|||+||+.||............ ..       .|..... ...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence             12233568899999988654 5788999999999999999999999765432211100 00       0000000 000


Q ss_pred             ccccCCcCCC---CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 LEVVDPRLNG---EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 ~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....+.....   ........++.+++.+||+.||++||++.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000000   000112346789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-36  Score=314.43  Aligned_cols=257  Identities=27%  Similarity=0.403  Sum_probs=205.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCe----EEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNT----QVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .+|+..+.||+|+||+||+|.++.+++    .+|+|.+.... .....++.+|+.++++++|||+++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            567788999999999999999865553    68999887654 3455788999999999999999999999987 78899


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++... ...+++..+++++.|++.||+|||+   ++++||||||+||+++.++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999998643 3358999999999999999999998   9999999999999999999999999999986643


Q ss_pred             CCCCce-eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNPST-TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ...... ....++..|+|||.+....++.++|+||||+++||+++ |+.||......+   +.    +....+..     
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~-----  229 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IP----DLLEKGER-----  229 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HH----HHHhCCCC-----
Confidence            322111 11223568999999988899999999999999999999 999987654221   11    11111111     


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                          ...+..+...+.+++.+||..+|++||++.++++.|+....
T Consensus       230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                01111123367889999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.8e-36  Score=307.23  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=206.1

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|+..+.||+|++|.||++....+++.+|+|.+...  .......+..|++++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            578889999999999999999888999999998654  233457889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-CcEEEcccccceeccCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla~~~~~~~~  500 (687)
                      +++++|.+++.......+++..+.+++.|++.+|.|||+   ++++||||||+||+++.+ ..+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            999999999976555568999999999999999999998   999999999999999865 4589999999987644322


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                        .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........   ....   . .+..         .
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~---~-~~~~---------~  219 (256)
T cd08220         158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKI---M-SGTF---------A  219 (256)
T ss_pred             --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHH---H-hcCC---------C
Confidence              2235688999999999988899999999999999999999999976543221   1111   1 1111         1


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ..+......+.+++.+||+.+|++||++.|+++.
T Consensus       220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1111233468899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-36  Score=314.59  Aligned_cols=240  Identities=25%  Similarity=0.396  Sum_probs=190.5

Q ss_pred             eeeeeCeEEEEEEEeCC------------------------CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceee
Q 005621          350 LLGFGGFGRVYKGTLPS------------------------TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQL  405 (687)
Q Consensus       350 ~lG~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l  405 (687)
                      .||+|+||.||+|.+..                        ....|++|++.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999998532                        124589999876655556788899999999999999999


Q ss_pred             eeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC---
Q 005621          406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL---  482 (687)
Q Consensus       406 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---  482 (687)
                      +++|.+....++||||+++|+|..++... ...+++..+.+++.||+.||+|||+   ++|+||||||+|||++.++   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999988543 3468999999999999999999998   8999999999999998653   


Q ss_pred             ----cEEEcccccceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHH-hCCCCCCCCCCcchhh
Q 005621          483 ----NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELI  556 (687)
Q Consensus       483 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~  556 (687)
                          .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+...
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence                3799999998643221     12356788999998875 56899999999999999995 6888887654322111


Q ss_pred             HHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          557 LVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       557 ~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                         +    +..       ...+....    ...+.+++.+||+.+|++||++.+|++.|.
T Consensus       233 ---~----~~~-------~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 ---F----YEK-------KHRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ---H----HHh-------ccCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence               1    100       01111111    236789999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.9e-36  Score=326.69  Aligned_cols=265  Identities=21%  Similarity=0.266  Sum_probs=201.5

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----  412 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----  412 (687)
                      ...++|...+.||+|+||.||++.+...++.||||++...  ......++.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999999888999999998754  233456788999999999999999999987543     


Q ss_pred             -CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          413 -GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       413 -~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                       ...++||||+++ +|.+.+.    ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence             357999999965 6666652    348899999999999999999998   9999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHH-------------
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV-------------  558 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~-------------  558 (687)
                      ++......  ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.....             
T Consensus       166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98653322  223357899999999999989999999999999999999999999765422111000             


Q ss_pred             ---HHHHHHhccc-ccccccCCcC--------CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          559 ---DWVWDRWKAG-AILEVVDPRL--------NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       559 ---~~v~~~~~~~-~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                         ..+....... .......+..        ...........+.+++.+|++.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               0000000000 0000000000        011111223467899999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-36  Score=314.97  Aligned_cols=257  Identities=26%  Similarity=0.342  Sum_probs=207.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|+..+.||+|+||+||++....+++.||+|++.... ....+++.+|+++++.++||||+++++++...+.+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56778889999999999999998889999999886543 33457889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++..  .+.+++..+..++.+++.||.|||+  .++++||||||+||+++.++.++|+|||++.......  
T Consensus        85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          85 MDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             CCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            999999998843  3468999999999999999999996  2589999999999999999999999999987543222  


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcch-----hhHHHHHHHHhcccccccccCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE-----LILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~-----~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                       .....|+..|+|||++.++.++.++|||||||++|||++|+.||......+.     ..+.+++......      ..+
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~  231 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------PPP  231 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------cCC
Confidence             2235689999999999888999999999999999999999999986543211     1111222111110      011


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                      .+.   .......+.+++.+|++.+|++||++.|+++..
T Consensus       232 ~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         232 RLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            111   112334688999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2e-36  Score=310.26  Aligned_cols=247  Identities=30%  Similarity=0.457  Sum_probs=200.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||+|+||.||++..  .++.||+|.+....  ....+.+|+.++++++|||++++++++... ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4578889999999999999976  67889999986543  235788999999999999999999998654 579999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++.......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......   
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999999976555568999999999999999999998   999999999999999999999999999987543221   


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                       .....+..|+|||.+.++.++.++|+||||+++|||++ |+.||......+.       ......+.         ...
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~---------~~~  217 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKGY---------RME  217 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCCC---------CCC
Confidence             11234568999999998899999999999999999998 9999876543211       11111111         111


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      .....+..+.+++.+||+.+|++||++.++++.|++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            112233478899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4e-36  Score=310.70  Aligned_cols=254  Identities=28%  Similarity=0.423  Sum_probs=203.8

Q ss_pred             CcccceeeeeeCeEEEEEEEeCC-CCeEEEEEEecCc----------chhhHHHHHHHHHHHhh-hcCCCceeeeeeeec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPS-TNTQVAVKRVSNE----------SKQGLREFASEISSIGR-LRHRNLVQLLGWCRR  411 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~  411 (687)
                      +|+..+.||+|+||.||+|.+.. .++.+|+|.+...          ......++..|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999977 6788999987532          22344567889988875 799999999999999


Q ss_pred             CCeeEEEEecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccc
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDF  489 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF  489 (687)
                      .+..++||||+++++|.+++..  .....+++..+++++.|++.||.|||+  ..+++||||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998843  234468999999999999999999995  268999999999999999999999999


Q ss_pred             ccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          490 GLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       490 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      |++.......  ......|+..|+|||.+.++.++.++||||||+++|||++|+.||........   ..    ....+.
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~----~~~~~~  229 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---AT----KIVEAV  229 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HH----HHhhcc
Confidence            9998654432  23345688999999999988899999999999999999999999865432211   11    111111


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      ..    +..    .......+.+++.+||+.||++||++.|+.++++
T Consensus       230 ~~----~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 YE----PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CC----cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11    100    1112346889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=319.66  Aligned_cols=253  Identities=24%  Similarity=0.305  Sum_probs=206.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|++|+||++....+++.+|+|.+.....   ...+.+..|++++++++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            468889999999999999999988899999999876532   24567899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+.+++|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            99999999999865555679999999999999999999998   999999999999999999999999999987543221


Q ss_pred             CC----------------------------ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCC
Q 005621          500 NP----------------------------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKAL  551 (687)
Q Consensus       500 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~  551 (687)
                      ..                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                            01124678899999999988899999999999999999999999976543


Q ss_pred             cchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC----HHHHHH
Q 005621          552 PEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT----MRQVVR  613 (687)
Q Consensus       552 ~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~  613 (687)
                      ....      ..         ..+..............+.+++.+||+.+|++||+    +.|+++
T Consensus       238 ~~~~------~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DETF------SN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHH------HH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2111      00         11111111111113457899999999999999999    777766

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.7e-36  Score=324.72  Aligned_cols=261  Identities=21%  Similarity=0.270  Sum_probs=200.8

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC------
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR------  412 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  412 (687)
                      ..++|...+.||+|+||.||++.+...++.||||++...  ......++.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999999888999999998754  233456788999999999999999999987543      


Q ss_pred             CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccc
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA  492 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla  492 (687)
                      ...++||||+++ +|.+++.    ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            357999999965 6766662    348889999999999999999998   99999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh-------
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW-------  565 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~-------  565 (687)
                      +......  ......||..|+|||++.+..++.++|||||||++|||++|+.||......+...   .+.+..       
T Consensus       174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~  248 (364)
T cd07875         174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN---KVIEQLGTPCPEF  248 (364)
T ss_pred             cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCCHHH
Confidence            8654322  2233568999999999999999999999999999999999999997654322111   010000       


Q ss_pred             ------------cccc-cc----cccCCcC----CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          566 ------------KAGA-IL----EVVDPRL----NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       566 ------------~~~~-~~----~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                                  .... ..    +...+..    ...........+.+++.+|++.||++|||+.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                        0000 00    0000000    011111123467899999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=315.55  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=206.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..+.||+|++|.||+|.+..+++.||+|+++...  ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999998889999999986542  3345678999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |++++.|..++.  ....+++.++..++.||+.||.|||+   .+++||||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            999877766553  23458999999999999999999998   8999999999999999999999999999987655443


Q ss_pred             CceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc--------c-ccc
Q 005621          501 PSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK--------A-GAI  570 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~--------~-~~~  570 (687)
                      .......++..|+|||++.+. .++.++||||||+++|||++|+.||......+.............        . ...
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            233345678899999999888 889999999999999999999999976543222111111110000        0 000


Q ss_pred             c--cccCCc----CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 L--EVVDPR----LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 ~--~~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .  +..+..    +...++......+.+++.+||+.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0  000000    000112223567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.5e-36  Score=308.50  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=199.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-----chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--Cee
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-----SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDL  415 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  415 (687)
                      .+|+..++||+|+||.||+|.+..+++.||||.+...     .....+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4788899999999999999999888999999987532     123356788999999999999999999988663  468


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++++|.+++..  ...+++....+++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            899999999999998843  3458899999999999999999998   89999999999999999999999999999865


Q ss_pred             cCCCC--CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          496 ERGTN--PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       496 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      .....  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.........      .+...       
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~-------  223 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIAT-------  223 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHhc-------
Confidence            32111  1122346889999999998888999999999999999999999999754321111      01100       


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        .......+......+.+++.+|+. +|++||++.+|++
T Consensus       224 --~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         224 --QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              001122233444567788888985 8999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.5e-36  Score=314.19  Aligned_cols=263  Identities=26%  Similarity=0.328  Sum_probs=208.0

Q ss_pred             cCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeec
Q 005621          333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRR  411 (687)
Q Consensus       333 ~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  411 (687)
                      ++.+++..++++|...+.||+|+||.||++....+++.+|+|++..... ...++..|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            4556777889999999999999999999999988899999999865432 235677899999999 89999999999865


Q ss_pred             C-----CeeEEEEecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          412 R-----GDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       412 ~-----~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      .     +..++||||+++++|.+++..  .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998853  234568999999999999999999998   899999999999999999999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccCC-----CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG-----KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD  559 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~  559 (687)
                      ||+|||++......... .....|+..|+|||.+...     .++.++|||||||++|||++|+.||......+..  . 
T Consensus       168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~--~-  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL--F-  243 (291)
T ss_pred             EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--H-
Confidence            99999998865432211 1234678899999998653     3688999999999999999999999765432111  1 


Q ss_pred             HHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          560 WVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       560 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                         + +..+..     +.+.  .+......+.+++.+||+.+|++||++.++++.
T Consensus       244 ---~-~~~~~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 ---K-IPRNPP-----PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ---H-HhcCCC-----CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence               1 111111     1111  111223368899999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=313.28  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=206.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||.|++|.||+|.+..++..+|+|.+........+.|..|++++++++|||++++++++......++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            56888899999999999999998889999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++... ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++....... ..
T Consensus        85 ~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (280)
T cd06611          85 DGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QK  159 (280)
T ss_pred             CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-cc
Confidence            999999988543 3468999999999999999999998   899999999999999999999999999987543322 22


Q ss_pred             eeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          503 TTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .....++..|+|||.+.     ...++.++||||||+++|||++|+.||........  ..     ....+.     .+.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~-----~~~~~~-----~~~  227 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL-----KILKSE-----PPT  227 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH-----HHhcCC-----CCC
Confidence            23456899999999975     34567899999999999999999999976532211  11     111111     011


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +.  .+......+.+++.+||+.+|++||++.++++
T Consensus       228 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         228 LD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             cC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            11  11122346788999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-36  Score=309.38  Aligned_cols=239  Identities=27%  Similarity=0.460  Sum_probs=192.3

Q ss_pred             eeeeeeCeEEEEEEEeCCCC----------eEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          349 ELLGFGGFGRVYKGTLPSTN----------TQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      +.||+|+||.||+|.+...+          ..+++|.+...... ...|.+|+.++++++|||++++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999997655          35888887655433 6788999999999999999999999988 788999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-------cEEEccccc
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-------NGRLGDFGL  491 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-------~~kl~DFGl  491 (687)
                      |||+++|+|.+++..... .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999865332 68999999999999999999998   9999999999999999887       799999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCC--CCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTG--KPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAG  568 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~  568 (687)
                      +.....     .....++..|+|||++...  .++.++||||||+++|||++ |..|+......+...   +    +...
T Consensus       155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~----~~~~  222 (259)
T cd05037         155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---F----YQDQ  222 (259)
T ss_pred             cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---H----HhcC
Confidence            986543     1223567789999999876  78999999999999999999 567776543221111   0    1100


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          569 AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       569 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      .       .+...    ....+.+++.+||+.+|++||++.+|++.|+
T Consensus       223 ~-------~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 H-------RLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C-------CCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0       00000    1147889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-36  Score=313.74  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=202.7

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      +|+..+.||+|+||.||++.+..++..||+|.+... ......++.+|+.++++++||||+++++.+...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            577889999999999999999888999999988754 3334578899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchh-hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          423 PNGSLDKCLFDEQ-KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       423 ~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      ++++|..++.... ...+++..+..++.|++.||.|||+  ..+|+||||||+||+++.++.+||+|||++..+....  
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence            9999998885421 2368999999999999999999996  2589999999999999999999999999997653222  


Q ss_pred             ceeeeecCCCCCchhhccCCC------CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          502 STTRVVGTLGYLAPELTRTGK------PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~------~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                       .....++..|+|||.+.+..      ++.++|+|||||++|||++|+.||...........    ......+     ..
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~-----~~  227 (286)
T cd06622         158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ----LSAIVDG-----DP  227 (286)
T ss_pred             -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH----HHHHhhc-----CC
Confidence             22345788999999986543      47899999999999999999999976432211110    0111111     11


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +.    .+.....++.+++.+||+.+|++||++.++++
T Consensus       228 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         228 PT----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CC----CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11    22234457889999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.5e-36  Score=308.75  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=191.2

Q ss_pred             eeeeeeCeEEEEEEEeCC--CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          349 ELLGFGGFGRVYKGTLPS--TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      +.||+|+||.||+|....  ....+|+|.+.... ......|.+|+.+++.++||||++++++|......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997533  34578999876543 334567889999999999999999999999999999999999999


Q ss_pred             Cchhhhhchh---hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC-
Q 005621          426 SLDKCLFDEQ---KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP-  501 (687)
Q Consensus       426 sL~~~L~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-  501 (687)
                      +|.+++....   ....++.....++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999996533   2335688889999999999999998   99999999999999999999999999998753222111 


Q ss_pred             ceeeeecCCCCCchhhccC-------CCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          502 STTRVVGTLGYLAPELTRT-------GKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..||......+.      ....... .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~-~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVRE-QDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhhc-cCccC
Confidence            1122345678999998743       356789999999999999999 7778765432111      1111111 11122


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      .++.+...+    ...+.+++..|| .||++||++.+|++.|.
T Consensus       231 ~~~~~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcccccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            223332222    335667888888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-37  Score=328.97  Aligned_cols=252  Identities=23%  Similarity=0.433  Sum_probs=203.7

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc----chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC--eeEEEE
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE----SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG--DLLLVY  419 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~  419 (687)
                      +...+||+|+|-+||||.+..+|..||--.++..    .....++|..|+.+|+.|+||||++++.++.+..  .+.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4456899999999999999989988886544322    3445689999999999999999999999886554  589999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-CcEEEcccccceeccCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLYERG  498 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla~~~~~~  498 (687)
                      |.|..|+|..|+.+  .+.++......|++||+.||.|||+. .++|+|||||.+||||+.+ |.+||||+|||......
T Consensus       123 EL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999999954  45688899999999999999999984 5899999999999999877 89999999999977554


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      ..   ..+.||+.|||||... ..|++..||||||++++||+|+..||..-..+..      ++++...|.....+    
T Consensus       200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ------IYKKV~SGiKP~sl----  265 (632)
T KOG0584|consen  200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ------IYKKVTSGIKPAAL----  265 (632)
T ss_pred             cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH------HHHHHHcCCCHHHh----
Confidence            33   2378999999999987 7899999999999999999999999986654332      22222223221111    


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCC
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEV  619 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~  619 (687)
                          ......++.+++.+|+.. ..+||++.|+++  +|....
T Consensus       266 ----~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~  303 (632)
T KOG0584|consen  266 ----SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG  303 (632)
T ss_pred             ----hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence                111123688999999999 999999999997  666543

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.7e-36  Score=307.48  Aligned_cols=248  Identities=28%  Similarity=0.440  Sum_probs=203.2

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-----hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-----KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      +|+..+.||+|++|+||+|....+++.|++|.+....     .+..+.+..|+.++++++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999998789999999886543     33557889999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++..  ...+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            999999999999843  3458999999999999999999998   99999999999999999999999999998865433


Q ss_pred             CCCceeeeecCCCCCchhhccCCC-CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .  ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||.......      ...........     + 
T Consensus       156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~-----~-  221 (258)
T cd06632         156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKEL-----P-  221 (258)
T ss_pred             c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccC-----C-
Confidence            2  223456888999999987766 8999999999999999999999997654211      11111110111     1 


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         .++......+.+++.+||+.+|++||++.++++
T Consensus       222 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 ---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               112222346788999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=320.86  Aligned_cols=253  Identities=25%  Similarity=0.306  Sum_probs=215.9

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~  416 (687)
                      ....|...+.||+|.||.||+++.+.+|+.+|+|.+.+...   .......+|+.+|+++. ||||+++++.++.....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            44678888999999999999999999999999999977643   23468899999999998 999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC----CcEEEcccccc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE----LNGRLGDFGLA  492 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGla  492 (687)
                      +|||++.||.|.+.+...   .+++..+..++.|++.++.|||+   .+|+||||||+|+|+...    +.+|++|||++
T Consensus       113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999999655   39999999999999999999999   999999999999999644    47999999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      .....  .......+||+.|+|||++....++..+||||+||++|.|++|..||..........       ....++.  
T Consensus       187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~--  255 (382)
T KOG0032|consen  187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF--  255 (382)
T ss_pred             eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC--
Confidence            98765  445667899999999999999999999999999999999999999999876533322       1112221  


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                          ....+........+.+++..|+..||.+|+++.++++.
T Consensus       256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                22223333345678899999999999999999999983

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5e-36  Score=312.53  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=203.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..+.||+|++|.||+|.++.+++.||+|++....  ....+.+.+|+.++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999998889999999886542  2234567899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|..++..  ...+++.++..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            9999988877632  3358999999999999999999998   9999999999999999999999999999987644321


Q ss_pred             CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhcccccc
Q 005621          501 PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV--------WDRWKAGAIL  571 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v--------~~~~~~~~~~  571 (687)
                       ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+......-.        ...+......
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1223457889999999876 56789999999999999999999999765543221111000        0000000000


Q ss_pred             -cccCCcCCCCCC-----HHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 -EVVDPRLNGEFN-----EIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 -~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       ....+......+     ......+.+++.+||+.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             000011100000     012346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3e-36  Score=317.37  Aligned_cols=265  Identities=23%  Similarity=0.320  Sum_probs=201.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|...+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56889999999999999999998889999999987543 22345677899999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      ++ ++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........ 
T Consensus        86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            97 5888888543 3458899999999999999999998   9999999999999999999999999999975433221 


Q ss_pred             ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHH--------HHHHhccc-ccc
Q 005621          502 STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW--------VWDRWKAG-AIL  571 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------v~~~~~~~-~~~  571 (687)
                      ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.......        .|..+... ...
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            1222356889999999865 3578899999999999999999999976543222111100        00000000 000


Q ss_pred             cccCCcCCCCC----CHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLNGEF----NEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..-.+......    .......+.+++.+|++.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00001111000    1112336789999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.2e-36  Score=312.94  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=212.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||+|+||.||++....++..||+|.+........+.+..|+.++++++|||++++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67889999999999999999988888999999987655555677899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++..   ..+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........ .
T Consensus        99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~  171 (293)
T cd06647          99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (293)
T ss_pred             CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence            99999999843   358899999999999999999998   9999999999999999999999999999876543322 2


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....|+..|+|||.+..+.++.++||||||+++||+++|+.||..........      .....+      .+..  ..
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~------~~~~--~~  237 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG------TPEL--QN  237 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCC------CCCC--CC
Confidence            223468889999999988889999999999999999999999997654321111      000000      0011  11


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCCCCCCCCC
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVPLPQAVA  626 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~~~~~~  626 (687)
                      .......+.+++.+||+.+|++||++.++++  +++...++.+.+|
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~  283 (293)
T cd06647         238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP  283 (293)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence            1223346889999999999999999999997  4665555554444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.7e-36  Score=309.50  Aligned_cols=250  Identities=28%  Similarity=0.397  Sum_probs=193.5

Q ss_pred             eeeeeeCeEEEEEEEeCC---CCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeee-cCCeeEEEEecCC
Q 005621          349 ELLGFGGFGRVYKGTLPS---TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCR-RRGDLLLVYDFMP  423 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~Ey~~  423 (687)
                      +.||+|+||.||+|.+..   ....+|+|++... .....+.+..|+.+++.++|||++++++++. .++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643   3467999998643 3345678899999999999999999999875 4556899999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC---
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN---  500 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~---  500 (687)
                      +++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+|||+++++.+||+|||+++.......   
T Consensus        81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            99999998543 2346788889999999999999998   8999999999999999999999999999975533211   


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCC-CCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRR-PIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~-p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      .......++..|+|||++.+..++.++||||||+++|||++|.. |+.....   ..+...+.    .+.     .+.. 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~----~~~-----~~~~-  223 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLL----QGR-----RLLQ-  223 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh----cCC-----CCCC-
Confidence            11112345778999999988899999999999999999999654 5543221   11121111    111     0111 


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                         +...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       224 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         224 ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             ---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               111234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.5e-36  Score=318.74  Aligned_cols=257  Identities=19%  Similarity=0.263  Sum_probs=197.2

Q ss_pred             cceeeeee--CeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          347 DKELLGFG--GFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       347 ~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ..++||+|  +|++||++..+.+++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35679999  78999999999999999999987642  333456778999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC-C
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN-P  501 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~-~  501 (687)
                      ++|+|.+++.......+++..+.+++.|++.||.|||+   .+|+||||||+|||++.++.++++||+.......... .
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999999965444568999999999999999999998   9999999999999999999999999986543221110 0


Q ss_pred             -----ceeeeecCCCCCchhhccC--CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          502 -----STTRVVGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       502 -----~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||........  .....     .+......
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-----~~~~~~~~  231 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKL-----NGTVPCLL  231 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHh-----cCCccccc
Confidence                 0112346778999999876  4588999999999999999999999975432111  00000     00000000


Q ss_pred             -------------------CCcC-----------------CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          575 -------------------DPRL-----------------NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       575 -------------------d~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                                         +..+                 ...........+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                               0000                 00111223347889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.9e-36  Score=309.42  Aligned_cols=255  Identities=26%  Similarity=0.434  Sum_probs=201.8

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc----------hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES----------KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG  413 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  413 (687)
                      +|...+.||+|++|.||+|....+++.+|+|.+....          ....+.+..|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667889999999999999998889999999875421          112346788999999999999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999998543  568999999999999999999998   899999999999999999999999999997


Q ss_pred             eccCCCCC-ceeeeecCCCCCchhhccCCC--CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          494 LYERGTNP-STTRVVGTLGYLAPELTRTGK--PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       494 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      ........ ......|+..|+|||.+....  ++.++|+||||+++||+++|..|+......+.      ..+.... ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~-~~  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGNK-RS  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhcc-cc
Confidence            65432211 123346889999999987654  78999999999999999999999864432111      1111111 11


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       571 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ...+.+    .........+.+++.+||+.+|++||++.+|++.
T Consensus       230 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111111    1112234478899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-36  Score=316.47  Aligned_cols=265  Identities=25%  Similarity=0.324  Sum_probs=202.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..++||+|++|.||+|.+..+++.||+|++.....  ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            468889999999999999999988899999998765422  234678899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.++...  ...+++.++..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            9999998887633  3358999999999999999999998   899999999999999999999999999998654433 


Q ss_pred             CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------hcccccc
Q 005621          501 PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR--------WKAGAIL  571 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~--------~~~~~~~  571 (687)
                      .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+...-.......        +......
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            22233467889999999875 45788999999999999999999998755432211111100000        0000000


Q ss_pred             -cccCCcCCCC-----CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 -EVVDPRLNGE-----FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 -~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       ....+.....     ........+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             0000000000     01122456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-36  Score=322.98  Aligned_cols=194  Identities=25%  Similarity=0.329  Sum_probs=168.2

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ...+|+..+.||+|+||.||+|.+..+++.||+|+....      ....|+.++++++||||+++++++...+..++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            346799999999999999999999888899999985433      23468999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+ .++|.+++... ...+++.++..|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       138 ~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        138 HY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             cc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            99 46888887543 3468999999999999999999998   89999999999999999999999999999743221  


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE  547 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~  547 (687)
                      .......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            22234568999999999999999999999999999999999666553

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.8e-36  Score=307.27  Aligned_cols=253  Identities=25%  Similarity=0.411  Sum_probs=204.9

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc------hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES------KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      +|+..+.||+|++|.||+|....+++.+|+|.+....      ....+++..|+.++++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999998889999999986532      1235678999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-cEEEcccccceecc
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-NGRLGDFGLAKLYE  496 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~  496 (687)
                      ||||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            9999999999999843  4468999999999999999999998   9999999999999998776 59999999987664


Q ss_pred             CCCC---CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          497 RGTN---PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       497 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ....   .......|+..|+|||.+.+..++.++||||+|+++++|++|+.||..........   ...+...       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~-------  225 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIAS-------  225 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhc-------
Confidence            3321   11223468899999999988889999999999999999999999997544322111   1111100       


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        .......+......+.+++.+|++.+|++||++.++++
T Consensus       226 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 --ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              00112233344457889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-36  Score=326.96  Aligned_cols=261  Identities=23%  Similarity=0.276  Sum_probs=201.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCC--CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPS--TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .+|...+.||+|+||.||++...+  .+..||+|.+...     ....+|++++++++||||+++++++......++|||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            468899999999999999997643  4578999988653     234679999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      ++. ++|.+++  .....+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       167 ~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        167 KYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            995 6888888  344579999999999999999999998   9999999999999999999999999999986544332


Q ss_pred             -CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc--------
Q 005621          501 -PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL--------  571 (687)
Q Consensus       501 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~--------  571 (687)
                       .......||..|+|||++.+..++.++|||||||++|||++|+.||..............+.+........        
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence             22334579999999999999999999999999999999999999997655432211111111111110000        


Q ss_pred             -----cccCCcCCCCCC-------HHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          572 -----EVVDPRLNGEFN-------EIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       572 -----~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                           .......+..+.       .....++.+++.+||+.+|++||++.|+++.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 000000000000       0123367789999999999999999999974

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.6e-36  Score=307.23  Aligned_cols=254  Identities=24%  Similarity=0.370  Sum_probs=205.7

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeec--CCeeEEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRR--RGDLLLVY  419 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~  419 (687)
                      +|+..+.||.|++|.||++.+..+++.+|+|++...  .....+++..|++++++++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999999888999999998653  33445678899999999999999999997753  45689999


Q ss_pred             ecCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccc--cCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          420 DFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEW--EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ||+++++|.+++...  ....+++.+++.++.|++.||.|||..+  ..+++||||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998542  2457899999999999999999999221  289999999999999999999999999999876


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......   .+.    +....+..     
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~-----  227 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA----SKIKEGKF-----  227 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH----HHHhcCCC-----
Confidence            543321 22346899999999999888999999999999999999999999865421   111    11111111     


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                          ...+......+.+++.+|++.+|++||++.+|++.
T Consensus       228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                12222334578899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.7e-36  Score=345.82  Aligned_cols=264  Identities=22%  Similarity=0.326  Sum_probs=206.1

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeec--C
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRR--R  412 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~  412 (687)
                      +.....++|.+.+.||+|+||+||++.+..++..+|+|.+...  .......|..|+.++++++||||+++++++..  .
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            3344567899999999999999999999999999999998754  33345678999999999999999999998754  4


Q ss_pred             CeeEEEEecCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccc----cCeEEeeccCCCcEEeccC-----
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEW----EQTVIHRDIKAGNVLLDSE-----  481 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~ivHrDlk~~NIll~~~-----  481 (687)
                      ..++|||||+++|+|.++|...  ....+++..++.|+.||+.||.|||+..    .++|+||||||+||||+.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            5789999999999999998542  2346999999999999999999999732    1459999999999999642     


Q ss_pred             ------------CcEEEcccccceeccCCCCCceeeeecCCCCCchhhccC--CCCCCccceehhhHHHHHHHhCCCCCC
Q 005621          482 ------------LNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRRPIE  547 (687)
Q Consensus       482 ------------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~  547 (687)
                                  ..+||+|||++..+....  ......||+.|+|||++..  ..++.++|||||||+||||++|+.||.
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                        348999999998654322  2234578999999999854  458899999999999999999999997


Q ss_pred             CCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          548 PKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       548 ~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                      .......      +...+..+       +.+..   ......+.+|+..||+.+|++||++.|+++  ++...
T Consensus       245 ~~~~~~q------li~~lk~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        245 KANNFSQ------LISELKRG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             cCCcHHH------HHHHHhcC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            5442211      11111111       11110   112346889999999999999999999994  55543

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-35  Score=306.30  Aligned_cols=250  Identities=26%  Similarity=0.421  Sum_probs=200.7

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc------hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES------KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      +|...+.||+|+||+||+|... +++.+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4778899999999999999874 67899999886432      2234568899999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++++|.+++..  ...+++..+..++.|++.||+|||+   .+|+|+||+|+||++++++.+||+|||++.....
T Consensus        80 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          80 FMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999999943  3468899999999999999999998   8999999999999999999999999999875432


Q ss_pred             CC-----CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          498 GT-----NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       498 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      ..     ........|+..|+|||++.+..++.++||||||+++|||++|+.||...........      . ..   ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------~-~~---~~  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY------I-GA---HR  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH------h-hh---cc
Confidence            11     1112234688999999999988899999999999999999999999975432211100      0 00   00


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ...+.+...    ....+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 GLMPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111222222    3346889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=323.77  Aligned_cols=241  Identities=25%  Similarity=0.329  Sum_probs=190.4

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh---cCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL---RHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ||+|+||+||+|++..+++.||||++....   .....++..|..++.+.   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999998889999999986542   22334456677777665   699999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|.+++.  ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~  154 (330)
T cd05586          81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN  154 (330)
T ss_pred             ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence            99998884  34568999999999999999999998   999999999999999999999999999987533222 1223


Q ss_pred             eeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCC
Q 005621          505 RVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN  583 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~  583 (687)
                      ...||..|+|||++.+. .++.++|||||||++|||++|+.||......+       .......+..      ++...  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~------~~~~~--  219 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV------RFPKN--  219 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC------CCCCc--
Confidence            45799999999998764 47999999999999999999999997654211       1111111111      11111  


Q ss_pred             HHHHHHHHHHHHhccccCcCcCC----CHHHHHH
Q 005621          584 EIEALDVVKLGLMCSNDAAEARP----TMRQVVR  613 (687)
Q Consensus       584 ~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~  613 (687)
                       .....+.+++.+||+.+|++||    ++.++++
T Consensus       220 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 -VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             1233677899999999999998    5666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.8e-36  Score=318.01  Aligned_cols=256  Identities=28%  Similarity=0.443  Sum_probs=202.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCe----EEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNT----QVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|+..+.||+|+||.||+|++..++.    .+|+|.+..... ....++.+|+.++++++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            467788899999999999999866664    578998876533 3345788999999999999999999998754 4679


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ++||+++|+|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999999998543 3358999999999999999999998   9999999999999999999999999999986643


Q ss_pred             CCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      .... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......   ..++    ...+..     
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~-----  229 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDL----LEKGER-----  229 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHCCCC-----
Confidence            3221 1222345678999999998899999999999999999997 899986543211   1111    111111     


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                        +  ..+..+...+.+++..||..+|++||++.++++.|+...
T Consensus       230 --~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         230 --L--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             --C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              0  011122347889999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=335.16  Aligned_cols=257  Identities=30%  Similarity=0.421  Sum_probs=213.1

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCe----EEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNT----QVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .+..++||+|+||+||||.+-..|+    +||+|++... ..+...++++|+.+|.+++|||+++|+|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            3456899999999999999854453    6999988665 4556789999999999999999999999998766 88999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      +|||.|+|.+|++.+ +..+..+..+.|..|||+||.|||+   +.++||||.++|||+.+...+||.|||+++......
T Consensus       777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            999999999999764 4568889999999999999999998   999999999999999999999999999999876554


Q ss_pred             CCcee-eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          500 NPSTT-RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       500 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      ..-.. ...-++.|||=|.+....++.++|||||||.+||++| |..|++.....+.-       +.++.|.        
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~ge--------  917 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEKGE--------  917 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhccc--------
Confidence            33222 1223568999999999999999999999999999999 99999876643322       2222222        


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCCC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLP  622 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  622 (687)
                       +-..++.+..++..++.+||..|++.||+++++...+.+.+..|
T Consensus       918 -RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  918 -RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             -cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence             22345667779999999999999999999999998877654433

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-35  Score=305.96  Aligned_cols=252  Identities=27%  Similarity=0.440  Sum_probs=204.4

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|...+.||+|++|.||+|....+++.|++|.+.....  ...+++..|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            57888999999999999999988899999999876543  3677899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++..  ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            999999999854  3458899999999999999999998   99999999999999999999999999999876443322


Q ss_pred             cee---eeecCCCCCchhhccCCC---CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          502 STT---RVVGTLGYLAPELTRTGK---PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       502 ~~~---~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ...   ...++..|+|||++....   .+.++||||||+++|||++|+.||.........     ..... .+     ..
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~~~~-~~-----~~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MFHVG-AG-----HK  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HHHHh-cC-----CC
Confidence            211   345788999999998766   889999999999999999999999754321111     11000 00     11


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +.+...  ......+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111  112346789999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.1e-37  Score=296.04  Aligned_cols=254  Identities=25%  Similarity=0.351  Sum_probs=209.1

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--------hhhHHHHHHHHHHHhhh-cCCCceeeeeeee
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--------KQGLREFASEISSIGRL-RHRNLVQLLGWCR  410 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~  410 (687)
                      .....|...+.||.|..+.|-++.++.++...|+|++....        ..-.+.-.+|+.+|+++ .||+|+++.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34567888899999999999999999999999999985321        12234456899999998 6999999999999


Q ss_pred             cCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       411 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                      .....++|+|.|+.|.|.++|  ...-.+++....+|++|+..|++|||.   .+||||||||+|||+|++.++||+|||
T Consensus        94 s~sF~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             CcchhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccc
Confidence            999999999999999999999  455679999999999999999999998   999999999999999999999999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccC------CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRT------GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      .++.+..+.  .....+||++|+|||.+..      ..|+...|+|++||++|-|+.|..||-....   .    .+.+.
T Consensus       169 Fa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---m----lMLR~  239 (411)
T KOG0599|consen  169 FACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---M----LMLRM  239 (411)
T ss_pred             eeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---H----HHHHH
Confidence            999886654  3456799999999999864      3578899999999999999999999864321   1    12223


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +.+|+..      ...+-..+....+.+|+.+|++.||.+|.|++|+++
T Consensus       240 ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  240 IMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            3333321      112222334447889999999999999999999986

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-36  Score=308.81  Aligned_cols=255  Identities=26%  Similarity=0.363  Sum_probs=204.6

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCC-----
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRG-----  413 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-----  413 (687)
                      .++++|+..+.||+|++|.||+|.++.+++.+++|++..... ..+++..|+.+++++ +|+|++++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            457899999999999999999999988889999999876543 346789999999999 7999999999996644     


Q ss_pred             -eeEEEEecCCCCCchhhhhchh--hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          414 -DLLLVYDFMPNGSLDKCLFDEQ--KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       414 -~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                       .+++||||+++++|.+++....  +..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999886533  4678999999999999999999998   999999999999999999999999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccC-----CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRT-----GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      ++........ ......|+..|+|||.+..     ..++.++||||||++++||++|+.||.........  .    +. 
T Consensus       159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~----~~-  230 (275)
T cd06608         159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--F----KI-  230 (275)
T ss_pred             cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--H----Hh-
Confidence            9876543222 2223468899999998753     34678999999999999999999999754321111  0    10 


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+     ..+.+  ..+......+.+++.+||..||++||++.++++
T Consensus       231 ~~~-----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRN-----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hcc-----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            011     11111  111223457889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.7e-36  Score=314.00  Aligned_cols=248  Identities=25%  Similarity=0.345  Sum_probs=202.5

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      .....||+|+||.||++....++..||||++........+.+.+|+.++++++|+|++++++.+...+..++||||++++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            33466999999999999998889999999987666556677899999999999999999999999999999999999999


Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceee
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR  505 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  505 (687)
                      +|.+++.   ...+++.++..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++....... .....
T Consensus       105 ~L~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~  177 (292)
T cd06658         105 ALTDIVT---HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKS  177 (292)
T ss_pred             cHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCce
Confidence            9999873   2358999999999999999999998   899999999999999999999999999987553322 22234


Q ss_pred             eecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHH
Q 005621          506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEI  585 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~  585 (687)
                      ..|+..|+|||.+.+..++.++||||||+++|||++|+.||..........       ...     ....+.+..  ...
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------~~~-----~~~~~~~~~--~~~  243 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------RIR-----DNLPPRVKD--SHK  243 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHH-----hcCCCcccc--ccc
Confidence            568999999999988889999999999999999999999987543221110       010     111111111  111


Q ss_pred             HHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          586 EALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       586 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ....+.+++.+|++.+|++||+++++++.
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            23367789999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-36  Score=323.74  Aligned_cols=260  Identities=21%  Similarity=0.292  Sum_probs=198.7

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----  412 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----  412 (687)
                      ...++|...+.||+|+||+||+|.+..+++.||||++....  ....+++.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999998889999999987542  22345678899999999999999999987533     


Q ss_pred             -CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          413 -GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       413 -~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                       ...++++|++ +++|.+++.   ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence             4579999988 788988773   3469999999999999999999998   9999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc----
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK----  566 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~----  566 (687)
                      ++.....    .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..........   .+.+...    
T Consensus       165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~  237 (343)
T cd07878         165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK---RIMEVVGTPSP  237 (343)
T ss_pred             ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHhCCCCH
Confidence            9865432    233468999999999876 568899999999999999999999997643221110   0000000    


Q ss_pred             -------ccccccccC--CcCCCC-C---CHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          567 -------AGAILEVVD--PRLNGE-F---NEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       567 -------~~~~~~~~d--~~l~~~-~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                             .......+.  +..... .   .......+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   000000000  000000 0   0001224679999999999999999999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-35  Score=313.52  Aligned_cols=257  Identities=20%  Similarity=0.258  Sum_probs=205.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||.||++.+...++.||+|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999999899999999987653   234567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            99999999999943  3568999999999999999999998   899999999999999999999999999986421110


Q ss_pred             C--------------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 005621          500 N--------------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       500 ~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      .              .......++..|+|||.+.+..++.++|+||||+++|||++|+.||......+      +. +..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~-~~~  228 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LF-GQV  228 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHH
Confidence            0              01112457889999999988889999999999999999999999997543211      11 111


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ..+.   ...+....    ..+..+.+++.+||+.+|++||++.++.+.|+..
T Consensus       229 ~~~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         229 ISDD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             Hhcc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            1111   11111111    1233678999999999999999987777777653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6e-36  Score=311.89  Aligned_cols=263  Identities=23%  Similarity=0.294  Sum_probs=205.4

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|+..+.||.|++|.||+|.+..+++.||+|++....  ......+.+|+.++++++|||++++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999998889999999987654  33456789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      + +++|.+++.... ..+++.++..++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9 999999885433 569999999999999999999998   89999999999999999999999999999876544322


Q ss_pred             ceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc-----------
Q 005621          502 STTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA-----------  569 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~-----------  569 (687)
                      ......|+..|+|||.+.+. .++.++||||+|++++||++|+.||......+   ...++........           
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcc
Confidence            23345688999999998654 46899999999999999999987776543221   1112221111000           


Q ss_pred             -cccccCCcCC----CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          570 -ILEVVDPRLN----GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       570 -~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                       ......+.-.    ..........+.+++.+|++.+|++||+++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0000000000    00011223578899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-35  Score=311.83  Aligned_cols=265  Identities=24%  Similarity=0.309  Sum_probs=203.2

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-----hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-----GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      +|...+.||+|++|.||+|.+..+++.||||++......     ....+..|++++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477888999999999999999888999999998765322     345677899999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+ +++|.+++.... ..+++..+..++.||++||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 999999985433 369999999999999999999998   89999999999999999999999999999876443


Q ss_pred             CCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc---------c
Q 005621          499 TNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA---------G  568 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~---------~  568 (687)
                      .. ......++..|+|||.+.+ ..++.++|||||||++|||++|..||......+..   .........         .
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhhhhcc
Confidence            22 1222356788999998865 46789999999999999999997777654432111   111111000         0


Q ss_pred             ccccccCCcCCCC-----CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH--Hhc
Q 005621          569 AILEVVDPRLNGE-----FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY--LEG  617 (687)
Q Consensus       569 ~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~  617 (687)
                      .............     ........+.+++.+||+.+|++||++.|+++.  +++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence            0000000000000     111224578899999999999999999999983  544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.4e-35  Score=305.19  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=191.5

Q ss_pred             eeeeeCeEEEEEEEeCCC--CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCC
Q 005621          350 LLGFGGFGRVYKGTLPST--NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGS  426 (687)
Q Consensus       350 ~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs  426 (687)
                      .||+|+||.||+|.....  ...+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999976433  2356778776543 3446789999999999999999999999999999999999999999


Q ss_pred             chhhhhchh--hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC-CCce
Q 005621          427 LDKCLFDEQ--KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT-NPST  503 (687)
Q Consensus       427 L~~~L~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~-~~~~  503 (687)
                      |.+++....  ....++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999996532  2346777888999999999999998   899999999999999999999999999986422111 1112


Q ss_pred             eeeecCCCCCchhhccC-------CCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          504 TRVVGTLGYLAPELTRT-------GKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||......+      ...... .+......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~-~~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVI-KDQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-hhcccccCC
Confidence            23467889999998753       245789999999999999997 466775433211      111111 122233344


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      +.+...+..    .+.+++..|| .+|++||++.+|++.|.
T Consensus       232 ~~~~~~~~~----~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELPYSE----RWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCCCcH----HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            444433333    5777888999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-35  Score=307.43  Aligned_cols=247  Identities=26%  Similarity=0.388  Sum_probs=203.0

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCC
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      |+..+.||+|+||.||+|.+..+++.+|+|.+.... ....+.+.+|+.++++++|||++++++++......++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            567788999999999999998889999999986543 3445678899999999999999999999999999999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +++|.+++.   ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        86 ~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~  158 (277)
T cd06641          86 GGSALDLLE---PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR  158 (277)
T ss_pred             CCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence            999999884   3468999999999999999999998   999999999999999999999999999987654322 112


Q ss_pred             eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN  583 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~  583 (687)
                      ....++..|+|||.+.+..++.++|+|||||++|||++|..|+.......      +... ...+.     .+.+    +
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~-----~~~~----~  222 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-IPKNN-----PPTL----E  222 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-HhcCC-----CCCC----C
Confidence            23467889999999988889999999999999999999999987543211      1111 11110     1112    2


Q ss_pred             HHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          584 EIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       584 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ......+.+++.+||+.+|++||++.++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            2233468899999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.8e-36  Score=304.59  Aligned_cols=264  Identities=25%  Similarity=0.329  Sum_probs=205.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh--hHHHHHHHHHHHhhhcCCC-ceeeeeeeecCC------
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ--GLREFASEISSIGRLRHRN-LVQLLGWCRRRG------  413 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------  413 (687)
                      ..|...++||+|.||+||+|+.+.+|+.||+|+++....+  .-....+|+.++++++|+| |++|++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4466677899999999999999999999999999876442  3345689999999999999 999999998777      


Q ss_pred             eeEEEEecCCCCCchhhhhchhh--ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQK--AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                      .+++|+||+ .-+|.+++.....  ..++...+..++.||+.||+|||+   ++|+||||||.||||++++.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence            889999999 4589999855332  357778899999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc--
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG--  568 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~--  568 (687)
                      |+.+.-... ..+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+....+...   .+.+.....  
T Consensus       167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~---~If~~lGtP~e  242 (323)
T KOG0594|consen  167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF---RIFRLLGTPNE  242 (323)
T ss_pred             HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH---HHHHHcCCCCc
Confidence            996543332 24456789999999999876 79999999999999999999998887766533222   222222111  


Q ss_pred             -cccc---ccCCc--CCC-----CCCHHH---HHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          569 -AILE---VVDPR--LNG-----EFNEIE---ALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       569 -~~~~---~~d~~--l~~-----~~~~~~---~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                       ....   ..+-.  ...     ......   .....+++.+|++.+|.+|.|++.++++
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             1000   00100  000     001111   1367899999999999999999999984

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-35  Score=306.92  Aligned_cols=258  Identities=24%  Similarity=0.320  Sum_probs=204.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecC--CeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~  419 (687)
                      ++|...+.||.|++|.||++.+..+++.+|+|.+..... ....++.+|++++++++||||++++++|...  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            468889999999999999999988899999999875433 4457789999999999999999999988543  4689999


Q ss_pred             ecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          420 DFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       420 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||+++++|.+++..  .....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988743  223568999999999999999999998   9999999999999999999999999999875432


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCc--chhhHHHHHHHHhcccccccccC
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP--EELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~--~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ...   ....++..|+|||.+.+..++.++||||||+++|||++|+.||......  .......++...    .... +.
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~-~~  229 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPE-LK  229 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchh-hc
Confidence            221   2345788999999999899999999999999999999999999865321  111222222110    1001 11


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....  ........+.+++.+||+.+|++||++.|+++
T Consensus       230 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 DEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0100  00112446889999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=296.04  Aligned_cols=252  Identities=24%  Similarity=0.358  Sum_probs=207.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      +++|+..+.||+|.|+.||++....+|+.+|+|+++..  +..+.+++.+|+.+-+.|+||||++|.+.+.+....|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46778888999999999999999999999999987543  3446788899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC---CcEEEcccccceecc
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE---LNGRLGDFGLAKLYE  496 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGla~~~~  496 (687)
                      |+|.|++|-.-+-  .+...++..+-..++||+++|.|+|.   ++|||||+||.|++|-+.   --+||+|||+|..+.
T Consensus        90 e~m~G~dl~~eIV--~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIV--AREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999865552  23457888888999999999999999   999999999999999543   348999999999876


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      .+  ..-...+||++|||||+++..+++..+|||+.||+||-|+.|..||.+....       .+++.+.+|..      
T Consensus       165 ~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~y------  229 (355)
T KOG0033|consen  165 DG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAY------  229 (355)
T ss_pred             Cc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhcccc------
Confidence            22  2333468999999999999999999999999999999999999999875432       23333333332      


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+.+.......++..+|+.+||..||.+|.|+.|.++
T Consensus       230 d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            1122122223347889999999999999999999885

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.6e-36  Score=313.83  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=201.2

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      .....||+|+||.||++.+..+++.||+|++........+.+.+|+.+++.++|||++++++++...+..++||||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            34457999999999999998889999999987655455567889999999999999999999999999999999999999


Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceee
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR  505 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  505 (687)
                      +|.+++.   ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... .....
T Consensus       104 ~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~  176 (297)
T cd06659         104 ALTDIVS---QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS  176 (297)
T ss_pred             CHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence            9998773   3458999999999999999999998   899999999999999999999999999987554322 12233


Q ss_pred             eecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHH
Q 005621          506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEI  585 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~  585 (687)
                      ..|+..|+|||++.+..++.++||||||+++|||++|+.||......+..   ..    +....     .+...  ....
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~----~~~~~-----~~~~~--~~~~  242 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KR----LRDSP-----PPKLK--NAHK  242 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH----HhccC-----CCCcc--ccCC
Confidence            56899999999999889999999999999999999999999754422111   11    11110     00000  0111


Q ss_pred             HHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          586 EALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       586 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....+.+++.+||+.+|++||++.++++
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            2236788999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-35  Score=313.04  Aligned_cols=197  Identities=23%  Similarity=0.365  Sum_probs=161.6

Q ss_pred             ceeeeeeCeEEEEEEEeCC--CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeec--CCeeEEEEecCC
Q 005621          348 KELLGFGGFGRVYKGTLPS--TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRR--RGDLLLVYDFMP  423 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~  423 (687)
                      .++||+|+||+||+|+++.  .++.+|+|.+.....  ...+.+|+.++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            4689999999999999753  568899999865432  2456789999999999999999998854  456899999995


Q ss_pred             CCCchhhhhch-------hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe----ccCCcEEEcccccc
Q 005621          424 NGSLDKCLFDE-------QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL----DSELNGRLGDFGLA  492 (687)
Q Consensus       424 ~gsL~~~L~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGla  492 (687)
                       ++|.+++...       ....+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5787776321       12358899999999999999999998   899999999999999    45678999999999


Q ss_pred             eeccCCCC--CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCC
Q 005621          493 KLYERGTN--PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKA  550 (687)
Q Consensus       493 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~  550 (687)
                      +.......  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            87654322  12234578999999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.3e-35  Score=299.70  Aligned_cols=254  Identities=25%  Similarity=0.422  Sum_probs=210.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|+..+.||+|++|.||+|++..+++.|+||++..... ....++..|+..+.+++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            367888999999999999999988899999999877644 4567899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++...  ..+++..+++++.|++.||.|||+.  .+++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999543  5789999999999999999999962  79999999999999999999999999999876543322


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                       .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+.............++.    ..     ..+.+...
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~-----~~~~~~~~  226 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DG-----PPPSLPAE  226 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cC-----CCCCCCcc
Confidence             224568899999999999999999999999999999999999997765322222222221    11     11111111


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         ..+..+.+++.+||+++|++||++.++++
T Consensus       227 ---~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         227 ---EFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             ---cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence               03347889999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=306.87  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=202.7

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhc---CCCceeeeeeeecCCeeEEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLR---HRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .|+..+.||+|+||.||+|.+..+++.+|+|.+... ......++.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999999888999999998754 3344567889999999997   999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++..   ..+++..++.++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            99999999998843   368999999999999999999998   999999999999999999999999999998765433


Q ss_pred             CCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      . ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||..........       ...     ....+.+
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~-----~~~~~~~  222 (277)
T cd06917         156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIP-----KSKPPRL  222 (277)
T ss_pred             c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccc-----cCCCCCC
Confidence            2 22334688999999998754 46889999999999999999999997643221110       000     0111222


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ...   .....+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            211   12347889999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=309.88  Aligned_cols=263  Identities=23%  Similarity=0.299  Sum_probs=199.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|+..+.||+|++|.||+|..+.+++.||+|.+...... ....+.+|++++++++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            5788999999999999999999888999999998754322 234567899999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++ +|.+++.... ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++........
T Consensus        85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            975 8998885433 368999999999999999999998   89999999999999999999999999998754322111


Q ss_pred             ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc---ccccc----
Q 005621          502 STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG---AILEV----  573 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~---~~~~~----  573 (687)
                       .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  .....++.....   .....    
T Consensus       160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhcc
Confidence             122346789999999875 4588999999999999999999999975542111  111111111100   00000    


Q ss_pred             --c--------CCcCCCCCC-HHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 --V--------DPRLNGEFN-EIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 --~--------d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        .        ...+..... ......+.+++.+|++.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              0        000000000 001146789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.5e-36  Score=310.75  Aligned_cols=261  Identities=24%  Similarity=0.313  Sum_probs=201.4

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|+..+.||.|++|.||+|++..+++.||||++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999998889999999987543  22345788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +. ++|.+++.......+++.++..++.|++.||+|||+   .+++||||+|+||+++.++.+||+|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 689888866556679999999999999999999998   8999999999999999999999999999876543221 


Q ss_pred             ceeeeecCCCCCchhhccCCC-CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc------------
Q 005621          502 STTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG------------  568 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~------------  568 (687)
                      ......++..|+|||++.+.. ++.++||||||+++|||+||+.||......+.  +.... +.....            
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIF-RTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCCCChhhhhhhhHHH
Confidence            122335688999999887644 68899999999999999999999976543211  11110 000000            


Q ss_pred             ----ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          569 ----AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       569 ----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                          .........+. .........+.+++.+||+.||++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                00000000000 000112235778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.1e-35  Score=320.89  Aligned_cols=261  Identities=25%  Similarity=0.313  Sum_probs=206.6

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-C-----CCceeeeeeeecCCeeEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-H-----RNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~l  417 (687)
                      +|.+.+.||+|.||.|-+|.+..+++.||||++++... -..+-..|+.+|..|+ |     -|+|++++++..++++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            78999999999999999999999999999999987643 3466678999999997 4     489999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC--CcEEEcccccceec
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE--LNGRLGDFGLAKLY  495 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DFGla~~~  495 (687)
                      |+|.+ .-+|.++|+.++-..++...+..|+.||+.||..||+   .+|||+||||+||||.+.  .++||+|||.++..
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99998 5699999988877789999999999999999999998   999999999999999765  46899999999875


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHh--
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV--------WDRW--  565 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v--------~~~~--  565 (687)
                      .....    ....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+....+....+.-+        .+..  
T Consensus       342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            44322    456788999999999999999999999999999999997777665433322211111        1100  


Q ss_pred             -----cc----------cc-----------------cccccCC-c---CCCCCCHHHHHHHHHHHHhccccCcCcCCCHH
Q 005621          566 -----KA----------GA-----------------ILEVVDP-R---LNGEFNEIEALDVVKLGLMCSNDAAEARPTMR  609 (687)
Q Consensus       566 -----~~----------~~-----------------~~~~~d~-~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  609 (687)
                           ..          ..                 ..+..-| .   +...........+++++.+|+..||.+|+|..
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence                 00          00                 0000001 0   00111113345689999999999999999999


Q ss_pred             HHHH
Q 005621          610 QVVR  613 (687)
Q Consensus       610 evl~  613 (687)
                      |+++
T Consensus       498 qal~  501 (586)
T KOG0667|consen  498 QALN  501 (586)
T ss_pred             HHhc
Confidence            9998

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=309.60  Aligned_cols=261  Identities=26%  Similarity=0.364  Sum_probs=203.2

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--CeeEEEEe
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDLLLVYD  420 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E  420 (687)
                      |+..+.||.|++|.||+|....+++.+|+|++....  ......+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999998889999999998763  33446788999999999999999999999888  89999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++ +|.+++.... ..+++.+++.++.||+.||.|||+   .+++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9975 8888875432 468999999999999999999998   8999999999999999999999999999987655433


Q ss_pred             CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc---cccc-----
Q 005621          501 PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA---GAIL-----  571 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~---~~~~-----  571 (687)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........   .+.+....   ....     
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhccccccc
Confidence            23334456889999998765 467899999999999999999999997665432211   11111100   0000     


Q ss_pred             ---c------ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 ---E------VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ---~------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         +      .....+...+...+...+.+++.+||+.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               0      00000011111112457889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.2e-35  Score=307.37  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=196.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHH-HhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISS-IGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..+.||+|+||.||++++..+++.||+|++.... .....++..|+.. ++.++|||++++++++...+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999999899999999987653 2234456666665 566689999999999999999999999


Q ss_pred             cCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccccC-eEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          421 FMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQ-TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       421 y~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      |++ |+|.+++...  ....+++..++.++.|++.||.|||+   + +++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6888877442  23568999999999999999999998   5 899999999999999999999999999986533


Q ss_pred             CCCCceeeeecCCCCCchhhccC----CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRT----GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ..  ..+...|+..|+|||.+.+    ..++.++|+||||+++|||++|+.||.........     +.... .     .
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~-~-----~  223 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-----LKQVV-E-----E  223 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-----HHHHH-h-----c
Confidence            21  1223467889999998865    45688999999999999999999998653321110     11111 0     1


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+.+..   ......+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111   112346889999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9e-36  Score=305.41  Aligned_cols=251  Identities=22%  Similarity=0.397  Sum_probs=205.0

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|+..+.||+|+||.||+|..+.++..+|+|.+....  ....+.+.+|+.++++++|+|++++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788899999999999999999889999999986542  23346788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-cEEEcccccceeccCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-NGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~~~  500 (687)
                      +++++|.+++.......+++..+..++.|++.||.|||+   .+++|+||||+||++++++ .+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            999999999966555568999999999999999999998   8999999999999999885 469999999986643322


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                       ......|+..|+|||++.+..++.++||||||+++|||++|+.||......      +++.+... +...         
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~---------  220 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-GYFA---------  220 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-ccCC---------
Confidence             222346889999999998888999999999999999999999998754321      22222111 1111         


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .........+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1111223468899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2e-35  Score=309.32  Aligned_cols=245  Identities=26%  Similarity=0.325  Sum_probs=203.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|++|.||++.+..+++.+|+|++....   ....+.+.+|++++++++||||+++++++...+.+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999998889999999986542   234567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999998543  568999999999999999999998   99999999999999999999999999999865443 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.......       ..+....+.      ..+.
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~------~~~~  218 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IYEKILEGK------VRFP  218 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCC------ccCC
Confidence               233468899999999988889999999999999999999999997654211       111111111      1111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ..    ....+.+++.+||+.+|++||     +++++++
T Consensus       219 ~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         219 SF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             cc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            22    234788999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-35  Score=305.59  Aligned_cols=255  Identities=27%  Similarity=0.384  Sum_probs=206.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|+..+.||.|++|.||++.+..+++.+|+|++.... ....+++.+|++++++++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999998889999999987653 34557789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++.... ..+++..+.+++.|++.||.|||+  ..+++||||||+||+++.++.+||+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            99999999885432 578999999999999999999997  379999999999999999999999999998755322211


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                         ...++..|+|||++.+..++.++||||||+++|+|++|+.||......... ..+.+.... .+     ..+.+...
T Consensus       158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~-~~-----~~~~~~~~  227 (265)
T cd06605         158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIV-NE-----PPPRLPSG  227 (265)
T ss_pred             ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHh-cC-----CCCCCChh
Confidence               156888999999999999999999999999999999999999765321111 111111111 11     11111111


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         .....+.+++.+||..+|++||++.++++
T Consensus       228 ---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         228 ---KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence               13446889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.9e-35  Score=306.15  Aligned_cols=255  Identities=27%  Similarity=0.400  Sum_probs=199.6

Q ss_pred             cccceeeeeeCeEEEEEEEeCC---CCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC------
Q 005621          345 FRDKELLGFGGFGRVYKGTLPS---TNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG------  413 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  413 (687)
                      |...+.||+|+||.||+|.+..   +++.||||++...  .....+++.+|++++++++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5667889999999999998643   4688999998754  3345677899999999999999999999885432      


Q ss_pred             eeEEEEecCCCCCchhhhhch----hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccc
Q 005621          414 DLLLVYDFMPNGSLDKCLFDE----QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDF  489 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF  489 (687)
                      ..++++||+++|+|.+++...    ....+++....+++.|++.||+|||+   .+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence            247899999999999887432    12357899999999999999999998   89999999999999999999999999


Q ss_pred             ccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          490 GLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       490 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      |+++....... .......++..|++||.+....++.++||||||+++|||++ |+.||......   .+..+..    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~----~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI----K  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH----c
Confidence            99986543221 11222345678999999998889999999999999999999 88888654321   1111111    1


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       568 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      +..     ...    +......+.+++.+||+.+|++||++.++++.|++.
T Consensus       231 ~~~-----~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR-----LKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110     011    112234789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.4e-35  Score=307.59  Aligned_cols=265  Identities=22%  Similarity=0.288  Sum_probs=200.1

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++++|...+.||+|+||.||+|....++..||+|++...... ....+.+|+.++++++|+||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            467899999999999999999999888999999998755332 2346788999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+. ++|.+++... ...+.+.++..++.|++.||.|||+   .+|+||||||+||+++.++++||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9995 6777766433 2457888999999999999999998   899999999999999999999999999997543221


Q ss_pred             CCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc---------c
Q 005621          500 NPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG---------A  569 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~---------~  569 (687)
                      . ......++..|+|||.+.+. .++.++||||||+++|||++|+.||+......+..  ...+......         .
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL--EKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH--HHHHHHcCCCChhhhhhhhh
Confidence            1 11223568899999998754 57889999999999999999999997654321111  1111111000         0


Q ss_pred             cc----ccc----CCcCCCCCC-HHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          570 IL----EVV----DPRLNGEFN-EIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       570 ~~----~~~----d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..    +..    .+.+..... ......+.+++.+|++.||++|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00    000    000000000 011346788999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.1e-35  Score=296.65  Aligned_cols=250  Identities=30%  Similarity=0.439  Sum_probs=207.0

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      .|...+.||+|++|.||++.+..+++.+++|++........+++.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            36778899999999999999988899999999987765566889999999999999999999999999999999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +++|.+++.... ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||.+........  .
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            999999885432 468999999999999999999998   9999999999999999999999999999986654332  3


Q ss_pred             eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN  583 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~  583 (687)
                      ....++..|+|||.+.+..++.++||||||+++++|++|+.|+...........      . .....     +.+..  .
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~-~~~~~-----~~~~~--~  220 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------I-ATNGP-----PGLRN--P  220 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------H-HhcCC-----CCcCc--c
Confidence            345788999999999988899999999999999999999999876542211110      0 00000     01110  0


Q ss_pred             HHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          584 EIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       584 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ......+.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111346889999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.5e-35  Score=308.86  Aligned_cols=262  Identities=22%  Similarity=0.282  Sum_probs=199.1

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|...+.||+|++|.||+|.+..+|+.+|+|++....  ......+.+|++++++++|||++++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999999899999999986542  22235678899999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      ++ ++|.+++... ...+++.++..++.||++||.|||+   ++++||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  154 (284)
T cd07839          81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-  154 (284)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence            96 5787777433 3468999999999999999999998   9999999999999999999999999999986543221 


Q ss_pred             ceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc------ccccc
Q 005621          502 STTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA------ILEVV  574 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~------~~~~~  574 (687)
                      ......++..|+|||++.+. .++.++|||||||++|||++|+.|+.........  .+.+........      ..+..
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhhhcc
Confidence            12234578899999998764 4789999999999999999999987543322111  111111110000      00000


Q ss_pred             CC----cCCC-----CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          575 DP----RLNG-----EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       575 d~----~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +.    ....     +........+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00    0000     011112346789999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.1e-35  Score=309.42  Aligned_cols=197  Identities=24%  Similarity=0.381  Sum_probs=161.5

Q ss_pred             ceeeeeeCeEEEEEEEeCC--CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeee--cCCeeEEEEecCC
Q 005621          348 KELLGFGGFGRVYKGTLPS--TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR--RRGDLLLVYDFMP  423 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV~Ey~~  423 (687)
                      ..+||+|+||+||+|+...  .+..||+|.+.....  ...+.+|+.++++++||||+++++++.  .....++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3689999999999999754  457899999875432  246778999999999999999999884  3567899999986


Q ss_pred             CCCchhhhhch-------hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe----ccCCcEEEcccccc
Q 005621          424 NGSLDKCLFDE-------QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL----DSELNGRLGDFGLA  492 (687)
Q Consensus       424 ~gsL~~~L~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGla  492 (687)
                      + +|.+++...       ....+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            4 777766321       12358899999999999999999998   999999999999999    55678999999999


Q ss_pred             eeccCCCCC--ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCC
Q 005621          493 KLYERGTNP--STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKA  550 (687)
Q Consensus       493 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~  550 (687)
                      +........  ......||..|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            876543221  2234578999999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5e-35  Score=305.66  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=203.8

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      +|...+.||+|++|.||++....+++.+++|++........+.+.+|+.++++++|||++++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            35556799999999999999988899999999876555556778899999999999999999999999999999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +++|.+++..   ..+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++........ ..
T Consensus       100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~  172 (285)
T cd06648         100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR  172 (285)
T ss_pred             CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence            9999998844   468999999999999999999998   9999999999999999999999999998875443221 22


Q ss_pred             eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN  583 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~  583 (687)
                      ....|+..|+|||.+.+..++.++||||||+++|||++|+.||........      .. ....+.     .+.+..  .
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~-~~~~~~-----~~~~~~--~  238 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MK-RIRDNL-----PPKLKN--L  238 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HH-HHHhcC-----CCCCcc--c
Confidence            234688999999999888899999999999999999999999876432111      11 111110     111111  1


Q ss_pred             HHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          584 EIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       584 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ......+.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            112347889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-35  Score=303.46  Aligned_cols=248  Identities=25%  Similarity=0.317  Sum_probs=205.0

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      +|...+.||.|+||.||++.+..+++.||+|.+....   ....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788899999999999999998889999999987542   2456789999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++...  ..+++.++..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999998433  578999999999999999999998   899999999999999999999999999988654332 


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                       ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......    .++.......      ..    .
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~------~~----~  219 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET------AD----V  219 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc------cc----c
Confidence             2233567889999999998889999999999999999999999998665421    1112221111      00    1


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCH--HHHH
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTM--RQVV  612 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl  612 (687)
                      ..+...+..+.+++.+||+.+|.+||++  +|++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1122233578899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.7e-35  Score=308.68  Aligned_cols=265  Identities=20%  Similarity=0.280  Sum_probs=202.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecC--CeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV  418 (687)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.....  .....+.+|+.++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            468888999999999999999988899999999875432  2234677899999999999999999998777  889999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||++ ++|.+++.... ..+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99997 48988875432 368999999999999999999998   89999999999999999999999999999866543


Q ss_pred             CCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHH-H-------HHHHHhcc--
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV-D-------WVWDRWKA--  567 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~-~-------~v~~~~~~--  567 (687)
                      .. ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||...........+ .       ..|..+..  
T Consensus       160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            21 22234578899999998764 4688999999999999999999999765432211100 0       00111100  


Q ss_pred             ----cccccccCCcCCCCCCHH-HHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          568 ----GAILEVVDPRLNGEFNEI-EALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       568 ----~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                          ..........+...++.. ....+.+++.+||+.+|++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                001111111122222222 2446789999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5e-35  Score=308.97  Aligned_cols=247  Identities=29%  Similarity=0.398  Sum_probs=199.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|++|+||+|....+++.||+|++...   .....+++.+|+++++.++|||+++++++|...+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4588889999999999999999888999999998643   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||++ |+|.+++... ...+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++...... 
T Consensus        95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9996 5777666432 3468999999999999999999998   89999999999999999999999999998754322 


Q ss_pred             CCceeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          500 NPSTTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                          ....++..|+|||++.   .+.++.++||||||+++|||++|+.|+.........      ..... .     ..+
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~~-~-----~~~  232 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-N-----DSP  232 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHhc-C-----CCC
Confidence                2346788999999874   456889999999999999999999998754321111      11000 0     011


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .+.   .......+.+++.+||+.+|++||++.+|++.
T Consensus       233 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 TLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            111   12234578899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.2e-35  Score=308.29  Aligned_cols=265  Identities=26%  Similarity=0.341  Sum_probs=202.2

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC----
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG----  413 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----  413 (687)
                      .+.++|+..+.||+|++|.||+|.++.+++.||+|+++...  ......+..|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999998889999999987543  223356778999999999999999999987654    


Q ss_pred             ------eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEc
Q 005621          414 ------DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       414 ------~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~  487 (687)
                            .+++|+||+++ +|.+.+... ...+++.++..++.|++.||+|||+   .+|+||||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999976 676666433 3468999999999999999999998   899999999999999999999999


Q ss_pred             ccccceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 005621          488 DFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK  566 (687)
Q Consensus       488 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~  566 (687)
                      |||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+...   .+.+...
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~---~~~~~~~  235 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE---LISRLCG  235 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhC
Confidence            999998765433222233456788999998865 457889999999999999999999997654322211   1111110


Q ss_pred             cc---ccccc--------cCC------cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          567 AG---AILEV--------VDP------RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       567 ~~---~~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..   .....        .++      ++...+. ..+..+.+++.+||+.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00   00000        000      0001111 12347889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.4e-35  Score=304.70  Aligned_cols=254  Identities=26%  Similarity=0.391  Sum_probs=207.7

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ..+++|+..+.||+|++|.||+|.+..++..+++|++..... ..+.+..|++.+++++|+|++++++.+...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            456778888999999999999999987889999999976554 5577889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++.... ..+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999995433 379999999999999999999998   999999999999999999999999999987543322


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+..........      .. .....     +.+.
T Consensus       171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~~-~~~~~-----~~~~  237 (286)
T cd06614         171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------LI-TTKGI-----PPLK  237 (286)
T ss_pred             h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-HhcCC-----CCCc
Confidence            1 1223457889999999988889999999999999999999999987543321110      00 00000     0010


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        ........+.+++.+||+.+|.+||++.++++
T Consensus       238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         238 --NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             --chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              11112347889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.5e-35  Score=307.94  Aligned_cols=254  Identities=27%  Similarity=0.372  Sum_probs=198.6

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|...+.||+|+||.||++.+..+++.+|+|++.... ......+..|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3445678999999999999999899999999987543 334567889999999996 99999999999999999999999


Q ss_pred             CCCCCchhhh---hchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          422 MPNGSLDKCL---FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       422 ~~~gsL~~~L---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      +.. +|.++.   .......+++..+.+++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 554433   23334579999999999999999999997  258999999999999999999999999999755332


Q ss_pred             CCCceeeeecCCCCCchhhccCC---CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTG---KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ..  .....|+..|+|||.+.+.   .++.++||||||+++|||++|+.||.....     ..+.+.+...      ...
T Consensus       162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~------~~~  228 (288)
T cd06616         162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK------GDP  228 (288)
T ss_pred             Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC------CCC
Confidence            21  1233578899999998776   689999999999999999999999875431     1111111111      111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +.+...........+.+++.+||+.+|++||++.+|++
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22222222234457889999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=312.17  Aligned_cols=245  Identities=28%  Similarity=0.391  Sum_probs=203.4

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .|..++.||.|.||.||-|.+..+.+.||||+++-..   .+.+.+++.|+..|++++|||.+.+-|++......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3566778999999999999999999999999997654   4557889999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      || -||-.+.|.- .+.++.+..+..|+.+.+.||+|||+   ++.||||||+.||||++.+.+||+|||.|-....   
T Consensus       107 YC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            99 4577776633 34579999999999999999999999   9999999999999999999999999999875433   


Q ss_pred             CceeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          501 PSTTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                        ...++||+.|||||++.   .+.|+-|+||||+|+...||.-.++|+-....-....-            +.+.-.|.
T Consensus       179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH------------IAQNesPt  244 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------------IAQNESPT  244 (948)
T ss_pred             --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH------------HHhcCCCC
Confidence              33578999999999975   57899999999999999999999999766543221110            11112233


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      |.   ..+-...++.++..||+.-|.+|||..++++
T Consensus       245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            33   2233447889999999999999999998875

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=307.10  Aligned_cols=261  Identities=25%  Similarity=0.300  Sum_probs=200.0

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      |+..+.||.|++|.||+|.+..+++.||+|++....  ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999998889999999987543  223457889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      + ++|.+++.......+++..+.+++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||+++........ 
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence            4 689998865444468999999999999999999998   89999999999999999999999999999765432211 


Q ss_pred             eeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc-----------c-
Q 005621          503 TTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG-----------A-  569 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~-----------~-  569 (687)
                      .....++..|+|||++.+. .++.++||||||+++|||++|+.||.........  .+.........           . 
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL--FRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChHHhhhhhhchhh
Confidence            1223568899999987654 5688999999999999999999999765432111  11110000000           0 


Q ss_pred             ---cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          570 ---ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       570 ---~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         ......+.. ..........+.+++.+|++++|++||+++|+++
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               000000000 0011112246889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.4e-35  Score=299.58  Aligned_cols=243  Identities=27%  Similarity=0.324  Sum_probs=198.8

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      ||.|++|.||++++..+++.+|+|++....   ....+.+..|+.++++++||||+++++++.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999998889999999987543   23456789999999999999999999999999999999999999999


Q ss_pred             hhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeee
Q 005621          428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV  507 (687)
Q Consensus       428 ~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  507 (687)
                      .+++..  ...+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.......  ......
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~  153 (262)
T cd05572          81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC  153 (262)
T ss_pred             HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence            999954  3458999999999999999999998   999999999999999999999999999998664432  222346


Q ss_pred             cCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHH
Q 005621          508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEA  587 (687)
Q Consensus       508 gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  587 (687)
                      ++..|++||.+....++.++|+||||+++|||++|..||........    +......         +......++....
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~~  220 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYNDIL---------KGNGKLEFPNYID  220 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHHHHh---------ccCCCCCCCcccC
Confidence            78899999999888899999999999999999999999976653111    1111111         0011112222224


Q ss_pred             HHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          588 LDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       588 ~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                      ..+.+++.+||+.+|++||+     ++|+++
T Consensus       221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            57899999999999999999     677765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-34  Score=295.69  Aligned_cols=251  Identities=27%  Similarity=0.399  Sum_probs=208.0

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecC--CeeEEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDLLLVY  419 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~  419 (687)
                      +|...+.||+|++|.||+|....+++.|++|++.....  ...+.+.+|+..+++++||||+++++.+...  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            47778999999999999999988899999999876542  4567889999999999999999999999988  8999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++...  ..+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            999999999998543  379999999999999999999998   999999999999999999999999999998765543


Q ss_pred             CC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 NP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      .. ......++..|+|||.+.+...+.++||||||+++++|++|+.||.......     ..++...         ....
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~---------~~~~  221 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIG---------SSGE  221 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhcc---------ccCC
Confidence            21 1233567889999999998889999999999999999999999997765111     1111111         1111


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....+......+.+++.+|++.+|++||++.++++
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11222233457899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=315.59  Aligned_cols=263  Identities=22%  Similarity=0.328  Sum_probs=199.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----Cee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----GDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  415 (687)
                      +++|...++||+|++|.||+|.+..+++.||+|++.... .....++..|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            578999999999999999999998899999999987532 33456788999999999999999999987544     358


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++|+||+++ +|.+++.   ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~-~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMET-DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhccc-CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999999964 7777663   3468999999999999999999998   99999999999999999999999999999865


Q ss_pred             cCCCCC--ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc---c
Q 005621          496 ERGTNP--STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG---A  569 (687)
Q Consensus       496 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~---~  569 (687)
                      ......  ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........   ...+.......   .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~  233 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQED  233 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHH
Confidence            432221  1123468899999998754 4688999999999999999999999965432111   11111111100   0


Q ss_pred             cccccCCc---------CCCCCC-----HHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          570 ILEVVDPR---------LNGEFN-----EIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       570 ~~~~~d~~---------l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .....+..         .....+     ......+.+++.+||+.+|++||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000         000000     1123468899999999999999999999984

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.6e-35  Score=297.86  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=208.2

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|...+.||.|++|.||++.+..++..+++|++.....  ...+++..|++++++++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            57788999999999999999988899999999876533  4567788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchh--hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          422 MPNGSLDKCLFDEQ--KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       422 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      +++++|.+++....  ...+++.++..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986543  3679999999999999999999998   899999999999999999999999999998765443


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       .......|+..|+|||......++.++||||+|+++++|++|+.||......+      .... ...+.     .+.+.
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~-~~~~~-----~~~~~  224 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALK-ILKGQ-----YPPIP  224 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHH-HhcCC-----CCCCC
Confidence             22233568889999999988889999999999999999999999987654221      1111 11111     11111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .    .....+.+++.+||+.+|++||++.++++.
T Consensus       225 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         225 S----QYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             C----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1    233478899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.9e-35  Score=298.99  Aligned_cols=249  Identities=25%  Similarity=0.411  Sum_probs=206.9

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|+..++||+|++|.||+++...+++.+|+|.+...  ......++..|++++++++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            478889999999999999999888999999998754  234456788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          422 MPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       422 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            9999999998552  23568999999999999999999998   999999999999999999999999999998765442


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         .....++..|+|||.+.+..++.++|+||||+++|||++|+.||......+   +.    .....+..         
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~----~~~~~~~~---------  218 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LR----YKVQRGKY---------  218 (256)
T ss_pred             ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHhcCCC---------
Confidence               222457889999999999899999999999999999999999997654321   11    11111111         


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ...+.....++.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11222344578999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.4e-35  Score=303.11  Aligned_cols=265  Identities=25%  Similarity=0.353  Sum_probs=202.2

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      +|+..+.||.|++|.||+|++..+++.||||++...... ....+..|++++++++|||++++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            578899999999999999999888999999998765432 3466788999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchh-hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          423 PNGSLDKCLFDEQ-KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       423 ~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      ++ +|.+++.... ...+++.++.+++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8888875432 3468999999999999999999998   8999999999999999999999999999976543221 


Q ss_pred             ceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHH--------HHHHhccccccc
Q 005621          502 STTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW--------VWDRWKAGAILE  572 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------v~~~~~~~~~~~  572 (687)
                      ......++..|++||++.+. .++.++||||||+++|||++|+.||......+......-        .++.+.......
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            11234568899999998654 578899999999999999999999986654322111100        011111000000


Q ss_pred             ccCCcCC----CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          573 VVDPRLN----GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       573 ~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ...+...    ....+.....+.+++.+|++.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000    0011122446789999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.4e-35  Score=305.38  Aligned_cols=263  Identities=21%  Similarity=0.253  Sum_probs=198.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCe-----
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLR-HRNLVQLLGWCRRRGD-----  414 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~-----  414 (687)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++.....  .....+.+|+.++++++ |||++++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468889999999999999999988899999998765432  23457888999999995 6999999999876665     


Q ss_pred             eEEEEecCCCCCchhhhhchh---hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-CCcEEEcccc
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQ---KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-ELNGRLGDFG  490 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFG  490 (687)
                      .++||||+++ +|.+++....   ...+++.++..++.||+.||.|||+   ++|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 8888875432   2468999999999999999999998   99999999999999998 8899999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      +++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||..........  . +.+......
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~--~-~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL--H-IFKLLGTPT  232 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH--H-HHHHhCCCC
Confidence            9986533221 1122356788999998865 457899999999999999999999997654322111  0 111100000


Q ss_pred             c---cccc-------CCcCC----CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          570 I---LEVV-------DPRLN----GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       570 ~---~~~~-------d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .   ....       -+...    ....+.....+.+++.+||+++|++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0   0000       00000    0001123346889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-34  Score=310.74  Aligned_cols=263  Identities=21%  Similarity=0.259  Sum_probs=201.2

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC------
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR------  412 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  412 (687)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++...  ......++..|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999889999999998643  233446778899999999999999999987543      


Q ss_pred             CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccc
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA  492 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla  492 (687)
                      ...++||||+. ++|.+.+..    .+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            35799999995 588877732    28899999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHH---------HH---
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV---------DW---  560 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~---------~~---  560 (687)
                      +.......  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+         ++   
T Consensus       166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            86543222  23346788999999999999999999999999999999999999765422111000         00   


Q ss_pred             ----HHHHhcccc------cccccCC----cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          561 ----VWDRWKAGA------ILEVVDP----RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       561 ----v~~~~~~~~------~~~~~d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                          .........      ..+....    .............+.+++.+||+.||++||++.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                000000000      0000000    0011112233456789999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-35  Score=308.08  Aligned_cols=266  Identities=20%  Similarity=0.284  Sum_probs=199.4

Q ss_pred             CcccceeeeeeCeEEEEEEEeCC--CCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--CeeE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPS--TNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDLL  416 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  416 (687)
                      +|+..+.||+|++|.||+|....  .+..||+|.+....   ......+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788999999999999999987  78999999988743   33346778899999999999999999999888  7899


Q ss_pred             EEEecCCCCCchhhhhch---hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc----CCcEEEccc
Q 005621          417 LVYDFMPNGSLDKCLFDE---QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS----ELNGRLGDF  489 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~----~~~~kl~DF  489 (687)
                      +||||+++ +|.+++...   ....+++..+..++.|++.||.|||+   .+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 666665322   22368999999999999999999998   99999999999999999    899999999


Q ss_pred             ccceeccCCCC--CceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcch------hhHHHH
Q 005621          490 GLAKLYERGTN--PSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE------LILVDW  560 (687)
Q Consensus       490 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~------~~~~~~  560 (687)
                      |+++.......  .......++..|+|||.+.+. .++.++||||||++++||++|+.||........      ......
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986544322  122335678899999988764 578999999999999999999999976543320      000011


Q ss_pred             HHHHhccc------------ccccccCCcCCCCCC---------H--HHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          561 VWDRWKAG------------AILEVVDPRLNGEFN---------E--IEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       561 v~~~~~~~------------~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +...+...            ......+......++         .  .....+.+++.+|++.+|++||++.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11111000            000000000000111         0  22346889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.9e-35  Score=301.95  Aligned_cols=245  Identities=26%  Similarity=0.347  Sum_probs=196.9

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      ||+|+||+||++....+++.+|+|.+....   ......+..|++++++++|||++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999986542   22345677899999999999999999999999999999999999999


Q ss_pred             hhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeee
Q 005621          428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV  507 (687)
Q Consensus       428 ~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  507 (687)
                      .+++.......+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||+++......  ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence            999966554579999999999999999999998   999999999999999999999999999987654322  222345


Q ss_pred             cCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHH
Q 005621          508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEA  587 (687)
Q Consensus       508 gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  587 (687)
                      ++..|+|||++.++.++.++||||||+++++|++|+.||..........   .+......      ..    ...+....
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~------~~----~~~~~~~~  222 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTLE------MA----VEYPDKFS  222 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhcccc------cc----ccCCccCC
Confidence            7889999999988889999999999999999999999997654311110   01110000      01    11122224


Q ss_pred             HHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          588 LDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       588 ~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ..+.+++.+||+.+|++||     ++.++++
T Consensus       223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            4788999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.6e-35  Score=305.40  Aligned_cols=263  Identities=24%  Similarity=0.302  Sum_probs=199.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..+.||+|++|+||+|.+..+++.||+|++.....  ...+.+.+|++++++++|||++++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            578899999999999999999988899999999865432  334678899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-CCcEEEcccccceeccCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-ELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~~~  499 (687)
                      |++ ++|.+++.......+++..+..++.||+.||.|||+   ++++||||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 578887754444446888899999999999999998   89999999999999985 4679999999997654322


Q ss_pred             CCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc--c-------
Q 005621          500 NPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG--A-------  569 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~--~-------  569 (687)
                      . ......++..|+|||++.+. .++.++||||||+++|+|+||+.||......+....   ....+...  .       
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK---IFRILGTPNEETWPGVTS  233 (294)
T ss_pred             c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChhhcccccc
Confidence            1 12234568899999998764 578999999999999999999999976543222111   11100000  0       


Q ss_pred             cccc--cCCcCCCC----CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          570 ILEV--VDPRLNGE----FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       570 ~~~~--~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +...  .-+.....    ........+.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000  00000000    01112346789999999999999999999987

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=297.68  Aligned_cols=250  Identities=26%  Similarity=0.367  Sum_probs=200.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-----chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--Cee
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-----SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDL  415 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  415 (687)
                      .+|+..+.||+|++|.||+|.+..++..||+|.+...     ..+....+.+|++++++++|+||+++++++.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999999888999999987532     233456788999999999999999999998654  468


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++|+||+++++|.+++..  ...+++....+++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            899999999999998843  3458899999999999999999998   89999999999999999999999999999865


Q ss_pred             cCCCC--CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          496 ERGTN--PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       496 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      .....  .......++..|+|||++.+..++.++|+|||||++|||++|+.||.........      .+..        
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~--------  222 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI------FKIA--------  222 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH------HHHH--------
Confidence            32111  1122356889999999999888999999999999999999999999754322111      1111        


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       .......++......+.+++.+||+ +|..||+..++++
T Consensus       223 -~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 -TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence             0111122233344578899999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-34  Score=306.42  Aligned_cols=250  Identities=28%  Similarity=0.384  Sum_probs=199.9

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      |...+.||+|+||.||+|++..++..+|+|++....   .....++..|+.++++++|||++++++++.+.+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667788999999999999998889999999986432   23446788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      ++ |+|.+.+... ...+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++.....    
T Consensus       107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            96 5777776433 4468999999999999999999998   9999999999999999999999999999875432    


Q ss_pred             ceeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          502 STTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                       .....|+..|+|||++.   .+.++.++|||||||++|||++|+.||.........      ......+      .+..
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~------~~~~  244 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE------SPTL  244 (317)
T ss_pred             -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHHhcc------CCCC
Confidence             22346788999999974   457889999999999999999999998654321111      0111100      0111


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                         ........+.+++.+||+.+|++||++.++++.+-...
T Consensus       245 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         245 ---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence               11123346889999999999999999999998654433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.8e-34  Score=300.60  Aligned_cols=243  Identities=23%  Similarity=0.299  Sum_probs=190.3

Q ss_pred             eeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHh---hhcCCCceeeeeeeecCCeeEEEEecCC
Q 005621          350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIG---RLRHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       350 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      +||+|+||.||++.+..+++.+|+|.+.....   .....+.+|..+++   ..+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999988899999998865421   12233444544333   3479999999999999999999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +++|.+++..  ...+++.++..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||+++......   .
T Consensus        81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~  152 (279)
T cd05633          81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P  152 (279)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence            9999998843  3469999999999999999999998   999999999999999999999999999997554322   1


Q ss_pred             eeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          504 TRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+.    ...      ......+    
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~------~~~~~~~----  218 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT------LTVNVEL----  218 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----HHh------hcCCcCC----
Confidence            23468999999999864 56889999999999999999999999765432221111    100      0011122    


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCC-----CHHHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARP-----TMRQVVRY  614 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  614 (687)
                      +.....++.+++.+||+.||++||     +++++++.
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            222344788999999999999999     59999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-35  Score=302.33  Aligned_cols=260  Identities=25%  Similarity=0.338  Sum_probs=202.9

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      |...+.||+|++|.||++....+++.+++|++.....  .....+..|++++++++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            5667899999999999999988899999999876533  24567889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++ +|.+++.... ..+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.+....... ..
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP  154 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence            75 8888775432 578999999999999999999998   999999999999999999999999999998765433 12


Q ss_pred             eeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc---ccccccC---
Q 005621          503 TTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG---AILEVVD---  575 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~---~~~~~~d---  575 (687)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....   ..+.....   ......+   
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhh
Confidence            2234578899999998876 789999999999999999999999976543221111   11110000   0000000   


Q ss_pred             ------CcC----CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          576 ------PRL----NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       576 ------~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                            +..    ..........++.+++.+||+++|.+||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                  000    00111223557899999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-35  Score=313.09  Aligned_cols=268  Identities=22%  Similarity=0.295  Sum_probs=202.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----Ce
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----GD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  414 (687)
                      .++|...+.||+|+||+||+|++..+++.||||.+...  ......++..|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46789999999999999999999889999999998753  233456778899999999999999999988644     35


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++||||+. ++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            899999995 688888743  3569999999999999999999998   8999999999999999999999999999986


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHh
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVW--------DRW  565 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~--------~~~  565 (687)
                      ..... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.............-+.        ...
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            54332 12233467889999998865 468899999999999999999999997653221111110000        000


Q ss_pred             ccccccc-------ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH--Hhc
Q 005621          566 KAGAILE-------VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY--LEG  617 (687)
Q Consensus       566 ~~~~~~~-------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~  617 (687)
                      ..+...+       ..++.+.. ........+.+++.+||+.+|++||+++++++.  ++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence            0000000       00111100 011234568899999999999999999999974  544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-34  Score=292.61  Aligned_cols=248  Identities=29%  Similarity=0.452  Sum_probs=205.6

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|+..+.||+|++|.||+++....++.|++|.+.....  ....++.+|++++++++|||++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47788999999999999999988899999999877643  4567899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999988433  579999999999999999999998   89999999999999999999999999999876543321


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                       .....++..|+|||...+...+.++|||++|+++|+|++|+.|+.......      ..+... ..     ..+.+   
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~-----~~~~~---  219 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA------ALFRIV-QD-----DHPPL---  219 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-cc-----CCCCC---
Confidence             233467889999999988888999999999999999999999987543111      011111 00     11111   


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       +......+.+++.+||+.+|++||++.+++.
T Consensus       220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             1222347889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.3e-34  Score=305.42  Aligned_cols=267  Identities=24%  Similarity=0.330  Sum_probs=198.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG------  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  413 (687)
                      -++|+..+.||+|+||.||+|....+++.||||++....  ......+.+|+.++++++||||++++++|....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357899999999999999999998899999999886542  222345678999999999999999999986543      


Q ss_pred             --eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          414 --DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       414 --~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                        ..++||||+. ++|.+++... ...+++.++..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence              4599999996 4787777432 3368999999999999999999998   8999999999999999999999999999


Q ss_pred             ceeccCCCCC---ceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          492 AKLYERGTNP---STTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       492 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      +.........   ......++..|+|||++.+. .++.++||||||+++|||++|+.||..............+......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9865433221   12234578899999988664 4788999999999999999999999765543322222222111100


Q ss_pred             cccc-----cccCC-cCCCCC---------CHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          568 GAIL-----EVVDP-RLNGEF---------NEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       568 ~~~~-----~~~d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....     +..+. .+....         ...+...+.+++.+||+.+|++||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000     00000 000000         0011235678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-34  Score=298.42  Aligned_cols=247  Identities=24%  Similarity=0.338  Sum_probs=199.7

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      ||+|+||.||++++..+++.+++|.+.....   ...+.+.+|++++++++|||++++++.+...+..+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999988899999999876533   4567788999999999999999999999999999999999999999


Q ss_pred             hhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC-------
Q 005621          428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN-------  500 (687)
Q Consensus       428 ~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~-------  500 (687)
                      .+++...  ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.+||+|||++........       
T Consensus        81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            9998543  368999999999999999999998   9999999999999999999999999999875433211       


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                      .......++..|+|||.......+.++||||||++++||++|..||......+.      .. ....+...      ...
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~-~~~~~~~~------~~~  222 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQ-NILNGKIE------WPE  222 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHhcCCcC------CCc
Confidence            122335678899999999888899999999999999999999999976542211      11 11111110      000


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ..  .....+.+++.+||+.+|++||++.++.+.|+.
T Consensus       223 ~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         223 DV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             cc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            00  013478899999999999999999777666653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.5e-35  Score=311.85  Aligned_cols=267  Identities=26%  Similarity=0.349  Sum_probs=200.8

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhh-cCCCceeeeeeeecC--Cee
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRL-RHRNLVQLLGWCRRR--GDL  415 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~  415 (687)
                      ..++|...+.||+|+||.||+|.+..+++.+|+|++...  .......+..|+.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            456788899999999999999999888999999988543  233445677899999999 999999999988643  468


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||++ ++|.+++..   ..+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999997 589888743   268999999999999999999998   99999999999999999999999999999865


Q ss_pred             cCCCC----CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------
Q 005621          496 ERGTN----PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVW--------  562 (687)
Q Consensus       496 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~--------  562 (687)
                      .....    .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.........        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            43322    22334568999999998765 467889999999999999999999997544322111100000        


Q ss_pred             HHhcc---cccccccCCcCC---CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          563 DRWKA---GAILEVVDPRLN---GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       563 ~~~~~---~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ..+..   ..+.+.+...-.   ..........+.+++.+||+.+|++||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000   000000000000   00011134578899999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.6e-34  Score=305.28  Aligned_cols=265  Identities=26%  Similarity=0.331  Sum_probs=198.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecC--CeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  417 (687)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++.....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4678999999999999999999988899999999865432  2233567899999999999999999998654  56899


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+. ++|.+++... ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            999996 4788877543 3568999999999999999999999   9999999999999999999999999999987644


Q ss_pred             CCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH--------HHHHHhccc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD--------WVWDRWKAG  568 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~v~~~~~~~  568 (687)
                      ... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.        ..|..+...
T Consensus       161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            321 2222345788999999865 457899999999999999999999997654322211110        000000000


Q ss_pred             ccccccC---CcCCCCCC---HHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          569 AILEVVD---PRLNGEFN---EIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       569 ~~~~~~d---~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .......   ..+. ...   ......+.+++.+|++.||++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         240 PLVGKFTLPKQPYN-NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccCCCCC-chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000   0000 000   012346788999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=296.70  Aligned_cols=245  Identities=23%  Similarity=0.274  Sum_probs=192.8

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHH-hhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSI-GRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|++|.||+|.+..+++.||+|.+.....   .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            568999999999999988899999999875432   2233445555444 445899999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      ++|.+++..  ...+++..+.+++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||+++....     ..
T Consensus        82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~  151 (260)
T cd05611          82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK  151 (260)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence            999999843  3468999999999999999999998   8999999999999999999999999999875432     22


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ...++..|+|||.+.+..++.++||||||+++|||++|..||.......       ++.....+...      .......
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~~  218 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN------WPEEVKE  218 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC------CCCcccc
Confidence            3457889999999988888999999999999999999999997644311       11111111110      0111111


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      .....+.+++.+||+.+|++||++.++.+.|.
T Consensus       219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            23347889999999999999998876666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.5e-34  Score=306.66  Aligned_cols=260  Identities=23%  Similarity=0.284  Sum_probs=196.5

Q ss_pred             eeeeee--CeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFG--GFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ..||+|  +||+||++.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999998899999999987542  33457788999999999999999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc--
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--  502 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~--  502 (687)
                      ++|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+|++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            999999865544568999999999999999999998   899999999999999999999999998654332211110  


Q ss_pred             ----eeeeecCCCCCchhhccCC--CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH------------
Q 005621          503 ----TTRVVGTLGYLAPELTRTG--KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR------------  564 (687)
Q Consensus       503 ----~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~------------  564 (687)
                          .....++..|+|||++.+.  .++.++|||||||++|||++|+.||........  ........            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccch
Confidence                0112345679999999764  478999999999999999999999976542211  11000000            


Q ss_pred             -----------hc---------ccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          565 -----------WK---------AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       565 -----------~~---------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                                 +.         .+......+..+...........+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                       00         00000111111222223345567899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.5e-34  Score=294.98  Aligned_cols=251  Identities=24%  Similarity=0.266  Sum_probs=196.2

Q ss_pred             HHHHHHHhcCcccceee--eeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeec
Q 005621          335 YEELKKATRGFRDKELL--GFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRR  411 (687)
Q Consensus       335 ~~el~~at~~f~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  411 (687)
                      ..++....++|...+.+  |+|+||.||++..+.++..+|+|.+.......     .|+.....+ +|||++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34455556777777776  99999999999999899999999986542211     122222222 79999999999999


Q ss_pred             CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-cEEEcccc
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-NGRLGDFG  490 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFG  490 (687)
                      .+..++||||+++++|.+++...  ..+++.++..++.|+++||.|||+   .+++||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            99999999999999999998543  379999999999999999999998   8999999999999999998 99999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      +++......     ...++..|+|||++.+..++.++||||||+++|||++|+.||..... +......+....  .   
T Consensus       156 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~--~---  224 (267)
T PHA03390        156 LCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ--Q---  224 (267)
T ss_pred             cceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh--c---
Confidence            988654322     23578999999999988999999999999999999999999984432 222222221111  0   


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC-HHHHHH
Q 005621          571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT-MRQVVR  613 (687)
Q Consensus       571 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~  613 (687)
                           ..  ..........+.+++.+||+.+|.+||+ +.++++
T Consensus       225 -----~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 -----KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -----cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                 00  0111133447889999999999999995 688874

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=295.51  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=208.7

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      |.++.+||+|.||.||++.++.+|+.+|||.+..+.  +++++..|+.++++++.|++|++||.+.....+|+|||||-.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            556788999999999999999999999999986553  568899999999999999999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |++.+.++. ++.+|++.++..+++..+.||+|||.   ..-+|||||+.||||+.+|.+||+|||.|..+.... ....
T Consensus       113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRN  187 (502)
T KOG0574|consen  113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRN  187 (502)
T ss_pred             CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhC
Confidence            999998854 45689999999999999999999998   888999999999999999999999999997654322 2334


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                      ++.||+.|||||++..-.|+.++||||+|+...||.-|++||..-.+-....              +-...|.---.-++
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------------MIPT~PPPTF~KPE  253 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------------MIPTKPPPTFKKPE  253 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------------eccCCCCCCCCChH
Confidence            5789999999999999999999999999999999999999998655422111              00011111111233


Q ss_pred             HHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          585 IEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       585 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .-..++.+++..||-..|++|-|+.++++
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            44457889999999999999999998886

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-35  Score=301.42  Aligned_cols=253  Identities=22%  Similarity=0.345  Sum_probs=215.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .+-|...+.||+|.|..|-+|++--+|+.||||++.+..  .-....+.+|++.|+.++|||||+||.+......+|||.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            345777889999999999999998899999999998753  233467889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec-cCCcEEEcccccceeccCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD-SELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGla~~~~~~  498 (687)
                      |.=++|+|.+|+.+... .+++....+++.||+.|+.|+|+   ..+|||||||+||.+- .-|-+||.|||++..+..+
T Consensus        97 ELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999999977655 48999999999999999999998   9999999999999875 4588999999999877655


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCC-CccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPT-TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .  ..++.+|...|-|||++.+..|+ ++.||||+||+||.|+||+.||+.....+....               ++|=.
T Consensus       173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDCK  235 (864)
T KOG4717|consen  173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDCK  235 (864)
T ss_pred             c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhccc
Confidence            4  34567899999999999998776 578999999999999999999998776554321               12211


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                        -..+.....++.+|+..||..||++|-+.++|+.  +|+.
T Consensus       236 --YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~  275 (864)
T KOG4717|consen  236 --YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA  275 (864)
T ss_pred             --ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence              1345566778999999999999999999999986  4543

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.1e-35  Score=310.86  Aligned_cols=266  Identities=23%  Similarity=0.331  Sum_probs=201.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeec----CCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRR----RGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~  415 (687)
                      .++|+..+.||+|++|.||+|....+++.||+|++....  ....+.+..|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999999899999999987642  2345677889999999999999999998753    3468


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+. ++|.+++..  ...+++..+..++.||+.||.|||+   ++|+||||||+||++++++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999995 689888843  3458999999999999999999998   99999999999999999999999999999765


Q ss_pred             cCCCCC---ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HH
Q 005621          496 ERGTNP---STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV--------WD  563 (687)
Q Consensus       496 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v--------~~  563 (687)
                      ......   ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...............        .+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            432221   1123468899999999865 46889999999999999999999999765432211110000        00


Q ss_pred             Hhccccccccc---CCcCCC---CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          564 RWKAGAILEVV---DPRLNG---EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       564 ~~~~~~~~~~~---d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ......+.+..   ...-..   .........+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00000000000   000000   001123457899999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.8e-34  Score=301.28  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=202.2

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCch
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLD  428 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~  428 (687)
                      .+||+|+||.||++....+++.||||++..........+..|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            56999999999999998899999999987655555677899999999999999999999999999999999999999999


Q ss_pred             hhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeec
Q 005621          429 KCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG  508 (687)
Q Consensus       429 ~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~g  508 (687)
                      +++.   ...+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++....... .......|
T Consensus       106 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  178 (292)
T cd06657         106 DIVT---HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG  178 (292)
T ss_pred             HHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence            9773   3358999999999999999999998   899999999999999999999999999987654322 12233468


Q ss_pred             CCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHH
Q 005621          509 TLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEAL  588 (687)
Q Consensus       509 t~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~  588 (687)
                      +..|+|||.+.+..++.++|+||||+++|||++|..||......+..   ..+..         ...+.+..  ......
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~~~---------~~~~~~~~--~~~~~~  244 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRD---------NLPPKLKN--LHKVSP  244 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---------hCCcccCC--cccCCH
Confidence            89999999998888999999999999999999999998754332111   11111         01111111  011233


Q ss_pred             HHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          589 DVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       589 ~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                      .+.+++.+||+.+|.+||++.++++  ++.+.
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence            6788999999999999999999997  45443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-34  Score=299.20  Aligned_cols=259  Identities=22%  Similarity=0.247  Sum_probs=196.3

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhc-CCCceeeeeeeecC--CeeEEEEe
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLR-HRNLVQLLGWCRRR--GDLLLVYD  420 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~E  420 (687)
                      |+..+.||+|+||.||+|....+++.||+|+++.... ........|+.++.++. |+|++++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            5677899999999999999988899999999876422 22234457888898885 99999999999887  88999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |++ ++|.+++... ...+++.++..++.|++.||.|||+   .+++||||||+||+++. +.+||+|||+++.......
T Consensus        81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            996 5888777443 2468999999999999999999998   89999999999999999 9999999999986543221


Q ss_pred             CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh-----------ccc
Q 005621          501 PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW-----------KAG  568 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~-----------~~~  568 (687)
                        .....++..|+|||++.. +.++.++|||||||++|||++|..||......+   .+.+..+..           ...
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccc
Confidence              123457889999997654 567889999999999999999999997654322   111111111           111


Q ss_pred             ccccccCCcCCC----CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          569 AILEVVDPRLNG----EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       569 ~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .......+....    .........+.+++.+||+++|++||++.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            100000010000    0011234678999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-34  Score=297.55  Aligned_cols=260  Identities=24%  Similarity=0.309  Sum_probs=197.7

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhh---cCCCceeeeeeeecCCe-----
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRL---RHRNLVQLLGWCRRRGD-----  414 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~-----  414 (687)
                      |+..+.||+|++|.||+|+++.+++.+|+|++.....  .....+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999988899999999874322  2234566787777666   59999999999987776     


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .+++|||++ ++|.+++.......+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            999999996 489888855444468999999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc-ccc---
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA-GAI---  570 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~-~~~---  570 (687)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+..  ..+ .+.... +..   
T Consensus       157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~  231 (287)
T cd07838         157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKI-FDVIGLPSEEEWP  231 (287)
T ss_pred             ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHH-HHHcCCCChHhcC
Confidence            644322  12335788999999999989999999999999999999999998765432211  111 111100 000   


Q ss_pred             ------ccccCCcCCC---CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 ------LEVVDPRLNG---EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 ------~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                            ..........   .........+.+++.+||+.||++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                  0000000000   111123356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-34  Score=297.40  Aligned_cols=263  Identities=24%  Similarity=0.299  Sum_probs=200.0

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEEEecC
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      |...+.||+|++|+||+|+...+++.|+||++..... .......+|+..+++++ |||++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5677899999999999999988899999999875432 22334567999999999 999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                       +|+|.+++.......+++.++..++.|++.+|.|||+   .+++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             8899998865544578999999999999999999998   8999999999999999999999999999986543221  


Q ss_pred             eeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHH----------HHHHHHhcccccc
Q 005621          503 TTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV----------DWVWDRWKAGAIL  571 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~----------~~v~~~~~~~~~~  571 (687)
                      .....++..|+|||++.. ..++.++|+||||++++||++|+.||......+.....          .|...........
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            223457889999998754 56789999999999999999999998765432221100          0100000000000


Q ss_pred             cccCCcCCC---CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLNG---EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+......   .........+.+++.+||+.+|++||+++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000   000111357889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-34  Score=308.67  Aligned_cols=267  Identities=24%  Similarity=0.322  Sum_probs=206.9

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC-----eeE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG-----DLL  416 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  416 (687)
                      +|...+.||.|++|.||+|+...+++.||||++....  ....+.+..|+.++++++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999998889999999987653  344578899999999999999999999987765     789


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +||||++ ++|.+++..  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999997 588888843  3379999999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCC--CceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc-------
Q 005621          497 RGTN--PSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK-------  566 (687)
Q Consensus       497 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~-------  566 (687)
                      ....  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....   +.....       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~  231 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEEDL  231 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChhHh
Confidence            4431  122334678899999999887 889999999999999999999999976653221111   111000       


Q ss_pred             ----ccccccccC---CcCC---CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCC
Q 005621          567 ----AGAILEVVD---PRLN---GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEV  619 (687)
Q Consensus       567 ----~~~~~~~~d---~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~  619 (687)
                          .....+.+.   ..-.   ..........+.+++.+||+.+|++||++.++++  ++++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                000000000   0000   0001112346889999999999999999999998  465543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-34  Score=309.59  Aligned_cols=275  Identities=23%  Similarity=0.343  Sum_probs=202.7

Q ss_pred             CHHHHHHHh----cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeee
Q 005621          334 SYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLG  407 (687)
Q Consensus       334 ~~~el~~at----~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~  407 (687)
                      +.+|+..++    ++|...+.||+|+||.||+|++..+++.||||++....  ......+.+|+.++++++||||+++++
T Consensus         2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~   81 (342)
T cd07879           2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD   81 (342)
T ss_pred             chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhh
Confidence            344555553    78999999999999999999998889999999986532  223456889999999999999999999


Q ss_pred             eeecC------CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC
Q 005621          408 WCRRR------GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE  481 (687)
Q Consensus       408 ~~~~~------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~  481 (687)
                      ++...      ...++|+||+.. +|..++    ...+++..+..++.|++.||.|||+   .+++||||||+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~  153 (342)
T cd07879          82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNED  153 (342)
T ss_pred             eecccccCCCCceEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCC
Confidence            88654      356999999964 666554    2358999999999999999999998   899999999999999999


Q ss_pred             CcEEEcccccceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 005621          482 LNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW  560 (687)
Q Consensus       482 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~  560 (687)
                      +.+||+|||+++.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus       154 ~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~  229 (342)
T cd07879         154 CELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  229 (342)
T ss_pred             CCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999998754322    223467889999999876 4688999999999999999999999986543221111000


Q ss_pred             H--------HHHhcccccccccC--CcC-CCCCC---HHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCCC
Q 005621          561 V--------WDRWKAGAILEVVD--PRL-NGEFN---EIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVP  620 (687)
Q Consensus       561 v--------~~~~~~~~~~~~~d--~~l-~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~  620 (687)
                      .        .+.+..........  +.. .....   ......+.+++.+||+.||++||++.++++  +++...+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0        00000000000000  000 00000   012336789999999999999999999995  4666543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-34  Score=299.05  Aligned_cols=249  Identities=23%  Similarity=0.346  Sum_probs=204.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|...+.||+|++|.||+|+...+++.||+|++...   .....+.+..|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4688899999999999999999889999999998763   2233467889999999998 99999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            999999999999853  3479999999999999999999998   99999999999999999999999999999865433


Q ss_pred             CC-------------------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005621          499 TN-------------------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD  559 (687)
Q Consensus       499 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~  559 (687)
                      ..                   .......++..|+|||.......+.++||||||++++++++|+.||.......   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQ  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH
Confidence            21                   12223467889999999988889999999999999999999999998654211   111


Q ss_pred             HHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCH----HHHHH
Q 005621          560 WVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTM----RQVVR  613 (687)
Q Consensus       560 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~  613 (687)
                      .+.    .      ...    .++......+.+++.+||+.+|++||++    +++++
T Consensus       233 ~~~----~------~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 KIL----K------LEY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHH----h------cCC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            110    0      011    1122224478899999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-35  Score=299.90  Aligned_cols=289  Identities=26%  Similarity=0.352  Sum_probs=233.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      +.|+.-++||+||||.||-++.+.+|+.+|.|++.+..   +++..-.+.|-.+|.+++.+.||.+--.++.++.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45788899999999999999999999999999886643   334455678999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ..|.||+|.-||+...+..+++..+.-.+.+|+.||++||.   ..||.|||||+|||||+.|+++|+|.|||..+..+.
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            99999999999988777789999999999999999999998   999999999999999999999999999999776544


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC-
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL-  578 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l-  578 (687)
                      .  ....+||.+|||||++.++.|+...|.||+||+||||+.|+.||.........                +-+|.+. 
T Consensus       342 ~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------------eEvdrr~~  403 (591)
T KOG0986|consen  342 P--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------------EEVDRRTL  403 (591)
T ss_pred             c--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----------------HHHHHHHh
Confidence            3  33348999999999999999999999999999999999999999765432111                1111111 


Q ss_pred             --CCCCCHHHHHHHHHHHHhccccCcCcCCCHH-----HHHH----------HHhcCCCCCCCCCCCCccCCCCccccCC
Q 005621          579 --NGEFNEIEALDVVKLGLMCSNDAAEARPTMR-----QVVR----------YLEGEVPLPQAVAAPDACDGKKEKTSGG  641 (687)
Q Consensus       579 --~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-----evl~----------~L~~~~~~~~~~~~~~~~~~~~~~~~~~  641 (687)
                        ..++++...+++.+|....|+.||++|...+     +|.+          .|+-..-.|+-.|.|.++-.++-.+-+.
T Consensus       404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeq  483 (591)
T KOG0986|consen  404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQ  483 (591)
T ss_pred             cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhh
Confidence              1234455556788888899999999997554     4443          2333333445555566666666666777


Q ss_pred             CCCCCCCCccc
Q 005621          642 GAGVDGPEFED  652 (687)
Q Consensus       642 ~~~~~~~~~~~  652 (687)
                      ++.+.+-.+++
T Consensus       484 Fs~VKGV~ld~  494 (591)
T KOG0986|consen  484 FSTVKGVKLDD  494 (591)
T ss_pred             cccccceeccc
Confidence            77777666554

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-33  Score=297.31  Aligned_cols=257  Identities=19%  Similarity=0.250  Sum_probs=187.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcchhhH-----------HHHHHHHHHHhhhcCCCceeeee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNESKQGL-----------REFASEISSIGRLRHRNLVQLLG  407 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~~  407 (687)
                      .++|...++||+|+||+||+|.+..+   +..+|+|+.........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999998766   56677776433221110           11233445566678999999999


Q ss_pred             eeecCC----eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          408 WCRRRG----DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       408 ~~~~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                      ++....    ..++++|++. .++.+.+..  ....++..+..|+.|++.||.|||+   ++|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence            765443    3477788764 355555522  2235788899999999999999998   89999999999999999999


Q ss_pred             EEEcccccceeccCCCC------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhH
Q 005621          484 GRLGDFGLAKLYERGTN------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELIL  557 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~  557 (687)
                      ++|+|||+++.+.....      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            99999999987643221      112234699999999999999999999999999999999999999987643222111


Q ss_pred             ---HHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          558 ---VDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       558 ---~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                         .++ ......+..        ..   ...+..+.+++..|++.+|++||++.++++.|.
T Consensus       245 ~~~~~~-~~~~~~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        245 AAKCDF-IKRLHEGKI--------KI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HhHHHH-HHHhhhhhh--------cc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence               111 111111111        00   112346889999999999999999999998763

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-34  Score=324.61  Aligned_cols=267  Identities=21%  Similarity=0.294  Sum_probs=189.4

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCe-EEEEE------------------EecCcchhhHHHHHHHHHHHhhhcCCC
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNT-QVAVK------------------RVSNESKQGLREFASEISSIGRLRHRN  401 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n  401 (687)
                      ..++|+..+.||+|+||+||++.++.... ..+.|                  .+. .......++.+|+.++++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            34689999999999999999987643221 12222                  111 11223456889999999999999


Q ss_pred             ceeeeeeeecCCeeEEEEecCCCCCchhhhhchh---hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ---KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       402 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                      |+++++++...+..++|+|++. ++|.+++....   .......++..|+.||+.||.|||+   ++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence            9999999999999999999984 57777764321   1223456778899999999999998   999999999999999


Q ss_pred             ccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCC-CCCCCCcchhhH
Q 005621          479 DSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP-IEPKALPEELIL  557 (687)
Q Consensus       479 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p-~~~~~~~~~~~~  557 (687)
                      +.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +..........+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999987654433333446799999999999999999999999999999999998764 433222111111


Q ss_pred             HHHHHHHhc--ccc-------cccccCC-cC---CCCCCH-----HHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          558 VDWVWDRWK--AGA-------ILEVVDP-RL---NGEFNE-----IEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       558 ~~~v~~~~~--~~~-------~~~~~d~-~l---~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+.+. .+.  ...       +.+.++. .+   ...++.     ....++.+++.+||+.||++||++.|+++
T Consensus       381 ~~~~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        381 LKIID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            11110 000  000       0000000 00   000000     01224667889999999999999999987

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=327.67  Aligned_cols=262  Identities=29%  Similarity=0.422  Sum_probs=210.8

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCC-------CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeee
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPS-------TNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWC  409 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~  409 (687)
                      +...++....+.||+|.||.|++|....       ....||||.+.... ....+.+..|+++|+.+ +|+|++.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3344455566699999999999998531       14579999987653 34567899999999999 699999999999


Q ss_pred             ecCCeeEEEEecCCCCCchhhhhchh------------h--ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCc
Q 005621          410 RRRGDLLLVYDFMPNGSLDKCLFDEQ------------K--AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGN  475 (687)
Q Consensus       410 ~~~~~~~lV~Ey~~~gsL~~~L~~~~------------~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  475 (687)
                      ..++..++|+||+..|+|.++|+..+            .  ..++..+.+.++.|||.||+||++   .+++||||.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence            99999999999999999999996654            0  138899999999999999999999   999999999999


Q ss_pred             EEeccCCcEEEcccccceeccCCCCCceeeee--cCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCc
Q 005621          476 VLLDSELNGRLGDFGLAKLYERGTNPSTTRVV--GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALP  552 (687)
Q Consensus       476 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~  552 (687)
                      ||+.++..+||+|||+|+............-.  -+..|||||.+....++.|||||||||+||||+| |..||......
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999965443333222122  2557999999999999999999999999999999 77887652211


Q ss_pred             chhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          553 EELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       553 ~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .+      +++.+++|..+         +.+..+..++.++++.||+.+|++||++.++++.++..
T Consensus       529 ~~------l~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  529 EE------LLEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HH------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11      23344444433         23344455888999999999999999999999999873

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.6e-34  Score=296.13  Aligned_cols=256  Identities=23%  Similarity=0.291  Sum_probs=202.3

Q ss_pred             CcccceeeeeeCeEEEEEEEeC---CCCeEEEEEEecCcc----hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCee
Q 005621          344 GFRDKELLGFGGFGRVYKGTLP---STNTQVAVKRVSNES----KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  415 (687)
                      +|+..+.||+|++|.||+++..   .+++.||||.+....    ....+++..|+.++.++ +|||++++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999864   356789999987532    22345688999999999 599999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++++|.+++..  ...+++..+..++.|+++||.|||+   .+++||||||+||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            999999999999998853  3468999999999999999999998   99999999999999999999999999999865


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCCC--CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTGK--PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ............|+..|+|||.+.+..  .+.++||||||+++|||++|..||........  ..+.......       
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~-------  226 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK-------  226 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc-------
Confidence            443332233356889999999987665  78899999999999999999999864322111  1111111111       


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ..+.....    ....+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       227 ~~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         227 SKPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             cCCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            01112222    23367889999999999999999999888765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.9e-33  Score=292.63  Aligned_cols=242  Identities=23%  Similarity=0.300  Sum_probs=190.0

Q ss_pred             eeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHH---HHhhhcCCCceeeeeeeecCCeeEEEEecCC
Q 005621          350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEIS---SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       350 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      +||+|+||.||++....+++.||+|.+.....   .....+..|..   .++...|||++++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999988899999999865421   11223344443   4444579999999999999999999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +++|.+++.  ....+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++......   .
T Consensus        81 g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~  152 (278)
T cd05606          81 GGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P  152 (278)
T ss_pred             CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence            999998884  34569999999999999999999998   899999999999999999999999999987553322   1


Q ss_pred             eeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      ....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||..........    .....      ...++.+..  
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~------~~~~~~~~~--  220 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT------LTMAVELPD--  220 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHh------hccCCCCCC--
Confidence            234689999999998754 68899999999999999999999997653322111    00100      011122222  


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                        .....+.+++.+|++.+|.+||     ++.++++
T Consensus       221 --~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         221 --SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              2244788999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-34  Score=305.88  Aligned_cols=271  Identities=21%  Similarity=0.274  Sum_probs=204.3

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWC  409 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~  409 (687)
                      ....+++..++++|...+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            4455677888999999999999999999999998889999999987542  22346688899999999999999999987


Q ss_pred             ecC------CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          410 RRR------GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       410 ~~~------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                      ...      ...++++|++ +++|.+++.   ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence            533      3468888887 789988773   2358999999999999999999998   99999999999999999999


Q ss_pred             EEEcccccceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH---
Q 005621          484 GRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD---  559 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~---  559 (687)
                      +||+|||+++.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............   
T Consensus       159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (345)
T cd07877         159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  234 (345)
T ss_pred             EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999998764322    223467889999999866 568889999999999999999999996543322111000   


Q ss_pred             -----HHHHHhcccc---cccccCCcCCCCCC---HHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          560 -----WVWDRWKAGA---ILEVVDPRLNGEFN---EIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       560 -----~v~~~~~~~~---~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                           .....+....   ....+.......+.   ......+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence                 0000000000   00000000000000   012336789999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1e-33  Score=299.29  Aligned_cols=248  Identities=28%  Similarity=0.400  Sum_probs=198.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      +.|...+.||+|++|.||+|++..+++.+|+|.+...   ......++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3466678899999999999999888999999998643   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+. |+|.+++... ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...... 
T Consensus        95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            9996 6887776433 3458999999999999999999998   89999999999999999999999999998765332 


Q ss_pred             CCceeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          500 NPSTTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                          ....++..|+|||.+.   .+.++.++|||||||++|||++|+.|+......+..      ... ..+.     .+
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~-~~~~-----~~  232 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHI-AQNE-----SP  232 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HHH-hhcC-----CC
Confidence                2346788999999974   356788999999999999999999998654321111      111 1111     01


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                      ...   .......+.+++.+||+.+|++||++.++++..
T Consensus       233 ~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            111   112334678999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=312.83  Aligned_cols=205  Identities=33%  Similarity=0.492  Sum_probs=178.5

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC------CeeEE
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRR------GDLLL  417 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l  417 (687)
                      +...+.||+|+||.||+|+.+.+|+.||||.++... ....+....|+++|++++|+|||++++.-+..      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            455678999999999999999999999999998754 33456778999999999999999999976543      36799


Q ss_pred             EEecCCCCCchhhhhchh-hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec--cCCc--EEEcccccc
Q 005621          418 VYDFMPNGSLDKCLFDEQ-KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD--SELN--GRLGDFGLA  492 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~~--~kl~DFGla  492 (687)
                      |||||.+|||...|...+ ...|++.+.+.++.+++.||.|||+   ++|+||||||.||++-  ++++  -||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999996633 3469999999999999999999998   9999999999999993  3343  699999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhcc-CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcch
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTR-TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE  554 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~  554 (687)
                      +.++.+.  ..+.++||..|++||.+. .+.|+..+|.|||||++||++||..||.+...+..
T Consensus       172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~  232 (732)
T KOG4250|consen  172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN  232 (732)
T ss_pred             ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc
Confidence            9887655  566789999999999998 48899999999999999999999999998776644

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=280.64  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=201.1

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEEEecCCC
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ....||.|..|+|++++.+.+|..+|||.+... .++..++++..+.++.+.+ +|.||+.+|||..+...++.||.| .
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence            345699999999999999999999999998765 5666788888888888775 899999999999999999999998 3


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      ..++.+|. .-.+++++...-++...+..||.||-+  +++|+|||+||+|||+|+.|++|+||||++..+-.+.  ..+
T Consensus       175 ~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Aht  249 (391)
T KOG0983|consen  175 TCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHT  249 (391)
T ss_pred             HHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--ccc
Confidence            35555553 335578888889999999999999998  6999999999999999999999999999997664433  234


Q ss_pred             eeecCCCCCchhhccC---CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          505 RVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      +..|-+.|||||.+.-   .+|+-++||||||+.|+||.||+.||.....+.+.. .          +++.-..|.|+..
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l-t----------kvln~ePP~L~~~  318 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL-T----------KVLNEEPPLLPGH  318 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH-H----------HHHhcCCCCCCcc
Confidence            4578899999999853   478889999999999999999999998865543321 1          1111122444432


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..  ....+++++..||..|+.+||...++++
T Consensus       319 ~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  319 MG--FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cC--cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            21  3447889999999999999999999986

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.9e-33  Score=297.73  Aligned_cols=257  Identities=22%  Similarity=0.272  Sum_probs=192.4

Q ss_pred             eeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       350 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      .+|.|+++.||+  ...+++.||||++...  .....+.+..|++++++++||||+++++++.+.+..+++|||+++++|
T Consensus         9 ~~~~~~~v~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           9 CFEDLMIVHLAK--HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             hhcCCceEEEEE--ecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            344445544444  4458899999998765  345567899999999999999999999999999999999999999999


Q ss_pred             hhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC------C
Q 005621          428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN------P  501 (687)
Q Consensus       428 ~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~------~  501 (687)
                      .+++.......+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||.+........      .
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            999976555568999999999999999999998   8999999999999999999999999999875432211      1


Q ss_pred             ceeeeecCCCCCchhhccCC--CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc----c-------c
Q 005621          502 STTRVVGTLGYLAPELTRTG--KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK----A-------G  568 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~----~-------~  568 (687)
                      ......++..|+|||++...  .++.++|||||||++|||++|+.||........  ..+.......    .       .
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcC
Confidence            11234567889999998763  578999999999999999999999986442211  1111110000    0       0


Q ss_pred             cccc----ccCCcC----CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          569 AILE----VVDPRL----NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       569 ~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....    ..++..    ..........++.+++.+||+.+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0000    000000    11112223457889999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-33  Score=297.18  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=195.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|...+.||+|++|.||+|.+..+++.||||++.... .....++..|+.++.+.. ||||++++++|......++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            56788899999999999999998889999999987543 234456677887777775 9999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |++ ++|.+++.. ....+++..+..++.|++.||.|||+  .++|+||||+|+||++++++.+||+|||++..+.....
T Consensus        95 ~~~-~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          95 LMS-TCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             ccC-cCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            985 467666533 23478999999999999999999996  25899999999999999999999999999876543221


Q ss_pred             CceeeeecCCCCCchhhccCCC----CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGK----PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                        .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||........     ........ ..     +
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~-~~-----~  237 (296)
T cd06618         171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-----VLTKILQE-EP-----P  237 (296)
T ss_pred             --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-----HHHHHhcC-CC-----C
Confidence              12235788999999987554    78899999999999999999999965322111     11111111 00     1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .+..  .......+.+++.+||+.+|++||++.++++.
T Consensus       238 ~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1110  01123468899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.4e-34  Score=303.42  Aligned_cols=262  Identities=23%  Similarity=0.282  Sum_probs=198.1

Q ss_pred             cCccc-ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhh--------------HHHHHHHHHHHhhhcCCCceeeee
Q 005621          343 RGFRD-KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG--------------LREFASEISSIGRLRHRNLVQLLG  407 (687)
Q Consensus       343 ~~f~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~  407 (687)
                      ++|.. .+.||+|+||+||+|.+..+++.||||++.......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45553 577999999999999998889999999986542211              125778999999999999999999


Q ss_pred             eeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEc
Q 005621          408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       408 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~  487 (687)
                      ++...+..++||||++ |+|.+++.  ....+++.....++.|++.||.|||+   .+++||||+|+||+++.++.+||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence            9999999999999996 68988884  34468999999999999999999998   999999999999999999999999


Q ss_pred             ccccceeccCCC-------------CCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcc
Q 005621          488 DFGLAKLYERGT-------------NPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPE  553 (687)
Q Consensus       488 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~  553 (687)
                      |||+++......             ........++..|+|||++.+. .++.++||||||+++|||++|+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999998654111             1111223467889999998764 46889999999999999999999997655322


Q ss_pred             hhhHHHHHHHHhcccc---cccc--------cCCcCCC---CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          554 ELILVDWVWDRWKAGA---ILEV--------VDPRLNG---EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       554 ~~~~~~~v~~~~~~~~---~~~~--------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .   ...+........   ..+.        ..+....   .........+.+++.+||+.+|++||++.|++.
T Consensus       242 ~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 Q---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             H---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1   111211111100   0000        0000000   001112346889999999999999999999997

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.7e-33  Score=294.60  Aligned_cols=252  Identities=21%  Similarity=0.296  Sum_probs=198.4

Q ss_pred             CcccceeeeeeCeEEEEEEEeC---CCCeEEEEEEecCcc----hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCee
Q 005621          344 GFRDKELLGFGGFGRVYKGTLP---STNTQVAVKRVSNES----KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  415 (687)
                      +|+..+.||+|+||.||++...   .+|..||+|++....    ....+++..|+.+++++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4778899999999999999874   367899999987542    22346678899999999 599999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||+|+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            999999999999999853  3468899999999999999999998   99999999999999999999999999999876


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCC--CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTG--KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ............|+..|+|||.+...  .++.++||||||+++|+|++|+.|+........  ..++.......      
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~------  227 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS------  227 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc------
Confidence            44333333345688999999998753  467899999999999999999999864332111  11111111111      


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                       .+.    ++......+.+++.+||+.+|++||     ++.++++
T Consensus       228 -~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 -EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence             111    1222334678999999999999997     6666655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.5e-34  Score=305.90  Aligned_cols=269  Identities=22%  Similarity=0.301  Sum_probs=199.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecC---------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRR---------  412 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------  412 (687)
                      .++|...+.||.|+||.||+|....+++.||+|++........+.+.+|++++++++||||+++++.+...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36899999999999999999999989999999998776656667888999999999999999999876543         


Q ss_pred             -----CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-CCcEEE
Q 005621          413 -----GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-ELNGRL  486 (687)
Q Consensus       413 -----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl  486 (687)
                           ...++||||++ ++|.+++.   ...+++..+..++.||+.||.|||+   .+|+||||||+||+++. ++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence                 35799999997 58888773   3468999999999999999999998   89999999999999974 567899


Q ss_pred             cccccceeccCCCCC--ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 005621          487 GDFGLAKLYERGTNP--STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       487 ~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      +|||+++........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+..........
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999865332111  1122357889999998754 5678899999999999999999999976543221111000000


Q ss_pred             Hhcc---cccc----cccC-CcCCCC-----CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          564 RWKA---GAIL----EVVD-PRLNGE-----FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       564 ~~~~---~~~~----~~~d-~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ....   ....    .... ......     .......++.+++.+||+.+|++||++.++++  +++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            0000   0000    0000 000000     00112346789999999999999999999996  4543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.2e-34  Score=299.94  Aligned_cols=266  Identities=26%  Similarity=0.319  Sum_probs=197.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecC-------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRR-------  412 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------  412 (687)
                      .++|+..++||+|++|.||+|++..+++.+|+|++.....  .....+.+|++++++++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            5789999999999999999999988899999998865432  2234667899999999999999999987443       


Q ss_pred             -CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          413 -GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       413 -~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                       ..+++|+||+.+ +|...+... ...+++.++..++.|+++||.|||+   .+++||||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             346999999964 676666432 3469999999999999999999998   8999999999999999999999999999


Q ss_pred             ceeccCCCCC----------ceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 005621          492 AKLYERGTNP----------STTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW  560 (687)
Q Consensus       492 a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~  560 (687)
                      ++........          ..+...++..|+|||.+.+. .++.++||||||+++|||++|+.||..............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9865432211          11234678899999987654 588999999999999999999999976543221111111


Q ss_pred             HHHHhccc------cccccc--------CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          561 VWDRWKAG------AILEVV--------DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       561 v~~~~~~~------~~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ........      .+....        .+.+...+. .....+.+++.+|++.+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG-KLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcc-cCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00000000      000000        000100000 11246789999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.8e-34  Score=291.61  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=197.7

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-----chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-----SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      +|...+.||+|+||.||++.+...+..+++|.++..     ......++..|+.++++++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            477889999999999999998766666666665432     122334677899999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          419 YDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      |||+++++|.+++..  .....+++.+++.++.|++.||.|||+   .+++|+||||+||+++. +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998854  234568999999999999999999998   99999999999999975 569999999987654


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      .... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+.......      ..... ..+     ..+
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~-~~~-----~~~  223 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRI-VEG-----PTP  223 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHH-HcC-----CCC
Confidence            3222 2223457889999999988888999999999999999999999986543211      11111 111     111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .    .+......+.+++.+||+.+|++||++.++++
T Consensus       224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1    22334457889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-34  Score=303.12  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=203.8

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecC--cchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeE
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  416 (687)
                      ...+.|+++++||+||.+.||++... +.+.+|+|++..  .+.+...-|..|+..|.+| .|.+||+|++|-..++.+|
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            34567889999999999999999874 456777776543  3456678899999999999 4999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      |||||= .-+|..+|.........| .+..+..|++.|+.++|+   ++|||.||||.|+|+- .|.+||+|||+|..+.
T Consensus       437 mvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             EEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            999975 558999996654444445 677899999999999998   9999999999999995 4699999999998776


Q ss_pred             CCCCC-ceeeeecCCCCCchhhccCC-----------CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 005621          497 RGTNP-STTRVVGTLGYLAPELTRTG-----------KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       497 ~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      ..... .....+||+.||+||.+...           +.+.+|||||+||+||+|+.|+.||.....         .+  
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~--  579 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QI--  579 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HH--
Confidence            55432 23457899999999987532           356799999999999999999999975321         11  


Q ss_pred             hcccccccccCCcCCCCCCHHHHH-HHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEAL-DVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~-~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                         .++..+.||.-..+|+..-.. ++++++..||+.||++||+..++++.
T Consensus       580 ---aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 ---AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ---HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence               134556677655555443222 38999999999999999999999983

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.5e-33  Score=296.97  Aligned_cols=245  Identities=28%  Similarity=0.398  Sum_probs=195.9

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      |...+.||+|+||+||+|++..+++.|++|++....   .....++..|++++++++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999998889999999986542   23446788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +. |+|.+++... ...+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            96 5777776432 3468999999999999999999998   8999999999999999999999999999864321    


Q ss_pred             ceeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          502 STTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                       .....|+..|+|||++.   .+.++.++||||||+++|||++|..|+.........      ..... ...     +..
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~-~~~-----~~~  240 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NDS-----PTL  240 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHh-cCC-----CCC
Confidence             22356888999999984   456888999999999999999999998765422111      11111 011     111


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .   .......+.+++.+||+.+|++||++.++++.
T Consensus       241 ~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 Q---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1   11122357889999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-35  Score=308.31  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      |.+...||.|+||.||+|+.+.++...|-|++...+.+.+++|+-|++||..++||+||+|++.|...+.+||..|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            34455699999999999999888888899999888888899999999999999999999999999999999999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |-.+..+..- ...|++.++.-++.|++.||.|||+   +.|||||||+.|||++-+|.++|+|||.+-.... ......
T Consensus       114 GAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRD  188 (1187)
T KOG0579|consen  114 GAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRD  188 (1187)
T ss_pred             chHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh-HHhhhc
Confidence            9998877543 4579999999999999999999999   9999999999999999999999999998754221 112233


Q ss_pred             eeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          505 RVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      .+.||+.|||||+..     ..+|+.++||||||+.|.||..+.+|-....+-  .++..     +..     --.|.|.
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllK-----iaK-----SePPTLl  256 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK-----IAK-----SEPPTLL  256 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHH-----Hhh-----cCCCccc
Confidence            578999999999865     468999999999999999999999886554321  11111     111     1112221


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .  +..-...+.++..+||..+|..||++.++++
T Consensus       257 q--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 Q--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             C--cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1  1223346788999999999999999999986

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.1e-33  Score=299.55  Aligned_cols=267  Identities=22%  Similarity=0.283  Sum_probs=201.8

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeec-CC
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRR-RG  413 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~  413 (687)
                      ++..++++|...+.||.|+||.||++....+++.||+|++....  ....+.+..|++++++++|||++++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            34457889999999999999999999998899999999886432  2334678899999999999999999998865 56


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++|+||+ +++|.+++.   ...+++.....++.|++.||.|||+   .+|+||||+|+||++++++.+||+|||+++
T Consensus        84 ~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            789999998 568888773   3457888899999999999999998   999999999999999999999999999997


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhH-HHH-------HHHH
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELIL-VDW-------VWDR  564 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~-~~~-------v~~~  564 (687)
                      .....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... .++       +.+.
T Consensus       157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            54322    123457889999998766 5689999999999999999999999975442111100 000       0000


Q ss_pred             hcccccccccC-CcCCCCCCH-----HHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          565 WKAGAILEVVD-PRLNGEFNE-----IEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       565 ~~~~~~~~~~d-~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ...+...+... .......+.     .....+.+++.+||+.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00111111100 000011111     123578899999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.8e-34  Score=302.81  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=209.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ...|.+.+.||+|.|++|.+|++..++..||||.+++..  ....+.+.+|+++|..++|||||+++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467889999999999999999999999999999998763  333456889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+.+|.+.+||.  ..+.+....+..++.|+.+|++|||+   +.|+|||||++||||+.++++||+|||++..+..+.
T Consensus       135 eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  135 EYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecccc
Confidence            9999999999994  34557778899999999999999999   999999999999999999999999999999886443


Q ss_pred             CCceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                        .....+|++.|.|||++.+..+ .+++|+||+|++||-|++|..||++....+-..               ..+...+
T Consensus       210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~gk~  272 (596)
T KOG0586|consen  210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRGKY  272 (596)
T ss_pred             --cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheeeee
Confidence              3445689999999999998765 578999999999999999999999876532110               0111111


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +  ++.-...++-+++++++-.+|.+|+++.++.+
T Consensus       273 r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  273 R--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             c--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            1  12222336778899999999999999999987

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=292.80  Aligned_cols=262  Identities=24%  Similarity=0.339  Sum_probs=201.5

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      |+..+.||+|++|.||+|+...+++.+|+|++....  ....+.+..|+.++++++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999998889999999987653  333467889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      + ++|.+++.... ..+++.++.+++.|++.||.|||+   .+|+||||+|+||++++++.+||+|||+++....... .
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  154 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T  154 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence            7 58999885432 469999999999999999999998   8999999999999999999999999999986543322 2


Q ss_pred             eeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHH--------HHHHHHhcccccccc
Q 005621          503 TTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV--------DWVWDRWKAGAILEV  573 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--------~~v~~~~~~~~~~~~  573 (687)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.....        +..|..+..-.....
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2233457789999998776 8899999999999999999999999765432211100        001111100000000


Q ss_pred             cCCcC-----CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VDPRL-----NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .-+..     ...++ .....+.+++.+||+.+|++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         235 TFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000     00011 11447899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-33  Score=300.02  Aligned_cols=269  Identities=23%  Similarity=0.322  Sum_probs=201.8

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC---
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG---  413 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---  413 (687)
                      ....++|...+.||+|++|.||++....+++.||||++...  .......+..|+.++++++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            33567899999999999999999999888999999998643  2333456889999999999999999999886543   


Q ss_pred             ---eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          414 ---DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       414 ---~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                         ..++||||+ +++|.+++.   ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence               469999999 778988773   3468999999999999999999998   999999999999999999999999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHH-H-------HH
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV-D-------WV  561 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~-~-------~v  561 (687)
                      ++.......    ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..........-. .       ..
T Consensus       164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            998653321    23457889999999876 45889999999999999999999999765421110000 0       00


Q ss_pred             HHHhcccccccccC--CcCC----CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          562 WDRWKAGAILEVVD--PRLN----GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       562 ~~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                      .+.+..........  +...    ..........+.+++.+|++.+|++||++.++++  +++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            00000000000000  0000    0011112335789999999999999999999995  55544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.5e-34  Score=323.37  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=195.3

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeec------
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRR------  411 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------  411 (687)
                      .....+|+..++||+||||.|||++.+-+|+.+|||++... +........+|+..+++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            34567788999999999999999999999999999998655 34455678899999999999999998732200      


Q ss_pred             --------------------------------------------------------------------------------
Q 005621          412 --------------------------------------------------------------------------------  411 (687)
Q Consensus       412 --------------------------------------------------------------------------------  411 (687)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhh
Q 005621          412 -------------------------R--------GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL  458 (687)
Q Consensus       412 -------------------------~--------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yL  458 (687)
                                               +        ..+||=||||+...|.+++..+.... .....++++++|++||+|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence                                     0        12578899998888877774332111 4667899999999999999


Q ss_pred             cccccCeEEeeccCCCcEEeccCCcEEEcccccceecc----------------CCC-CCceeeeecCCCCCchhhccCC
Q 005621          459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE----------------RGT-NPSTTRVVGTLGYLAPELTRTG  521 (687)
Q Consensus       459 H~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~----------------~~~-~~~~~~~~gt~~y~aPE~~~~~  521 (687)
                      |+   ++||||||||.|||||++..+||+|||+|+...                .+. ....+..+||.-|+|||++.+.
T Consensus       714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99   999999999999999999999999999998621                011 1234567899999999999764


Q ss_pred             ---CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhcc
Q 005621          522 ---KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCS  598 (687)
Q Consensus       522 ---~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl  598 (687)
                         +|+.|+|+||+|||++||+.   ||....  +...    +...++.+.+...      ..+...+...-.+++.+++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERAS----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchH--HHHH----HHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence               59999999999999999976   454322  2211    2233334433221      2233344445678999999


Q ss_pred             ccCcCcCCCHHHHHH
Q 005621          599 NDAAEARPTMRQVVR  613 (687)
Q Consensus       599 ~~dP~~RPs~~evl~  613 (687)
                      +.||.+|||+.|+++
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999975

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-33  Score=301.03  Aligned_cols=263  Identities=19%  Similarity=0.286  Sum_probs=200.5

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe---
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD---  414 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---  414 (687)
                      ...++|...+.||+|++|.||+|.+..+++.||+|++...  .....+++..|+.++++++|||++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            3467899999999999999999999888999999998653  23344667889999999999999999998766554   


Q ss_pred             ---eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          415 ---LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       415 ---~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                         .++|+||+ +++|.+++..   ..+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence               89999999 6799888843   469999999999999999999998   8999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHH-H-------HHH
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV-D-------WVW  562 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~-~-------~v~  562 (687)
                      +......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+ +       ..+
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            9865432    223457889999999865 36788999999999999999999999755432211100 0       000


Q ss_pred             HHhcccccccc---cCCcCCCCCC---HHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          563 DRWKAGAILEV---VDPRLNGEFN---EIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       563 ~~~~~~~~~~~---~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+........   +...-+..+.   ......+.+++.+||+.+|++||++.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00000000000   0000000010   112457889999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.1e-33  Score=298.78  Aligned_cols=260  Identities=22%  Similarity=0.284  Sum_probs=194.9

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCC--CeEEEEEEecCcc--hhhHHHHHHHHHHHhhh-cCCCceeeeeeeec----CCe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPST--NTQVAVKRVSNES--KQGLREFASEISSIGRL-RHRNLVQLLGWCRR----RGD  414 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~  414 (687)
                      +|+..+.||+|+||.||++.....  +..||+|++....  ....+.+..|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477889999999999999999877  8899999987532  22356788999999999 59999999997543    245


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++++||+. ++|.+++..  ...+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788999985 689888843  4468999999999999999999998   9999999999999999999999999999986


Q ss_pred             ccCCCCC---ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh-----
Q 005621          495 YERGTNP---STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW-----  565 (687)
Q Consensus       495 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~-----  565 (687)
                      .......   ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.........   ..+....     
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~  231 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQL---NQILQVLGTPDE  231 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHH---HHHHHHhCCCCH
Confidence            5432221   1233568999999998765 46889999999999999999999998765421111   1000000     


Q ss_pred             ------cccccc-------cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          566 ------KAGAIL-------EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       566 ------~~~~~~-------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                            ......       ......+. .........+.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  000000       00000000 000112346889999999999999999999885

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-33  Score=283.82  Aligned_cols=237  Identities=25%  Similarity=0.317  Sum_probs=195.1

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCc
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL  427 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL  427 (687)
                      ||+|++|.||++....+++.+|+|++.....   .....+..|++++++++|||++++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999988899999999876532   2456788999999999999999999999999999999999999999


Q ss_pred             hhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeee
Q 005621          428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV  507 (687)
Q Consensus       428 ~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  507 (687)
                      .+++..  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~  154 (250)
T cd05123          81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC  154 (250)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence            999843  3368999999999999999999998   999999999999999999999999999998654432 1233456


Q ss_pred             cCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHH
Q 005621          508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEA  587 (687)
Q Consensus       508 gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  587 (687)
                      ++..|++||...+...+.++|+||||+++|||++|+.||......   .....+    ..+      ..    .++....
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~----~~~------~~----~~~~~~~  217 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKI----LKD------PL----RFPEFLS  217 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----hcC------CC----CCCCCCC
Confidence            788999999998888999999999999999999999999654321   111111    110      11    1122223


Q ss_pred             HHHHHHHHhccccCcCcCCCHHH
Q 005621          588 LDVVKLGLMCSNDAAEARPTMRQ  610 (687)
Q Consensus       588 ~~l~~l~~~Cl~~dP~~RPs~~e  610 (687)
                      ..+.+++.+||..+|++||++.+
T Consensus       218 ~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         218 PEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHHhcCCHhhCCCccc
Confidence            47889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-35  Score=330.39  Aligned_cols=252  Identities=27%  Similarity=0.385  Sum_probs=204.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      +-++.....||.|.||.||-|....+|+..|+|-+...  .....+...+|+.++..++|||+|+.+|+-..++..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            34556678999999999999999999999999977544  3445567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |||++|+|.+.+.  ..+..++.....+..|++.|++|||+   ++||||||||.||+|+.+|.+|++|||.|.......
T Consensus      1314 EyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            9999999999983  34456667777789999999999999   999999999999999999999999999999876543


Q ss_pred             C---CceeeeecCCCCCchhhccCC---CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH-hccccccc
Q 005621          500 N---PSTTRVVGTLGYLAPELTRTG---KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR-WKAGAILE  572 (687)
Q Consensus       500 ~---~~~~~~~gt~~y~aPE~~~~~---~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~-~~~~~~~~  572 (687)
                      .   .......||+.|||||++.+.   ...-+.||||+|||++||+||++||...+..       |..-. ...|.   
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh--- 1458 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGH--- 1458 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccC---
Confidence            2   122345799999999999753   3456899999999999999999999876542       21111 11111   


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                            .+.+++....+-.+++..|+..||+.|-++.|+++.
T Consensus      1459 ------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 ------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                  123444455567889999999999999998888764

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=278.11  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=205.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|..+++||+|.||+|.+++-+.+++.+|+|+++++.   +.....-..|-++|+..+||.+..|--.+...+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            357888999999999999999999999999999998873   44455667899999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||..||.|.-+|.  +.+.+++....-.-..|..||.|||+   ++||.||||.+|.|||.+|.+||.||||++.-- .
T Consensus       247 MeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-K  320 (516)
T ss_pred             EEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc-c
Confidence            99999999999884  34568888888889999999999999   999999999999999999999999999987321 2


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      ....+.+.+||+.|+|||++....|..+.|.|.+|||+|||+||+.||...+...-..++       ..+      |-  
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-------l~e------d~--  385 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-------LME------DL--  385 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-------Hhh------hc--
Confidence            234456789999999999999999999999999999999999999999876543222111       111      11  


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                        .++.....+...|....+..||.+|.     .++||.+
T Consensus       386 --kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  386 --KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             --cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence              12333333677788889999999996     4566654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=275.55  Aligned_cols=261  Identities=23%  Similarity=0.347  Sum_probs=211.7

Q ss_pred             cCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeec
Q 005621          333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRR  411 (687)
Q Consensus       333 ~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  411 (687)
                      =+++++.+.|+     +.||+|+|+.|--++...++..+|||++.+.......+..+|++++.+. .|+||++|++||++
T Consensus        73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            35778888875     6799999999999999899999999999998777778899999999999 59999999999999


Q ss_pred             CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc---EEEcc
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN---GRLGD  488 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~D  488 (687)
                      +..+|||||-|.||+|..++.+  ...+++.++.++.++|+.||.+||.   ++|.||||||+|||..+...   +||+|
T Consensus       148 d~~FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             cceEEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeec
Confidence            9999999999999999999944  4569999999999999999999998   99999999999999977654   79999


Q ss_pred             cccceecc--CC----CCCceeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcc----
Q 005621          489 FGLAKLYE--RG----TNPSTTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE----  553 (687)
Q Consensus       489 FGla~~~~--~~----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~----  553 (687)
                      |.|.--..  ..    ..+...+.+|+..|||||+..     ...|+.++|.||||||||-|++|..||.+....+    
T Consensus       223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd  302 (463)
T KOG0607|consen  223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD  302 (463)
T ss_pred             cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence            99875321  11    223344567889999999863     2468899999999999999999999998765421    


Q ss_pred             ----hhhHHHHHHHHhcccccccccCCcCCCCCCHH----HHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          554 ----ELILVDWVWDRWKAGAILEVVDPRLNGEFNEI----EALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       554 ----~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                          ...-.+.+.+.+++|..          +|++.    ...+..+++...+-.++.+|.++.++++
T Consensus       303 rGe~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCCccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                11222333444444432          23332    3345678888888999999999999987

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=275.35  Aligned_cols=268  Identities=22%  Similarity=0.289  Sum_probs=209.9

Q ss_pred             HhcCcccc-eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeec----CCe
Q 005621          341 ATRGFRDK-ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRR----RGD  414 (687)
Q Consensus       341 at~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~  414 (687)
                      .|++|++. ++||-|-.|.|-.+..+.+++.+|+|++....     ..++|+++.-.. .|||||+++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45566543 68999999999999999999999999986543     345677765554 69999999998753    467


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC---CcEEEccccc
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE---LNGRLGDFGL  491 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGl  491 (687)
                      +++|||.|+||.|...+.++....+++.++-.|++||+.|+.|||+   .+|.||||||+|+|....   -.+||+|||.
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence            8999999999999999987777789999999999999999999999   999999999999999654   4589999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      |+.-..  .....+.+-|+.|.|||++...+|+..+|+||+||++|-|+||.+||.....   ..+..-+...++.|.. 
T Consensus       211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy-  284 (400)
T KOG0604|consen  211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQY-  284 (400)
T ss_pred             ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCc-
Confidence            986433  2233446779999999999999999999999999999999999999987543   1111112222222221 


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCCCCCCCCCC
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVPLPQAVAA  627 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~~~~~~~  627 (687)
                      +     +..+-.....+...++++..|..+|.+|.|+.++++  ++.+...+|+.+..
T Consensus       285 ~-----FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~  337 (400)
T KOG0604|consen  285 E-----FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS  337 (400)
T ss_pred             c-----CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence            1     111111233456788999999999999999999997  56666666665543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=290.19  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=201.8

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      .++||+|.||+||-|+++.+|+.||||++.+.  ......++++|+.+|++++||.||.+.-.|+..+..+.|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            57899999999999999999999999999775  3344578899999999999999999999999999999999999 55


Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC---CcEEEcccccceeccCCCCCc
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE---LNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGla~~~~~~~~~~  502 (687)
                      +..+.+...++++|++....-++.||+.||.|||.   ++|+|+||||+||||.+.   .++||||||.||......-. 
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR-  723 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR-  723 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence            66666656667889999999999999999999998   999999999999999654   57999999999988654432 


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                       ..++||+.|+|||+++.+.|+..-|+||.||++|.-++|..||..+..-.+         .++....   +-|   ...
T Consensus       724 -rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---------QIQNAaF---MyP---p~P  787 (888)
T KOG4236|consen  724 -RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---------QIQNAAF---MYP---PNP  787 (888)
T ss_pred             -hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH---------Hhhcccc---ccC---CCc
Confidence             347899999999999999999999999999999999999999986543111         1111111   111   112


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+.....++|+...|+..-.+|-+..+-+.
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            2233446788999999999999999887664

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.6e-32  Score=313.52  Aligned_cols=146  Identities=28%  Similarity=0.407  Sum_probs=133.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...++||+|+||+||+|.+..+++.||||++....   ......+..|+.+++.++||||+++++++...+.++|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67899999999999999999998889999999987542   333467889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ||+++++|.+++..  ...+++..+++|+.||+.||.|||.   ++|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999843  3468899999999999999999998   899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=9.9e-33  Score=278.69  Aligned_cols=263  Identities=25%  Similarity=0.297  Sum_probs=209.7

Q ss_pred             HHHHHHhcCcccceeeeeeCeEEEEEEEeCCCC-----eEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeee
Q 005621          336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTN-----TQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWC  409 (687)
Q Consensus       336 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~  409 (687)
                      +|+.....+++...++-+|.||.||+|.+.+.+     +.|-+|.++.. +.-....+..|...+..+.|||+.++.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            456666678888889999999999999886543     34667766544 344567789999999999999999999988


Q ss_pred             ec-CCeeEEEEecCCCCCchhhhhc------hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC
Q 005621          410 RR-RGDLLLVYDFMPNGSLDKCLFD------EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL  482 (687)
Q Consensus       410 ~~-~~~~~lV~Ey~~~gsL~~~L~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~  482 (687)
                      .+ ....+.+|.++.-|+|..+|..      ...+.++..+...++.|++.|++|||.   +++||.||.++|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhe
Confidence            65 4577999999999999999962      223467888899999999999999998   9999999999999999999


Q ss_pred             cEEEcccccceeccCCCCCc-eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 005621          483 NGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDW  560 (687)
Q Consensus       483 ~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~  560 (687)
                      ++||+|=.++|.+-...... ......+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.+..     
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-----  508 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-----  508 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-----
Confidence            99999999998654433221 122234779999999999999999999999999999999 88898766543322     


Q ss_pred             HHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       561 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                        ..+++|.       |+.  -+..++.++..++..||...|++||+++|++.-|.+
T Consensus       509 --~ylkdGy-------Rla--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  509 --HYLKDGY-------RLA--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             --HHHhccc-------eec--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence              2233332       222  233456689999999999999999999999987754

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=4.1e-34  Score=275.89  Aligned_cols=262  Identities=26%  Similarity=0.345  Sum_probs=204.1

Q ss_pred             CCccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhh-cCCCceeeee
Q 005621          330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRL-RHRNLVQLLG  407 (687)
Q Consensus       330 ~~~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~  407 (687)
                      .+.|+-+.|+.       +..||.|+||+|+|-.++..|+..|||+++.... ...++++.|.+...+- ++||||+++|
T Consensus        58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            45677666665       4569999999999999999999999999986643 5567888888776665 7999999999


Q ss_pred             eeecCCeeEEEEecCCCCCchhhh---hchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          408 WCRRRGDLLLVYDFMPNGSLDKCL---FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       408 ~~~~~~~~~lV~Ey~~~gsL~~~L---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      .+..++..|+.||.| .-||+.+.   +..++..+++.-.-.|......||.||-+  +..|+|||+||+||||+..|.+
T Consensus       131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCE
Confidence            999999999999999 44665543   44566789999999999999999999998  4899999999999999999999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccC--CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVW  562 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~  562 (687)
                      ||||||++..+..+.  ..+.-+|-..|||||.+..  ..|+-+|||||||+.|+|+.||+.|+..-..     ..+.+.
T Consensus       208 KLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~  280 (361)
T KOG1006|consen  208 KLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLC  280 (361)
T ss_pred             eeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHH
Confidence            999999987654332  2234468889999999864  3488999999999999999999999876432     111111


Q ss_pred             HHhcccccccccCCcCCCC-CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          563 DRWKAGAILEVVDPRLNGE-FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       563 ~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      +.. .|..     |.|... -.......+..++..|+-.|...||...++.++
T Consensus       281 ~Vv-~gdp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  281 QVV-IGDP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHH-cCCC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            111 1111     112111 112234478889999999999999999998863

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=2.2e-32  Score=277.85  Aligned_cols=220  Identities=20%  Similarity=0.162  Sum_probs=178.3

Q ss_pred             eCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCchhhhhc
Q 005621          354 GGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD  433 (687)
Q Consensus       354 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~  433 (687)
                      |.+|.||++.++.+++.+|+|++....     .+..|...+....|||++++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999999999999999987653     233455555566799999999999999999999999999999999853


Q ss_pred             hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeecCCCCC
Q 005621          434 EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL  513 (687)
Q Consensus       434 ~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~  513 (687)
                        ...+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++++|||++.......    ....++..|+
T Consensus        79 --~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~  149 (237)
T cd05576          79 --FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC  149 (237)
T ss_pred             --hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence              3458999999999999999999998   999999999999999999999999999886554321    1234567899


Q ss_pred             chhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHH
Q 005621          514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKL  593 (687)
Q Consensus       514 aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  593 (687)
                      |||......++.++||||+|+++|||++|+.|+.......                 ......    ..+......+.++
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~~l  208 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTL----NIPEWVSEEARSL  208 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------cccccc----CCcccCCHHHHHH
Confidence            9999988889999999999999999999998865322100                 000000    1122233468899


Q ss_pred             HHhccccCcCcCCCH
Q 005621          594 GLMCSNDAAEARPTM  608 (687)
Q Consensus       594 ~~~Cl~~dP~~RPs~  608 (687)
                      +.+|++.||++||++
T Consensus       209 i~~~l~~dp~~R~~~  223 (237)
T cd05576         209 LQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHccCCHHHhcCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.4e-33  Score=313.84  Aligned_cols=265  Identities=24%  Similarity=0.249  Sum_probs=214.8

Q ss_pred             CCccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeee
Q 005621          330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLL  406 (687)
Q Consensus       330 ~~~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~  406 (687)
                      |.--...+++-..++|.+.++||+|+||.|..++++.+++.+|.|++++.   .+....-|..|-.+|..-+.+-|++++
T Consensus        62 p~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   62 PIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            33344566777788999999999999999999999999999999999884   234456789999999999999999999


Q ss_pred             eeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEE
Q 005621          407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL  486 (687)
Q Consensus       407 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl  486 (687)
                      -.|.+.+.+|+|||||+||+|..+|.+..  ++++..+.-++..|..||.-||+   .|+|||||||+|||||..|.+||
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEee
Confidence            99999999999999999999999995543  68999999999999999999999   99999999999999999999999


Q ss_pred             cccccceeccCCCCCceeeeecCCCCCchhhccC-----CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 005621          487 GDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT-----GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV  561 (687)
Q Consensus       487 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v  561 (687)
                      +|||.+-.+..+..-.....+|||.|++||+++.     +.|++.+|.||+||++|||+.|..||..+...+...     
T Consensus       217 ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~-----  291 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG-----  291 (1317)
T ss_pred             ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH-----
Confidence            9999998887666555666799999999999863     578999999999999999999999998765432221     


Q ss_pred             HHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC---HHHHHH
Q 005621          562 WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT---MRQVVR  613 (687)
Q Consensus       562 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~  613 (687)
                       ..+.......+.       -....+....+|+.+.+. +|+.|..   +.++..
T Consensus       292 -KIm~hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  292 -KIMNHKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             -HHhchhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence             111111111111       011233456667766554 5777777   888876

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.6e-31  Score=269.86  Aligned_cols=239  Identities=27%  Similarity=0.353  Sum_probs=195.4

Q ss_pred             CeEEEEEEEeCCCCeEEEEEEecCcchhh-HHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCchhhhhc
Q 005621          355 GFGRVYKGTLPSTNTQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD  433 (687)
Q Consensus       355 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~  433 (687)
                      +||.||+|+...+++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999998889999999998765444 68899999999999999999999999999999999999999999998854


Q ss_pred             hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeecCCCCC
Q 005621          434 EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL  513 (687)
Q Consensus       434 ~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~  513 (687)
                      ..  .+++.++..++.+++.++.|||+   .+++|+||+|+||+++.++.++|+|||.+.......  ......++..|+
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~  153 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM  153 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence            32  38999999999999999999998   899999999999999999999999999998765432  223456788999


Q ss_pred             chhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHH
Q 005621          514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKL  593 (687)
Q Consensus       514 aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  593 (687)
                      +||.+....++.++|||+||+++++|++|..||.......  ...+    ....+....       ..........+.++
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~----~~~~~~~~~-------~~~~~~~~~~~~~~  220 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFK----KIGKPKPPF-------PPPEWKISPEAKDL  220 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH----HHhccCCCC-------ccccccCCHHHHHH
Confidence            9999998889999999999999999999999987632211  1111    111111100       00000023478899


Q ss_pred             HHhccccCcCcCCCHHHHHH
Q 005621          594 GLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       594 ~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +.+|+..+|++||++.++++
T Consensus       221 i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      221 IRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHccCCchhccCHHHHhh
Confidence            99999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=276.70  Aligned_cols=263  Identities=22%  Similarity=0.319  Sum_probs=209.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-C-C----CceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-H-R----NLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~~~~~~~~~~  415 (687)
                      +++|.+..++|+|.||.|-++.+...+..||||+++...+. .+..+-|++++.++. + |    -++++.+|++-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            68899999999999999999999888999999999765443 244567999999993 2 2    378899999999999


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc---------------
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---------------  480 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~---------------  480 (687)
                      |||+|.+ |-|+.++|..+.-.+++..++..|+.|+++++++||+   .+++|-||||+|||+.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999988 7799999988777889999999999999999999999   99999999999999932               


Q ss_pred             -----CCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchh
Q 005621          481 -----ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL  555 (687)
Q Consensus       481 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~  555 (687)
                           +..+||+|||.|+.-...    ...++.|..|.|||++.+-.++.++||||+||||.||.||..-|+.....+.+
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             eccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                 335899999999864332    24578899999999999999999999999999999999999999877655544


Q ss_pred             hHHHHHHH--------------Hhccccc-----------ccccCCc--C--CCCCCHHHHHHHHHHHHhccccCcCcCC
Q 005621          556 ILVDWVWD--------------RWKAGAI-----------LEVVDPR--L--NGEFNEIEALDVVKLGLMCSNDAAEARP  606 (687)
Q Consensus       556 ~~~~~v~~--------------~~~~~~~-----------~~~~d~~--l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  606 (687)
                      ...+.+..              ....|.+           ....++.  +  .......+...+.+|+.++|..||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence            33333211              1111110           0001110  0  1122345666899999999999999999


Q ss_pred             CHHHHHH
Q 005621          607 TMRQVVR  613 (687)
Q Consensus       607 s~~evl~  613 (687)
                      |++|+++
T Consensus       399 Tl~EAL~  405 (415)
T KOG0671|consen  399 TLREALS  405 (415)
T ss_pred             cHHHHhc
Confidence            9999987

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=5.3e-32  Score=266.38  Aligned_cols=268  Identities=24%  Similarity=0.327  Sum_probs=199.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCC----eEEEEEEecCcchh--hHHHHHHHHHHHhhhcCCCceeeeeeeec-CCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTN----TQVAVKRVSNESKQ--GLREFASEISSIGRLRHRNLVQLLGWCRR-RGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  414 (687)
                      ...|+....||+|.||.||+|..+.++    ..+|||+++.+...  ......+|+.+++.++|||++.|..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            346888999999999999999765443    36899998766322  23456789999999999999999998876 778


Q ss_pred             eEEEEecCCCCCchhhhhc---hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC----CcEEEc
Q 005621          415 LLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE----LNGRLG  487 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~  487 (687)
                      .+|++||.+. +|...++.   .....++...+..|+.||+.|+.|||+   .=|+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999976 77777743   223568899999999999999999999   779999999999999887    899999


Q ss_pred             ccccceeccCCCCC--ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCC------cchhhHH
Q 005621          488 DFGLAKLYERGTNP--STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKAL------PEELILV  558 (687)
Q Consensus       488 DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~------~~~~~~~  558 (687)
                      |+|++|.+...-.+  ....++-|..|.|||.+.+ ..||++.|||+.||++.||+|-.+-|.+...      +......
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999988665433  2345778999999999887 4699999999999999999998887765432      2222222


Q ss_pred             HHHHHHhcccccccccC----Cc---C----C-CCCCHH-----------HHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          559 DWVWDRWKAGAILEVVD----PR---L----N-GEFNEI-----------EALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       559 ~~v~~~~~~~~~~~~~d----~~---l----~-~~~~~~-----------~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +.+.+.+....-.+..+    |.   +    + ..++..           ......+|..++|..||.+|.|+++.++
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            33322221111000000    00   0    0 000000           1123678899999999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=291.26  Aligned_cols=240  Identities=26%  Similarity=0.307  Sum_probs=196.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      +..|.....+|.|+|+.|-++.+..+++..+||++.+...    +-.+|+.++... +|||++++.+.+.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5677888889999999999999999999999999987622    234566666555 79999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe-ccCCcEEEcccccceeccCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL-DSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll-~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ++.++-|.+.+....   ....++..|+.+|+.|+.|||+   ++++||||||+|||+ ++.++++|+|||.++..... 
T Consensus       397 ~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            999998877664332   2226777899999999999999   999999999999999 58899999999999876554 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         ....+-|..|.|||++....+++++|+||||++||+|++|+.||.......      -+...+..+           
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~~~-----------  529 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQMP-----------  529 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhcCC-----------
Confidence               222355889999999999999999999999999999999999998765431      112222222           


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       .+.........+|+.+||+.||.+||+|.++..
T Consensus       530 -~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 -KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence             222334457889999999999999999999986

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-32  Score=277.49  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=201.9

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chh-----hHHHHHHHHHHHhhhcCCCceeeeeeee-cC
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQ-----GLREFASEISSIGRLRHRNLVQLLGWCR-RR  412 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~  412 (687)
                      ..++|-.+++||+|||+.||+|.+....+.||||+-...  -+.     -.+...+|..+.+.|+||.||++|+|+. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            345788889999999999999999888999999985432  111     1345678999999999999999999986 55


Q ss_pred             CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc---CCcEEEccc
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLGDF  489 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DF  489 (687)
                      +.+|-|.|||+|.+|+-||.  +...+++.++..|+.||+.||.||.+ ...+|||-||||.||||..   -|.+||.||
T Consensus       541 dsFCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ccceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeec
Confidence            67899999999999999994  45679999999999999999999996 5689999999999999954   478999999


Q ss_pred             ccceeccCCCCC------ceeeeecCCCCCchhhccCC----CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005621          490 GLAKLYERGTNP------STTRVVGTLGYLAPELTRTG----KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD  559 (687)
Q Consensus       490 Gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~  559 (687)
                      ||++.++.....      .+....||..|++||++.-+    +.+.|.||||.||++|.++.|++||.........    
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI----  693 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI----  693 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH----
Confidence            999988765432      24457899999999998643    5788999999999999999999999876532211    


Q ss_pred             HHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          560 WVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       560 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                           +....++..-.-.+  ...+....+...++++||+..-++|....++..
T Consensus       694 -----LqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  694 -----LQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             -----HhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                 11112222111111  111122336778999999999999988777653

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=3.9e-31  Score=299.38  Aligned_cols=256  Identities=18%  Similarity=0.255  Sum_probs=173.1

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCC----CeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeee------ee
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPST----NTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW------CR  410 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~  410 (687)
                      ..++|...++||+|+||.||+|++..+    +..||||++......  +.+..|  .++...+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567899999999999999999999888    889999987643221  111111  1122222233222221      24


Q ss_pred             cCCeeEEEEecCCCCCchhhhhchhh------------------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccC
Q 005621          411 RRGDLLLVYDFMPNGSLDKCLFDEQK------------------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIK  472 (687)
Q Consensus       411 ~~~~~~lV~Ey~~~gsL~~~L~~~~~------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  472 (687)
                      .....++||||+++++|.+++.....                  .......+..++.||+.||.|||+   ++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence            56789999999999999998854221                  011233456799999999999998   899999999


Q ss_pred             CCcEEecc-CCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCC----------------------CCCCccce
Q 005621          473 AGNVLLDS-ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG----------------------KPTTSSDV  529 (687)
Q Consensus       473 ~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDV  529 (687)
                      |+|||++. ++.+||+|||+++.+............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57899999999986654444444456789999999965322                      23456799


Q ss_pred             ehhhHHHHHHHhCCCCCCCCCCcc-------hhhHHHHHHHHhcccccccccCCcCCCC----C--CHHHHHHHHHHHHh
Q 005621          530 YAFGALLLEVVCGRRPIEPKALPE-------ELILVDWVWDRWKAGAILEVVDPRLNGE----F--NEIEALDVVKLGLM  596 (687)
Q Consensus       530 ~S~Gvvl~elltG~~p~~~~~~~~-------~~~~~~~v~~~~~~~~~~~~~d~~l~~~----~--~~~~~~~l~~l~~~  596 (687)
                      |||||+||||+++..|.+......       ...+..|.          ....+....+    +  .........+|+.+
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWR----------KLVEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHH----------HhhccccchhhhhhhhhccccchHHHHHHHH
Confidence            999999999999776643221000       00011111          0111111000    0  00112245689999


Q ss_pred             ccccCcCcCCCHHHHHH
Q 005621          597 CSNDAAEARPTMRQVVR  613 (687)
Q Consensus       597 Cl~~dP~~RPs~~evl~  613 (687)
                      |++.||++|||+.|+++
T Consensus       433 mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        433 MMRFKGRQRISAKAALA  449 (566)
T ss_pred             HccCCcccCCCHHHHhC
Confidence            99999999999999997

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=242.99  Aligned_cols=265  Identities=23%  Similarity=0.285  Sum_probs=200.4

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +|...++||+|.||+||+|+...+++.||+|+++.+.  ...-....+|+.+++.++|+|||++++....++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566788999999999999999999999999987653  22345678999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      | ..+|..+. +.-++.++.+.+..++.|+++||.++|+   +++.||||||.|.+++.+|+.|++|||+++.+.-... 
T Consensus        83 c-dqdlkkyf-dslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr-  156 (292)
T KOG0662|consen   83 C-DQDLKKYF-DSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-  156 (292)
T ss_pred             h-hHHHHHHH-HhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence            9 45777765 3446679999999999999999999999   9999999999999999999999999999997754332 


Q ss_pred             ceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCC-CCCCCCcchhhHHHHHHHHhccccc---ccccCC
Q 005621          502 STTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRP-IEPKALPEELILVDWVWDRWKAGAI---LEVVDP  576 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p-~~~~~~~~~~~~~~~v~~~~~~~~~---~~~~d~  576 (687)
                      .....+-|..|.+|+++.+. -|+...|+||-||++.|+....+| |.+.+..+...-+-|+.....+...   ....|-
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            22334568999999999875 588899999999999999985544 4444444443333343333332222   122222


Q ss_pred             cCCCCCCHH---------HHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          577 RLNGEFNEI---------EALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       577 ~l~~~~~~~---------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .....++..         ....=.++....+.-+|.+|.++++.++.
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            222222211         11123456666777789999999988763

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1e-30  Score=289.03  Aligned_cols=262  Identities=22%  Similarity=0.285  Sum_probs=182.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeC----------------CCCeEEEEEEecCcchhhHHHH--------------HHHH
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLP----------------STNTQVAVKRVSNESKQGLREF--------------ASEI  391 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~  391 (687)
                      .++|+..++||+|+||+||+|.+.                ..++.||||++........++|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            568999999999999999999752                2346799999876543333333              3477


Q ss_pred             HHHhhhcCCCc-----eeeeeeeec--------CCeeEEEEecCCCCCchhhhhchh----------------------h
Q 005621          392 SSIGRLRHRNL-----VQLLGWCRR--------RGDLLLVYDFMPNGSLDKCLFDEQ----------------------K  436 (687)
Q Consensus       392 ~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~L~~~~----------------------~  436 (687)
                      .++.+++|.++     ++++++|..        .+..+|||||+++++|.++|+...                      .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777876654     678888753        357899999999999999886421                      1


Q ss_pred             ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeecCCCCCchh
Q 005621          437 AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE  516 (687)
Q Consensus       437 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE  516 (687)
                      ..++|..+..++.|++.+|.|||+   .+|+||||||+|||++.++.+||+|||+++..............+++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            235678899999999999999998   89999999999999999999999999999765433222222234578999999


Q ss_pred             hccCCCC----------------------CCccceehhhHHHHHHHhCCC-CCCCCCCcc-hhh---HHHHHHHHhcccc
Q 005621          517 LTRTGKP----------------------TTSSDVYAFGALLLEVVCGRR-PIEPKALPE-ELI---LVDWVWDRWKAGA  569 (687)
Q Consensus       517 ~~~~~~~----------------------~~~sDV~S~Gvvl~elltG~~-p~~~~~~~~-~~~---~~~~v~~~~~~~~  569 (687)
                      .+.....                      ..+.||||+||+++||++|.. |+....... ...   .....|+.+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            8754321                      234799999999999999875 654321100 000   0000111111111


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCc---CcCCCHHHHHHH
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAA---EARPTMRQVVRY  614 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~  614 (687)
                      .    +    -...........+++.+++..+|   .+|+|+.|+++.
T Consensus       461 ~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        461 Y----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             C----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            1    1    01111223467788889998765   689999999863

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-31  Score=289.34  Aligned_cols=260  Identities=25%  Similarity=0.357  Sum_probs=214.0

Q ss_pred             HHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeec--
Q 005621          335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRR--  411 (687)
Q Consensus       335 ~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~--  411 (687)
                      ++.+..-++-|++.+.||.|.+|.||+++...+++..|+|++...... .++...|.++++.+ +|||++.++|++..  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            334444567788999999999999999999999999999998776443 35667888999887 69999999998853  


Q ss_pred             ---CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcc
Q 005621          412 ---RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGD  488 (687)
Q Consensus       412 ---~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  488 (687)
                         ++.+|||||||.+||..|++..-....+.|..+.-|+..++.||.+||.   ..++|||||-.|||++.++.+||.|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEee
Confidence               4689999999999999999977667889999999999999999999998   9999999999999999999999999


Q ss_pred             cccceeccCCCCCceeeeecCCCCCchhhccCC-----CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 005621          489 FGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG-----KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       489 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      ||++..+...... ..+..||+.|||||++...     .|+..+|+||||++..||.-|.+|+-...+...+.+      
T Consensus       167 FGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~------  239 (953)
T KOG0587|consen  167 FGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------  239 (953)
T ss_pred             eeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc------
Confidence            9999877654433 3446899999999998643     467789999999999999999999877654222111      


Q ss_pred             HhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       564 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                            +.  -+|...-.-+..-..++.+++..|+..|.++||++.++++
T Consensus       240 ------Ip--RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 ------IP--RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ------CC--CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                  11  1222222334555668899999999999999999999886

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=272.34  Aligned_cols=251  Identities=25%  Similarity=0.299  Sum_probs=201.1

Q ss_pred             cCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhh-cCCCceeeeee
Q 005621          333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRL-RHRNLVQLLGW  408 (687)
Q Consensus       333 ~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~  408 (687)
                      .+-.+...+ .+|..+.+||+|.||.|.+|..+++.+.+|||+++++-.   .+.+--+.|-++|... +-|.+++++.+
T Consensus       340 ~~~~d~i~~-tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  340 SSKRDRIKA-TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             CCcccceee-cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence            444443333 468889999999999999999999999999999987632   2233345677777766 56789999999


Q ss_pred             eecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcc
Q 005621          409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGD  488 (687)
Q Consensus       409 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  488 (687)
                      +..-+.+|+||||+.||+|--++  ++-+.+.+..+.-.+..||-||-+||+   ++|+.||||.+|||||.+|.+||.|
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~D  493 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIAD  493 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeee
Confidence            99999999999999999998777  445678888999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc
Q 005621          489 FGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG  568 (687)
Q Consensus       489 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~  568 (687)
                      ||+++.--. ....+.+.+||+.|+|||++...+|....|.|||||+||||+.|+.||++.+..+-.       +.+.+ 
T Consensus       494 FGmcKEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF-------~aI~e-  564 (683)
T KOG0696|consen  494 FGMCKENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------QAIME-  564 (683)
T ss_pred             ccccccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHH-
Confidence            999873211 123355689999999999999999999999999999999999999999987653322       11111 


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC
Q 005621          569 AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT  607 (687)
Q Consensus       569 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  607 (687)
                             ..  -.++.....+...+....+...|.+|..
T Consensus       565 -------hn--vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  565 -------HN--VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -------cc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence                   11  1344445557778888888899988853

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.2e-32  Score=263.55  Aligned_cols=266  Identities=26%  Similarity=0.416  Sum_probs=204.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hh-hHHHHHHHHHHHhhhcCCCceeeeeeeec--------C
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQ-GLREFASEISSIGRLRHRNLVQLLGWCRR--------R  412 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~  412 (687)
                      +.|....+||+|.||.||+|+.+.+++.||+|++-.+. +. --....+|+++|..++|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34566778999999999999999999999998754322 22 23456789999999999999999998853        3


Q ss_pred             CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccc
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA  492 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla  492 (687)
                      ..+|+||++|+. +|...|.. ....++..++.++++++..||.|+|.   ..|+|||+|+.|+||+.++.+||+|||++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            358999999965 78877743 33568999999999999999999998   99999999999999999999999999999


Q ss_pred             eeccCCCC---CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc
Q 005621          493 KLYERGTN---PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG  568 (687)
Q Consensus       493 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~  568 (687)
                      |.+.....   +..+..+-|..|.+||.+.+ +.++++.|||.-||++.||.||.+-++.........++.-+...+...
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            97755433   33455667999999999876 579999999999999999999999888877655555544432222211


Q ss_pred             --------cccccc--CCcCCCCCCHH--------HHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          569 --------AILEVV--DPRLNGEFNEI--------EALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       569 --------~~~~~~--d~~l~~~~~~~--------~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                              .+.+.+  .|--.+.+...        ...+.++|+..++..||.+|+++.+++.
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                    111111  11111111110        1226778999999999999999999987

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=8.2e-31  Score=287.52  Aligned_cols=243  Identities=26%  Similarity=0.401  Sum_probs=187.6

Q ss_pred             cccceeeeeeCeEE-EEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecC
Q 005621          345 FRDKELLGFGGFGR-VYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       345 f~~~~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      |...+.+|.|..|+ ||+|..  .++.||||++-.+..   .-..+|+..|+.- +|||||++++.-.+....||..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            45567899999885 899999  678999999865432   3446899999988 6999999999989999999999999


Q ss_pred             CCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc---C--CcEEEcccccceec
Q 005621          423 PNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---E--LNGRLGDFGLAKLY  495 (687)
Q Consensus       423 ~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~--~~~kl~DFGla~~~  495 (687)
                       ..+|.+++...  ......-...+.+..|++.||++||+   .+||||||||.||||+.   +  .+++|+|||+++.+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             56999999552  11111113456788999999999999   99999999999999976   3  57899999999988


Q ss_pred             cCCCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhccccc-c
Q 005621          496 ERGTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCG-RRPIEPKALPEELILVDWVWDRWKAGAI-L  571 (687)
Q Consensus       496 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG-~~p~~~~~~~~~~~~~~~v~~~~~~~~~-~  571 (687)
                      ..+...  ......||.+|+|||.+....-+.+.||||+|||+|+.++| .+||...-..+... .        .+.. +
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-l--------~~~~~L  732 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-L--------TGNYTL  732 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-h--------cCccce
Confidence            765542  23456799999999999999889999999999999999995 89997643211100 0        0110 0


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..    |.  ...++  ...+|+.+|++++|..||++.+|+.
T Consensus       733 ~~----L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 VH----LE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ee----ec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            00    11  11111  6788999999999999999999984

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=243.14  Aligned_cols=202  Identities=28%  Similarity=0.383  Sum_probs=170.7

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-chhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEecCC
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      .....||+|++|.|-+-++..+|+..|+|++... ..+..++.+.|+.+..+. .+|.+|.++|...+.+..++.||.| 
T Consensus        49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-  127 (282)
T KOG0984|consen   49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-  127 (282)
T ss_pred             hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-
Confidence            3456799999999999999999999999998765 345567778888877665 7999999999999999999999999 


Q ss_pred             CCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          424 NGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       424 ~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      .-||+.+..+  .....+++...-+|+..+.+||.|||+  +..++|||+||+|||++.+|++|+||||.+..+..+...
T Consensus       128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk  205 (282)
T KOG0984|consen  128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK  205 (282)
T ss_pred             hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence            4578776643  345678999999999999999999999  589999999999999999999999999999876543322


Q ss_pred             ceeeeecCCCCCchhhccC----CCCCCccceehhhHHHHHHHhCCCCCCCCCCc
Q 005621          502 STTRVVGTLGYLAPELTRT----GKPTTSSDVYAFGALLLEVVCGRRPIEPKALP  552 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~  552 (687)
                        +...|-..|||||.+..    ..|+-||||||||+.+.||.+++.||+.-..+
T Consensus       206 --t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  206 --TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             --HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence              22457788999998753    36889999999999999999999999876554

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-31  Score=273.43  Aligned_cols=249  Identities=24%  Similarity=0.302  Sum_probs=207.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .++.....||-||||.|=++........+|+|++++.   .....+....|-.+|..++.|.||++|..|.+.+..|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            3445566799999999999998665556888888764   3334566788999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |-|-||.|...|+  .++.++.....-++..+++|++|||.   ++||+|||||+|.|||.+|-+||.|||.|+.+..+ 
T Consensus       500 EaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-  573 (732)
T KOG0614|consen  500 EACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-  573 (732)
T ss_pred             HhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence            9999999999994  45678888899999999999999999   99999999999999999999999999999987654 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       ..+.+++||+.|.|||++.++..+.+.|.||+|+++|||++|.+||...++-....++            +.-+|.   
T Consensus       574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------------LkGid~---  637 (732)
T KOG0614|consen  574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------------LKGIDK---  637 (732)
T ss_pred             -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------------Hhhhhh---
Confidence             4566789999999999999999999999999999999999999999987754333222            111111   


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                      .+++........+|+++.+..+|.+|..     +.+|.+
T Consensus       638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence            2344455557888999999999999986     556665

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.9e-30  Score=252.02  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=199.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++|..+++||+|.|.+|.++.++++.+.+|+|+++++.   .+...=...|-.+..+. +||.+|-+..++..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357889999999999999999999999999999987652   22233344566666555 79999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      |.||++||+|--++  .+++.|+++.+.-....|..||.|||+   ++|+.||||.+|||+|..+.+||.|+|+++.-- 
T Consensus       329 vieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l-  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-  402 (593)
T ss_pred             EEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC-
Confidence            99999999997777  445679999999999999999999999   999999999999999999999999999987422 


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCc-chhhHHHHHHHHhcccccccccCC
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP-EELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      .....+.+++||+.|+|||++++..|....|.|++||+++||+.|+.||+--... .+...-+++.+.+-+..+      
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi------  476 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI------  476 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc------
Confidence            2223456689999999999999999999999999999999999999999753321 222334455554433221      


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCC
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPT  607 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  607 (687)
                          .++.....+...+...-++.||.+|..
T Consensus       477 ----riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  477 ----RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ----cccceeehhhHHHHHHhhcCCcHHhcC
Confidence                122223335667778899999999853

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.8e-31  Score=253.25  Aligned_cols=266  Identities=24%  Similarity=0.346  Sum_probs=204.0

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----CeeEE
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----GDLLL  417 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~l  417 (687)
                      ....+.||.|+||.||..+++.+|+.||+|++...-  -...+++.+|+++|+.++|.|++..++...-.     .++|.
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            345678999999999999999999999999986542  23457888999999999999999988865433     36789


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ++|.| ..+|.+.+-  ....++...+.-++.||++||.|||+   .+|.||||||.|.|+++|-..||||||++|..+.
T Consensus       135 ~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence            99998 457777763  34568888899999999999999999   9999999999999999999999999999998877


Q ss_pred             CCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------Hhccc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWD--------RWKAG  568 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~--------~~~~~  568 (687)
                      .....++..+-|..|.|||++.+ +.|+.+.||||.||++.||+-.+.-|....+-+...++--+..        .--+|
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            77777777788999999999987 4799999999999999999999988887665544433221111        00111


Q ss_pred             ccccccCCcCC-CC--------CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          569 AILEVVDPRLN-GE--------FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       569 ~~~~~~d~~l~-~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      .-..++....+ ..        -+.....+...+...++.+||++|.+..+.+..+.
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            11111111111 00        01112224566777889999999999999887654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.9e-29  Score=267.50  Aligned_cols=206  Identities=25%  Similarity=0.398  Sum_probs=178.2

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      -|..++.||-|+||+|.++.-.++...+|.|.+++.+   +......++|-.||...+.+-||+||-.|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            4666789999999999999988888899999998764   3445667899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc----
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE----  496 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~----  496 (687)
                      |++||++-.+|.  +.+.+.+..+.-++..+..|+++.|.   .|+|||||||+|||||.+|.+||.||||+.-+.    
T Consensus       710 YIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  710 YIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             ccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            999999999884  45678888888999999999999998   999999999999999999999999999985331    


Q ss_pred             -----CCCC----------------C----------------ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHH
Q 005621          497 -----RGTN----------------P----------------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV  539 (687)
Q Consensus       497 -----~~~~----------------~----------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~el  539 (687)
                           .+..                .                .....+||..|+|||++....++..+|.||.|||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                 0000                0                00124799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCcch
Q 005621          540 VCGRRPIEPKALPEE  554 (687)
Q Consensus       540 ltG~~p~~~~~~~~~  554 (687)
                      +.|+.||-...+.+.
T Consensus       865 ~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGET  879 (1034)
T ss_pred             hhCCCCccCCCCCcc
Confidence            999999988776543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=3e-28  Score=239.64  Aligned_cols=211  Identities=34%  Similarity=0.542  Sum_probs=185.5

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCchh
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDK  429 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~  429 (687)
                      ||+|.+|.||++....+++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999777999999999876543 45678999999999999999999999999999999999999999999


Q ss_pred             hhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-CCcEEEcccccceeccCCCCCceeeeec
Q 005621          430 CLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-ELNGRLGDFGLAKLYERGTNPSTTRVVG  508 (687)
Q Consensus       430 ~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~g  508 (687)
                      ++.... ..+++.++..++.+++++|.+||+   .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG  155 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence            984332 368999999999999999999998   89999999999999999 89999999999986644321 1223457


Q ss_pred             CCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHH
Q 005621          509 TLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEA  587 (687)
Q Consensus       509 t~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  587 (687)
                      ...|++||..... ..+.+.|+|++|+++++|                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8899999999887 888999999999999999                                                


Q ss_pred             HHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          588 LDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       588 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ..+.+++..|++.+|++||++.++++.
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            267889999999999999999999865

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=248.45  Aligned_cols=134  Identities=27%  Similarity=0.350  Sum_probs=116.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-----C---CCceeeeeeeec--
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-----H---RNLVQLLGWCRR--  411 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~--  411 (687)
                      .++|...++||.|.|++||++.+....+.||+|+.+... .-.+..+.|+++|++++     |   .+||+|++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            368999999999999999999999999999999987543 22355688999999983     3   479999999864  


Q ss_pred             --CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec
Q 005621          412 --RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD  479 (687)
Q Consensus       412 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  479 (687)
                        +.+.|||+|++ |.+|..++....-+.++...+.+|++||+.||.|||.+  .+|||-||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence              45899999999 88999999777777799999999999999999999995  7999999999999994

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.4e-27  Score=237.15  Aligned_cols=200  Identities=32%  Similarity=0.474  Sum_probs=175.4

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCC
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      |+..+.||.|++|.||++....+++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            55678999999999999999877899999999876554 66789999999999999999999999999999999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +++|.+++..... .+++.++..++.+++.++.+||+   .+++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999998854322 18999999999999999999998   8999999999999999999999999999987654431122


Q ss_pred             eeeecCCCCCchhhc-cCCCCCCccceehhhHHHHHHHhCCCCCCC
Q 005621          504 TRVVGTLGYLAPELT-RTGKPTTSSDVYAFGALLLEVVCGRRPIEP  548 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~-~~~~~~~~sDV~S~Gvvl~elltG~~p~~~  548 (687)
                      ....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            345678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=2.4e-28  Score=231.25  Aligned_cols=257  Identities=21%  Similarity=0.317  Sum_probs=196.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeeeeecC--CeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWCRRR--GDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV  418 (687)
                      .++|++.+++|+|.++.||.|....+++.++||++++..+   +.+.+|+.+|..|. ||||++|++...+.  ..+.||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4678889999999999999999888899999999987543   56788999999997 99999999998765  467999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-CcEEEcccccceeccC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLYER  497 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla~~~~~  497 (687)
                      +||+.+.+...+.     ..++...+...+.+++.||.|+|+   .||+|||+||.|+|+|.. -.++|+|+|||..+..
T Consensus       114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9999988776644     357777888899999999999999   999999999999999976 5689999999998765


Q ss_pred             CCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCC-cchhhHHHHHH------HHhcccc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKAL-PEELILVDWVW------DRWKAGA  569 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~v~------~~~~~~~  569 (687)
                      +...  .-.+.+..|..||.+.. ..++..-|+|||||++..|+..+.||-.... .+...-+..+.      ..+..  
T Consensus       186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K--  261 (338)
T KOG0668|consen  186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK--  261 (338)
T ss_pred             Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH--
Confidence            5432  22356778899999865 5688899999999999999999999865443 22222111111      00000  


Q ss_pred             cccccCCcCCC--------CC--------CHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          570 ILEVVDPRLNG--------EF--------NEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       570 ~~~~~d~~l~~--------~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..-.+||++..        .+        ......++++++...+..|-++|||++|.+.
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            00012332211        00        0011246788999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-28  Score=255.71  Aligned_cols=197  Identities=29%  Similarity=0.399  Sum_probs=170.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--------hhHHHHHHHHHHHhhhc---CCCceeeeeeeec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--------QGLREFASEISSIGRLR---HRNLVQLLGWCRR  411 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~  411 (687)
                      ..|...+.+|.|+||.|+++.++.....|+||.+.++..        ..+-..-.|+.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            357888999999999999999999989999999877531        11123457999999997   9999999999999


Q ss_pred             CCeeEEEEecCC-CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          412 RGDLLLVYDFMP-NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       412 ~~~~~lV~Ey~~-~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                      .+.+||+||-.- +-+|.+++  +.+..+++.++.-|++||+.|+++||+   ++|||||||-+||.++.+|-+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I--E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI--EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh--hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence            999999999764 44777777  456679999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCC
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIE  547 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~  547 (687)
                      .+-....   .....++||.+|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus       716 saa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9876433   23445789999999999998776 557899999999999999988875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=231.77  Aligned_cols=255  Identities=21%  Similarity=0.363  Sum_probs=194.5

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeee-eecCCeeEEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGW-CRRRGDLLLV  418 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lV  418 (687)
                      ..+.|.+.+.||+|.||.+-++.++.+.+.+++|.+.... ...++|.+|..-=-.| .|.||+.-|+. |...+.+.++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3467889999999999999999999999999999887643 3457888888654445 58999988874 6667788999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe-cc-CCcEEEcccccceecc
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL-DS-ELNGRLGDFGLAKLYE  496 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll-~~-~~~~kl~DFGla~~~~  496 (687)
                      +||+|.|+|..-+-   ...+.+....+++.|+++|+.|+|+   .++||||||.+|||| +. ..++||||||+.+..+
T Consensus       101 qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             eccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999998773   2457788889999999999999999   999999999999999 33 3579999999998643


Q ss_pred             CCCCCceeeeecCCCCCchhhccCC-----CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTG-----KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ....    ...-+..|.+||.....     ...+.+|+|.||++++.++||+.|++.....+..   -|-|..|..+...
T Consensus       175 ~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~~rk~~  247 (378)
T KOG1345|consen  175 TTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWLKRKNP  247 (378)
T ss_pred             ceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHhcccCc
Confidence            3221    22345679999976532     4577899999999999999999999965443322   2444555555443


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHH
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL  615 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  615 (687)
                      ..  |+.-..+.+    .+.++..+-+.++|++|-...++.++.
T Consensus       248 ~~--P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  248 AL--PKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             cC--chhhcccCH----HHHHHHHHhcCCcccccchhHHHHHHH
Confidence            22  222223333    677788889999999997666666544

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=8e-28  Score=238.63  Aligned_cols=261  Identities=21%  Similarity=0.249  Sum_probs=197.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeec------CC
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRR------RG  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~  413 (687)
                      ..+|..++.+|.|.- .|-.+.+.-.+++||+|++...  .....++..+|+.++..++|+|+++++.++.-      -.
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777888999998 7888888778999999987543  33445778899999999999999999998853      34


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      +.|+||||| ..+|...+.    -.++-.....|..|++.|+.|||+   .+|+||||||+||++..+..+||.|||+|+
T Consensus        95 e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence            679999999 568877774    236677888999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhh----------------H
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELI----------------L  557 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~----------------~  557 (687)
                      ..+..  -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+...-+...                +
T Consensus       167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            65433  34556788999999999998889999999999999999999998876543211111                0


Q ss_pred             HHHHHHHhc------ccccccc-cCCcCC--CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          558 VDWVWDRWK------AGAILEV-VDPRLN--GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       558 ~~~v~~~~~------~~~~~~~-~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..-++...+      .-...+. .|....  .+.+......+.+++.+||-.+|++|-+++++++
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            111111111      0011111 111111  1111223335788999999999999999999998

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=8.4e-28  Score=257.53  Aligned_cols=252  Identities=26%  Similarity=0.354  Sum_probs=203.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      .+|...+++|.|.||.|||++++.+++..|+|+++.+......-..+|+-+++..+||||+.++|.+...+.+|++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            57888999999999999999999999999999998887777777788999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      .+|+|.+.-+  -.+++++.++..+++..++||.|||+   .+-+|||||-.||++++.+.+|+.|||.+-.+.... ..
T Consensus        95 gggslQdiy~--~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K  168 (829)
T KOG0576|consen   95 GGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK  168 (829)
T ss_pred             CCCcccceee--ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence            9999998763  35689999999999999999999999   899999999999999999999999999987654322 22


Q ss_pred             eeeeecCCCCCchhhc---cCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC-cC
Q 005621          503 TTRVVGTLGYLAPELT---RTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP-RL  578 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~---~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~-~l  578 (687)
                      .....||+.|||||+.   +.+.|..++|||+.|+...|+---+.|.....+-....+.       ..    ...+| .+
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-------Tk----S~~qpp~l  237 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-------TK----SGFQPPTL  237 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-------hc----cCCCCCcc
Confidence            3346899999999986   4578999999999999999997766664433221111110       00    11111 22


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ...  ..-...+.+++..|+-.+|++||+++.+++
T Consensus       238 kDk--~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCC--ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            211  112235778999999999999999987664

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=4.8e-27  Score=244.90  Aligned_cols=283  Identities=20%  Similarity=0.223  Sum_probs=213.4

Q ss_pred             cccccccCCCCccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc--
Q 005621          321 LESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR--  398 (687)
Q Consensus       321 ~~~~~~~~~~~~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--  398 (687)
                      .+.|....+-.++..-|+  .-.+|.+....|+|-|++|.+|.+...|..||||++.+... ..+.=+.|+++|++|+  
T Consensus       412 ~DNWdDaEGYYrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~A  488 (752)
T KOG0670|consen  412 QDNWDDAEGYYRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDA  488 (752)
T ss_pred             ccCcccccceEEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhcc
Confidence            445665555555544444  45789999999999999999999998899999999987532 2344568999999995  


Q ss_pred             ----CCCceeeeeeeecCCeeEEEEecCCCCCchhhhhch-hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCC
Q 005621          399 ----HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE-QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKA  473 (687)
Q Consensus       399 ----H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  473 (687)
                          --|+++|+..|...+++|||+|-+ ..+|.+.|..- .+..|....+..++.|+.-||..|-.   ++|+|.||||
T Consensus       489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKP  564 (752)
T KOG0670|consen  489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKP  564 (752)
T ss_pred             CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCc
Confidence                358999999999999999999977 56888888552 34458888999999999999999998   9999999999


Q ss_pred             CcEEeccC-CcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCc
Q 005621          474 GNVLLDSE-LNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP  552 (687)
Q Consensus       474 ~NIll~~~-~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~  552 (687)
                      +|||+++. ..+||||||.|.....+.   .+...-...|.|||++.+-.|+...|+||.||.||||.||+..|.+....
T Consensus       565 DNiLVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN  641 (752)
T KOG0670|consen  565 DNILVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN  641 (752)
T ss_pred             cceEeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence            99999987 457999999997655433   22234456799999999999999999999999999999999999877654


Q ss_pred             chhhHHHHHHHH-----hcccc---------------------------cccccCCc------CC--CCCCH---HHHHH
Q 005621          553 EELILVDWVWDR-----WKAGA---------------------------ILEVVDPR------LN--GEFNE---IEALD  589 (687)
Q Consensus       553 ~~~~~~~~v~~~-----~~~~~---------------------------~~~~~d~~------l~--~~~~~---~~~~~  589 (687)
                      ..+-+..-+...     ++.|.                           ++..+.|.      |.  ..++.   .....
T Consensus       642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~  721 (752)
T KOG0670|consen  642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ  721 (752)
T ss_pred             HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence            433222111111     11111                           11112221      11  11222   23456


Q ss_pred             HHHHHHhccccCcCcCCCHHHHHH
Q 005621          590 VVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       590 l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +.+|+..|+..||++|.+..|.++
T Consensus       722 ~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  722 LRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHHHHHhccChhhcCCHHHHhc
Confidence            889999999999999999999876

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=1.2e-25  Score=231.10  Aligned_cols=266  Identities=22%  Similarity=0.327  Sum_probs=198.5

Q ss_pred             HHHHhcCcccceeeeeeCeEEEEEEEeCC---CCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCC
Q 005621          338 LKKATRGFRDKELLGFGGFGRVYKGTLPS---TNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRG  413 (687)
Q Consensus       338 l~~at~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  413 (687)
                      +....+.|...++||.|.|++||++++..   .++.||+|.+...+..  .+...|+++|..+ -+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            44455678899999999999999999876   6789999998765432  4678999999999 5999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-CcEEEcccccc
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLA  492 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla  492 (687)
                      ...+|+||++.....+++.     .++..++...+..++.||.++|.   .|||||||||+|+|.+.. +.-.|.|||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence            9999999999998888773     46788899999999999999999   999999999999999865 66799999999


Q ss_pred             eeccCCC--------------C-----------------------------CceeeeecCCCCCchhhccC-CCCCCccc
Q 005621          493 KLYERGT--------------N-----------------------------PSTTRVVGTLGYLAPELTRT-GKPTTSSD  528 (687)
Q Consensus       493 ~~~~~~~--------------~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~sD  528 (687)
                      ...+...              .                             .......||+||.|||++.. ...+++.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7221000              0                             00112469999999999864 56789999


Q ss_pred             eehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HH-Hhcccc--ccc---------c------cC-Cc----
Q 005621          529 VYAFGALLLEVVCGRRPIEPKALPEELILVDWV--------WD-RWKAGA--ILE---------V------VD-PR----  577 (687)
Q Consensus       529 V~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v--------~~-~~~~~~--~~~---------~------~d-~~----  577 (687)
                      |||.||+++-+++++.||-....+-. .+.+.+        .+ ....|.  +.+         .      ++ ..    
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             eeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            99999999999999999965432211 111110        00 000111  111         0      10 00    


Q ss_pred             ----C-CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          578 ----L-NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       578 ----l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                          + .....+..+..++++..+|+..||.+|.++++.++.
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                0 011112223367899999999999999999999863

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=2.5e-26  Score=272.58  Aligned_cols=195  Identities=17%  Similarity=0.265  Sum_probs=141.0

Q ss_pred             hhcC-CCceeeeeee-------ecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEE
Q 005621          396 RLRH-RNLVQLLGWC-------RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI  467 (687)
Q Consensus       396 ~l~H-~niv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  467 (687)
                      .++| +||++++++|       .+...+++++||+ +++|.++|... ...+++.+++.++.||++||.|||+   ++|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence            3456 6888888887       2334678889988 66999999543 3469999999999999999999998   9999


Q ss_pred             eeccCCCcEEecc-------------------CCcEEEcccccceeccCCCC---------------CceeeeecCCCCC
Q 005621          468 HRDIKAGNVLLDS-------------------ELNGRLGDFGLAKLYERGTN---------------PSTTRVVGTLGYL  513 (687)
Q Consensus       468 HrDlk~~NIll~~-------------------~~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~y~  513 (687)
                      ||||||+||||+.                   ++.+|++|||+++.......               .......||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   45567777777764321000               0011245788999


Q ss_pred             chhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHH
Q 005621          514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKL  593 (687)
Q Consensus       514 aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  593 (687)
                      |||++.+..++.++|||||||+||||++|..|+.....    ....     +..    ....+...     ........+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~-----~~~----~~~~~~~~-----~~~~~~~~~  244 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS-----LRH----RVLPPQIL-----LNWPKEASF  244 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH-----HHH----hhcChhhh-----hcCHHHHHH
Confidence            99999999999999999999999999998887643210    0010     000    01111111     112245678


Q ss_pred             HHhccccCcCcCCCHHHHHH
Q 005621          594 GLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       594 ~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +.+||+++|.+||+|.|+++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            88999999999999999986

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1e-23  Score=224.06  Aligned_cols=178  Identities=21%  Similarity=0.253  Sum_probs=137.4

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCC-CCeEEEEEEecCc-----chhhHHHHHHHHHHHhhhcCCCcee-eeeee
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPS-TNTQVAVKRVSNE-----SKQGLREFASEISSIGRLRHRNLVQ-LLGWC  409 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~  409 (687)
                      ......++|...+.||+|+||+||+|.+.. +++.||||++...     .....+.|.+|+++|++++|+|+++ ++++ 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            344566889999999999999999998865 6778899987533     1223466899999999999999985 5432 


Q ss_pred             ecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeecc-CCCcEEeccCCcEEEcc
Q 005621          410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDI-KAGNVLLDSELNGRLGD  488 (687)
Q Consensus       410 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-k~~NIll~~~~~~kl~D  488 (687)
                         +..++||||+++++|.. +.  ..   .   ...++.|++++|.|||+   ++|+|||| ||+|||++.++++||+|
T Consensus        91 ---~~~~LVmE~~~G~~L~~-~~--~~---~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         91 ---GKDGLVRGWTEGVPLHL-AR--PH---G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             ---CCcEEEEEccCCCCHHH-hC--cc---c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence               45799999999999963 21  11   1   14678899999999998   99999999 99999999999999999


Q ss_pred             cccceeccCCCC-------CceeeeecCCCCCchhhccCC------CCCCcccee
Q 005621          489 FGLAKLYERGTN-------PSTTRVVGTLGYLAPELTRTG------KPTTSSDVY  530 (687)
Q Consensus       489 FGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~------~~~~~sDV~  530 (687)
                      ||+++.+.....       ...+...+++.|+|||++.-.      ..+..+|-|
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999997654321       111356788899999988643      223346666

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=7.9e-24  Score=204.46  Aligned_cols=166  Identities=21%  Similarity=0.181  Sum_probs=124.8

Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                      |+|.+++... +..+++.+++.|+.|++.||.|||+   .+      ||+|||++.++.+|+  ||+++......     
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence            6889988543 4469999999999999999999998   44      999999999999999  99998654322     


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCH
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE  584 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~  584 (687)
                       ..||+.|||||++.+..++.++|||||||++|||++|+.||........ .+..+ ......      .++.-. ....
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~-~~~~~~------~~~~~~-~~~~  133 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEIL-LNGMPA------DDPRDR-SNLE  133 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHH-HHHhcc------CCcccc-ccHH
Confidence             2578999999999999999999999999999999999999865432111 11111 111100      001000 1111


Q ss_pred             HHH--HHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          585 IEA--LDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       585 ~~~--~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      ...  ..+.+++.+||+.+|++||++.|+++.+..
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            222  258899999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=2.1e-22  Score=214.01  Aligned_cols=259  Identities=22%  Similarity=0.264  Sum_probs=197.0

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCC-eEEEEEEecCcchhhHHHHHHHHHHHhhhcC----CCceeeeeee-ecCCeeEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTN-TQVAVKRVSNESKQGLREFASEISSIGRLRH----RNLVQLLGWC-RRRGDLLL  417 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l  417 (687)
                      +|...++||+|+||.||++.....+ ..+|+|............+..|..++..+..    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999986654 6789998766543333367788899988873    6899999988 47778899


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-----CcEEEcccccc
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-----LNGRLGDFGLA  492 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-----~~~kl~DFGla  492 (687)
                      ||+.+ |.+|.++......+.++....++|+.|++.+|.+||+   .+++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 8899997755555789999999999999999999998   999999999999999765     46899999999


Q ss_pred             e--eccCCCC-----C-c-eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 005621          493 K--LYERGTN-----P-S-TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       493 ~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      +  .+.....     . . .....||.+|++++...+...+.+.|+||++.++.|++.|..|+.............   +
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~---~  251 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE---K  251 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---H
Confidence            8  3221111     1 1 123569999999999999999999999999999999999999996655332211111   1


Q ss_pred             HhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       564 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ....    .....     .....+..+.++...+-..+...+|....+...|+..
T Consensus       252 ~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  252 DPRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             Hhhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            0000    00000     1111223455666666668999999999999887654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.6e-24  Score=206.73  Aligned_cols=244  Identities=20%  Similarity=0.346  Sum_probs=192.5

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGS  426 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs  426 (687)
                      -+|.+...|..|+|++++  ..++.|++.-.  .....++|..|.-.|+-+.||||+.++|.|...-.+.++..|||.|+
T Consensus       196 tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            357888899999999954  45667776533  33445789999999999999999999999999999999999999999


Q ss_pred             chhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEc--ccccceeccCCCCCcee
Q 005621          427 LDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG--DFGLAKLYERGTNPSTT  504 (687)
Q Consensus       427 L~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~--DFGla~~~~~~~~~~~~  504 (687)
                      |...|++...-..+..|+.+++.++|+|++|||+- ++-|.---|.+..|++|++.+++|.  |--.+..        ..
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq--------e~  344 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------EV  344 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee--------cc
Confidence            99999988888889999999999999999999983 3334444689999999999998874  2211110        01


Q ss_pred             eeecCCCCCchhhccCCCCC---CccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          505 RVVGTLGYLAPELTRTGKPT---TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~---~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      ...-.+.||+||.++..+.+   .++|+|||++++|||.|...||..-.+-+...               .+.-..|+..
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglrv~  409 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLRVH  409 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhcccccc
Confidence            11236789999999876543   47999999999999999999998765533221               1222344555


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      +++.....+.+|+.-|++.||.+||.+.+|+-.|++.
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            6666667899999999999999999999999988764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=7.1e-21  Score=199.40  Aligned_cols=259  Identities=28%  Similarity=0.395  Sum_probs=198.7

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh---hHHHHHHHHHHHhhhcCC-CceeeeeeeecCCeeEEEEe
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ---GLREFASEISSIGRLRHR-NLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~E  420 (687)
                      |...+.||.|+||.||++.+.   ..+++|.+......   ....+.+|+.+++.+.|+ +++++++.+......++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            667789999999999999985   78999998765432   467899999999999988 79999999977777899999


Q ss_pred             cCCCCCchhhhhchhh-ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-cEEEcccccceeccCC
Q 005621          421 FMPNGSLDKCLFDEQK-AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-NGRLGDFGLAKLYERG  498 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~  498 (687)
                      |+.+++|.+++..... ..+.......++.|++.++.|+|+   .+++|||+||+||+++... .++++|||+++.....
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999966633221 268899999999999999999998   8899999999999999998 7999999999865443


Q ss_pred             CCC-----ceeeeecCCCCCchhhccC---CCCCCccceehhhHHHHHHHhCCCCCCCCCCc-chhhHHHHHHHHhcccc
Q 005621          499 TNP-----STTRVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALP-EELILVDWVWDRWKAGA  569 (687)
Q Consensus       499 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~v~~~~~~~~  569 (687)
                      ...     ......|+..|+|||.+..   .......|+|++|++++++++|..|+...... ......+.+......  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence            322     2355789999999999987   57889999999999999999999996655431 011111111111110  


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                         .................+.+++..|+..+|..|.++.+....
T Consensus       234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence               000111111112223467789999999999999999987764

>cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

Probab=99.86  E-value=3.4e-20  Score=185.42  Aligned_cols=194  Identities=23%  Similarity=0.233  Sum_probs=135.4

Q ss_pred             CCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCCC
Q 005621           38 NNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKEL  117 (687)
Q Consensus        38 ~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~  117 (687)
                      .++.+.|+|.+. ++.|+||++..++.|+++|+.|+++         .+|+|+|+|.|.... ..+||||||+++|....
T Consensus        20 ~~w~~~G~a~~~-~~~i~LT~~~~~~~G~~~~~~pi~~---------~~F~~~f~F~i~~~~-~~~gdG~af~~~~~~~~   88 (218)
T cd07308          20 GNWTVGGSTVIT-KNYIRLTPDVPSQSGSLWSRVPIPA---------KDFEIEVEFSIHGGS-GLGGDGFAFWYTEEPGS   88 (218)
T ss_pred             CCeEEcCCeEEe-CCEEEeCCCCCCCEeEEEeCCCccC---------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCCCC
Confidence            589999999997 8999999999999999999999998         279999999998753 56899999999996532


Q ss_pred             CCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeC-CCCcccccccccccccccccccccC-CCC
Q 005621          118 PGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDIN-SLRSNASEPAAYFLENSTKQVLNLK-SGE  195 (687)
Q Consensus       118 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~n-s~~s~~~~~~~~~~~~~~~~~~~~~-~g~  195 (687)
                          .|..+|..       ...+-+||||||+.|.   +-...+|.+-+| +..+.....-+.. .......+... +++
T Consensus        89 ----~g~~~G~~-------~~~~Glai~fdt~~n~---~~~~p~i~~~~Ndg~~~~~~~~d~~~-~~~~~c~~~~~~~~~  153 (218)
T cd07308          89 ----DGPLFGGP-------DKFKGLAIFFDTYDND---GKGFPSISVFLNDGTKSYDYETDGEK-LELASCSLKFRNSNA  153 (218)
T ss_pred             ----CCcccccC-------CCCCEEEEEEEcCCCC---CCCCCeEEEEEeCCCceecccCCCcc-ccccceeEecccCCC
Confidence                44555652       2346699999999985   333345555443 2222110000000 00011112222 268


Q ss_pred             eEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCc-cccccceeeeeccCCcccceeEEEEeeec
Q 005621          196 VIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSP-IVKETMYVGFSSSTGLLASSHYILGWSFN  263 (687)
Q Consensus       196 ~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~-~l~~~~~vGFsastG~~~~~~~i~sWsf~  263 (687)
                      .++++|.|+  .+.|.|.+......  ..  ....++.. .+|+..|+||||+||...+.|.|++|.+.
T Consensus       154 ~~~~~I~y~--~~~l~v~i~~~~~~--~~--~~c~~~~~~~l~~~~y~G~sA~tg~~~d~~dIls~~~~  216 (218)
T cd07308         154 PTTLRISYL--NNTLKVDITYSEGN--NW--KECFTVEDVILPSQGYFGFSAQTGDLSDNHDILSVHTY  216 (218)
T ss_pred             CeEEEEEEE--CCEEEEEEeCCCCC--Cc--cEEEEcCCcccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence            999999999  68899988753211  11  13344443 47789999999999999999999999874

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=6.7e-21  Score=182.30  Aligned_cols=257  Identities=20%  Similarity=0.228  Sum_probs=195.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC-CCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH-RNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .+.|...++||+|.||.+|.|....+|+.||||.-+...+  ..++..|.++.+.|++ ..|..+..|..++..-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4679999999999999999999999999999998765433  2467789999999975 677888888888999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC---CcEEEcccccceeccC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE---LNGRLGDFGLAKLYER  497 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGla~~~~~  497 (687)
                      .+ |.||++++ .-..+.++...++-++-|++.-++|+|.   ++++||||||+|+|+.-+   ..+.++|||||+.+..
T Consensus        92 LL-GPsLEdLf-nfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   92 LL-GPSLEDLF-NFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             cc-CccHHHHH-HHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            88 88999866 3445679999999999999999999998   999999999999999644   5689999999987643


Q ss_pred             CCC------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          498 GTN------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       498 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ...      .......||.+|.+-....+...+...|+=|+|.+|.++.-|..||++.........-+.+.    +.++.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~----EkK~s  242 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS----EKKMS  242 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH----HhhcC
Confidence            322      22345679999998887777778889999999999999999999999866533322222111    11111


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      - .-..|...++.    ++.-.+.-|-..--++-|...-+.+.
T Consensus       243 ~-~ie~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrql  280 (341)
T KOG1163|consen  243 T-PIEVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQL  280 (341)
T ss_pred             C-CHHHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence            1 01112233333    44555666777777777876655543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=5.4e-22  Score=224.41  Aligned_cols=254  Identities=20%  Similarity=0.239  Sum_probs=191.8

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEec----C-cch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS----N-ESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~----~-~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ...+++|.|++|.|+...........+.|...    . ... .....+..|+.+-..++|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988888776555555555433    1 111 11223677888889999999999888887777777779


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |||++ +|..++..  ...++..++..+++|++.|+.|||+   .+|.|||+|++|++++.++.+||+|||.+..+....
T Consensus       401 E~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 99988833  2468888999999999999999999   999999999999999999999999999998765443


Q ss_pred             C---CceeeeecCCCCCchhhccCCCCCC-ccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          500 N---PSTTRVVGTLGYLAPELTRTGKPTT-SSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       500 ~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      .   ......+|...|+|||.+....|.+ ..||||.|+++..|++|+.||......+....     +   .....+.-.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~---~~~~~~~~~  546 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----T---NNYSDQRNI  546 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----h---hcccccccc
Confidence            3   2344578999999999999988877 58999999999999999999987655433210     0   000000000


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..-........+.....++.++++++|.+|-++.+|++
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00001122334456788999999999999999999997

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=2.8e-20  Score=185.60  Aligned_cols=203  Identities=23%  Similarity=0.300  Sum_probs=173.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      -.|++.++||+|.||..+.|+.--++++||||.-...+  ...++..|.+..+.| ..++|.+.+-+..++.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            36889999999999999999988889999999754332  335677888888888 579999999999999999999998


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-----CcEEEcccccceecc
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-----LNGRLGDFGLAKLYE  496 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-----~~~kl~DFGla~~~~  496 (687)
                      + |.||+|++ +-+.+.++...+..||.|++.-++|+|+   +.+|.|||||+|+||...     ..+.++|||+|+.+.
T Consensus       106 L-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  106 L-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             h-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            8 88999854 6677789999999999999999999999   999999999999999643     358999999999765


Q ss_pred             CCCC------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCc
Q 005621          497 RGTN------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP  552 (687)
Q Consensus       497 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~  552 (687)
                      ....      .......||.+||+-....++..+.+-|+=|+|-++++.+-|..||++...+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            4332      1233467999999999999999999999999999999999999999886543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=2e-20  Score=182.86  Aligned_cols=139  Identities=15%  Similarity=0.107  Sum_probs=108.6

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh--h-------HHH-----------------HHHHHHHHhhhcCCC
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ--G-------LRE-----------------FASEISSIGRLRHRN  401 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~n  401 (687)
                      ...||+|++|.||+|.+. +|+.||||+++.....  .       ..+                 ...|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            357999999999999996 7999999998754211  0       112                 234999999998887


Q ss_pred             ceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhh-cccccCeEEeeccCCCcEEecc
Q 005621          402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL-HEEWEQTVIHRDIKAGNVLLDS  480 (687)
Q Consensus       402 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDlk~~NIll~~  480 (687)
                      +.....+..  ...+|||||+++++|...+.  ....+++.+..+++.|++.+|.|| |+   .+|+||||||+|||++ 
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-  152 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence            643332222  23389999999887765432  234689999999999999999999 66   8999999999999998 


Q ss_pred             CCcEEEcccccceec
Q 005621          481 ELNGRLGDFGLAKLY  495 (687)
Q Consensus       481 ~~~~kl~DFGla~~~  495 (687)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.6e-20  Score=186.15  Aligned_cols=171  Identities=11%  Similarity=0.131  Sum_probs=133.6

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhH---HH------HHHHHHHHhhhcCCCceeeeeeeec
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL---RE------FASEISSIGRLRHRNLVQLLGWCRR  411 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~H~niv~l~~~~~~  411 (687)
                      ..++|+..+++|.|+||.||+...  ++..+|||.++.......   ..      +.+|+..+.++.|++|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            468999999999999999999765  466899999976532222   22      6799999999999999999988553


Q ss_pred             C--------CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          412 R--------GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       412 ~--------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                      .        +..+|||||++|.+|.++.      .++.    ....+++.+|..||.   .+++|||+||+||+++.++ 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence            2        3579999999999998764      1222    245699999999998   9999999999999999988 


Q ss_pred             EEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHH
Q 005621          484 GRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV  540 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ell  540 (687)
                      ++|+|||...........             ..+.....+..++|+|+||+.+..+.
T Consensus       173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988754221111             11344455668999999999987653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-19  Score=196.82  Aligned_cols=214  Identities=25%  Similarity=0.402  Sum_probs=162.8

Q ss_pred             HhhhcCCCceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeE-EeeccC
Q 005621          394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV-IHRDIK  472 (687)
Q Consensus       394 l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-vHrDlk  472 (687)
                      |+.+.|.|+.+++|.+.+....++|.+||..|+|.+.+... ...++|.-...++++|+.||.|||.   .+| .|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeec
Confidence            45789999999999999999999999999999999999663 4468999999999999999999998   444 999999


Q ss_pred             CCcEEeccCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCC-------CCCCccceehhhHHHHHHHhCCC
Q 005621          473 AGNVLLDSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTG-------KPTTSSDVYAFGALLLEVVCGRR  544 (687)
Q Consensus       473 ~~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDV~S~Gvvl~elltG~~  544 (687)
                      ++|+++|..+.+||.|||+......... .......-..-|.|||.++..       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            9999999999999999999876542111 111111234579999998763       14678999999999999999999


Q ss_pred             CCCCCCCcchh-hHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          545 PIEPKALPEEL-ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       545 p~~~~~~~~~~-~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ||......+.. .++.++..     .......|.+....  +....+..++..||..+|++||++++|-..++..
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            99875543332 22222222     11122233322111  2233688999999999999999999998877654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=5.1e-19  Score=173.35  Aligned_cols=142  Identities=16%  Similarity=0.151  Sum_probs=111.7

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh--------------------------hHHHHHHHHHHHhhhcCCC
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ--------------------------GLREFASEISSIGRLRHRN  401 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~n  401 (687)
                      ...||+|++|.||+|.+. +|+.||||+++.....                          ....+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999986 7999999998764211                          0112357899999999998


Q ss_pred             ceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC
Q 005621          402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE  481 (687)
Q Consensus       402 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~  481 (687)
                      +.....+...  ..+|||||++++++.....  ....++..+..+++.|++.++.+||+  ..+|+||||||+|||++ +
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~  153 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence            7544433322  2489999999886544321  23457888999999999999999997  37999999999999999 8


Q ss_pred             CcEEEcccccceeccC
Q 005621          482 LNGRLGDFGLAKLYER  497 (687)
Q Consensus       482 ~~~kl~DFGla~~~~~  497 (687)
                      ++++|+|||++...+.
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=4.1e-20  Score=208.39  Aligned_cols=249  Identities=21%  Similarity=0.232  Sum_probs=179.8

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHH--HhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISS--IGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++...+.||.+.|=+|.+|++.+ |. |+||++-+.. .-.++.|.++++-  ...++|||.+++.-+-...+..|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            56778899999999999999853 44 9999976553 3345555544433  444589999999998888888899999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee--ccCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL--YERG  498 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~--~~~~  498 (687)
                      |..+ +|.|.|.  .+.-+...+..-|+.|++.||..+|.   .+|+|||||.+||||+.-+-+.|+||..-+.  +.++
T Consensus       102 yvkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  102 YVKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            9954 8888883  34457777888899999999999998   9999999999999999999999999987652  2222


Q ss_pred             CCCceeeeec----CCCCCchhhccCC-----------CCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 005621          499 TNPSTTRVVG----TLGYLAPELTRTG-----------KPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVW  562 (687)
Q Consensus       499 ~~~~~~~~~g----t~~y~aPE~~~~~-----------~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~  562 (687)
                      .....+.+..    -.+|+|||.+...           ..+++.||||+||++.||++ |++||.....      ..   
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~a---  246 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------LA---  246 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------Hh---
Confidence            2222222222    2479999987541           26778999999999999999 6777753221      10   


Q ss_pred             HHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       563 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                        ++.+.   ..|+..  .....+...++.+++.|++.||.+|.++++.++.-.
T Consensus       247 --Yr~~~---~~~~e~--~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  247 --YRSGN---ADDPEQ--LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             --HhccC---ccCHHH--HHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence              11111   000000  000111226788999999999999999999998643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=5.4e-19  Score=180.37  Aligned_cols=233  Identities=22%  Similarity=0.251  Sum_probs=153.4

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhc----------CCCceeeeeee-
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLR----------HRNLVQLLGWC-  409 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------H~niv~l~~~~-  409 (687)
                      .+...+.||.|+++.||.+++..+++.+|||+....   .....+++++|.-.+..+.          |-.++-.++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            445678999999999999999999999999987433   3345677777776655532          21222222221 


Q ss_pred             --------ecC---C-----eeEEEEecCCCCCchhhhhc---hh--hccCCHHHHHHHHHHHHhhhhhhcccccCeEEe
Q 005621          410 --------RRR---G-----DLLLVYDFMPNGSLDKCLFD---EQ--KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH  468 (687)
Q Consensus       410 --------~~~---~-----~~~lV~Ey~~~gsL~~~L~~---~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  468 (687)
                              ...   .     ..+++|+-+ -++|.+++..   ..  ...+....++.+..|+++.+++||+   .+++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence                    111   1     236778877 5688777532   11  1235566677888999999999999   99999


Q ss_pred             eccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCC--------CCCCccceehhhHHHHHHH
Q 005621          469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG--------KPTTSSDVYAFGALLLEVV  540 (687)
Q Consensus       469 rDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDV~S~Gvvl~ell  540 (687)
                      +||||+|++++.+|.++|+||+.....+.....    ...+..|.+||.....        .++.+.|.|++|+++|.|.
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999988754332111    2345789999976442        4788999999999999999


Q ss_pred             hCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcC
Q 005621          541 CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEAR  605 (687)
Q Consensus       541 tG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  605 (687)
                      ||+.||..........   |                .+ ..+. ..++.+..|+..+|+.+|++|
T Consensus       245 C~~lPf~~~~~~~~~~---~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPE---W----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSG---G----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCcccccc---c----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999998664321110   0                11 2333 556688999999999999998

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=1.7e-18  Score=168.12  Aligned_cols=187  Identities=17%  Similarity=0.105  Sum_probs=141.8

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhh----HHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEEEe
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG----LREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .....|++|+||+||.+..  .+.+++.+.+.......    ...|.+|+++|++|. |+++++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999997766  57788888777654321    235789999999995 5889999987    34699999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeecc-CCCcEEeccCCcEEEcccccceeccCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDI-KAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-k~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |+.|.+|.+.+..         ....++.|++.+|.++|+   .+|+|||| ||+|||++.++.++|+|||++.......
T Consensus        79 yI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         79 YLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             eecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            9999998654311         123578899999999998   99999999 7999999999999999999998654433


Q ss_pred             CC----c--------eeeeecCCCCCchhhccCC-CCC-CccceehhhHHHHHHHhCCCCCCCCC
Q 005621          500 NP----S--------TTRVVGTLGYLAPELTRTG-KPT-TSSDVYAFGALLLEVVCGRRPIEPKA  550 (687)
Q Consensus       500 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDV~S~Gvvl~elltG~~p~~~~~  550 (687)
                      ..    .        ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            10    0        0112357788888864321 223 46788899999999999998865544

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=2.6e-18  Score=169.75  Aligned_cols=137  Identities=17%  Similarity=0.229  Sum_probs=109.2

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-----cCCCceeeeeeeecCC---e-e
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-----RHRNLVQLLGWCRRRG---D-L  415 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~  415 (687)
                      +...++||+|++|.||.  ++.++.. +||++........+++.+|+.+++++     .||||++++|+++.+.   . +
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34567899999999996  6666655 69998766555567899999999999     5799999999998763   3 3


Q ss_pred             EEEEec--CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhh-hhhcccccCeEEeeccCCCcEEeccC----CcEEEcc
Q 005621          416 LLVYDF--MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGL-LYLHEEWEQTVIHRDIKAGNVLLDSE----LNGRLGD  488 (687)
Q Consensus       416 ~lV~Ey--~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~D  488 (687)
                      .+|+||  +++++|.+++..   ..+++.  ..++.+++.++ .|||+   ++|+||||||+|||++..    .+++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            478999  668999999943   235555  35678888777 99998   999999999999999743    4799999


Q ss_pred             cccc
Q 005621          489 FGLA  492 (687)
Q Consensus       489 FGla  492 (687)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=1.8e-17  Score=191.19  Aligned_cols=201  Identities=20%  Similarity=0.184  Sum_probs=159.4

Q ss_pred             HHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc---CCCceeeeeeeecC
Q 005621          336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR---HRNLVQLLGWCRRR  412 (687)
Q Consensus       336 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~  412 (687)
                      .+.+.....|.+.+.||+|+||+||+|.... |+.||+|+-+.....   +|.--.+++.+|+   -+-|..+.....-.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            3445556778889999999999999999865 999999997766543   2222233444444   23344444555566


Q ss_pred             CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-------CCcEE
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-------ELNGR  485 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-------~~~~k  485 (687)
                      +..+||+||.+.|+|.+++.  ..+.++|..++.++.|++..+.+||.   .+|||+||||+|.||..       ...++
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             CcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence            77899999999999999995  55679999999999999999999998   99999999999999942       34589


Q ss_pred             EcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCC
Q 005621          486 LGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP  545 (687)
Q Consensus       486 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p  545 (687)
                      |+|||.+..+.--.. ......++|..+-.+|...++.++...|.|.++.+++-|+.|+..
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999999874432221 244557889999999999999999999999999999999999754

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=2.8e-17  Score=166.23  Aligned_cols=144  Identities=15%  Similarity=0.160  Sum_probs=113.3

Q ss_pred             cCcccceeeeeeCeEEEEEEE-eCCCCeEEEEEEecCcchh------------------------hHHHHHHHHHHHhhh
Q 005621          343 RGFRDKELLGFGGFGRVYKGT-LPSTNTQVAVKRVSNESKQ------------------------GLREFASEISSIGRL  397 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  397 (687)
                      ..|...+.||+|++|.||+|. +..+|+.||+|++......                        ....+..|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347888999999999999998 6568999999998753210                        112356899999999


Q ss_pred             cCC--CceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCe-EEeeccCCC
Q 005621          398 RHR--NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT-VIHRDIKAG  474 (687)
Q Consensus       398 ~H~--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDlk~~  474 (687)
                      .+.  .+.+++++    ...++||||+++++|...+..  ...+...+...++.|++.+|.+||+   .+ ++||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChh
Confidence            753  34455553    235899999999888765522  2345566778999999999999998   88 999999999


Q ss_pred             cEEeccCCcEEEcccccceecc
Q 005621          475 NVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       475 NIll~~~~~~kl~DFGla~~~~  496 (687)
                      ||+++ +++++|+|||++....
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999987543

>cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain

Probab=99.72  E-value=6.7e-16  Score=155.34  Aligned_cols=198  Identities=17%  Similarity=0.165  Sum_probs=129.4

Q ss_pred             CCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCCC
Q 005621           38 NNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKEL  117 (687)
Q Consensus        38 ~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~  117 (687)
                      .++.+.|+|.+. ++.|+||++.+++.|+++|+.|+++         .+|+++|+|+|.+.....+||||||+++.... 
T Consensus        20 ~~w~~~G~a~v~-~~~IrLTp~~~~~~G~~w~~~p~~~---------~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~~-   88 (248)
T cd06901          20 PLWDFLGSTMVT-SQYIRLTPDHQSKQGSIWNRVPCYL---------RDWEMHVHFKVHGSGKNLFGDGFAIWYTKERM-   88 (248)
T ss_pred             CCEEEcceEEEc-CCeEEECCCCCCCEEEEeccCCccC---------CCEEEEEEEEEeCCCCCCCCCEEEEEEEcCCC-
Confidence            589999999987 7799999998889999999999998         27999999999887666789999999998642 


Q ss_pred             CCCCCCccccccccCCCCCCcceEEEEEeecccCCCC-CCCCCCeeeEEe-CCCCcccccccccccccccccccc-cCCC
Q 005621          118 PGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEF-GDINDNHVGIDI-NSLRSNASEPAAYFLENSTKQVLN-LKSG  194 (687)
Q Consensus       118 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgi~~-ns~~s~~~~~~~~~~~~~~~~~~~-~~~g  194 (687)
                         ..|..+|-.+.       -.=+||-|||+.|..- .....+-|-+-+ ++........-+....-.. .... -+.+
T Consensus        89 ---~~G~~fG~~~~-------f~Gl~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~~~Dg~~~~~~~-C~~~~rn~~  157 (248)
T cd06901          89 ---QPGPVFGSKDN-------FHGLAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDHDRDGTHTELAG-CSAPFRNKD  157 (248)
T ss_pred             ---ccCcccccCCC-------CceEEEEEECCCCCCCcccCCCceEEEEEcCCCeeecccCCCchhhcCc-eeeeccCCC
Confidence               23444444221       1237999999998531 011222342222 2322211110000000000 1111 2345


Q ss_pred             CeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCcc-ccccceeeeeccCCcccceeEEEEeeec
Q 005621          195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPI-VKETMYVGFSSSTGLLASSHYILGWSFN  263 (687)
Q Consensus       195 ~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~-l~~~~~vGFsastG~~~~~~~i~sWsf~  263 (687)
                      ...+++|.|..  ..|.|.+...+.. .   .....+...+ ||...|+||||+||...+.|.|++-.+.
T Consensus       158 ~~t~~rI~Y~~--~~l~v~vd~~~~~-~---w~~Cf~~~~v~LP~~~yfGiSA~Tg~~sd~hdIlsv~~~  221 (248)
T cd06901         158 HDTFVAIRYSK--GRLTVMTDIDGKN-E---WKECFDVTGVRLPTGYYFGASAATGDLSDNHDIISMKLY  221 (248)
T ss_pred             CCeEEEEEEEC--CeEEEEEecCCCC-c---eeeeEEeCCeecCCCCEEEEEecCCCCCCcEEEEEEEEe
Confidence            56789999996  4577777643311 1   1122333333 7788999999999999999999998775

The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.6e-18  Score=187.41  Aligned_cols=187  Identities=27%  Similarity=0.341  Sum_probs=154.5

Q ss_pred             eeeeeCeEEEEEEEe---CCCCeEEEEEEecCcchh--hHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEEEecCC
Q 005621          350 LLGFGGFGRVYKGTL---PSTNTQVAVKRVSNESKQ--GLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       350 ~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      .+|+|.||.|+++.-   .+.+..+|.|.+.+....  .......|-.++...+ ||.++++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999987643   234667888887664311  1124566888888887 9999999999999999999999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCce
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +|.|...+...  ..............++-+++++|+   .+|+|||+|++||+++.+|.+++.|||+++..-.....  
T Consensus        81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            99998888443  346667777788889999999998   99999999999999999999999999999854332221  


Q ss_pred             eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP  548 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~  548 (687)
                         +||..|||||++.  .....+|.||||++++||+||..||..
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence               8999999999998  567899999999999999999999986

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=5.7e-17  Score=161.46  Aligned_cols=134  Identities=17%  Similarity=0.260  Sum_probs=113.3

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--------hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--------QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      +.||+|++|.||+|.+  .+..+++|+......        ....++..|+.++..++|+++.....++...+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999988  567899998654321        112457889999999999999887777777788899999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      |++|++|.+++...     .+ .+..++.+++.+|.+||+   .+++|||++|.|||++ ++.++|+|||+++.
T Consensus        80 ~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999988432     12 788999999999999998   9999999999999999 78999999999864

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=7.3e-17  Score=164.65  Aligned_cols=197  Identities=20%  Similarity=0.250  Sum_probs=138.8

Q ss_pred             cCCCceeeeeeeec---------------------------CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHH
Q 005621          398 RHRNLVQLLGWCRR---------------------------RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG  450 (687)
Q Consensus       398 ~H~niv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~  450 (687)
                      +|||||++.++|.+                           ...+|+||.-.+ .+|.++|..+   ..+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHH
Confidence            68888888876532                           346799999874 4899999543   4566777889999


Q ss_pred             HHhhhhhhcccccCeEEeeccCCCcEEec--cC--CcEEEcccccceeccCCC-----CCceeeeecCCCCCchhhccCC
Q 005621          451 VASGLLYLHEEWEQTVIHRDIKAGNVLLD--SE--LNGRLGDFGLAKLYERGT-----NPSTTRVVGTLGYLAPELTRTG  521 (687)
Q Consensus       451 ia~~L~yLH~~~~~~ivHrDlk~~NIll~--~~--~~~kl~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~  521 (687)
                      +++|+.|||.   ++|.|||+|++|||+.  +|  ....|+|||++-.-+...     ....-...|...-||||+....
T Consensus       350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            9999999998   9999999999999994  33  346899999875322210     1111223577789999998643


Q ss_pred             C------CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHH
Q 005621          522 K------PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGL  595 (687)
Q Consensus       522 ~------~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~  595 (687)
                      .      .-.|+|.|+.|.+.||++....||......   .+.        .....+.--|.+...    ++..+.+++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~--------~r~Yqe~qLPalp~~----vpp~~rqlV~  491 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLD--------TRTYQESQLPALPSR----VPPVARQLVF  491 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eec--------hhhhhhhhCCCCccc----CChHHHHHHH
Confidence            2      234899999999999999999999873321   000        001111112333333    3336788999


Q ss_pred             hccccCcCcCCCHHHHHHHHh
Q 005621          596 MCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       596 ~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      ..+++||.+|++..-....|+
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            999999999999876666554

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=1.3e-16  Score=157.39  Aligned_cols=145  Identities=16%  Similarity=0.173  Sum_probs=113.1

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch----------------------hhHHHHHHHHHHH
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK----------------------QGLREFASEISSI  394 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l  394 (687)
                      ++......|...+.||+|+||.||++... +|+.||||++.....                      .....+..|..++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            34444444788899999999999999885 689999998764320                      0112356789999


Q ss_pred             hhhcCC--CceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccC
Q 005621          395 GRLRHR--NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIK  472 (687)
Q Consensus       395 ~~l~H~--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  472 (687)
                      .++.|+  .+.+.++.    ...++||||+++++|.+....        .....++.+++.++.++|+   .+++|||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~  152 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLS  152 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCC
Confidence            999887  45555543    345899999999998765420        3456788999999999998   999999999


Q ss_pred             CCcEEeccCCcEEEcccccceeccC
Q 005621          473 AGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       473 ~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      |+||++++++.++|+|||++.....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=1.2e-16  Score=157.76  Aligned_cols=130  Identities=17%  Similarity=0.294  Sum_probs=106.5

Q ss_pred             eeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--------hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--------KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       350 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .||+|++|.||+|.+  .+..+++|+.....        .....++.+|++++..++|+++.....++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999996  56789999864321        11235678899999999988766555555566677999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      ++|++|.+++.....         .++.+++.+|.+||+   .+++|||++|.||+++ ++.++++|||+++.
T Consensus        79 ~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999987733211         789999999999998   9999999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=5.1e-18  Score=180.31  Aligned_cols=173  Identities=25%  Similarity=0.384  Sum_probs=130.6

Q ss_pred             CeeEEEEecCCCCCchhhhhc-hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          413 GDLLLVYDFMPNGSLDKCLFD-EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                      ..+++.|++|.-.+|.+||.. ......++...+.++.|++.|+.|      ++.+|||+||.||+...+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            357999999999999999964 334467888999999999999999      6899999999999999999999999999


Q ss_pred             ceeccCCC-----CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHh
Q 005621          492 AKLYERGT-----NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       492 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      ........     ....+...||..||+||.+.+..|+.|+||||||++|+||+. =..+++....          ..-+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----------~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT----------LTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----------hhhh
Confidence            98766544     234566789999999999999999999999999999999988 2222221110          1111


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHH
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQ  610 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  610 (687)
                      +.|.+    +|....+++     .-..+..+++++.|.+||++.+
T Consensus       473 r~g~i----p~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  473 RDGII----PPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hcCCC----ChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence            12211    111111111     2346788999999999994443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=1e-16  Score=182.03  Aligned_cols=144  Identities=17%  Similarity=0.240  Sum_probs=115.9

Q ss_pred             HHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--c------hhhHHHHHHHHHHHhhhcCCCceeee
Q 005621          335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--S------KQGLREFASEISSIGRLRHRNLVQLL  406 (687)
Q Consensus       335 ~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~H~niv~l~  406 (687)
                      +.........|...++||+|+||+||+|.+..  ..+++|+....  .      ....+++..|++++++++|++++..+
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  402 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV  402 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence            33334445566778999999999999999854  33444432211  1      11235688999999999999999888


Q ss_pred             eeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEE
Q 005621          407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL  486 (687)
Q Consensus       407 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl  486 (687)
                      .++......++||||+++++|.+++.          ....++.+++.+|.|||+   .+++||||||+|||+ .++.++|
T Consensus       403 ~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        403 IYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             EEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEE
Confidence            88877778899999999999998873          356789999999999998   999999999999999 6789999


Q ss_pred             ccccccee
Q 005621          487 GDFGLAKL  494 (687)
Q Consensus       487 ~DFGla~~  494 (687)
                      +|||+++.
T Consensus       469 iDFGla~~  476 (535)
T PRK09605        469 IDFGLGKY  476 (535)
T ss_pred             EeCccccc
Confidence            99999975

>cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain

Probab=99.66  E-value=1.6e-14  Score=143.54  Aligned_cols=198  Identities=17%  Similarity=0.191  Sum_probs=134.4

Q ss_pred             CCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCCC
Q 005621           38 NNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKEL  117 (687)
Q Consensus        38 ~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~  117 (687)
                      .+..+.|+|.+. ++.|+||++.+++.|.++.+.|++.   .      +|+.+|+|+|.... ..+||||||.+..... 
T Consensus        22 ~~W~~~G~t~~~-~~~IrLTp~~~~~~G~iw~~~~~~~---~------~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~~-   89 (225)
T cd06902          22 PFWSHGGDAIAS-LEQVRLTPSLRSKKGSVWTKNPFSF---E------NWEVEVTFRVTGRG-RIGADGLAIWYTKERG-   89 (225)
T ss_pred             CceEecccEEec-CCEEEECCCCCCCEEEEeeCCCcCC---C------CEEEEEEEEEecCC-CCCCCEEEEEEECCCC-
Confidence            579999999886 8899999999999999999999983   1      69999999998653 3578999999987642 


Q ss_pred             CCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeC-CCCccccccccccccccccccccc-CCCC
Q 005621          118 PGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDIN-SLRSNASEPAAYFLENSTKQVLNL-KSGE  195 (687)
Q Consensus       118 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~n-s~~s~~~~~~~~~~~~~~~~~~~~-~~g~  195 (687)
                         ..|..+|..+.       -.=+||.|||+.|.+  ..+...|-+-.| +.+......-+.... ........ +...
T Consensus        90 ---~~G~~~G~~~~-------f~Gl~I~~Dt~~n~~--~~~~p~i~~~~NDGt~~yd~~~D~~~~~-~~~C~~~~rn~~~  156 (225)
T cd06902          90 ---EEGPVFGSSDK-------WNGVGIFFDSFDNDG--KKNNPAILVVGNDGTKSYDHQNDGLTQA-LGSCLRDFRNKPY  156 (225)
T ss_pred             ---CCCCccCCCCc-------ccEEEEEEECCCCCC--CCCCcEEEEEECCCCeeccccCCCcccc-cceEEEeccCCCC
Confidence               24555665322       234799999998853  223346644443 322222111000000 00111222 3356


Q ss_pred             eEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCcc-ccccceeeeeccCCcccceeEEEEeeec
Q 005621          196 VIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPI-VKETMYVGFSSSTGLLASSHYILGWSFN  263 (687)
Q Consensus       196 ~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~-l~~~~~vGFsastG~~~~~~~i~sWsf~  263 (687)
                      +.+++|.|..  ..|+|.++... .+........+++..+ ||+..|+||||+||...+.|.|++|++.
T Consensus       157 p~~~rI~Y~~--~~l~V~~d~~~-~~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~  222 (225)
T cd06902         157 PVRAKITYYQ--NVLTVSINNGF-TPNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFLTF  222 (225)
T ss_pred             CeEEEEEEEC--CeEEEEEeCCc-CCCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEe
Confidence            8899999997  56888887432 2222223445555554 7888999999999999999999999986

ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=3.4e-15  Score=139.21  Aligned_cols=135  Identities=21%  Similarity=0.208  Sum_probs=115.9

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC--CCceeeeeeeecCCeeEEEEecCCC
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH--RNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.+.||+|.++.||++...  +..+++|.......  ..++..|+..++.++|  .++++++++....+..+++|||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            4578999999999999984  37899999866543  4678899999999987  5999999999888899999999998


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      +.+..+         +......++.+++.+|.+||.....+++|+|++|+||+++..+.+++.|||.++.
T Consensus        78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            887654         5566778899999999999985445899999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.62  E-value=2.7e-16  Score=178.02  Aligned_cols=212  Identities=24%  Similarity=0.271  Sum_probs=146.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      .+|...++|-.|++|.||..+++.+.+++|+| +++...-     .+-  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-----hhc--cccccCCccee-------------------
Confidence            46788899999999999999998888999994 4332210     000  22223334333                   


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC--
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN--  500 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~--  500 (687)
                        |+-...+..  .+.++..        ++.+++|||+   .+|+|||+||+|.+|+.-|.+|+.|||+.+.......  
T Consensus       136 --gDc~tllk~--~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 --GDCATLLKN--IGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             --chhhhhccc--CCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence              333333321  1233322        2788999999   9999999999999999999999999999864322110  


Q ss_pred             ------------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc
Q 005621          501 ------------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG  568 (687)
Q Consensus       501 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~  568 (687)
                                  -....++||+.|.|||++..+.|....|.|++|+++||.+-|+.||.++.+++-...+  +...    
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v--isd~----  274 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--ISDD----  274 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh--hhhh----
Confidence                        1123468999999999999999999999999999999999999999988764422111  0000    


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHH
Q 005621          569 AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQ  610 (687)
Q Consensus       569 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  610 (687)
                        .+.      .+-++....++.+++.+.++.+|..|--...
T Consensus       275 --i~w------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~g  308 (1205)
T KOG0606|consen  275 --IEW------PEEDEALPPEAQDLIEQLLRQNPLCRLGTGG  308 (1205)
T ss_pred             --ccc------cccCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence              000      0112222336788888999999999964443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=5.8e-15  Score=144.07  Aligned_cols=138  Identities=18%  Similarity=0.199  Sum_probs=99.8

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh--hHHH----------------------HHHHHHHHhhhcCCC--
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ--GLRE----------------------FASEISSIGRLRHRN--  401 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--  401 (687)
                      .+.||+|+||+||+|.+. +++.||||++......  ....                      ...|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 7889999998754211  1111                      135666666665443  


Q ss_pred             ceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC
Q 005621          402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE  481 (687)
Q Consensus       402 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~  481 (687)
                      +.+.+++    ...++||||++++.+.........  .. .+..+++.+++.++.++|.  .++|+||||||+||+++ +
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-C
Confidence            4445543    245899999999654322111111  11 5678899999999999997  37899999999999999 8


Q ss_pred             CcEEEcccccceecc
Q 005621          482 LNGRLGDFGLAKLYE  496 (687)
Q Consensus       482 ~~~kl~DFGla~~~~  496 (687)
                      +.++|+|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=1.8e-14  Score=146.09  Aligned_cols=135  Identities=19%  Similarity=0.182  Sum_probs=105.7

Q ss_pred             ceeee-eeCeEEEEEEEeCCCCeEEEEEEecCcc-------------hhhHHHHHHHHHHHhhhcCCCc--eeeeeeeec
Q 005621          348 KELLG-FGGFGRVYKGTLPSTNTQVAVKRVSNES-------------KQGLREFASEISSIGRLRHRNL--VQLLGWCRR  411 (687)
Q Consensus       348 ~~~lG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~  411 (687)
                      ...|| .||.|+||++..  .+..++||++....             ......+.+|++++.+++|+++  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45788 899999999988  36789999875321             1223567889999999998875  677776543


Q ss_pred             CC----eeEEEEecCCC-CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEE
Q 005621          412 RG----DLLLVYDFMPN-GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL  486 (687)
Q Consensus       412 ~~----~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl  486 (687)
                      ..    ..++||||+++ .+|.+++..   ..++..    .+.+++.+|.+||+   .+|+||||||.|||++.++.++|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence            32    23599999997 688888733   234443    35789999999998   99999999999999999899999


Q ss_pred             ccccccee
Q 005621          487 GDFGLAKL  494 (687)
Q Consensus       487 ~DFGla~~  494 (687)
                      +|||.++.
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=2.7e-15  Score=170.06  Aligned_cols=256  Identities=23%  Similarity=0.282  Sum_probs=190.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCC-CeEEEEEEecCcc--hhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPST-NTQVAVKRVSNES--KQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV  418 (687)
                      ..|...+.||+|.++.|-......+ ...+|+|.+....  .....+...|..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4566777899999999988876433 3457777765543  222344456777777776 99999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhc-ccccCeEEeeccCCCcEEeccCC-cEEEcccccceecc
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLH-EEWEQTVIHRDIKAGNVLLDSEL-NGRLGDFGLAKLYE  496 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~  496 (687)
                      .||..++++.+-+........+....-..+.|+..++.|+| .   .++.|||+||+|.+++..+ ..++.|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999988774222224566677789999999999999 6   9999999999999999999 99999999998776


Q ss_pred             C--CCCCceeeeec-CCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          497 R--GTNPSTTRVVG-TLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       497 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      .  +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|...     .   
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~-----~---  247 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN-----K---  247 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc-----c---
Confidence            5  33333445678 9999999998874 5567899999999999999999998766543211 1111110     0   


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         .+..............++..+++..+|..|.+.+++..
T Consensus       248 ---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 ---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence               00001111112225667788899899999999988765

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=9e-14  Score=139.34  Aligned_cols=204  Identities=20%  Similarity=0.285  Sum_probs=142.3

Q ss_pred             HHHHHHHhhhcCCCceeeeeeeecCC-----eeEEEEecCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcc
Q 005621          388 ASEISSIGRLRHRNLVQLLGWCRRRG-----DLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHE  460 (687)
Q Consensus       388 ~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~  460 (687)
                      ..-+..|-++.|-||++++.|+.+.+     +..++.|||..|+|..+|++.  ....+......+|+-||+.||.|||+
T Consensus       115 ~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs  194 (458)
T KOG1266|consen  115 RAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS  194 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence            33456666778999999999886543     578999999999999999763  34467788888999999999999998


Q ss_pred             cccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC----CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHH
Q 005621          461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG----TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALL  536 (687)
Q Consensus       461 ~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl  536 (687)
                       |.++|+|+++..+.|++..++-+|++----. .....    .........+-++|.+||+=.....+.++|||+||+..
T Consensus       195 -~~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA  272 (458)
T KOG1266|consen  195 -CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA  272 (458)
T ss_pred             -cCCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence             6799999999999999999999998532111 00000    00111223457899999987777788899999999999


Q ss_pred             HHHHhCCCCCC-CCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          537 LEVVCGRRPIE-PKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       537 ~elltG~~p~~-~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +||.-+..--. .....+.....        ...+. .+...+           -+.++..|++..|..||+|++++.
T Consensus       273 lemailEiq~tnseS~~~~ee~i--------a~~i~-~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  273 LEMAILEIQSTNSESKVEVEENI--------ANVII-GLENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHHheeccCCCcceeehhhhh--------hhhee-eccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            99988765321 11110000000        00000 011111           124567899999999999998875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=5.9e-13  Score=146.54  Aligned_cols=141  Identities=17%  Similarity=0.198  Sum_probs=100.3

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhH----------------------------------------HHH
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL----------------------------------------REF  387 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~  387 (687)
                      .+.||+|++|.||+|+++ +|+.||||+.++......                                        -+|
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            368999999999999985 689999999876421110                                        024


Q ss_pred             HHHHHHHhhhc----CCCceeeeeee-ecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHh-hhhhhccc
Q 005621          388 ASEISSIGRLR----HRNLVQLLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS-GLLYLHEE  461 (687)
Q Consensus       388 ~~E~~~l~~l~----H~niv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~  461 (687)
                      ..|+..+.+++    |.+-+.+-..+ ......+|||||++|++|.+++..... ..   .+.+++.+++. .+..+|. 
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~-  275 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLR-  275 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHh-
Confidence            55666666653    33333333332 223457999999999999987643211 12   23456666665 4677887 


Q ss_pred             ccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       462 ~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                        .+++|+|+||.||+++.+++++++|||++..++
T Consensus       276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             --CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence              899999999999999999999999999998664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates

Probab=99.42  E-value=2.9e-11  Score=121.33  Aligned_cols=199  Identities=21%  Similarity=0.249  Sum_probs=122.0

Q ss_pred             CCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCCC
Q 005621           38 NNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKEL  117 (687)
Q Consensus        38 ~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~  117 (687)
                      .+..+.|+|.+. ++.|+||++.+++.|.++.+.|++.   .      +|+.+|+|.|........||||||.+......
T Consensus        22 ~~W~~~G~t~i~-~~~IrLTp~~~~~~G~iws~~~~~~---~------~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~~   91 (229)
T PF03388_consen   22 PNWDIGGSTVIT-DNFIRLTPDRQSQSGSIWSRKPIPF---D------NWEIEFTFRISGQEKGLGGDGMAFWYTKDPGS   91 (229)
T ss_dssp             TTEEEEET-EEE-SSEEEEE-SSTTEEEEEEESS-BEE---S------EEEEEEEEEEESS-SSS-S-EEEEEEESSSSS
T ss_pred             CCEEECCeEEec-CCEEEECCCcccCEEEEEEcCCCCc---c------CEEEEEEEEEeccccCcCCCeEEEEEEcCccc
Confidence            378999999987 8899999999999999999999997   1      79999999998775566899999999876532


Q ss_pred             CCCCCCccccccccCCCCCCcceEEEEEeecccCCCCC-CCCCCeeeEEeC-CCCccccccccccccccccccccc-CCC
Q 005621          118 PGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFG-DINDNHVGIDIN-SLRSNASEPAAYFLENSTKQVLNL-KSG  194 (687)
Q Consensus       118 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~Hvgi~~n-s~~s~~~~~~~~~~~~~~~~~~~~-~~g  194 (687)
                          .|..+|..+       .-.=+||=||||.|.+-. .-....|.+-+| +..+......+... ......... +.+
T Consensus        92 ----~G~~fG~~~-------~f~Gl~i~idt~~N~~~~~~~~~p~i~~~~NDGt~~~~~~~dg~~~-~~~~C~~~~rn~~  159 (229)
T PF03388_consen   92 ----DGPVFGGPD-------KFDGLGIFIDTYDNDEGGHKRGFPYISAMLNDGTKSYDHDNDGKDQ-SLGSCSADYRNSD  159 (229)
T ss_dssp             ----SCSBTTB-S-------S-EEEEEEEEES-TTCTTCTSTSSEEEEEEEESSS---GGGTTTTT--SEEEE---BTES
T ss_pred             ----cccccCCCc-------ccceEEEEEEcccCCCcccccccceEEEEecCCCccccccccCccc-ccccceeccCcCC
Confidence                555566522       223479999999986311 112345544443 22221111110000 000111222 245


Q ss_pred             CeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCc-cccccceeeeeccCCcccceeEEEEee
Q 005621          195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSP-IVKETMYVGFSSSTGLLASSHYILGWS  261 (687)
Q Consensus       195 ~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~-~l~~~~~vGFsastG~~~~~~~i~sWs  261 (687)
                      ...+++|.|..  +.|.|.+...-.+.... -........ .||+..|+||||+||...+.|.|++-.
T Consensus       160 ~p~~~ri~Y~~--~~l~v~id~~~~~~~~~-~~~Cf~~~~v~LP~~~yfGvSA~Tg~~~d~hdi~s~~  224 (229)
T PF03388_consen  160 VPTRIRISYSK--NTLTVSIDSNYLKNQDD-WELCFTTDGVDLPEGYYFGVSAATGELSDNHDILSVK  224 (229)
T ss_dssp             SEEEEEEEEET--TEEEEEEETSCCSECCT-TEEEEEESTEEGGSSBEEEEEEEESSSGGEEEEEEEE
T ss_pred             CCEEEEEEEEC--CeEEEEEecccccCCcC-CcEEEEcCCeecCCCCEEEEEecCCCCCCcEEEEEEE
Confidence            67899999996  56777776321111111 112222222 278889999999999999999999854

This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B ....

>cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain

Probab=99.41  E-value=2.1e-11  Score=120.17  Aligned_cols=188  Identities=14%  Similarity=0.151  Sum_probs=124.7

Q ss_pred             CCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCCC
Q 005621           38 NNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKEL  117 (687)
Q Consensus        38 ~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~  117 (687)
                      .+..+.|+|.+. ++.|+||.+ +++.|.++-+.|+++-+        +|+.+|+|+|.... ..+||||||.+......
T Consensus        21 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~iWs~~pl~~~~--------~w~ie~~Fri~G~~-~~~gdGla~W~t~~~~~   89 (215)
T cd06903          21 PNWQTSGNPKLE-SGRIILTPP-GNQRGSLWLKKPLSLKD--------EWTIEWTFRSTGPE-GRSGGGLNFWLVKDGNA   89 (215)
T ss_pred             CCeEEcCcEEee-CCeEEECCC-CCceEeEeeCCcCCCCC--------CEEEEEEEEecccC-CcCCCEEEEEEECCCcc
Confidence            479999999987 889999999 99999999999998732        59999999997653 26899999999876421


Q ss_pred             CCCCCC-ccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccccccccccccccccccCCCCe
Q 005621          118 PGTLPS-QYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEV  196 (687)
Q Consensus       118 ~~~~~g-~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~  196 (687)
                      .   .+ ..+|-.+.       -.=+||.|||+.|.   .|  ...++.-++.+......- +-..-+.+.---.+.+..
T Consensus        90 ~---~g~~~fG~~~~-------f~Gl~I~~Dt~~n~---~p--~i~~~~NDGt~~yd~~~d-~~~~~g~C~~~~rn~~~p  153 (215)
T cd06903          90 D---VGTSSIYGPSK-------FDGLQLLIDNNGGS---GG--SLRGFLNDGSKDYKNEDV-DSLAFGSCLFAYQDSGVP  153 (215)
T ss_pred             c---CCccccCCCCC-------CcEEEEEEECCCCC---Cc--eEEEEECCCCeeccccCC-cccccceeeEeccCCCCC
Confidence            1   12 33333221       12379999999873   12  122333233332221110 000000111112356678


Q ss_pred             EEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCcc-cc-ccceeeeeccCCcccceeEEEEeee
Q 005621          197 IQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPI-VK-ETMYVGFSSSTGLLASSHYILGWSF  262 (687)
Q Consensus       197 ~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~-l~-~~~~vGFsastG~~~~~~~i~sWsf  262 (687)
                      .+++|.|....+.|+|.++..          ...+..++ || .-.|+||||+||...+.|.|++-..
T Consensus       154 ~~iri~Y~~~~~~l~v~vd~~----------~Cf~~~~v~lP~~~y~fGiSAaTg~~~d~hdIl~~~~  211 (215)
T cd06903         154 STIRLSYDALNSLFKVQVDNR----------LCFQTDKVQLPQGGYRFGITAANADNPESFEILKLKV  211 (215)
T ss_pred             EEEEEEEECCCCEEEEEECCC----------EEEecCCeecCCCCCEEEEEEcCCCCCCcEEEEEEEE
Confidence            999999998778999987531          22333332 56 5678999999999999999998665

EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.34  E-value=1.4e-12  Score=141.86  Aligned_cols=248  Identities=23%  Similarity=0.290  Sum_probs=183.8

Q ss_pred             Ccccceeeee--eCeEEEEEEEe--CCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeE
Q 005621          344 GFRDKELLGF--GGFGRVYKGTL--PSTNTQVAVKRVSNESK--QGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       344 ~f~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  416 (687)
                      .|...+.+|.  |.+|.||.+..  ..++..+|+|+-+....  ..-..=.+|+....++ .|+|.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556778999  99999999998  78889999998443322  2222334566666666 4999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHh----hhhhhcccccCeEEeeccCCCcEEeccC-CcEEEccccc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS----GLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGL  491 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGl  491 (687)
                      +-+|++ +.+|..+..... ..++....+.+..+..+    ||.++|.   ..++|-|+||.||++..+ ..++++|||+
T Consensus       195 iqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence            999988 577877764322 23666677777777777    9999999   999999999999999999 8899999999


Q ss_pred             ceeccCCCCCc----eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          492 AKLYERGTNPS----TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       492 a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      ...+....-..    ..+..|...|++||..+ +.++.++|+|++|.+.++..++..+........        |...+.
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r~  340 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLRQ  340 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--------cccccc
Confidence            99876554211    12235777899999976 577899999999999999999887765442111        111111


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       568 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +-        +..++......++......+++.+|..|++.+.+..
T Consensus       341 ~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 GY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            11        222333333345666888999999999999988765

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.32  E-value=1.9e-12  Score=144.25  Aligned_cols=144  Identities=15%  Similarity=0.177  Sum_probs=96.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhh------------------------------H----H---
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG------------------------------L----R---  385 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------------------------~----~---  385 (687)
                      ..|+. +.||+|++|.||+|+++.+|+.||||++++...+.                              .    +   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 78999999999999998779999999997642110                              0    1   


Q ss_pred             ---HHHHHHHHHhhhc----CCCceeeeeeeec-CCeeEEEEecCCCCCchhhhhchhh----ccCCHHHHHHHHHHHHh
Q 005621          386 ---EFASEISSIGRLR----HRNLVQLLGWCRR-RGDLLLVYDFMPNGSLDKCLFDEQK----AILTWEQRYRIIKGVAS  453 (687)
Q Consensus       386 ---~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~----~~l~~~~~~~i~~~ia~  453 (687)
                         +|..|+..+.+++    +.+.+.+-..+.+ ....+|||||++|+.|.+.-.-...    ..+.......++.|+. 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence               2344555555542    3333333333322 3456899999999999874211111    1233333444444443 


Q ss_pred             hhhhhcccccCeEEeeccCCCcEEeccCC----cEEEcccccceeccC
Q 005621          454 GLLYLHEEWEQTVIHRDIKAGNVLLDSEL----NGRLGDFGLAKLYER  497 (687)
Q Consensus       454 ~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGla~~~~~  497 (687)
                            .   .+++|+|+||.||+++.++    ++++.|||++..++.
T Consensus       278 ------~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 ------R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  2   7899999999999999988    999999999987643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.27  E-value=1.3e-11  Score=118.28  Aligned_cols=130  Identities=20%  Similarity=0.136  Sum_probs=96.8

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCce-eeeeeeecCCeeEEEEecCCCCC
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV-QLLGWCRRRGDLLLVYDFMPNGS  426 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~gs  426 (687)
                      .+.|+.|.++.||+++.  .+..+++|....... ....+..|+.+++.+.+.+++ +++.+..  ...++||||+++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            35688999999999997  478899998765432 223467899999998765544 4555433  34589999999988


Q ss_pred             chhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccc--cCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          427 LDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW--EQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       427 L~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      +.+..          .....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            86531          011345678999999999821  12369999999999999 6789999999986

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.22  E-value=1.3e-10  Score=127.75  Aligned_cols=170  Identities=19%  Similarity=0.248  Sum_probs=130.8

Q ss_pred             EEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCC
Q 005621          361 KGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILT  440 (687)
Q Consensus       361 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~  440 (687)
                      .|..+.++.+|.|+..+...........+-++.|+.++||||++++...+..+.+|||+|-+.  .|..++..     +.
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hH
Confidence            466677888999998887766445566778899999999999999999999999999999874  56666633     23


Q ss_pred             HHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccC
Q 005621          441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT  520 (687)
Q Consensus       441 ~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  520 (687)
                      .....-.+.||+.||.+||+  +.+++|++|..+.|+++..|+-||++|.++...+.... ......--..|..|+.+..
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence            45556678999999999997  48899999999999999999999999999875433221 1111112235667765432


Q ss_pred             CCCCCccceehhhHHHHHHHhC
Q 005621          521 GKPTTSSDVYAFGALLLEVVCG  542 (687)
Q Consensus       521 ~~~~~~sDV~S~Gvvl~elltG  542 (687)
                      ..  -..|.|.||++++|++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            21  346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.15  E-value=4e-10  Score=109.66  Aligned_cols=138  Identities=17%  Similarity=0.130  Sum_probs=99.8

Q ss_pred             eeeeeeCeEEEEEEEeCC------CCeEEEEEEecCcc----------------------hhhHHHH----HHHHHHHhh
Q 005621          349 ELLGFGGFGRVYKGTLPS------TNTQVAVKRVSNES----------------------KQGLREF----ASEISSIGR  396 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~~  396 (687)
                      ..||.|.-+.||.|....      .+..+|||+.+...                      ....+.+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998643      24789999764310                      0011222    379999999


Q ss_pred             hcC--CCceeeeeeeecCCeeEEEEecCCCCCchh-hhhchhhccCCHHHHHHHHHHHHhhhhhh-cccccCeEEeeccC
Q 005621          397 LRH--RNLVQLLGWCRRRGDLLLVYDFMPNGSLDK-CLFDEQKAILTWEQRYRIIKGVASGLLYL-HEEWEQTVIHRDIK  472 (687)
Q Consensus       397 l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDlk  472 (687)
                      +..  -++.+++++    ..-+|||||+.+..+.. .|   ....++..+...+..+++.+|..| |.   .+++|+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence            854  466677764    45689999997654422 22   122345556778889999999999 77   899999999


Q ss_pred             CCcEEeccCCcEEEcccccceeccC
Q 005621          473 AGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       473 ~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      +.|||++ ++.+.|+|||.+...++
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999997 46899999998875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport]

Probab=99.12  E-value=2.9e-09  Score=106.97  Aligned_cols=196  Identities=18%  Similarity=0.210  Sum_probs=133.8

Q ss_pred             CCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCCC
Q 005621           38 NNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKEL  117 (687)
Q Consensus        38 ~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~  117 (687)
                      .+..+.|++.+. ..-|+||.+.+++.|.++=..||...         +|...+.|.+..+.+...|||||+.++-... 
T Consensus        72 ~~W~~~Gstvv~-~~~irLT~d~qsk~GAv~n~~Pv~s~---------~wev~v~fkv~~~s~~lfgdG~Aiw~t~Er~-  140 (351)
T KOG3839|consen   72 PNWNLSGSTVVT-SNYIRLTPDEQSKSGAVWNRQPVFSR---------DWEVLVHFKVHGQSKNLFGDGMAIWYTKERA-  140 (351)
T ss_pred             cCccccccEEEE-eeeeeccccccccccccccCCCcccc---------ceeEEEEEEEecCCCcccccceEEEeecccc-
Confidence            478889999887 67799999999999999999999742         5999999999988888899999999987653 


Q ss_pred             CCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCC--CCeeeEEeC-CCCcccccccccccccccccccccCCC
Q 005621          118 PGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDIN--DNHVGIDIN-SLRSNASEPAAYFLENSTKQVLNLKSG  194 (687)
Q Consensus       118 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgi~~n-s~~s~~~~~~~~~~~~~~~~~~~~~~g  194 (687)
                         ..|..+|-++.-       +.+||=.|||.|.+ +-+.  -.-|.+.+| +..|..-..-+.... ........++.
T Consensus       141 ---q~GPvFG~~dkF-------~GL~vfidtY~n~~-g~~~~v~P~isvmv~~gs~sYD~~~Dg~~te-l~gc~a~~rn~  208 (351)
T KOG3839|consen  141 ---QPGPVFGSKDKF-------TGLAVFIDTYGNHN-GPHEHVFPYISVMVNIGSLSYDHSKDGTHTE-LAGCTANFRNL  208 (351)
T ss_pred             ---cCCCCCCCcccc-------eeEEEEEeccCCcC-CCcccceeeEEEEeccCCcccccCCCCCccc-cccceeeeccC
Confidence               256667765432       44799999998863 1111  122333332 222211110000000 00011112222


Q ss_pred             C-eEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCcc-ccccceeeeeccCCcccceeEEEEeee
Q 005621          195 E-VIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPI-VKETMYVGFSSSTGLLASSHYILGWSF  262 (687)
Q Consensus       195 ~-~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~-l~~~~~vGFsastG~~~~~~~i~sWsf  262 (687)
                      . ...+-|.|+.  ++|++..+..+.    -.....+++..+ +|.--|+|+||+||...+.|.|.|-.+
T Consensus       209 ~~dt~~~iry~~--~~l~~~~dl~~~----~~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~kl  272 (351)
T KOG3839|consen  209 PHDTLVVIRYEK--KTLSISIDLEGP----NEWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSLKL  272 (351)
T ss_pred             CCcceeEEEecC--CceEEEEecCCC----ceeeeeeeecceecccceEEeeeeccCccchhhHHHHhhh
Confidence            1 2446789987  778887776551    126677888777 889999999999999999999999755

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=4.9e-10  Score=112.02  Aligned_cols=142  Identities=21%  Similarity=0.248  Sum_probs=110.8

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhcC--CCceeeeeeeecCC---eeEEEEecC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRH--RNLVQLLGWCRRRG---DLLLVYDFM  422 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lV~Ey~  422 (687)
                      +.|+.|..+.||++...+ |+.+++|+...... ....++..|+++++.+.+  .++.+++.++....   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998843 57899999765432 234578899999999976  44677888877643   568999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhccc-----------------------------------------
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE-----------------------------------------  461 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----------------------------------------  461 (687)
                      ++.++.+.+..   ..++..++..++.+++.+|.+||+.                                         
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99998876521   3467777888888888888888842                                         


Q ss_pred             ------------ccCeEEeeccCCCcEEecc--CCcEEEccccccee
Q 005621          462 ------------WEQTVIHRDIKAGNVLLDS--ELNGRLGDFGLAKL  494 (687)
Q Consensus       462 ------------~~~~ivHrDlk~~NIll~~--~~~~kl~DFGla~~  494 (687)
                                  ....++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        1356899999999999998  56689999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.10  E-value=1.2e-10  Score=126.85  Aligned_cols=250  Identities=19%  Similarity=0.176  Sum_probs=177.2

Q ss_pred             HHHHhcCcccceeeeeeCeEEEEEEEeC-CCCeEEEEEEecCcchhhHHH--HHHHHHHHhhh-cCCCceeeeeeeecCC
Q 005621          338 LKKATRGFRDKELLGFGGFGRVYKGTLP-STNTQVAVKRVSNESKQGLRE--FASEISSIGRL-RHRNLVQLLGWCRRRG  413 (687)
Q Consensus       338 l~~at~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~~~~~~~~  413 (687)
                      ....+.+|..+..||.|.|+.|++.... .++..+++|.+.+.......+  -..|+.+...+ .|.++++....+....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            3445667889999999999999998765 577889999876654332222  13466555555 5888888777666667


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-CcEEEcccccc
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLA  492 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla  492 (687)
                      ..++=-|||+++++...+  .....+....++++..|++.++.++|+   +.++|+|+||+||++..+ +..+++|||++
T Consensus       340 ~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccc
Confidence            777999999999987665  334457888899999999999999998   999999999999999886 88899999998


Q ss_pred             eeccCCCCCceeeeecCCCCC--chhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          493 KLYERGTNPSTTRVVGTLGYL--APELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      ..+.-.    ........+++  +|+......+..+.|+++||.-+.|.+++..--.....        |  .....+  
T Consensus       415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~--~~i~~~--  478 (524)
T KOG0601|consen  415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------S--LTIRSG--  478 (524)
T ss_pred             ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------c--eeeecc--
Confidence            642111    11112333444  55566667788999999999999999998654332211        0  001111  


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       571 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                         .-+++.+..     ..+..+...+..+++..||.+.+.....+
T Consensus       479 ---~~p~~~~~~-----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  479 ---DTPNLPGLK-----LQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ---cccCCCchH-----HhhhhhhhhhcCCccccchhhhhhcccch
Confidence               112222211     35666777889999999999988776543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.07  E-value=1.2e-09  Score=102.23  Aligned_cols=142  Identities=19%  Similarity=0.230  Sum_probs=106.5

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEEEEe-cCc-------chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRV-SNE-------SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ...+|-+|+-+.|+++.+  .|+...||.- .+.       .+-..++..+|++.+.+++--.|.-..=++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567899999999999998  5777777742 221       112245678899999998755554444445556666889


Q ss_pred             EecCCC-CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC---cEEEcccccce
Q 005621          419 YDFMPN-GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL---NGRLGDFGLAK  493 (687)
Q Consensus       419 ~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGla~  493 (687)
                      |||+++ .++.+++...............++..|-+.+.-||.   ..|+|+||..+||+|..++   .+.++|||++.
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence            999977 478888865444334444447889999999999998   9999999999999997664   35899999985

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.04  E-value=2.4e-09  Score=114.16  Aligned_cols=170  Identities=20%  Similarity=0.295  Sum_probs=133.7

Q ss_pred             CeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeee----cCCeeEEEEecCCC-CCchh
Q 005621          355 GFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR----RRGDLLLVYDFMPN-GSLDK  429 (687)
Q Consensus       355 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~~~~~~lV~Ey~~~-gsL~~  429 (687)
                      .-.+.||+....+|..|++|+++....+.......-++.++++.|+|+|++...+.    ....+++||+|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34589999999999999999996554444334456688999999999999999875    34578999999985 46766


Q ss_pred             hhhch-------------hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          430 CLFDE-------------QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       430 ~L~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +-+..             ++...++...+.++.|+..||.++|+   .|+.-+-|.+.+|+++.+.+++|+.+|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            55432             22346788999999999999999999   999999999999999999999999999887654


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP  545 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p  545 (687)
                      .+..               |-+.+   -.+-|.=.||.+++.|.||...
T Consensus       445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            4331               11111   2367888999999999999654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.01  E-value=1.9e-09  Score=101.44  Aligned_cols=131  Identities=18%  Similarity=0.268  Sum_probs=100.6

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEe-cCcc-------hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRV-SNES-------KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ..+++|+-+.+|.+.+  -|.++++|.- .+.-       +-...+-..|+.++++++--.|.-.+=+..+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3578999999999977  3555777743 2221       1112346789999999976666555556667778899999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      |.+|..|.+.+...         ...++..+-.-+.-||.   .+|+|+||.++||++.... +.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999998888433         35677788888889998   9999999999999997764 99999999863

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.89  E-value=1.7e-08  Score=103.74  Aligned_cols=141  Identities=18%  Similarity=0.113  Sum_probs=103.6

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-hHH----------HHHHHHHHHhhhcCCC--ceeeeeeeec----
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLR----------EFASEISSIGRLRHRN--LVQLLGWCRR----  411 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~H~n--iv~l~~~~~~----  411 (687)
                      +.+-.-....|++..+  .|+.+.||+....... ..+          .+.+|...+.+|...+  .++++++.+.    
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            4555444455778777  5788999987544311 112          3778999999885433  3455556543    


Q ss_pred             -CCeeEEEEecCCCC-CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-------CC
Q 005621          412 -RGDLLLVYDFMPNG-SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-------EL  482 (687)
Q Consensus       412 -~~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-------~~  482 (687)
                       ...-+||+|++++. +|.+++........+...+..++.+++..+.-||.   .+|+|+|++++|||++.       +.
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence             23578999999886 88888743223345667788999999999999999   99999999999999975       46


Q ss_pred             cEEEccccccee
Q 005621          483 NGRLGDFGLAKL  494 (687)
Q Consensus       483 ~~kl~DFGla~~  494 (687)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            789999998853

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.87  E-value=1.5e-09  Score=124.11  Aligned_cols=250  Identities=21%  Similarity=0.229  Sum_probs=167.4

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ..+.+.+.+-+-+|.++.++.+.-...+...++|.......   ...+....+-.++-..+||-++...--+......+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            34556666777788899888887766666566655433221   112222223333323345666655544555678899


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc-
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE-  496 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~-  496 (687)
                      +++|..+++|...|+...  ..+.+-....+..+..+++|||.   ..+.|||++|.|++...++..++.|||+..... 
T Consensus       882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence            999999999988885432  34555555566778889999998   779999999999999999999999998433210 


Q ss_pred             --------------------CCCC---------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCC
Q 005621          497 --------------------RGTN---------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE  547 (687)
Q Consensus       497 --------------------~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~  547 (687)
                                          ....         .......||+.|.+||...+......+|.|++|++++|.++|..||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                                0000         11223568999999999999999999999999999999999999998


Q ss_pred             CCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHH
Q 005621          548 PKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMR  609 (687)
Q Consensus       548 ~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  609 (687)
                      ........       +.+..+.+     +.  ..-+........+++...+..+|.+|-.|.
T Consensus      1037 a~tpq~~f-------~ni~~~~~-----~~--p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF-------ENILNRDI-----PW--PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhhh-------hccccCCC-----CC--CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            76643221       11111111     10  111222233566677778888888888776

>KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport]

Probab=98.79  E-value=3.5e-07  Score=93.54  Aligned_cols=227  Identities=19%  Similarity=0.274  Sum_probs=141.8

Q ss_pred             HHHHHHHHHHhccCCCcc------cceEe-CCCCCCCC------CCCeEEeeceEEccCCcEEecCCCCCeeEEEEecCC
Q 005621            6 KFFLVLFIFLANPVFSQQ------EEFFF-SGFRDAAN------NNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSP   72 (687)
Q Consensus         6 ~~~~~~~~~l~~~~~~~~------~~f~~-~~F~~~~~------~~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p   72 (687)
                      ++|++|+++|.-.+....      --|-| .+|.....      -.-....|||.. +...|+|+++..++.|.+|-+.-
T Consensus         9 p~f~~lLllLa~~~~~~~~~~~~~rrFEYK~SFk~P~Laq~dgtiPFW~~~GdAIa-s~eqvRlaPSmrsrkGavWtka~   87 (497)
T KOG3838|consen    9 PLFCALLLLLAPHVPETGCGTPPHRRFEYKYSFKGPRLAQPDGTIPFWSHHGDAIA-SSEQVRLAPSMRSRKGAVWTKAS   87 (497)
T ss_pred             chHHHHHHHccCcCcccccCCCccceeeeeecccCCccccCCCCcceeeecCcccc-cccceeeccccccccCceeeccc
Confidence            466666565554433321      13555 25655321      123677899954 57789999999999999988876


Q ss_pred             eecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCC
Q 005621           73 IKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDF  152 (687)
Q Consensus        73 ~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~  152 (687)
                      +++-         .|..+-+|.|+.. ...++|||||--+....    --|..||-.+.      = .-+++=||.|.|.
T Consensus        88 ~~fe---------~weVev~~rVtGr-GRiGAdGlaiWYt~~~G----~~GpVfGg~d~------W-nGigiffDSfdnD  146 (497)
T KOG3838|consen   88 VPFE---------NWEVEVQFRVTGR-GRIGADGLAIWYTRGRG----HVGPVFGGLDS------W-NGIGIFFDSFDND  146 (497)
T ss_pred             CCcc---------cceEEEEEEeccc-ccccCCceEEEEecCCC----ccccccccccc------c-cceEEEeeccccc
Confidence            6652         4788899999875 55689999999876442    22333443221      1 1268999999885


Q ss_pred             CCCCCCCCeeeEEeCC-CCcccccccccccccccccccccCC-CCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeee
Q 005621          153 EFGDINDNHVGIDINS-LRSNASEPAAYFLENSTKQVLNLKS-GEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDV  230 (687)
Q Consensus       153 ~~~d~~~~Hvgi~~ns-~~s~~~~~~~~~~~~~~~~~~~~~~-g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~  230 (687)
                        +.-|+.-|.+-.|. ..+..-..-+. ....+..-.+.+| --++.++|+|-  .++|+|.+... ..|..+ -.-.+
T Consensus       147 --~qknnP~Is~~lndGt~~ydh~~DGa-sQ~LssCqrDFRNkPyPvRarItY~--~nvLtv~innG-mtp~d~-yE~C~  219 (497)
T KOG3838|consen  147 --GQKNNPAISVLLNDGTIPYDHPGDGA-SQGLSSCQRDFRNKPYPVRARITYY--GNVLTVMINNG-MTPSDD-YEFCV  219 (497)
T ss_pred             --CCcCCccEEEEecCCcccccCCCccH-HHHHHHhhHHhccCCCCceEEEEEe--ccEEEEEEcCC-CCCCCC-cceeE
Confidence              24456667665553 22211110000 0011122222222 24688999998  48899988643 344432 34455


Q ss_pred             cCCcc-ccccceeeeeccCCcccceeEEEEee
Q 005621          231 DLSPI-VKETMYVGFSSSTGLLASSHYILGWS  261 (687)
Q Consensus       231 dl~~~-l~~~~~vGFsastG~~~~~~~i~sWs  261 (687)
                      +...+ ||..-|+|.||+||.+..-|.|++..
T Consensus       220 rve~~~lp~nGyFGvSAATGgLADDHDVl~Fl  251 (497)
T KOG3838|consen  220 RVENLLLPPNGYFGVSAATGGLADDHDVLSFL  251 (497)
T ss_pred             eccceeccCCCeeeeeecccccccccceeeeE
Confidence            55555 68999999999999999999999984

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=6.1e-08  Score=94.03  Aligned_cols=125  Identities=22%  Similarity=0.282  Sum_probs=81.1

Q ss_pred             EEEEEEeCCCCeEEEEEEecCcc--------------h------------hhHHHHHHHHHHHhhhcCC--Cceeeeeee
Q 005621          358 RVYKGTLPSTNTQVAVKRVSNES--------------K------------QGLREFASEISSIGRLRHR--NLVQLLGWC  409 (687)
Q Consensus       358 ~Vy~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~H~--niv~l~~~~  409 (687)
                      .||.|... +|..+|||+.+...              +            .......+|.+.|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999884 57899999864310              0            0112356799999999765  566777553


Q ss_pred             ecCCeeEEEEecCC--CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhh-hcccccCeEEeeccCCCcEEeccCCcEEE
Q 005621          410 RRRGDLLLVYDFMP--NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY-LHEEWEQTVIHRDIKAGNVLLDSELNGRL  486 (687)
Q Consensus       410 ~~~~~~~lV~Ey~~--~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivHrDlk~~NIll~~~~~~kl  486 (687)
                          .-.|||||++  |..+.. |...   .++......++.+++..+.. +|.   .+|+|+||.+.||+++++ .+.|
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~---~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDV---DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHC---GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred             ----CCEEEEEecCCCccchhh-HHhc---cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence                3479999998  544443 3221   12234456677788886665 466   899999999999999988 9999


Q ss_pred             cccccceec
Q 005621          487 GDFGLAKLY  495 (687)
Q Consensus       487 ~DFGla~~~  495 (687)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain

Probab=98.63  E-value=2.5e-06  Score=83.12  Aligned_cols=196  Identities=16%  Similarity=0.171  Sum_probs=111.0

Q ss_pred             CCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCC-CCCCCCCcccccc
Q 005621           51 NGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKE-LPGTLPSQYLGLL  129 (687)
Q Consensus        51 ~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~-~~~~~~g~~lGl~  129 (687)
                      +|.|+||+...+++|-+.|.+++|--+.       -...+|.+-.-.. ...++||+||||+-... +..+..||.||+.
T Consensus        31 ~g~LRLT~~~~nqata~~~~~~FPs~~n-------~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGsLGYa  102 (255)
T cd06900          31 NNRLRLTDASGNQATAVTLQRLFPSAGN-------YVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGSLGYA  102 (255)
T ss_pred             cCeEEeccCccCcceeEEEeeeeccCCC-------eEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcccccc
Confidence            6899999999999999999999986331       2556676665433 45689999999984332 2235688899998


Q ss_pred             ccCC-CCCCcceEEEEEeecccCCCCCCCCC----------CeeeEEeCCCCccccccccccccccccc-ccccCC----
Q 005621          130 NSSD-LGNLTNHIFAVEFDTVKDFEFGDIND----------NHVGIDINSLRSNASEPAAYFLENSTKQ-VLNLKS----  193 (687)
Q Consensus       130 ~~~~-~~~~~~~~vaVEFDt~~n~~~~d~~~----------~Hvgi~~ns~~s~~~~~~~~~~~~~~~~-~~~~~~----  193 (687)
                      -... ...-....++|-||-|-|..  .+.+          +-|+|--.  -+. +....|...+.... .++..+    
T Consensus       103 ~~~~~~~GfaGGwLGiGlDEyGNFs--n~~eg~~~~~g~r~~sV~vRGs--g~g-~~gY~yl~gt~~~~~~id~~~~~~~  177 (255)
T cd06900         103 QRNDGVPGFAGGWLGIGLDEYGNFS--NPNEGRNGFSGRRPQSVTVRGS--GSG-YTGYKYITGTGVLPPGIDNNSTSTP  177 (255)
T ss_pred             cccCCCCccccceEEEEEecccccc--CCCCCccCCcccccceEEEECC--CCC-CcCceEecccCCCCcccccCCCCCC
Confidence            6542 22235568889888776632  2221          22332111  110 01111111111111 111111    


Q ss_pred             CCeEEEEEEEeCC---CCeEEEEEeeCCCCCCCcceeee---ecCC--ccccccceeeeeccCCcccceeEEEEe
Q 005621          194 GEVIQAWIDYDSS---KNHLEVRLAPSSVKPRSPILSFD---VDLS--PIVKETMYVGFSSSTGLLASSHYILGW  260 (687)
Q Consensus       194 g~~~~~~I~Yd~~---~~~l~V~~~~~~~~~~~~~ls~~---~dl~--~~l~~~~~vGFsastG~~~~~~~i~sW  260 (687)
                      ...+.=+|.-|+.   ...|+|.-+..+..-..+ +-..   ++..  ..+|+..+++|++|||..+-.|.|-..
T Consensus       178 ~~~hrY~i~Ids~~~~~~~vsV~R~~~~gg~~~~-~I~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEIdnf  251 (255)
T cd06900         178 APGHRYRITIDSTNGDNAWLSVERDIGNGGAYFV-VILTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEIDNF  251 (255)
T ss_pred             CCceEEEEEEecCCCCceEEEEEEEccCCceeEE-eecceeeccccCCCCCCccEEEEEEecCCCcccceeecce
Confidence            1224444555543   233455544322111111 2222   2333  568999999999999999999998654

This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.50  E-value=6.2e-07  Score=88.96  Aligned_cols=107  Identities=21%  Similarity=0.304  Sum_probs=85.2

Q ss_pred             HHHHHHHHHHHhhhcCC--CceeeeeeeecCC----eeEEEEecCCCC-CchhhhhchhhccCCHHHHHHHHHHHHhhhh
Q 005621          384 LREFASEISSIGRLRHR--NLVQLLGWCRRRG----DLLLVYDFMPNG-SLDKCLFDEQKAILTWEQRYRIIKGVASGLL  456 (687)
Q Consensus       384 ~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~  456 (687)
                      .....+|...+.+|...  ...+.+++.....    ..+||+|++++. +|.+++.....  ++......++.+++..+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            34677888888888543  3466777766533    458999999884 78888844222  666778899999999999


Q ss_pred             hhcccccCeEEeeccCCCcEEeccCC---cEEEcccccceec
Q 005621          457 YLHEEWEQTVIHRDIKAGNVLLDSEL---NGRLGDFGLAKLY  495 (687)
Q Consensus       457 yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGla~~~  495 (687)
                      -||+   .+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999   9999999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.50  E-value=9.3e-07  Score=86.40  Aligned_cols=138  Identities=17%  Similarity=0.150  Sum_probs=104.5

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcc------hhhHHHHHHHHHHHhhhcCC--Cceeeeeeee-cC----CeeEE
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES------KQGLREFASEISSIGRLRHR--NLVQLLGWCR-RR----GDLLL  417 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~-~~----~~~~l  417 (687)
                      -|+||-+.|++..+  .|..+-+|+.....      ......|.+|+..|.+|..-  ++.+++ ++. ..    ..-+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            46688888999887  45578899876321      23457899999999999532  345555 332 21    24689


Q ss_pred             EEecCCC-CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc--EEEccccccee
Q 005621          418 VYDFMPN-GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN--GRLGDFGLAKL  494 (687)
Q Consensus       418 V~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DFGla~~  494 (687)
                      |+|-+++ -+|.+++......+.+..++..++.+++..+.-||+   .++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9997753 488888854444456788889999999999999999   99999999999999986666  99999987653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.47  E-value=7.6e-07  Score=89.02  Aligned_cols=136  Identities=18%  Similarity=0.182  Sum_probs=94.1

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--------------------c--hhhHHHHHHHHHHHhhhcCC--
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--------------------S--KQGLREFASEISSIGRLRHR--  400 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~H~--  400 (687)
                      ......||-|.-+.||.|..+ .|.++|||.-+..                    +  .-......+|.++|.+|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345678999999999999996 5889999953211                    0  00112356799999998655  


Q ss_pred             CceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc
Q 005621          401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS  480 (687)
Q Consensus       401 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~  480 (687)
                      .+.+.++|-    .-.+||||.+|-.|...-       ++.+..-.|+..|+.-+.-+-.   .+|||+|+++-||++++
T Consensus       172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~  237 (304)
T COG0478         172 KVPKPIAWN----RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCccccc----cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence            677777654    448999999887665432       1222222333333333333323   89999999999999999


Q ss_pred             CCcEEEcccccceec
Q 005621          481 ELNGRLGDFGLAKLY  495 (687)
Q Consensus       481 ~~~~kl~DFGla~~~  495 (687)
                      |+.+.++||--+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999876543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.38  E-value=1.9e-06  Score=95.90  Aligned_cols=140  Identities=18%  Similarity=0.230  Sum_probs=91.2

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhH------------------------------H----------HHH
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL------------------------------R----------EFA  388 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~  388 (687)
                      +-|+.++-|.||+|+++. |+.||||+.++.-.+..                              +          ++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            678999999999999964 99999999876422111                              0          134


Q ss_pred             HHHHHHhhhc-----CCCceeeeeee-ecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhh-hhhccc
Q 005621          389 SEISSIGRLR-----HRNLVQLLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGL-LYLHEE  461 (687)
Q Consensus       389 ~E~~~l~~l~-----H~niv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~  461 (687)
                      .|...+.+++     .++ +++=..+ +-.+...|+|||++|-.+.+...-+. ..++...   ++..++++. ..+-  
T Consensus       210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~--  282 (517)
T COG0661         210 REAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLL--  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHH--
Confidence            4555555542     222 2222222 23456799999999999988753222 2344222   222222211 1111  


Q ss_pred             ccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       462 ~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                       ..++.|.|.+|.||+++.++++.+.|||+...++.
T Consensus       283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             16899999999999999999999999999876643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=1.8e-07  Score=103.69  Aligned_cols=150  Identities=19%  Similarity=0.253  Sum_probs=102.4

Q ss_pred             HHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc--------eeeeecCCCCCchhhccC
Q 005621          449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--------TTRVVGTLGYLAPELTRT  520 (687)
Q Consensus       449 ~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~  520 (687)
                      .+++.||.|+|.  ..++||++|.|++|.++.++..||+.|+.+..........        .--......|.|||++..
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            445699999998  5899999999999999999999999999875433311110        011234568999999999


Q ss_pred             CCCCCccceehhhHHHHHHHhCCCCCC-CCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccc
Q 005621          521 GKPTTSSDVYAFGALLLEVVCGRRPIE-PKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSN  599 (687)
Q Consensus       521 ~~~~~~sDV~S~Gvvl~elltG~~p~~-~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~  599 (687)
                      ...+.++|+||+|+++|-+..|..+.- ...........             ...+..-...+....+.++.+=+.+.+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHhc
Confidence            889999999999999999986555543 22211111100             0011111111223344467777888999


Q ss_pred             cCcCcCCCHHHHHH
Q 005621          600 DAAEARPTMRQVVR  613 (687)
Q Consensus       600 ~dP~~RPs~~evl~  613 (687)
                      .++..||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998877765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.36  E-value=3.1e-06  Score=88.71  Aligned_cols=258  Identities=18%  Similarity=0.205  Sum_probs=156.0

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeee------ecCC-eeEEEE
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWC------RRRG-DLLLVY  419 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~------~~~~-~~~lV~  419 (687)
                      ..+.||+|+-+.+|-.-.-   .-.+-|+.+........+...|+  ..--.||-+-.=+.|=      -+++ ..-+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4577999999999965331   12345777665443333322222  2223566544323221      1222 366778


Q ss_pred             ecCCCCC-chhhhhc----hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          420 DFMPNGS-LDKCLFD----EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       420 Ey~~~gs-L~~~L~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      ..+++.- ..+++..    ..-....|.-.++.++.+|.+.+.||.   .|.+-+|+.++|+|+.++..+.|.|=..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence            8776642 2232321    112347899999999999999999998   9999999999999999999999988554333


Q ss_pred             ccCCCCCceeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhC-CCCCCCCCCcchh-hHHHHHHHHhcc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCG-RRPIEPKALPEEL-ILVDWVWDRWKA  567 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG-~~p~~~~~~~~~~-~~~~~v~~~~~~  567 (687)
                      ..+  .......+|...|.+||.-.     +-.-+...|-|.+||++++|+.| ++||.+-...... ...   ...+..
T Consensus       167 ~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~---E~~Ia~  241 (637)
T COG4248         167 NAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL---ETDIAH  241 (637)
T ss_pred             ccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc---hhhhhc
Confidence            222  12233357888999999754     33557789999999999999986 9999764321000 000   001112


Q ss_pred             cccccccCCcC-----CCCCCH-HHHHHHHHHHHhccccC--cCcCCCHHHHHHHHhc
Q 005621          568 GAILEVVDPRL-----NGEFNE-IEALDVVKLGLMCSNDA--AEARPTMRQVVRYLEG  617 (687)
Q Consensus       568 ~~~~~~~d~~l-----~~~~~~-~~~~~l~~l~~~Cl~~d--P~~RPs~~evl~~L~~  617 (687)
                      |......|.+.     ...++- .....+..+..+|+...  +.-||+.+..+..|..
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            22222222111     111211 12235566677777643  5689999988876653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.28  E-value=8.3e-06  Score=80.09  Aligned_cols=138  Identities=13%  Similarity=0.173  Sum_probs=95.1

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHH---------HHHHHHhhhcCC---Cceeeeee
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA---------SEISSIGRLRHR---NLVQLLGW  408 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~H~---niv~l~~~  408 (687)
                      ..++|...+++-......|.+-..  ++..+++|..+.......+.|.         +++..+.+++..   ....++..
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            356788888888877777877776  6789999988776544433332         344444444332   22333332


Q ss_pred             ee-----cCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          409 CR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       409 ~~-----~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                      ..     .....+|+|||++|..|.++..      ++.    .++..+.+++.-||.   .|+.|+|..|+|++++.+ .
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-c
Confidence            22     2345679999999998877541      222    245567788999998   999999999999999855 5


Q ss_pred             EEEccccccee
Q 005621          484 GRLGDFGLAKL  494 (687)
Q Consensus       484 ~kl~DFGla~~  494 (687)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.27  E-value=7.5e-06  Score=82.35  Aligned_cols=138  Identities=16%  Similarity=0.192  Sum_probs=85.1

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCC--ceeeeeeeecCCeeEEEEecCCCCC
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--LVQLLGWCRRRGDLLLVYDFMPNGS  426 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~gs  426 (687)
                      ..||+|..+.||+.    .+..+++|......  ......+|.++++.+..-.  +.+.++++...+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            56899999999984    24467788876533  2244678999999986443  4778888888888899999999863


Q ss_pred             -chhhhh---------------------chhhccCCHHHHH-HHHHHH----------Hhh-hhhhcc-cccCeEEeecc
Q 005621          427 -LDKCLF---------------------DEQKAILTWEQRY-RIIKGV----------ASG-LLYLHE-EWEQTVIHRDI  471 (687)
Q Consensus       427 -L~~~L~---------------------~~~~~~l~~~~~~-~i~~~i----------a~~-L~yLH~-~~~~~ivHrDl  471 (687)
                       +...+.                     .-........... ++..++          ... ..+|.. .....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             221110                     0000001111100 000000          000 111111 11346799999


Q ss_pred             CCCcEEeccCCcEEEcccccce
Q 005621          472 KAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       472 k~~NIll~~~~~~kl~DFGla~  493 (687)
                      .|.||++++++ +.|+||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.20  E-value=2e-05  Score=78.24  Aligned_cols=154  Identities=19%  Similarity=0.189  Sum_probs=101.9

Q ss_pred             ccCHHHHHHHhcCcccceeee---eeCeEEEEEEEeCCCCeEEEEEEecCcchhhH---------HH-------------
Q 005621          332 RFSYEELKKATRGFRDKELLG---FGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL---------RE-------------  386 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG---~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---------~~-------------  386 (687)
                      ..+.+.+.....+..+....|   .|.-..||+|.. .++..+|||++........         ..             
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            456777888888877777666   566778999986 4688999999865421110         01             


Q ss_pred             --HHHHHHHHhhhc--CCCceeeeeeeecCCeeEEEEecCCCCC-chhhhhchhhccCCHHHHHHHHHHHHhhhhhhccc
Q 005621          387 --FASEISSIGRLR--HRNLVQLLGWCRRRGDLLLVYDFMPNGS-LDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE  461 (687)
Q Consensus       387 --~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey~~~gs-L~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~  461 (687)
                        ..+|+..|.++.  +=.+.+-+++.    .-.|||||+...- -.-.|.   ...+...+...+..++++.+.-|-. 
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~-  184 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYK-  184 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHH-
Confidence              235667776663  33344444433    2379999996441 111121   1123333566677777777766654 


Q ss_pred             ccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       462 ~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                       ..++||+||+.-|||+. ++.+.|+|+|-|....
T Consensus       185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence             37899999999999999 8899999999887554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.17  E-value=2e-05  Score=79.11  Aligned_cols=143  Identities=20%  Similarity=0.213  Sum_probs=85.2

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCC--Cceeeeeeeec---CCeeEEEEecC
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHR--NLVQLLGWCRR---RGDLLLVYDFM  422 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~---~~~~~lV~Ey~  422 (687)
                      .+.|+.|..+.||+.....  ..+++|.....  ........|..+++.+...  .+.+++.++..   ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4678999999999999854  58999997665  4456777888888888533  35677765432   33578999999


Q ss_pred             CCCCchh----------------hhh---ch--hhccCCHHH---------HHHH------------HHHHHh-hhhhhc
Q 005621          423 PNGSLDK----------------CLF---DE--QKAILTWEQ---------RYRI------------IKGVAS-GLLYLH  459 (687)
Q Consensus       423 ~~gsL~~----------------~L~---~~--~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH  459 (687)
                      ++..+..                .+.   ..  ......+..         ....            ...+.+ .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                110   00  000000000         0000            111222 233333


Q ss_pred             c----cccCeEEeeccCCCcEEec-cCCcEEEccccccee
Q 005621          460 E----EWEQTVIHRDIKAGNVLLD-SELNGRLGDFGLAKL  494 (687)
Q Consensus       460 ~----~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGla~~  494 (687)
                      .    .....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2    1347899999999999999 566678999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.12  E-value=7.1e-07  Score=97.93  Aligned_cols=184  Identities=18%  Similarity=0.136  Sum_probs=134.7

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCC-ceeeeeeeecCCeeEEEEecCCCC
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN-LVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      .-+-+++++++++||.+.......+ ++.+...     ....-++++|.+++||| .+..++-+..+...+++++++..+
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            3445788999999998875443333 5655443     33456889999999999 677777777788899999999887


Q ss_pred             -CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCcee
Q 005621          426 -SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT  504 (687)
Q Consensus       426 -sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  504 (687)
                       +-..-. ......+..-+...+.+.-+++++|||+   ..=+|||    ||+..+ ...|.+||+....+....  ...
T Consensus       320 rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~  388 (829)
T KOG0576|consen  320 RSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR  388 (829)
T ss_pred             ccccccC-ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence             322211 1112234445556677778899999998   4457888    777655 688999999988765543  234


Q ss_pred             eeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCC
Q 005621          505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE  547 (687)
Q Consensus       505 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~  547 (687)
                      ...+++.++|||+.....+..+-|+|+.|+--.++.-|..|-.
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            4678999999999999999999999999987777777766643

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.05  E-value=2.1e-05  Score=87.41  Aligned_cols=140  Identities=16%  Similarity=0.203  Sum_probs=91.2

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhH-------------------------------------HHHHHHH
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL-------------------------------------REFASEI  391 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~E~  391 (687)
                      +-||.-..|.||+|+++. |+.||||+.++.-+...                                     -+|..|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            679999999999999975 99999998776422110                                     0145555


Q ss_pred             HHHhhh----cCCC------ceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhccc
Q 005621          392 SSIGRL----RHRN------LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE  461 (687)
Q Consensus       392 ~~l~~l----~H~n------iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~  461 (687)
                      +...+.    +|-+      |.+++-  .-.....|+||||+|..+.+.-.-. ...++...+.   ..+.++.  ++.-
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~---~~l~~~~--~~qI  317 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAID-KRGISPHDIL---NKLVEAY--LEQI  317 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHH-HcCCCHHHHH---HHHHHHH--HHHH
Confidence            544444    3545      223332  2234679999999999888764322 2235544333   3332222  1111


Q ss_pred             ccCeEEeeccCCCcEEecc----CCcEEEcccccceeccC
Q 005621          462 WEQTVIHRDIKAGNVLLDS----ELNGRLGDFGLAKLYER  497 (687)
Q Consensus       462 ~~~~ivHrDlk~~NIll~~----~~~~kl~DFGla~~~~~  497 (687)
                      ...|++|+|=+|.||++..    +.++.+-|||+......
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            1268999999999999984    67899999999876544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.03  E-value=3e-05  Score=78.96  Aligned_cols=138  Identities=15%  Similarity=0.128  Sum_probs=85.1

Q ss_pred             eeeeCe-EEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEEEecCCCCCch
Q 005621          351 LGFGGF-GRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVYDFMPNGSLD  428 (687)
Q Consensus       351 lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~  428 (687)
                      |-.|.. ..||+....  +..+.||+.....   ..+..+|+++++.+. +-.+.+++++....+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444555 689999763  4678888876543   345677898888884 445667888887767789999999998876


Q ss_pred             hhhh-------------------chh--hccCC--HHHHHHH-----------------------HHHHHhhhhhhc-cc
Q 005621          429 KCLF-------------------DEQ--KAILT--WEQRYRI-----------------------IKGVASGLLYLH-EE  461 (687)
Q Consensus       429 ~~L~-------------------~~~--~~~l~--~~~~~~i-----------------------~~~ia~~L~yLH-~~  461 (687)
                      ....                   ...  .....  .......                       ...+...|.... ..
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4321                   000  00000  0000000                       011111111100 11


Q ss_pred             ccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       462 ~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ....++|+|+.|.|||++++....|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23669999999999999998778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=97.94  E-value=8.3e-05  Score=89.05  Aligned_cols=81  Identities=10%  Similarity=0.225  Sum_probs=59.4

Q ss_pred             ceeeeeeCeEEEEEEEeCCCC--eEEEEEEecCcc-hhhHHHHHHHHHHHhhhc-CCCc--eeeeeeeecC---CeeEEE
Q 005621          348 KELLGFGGFGRVYKGTLPSTN--TQVAVKRVSNES-KQGLREFASEISSIGRLR-HRNL--VQLLGWCRRR---GDLLLV  418 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lV  418 (687)
                      .+.++.|.+..+|+......+  ..+++|+..... ......+.+|+++++.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567889999999998875432  467888765432 122356789999999995 6665  8888888764   467999


Q ss_pred             EecCCCCCch
Q 005621          419 YDFMPNGSLD  428 (687)
Q Consensus       419 ~Ey~~~gsL~  428 (687)
                      |||++|..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999887543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.88  E-value=4.2e-05  Score=74.49  Aligned_cols=103  Identities=22%  Similarity=0.182  Sum_probs=82.2

Q ss_pred             HHHHHHhhhcC-CCceeeeeeeecCCeeEEEEecCCCCCchhhhhc-hhhccCCHHHHHHHHHHHHhhhhhhcccccCeE
Q 005621          389 SEISSIGRLRH-RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD-EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV  466 (687)
Q Consensus       389 ~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  466 (687)
                      .|.-+++.+.+ +++++++|+|-.    ++|.||.+.+++...-.. .+-...+|.+|.+|+.++++.+.+|++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57888888876 699999999943    779999987765421000 011246899999999999999999998665668


Q ss_pred             EeeccCCCcEEeccCCcEEEcccccceec
Q 005621          467 IHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       467 vHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      .-.|++++|+-+++++++|+.|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            89999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.81  E-value=0.0003  Score=73.93  Aligned_cols=79  Identities=10%  Similarity=0.018  Sum_probs=57.8

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC---CCceeeeeeeec---CCeeEEE
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH---RNLVQLLGWCRR---RGDLLLV  418 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~---~~~~~lV  418 (687)
                      ....+.||.|..+.||+....+ + .+.+|..+...  ....+..|.+.|+.+.-   -.+.+++++|..   .+..+||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hheeeecCCccceeEEEEEcCC-C-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            3445789999999999987632 3 46677743311  22577889999998853   468889988854   3668999


Q ss_pred             EecCCCCCc
Q 005621          419 YDFMPNGSL  427 (687)
Q Consensus       419 ~Ey~~~gsL  427 (687)
                      ||+++++++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998766

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.71  E-value=0.00024  Score=69.13  Aligned_cols=125  Identities=28%  Similarity=0.370  Sum_probs=91.6

Q ss_pred             cCcccceeeeeeCe-EEEEEEEeCCCCeEEEEEEecCc------------ch---------hhHHHHHHHHHHHhhhc--
Q 005621          343 RGFRDKELLGFGGF-GRVYKGTLPSTNTQVAVKRVSNE------------SK---------QGLREFASEISSIGRLR--  398 (687)
Q Consensus       343 ~~f~~~~~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~------------~~---------~~~~~~~~E~~~l~~l~--  398 (687)
                      ..++..+.||.|.. |.||++..  .|+.+|+|.+...            ..         .-...|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            77888999999999 99999999  6789999993221            00         11235889999999985  


Q ss_pred             -CCCc--eeeeeeeecC------------------CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhh
Q 005621          399 -HRNL--VQLLGWCRRR------------------GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY  457 (687)
Q Consensus       399 -H~ni--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~y  457 (687)
                       +.++  ++++||..-.                  -...||.||.+...           .++.    +-+.+|.+-|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHH
Confidence             4466  9999987321                  12467888776543           1222    234567777788


Q ss_pred             hcccccCeEEeeccCCCcEEeccCCcEEEcccccc
Q 005621          458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA  492 (687)
Q Consensus       458 LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla  492 (687)
                      +|.   .+|+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            998   99999999999975     5689999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.69  E-value=0.00024  Score=72.00  Aligned_cols=74  Identities=16%  Similarity=0.136  Sum_probs=47.8

Q ss_pred             eeeeeeCeE-EEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCC---CceeeeeeeecC---CeeEEEEec
Q 005621          349 ELLGFGGFG-RVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHR---NLVQLLGWCRRR---GDLLLVYDF  421 (687)
Q Consensus       349 ~~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~---~~~~lV~Ey  421 (687)
                      +.|+.|+.. .||+..     ..+++|..+...  ...++..|.++++.+...   .+.++++.+...   ...+++||+
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            467777766 588752     246778755422  235788899999888532   345555544332   235889999


Q ss_pred             CCCCCchh
Q 005621          422 MPNGSLDK  429 (687)
Q Consensus       422 ~~~gsL~~  429 (687)
                      ++|.++.+
T Consensus        76 i~G~~l~~   83 (235)
T cd05155          76 LEGETATA   83 (235)
T ss_pred             ecCCCCCc
Confidence            99988754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.60  E-value=0.0004  Score=68.07  Aligned_cols=129  Identities=19%  Similarity=0.326  Sum_probs=90.1

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc----------------hhhHHHHHHHHHHHhhhc------CCCcee
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES----------------KQGLREFASEISSIGRLR------HRNLVQ  404 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~  404 (687)
                      ....||+|+.-.||.-  +. +....||+.....                ....++..+|+.-...+.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            4567999999999964  32 4457788887665                223456677777666665      889999


Q ss_pred             eeeeeecCCeeEEEEecCCCC------CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          405 LLGWCRRRGDLLLVYDFMPNG------SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       405 l~~~~~~~~~~~lV~Ey~~~g------sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                      ++|+.+.+.-+-+|+|.+.+.      +|.+++.   ...++. ...+.+.+.   ..||-+   ..|+.+|++|.||++
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~L~~f---~~~l~~---~~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQALDEF---KRYLLD---HHIVIRDLNPHNIVV  151 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHHHHHH---HHHHHH---cCCeecCCCcccEEE
Confidence            999999999999999986542      5667762   223554 333333333   345554   789999999999999


Q ss_pred             ccCC----cEEEcc
Q 005621          479 DSEL----NGRLGD  488 (687)
Q Consensus       479 ~~~~----~~kl~D  488 (687)
                      ..+.    .+.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            6542    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.57  E-value=0.0003  Score=66.30  Aligned_cols=129  Identities=17%  Similarity=0.213  Sum_probs=87.5

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCce-eeeeeeecCCeeEEEEecCCC
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV-QLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ...+.|++|.+|.||+|.+  .|..+|+|+-+.++..  ..+..|+++|..+.-.++. +++.|..+    .+.|||..|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G   96 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG   96 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence            3456799999999999999  4668999988766543  5778899999998876664 45554433    445999998


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccC-CCcEEeccCCcEEEccccccee
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIK-AGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk-~~NIll~~~~~~kl~DFGla~~  494 (687)
                      -.|.+.-...     +-.+    +..+++.-.-|-.   .+|-|+.|. |...+|-.+..+.|+||.-|..
T Consensus        97 ~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG-----DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc-----cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8887654221     1222    2333444222333   778888886 4444444455999999998873

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.52  E-value=0.00068  Score=68.48  Aligned_cols=141  Identities=18%  Similarity=0.197  Sum_probs=81.9

Q ss_pred             ceeeeeeCeEEEEEEEeCC-CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc-eeeeeeeecCCeeEEEEecCCCC
Q 005621          348 KELLGFGGFGRVYKGTLPS-TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL-VQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      .+.|..|-...+|+..... .+..+++|+....... ..+...|+.+++.+...++ +++++.+.    -.++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3567778888999997643 2567889977654222 1233478888888854333 44554433    24799999998


Q ss_pred             Cchhhh-----------------hchh-h--------ccC-CHHHHHHHHHH----------------------H---Hh
Q 005621          426 SLDKCL-----------------FDEQ-K--------AIL-TWEQRYRIIKG----------------------V---AS  453 (687)
Q Consensus       426 sL~~~L-----------------~~~~-~--------~~l-~~~~~~~i~~~----------------------i---a~  453 (687)
                      ++....                 +... .        ... -+..+..+...                      +   +.
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            764220                 0000 0        001 12221121111                      1   11


Q ss_pred             hh-hhhcc-cccCeEEeeccCCCcEEecc-CCcEEEcccccce
Q 005621          454 GL-LYLHE-EWEQTVIHRDIKAGNVLLDS-ELNGRLGDFGLAK  493 (687)
Q Consensus       454 ~L-~yLH~-~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~  493 (687)
                      .| ..+.. .....++|+|+.+.|||++. +..+.++||..|.
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            11 11111 12357999999999999998 5789999998875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.51  E-value=0.00042  Score=72.66  Aligned_cols=141  Identities=18%  Similarity=0.155  Sum_probs=84.8

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCC--ceeeeee------eecCCeeEEEE
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--LVQLLGW------CRRRGDLLLVY  419 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~  419 (687)
                      .+.|..|....+|+...  .+..+++|+....   ...+...|+.++..+.+.+  +.+++..      ....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            45677777789999876  3447889987652   2345667888888875432  4455442      12345678999


Q ss_pred             ecCCCCCchh----hh----------hchhh---------ccCCHHHHH----------HHHHHHHhhhhhhcc----cc
Q 005621          420 DFMPNGSLDK----CL----------FDEQK---------AILTWEQRY----------RIIKGVASGLLYLHE----EW  462 (687)
Q Consensus       420 Ey~~~gsL~~----~L----------~~~~~---------~~l~~~~~~----------~i~~~ia~~L~yLH~----~~  462 (687)
                      ||++|..+..    .+          +....         ....|....          .....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999987643    01          00000         011222111          011112233333332    22


Q ss_pred             cCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       463 ~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..+++|+|+.|.||+++++..+.|.||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3579999999999999998777899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.47  E-value=0.00048  Score=70.71  Aligned_cols=136  Identities=14%  Similarity=0.052  Sum_probs=78.9

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc-eeeeeeeecCCeeEEEEecCCCCCchh
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL-VQLLGWCRRRGDLLLVYDFMPNGSLDK  429 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~  429 (687)
                      +..|-.+.+|+...  ++..+++|..........-+...|..+++.+....+ .+++..+.    -++||||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            45577788998874  567888987654432211235678889988864433 44554432    368999999877653


Q ss_pred             h-------h----------hchh--hccCCHHHH-HHHHH------------HHHhhhhhh--cccccCeEEeeccCCCc
Q 005621          430 C-------L----------FDEQ--KAILTWEQR-YRIIK------------GVASGLLYL--HEEWEQTVIHRDIKAGN  475 (687)
Q Consensus       430 ~-------L----------~~~~--~~~l~~~~~-~~i~~------------~ia~~L~yL--H~~~~~~ivHrDlk~~N  475 (687)
                      .       +          +...  ..+++.... .....            .+...+...  .......++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            2       1          1100  111121111 11111            111111111  01123579999999999


Q ss_pred             EEeccCCcEEEcccccce
Q 005621          476 VLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       476 Ill~~~~~~kl~DFGla~  493 (687)
                      |++++++ ++|+||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999876 7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.47  E-value=0.0019  Score=68.52  Aligned_cols=156  Identities=16%  Similarity=0.146  Sum_probs=84.8

Q ss_pred             cCHHHHHHHhcCccc-----ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCC--Cceee
Q 005621          333 FSYEELKKATRGFRD-----KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHR--NLVQL  405 (687)
Q Consensus       333 ~~~~el~~at~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l  405 (687)
                      .+.+++......|..     .+.|+.|....+|+....  +..+++|+......   ++...|+.++..|...  .+.+.
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~   81 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT--QGEYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAP   81 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC--CCcEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcc
Confidence            345555555555543     345667777899998763  33688998762222   3333455555555322  23333


Q ss_pred             eee------eecCCeeEEEEecCCCCCchh-----------hh---hchhh---------ccCCH-HHHHH---------
Q 005621          406 LGW------CRRRGDLLLVYDFMPNGSLDK-----------CL---FDEQK---------AILTW-EQRYR---------  446 (687)
Q Consensus       406 ~~~------~~~~~~~~lV~Ey~~~gsL~~-----------~L---~~~~~---------~~l~~-~~~~~---------  446 (687)
                      +..      ....+..++++||++|..+..           .|   +....         ..+.| .+...         
T Consensus        82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (319)
T PRK05231         82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE  161 (319)
T ss_pred             eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence            321      223456799999999876521           11   10000         01111 11111         


Q ss_pred             ---HH-HHHHhhhhhhcc----cccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          447 ---II-KGVASGLLYLHE----EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       447 ---i~-~~ia~~L~yLH~----~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                         .+ ..+...+..+..    ....+++|+|+.+.||+++.+...-|+||+.+.
T Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence               11 111112222221    134689999999999999976556899999875

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.44  E-value=0.0012  Score=71.76  Aligned_cols=77  Identities=12%  Similarity=0.066  Sum_probs=55.0

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-------hhhHHHHHHHHHHHhhhc---CCCceeeeeeeecCCeeEE
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-------KQGLREFASEISSIGRLR---HRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l  417 (687)
                      .+.||.|.+..||++...++++.++||.-.+..       ....+++..|.+.|..+.   -.++++++.+..  +..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            357899999999999996544689999854221       123456777888888763   245777887744  55789


Q ss_pred             EEecCCCCC
Q 005621          418 VYDFMPNGS  426 (687)
Q Consensus       418 V~Ey~~~gs  426 (687)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.37  E-value=0.00081  Score=79.31  Aligned_cols=197  Identities=18%  Similarity=0.195  Sum_probs=133.8

Q ss_pred             HHHHHHHHHhhhcCCCceeeeeeeecCCee----EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhccc
Q 005621          386 EFASEISSIGRLRHRNLVQLLGWCRRRGDL----LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE  461 (687)
Q Consensus       386 ~~~~E~~~l~~l~H~niv~l~~~~~~~~~~----~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~  461 (687)
                      .-..|+..+.++.|+|++.++.|..++...    .+..|++..-++...+  ..-..++....+.+..++..||.|+|+ 
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHHH-
Confidence            345678888889999999999987665433    3446778777777777  334568888999999999999999998 


Q ss_pred             ccCeEEeeccCCC---cEEeccCCcEEEc--ccccceeccCCCCCceeeeecCCCCCchhhccCCCCCC--ccceehhhH
Q 005621          462 WEQTVIHRDIKAG---NVLLDSELNGRLG--DFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTT--SSDVYAFGA  534 (687)
Q Consensus       462 ~~~~ivHrDlk~~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDV~S~Gv  534 (687)
                        ....|.-|..+   +.-.+.++...++  ||+....+.......  ...-+..+.+||......+..  ..|+|++|.
T Consensus       305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             --hccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHH
Confidence              55555544444   4444555666666  888777554333221  123355677888777655544  479999999


Q ss_pred             HHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          535 LLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       535 vl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .+..+..|..+-........                  .    +...+..    ...+....|+..++++|++..+++..
T Consensus       381 l~~~~~~~~~i~~~~~~~~~------------------~----l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAVPVS------------------L----LDVLSTS----ELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHhhhhhcCcccccccchhh------------------h----hccccch----hhhhhhhhhcchhhhhccchhhhhhc
Confidence            99999988766433221110                  0    1111111    35566778999999999999999875


Q ss_pred             H
Q 005621          615 L  615 (687)
Q Consensus       615 L  615 (687)
                      .
T Consensus       435 ~  435 (1351)
T KOG1035|consen  435 P  435 (1351)
T ss_pred             h
Confidence            3

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.18  E-value=0.0019  Score=67.97  Aligned_cols=140  Identities=24%  Similarity=0.279  Sum_probs=83.5

Q ss_pred             eeeeeeCeEEEEEEEeCC------CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc-eeeeeeeecCCeeEEEEec
Q 005621          349 ELLGFGGFGRVYKGTLPS------TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL-VQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey  421 (687)
                      +.|..|-...+|+.....      .++.+++|+...... ...+...|.+++..+....+ .++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            455666677899988643      157899999765432 22345678888888854333 456665542    368999


Q ss_pred             CCCCCchhhh-----------------hchhhc-------c--CCHHHHHHH--------------------------HH
Q 005621          422 MPNGSLDKCL-----------------FDEQKA-------I--LTWEQRYRI--------------------------IK  449 (687)
Q Consensus       422 ~~~gsL~~~L-----------------~~~~~~-------~--l~~~~~~~i--------------------------~~  449 (687)
                      ++|..+....                 +.....       .  .-|....++                          ..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9988775321                 110000       0  001111111                          11


Q ss_pred             HHHhhhhhhc------ccccCeEEeeccCCCcEEeccC----CcEEEcccccce
Q 005621          450 GVASGLLYLH------EEWEQTVIHRDIKAGNVLLDSE----LNGRLGDFGLAK  493 (687)
Q Consensus       450 ~ia~~L~yLH------~~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGla~  493 (687)
                      .+..-+..|.      ......++|+|+.+.|||++++    +.++++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            1222223332      1235789999999999999985    889999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.16  E-value=0.0054  Score=64.77  Aligned_cols=156  Identities=19%  Similarity=0.153  Sum_probs=88.9

Q ss_pred             CHHHHHHHhcCccc-----ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCC--Cceeee
Q 005621          334 SYEELKKATRGFRD-----KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHR--NLVQLL  406 (687)
Q Consensus       334 ~~~el~~at~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~  406 (687)
                      +.++|....++|..     .+.++.|....+|+... . +..+++|+.+....  ..+...|++++..|...  ++.+++
T Consensus         8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i   83 (307)
T TIGR00938         8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPV   83 (307)
T ss_pred             CHHHHHHHHHhcCCCCceeccccCCccccceEEEEe-C-CCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence            34555555555543     34566676788999875 2 33677898755321  23445667777777432  244444


Q ss_pred             eee------ecCCeeEEEEecCCCCCchhh----h----------hchhhc----------cCCHHHHHH----------
Q 005621          407 GWC------RRRGDLLLVYDFMPNGSLDKC----L----------FDEQKA----------ILTWEQRYR----------  446 (687)
Q Consensus       407 ~~~------~~~~~~~lV~Ey~~~gsL~~~----L----------~~~~~~----------~l~~~~~~~----------  446 (687)
                      ...      ...+..++++||++|..+...    .          +.....          .-.|.....          
T Consensus        84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~  163 (307)
T TIGR00938        84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE  163 (307)
T ss_pred             cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence            422      224567899999998664311    0          110000          011211110          


Q ss_pred             --HHHHHHhhhhhhcc----cccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          447 --IIKGVASGLLYLHE----EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       447 --i~~~ia~~L~yLH~----~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                        ....+...+.++..    ....+++|+|+++.||+++.+....|+||+.+.
T Consensus       164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence              01112233444432    235789999999999999988777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.84  E-value=0.009  Score=62.19  Aligned_cols=75  Identities=20%  Similarity=0.329  Sum_probs=48.8

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc---CCCceeeeeeeecCCeeEEEEecC
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR---HRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ...+.|+.|....+|+..  .+++.+.||.-..   .....|..|.+-|+.|.   --.+.+++++....+..+||+||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            345678889999999987  4678899998762   23356778888888883   456788999988777889999999


Q ss_pred             CCC
Q 005621          423 PNG  425 (687)
Q Consensus       423 ~~g  425 (687)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=96.76  E-value=0.009  Score=64.12  Aligned_cols=141  Identities=19%  Similarity=0.250  Sum_probs=83.2

Q ss_pred             eeeeeeCeEEEEEEEeCC----CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc-eeeeeeeecCCeeEEEEecCC
Q 005621          349 ELLGFGGFGRVYKGTLPS----TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL-VQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      +.|-.|-...+|+.....    .++.+++|+.......... -..|..+++.+...++ .++++.+...    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345446677899987532    2367999988765433222 3678999988865554 3566655332    5899998


Q ss_pred             CCCchhh-h----------------hchh----hccCCHHHHHHHHHHHH-----------------hhhhh----hcc-
Q 005621          424 NGSLDKC-L----------------FDEQ----KAILTWEQRYRIIKGVA-----------------SGLLY----LHE-  460 (687)
Q Consensus       424 ~gsL~~~-L----------------~~~~----~~~l~~~~~~~i~~~ia-----------------~~L~y----LH~-  460 (687)
                      +.+|... +                |...    .....|.+..++..++.                 ..+..    +.. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776421 0                1100    00112333333322211                 11111    111 


Q ss_pred             cccCeEEeeccCCCcEEecc-CCcEEEccccccee
Q 005621          461 EWEQTVIHRDIKAGNVLLDS-ELNGRLGDFGLAKL  494 (687)
Q Consensus       461 ~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~  494 (687)
                      .....++|+|+++.|||+++ +..++++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22357999999999999986 46899999998753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.65  E-value=0.002  Score=66.38  Aligned_cols=146  Identities=15%  Similarity=0.125  Sum_probs=94.5

Q ss_pred             cCHHHHHHHhcC---cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--------------------chhhH--HHH
Q 005621          333 FSYEELKKATRG---FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--------------------SKQGL--REF  387 (687)
Q Consensus       333 ~~~~el~~at~~---f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--------------------~~~~~--~~~  387 (687)
                      +.|-.|+...++   ++..+.||-|.-+-+|.+-+. .|.+.++|.-+..                    +..-+  -..
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            444555555543   567899999999999999984 5788888842110                    00001  124


Q ss_pred             HHHHHHHhhhcC--CCceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCe
Q 005621          388 ASEISSIGRLRH--RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT  465 (687)
Q Consensus       388 ~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  465 (687)
                      .+|+..|+.|.-  --+.+.++++    .-++|||++.+-.|.+.-+     ..+..+++.-+.++   +.-|-.   +|
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~---Iv~la~---~G  222 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGL---IVRLAN---HG  222 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeee-----cCChHHHHHHHHHH---HHHHHH---cC
Confidence            568888888743  2345555544    4589999998888865431     12223333222222   222223   89


Q ss_pred             EEeeccCCCcEEeccCCcEEEccccccee
Q 005621          466 VIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       466 ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      +||+|..-=||+++++..++++||--...
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHhhc
Confidence            99999999999999999999999976543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.61  E-value=0.017  Score=60.57  Aligned_cols=133  Identities=17%  Similarity=0.213  Sum_probs=80.6

Q ss_pred             eCeEEEEEEEeCCCCeEEEEEEec-CcchhhHHHHHHHHHHHhhhc--CCCceeeeeeeecCC--eeEEEEecCCCCCch
Q 005621          354 GGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLR--HRNLVQLLGWCRRRG--DLLLVYDFMPNGSLD  428 (687)
Q Consensus       354 G~~g~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~--~~~lV~Ey~~~gsL~  428 (687)
                      |-.-.+|.....  ++++++.+-. ...........+|+.+++.+.  ---+...+++|.++.  ..+.||+|++|..+.
T Consensus        36 G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~  113 (321)
T COG3173          36 GWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW  113 (321)
T ss_pred             CcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence            333345555542  6778888221 123334455667888888774  234556777887665  779999999886544


Q ss_pred             hhhhchhhccCCHHHHHHHH-HHHHhhhhhhc------------------------------------------------
Q 005621          429 KCLFDEQKAILTWEQRYRII-KGVASGLLYLH------------------------------------------------  459 (687)
Q Consensus       429 ~~L~~~~~~~l~~~~~~~i~-~~ia~~L~yLH------------------------------------------------  459 (687)
                      +.+......       .+++ ..++..|.-||                                                
T Consensus       114 ~~~~~~~~~-------~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W  186 (321)
T COG3173         114 SALPPESLG-------RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW  186 (321)
T ss_pred             CcCCcccch-------HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence            433111000       0001 12222222222                                                


Q ss_pred             --c-----cccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          460 --E-----EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       460 --~-----~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                        .     .....++|+|+++.|++++.+.-+=|.||+++..-
T Consensus       187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence              2     12357999999999999999888999999998753

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.50  E-value=0.026  Score=61.17  Aligned_cols=73  Identities=11%  Similarity=0.098  Sum_probs=50.7

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-------hhHHHHHHHHHHHhhhc---CCCceeeeeeeecCCeeEE
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-------QGLREFASEISSIGRLR---HRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l  417 (687)
                      .+.||.|....||+...  .+..++||+-....+       ....+-..|.+.|+.+.   ..++.+++.+|.+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            56789999999999887  345699997542111       12344445666666653   3578889999884  4578


Q ss_pred             EEecCCC
Q 005621          418 VYDFMPN  424 (687)
Q Consensus       418 V~Ey~~~  424 (687)
                      +|||+++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999977

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.45  E-value=0.023  Score=58.99  Aligned_cols=31  Identities=29%  Similarity=0.559  Sum_probs=26.1

Q ss_pred             CeEEeeccCCCcEEeccCCc-EEEccccccee
Q 005621          464 QTVIHRDIKAGNVLLDSELN-GRLGDFGLAKL  494 (687)
Q Consensus       464 ~~ivHrDlk~~NIll~~~~~-~kl~DFGla~~  494 (687)
                      ..++|+|+++.|||++++++ .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            56999999999999997555 46999998863

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.41  E-value=0.029  Score=60.51  Aligned_cols=75  Identities=13%  Similarity=0.058  Sum_probs=50.0

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc------chhhHHHHHHHHHHHhhhc--CC-CceeeeeeeecCCeeEEE
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE------SKQGLREFASEISSIGRLR--HR-NLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~--H~-niv~l~~~~~~~~~~~lV  418 (687)
                      .+.||-|.-..||++.++..++.|+||.-...      -.-..++..-|.+.|+...  .| .+++++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            45789999999999998544567999964321      1233456667777777663  45 34555544  33455789


Q ss_pred             EecCCC
Q 005621          419 YDFMPN  424 (687)
Q Consensus       419 ~Ey~~~  424 (687)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999865

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.07  E-value=0.041  Score=58.68  Aligned_cols=74  Identities=14%  Similarity=0.052  Sum_probs=47.9

Q ss_pred             eeeeeCeEEEEEEEeCCCCeEEEEEEecCc-------chhhHHHHHHHHHHHhhhc--CC-CceeeeeeeecCCeeEEEE
Q 005621          350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-------SKQGLREFASEISSIGRLR--HR-NLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       350 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~--H~-niv~l~~~~~~~~~~~lV~  419 (687)
                      .||-|....||++..+.+++.|+||.-...       -.-...+..-|.+.|+...  .| .+.+++.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478999999999998644468999964321       1223445566777776653  34 34445543  344557999


Q ss_pred             ecCCCC
Q 005621          420 DFMPNG  425 (687)
Q Consensus       420 Ey~~~g  425 (687)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.02  E-value=0.025  Score=56.07  Aligned_cols=120  Identities=15%  Similarity=0.216  Sum_probs=61.2

Q ss_pred             CeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc-eeeeeeeecCCeeEEEEecCCCCCchhh-h--------------
Q 005621          368 NTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL-VQLLGWCRRRGDLLLVYDFMPNGSLDKC-L--------------  431 (687)
Q Consensus       368 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~~-L--------------  431 (687)
                      ++.|+||+...... ..-.-..|..+++.+...++ .++++++...    +|+||+++.+|..- +              
T Consensus         2 ~~~~~~Ri~g~~t~-~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGTE-NFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCGC-SHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcc-cccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            35788888876633 33455678889988865444 5566655432    57799977665331 1              


Q ss_pred             --hchhh-----ccCCHHHHHHH-----------------------------HHHHHhhhhhhcccccCeEEeeccCCCc
Q 005621          432 --FDEQK-----AILTWEQRYRI-----------------------------IKGVASGLLYLHEEWEQTVIHRDIKAGN  475 (687)
Q Consensus       432 --~~~~~-----~~l~~~~~~~i-----------------------------~~~ia~~L~yLH~~~~~~ivHrDlk~~N  475 (687)
                        +....     ..--|....++                             +..+-..+....+  ...++|+|+.+.|
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~--~~v~cHnDl~~~N  154 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNS--PLVFCHNDLNPGN  154 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCG--GEEEE-S--SGGG
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCC--CceEeeccCcccc
Confidence              00000     00011111111                             1111111111112  3679999999999


Q ss_pred             EEe-ccCCcEEEccccccee
Q 005621          476 VLL-DSELNGRLGDFGLAKL  494 (687)
Q Consensus       476 Ill-~~~~~~kl~DFGla~~  494 (687)
                      ||+ +.++.++++||..+..
T Consensus       155 il~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  155 ILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEETSSSSCEEE--GTT-EE
T ss_pred             EEeccCCCeEEEecHHHHhh
Confidence            999 8889999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.00  E-value=0.044  Score=58.46  Aligned_cols=141  Identities=17%  Similarity=0.261  Sum_probs=81.7

Q ss_pred             eeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc-eeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPST---NTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL-VQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.|..|-...+|+....+.   +..|++|+........ -+-.+|..+++.+..-++ .++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            3454466678898876432   2378899886654322 233578889988876555 45666653 22   58999987


Q ss_pred             CCchhh-------h----------hchh----hccCCHHHHHHHHHHHH----------------------hhhh----h
Q 005621          425 GSLDKC-------L----------FDEQ----KAILTWEQRYRIIKGVA----------------------SGLL----Y  457 (687)
Q Consensus       425 gsL~~~-------L----------~~~~----~~~l~~~~~~~i~~~ia----------------------~~L~----y  457 (687)
                      ..|..-       +          +...    ...--|....++..++.                      .-+.    +
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            766321       1          1100    00112333333222221                      1111    1


Q ss_pred             hcc-cccCeEEeeccCCCcEEecc-CCcEEEccccccee
Q 005621          458 LHE-EWEQTVIHRDIKAGNVLLDS-ELNGRLGDFGLAKL  494 (687)
Q Consensus       458 LH~-~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~  494 (687)
                      +.. .....++|.|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111 12246899999999999975 47899999998853

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.92  E-value=0.1  Score=55.40  Aligned_cols=155  Identities=17%  Similarity=0.196  Sum_probs=86.7

Q ss_pred             CHHHHHHHhcCccc-----ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc---ee-
Q 005621          334 SYEELKKATRGFRD-----KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL---VQ-  404 (687)
Q Consensus       334 ~~~el~~at~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni---v~-  404 (687)
                      +-.++..+...|..     .+.|.+ .-..+|+....+ |. +++|+.+..  ....+...|+..+..|.-..+   ++ 
T Consensus        12 ~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl   86 (331)
T COG2334          12 TSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPL   86 (331)
T ss_pred             ChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            33444444444433     233444 556789988743 33 489988876  233556667777777732221   22 


Q ss_pred             --eee----eeecCCeeEEEEecCCCCCchh-hh--------------hc----------hhhccCCHHH----------
Q 005621          405 --LLG----WCRRRGDLLLVYDFMPNGSLDK-CL--------------FD----------EQKAILTWEQ----------  443 (687)
Q Consensus       405 --l~~----~~~~~~~~~lV~Ey~~~gsL~~-~L--------------~~----------~~~~~l~~~~----------  443 (687)
                        +=|    ........+-+++|++|..+.. ..              +.          .......|..          
T Consensus        87 ~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~  166 (331)
T COG2334          87 PSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLD  166 (331)
T ss_pred             cCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhc
Confidence              112    1111137788999999998873 11              00          0011233430          


Q ss_pred             ---HHHHHHHHHhhhhhhcc----cccCe---EEeeccCCCcEEeccCCc-EEEcccccce
Q 005621          444 ---RYRIIKGVASGLLYLHE----EWEQT---VIHRDIKAGNVLLDSELN-GRLGDFGLAK  493 (687)
Q Consensus       444 ---~~~i~~~ia~~L~yLH~----~~~~~---ivHrDlk~~NIll~~~~~-~kl~DFGla~  493 (687)
                         ......++...+..+.+    .....   +||+|+.|.||+++.+.. +.+.||+-++
T Consensus       167 ~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         167 LVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               01122233333333332    22223   999999999999999885 8999999875

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.74  E-value=0.0016  Score=78.51  Aligned_cols=158  Identities=14%  Similarity=-0.018  Sum_probs=110.6

Q ss_pred             HHHHHHHhhhcCCCceeeeeeee--cCCeeEEEEecCCCCCchhhhhchh--hccCCHHHHHHHHHHHHhhhhhhccc--
Q 005621          388 ASEISSIGRLRHRNLVQLLGWCR--RRGDLLLVYDFMPNGSLDKCLFDEQ--KAILTWEQRYRIIKGVASGLLYLHEE--  461 (687)
Q Consensus       388 ~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~--  461 (687)
                      ..|...++...|+++.....-..  +..+.+.+++|+..|.+.+.+.+..  ...+...-+.....+...+..-+|..  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            34445566678998876655442  3346789999999999998885432  22233333333333434455554442  


Q ss_pred             ccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh
Q 005621          462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC  541 (687)
Q Consensus       462 ~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt  541 (687)
                      ...-.+|++||+-|.+|..+.++|++++|+.+...+.. .......+++.|+.|++...-+++.++|+|..|+.+|++.-
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            23458999999999999999999999999998332221 12223467788999999888888999999999999999988


Q ss_pred             CCCCC
Q 005621          542 GRRPI  546 (687)
Q Consensus       542 G~~p~  546 (687)
                      |..+|
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            87665

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	687
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-57
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-55
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-45
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-41
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-39
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-24
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-22
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-22
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-20
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-18
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-17
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-17
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-17
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-17
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-16
1g8w_A	233	Improved Structure Of Phytohemagglutinin-L From The		4e-16
1fat_A	252	Phytohemagglutinin-L Length = 252		4e-16
2fmd_A	240	Structural Basis Of Carbohydrate Recognition By Bow		4e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-15
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-15
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-15
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-15
3usu_B	242	Crystal Structure Of Butea Monosperma Seed Lectin L		9e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-14
3usu_A	256	Crystal Structure Of Butea Monosperma Seed Lectin L		1e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-14
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-14
1avb_A	226	Arcelin-1 From Phaseolus Vulgaris L Length = 226		3e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-13
3ujo_A	281	Galactose-Specific Seed Lectin From Dolichos Lablab		3e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
1uzy_A	242	Erythrina Crystagalli Lectin Length = 242		6e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
1gz9_A	239	High-Resolution Crystal Structure Of Erythrina Cris		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-12
1fny_A	237	Legume Lectin Of The Bark Of Robinia Pseudoacacia.		3e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-12
2sba_A	253	Soybean Agglutinin Complexed With 2,6-Pentasacchari		4e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-12
1qnw_A	242	Lectin Ii From Ulex Europaeus Length = 242		4e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-12
1ax0_A	239	Erythrina Corallodendron Lectin In Complex With N-A		6e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-12
1sfy_A	239	Crystal Structure Of Recombinant Erythrina Corallod		6e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3ipv_B	239	Crystal Structure Of Spatholobus Parviflorus Seed L		6e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-12
3ipv_A	251	Crystal Structure Of Spatholobus Parviflorus Seed L		6e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-12
3n35_A	242	Erythrina Corallodendron Lectin Mutant (Y106g) With		8e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-12
1lte_A	239	Structure Of A Legume Lectin With An Ordered N-Link		9e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
1fyu_A	255	Crystal Structure Of Erythrina Corallodendron Lecti		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
2d3p_A	236	Cratylia Floribunda Seed Lectin Crystallized At Bas		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
1n47_A	233	Isolectin B4 From Vicia Villosa In Complex With The		3e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-11
3u4x_A	236	Crystal Structure Of A Lectin From Camptosema Pedic		3e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
2bqp_A	234	The Structure Of The Pea Lectin-D-Glucopyranose Com		3e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-10
2jdz_A	239	Crystal Structure Of Recombinant Dioclea Guianensis		1e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
1qmo_E	133	Structure Of Fril, A Legume Lectin That Delays Hema		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-10
2je7_A	239	Crystal Structure Of Recombinant Dioclea Guianensis		1e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-10
1mvq_A	236	Cratylia Mollis Lectin (Isoform 1) In Complex With		1e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
2zbj_A	237	Crystal Structure Of Dioclea Rostrata Lectin Length		1e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-10
2jec_A	239	Crystal Structure Of Recombinant Dioclea Grandiflor		1e-10
1wuv_A	237	Crystal Structure Of Native Canavalia Gladiata Lect		1e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-10
2je9_A	239	Crystal Structure Of Recombinant Dioclea Grandiflor		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-10
2gdf_A	237	Crystal Structure Of Dioclea Violacea Seed Lectin L		1e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-10
3sh3_A	237	Crystal Structure Of A Pro-Inflammatory Lectin From		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-10
1bjq_A	253	The Dolichos Biflorus Seed Lectin In Complex With A		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-10
3a0k_A	237	Crystal Structure Of An Antiflamatory Legume Lectin		2e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-10
1h9w_A	237	Native Dioclea Guianensis Seed Lectin Length = 237		2e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-10
1h9p_A	237	Crystal Structure Of Dioclea Guianensis Seed Lectin		2e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-10
3rrd_A	237	Native Structure Of Dioclea Virgata Lectin Length =		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-10
2ctv_A	237	High Resolution Crystallographic Studies Of Native		3e-10
2yz4_A	237	The Neutron Structure Of Concanavalin A At 2.2 Angs		3e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-10
1cn1_A	237	Crystal Structure Of Demetallized Concanavalin A. T		4e-10
2cna_A	237	The Covalent And Three-Dimensional Structure Of Con		4e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-10
2ovu_A	237	Crystal Strucure Of A Lectin From Canavalia Gladiat		5e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-10
1azd_A	237	Concanavalin From Canavalia Brasiliensis Length = 2		5e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-10
1dgl_A	237	Lectin From Dioclea Grandiflora Complexed To Triman		6e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-10
1ioa_A	240	Arcelin-5, A Lectin-Like Defense Protein From Phase		6e-10
2cwm_A	237	Native Crystal Structure Of No Releasing Inductive		6e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-10
2ow4_A	237	Crystal Structure Of A Lectin From Canavalia Mariti		7e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
1lul_A	253	Db58, A Legume Lectin From Dolichos Biflorus Length		8e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
3soa_A	444	Full-Length Human Camkii Length = 444		1e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-09
1bzw_A	232	Peanut Lectin Complexed With C-Lactose Length = 232		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-09
2pel_A	236	Peanut Lectin Length = 236		3e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-09
1fay_A	238	Winged Bean Acidic Lectin Complexed With Methyl-Alp		4e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-09
1gsl_A	243	Lectin (Fourth Isolated From (Griffonia Simplicifol		5e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-09
1dbn_A	239	Maackia Amurensis Leukoagglutinin (Lectin) With Sia		5e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-08
1n3o_A	252	Pterocarcpus Angolensis Lectin In Complex With Alph		1e-08
1q8o_A	252	Pterocartpus Angolensis Lectin Pal In Complex With		1e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-08
2e7q_A	237	Crystal Structure Of Basic Winged Bean Lectin In Co		2e-08
2eig_A	234	Lotus Tetragonolobus Seed Lectin (Isoform) Length =		2e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
1wbf_A	242	Winged Bean Lectin, Saccharide Free Form Length = 2		2e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
1wbl_A	241	Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga		2e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-07

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  218 bits (556), Expect = 6e-57,   Method: Compositional matrix adjust.
 Identities = 120/292 (41%), Positives = 176/292 (60%), Gaps = 6/292 (2%)
Query: 332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASE 390
           RFS  EL+ A+  F +K +LG GGFG+VYKG L +  T VAVKR+  E  QG   +F +E
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRII 448
           +  I    HRNL++L G+C    + LLVY +M NGS+  CL +  E +  L W +R RI 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG 508
            G A GL YLH+  +  +IHRD+KA N+LLD E    +GDFGLAKL +         V G
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 205
Query: 509 TLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP--EELILVDWVWDRWK 566
           T+G++APE   TGK +  +DV+ +G +LLE++ G+R  +   L   ++++L+DWV    K
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE 618
              +  +VD  L G + + E   ++++ L+C+  +   RP M +VVR LEG+
Sbjct: 266 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  214 bits (545), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 118/292 (40%), Positives = 174/292 (59%), Gaps = 6/292 (2%)
Query: 332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASE 390
           RFS  EL+ A+  F +K +LG GGFG+VYKG L +    VAVKR+  E  QG   +F +E
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRL-ADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRII 448
           +  I    HRNL++L G+C    + LLVY +M NGS+  CL +  E +  L W +R RI 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG 508
            G A GL YLH+  +  +IHRD+KA N+LLD E    +GDFGLAKL +         V G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 197
Query: 509 TLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP--EELILVDWVWDRWK 566
            +G++APE   TGK +  +DV+ +G +LLE++ G+R  +   L   ++++L+DWV    K
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE 618
              +  +VD  L G + + E   ++++ L+C+  +   RP M +VVR LEG+
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  181 bits (459), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 117/305 (38%), Positives = 178/305 (58%), Gaps = 21/305 (6%)
Query: 331 HRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASE 390
           +R    +L++AT  F  K L+G G FG+VYKG L     +VA+KR + ES QG+ EF +E
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETE 85
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF--DEQKAILTWEQRYRII 448
           I ++   RH +LV L+G+C  R +++L+Y +M NG+L + L+  D     ++WEQR  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--- 505
            G A GL YLH    + +IHRD+K+ N+LLD     ++ DFG++K   +GT    T    
Sbjct: 146 IGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK---KGTELDQTHLXX 199
Query: 506 -VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELI-LVDWVWD 563
            V GTLGY+ PE    G+ T  SDVY+FG +L EV+C R  I  ++LP E++ L +W  +
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVE 258
Query: 564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLG---LMCSNDAAEARPTMRQVVRYLEGEVP 620
               G + ++VDP L    ++I    + K G   + C   ++E RP+M  V+  LE  + 
Sbjct: 259 SHNNGQLEQIVDPNLA---DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
Query: 621 LPQAV 625
           L ++V
Sbjct: 316 LQESV 320

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  181 bits (459), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 117/305 (38%), Positives = 178/305 (58%), Gaps = 21/305 (6%)
Query: 331 HRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASE 390
           +R    +L++AT  F  K L+G G FG+VYKG L     +VA+KR + ES QG+ EF +E
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETE 85
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF--DEQKAILTWEQRYRII 448
           I ++   RH +LV L+G+C  R +++L+Y +M NG+L + L+  D     ++WEQR  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--- 505
            G A GL YLH    + +IHRD+K+ N+LLD     ++ DFG++K   +GT    T    
Sbjct: 146 IGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK---KGTELGQTHLXX 199
Query: 506 -VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELI-LVDWVWD 563
            V GTLGY+ PE    G+ T  SDVY+FG +L EV+C R  I  ++LP E++ L +W  +
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVE 258
Query: 564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLG---LMCSNDAAEARPTMRQVVRYLEGEVP 620
               G + ++VDP L    ++I    + K G   + C   ++E RP+M  V+  LE  + 
Sbjct: 259 SHNNGQLEQIVDPNLA---DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
Query: 621 LPQAV 625
           L ++V
Sbjct: 316 LQESV 320

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (429), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/303 (34%), Positives = 167/303 (55%), Gaps = 22/303 (7%)
Query: 327 DVGPHRFSYEELKKATRGFRDKEL------LGFGGFGRVYKGTLPSTNTQVAVKR----V 376
           D   H FS+ ELK  T  F ++ +      +G GGFG VYKG +   NT VAVK+    V
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 66
Query: 377 SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGS-LDKCLFDEQ 435
              +++  ++F  EI  + + +H NLV+LLG+     DL LVY +MPNGS LD+    + 
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
              L+W  R +I +G A+G+ +LHE      IHRDIK+ N+LLD     ++ DFGLA+  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 496 ER-GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE 554
           E+       +R+VGT  Y+APE  R G+ T  SD+Y+FG +LLE++ G   ++    P +
Sbjct: 184 EKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-Q 241
Query: 555 LILVDWVWDRWKAGAILEVVDPRLN-GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
           L+L        +   I + +D ++N  +   +EA+    +   C ++    RP +++V +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIKKVQQ 299
Query: 614 YLE 616
            L+
Sbjct: 300 LLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  168 bits (426), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 106/303 (34%), Positives = 166/303 (54%), Gaps = 22/303 (7%)
Query: 327 DVGPHRFSYEELKKATRGFRDKEL------LGFGGFGRVYKGTLPSTNTQVAVKR----V 376
           D   H FS+ ELK  T  F ++ +      +G GGFG VYKG +   NT VAVK+    V
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 66
Query: 377 SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGS-LDKCLFDEQ 435
              +++  ++F  EI  + + +H NLV+LLG+     DL LVY +MPNGS LD+    + 
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
              L+W  R +I +G A+G+ +LHE      IHRDIK+ N+LLD     ++ DFGLA+  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 496 ER-GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE 554
           E+        R+VGT  Y+APE  R G+ T  SD+Y+FG +LLE++ G   ++    P +
Sbjct: 184 EKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-Q 241
Query: 555 LILVDWVWDRWKAGAILEVVDPRLN-GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
           L+L        +   I + +D ++N  +   +EA+    +   C ++    RP +++V +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIKKVQQ 299
Query: 614 YLE 616
            L+
Sbjct: 300 LLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 106/303 (34%), Positives = 166/303 (54%), Gaps = 22/303 (7%)
Query: 327 DVGPHRFSYEELKKATRGFRDKEL------LGFGGFGRVYKGTLPSTNTQVAVKR----V 376
           D   H FS+ ELK  T  F ++ +      +G GGFG VYKG +   NT VAVK+    V
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 60
Query: 377 SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGS-LDKCLFDEQ 435
              +++  ++F  EI  + + +H NLV+LLG+     DL LVY +MPNGS LD+    + 
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 120
Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
              L+W  R +I +G A+G+ +LHE      IHRDIK+ N+LLD     ++ DFGLA+  
Sbjct: 121 TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 177
Query: 496 ER-GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE 554
           E+        R+VGT  Y+APE  R G+ T  SD+Y+FG +LLE++ G   ++    P +
Sbjct: 178 EKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-Q 235
Query: 555 LILVDWVWDRWKAGAILEVVDPRLN-GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
           L+L        +   I + +D ++N  +   +EA+    +   C ++    RP +++V +
Sbjct: 236 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIKKVQQ 293
Query: 614 YLE 616
            L+
Sbjct: 294 LLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  159 bits (403), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 160/299 (53%), Gaps = 22/299 (7%)
Query: 331 HRFSYEELKKATRGFRDKEL------LGFGGFGRVYKGTLPSTNTQVAVKR----VSNES 380
           H FS+ ELK  T  F ++ +       G GGFG VYKG +   NT VAVK+    V   +
Sbjct: 4   HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT 61
Query: 381 KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGS-LDKCLFDEQKAIL 439
           ++  ++F  EI    + +H NLV+LLG+     DL LVY + PNGS LD+    +    L
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER-G 498
           +W  R +I +G A+G+ +LHE      IHRDIK+ N+LLD     ++ DFGLA+  E+  
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
                +R+VGT  Y APE  R G+ T  SD+Y+FG +LLE++ G   ++    P +L+L 
Sbjct: 179 QXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 236
Query: 559 DWVWDRWKAGAILEVVDPRLN-GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
                  +   I + +D + N  +   +EA     +   C ++    RP +++V + L+
Sbjct: 237 IKEEIEDEEKTIEDYIDKKXNDADSTSVEA--XYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 155/314 (49%), Gaps = 40/314 (12%)
Query: 333 FSYEELKKATRGF---------RDKELLGFGGFGRVYKGTLPSTNTQ---VAVKRV-SNE 379
           F++E+  +A R F         + ++++G G FG V  G L     +   VA+K + S  
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
           +++  R+F SE S +G+  H N++ L G   +   ++++ +FM NGSLD  L  +     
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQF 132
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
           T  Q   +++G+A+G+ YL    +   +HRD+ A N+L++S L  ++ DFGL++  E  T
Sbjct: 133 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 189
Query: 500 -NPSTTRVVG---TLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEE 554
            +P+ T  +G    + + APE  +  K T++SDV+++G ++ EV+  G RP         
Sbjct: 190 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--------- 240
Query: 555 LILVDWVWDRWKAGAILEV-VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
                  WD      I  +  D RL    +   AL   +L L C       RP   Q+V 
Sbjct: 241 ------YWDMTNQDVINAIEQDYRLPPPMDCPSALH--QLMLDCWQKDRNHRPKFGQIVN 292
Query: 614 YLEGEVPLPQAVAA 627
            L+  +  P ++ A
Sbjct: 293 TLDKMIRNPNSLKA 306

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 144/290 (49%), Gaps = 31/290 (10%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQ---VAVKRV-SNESKQGLREFASEISSIGRLRHRNLV 403
           ++++G G FG V  G L     +   VA+K + S  +++  R+F SE S +G+  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            L G   +   ++++ +FM NGSLD  L  +     T  Q   +++G+A+G+ YL    +
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLA---D 127
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT-NPSTTRVVG---TLGYLAPELTR 519
              +HR + A N+L++S L  ++ DFGL++  E  T +P+ T  +G    + + APE  +
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 520 TGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEV-VDPR 577
             K T++SDV+++G ++ EV+  G RP                WD      I  +  D R
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERP---------------YWDMTNQDVINAIEQDYR 232
Query: 578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAA 627
           L    +   AL   +L L C       RP   Q+V  L+  +  P ++ A
Sbjct: 233 LPPPMDCPSALH--QLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKA 280

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 122/209 (58%), Gaps = 17/209 (8%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQ---VAVKRVSN-ESKQGLREFASEISSIGRLRHRNLV 403
           +E++G G FG V +G L +   +   VA+K +    +++  REF SE S +G+  H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLF--DEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +L G       ++++ +FM NG+LD  L   D Q  ++   Q   +++G+ASG+ YL   
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLA-- 135
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVG---TLGYLAPEL 517
            E + +HRD+ A N+L++S L  ++ DFGL++ L E  ++P+ T  +G    + + APE 
Sbjct: 136 -EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 518 TRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
               K T++SD +++G ++ EV+  G RP
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 122/209 (58%), Gaps = 17/209 (8%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQ---VAVKRVSN-ESKQGLREFASEISSIGRLRHRNLV 403
           +E++G G FG V +G L +   +   VA+K +    +++  REF SE S +G+  H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLF--DEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +L G       ++++ +FM NG+LD  L   D Q  ++   Q   +++G+ASG+ YL   
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLA-- 133
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVG---TLGYLAPEL 517
            E + +HRD+ A N+L++S L  ++ DFGL++ L E  ++P+ T  +G    + + APE 
Sbjct: 134 -EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 518 TRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
               K T++SD +++G ++ EV+  G RP
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 107/199 (53%), Gaps = 3/199 (1%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           KE +G G FG V++     ++  V +    +   + + EF  E++ + RLRH N+V  +G
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDE-QKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
              +  +L +V +++  GSL + L     +  L   +R  +   VA G+ YLH      +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HR++K+ N+L+D +   ++ DFGL++L +  T  S+    GT  ++APE+ R       
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 527 SDVYAFGALLLEVVCGRRP 545
           SDVY+FG +L E+   ++P
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 26/213 (12%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES----KQGLREFASEISSIGRLRHRNLV 403
           +E++G GGFG+VY+        +VAVK   ++      Q +     E      L+H N++
Sbjct: 12  EEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ---KAILTWEQRYRIIKGVASGLLYLHE 460
            L G C +  +L LV +F   G L++ L  ++     ++ W  +      +A G+ YLH+
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHD 123
Query: 461 EWEQTVIHRDIKAGNVLLDSEL-NG-------RLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           E    +IHRD+K+ N+L+  ++ NG       ++ DFGLA+ + R T  S     G   +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAYAW 180
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+ R    +  SDV+++G LL E++ G  P
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 117/206 (56%), Gaps = 12/206 (5%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQ----VAVKRVSNESKQGLR-EFASEISSIGRLRHRNL 402
           ++++G G FG VYKG L +++ +    VA+K +     +  R +F  E   +G+  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           ++L G   +   ++++ ++M NG+LDK L  E+    +  Q   +++G+A+G+ YL    
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLA--- 164
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG--YLAPELTRT 520
               +HRD+ A N+L++S L  ++ DFGL+++ E     + T   G +   + APE    
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 521 GKPTTSSDVYAFGALLLEVVC-GRRP 545
            K T++SDV++FG ++ EV+  G RP
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 105/199 (52%), Gaps = 3/199 (1%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           KE +G G FG V++     ++  V +    +   + + EF  E++ + RLRH N+V  +G
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDE-QKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
              +  +L +V +++  GSL + L     +  L   +R  +   VA G+ YLH      +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRD+K+ N+L+D +   ++ DFGL++L +      +    GT  ++APE+ R       
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLRDEPSNEK 219
Query: 527 SDVYAFGALLLEVVCGRRP 545
           SDVY+FG +L E+   ++P
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 14/213 (6%)
Query: 347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           D+ +LG G +G VY G   S   ++A+K +     +  +    EI+    L+H+N+VQ L
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRI-IKGVASGLLYLHEEWEQT 465
           G     G + +  + +P GSL   L  +   +   EQ      K +  GL YLH   +  
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 142
Query: 466 VIHRDIKAGNVLLDSELNG--RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           ++HRDIK  NVL+++  +G  ++ DFG +K    G NP T    GTL Y+APE+   G  
Sbjct: 143 IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 524 --TTSSDVYAFGALLLEVVCGRRPI----EPKA 550
               ++D+++ G  ++E+  G+ P     EP+A
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 14/213 (6%)
Query: 347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           D+ +LG G +G VY G   S   ++A+K +     +  +    EI+    L+H+N+VQ L
Sbjct: 12  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRI-IKGVASGLLYLHEEWEQT 465
           G     G + +  + +P GSL   L  +   +   EQ      K +  GL YLH   +  
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 128
Query: 466 VIHRDIKAGNVLLDSELNG--RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           ++HRDIK  NVL+++  +G  ++ DFG +K    G NP T    GTL Y+APE+   G  
Sbjct: 129 IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 524 --TTSSDVYAFGALLLEVVCGRRPI----EPKA 550
               ++D+++ G  ++E+  G+ P     EP+A
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 219

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/234 (34%), Positives = 125/234 (53%), Gaps = 22/234 (9%)
Query: 328 VGPHRF-----SYEELKK---ATRGFRDKELLGFGGFGRVYKG--TLPSTN-TQVAVK-- 374
           V PH F     +  E  K   AT    DK ++G G FG V  G   LPS     VA+K  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDK-VVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 375 RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE 434
           +V    KQ  R+F  E S +G+  H N+++L G   +   +++V ++M NGSLD  L  +
Sbjct: 82  KVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RK 139
Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
             A  T  Q   +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGLA++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLARV 196
Query: 495 YERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
            E     + T   G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/234 (34%), Positives = 125/234 (53%), Gaps = 22/234 (9%)
Query: 328 VGPHRF-----SYEELKK---ATRGFRDKELLGFGGFGRVYKG--TLPSTN-TQVAVK-- 374
           V PH F     +  E  K   AT    DK ++G G FG V  G   LPS     VA+K  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDK-VVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 375 RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE 434
           +V    KQ  R+F  E S +G+  H N+++L G   +   +++V ++M NGSLD  L  +
Sbjct: 82  KVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RK 139
Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
             A  T  Q   +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL+++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 495 YERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
            E     + T   G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/235 (32%), Positives = 125/235 (53%), Gaps = 24/235 (10%)
Query: 328 VGPHRFSYEELKKATRGFRDK---------ELLGFGGFGRVYKG--TLPSTN-TQVAVK- 374
           V PH  +YE+  +    F  +         +++G G FG V  G   LPS     VA+K 
Sbjct: 21  VDPH--TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 78
Query: 375 -RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD 433
            +V    KQ  R+F  E S +G+  H N+++L G   +   +++V ++M NGSLD  L  
Sbjct: 79  LKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-R 136
Query: 434 EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK 493
           +  A  T  Q   +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL++
Sbjct: 137 KHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSR 193
Query: 494 LYERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + E     + T   G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 194 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/235 (32%), Positives = 125/235 (53%), Gaps = 24/235 (10%)
Query: 328 VGPHRFSYEELKKATRGFRDK---------ELLGFGGFGRVYKG--TLPSTN-TQVAVK- 374
           V PH  +YE+  +    F  +         +++G G FG V  G   LPS     VA+K 
Sbjct: 23  VDPH--TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 375 -RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD 433
            +V    KQ  R+F  E S +G+  H N+++L G   +   +++V ++M NGSLD  L  
Sbjct: 81  LKVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-R 138
Query: 434 EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK 493
           +  A  T  Q   +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 494 LYERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + E     + T   G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/234 (34%), Positives = 125/234 (53%), Gaps = 22/234 (9%)
Query: 328 VGPHRF-----SYEELKK---ATRGFRDKELLGFGGFGRVYKG--TLPSTN-TQVAVK-- 374
           V PH F     +  E  K   AT    DK ++G G FG V  G   LPS     VA+K  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDK-VVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 375 RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE 434
           +V    KQ  R+F  E S +G+  H N+++L G   +   +++V ++M NGSLD  L  +
Sbjct: 82  KVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RK 139
Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
             A  T  Q   +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL+++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 495 YERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
            E     + T   G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/234 (34%), Positives = 125/234 (53%), Gaps = 22/234 (9%)
Query: 328 VGPHRF-----SYEELKK---ATRGFRDKELLGFGGFGRVYKG--TLPSTN-TQVAVK-- 374
           V PH F     +  E  K   AT    DK ++G G FG V  G   LPS     VA+K  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDK-VVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 375 RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE 434
           +V    KQ  R+F  E S +G+  H N+++L G   +   +++V ++M NGSLD  L  +
Sbjct: 82  KVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RK 139
Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
             A  T  Q   +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL+++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 495 YERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
            E     + T   G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/235 (32%), Positives = 125/235 (53%), Gaps = 24/235 (10%)
Query: 328 VGPHRFSYEELKKATRGFRDK---------ELLGFGGFGRVYKG--TLPSTN-TQVAVK- 374
           V PH  +YE+  +    F  +         +++G G FG V  G   LPS     VA+K 
Sbjct: 23  VDPH--TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 375 -RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD 433
            +V    KQ  R+F  E S +G+  H N+++L G   +   +++V ++M NGSLD  L  
Sbjct: 81  LKVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-R 138
Query: 434 EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK 493
           +  A  T  Q   +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 494 LYERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + E     + T   G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 123/229 (53%), Gaps = 20/229 (8%)
Query: 333 FSYEELKKATRGF---------RDKELLGFGGFGRVYKGTLPSTNTQ---VAVKRV-SNE 379
           F++E+  +A R F         + ++++G G FG V  G L     +   VA+K + +  
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
           + +  R+F SE S +G+  H N++ L G   +   ++++ ++M NGSLD     +     
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD-AFLRKNDGRF 128
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
           T  Q   +++G+ SG+ YL    + + +HRD+ A N+L++S L  ++ DFG++++ E   
Sbjct: 129 TVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP 185
Query: 500 NPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
             + T   G +   + APE     K T++SDV+++G ++ EV+  G RP
Sbjct: 186 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 122/223 (54%), Gaps = 16/223 (7%)
Query: 331 HRFSYEELKKATRGFRDKELLGFGGFGRVYKG--TLPSTN-TQVAVK--RVSNESKQGLR 385
           H F+ E    AT    DK ++G G FG V  G   LPS     VA+K  +V    KQ  R
Sbjct: 7   HEFAKE--LDATNISIDK-VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-R 62
Query: 386 EFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY 445
           +F  E S +G+  H N+++L G   +   +++V ++M NGSLD  L  +  A  T  Q  
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLV 121
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
            +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL+++ E     + T 
Sbjct: 122 GMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 506 VVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
             G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 179 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 122/223 (54%), Gaps = 16/223 (7%)
Query: 331 HRFSYEELKKATRGFRDKELLGFGGFGRVYKG--TLPSTN-TQVAVK--RVSNESKQGLR 385
           H F+ E    AT    DK ++G G FG V  G   LPS     VA+K  +V    KQ  R
Sbjct: 24  HEFAKE--LDATNISIDK-VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RR 79
Query: 386 EFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY 445
           +F  E S +G+  H N+++L G   +   +++V ++M NGSLD  L  +  A  T  Q  
Sbjct: 80  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLV 138
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
            +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL+++ E     + T 
Sbjct: 139 GMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 195
Query: 506 VVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
             G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 196 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/234 (34%), Positives = 124/234 (52%), Gaps = 22/234 (9%)
Query: 328 VGPHRF-----SYEELKK---ATRGFRDKELLGFGGFGRVYKG--TLPSTN-TQVAVK-- 374
           V PH F     +  E  K   AT    DK ++G G FG V  G   LPS     VA+K  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDK-VVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 375 RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE 434
           +V    KQ  R+F  E S +G+  H N+++L G   +   +++V ++M NGSLD  L  +
Sbjct: 82  KVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RK 139
Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
             A  T  Q   +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL ++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
Query: 495 YERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
            E     + T   G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 120/229 (52%), Gaps = 22/229 (9%)
Query: 334 SYEELKKATRGF---------RDKELLGFGGFGRVYKGTLP---STNTQVAVK--RVSNE 379
           +YE+  +A   F         + + ++G G FG V  G L      +  VA+K  +V   
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
            KQ  R+F  E S +G+  H N+V L G   R   +++V +FM NG+LD  L  +     
Sbjct: 85  EKQ-RRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL-RKHDGQF 142
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
           T  Q   +++G+A+G+ YL    +   +HRD+ A N+L++S L  ++ DFGL+++ E   
Sbjct: 143 TVIQLVGMLRGIAAGMRYLA---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDP 199
Query: 500 NPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
               T   G +   + APE  +  K T++SDV+++G ++ EV+  G RP
Sbjct: 200 EAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/234 (34%), Positives = 124/234 (52%), Gaps = 22/234 (9%)
Query: 328 VGPHRF-----SYEELKK---ATRGFRDKELLGFGGFGRVYKG--TLPSTN-TQVAVK-- 374
           V PH F     +  E  K   AT    DK ++G G FG V  G   LPS     VA+K  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDK-VVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 375 RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE 434
           +V    KQ  R+F  E S +G+  H N+++L G   +   +++V + M NGSLD  L  +
Sbjct: 82  KVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RK 139
Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
             A  T  Q   +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL+++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 495 YERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
            E     + T   G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 94/317 (29%), Positives = 153/317 (48%), Gaps = 44/317 (13%)
Query: 330 PHRFSYEELKKATRGF-RDKE--------LLGFGGFGRVYKGTLP---STNTQVAVKRV- 376
           PH  +YEE  +A R F R+ E        ++G G  G V  G L      +  VA+K + 
Sbjct: 29  PH--TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK 86
Query: 377 SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--FDE 434
           +  +++  R+F SE S +G+  H N+++L G   R    ++V ++M NGSLD  L   D 
Sbjct: 87  AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG 146
Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
           Q  I+   Q   +++GV +G+ YL    +   +HRD+ A NVL+DS L  ++ DFGL+++
Sbjct: 147 QFTIM---QLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 495 YERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKAL 551
            E   + + T   G +   + APE       +++SDV++FG ++ EV+  G RP      
Sbjct: 201 LEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP------ 254
Query: 552 PEELILVDWVWDRWKAGAILEVVDP-RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQ 610
                     W+      I  V +  RL        AL   +L L C +     RP   Q
Sbjct: 255 ---------YWNMTNRDVISSVEEGYRLPAPMGCPHALH--QLMLDCWHKDRAQRPRFSQ 303
Query: 611 VVRYLEGEVPLPQAVAA 627
           +V  L+  +  P+++ A
Sbjct: 304 IVSVLDALIRSPESLRA 320

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/235 (32%), Positives = 124/235 (52%), Gaps = 24/235 (10%)
Query: 328 VGPHRFSYEELKKATRGFRDK---------ELLGFGGFGRVYKG--TLPSTN-TQVAVK- 374
           V PH  +YE+  +    F  +         +++G G FG V  G   LPS     VA+K 
Sbjct: 23  VDPH--TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 375 -RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD 433
            +V    KQ  R+F  E S +G+  H N+++L G   +   +++V + M NGSLD  L  
Sbjct: 81  LKVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-R 138
Query: 434 EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK 493
           +  A  T  Q   +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 494 LYERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + E     + T   G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 121/223 (54%), Gaps = 16/223 (7%)
Query: 331 HRFSYEELKKATRGFRDKELLGFGGFGRVYKG--TLPSTN-TQVAVK--RVSNESKQGLR 385
           H F+ E    AT    DK ++G G FG V  G   LPS     VA+K  +V    KQ  R
Sbjct: 7   HEFAKE--LDATNISIDK-VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-R 62
Query: 386 EFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY 445
           +F  E S +G+  H N+++L G   +   +++V + M NGSLD  L  +  A  T  Q  
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLV 121
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
            +++G+ASG+ YL    +   +HRD+ A N+L++S L  ++ DFGL+++ E     + T 
Sbjct: 122 GMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 506 VVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
             G +   + +PE     K T++SDV+++G +L EV+  G RP
Sbjct: 179 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 94/317 (29%), Positives = 153/317 (48%), Gaps = 44/317 (13%)
Query: 330 PHRFSYEELKKATRGF-RDKE--------LLGFGGFGRVYKGTLP---STNTQVAVKRV- 376
           PH  +YEE  +A R F R+ E        ++G G  G V  G L      +  VA+K + 
Sbjct: 29  PH--TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK 86
Query: 377 SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--FDE 434
           +  +++  R+F SE S +G+  H N+++L G   R    ++V ++M NGSLD  L   D 
Sbjct: 87  AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG 146
Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
           Q  I+   Q   +++GV +G+ YL    +   +HRD+ A NVL+DS L  ++ DFGL+++
Sbjct: 147 QFTIM---QLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 495 YERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKAL 551
            E   + + T   G +   + APE       +++SDV++FG ++ EV+  G RP      
Sbjct: 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP------ 254
Query: 552 PEELILVDWVWDRWKAGAILEVVDP-RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQ 610
                     W+      I  V +  RL        AL   +L L C +     RP   Q
Sbjct: 255 ---------YWNMTNRDVISSVEEGYRLPAPMGCPHALH--QLMLDCWHKDRAQRPRFSQ 303
Query: 611 VVRYLEGEVPLPQAVAA 627
           +V  L+  +  P+++ A
Sbjct: 304 IVSVLDALIRSPESLRA 320

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 121/233 (51%), Gaps = 24/233 (10%)
Query: 330 PHRFSYEELKKATRGFRDK---------ELLGFGGFGRVYKGTLPSTNTQ---VAVK--R 375
           PH  +YE+  +A   F  +          ++G G FG V  G L     +   VA+K  +
Sbjct: 2   PH--TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLK 59
Query: 376 VSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ 435
           V    KQ  R+F  E S +G+  H N++ L G   +   +++V ++M NGSLD  L  + 
Sbjct: 60  VGYTEKQR-RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKN 117
Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
               T  Q   +++G+++G+ YL    +   +HRD+ A N+L++S L  ++ DFGL+++ 
Sbjct: 118 DGQFTVIQLVGMLRGISAGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 174
Query: 496 ERGTNPSTTRVVGTLG--YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           E     + T   G +   + APE     K T++SDV+++G ++ EVV  G RP
Sbjct: 175 EDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQ---VAVKRV-SNESKQGLREFASEISSIGRLRHRNLV 403
           ++++G G FG V  G L     +   VA+K + +  + +  R+F SE S +G+  H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            L G   +   ++++ ++M NGSLD     +     T  Q   +++G+ SG+ YL    +
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLD-AFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---D 128
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG--YLAPELTRTG 521
            + +HRD+ A N+L++S L  ++ DFG++++ E     + T   G +   + APE     
Sbjct: 129 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 188
Query: 522 KPTTSSDVYAFGALLLEVVC-GRRP 545
           K T++SDV+++G ++ EV+  G RP
Sbjct: 189 KFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQ---VAVKRV-SNESKQGLREFASEISSIGRLRHRNLV 403
           ++++G G FG V  G L     +   VA+K + +  + +  R+F SE S +G+  H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            L G   +   ++++ ++M NGSLD     +     T  Q   +++G+ SG+ YL    +
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLD-AFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---D 134
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG--YLAPELTRTG 521
            + +HRD+ A N+L++S L  ++ DFG++++ E     + T   G +   + APE     
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 194
Query: 522 KPTTSSDVYAFGALLLEVVC-GRRP 545
           K T++SDV+++G ++ EV+  G RP
Sbjct: 195 KFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG+VYK     T    A K +  +S++ L ++  EI  +    H  +V+LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
             G L ++ +F P G++D  + +  +  LT  Q   + + +   L +LH    + +IHRD
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLH---SKRIIHRD 134
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE--LTRTGKPTT--- 525
           +KAGNVL+  E + RL DFG++      T       +GT  ++APE  +  T K T    
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 193
Query: 526 SSDVYAFGALLLEV 539
            +D+++ G  L+E+
Sbjct: 194 KADIWSLGITLIEM 207

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G FG VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----LYMATQISSAMEYLEK--- 127
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 188 SIKSDVWAFGVLLWEI 203

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 116/237 (48%), Gaps = 23/237 (9%)
Query: 326 LDVGPHRFSYEELKK---ATRGFRDKEL------LGFGGFGRVYKGTLPSTNTQVAVKRV 376
           +D+G     ++ +K+    TR    ++       LG G FG+VYK     T+   A K +
Sbjct: 11  VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI 70
Query: 377 SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQK 436
             +S++ L ++  EI  +    H N+V+LL       +L ++ +F   G++D  + + ++
Sbjct: 71  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER 130
Query: 437 AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE 496
             LT  Q   + K     L YLH   +  +IHRD+KAGN+L   + + +L DFG++    
Sbjct: 131 P-LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 186
Query: 497 RGTNPSTTRVVGTLGYLAPEL----TRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           R T       +GT  ++APE+    T   +P    +DV++ G  L+E+      IEP
Sbjct: 187 R-TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA----EIEP 238

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG+VYK     T    A K +  +S++ L ++  EI  +    H  +V+LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
             G L ++ +F P G++D  + +  +  LT  Q   + + +   L +LH    + +IHRD
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLH---SKRIIHRD 142
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE--LTRTGKPTT--- 525
           +KAGNVL+  E + RL DFG++      T       +GT  ++APE  +  T K T    
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 201
Query: 526 SSDVYAFGALLLEV 539
            +D+++ G  L+E+
Sbjct: 202 KADIWSLGITLIEM 215

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 116/237 (48%), Gaps = 23/237 (9%)
Query: 326 LDVGPHRFSYEELKK---ATRGFRDKEL------LGFGGFGRVYKGTLPSTNTQVAVKRV 376
           +D+G     ++ +K+    TR    ++       LG G FG+VYK     T+   A K +
Sbjct: 11  VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI 70
Query: 377 SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQK 436
             +S++ L ++  EI  +    H N+V+LL       +L ++ +F   G++D  + + ++
Sbjct: 71  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER 130
Query: 437 AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE 496
             LT  Q   + K     L YLH   +  +IHRD+KAGN+L   + + +L DFG++    
Sbjct: 131 P-LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 186
Query: 497 RGTNPSTTRVVGTLGYLAPEL----TRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           R      +  +GT  ++APE+    T   +P    +DV++ G  L+E+      IEP
Sbjct: 187 RXIQRRDS-FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA----EIEP 238

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 115/237 (48%), Gaps = 23/237 (9%)
Query: 326 LDVGPHRFSYEELKK---ATRGFRDKEL------LGFGGFGRVYKGTLPSTNTQVAVKRV 376
           +D+G     ++ +K+    TR    ++       LG G FG+VYK     T+   A K +
Sbjct: 11  VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI 70
Query: 377 SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQK 436
             +S++ L ++  EI  +    H N+V+LL       +L ++ +F   G++D  + + ++
Sbjct: 71  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER 130
Query: 437 AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE 496
             LT  Q   + K     L YLH   +  +IHRD+KAGN+L   + + +L DFG++    
Sbjct: 131 P-LTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 186
Query: 497 RGTNPSTTRVVGTLGYLAPEL----TRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           R         +GT  ++APE+    T   +P    +DV++ G  L+E+      IEP
Sbjct: 187 RXIQ-RRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA----EIEP 238

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL----LYMATQISSAMEYLEK--- 130
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 190
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 191 SIKSDVWAFGVLLWEI 206

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 8/212 (3%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C R     ++ +FM  G+L   L +  +  ++      +   ++S + YL +   +  I
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 131
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HRD+ A N L+      ++ DFGL++L    T  +       + + APE     K +  S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 528 DVYAFGALLLEVVC-GRRP---IEPKALPEEL 555
           DV+AFG LL E+   G  P   I+P  + E L
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 12/216 (5%)
Query: 328 VGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF 387
           + P   +Y++ +        K  LG G +G VY+G     +  VAVK +  ++ + + EF
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 61
Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQ 443
             E + +  ++H NLVQLLG C R     ++ +FM  G+L     +C   E  A++    
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL--- 118
Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
              +   ++S + YL +   +  IHRD+ A N L+      ++ DFGL++L    T  + 
Sbjct: 119 -LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH 174
Query: 504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                 + + APE     K +  SDV+AFG LL E+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 12/216 (5%)
Query: 328 VGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF 387
           + P   +Y++ +        K  LG G +G VY+G     +  VAVK +  ++ + + EF
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 61
Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQ 443
             E + +  ++H NLVQLLG C R     ++ +FM  G+L     +C   E  A++    
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL--- 118
Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
              +   ++S + YL +   +  IHRD+ A N L+      ++ DFGL++L    T  + 
Sbjct: 119 -LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 174
Query: 504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                 + + APE     K +  SDV+AFG LL E+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL----LYMATQISSAMEYLEK--- 129
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 190 SIKSDVWAFGVLLWEI 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 12/216 (5%)
Query: 328 VGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF 387
           + P   +Y++ +        K  LG G +G VY+G     +  VAVK +  ++ + + EF
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 61
Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQ 443
             E + +  ++H NLVQLLG C R     ++ +FM  G+L     +C   E  A++    
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL--- 118
Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
              +   ++S + YL +   +  IHRD+ A N L+      ++ DFGL++L    T  + 
Sbjct: 119 -LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 174
Query: 504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                 + + APE     K +  SDV+AFG LL E+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 18/220 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E+LG G FG+  K T   T   + +K +    ++  R F  E+  +  L H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
             +   L  + +++  G+L + +     +   W QR    K +ASG+ YLH      +IH
Sbjct: 76  LYKDKRLNFITEYIKGGTL-RGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLY-ERGTNPSTTR------------VVGTLGYLAP 515
           RD+ + N L+    N  + DFGLA+L  +  T P   R            VVG   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL 555
           E+          DV++FG +L E++ GR   +P  LP  +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTM 230

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----LYMATQISSAMEYLEK--- 133
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 194 SIKSDVWAFGVLLWEI 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----LYMATQISSAMEYLEK--- 129
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 190 SIKSDVWAFGVLLWEI 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----LYMATQISSAMEYLEK--- 131
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKF 191
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 192 SIKSDVWAFGVLLWEI 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----LYMATQISSAMEYLEK--- 129
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 190 SIKSDVWAFGVLLWEI 205

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----LYMATQISSAMEYLEK--- 130
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKF 190
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 191 SIKSDVWAFGVLLWEI 206

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----LYMATQISSAMEYLEK--- 131
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 191
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 192 SIKSDVWAFGVLLWEI 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----LYMATQISSAMEYLEK--- 131
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 191
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 192 SIKSDVWAFGVLLWEI 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 12/216 (5%)
Query: 328 VGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF 387
           + P   +Y++ +        K  LG G +G VY+G     +  VAVK +  ++ + + EF
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 61
Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQ 443
             E + +  ++H NLVQLLG C R     ++ +FM  G+L     +C   E  A++    
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL--- 118
Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
              +   ++S + YL +   +  IHRD+ A N L+      ++ DFGL++L    T  + 
Sbjct: 119 -LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 174
Query: 504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                 + + APE     K +  SDV+AFG LL E+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----LYMATQISSAMEYLEK--- 129
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 190 SIKSDVWAFGVLLWEI 205

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----LYMATQISSAMEYLEK--- 142
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 143 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 202
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 203 SIKSDVWAFGVLLWEI 218

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL----LYMATQISSAMEYLEK--- 129
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 190 SIKSDVWAFGVLLWEI 205

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLV--- 403
           KE LG GGFG V +     T  QVA+K+   E     RE +  EI  + +L H N+V   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 404 ------QLLGWCRRRGDL-LLVYDFMPNGSLDKCLFDEQKAILTWEQRYR-IIKGVASGL 455
                 Q L       DL LL  ++   G L K L   +      E   R ++  ++S L
Sbjct: 79  EVPDGLQKLA----PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
            YLHE     +IHRD+K  N++L      L  ++ D G AK  ++G     T  VGTL Y
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQY 189
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP 552
           LAPEL    K T + D ++FG L  E + G RP  P   P
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 4/192 (2%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C R     ++ +FM  G+L   L +  +  ++      +   ++S + YL +   +  I
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 138
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HRD+ A N L+      ++ DFGL++L    T  +       + + APE     K +  S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 528 DVYAFGALLLEV 539
           DV+AFG LL E+
Sbjct: 199 DVWAFGVLLWEI 210

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLV--- 403
           KE LG GGFG V +     T  QVA+K+   E     RE +  EI  + +L H N+V   
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 404 ------QLLGWCRRRGDL-LLVYDFMPNGSLDKCLFDEQKAILTWEQRYR-IIKGVASGL 455
                 Q L       DL LL  ++   G L K L   +      E   R ++  ++S L
Sbjct: 80  EVPDGLQKLA----PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 135
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
            YLHE     +IHRD+K  N++L      L  ++ D G AK  ++G     T  VGTL Y
Sbjct: 136 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQY 190
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP 552
           LAPEL    K T + D ++FG L  E + G RP  P   P
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 230

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 12/220 (5%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRH 399
           ++  F+  E LG G +  VYKG   +T   VA+K V  +S++G    A  EIS +  L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIK----GVASGL 455
            N+V+L         L LV++FM N  L K +               ++K     +  GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
            + HE     ++HRD+K  N+L++     +LGDFGLA+ +    N  ++ VV TL Y AP
Sbjct: 122 AFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAP 177
Query: 516 ELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEE 554
           ++    +  +TS D+++ G +L E++ G +P+ P    EE
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEE 216

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----LYMATQISSAMEYLEK--- 129
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 190 SIKSDVWAFGVLLWEI 205

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +G+
Sbjct: 21  IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV------ASGLLYLHEEW 462
             +   L +V  +    SL   L          E ++ +IK +      A G+ YLH   
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLH-------IIETKFEMIKLIDIARQTAQGMDYLHA-- 127
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTRTG 521
            +++IHRD+K+ N+ L  +L  ++GDFGLA +  R +      ++ G++ ++APE+ R  
Sbjct: 128 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 522 KP---TTSSDVYAFGALLLEVVCGRRP 545
                +  SDVYAFG +L E++ G+ P
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +G+
Sbjct: 18  IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV------ASGLLYLHEEW 462
             +   L +V  +    SL   L          E ++ +IK +      A G+ YLH   
Sbjct: 75  STK-PQLAIVTQWCEGSSLYHHLH-------IIETKFEMIKLIDIARQTAQGMDYLHA-- 124
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTRTG 521
            +++IHRD+K+ N+ L  +L  ++GDFGLA +  R +      ++ G++ ++APE+ R  
Sbjct: 125 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 522 KP---TTSSDVYAFGALLLEVVCGRRP 545
                +  SDVYAFG +L E++ G+ P
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----LYMATQISSAMEYLEK--- 127
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRD+ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKF 187
Query: 524 TTSSDVYAFGALLLEV 539
           +  SDV+AFG LL E+
Sbjct: 188 SIKSDVWAFGVLLWEI 203

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +G+
Sbjct: 16  IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV------ASGLLYLHEEW 462
             +   L +V  +    SL   L          E ++ +IK +      A G+ YLH   
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLH-------IIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTRTG 521
            +++IHRD+K+ N+ L  +L  ++GDFGLA +  R +      ++ G++ ++APE+ R  
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 522 KP---TTSSDVYAFGALLLEVVCGRRP 545
                +  SDVYAFG +L E++ G+ P
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 11/209 (5%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR 398
           K+    F   E LG G +G VYK     T   VA+K+V  ES   L+E   EIS + +  
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCD 82
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
             ++V+  G   +  DL +V ++   GS+   +    K  LT ++   I++    GL YL
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYL 141
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPE 516
           H       IHRDIKAGN+LL++E + +L DFG+A    + T+    R  V+GT  ++APE
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDXMAKRNXVIGTPFWMAPE 195
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           + +       +D+++ G   +E+  G+ P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 8/198 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV---SNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           LG GG   VY       N +VA+K +     E ++ L+ F  E+ +  +L H+N+V ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
                    LV +++   +L + +  E    L+ +        +  G+ + H+     ++
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHD---MRIV 133
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HRDIK  N+L+DS    ++ DFG+AK     +   T  V+GT+ Y +PE  +       +
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 528 DVYAFGALLLEVVCGRRP 545
           D+Y+ G +L E++ G  P
Sbjct: 194 DIYSIGIVLYEMLVGEPP 211

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 111/229 (48%), Gaps = 30/229 (13%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E+   G FG V+K  L   N  VAVK    + KQ  +    EI S   ++H NL+Q +  
Sbjct: 21  EIKARGRFGCVWKAQL--MNDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIA- 76
Query: 409 CRRRG-----DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE-- 461
             +RG     +L L+  F   GSL   L   +  I+TW +   + + ++ GL YLHE+  
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDVP 133
Query: 462 W------EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLA 514
           W      + ++ HRD K+ NVLL S+L   L DFGLA  +E G  P  T   VGT  Y+A
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMA 193
Query: 515 PELTRTG-----KPTTSSDVYAFGALLLEVVCGRR----PIEPKALPEE 554
           PE+               D+YA G +L E+V   +    P++   LP E
Sbjct: 194 PEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFE 242

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +G+
Sbjct: 21  IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV------ASGLLYLHEEW 462
             +   L +V  +    SL   L          E ++ +IK +      A G+ YLH   
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLH-------IIETKFEMIKLIDIARQTAQGMDYLHA-- 127
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTRTG 521
            +++IHRD+K+ N+ L  +L  ++GDFGLA +  R +      ++ G++ ++APE+ R  
Sbjct: 128 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 522 KP---TTSSDVYAFGALLLEVVCGRRP 545
                +  SDVYAFG +L E++ G+ P
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA- 75
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              +  + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 132
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 7/217 (3%)
Query: 326 LDVGPHRFSYEELKKATRGFRD---KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ 382
           +D+G     ++ + K      D   K  LG G +G VY G     +  VAVK +  ++ +
Sbjct: 12  VDLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME 71
Query: 383 GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWE 442
            + EF  E + +  ++H NLVQLLG C       +V ++MP G+L   L +  +  +T  
Sbjct: 72  -VEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAV 130
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS 502
               +   ++S + YL +   +  IHRD+ A N L+      ++ DFGL++L    T  +
Sbjct: 131 VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTA 187
Query: 503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                  + + APE       +  SDV+AFG LL E+
Sbjct: 188 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 21  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA- 77
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              +  + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 78  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 134
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 194
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 195 VWSFGILLTEIVTHGRIPYPGMTNPE 220

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 28  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA- 84
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              +  + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 85  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 141
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 201
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 202 VWSFGILLTEIVTHGRIPYPGMTNPE 227

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 20  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA- 76
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              +  + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 77  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 133
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 193
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 194 VWSFGILLTEIVTHGRIPYPGMTNPE 219

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 10/199 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG VYKG     +  V + +V + + +  + F +E++ + + RH N++  +G+  
Sbjct: 44  IGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           +  +L +V  +    SL K L  ++     + Q   I +  A G+ YLH    + +IHRD
Sbjct: 103 K-DNLAIVTQWCEGSSLYKHLHVQETKFQMF-QLIDIARQTAQGMDYLHA---KNIIHRD 157
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGT-NPSTTRVVGTLGYLAPELTRT--GKP-TTS 526
           +K+ N+ L   L  ++GDFGLA +  R + +    +  G++ ++APE+ R     P +  
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 527 SDVYAFGALLLEVVCGRRP 545
           SDVY++G +L E++ G  P
Sbjct: 218 SDVYSYGIVLYELMTGELP 236

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA- 75
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              +  + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 132
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 26/209 (12%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           + +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +
Sbjct: 41  QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV------ASGLLYLHE 460
           G+  +   L +V  +    SL   L          E ++ +IK +      A G+ YLH 
Sbjct: 98  GYSTK-PQLAIVTQWCEGSSLYHHLH-------IIETKFEMIKLIDIARQTAQGMDYLHA 149
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTR 519
              +++IHRD+K+ N+ L  +L  ++GDFGLA +  R +      ++ G++ ++APE+ R
Sbjct: 150 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 520 TGKP---TTSSDVYAFGALLLEVVCGRRP 545
                  +  SDVYAFG +L E++ G+ P
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 25  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA- 81
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              +  + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 138
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 199 VWSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA- 75
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              +  + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 132
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 27  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 84
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
             +   + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 85  VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 140
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 200
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 201 VWSFGILLTEIVTHGRIPYPGMTNPE 226

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 25  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA- 81
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              +  + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 138
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 199 VWSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 109/222 (49%), Gaps = 11/222 (4%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGL-REFASEISSIGRLRHRN 401
           F+   LLG G F  VY+     T  +VA+K +  ++  K G+ +   +E+    +L+H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++L  +      + LV +   NG +++ L +  K     E R+  +  + +G+LYLH  
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-FMHQIITGMLYLHS- 130
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
               ++HRD+   N+LL   +N ++ DFGLA   +       T + GT  Y++PE+    
Sbjct: 131 --HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRS 187
Query: 522 KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL---ILVDW 560
                SDV++ G +   ++ GR P +   +   L   +L D+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 24  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA- 80
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              +  + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 81  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 137
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 197
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 198 VWSFGILLTEIVTHGRIPYPGMTNPE 223

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 26/209 (12%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           + +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +
Sbjct: 42  QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV------ASGLLYLHE 460
           G+  +   L +V  +    SL   L          E ++ +IK +      A G+ YLH 
Sbjct: 99  GYSTK-PQLAIVTQWCEGSSLYHHLH-------IIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTR 519
              +++IHRD+K+ N+ L  +L  ++GDFGLA +  R +      ++ G++ ++APE+ R
Sbjct: 151 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 520 TGKP---TTSSDVYAFGALLLEVVCGRRP 545
                  +  SDVYAFG +L E++ G+ P
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 29  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 86
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
             +   + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 87  VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 142
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 202
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 203 VWSFGILLTEIVTHGRIPYPGMTNPE 228

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 14  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 71
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
             +   + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 72  VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 127
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 187
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 188 VWSFGILLTEIVTHGRIPYPGMTNPE 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 26/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +G+
Sbjct: 16  IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV------ASGLLYLHEEW 462
                 L +V  +    SL   L          E ++ +IK +      A G+ YLH   
Sbjct: 73  STA-PQLAIVTQWCEGSSLYHHLH-------IIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTRTG 521
            +++IHRD+K+ N+ L  +L  ++GDFGLA +  R +      ++ G++ ++APE+ R  
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 522 KP---TTSSDVYAFGALLLEVVCGRRP 545
                +  SDVYAFG +L E++ G+ P
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 26/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +G+
Sbjct: 16  IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV------ASGLLYLHEEW 462
             +   L +V  +    SL   L          E ++ +IK +      A G+ YLH   
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLH-------IIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTRTG 521
            +++IHRD+K+ N+ L  +L  ++GDFGLA    R +      ++ G++ ++APE+ R  
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 522 KP---TTSSDVYAFGALLLEVVCGRRP 545
                +  SDVYAFG +L E++ G+ P
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 27/239 (11%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C R     ++ +FM  G+L   L +  +  ++      +   ++S + YL +   +  I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 340
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HR++ A N L+      ++ DFGL++L    T  +       + + APE     K +  S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 528 DVYAFGALLLEVVC-GRRPI-------------------EPKALPE---ELILVDWVWD 563
           DV+AFG LL E+   G  P                     P+  PE   EL+   W W+
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 459

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 26/209 (12%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           + +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +
Sbjct: 34  QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV------ASGLLYLHE 460
           G+  +   L +V  +    SL   L          E ++ +IK +      A G+ YLH 
Sbjct: 91  GYSTK-PQLAIVTQWCEGSSLYHHLH-------IIETKFEMIKLIDIARQTAQGMDYLHA 142
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTR 519
              +++IHRD+K+ N+ L  +L  ++GDFGLA    R +      ++ G++ ++APE+ R
Sbjct: 143 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 520 TGKP---TTSSDVYAFGALLLEVVCGRRP 545
                  +  SDVYAFG +L E++ G+ P
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 35/243 (14%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  ++ + + EF  E + +  ++H NLVQLLG
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 322
Query: 408 WCRRRGDLLLVYDFMPNGSL----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            C R     ++ +FM  G+L     +C   E  A++       +   ++S + YL +   
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----LYMATQISSAMEYLEK--- 375
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHR++ A N L+      ++ DFGL++L    T  +       + + APE     K 
Sbjct: 376 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 435
Query: 524 TTSSDVYAFGALLLEVVC-GRRPI-------------------EPKALPE---ELILVDW 560
           +  SDV+AFG LL E+   G  P                     P+  PE   EL+   W
Sbjct: 436 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 495
Query: 561 VWD 563
            W+
Sbjct: 496 QWN 498

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 109/228 (47%), Gaps = 29/228 (12%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E+   G FG V+K  L   N  VAVK    + KQ  +    E+ S+  ++H N++Q +G 
Sbjct: 30  EVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIG- 85
Query: 409 CRRRG-----DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE-- 461
             +RG     DL L+  F   GSL   L   +  +++W +   I + +A GL YLHE+  
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIP 142
Query: 462 -----WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLAP 515
                 +  + HRDIK+ NVLL + L   + DFGLA  +E G +   T   VGT  Y+AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 516 ELTRTG-----KPTTSSDVYAFGALLLEV----VCGRRPIEPKALPEE 554
           E+               D+YA G +L E+         P++   LP E
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           + +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +
Sbjct: 18  QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G+  +   L +V  +    SL   L   +      ++   I +  A G+ YLH    +++
Sbjct: 75  GYSTK-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHA---KSI 129
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTR---TGK 522
           IHRD+K+ N+ L  +   ++GDFGLA +  R +      ++ G++ ++APE+ R   +  
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
            +  SDVYAFG +L E++ G+ P
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 26/209 (12%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           + +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +
Sbjct: 42  QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV------ASGLLYLHE 460
           G+  +   L +V  +    SL   L          E ++ +IK +      A G+ YLH 
Sbjct: 99  GYSTK-PQLAIVTQWCEGSSLYHHLH-------IIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTR 519
              +++IHRD+K+ N+ L  +L  ++GDFGLA    R +      ++ G++ ++APE+ R
Sbjct: 151 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 520 TGKP---TTSSDVYAFGALLLEVVCGRRP 545
                  +  SDVYAFG +L E++ G+ P
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +F+P GSL + L  + K  +   +  +    +  G+ YL     +
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 136
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 197 FSVASDVWSFGVVLYEL 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 16  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 74  EE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 129
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 190 SFGILLTELTTKGRVP 205

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 17  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 75  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 130
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 191 SFGILLTELTTKGRVP 206

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 250 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 366 SFGILLTELTTKGRVP 381

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 15  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 73  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 128
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 189 SFGILLTELTTKGRVP 204

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 13/218 (5%)
Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS----NESKQGL-REFASEI 391
           ++K   + +   + LG G F  VYK    +TN  VA+K++     +E+K G+ R    EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 392 SSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV 451
             +  L H N++ LL     + ++ LV+DFM      + +  +   +LT       +   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDL--EVIIKDNSLVLTPSHIKAYMLMT 121
Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG 511
             GL YLH+ W   ++HRD+K  N+LLD     +L DFGLAK +         +VV T  
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRW 177
Query: 512 YLAPELTRTGKPT-TSSDVYAFGALLLEVVCGRRPIEP 548
           Y APEL    +      D++A G +L E++  R P  P
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLP 214

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 250 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 366 SFGILLTELTTKGRVP 381

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 15  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 72
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
             +   + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 73  VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 128
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           R+++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 188
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 189 VWSFGILLTEIVTHGRIPYPGMTNPE 214

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 19  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 77  EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 132
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 193 SFGILLTELTTKGRVP 208

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 333 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 388
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 449 SFGILLTELTTKGRVP 464

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG- 407
           + +G G FG V  G       +VAVK + N++    + F +E S + +LRH NLVQLLG 
Sbjct: 27  QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
               +G L +V ++M  GSL   L    +++L  +   +    V   + YL        +
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 139
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYLAPELTRTGKPTT 525
           HRD+ A NVL+  +   ++ DFGL K        S+T+  G L   + APE  R  K +T
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 526 SSDVYAFGALLLEVVC-GRRP 545
            SDV++FG LL E+   GR P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG- 407
           + +G G FG V  G       +VAVK + N++    + F +E S + +LRH NLVQLLG 
Sbjct: 199 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
               +G L +V ++M  GSL   L    +++L  +   +    V   + YL        +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 311
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYLAPELTRTGKPTT 525
           HRD+ A NVL+  +   ++ DFGL K        S+T+  G L   + APE  R  K +T
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 526 SSDVYAFGALLLEVVC-GRRP 545
            SDV++FG LL E+   GR P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 250 EE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 366 SFGILLTELTTKGRVP 381

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG- 407
           + +G G FG V  G       +VAVK + N++    + F +E S + +LRH NLVQLLG 
Sbjct: 12  QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
               +G L +V ++M  GSL   L    +++L  +   +    V   + YL        +
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 124
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYLAPELTRTGKPTT 525
           HRD+ A NVL+  +   ++ DFGL K        S+T+  G L   + APE  R  K +T
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 526 SSDVYAFGALLLEVVC-GRRP 545
            SDV++FG LL E+   GR P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVS--NESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           LG G FG V+ GT   T T+VA+K +   N S +    F  E   + +LRH  LVQL   
Sbjct: 193 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEKLVQLYAV 248
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
                 + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +H
Sbjct: 249 VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 304
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L  ++ DFGL +L E     +       + + APE    G+ T  SD
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 529 VYAFGALLLEVVCGRRPIEPKALPEELI 556
           V++FG LL E+    R   P  +  E++
Sbjct: 365 VWSFGILLTELTTKGRVPYPGMVNREVL 392

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 7/206 (3%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G  G V+ G   + +T+VAVK +   S      F +E + + +L+H+ LV+L   
Sbjct: 19  ERLGAGQAGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA- 75
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              +  + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  IH
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 132
Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           RD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T  SD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 529 VYAFGALLLEVVC-GRRPIEPKALPE 553
           V++FG LL E+V  GR P      PE
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + ++RH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT  + NT+VA+K +          F  E   + +L+H  LVQL     
Sbjct: 17  LGNGQFGEVWMGTW-NGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L D +   L       +   VA+G+ Y+        IHRD
Sbjct: 75  EE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 130
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           +++ N+L+ + L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+V  GR P
Sbjct: 191 SFGILLTELVTKGRVP 206

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLR-EFASEISSIGRLRHRNLVQLLG 407
           LG G FG+V      +T  +VA+K ++ +  +K  ++     EIS +  LRH ++++L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
             + + ++++V ++  N   D  +   Q+  ++ ++  R  + + S + Y H      ++
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHR---HKIV 135
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK--PTT 525
           HRD+K  N+LLD  LN ++ DFGL+ +   G    T+   G+  Y APE+  +GK     
Sbjct: 136 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-SGKLYAGP 192
Query: 526 SSDVYAFGALLLEVVCGRRPIEPKALP 552
             DV++ G +L  ++C R P + +++P
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDESIP 219

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLR-EFASEISSIGRLRHRNLVQLLG 407
           LG G FG+V      +T  +VA+K ++ +  +K  ++     EIS +  LRH ++++L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
             + + ++++V ++  N   D  +   Q+  ++ ++  R  + + S + Y H      ++
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHR---HKIV 134
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK--PTT 525
           HRD+K  N+LLD  LN ++ DFGL+ +   G    T+   G+  Y APE+  +GK     
Sbjct: 135 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-SGKLYAGP 191
Query: 526 SSDVYAFGALLLEVVCGRRPIEPKALP 552
             DV++ G +L  ++C R P + +++P
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDESIP 218

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 93/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 121/258 (46%), Gaps = 22/258 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ G   + +T+VAVK +       ++ F  E + +  L+H  LV+L     
Sbjct: 21  LGAGQFGEVWMGYY-NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           R   + ++ ++M  GSL   L  ++   +   +       +A G+ Y+     +  IHRD
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRD 135
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A NVL+   L  ++ DFGLA++ E     +       + + APE    G  T  SDV+
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 531 AFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALD 589
           +FG LL E+V  G+ P   +   + +  +         G  +    PR+    +E+   D
Sbjct: 196 SFGILLYEIVTYGKIPYPGRTNADVMTALS-------QGYRM----PRVENCPDEL--YD 242
Query: 590 VVKLGLMCSNDAAEARPT 607
           ++K   MC  + AE RPT
Sbjct: 243 IMK---MCWKEKAEERPT 257

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           + +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +
Sbjct: 30  QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G+  +   L +V  +    SL   L   +      ++   I +  A G+ YLH    +++
Sbjct: 87  GYSTK-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTR---TGK 522
           IHRD+K+ N+ L  +   ++GDFGLA    R +      ++ G++ ++APE+ R   +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
            +  SDVYAFG +L E++ G+ P
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 122/266 (45%), Gaps = 23/266 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG V+ G   + + +VA+K +  E      +F  E   + +L H  LVQL G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
            +  + LV++FM +G L   L   Q+ +   E    +   V  G+ YL E    +VIHRD
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRD 128
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L+      ++ DFG+ +        S+T     + + +PE+    + ++ SDV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 531 AFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALD 589
           +FG L+ EV   G+ P E ++  E       V +    G    +  PRL        +  
Sbjct: 189 SFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTG--FRLYKPRLA-------STH 232
Query: 590 VVKLGLMCSNDAAEARPTMRQVVRYL 615
           V ++   C  +  E RP   +++R L
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 93/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  G L   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 132
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 192
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 193 FSVASDVWSFGVVLYEL 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLR-EFASEISSIGRLRHRNLVQLLG 407
           LG G FG+V      +T  +VA+K ++ +  +K  ++     EIS +  LRH ++++L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
             + + ++++V ++  N   D  +   Q+  ++ ++  R  + + S + Y H      ++
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHR---HKIV 129
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK--PTT 525
           HRD+K  N+LLD  LN ++ DFGL+ +   G    T+   G+  Y APE+  +GK     
Sbjct: 130 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-SGKLYAGP 186
Query: 526 SSDVYAFGALLLEVVCGRRPIEPKALP 552
             DV++ G +L  ++C R P + +++P
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIP 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 81  EE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRD 136
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 197 SFGILLTELTTKGRVP 212

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLR-EFASEISSIGRLRHRNLVQLLG 407
           LG G FG+V      +T  +VA+K ++ +  +K  ++     EIS +  LRH ++++L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
             + + ++++V ++  N   D  +   Q+  ++ ++  R  + + S + Y H      ++
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHR---HKIV 125
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK--PTT 525
           HRD+K  N+LLD  LN ++ DFGL+ +   G    T+   G+  Y APE+  +GK     
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-SGKLYAGP 182
Query: 526 SSDVYAFGALLLEVVCGRRPIEPKALP 552
             DV++ G +L  ++C R P + +++P
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIP 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 131
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 191
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 192 FSVASDVWSFGVVLYEL 208

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 139
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 199
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 200 FSVASDVWSFGVVLYEL 216

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQV--AVKRVSN-ESKQGLREFASEISSIGRL-RHRNLV 403
           ++++G G FG+V K  +     ++  A+KR+    SK   R+FA E+  + +L  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCL--------------FDEQKAILTWEQRYRIIK 449
            LLG C  RG L L  ++ P+G+L   L               +   + L+ +Q      
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT 509
            VA G+ YL    ++  IHRD+ A N+L+      ++ DFGL+    RG      + +G 
Sbjct: 140 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGR 192
Query: 510 L--GYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           L   ++A E       TT+SDV+++G LL E+V
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 194 FSVASDVWSFGVVLYEL 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 138
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 198
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 199 FSVASDVWSFGVVLYEL 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 194 FSVASDVWSFGVVLYEL 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 164
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 224
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 225 FSVASDVWSFGVVLYEL 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 140
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 200
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 201 FSVASDVWSFGVVLYEL 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 137
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 197
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 198 FSVASDVWSFGVVLYEL 214

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 136
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 197 FSVASDVWSFGVVLYEL 213

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQV--AVKRVSN-ESKQGLREFASEISSIGRL-RHRNLV 403
           ++++G G FG+V K  +     ++  A+KR+    SK   R+FA E+  + +L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCL--------------FDEQKAILTWEQRYRIIK 449
            LLG C  RG L L  ++ P+G+L   L               +   + L+ +Q      
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT 509
            VA G+ YL    ++  IHRD+ A N+L+      ++ DFGL+    RG      + +G 
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGR 202
Query: 510 L--GYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           L   ++A E       TT+SDV+++G LL E+V
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 23/266 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG V+ G   + + +VA+K +  E      +F  E   + +L H  LVQL G C 
Sbjct: 13  IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
            +  + LV++FM +G L   L   Q+ +   E    +   V  G+ YL E     VIHRD
Sbjct: 71  EQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 126
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L+      ++ DFG+ +        S+T     + + +PE+    + ++ SDV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 531 AFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALD 589
           +FG L+ EV   G+ P E ++  E       V +    G    +  PRL        +  
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTG--FRLYKPRLA-------STH 230
Query: 590 VVKLGLMCSNDAAEARPTMRQVVRYL 615
           V ++   C  +  E RP   +++R L
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 81  EE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRD 136
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 197 SFGILLTELTTKGRVP 212

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 93/196 (47%), Gaps = 7/196 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
               + +V ++M  G L   L  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 531 AFGALLLEVVC-GRRP 545
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 23/266 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG V+ G   + + +VA+K +  E      +F  E   + +L H  LVQL G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
            +  + LV++FM +G L   L   Q+ +   E    +   V  G+ YL E     VIHRD
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 128
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L+      ++ DFG+ +        S+T     + + +PE+    + ++ SDV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 531 AFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALD 589
           +FG L+ EV   G+ P E ++  E       V +    G    +  PRL        +  
Sbjct: 189 SFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTG--FRLYKPRLA-------STH 232
Query: 590 VVKLGLMCSNDAAEARPTMRQVVRYL 615
           V ++   C  +  E RP   +++R L
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 151
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 212 FSVASDVWSFGVVLYEL 228

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+  T  + +T+VAVK +   S   +  F +E + +  L+H  LV+L     
Sbjct: 23  LGAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           +   + ++ +FM  GSL   L  ++ +     +       +A G+ ++ +   +  IHRD
Sbjct: 81  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 136
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+ + L  ++ DFGLA++ E     +       + + APE    G  T  SDV+
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 531 AFGALLLEVVC-GRRPIEPKALPE 553
           +FG LL+E+V  GR P    + PE
Sbjct: 197 SFGILLMEIVTYGRIPYPGMSNPE 220

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 327 DVGPHRFSYEELKKATRGFRDKELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESK- 381
           +V P  F    LK+     RD   LG G FG+V    Y     +T  QVAVK +  ES  
Sbjct: 12  EVDPTHFEKRFLKR----IRD---LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG 64
Query: 382 QGLREFASEISSIGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAIL 439
             + +   EI  +  L H N+V+  G C   G   + L+ +F+P+GSL + L  + K  +
Sbjct: 65  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI 123
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
             +Q+ +    +  G+ YL     +  +HRD+ A NVL++SE   ++GDFGL K  E   
Sbjct: 124 NLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
Query: 500 NPSTTR--VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
              T +      + + APE     K   +SDV++FG  L E++
Sbjct: 181 EXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 343 RGFRDKELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR 398
           R  +  + LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+
Sbjct: 28  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 87
Query: 399 HRNLVQLLGWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           H N+V+  G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ 
Sbjct: 88  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGME 146
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLA 514
           YL     +  IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + A
Sbjct: 147 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 515 PELTRTGKPTTSSDVYAFGALLLEV 539
           PE     K + +SDV++FG +L E+
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYEL 228

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 23/266 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG V+ G   + + +VA+K +  E      +F  E   + +L H  LVQL G C 
Sbjct: 18  IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
            +  + LV++FM +G L   L   Q+ +   E    +   V  G+ YL E     VIHRD
Sbjct: 76  EQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 131
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L+      ++ DFG+ +        S+T     + + +PE+    + ++ SDV+
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 531 AFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALD 589
           +FG L+ EV   G+ P E ++  E       V +    G    +  PRL        +  
Sbjct: 192 SFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTG--FRLYKPRLA-------STH 235
Query: 590 VVKLGLMCSNDAAEARPTMRQVVRYL 615
           V ++   C  +  E RP   +++R L
Sbjct: 236 VYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG- 407
           + +G G FG V  G       +VAVK + N++    + F +E S + +LRH NLVQLLG 
Sbjct: 18  QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 73
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
               +G L +V ++M  GSL   L    +++L  +   +    V   + YL        +
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 130
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYLAPELTRTGKPTT 525
           HRD+ A NVL+  +   ++ DFGL K        S+T+  G L   + APE  R    +T
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREAAFST 184
Query: 526 SSDVYAFGALLLEVVC-GRRP 545
            SDV++FG LL E+   GR P
Sbjct: 185 KSDVWSFGILLWEIYSFGRVP 205

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR---EFASEISSIGRLRHRNLVQLLG 407
           LG G FG+V  G    T  +VAVK ++ +  + L    +   EI ++   RH ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
                 D+ +V +++  G L    FD   +   L  ++  R+ + + SG+ Y H      
Sbjct: 84  VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCHR---HM 136
Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK--P 523
           V+HRD+K  NVLLD+ +N ++ DFGL+ +   G     +   G+  Y APE+  +G+   
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS--CGSPNYAAPEVI-SGRLYA 193
Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALP 552
               D+++ G +L  ++CG  P +   +P
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVP 222

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+ G   + +T+VAVK +       ++ F  E + +  L+H  LV+L     
Sbjct: 20  LGAGQFGEVWMGYY-NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           +   + ++ +FM  GSL   L  ++   +   +       +A G+ Y+     +  IHRD
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRD 134
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A NVL+   L  ++ DFGLA++ E     +       + + APE    G  T  S+V+
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 531 AFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALD 589
           +FG LL E+V  G+ P   +   +       V      G  +    PR+    +E+   D
Sbjct: 195 SFGILLYEIVTYGKIPYPGRTNAD-------VMSALSQGYRM----PRMENCPDEL--YD 241
Query: 590 VVKLGLMCSNDAAEARPT 607
           ++K   MC  + AE RPT
Sbjct: 242 IMK---MCWKEKAEERPT 256

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 23/266 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG V+ G   + + +VA+K +  E      +F  E   + +L H  LVQL G C 
Sbjct: 35  IGSGQFGLVHLGYWLNKD-KVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
            +  + LV++FM +G L   L   Q+ +   E    +   V  G+ YL E     VIHRD
Sbjct: 93  EQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 148
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L+      ++ DFG+ +        S+T     + + +PE+    + ++ SDV+
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 531 AFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALD 589
           +FG L+ EV   G+ P E ++  E       V +    G    +  PRL        +  
Sbjct: 209 SFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTG--FRLYKPRLA-------STH 252
Query: 590 VVKLGLMCSNDAAEARPTMRQVVRYL 615
           V ++   C  +  E RP   +++R L
Sbjct: 253 VYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 106/203 (52%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           + +G G FG VYKG     +  VAVK   V+  + Q L+ F +E+  + + RH N++  +
Sbjct: 30  QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G+      L +V  +    SL   L   +      ++   I +  A G+ YLH    +++
Sbjct: 87  GYSTA-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST-TRVVGTLGYLAPELTR---TGK 522
           IHRD+K+ N+ L  +   ++GDFGLA    R +      ++ G++ ++APE+ R   +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
            +  SDVYAFG +L E++ G+ P
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 329 GPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EF 387
           GP R+   E  +    FRD  +LG G F  V       T   VA+K ++ E+ +G     
Sbjct: 7   GP-RWKQAEDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSM 63
Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRY 445
            +EI+ + +++H N+V L       G L L+   +  G L    FD   +K   T     
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL---LDSELNGRLGDFGLAKLYERGTNPS 502
           R+I  V   + YLH+     ++HRD+K  N+L   LD +    + DFGL+K+ + G+  S
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           T    GT GY+APE+      + + D ++ G +   ++CG  P
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 20/222 (9%)
Query: 328 VGPHRFSYEELKKATRGFRDKELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESK-Q 382
           V P  F    LK+     RD   LG G FG+V    Y     +T  QVAVK +  ES   
Sbjct: 1   VDPTHFEKRFLKR----IRD---LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN 53
Query: 383 GLREFASEISSIGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILT 440
            + +   EI  +  L H N+V+  G C   G   + L+ +F+P+GSL + L  + K  + 
Sbjct: 54  HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKIN 112
Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN 500
            +Q+ +    +  G+ YL     +  +HRD+ A NVL++SE   ++GDFGL K  E    
Sbjct: 113 LKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 169
Query: 501 PSTTR--VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
             T +      + + APE     K   +SDV++FG  L E++
Sbjct: 170 XXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 329 GPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EF 387
           GP R+   E  +    FRD  +LG G F  V       T   VA+K ++ E+ +G     
Sbjct: 7   GP-RWKQAEDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSM 63
Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRY 445
            +EI+ + +++H N+V L       G L L+   +  G L    FD   +K   T     
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL---LDSELNGRLGDFGLAKLYERGTNPS 502
           R+I  V   + YLH+     ++HRD+K  N+L   LD +    + DFGL+K+ + G+  S
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           T    GT GY+APE+      + + D ++ G +   ++CG  P
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+  T  + +T+VAVK +   S   +  F +E + +  L+H  LV+L     
Sbjct: 196 LGAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           +   + ++ +FM  GSL   L  ++ +     +       +A G+ ++ +   +  IHRD
Sbjct: 254 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 309
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+ + L  ++ DFGLA++ E     +       + + APE    G  T  SDV+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 531 AFGALLLEVVC-GRRPIEPKALPE 553
           +FG LL+E+V  GR P    + PE
Sbjct: 370 SFGILLMEIVTYGRIPYPGMSNPE 393

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 194 FSVASDVWSFGVVLYEL 210

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 329 GPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EF 387
           GP R+   E  +    FRD  +LG G F  V       T   VA+K ++ E+ +G     
Sbjct: 7   GP-RWKQAEDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSM 63
Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRY 445
            +EI+ + +++H N+V L       G L L+   +  G L    FD   +K   T     
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL---LDSELNGRLGDFGLAKLYERGTNPS 502
           R+I  V   + YLH+     ++HRD+K  N+L   LD +    + DFGL+K+ + G+  S
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           T    GT GY+APE+      + + D ++ G +   ++CG  P
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV-------SNESKQGLREFASEISSIGRLRHRNLV 403
           +G GGFG V+KG L    + VA+K +         E  +  +EF  E+  +  L H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L G         +V +F+P G L   L D+   I  W  + R++  +A G+ Y+  +  
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIALGIEYMQNQ-N 142
Query: 464 QTVIHRDIKAGNVLLDS-----ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
             ++HRD+++ N+ L S      +  ++ DFGL++     +  S + ++G   ++APE  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPETI 198
Query: 519 RTGKP--TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP 576
              +   T  +D Y+F  +L  ++ G  P +  +   ++  ++ + +      I E   P
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY-GKIKFINMIREEGLRPTIPEDCPP 257
Query: 577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           RL    N IE         +C +   + RP    +V+ L
Sbjct: 258 RLR---NVIE---------LCWSGDPKKRPHFSYIVKEL 284

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQV--AVKRVSN-ESKQGLREFASEISSIGRL-RHRNLV 403
           ++++G G FG+V K  +     ++  A+KR+    SK   R+FA E+  + +L  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCL--------------FDEQKAILTWEQRYRIIK 449
            LLG C  RG L L  ++ P+G+L   L               +   + L+ +Q      
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT 509
            VA G+ YL    ++  IHR++ A N+L+      ++ DFGL+    RG      + +G 
Sbjct: 147 DVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGR 199
Query: 510 L--GYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           L   ++A E       TT+SDV+++G LL E+V
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L    + I    +  +    +  G+ YL     +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI-DHIKLLQYTSQICKGMEYL---GTK 136
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHRD+   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 197 FSVASDVWSFGVVLYEL 213

>pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 117/237 (49%), Gaps = 30/237 (12%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFST 89
           N  N+ L   A +  +G+L LTN        +  LG AFYS+PI+  ++T  + + SF+T
Sbjct: 12  NETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVA-SFAT 70
Query: 90  CFAFAIVPEYTALGGHGFAFTISASKELP-GTLPSQYXXXXXXXXXXXXTNHIFAVEFDT 148
            F F I     A    G AF +     +P G+ P                 H  AVEFDT
Sbjct: 71  SFTFNIQVPNNAGPADGLAFAL-----VPVGSQPKDKGGFLGLFDGSNSNFHTVAVEFDT 125
Query: 149 VKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKN 208
           + + ++ D  + H+GID+NS+RS         ++ +    +N ++ EV+   I YDSS N
Sbjct: 126 LYNKDW-DPTERHIGIDVNSIRS---------IKTTRWDFVNGENAEVL---ITYDSSTN 172
Query: 209 HLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSF 262
            L   L   S K  S I+S  VDL  ++ E + VGFS++TG+      ++ +L WSF
Sbjct: 173 LLVASLVYPSQK-TSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 117/237 (49%), Gaps = 30/237 (12%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFST 89
           N  N+ L   A +  +G+L LTN        +  LG AFYS+PI+  ++T  + + SF+T
Sbjct: 12  NETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVA-SFAT 70
Query: 90  CFAFAIVPEYTALGGHGFAFTISASKELP-GTLPSQYXXXXXXXXXXXXTNHIFAVEFDT 148
            F F I     A    G AF +     +P G+ P                 H  AVEFDT
Sbjct: 71  SFTFNIQVPNNAGPADGLAFAL-----VPVGSQPKDKGGFLGLFDGSNSNFHTVAVEFDT 125
Query: 149 VKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKN 208
           + + ++ D  + H+GID+NS+RS         ++ +    +N ++ EV+   I YDSS N
Sbjct: 126 LYNKDW-DPTERHIGIDVNSIRS---------IKTTRWDFVNGENAEVL---ITYDSSTN 172
Query: 209 HLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSF 262
            L   L   S K  S I+S  VDL  ++ E + VGFS++TG+      ++ +L WSF
Sbjct: 173 LLVASLVYPSQK-TSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 24/231 (10%)
Query: 42  LNGAAEIEKNGKLMLTNTTLR------VLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI 95
             G A +  N  L LT    +       +G A Y++PI+   S+  S   SF T F F+I
Sbjct: 20  FQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQSS--SLVASFETTFTFSI 77
Query: 96  VPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEFG 155
               +        F  S   ++P     +              N + +VEFDT  + + G
Sbjct: 78  SQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIG 137
Query: 156 DINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLA 215
           D N  H+GID+NS+RS A+               + ++G+   A I Y+S+   L V   
Sbjct: 138 DPNYRHIGIDVNSIRSKAASK------------WDWQNGKTATAHISYNSASKRLSVV-- 183
Query: 216 PSSVKPRSP-ILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMS 265
            SS    SP ++SFDV+L+ +    + VGFS++TG    ++ IL WSF  S
Sbjct: 184 -SSYPNSSPVVVSFDVELNNVXPXWVRVGFSATTGQYTQTNNILAWSFRSS 233

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 7/201 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG V+ G   + + +VA+K +  E      +F  E   + +L H  LVQL G C 
Sbjct: 16  IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
            +  + LV +FM +G L   L   Q+ +   E    +   V  G+ YL E     VIHRD
Sbjct: 74  EQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 129
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L+      ++ DFG+ +        S+T     + + +PE+    + ++ SDV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 531 AFGALLLEVVC-GRRPIEPKA 550
           +FG L+ EV   G+ P E ++
Sbjct: 190 SFGVLMWEVFSEGKIPYENRS 210

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR---EFASEISSIGRLRHRNLVQLLG 407
           LG G FG+V  G    T  +VAVK ++ +  + L    +   EI ++   RH ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
                 D  +V +++  G L    FD   +   +   E R R+ + + S + Y H     
Sbjct: 79  VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEAR-RLFQQILSAVDYCHR---H 130
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
            V+HRD+K  NVLLD+ +N ++ DFGL+ +   G    T+   G+  Y APE+  +G+  
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVI-SGRLY 187
Query: 525 TSS--DVYAFGALLLEVVCGRRPIEPKALP 552
                D+++ G +L  ++CG  P + + +P
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ + +++ LR+F  EI  +  L+H N+V+  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 407 GWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G C    R +L L+ +++P GSL   L  + K  +   +  +    +  G+ YL     +
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 134
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             IHR++   N+L+++E   ++GDFGL K+  +       +  G   + + APE     K
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 194
Query: 523 PTTSSDVYAFGALLLEV 539
            + +SDV++FG +L E+
Sbjct: 195 FSVASDVWSFGVVLYEL 211

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE----SKQGLREFASEISSIGRLRHRNLV 403
           +E LG G FG+V   T   T  +VA+K +S +    S   +R    EIS +  LRH +++
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHII 72
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L        D+++V ++      D  +   +K  +T ++  R  + +   + Y H    
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHR--- 126
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK- 522
             ++HRD+K  N+LLD  LN ++ DFGL+ +   G    T+   G+  Y APE+   GK 
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-NGKL 183
Query: 523 -PTTSSDVYAFGALLLEVVCGRRPIEPKALP 552
                 DV++ G +L  ++ GR P + + +P
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 348 KELLGFGGFGRVYKGTL----PSTNTQ-VAVKRVSNESKQGLREFASEISSIGRLRHRNL 402
           K  LG G FG+V+        P+ +   VAVK + + +    ++F  E   +  L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDK----------CLFDEQ----KAILTWEQRYRII 448
           V+  G C     L++V+++M +G L+K           L D Q    K  L   Q   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             +ASG++YL     Q  +HRD+   N L+ + L  ++GDFG+++ +Y           +
Sbjct: 140 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
             + ++ PE     K TT SDV++FG +L E+   G++P
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 339 KKATRGFRDKELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISS 393
           K+  +  RD   LG G FG+V    Y  T   T   VAVK +  ++    R  +  EI  
Sbjct: 30  KRYLKKIRD---LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 394 IGRLRHRNLVQLLGWCRRRG--DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV 451
           +  L H ++++  G C   G   L LV +++P GSL   L    +  +   Q     + +
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQI 143
Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG--T 509
             G+ YLH    Q  IHRD+ A NVLLD++   ++GDFGLAK    G      R  G   
Sbjct: 144 CEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP 200
Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           + + APE  +  K   +SDV++FG  L E++
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 329 GPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EF 387
           GP R+   E  +    FRD  +LG G F  V       T   VA+K ++ ++ +G     
Sbjct: 7   GP-RWKQAEDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSM 63
Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRY 445
            +EI+ + +++H N+V L       G L L+   +  G L    FD   +K   T     
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL---LDSELNGRLGDFGLAKLYERGTNPS 502
           R+I  V   + YLH+     ++HRD+K  N+L   LD +    + DFGL+K+ + G+  S
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           T    GT GY+APE+      + + D ++ G +   ++CG  P
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 127/279 (45%), Gaps = 35/279 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV-------SNESKQGLREFASEISSIGRLRHRNLV 403
           +G GGFG V+KG L    + VA+K +         E  +  +EF  E+  +  L H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L G         +V +F+P G L   L D+   I  W  + R++  +A G+ Y+  +  
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIALGIEYMQNQ-N 142
Query: 464 QTVIHRDIKAGNVLLDS-----ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
             ++HRD+++ N+ L S      +  ++ DF L++     +  S + ++G   ++APE  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLGNFQWMAPETI 198
Query: 519 RTGKP--TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP 576
              +   T  +D Y+F  +L  ++ G  P +  +   ++  ++ + +      I E   P
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY-GKIKFINMIREEGLRPTIPEDCPP 257
Query: 577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           RL    N IE         +C +   + RP    +V+ L
Sbjct: 258 RLR---NVIE---------LCWSGDPKKRPHFSYIVKEL 284

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 127/279 (45%), Gaps = 35/279 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV-------SNESKQGLREFASEISSIGRLRHRNLV 403
           +G GGFG V+KG L    + VA+K +         E  +  +EF  E+  +  L H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L G         +V +F+P G L   L D+   I  W  + R++  +A G+ Y+  +  
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIALGIEYMQNQ-N 142
Query: 464 QTVIHRDIKAGNVLLDS-----ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
             ++HRD+++ N+ L S      +  ++ DFG ++     +  S + ++G   ++APE  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLGNFQWMAPETI 198
Query: 519 RTGKP--TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP 576
              +   T  +D Y+F  +L  ++ G  P +  +   ++  ++ + +      I E   P
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY-GKIKFINMIREEGLRPTIPEDCPP 257
Query: 577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           RL    N IE         +C +   + RP    +V+ L
Sbjct: 258 RLR---NVIE---------LCWSGDPKKRPHFSYIVKEL 284

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 114/211 (54%), Gaps = 19/211 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           ++  E +G G +G VYK    S    VA+KR+  +++ +G+   A  EIS +  L H N+
Sbjct: 23  YQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ----RYRIIKGVASGLLYL 458
           V L+        L LV++FM    L K L DE K  L   Q     Y++++GVA    + 
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQLLRGVA----HC 135
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-L 517
           H+     ++HRD+K  N+L++S+   +L DFGLA+ +       T  VV TL Y AP+ L
Sbjct: 136 HQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
             + K +TS D+++ G +  E++ G +P+ P
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITG-KPLFP 221

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 339 KKATRGFRDKELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISS 393
           K+  +  RD   LG G FG+V    Y  T   T   VAVK +  +     R  +  EI  
Sbjct: 13  KRYLKKIRD---LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDI 69
Query: 394 IGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV 451
           +  L H ++++  G C  +G+  L LV +++P GSL   L    +  +   Q     + +
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQI 126
Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG--T 509
             G+ YLH    Q  IHR++ A NVLLD++   ++GDFGLAK    G      R  G   
Sbjct: 127 CEGMAYLHS---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           + + APE  +  K   +SDV++FG  L E++
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 114/211 (54%), Gaps = 19/211 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           ++  E +G G +G VYK    S    VA+KR+  +++ +G+   A  EIS +  L H N+
Sbjct: 23  YQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ----RYRIIKGVASGLLYL 458
           V L+        L LV++FM    L K L DE K  L   Q     Y++++GVA    + 
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQLLRGVA----HC 135
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-L 517
           H+     ++HRD+K  N+L++S+   +L DFGLA+ +       T  VV TL Y AP+ L
Sbjct: 136 HQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
             + K +TS D+++ G +  E++ G +P+ P
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITG-KPLFP 221

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH----- 399
           F +  +LG G FG+V K      +   A+K++ + +++ L    SE+  +  L H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 400 --------RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR---YRII 448
                   RN V+ +   +++  L +  ++  NG+L   +  E       +QR   +R+ 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN----QQRDEYWRLF 122
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER----------- 497
           + +   L Y+H    Q +IHRD+K  N+ +D   N ++GDFGLAK   R           
Sbjct: 123 RQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 498 --GTNPSTTRVVGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVV 540
             G++ + T  +GT  Y+A E L  TG      D+Y+ G +  E++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 339 KKATRGFRDKELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISS 393
           K+  +  RD   LG G FG+V    Y  T   T   VAVK +  +     R  +  EI  
Sbjct: 13  KRYLKKIRD---LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDI 69
Query: 394 IGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV 451
           +  L H ++++  G C  +G+  L LV +++P GSL   L    +  +   Q     + +
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQI 126
Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG--T 509
             G+ YLH    Q  IHR++ A NVLLD++   ++GDFGLAK    G      R  G   
Sbjct: 127 CEGMAYLHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           + + APE  +  K   +SDV++FG  L E++
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ YL 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA 149
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E
Sbjct: 150 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 266
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 267 EVMLKCW 273

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 339 KKATRGFRDKELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISS 393
           K+  +  RD   LG G FG+V    Y  T   T   VAVK +       LR  +  EI  
Sbjct: 8   KRYLKKIRD---LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEI 64
Query: 394 IGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV 451
           +  L H ++V+  G C  +G+  + LV +++P GSL   L    +  +   Q     + +
Sbjct: 65  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQI 121
Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG--T 509
             G+ YLH    Q  IHR + A NVLLD++   ++GDFGLAK    G      R  G   
Sbjct: 122 CEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 178
Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           + + APE  +  K   +SDV++FG  L E++
Sbjct: 179 VFWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 339 KKATRGFRDKELLGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISS 393
           K+  +  RD   LG G FG+V    Y  T   T   VAVK +       LR  +  EI  
Sbjct: 7   KRYLKKIRD---LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEI 63
Query: 394 IGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV 451
           +  L H ++V+  G C  +G+  + LV +++P GSL   L    +  +   Q     + +
Sbjct: 64  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQI 120
Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG--T 509
             G+ YLH    Q  IHR + A NVLLD++   ++GDFGLAK    G      R  G   
Sbjct: 121 CEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 177
Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
           + + APE  +  K   +SDV++FG  L E++
Sbjct: 178 VFWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 10/224 (4%)
Query: 326 LDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQG 383
           +D+G     ++ ++K  R     + +G G FG+           Q  +K +  S  S + 
Sbjct: 11  VDLGTENLYFQSMEKYVR----LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 384 LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ 443
             E   E++ +  ++H N+VQ        G L +V D+   G L K + + QK +L  E 
Sbjct: 67  REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQED 125
Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
           +  I+       L L    ++ ++HRDIK+ N+ L  +   +LGDFG+A++    T    
Sbjct: 126 Q--ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELA 182
Query: 504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
              +GT  YL+PE+         SD++A G +L E+   +   E
Sbjct: 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 348 KELLGFGGFGRV-----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL 402
           K  LG G FG+V     Y          VAVK + + S    ++F  E   +  L+H ++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE-----------QKAILTWEQRYRIIKGV 451
           V+  G C     L++V+++M +G L+K L                  LT  Q   I + +
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL 510
           A+G++YL     Q  +HRD+   N L+   L  ++GDFG+++ +Y           +  +
Sbjct: 138 AAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
            ++ PE     K TT SDV++ G +L E+   G++P
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSI 394
           E++KK    F  KE LG G F  V      +T    AVK +  ++ +G      +EI+ +
Sbjct: 18  EDIKKI---FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 395 GRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVA 452
            +++H N+V L         L LV   +  G L    FD   +K   T +    +I+ V 
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVL 130
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLL---DSELNGRLGDFGLAKLYERGTNPSTTRVVGT 509
             + YLH      ++HRD+K  N+L    D E    + DFGL+K+  +G   ST    GT
Sbjct: 131 DAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA--CGT 185
Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            GY+APE+      + + D ++ G +   ++CG  P
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR---EFASEISSIGRLRHRNLVQLLG 407
           LG G FG+V  G    T  +VAVK ++ +  + L    +   EI ++   RH ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
                 D  +V +++  G L    FD   +   +   E R R+ + + S + Y H     
Sbjct: 79  VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEAR-RLFQQILSAVDYCHR---H 130
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
            V+HRD+K  NVLLD+ +N ++ DFGL+ +   G     +   G+  Y APE+  +G+  
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSPNYAAPEVI-SGRLY 187
Query: 525 TSS--DVYAFGALLLEVVCGRRPIEPKALP 552
                D+++ G +L  ++CG  P + + +P
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ YL 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA 150
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E
Sbjct: 151 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 267
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 268 EVMLKCW 274

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 119/247 (48%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ +L 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLA 148
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++  +    +    L   ++A E
Sbjct: 149 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 265
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 266 EVMLKCW 272

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ YL 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA 145
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E
Sbjct: 146 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 262
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 263 EVMLKCW 269

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 119/247 (48%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ +L 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLA 150
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++  +    +    L   ++A E
Sbjct: 151 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 267
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 268 EVMLKCW 274

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ YL 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA 149
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E
Sbjct: 150 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 266
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 267 EVMLKCW 273

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 114/239 (47%), Gaps = 40/239 (16%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ YL 
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA 169
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E
Sbjct: 170 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPEEL 555
             +T K TT SDV++FG LL E++                     GRR ++P+  P+ L
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 285

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 114/239 (47%), Gaps = 40/239 (16%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ YL 
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA 168
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E
Sbjct: 169 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPEEL 555
             +T K TT SDV++FG LL E++                     GRR ++P+  P+ L
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 284

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ YL 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA 150
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E
Sbjct: 151 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 267
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 268 EVMLKCW 274

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 119/247 (48%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ +L 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLA 209
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++  +    +    L   ++A E
Sbjct: 210 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 327 EVMLKCW 333

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      ++  VA+K +  S   K+G+  +   EI     L H N+++L  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 408 WCRRRGDLLLVYDFMPNGSLDK-----CLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +   R  + L+ ++ P G L K     C FDEQ+     E+       +A  L+Y H   
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEE-------LADALMYCHG-- 141
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL  +   ++ DFG +        PS  R  + GTL YL PE+   
Sbjct: 142 -KKVIHRDIKPENLLLGLKGELKIADFGWS-----VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIE 547
                  D++  G L  E++ G  P E
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 114/239 (47%), Gaps = 40/239 (16%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ YL 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA 147
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E
Sbjct: 148 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPEEL 555
             +T K TT SDV++FG LL E++                     GRR ++P+  P+ L
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 263

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 119/247 (48%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ +L 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLA 151
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++  +    +    L   ++A E
Sbjct: 152 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 268
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 269 EVMLKCW 275

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ YL 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA 148
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E
Sbjct: 149 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 265
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 266 EVMLKCW 272

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 119/247 (48%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ +L 
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFL- 154
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++  +    +    L   ++A E
Sbjct: 155 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 272
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 273 EVMLKCW 279

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 119/247 (48%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ +L 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLA 150
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++  +    +    L   ++A E
Sbjct: 151 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 267
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 268 EVMLKCW 274

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 131/285 (45%), Gaps = 42/285 (14%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLL 406
           EL+G G FG+VY G     + +VA++ +  E  ++  L+ F  E+ +  + RH N+V  +
Sbjct: 39  ELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G C     L ++       +L   + D  K +L   +  +I + +  G+ YLH    + +
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 467 IHRDIKAGNVLLDSELNGR--LGDFGL---AKLYERGTNPSTTRVV-GTLGYLAPELTRT 520
           +H+D+K+ NV  D   NG+  + DFGL   + + + G      R+  G L +LAPE+ R 
Sbjct: 152 LHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 521 GKPTTS---------SDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL 571
             P T          SDV+A G +  E+     P   K  P E I+       W+ G  +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF--KTQPAEAII-------WQMGTGM 259
Query: 572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
           +   P L+      E  D++   L C     E RPT  +++  LE
Sbjct: 260 K---PNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLE 298

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 43/247 (17%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ YL 
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA 142
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPE 516
               +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E
Sbjct: 143 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE--- 553
             +T K TT SDV++FG LL E++                     GRR ++P+  P+   
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 259
Query: 554 ELILVDW 560
           E++L  W
Sbjct: 260 EVMLKCW 266

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASE--ISSIGRLRHRNLVQ 404
           +LG G FG+V    +  T    AVK +  +       +    +E  I S+ R  H  L Q
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 88
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWE 463
           L    +    L  V +F+  G L   +F  QK+    E R R     + S L++LH+   
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMFLHD--- 142
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELTRTGK 522
           + +I+RD+K  NVLLD E + +L DFG+ K  E   N  TT    GT  Y+APE+ +   
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIE 547
              + D +A G LL E++CG  P E
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG---LREFASEISSIGRLRHRN 401
           F D   +G G FG VY       +  VA+K++S   KQ     ++   E+  + +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
            +Q  G   R     LV ++    + D  L +  K  L   +   +  G   GL YLH  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 172
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT- 520
               +IHRD+KAGN+LL      +LGDFG A +            VGT  ++APE+    
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEVILAM 225
Query: 521 --GKPTTSSDVYAFGALLLEVVCGRRPI 546
             G+     DV++ G   +E+   + P+
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY          +A+K +  S   K+G+  +   EI     LRH N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +   R  + L+ +F P G L K L     FDEQ++    E+       +A  L Y HE  
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-------LADALHYCHE-- 132
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+L+  +   ++ DFG +        PS  R  + GTL YL PE+   
Sbjct: 133 -RKVIHRDIKPENLLMGYKGELKIADFGWS-----VHAPSLRRRXMCGTLDYLPPEMIEG 186
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIE 547
                  D++  G L  E + G  P +
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG---LREFASEISSIGRLRHRN 401
           F D   +G G FG VY       +  VA+K++S   KQ     ++   E+  + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
            +Q  G   R     LV ++    + D  L +  K  L   +   +  G   GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 133
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT- 520
               +IHRD+KAGN+LL      +LGDFG A +            VGT  ++APE+    
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAM 186
Query: 521 --GKPTTSSDVYAFGALLLEVVCGRRPI 546
             G+     DV++ G   +E+   + P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 115/267 (43%), Gaps = 23/267 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V  G        VAVK +  E      EF  E  ++ +L H  LV+  G C 
Sbjct: 16  LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           +   + +V +++ NG L   L    K  L   Q   +   V  G+ +L        IHRD
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L+D +L  ++ DFG+ +        S+      + + APE+    K ++ SDV+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 531 AFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALD 589
           AFG L+ EV   G+ P +     E ++         K      +  P L  +        
Sbjct: 190 AFGILMWEVFSLGKMPYDLYTNSEVVL---------KVSQGHRLYRPHLASD-------T 233
Query: 590 VVKLGLMCSNDAAEARPTMRQVVRYLE 616
           + ++   C ++  E RPT +Q++  +E
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY          +A+K +  S   K+G+  +   EI     LRH N++++  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +   R  + L+ +F P G L K L     FDEQ++    E+       +A  L Y HE  
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-------LADALHYCHE-- 133
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+L+  +   ++ DFG +        PS  R  + GTL YL PE+   
Sbjct: 134 -RKVIHRDIKPENLLMGYKGELKIADFGWS-----VHAPSLRRRXMCGTLDYLPPEMIEG 187
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIE 547
                  D++  G L  E + G  P +
Sbjct: 188 KTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFA-SEISSIGRLRHRNLVQLLGW 408
           +G G FG V+K     T  +VA+K+V  E+ K+G    A  EI  +  L+H N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 409 CRRR--------GDLLLVYDFMPN---GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
           CR +        G + LV+DF  +   G L   L        T  +  R+++ + +GL Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNGLYY 140
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV---VGTLGYLA 514
           +H      ++HRD+KA NVL+  +   +L DFGLA+ +    N    R    V TL Y  
Sbjct: 141 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 515 PEL----TRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           PEL       G P    D++  G ++ E +  R PI
Sbjct: 198 PELLLGERDYGPPI---DLWGAGCIMAE-MWTRSPI 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFA-SEISSIGRLRHRNLVQLLGW 408
           +G G FG V+K     T  +VA+K+V  E+ K+G    A  EI  +  L+H N+V L+  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 409 CRRR--------GDLLLVYDFMPN---GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
           CR +        G + LV+DF  +   G L   L        T  +  R+++ + +GL Y
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNGLYY 139
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV---VGTLGYLA 514
           +H      ++HRD+KA NVL+  +   +L DFGLA+ +    N    R    V TL Y  
Sbjct: 140 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 515 PEL----TRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           PEL       G P    D++  G ++ E +  R PI
Sbjct: 197 PELLLGERDYGPPI---DLWGAGCIMAE-MWTRSPI 228

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFA-SEISSIGRLRHRNLVQLLGW 408
           +G G FG V+K     T  +VA+K+V  E+ K+G    A  EI  +  L+H N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 409 CRRR--------GDLLLVYDFMPN---GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
           CR +        G + LV+DF  +   G L   L        T  +  R+++ + +GL Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNGLYY 140
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV---VGTLGYLA 514
           +H      ++HRD+KA NVL+  +   +L DFGLA+ +    N    R    V TL Y  
Sbjct: 141 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 515 PEL----TRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           PEL       G P    D++  G ++ E +  R PI
Sbjct: 198 PELLLGERDYGPPI---DLWGAGCIMAE-MWTRSPI 229

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 336 EELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFAS 389
           EE KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   
Sbjct: 24  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 390 EISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQR 444
           E+     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+        
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT----- 138
Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT 504
              I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +       +   T
Sbjct: 139 --YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT 190
Query: 505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
            + GTL YL PE+          D+++ G L  E + G+ P E
Sbjct: 191 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 28/225 (12%)
Query: 336 EELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFAS 389
           EE KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   
Sbjct: 24  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 390 EISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQR 444
           E+     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+        
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT----- 138
Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT 504
              I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +        PS+ 
Sbjct: 139 --YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSR 188
Query: 505 R--VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
           R  + GTL YL PE+          D+++ G L  E + G+ P E
Sbjct: 189 RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 346 RDKELLGFGGFGRVYKGTL----PSTNTQ-VAVKRVSNESKQGLRE-FASEISSIGRLRH 399
           R  E LG   FG+VYKG L    P   TQ VA+K + ++++  LRE F  E     RL+H
Sbjct: 29  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 88
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF------------DEQ--KAILTWEQRY 445
            N+V LLG   +   L +++ +  +G L + L             D++  K+ L      
Sbjct: 89  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTT 504
            ++  +A+G+ YL       V+H+D+   NVL+  +LN ++ D GL + +Y         
Sbjct: 149 HLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
             +  + ++APE    GK +  SD++++G +L EV
Sbjct: 206 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 346 RDKELLGFGGFGRVYKGTL----PSTNTQ-VAVKRVSNESKQGLRE-FASEISSIGRLRH 399
           R  E LG   FG+VYKG L    P   TQ VA+K + ++++  LRE F  E     RL+H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF------------DEQ--KAILTWEQRY 445
            N+V LLG   +   L +++ +  +G L + L             D++  K+ L      
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTT 504
            ++  +A+G+ YL       V+H+D+   NVL+  +LN ++ D GL + +Y         
Sbjct: 132 HLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
             +  + ++APE    GK +  SD++++G +L EV
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 336 EELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFAS 389
           EE KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   
Sbjct: 15  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 74
Query: 390 EISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQR 444
           E+     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+        
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT----- 129
Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT 504
              I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +       +   T
Sbjct: 130 --YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT 181
Query: 505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
            + GTL YL PE+          D+++ G L  E + G+ P E
Sbjct: 182 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 108/242 (44%), Gaps = 37/242 (15%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNTTL------RVLGHAFYSSPIKFKNSTRNSKSLSFST 89
           N  N+   G A +  +G L LT          + LG A Y+SPI   +S +     SF+T
Sbjct: 15  NQPNLKKQGDATVTSSGTLQLTKVDKNGVPDPKSLGRALYASPINIWDS-KTGVVASFAT 73
Query: 90  CFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIF---AVEF 146
            F F I     A    G AF ++     P + P +              N  +   AVEF
Sbjct: 74  SFRFTIYAPNIATIADGLAFFLA-----PVSSPPKAGAGFLGLFDSAVFNSSYQTVAVEF 128
Query: 147 DTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQAWIDYDS 205
           DT ++  F D  D H+GID+NS++             S K V  +L +GE  +  I YDS
Sbjct: 129 DTYENTVFLDPPDTHIGIDVNSIK-------------SIKTVKWDLANGEAAKVLITYDS 175
Query: 206 SKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYI-----LGW 260
           S   L   L   S K  S ILS  VDL  ++ E + +GFS++TG  ASS YI       W
Sbjct: 176 SAKLLVAALVYPSSK-TSFILSDVVDLKSVLPEWVSIGFSAATG--ASSGYIETHDVFSW 232
Query: 261 SF 262
           SF
Sbjct: 233 SF 234

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V+  T  + +T+VAVK +   S   +  F +E + +  L+H  LV+L     
Sbjct: 190 LGAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           +   + ++ +FM  GSL   L  ++ +     +       +A G+ ++ +   +  IHRD
Sbjct: 248 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 303
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           ++A N+L+ + L  ++ DFGLA++  +            + + APE    G  T  SDV+
Sbjct: 304 LRAANILVSASLVCKIADFGLARVGAK----------FPIKWTAPEAINFGSFTIKSDVW 353
Query: 531 AFGALLLEVVC-GRRPIEPKALPE 553
           +FG LL+E+V  GR P    + PE
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPE 377

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 337 ELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASE 390
           E KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   E
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRY 445
           +     LRH N+++L G+      + L+ ++ P G + K L     FDEQ+         
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT------ 117
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
             I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +       +   T 
Sbjct: 118 -YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTT 170
Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           + GTL YL PE+          D+++ G L  E + G+ P E     E
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E+LG G FG+V+K    +T  ++A K +     +   E  +EIS + +L H NL+QL   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              + D++LV +++  G L   + DE    LT       +K +  G+ ++H+ +   ++H
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMHQMY---ILH 210
Query: 469 RDIKAGNVLL---DSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTT 525
            D+K  N+L    D++   ++ DFGLA+ Y+           GT  +LAPE+      + 
Sbjct: 211 LDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYDFVSF 267
Query: 526 SSDVYAFGALLLEVVCGRRP 545
            +D+++ G +   ++ G  P
Sbjct: 268 PTDMWSVGVIAYMLLSGLSP 287

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLL 406
           +E++G G    V          +VA+KR++ E  Q  + E   EI ++ +  H N+V   
Sbjct: 20  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLF------DEQKAILTWEQRYRIIKGVASGLLYLHE 460
                + +L LV   +  GS+   +       + +  +L       I++ V  GL YLH+
Sbjct: 80  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV----VGTLGYLAPE 516
             +   IHRD+KAGN+LL  + + ++ DFG++     G + +  +V    VGT  ++APE
Sbjct: 140 NGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 517 LTRTGKPTT-SSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD 575
           +    +     +D+++FG   +E+  G  P   K  P +++++            L+   
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYH-KYPPMKVLML-----------TLQNDP 244
Query: 576 PRLNGEFNEIEAL-----DVVKLGLMCSNDAAEARPTMRQVVRY 614
           P L     + E L        K+  +C     E RPT  +++R+
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG--LREFASEISSIGRLRHRNLVQLLG 407
           +LG G FG V K     T  + AVK ++  S +         E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
                    +V +    G L    FDE  ++   +     RIIK V SG+ Y+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 466 VIHRDIKAGNVLLDS---ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
           ++HRD+K  N+LL+S   + + ++ DFGL+  +++ T       +GT  Y+APE+ R G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLL 406
           +E++G G    V          +VA+KR++ E  Q  + E   EI ++ +  H N+V   
Sbjct: 15  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 74
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLF------DEQKAILTWEQRYRIIKGVASGLLYLHE 460
                + +L LV   +  GS+   +       + +  +L       I++ V  GL YLH+
Sbjct: 75  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 134
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV----VGTLGYLAPE 516
             +   IHRD+KAGN+LL  + + ++ DFG++     G + +  +V    VGT  ++APE
Sbjct: 135 NGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 191
Query: 517 LTRTGKPTT-SSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD 575
           +    +     +D+++FG   +E+  G  P   K  P +++++            L+   
Sbjct: 192 VMEQVRGYDFKADIWSFGITAIELATGAAPYH-KYPPMKVLML-----------TLQNDP 239
Query: 576 PRLNGEFNEIEALDVV-----KLGLMCSNDAAEARPTMRQVVRY 614
           P L     + E L        K+  +C     E RPT  +++R+
Sbjct: 240 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 283

>pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 108/242 (44%), Gaps = 37/242 (15%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNTTL------RVLGHAFYSSPIKFKNSTRNSKSLSFST 89
           N  N+   G A +  +G L LT          + LG A Y+SPI   +S +     SF+T
Sbjct: 15  NQPNLKKQGDATVTSSGTLQLTKVDKNGVPDPKSLGRALYASPINIWDS-KTGVVASFAT 73
Query: 90  CFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIF---AVEF 146
            F F I     A    G AF ++     P + P +              N  +   AVEF
Sbjct: 74  SFRFTIYAPNIATIADGLAFFLA-----PVSSPPKAGAGFLGLFDSAVFNSSYQTVAVEF 128
Query: 147 DTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQAWIDYDS 205
           DT ++  F D  D H+GID+NS++             S K V  +L +GE  +  I YDS
Sbjct: 129 DTYENTVFLDPPDTHIGIDVNSIK-------------SIKTVKWDLANGEAAKVLITYDS 175
Query: 206 SKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYI-----LGW 260
           S   L   L   S K  S ILS  VDL  ++ E + +GFS++TG  ASS YI       W
Sbjct: 176 SAKLLVAALVYPSSK-TSFILSDVVDLKSVLPEWVSIGFSAATG--ASSGYIETHDVFSW 232
Query: 261 SF 262
           SF
Sbjct: 233 SF 234

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH----- 399
           F +  +LG G FG+V K      +   A+K++ + +++ L    SE+  +  L H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 400 --------RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR---YRII 448
                   RN V+ +   +++  L +  ++  N +L   +  E       +QR   +R+ 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLN----QQRDEYWRLF 122
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER----------- 497
           + +   L Y+H    Q +IHRD+K  N+ +D   N ++GDFGLAK   R           
Sbjct: 123 RQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 498 --GTNPSTTRVVGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVV 540
             G++ + T  +GT  Y+A E L  TG      D+Y+ G +  E++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 351 LGFGGFGRVY----KGTLPSTNTQ-VAVKRVSNESKQGLREFASEISSIGRLRHRNLVQL 405
           LG G FG+V+       LP  +   VAVK +   S+   ++F  E   +  L+H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLF-------------DEQKAILTWEQRYRIIKGVA 452
            G C     LL+V+++M +G L++ L              D     L   Q   +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLG 511
           +G++YL        +HRD+   N L+   L  ++GDFG+++ +Y         R +  + 
Sbjct: 146 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           ++ PE     K TT SDV++FG +L E+   G++P
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 351 LGFGGFGRVY----KGTLPSTNTQ-VAVKRVSNESKQGLREFASEISSIGRLRHRNLVQL 405
           LG G FG+V+       LP  +   VAVK +   S+   ++F  E   +  L+H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLF-------------DEQKAILTWEQRYRIIKGVA 452
            G C     LL+V+++M +G L++ L              D     L   Q   +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLG 511
           +G++YL        +HRD+   N L+   L  ++GDFG+++ +Y         R +  + 
Sbjct: 140 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           ++ PE     K TT SDV++FG +L E+   G++P
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 9/207 (4%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGR-LRHRNLVQLL 406
            LG GGF + ++ +   T    A K V      K   RE  S   SI R L H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G+      + +V +     SL + L   +KA+   E RY  ++ +  G  YLH      V
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHR---NRV 138
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           IHRD+K GN+ L+ +L  ++GDFGLA   E       T + GT  Y+APE+      +  
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFE 197
Query: 527 SDVYAFGALLLEVVCGRRPIEPKALPE 553
            DV++ G ++  ++ G+ P E   L E
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 28/230 (12%)
Query: 337 ELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASE 390
           E KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   E
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRY 445
           +     LRH N+++L G+      + L+ ++ P G + K L     FDEQ+         
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT------ 117
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
             I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +        PS+ R
Sbjct: 118 -YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRR 168
Query: 506 --VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
             + GTL YL PE+          D+++ G L  E + G+ P E     E
Sbjct: 169 XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG--LREFASEISSIGRLRHRNLVQLLG 407
           +LG G FG V K     T  + AVK ++  S +         E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
                    +V +    G L    FDE  ++   +     RIIK V SG+ Y+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 466 VIHRDIKAGNVLLDS---ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
           ++HRD+K  N+LL+S   + + ++ DFGL+  +++ T       +GT  Y+APE+ R G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 9/207 (4%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGR-LRHRNLVQLL 406
            LG GGF + ++ +   T    A K V      K   RE  S   SI R L H+++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G+      + +V +     SL + L   +KA+   E RY  ++ +  G  YLH      V
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHR---NRV 142
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           IHRD+K GN+ L+ +L  ++GDFGLA   E       T + GT  Y+APE+      +  
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFE 201
Query: 527 SDVYAFGALLLEVVCGRRPIEPKALPE 553
            DV++ G ++  ++ G+ P E   L E
Sbjct: 202 VDVWSIGCIMYTLLVGKPPFETSCLKE 228

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 351 LGFGGFGRVY----KGTLPSTNTQ-VAVKRVSNESKQGLREFASEISSIGRLRHRNLVQL 405
           LG G FG+V+       LP  +   VAVK +   S+   ++F  E   +  L+H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLF-------------DEQKAILTWEQRYRIIKGVA 452
            G C     LL+V+++M +G L++ L              D     L   Q   +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLG 511
           +G++YL        +HRD+   N L+   L  ++GDFG+++ +Y         R +  + 
Sbjct: 169 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           ++ PE     K TT SDV++FG +L E+   G++P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG--LREFASEISSIGRLRHRNLVQLLG 407
           +LG G FG V K     T  + AVK ++  S +         E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
                    +V +    G L    FDE  ++   +     RIIK V SG+ Y+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 466 VIHRDIKAGNVLLDS---ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
           ++HRD+K  N+LL+S   + + ++ DFGL+  +++ T       +GT  Y+APE+ R G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 9/207 (4%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGR-LRHRNLVQLL 406
            LG GGF + ++ +   T    A K V      K   RE  S   SI R L H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G+      + +V +     SL + L   +KA+   E RY  ++ +  G  YLH      V
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHR---NRV 138
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           IHRD+K GN+ L+ +L  ++GDFGLA   E       T + GT  Y+APE+      +  
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFE 197
Query: 527 SDVYAFGALLLEVVCGRRPIEPKALPE 553
            DV++ G ++  ++ G+ P E   L E
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ---GLREFASEISSIGRLRHRN 401
           F D  +LG GGFG V+   + +T    A K+++ +  +   G +    E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL---------DKCLFDEQKAILTWEQRYRIIKGVA 452
           +V L      + DL LV   M  G +         D   F E +AI    Q       + 
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-------IV 299
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           SGL +LH+   + +I+RD+K  NVLLD + N R+ D GLA   + G    T    GT G+
Sbjct: 300 SGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGF 355
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPK 549
           +APEL    +   S D +A G  L E++  R P   +
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ---GLREFASEISSIGRLRHRN 401
           F D  +LG GGFG V+   + +T    A K+++ +  +   G +    E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL---------DKCLFDEQKAILTWEQRYRIIKGVA 452
           +V L      + DL LV   M  G +         D   F E +AI    Q       + 
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-------IV 299
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           SGL +LH+   + +I+RD+K  NVLLD + N R+ D GLA   + G    T    GT G+
Sbjct: 300 SGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGF 355
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPK 549
           +APEL    +   S D +A G  L E++  R P   +
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ---GLREFASEISSIGRLRHRN 401
           F D  +LG GGFG V+   + +T    A K+++ +  +   G +    E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL---------DKCLFDEQKAILTWEQRYRIIKGVA 452
           +V L      + DL LV   M  G +         D   F E +AI    Q       + 
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-------IV 299
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           SGL +LH+   + +I+RD+K  NVLLD + N R+ D GLA   + G    T    GT G+
Sbjct: 300 SGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGF 355
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPK 549
           +APEL    +   S D +A G  L E++  R P   +
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ---GLREFASEISSIGRLRHRN 401
           F D  +LG GGFG V+   + +T    A K+++ +  +   G +    E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL---------DKCLFDEQKAILTWEQRYRIIKGVA 452
           +V L      + DL LV   M  G +         D   F E +AI    Q       + 
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-------IV 299
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           SGL +LH+   + +I+RD+K  NVLLD + N R+ D GLA   + G    T    GT G+
Sbjct: 300 SGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGF 355
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPK 549
           +APEL    +   S D +A G  L E++  R P   +
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 119/249 (47%), Gaps = 47/249 (18%)
Query: 349 ELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG----VASGLLYLH 459
           LLG C R  G  L+V  +M +G L   + +E     T     + + G    VA G+ +L 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLA 151
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-----KLYERGTNPSTTRVVGTLGYLA 514
               +  +HRD+ A N +LD +   ++ DFGLA     K ++   N +  ++   + ++A
Sbjct: 152 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL--PVKWMA 206
Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPE- 553
            E  +T K TT SDV++FG LL E++                     GRR ++P+  P+ 
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 266
Query: 554 --ELILVDW 560
             E++L  W
Sbjct: 267 LYEVMLKCW 275

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V  G        VA+K +  E      EF  E   +  L H  LVQL G C 
Sbjct: 32  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           ++  + ++ ++M NG L   L + +    T +Q   + K V   + YL     +  +HRD
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L++ +   ++ DFGL++        S+      + +  PE+    K ++ SD++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 531 AFGALLLEVV-CGRRPIE 547
           AFG L+ E+   G+ P E
Sbjct: 206 AFGVLMWEIYSLGKMPYE 223

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 331 HRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASE 390
           H   Y+E++        +E++G G FG V K    + +  VA+K++ +ES++  + F  E
Sbjct: 4   HMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKD--VAIKQIESESER--KAFIVE 52
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD-EQKAILTWEQRYRIIK 449
           +  + R+ H N+V+L G C     + LV ++   GSL   L   E     T         
Sbjct: 53  LRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 110
Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVG 508
             + G+ YLH    + +IHRD+K  N+LL +     ++ DFG A           T   G
Sbjct: 111 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKG 166
Query: 509 TLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
           +  ++APE+      +   DV+++G +L EV+  R+P +
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 13/224 (5%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSI 394
           +K+  RG      LG GGF + Y+ T   T    A K V            + ++EI+  
Sbjct: 41  MKRYMRG----RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 395 GRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
             L + ++V   G+      + +V +     SL + L   +KA+   E RY  ++    G
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQG 154
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           + YLH      VIHRD+K GN+ L+ +++ ++GDFGLA   E       T + GT  Y+A
Sbjct: 155 VQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIA 210
Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
           PE+      +   D+++ G +L  ++ G+ P E   L E  I +
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 331 HRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASE 390
           H   Y+E++        +E++G G FG V K    + +  VA+K++ +ES++  + F  E
Sbjct: 3   HMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKD--VAIKQIESESER--KAFIVE 51
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD-EQKAILTWEQRYRIIK 449
           +  + R+ H N+V+L G C     + LV ++   GSL   L   E     T         
Sbjct: 52  LRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVG 508
             + G+ YLH    + +IHRD+K  N+LL +     ++ DFG A           T   G
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKG 165
Query: 509 TLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
           +  ++APE+      +   DV+++G +L EV+  R+P +
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V  G        VA+K +  E      EF  E   +  L H  LVQL G C 
Sbjct: 16  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           ++  + ++ ++M NG L   L + +    T +Q   + K V   + YL     +  +HRD
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRD 129
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L++ +   ++ DFGL++        S+      + +  PE+    K ++ SD++
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 531 AFGALLLEVV-CGRRPIE 547
           AFG L+ E+   G+ P E
Sbjct: 190 AFGVLMWEIYSLGKMPYE 207

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFA-SEISSIGRLRHRNLVQLLGW 408
           +G G FG V+K     T  +VA+K+V  E+ K+G    A  EI  +  L+H N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 409 CRRRGD--------LLLVYDFMPN---GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
           CR +          + LV+DF  +   G L   L        T  +  R+++ + +GL Y
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNGLYY 140
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV---VGTLGYLA 514
           +H      ++HRD+KA NVL+  +   +L DFGLA+ +    N    R    V TL Y  
Sbjct: 141 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 515 PEL----TRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           PEL       G P    D++  G ++ E +  R PI
Sbjct: 198 PELLLGERDYGPPI---DLWGAGCIMAE-MWTRSPI 229

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 31/287 (10%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V K     +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHR 469
              G++ +  + M  GSLD+ L + ++  +  E   ++   V  GL YL E+ +  ++HR
Sbjct: 84  YSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQ--IMHR 139
Query: 470 DIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           D+K  N+L++S    +L DFG++ +L +   N      VGT  Y+APE  +    +  SD
Sbjct: 140 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMAPERLQGTHYSVQSD 195
Query: 529 VYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEAL 588
           +++ G  L+E+  GR PI P    E    ++ ++ R           P ++GE  E  ++
Sbjct: 196 IWSMGLSLVELAVGRYPIPPPDAKE----LEAIFGR-----------PVVDGEEGEPHSI 240
Query: 589 D--VVKLGLMCSNDAAEARPTMR--QVVRYLEGEVP--LPQAVAAPD 629
                  G   S    ++RP M   +++ Y+  E P  LP  V  PD
Sbjct: 241 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPD 287

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 337 ELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASE 390
           E KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   E
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRY 445
           +     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+         
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT------ 115
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
             I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +       +   T 
Sbjct: 116 -YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTT 168
Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           + GTL YL PE+          D+++ G L  E + G+ P E     E
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V  G        VA+K +  E      EF  E   +  L H  LVQL G C 
Sbjct: 32  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           ++  + ++ ++M NG L   L + +    T +Q   + K V   + YL     +  +HRD
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L++ +   ++ DFGL++        S+      + +  PE+    K ++ SD++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 531 AFGALLLEVV-CGRRPIE 547
           AFG L+ E+   G+ P E
Sbjct: 206 AFGVLMWEIYSLGKMPYE 223

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 28/230 (12%)
Query: 337 ELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASE 390
           E KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   E
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRY 445
           +     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+         
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT------ 114
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
             I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +        PS+ R
Sbjct: 115 -YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRR 165
Query: 506 --VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
             + GTL YL PE+          D+++ G L  E + G+ P E     E
Sbjct: 166 XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V  G        VA+K +  E      EF  E   +  L H  LVQL G C 
Sbjct: 12  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           ++  + ++ ++M NG L   L + +    T +Q   + K V   + YL     +  +HRD
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRD 125
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L++ +   ++ DFGL++        S+      + +  PE+    K ++ SD++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 531 AFGALLLEVV-CGRRPIE 547
           AFG L+ E+   G+ P E
Sbjct: 186 AFGVLMWEIYSLGKMPYE 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 337 ELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASE 390
           E KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   E
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRY 445
           +     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+         
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT------ 117
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
             I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +       +   T 
Sbjct: 118 -YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTT 170
Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           + GTL YL PE+          D+++ G L  E + G+ P E     E
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V  G        VA+K +  E      EF  E   +  L H  LVQL G C 
Sbjct: 17  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           ++  + ++ ++M NG L   L + +    T +Q   + K V   + YL     +  +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L++ +   ++ DFGL++        S+      + +  PE+    K ++ SD++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 531 AFGALLLEVV-CGRRPIE 547
           AFG L+ E+   G+ P E
Sbjct: 191 AFGVLMWEIYSLGKMPYE 208

>pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 104/233 (44%), Gaps = 29/233 (12%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNTTLR---VLGHAFYSSPIKFKNSTRNSKSLSFSTCFA 92
           N  N+ L G A +   G L+LTN        +G AFYS+PI+  + T ++ + SFST F 
Sbjct: 12  NKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLA-SFSTNFT 70
Query: 93  FAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDF 152
           F I  +      +G AF +      P  L  +Y              H  AV FDTV   
Sbjct: 71  FRINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTTNYDRDA-HTVAVVFDTVS-- 126
Query: 153 EFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEV 212
                  N + ID+NS+R  A+E   +   N          GE  +  I YDS KN L V
Sbjct: 127 -------NRIEIDVNSIRPIATESCNFGHNN----------GEKAEVRITYDSPKNDLRV 169
Query: 213 RLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSF 262
            L   S + +  + S  V L   V++ + VGFS+++G       +H +L WSF
Sbjct: 170 SLLYPSSEEKCHV-SATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSF 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 15/214 (7%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V+K +   +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEWEQTVIH 468
              G++ +  + M  GSLD+ L   +KA    EQ   ++   V  GL YL E+    ++H
Sbjct: 77  YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 131
Query: 469 RDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           RD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  S
Sbjct: 132 RDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN----EFVGTRSYMSPERLQGTHYSVQS 187
Query: 528 DVYAFGALLLEVVCGRRPIEPKALPEELILVDWV 561
           D+++ G  L+E+  GR P  P A+ E   L+D++
Sbjct: 188 DIWSMGLSLVEMAVGRYPRPPMAIFE---LLDYI 218

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V  G        VA+K +  E      EF  E   +  L H  LVQL G C 
Sbjct: 23  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           ++  + ++ ++M NG L   L + +    T +Q   + K V   + YL     +  +HRD
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRD 136
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L++ +   ++ DFGL++        S+      + +  PE+    K ++ SD++
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 531 AFGALLLEVV-CGRRPIE 547
           AFG L+ E+   G+ P E
Sbjct: 197 AFGVLMWEIYSLGKMPYE 214

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 126
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + VIHRDIK  N+LL S    ++ DFG +       +   T + GTL YL PE+     
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                D+++ G L  E + G+ P E     E
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 337 ELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASE 390
           E KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   E
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRY 445
           +     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+         
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT------ 115
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
             I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +       +   T 
Sbjct: 116 -YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTT 168
Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           + GTL YL PE+          D+++ G L  E + G+ P E     E
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY     ++   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 126
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 127 -KKVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCGTLDYLPPEMIEG 180
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIE 547
                  D+++ G L  E + G+ P E
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 28/230 (12%)
Query: 337 ELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASE 390
           E KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   E
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRY 445
           +     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+         
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT------ 115
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
             I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +        PS+ R
Sbjct: 116 -YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRR 166
Query: 506 --VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
             + GTL YL PE+          D+++ G L  E + G+ P E     E
Sbjct: 167 XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGR-LRHRNLVQLL 406
            LG GGF + ++ +   T    A K V      K   RE  S   SI R L H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G+      + +V +     SL + L   +KA+   E RY  ++ +  G  YLH      V
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHR---NRV 136
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           IHRD+K GN+ L+ +L  ++GDFGLA   E         + GT  Y+APE+      +  
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 195
Query: 527 SDVYAFGALLLEVVCGRRPIEPKALPE 553
            DV++ G ++  ++ G+ P E   L E
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKE 222

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 133/285 (46%), Gaps = 35/285 (12%)
Query: 351 LGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VAVK V+  +    R EF +E S +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLF--------DEQKAILTWEQRYRIIKGVASGLL 456
           LLG   +    L+V + M +G L   L         +  +   T ++  ++   +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+    +  +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + ++AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVV 574
           E  + G  TTSSD+++FG +L E+     +P +   L  E +L  +V D    G  L+  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ--GLSNEQVL-KFVMD----GGYLDQP 254
Query: 575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           D       N  E   V  L  MC     + RPT  ++V  L+ ++
Sbjct: 255 D-------NCPER--VTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 132/296 (44%), Gaps = 49/296 (16%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG+V K T       +  T VAVK +  N S   LR+  SE + + ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKA----------------------ILTWE 442
           L G C + G LLL+ ++   GSL   L + +K                        LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNP 501
                   ++ G+ YL    E +++HRD+ A N+L+      ++ DFGL++ +YE  +  
Sbjct: 151 DLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDW 560
             ++    + ++A E       TT SDV++FG LL E+V  G  P  P   PE L     
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIPPERL----- 261
Query: 561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
            ++  K G  +E  D       N  E  ++ +L L C     + RP    + + LE
Sbjct: 262 -FNLLKTGHRMERPD-------NCSE--EMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 98/193 (50%), Gaps = 8/193 (4%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLG 407
           E +G G FG V+ G L + NT VAVK         L+ +F  E   + +  H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C ++  + +V + +  G     L  E  A L  +   +++   A+G+ YL     +  I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCI 235
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST--TRVVGTLGYLAPELTRTGKPTT 525
           HRD+ A N L+  +   ++ DFG+++    G   ++   R V  + + APE    G+ ++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV-PVKWTAPEALNYGRYSS 294
Query: 526 SSDVYAFGALLLE 538
            SDV++FG LL E
Sbjct: 295 ESDVWSFGILLWE 307

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 21/232 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V+K +   +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEWEQTVIH 468
              G++ +  + M  GSLD+ L   +KA    EQ   ++   V  GL YL E+    ++H
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 128
Query: 469 RDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           RD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  S
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQS 184
Query: 528 DVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN 579
           D+++ G  L+E+  GR PI P          D   D     AI E++D  +N
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPP---------DAKEDSRPPMAIFELLDYIVN 227

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGR-LRHRNLVQLL 406
            LG GGF + ++ +   T    A K V      K   RE  S   SI R L H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G+      + +V +     SL + L   +KA+   E RY  ++ +  G  YLH      V
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHR---NRV 162
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           IHRD+K GN+ L+ +L  ++GDFGLA   E         + GT  Y+APE+      +  
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 221
Query: 527 SDVYAFGALLLEVVCGRRPIEPKALPE 553
            DV++ G ++  ++ G+ P E   L E
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKE 248

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+   S+D   F +  A+      L     +++++G+A
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 121 ----FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 172
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGR-LRHRNLVQLL 406
            LG GGF + ++ +   T    A K V      K   RE  S   SI R L H+++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G+      + +V +     SL + L   +KA+   E RY  ++ +  G  YLH      V
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHR---NRV 160
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           IHRD+K GN+ L+ +L  ++GDFGLA   E         + GT  Y+APE+      +  
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 219
Query: 527 SDVYAFGALLLEVVCGRRPIEPKALPE 553
            DV++ G ++  ++ G+ P E   L E
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFETSCLKE 246

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 131
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDYLPPEMIEG 185
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                  D+++ G L  E + G+ P E     E
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 127
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRDTLCGTLDYLPPEMIEG 181
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                  D+++ G L  E + G+ P E     E
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 127
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                  D+++ G L  E + G+ P E     E
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 129
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRAALCGTLDYLPPEMIEG 183
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                  D+++ G L  E + G+ P E     E
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+   S+D   F +  A+      L     +++++G+A
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 119 ----FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 170
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 127
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV--GTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R    GTL YL PE+   
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWS-----CHAPSSRRTTLSGTLDYLPPEMIEG 181
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                  D+++ G L  E + G+ P E     E
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 126
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                  D+++ G L  E + G+ P E     E
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 126
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + VIHRDIK  N+LL S    ++ DFG +       +   T + GTL YL PE+     
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                D+++ G L  E + G+ P E     E
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G FG V  G        VA+K +  E      EF  E   +  L H  LVQL G C 
Sbjct: 17  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
           ++  + ++ ++M NG L   L + +    T +Q   + K V   + YL     +  +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           + A N L++ +   ++ DFGL++        S+      + +  PE+    K ++ SD++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 531 AFGALLLEVV-CGRRPIE 547
           AFG L+ E+   G+ P E
Sbjct: 191 AFGVLMWEIYSLGKMPYE 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 126
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                  D+++ G L  E + G+ P E     E
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 24/230 (10%)
Query: 335 YEELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFA 388
           + E KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +  
Sbjct: 2   HXESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 389 SEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQ 443
            E+     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+       
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---- 117
Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
               I  +A+ L Y H    + VIHRDIK  N+LL S    ++ DFG +       +   
Sbjct: 118 ---YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRR 168
Query: 504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           T + GTL YL PE           D+++ G L  E + G+ P E     E
Sbjct: 169 TTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 126
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + VIHRDIK  N+LL S    ++ DFG +       +   T + GTL YL PE+     
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTXLCGTLDYLPPEMIEGRM 182
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                D+++ G L  E + G+ P E     E
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 98/193 (50%), Gaps = 8/193 (4%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLG 407
           E +G G FG V+ G L + NT VAVK         L+ +F  E   + +  H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C ++  + +V + +  G     L  E  A L  +   +++   A+G+ YL     +  I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCI 235
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST--TRVVGTLGYLAPELTRTGKPTT 525
           HRD+ A N L+  +   ++ DFG+++    G   ++   R V  + + APE    G+ ++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV-PVKWTAPEALNYGRYSS 294
Query: 526 SSDVYAFGALLLE 538
            SDV++FG LL E
Sbjct: 295 ESDVWSFGILLWE 307

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V+K +   +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEWEQTVIH 468
              G++ +  + M  GSLD+ L   +KA    EQ   ++   V  GL YL E+    ++H
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 128
Query: 469 RDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           RD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  S
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQS 184
Query: 528 DVYAFGALLLEVVCGRRPIEP 548
           D+++ G  L+E+  GR PI P
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPP 205

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 126
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCGTLDYLPPEMIEG 180
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIE 547
                  D+++ G L  E + G+ P E
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 13/224 (5%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSI 394
           +K+  RG      LG GGF + Y+ T   T    A K V            + ++EI+  
Sbjct: 41  MKRYMRG----RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 395 GRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
             L + ++V   G+      + +V +     SL + L   +KA+   E RY  ++    G
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQG 154
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           + YLH      VIHRD+K GN+ L+ +++ ++GDFGLA   E         + GT  Y+A
Sbjct: 155 VQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-RKKXLCGTPNYIA 210
Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
           PE+      +   D+++ G +L  ++ G+ P E   L E  I +
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+   S+D   F +  A+      L     +++++G+A
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 121 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 172
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+   S+D   F +  A+      L     +++++G+A
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 120 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 171
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 133/285 (46%), Gaps = 35/285 (12%)
Query: 351 LGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VAVK V+  +    R EF +E S +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLF--------DEQKAILTWEQRYRIIKGVASGLL 456
           LLG   +    L+V + M +G L   L         +  +   T ++  ++   +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+    +  +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + ++AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVV 574
           E  + G  TTSSD+++FG +L E+     +P +   L  E +L  +V D    G  L+  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ--GLSNEQVL-KFVMD----GGYLDQP 254
Query: 575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           D       N  E   V  L  MC     + RPT  ++V  L+ ++
Sbjct: 255 D-------NCPER--VTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 126
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRXXLCGTLDYLPPEMIEG 180
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                  D+++ G L  E + G+ P E     E
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V+K +   +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEWEQTVIH 468
              G++ +  + M  GSLD+ L   +KA    EQ   ++   V  GL YL E+    ++H
Sbjct: 136 YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 190
Query: 469 RDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           RD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  S
Sbjct: 191 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQS 246
Query: 528 DVYAFGALLLEVVCGRRPIEP 548
           D+++ G  L+E+  GR PI P
Sbjct: 247 DIWSMGLSLVEMAVGRYPIPP 267

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 131/296 (44%), Gaps = 49/296 (16%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG+V K T       +  T VAVK +  N S   LR+  SE + + ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKA----------------------ILTWE 442
           L G C + G LLL+ ++   GSL   L + +K                        LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNP 501
                   ++ G+ YL    E  ++HRD+ A N+L+      ++ DFGL++ +YE  +  
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDW 560
             ++    + ++A E       TT SDV++FG LL E+V  G  P  P   PE L     
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIPPERL----- 261
Query: 561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
            ++  K G  +E  D       N  E  ++ +L L C     + RP    + + LE
Sbjct: 262 -FNLLKTGHRMERPD-------NCSE--EMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 125
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + VIHRDIK  N+LL S    ++ DFG +       +   T + GTL YL PE+     
Sbjct: 126 -KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRM 181
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                D+++ G L  E + G+ P E     E
Sbjct: 182 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 212

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 338 LKKATRGFRDKEL-----LGFGGFGRVYKGT-LP---STNTQVAVKRVSNES-KQGLREF 387
           +K   R F++ EL     LG G FG V+KG  +P   S    V +K + ++S +Q  +  
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV 62
Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-----LTWE 442
              + +IG L H ++V+LLG C     L LV  ++P GSL   +   + A+     L W 
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG 121
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS 502
            +      +A G+ YL E     ++HR++ A NVLL S    ++ DFG+A L        
Sbjct: 122 VQ------IAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172
Query: 503 TTRVVGT-LGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
                 T + ++A E    GK T  SDV+++G  + E++
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V+K +   +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEWEQTVIH 468
              G++ +  + M  GSLD+ L   +KA    EQ   ++   V  GL YL E+    ++H
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 128
Query: 469 RDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           RD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  S
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQS 184
Query: 528 DVYAFGALLLEVVCGRRPIEP 548
           D+++ G  L+E+  GR PI P
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPP 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 130
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + VIHRDIK  N+LL S    ++ DFG +       +   T + GTL YL PE+     
Sbjct: 131 -KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                D+++ G L  E + G+ P E     E
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 217

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 129
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRDDLCGTLDYLPPEMIEG 183
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIE 547
                  D+++ G L  E + G+ P E
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK----------RVSNESK---QGLREFASEISSIGRL 397
           LG G +G V      + +++ A+K          R S+++K   +   E  +EIS +  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 398 RHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVA 452
            H N+++L      +    LV +F   G L     ++  FDE  A         I+K + 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-------NIMKQIL 156
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSE---LNGRLGDFGLAKLYERGTNPSTTRVVGT 509
           SG+ YLH+     ++HRDIK  N+LL+++   LN ++ DFGL+  + +  +      +GT
Sbjct: 157 SGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRLGT 211
Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
             Y+APE+ +  K     DV++ G ++  ++CG  P 
Sbjct: 212 AYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 13/224 (5%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSI 394
           +K+  RG      LG GGF + Y+ T   T    A K V            + ++EI+  
Sbjct: 41  MKRYMRG----RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 395 GRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
             L + ++V   G+      + +V +     SL + L   +KA+   E RY  ++    G
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQG 154
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           + YLH      VIHRD+K GN+ L+ +++ ++GDFGLA   E         + GT  Y+A
Sbjct: 155 VQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-RKKDLCGTPNYIA 210
Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
           PE+      +   D+++ G +L  ++ G+ P E   L E  I +
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V+K +   +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEWEQTVIH 468
              G++ +  + M  GSLD+ L   +KA    EQ   ++   V  GL YL E+    ++H
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 128
Query: 469 RDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           RD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  S
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQS 184
Query: 528 DVYAFGALLLEVVCGRRPIEP 548
           D+++ G  L+E+  GR PI P
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V+K +   +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEWEQTVIH 468
              G++ +  + M  GSLD+ L   +KA    EQ   ++   V  GL YL E+    ++H
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 128
Query: 469 RDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           RD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  S
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQS 184
Query: 528 DVYAFGALLLEVVCGRRPIEP 548
           D+++ G  L+E+  GR PI P
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPP 205

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 124
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE
Sbjct: 125 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 180
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 117
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE
Sbjct: 118 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 13/224 (5%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSI 394
           +K+  RG      LG GGF + Y+ T   T    A K V            + ++EI+  
Sbjct: 25  MKRYMRG----RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 80
Query: 395 GRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
             L + ++V   G+      + +V +     SL + L   +KA+   E RY  ++    G
Sbjct: 81  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQG 138
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           + YLH      VIHRD+K GN+ L+ +++ ++GDFGLA   E         + GT  Y+A
Sbjct: 139 VQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-RKKDLCGTPNYIA 194
Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
           PE+      +   D+++ G +L  ++ G+ P E   L E  I +
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 238

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y
Sbjct: 119 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 170
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 117
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE
Sbjct: 118 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 116
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 172
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 117
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE
Sbjct: 118 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 116
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 172
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 131/296 (44%), Gaps = 49/296 (16%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG+V K T       +  T VAVK +  N S   LR+  SE + + ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKA----------------------ILTWE 442
           L G C + G LLL+ ++   GSL   L + +K                        LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNP 501
                   ++ G+ YL    E  ++HRD+ A N+L+      ++ DFGL++ +YE  +  
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDW 560
             ++    + ++A E       TT SDV++FG LL E+V  G  P  P   PE L     
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIPPERL----- 261
Query: 561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
            ++  K G  +E  D       N  E  ++ +L L C     + RP    + + LE
Sbjct: 262 -FNLLKTGHRMERPD-------NCSE--EMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 133/285 (46%), Gaps = 35/285 (12%)
Query: 351 LGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VAVK V+  +    R EF +E S +      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLF--------DEQKAILTWEQRYRIIKGVASGLL 456
           LLG   +    L+V + M +G L   L         +  +   T ++  ++   +A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+    +  +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + ++AP
Sbjct: 144 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVV 574
           E  + G  TTSSD+++FG +L E+     +P +   L  E +L  +V D    G  L+  
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ--GLSNEQVL-KFVMD----GGYLDQP 253
Query: 575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           D       N  E   V  L  MC     + RPT  ++V  L+ ++
Sbjct: 254 D-------NCPER--VTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 289

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 124
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE
Sbjct: 125 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 180
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 27/206 (13%)
Query: 349 ELLGFGGFGRVYKGT-LPSTNT---QVAVKRVSNESK--QGLREFASEISSIGRLRHRNL 402
           ++LG G FG VYKG  +P   T    VA+K + NE+   +   EF  E   +  + H +L
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ-----KAILTWEQRYRIIKGVASGLLY 457
           V+LLG C     + LV   MP+G L + + + +     + +L W         +A G++Y
Sbjct: 80  VRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMY 132
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYLA 514
           L E   + ++HRD+ A NVL+ S  + ++ DFGLA+L    E+  N    ++   + ++A
Sbjct: 133 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMA 187
Query: 515 PELTRTGKPTTSSDVYAFGALLLEVV 540
            E     K T  SDV+++G  + E++
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELM 213

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 121
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE
Sbjct: 122 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 177
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGLREFASEISSIGRLRHRN 401
           ++ + +LG G FG V       T  + AVK +S    + K        E+  + +L H N
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY------RIIKGVASGL 455
           +++L  +   +G   LV +    G L    FDE    +   +R+      RII+ V SG+
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGEL----FDE----IISRKRFSEVDAARIIRQVLSGI 139
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
            Y+H+     ++HRD+K  N+LL+S   + N R+ DFGL+  +E   +      +GT  Y
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYY 194
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+   G      DV++ G +L  ++ G  P
Sbjct: 195 IAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY          +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELANALSYCHS-- 123
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + VIHRDIK  N+LL S    ++ DFG +       +   T + GTL YL PE+     
Sbjct: 124 -KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRM 179
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                D+++ G L  E + G+ P E     E
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 210

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V+K +   +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEWEQTVIH 468
              G++ +  + M  GSLD+ L   +KA    EQ   ++   V  GL YL E+    ++H
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 155
Query: 469 RDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           RD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  S
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQS 211
Query: 528 DVYAFGALLLEVVCGRRPIEP 548
           D+++ G  L+E+  GR PI P
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPP 232

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 11/215 (5%)
Query: 349 ELLGFGGFGRVY---KGTLPSTNTQVAVKRVSNESKQGLREFASEISS--IGRLRHRNLV 403
           ++LG G FG+V+   K T P +    A+K +   + +      +++    +  + H  +V
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L    +  G L L+ DF+  G L   L   ++ + T E     +  +A GL +LH    
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALGLDHLHS--- 148
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
             +I+RD+K  N+LLD E + +L DFGL+K        + +   GT+ Y+APE+      
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGTVEYMAPEVVNRQGH 207
Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
           + S+D +++G L+ E++ G  P + K   E + L+
Sbjct: 208 SHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 337 ELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASE 390
           E KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   E
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRY 445
           +     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+         
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT------ 115
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
             I  +A+ L Y H    + VIHRDIK  N+LL S    ++ +FG +       +   T 
Sbjct: 116 -YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTT 168
Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           + GTL YL PE+          D+++ G L  E + G+ P E     E
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 26/218 (11%)
Query: 339 KKATRGFRDKEL-----LGFGGFGRVYKGT-LP---STNTQVAVKRVSNES-KQGLREFA 388
           K   R F++ EL     LG G FG V+KG  +P   S    V +K + ++S +Q  +   
Sbjct: 22  KVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT 81
Query: 389 SEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-----LTWEQ 443
             + +IG L H ++V+LLG C     L LV  ++P GSL   +   + A+     L W  
Sbjct: 82  DHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 140
Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
           +      +A G+ YL E     ++HR++ A NVLL S    ++ DFG+A L         
Sbjct: 141 Q------IAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 191
Query: 504 TRVVGT-LGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
                T + ++A E    GK T  SDV+++G  + E++
Sbjct: 192 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 329 GPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGLR 385
           GP  F        +  ++ + +LG G FG V       T  + AVK +S    + K    
Sbjct: 18  GPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 77
Query: 386 EFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY 445
               E+  + +L H N+++L  +   +G   LV +    G L    FDE    +   +R+
Sbjct: 78  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDE----IISRKRF 129
Query: 446 ------RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLAKLYE 496
                 RII+ V SG+ Y+H+     ++HRD+K  N+LL+S   + N R+ DFGL+  +E
Sbjct: 130 SEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 186
Query: 497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
              +      +GT  Y+APE+   G      DV++ G +L  ++ G  P
Sbjct: 187 --ASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 232

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPS--TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y  G        +  + ++ P
Sbjct: 199 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 337 ELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASE 390
           E KK      D E+   LG G FG VY      +   +A+K +  +   K G+  +   E
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRY 445
           +     LRH N+++L G+      + L+ ++ P G++ + L     FDEQ+         
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT------ 114
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
             I  +A+ L Y H    + VIHRDIK  N+LL S    ++ +FG +       +   T 
Sbjct: 115 -YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTT 167
Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           + GTL YL PE+          D+++ G L  E + G+ P E     E
Sbjct: 168 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 9/207 (4%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGLREFASEISSIGRLRHR 400
            FR ++ +G G F  VY+         VA+K+V        +   +   EI  + +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQRYRIIKGVASGLLYL 458
           N+++         +L +V +    G L + +  F +QK ++     ++    + S L ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H    + V+HRDIK  NV + +    +LGD GL + +   T  + + +VGT  Y++PE  
Sbjct: 153 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 208
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   SD+++ G LL E+   + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 40/228 (17%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           F++ EL+G GGFG+V+K           ++RV   +++  R    E+ ++ +L H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 405 LLG-WC------RRRGDLLLVYDFMPNGSLD------KCLFDEQK-----AILTWEQRYR 446
             G W           D L   D+ P  S +      KCLF + +      +  W ++ R
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 447 -----------IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
                      + + +  G+ Y+H    + +IHRD+K  N+ L      ++GDFGL    
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV--VC 541
           +   +   TR  GTL Y++PE   +       D+YA G +L E+  VC
Sbjct: 187 K--NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC 232

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 27/206 (13%)
Query: 349 ELLGFGGFGRVYKGT-LPSTNT---QVAVKRVSNES--KQGLREFASEISSIGRLRHRNL 402
           ++LG G FG VYKG  +P   T    VA+K + NE+   +   EF  E   +  + H +L
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ-----KAILTWEQRYRIIKGVASGLLY 457
           V+LLG C     + LV   MP+G L + + + +     + +L W  +      +A G++Y
Sbjct: 103 VRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 155
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYLA 514
           L E   + ++HRD+ A NVL+ S  + ++ DFGLA+L    E+  N    ++   + ++A
Sbjct: 156 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMA 210
Query: 515 PELTRTGKPTTSSDVYAFGALLLEVV 540
            E     K T  SDV+++G  + E++
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELM 236

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPSTNT--QVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y  G        +  + ++ P
Sbjct: 176 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 8/202 (3%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V+LL        L LV++F+ +  L K +       +        +  +  GL + H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS-- 121
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE+    K
Sbjct: 122 -HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 179
Query: 523 -PTTSSDVYAFGALLLEVVCGR 543
             +T+ D+++ G +  E+V  R
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLVQLLGWC 409
           LG G +  VYKG    T+  VA+K +  E ++G    A  E+S +  L+H N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHR 469
                L LV++++      K   D+   I+        +  +  GL Y H    Q V+HR
Sbjct: 70  HTEKSLTLVFEYLDKDL--KQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHR 124
Query: 470 DIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGKPTTSSD 528
           D+K  N+L++     +L DFGLA+     T      VV TL Y  P+ L  +   +T  D
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQID 183
Query: 529 VYAFGALLLEVVCGRRPIEPKALPEE 554
           ++  G +  E+  G RP+ P +  EE
Sbjct: 184 MWGVGCIFYEMATG-RPLFPGSTVEE 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 11/215 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQ--VAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLG 407
           LG G FG V +G       Q  VA+K +     K    E   E   + +L +  +V+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C+    L+LV +    G L K L  +++ I        ++  V+ G+ YL E   +  +
Sbjct: 78  VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPV-SNVAELLHQVSMGMKYLEE---KNFV 132
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGKPTT 525
           HRD+ A NVLL +    ++ DFGL+K      +  T R  G   L + APE     K ++
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 526 SSDVYAFGALLLEVVC-GRRPIEPKALPEELILVD 559
            SDV+++G  + E +  G++P +    PE +  ++
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGLREFASEISSIGRLRHRN 401
           ++ + +LG G FG V       T  + AVK +S    + K        E+  + +L H N
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY------RIIKGVASGL 455
           +++L  +   +G   LV +    G L    FDE    +   +R+      RII+ V SG+
Sbjct: 111 IMKLYEFFEDKGYFYLVGEVYTGGEL----FDE----IISRKRFSEVDAARIIRQVLSGI 162
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
            Y+H+     ++HRD+K  N+LL+S   + N R+ DFGL+  +E   +      +GT  Y
Sbjct: 163 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYY 217
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+   G      DV++ G +L  ++ G  P
Sbjct: 218 IAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 249

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRNL 402
           +R ++ +G G F +V       T  +VAVK +  +  +   L++   E+  +  L H N+
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLY 457
           V+L         L LV ++   G +   L       E++A   + Q       + S + Y
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-------IVSAVQY 129
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
            H+++   ++HRD+KA N+LLD ++N ++ DFG +  +  G    T    G+  Y APEL
Sbjct: 130 CHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPEL 184
Query: 518 TRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
            +  K      DV++ G +L  +V G  P + + L E
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 24/231 (10%)
Query: 326 LDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQG 383
           +D+G     ++ ++K    + +  L+G G +G V K     T   VA+K+   S++ K  
Sbjct: 12  VDLGTENLYFQSMEK----YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV 67
Query: 384 LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ 443
            +    EI  + +LRH NLV LL  C+++    LV++F+ +  LD              Q
Sbjct: 68  KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ 127
Query: 444 RY--RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP 501
           +Y  +II G+  G  + H      +IHRDIK  N+L+      +L DFG A+        
Sbjct: 128 KYLFQIINGI--GFCHSH-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGE 179
Query: 502 STTRVVGTLGYLAPEL----TRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
                V T  Y APEL     + GK   + DV+A G L+ E+  G  P+ P
Sbjct: 180 VYDDEVATRWYRAPELLVGDVKYGK---AVDVWAIGCLVTEMFMG-EPLFP 226

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGLREFASEISSIGRLRHRN 401
           ++ + +LG G FG V       T  + AVK +S    + K        E+  + +L H N
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLH 459
           +++L  +   +G   LV +    G L    FDE   +   +     RII+ V SG+ Y+H
Sbjct: 112 IMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMH 167
Query: 460 EEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           +     ++HRD+K  N+LL+S   + N R+ DFGL+  +E   +      +GT  Y+APE
Sbjct: 168 K---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPE 222
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +   G      DV++ G +L  ++ G  P
Sbjct: 223 VLH-GTYDEKCDVWSTGVILYILLSGCPP 250

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL 402
           + F   E+LG G F  V+      T    A+K +            +EI+ + +++H N+
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           V L           LV   +  G L D+ L   ++ + T +    +I+ V S + YLHE 
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHE- 124
Query: 462 WEQTVIHRDIKAGNVL-LDSELNGRL--GDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               ++HRD+K  N+L L  E N ++   DFGL+K+ + G     +   GT GY+APE+ 
Sbjct: 125 --NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVL 179
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                + + D ++ G +   ++CG  P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPS--TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +L H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
              E   IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH----- 399
           F +  +LG G FG+V K      +   A+K++ + +++ L    SE+  +  L H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVXLLASLNHQYVVR 66
Query: 400 --------RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR---YRII 448
                   RN V+     +++  L +  ++  N +L   +  E       +QR   +R+ 
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLN----QQRDEYWRLF 122
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER----------- 497
           + +   L Y+H    Q +IHR++K  N+ +D   N ++GDFGLAK   R           
Sbjct: 123 RQILEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 498 --GTNPSTTRVVGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVV 540
             G++ + T  +GT  Y+A E L  TG      D Y+ G +  E +
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTAT-------YITELANALSYCHS-- 130
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + VIHRDIK  N+LL S    ++ DFG +       +   T + GTL YL PE+     
Sbjct: 131 -KRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                D+++ G L  E + G  P E     E
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL-REFASEISSIGRLRHRNLVQLLG 407
           LG G FG VY      +   +A+K +  +   K G+  +   E+     LRH N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +      + L+ ++ P G++ + L     FDEQ+           I  +A+ L Y H   
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTAT-------YITELANALSYCHS-- 130
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTRT 520
            + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+   
Sbjct: 131 -KRVIHRDIKPENLLLGSNGELKIADFGWSV-----HAPSSRRDTLCGTLDYLPPEMIEG 184
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                  D+++ G L  E + G  P E     E
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 118 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 169
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPS--TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +L H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
              E   IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIK---GVASGLL 456
           LLG   +    L++ + M  G L   L       E   +L      ++I+    +A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIK---GVASGLL 456
           LLG   +    L++ + M  G L   L       E   +L      ++I+    +A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 146 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VAVK V+  +    R EF +E S +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLF--------DEQKAILTWEQRYRIIKGVASGLL 456
           LLG   +    L+V + M +G L   L         +  +   T ++  ++   +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+    +  +HR++ A N ++  +   ++GDFG+ + +YE        + +  + ++AP
Sbjct: 145 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TTSSD+++FG +L E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIK---GVASGLL 456
           LLG   +    L++ + M  G L   L       E   +L      ++I+    +A G+ 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 144 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+     D   F +  A+      L     +++++G+A
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKD---FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 118 ----FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 169
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 116/240 (48%), Gaps = 35/240 (14%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNT------TLRVLGHAFYSSPIKFKNSTRNSKSLSFST 89
           N  N+ L   A +  +GKL +T        T   LG AFYS+PI+  ++T  + + S++T
Sbjct: 35  NETNLILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDNTTGTVA-SWAT 92
Query: 90  CFAFAIVPEYTALGGHGFAFTI----SASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVE 145
            F F +     A    G AF +    S  K+  G L                +N   AVE
Sbjct: 93  SFTFNLQAPNAASPADGLAFALVPVGSQPKDKGGFL------GLFDSKNYASSNQTVAVE 146
Query: 146 FDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDS 205
           FDT  +  + D  + H+GID+NS++S         ++ ++    N ++ EV+   I YDS
Sbjct: 147 FDTFYNGGW-DPTERHIGIDVNSIKS---------IKTTSWDFANGENAEVL---ITYDS 193
Query: 206 SKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSF 262
           S N L   L   S K  S I+S  VDL+ ++ E + VGFS++TGL      ++ +L WSF
Sbjct: 194 STNLLVASLVHPSQK-TSFIVSERVDLTSVLPEWVSVGFSATTGLSKGYVETNEVLSWSF 252

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 118 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 169
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIK---GVASGLL 456
           LLG   +    L++ + M  G L   L       E   +L      ++I+    +A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 146 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 116
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y APE
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 172
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 118
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y APE
Sbjct: 119 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VAVK V+  +    R EF +E S +      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLF--------DEQKAILTWEQRYRIIKGVASGLL 456
           LLG   +    L+V + M +G L   L         +  +   T ++  ++   +A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+    +  +HR++ A N ++  +   ++GDFG+ + +YE        + +  + ++AP
Sbjct: 146 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TTSSD+++FG +L E+
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 118 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 169
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 120 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 171
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 118 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 169
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 119 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 170
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIK---GVASGLL 456
           LLG   +    L++ + M  G L   L       E   +L      ++I+    +A G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 147 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 121 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 172
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 120 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 171
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 7/195 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G  G V   T   T  QVAVK++    +Q      +E+  +    H N+V +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
              +L +V +F+  G+L   +   +   +  EQ   +   V   L YLH    Q VIHRD
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHN---QGVIHRD 166
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           IK+ ++LL S+   +L DFG      +   P    +VGT  ++APE+       T  D++
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 531 AFGALLLEVVCGRRP 545
           + G +++E++ G  P
Sbjct: 226 SLGIMVIEMIDGEPP 240

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 116
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y APE
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 172
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+     D   F +  A+      L     +++++G+A
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 121 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 172
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL--------TWEQRYRIIKGVASGLL 456
           LLG   +    L++ + M  G L   L   + A+         +  +  ++   +A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 120 ----FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 171
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 119 ----FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 170
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 121 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 172
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIK---GVASGLL 456
           LLG   +    L++ + M  G L   L       E   +L      ++I+    +A G+ 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 175 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+ ++  +++ +G+   A  EIS +  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 117
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE
Sbjct: 118 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 20/208 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+ ++  +++ +G+   A  EIS +  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVASGLL 456
           V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A    
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA---- 116
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y APE
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 172
Query: 517 LTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           +    K  +T+ D+++ G +  E+V  R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 35/285 (12%)
Query: 351 LGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VAVK V+  +    R EF +E S +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLF--------DEQKAILTWEQRYRIIKGVASGLL 456
           LLG   +    L+V + M +G L   L         +  +   T ++  ++   +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+    +  +HRD+ A N ++  +   ++GDFG+ + + E        + +  + ++AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVV 574
           E  + G  TTSSD+++FG +L E+     +P +   L  E +L  +V D    G  L+  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ--GLSNEQVL-KFVMD----GGYLDQP 254
Query: 575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           D       N  E   V  L  MC     + RPT  ++V  L+ ++
Sbjct: 255 D-------NCPER--VTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI------LTWEQRYRIIKGVA 452
           H N+V+LL        L LV++F+ +  L K  F +  A+      L     +++++G+A
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
               + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL Y
Sbjct: 122 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 173
Query: 513 LAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VAVK V+  +    R EF +E S +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLF--------DEQKAILTWEQRYRIIKGVASGLL 456
           LLG   +    L+V + M +G L   L         +  +   T ++  ++   +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+    +  +HRD+ A N ++  +   ++GDFG+ + + E        + +  + ++AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TTSSD+++FG +L E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL--------TWEQRYRIIKGVASGLL 456
           LLG   +    L++ + M  G L   L   + A+         +  +  ++   +A G+ 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 143 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 11/215 (5%)
Query: 349 ELLGFGGFGRVY--KGTLPSTNTQVAVKRVSNESKQGLREFAS---EISSIGRLRHRNLV 403
           ++LG G FG+V+  K    S   Q+   +V  ++   +R+      E   +  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L    +  G L L+ DF+  G L   L  E   + T E     +  +A  L +LH    
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS--- 144
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
             +I+RD+K  N+LLD E + +L DFGL+K              GT+ Y+APE+      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
           T S+D ++FG L+ E++ G  P + K   E + ++
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIK---GVASGLL 456
           LLG   +    L++ + M  G L   L       E   +L      ++I+    +A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 140 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPS--TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 158 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 26/225 (11%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK-------RVSNESKQGLREFASEI 391
           K+  + +  K+++G G    V +    +T  + AVK       R+S E  + +RE     
Sbjct: 90  KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 392 SSIGRLR--HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRI 447
           + I R    H +++ L+        + LV+D M  G L    FD   +K  L+ ++   I
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSI 205
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
           ++ +   + +LH      ++HRD+K  N+LLD  +  RL DFG +   E G       + 
Sbjct: 206 MRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELC 260
Query: 508 GTLGYLAPELTRTGKPTTSS------DVYAFGALLLEVVCGRRPI 546
           GT GYLAPE+ +     T        D++A G +L  ++ G  P 
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 327 DVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL 384
           D  PH  +Y  LK           +G G F +V       T  +VAVK +  +  +   L
Sbjct: 8   DEQPHIGNYRLLKT----------IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL 57
Query: 385 REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAIL 439
           ++   E+  +  L H N+V+L         L LV ++   G +   L       E++A  
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
            + Q       + S + Y H+++   ++HRD+KA N+LLD+++N ++ DFG +  +  G 
Sbjct: 118 KFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167
Query: 500 NPSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
              T    G+  Y APEL +  K      DV++ G +L  +V G  P + + L E
Sbjct: 168 KLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 35/285 (12%)
Query: 351 LGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VAVK V+  +    R EF +E S +      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLF--------DEQKAILTWEQRYRIIKGVASGLL 456
           LLG   +    L+V + M +G L   L         +  +   T ++  ++   +A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+    +  +HRD+ A N ++  +   ++GDFG+ + + E        + +  + ++AP
Sbjct: 142 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVV 574
           E  + G  TTSSD+++FG +L E+     +P +   L  E +L  +V D    G  L+  
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ--GLSNEQVL-KFVMD----GGYLDQP 251
Query: 575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           D       N  E   V  L  MC     + RPT  ++V  L+ ++
Sbjct: 252 D-------NCPER--VTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 287

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELL---GFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRL 397
           G +D +LL   G G + +V    L  T+   A+K V  E     + +    +E     + 
Sbjct: 3   GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 62
Query: 398 -RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGL 455
             H  LV L    +    L  V +++  G L   +F  Q+     E+  R     ++  L
Sbjct: 63  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLAL 119
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYL 513
            YLHE   + +I+RD+K  NVLLDSE + +L D+G+ K    G  P  +T+   GT  Y+
Sbjct: 120 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYI 173
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
           APE+ R      S D +A G L+ E++ GR P +
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 327 DVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL 384
           D  PH  +Y  LK           +G G F +V       T  +VAVK +  +  +   L
Sbjct: 8   DEQPHIGNYRLLKT----------IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL 57
Query: 385 REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAIL 439
           ++   E+  +  L H N+V+L         L LV ++   G +   L       E++A  
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
            + Q       + S + Y H+++   ++HRD+KA N+LLD+++N ++ DFG +  +  G 
Sbjct: 118 KFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167
Query: 500 NPSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
              T    G+  Y APEL +  K      DV++ G +L  +V G  P + + L E
Sbjct: 168 KLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 11/215 (5%)
Query: 349 ELLGFGGFGRVY--KGTLPSTNTQVAVKRVSNESKQGLREFAS---EISSIGRLRHRNLV 403
           ++LG G FG+V+  K    S   Q+   +V  ++   +R+      E   +  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L    +  G L L+ DF+  G L   L  E   + T E     +  +A  L +LH    
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS--- 144
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
             +I+RD+K  N+LLD E + +L DFGL+K              GT+ Y+APE+      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
           T S+D ++FG L+ E++ G  P + K   E + ++
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPS--TNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPSTNT--QVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 173 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRNL 402
           +R  + +G G F +V       T  +VAVK +  +  +   L++   E+  +  L H N+
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLY 457
           V+L         L LV ++   G +   L       E++A   + Q       + S + Y
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ-------IVSAVQY 121
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
            H+++   ++HRD+KA N+LLD+++N ++ DFG +  +  G    T    G+  Y APEL
Sbjct: 122 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPEL 176
Query: 518 TRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
            +  K      DV++ G +L  +V G  P + + L E
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 213

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 11/215 (5%)
Query: 349 ELLGFGGFGRVY--KGTLPSTNTQVAVKRVSNESKQGLREFAS---EISSIGRLRHRNLV 403
           ++LG G FG+V+  K    S   Q+   +V  ++   +R+      E   +  + H  +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L    +  G L L+ DF+  G L   L  E   + T E     +  +A  L +LH    
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS--- 145
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
             +I+RD+K  N+LLD E + +L DFGL+K              GT+ Y+APE+      
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 204
Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
           T S+D ++FG L+ E++ G  P + K   E + ++
Sbjct: 205 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 341 ATRGFRDKELL---GFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSI 394
           ++ G +D +LL   G G + +V    L  T+   A+K V  E     + +    +E    
Sbjct: 15  SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVF 74
Query: 395 GRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VA 452
            +   H  LV L    +    L  V +++  G L   +F  Q+     E+  R     ++
Sbjct: 75  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEIS 131
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTL 510
             L YLHE   + +I+RD+K  NVLLDSE + +L D+G+ K    G  P  +T+   GT 
Sbjct: 132 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTP 185
Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
            Y+APE+ R      S D +A G L+ E++ GR P +
Sbjct: 186 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPS--TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 158 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 403 VQLLGWCRRRGDLLLVYD--------FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
           V+LL        L LV++        FM   +L        K+ L     +++++G+A  
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL-----FQLLQGLA-- 116
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
             + H      V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV TL Y A
Sbjct: 117 --FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 170
Query: 515 PELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
           PE+    K  +T+ D+++ G +  E+V  R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V++ T  +T    A K V    +        EI ++  LRH  LV L   
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
                +++++Y+FM  G L + + DE    ++ ++    ++ V  GL ++H   E   +H
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH---ENNYVH 172
Query: 469 RDIKAGNVLLDSELNGRLG--DFGL-AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT- 524
            D+K  N++  ++ +  L   DFGL A L  + +   TT   GT  + APE+   GKP  
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE-GKPVG 228
Query: 525 TSSDVYAFGALLLEVVCGRRPI 546
             +D+++ G L   ++ G  P 
Sbjct: 229 YYTDMWSVGVLSYILLSGLSPF 250

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 8/208 (3%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ---GLREFASEISSIGRLRHRN 401
           FR   +LG GGFG V    + +T    A K++  +  +   G     +E   + ++  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +V L      +  L LV   M  G L   ++   +A     +       +  GL  LH E
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
               +++RD+K  N+LLD   + R+ D GLA     G   +    VGT+GY+APE+ +  
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNE 360
Query: 522 KPTTSSDVYAFGALLLEVVCGRRPIEPK 549
           + T S D +A G LL E++ G+ P + +
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELL---GFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRL 397
           G +D +LL   G G + +V    L  T+   A+K V  E     + +    +E     + 
Sbjct: 7   GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 398 -RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGL 455
             H  LV L    +    L  V +++  G L   +F  Q+     E+  R     ++  L
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLAL 123
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYL 513
            YLHE   + +I+RD+K  NVLLDSE + +L D+G+ K    G  P  +T+   GT  Y+
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYI 177
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
           APE+ R      S D +A G L+ E++ GR P +
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 17/226 (7%)
Query: 330 PHRFSYEELKKA---------TRGFRDKEL-LGFGGFGRVYKGTLPSTNTQVAVKRVSNE 379
           P R S+E+ + A          R + D  + +G G  G V   T+ S+   VAVK++   
Sbjct: 8   PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR 67
Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
            +Q      +E+  +   +H N+V++        +L +V +F+  G+L   +   +   +
Sbjct: 68  KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---M 124
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
             EQ   +   V   L  LH    Q VIHRDIK+ ++LL  +   +L DFG      +  
Sbjct: 125 NEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 181
Query: 500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            P    +VGT  ++APEL          D+++ G +++E+V G  P
Sbjct: 182 -PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V++ T  +T    A K V    +        EI ++  LRH  LV L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
                +++++Y+FM  G L + + DE    ++ ++    ++ V  GL ++H   E   +H
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH---ENNYVH 278
Query: 469 RDIKAGNVLLDSELNGRLG--DFGL-AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT- 524
            D+K  N++  ++ +  L   DFGL A L  + +   TT   GT  + APE+   GKP  
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE-GKPVG 334
Query: 525 TSSDVYAFGALLLEVVCGRRPI 546
             +D+++ G L   ++ G  P 
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPF 356

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLV 403
           F   E +G G FG V+KG    T   VA+K +   E++  + +   EI+ + +     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCL----FDEQKAILTWEQRYRIIKGVASGLLYLH 459
           +  G   +   L ++ +++  GS    L    FDE        Q   ++K +  GL YLH
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDE-------FQIATMLKEILKGLDYLH 137
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELT 518
            E +   IHRDIKA NVLL  + + +L DFG+A +L +     +T   VGT  ++APE+ 
Sbjct: 138 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 192
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +     + +D+++ G   +E+  G  P
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 17/226 (7%)
Query: 330 PHRFSYEELKKA---------TRGFRDKEL-LGFGGFGRVYKGTLPSTNTQVAVKRVSNE 379
           P R S+E+ + A          R + D  + +G G  G V   T+ S+   VAVK++   
Sbjct: 6   PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR 65
Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
            +Q      +E+  +   +H N+V++        +L +V +F+  G+L   +   +   +
Sbjct: 66  KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---M 122
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
             EQ   +   V   L  LH    Q VIHRDIK+ ++LL  +   +L DFG      +  
Sbjct: 123 NEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 179
Query: 500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            P    +VGT  ++APEL          D+++ G +++E+V G  P
Sbjct: 180 -PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 351 LGFGGFGRVYK----GTLP-STNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           +G G FGRV++    G LP    T VAVK +  E+   ++ +F  E + +    + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI----------------------LTWE 442
           LLG C     + L++++M  G L++ L                             L+  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNP 501
           ++  I + VA+G+ YL E   +  +HRD+   N L+   +  ++ DFGL++ +Y      
Sbjct: 175 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
           +       + ++ PE     + TT SDV+A+G +L E+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 113/241 (46%), Gaps = 44/241 (18%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV------SNESKQGLREFA--SE 390
           +   R +   + LG G +G V+K     T   VAVK++      S ++++  RE    +E
Sbjct: 5   RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTE 64
Query: 391 ISSIGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRII 448
           +S      H N+V LL   R   D  + LV+D+M    L   +   +  IL    +  ++
Sbjct: 65  LSG-----HENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI---RANILEPVHKQYVV 115
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTN----- 500
             +   + YLH      ++HRD+K  N+LL++E + ++ DFGL++ +    R TN     
Sbjct: 116 YQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 501 ------------PSTTRVVGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
                       P  T  V T  Y APE L  + K T   D+++ G +L E++CG +PI 
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIF 231
Query: 548 P 548
           P
Sbjct: 232 P 232

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPS--TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 150 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLG 407
           EL+G G +G+VYKG    T  Q+A  +V + +     E   EI+ + +   HRN+    G
Sbjct: 30  ELVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 408 WCRRRG------DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
              ++        L LV +F   GS+   + + +   L  E    I + +  GL +LH+ 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ- 147
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
               VIHRDIK  NVLL      +L DFG++   +R      T  +GT  ++APE+    
Sbjct: 148 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 204
Query: 522 K-PTTS----SDVYAFGALLLEVVCGRRPI 546
           + P  +    SD+++ G   +E+  G  P+
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGLREFASEISSIGRLRHRN 401
           ++ + +LG G FG V       T  + AVK +S    + K        E+  + +L H N
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLH 459
           + +L  +   +G   LV +    G L    FDE   +   +     RII+ V SG+ Y H
Sbjct: 88  IXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYXH 143
Query: 460 EEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           +     ++HRD+K  N+LL+S   + N R+ DFGL+  +E   +      +GT  Y+APE
Sbjct: 144 K---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKXKDKIGTAYYIAPE 198
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +   G      DV++ G +L  ++ G  P
Sbjct: 199 VLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASE--ISSIGRLRHRNLVQLL 406
           EL+G G +G VYKG+L      VAVK  S  ++Q    F +E  I  +  + H N+ + +
Sbjct: 19  ELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFI 73
Query: 407 GWCRR-----RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
               R     R + LLV ++ PNGSL K L         W    R+   V  GL YLH E
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 462 ------WEQTVIHRDIKAGNVLLDSELNGRLGDFGLA------KLYERG-TNPSTTRVVG 508
                 ++  + HRD+ + NVL+ ++    + DFGL+      +L   G  + +    VG
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 509 TLGYLAPE-------LTRTGKPTTSSDVYAFGALLLEV 539
           T+ Y+APE       L          D+YA G +  E+
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPS--TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 175 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 8/208 (3%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ---GLREFASEISSIGRLRHRN 401
           FR   +LG GGFG V    + +T    A K++  +  +   G     +E   + ++  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +V L      +  L LV   M  G L   ++   +A     +       +  GL  LH E
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
               +++RD+K  N+LLD   + R+ D GLA     G   +    VGT+GY+APE+ +  
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNE 360
Query: 522 KPTTSSDVYAFGALLLEVVCGRRPIEPK 549
           + T S D +A G LL E++ G+ P + +
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPS--TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 165 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPSTNT--QVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/242 (30%), Positives = 111/242 (45%), Gaps = 33/242 (13%)
Query: 37  NNNMSLNGAAEIEKNGKLMLTNTTLRVL------GHAFYSSPIKFKNSTRNSKSLSFSTC 90
           NN+++L GAA I ++G L LT      +      G   Y+ P+   + T  + + SF T 
Sbjct: 15  NNDLTLQGAAIITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHIWDMTTGTVA-SFETR 73
Query: 91  FAFAIVPEYT-ALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTN--HIFAVEFD 147
           F+F+I   YT  L   G  F +  +K    + P+Q              N     AVEFD
Sbjct: 74  FSFSIEQPYTRPLPADGLVFFMGPTK----SKPAQGYGYLGVFNNSKQDNSYQTLAVEFD 129
Query: 148 TVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYD-SS 206
           T  +  +      H+GID+NS+RS  ++P              L +G+V    I YD SS
Sbjct: 130 TFSN-PWDPPQVPHIGIDVNSIRSIKTQP------------FQLDNGQVANVVIKYDASS 176
Query: 207 KNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSFN 263
           K  L V + PSS    +  ++  VD+  ++ E + VG S +TG     A +H +  WSF+
Sbjct: 177 KILLAVLVYPSSGAIYT--IAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFH 234
Query: 264 MS 265
            S
Sbjct: 235 AS 236

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 40/224 (17%)
Query: 349 ELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQGLRE-FASEISSIGRL-RHRN 401
           ++LG G FG+V   T         + QVAVK +  ++    RE   SE+  + +L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL-------------DKCLFDEQKA--------ILT 440
           +V LLG C   G + L++++   G L             D+  ++ QK         +LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN 500
           +E        VA G+ +L     ++ +HRD+ A NVL+      ++ DFGLA    R   
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLA----RDIM 223
Query: 501 PSTTRVVG-----TLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
             +  VV       + ++APE    G  T  SDV+++G LL E+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPSTNT--QVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 159 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGT---LPS--TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G    +P+  +  QVAVK +    S+Q   +F  E   I +  H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIKGVASGLLYLH 459
            +G   +     ++ + M  G L   L +      Q + L       + + +A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           E      IHRDI A N LL     GR   +GDFG+A+ +Y           +  + ++ P
Sbjct: 185 E---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E    G  T+ +D ++FG LL E+
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 17/226 (7%)
Query: 330 PHRFSYEELKKA---------TRGFRDKEL-LGFGGFGRVYKGTLPSTNTQVAVKRVSNE 379
           P R S+E+ + A          R + D  + +G G  G V   T+ S+   VAVK++   
Sbjct: 51  PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR 110
Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
            +Q      +E+  +   +H N+V++        +L +V +F+  G+L   +   +   +
Sbjct: 111 KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---M 167
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
             EQ   +   V   L  LH    Q VIHRDIK+ ++LL  +   +L DFG      +  
Sbjct: 168 NEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224
Query: 500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            P    +VGT  ++APEL          D+++ G +++E+V G  P
Sbjct: 225 -PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 327 DVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL 384
           D  PH  +Y  LK           +G G F +V       T  +VAV+ +  +  +   L
Sbjct: 8   DEQPHIGNYRLLKT----------IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL 57
Query: 385 REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAIL 439
           ++   E+  +  L H N+V+L         L LV ++   G +   L       E++A  
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
            + Q       + S + Y H+++   ++HRD+KA N+LLD+++N ++ DFG +  +  G 
Sbjct: 118 KFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167
Query: 500 NPSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
              T    G+  Y APEL +  K      DV++ G +L  +V G  P + + L E
Sbjct: 168 KLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 341 ATRGFRDKELL---GFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSI 394
           ++ G +D +LL   G G + +V    L  T+   A++ V  E     + +    +E    
Sbjct: 47  SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVF 106
Query: 395 GRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VA 452
            +   H  LV L    +    L  V +++  G L   +F  Q+     E+  R     ++
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEIS 163
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTL 510
             L YLHE   + +I+RD+K  NVLLDSE + +L D+G+ K    G  P  +T+   GT 
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTP 217
Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
            Y+APE+ R      S D +A G L+ E++ GR P +
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIK---GVASGLL 456
           LLG   +    L++ + M  G L   L       E   +L      ++I+    +A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N  +  +   ++GDFG+ + +YE        + +  + +++P
Sbjct: 140 YLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 14/216 (6%)
Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR 396
           ++K     F   ++LG G FG+V+      TN   A+K +  +    L +   E + + +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--VLMDDDVECTMVEK 69
Query: 397 ------LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG 450
                   H  L  +    + + +L  V +++  G L   +    K  L+    Y     
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAE 127
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL 510
           +  GL +LH    + +++RD+K  N+LLD + + ++ DFG+ K    G +  T    GT 
Sbjct: 128 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNEFCGTP 183
Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
            Y+APE+    K   S D ++FG LL E++ G+ P 
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 109/242 (45%), Gaps = 33/242 (13%)
Query: 37  NNNMSLNGAAEIEKNGKLMLTNTTLRVL------GHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N+N++L GAA I ++G L LT      +      G   Y+ P+   +ST  + + SF T 
Sbjct: 15  NDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVA-SFETR 73
Query: 91  FAFAIVPEYT-ALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTN--HIFAVEFD 147
           F+F+I   YT  L   G  F +  +K    + P+Q              N     AVEFD
Sbjct: 74  FSFSIEQPYTRPLPADGLVFFMGPTK----SKPAQGYGYLGVFNNSKQDNSYQTLAVEFD 129
Query: 148 TVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSK 207
           T  +  +      H+GID+NS+RS  ++P              L +G+V    I YD+  
Sbjct: 130 TFSN-PWDPPQVPHIGIDVNSIRSIKTQP------------FQLDNGQVANVVIKYDAPS 176
Query: 208 NHLEVRLA-PSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSFN 263
             L V L  PSS    +  ++  VD+  ++ + + VG S +TG     A +H +  WSF 
Sbjct: 177 KILHVVLVYPSSGAIYT--IAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQ 234
Query: 264 MS 265
            S
Sbjct: 235 AS 236

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQLLGWC 409
           LG G  G V+K +   +   +A K +  E K  +R +   E+  +       +V   G  
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-RIIKGVASGLLYLHEEWEQTVIH 468
              G++ +  + M  GSLD+ L   +KA    EQ   ++   V  GL YL E+    ++H
Sbjct: 93  YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 147
Query: 469 RDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           RD+K  N+L++S    +L DFG++ +L +   N      VGT  Y++PE  +    +  S
Sbjct: 148 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQGTHYSVQS 203
Query: 528 DVYAFGALLLEVVCGRRPI 546
           D+++ G  L+E+  GR PI
Sbjct: 204 DIWSMGLSLVEMAVGRYPI 222

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 30/240 (12%)
Query: 318 ADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS 377
            ++++    DVGP    Y +L          + +G G +G V         T+VA+K++S
Sbjct: 31  VEMVKGQPFDVGPR---YTQL----------QYIGEGAYGMVSSAYDHVRKTRVAIKKIS 77
Query: 378 N-ESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG-----DLLLVYDFMPNGSLDKCL 431
             E +   +    EI  + R RH N++ +    R        D+ +V D M    L K L
Sbjct: 78  PFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLM-ETDLYKLL 136
Query: 432 FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL 491
             +Q   L+ +     +  +  GL Y+H      V+HRD+K  N+L+++  + ++ DFGL
Sbjct: 137 KSQQ---LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGL 190
Query: 492 AKLY--ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           A++   E       T  V T  Y APE+    K  T S D+++ G +L E++   RPI P
Sbjct: 191 ARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFP 249

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 9/203 (4%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFA-SEISSIGRLRHRNLVQLL 406
           E +G G +G V+K     T+  VA+KRV  ++  +G+   A  EI  +  L+H+N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                   L LV++F  +  L K  FD     L  E     +  +  GL + H    + V
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKK-YFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNV 122
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP-TT 525
           +HRD+K  N+L++     +L DFGLA+ +       +  VV TL Y  P++    K  +T
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYST 181
Query: 526 SSDVYAFGALLLEVVCGRRPIEP 548
           S D+++ G +  E+    RP+ P
Sbjct: 182 SIDMWSAGCIFAELANAARPLFP 204

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 17/226 (7%)
Query: 330 PHRFSYEELKKA---------TRGFRDKEL-LGFGGFGRVYKGTLPSTNTQVAVKRVSNE 379
           P R S+E+ + A          R + D  + +G G  G V   T+ S+   VAVK++   
Sbjct: 128 PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR 187
Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
            +Q      +E+  +   +H N+V++        +L +V +F+  G+L   +   +   +
Sbjct: 188 KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---M 244
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
             EQ   +   V   L  LH    Q VIHRDIK+ ++LL  +   +L DFG      +  
Sbjct: 245 NEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301
Query: 500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            P    +VGT  ++APEL          D+++ G +++E+V G  P
Sbjct: 302 -PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 410 R-----RRGDLLLVYDFMPNG--SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           R     +  D+ +V D M      L KC       I  +   Y+I++G    L Y+H   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF--LYQILRG----LKYIHS-- 146
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRT 520
              V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+   
Sbjct: 147 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 521 GKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
            K  T S D+++ G +L E++   RPI P
Sbjct: 206 SKGYTKSIDIWSVGCILAEML-SNRPIFP 233

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIK---GVASGLL 456
           LLG   +    L++ + M  G L   L       E   +L      ++I+    +A G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + + E        + +  + +++P
Sbjct: 147 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ +      R+F  EI  +  L    +V+  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 407 G--WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G  +   R +L LV +++P+G L        +A L   +       +  G+ YL     +
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYLGS---R 130
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             +HRD+ A N+L++SE + ++ DFGLAKL     +    R  G   + + APE      
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 523 PTTSSDVYAFGALLLEV 539
            +  SDV++FG +L E+
Sbjct: 191 FSRQSDVWSFGVVLYEL 207

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLV 403
           F   E +G G FG V+KG    T   VA+K +   E++  + +   EI+ + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +  G   +   L ++ +++  GS    L   +   L   Q   I++ +  GL YLH E +
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
              IHRDIKA NVLL      +L DFG+A      T       VGT  ++APE+ +    
Sbjct: 141 ---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
            + +D+++ G   +E+  G  P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKR-----VSNESKQGLREFASEISSIGRLRHRNLVQL 405
           +G G +GR  K    S    +  K      ++   KQ L    SE++ +  L+H N+V+ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSEVNLLRELKHPNIVRY 70
Query: 406 LGWC--RRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEE 461
                 R    L +V ++   G L   +    +++  L  E   R++  +   L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 462 WE--QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
            +   TV+HRD+K  NV LD + N +LGDFGLA++    T+ + T  VGT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMN 189
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                  SD+++ G LL E +C   P
Sbjct: 190 RMSYNEKSDIWSLGCLLYE-LCALMP 214

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 17/222 (7%)
Query: 334 SYEELKKATRGFRDK---ELL-------GFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG 383
           ++E+ K A R   D+    LL       G G  G V       +  QVAVK +    +Q 
Sbjct: 26  THEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR 85
Query: 384 LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ 443
                +E+  +   +H N+V++        +L ++ +F+  G+L   +    +  L  EQ
Sbjct: 86  RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQ 142
Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
              + + V   L YLH    Q VIHRDIK+ ++LL  +   +L DFG      +   P  
Sbjct: 143 IATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 198
Query: 504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
             +VGT  ++APE+       T  D+++ G +++E+V G  P
Sbjct: 199 KXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 11/215 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQ--VAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLG 407
           LG G FG V +G       Q  VA+K +     K    E   E   + +L +  +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C+    L+LV +    G L K L  +++ I        ++  V+ G+ YL E   +  +
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPV-SNVAELLHQVSMGMKYLEE---KNFV 458
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGKPTT 525
           HR++ A NVLL +    ++ DFGL+K      +  T R  G   L + APE     K ++
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 526 SSDVYAFGALLLEVVC-GRRPIEPKALPEELILVD 559
            SDV+++G  + E +  G++P +    PE +  ++
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLV 403
           F   E +G G FG V+KG    T   VA+K +   E++  + +   EI+ + +     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +  G   +   L ++ +++  GS    L   +   L   Q   I++ +  GL YLH E +
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
              IHRDIKA NVLL      +L DFG+A      T       VGT  ++APE+ +    
Sbjct: 146 ---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSAY 201
Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
            + +D+++ G   +E+  G  P
Sbjct: 202 DSKADIWSLGITAIELARGEPP 223

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 113/244 (46%), Gaps = 30/244 (12%)
Query: 320 VLESWELD----VGPHRFSYEELKKATRG-FRDKELLGFGGFGRVYKGTL-----PSTNT 369
           ++ES+E +    + P +  Y E  +  R   +  + LG G FG+V + T           
Sbjct: 10  IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL 69
Query: 370 QVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSL 427
           +VAVK + + +    +E   SE+  +  L +H N+V LLG C   G +L++ ++   G L
Sbjct: 70  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 428 DKCLFDEQKAILTWEQ--------RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD 479
              L  + +A L  E                VA G+ +L     +  IHRD+ A NVLL 
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 186
Query: 480 SELNGRLGDFGLAKLYERGTNPSTTRVVGT----LGYLAPELTRTGKPTTSSDVYAFGAL 535
           +    ++GDFGLA+      N S   V G     + ++APE       T  SDV+++G L
Sbjct: 187 NGHVAKIGDFGLAR---DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 243
Query: 536 LLEV 539
           L E+
Sbjct: 244 LWEI 247

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLR 398
           +   F+  E +G G +G VYK     T   VA+K++  +++ +G+   A  EIS +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 399 HRNLVQLLGWCRRRGDLLLVYD--------FMPNGSLDKCLFDEQKAILTWEQRYRIIKG 450
           H N+V+LL        L LV++        FM   +L        K+ L     +++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL 510
           +A    + H      V+HRD+K  N+L+++E   +L DFGLA+ +          VV TL
Sbjct: 119 LA----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 511 GYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGR 543
            Y APE+    K  +T+ D+++ G +  E+V  R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           LG G +G V       T+ + A+K  R ++ S     +   E++ +  L H N+++L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ--RYRIIKGVASGLLYLHEEWEQTV 466
              + +  LV +    G L    FDE    + + +     IIK V SG+ YLH+     +
Sbjct: 105 FEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNI 157
Query: 467 IHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +HRD+K  N+LL+S+      ++ DFGL+ ++E          +GT  Y+APE+ R  K 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLRK-KY 214
Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
               DV++ G +L  ++ G  P
Sbjct: 215 DEKCDVWSIGVILFILLAGYPP 236

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 351 LGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLR-EFASEISSIGRLRHRNLVQ 404
           LG G FG VY+G           T+VA+K V+  +    R EF +E S +      ++V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFD-----EQKAILTWEQRYRIIK---GVASGLL 456
           LLG   +    L++ + M  G L   L       E   +L      ++I+    +A G+ 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YL+       +HRD+ A N ++  +   ++GDFG+ + + E        + +  + +++P
Sbjct: 138 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 516 ELTRTGKPTTSSDVYAFGALLLEV 539
           E  + G  TT SDV++FG +L E+
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 30/235 (12%)
Query: 327 DVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL 384
           D  PH  +Y  LK           +G G F +V       T  +VAVK +  +  +   L
Sbjct: 8   DEQPHIGNYRLLKT----------IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL 57
Query: 385 REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAIL 439
           ++   E+  +  L H N+V+L         L LV ++   G +   L       E++A  
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
            + Q       + S + Y H+++   ++HRD+KA N+LLD+++N ++ DFG +  +  G 
Sbjct: 118 KFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167
Query: 500 NPSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                   G   Y APEL +  K      DV++ G +L  +V G  P + + L E
Sbjct: 168 KLDA--FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 14/216 (6%)
Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR 396
           ++K     F   ++LG G FG+V+      TN   A+K +  +    L +   E + + +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--VLMDDDVECTMVEK 68
Query: 397 ------LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG 450
                   H  L  +    + + +L  V +++  G L   +    K  L+    Y     
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAE 126
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL 510
           +  GL +LH    + +++RD+K  N+LLD + + ++ DFG+ K    G +  T    GT 
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNXFCGTP 182
Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
            Y+APE+    K   S D ++FG LL E++ G+ P 
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 113/244 (46%), Gaps = 30/244 (12%)
Query: 320 VLESWELD----VGPHRFSYEELKKATRG-FRDKELLGFGGFGRVYKGTL-----PSTNT 369
           ++ES+E +    + P +  Y E  +  R   +  + LG G FG+V + T           
Sbjct: 18  IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL 77
Query: 370 QVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSL 427
           +VAVK + + +    +E   SE+  +  L +H N+V LLG C   G +L++ ++   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 428 DKCLFDEQKAILTWEQ--------RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD 479
              L  + +A L  E                VA G+ +L     +  IHRD+ A NVLL 
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 194
Query: 480 SELNGRLGDFGLAKLYERGTNPSTTRVVGT----LGYLAPELTRTGKPTTSSDVYAFGAL 535
           +    ++GDFGLA+      N S   V G     + ++APE       T  SDV+++G L
Sbjct: 195 NGHVAKIGDFGLAR---DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 251
Query: 536 LLEV 539
           L E+
Sbjct: 252 LWEI 255

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLV 403
           F   E +G G FG V+KG    T   VA+K +   E++  + +   EI+ + +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +  G   +   L ++ +++  GS    L   +   L   Q   I++ +  GL YLH E +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
              IHRDIKA NVLL      +L DFG+A      T       VGT  ++APE+ +    
Sbjct: 126 ---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
            + +D+++ G   +E+  G  P
Sbjct: 182 DSKADIWSLGITAIELARGEPP 203

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 93  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 145
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 206 GYTKSIDIWSVGCILAEML-SNRPIFP 231

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 341 ATRGFRD----KELLGFGGFGRVYKGTLPSTNTQVAVKRV--------SNESKQGLREFA 388
           +T GF +    KE+LG G    V +     T  + AVK +        S E  Q LRE  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE-- 68
Query: 389 SEISSIGRLR----HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWE 442
           + +  +  LR    H N++QL           LV+D M  G L    FD   +K  L+ +
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK 124
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS 502
           +  +I++ +   +  LH+     ++HRD+K  N+LLD ++N +L DFG +   + G    
Sbjct: 125 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179
Query: 503 TTRVVGTLGYLAPELTRTGKPTTSS------DVYAFGALLLEVVCGRRP 545
              V GT  YLAPE+                D+++ G ++  ++ G  P
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 143
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 204 GYTKSIDIWSVGCILAEML-SNRPIFP 229

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLV 403
           F   E +G G FG V+KG    T   VA+K +   E++  + +   EI+ + +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +  G   +   L ++ +++  GS    L   +   L   Q   I++ +  GL YLH E +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
              IHRDIKA NVLL      +L DFG+A      T       VGT  ++APE+ +    
Sbjct: 126 ---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
            + +D+++ G   +E+  G  P
Sbjct: 182 DSKADIWSLGITAIELARGEPP 203

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 35/229 (15%)
Query: 341 ATRGFRD----KELLGFGGFGRVYKGTLPSTNTQVAVKRV--------SNESKQGLREFA 388
           +T GF +    KE+LG G    V +     T  + AVK +        S E  Q LRE  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE-- 68
Query: 389 SEISSIGRLR----HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWE 442
           + +  +  LR    H N++QL           LV+D M  G L    FD   +K  L+ +
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK 124
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS 502
           +  +I++ +   +  LH+     ++HRD+K  N+LLD ++N +L DFG +   + G    
Sbjct: 125 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 503 TTRVVGTLGYLAPELTRTGKPTTSS------DVYAFGALLLEVVCGRRP 545
           +  V GT  YLAPE+                D+++ G ++  ++ G  P
Sbjct: 182 S--VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISS 393
           KK    F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDV 62
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRII 448
           + RL H   V+L    +    L     +  NG L K +     FDE     T  + Y   
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--T 115
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             + S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            V
Sbjct: 116 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 172
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           GT  Y++PEL        SSD++A G ++ ++V G  P 
Sbjct: 173 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 143
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 204 GYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 30/235 (12%)
Query: 327 DVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL 384
           D  PH  +Y  LK           +G G F +V       T  +VAV+ +  +  +   L
Sbjct: 8   DEQPHIGNYRLLKT----------IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL 57
Query: 385 REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAIL 439
           ++   E+  +  L H N+V+L         L LV ++   G +   L       E++A  
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
            + Q       + S + Y H+++   ++HRD+KA N+LLD+++N ++ DFG +  +  G 
Sbjct: 118 KFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167
Query: 500 NPSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                   G+  Y APEL +  K      DV++ G +L  +V G  P + + L E
Sbjct: 168 --KLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 99  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 151
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 152 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 212 GYTKSIDIWSVGCILAEML-SNRPIFP 237

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 143
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 204 GYTKSIDIWSVGCILAEML-SNRPIFP 229

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              +A G+ YL     Q  IHRD+ A NVL+      R+ DFGLA+       Y++ TN 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 220 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 143
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 204 GYTKSIDIWSVGCILAEML-SNRPIFP 229

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 115/246 (46%), Gaps = 30/246 (12%)
Query: 320 VLESWELD----VGPHRFSYEELKKATRG-FRDKELLGFGGFGRVYKGTL-----PSTNT 369
           ++ES+E +    + P +  Y E  +  R   +  + LG G FG+V + T           
Sbjct: 18  IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL 77
Query: 370 QVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSL 427
           +VAVK + + +    +E   SE+  +  L +H N+V LLG C   G +L++ ++   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 428 DKCLFDEQKAILTWEQRYRIIKGVAS--GLLYLHEEWEQ--------TVIHRDIKAGNVL 477
              L  + + + T +  + I    AS   LL+   +  Q          IHRD+ A NVL
Sbjct: 138 LNFLRRKSRVLET-DPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196
Query: 478 LDSELNGRLGDFGLAKLYERGTNPSTTRVVGT----LGYLAPELTRTGKPTTSSDVYAFG 533
           L +    ++GDFGLA+      N S   V G     + ++APE       T  SDV+++G
Sbjct: 197 LTNGHVAKIGDFGLAR---DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253
Query: 534 ALLLEV 539
            LL E+
Sbjct: 254 ILLWEI 259

>pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 106/237 (44%), Gaps = 25/237 (10%)
Query: 34  AANNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKFKNSTRNSKSLSFS 88
           A N   +   G A +   G L LTN      + + LG A Y++P +  +ST  + + SF 
Sbjct: 12  APNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVA-SFV 70
Query: 89  TCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDT 148
           T F F I     A    G AF ++     P  L                +N I AVEFDT
Sbjct: 71  TSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNK--SNQIVAVEFDT 128
Query: 149 VKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKN 208
             + ++ D    H+GI++NS+ S  + P             N  +GEV   +I Y++S  
Sbjct: 129 FSNGDW-DPKGRHLGINVNSIESIKTVP------------WNWTNGEVANVFISYEASTK 175
Query: 209 HLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSF 262
            L   L   S++  S I+   VD+  ++ E +  GFS++TG+      ++ +L WSF
Sbjct: 176 SLTASLVYPSLE-TSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSF 231

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 143
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 204 GYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISS 393
           KK    F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDV 63
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRII 448
           + RL H   V+L    +    L     +  NG L K +     FDE     T  + Y   
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--T 116
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             + S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            V
Sbjct: 117 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 173
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           GT  Y++PEL        SSD++A G ++ ++V G  P 
Sbjct: 174 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L   +              +  L+ +     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+ ++       TT  
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG LL E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 89  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 141
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 142 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 202 GYTKSIDIWSVGCILAEML-SNRPIFP 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 96  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 148
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 149 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 209 GYTKSIDIWSVGCILAEML-SNRPIFP 234

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 97  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 149
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 150 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 210 GYTKSIDIWSVGCILAEML-SNRPIFP 235

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 88  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 140
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 141 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 201 GYTKSIDIWSVGCILAEML-SNRPIFP 226

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 147
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPIFP 233

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 89  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 141
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 142 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 202 GYTKSIDIWSVGCILAEML-SNRPIFP 227

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           F++ EL+G GGFG+V+K           +KRV   +++  R    E+ ++ +L H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 405 LLG-W--------------CRRRGDLLLV-YDFMPNGSLDKCLFDEQKAILTWEQRYRII 448
             G W               R +   L +  +F   G+L++ +   +   L       + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG 508
           + +  G+ Y+H    + +I+RD+K  N+ L      ++GDFGL    +   +    R  G
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGKRXRSKG 183
Query: 509 TLGYLAPELTRTGKPTTSSDVYAFGALLLEV--VC 541
           TL Y++PE   +       D+YA G +L E+  VC
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC 218

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISS 393
           KK    F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDV 61
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRII 448
           + RL H   V+L    +    L     +  NG L K +     FDE     T  + Y   
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--T 114
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             + S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            V
Sbjct: 115 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 171
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           GT  Y++PEL        SSD++A G ++ ++V G  P 
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLR 398
           AT  +     +G G +G VYK   P +   VA+K  RV N    G     S +  +  LR
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 399 ------HRNLVQLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRI 447
                 H N+V+L+  C      R   + LV++ + +  L   L       L  E    +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
           ++    GL +LH      ++HRD+K  N+L+ S    +L DFGLA++Y      + T VV
Sbjct: 126 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVV 180
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
            TL Y APE+       T  D+++ G +  E+   R+P+
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKPL 218

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISS 393
           KK    F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDV 60
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRII 448
           + RL H   V+L    +    L     +  NG L K +     FDE     T  + Y   
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--T 113
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             + S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            V
Sbjct: 114 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 170
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           GT  Y++PEL        SSD++A G ++ ++V G  P 
Sbjct: 171 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 111 RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 163
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 164 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 224 GYTKSIDIWSVGCILAEML-SNRPIFP 249

>pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 108/232 (46%), Gaps = 28/232 (12%)
Query: 39  NMSLNGAAEIEKNGKLMLT----NTTLR--VLGHAFYSSPIKFKNSTRNSKSLSFSTCFA 92
           NM L G A +  +GKL L     N T +   LG A YS+PI   +    S + SF+  F 
Sbjct: 17  NMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVA-SFAASFN 75
Query: 93  FAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDF 152
           F      T     G AF ++       T P  +             + + AVEFDT ++ 
Sbjct: 76  FTFYAPDTKRLADGLAFFLAPID----TKPQTHAGYLGLFNENESGDQVVAVEFDTFRNS 131
Query: 153 EFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEV 212
              D  + H+GI++NS+RS         ++ ++  + N K  +V+   I YD+S + L  
Sbjct: 132 --WDPPNPHIGINVNSIRS---------IKTTSWDLANNKVAKVL---ITYDASTSLLVA 177
Query: 213 RLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL--LASSHYILGWSF 262
            L   S +  S ILS  VDL   + E + +GFS++TGL     SH +L WSF
Sbjct: 178 SLVYPSQR-TSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSF 228

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 73  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLG 407
           +G G FG+V       T    A+K ++ +    +  +R    E+  +  L H  LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
             +   D+ +V D +  G L   L  +Q      E     I  +   L YL     Q +I
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMALDYLQN---QRII 137
Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
           HRD+K  N+LLD   +  + DF +A +  R T  +T  + GT  Y+APE+  + K    S
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKGAGYS 195
Query: 528 ---DVYAFGALLLEVVCGRRP 545
              D ++ G    E++ GRRP
Sbjct: 196 FAVDWWSLGVTAYELLRGRRP 216

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 147
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPIFP 233

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTW--------------EQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L   +   L +              +     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+ ++       TT  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG LL E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 112/248 (45%), Gaps = 34/248 (13%)
Query: 320 VLESWELD----VGPHRFSYEELKKATRG-FRDKELLGFGGFGRVYKGTL-----PSTNT 369
           ++ES+E +    + P +  Y E  +  R   +  + LG G FG+V + T           
Sbjct: 18  IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL 77
Query: 370 QVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSL 427
           +VAVK + + +    +E   SE+  +  L +H N+V LLG C   G +L++ ++   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 428 DKCL------------FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGN 475
              L            F    + L+          VA G+ +L     +  IHRD+ A N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARN 194
Query: 476 VLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT----LGYLAPELTRTGKPTTSSDVYA 531
           VLL +    ++GDFGLA+      N S   V G     + ++APE       T  SDV++
Sbjct: 195 VLLTNGHVAKIGDFGLAR---DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251
Query: 532 FGALLLEV 539
           +G LL E+
Sbjct: 252 YGILLWEI 259

>pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 105/235 (44%), Gaps = 24/235 (10%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNT---TLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFA 92
           N  N+   G A +   G L +T     T   +G A Y++PI+  +S    K  SF+T F+
Sbjct: 16  NQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITG-KVASFATSFS 74
Query: 93  FAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTV--K 150
           F +V    + G  G AF ++ +     +  S              +N I AVEFDT   K
Sbjct: 75  F-VVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFDTYFGK 133
Query: 151 DFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQAWIDYDSSKNH 209
            +   D +  H+GID+NS++S              K V  + ++GEV    I Y +    
Sbjct: 134 AYNPWDPDFKHIGIDVNSIKS-------------IKTVKWDWRNGEVADVVITYRAPTKS 180
Query: 210 LEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA--SSHYILGWSF 262
           L V L+  S    S I++  VDL  I+ E + VGFS   G  A   +H +L W F
Sbjct: 181 LTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYF 234

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 147
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 208 GYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--------SNESKQGLREFASEISSIGR 396
           +  KE+LG G    V +     T  + AVK +        S E  Q LRE  + +  +  
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE--ATLKEVDI 63
Query: 397 LR----HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKG 450
           LR    H N++QL           LV+D M  G L    FD   +K  L+ ++  +I++ 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRA 119
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL 510
           +   +  LH+     ++HRD+K  N+LLD ++N +L DFG +   + G       V GT 
Sbjct: 120 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTP 174
Query: 511 GYLAPELTRTGKPTTSS------DVYAFGALLLEVVCGRRP 545
            YLAPE+                D+++ G ++  ++ G  P
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ +      R+F  EI  +  L    +V+  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 407 G--WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G  +   R  L LV +++P+G L +      +A L   +       +  G+ YL     +
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYL---GSR 133
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             +HRD+ A N+L++SE + ++ DFGLAKL     +    R  G   + + APE      
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 523 PTTSSDVYAFGALLLEV 539
            +  SDV++FG +L E+
Sbjct: 194 FSRQSDVWSFGVVLYEL 210

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 7/195 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G  G V   T+ S+   VAVK++    +Q      +E+  +   +H N+V++     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
              +L +V +F+  G+L   +   +   +  EQ   +   V   L  LH    Q VIHRD
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLH---AQGVIHRD 141
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           IK+ ++LL  +   +L DFG      +   P    +VGT  ++APEL          D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 531 AFGALLLEVVCGRRP 545
           + G +++E+V G  P
Sbjct: 201 SLGIMVIEMVDGEPP 215

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ +      R+F  EI  +  L    +V+  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 407 G--WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G  +   R  L LV +++P+G L        +A L   +       +  G+ YL     +
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYL---GSR 146
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             +HRD+ A N+L++SE + ++ DFGLAKL     +    R  G   + + APE      
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 523 PTTSSDVYAFGALLLEV 539
            +  SDV++FG +L E+
Sbjct: 207 FSRQSDVWSFGVVLYEL 223

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTW--------------EQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L   +   L +              +     
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+ ++       TT  
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG LL E+
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 26/234 (11%)
Query: 326 LDVGPHRFSYEELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ 382
           +D+G     ++ +   TR   D +L   LG G F  V +  +  T TQ    ++ N  K 
Sbjct: 11  VDLGTENLYFQXMATCTRFTDDYQLFEELGKGAFS-VVRRCVKKTPTQEYAAKIINTKKL 69
Query: 383 GLRE---FASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
             R+      E      L+H N+V+L       G   LV+D +  G L    F++  A  
Sbjct: 70  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVARE 125
Query: 440 TWEQR--YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKL 494
            + +      I  +   + ++H+     ++HRD+K  N+LL S+  G   +L DFGLA +
Sbjct: 126 YYSEADASHCIHQILESVNHIHQ---HDIVHRDLKPENLLLASKCKGAAVKLADFGLA-I 181
Query: 495 YERGTNPSTTRVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRP 545
             +G   +     GT GYL+PE+ R    GKP    D++A G +L  ++ G  P
Sbjct: 182 EVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPV---DIWACGVILYILLVGYPP 232

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 351 LGFGGFGRV----YKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
           LG G FG V    Y     +T   VAVK++ +      R+F  EI  +  L    +V+  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 407 G--WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           G  +   R  L LV +++P+G L        +A L   +       +  G+ YL     +
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYL---GSR 134
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGK 522
             +HRD+ A N+L++SE + ++ DFGLAKL     +    R  G   + + APE      
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 523 PTTSSDVYAFGALLLEV 539
            +  SDV++FG +L E+
Sbjct: 195 FSRQSDVWSFGVVLYEL 211

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 20/230 (8%)
Query: 327 DVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL 384
           D  PH  +Y  LK           +G G F +V       T  +VA+K +  +  +   L
Sbjct: 6   DEQPHIGNYRLLKT----------IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL 55
Query: 385 REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR 444
           ++   E+  +  L H N+V+L         L L+ ++   G +   L    + +   E R
Sbjct: 56  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEAR 114
Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT 504
            +  + + S + Y H+   + ++HRD+KA N+LLD+++N ++ DFG +  +  G    T 
Sbjct: 115 SKF-RQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT- 169
Query: 505 RVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
              G+  Y APEL +  K      DV++ G +L  +V G  P + + L E
Sbjct: 170 -FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 218

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTW--------------EQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L   +   L +              +     
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+ ++       TT  
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG LL E+
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLV 403
           F   + +G G FG VYKG    T   VA+K +   E++  + +   EI+ + +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLLYLHE 460
           +  G   +   L ++ +++  GS    L     E+  I T      I++ +  GL YLH 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYLHS 134
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
           E +   IHRDIKA NVLL  + + +L DFG+A      T       VGT  ++APE+ + 
Sbjct: 135 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 521 GKPTTSSDVYAFGALLLEVVCGRRP 545
                 +D+++ G   +E+  G  P
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 7/195 (3%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G  G V   T+ S+   VAVK++    +Q      +E+  +   +H N+V++     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD 470
              +L +V +F+  G+L   +   +   +  EQ   +   V   L  LH    Q VIHRD
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLH---AQGVIHRD 145
Query: 471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVY 530
           IK+ ++LL  +   +L DFG      +   P    +VGT  ++APEL          D++
Sbjct: 146 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 531 AFGALLLEVVCGRRP 545
           + G +++E+V G  P
Sbjct: 205 SLGIMVIEMVDGEPP 219

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTW--------------EQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L   +   L +              +     
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+ ++       TT  
Sbjct: 141 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG LL E+
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTW--------------EQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L   +   L +              +     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+ ++       TT  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG LL E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTW--------------EQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L   +   L +              +     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+ ++       TT  
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG LL E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 107/242 (44%), Gaps = 33/242 (13%)
Query: 37  NNNMSLNGAAEIEKNGKLMLTNTTLRVL------GHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N+N++L GAA I ++G L LT      +      G   Y+ P+   + T  + + SF T 
Sbjct: 15  NDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWDMTTGTVA-SFETR 73
Query: 91  FAFAIVPEYT-ALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTN--HIFAVEFD 147
           F+F+I   YT  L   G  F +  +K    + P+Q              N      VEFD
Sbjct: 74  FSFSIEQPYTRPLPADGLVFFMGPTK----SKPAQGYGYLGIFNNSKQDNSYQTLGVEFD 129
Query: 148 TVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSK 207
           T  +  +      H+GID+NS+RS  ++P              L +G+V    I YD+S 
Sbjct: 130 TFSN-PWDPPQVPHIGIDVNSIRSIKTQP------------FQLDNGQVANVVIKYDASS 176
Query: 208 NHLEVRLA-PSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSFN 263
             L   L  PSS    +  ++  VD+  ++ E + VG S +TG     A +H +  WSF 
Sbjct: 177 KILHAVLVYPSSGAIYT--IAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQ 234
Query: 264 MS 265
            S
Sbjct: 235 AS 236

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 72  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 123
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 33/242 (13%)
Query: 37  NNNMSLNGAAEIEKNGKLMLTNTTLRVL------GHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N+N++L GA+ I ++G L LT      +      G   Y+ P+   + T  + + SF T 
Sbjct: 15  NDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWDMTTGTVA-SFETR 73
Query: 91  FAFAIVPEYT-ALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTN--HIFAVEFD 147
           F+F+I   YT  L   G  F +  +K    + P+Q              N      VEFD
Sbjct: 74  FSFSIEQPYTRPLPADGLVFFMGPTK----SKPAQGYGYLGIFNNSKQDNSYQTLGVEFD 129
Query: 148 TVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSK 207
           T  + ++      H+GID+NS+RS  ++P              L +G+V    I YD+S 
Sbjct: 130 TFSN-QWDPPQVPHIGIDVNSIRSIKTQP------------FQLDNGQVANVVIKYDASS 176
Query: 208 NHLEVRLA-PSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSFN 263
             L   L  PSS    +  ++  VD+  ++ E + VG S +TG     A +H +  WSF 
Sbjct: 177 KLLHAVLVYPSSGAIYT--IAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQ 234
Query: 264 MS 265
            S
Sbjct: 235 AS 236

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 73  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ TN 
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 220 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 101/234 (43%), Gaps = 27/234 (11%)
Query: 39  NMSLNGAAEIEKNGKLMLTNTTLR------VLGHAFYSSPIKFKNSTRNSKSLSFSTCFA 92
           N+ L G A +   G L LTN           LG A YS+PI   +S     + SF+T F 
Sbjct: 17  NLILQGDALVTVAGVLQLTNVDSNGVPEPSSLGRATYSAPINIWDSATGLVA-SFATSFR 75
Query: 93  FAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDF 152
           F I     A    G AF ++     P +                 T    AVEFDT ++ 
Sbjct: 76  FTIYAPNIATIADGLAFFLAPVASAPDS--GGGFLGLFDSAVGDTTYQTVAVEFDTYENT 133
Query: 153 EFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQAWIDYDSSKNHLE 211
            F D    H+G D+NS+             +S K V  +L +GE  +  I Y+S+   L 
Sbjct: 134 VFTDPPYTHIGFDVNSI-------------SSIKTVKWSLANGEAAKVLITYNSAVKLLV 180
Query: 212 VRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSF 262
             L   S K  S IL+  VDLS ++ E + VGFS++TG       +H +  WSF
Sbjct: 181 ASLVYPSSK-TSFILADIVDLSSVLPEWVRVGFSAATGASKGYIETHDVFSWSF 233

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 72  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 123
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 101/234 (43%), Gaps = 27/234 (11%)
Query: 39  NMSLNGAAEIEKNGKLMLTNTTLR------VLGHAFYSSPIKFKNSTRNSKSLSFSTCFA 92
           N+ L G A +   G L LTN           LG A YS+PI   +S     + SF+T F 
Sbjct: 17  NLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLVA-SFATSFR 75
Query: 93  FAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDF 152
           F I     A    G AF ++     P +                 T    AVEFDT ++ 
Sbjct: 76  FTIYAPNIATIADGLAFFLAPVASAPDS--GGGFLGLFDSAVSGSTYQTVAVEFDTYENT 133
Query: 153 EFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQAWIDYDSSKNHLE 211
            F D    H+G D+NS+             +S K V  +L +GE  +  I Y+S+   L 
Sbjct: 134 VFTDPPYTHIGFDVNSI-------------SSIKTVKWSLANGEAAKVLITYNSAVKLLV 180
Query: 212 VRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLAS---SHYILGWSF 262
             L   S K  S IL+  VDLS ++ E + VGFS++TG       +H +  WSF
Sbjct: 181 ASLVYPSSK-TSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSF 233

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTW--------------EQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L   +   L +              +     
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+ ++       TT  
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG LL E+
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ TN 
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 220 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKR-----VSNESKQGLREFASEISSIGRLRHRNLVQL 405
           +G G +GR  K    S    +  K      ++   KQ L    SE++ +  L+H N+V+ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSEVNLLRELKHPNIVRY 70
Query: 406 LGWC--RRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEE 461
                 R    L +V ++   G L   +    +++  L  E   R++  +   L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 462 WE--QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
            +   TV+HRD+K  NV LD + N +LGDFGLA++    T+ +    VGT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMN 189
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                  SD+++ G LL E +C   P
Sbjct: 190 RMSYNEKSDIWSLGCLLYE-LCALMP 214

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 408 WCRRRGDLLLVYDFMPNGSLDKC----LFD--EQKAILTWEQRYRIIKGVASGLLYLHEE 461
             RR G++  ++       L+ C    LFD  E    +      R    + +G++YLH  
Sbjct: 73  -HRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG- 123
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTR 519
               + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                   DV++ G +L  ++ G  P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 72  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 123
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 9/203 (4%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFA-SEISSIGRLRHRNLVQLL 406
           E +G G +G V+K     T+  VA+KRV  ++  +G+   A  EI  +  L+H+N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                   L LV++F  +  L K  FD     L  E     +  +  GL + H    + V
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKK-YFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNV 122
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP-TT 525
           +HRD+K  N+L++     +L +FGLA+ +       +  VV TL Y  P++    K  +T
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYST 181
Query: 526 SSDVYAFGALLLEVVCGRRPIEP 548
           S D+++ G +  E+    RP+ P
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFP 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 73  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  + A K    R S  S++G+   E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      R D++L+ + +  G L   L   QK  L+ E+    IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 463 EQTVIHRDIKAGNV-LLDSEL---NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
            + + H D+K  N+ LLD  +   + +L DFGLA   E G       + GT  ++APE+ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIV 190
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 72  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 123
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 408 WCRRRGDLLLVYDFMPNGSLDKC----LFD--EQKAILTWEQRYRIIKGVASGLLYLHEE 461
             RR G++  ++       L+ C    LFD  E    +      R    + +G++YLH  
Sbjct: 72  -HRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG- 122
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTR 519
               + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R
Sbjct: 123 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                   DV++ G +L  ++ G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA++++S  E +   +    EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 147
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPIFP 233

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTW--------------EQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L   +   L +              +     
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+ ++       TT  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG LL E+
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ---RYRIIKGVASGLL 456
              V+L    +    L     +  NG    CL    + I ++++   R+   + + S L 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNG----CLLKYIRKIGSFDETCTRFYTAE-IVSALE 146
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAP 515
           YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y++P
Sbjct: 147 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           EL      + SSD++A G ++ ++V G  P 
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 71  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 122
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELP 205

>pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 33/242 (13%)
Query: 37  NNNMSLNGAAEIEKNGKLMLTNTTLRVL------GHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N+N++L GA+ I ++G L LT      +      G   Y+ P+   + T  + + SF T 
Sbjct: 15  NDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWDMTTGTVA-SFETR 73
Query: 91  FAFAIVPEYT-ALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTN--HIFAVEFD 147
           F+F+I   YT  L   G  F +  +K    + P+Q              N      VEFD
Sbjct: 74  FSFSIEQPYTRPLPADGLVFFMGPTK----SKPAQGGGYLGIFNNSKQDNSYQTLGVEFD 129
Query: 148 TVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSK 207
           T  + ++      H+GID+NS+RS  ++P              L +G+V    I YD+S 
Sbjct: 130 TFSN-QWDPPQVPHIGIDVNSIRSIKTQP------------FQLDNGQVANVVIKYDASS 176
Query: 208 NHLEVRLA-PSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSFN 263
             L   L  PSS    +  ++  VD+  ++ E + VG S +TG     A +H +  WSF 
Sbjct: 177 KILHAVLVYPSSGAIYT--IAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQ 234
Query: 264 MS 265
            S
Sbjct: 235 AS 236

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 72  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 123
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 72  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 123
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 73  H-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 73  H-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 73  H-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 349 ELLGFGGFGRVYKGTLPS---TNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLV 403
           ++LG G FG V +G L     T+ +VAVK  ++ N S++ + EF SE + +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 404 QLLGWCRRRGDL-----LLVYDFMPNGSLDKCLFDEQKAI----LTWEQRYRIIKGVASG 454
           +LLG C           +++  FM  G L   L   +       +  +   + +  +A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT-LGYL 513
           + YL     +  +HRD+ A N +L  ++   + DFGL+K    G      R+    + ++
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 514 APELTRTGKPTTSSDVYAFGALLLEV 539
           A E       T+ SDV+AFG  + E+
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ TN 
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 220 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGL--REFASEISSIGRLRHRNLV 403
           E++G G F  V +     T  Q AVK V      S  GL   +   E S    L+H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY--RIIKGVASGLLYLHEE 461
           +LL      G L +V++FM    L   +     A   + +      ++ +   L Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPEL 517
               +IHRD+K  NVLL S+ N    +LGDFG+A +L E G        VGT  ++APE+
Sbjct: 149 --NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPEV 204
Query: 518 TRT---GKPTTSSDVYAFGALLLEVVCGRRP 545
            +    GKP    DV+  G +L  ++ G  P
Sbjct: 205 VKREPYGKPV---DVWGCGVILFILLSGCLP 232

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 149
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 150 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 107/242 (44%), Gaps = 33/242 (13%)
Query: 37  NNNMSLNGAAEIEKNGKLMLTNTTLRVL------GHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N+N++L GA+ I ++G L LT      +      G   Y+ P+   + T  + + SF T 
Sbjct: 15  NDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWDMTTGTVA-SFETR 73
Query: 91  FAFAIVPEYT-ALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTN--HIFAVEFD 147
           F+F+I   YT  L   G  F +  +K    + P+Q              N      VEFD
Sbjct: 74  FSFSIEQPYTRPLPADGLVFFMGPTK----SKPAQGYGYLGIFNQSKQDNSYQTLGVEFD 129
Query: 148 TVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSK 207
           T  +  +      H+GID+NS+RS  ++P              L +G+V    I YD+S 
Sbjct: 130 TFSN-PWDPPQVPHIGIDVNSIRSIKTQP------------FQLDNGQVANVVIKYDASS 176
Query: 208 NHLEVRLA-PSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSFN 263
             L   L  PSS    +  ++  VD+  ++ E + VG S +TG     A +H +  WSF 
Sbjct: 177 KLLHAVLVYPSSGAIYT--IAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQ 234
Query: 264 MS 265
            S
Sbjct: 235 AS 236

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 72  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 123
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  + A K    R S  S++G+   E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      R D++L+ + +  G L   L   QK  L+ E+    IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 463 EQTVIHRDIKAGNV-LLDSEL---NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
            + + H D+K  N+ LLD  +   + +L DFGLA   E G       + GT  ++APE+ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIV 190
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  + A K    R S  S++G+   E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      R D++L+ + +  G L   L   QK  L+ E+    IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 463 EQTVIHRDIKAGNV-LLDSEL---NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
            + + H D+K  N+ LLD  +   + +L DFGLA   E G       + GT  ++APE+ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIV 190
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 408 WCRRRGDLLLVYDFMPNGSLDKC----LFD--EQKAILTWEQRYRIIKGVASGLLYLHEE 461
             RR G++  ++       L+ C    LFD  E    +      R    + +G++YLH  
Sbjct: 73  -HRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG- 123
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTR 519
               + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                   DV++ G +L  ++ G  P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 126
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 127 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+ +        TT  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  + A K    R S  S++G+   E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      R D++L+ + +  G L   L   QK  L+ E+    IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 463 EQTVIHRDIKAGNV-LLDSEL---NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
            + + H D+K  N+ LLD  +   + +L DFGLA   E G       + GT  ++APE+ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIV 190
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 408 WCRRRGDLLLVYDFMPNGSLDKC----LFD--EQKAILTWEQRYRIIKGVASGLLYLHEE 461
             RR G++  ++       L+ C    LFD  E    +      R    + +G++YLH  
Sbjct: 72  -HRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG- 122
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTR 519
               + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R
Sbjct: 123 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                   DV++ G +L  ++ G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 72  -HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 123
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLREFASEISSIGRLRHRNLVQL 405
           LG G +G V       T  + A+K      V+  S  G      E++ + +L H N+++L
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSG--ALLDEVAVLKQLDHPNIMKL 86
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR------IIKGVASGLLYLH 459
             +   + +  LV +    G L    FDE    +   Q++       I+K V SG  YLH
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGEL----FDE----IILRQKFSEVDAAVIMKQVLSGTTYLH 138
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           +     ++HRD+K  N+LL+S+      ++ DFGL+  +E G        +GT  Y+APE
Sbjct: 139 K---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGTAYYIAPE 193
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           + R  K     DV++ G +L  ++CG  P
Sbjct: 194 VLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+ +        TT  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ TN 
Sbjct: 152 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 209 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 17/216 (7%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLR 398
           AT  +     +G G +G VYK   P +   VA+K  RV N  +        E++ + RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 399 ---HRNLVQLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG 450
              H N+V+L+  C      R   + LV++ + +  L   L       L  E    +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL 510
              GL +LH      ++HRD+K  N+L+ S    +L DFGLA++Y      +   VV TL
Sbjct: 121 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALAPVVVTL 175
Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
            Y APE+       T  D+++ G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKPL 210

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLREFASEISSIGRLRHRNLVQL 405
           LG G +G V       T  + A+K      V+  S  G      E++ + +L H N+++L
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSG--ALLDEVAVLKQLDHPNIMKL 69
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR------IIKGVASGLLYLH 459
             +   + +  LV +    G L    FDE    +   Q++       I+K V SG  YLH
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGEL----FDE----IILRQKFSEVDAAVIMKQVLSGTTYLH 121
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           +     ++HRD+K  N+LL+S+      ++ DFGL+  +E G        +GT  Y+APE
Sbjct: 122 K---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER--LGTAYYIAPE 176
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           + R  K     DV++ G +L  ++CG  P
Sbjct: 177 VLRK-KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ LV   M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 111 RAPTIEQMKDVYLVTHLM-GADLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 163
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 164 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 224 GYTKSIDIWSVGCILAEML-SNRPIFP 249

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 145
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 146 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  + A K    R S  S++G+   E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      R D++L+ + +  G L   L   QK  L+ E+    IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 463 EQTVIHRDIKAGNV-LLDSEL---NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
            + + H D+K  N+ LLD  +   + +L DFGLA   E G       + GT  ++APE+ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIV 190
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ TN 
Sbjct: 155 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 212 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 408 WCRRRGDLLLVYDFMPNGSLDKC----LFD--EQKAILTWEQRYRIIKGVASGLLYLHEE 461
             RR G++  ++       L+ C    LFD  E    +      R    + +G++YLH  
Sbjct: 72  -HRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG- 122
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTR 519
               + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R
Sbjct: 123 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                   DV++ G +L  ++ G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 142
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 144
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 141
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 142 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 107/242 (44%), Gaps = 33/242 (13%)
Query: 37  NNNMSLNGAAEIEKNGKLMLTNTTLRVL------GHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N+N++L GAA I ++G L LT      +      G   Y+ P+   + T  + + SF T 
Sbjct: 15  NDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWDMTTGTVA-SFETR 73
Query: 91  FAFAIVPEYT-ALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTN--HIFAVEFD 147
           F+F+I   YT  L   G  F +  +K    + P+Q              N      VEFD
Sbjct: 74  FSFSIEQPYTRPLPADGLVFFMGPTK----SKPAQGYGYLGIFNNSKQDNSYQTLGVEFD 129
Query: 148 TVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSK 207
           T  +  +      H+GID+NS+RS  ++P              L +G+V    I YD+S 
Sbjct: 130 TFSN-PWDPPQVPHIGIDVNSIRSIKTQP------------FQLDNGQVANVVIKYDASS 176
Query: 208 NHLEVRLA-PSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSFN 263
             L   L  PSS    +  ++  VD+  ++ E + VG S +TG     A +H +  WSF 
Sbjct: 177 KILHAVLVYPSSGAIYT--IAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQ 234
Query: 264 MS 265
            S
Sbjct: 235 AS 236

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 144
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ TN 
Sbjct: 150 TYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 207 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|2D3P|A Chain A, Cratylia Floribunda Seed Lectin Crystallized At Basic Ph Length = 236

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 74/152 (48%), Gaps = 24/152 (15%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD N  H+GI+I S+RS A+               N++ G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPNYQHIGINIKSIRSKATTR------------WNVQDGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKP--RSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYIL 258
           I Y    N +  RL+     P   S  +S+DVDL+ I+ E + VG S+STGL   ++ IL
Sbjct: 52  ISY----NSVAKRLSAIVSYPGGSSATVSYDVDLNNILPEWVRVGLSASTGLYKETNTIL 107
Query: 259 GWSF------NMSGDAKXXXXXXXXXXXGPKE 284
            WSF      N + DA+            PK+
Sbjct: 108 SWSFTSKLKTNSTADAQSLHFTFNQFSQNPKD 139

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 145
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 146 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 147
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 148 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 141
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 142 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 142
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 142
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRV 506
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+ +       +TT  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
              + ++APE       T  SDV++FG L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 144
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGR-LRHR 400
           F   +++G G FG+V      +     AVK +  ++   K+  +   SE + + + ++H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLH 459
            LV L    +    L  V D++  G L    +  Q+     E R R     +AS L YLH
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
                 +++RD+K  N+LLDS+ +  L DFGL K      N +T+   GT  YLAPE+  
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRPI 546
                 + D +  GA+L E++ G  P 
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLR 398
           AT  +     +G G +G VYK   P +   VA+K  RV N  +        E++ + RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 399 ---HRNLVQLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG 450
              H N+V+L+  C      R   + LV++ + +  L   L       L  E    +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL--YERGTNPSTTRVVG 508
              GL +LH      ++HRD+K  N+L+ S    +L DFGLA++  Y+   +P    VV 
Sbjct: 121 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP----VVV 173
Query: 509 TLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           TL Y APE+       T  D+++ G +  E+   R+P+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKPL 210

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 144
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 78  G-VITENPVWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRF 132
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSA 192
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 193 SDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 147
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +      V T  Y APE+    K
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPIFP 233

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  + R RH N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 96  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 148
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +      V T  Y APE+    K
Sbjct: 149 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 209 GYTKSIDIWSVGCILAEML-SNRPIFP 234

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F  V      +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 144
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++ ++   G+L + L           +D  +     +T++     
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ TN 
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 266 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  +   RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 93  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 145
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 206 GYTKSIDIWSVGCILAEML-SNRPIFP 231

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNLVQLL 406
           E +G G +G VYK       T  A+K++  E + +G+      EIS +  L+H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                +  L+LV++ +      K L D  +  L        +  + +G+ Y H+   + V
Sbjct: 67  DVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGKPTT 525
           +HRD+K  N+L++ E   ++ DFGLA+ +       T  VV TL Y AP+ L  + K +T
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 526 SSDVYAFGALLLEVVCG 542
           + D+++ G +  E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNLVQLL 406
           E +G G +G VYK       T  A+K++  E + +G+      EIS +  L+H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                +  L+LV++ +      K L D  +  L        +  + +G+ Y H+   + V
Sbjct: 67  DVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGKPTT 525
           +HRD+K  N+L++ E   ++ DFGLA+ +       T  VV TL Y AP+ L  + K +T
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 526 SSDVYAFGALLLEVVCGRRPIEP 548
           + D+++ G +  E+V G  P+ P
Sbjct: 181 TIDIWSVGCIFAEMVNG-TPLFP 202

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++  +   G+L + L           +D  +     +T++     
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ TN 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 220 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E+R R     + S L YLH    +
Sbjct: 76  KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS---R 129
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLAPELTRTGKP 523
            V++RDIK  N++LD + + ++ DFGL K  E  ++ +T +   GT  YLAPE+      
Sbjct: 130 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY 187
Query: 524 TTSSDVYAFGALLLEVVCGRRPI 546
             + D +  G ++ E++CGR P 
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 351 LGFGGFGRVYKGTL-------PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRL-RHRN 401
           LG G FG+V            P     VAVK + ++ +++ L +  SE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----------FDEQKA---ILTWEQRYRI 447
           ++ LLG C + G L ++  +   G+L + L           +D  +     +T++     
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK------LYERGTNP 501
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ TN 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV 539
                   + ++APE       T  SDV++FG L+ E+
Sbjct: 220 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 30/235 (12%)
Query: 327 DVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL 384
           D  PH  +Y  LK           +G G F +V       T  +VAVK +  +  +   L
Sbjct: 8   DEQPHIGNYRLLKT----------IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL 57
Query: 385 REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF-----DEQKAIL 439
           ++   E+     L H N+V+L         L LV ++   G +   L       E++A  
Sbjct: 58  QKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARA 117
Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
            + Q       + S + Y H+++   ++HRD+KA N+LLD++ N ++ DFG +  +  G 
Sbjct: 118 KFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN 167
Query: 500 NPSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                   G   Y APEL +  K      DV++ G +L  +V G  P + + L E
Sbjct: 168 KLDA--FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQLLG 407
           E +G G +G V++G     +  VAVK  S+  +Q   RE  +EI +   LRH N++  + 
Sbjct: 14  ECVGKGRYGEVWRGLWHGES--VAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIA 69
Query: 408 --WCRRRG--DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW- 462
                R     L L+  +  +GSL   L   Q+  L      R+    A GL +LH E  
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFL---QRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 463 ----EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT-------NPSTTRVVGTLG 511
               +  + HRD K+ NVL+ S L   + D GLA ++ +G+       NP     VGT  
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR----VGTKR 182
Query: 512 YLAPEL------TRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           Y+APE+      T   +    +D++AFG +L E+   RR I
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E+R R     + S L YLH    +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS---R 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLAPELTRTGKP 523
            V++RDIK  N++LD + + ++ DFGL K  E  ++ +T +   GT  YLAPE+      
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 524 TTSSDVYAFGALLLEVVCGRRPI 546
             + D +  G ++ E++CGR P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 17/216 (7%)
Query: 341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLR 398
           AT  +     +G G +G VYK   P +   VA+K  RV N  +        E++ + RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 399 ---HRNLVQLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG 450
              H N+V+L+  C      R   + LV++ + +  L   L       L  E    +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL 510
              GL +LH      ++HRD+K  N+L+ S    +L DFGLA++Y      +   VV TL
Sbjct: 121 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALFPVVVTL 175
Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
            Y APE+       T  D+++ G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKPL 210

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E+R R     + S L YLH    +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS---R 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELTRTGKP 523
            V++RDIK  N++LD + + ++ DFGL K  E  ++ +T +   GT  YLAPE+      
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 524 TTSSDVYAFGALLLEVVCGRRPI 546
             + D +  G ++ E++CGR P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKG--TLPSTNTQVAVKRVSNESKQ-GLR-EFASEISS 393
           L +      DKEL G G FG V KG   +      VAVK + NE+    L+ E  +E + 
Sbjct: 23  LDRKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 81
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
           + +L +  +V+++G C      +LV +    G L+K L  +Q   +  +    ++  V+ 
Sbjct: 82  MQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSM 138
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LG 511
           G+ YL E      +HRD+ A NVLL ++   ++ DFGL+K      N    +  G   + 
Sbjct: 139 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + APE     K ++ SDV++FG L+ E    G++P
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKG--TLPSTNTQVAVKRVSNESKQ-GLR-EFASEISS 393
           L +      DKEL G G FG V KG   +      VAVK + NE+    L+ E  +E + 
Sbjct: 23  LDRKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 81
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
           + +L +  +V+++G C      +LV +    G L+K L  +Q   +  +    ++  V+ 
Sbjct: 82  MQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSM 138
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LG 511
           G+ YL E      +HRD+ A NVLL ++   ++ DFGL+K      N    +  G   + 
Sbjct: 139 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + APE     K ++ SDV++FG L+ E    G++P
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKG--TLPSTNTQVAVKRVSNESKQ-GLR-EFASEISS 393
           L +      DKEL G G FG V KG   +      VAVK + NE+    L+ E  +E + 
Sbjct: 7   LDRKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 65
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
           + +L +  +V+++G C      +LV +    G L+K L  +Q   +  +    ++  V+ 
Sbjct: 66  MQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSM 122
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LG 511
           G+ YL E      +HRD+ A NVLL ++   ++ DFGL+K      N    +  G   + 
Sbjct: 123 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVK 179
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + APE     K ++ SDV++FG L+ E    G++P
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG----LREFASEISSIGRLRHRNLVQ 404
           E+LGFGG   V+       +  VAVK +  +  +     LR F  E  +   L H  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76
Query: 405 L--LGWCRRRGDLL--LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           +   G        L  +V +++   +L   +  E    +T ++   +I      L + H+
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELT 518
                +IHRD+K  N+L+ +    ++ DFG+A+      N    T  V+GT  YL+PE  
Sbjct: 135 NG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           R       SDVY+ G +L EV+ G  P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFA-SEISSIGRLRHRNLVQLL 406
           E +G G +G VYK       T  A+K++  E + +G+      EIS +  L+H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                +  L+LV++ +      K L D  +  L        +  + +G+ Y H+   + V
Sbjct: 67  DVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGKPTT 525
           +HRD+K  N+L++ E   ++ DFGLA+ +       T  +V TL Y AP+ L  + K +T
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYST 180
Query: 526 SSDVYAFGALLLEVVCGRRPIEP 548
           + D+++ G +  E+V G  P+ P
Sbjct: 181 TIDIWSVGCIFAEMVNG-TPLFP 202

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKR-----VSNESKQGLREFASEISSIGRLRHRNLVQL 405
           +G G +GR  K    S    +  K      ++   KQ L    SE++ +  L+H N+V+ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSEVNLLRELKHPNIVRY 70
Query: 406 LGWC--RRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEE 461
                 R    L +V ++   G L   +    +++  L  E   R++  +   L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 462 WE--QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
            +   TV+HRD+K  NV LD + N +LGDFGLA++     + +    VGT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA-KEFVGTPYYMSPEQMN 189
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                  SD+++ G LL E +C   P
Sbjct: 190 RMSYNEKSDIWSLGCLLYE-LCALMP 214

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 75  G-VITENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 129
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQ 211

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA---SEISSIG 395
           K + + F+    LG G FGRV+           A+K +  E    L++      E   + 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 396 RLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGL 455
            + H  ++++ G  +    + ++ D++  G L   L   Q+      + Y     V   L
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVCLAL 119
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
            YLH    + +I+RD+K  N+LLD   + ++ DFG AK         T  + GT  Y+AP
Sbjct: 120 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYXLCGTPDYIAP 172
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           E+  T     S D ++FG L+ E++ G  P 
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS---EISSIGR 396
           K +  +  KE LG G F  V +    +T  + A K + N  K   R+F     E     +
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRK 60
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASG 454
           L+H N+V+L    +      LV+D +  G L    F++   +   +       I+ +   
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILES 116
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLG 511
           + Y H      ++HR++K  N+LL S+  G   +L DFGLA   E   + +     GT G
Sbjct: 117 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 171
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           YL+PE+ +    +   D++A G +L  ++ G  P
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS---EISSIGR 396
           K +  +  KE LG G F  V +    +T  + A K + N  K   R+F     E     +
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRK 61
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASG 454
           L+H N+V+L    +      LV+D +  G L    F++   +   +       I+ +   
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILES 117
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLG 511
           + Y H      ++HR++K  N+LL S+  G   +L DFGLA   E   + +     GT G
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 172
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           YL+PE+ +    +   D++A G +L  ++ G  P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 20/230 (8%)
Query: 327 DVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGL 384
           D  PH  +Y  LK           +G G F +V       T  +VA+K +  +  +   L
Sbjct: 9   DEQPHIGNYRLLKT----------IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL 58
Query: 385 REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR 444
           ++   E+  +  L H N+V+L         L L+ ++   G +   L    + +   E R
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEAR 117
Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT 504
            +  + + S + Y H+   + ++HRD+KA N+LLD+++N ++ DFG +  +  G      
Sbjct: 118 SKF-RQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA- 172
Query: 505 RVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
              G   Y APEL +  K      DV++ G +L  +V G  P + + L E
Sbjct: 173 -FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E+R R     + S L YLH    +
Sbjct: 74  KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS---R 127
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELTRTGKP 523
            V++RDIK  N++LD + + ++ DFGL K  E  ++ +T +   GT  YLAPE+      
Sbjct: 128 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 185
Query: 524 TTSSDVYAFGALLLEVVCGRRPI 546
             + D +  G ++ E++CGR P 
Sbjct: 186 GRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS---EISSIGR 396
           K +  +  KE LG G F  V +    +T  + A K + N  K   R+F     E     +
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRK 61
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASG 454
           L+H N+V+L    +      LV+D +  G L    F++   +   +       I+ +   
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILES 117
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLG 511
           + Y H      ++HR++K  N+LL S+  G   +L DFGLA   E   + +     GT G
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 172
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           YL+PE+ +    +   D++A G +L  ++ G  P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKG--TLPSTNTQVAVKRVSNESKQ-GLR-EFASEISS 393
           L +      DKEL G G FG V KG   +      VAVK + NE+    L+ E  +E + 
Sbjct: 21  LDRKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 79
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
           + +L +  +V+++G C      +LV +    G L+K L  +Q   +  +    ++  V+ 
Sbjct: 80  MQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSM 136
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LG 511
           G+ YL E      +HRD+ A NVLL ++   ++ DFGL+K      N    +  G   + 
Sbjct: 137 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 193
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + APE     K ++ SDV++FG L+ E    G++P
Sbjct: 194 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 106 G-VITENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 160
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 220
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 221 SDVWMFGVCMWEILMHGVKPFQ 242

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 80  G-VITENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 134
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 194
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 195 SDVWMFGVCMWEILMHGVKPFQ 216

>pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 99/240 (41%), Gaps = 32/240 (13%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNTTLRV-----LGHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N NN+ L   A +   G L LT           LG A Y++PI   +   N+   SF+T 
Sbjct: 14  NQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHD---NTTLASFTTS 70
Query: 91  FAFAIVPEYTALGGHGFAFTISASKELPGTLPSQY--XXXXXXXXXXXXTNHIFAVEFDT 148
           F+F +     A    G AF ++     P T P                 +    AVEFDT
Sbjct: 71  FSFVMAAPAAAAVADGLAFFLAP----PDTQPQARGGFLGLFADRAHDASYQTVAVEFDT 126
Query: 149 VKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKN 208
             +    D N  H+GID N + S  + P             ++  GE     I Y +S  
Sbjct: 127 YSNA--WDPNYTHIGIDTNGIESKKTTP------------FDMVYGEKANIVITYQASTK 172
Query: 209 HLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSFNMS 265
            L   L    V   S  +S  VDL  I+ E + VGFS++TGL   +  +H I+ WSF +S
Sbjct: 173 ALAASLV-FPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E+R R     + S L YLH    +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS---R 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELTRTGKP 523
            V++RDIK  N++LD + + ++ DFGL K  E  ++ +T +   GT  YLAPE+      
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 524 TTSSDVYAFGALLLEVVCGRRPI 546
             + D +  G ++ E++CGR P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 458 GVITE-NPVWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRF 512
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQ 594

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 83  G-VITENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 137
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQ 219

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  + A K    R S  S++G+   E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHE 460
           + L      R D++L+ + +  G     LFD   QK  L+ E+    IK +  G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 461 EWEQTVIHRDIKAGNV-LLDSEL---NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
              + + H D+K  N+ LLD  +   + +L DFGLA   E G       + GT  ++APE
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPE 188
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +         +D+++ G +   ++ G  P
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E+R R     + S L YLH    +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS---R 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLAPELTRTGKP 523
            V++RDIK  N++LD + + ++ DFGL K  E  ++ +T +   GT  YLAPE+      
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 524 TTSSDVYAFGALLLEVVCGRRPI 546
             + D +  G ++ E++CGR P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 78  G-VITENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 132
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 193 SDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 78  G-VITENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 132
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 193 SDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 81  G-VITENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 135
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 195
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 196 SDVWMFGVCMWEILMHGVKPFQ 217

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKG--TLPSTNTQVAVKRVSNESKQ-GLR-EFASEISS 393
           L +      DKEL G G FG V KG   +      VAVK + NE+    L+ E  +E + 
Sbjct: 3   LDRKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
           + +L +  +V+++G C      +LV +    G L+K L  +Q   +  +    ++  V+ 
Sbjct: 62  MQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSM 118
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LG 511
           G+ YL E      +HRD+ A NVLL ++   ++ DFGL+K      N    +  G   + 
Sbjct: 119 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + APE     K ++ SDV++FG L+ E    G++P
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKG--TLPSTNTQVAVKRVSNESKQ-GLR-EFASEISS 393
           L +      DKEL G G FG V KG   +      VAVK + NE+    L+ E  +E + 
Sbjct: 13  LDRKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 71
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
           + +L +  +V+++G C      +LV +    G L+K L  +Q   +  +    ++  V+ 
Sbjct: 72  MQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSM 128
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LG 511
           G+ YL E      +HRD+ A NVLL ++   ++ DFGL+K      N    +  G   + 
Sbjct: 129 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + APE     K ++ SDV++FG L+ E    G++P
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKG--TLPSTNTQVAVKRVSNESKQ-GLR-EFASEISS 393
           L +      DKEL G G FG V KG   +      VAVK + NE+    L+ E  +E + 
Sbjct: 7   LDRKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 65
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
           + +L +  +V+++G C      +LV +    G L+K L  +Q   +  +    ++  V+ 
Sbjct: 66  MQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSM 122
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LG 511
           G+ YL E      +HRD+ A NVLL ++   ++ DFGL+K      N    +  G   + 
Sbjct: 123 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 179
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + APE     K ++ SDV++FG L+ E    G++P
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG----LREFASEISSIGRLRHRNLVQ 404
           E+LGFGG   V+       +  VAVK +  +  +     LR F  E  +   L H  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76
Query: 405 LLGWCRRR---GDL-LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           +          G L  +V +++   +L   +  E    +T ++   +I      L + H+
Sbjct: 77  VYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELT 518
                +IHRD+K  N+++ +    ++ DFG+A+      N    T  V+GT  YL+PE  
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           R       SDVY+ G +L EV+ G  P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG----LREFASEISSIGRLRHRNLVQ 404
           E+LGFGG   V+       +  VAVK +  +  +     LR F  E  +   L H  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76
Query: 405 L--LGWCRRRGDLL--LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           +   G        L  +V +++   +L   +  E    +T ++   +I      L + H+
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELT 518
                +IHRD+K  N+++ +    ++ DFG+A+      N    T  V+GT  YL+PE  
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           R       SDVY+ G +L EV+ G  P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3U4X|A Chain A, Crystal Structure Of A Lectin From Camptosema Pedicellatum Seeds In Complex With 5-Bromo-4-Chloro-3-Indolyl-Alpha-D-Mannose Length = 236

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 73/150 (48%), Gaps = 20/150 (13%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD N  H+GI+I S+RS A+               N++ G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPNYQHIGINIKSIRSKATT------------RWNVQDGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL+ I+ E + VG S+STG+   ++ IL W
Sbjct: 52  ISYNSVAKRLSAIV--SYPGGSSATVSYDVDLNNILPEWVRVGLSASTGVYKETNTILSW 109
Query: 261 SF------NMSGDAKXXXXXXXXXXXGPKE 284
           SF      N + DA+            PK+
Sbjct: 110 SFTSKLKTNSTADAQSLHFTFNQFSQSPKD 139

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E+R R     + S L YLH    +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS---R 124
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLAPELTRTGKP 523
            V++RDIK  N++LD + + ++ DFGL K  E  ++ +T +   GT  YLAPE+      
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 524 TTSSDVYAFGALLLEVVCGRRPI 546
             + D +  G ++ E++CGR P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG----LREFASEISSIGRLRHRNLVQ 404
           E+LGFGG   V+       +  VAVK +  +  +     LR F  E  +   L H  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76
Query: 405 L--LGWCRRRGDLL--LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           +   G        L  +V +++   +L   +  E    +T ++   +I      L + H+
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELT 518
                +IHRD+K  N+++ +    ++ DFG+A+      N    T  V+GT  YL+PE  
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           R       SDVY+ G +L EV+ G  P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 338 LKKATRGFRDKELLGFGGFGRVYKG--TLPSTNTQVAVKRVSNESKQ-GLR-EFASEISS 393
           L +      DKEL G G FG V KG   +      VAVK + NE+    L+ E  +E + 
Sbjct: 1   LDRKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 59
Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
           + +L +  +V+++G C      +LV +    G L+K L  +Q   +  +    ++  V+ 
Sbjct: 60  MQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSM 116
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LG 511
           G+ YL E      +HRD+ A NVLL ++   ++ DFGL+K      N    +  G   + 
Sbjct: 117 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 173
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           + APE     K ++ SDV++FG L+ E    G++P
Sbjct: 174 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 14/203 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G  G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 408 WCRRRGDL-LLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             RR G++  L  ++   G L    FD  E    +      R    + +G++YLH     
Sbjct: 72  H-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---I 123
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPE-LTRTGK 522
            + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APE L R   
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                DV++ G +L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 53  KLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTIS 112
           KL LT      +G A YSSPI   +        +F T F F I    +     GF F I+
Sbjct: 30  KLTLTKAVKNTVGRALYSSPIHIWDR-ETGNVANFVTSFTFVINAPNSYNVADGFTFFIA 88
Query: 113 ASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEFGDIN-DNHVGIDINSLRS 171
                P T    Y            T  + AVEFDT  +  +   N D H+GID+NS++S
Sbjct: 89  PVDTKPQT-GGGYLGVFNSAEYDKTTQTV-AVEFDTFYNAAWDPSNRDRHIGIDVNSIKS 146
Query: 172 NASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFD-- 229
                          +   L++GE     I ++++ N L V L   +      + S+   
Sbjct: 147 ------------VNTKSWKLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLS 194
Query: 230 --VDLSPIVKETMYVGFSSSTGLLASSHYILGWSFN 263
             V L  +V E + +GFS++TG   ++H +L WSF+
Sbjct: 195 DVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFH 230

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLGWC 409
           +G G +G V          +VA+K++S  E +   +    EI  +   RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 410 R-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           R     +  D+ +V D M    L K L  +    L+ +     +  +  GL Y+H     
Sbjct: 93  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS---A 145
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPELTRTGK 522
            V+HRD+K  N+LL++  + ++ DFGLA++ +   + +   T  V T  Y APE+    K
Sbjct: 146 NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 523 PTTSS-DVYAFGALLLEVVCGRRPIEP 548
             T S D+++ G +L E++   RPI P
Sbjct: 206 GYTKSIDIWSVGCILAEML-SNRPIFP 231

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 103/236 (43%), Gaps = 30/236 (12%)
Query: 330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ--GLREF 387
           P R  Y      +  F+ K LLG G +G V   T   T   VA+K++    K    LR  
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 388 ASEISSIGRLRHRNLVQLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWE 442
             EI  +   +H N++ +    R        ++ ++ + M    L + +      +L+ +
Sbjct: 58  -REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLSDD 112
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER----- 497
                I      +  LH      VIHRD+K  N+L++S  + ++ DFGLA++ +      
Sbjct: 113 HIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 498 ----GTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEP 548
               G     T  V T  Y APE+  T  K + + DV++ G +L E+   RRPI P
Sbjct: 170 SEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 103/236 (43%), Gaps = 30/236 (12%)
Query: 330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ--GLREF 387
           P R  Y      +  F+ K LLG G +G V   T   T   VA+K++    K    LR  
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 388 ASEISSIGRLRHRNLVQLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWE 442
             EI  +   +H N++ +    R        ++ ++ + M    L + +      +L+ +
Sbjct: 58  -REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLSDD 112
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER----- 497
                I      +  LH      VIHRD+K  N+L++S  + ++ DFGLA++ +      
Sbjct: 113 HIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 498 ----GTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEP 548
               G     T  V T  Y APE+  T  K + + DV++ G +L E+   RRPI P
Sbjct: 170 SEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E R R     + S L YLH E  +
Sbjct: 75  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE--K 129
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT--RVVGTLGYLAPELTRTGK 522
            V++RD+K  N++LD + + ++ DFGL K    G     T     GT  YLAPE+     
Sbjct: 130 NVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEVLEDND 186
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI 546
              + D +  G ++ E++CGR P 
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNL 402
           G+  KE +G G +    +    +TN + AVK V ++SK   R+ + EI  + R  +H N+
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVK-VIDKSK---RDPSEEIEILLRYGQHPNI 83
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           + L         + LV + M  G L DK L   QK     E  + ++  +   + YLH  
Sbjct: 84  ITLKDVYDDGKHVYLVTELMRGGELLDKIL--RQKFFSEREASF-VLHTIGKTVEYLHS- 139
Query: 462 WEQTVIHRDIKAGNVLLDSELNG----RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
             Q V+HRD+K  N+L   E       R+ DFG AK   R  N        T  ++APE+
Sbjct: 140 --QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLLMTPCYTANFVAPEV 196
Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRPIE--PKALPEELI 556
            +        D+++ G LL  ++ G  P    P   PEE++
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG----LREFASEISSIGRLRHRNLVQ 404
           E+LGFGG   V+       +  VAVK +  +  +     LR F  E  +   L H  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76
Query: 405 L--LGWCRRRGDLL--LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           +   G        L  +V +++   +L   +  E    +T ++   +I      L + H+
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELT 518
                +IHRD+K  N+++ +    ++ DFG+A+      N    T  V+GT  YL+PE  
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           R       SDVY+ G +L EV+ G  P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-----FASEISSIGRLRH 399
           F+  ++LG G F         +T+ + A+K +  E +  ++E        E   + RL H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASG 454
              V+L    +    L     +  NG L K +     FDE     T  + Y     + S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-----TCTRFY--TAEIVSA 142
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL 513
           L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK L            VGT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
           +PEL        SSD++A G ++ ++V G  P 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 112/250 (44%), Gaps = 36/250 (14%)
Query: 320 VLESWELD----VGPHRFSYEELKKATRG-FRDKELLGFGGFGRVYKGTL-----PSTNT 369
           ++ES+E +    + P +  Y E  +  R   +  + LG G FG+V + T           
Sbjct: 18  IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL 77
Query: 370 QVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSL 427
           +VAVK + + +    +E   SE+  +  L +H N+V LLG C   G +L++ ++   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 428 DKCLFDEQKAILTWEQR--------------YRIIKGVASGLLYLHEEWEQTVIHRDIKA 473
              L  ++   L +                       VA G+ +L     +  IHRD+ A
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLAS---KNCIHRDVAA 194
Query: 474 GNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT----LGYLAPELTRTGKPTTSSDV 529
            NVLL +    ++GDFGLA+      N S   V G     + ++APE       T  SDV
Sbjct: 195 RNVLLTNGHVAKIGDFGLAR---DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 251
Query: 530 YAFGALLLEV 539
           +++G LL E+
Sbjct: 252 WSYGILLWEI 261

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E R R     + S L YLH E  +
Sbjct: 76  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE--K 130
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT--RVVGTLGYLAPELTRTGK 522
            V++RD+K  N++LD + + ++ DFGL K    G     T     GT  YLAPE+     
Sbjct: 131 NVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEVLEDND 187
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI 546
              + D +  G ++ E++CGR P 
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 115/257 (44%), Gaps = 43/257 (16%)
Query: 320 VLESWELD----VGPHRFSYEELKKATRG-FRDKELLGFGGFGRVYKGTL-----PSTNT 369
           ++ES+E +    + P +  Y E  +  R   +  + LG G FG+V + T           
Sbjct: 3   IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL 62
Query: 370 QVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSL 427
           +VAVK + + +    +E   SE+  +  L +H N+V LLG C   G +L++ ++   G L
Sbjct: 63  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 428 DKCLFDEQKAIL-------------------TWEQR--YRIIKGVASGLLYLHEEWEQTV 466
              L  + +A+L                     E R        VA G+ +L     +  
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNC 179
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT----LGYLAPELTRTGK 522
           IHRD+ A NVLL +    ++GDFGLA+      N S   V G     + ++APE      
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLAR---DIMNDSNYIVKGNARLPVKWMAPESIFDCV 236
Query: 523 PTTSSDVYAFGALLLEV 539
            T  SDV+++G LL E+
Sbjct: 237 YTVQSDVWSYGILLWEI 253

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 104/239 (43%), Gaps = 32/239 (13%)
Query: 329 GPHRFSY----------EELKKATRGFRD----KELLGFGGFGRVYKGTLPSTNTQVAVK 374
           GPH  S           E +  A+  F D    KE LG G F  V +    +T  + A K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 375 RVSNESKQGLREFAS---EISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL 431
            + N  K   R+F     E     +L+H N+V+L    +      LV+D +  G L    
Sbjct: 61  -IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---- 115
Query: 432 FDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RL 486
           F++   +   +       I+ +   + Y H      ++HR++K  N+LL S+  G   +L
Sbjct: 116 FEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKL 172
Query: 487 GDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            DFGLA   E   + +     GT GYL+PE+ +    +   D++A G +L  ++ G  P
Sbjct: 173 ADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 73
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E R R     + S L YLH E  +
Sbjct: 74  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE--K 128
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT--RVVGTLGYLAPELTRTGK 522
            V++RD+K  N++LD + + ++ DFGL K    G     T     GT  YLAPE+     
Sbjct: 129 NVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEVLEDND 185
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI 546
              + D +  G ++ E++CGR P 
Sbjct: 186 YGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 33/252 (13%)
Query: 321 LESWELDVGPHR-------------FSYEELKKATRGFRDKELL-------GFGGFGRVY 360
           L  W  D GP R             F+  E  +    + D++LL       G G FG V 
Sbjct: 327 LAPWAADKGPQREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVK 386
Query: 361 KG--TLPSTNTQVAVKRVSNESKQ-GLR-EFASEISSIGRLRHRNLVQLLGWCRRRGDLL 416
           KG   +      VAVK + NE+    L+ E  +E + + +L +  +V+++G C      +
Sbjct: 387 KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWM 445
Query: 417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNV 476
           LV +    G L+K L  +Q   +  +    ++  V+ G+ YL E      +HRD+ A NV
Sbjct: 446 LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNV 500
Query: 477 LLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGKPTTSSDVYAFGA 534
           LL ++   ++ DFGL+K      N    +  G   + + APE     K ++ SDV++FG 
Sbjct: 501 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 560
Query: 535 LLLEVVC-GRRP 545
           L+ E    G++P
Sbjct: 561 LMWEAFSYGQKP 572

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E R R     + S L YLH E  +
Sbjct: 217 KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE--K 271
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELTRTGKP 523
            V++RD+K  N++LD + + ++ DFGL K  E   + +T +   GT  YLAPE+      
Sbjct: 272 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY 329
Query: 524 TTSSDVYAFGALLLEVVCGRRPI 546
             + D +  G ++ E++CGR P 
Sbjct: 330 GRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 29/205 (14%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKR-VSNESKQGLREFA-SEISSIGRLRHRNLVQLLGW 408
           +G G +G V+K     T   VA+K+ + +E    +++ A  EI  + +L+H NLV LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-------LTWEQRYRIIKGVASGLLYLHEE 461
            RR+  L LV+++  +  L + L   Q+ +       +TW+            + + H+ 
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE-LDRYQRGVPEHLVKSITWQ--------TLQAVNFCHK- 120
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL---- 517
                IHRD+K  N+L+      +L DFG A+L   G +      V T  Y +PEL    
Sbjct: 121 --HNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVATRWYRSPELLVGD 177
Query: 518 TRTGKPTTSSDVYAFGALLLEVVCG 542
           T+ G P    DV+A G +  E++ G
Sbjct: 178 TQYGPPV---DVWAIGCVFAELLSG 199

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG----LREFASEISSIGRLRHRNLVQ 404
           E+LGFGG   V+       +  VAVK +  +  +     LR F  E  +   L H  +V 
Sbjct: 35  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 93
Query: 405 LL--GWCRRRGDLL--LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           +   G        L  +V +++   +L   +  E    +T ++   +I      L + H+
Sbjct: 94  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 151
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELT 518
                +IHRD+K  N+++ +    ++ DFG+A+      N    T  V+GT  YL+PE  
Sbjct: 152 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
           R       SDVY+ G +L EV+ G  P
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 114/252 (45%), Gaps = 33/252 (13%)
Query: 321 LESWELDVGPHRFS-------YEELKKATRGFRDKEL-------------LGFGGFGRVY 360
           L  W  D GP R +       YE         R KE+             LG G FG V 
Sbjct: 328 LAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVK 387
Query: 361 KG--TLPSTNTQVAVKRVSNESKQ-GLR-EFASEISSIGRLRHRNLVQLLGWCRRRGDLL 416
           KG   +      VAVK + NE+    L+ E  +E + + +L +  +V+++G C      +
Sbjct: 388 KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWM 446
Query: 417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNV 476
           LV +    G L+K L  +Q   +  +    ++  V+ G+ YL E      +HRD+ A NV
Sbjct: 447 LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNV 501
Query: 477 LLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT--LGYLAPELTRTGKPTTSSDVYAFGA 534
           LL ++   ++ DFGL+K      N    +  G   + + APE     K ++ SDV++FG 
Sbjct: 502 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 561
Query: 535 LLLEVVC-GRRP 545
           L+ E    G++P
Sbjct: 562 LMWEAFSYGQKP 573

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  L  L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQ 464
               +    L  V ++   G L    F   +  +  E R R     + S L YLH E  +
Sbjct: 214 KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE--K 268
Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-VGTLGYLAPELTRTGKP 523
            V++RD+K  N++LD + + ++ DFGL K  E   + +T +   GT  YLAPE+      
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY 326
Query: 524 TTSSDVYAFGALLLEVVCGRRPI 546
             + D +  G ++ E++CGR P 
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 78  G-VITENPVWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRF 132
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ +    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 193 SDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 111/225 (49%), Gaps = 30/225 (13%)
Query: 336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIG 395
           E  +K    F+ + + G G FG V  G   ST   VA+K+V  + +   RE    +  + 
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLA 74
Query: 396 RLRHRNLVQLLGWC-----RRRGDLLL--VYDFMPNGSLDKCL---FDEQKA---ILTWE 442
            L H N+VQL  +      R R D+ L  V +++P+ +L +C    +  Q A   IL   
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKV 133
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG--RLGDFGLAKLYERGTN 500
             +++I+ +  G L+L       V HRDIK  NVL++ E +G  +L DFG AK      +
Sbjct: 134 FLFQLIRSI--GCLHL---PSVNVCHRDIKPHNVLVN-EADGTLKLCDFGSAK----KLS 183
Query: 501 PSTTRV--VGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCG 542
           PS   V  + +  Y APEL    +  TT+ D+++ G +  E++ G
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 351 LGFGGFGRVYKGTLPSTNT---QVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G       + ++ +    G L +     +K  L           +++ L YL     +  
Sbjct: 458 GVITE-NPVWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRF 512
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRDI A NVL+ +    +LGDFGL++  E  T    ++    + ++APE     + T++
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 527 SDVYAFGALLLEVVC-GRRPIE 547
           SDV+ FG  + E++  G +P +
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQ 594

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRH 399
           T  ++  E +G G F  V +     T  + A K ++ +  S +  ++   E      L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR--YRIIKGVASGLLY 457
            N+V+L       G   LV+D +  G L    F++  A   + +      I+ +   +L+
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
            H+     V+HRD+K  N+LL S+  G   +L DFGLA +  +G   +     GT GYL+
Sbjct: 119 CHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLS 174
Query: 515 PELTRT---GKPTTSSDVYAFGALLLEVVCGRRP 545
           PE+ R    GKP    D++A G +L  ++ G  P
Sbjct: 175 PEVLRKEAYGKPV---DIWACGVILYILLVGYPP 205

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNL 402
           G+  KE +G G +    +    +TN + AVK V ++SK   R+ + EI  + R  +H N+
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVK-VIDKSK---RDPSEEIEILLRYGQHPNI 83
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           + L         + LV + M  G L DK L   QK     E  + ++  +   + YLH  
Sbjct: 84  ITLKDVYDDGKHVYLVTELMRGGELLDKIL--RQKFFSEREASF-VLHTIGKTVEYLHS- 139
Query: 462 WEQTVIHRDIKAGNVLLDSELNG----RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
             Q V+HRD+K  N+L   E       R+ DFG AK   R  N        T  ++APE+
Sbjct: 140 --QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLLMTPCYTANFVAPEV 196
Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRPIE--PKALPEELI 556
            +        D+++ G LL  ++ G  P    P   PEE++
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLG 407
           E +G G +G V++G+    N  VAVK  S+ + K   RE  +E+ +   LRH N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 69
Query: 408 --WCRRRG--DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW- 462
                R     L L+  +   GSL   L   Q   L      RI+  +ASGL +LH E  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 463 ----EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGTLGYLAP 515
               +  + HRD+K+ N+L+       + D GLA ++ + TN         VGT  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 516 EL------TRTGKPTTSSDVYAFGALLLEV 539
           E+                D++AFG +L EV
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLL 406
           +E +G G FG V++G       +VAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 9   QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 64
Query: 407 G--------WCRRRGDLLLVYDFMPNGSLDKCLFDE-QKAILTWEQRYRIIKGVASGLLY 457
                    W +    L LV D+  +GSL    FD   +  +T E   ++    ASGL +
Sbjct: 65  AADNKDNGTWTQ----LWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 116
Query: 458 LHEEWEQT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGT 509
           LH E   T     + HRD+K+ N+L+       + D GLA  ++  T+    +    VGT
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 176
Query: 510 LGYLAPEL------TRTGKPTTSSDVYAFGALLLEV 539
             Y+APE+       +  +    +D+YA G +  E+
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLL 406
           E LG G F  V +        + A K ++ +  S +  ++   E      L+H N+V+L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR--YRIIKGVASGLLYLHEEWEQ 464
                 G   L++D +  G L    F++  A   + +      I+ +   +L+ H+    
Sbjct: 88  DSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQ---M 140
Query: 465 TVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT- 520
            V+HRD+K  N+LL S+L G   +L DFGLA   E G   +     GT GYL+PE+ R  
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 521 --GKPTTSSDVYAFGALLLEVVCGRRP 545
             GKP    D++A G +L  ++ G  P
Sbjct: 200 PYGKPV---DLWACGVILYILLVGYPP 223

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLG 407
           E +G G +G V++G+    N  VAVK  S+ + K   RE  +E+ +   LRH N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 69
Query: 408 --WCRRRG--DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW- 462
                R     L L+  +   GSL   L   Q   L      RI+  +ASGL +LH E  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 463 ----EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGTLGYLAP 515
               +  + HRD+K+ N+L+       + D GLA ++ + TN         VGT  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 516 EL------TRTGKPTTSSDVYAFGALLLEV 539
           E+                D++AFG +L EV
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLL 406
           +E +G G FG V++G       +VAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 8   QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 63
Query: 407 G--------WCRRRGDLLLVYDFMPNGSLDKCLFDE-QKAILTWEQRYRIIKGVASGLLY 457
                    W +    L LV D+  +GSL    FD   +  +T E   ++    ASGL +
Sbjct: 64  AADNKDNGTWTQ----LWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 115
Query: 458 LHEEWEQT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGT 509
           LH E   T     + HRD+K+ N+L+       + D GLA  ++  T+    +    VGT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 510 LGYLAPEL------TRTGKPTTSSDVYAFGALLLEV 539
             Y+APE+       +  +    +D+YA G +  E+
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLL 406
           +LG G FG+V       T    A+K +  +       +     E   +  L     +  L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 407 GWCRRRGD-LLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHE 460
             C +  D L  V +++  G L   +     F E +A+    +       ++ GL +LH+
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE-------ISIGLFFLHK 138
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLAPELTR 519
              + +I+RD+K  NV+LDSE + ++ DFG+ K  E   +  TTR   GT  Y+APE+  
Sbjct: 139 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPEIIA 193
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRPIE 547
                 S D +A+G LL E++ G+ P +
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLL 406
           +E +G G FG V++G       +VAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 14  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 69
Query: 407 G--------WCRRRGDLLLVYDFMPNGSLDKCLFDE-QKAILTWEQRYRIIKGVASGLLY 457
                    W +    L LV D+  +GSL    FD   +  +T E   ++    ASGL +
Sbjct: 70  AADNKDNGTWTQ----LWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 121
Query: 458 LHEEWEQT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGT 509
           LH E   T     + HRD+K+ N+L+       + D GLA  ++  T+    +    VGT
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 181
Query: 510 LGYLAPEL------TRTGKPTTSSDVYAFGALLLEV 539
             Y+APE+       +  +    +D+YA G +  E+
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLL 406
           +E +G G FG V++G       +VAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 11  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 66
Query: 407 G--------WCRRRGDLLLVYDFMPNGSLDKCLFDE-QKAILTWEQRYRIIKGVASGLLY 457
                    W +    L LV D+  +GSL    FD   +  +T E   ++    ASGL +
Sbjct: 67  AADNKDNGTWTQ----LWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 118
Query: 458 LHEEWEQT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGT 509
           LH E   T     + HRD+K+ N+L+       + D GLA  ++  T+    +    VGT
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 178
Query: 510 LGYLAPEL------TRTGKPTTSSDVYAFGALLLEV 539
             Y+APE+       +  +    +D+YA G +  E+
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLLG 407
           E +G G +G V++G+    N  VAVK  S+ + K   RE  +E+ +   LRH N++  + 
Sbjct: 43  ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 98
Query: 408 --WCRRRG--DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW- 462
                R     L L+  +   GSL   L   Q   L      RI+  +ASGL +LH E  
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 463 ----EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGTLGYLAP 515
               +  + HRD+K+ N+L+       + D GLA ++ + TN         VGT  Y+AP
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 516 EL------TRTGKPTTSSDVYAFGALLLEV 539
           E+                D++AFG +L EV
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 351 LGFGGFGRVYKGT-LPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRLRHRNLV 403
           +G G +G+V+K   L +    VA+KRV  ++ +       +RE A  +  +    H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 77
Query: 404 QLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
           +L   C      R   L LV++ + +  L   L    +  +  E    ++  +  GL +L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H      V+HRD+K  N+L+ S    +L DFGLA++Y      + T VV TL Y APE+ 
Sbjct: 137 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 191
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRPI 546
                 T  D+++ G +  E+   R+P+
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMF-RRKPL 218

>pdb|2JDZ|A Chain A, Crystal Structure Of Recombinant Dioclea Guianensis Lectin Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 67/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD +  H+GIDI S+RS ++               N+++G+V  A 
Sbjct: 6   IVAVELDSYPNTDIGDPSYPHIGIDIKSIRSKSTAR------------WNMQTGKVGTAH 53
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   ++ S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 54  ISYNSVAKRLSAVVSYSGTS--STTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 111
Query: 261 SF 262
           SF
Sbjct: 112 SF 113

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 30/236 (12%)
Query: 330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ--GLREF 387
           P R  Y      +  F+ K LLG G +G V   T   T   VA+K++    K    LR  
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 388 ASEISSIGRLRHRNLVQLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWE 442
             EI  +   +H N++ +    R        ++ ++ + M    L + +      +L+ +
Sbjct: 58  -REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLSDD 112
Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER----- 497
                I      +  LH      VIHRD+K  N+L++S  + ++ DFGLA++ +      
Sbjct: 113 HIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 498 ----GTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEP 548
               G        V T  Y APE+  T  K + + DV++ G +L E+   RRPI P
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR 398
           KK TR     E +G G  G VY     +T  +VA+++++ + +       +EI  +   +
Sbjct: 20  KKYTRF----EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVAS 453
           + N+V  L       +L +V +++  GSL     + C+ + Q A +  E           
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQ 127
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGY 512
            L +LH      VIHRDIK+ N+LL  + + +L DFG  A++    +  ST  +VGT  +
Sbjct: 128 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 182
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+          D+++ G + +E++ G  P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQGLREFA-SEISSIGRLRHRNL 402
           +R    LG G +G VYK     TN  VA+KR+  E  ++G+   A  E+S +  L+HRN+
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 403 VQLLGWCRRRGDLLLVYDFMPNG---SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
           ++L         L L++++  N     +DK      + I ++   Y++I GV     + H
Sbjct: 96  IELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSF--LYQLINGVN----FCH 149
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNG-----RLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
               +  +HRD+K  N+LL           ++GDFGLA+ +       T  ++ TL Y  
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRP 205
Query: 515 PELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           PE+    +  +TS D+++   +  E++  + P+ P
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFP 239

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           LG G    VY+     T    A+K +     + +    +EI  + RL H N+++L     
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 411 RRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
              ++ LV + +  G L    FD   +K   +       +K +   + YLHE     ++H
Sbjct: 119 TPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVH 171
Query: 469 RDIKAGNVLL-----DSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           RD+K  N+L      D+ L  ++ DFGL+K+ E      T  V GT GY APE+ R    
Sbjct: 172 RDLKPENLLYATPAPDAPL--KIADFGLSKIVEHQVLMKT--VCGTPGYCAPEILRGCAY 227
Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
               D+++ G +   ++CG  P
Sbjct: 228 GPEVDMWSVGIITYILLCGFEP 249

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLL 406
           +E +G G FG V++G       +VAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 102
Query: 407 G--------WCRRRGDLLLVYDFMPNGSLDKCLFDE-QKAILTWEQRYRIIKGVASGLLY 457
                    W +    L LV D+  +GSL    FD   +  +T E   ++    ASGL +
Sbjct: 103 AADNKDNGTWTQ----LWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 154
Query: 458 LHEEWEQT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGT 509
           LH E   T     + HRD+K+ N+L+       + D GLA  ++  T+    +    VGT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 510 LGYLAPEL------TRTGKPTTSSDVYAFGALLLEV 539
             Y+APE+       +  +    +D+YA G +  E+
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1QMO|E Chain E, Structure Of Fril, A Legume Lectin That Delays Hematopoietic Progenitor Maturation Length = 133

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 67/126 (53%), Gaps = 14/126 (11%)
Query: 140 HIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQA 199
           ++ AVEFDT  + ++GD N  H+GID+NS+RS  +               + ++G++  A
Sbjct: 2   NVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAK------------WDWQNGKIATA 49
Query: 200 WIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILG 259
            I Y+S    L V    +  KP +  LS+D++L  ++ E + VG S+STG     + +  
Sbjct: 50  HISYNSVSKRLSVTSYYAGSKPAT--LSYDIELHTVLPEWVRVGLSASTGQDKERNTVHS 107
Query: 260 WSFNMS 265
           WSF  S
Sbjct: 108 WSFTSS 113

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 343 RGFRDKELLGFGGFGRVYKGTL--PSTNT-QVAVKRVSNE---SKQGLREFASEISSIGR 396
           +  R  E LG G FG V +G    PS  T  VAVK +  +     + + +F  E++++  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGL 455
           L HRNL++L G       + +V +  P GSL D+    +   +L    RY +   VA G+
Sbjct: 68  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYL 513
            YL     +  IHRD+ A N+LL +    ++GDFGL +   +  +    +    +   + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           APE  +T   + +SD + FG  L E+   G+ P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2JE7|A Chain A, Crystal Structure Of Recombinant Dioclea Guianensis Lectin S131h Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 67/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD +  H+GIDI S+RS ++               N+++G+V  A 
Sbjct: 6   IVAVELDSYPNTDIGDPSYPHIGIDIKSIRSKSTAR------------WNMQTGKVGTAH 53
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   ++ S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 54  ISYNSVAKRLSAVVSYSGTS--STTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 111
Query: 261 SF 262
           SF
Sbjct: 112 SF 113

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 81  PHVCRLLGICLT-STVQLIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 136 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 190
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 234
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 235 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 343 RGFRDKELLGFGGFGRVYKGTL--PSTNT-QVAVKRVSNE---SKQGLREFASEISSIGR 396
           +  R  E LG G FG V +G    PS  T  VAVK +  +     + + +F  E++++  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGL 455
           L HRNL++L G       + +V +  P GSL D+    +   +L    RY +   VA G+
Sbjct: 78  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 134
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT---RVVGTLGY 512
            YL     +  IHRD+ A N+LL +    ++GDFGL +   +  +       R V    +
Sbjct: 135 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAW 190
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
            APE  +T   + +SD + FG  L E+   G+ P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1MVQ|A Chain A, Cratylia Mollis Lectin (Isoform 1) In Complex With Methyl-Alpha-D- Mannose Length = 236

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 20/150 (13%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD +  H+GI+I S+RS A+               ++++G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPSYQHIGINIKSIRSKATTR------------WDVQNGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL+ I+ E + VG S+STGL   ++ IL W
Sbjct: 52  ISYNSVAKRLSAVV--SYPGGSSATVSYDVDLNNILPEWVRVGLSASTGLYKETNTILSW 109
Query: 261 SF------NMSGDAKXXXXXXXXXXXGPKE 284
           SF      N + DA+            PK+
Sbjct: 110 SFTSKLKSNSTADAQSLHFTFNQFSQSPKD 139

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 78  PHVCRLLGICLT-STVQLIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 133 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 187
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 231
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 232 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 80  PHVCRLLGICLT-STVQLIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 135 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 233
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 234 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 343 RGFRDKELLGFGGFGRVYKGTL--PSTNT-QVAVKRVSNE---SKQGLREFASEISSIGR 396
           +  R  E LG G FG V +G    PS  T  VAVK +  +     + + +F  E++++  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGL 455
           L HRNL++L G       + +V +  P GSL D+    +   +L    RY +   VA G+
Sbjct: 72  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 128
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYL 513
            YL     +  IHRD+ A N+LL +    ++GDFGL +   +  +    +    +   + 
Sbjct: 129 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           APE  +T   + +SD + FG  L E+   G+ P
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 77  PHVCRLLGICLT-STVQLIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 132 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 230
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 104
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 165 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 219
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 252

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 79  PHVCRLLGICLT-STVQLIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 134 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 232
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 233 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 118/285 (41%), Gaps = 38/285 (13%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF----------DEQKAILTWEQRYRIIKGVA 452
            LLG C + G  L+++ +F   G+L   L           D  K  LT E        VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLG 511
            G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+ +Y+             L 
Sbjct: 155 KGMEFLAS---RKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAI 570
           ++APE       T  SDV++FG LL E+   G  P     + EE         R K G  
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFX------RRLKEGTR 265
Query: 571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 266 MRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2ZBJ|A Chain A, Crystal Structure Of Dioclea Rostrata Lectin Length = 237

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 65/122 (53%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD N  H+GIDI S+RS ++               N+++G+V    
Sbjct: 4   IVAVELDSYPNTDIGDPNYPHIGIDIKSIRSKSTA------------RWNMQTGKVGTVH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 52  ISYNSVAKRLSAVV--SYTGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 88
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 203
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 236

>pdb|2JEC|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Mutant E123a-H131n-K132q Complexed With 5-Bromo-4-Chloro-3- Indolyl-A-D-Mannose Length = 239

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 66/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD N  H+GIDI S+RS ++               N+++G+V    
Sbjct: 6   IVAVELDSYPNTDIGDPNYPHIGIDIKSIRSKSTAR------------WNMQTGKVGTVH 53
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   ++ S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 54  ISYNSVAKRLSAVVSYSG--SSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 111
Query: 261 SF 262
           SF
Sbjct: 112 SF 113

>pdb|1WUV|A Chain A, Crystal Structure Of Native Canavalia Gladiata Lectin (Cgl): A Tetrameric Cona-Like Lectin Length = 237

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 64/122 (52%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD N  H+GIDI S+RS  +               N+++G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPNYPHIGIDIKSVRSKKTAK------------WNMQNGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL  ++ E + VG S+STGL   ++ IL W
Sbjct: 52  IIYNSVGKRLSAVV--SYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 351 LGFGGFGRVYKGT-LPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRLRHRNLV 403
           +G G +G+V+K   L +    VA+KRV  ++ +       +RE A  +  +    H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 77
Query: 404 QLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
           +L   C      R   L LV++ + +  L   L    +  +  E    ++  +  GL +L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H      V+HRD+K  N+L+ S    +L DFGLA++Y      + T VV TL Y APE+ 
Sbjct: 137 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 191
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRPI 546
                 T  D+++ G +  E+   R+P+
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMF-RRKPL 218

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 130
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 188
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2JE9|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 66/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD N  H+GIDI S+RS ++               N+++G+V    
Sbjct: 6   IVAVELDSYPNTDIGDPNYPHIGIDIKSIRSKSTAR------------WNMQTGKVGTVH 53
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   ++ S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 54  ISYNSVAKRLSAVVSYSG--SSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 111
Query: 261 SF 262
           SF
Sbjct: 112 SF 113

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-ESKQGLREFASEISSIGRLRHRNLVQLL 406
           +E +G G FG V++G       +VAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 34  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 89
Query: 407 G--------WCRRRGDLLLVYDFMPNGSLDKCLFDE-QKAILTWEQRYRIIKGVASGLLY 457
                    W +    L LV D+  +GSL    FD   +  +T E   ++    ASGL +
Sbjct: 90  AADNKDNGTWTQ----LWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAH 141
Query: 458 LHEEWEQT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGT 509
           LH E   T     + HRD+K+ N+L+       + D GLA  ++  T+    +    VGT
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 201
Query: 510 LGYLAPEL------TRTGKPTTSSDVYAFGALLLEV 539
             Y+APE+       +  +    +D+YA G +  E+
Sbjct: 202 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 351 LGFGGFGRVYKGT-LPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRLRHRNLV 403
           +G G +G+V+K   L +    VA+KRV  ++ +       +RE A  +  +    H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 77
Query: 404 QLLGWCR-----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
           +L   C      R   L LV++ + +  L   L    +  +  E    ++  +  GL +L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H      V+HRD+K  N+L+ S    +L DFGLA++Y      + T VV TL Y APE+ 
Sbjct: 137 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 191
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRPI 546
                 T  D+++ G +  E+   R+P+
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMF-RRKPL 218

>pdb|2GDF|A Chain A, Crystal Structure Of Dioclea Violacea Seed Lectin Length = 237

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 66/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD N  H+GIDI S+RS ++               N+++G+V    
Sbjct: 4   IVAVELDSYPNTDIGDPNYPHIGIDIKSIRSKST------------ARWNMQTGKVGTVH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   ++ S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 52  ISYNSVAKRLSAVVSYSG--SSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 81
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 142 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 196
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 229

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 102 PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 157 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 211
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 255
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 256 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|3SH3|A Chain A, Crystal Structure Of A Pro-Inflammatory Lectin From The Seeds Of Dioclea Wilsonii Standl Length = 237

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 66/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD N  H+GIDI S+RS ++               N+++G+V    
Sbjct: 4   IVAVELDSYPNTDIGDPNYPHIGIDIKSIRSKST------------ARWNMQTGKVGTVH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   ++ S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 52  ISYNSVAKRLSAVVSYSG--SSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 84
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 145 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 199
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 232

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 130
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 188
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 113/239 (47%), Gaps = 33/239 (13%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNT------TLRVLGHAFYSSPIKFKNSTRNSKSLSFST 89
           N+ +  L G A +  +GKL LT        T   LG AFYSSPI+  + +  + + S++T
Sbjct: 12  NSPSFILQGDATV-SSGKLQLTKVKENGIPTPSSLGRAFYSSPIQIYDKSTGAVA-SWAT 69
Query: 90  CFAFAIVPEYTALGGHGFAFTISASKELP-GTLPSQYXXXXXXXXXXXXTN--HIFAVEF 146
            F   I     A    G AF +     +P G+ P +              N     AVEF
Sbjct: 70  SFTVKISAPSKASFADGIAFAL-----VPVGSEPRRNGGYLGVFDSDVYNNSAQTVAVEF 124
Query: 147 DTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSS 206
           DT+ +  + D +  H+GID+NS++S A+               +L +GE  +  I Y+++
Sbjct: 125 DTLSNSGW-DPSMKHIGIDVNSIKSIATVS------------WDLANGENAEILITYNAA 171
Query: 207 KNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSF 262
            + L   L   S +  S ILS  VD++  + E + VGFS++TGL      +H +L WSF
Sbjct: 172 TSLLVASLVHPS-RRTSYILSERVDITNELPEYVSVGFSATTGLSEGYIETHDVLSWSF 229

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 110
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 225
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 258

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 88
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 203
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 236

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 191
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 191
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 95
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 156 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 210
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 243

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 343 RGFRDKELLGFGGFGRVYKGTL--PSTNT-QVAVKRVSNE---SKQGLREFASEISSIGR 396
           +  R  E LG G FG V +G    PS  T  VAVK +  +     + + +F  E++++  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGL 455
           L HRNL++L G       + +V +  P GSL D+    +   +L    RY +   VA G+
Sbjct: 68  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYL 513
            YL     +  IHRD+ A N+LL +    ++GDFGL +   +  +    +    +   + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           APE  +T   + +SD + FG  L E+   G+ P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 80  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 135 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 233
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 234 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 343 RGFRDKELLGFGGFGRVYKGTL--PSTNT-QVAVKRVSNE---SKQGLREFASEISSIGR 396
           +  R  E LG G FG V +G    PS  T  VAVK +  +     + + +F  E++++  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGL 455
           L HRNL++L G       + +V +  P GSL D+    +   +L    RY +   VA G+
Sbjct: 78  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 134
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT---RVVGTLGY 512
            YL     +  IHRD+ A N+LL +    ++GDFGL +   +  +       R V    +
Sbjct: 135 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAW 190
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
            APE  +T   + +SD + FG  L E+   G+ P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 343 RGFRDKELLGFGGFGRVYKGTL--PSTNT-QVAVKRVSNE---SKQGLREFASEISSIGR 396
           +  R  E LG G FG V +G    PS  T  VAVK +  +     + + +F  E++++  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGL 455
           L HRNL++L G       + +V +  P GSL D+    +   +L    RY +   VA G+
Sbjct: 68  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYL 513
            YL     +  IHRD+ A N+LL +    ++GDFGL +   +  +    +    +   + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           APE  +T   + +SD + FG  L E+   G+ P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 77  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 132 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 230
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 83  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 137
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 138 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 192
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 236
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 237 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 34/233 (14%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIGRLRHRNL 402
           E +G G +G V       T  QVA+K++ N       +K+ LRE    +  +   +H N+
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRE----LKILKHFKHDNI 115
Query: 403 VQLLGWCRRR---GDLLLVY---DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           + +    R     G+   VY   D M    L + +   Q   LT E     +  +  GL 
Sbjct: 116 IAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP--LTLEHVRYFLYQLLRGLK 172
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG--TNPS-----TTRVVGT 509
           Y+H      VIHRD+K  N+L++     ++GDFG+A    RG  T+P+      T  V T
Sbjct: 173 YMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA----RGLCTSPAEHQYFMTEYVAT 225
Query: 510 LGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV 561
             Y APEL  +  + T + D+++ G +  E++  R+    K    +L L+  V
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 80  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 135 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 233
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 234 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3A0K|A Chain A, Crystal Structure Of An Antiflamatory Legume Lectin From Cymbosema Roseum Seeds Length = 237

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 67/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD +  H+GIDI S+RS ++               N+++G+V  A 
Sbjct: 4   IVAVELDSYPNTDIGDPSYPHIGIDIKSIRSKSTAR------------WNMQTGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   ++ S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 52  ISYNSVAKRLTAVVSYSG--SSSTTVSYDVDLTNVLPEWVRVGLSATTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 89
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 150 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 204
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 237

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 343 RGFRDKELLGFGGFGRVYKGTL--PSTNT-QVAVKRVSNE---SKQGLREFASEISSIGR 396
           +  R  E LG G FG V +G    PS  T  VAVK +  +     + + +F  E++++  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGL 455
           L HRNL++L G       + +V +  P GSL D+    +   +L    RY +   VA G+
Sbjct: 72  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 128
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYL 513
            YL     +  IHRD+ A N+LL +    ++GDFGL +   +  +    +    +   + 
Sbjct: 129 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           APE  +T   + +SD + FG  L E+   G+ P
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 77
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 138 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 192
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 225

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 84  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 139 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 237
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 238 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 191
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 191
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 80
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 141 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 195
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 228

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 110
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 225
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 258

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 79  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 134 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 232
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 233 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|1H9W|A Chain A, Native Dioclea Guianensis Seed Lectin Length = 237

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 66/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD +  H+GIDI S+RS ++               N+++G+V  A 
Sbjct: 4   IVAVELDSYPNTDIGDPSYPHIGIDIKSIRSKSTAR------------WNMQTGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 52  ISYNSVAKRLSAVV--SYTGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 113
Query: 405 LLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLLY 457
           L  +    G+      L LV D++P         +   K  L        +  +   L Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           +H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y APE
Sbjct: 174 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAPE 228
Query: 517 LTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           L       TSS DV++ G +L E++ G +PI P
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 260

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 156
Query: 405 LLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLLY 457
           L  +    G+      L LV D++P         +   K  L        +  +   L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           +H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y APE
Sbjct: 217 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAPE 271
Query: 517 LTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           L       TSS DV++ G +L E++ G +PI P
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 303

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 74  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAEGMN 128
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 129 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 183
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 227
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 228 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1H9P|A Chain A, Crystal Structure Of Dioclea Guianensis Seed Lectin Length = 237

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 66/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD +  H+GIDI S+RS ++               N+++G+V  A 
Sbjct: 4   IVAVELDSYPNTDIGDPSYPHIGIDIKSIRSKSTA------------RWNMQTGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 52  ISYNSVAKRLSAVV--SYTGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIGRLRHRNL 402
           E +G G +G V       T  QVA+K++ N       +K+ LRE    +  +   +H N+
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRE----LKILKHFKHDNI 116
Query: 403 VQLLGWCRRR---GDLLLVY---DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           + +    R     G+   VY   D M    L + +   Q   LT E     +  +  GL 
Sbjct: 117 IAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP--LTLEHVRYFLYQLLRGLK 173
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG--TNPS-----TTRVVGT 509
           Y+H      VIHRD+K  N+L++     ++GDFG+A    RG  T+P+      T  V T
Sbjct: 174 YMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA----RGLCTSPAEHQYFMTEYVAT 226
Query: 510 LGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRR 544
             Y APEL  +  + T + D+++ G +  E++  R+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 115
Query: 405 LLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLLY 457
           L  +    G+      L LV D++P         +   K  L        +  +   L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           +H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y APE
Sbjct: 176 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAPE 230
Query: 517 LTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           L       TSS DV++ G +L E++ G +PI P
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 262

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPAFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 71  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 180
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 224
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3RRD|A Chain A, Native Structure Of Dioclea Virgata Lectin Length = 237

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 66/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE D+  + + GD +  H+GIDI S+RS ++               N+++G+V  A 
Sbjct: 4   IVAVELDSYPNTDIGDPSYPHIGIDIKSVRSKSTA------------RWNMQTGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 52  ISYNSVAKRLSAVV--SYTGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 26/236 (11%)
Query: 323 SWELDVGPHR---FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV-SN 378
           S +L + P +   F+ E+LK       D   +G G +G V K     +   +AVKR+ S 
Sbjct: 6   SGKLKISPEQHWDFTAEDLK-------DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 379 ESKQGLREFASEISSIGRLRH-RNLVQLLGWCRRRGDLLLVYDFMPNGSLDK---CLFDE 434
             ++  ++   ++  + R      +VQ  G   R GD  +  + M + S DK    ++  
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSV 117
Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
              ++  E   +I       L +L E  +  +IHRDIK  N+LLD   N +L DFG++  
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISG- 174
Query: 495 YERGTNPSTTRVVGTLGYLAPE-----LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            +   + + TR  G   Y+APE      +R G     SDV++ G  L E+  GR P
Sbjct: 175 -QLVDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFP 228

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 118/285 (41%), Gaps = 38/285 (13%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF----------DEQKAILTWEQRYRIIKGVA 452
            LLG C + G  L+++ +F   G+L   L           D  K  LT E        VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLG 511
            G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+ +Y+             L 
Sbjct: 155 KGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAI 570
           ++APE       T  SDV++FG LL E+   G  P     + EE         R K G  
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLKEGTR 265
Query: 571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 266 MRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 103/212 (48%), Gaps = 12/212 (5%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLL 406
           K  LG G FG V+     S+  +  +K ++ +  Q  + +  +EI  +  L H N++++ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY--RIIKGVASGLLYLHEEWEQ 464
                  ++ +V +    G L + +   Q       + Y   ++K + + L Y H    Q
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---Q 143
Query: 465 TVIHRDIKAGNVLL-DSELNG--RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
            V+H+D+K  N+L  D+  +   ++ DFGLA+L++  ++  +T   GT  Y+APE+ +  
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAAGTALYMAPEVFKRD 201
Query: 522 KPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
             T   D+++ G ++  ++ G  P    +L E
Sbjct: 202 -VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 119/289 (41%), Gaps = 44/289 (15%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF------------DEQKAILTWEQRYRIIKG 450
            LLG C + G  L+++ +F   G+L   L             D  K  LT E        
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR---VV 507
           VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+  +   +P   R     
Sbjct: 157 VAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDAR 211
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWK 566
             L ++APE       T  SDV++FG LL E+   G  P     + EE         R K
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLK 265
Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 266 EGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2CTV|A Chain A, High Resolution Crystallographic Studies Of Native Concanavalin A Using Rapid Laue Data Collection Methods And The Introduction Of A Monochromatic Large-Angle Oscillation Technique (Lot) Length = 237

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/124 (36%), Positives = 66/124 (53%), Gaps = 18/124 (14%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD +  H+GIDI S+RS  +               N+++G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQNGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPR--SPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYIL 258
           I Y    N ++ RL+     P   S  +S+DVDL  ++ E + VG S+STGL   ++ IL
Sbjct: 52  IIY----NSVDKRLSAVVSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTIL 107
Query: 259 GWSF 262
            WSF
Sbjct: 108 SWSF 111

>pdb|2YZ4|A Chain A, The Neutron Structure Of Concanavalin A At 2.2 Angstroms Length = 237

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/124 (36%), Positives = 66/124 (53%), Gaps = 18/124 (14%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD +  H+GIDI S+RS  +               N+++G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQNGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPR--SPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYIL 258
           I Y    N ++ RL+     P   S  +S+DVDL  ++ E + VG S+STGL   ++ IL
Sbjct: 52  IIY----NSVDKRLSAVVSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTIL 107
Query: 259 GWSF 262
            WSF
Sbjct: 108 SWSF 111

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 100/231 (43%), Gaps = 24/231 (10%)
Query: 329 GPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA 388
           GPH    E L+     ++   LLG GGFG VY G   S N  VA+K V  +      E  
Sbjct: 20  GPHMKEKEPLESQ---YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 76
Query: 389 S------EISSIGRLR--HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILT 440
           +      E+  + ++      +++LL W  R    +L+ +  P    D   F  ++  L 
Sbjct: 77  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ 135
Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYER 497
            E        V   + + H      V+HRDIK  N+L+D    EL  +L DFG   L + 
Sbjct: 136 EELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK- 189
Query: 498 GTNPSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
             +   T   GT  Y  PE  R  +    S+ V++ G LL ++VCG  P E
Sbjct: 190 --DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 238

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V     QG      E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCLFDEQKAILTWEQRY--RIIKGVASGL 455
           +L  +    G+      L LV D++P  ++ +      +A  T    Y    +  +   L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
            Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y A
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRA 190
Query: 515 PELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           PEL       TSS DV++ G +L E++ G +PI P
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILIGELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLL-G 407
           +G G F  VYKG    T  +VA   + +   +K   + F  E   +  L+H N+V+    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 408 W---CRRRGDLLLVYDFMPNGSLDKCL----FDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           W    + +  ++LV +   +G+L   L      + K + +W       + +  GL +LH 
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGLQFLHT 147
Query: 461 EWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
                +IHRD+K  N+ +       ++GD GLA L +R +      V+GT  + APE   
Sbjct: 148 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKA--VIGTPEFXAPEXYE 203
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
             K   S DVYAFG   LE      P
Sbjct: 204 E-KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1CN1|A Chain A, Crystal Structure Of Demetallized Concanavalin A. The Metal- Binding Region Length = 237

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 65/122 (53%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD +  H+GIDI S+RS  +               N++ G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQDGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   ++  +    S  +S+DVDL+ ++ E + VG S+STGL   ++ IL W
Sbjct: 52  IIYNSVDKRLSAVVSYPNADATS--VSYDVDLNDVLPEWVRVGLSASTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|2CNA|A Chain A, The Covalent And Three-Dimensional Structure Of Concanavalin A, Iv.Atomic Coordinates,Hydrogen Bonding,And Quaternary Structure Length = 237

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 65/122 (53%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD +  H+GIDI S+RS  +               N++ G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQDGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   ++  +    S  +S+DVDL+ ++ E + VG S+STGL   ++ IL W
Sbjct: 52  IIYNSVDKRLSAVVSYPNADATS--VSYDVDLNDVLPEWVRVGLSASTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR 398
           KK TR     E +G G  G VY     +T  +VA+++++ + +       +EI  +   +
Sbjct: 20  KKYTRF----EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVAS 453
           + N+V  L       +L +V +++  GSL     + C+ + Q A +  E           
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQ 127
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGY 512
            L +LH      VIHRDIK+ N+LL  + + +L DFG  A++    +  S   +VGT  +
Sbjct: 128 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--EMVGTPYW 182
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+          D+++ G + +E++ G  P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K    ST  Q A K    R +  S++G+   +   E+S +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT E+    +K + +G+ YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
              + H D+K  N+ LLD  +     ++ DFGLA   + G       + GT  ++APE+ 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE--------SKQGLREFASEISSIGRLRHRNL 402
           LG G FG V+       N +V VK +  E            L +   EI+ + R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           +++L     +G   LV +   +G LD   F ++   L       I + + S + YL    
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL-- 148
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + +IHRDIK  N+++  +   +L DFG A   ERG    T    GT+ Y APE+   G 
Sbjct: 149 -KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTIEYCAPEVL-MGN 204
Query: 523 PTTSS--DVYAFGALLLEVVCGRRP 545
           P      ++++ G  L  +V    P
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V     QG      E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 191
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + D +++G G FG VY+  L  +   VA+K+V     QG      E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWEQRYRIIKGVASGLL 456
           +L  +    G+      L LV D++P         +   K  L        +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 191
Query: 516 ELTRTGKPTTSS-DVYAFGALLLEVVCGRRPIEP 548
           EL       TSS DV++ G +L E++ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K     T  + A K    R  + S++G+   E   E++ +  +RH N+
Sbjct: 18  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT ++  + +K +  G+ YLH   
Sbjct: 78  ITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLH--- 132
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
            + + H D+K  N+ LLD  +     +L DFG+A   E G       + GT  ++APE+ 
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIV 190
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR 398
           KK TR     E +G G  G VY     +T  +VA+++++ + +       +EI  +   +
Sbjct: 20  KKYTRF----EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVAS 453
           + N+V  L       +L +V +++  GSL     + C+ + Q A +  E           
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQ 127
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGY 512
            L +LH      VIHRDIK+ N+LL  + + +L DFG  A++    +  S   +VGT  +
Sbjct: 128 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYW 182
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+          D+++ G + +E++ G  P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR 398
           KK TR     E +G G  G VY     +T  +VA+++++ + +       +EI  +   +
Sbjct: 21  KKYTRF----EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 76
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVAS 453
           + N+V  L       +L +V +++  GSL     + C+ + Q A +  E           
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQ 128
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGY 512
            L +LH      VIHR+IK+ N+LL  + + +L DFG  A++    +  ST  +VGT  +
Sbjct: 129 ALEFLH---SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 183
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+          D+++ G + +E++ G  P
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 126/282 (44%), Gaps = 42/282 (14%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-----LTWEQRYRIIKGVASG 454
            ++ +LLG C     + L+   MP G L   + + +  I     L W         +A G
Sbjct: 78  PHVCRLLGICLT-STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLG 511
           + YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + 
Sbjct: 131 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIK 185
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAI 570
           ++A E       T  SDV+++G  + E++  G +P                +D   A  I
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEI 229
Query: 571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
             +++         I  +DV  + + C    A++RP  R+++
Sbjct: 230 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 19/223 (8%)
Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHR 400
           T G+  KE +G G +    +    +TN + AVK + ++SK   R+   EI  + R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK-IIDKSK---RDPTEEIEILLRYGQHP 76
Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
           N++ L         + +V + M  G L DK L   ++   +  +   ++  +   + YLH
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLH 133
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNG----RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
               Q V+HRD+K  N+L   E       R+ DFG AK   R  N        T  ++AP
Sbjct: 134 A---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCYTANFVAP 189
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE--PKALPEELI 556
           E+        + D+++ G LL  ++ G  P    P   PEE++
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 119/290 (41%), Gaps = 45/290 (15%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF-------------DEQKAILTWEQRYRIIK 449
            LLG C + G  L+++ +F   G+L   L              D  K  LT E       
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR---V 506
            VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+  +   +P   R    
Sbjct: 156 QVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDA 210
Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRW 565
              L ++APE       T  SDV++FG LL E+   G  P     + EE         R 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRL 264
Query: 566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           K G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 265 KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR 398
           KK TR     E +G G  G VY     +T  +VA+++++ + +       +EI  +   +
Sbjct: 21  KKYTRF----EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 76
Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVAS 453
           + N+V  L       +L +V +++  GSL     + C+ + Q A +  E           
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQ 128
Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGY 512
            L +LH      VIHRDIK+ N+LL  + + +L DFG  A++    +  S   +VGT  +
Sbjct: 129 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYW 183
Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+          D+++ G + +E++ G  P
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2OVU|A Chain A, Crystal Strucure Of A Lectin From Canavalia Gladiata (Cgl) In Complex With Man1-2man-Ome Length = 237

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD +  H+GIDI S+RS  +               N+++G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPDYPHIGIDIKSVRSKKTAK------------WNMQNGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL  ++ E + VG S+STGL   ++ IL W
Sbjct: 52  IIYNSVGKRLSAVV--SYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 87  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 141
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 142 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 196
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 240
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  +   C    A++RP  R+++
Sbjct: 241 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 80  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 135 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 233
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  +   C    A++RP  R+++
Sbjct: 234 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|1AZD|A Chain A, Concanavalin From Canavalia Brasiliensis Length = 237

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD +  H+GIDI S+RS  +               N+++G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQNGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL  ++ E + VG S+STGL   ++ IL W
Sbjct: 52  IIYNSVGKRLSAVV--SYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF--------------DEQKAILTWEQRYRII 448
            LLG C + G  L+++ +F   G+L   L               D  K  LT E      
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+ +Y+           
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWK 566
             L ++APE       T  SDV++FG LL E+   G  P     + EE         R K
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLK 265
Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 266 EGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1DGL|A Chain A, Lectin From Dioclea Grandiflora Complexed To Trimannoside Length = 237

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 66/122 (54%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE ++  + + GD N  H+GIDI S+RS ++               N+++G+V    
Sbjct: 4   IVAVELNSYPNTDIGDPNYPHIGIDIKSIRSKSTAR------------WNMQTGKVGTVH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   ++ S     S  +S+DVDL+ ++ E + VG S++TGL   ++ IL W
Sbjct: 52  ISYNSVAKRLSAVVSYSG--SSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 77  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 132 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 230
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  +   C    A++RP  R+++
Sbjct: 231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|1IOA|A Chain A, Arcelin-5, A Lectin-Like Defense Protein From Phaseolus Vulgaris Length = 240

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 99/242 (40%), Gaps = 34/242 (14%)
Query: 30  GFRDAANNNNMSLNGAAEIEKNGKLMLT----NTTLRV--LGHAFYSSPIKFKNSTRNSK 83
            F +   ++ + L G A I   G+L LT    N   RV  LG AFYS PI+ K+S   + 
Sbjct: 7   NFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS---NN 63
Query: 84  SLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFA 143
             SF+T F F I  +  ++  +G AF +      P     Q                  A
Sbjct: 64  VASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQ--KKQEFLGIFNTNNPEPNARTVA 121
Query: 144 VEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDY 203
           V F+T K         N +  D N ++   +E   +   N          GE     I Y
Sbjct: 122 VVFNTFK---------NRIDFDKNFIKPYVNENCDFHKYN----------GEKTDVQITY 162
Query: 204 DSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGW 260
           DSS N L V L  +  + +  + S  V L   V E + VGFS ++GL      +H +L W
Sbjct: 163 DSSNNDLRVFLHFTVSQVKCSV-SATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSW 221
Query: 261 SF 262
           SF
Sbjct: 222 SF 223

>pdb|2CWM|A Chain A, Native Crystal Structure Of No Releasing Inductive Lectin From Seeds Of The Canavalia Maritima (Conm) Length = 237

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD +  H+GIDI S+RS  +               N+++G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQNGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL  ++ E + VG S+STGL   ++ IL W
Sbjct: 52  IIYNSVGKRLSAVV--SYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 126/282 (44%), Gaps = 42/282 (14%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-----LTWEQRYRIIKGVASG 454
            ++ +LLG C     + L+   MP G L   + + +  I     L W         +A G
Sbjct: 77  PHVCRLLGICLT-STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLG 511
           + YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + 
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIK 184
Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAI 570
           ++A E       T  SDV+++G  + E++  G +P                +D   A  I
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEI 228
Query: 571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
             +++         I  +DV  + + C    A++RP  R+++
Sbjct: 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGT 509
           +A GL +L     + +I+RD+K  NV+LDSE + ++ DFG+ K  E   +  TT+   GT
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGT 184
Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
             Y+APE+        S D +AFG LL E++ G+ P E
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++L  G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 84  PHVCRLLGICLT-STVQLIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 139 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 237
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 238 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF--------------DEQKAILTWEQRYRII 448
            LLG C + G  L+++ +F   G+L   L               D  K  LT E      
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--- 505
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+  +   +P   R   
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGD 209
Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDR 564
               L ++APE       T  SDV++FG LL E+   G  P     + EE         R
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RR 263
Query: 565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            K G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 264 LKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 92/347 (26%), Positives = 149/347 (42%), Gaps = 45/347 (12%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRV---SNESKQGL--REFASEISSIGRLRHRNLV 403
           E++G G F  V +     T  Q AVK V      S  GL   +   E S    L+H ++V
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY--RIIKGVASGLLYLHEE 461
           +LL      G L +V++FM    L   +     A   + +      ++ +   L Y H  
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-- 149
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPEL 517
            +  +IHRD+K   VLL S+ N    +LG FG+A +L E G        VGT  ++APE+
Sbjct: 150 -DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEV 206
Query: 518 TRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV 574
            +    GKP    DV+  G +L  ++ G  P       +E +    +  ++K       +
Sbjct: 207 VKREPYGKPV---DVWGCGVILFILLSGCLPFYGT---KERLFEGIIKGKYK-------M 253
Query: 575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEA--------RPTMRQVVRYLEGEVPLPQAVA 626
           +PR     +E  A D+V+  LM   D AE          P +++  RY   ++ LP+ V 
Sbjct: 254 NPRQWSHISE-SAKDLVRRMLML--DPAERITVYEALNHPWLKERDRYAY-KIHLPETVE 309
Query: 627 APDACDGKKEKTSGGGAGVDGPEFEDFVYSYPNSSLLEKVSNWSSAG 673
                + +++      A V   +F  F Y  P   L +   + +S+G
Sbjct: 310 QLRKFNARRKLKGAVLAAVSSHKFNSF-YGDPPEELPDFSEDPTSSG 355

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF--------------DEQKAILTWEQRYRII 448
            LLG C + G  L+++ +F   G+L   L               D  K  LT E      
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+ +Y+           
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWK 566
             L ++APE       T  SDV++FG LL E+   G  P     + EE         R K
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLK 265
Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 266 EGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----RVSNESKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K     T  + A K    R  + S++G+   E   E++ +  +RH N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT ++  + +K +  G+ YLH   
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLH--- 125
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
            + + H D+K  N+ LLD  +     +L DFG+A   E G       + GT  ++APE+ 
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIV 183
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 350 LLGFGGFGRVYKGTLPS---TNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQL 405
           +LG G FG VY+G   +       VAVK    +     +E F SE   +  L H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
           +G        +++ +  P G L   L   + ++         ++ +   + YL       
Sbjct: 79  IGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQ-ICKAMAYLES---IN 133
Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT--NPSTTRVVGTLGYLAPELTRTGKP 523
            +HRDI   N+L+ S    +LGDFGL++  E       S TR+   + +++PE     + 
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 524 TTSSDVYAFGALLLEVVC-GRRP 545
           TT+SDV+ F   + E++  G++P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214

>pdb|2OW4|A Chain A, Crystal Structure Of A Lectin From Canavalia Maritima Seeds (Conm) In Complex With Man1-2man-Ome Length = 237

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 14/122 (11%)
Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVE DT  + + GD +  H+GIDI S+RS  +               N+++G+V  A 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQNGKVGTAH 51
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           I Y+S    L   +  S     S  +S+DVDL  ++ E + VG S+STGL   ++ IL W
Sbjct: 52  IIYNSVGKRLSAVV--SYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSW 109
Query: 261 SF 262
           SF
Sbjct: 110 SF 111

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 350 LLGFGGFGRVYKGTLPS---TNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQL 405
           +LG G FG VY+G   +       VAVK    +     +E F SE   +  L H ++V+L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
           +G        +++ +  P G L   L   + ++         ++ +   + YL       
Sbjct: 75  IGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQ-ICKAMAYLES---IN 129
Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT--NPSTTRVVGTLGYLAPELTRTGKP 523
            +HRDI   N+L+ S    +LGDFGL++  E       S TR+   + +++PE     + 
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 187
Query: 524 TTSSDVYAFGALLLEVVC-GRRP 545
           TT+SDV+ F   + E++  G++P
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQP 210

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF--------------DEQKAILTWEQRYRII 448
            LLG C + G  L+++ +F   G+L   L               D  K  LT E      
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--- 505
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+  +   +P   R   
Sbjct: 146 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGD 200
Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDR 564
               L ++APE       T  SDV++FG LL E+   G  P     + EE         R
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RR 254
Query: 565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            K G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 255 LKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF--------------DEQKAILTWEQRYRII 448
            LLG C + G  L+++ +F   G+L   L               D  K  LT E      
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+ +Y+           
Sbjct: 157 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWK 566
             L ++APE       T  SDV++FG LL E+   G  P     + EE         R K
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLK 267
Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 268 EGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 350 LLGFGGFGRVYKGTLPS---TNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQL 405
           +LG G FG VY+G   +       VAVK    +     +E F SE   +  L H ++V+L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
           +G        +++ +  P G L   L   + ++         ++ +   + YL       
Sbjct: 91  IGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQ-ICKAMAYLES---IN 145
Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT--NPSTTRVVGTLGYLAPELTRTGKP 523
            +HRDI   N+L+ S    +LGDFGL++  E       S TR+   + +++PE     + 
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 203
Query: 524 TTSSDVYAFGALLLEVVC-GRRP 545
           TT+SDV+ F   + E++  G++P
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQP 226

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 49/297 (16%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLV 403
           LG G FG+V + T            VAVK +   +    RE   SE+  +  L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG------------- 450
            LLG C   G  L++ ++   G L   L  ++ + +  +    I++              
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 451 ---VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
              VA G+ +L     +  IHRD+ A N+LL      ++ DFGLA+  +   N S   V 
Sbjct: 174 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARHIK---NDSNYVVK 227
Query: 508 GT----LGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVW 562
           G     + ++APE       T  SDV+++G  L E+   G  P     +P +      + 
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--GMPVDSKFYKMIK 285
Query: 563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           + ++           L+ E    E  D++K    C +     RPT +Q+V+ +E ++
Sbjct: 286 EGFRM----------LSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQI 329

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF--------------DEQKAILTWEQRYRII 448
            LLG C + G  L+++ +F   G+L   L               D  K  LT E      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--- 505
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+  +   +P   R   
Sbjct: 146 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGD 200
Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDR 564
               L ++APE       T  SDV++FG LL E+   G  P     + EE         R
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RR 254
Query: 565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            K G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 255 LKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 114/239 (47%), Gaps = 33/239 (13%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNT------TLRVLGHAFYSSPIKFKNSTRNSKSLSFST 89
           N+++  L G A +  + KL LT        TL  LG AFYSSPI+  + +  + + S++T
Sbjct: 12  NSSSFILQGDATVSSS-KLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVA-SWAT 69
Query: 90  CFAFAIVPEYTALGGHGFAFTISASKELP-GTLPSQYXXXXXXXXXXXXTN--HIFAVEF 146
            F   I     +    G AF +     +P G+ P                N     AVEF
Sbjct: 70  SFTANIFAPNKSSSADGIAFAL-----VPVGSEPKSNSGFLGVFDSDVYDNSAQTVAVEF 124
Query: 147 DTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSS 206
           DT  + ++ D    H+GID+NS++S         +  ++  + N ++ E++   I Y+++
Sbjct: 125 DTFSNTDW-DPTSRHIGIDVNSIKS---------IRTASWGLANGQNAEIL---ITYNAA 171
Query: 207 KNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYILGWSF 262
            + L   L   S +  S I+S  VD++  + E + +GFS++TGL      +H +L WSF
Sbjct: 172 TSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSF 229

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF--------------DEQKAILTWEQRYRII 448
            LLG C + G  L+++ +F   G+L   L               D  K  LT E      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+ +Y+           
Sbjct: 146 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWK 566
             L ++APE       T  SDV++FG LL E+   G  P     + EE         R K
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLK 256
Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 257 EGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 81  PHVCRLLGICLT-STVQLIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFG AKL    E+  +    +V   + ++
Sbjct: 136 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 190
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 234
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 235 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 49/297 (16%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLV 403
           LG G FG+V + T            VAVK +   +    RE   SE+  +  L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG------------- 450
            LLG C   G  L++ ++   G L   L  ++ + +  +    I++              
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 451 ---VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
              VA G+ +L     +  IHRD+ A N+LL      ++ DFGLA+  +   N S   V 
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK---NDSNYVVK 204
Query: 508 GT----LGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVW 562
           G     + ++APE       T  SDV+++G  L E+   G  P     +P +      + 
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--GMPVDSKFYKMIK 262
Query: 563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           + ++           L+ E    E  D++K    C +     RPT +Q+V+ +E ++
Sbjct: 263 EGFRM----------LSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQI 306

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++L  G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 77  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 132 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 230
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGT 509
           +A GL +L     + +I+RD+K  NV+LDSE + ++ DFG+ K  E   +  TT+   GT
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGT 505
Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
             Y+APE+        S D +AFG LL E++ G+ P E
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++L  G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 84  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 139 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 237
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 238 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE----SKQGL--REFASEISSIGRLRHRNL 402
           E LG G F  V K     T  + A K +       S++G+   E   E++ +  +RH N+
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           + L      + D++L+ + +  G L   L   +K  LT ++  + +K +  G+ YLH   
Sbjct: 92  ITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLH--- 146
Query: 463 EQTVIHRDIKAGNV-LLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
            + + H D+K  N+ LLD  +     +L DFG+A   E G       + GT  ++APE+ 
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIV 204
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
                   +D+++ G +   ++ G  P
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 79  PHVCRLLGICLT-STVQLIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFG AKL    E+  +    +V   + ++
Sbjct: 134 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 232
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 233 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF--------------DEQKAILTWEQRYRII 448
            LLG C + G  L+++ +F   G+L   L               D  K  LT E      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+ +Y+           
Sbjct: 146 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWK 566
             L ++APE       T  SDV++FG LL E+   G  P     + EE         R K
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLK 256
Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 257 EGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSIGRL-RHRNLV 403
           LG G FG+V +         +T   VAVK +   +     R   SE+  +  +  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 404 QLLGWCRRRG-DLLLVYDFMPNGSLDKCLF--------------DEQKAILTWEQRYRII 448
            LLG C + G  L+++ +F   G+L   L               D  K  LT E      
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+ +Y+           
Sbjct: 192 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWK 566
             L ++APE       T  SDV++FG LL E+   G  P     + EE         R K
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLK 302
Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
            G  +   D             ++ +  L C +     RPT  ++V +L
Sbjct: 303 EGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRV---SNESKQGL--REFASEISSIGRLRHRNLV 403
           E++G G F  V +     T  Q AVK V      S  GL   +   E S    L+H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY--RIIKGVASGLLYLHEE 461
           +LL      G L +V++FM    L   +     A   + +      ++ +   L Y H  
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-- 147
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPEL 517
            +  +IHRD+K   VLL S+ N    +LG FG+A +L E G        VGT  ++APE+
Sbjct: 148 -DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEV 204
Query: 518 TRT---GKPTTSSDVYAFGALLLEVVCGRRP 545
            +    GKP    DV+  G +L  ++ G  P
Sbjct: 205 VKREPYGKPV---DVWGCGVILFILLSGCLP 232

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 77  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFG AKL    E+  +    +V   + ++
Sbjct: 132 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 230
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 123/280 (43%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL-----REFASEISSIGRLRH 399
           F+  ++LG G FG VYKG       +V +     E ++       +E   E   +  + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 111 PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 165
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFGLAKL    E+  +    +V   + ++
Sbjct: 166 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 220
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 264
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 265 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 49/297 (16%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLV 403
           LG G FG+V + T            VAVK +   +    RE   SE+  +  L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG------------- 450
            LLG C   G  L++ ++   G L   L  ++ + +  +    I++              
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 451 ---VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
              VA G+ +L     +  IHRD+ A N+LL      ++ DFGLA+  +   N S   V 
Sbjct: 169 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK---NDSNYVVK 222
Query: 508 GT----LGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVW 562
           G     + ++APE       T  SDV+++G  L E+   G  P     +P +      + 
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--GMPVDSKFYKMIK 280
Query: 563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           + ++           L+ E    E  D++K    C +     RPT +Q+V+ +E ++
Sbjct: 281 EGFRM----------LSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQI 324

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVA-----VKRVSNESKQGLREFASEISSIGR 396
           T  ++  E LG G F  V +        + A      K++S    Q L E  + I  +  
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL-EREARICRL-- 66
Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR--YRIIKGVASG 454
           L+H N+V+L       G   L++D +  G L    F++  A   + +      I+ +   
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEA 122
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLG 511
           +L+ H+     V+HR++K  N+LL S+L G   +L DFGLA   E G   +     GT G
Sbjct: 123 VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPG 178
Query: 512 YLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRP 545
           YL+PE+ R    GKP    D++A G +L  ++ G  P
Sbjct: 179 YLSPEVLRKDPYGKPV---DLWACGVILYILLVGYPP 212

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 71  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 128 -NXGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 181
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 49/297 (16%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLV 403
           LG G FG+V + T            VAVK +   +    RE   SE+  +  L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG------------- 450
            LLG C   G  L++ ++   G L   L  ++ + +  +    I++              
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 451 ---VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
              VA G+ +L     +  IHRD+ A N+LL      ++ DFGLA+  +   N S   V 
Sbjct: 167 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK---NDSNYVVK 220
Query: 508 GT----LGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVW 562
           G     + ++APE       T  SDV+++G  L E+   G  P     +P +      + 
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--GMPVDSKFYKMIK 278
Query: 563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           + ++           L+ E    E  D++K    C +     RPT +Q+V+ +E ++
Sbjct: 279 EGFRM----------LSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQI 322

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 350 LLGFGGFGRVY---KGTLPSTNTQVAVKRVSN----ESKQGLREFASEISSIGRLRHRNL 402
           +LG GG+G+V+   K T  +T    A+K +       + +      +E + +  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V L+   +  G L L+ +++  G L   L  E++ I   +     +  ++  L +LH+  
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMALGHLHQ-- 139
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAPELTRTG 521
            + +I+RD+K  N++L+ + + +L DFGL K     GT   T    GT+ Y+APE+    
Sbjct: 140 -KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAPEILMRS 196
Query: 522 KPTTSSDVYAFGALLLEVVCGRRPI 546
               + D ++ GAL+ +++ G  P 
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 350 LLGFGGFGRVY---KGTLPSTNTQVAVKRVSN----ESKQGLREFASEISSIGRLRHRNL 402
           +LG GG+G+V+   K T  +T    A+K +       + +      +E + +  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V L+   +  G L L+ +++  G L   L  E++ I   +     +  ++  L +LH+  
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMALGHLHQ-- 139
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAPELTRTG 521
            + +I+RD+K  N++L+ + + +L DFGL K     GT   T    GT+ Y+APE+    
Sbjct: 140 -KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRS 196
Query: 522 KPTTSSDVYAFGALLLEVVCGRRPI 546
               + D ++ GAL+ +++ G  P 
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 49/297 (16%)
Query: 351 LGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQGLRE-FASEISSIGRL-RHRNLV 403
           LG G FG+V + T            VAVK +   +    RE   SE+  +  L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG------------- 450
            LLG C   G  L++ ++   G L   L  ++ + +  +    I++              
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 451 ---VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
              VA G+ +L     +  IHRD+ A N+LL      ++ DFGLA+  +   N S   V 
Sbjct: 174 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK---NDSNYVVK 227
Query: 508 GT----LGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVW 562
           G     + ++APE       T  SDV+++G  L E+   G  P     +P +      + 
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--GMPVDSKFYKMIK 285
Query: 563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           + ++           L+ E    E  D++K    C +     RPT +Q+V+ +E ++
Sbjct: 286 EGFRM----------LSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQI 329

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 160
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 161 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 214
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 160
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 161 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 214
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 76  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 132
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 186
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + +G G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V ++MP G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + +G G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V ++MP G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 160
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 161 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 214
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 159
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 160 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 213
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 159
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 160 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 213
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 160
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 161 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 214
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 84  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFG AKL    E+  +    +V   + ++
Sbjct: 139 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 237
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    A++RP  R+++
Sbjct: 238 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 90  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 146
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 147 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 200
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 90  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 146
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 147 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 200
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 76  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 132
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D  LN    +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 133 -NCGVLHRDIKDENILID--LNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 186
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 91  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 147
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 148 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 201
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 159
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 160 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 213
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 91  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 147
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 148 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 201
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 118 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 174
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 175 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 228
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 159
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 160 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 213
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 71  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 181
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 76  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 132
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 186
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 91  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 147
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 148 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 201
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 118 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 174
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 175 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 228
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 75  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 131
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 132 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 185
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 74  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 130
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 131 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 184
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 4   FYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 63
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC      A 
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------AK 117
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 170
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILT 440
              E+  +  ++H N++ LL             D+ LV   M  G+    +   QK  LT
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQK--LT 123
Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN 500
            +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R T+
Sbjct: 124 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLA----RHTD 176
Query: 501 PSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
              T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILT 440
              E+  +  ++H N++ LL             D+ LV   M  G+    +   QK  LT
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQK--LT 123
Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN 500
            +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R T+
Sbjct: 124 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTD 176
Query: 501 PSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
              T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRV-SNESKQGLREFASEISSIGRLRH 399
            R  ++LG G FG VYKG  +P   +    VA+K +  N S +  +E   E   +  +  
Sbjct: 19  LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 78
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
             + +LLG C     + LV   MP G    CL D   E +  L  +        +A G+ 
Sbjct: 79  PYVSRLLGICLT-STVQLVTQLMPYG----CLLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG---TLGYL 513
           YL +     ++HRD+ A NVL+ S  + ++ DFGLA+L +   + +     G    + ++
Sbjct: 134 YLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIKWM 188
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E     + T  SDV+++G  + E++  G +P                +D   A  I +
Sbjct: 189 ALESILRRRFTHQSDVWSYGVTVWELMTFGAKP----------------YDGIPAREIPD 232
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  + + C    +E RP  R++V
Sbjct: 233 LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 272

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWC 409
           LG G F    K     +N   AVK +S   +   ++   EI+++     H N+V+L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHR 469
             +    LV + +  G L + +  ++K   +  +   I++ + S + ++H+     V+HR
Sbjct: 76  HDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHR 130
Query: 470 DIKAGNVLLDSE---LNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           D+K  N+L   E   L  ++ DFG A+L      P  T    TL Y APEL        S
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDES 189
Query: 527 SDVYAFGALLLEVVCGRRPIE 547
            D+++ G +L  ++ G+ P +
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQ 210

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 13  FYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 72
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 73  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 126
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLA----RH 179
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 110 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 166
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 220
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 71  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 181
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ +  P    D   F  ++  L  E        V   + + H  
Sbjct: 123 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 179
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 180 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 233
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 14  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 73
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 74  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 127
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 180
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 63
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 117
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA----RH 170
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 14  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 73
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 74  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 127
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 180
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 13  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 72
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 73  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 126
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 179
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 7   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 66
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 67  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 120
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 121 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 173
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 174 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 15  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 75  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 128
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 181
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 182 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHRNL 402
           +RD + +G G +G V       T  +VA+K++    +S+   +    E+  +  +RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 403 VQLLG------WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR-IIKGVASGL 455
           + LL             D  LV  FM    L K +  E+      E R + ++  +  GL
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLG----EDRIQFLVYQMLKGL 141
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
            Y+H      +IHRD+K GN+ ++ +   ++ DFGLA    R  +      V T  Y AP
Sbjct: 142 RYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMXGXVVTRWYRAP 194
Query: 516 ELTRT-GKPTTSSDVYAFGALLLEVVCGR 543
           E+     + T + D+++ G ++ E++ G+
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 13  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 72
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 73  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 126
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 179
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 14  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 73
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 74  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 127
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 180
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 5   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 64
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 65  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 118
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 171
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G +G V       T  +VAVK++S   +S    +    E+  +  ++H N++ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 409 ------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
                      D+ LV   M     ++ KC    QK  LT +    +I  +  GL Y+H 
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK--LTDDHVQFLIYQILRGLKYIHS 153
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
                +IHRD+K  N+ ++ +   ++ DFGLA    R T+   T  V T  Y APE+   
Sbjct: 154 ---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLN 206
Query: 521 GKPTTSS-DVYAFGALLLEVVCGR 543
                 + D+++ G ++ E++ GR
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 79  PHVCRLLGICLT-STVQLIMQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFG AKL    E+  +    +V   + ++
Sbjct: 134 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 232
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  +   C    A++RP  R+++
Sbjct: 233 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 20  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR 79
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 80  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 133
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 186
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 10  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 69
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 70  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 123
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 176
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 5   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 64
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 65  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 118
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 171
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 10  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 69
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 70  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 123
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 176
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 13  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 72
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 73  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 126
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLA----RH 179
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L+E    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V ++ P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+++D +   ++ DFGLAK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 117
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA----RH 170
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 6   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 65
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 66  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 119
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 120 LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA----RH 172
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 173 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 19  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 78
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 79  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 132
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 185
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 10  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 69
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 70  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 123
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 176
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 20  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 79
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 80  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 133
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 186
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 19  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 78
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 79  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 132
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLA----RH 185
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 20  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 79
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 80  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 133
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 186
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 36/213 (16%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLVQLLG-- 407
           +G G +G V+ G       +VAVK   + E     RE  +EI     +RH N++  +   
Sbjct: 45  IGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAAD 100
Query: 408 ------WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
                 W +    L L+ D+  NGSL   L   +   L  +   ++     SGL +LH E
Sbjct: 101 IKGTGSWTQ----LYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 462 WEQT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN----PSTTRVVGTLGY 512
              T     + HRD+K+ N+L+       + D GLA  +   TN    P  TR VGT  Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-VGTKRY 212
Query: 513 LAPE-----LTRTG-KPTTSSDVYAFGALLLEV 539
           + PE     L R   +    +D+Y+FG +L EV
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 27  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 86
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 87  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 140
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 193
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 28  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 87
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 88  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 141
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 194
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 38/280 (13%)
Query: 345 FRDKELLGFGGFGRVYKGT-LP---STNTQVAVKRVSN-ESKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG  +P        VA+K +    S +  +E   E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLL 456
            ++ +LLG C     + L+   MP G    CL D   E K  +  +        +A G+ 
Sbjct: 79  PHVCRLLGICLT-STVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYL 513
           YL +   + ++HRD+ A NVL+ +  + ++ DFG AKL    E+  +    +V   + ++
Sbjct: 134 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           A E       T  SDV+++G  + E++  G +P                +D   A  I  
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISS 232
Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
           +++         I  +DV  +   C    A++RP  R+++
Sbjct: 233 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 23/230 (10%)
Query: 37  NNNMSLNGAAEIEKNGKLMLTN-TTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI 95
           N  ++  G   +  NG + LTN   +  +G   Y+ P++  +S   + + SF T F+F +
Sbjct: 15  NPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVA-SFLTSFSFEM 73
Query: 96  --VPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFE 153
             + +Y    G  F F      ++P                     H   VEFDT  + E
Sbjct: 74  KDIKDYDPADGIIF-FIAPEDTQIPA---GSIGGGTLGVSDTKGAGHFVGVEFDTYSNSE 129
Query: 154 FGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVR 213
           + D   +HVGID+NS+ S  + P             N  SG V++  + YDSS   L V 
Sbjct: 130 YNDPPTDHVGIDVNSVDSVKTVP------------WNSVSGAVVKVTVIYDSSTKTLSVA 177
Query: 214 LAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASS-HYILGWSF 262
           +   +    +  ++  VDL   + E +  GFS+S  L     H I  WSF
Sbjct: 178 VTNDNGDITT--IAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSF 225

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 28  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 87
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 88  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 141
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 194
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 27  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 86
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 87  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 140
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 193
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2PEL|A Chain A, Peanut Lectin Length = 236

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 23/230 (10%)
Query: 37  NNNMSLNGAAEIEKNGKLMLTN-TTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI 95
           N  ++  G   +  NG + LTN   +  +G   Y+ P++  +S   + + SF T F+F +
Sbjct: 15  NPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVA-SFLTSFSFEM 73
Query: 96  --VPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFE 153
             + +Y    G  F F      ++P                     H   VEFDT  + E
Sbjct: 74  KDIKDYDPADGIIF-FIAPEDTQIPA---GSIGGGTLGVSDTKGAGHFVGVEFDTYSNSE 129
Query: 154 FGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVR 213
           + D   +HVGID+NS+ S  + P             N  SG V++  + YDSS   L V 
Sbjct: 130 YNDPPTDHVGIDVNSVDSVKTVP------------WNSVSGAVVKVTVIYDSSTKTLSV- 176
Query: 214 LAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASS-HYILGWSF 262
            A ++       ++  VDL   + E +  GFS+S  L     H I  WSF
Sbjct: 177 -AVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSF 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 31  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 90
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 91  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 144
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 145 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 197
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 198 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L+E    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V ++ P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+++D +   ++ DFGLAK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 148
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 201
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 244

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLR--HRN 401
           LLG GGFG VY G   S N  VA+K V  +      E  +      E+  + ++      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++LL W  R    +L+ + M     D   F  ++  L  E        V   + + H  
Sbjct: 75  VIRLLDWFERPDSFVLILERM-EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 131
Query: 462 WEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               V+HRDIK  N+L+D    EL  +L DFG   L +   +   T   GT  Y  PE  
Sbjct: 132 -NCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 185
Query: 519 RTGK-PTTSSDVYAFGALLLEVVCGRRPIE 547
           R  +    S+ V++ G LL ++VCG  P E
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/242 (31%), Positives = 103/242 (42%), Gaps = 33/242 (13%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFST 89
           N+  ++L   A I+ NG L LT  T       +  G A Y+ PIK  +ST  + + SF T
Sbjct: 13  NSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVA-SFET 71
Query: 90  CFAFAIVPEYT-ALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDT 148
            F+F I   Y       G  F +     +P   P                ++ FAVEFDT
Sbjct: 72  RFSFNITQPYAYPEPADGLTFFM-----VPPNSPQGEDGGNLGVFKPPEGDNAFAVEFDT 126
Query: 149 VKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKN 208
            ++    D    H+GID+NS+ S  S+   + LEN          G V    I YDS   
Sbjct: 127 FQNT--WDPQVPHIGIDVNSIVS--SKTLHFQLEN----------GGVANVVIKYDSPTK 172
Query: 209 HLEVRLAPSSVKPRSPILSFDVDLSPIV--KETMYVGFSSSTGL---LASSHYILGWSFN 263
            L V LA  SV      LS  VDL       E + VG S++TG       +H I+ WSF 
Sbjct: 173 ILNVVLAFHSVGTVY-TLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFT 231
Query: 264 MS 265
            S
Sbjct: 232 SS 233

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 14  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 73
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 74  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 127
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLA----RH 180
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           + D + LG GG G V+       + +VA+K++     Q ++    EI  I RL H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 405 L--------------LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR---YRI 447
           +              +G       + +V ++M     D     EQ  +L    R   Y++
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---DLANVLEQGPLLEEHARLFMYQL 129
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLYERGTNPSTTRV 506
           ++    GL Y+H      V+HRD+K  N+ +++E L  ++GDFGLA++ +   +      
Sbjct: 130 LR----GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 507 VG--TLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
            G  T  Y +P L  +    T + D++A G +  E++ G+
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 10  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 69
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 70  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 123
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLA----RH 176
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFE 148
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 201
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 244

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G +G V       +  +VA+K++S   +S+   +    E+  +  ++H N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 409 CRRRGDLLLVYDF---MP--NGSLDKCL---FDEQKAILTWEQRYRIIKGVASGLLYLHE 460
                 L   YDF   MP     L K +   F E+K       +Y ++  +  GL Y+H 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI------QY-LVYQMLKGLKYIHS 144
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
                V+HRD+K GN+ ++ +   ++ DFGLA    R  +   T  V T  Y APE+  +
Sbjct: 145 A---GVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGYVVTRWYRAPEVILS 197
Query: 521 GKPTTSS-DVYAFGALLLEVVCGR 543
                 + D+++ G ++ E++ G+
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 349 ELLGFGGFGRVYKGTLPST-------NTQVAVKRVSNESKQGLREFASEISSIGRLRHRN 401
           E LG G F +++KG             T+V +K +    +     F    S + +L H++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-LTWEQRYRIIKGVASGLLYLHE 460
           LV   G C    + +LV +F+  GSLD  L   +  I + W  +  + K +A+ + +L  
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE- 130
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR---VVGTLGYLAPEL 517
             E T+IH ++ A N+LL  E + + G+    KL + G + +      +   + ++ PE 
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 518 TRTGKP-TTSSDVYAFGALLLEVVCG 542
               K    ++D ++FG  L E+  G
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 46/270 (17%)
Query: 350 LLGFGGFGRVYKGTL---PSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQL 405
           ++G G FG VY G          Q A+K +S  ++ Q +  F  E   +  L H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-------VASGLLYL 458
           +G       ++L  + +P+  L      +    +   QR   +K        VA G+ YL
Sbjct: 88  IG-------IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAP 515
            E   Q  +HRD+ A N +LD     ++ DFGLA+ + +R            L   + A 
Sbjct: 141 AE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVC--------------------GRRPIEPKALPEEL 555
           E  +T + TT SDV++FG LL E++                     GRR  +P+  P+ L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257
Query: 556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEI 585
             V  +   W+A   +      L GE  +I
Sbjct: 258 YQV--MQQCWEADPAVRPTFRVLVGEVEQI 285

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS 389
           P  F  +  ++ +R       LG G +G V+K          AVKR S    +G ++ A 
Sbjct: 51  PESFFQQSFQRLSR-------LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRAR 102
Query: 390 EISSIGRL----RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY 445
           +++ +G      +H   V+L       G L L  +         C  +   A L   Q +
Sbjct: 103 KLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHC--EAWGASLPEAQVW 160
Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
             ++     L +LH    Q ++H D+K  N+ L      +LGDFGL  L E GT  +   
Sbjct: 161 GYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEV 215
Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC 541
             G   Y+APEL + G   T++DV++ G  +LEV C
Sbjct: 216 QEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVAC 250

>pdb|1GSL|A Chain A, Lectin (Fourth Isolated From (Griffonia Simplicifolia)) Complex With Y Human Blood Group Determinant Length = 243

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 65  GHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTI----SASKELPGT 120
           G A YS P+   +ST   K+ SF T F F ++  Y A    G AF +    S+ K+  G 
Sbjct: 52  GQASYSEPVFLWDST--GKAASFYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKDYGGF 108
Query: 121 LPSQYXXXXXXXXXXXXTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYF 180
           L                 N + AVEFDT  + ++ D    H+GID+NS+ S A+      
Sbjct: 109 L----GLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTR---- 160
Query: 181 LENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETM 240
            EN      +     +  A I YD+    L V L  S    R  ILS  VDL+ ++ + +
Sbjct: 161 WEND-----DAYGSSIATAHITYDARSKILTVLL--SYEHGRDYILSHVVDLAKVLPQKV 213
Query: 241 YVGFSSSTGLLASSHYILGWSF 262
            +GFS+  G    + YIL W F
Sbjct: 214 RIGFSAGVGYDEVT-YILSWHF 234

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ D+GLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 19/223 (8%)
Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHR 400
           T G+  KE +G G +    +    +TN + AVK + ++SK   R+   EI  + R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVK-IIDKSK---RDPTEEIEILLRYGQHP 76
Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
           N++ L         + +V +    G L DK L   ++   +  +   ++  +   + YLH
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLH 133
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNG----RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
               Q V+HRD+K  N+L   E       R+ DFG AK   R  N        T  ++AP
Sbjct: 134 A---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLXTPCYTANFVAP 189
Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE--PKALPEELI 556
           E+        + D+++ G LL   + G  P    P   PEE++
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEIL 232

>pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 104/240 (43%), Gaps = 29/240 (12%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N  ++   G A +   G L LT           +G A Y++P++   +T  S + SFST 
Sbjct: 14  NEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVA-SFSTS 72
Query: 91  FAFAIVPEYTALGGHGFAFTISA-SKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDT- 148
           F F +      +   G AF ++    ++P    S+Y            +N I AVEFDT 
Sbjct: 73  FTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDS-SNQIVAVEFDTY 131
Query: 149 -VKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQAWIDYDSS 206
               ++  D N  H+GID+N + S              K V  +  +G V  A I Y + 
Sbjct: 132 FAHSYDPWDPNYRHIGIDVNGIES-------------IKTVQWDWINGGVAFATITYLAP 178
Query: 207 KNHLEVRLA-PSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA--SSHYILGWSFN 263
              L   L  PS+    S  ++  VDL  I+ E + VGFS++TG      +H +L WSF 
Sbjct: 179 NKTLIASLVYPSNQTTFS--VAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSFT 236

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 15  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 75  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 128
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 181
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T    T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G +G V       +  +VA+K++S   +S+   +    E+  +  ++H N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 409 CRRRGDLLLVYDF---MP--NGSLDKCL---FDEQKAILTWEQRYRIIKGVASGLLYLHE 460
                 L   YDF   MP     L K +   F E+K       +Y ++  +  GL Y+H 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKI------QY-LVYQMLKGLKYIHS 162
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
                V+HRD+K GN+ ++ +   ++ DFGLA    R  +   T  V T  Y APE+  +
Sbjct: 163 A---GVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGYVVTRWYRAPEVILS 215
Query: 521 GKPTTSS-DVYAFGALLLEVVCGR 543
                 + D+++ G ++ E++ G+
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 15  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 75  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 128
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 181
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T    T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + +G G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 176
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 229
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 272

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 15  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 75  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 128
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 181
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T    T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPE 209
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 19/215 (8%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR------ 398
           +R   LLG GGFG V+ G   +   QVA+K +      G    +  ++    +       
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 399 ----HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
               H  +++LL W   +   +LV +  P  + D   +  +K  L           V + 
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELN-GRLGDFGLAKLYERGTNPSTTRVVGTLGYL 513
           + + H    + V+HRDIK  N+L+D      +L DFG   L     +   T   GT  Y 
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFDGTRVYS 205
Query: 514 APE-LTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
            PE ++R       + V++ G LL ++VCG  P E
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+      V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLL 406
           E LG G F  V +     T  + A K ++ +  S +  ++   E      L+H N+V+L 
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR--YRIIKGVASGLLYLHEEWEQ 464
                 G   LV+D +  G L    F++  A   + +      I+ +   + + H     
Sbjct: 70  DSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILESVNHCHL---N 122
Query: 465 TVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT- 520
            ++HRD+K  N+LL S+  G   +L DFGLA +  +G   +     GT GYL+PE+ R  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRKD 181
Query: 521 --GKPTTSSDVYAFGALLLEVVCGRRP 545
             GKP    D++A G +L  ++ G  P
Sbjct: 182 PYGKPV---DMWACGVILYILLVGYPP 205

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 141
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPE 194
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 195 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 237

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+      V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 91/212 (42%), Gaps = 24/212 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG         +N  VAVK +    K        EI +   LRH N+V+      
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 411 RRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
               L +V ++   G L + +     F E +A   ++Q       + SG+ Y H      
Sbjct: 85  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------LISGVSYCHA---MQ 134
Query: 466 VIHRDIKAGNVLLDSELNGRLG--DFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGK 522
           V HRD+K  N LLD     RL   DFG +K     + P +T  VGT  Y+APE L +   
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 192
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPEE 554
               +DV++ G  L  ++ G  P E    PEE
Sbjct: 193 DGKVADVWSCGVTLYVMLVGAYPFED---PEE 221

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFE 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 63
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 117
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA----RH 170
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+      V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 171 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG         +N  VAVK +    K        EI +   LRH N+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAAN-VKREIINHRSLRHPNIVRFKEVIL 85
Query: 411 RRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
               L +V ++   G L + +     F E +A   ++Q       + SG+ Y H      
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------LISGVSYCHA---MQ 135
Query: 466 VIHRDIKAGNVLLDSELNGRLG--DFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGK 522
           V HRD+K  N LLD     RL   DFG +K     + P +T  VGT  Y+APE L +   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 193
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
               +DV++ G  L  ++ G  P E    P+
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILT 440
              E+  +  ++H N++ LL             D+ LV   M  G+    +   QK  LT
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQK--LT 123
Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN 500
            +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGL     R T+
Sbjct: 124 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLC----RHTD 176
Query: 501 PSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
              T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V ++ P G +   L     F E  A     Q       +     
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+++D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 31  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 90
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 91  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 144
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 145 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 197
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+      V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 198 TDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 22/232 (9%)
Query: 335 YEELKKATRGFRDK-------ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLR 385
           YE++ K  RG + K       +++G G FG V      ++    A+K +S     K+   
Sbjct: 60  YEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDS 119
Query: 386 EFASEISSIGRLRHRN-LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR 444
            F  E   I    +   +VQL    +    L +V ++MP G L   L         W + 
Sbjct: 120 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF 178
Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPST 503
           Y      A  +L L       +IHRD+K  N+LLD   + +L DFG   K+ E G     
Sbjct: 179 Y-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCD 233
Query: 504 TRVVGTLGYLAPELTRT----GKPTTSSDVYAFGALLLEVVCGRRPIEPKAL 551
           T  VGT  Y++PE+ ++    G      D ++ G  L E++ G  P    +L
Sbjct: 234 T-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 284

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 349 ELLGFGGFGRVYKGTLPST-------NTQVAVKRVSNESKQGLREFASEISSIGRLRHRN 401
           E LG G F +++KG             T+V +K +    +     F    S + +L H++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI-LTWEQRYRIIKGVASGLLYLHE 460
           LV   G C    + +LV +F+  GSLD  L   +  I + W  +  + K +A  + +L  
Sbjct: 74  LVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLE- 130
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR---VVGTLGYLAPEL 517
             E T+IH ++ A N+LL  E + + G+    KL + G + +      +   + ++ PE 
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 518 TRTGKP-TTSSDVYAFGALLLEVVCG 542
               K    ++D ++FG  L E+  G
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLL 406
           E LG G F  V +     T  + A K ++ +  S +  ++   E      L+H N+V+L 
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR--YRIIKGVASGLLYLHEEWEQ 464
                 G   LV+D +  G L    F++  A   + +      I+ +   + + H     
Sbjct: 70  DSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILESVNHCHL---N 122
Query: 465 TVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT- 520
            ++HRD+K  N+LL S+  G   +L DFGLA +  +G   +     GT GYL+PE+ R  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRKD 181
Query: 521 --GKPTTSSDVYAFGALLLEVVCGRRP 545
             GKP    D++A G +L  ++ G  P
Sbjct: 182 PYGKPV---DMWACGVILYILLVGYPP 205

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 28  FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 87
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 88  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 141
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R 
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RH 194
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+      V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 195 TDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASE--ISSIGRLRH 399
           F    ++G GGFG VY      T    A+K +  +    KQG     +E  + S+     
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 400 RNLVQLLGWCRRRGDLL-LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
              +  + +     D L  + D M  G L   L   Q  + +          +  GL ++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHM 308
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H  +   V++RD+K  N+LLD   + R+ D GLA  + +   P  +  VGT GY+APE+ 
Sbjct: 309 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEVL 362
Query: 519 RTGKPTTSS-DVYAFGALLLEVVCGRRPI 546
           + G    SS D ++ G +L +++ G  P 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASE--ISSIGRLRH 399
           F    ++G GGFG VY      T    A+K +  +    KQG     +E  + S+     
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 400 RNLVQLLGWCRRRGDLL-LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
              +  + +     D L  + D M  G L   L   Q  + +          +  GL ++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHM 308
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H  +   V++RD+K  N+LLD   + R+ D GLA  + +   P  +  VGT GY+APE+ 
Sbjct: 309 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEVL 362
Query: 519 RTGKPTTSS-DVYAFGALLLEVVCGRRPI 546
           + G    SS D ++ G +L +++ G  P 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V ++ P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+++D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASE--ISSIGRLRH 399
           F    ++G GGFG VY      T    A+K +  +    KQG     +E  + S+     
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 400 RNLVQLLGWCRRRGDLL-LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
              +  + +     D L  + D M  G L   L   Q  + +          +  GL ++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHM 308
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H  +   V++RD+K  N+LLD   + R+ D GLA  + +   P  +  VGT GY+APE+ 
Sbjct: 309 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEVL 362
Query: 519 RTGKPTTSS-DVYAFGALLLEVVCGRRPI 546
           + G    SS D ++ G +L +++ G  P 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G +G V       +  ++AVK++S   +S    +    E+  +  ++H N++ LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 409 ------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
                      D+ LV   M     ++ KC    QK  LT +    +I  +  GL Y+H 
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKC----QK--LTDDHVQFLIYQILRGLKYIHS 172
Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
                +IHRD+K  N+ ++ +   ++ DFGLA    R T+   T  V T  Y APE+   
Sbjct: 173 ---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLN 225
Query: 521 -GKPTTSSDVYAFGALLLEVVCGR 543
                 + D+++ G ++ E++ GR
Sbjct: 226 WMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 350 LLGFGGFGRVYKGTLPSTN---TQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQ 404
           +LG G FG V +  L   +    +VAVK +  +  +   + EF  E + +    H ++ +
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 405 LLG---WCRRRGDL---LLVYDFMPNGSLDKCLF----DEQKAILTWEQRYRIIKGVASG 454
           L+G     R +G L   +++  FM +G L   L      E    L  +   R +  +A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYL 513
           + YL     +  IHRD+ A N +L  ++   + DFGL+ K+Y              + +L
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 514 APELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           A E       T  SDV+AFG  + E++  G+ P
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 86/167 (51%), Gaps = 12/167 (7%)
Query: 384 LREFASEISSIGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTW 441
           + +   EI+ + +L H N+V+L+       +  L +V++ +  G + +         L+ 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSE 136
Query: 442 EQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP 501
           +Q     + +  G+ YLH    Q +IHRDIK  N+L+  + + ++ DFG++  + +G++ 
Sbjct: 137 DQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDA 192
Query: 502 STTRVVGTLGYLAPE-LTRTGKPTTSS--DVYAFGALLLEVVCGRRP 545
             +  VGT  ++APE L+ T K  +    DV+A G  L   V G+ P
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASE--ISSIGRLRH 399
           F    ++G GGFG VY      T    A+K +  +    KQG     +E  + S+     
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 400 RNLVQLLGWCRRRGDLL-LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
              +  + +     D L  + D M  G L   L   Q  + +          +  GL ++
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHM 307
Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H  +   V++RD+K  N+LLD   + R+ D GLA  + +   P  +  VGT GY+APE+ 
Sbjct: 308 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEVL 361
Query: 519 RTGKPTTSS-DVYAFGALLLEVVCGRRPI 546
           + G    SS D ++ G +L +++ G  P 
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 34/224 (15%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLV 403
           F   + LG GGFG V++      +   A+KR+   +++  RE    E+ ++ +L H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 404 QLL-GWCRRRGDLLL------VYDFMPNGSLDKC----LFDEQKAILTWEQRYR-----I 447
           +    W  +     L      VY ++    +  C    L D      T E+R R     I
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYI---QMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST---- 503
              +A  + +LH    + ++HRD+K  N+    +   ++GDFGL    ++     T    
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 504 -------TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
                  T  VGT  Y++PE       +   D+++ G +L E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1N3O|A Chain A, Pterocarcpus Angolensis Lectin In Complex With Alpha-Methyl Glucose Length = 252

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 35/242 (14%)
Query: 35  ANNNNMSLNGAAEIEKNGKLMLT------NTTLRVLGHAFYSSPIKFKNSTRNSKSLSFS 88
           ++  N+   G A+I KN  + LT      N     +G   +S+ +     + +S+  +F 
Sbjct: 13  SDQKNLIFQGDAQI-KNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKS-SSRVANFQ 70
Query: 89  TCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXX-----XXXXXXTNHIFA 143
           + F+F++    +  G  G AF I+       T+PS                    N + A
Sbjct: 71  SQFSFSLKSPLSN-GADGIAFFIAPPDT---TIPSGSGGGLLGLFAPGTAQNTSANQVIA 126
Query: 144 VEFDT--VKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQAW 200
           VEFDT   +D    D N  H+GID+NS+RS              K V  + + G+ +   
Sbjct: 127 VEFDTFYAQDSNTWDPNYPHIGIDVNSIRS-------------VKTVKWDRRDGQSLNVL 173
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           + ++ S  +L+V +A  S   R  + S++VD+  ++ E + VGFS+++G    +H +  W
Sbjct: 174 VTFNPSTRNLDV-VATYSDGTRYEV-SYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESW 231
Query: 261 SF 262
           SF
Sbjct: 232 SF 233

>pdb|1Q8O|A Chain A, Pterocartpus Angolensis Lectin Pal In Complex With The Dimmanoside Man(Alpha1-2)man Length = 252

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 35/242 (14%)
Query: 35  ANNNNMSLNGAAEIEKNGKLMLT------NTTLRVLGHAFYSSPIKFKNSTRNSKSLSFS 88
           ++  N+   G A+I KN  + LT      N     +G   +S+ +     + +S+  +F 
Sbjct: 13  SDQKNLIFQGDAQI-KNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKS-SSRVANFQ 70
Query: 89  TCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXX-----XXXXXXTNHIFA 143
           + F+F++    +  G  G AF I+       T+PS                    N + A
Sbjct: 71  SQFSFSLKSPLSN-GADGIAFFIAPPDT---TIPSGSGGGLLGLFAPGTAQNTSANQVIA 126
Query: 144 VEFDT--VKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQAW 200
           VEFDT   +D    D N  H+GID+NS+RS              K V  + + G+ +   
Sbjct: 127 VEFDTFYAQDSNTWDPNYPHIGIDVNSIRS-------------VKTVKWDRRDGQSLNVL 173
Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW 260
           + ++ S  +L+V +A  S   R  + S++VD+  ++ E + VGFS+++G    +H +  W
Sbjct: 174 VTFNPSTRNLDV-VATYSDGTRYEV-SYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESW 231
Query: 261 SF 262
           SF
Sbjct: 232 SF 233

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 80
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 81  LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 133
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 134 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTEPCYTPYYVAPEVL 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V ++ P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+++D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V ++ P G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+++D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHRNLVQL 405
           K L+G G +G VY     +T   VA+K+V+   E     +    EI+ + RL+   +++L
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 406 LGWC----RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
                     + D L +   + +  L K    +    LT E    I+  +  G  ++HE 
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADSDLKKLF--KTPIFLTEEHIKTILYNLLLGENFIHE- 147
Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY--ERGTN------------------- 500
               +IHRD+K  N LL+ + + ++ DFGLA+    E+ TN                   
Sbjct: 148 --SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 501 PSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVV 540
              T  V T  Y APEL    +  T S D+++ G +  E++
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 98/243 (40%), Gaps = 34/243 (13%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N   + L   A I  N  L LT       T    G A Y+ P++  +ST  + + SF T 
Sbjct: 13  NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVA-SFETR 71
Query: 91  FAFAI-VPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTV 149
           F+F+I  P        G  F I+      G     +                 AVEFDT 
Sbjct: 72  FSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSPYP-----FVAVEFDTF 126
Query: 150 KDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNH 209
           ++    D    H+GID+NS+ S  + P              L +G +    I YD+S   
Sbjct: 127 RNT--WDPQIPHIGIDVNSVISTKTVP------------FTLDNGGIANVVIKYDASTKI 172
Query: 210 LEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTG-------LLASSHYILGWSF 262
           L V L   S+     I    VDL  ++ E++ VGFS++TG           +H IL WSF
Sbjct: 173 LHVVLVFPSLGTIYTIADI-VDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSF 231
Query: 263 NMS 265
           + S
Sbjct: 232 SAS 234

>pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 27/234 (11%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNTTL--RVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAF 93
           ++ ++   G A+I  +G+L +    L  R   HA Y++P+   +S   + + SF T F+F
Sbjct: 10  DDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVA-SFITSFSF 68
Query: 94  AI--VPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTVKD 151
            +  V  Y    G  F F      E+P   P+               N   AVEFD+  +
Sbjct: 69  IVSNVQRYPPTDGVVF-FLAPWGTEIP---PNSQGGYLGITDSSNSQNQFVAVEFDSHPN 124
Query: 152 -FEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQV-LNLKSGEVIQAWIDYDSSKNH 209
            ++   +  +H+GID+NS+ S              K V  N  SG + +A I YDS    
Sbjct: 125 VWDPKSLRSSHIGIDVNSIMS-------------LKAVNWNRVSGSLEKATIIYDSDTKI 171
Query: 210 LEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSST-GLLASSHYILGWSF 262
           L V +   + +  +  +S ++DL  ++ E + VGFS++T       H I  WSF
Sbjct: 172 LTVVMTHQNGQITT--ISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSF 223

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 82
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 83  LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 135
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 136 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 191
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 29  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 87
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 88  LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 140
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 141 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 196
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 197 GPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DF LA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 98/243 (40%), Gaps = 34/243 (13%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N   + L   A I  N  L LT       T    G A Y+ P++  +ST  + + SF T 
Sbjct: 14  NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVA-SFETR 72
Query: 91  FAFAI-VPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTV 149
           F+F+I  P        G  F I+      G     +                 AVEFDT 
Sbjct: 73  FSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSPYP-----FVAVEFDTF 127
Query: 150 KDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNH 209
           ++    D    H+GID+NS+ S  + P              L +G +    I YD+S   
Sbjct: 128 RNT--WDPQIPHIGIDVNSVISTKTVP------------FTLDNGGIANVVIKYDASTKI 173
Query: 210 LEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTG-------LLASSHYILGWSF 262
           L V L   S+     I    VDL  ++ E++ VGFS++TG           +H IL WSF
Sbjct: 174 LHVVLVFPSLGTIYTIADI-VDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSF 232
Query: 263 NMS 265
           + S
Sbjct: 233 SAS 235

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 17/223 (7%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           E LG G FG V++    +T      K ++           +EIS + +L H  L+ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 409 CRRRGDLLLVYDFMPNGSL-DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
              + +++L+ +F+  G L D+   ++ K  ++  +    ++    GL ++H   E +++
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH---EHSIV 171
Query: 468 HRDIKAGNVLLDSELNG--RLGDFGLAKLYERGTNPSTTRVV--GTLGYLAPELTRTGKP 523
           H DIK  N++ +++     ++ DFGLA       NP     V   T  + APE+      
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLAT----KLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV---DWVWD 563
              +D++A G L   ++ G  P   +   E L  V   DW +D
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 23  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 81
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 82  LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 134
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 135 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 190
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 191 GPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 30  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 88
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 89  LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 141
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 142 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 197
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 198 GPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 89/212 (41%), Gaps = 24/212 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG          N  VAVK +    K        EI +   LRH N+V+      
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 411 RRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
               L +V ++   G L + +     F E +A   ++Q       + SG+ Y H      
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------LISGVSYAHA---MQ 135
Query: 466 VIHRDIKAGNVLLDSELNGRL--GDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGK 522
           V HRD+K  N LLD     RL   DFG +K     + P +   VGT  Y+APE L +   
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA--VGTPAYIAPEVLLKKEY 193
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPEE 554
               +DV++ G  L  ++ G  P E    PEE
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFED---PEE 222

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 80
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 81  LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 133
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 134 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 189
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 28  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 86
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 87  LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 139
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 140 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 195
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 196 GPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 351 LGFGGFG--RVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           +G G FG  R+ +  L  T   VAVK +  E    + E    EI +   LRH N+V+   
Sbjct: 28  IGSGNFGVARLMRDKL--TKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
                  L ++ ++   G L + +     F E +A   ++Q       + SG+ Y H   
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ-------LLSGVSYCHS-- 134
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLG--DFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTR 519
              + HRD+K  N LLD     RL   DFG +K     + P +T  VGT  Y+APE L R
Sbjct: 135 -MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 191
Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE 554
                  +DV++ G  L  ++ G  P E    P +
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226

>pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 98/243 (40%), Gaps = 34/243 (13%)
Query: 36  NNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKFKNSTRNSKSLSFSTC 90
           N   + L   A I  N  L LT       T    G A Y+ P++  +ST  + + SF T 
Sbjct: 13  NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVA-SFETR 71
Query: 91  FAFAI-VPEYTALGGHGFAFTISASKELPGTLPSQYXXXXXXXXXXXXTNHIFAVEFDTV 149
           F+F+I  P        G  F I+      G     +                 AVEFDT 
Sbjct: 72  FSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSPYP-----FVAVEFDTF 126
Query: 150 KDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNH 209
           ++    D    H+GID+NS+ S  + P              L +G +    I YD+S   
Sbjct: 127 RNT--WDPQIPHIGIDVNSVISTKTVP------------FTLDNGGIANVVIKYDASTKI 172
Query: 210 LEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTG-------LLASSHYILGWSF 262
           L V L   S+     I    VDL  ++ E++ VGFS++TG           +H IL WSF
Sbjct: 173 LHVVLVFPSLGTIYTIADI-VDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSF 231
Query: 263 NMS 265
           + S
Sbjct: 232 SAS 234

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLR-EFASEISSIGRLRH-RNLVQLLG 407
           LG G F  V +    ST  + A K +    + Q  R E   EI+ +   +    ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
                 +++L+ ++   G +      E   +++     R+IK +  G+ YLH   +  ++
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIV 153
Query: 468 HRDIKAGNVLLDSEL---NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
           H D+K  N+LL S     + ++ DFG+++  + G       ++GT  YLAPE+      T
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELREIMGTPEYLAPEILNYDPIT 211
Query: 525 TSSDVYAFGALLLEVVCGRRP 545
           T++D++  G +   ++    P
Sbjct: 212 TATDMWNIGIIAYMLLTHTSP 232

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 96
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 97  LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 149
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 150 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 205
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 206 GPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       T    A+K +  +    L++    ++     +  N   LV+L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V ++ P G +   L     F E  A     Q       +     YLH   
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 160
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 215
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++  FGLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ D GLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 82
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 83  LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 135
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 136 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 191
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 126
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 127 LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 179
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 235
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPP 262

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 48/238 (20%)
Query: 340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRL 397
           K    +  K L+G G +G VY     + N  VA+K+V+   E     +    EI+ + RL
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 398 RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLD----------KCLFDEQKAILTWEQRYRI 447
           +   +++L        DL++  D +    L           K LF +    LT +    I
Sbjct: 85  KSDYIIRL-------HDLIIPEDLLKFDELYIVLEIADSDLKKLF-KTPIFLTEQHVKTI 136
Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL------------- 494
           +  +  G  ++HE     +IHRD+K  N LL+ + + ++ DFGLA+              
Sbjct: 137 LYNLLLGEKFIHE---SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193
Query: 495 -----------YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVV 540
                      + +      T  V T  Y APEL    +  T+S D+++ G +  E++
Sbjct: 194 EEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 74  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 132
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I+K +   + YLH  
Sbjct: 133 LYA------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 185
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 186 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 241
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D+++ G ++  ++CG  P
Sbjct: 242 GPEKYDKSCDMWSLGVIMYILLCGYPP 268

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ D GLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSI 394
           E+ +  +G R    +G G +G V          +VAVK++S   +S    R    E+  +
Sbjct: 17  EVPQRLQGLRP---VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 73
Query: 395 GRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKC--LFDEQKAILTWEQR 444
             L+H N++ LL             ++ LV   M     ++ KC  L DE    L ++  
Sbjct: 74  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQ-- 131
Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT 504
                 +  GL Y+H      +IHRD+K  NV ++ +   R+ DFGLA    R  +   T
Sbjct: 132 ------LLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA----RQADEEMT 178
Query: 505 RVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
             V T  Y APE+         + D+++ G ++ E++ G+
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           L +L    +   +L +V ++ P G +   L     F E  A     Q       +     
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+++D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIG 395
           EE+  AT   R    LG G FG V++     T  Q AVK+V  E  +     A E+ +  
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-----AEELMACA 140
Query: 396 RLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGL 455
            L    +V L G  R    + +  + +  GSL + L  EQ  +      Y + + +  GL
Sbjct: 141 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQAL-EGL 198
Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLA-KLYERGTNPSTTR---VVGTL 510
            YLH    + ++H D+KA NVLL S+  +  L DFG A  L   G   S      + GT 
Sbjct: 199 EYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTE 255
Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            ++APE+          DV++   ++L ++ G  P
Sbjct: 256 THMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           L +L    +   +L +V ++ P G +   L     F E  A     Q       +     
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+++D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-----KQGLREFASEISSIGRLRHRNLV 403
           ++LG G    V++G    T    A+K  +N S        +REF      + +L H+N+V
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF----EVLKKLNHKNIV 70
Query: 404 QLLGW-----CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRII-KGVASGLLY 457
           +L         R +   +L+ +F P GSL   L +   A    E  + I+ + V  G+ +
Sbjct: 71  KLFAIEEETTTRHK---VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 458 LHEEWEQTVIHRDIKAGNVLL----DSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL 513
           L E     ++HR+IK GN++     D +   +L DFG A+  E   +     + GT  YL
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVXLYGTEEYL 182
Query: 514 APELTRTG--------KPTTSSDVYAFGALLLEVVCGRRPIEP 548
            P++            K   + D+++ G        G  P  P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 333 FSYEELKKAT----RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLRE 386
           F  +EL K        +++   +G G +G V       T  +VAVK++S   +S    + 
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 67
Query: 387 FASEISSIGRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKCLFDEQKAI 438
              E+  +  ++H N++ LL             D+ LV   M     ++ KC    QK  
Sbjct: 68  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK-- 121
Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           LT +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ D GLA    R 
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLA----RH 174
Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
           T+   T  V T  Y APE+         + D+++ G ++ E++ GR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           L +L    +   +L +V ++ P G +   L     F E  A     Q       +     
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFE 156
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+++D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRN---LVQLL 406
           +G G  G+V+K     T   +AVK++    +K+  +    ++  +  L+  +   +VQ  
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV--LKSHDCPYIVQCF 90
Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G      D+ +  + M  G+  + L    +  +      ++   +   L YL E+    V
Sbjct: 91  GTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGV 146
Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTT 525
           IHRD+K  N+LLD     +L DFG++ +L +   + +  R  G   Y+APE      PT 
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 526 -----SSDVYAFGALLLEVVCGRRP 545
                 +DV++ G  L+E+  G+ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFP 228

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-----KQGLREFASEISSIGRLRHRNLV 403
           ++LG G    V++G    T    A+K  +N S        +REF      + +L H+N+V
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF----EVLKKLNHKNIV 70
Query: 404 QLLGW-----CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRII-KGVASGLLY 457
           +L         R +   +L+ +F P GSL   L +   A    E  + I+ + V  G+ +
Sbjct: 71  KLFAIEEETTTRHK---VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 458 LHEEWEQTVIHRDIKAGNVLL----DSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL 513
           L E     ++HR+IK GN++     D +   +L DFG A+  E   +     + GT  YL
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYL 182
Query: 514 APELTRTG--------KPTTSSDVYAFGALLLEVVCGRRPIEP 548
            P++            K   + D+++ G        G  P  P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 330 PHRFSY-EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA 388
           P  + Y EE+  AT   R    LG G FG V++     T  Q AVK+V  E  +     A
Sbjct: 64  PVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-----A 114
Query: 389 SEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRII 448
            E+ +   L    +V L G  R    + +  + +  GSL + L  EQ  +      Y + 
Sbjct: 115 EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLG 173
Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLYER---GTNPSTT 504
           + +  GL YLH    + ++H D+KA NVLL S+  +  L DFG A   +    G +  T 
Sbjct: 174 QAL-EGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTG 229
Query: 505 RVV-GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
             + GT  ++APE+          DV++   ++L ++ G  P
Sbjct: 230 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    EP  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIV 251

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG         +N  VAVK +    K        EI +   LRH N+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 411 RRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
               L +V ++   G L + +     F E +A   ++Q       + SG+ Y H      
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------LISGVSYCHA---MQ 135
Query: 466 VIHRDIKAGNVLLDSELNGRLG--DFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGK 522
           V HRD+K  N LLD     RL    FG +K     + P +T  VGT  Y+APE L +   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 193
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
               +DV++ G  L  ++ G  P E    P+
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--- 401
           F   + LG G FGRV       T    A+K +  +    L++    ++    L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           LV+L    +   +L +V +++  G +   L     F E  A     Q       +     
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFE 155
Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
           +  +     + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSI 394
           E+ +  +G R    +G G +G V          +VAVK++S   +S    R    E+  +
Sbjct: 25  EVPQRLQGLRP---VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 395 GRLRHRNLVQLLGW------CRRRGDLLLVYDFMPN--GSLDKC--LFDEQKAILTWEQR 444
             L+H N++ LL             ++ LV   M     ++ KC  L DE    L ++  
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQ-- 139
Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT 504
                 +  GL Y+H      +IHRD+K  NV ++ +   R+ DFGLA    R  +   T
Sbjct: 140 ------LLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLA----RQADEEMT 186
Query: 505 RVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
             V T  Y APE+         + D+++ G ++ E++ G+
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 31/220 (14%)
Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSI 394
           E+ +  +G R    +G G +G V          +VAVK++S   +S    R    E+  +
Sbjct: 25  EVPQRLQGLRP---VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 395 GRLRHRNLVQLLGW------CRRRGDLLLVYDFM----PNGSLDKCLFDEQKAILTWEQR 444
             L+H N++ LL             ++ LV   M     N    + L DE    L ++  
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQ-- 139
Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT 504
                 +  GL Y+H      +IHRD+K  NV ++ +   R+ DFGLA    R  +   T
Sbjct: 140 ------LLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLA----RQADEEMT 186
Query: 505 RVVGTLGYLAPELTRTGKPTTSS-DVYAFGALLLEVVCGR 543
             V T  Y APE+         + D+++ G ++ E++ G+
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 180
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK        +T  + GT  YLAPE+  +  
Sbjct: 181 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGATWTLCGTPEYLAPEIILSKG 235
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 272

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 15/217 (6%)
Query: 339 KKATRGFRDKELLGFGGFGRVY---KGTLPSTNTQVAVKRVSN----ESKQGLREFASEI 391
           K     F   ++LG G +G+V+   K +   T    A+K +      +  +      +E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 392 SSIGRLRHRNLVQLLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG 450
             +  +R    +  L +  +    L L+ D++  G L   L   Q+   T  +    +  
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGE 167
Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL 510
           +   L +LH+     +I+RDIK  N+LLDS  +  L DFGL+K +            GT+
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 511 GYLAPELTRTGKP--TTSSDVYAFGALLLEVVCGRRP 545
            Y+AP++ R G      + D ++ G L+ E++ G  P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR 410
           +G G FG         +N  VAVK +    K        EI +   LRH N+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 411 RRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
               L +V ++   G L + +     F E +A   ++Q       + SG+ Y H      
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------LISGVSYCHA---MQ 135
Query: 466 VIHRDIKAGNVLLDSELNGRLG--DFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGK 522
           V HRD+K  N LLD     RL    FG +K     + P  T  VGT  Y+APE L +   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT--VGTPAYIAPEVLLKKEY 193
Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
               +DV++ G  L  ++ G  P E    P+
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLAGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 160
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 215
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 252

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRV-----SNESKQGLREFASEISSIGRLRHRNLVQL 405
           LG G +G V K     +   +AVKR+     S E K+ L +    + ++        V  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD---CPFTVTF 115
Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKC---LFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
            G   R GD+ +  + M + SLDK    + D+ + I   +   +I   +   L +LH + 
Sbjct: 116 YGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTI-PEDILGKIAVSIVKALEHLHSKL 173
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA-----PEL 517
             +VIHRD+K  NVL+++    ++ DFG++         + T   G   Y+A     PEL
Sbjct: 174 --SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPEL 229
Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR 577
            + G  +  SD+++ G  ++E+   R P +            W     +   ++E   P+
Sbjct: 230 NQKGY-SVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQ 277
Query: 578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY 614
           L  +    E +D       C    ++ RPT  +++++
Sbjct: 278 LPADKFSAEFVDFTS---QCLKKNSKERPTYPELMQH 311

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 146
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 147 -LDLIYRDLKPENLLIDEQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 201
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 202 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLXGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHR 400
           + +++ + +G G  G V           VA+K++S   +++   +    E+  +  + H+
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 401 NLVQLLGWCRRRGDLLLVYD-FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
           N++ LL     +  L    D ++    +D  L    +  L  E+   ++  +  G+ +LH
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
                 +IHRD+K  N+++ S+   ++ DFGLA+    GT+   T  V T  Y APE+  
Sbjct: 138 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 520 TGKPTTSSDVYAFGALLLEVVCGR 543
                 + D+++ G ++ E+VC +
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFEYLHS-- 154
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 155 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 209
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 210 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 246

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFEYLHS-- 180
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 181 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 235
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 272

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHR 400
           + +++ + +G G  G V           VA+K++S   +++   +    E+  +  + H+
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 401 NLVQLLGWCRRRGDLLLVYD-FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
           N++ LL     +  L    D ++    +D  L    +  L  E+   ++  +  G+ +LH
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 148
Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
                 +IHRD+K  N+++ S+   ++ DFGLA+    GT+   T  V T  Y APE+  
Sbjct: 149 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 203
Query: 520 TGKPTTSSDVYAFGALLLEVVCGR 543
                 + D+++ G ++ E+VC +
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN---LVQLLG 407
           LG G FGRV       +    A+K +  +    L++    ++    L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 408 WCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
             +   +L +V +++  G +   L     F E  A     Q       +     YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQ-------IVLTFEYLHS-- 159
Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLAPE+  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 523 PTTSSDVYAFGALLLEVVCGRRPI---EPKALPEELI 556
              + D +A G L+ E+  G  P    +P  + E+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 87/194 (44%), Gaps = 12/194 (6%)
Query: 357 GRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRR--RGD 414
           G ++KG     +  V V +V + S +  R+F  E   +    H N++ +LG C+      
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAG 474
             L+  +MP GSL   L +    ++   Q  +    +A G+ +LH   E  +    + + 
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSR 142
Query: 475 NVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTT---SSDVYA 531
           +V++D ++  R+    +   ++     S  R+     ++APE  +     T   S+D+++
Sbjct: 143 SVMIDEDMTARISMADVKFSFQ-----SPGRMYAP-AWVAPEALQKKPEDTNRRSADMWS 196
Query: 532 FGALLLEVVCGRRP 545
           F  LL E+V    P
Sbjct: 197 FAVLLWELVTREVP 210

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFASEISSIGRLRHR 400
           + ++  + +G G  G V           VAVK++S   +++   +    E+  +  + H+
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 83
Query: 401 NLVQLLG------WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
           N++ LL             D+ LV + M + +L + +  E    L  E+   ++  +  G
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHME----LDHERMSYLLYQMLCG 138
Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           + +LH      +IHRD+K  N+++ S+   ++ DFGLA+     TN   T  V T  Y A
Sbjct: 139 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRA 193
Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCG 542
           PE+        + D+++ G ++ E+V G
Sbjct: 194 PEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF-----ASEISSIGRLR--HRN 401
           ++LG G  G+V +     T  + A+K + +  K   RE      AS+   I R+   + N
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKXLQDCPK-ARREVELHWRASQCPHIVRIVDVYEN 126
Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L         R  LL+V + +  G L   + D      T  +   I K +   + YLH  
Sbjct: 127 LYA------GRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHS- 179
Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
               + HRD+K  N+L  S+      +L DFG AK  E  ++ S T    T  Y+APE+ 
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 235
Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRP 545
              K   S D ++ G +   ++CG  P
Sbjct: 236 GPEKYDKSCDXWSLGVIXYILLCGYPP 262

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 103/225 (45%), Gaps = 24/225 (10%)
Query: 324 WELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESK 381
           + ++VG   F+        + +++ + +G G  G V        +  VA+K++S   +++
Sbjct: 49  YSVEVGDSTFT------VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ 102
Query: 382 QGLREFASEISSIGRLRHRNLVQLLG------WCRRRGDLLLVYDFMPNGSLDKCLFDEQ 435
              +    E+  +  + H+N++ LL             D+ LV + M     D  L    
Sbjct: 103 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI 157
Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
           +  L  E+   ++  +  G+ +LH      +IHRD+K  N+++ S+   ++ DFGLA+  
Sbjct: 158 QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 212
Query: 496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV 540
             GT+   T  V T  Y APE+        + D+++ G ++ E+V
Sbjct: 213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + + +++G G FG V++  L  ++ +VA+K+V  + +   RE   +I  I  ++H N+V
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNREL--QIMRI--VKHPNVV 95
Query: 404 QLLGWCRRRGD------LLLVYDFMPNGSLDKC-----LFDEQKAILTWEQRYRIIKGVA 452
            L  +    GD      L LV +++P            L      +L     Y++++ +A
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG--RLGDFGLAKLYERGTNPSTTRVVGTL 510
               Y+H      + HRDIK  N+LLD   +G  +L DFG AK+   G  P+ + +    
Sbjct: 156 ----YIHS---IGICHRDIKPQNLLLDPP-SGVLKLIDFGSAKILIAG-EPNVSXICSRY 206
Query: 511 GYLAPELTR-TGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
            Y APEL       TT+ D+++ G ++ E++ G +P+ P
Sbjct: 207 -YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLFP 243
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	687
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-139
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-128
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-123
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-84
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	6e-68
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	1e-67
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	2e-66
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	8e-66
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	2e-65
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	2e-63
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-63
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	2e-63
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	6e-63
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	7e-61
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	8e-61
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	9e-61
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	1e-60
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	2e-60
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	3e-60
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	4e-60
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	2e-59
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	1e-58
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	2e-58
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	2e-57
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	2e-57
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	8e-57
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-54
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	4e-54
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-50
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	5e-49
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-43
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-41
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	5e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-37
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	1e-36
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	3e-15
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-35
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-35
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-34
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-34
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-28
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-27
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-26
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-22
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	1e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-20
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-14
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	1e-12
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-10
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	3e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  410 bits (1056), Expect = e-139
 Identities = 125/303 (41%), Positives = 181/303 (59%), Gaps = 7/303 (2%)

Query: 322 ESWELDVG-PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES 380
           E  E+ +G   RFS  EL+ A+  F +K +LG GGFG+VYKG L    T VAVKR+  E 
Sbjct: 8   EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEER 66

Query: 381 KQGL-REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKA 437
            QG   +F +E+  I    HRNL++L G+C    + LLVY +M NGS+  CL +  E + 
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126

Query: 438 ILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER 497
            L W +R RI  G A GL YLH+  +  +IHRD+KA N+LLD E    +GDFGLAKL + 
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186

Query: 498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE--L 555
                TT V GT+G++APE   TGK +  +DV+ +G +LLE++ G+R  +   L  +  +
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
           +L+DWV    K   +  +VD  L G + + E   ++++ L+C+  +   RP M +VVR L
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

Query: 616 EGE 618
           EG+
Sbjct: 307 EGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  382 bits (983), Expect = e-128
 Identities = 111/307 (36%), Positives = 168/307 (54%), Gaps = 7/307 (2%)

Query: 322 ESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK 381
            S+ +    +R    +L++AT  F  K L+G G FG+VYKG L     +VA+KR + ES 
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESS 76

Query: 382 QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLF--DEQKAIL 439
           QG+ EF +EI ++   RH +LV L+G+C  R +++L+Y +M NG+L + L+  D     +
Sbjct: 77  QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136

Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
           +WEQR  I  G A GL YLH      +IHRD+K+ N+LLD     ++ DFG++K      
Sbjct: 137 SWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193

Query: 500 NPS-TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
               +T V GTLGY+ PE    G+ T  SDVY+FG +L EV+C R  I      E + L 
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253

Query: 559 DWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE 618
           +W  +    G + ++VDP L  +             + C   ++E RP+M  V+  LE  
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

Query: 619 VPLPQAV 625
           + L ++V
Sbjct: 314 LRLQESV 320

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  367 bits (945), Expect = e-123
 Identities = 102/306 (33%), Positives = 163/306 (53%), Gaps = 22/306 (7%)

Query: 327 DVGPHRFSYEELKKATRGFRDKE------LLGFGGFGRVYKGTLPSTNTQVAVKRVSN-- 378
           D   H FS+ ELK  T  F ++        +G GGFG VYKG +   NT VAVK+++   
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMV 66

Query: 379 --ESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD-EQ 435
              +++  ++F  EI  + + +H NLV+LLG+     DL LVY +MPNGSL   L   + 
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126

Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
              L+W  R +I +G A+G+ +LHE      IHRDIK+ N+LLD     ++ DFGLA+  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 496 ERGTNPS-TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE 554
           E+      T+R+VGT  Y+APE    G+ T  SD+Y+FG +LLE++ G   ++     E 
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH--REP 240

Query: 555 LILVDWVWDRWK-AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
            +L+D   +       I + +D ++  + +      +  +   C ++    RP +++V +
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299

Query: 614 YLEGEV 619
            L+   
Sbjct: 300 LLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  266 bits (682), Expect = 8e-84
 Identities = 83/307 (27%), Positives = 129/307 (42%), Gaps = 29/307 (9%)

Query: 333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEIS 392
              E L   +   +  E+   G FG V+K  L   N  VAVK    + KQ   +   E+ 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSW-QNEYEVY 70

Query: 393 SIGRLRHRNLVQLLGWCRR----RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRII 448
           S+  ++H N++Q +G  +R      DL L+  F   GSL   L   +  +++W +   I 
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIA 127

Query: 449 KGVASGLLYLHEEWEQT-------VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP 501
           + +A GL YLHE+           + HRDIK+ NVLL + L   + DFGLA  +E G + 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 502 -STTRVVGTLGYLAPELTRTGKPTTS-----SDVYAFGALLLEVVCGRRPIEPKALPEEL 555
             T   VGT  Y+APE+               D+YA G +L E+       +       L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 556 ILVDWVWDRWKAGAILEVV-----DPRLNGEFNEIEAL-DVVKLGLMCSNDAAEARPTMR 609
              + +        + EVV      P L   + +   +  + +    C +  AEAR +  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 610 QVVRYLE 616
            V   + 
Sbjct: 308 CVGERIT 314

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score =  222 bits (566), Expect = 6e-68
 Identities = 80/265 (30%), Positives = 115/265 (43%), Gaps = 27/265 (10%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRV------LGHAFYSSPIK 74
           +++  F FS F+      N+ L G A +   G L LTN           LG A YS+PI 
Sbjct: 1   AEETSFVFSKFKP--LEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPIN 58

Query: 75  FKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDL 134
             +S       SF+T F F I     A    G AF ++     P +    +LGL +S+  
Sbjct: 59  IWDSA-TGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDS-GGGFLGLFDSAVS 116

Query: 135 GNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSG 194
           G+ T    AVEFDT ++  F D    H+G D+NS+ S  +               +L +G
Sbjct: 117 GS-TYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK------------WSLANG 163

Query: 195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA-- 252
           E  +  I Y+S+   L   L   S    S IL+  VDLS ++ E + VGFS++TG     
Sbjct: 164 EAAKVLITYNSAVKLLVASLVYPS-SKTSFILADIVDLSSVLPEWVRVGFSAATGASGGK 222

Query: 253 -SSHYILGWSFNMSGDAKSLSLDSL 276
             +H +  WSF            S 
Sbjct: 223 IETHDVFSWSFASKLAGXXTKDSSF 247

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score =  221 bits (563), Expect = 1e-67
 Identities = 72/253 (28%), Positives = 114/253 (45%), Gaps = 24/253 (9%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLT------NTTLRVLGHAFYSSPIKFKNST 79
           F F+ F       ++   G A +  N  L LT      N     +G A Y++PI+   S+
Sbjct: 6   FTFTDFES--GQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQSS 63

Query: 80  RNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTN 139
               S  F T F F+I    +        F  S   ++P     + LGL  SS+     N
Sbjct: 64  SLVAS--FETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDN 121

Query: 140 HIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQA 199
            + +VEFDT  + + GD N  H+GID+NS+RS A+               + ++G+   A
Sbjct: 122 GVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKW------------DWQNGKTATA 169

Query: 200 WIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILG 259
            I Y+S+   L V  +         ++SFDV+L+ +  + + VGFS++TG    ++ IL 
Sbjct: 170 HISYNSASKRLSVVSSYP--NSSPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILA 227

Query: 260 WSFNMSGDAKSLS 272
           WSF  S      +
Sbjct: 228 WSFRSSLMGYQAN 240

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score =  217 bits (554), Expect = 2e-66
 Identities = 68/247 (27%), Positives = 101/247 (40%), Gaps = 21/247 (8%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTN-TTLRVLGHAFYSSPIKFKNST 79
           ++   F F+ F +   N  ++  G   +  NG + LTN   +  +G   Y+ P++  +S 
Sbjct: 1   AETVSFNFNSFSE--GNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSA 58

Query: 80  RNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTN 139
                 SF T F+F +          G  F I+          S   G L  SD      
Sbjct: 59  -TGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPA-GSIGGGTLGVSD-TKGAG 115

Query: 140 HIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQA 199
           H   VEFDT  + E+ D   +HVGID+NS+ S  + P             N  SG V++ 
Sbjct: 116 HFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP------------WNSVSGAVVKV 163

Query: 200 WIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASS-HYIL 258
            + YDSS   L V +           ++  VDL   + E +  GFS+S  L     H I 
Sbjct: 164 TVIYDSSTKTLSVAVTND--NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIR 221

Query: 259 GWSFNMS 265
            WSF  +
Sbjct: 222 SWSFTST 228

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score =  216 bits (552), Expect = 8e-66
 Identities = 64/274 (23%), Positives = 108/274 (39%), Gaps = 28/274 (10%)

Query: 11  LFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVL 64
           + +  AN   S    F F  F    +  N+   G A   +N  L LT T          +
Sbjct: 1   MLLNRANSTDSLS--FSFINF--DRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTV 56

Query: 65  GHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQ 124
           G   +S+ ++    +  ++  +  T F+F +    +        F       +P      
Sbjct: 57  GRILHSAQVRLWEKS-TNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGG 115

Query: 125 YLGLLNSSDLGNLT-NHIFAVEFDTV--KDFEFGDINDNHVGIDINSLRSNASEPAAYFL 181
            LGL N     N + N + AVEFDT   ++    D N  H+GID+NS+RS+         
Sbjct: 116 LLGLFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVR----- 170

Query: 182 ENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMY 241
                     + G+ +   + Y+ S   ++V         +   LS  VDL+ I+ E + 
Sbjct: 171 -------WERREGKTLNVLVTYNPSTRTIDVVATYP--DGQRYQLSHVVDLTTILPEWVR 221

Query: 242 VGFSSSTGLLASSHYILGWSFNMSGDAKSLSLDS 275
           VGFS+++G    +H +  WSF  +    +   D 
Sbjct: 222 VGFSAASGEQFQTHNLESWSFTSTLLYTAQKEDE 255

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score =  215 bits (548), Expect = 2e-65
 Identities = 73/251 (29%), Positives = 109/251 (43%), Gaps = 27/251 (10%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKFKNSTR 80
           F F  F  A N   +   G A +   G L LTN      + + LG A Y++P +  +ST 
Sbjct: 6   FSFPKF--APNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDST- 62

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
                SF T F F I     A    G AF ++     P       LG+       N +N 
Sbjct: 63  TGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLD-LGGMLGIFKDGY-FNKSNQ 120

Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVEFDT  + ++ D    H+GI++NS+ S  + P             N  +GEV   +
Sbjct: 121 IVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVP------------WNWTNGEVANVF 167

Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYI 257
           I Y++S   L   L   S    S I+   VD+  ++ E +  GFS++TG+      ++ +
Sbjct: 168 ISYEASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDV 226

Query: 258 LGWSFNMSGDA 268
           L WSF  +   
Sbjct: 227 LSWSFESNLPG 237

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257

 Score =  210 bits (535), Expect = 2e-63
 Identities = 73/269 (27%), Positives = 112/269 (41%), Gaps = 24/269 (8%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIK 74
           S    F F  F  +   +++   G A     G L L  T           G A YS P++
Sbjct: 2   SDSVSFTFPNF-WSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQ 59

Query: 75  FKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDL 134
             ++       SF T F F +          G AF ++           +YLGL N S  
Sbjct: 60  LWDNK-TESVASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKD-AGEYLGLFNKSTA 116

Query: 135 GNLT-NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKS 193
              + N + AVEFDT  +  F + +  H+GI++NS+ S A++              ++ S
Sbjct: 117 TQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDS---------DIFS 167

Query: 194 GEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLAS 253
           G++  A I YD S   L V L+         ILS  VD+   + E++ VG S+STG    
Sbjct: 168 GKIATARISYDGSAEILTVVLSYP--DGSDYILSHSVDMRQNLPESVRVGISASTGNNQF 225

Query: 254 -SHYILGWSFNMSGDAKSLSLDSLPSLPG 281
            + YIL W F+ +  + S+     P +  
Sbjct: 226 LTVYILSWRFSSNLQSTSVKAAMEPEITR 254

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  213 bits (543), Expect = 2e-63
 Identities = 75/318 (23%), Positives = 117/318 (36%), Gaps = 40/318 (12%)

Query: 333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEIS 392
            +  E        +  EL+G G +G VYKG+L      VAVK  S  ++Q        I 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEK-NIY 59

Query: 393 SIGRLRHRNLVQLLGWCRRRGD-----LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRI 447
            +  + H N+ + +    R         LLV ++ PNGSL K L         W    R+
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRL 116

Query: 448 IKGVASGLLYLHEEWEQT------VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT-- 499
              V  GL YLH E  +       + HRD+ + NVL+ ++    + DFGL+         
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 500 -----NPSTTRVVGTLGYLAPE-------LTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
                + +    VGT+ Y+APE       L          D+YA G +  E+      + 
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 548 PKALPEELILV--DWVWDRWKAGAILEVVD-----PRLNGEFNEIEALDVVKLGLM--CS 598
           P     E  +     V +      +  +V      P+    + E           +  C 
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

Query: 599 NDAAEARPTMRQVVRYLE 616
           +  AEAR T +     + 
Sbjct: 297 DQDAEARLTAQXAEERMA 314

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score =  209 bits (533), Expect = 2e-63
 Identities = 63/249 (25%), Positives = 106/249 (42%), Gaps = 24/249 (9%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL--RVLGHAFYSSPIKFKNSTRNSK 83
           F ++ F    ++ ++   G A+I  +G+L +    L  R   HA Y++P+   +S     
Sbjct: 3   FNYTRF---KDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSA-TGN 58

Query: 84  SLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFA 143
             SF T F+F +          G  F ++         P+   G L  +D  N  N   A
Sbjct: 59  VASFITSFSFIVSNVQRYPPTDGVVFFLAPWG--TEIPPNSQGGYLGITDSSNSQNQFVA 116

Query: 144 VEFDTVKD-FEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWID 202
           VEFD+  + ++   +  +H+GID+NS+ S  +               N  SG + +A I 
Sbjct: 117 VEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVN------------WNRVSGSLEKATII 164

Query: 203 YDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSST-GLLASSHYILGWS 261
           YDS    L V +       +   +S ++DL  ++ E + VGFS++T       H I  WS
Sbjct: 165 YDSDTKILTVVMTHQ--NGQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWS 222

Query: 262 FNMSGDAKS 270
           F  +     
Sbjct: 223 FTSTLKEPE 231

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234

 Score =  208 bits (530), Expect = 6e-63
 Identities = 72/250 (28%), Positives = 112/250 (44%), Gaps = 23/250 (9%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTR 80
           ++   F  + F  + +  N+   G        KL LT      +G A YSSPI   +   
Sbjct: 1   TETTSFLITKF--SPDQQNLIFQGDGYTT-KEKLTLTKAVKNTVGRALYSSPIHIWDRE- 56

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
                +F T F F I    +     GF F I+     P T    YLG+ NS++  + T  
Sbjct: 57  TGNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQT-GGGYLGVFNSAE-YDKTTQ 114

Query: 141 IFAVEFDTVKDFEFGDIN-DNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQA 199
             AVEFDT  +  +   N D H+GID+NS++S  ++               L++GE    
Sbjct: 115 TVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKS------------WKLQNGEEANV 162

Query: 200 WIDYDSSKNHLEVRLAPSS----VKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSH 255
            I ++++ N L V L   +     +  S  LS  V L  +V E + +GFS++TG   ++H
Sbjct: 163 VIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAH 222

Query: 256 YILGWSFNMS 265
            +L WSF+  
Sbjct: 223 EVLSWSFHSE 232

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score =  203 bits (516), Expect = 7e-61
 Identities = 77/251 (30%), Positives = 112/251 (44%), Gaps = 29/251 (11%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNST 79
           F FS F     N+N++L GAA I ++G L LT             G   Y+ P+   +ST
Sbjct: 6   FSFSEF--EPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDST 63

Query: 80  RNSKSLSFSTCFAFAIVPEYT-ALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLT 138
                 SF T F+F+I   YT  L   G  F +  +K  P      YLG+ N+S   N +
Sbjct: 64  -TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGVFNNSKQDN-S 120

Query: 139 NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQ 198
               AVEFDT  +  +      H+GID+NS+RS  ++P              L +G+V  
Sbjct: 121 YQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQP------------FQLDNGQVAN 167

Query: 199 AWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSH 255
             I YD+    L V L   S       ++  VD+  ++ + + VG S +TG     A +H
Sbjct: 168 VVIKYDAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETH 226

Query: 256 YILGWSFNMSG 266
            +  WSF  S 
Sbjct: 227 DVYSWSFQASL 237

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score =  203 bits (517), Expect = 8e-61
 Identities = 84/264 (31%), Positives = 122/264 (46%), Gaps = 36/264 (13%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRV------LGHAFYSSPIKFKNST 79
           F F  F    N  N+ L   A +  +G+L LTN           LG AFYS+PI+  ++T
Sbjct: 6   FNFQRF----NETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNT 61

Query: 80  RNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTN 139
                 SF+T F F I     A    G AF +       G+ P    G L   D  N   
Sbjct: 62  -TGTVASFATSFTFNIQVPNNAGPADGLAFALVPV----GSQPKDKGGFLGLFDGSNSNF 116

Query: 140 HIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQA 199
           H  AVEFDT+ + ++ D  + H+GID+NS+RS  +               +  +GE  + 
Sbjct: 117 HTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRW------------DFVNGENAEV 163

Query: 200 WIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA---SSHY 256
            I YDSS N L   L   S +  S I+S  VDL  ++ E + VGFS++TG+      ++ 
Sbjct: 164 LITYDSSTNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETND 222

Query: 257 ILGWSFNMS----GDAKSLSLDSL 276
           +L WSF         ++ L+L +L
Sbjct: 223 VLSWSFASKLSDETTSEGLNLANL 246

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score =  203 bits (516), Expect = 9e-61
 Identities = 79/260 (30%), Positives = 118/260 (45%), Gaps = 30/260 (11%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNST 79
           F ++ F       NM L G A +  +GKL L             LG A YS+PI   +  
Sbjct: 6   FSWNKF--VPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKE 63

Query: 80  RNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTN 139
                 SF+  F F      T     G AF ++     P T  + YLGL N ++ G+   
Sbjct: 64  -TGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQT-HAGYLGLFNENESGD--- 118

Query: 140 HIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQA 199
            + AVEFDT ++    D  + H+GI++NS+RS  +               +L + +V + 
Sbjct: 119 QVVAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTTS------------WDLANNKVAKV 164

Query: 200 WIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTG--LLASSHYI 257
            I YD+S + L   L   S +  S ILS  VDL   + E + +GFS++TG  +   SH +
Sbjct: 165 LITYDASTSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDV 223

Query: 258 LGWSFNMSGDAKSLSLDSLP 277
           L WSF  +    S ++D L 
Sbjct: 224 LSWSFASNLPHASSNIDPLD 243

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243

 Score =  202 bits (515), Expect = 1e-60
 Identities = 71/254 (27%), Positives = 104/254 (40%), Gaps = 26/254 (10%)

Query: 26  FFFSGF--RDAANNNNMSLNGAAEIEKNGKLMLT------NTTLRVLGHAFYSSPIKFKN 77
           F +  F      N   ++  G A     G L LT      N      G A YS P+   +
Sbjct: 6   FTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWD 64

Query: 78  STRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNL 137
           ST   K+ SF T F F +   Y A    G AF ++            +LGL       + 
Sbjct: 65  ST--GKAASFYTSFTFLLKN-YGAPTADGLAFFLAPVDSSVKD-YGGFLGLFRHETAADP 120

Query: 138 T-NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEV 196
           + N + AVEFDT  + ++ D    H+GID+NS+ S A+               +     +
Sbjct: 121 SKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWEND---------DAYGSSI 171

Query: 197 IQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHY 256
             A I YD+    L V L+      R  ILS  VDL+ ++ + + +GFS+  G      Y
Sbjct: 172 ATAHITYDARSKILTVLLSYE--HGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTY 228

Query: 257 ILGWSFNMSGDAKS 270
           IL W F  + D  +
Sbjct: 229 ILSWHFFSTLDGTN 242

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score =  201 bits (512), Expect = 2e-60
 Identities = 74/254 (29%), Positives = 108/254 (42%), Gaps = 30/254 (11%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRV-----LGHAFYSSPIKF 75
           ++   F F+ F    N NN+ L   A +   G L LT           LG A Y++PI  
Sbjct: 1   TESTSFSFTNFNP--NQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHI 58

Query: 76  KNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLG 135
            ++T  +   SF+T F+F +     A    G AF ++     P      +LGL       
Sbjct: 59  HDNTTLA---SFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFADRA-H 113

Query: 136 NLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGE 195
           + +    AVEFDT  +    D N  H+GID N + S  + P             ++  GE
Sbjct: 114 DASYQTVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKTTP------------FDMVYGE 159

Query: 196 VIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LA 252
                I Y +S   L   L        S  +S  VDL  I+ E + VGFS++TGL   + 
Sbjct: 160 KANIVITYQASTKALAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVV 218

Query: 253 SSHYILGWSFNMSG 266
            +H I+ WSF +S 
Sbjct: 219 ETHDIVSWSFAVSL 232

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score =  201 bits (512), Expect = 3e-60
 Identities = 68/252 (26%), Positives = 99/252 (39%), Gaps = 23/252 (9%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLT----NTTLRVLGHAFYSSPIKFK 76
           S    F F  F  + N  ++S  G A + + G L L     N      G A Y +PI   
Sbjct: 1   SDDLSFKFKNF--SQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIW 58

Query: 77  NSTRNSKSLSFSTCFAFAIV-PEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLG 135
           N     +  SF T F+F +           G  F ++     P      Y GL N +   
Sbjct: 59  NCN-TGELASFITSFSFFMETSANPKAATDGLTFFLAPPD-SPLRRAGGYFGLFNDTK-C 115

Query: 136 NLTNHIFAVEFDTVKDF-EFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSG 194
           + +    AVEFDT+     F D    H+GID+N ++S  +E                   
Sbjct: 116 DSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNK----------RYGLN 165

Query: 195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL-LAS 253
            V    I Y++S   L   L   S    S  ++  VDL  I+ E + VGFS ST +   +
Sbjct: 166 NVANVEIIYEASSKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQA 224

Query: 254 SHYILGWSFNMS 265
           +H +L W F  +
Sbjct: 225 THEVLNWYFTST 236

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242

 Score =  201 bits (511), Expect = 4e-60
 Identities = 73/258 (28%), Positives = 104/258 (40%), Gaps = 36/258 (13%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKFKNSTR 80
           F F+ F    N   + L   A I  N  L LT       T    G A Y+ P++  +ST 
Sbjct: 6   FNFNQF--HQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDST- 62

Query: 81  NSKSLSFSTCFAFAIVPEY-TALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTN 139
                SF T F+F+I   +       G  F I+      G     Y G+ N         
Sbjct: 63  TGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGE-GGGYFGIYNPLS----PY 117

Query: 140 HIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQA 199
              AVEFDT ++    D    H+GID+NS+ S  + P              L +G +   
Sbjct: 118 PFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVP------------FTLDNGGIANV 163

Query: 200 WIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTG-------LLA 252
            I YD+S   L V L   S       ++  VDL  ++ E++ VGFS++TG          
Sbjct: 164 VIKYDASTKILHVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNAT 222

Query: 253 SSHYILGWSFNMSGDAKS 270
            +H IL WSF+ S    +
Sbjct: 223 ETHDILSWSFSASLPGTN 240

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242

 Score =  199 bits (506), Expect = 2e-59
 Identities = 76/258 (29%), Positives = 119/258 (46%), Gaps = 26/258 (10%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRV---LGHAFYSSPIKFKN 77
           S    F F  F    N  N+   G A +   G L +T  +      +G A Y++PI+  +
Sbjct: 3   SDDLSFNFDKF--VPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD 60

Query: 78  STRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASK-ELPGTLPSQYLGLLNSSDLGN 136
           S    K  SF+T F+F +  + +  G  G AF ++ +  ++P    +   GL +SSD   
Sbjct: 61  SI-TGKVASFATSFSFVVKADKSD-GVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SK 117

Query: 137 LTNHIFAVEFDTVKDFEF--GDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSG 194
            +N I AVEFDT     +   D +  H+GID+NS++S  +               + ++G
Sbjct: 118 SSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKW------------DWRNG 165

Query: 195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA-- 252
           EV    I Y +    L V L+  S    S I++  VDL  I+ E + VGFS   G  A  
Sbjct: 166 EVADVVITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEF 224

Query: 253 SSHYILGWSFNMSGDAKS 270
            +H +L W F  + +A +
Sbjct: 225 ETHDVLSWYFTSNLEANN 242

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253

 Score =  197 bits (502), Expect = 1e-58
 Identities = 74/261 (28%), Positives = 120/261 (45%), Gaps = 31/261 (11%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT------TLRVLGHAFYSSPIK 74
           +  + F F  F    N+++  L G A +  + KL LT        TL  LG AFYSSPI+
Sbjct: 1   ADIQSFSFKNF----NSSSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQ 55

Query: 75  FKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDL 134
             + +      S++T F   I     +    G AF +      P +  S +LG+ +S   
Sbjct: 56  IYDKS-TGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGVFDSDVY 113

Query: 135 GNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSG 194
            N +    AVEFDT  + ++ D    H+GID+NS++S  +                L +G
Sbjct: 114 DN-SAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASW------------GLANG 159

Query: 195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---L 251
           +  +  I Y+++ + L   L   S +  S I+S  VD++  + E + +GFS++TGL    
Sbjct: 160 QNAEILITYNAATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGY 218

Query: 252 ASSHYILGWSFNMSGDAKSLS 272
             +H +L WSF       S +
Sbjct: 219 TETHDVLSWSFASKLPDDSTT 239

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score =  195 bits (497), Expect = 2e-58
 Identities = 79/251 (31%), Positives = 111/251 (44%), Gaps = 33/251 (13%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL---RVLGHAFYSSPIKFKN 77
           S    F    F    N  N+ L G A +   G L+LTN        +G AFYS+PI+  +
Sbjct: 1   SNDASFNVETF----NKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIND 56

Query: 78  STRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNL 137
            T      SFST F F I  +      +G AF +      P  L  +YLGL N+++  + 
Sbjct: 57  RT-IDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTTN-YDR 113

Query: 138 TNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVI 197
             H  AV FDT           N + ID+NS+R  A+E   +   N          GE  
Sbjct: 114 DAHTVAVVFDT---------VSNRIEIDVNSIRPIATESCNFGHNN----------GEKA 154

Query: 198 QAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASS 254
           +  I YDS KN L V L   S       +S  V L   V++ + VGFS+++G       +
Sbjct: 155 EVRITYDSPKNDLRVSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTET 213

Query: 255 HYILGWSFNMS 265
           H +L WSF+ +
Sbjct: 214 HNVLSWSFSSN 224

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score =  193 bits (492), Expect = 2e-57
 Identities = 77/261 (29%), Positives = 108/261 (41%), Gaps = 35/261 (13%)

Query: 22  QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKF 75
           + + F F  F +  N+  ++L   A I+ NG L LT  T       +  G A Y+ PIK 
Sbjct: 1   ETQSFNFDHFEE--NSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKI 58

Query: 76  KNSTRNSKSLSFSTCFAFAIVPEY-TALGGHGFAFTISASKELPGTLPSQYLGLLNSSDL 134
            +ST      SF T F+F I   Y       G  F +       G      LG+    + 
Sbjct: 59  WDST-TGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGE-DGGNLGVFKPPE- 115

Query: 135 GNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSG 194
               ++ FAVEFDT ++    D    H+GID+NS+ S+ +                L++G
Sbjct: 116 ---GDNAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKTLH------------FQLENG 158

Query: 195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIV--KETMYVGFSSSTGL-- 250
            V    I YDS    L V LA  S       LS  VDL       E + VG S++TG   
Sbjct: 159 GVANVVIKYDSPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQK 217

Query: 251 -LASSHYILGWSFNMSGDAKS 270
               +H I+ WSF  S    +
Sbjct: 218 NAVETHEIISWSFTSSLQETN 238

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score =  193 bits (491), Expect = 2e-57
 Identities = 72/253 (28%), Positives = 110/253 (43%), Gaps = 27/253 (10%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKF 75
           S +  F  + F    N  ++   G A +   G L LT           +G A Y++P++ 
Sbjct: 1   SDELSFTINNF--VPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRI 58

Query: 76  KNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTI-SASKELPGTLPSQYLGLLNSSDL 134
             +T      SFST F F +      +   G AF +     ++P    S+YLGL N+S+ 
Sbjct: 59  WGNT-TGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN- 116

Query: 135 GNLTNHIFAVEFDTVKDFEFG--DINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLK 192
            + +N I AVEFDT     +   D N  H+GID+N + S  +               +  
Sbjct: 117 SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQW------------DWI 164

Query: 193 SGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA 252
           +G V  A I Y +    L   L   S    +  ++  VDL  I+ E + VGFS++TG   
Sbjct: 165 NGGVAFATITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPT 223

Query: 253 --SSHYILGWSFN 263
              +H +L WSF 
Sbjct: 224 EVETHDVLSWSFT 236

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score =  191 bits (487), Expect = 8e-57
 Identities = 71/263 (26%), Positives = 111/263 (42%), Gaps = 37/263 (14%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIK 74
           + +  F F  F     ++ + L G A I   G+L LT         +  LG AFYS PI+
Sbjct: 1   ATETSFNFPNFHT---DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQ 57

Query: 75  FKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDL 134
            K+S   +   SF+T F F I  +  ++  +G AF +      P     ++LG+ N+++ 
Sbjct: 58  IKDSNNVA---SFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQK-KQEFLGIFNTNN- 112

Query: 135 GNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSG 194
                   AV F+T K         N +  D N ++   +E   +          +  +G
Sbjct: 113 PEPNARTVAVVFNTFK---------NRIDFDKNFIKPYVNENCDF----------HKYNG 153

Query: 195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA-- 252
           E     I YDSS N L V L  +        +S  V L   V E + VGFS ++GL    
Sbjct: 154 EKTDVQITYDSSNNDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDT 212

Query: 253 -SSHYILGWSFNMSGDAKSLSLD 274
             +H +L WSF+     K  ++ 
Sbjct: 213 TETHDVLSWSFSSKFRNKLSNIL 235

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  193 bits (493), Expect = 1e-56
 Identities = 73/301 (24%), Positives = 133/301 (44%), Gaps = 42/301 (13%)

Query: 322 ESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNE 379
           +  ++        + +L         KE +G G FG V++       + VAVK     + 
Sbjct: 30  DDMDIP-------WCDLN-------IKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF 73

Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD-EQKAI 438
             + + EF  E++ + RLRH N+V  +G   +  +L +V +++  GSL + L     +  
Sbjct: 74  HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133

Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           L   +R  +   VA G+ YLH      ++HR++K+ N+L+D +   ++ DFGL++L +  
Sbjct: 134 LDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KAS 191

Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV 558
           T  S+    GT  ++APE+ R       SDVY+FG +L E+   ++P         L   
Sbjct: 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW------GNLNPA 245

Query: 559 DWVWDRWKAGAILEV---VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
             V         LE+   ++P++              +   C  +    RP+   ++  L
Sbjct: 246 QVVAAVGFKCKRLEIPRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLL 293

Query: 616 E 616
            
Sbjct: 294 R 294

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (481), Expect = 9e-55
 Identities = 63/312 (20%), Positives = 113/312 (36%), Gaps = 51/312 (16%)

Query: 321 LESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES 380
           +               +L          E+LG G FG+  K T   T   + +K +    
Sbjct: 2   MPHRIFR-------PSDLIH-------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD 47

Query: 381 KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILT 440
           ++  R F  E+  +  L H N+++ +G   +   L  + +++  G+L   +     +   
Sbjct: 48  EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYP 106

Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE---- 496
           W QR    K +ASG+ YLH      +IHRD+ + N L+    N  + DFGLA+L      
Sbjct: 107 WSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163

Query: 497 ---------RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE 547
                    +        VVG   ++APE+          DV++FG +L E++       
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223

Query: 548 PKALPEELILVDWVWDRWKAGAILEV---VDPRLNGEFNEIEALDVVKLGLMCSNDAAEA 604
                     ++      +            P                + + C +   E 
Sbjct: 224 DYLPRTMDFGLN-----VRGFLDRYCPPNCPPSF------------FPITVRCCDLDPEK 266

Query: 605 RPTMRQVVRYLE 616
           RP+  ++  +LE
Sbjct: 267 RPSFVKLEHWLE 278

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score =  184 bits (467), Expect = 4e-54
 Identities = 61/274 (22%), Positives = 99/274 (36%), Gaps = 58/274 (21%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTR 80
           + +  F    F    N  N+ L G A +  NG L L+  +   +  AFYS+PI+ ++ST 
Sbjct: 1   ATETSFIIDAF----NKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDST- 55

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
                SF T F   I     A    G  F +                             
Sbjct: 56  TGNVASFDTNFTMNIRTHRQANSAVGLDFVL-------------------VPVQPESKGD 96

Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
              VEFDT           + + ID+N+               S    ++   G+  +  
Sbjct: 97  TVTVEFDTFL---------SRISIDVNNNDI-----------KSVPWDVHDYDGQNAEVR 136

Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA---SSHYI 257
           I Y+SS     V L+  S   +S  +S  V+L   V + + VGFS+++G       +H +
Sbjct: 137 ITYNSSTKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDV 195

Query: 258 LGWSFNMSGDAKSLSLDSLPSLPGPKEKHLGLIV 291
           L WSF+              +L   K +   +++
Sbjct: 196 LSWSFSS----------KFINLKDQKSERSNIVL 219

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  186 bits (474), Expect = 8e-54
 Identities = 71/284 (25%), Positives = 121/284 (42%), Gaps = 33/284 (11%)

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSI 394
           Y+E++        +E++G G FG V K         VA+K++ +ES+   + F  E+  +
Sbjct: 7   YKEIE-------VEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESE--RKAFIVELRQL 55

Query: 395 GRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD-EQKAILTWEQRYRIIKGVAS 453
            R+ H N+V+L G C     + LV ++   GSL   L   E     T           + 
Sbjct: 56  SRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELN-GRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           G+ YLH    + +IHRD+K  N+LL +     ++ DFG A           T   G+  +
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAW 169

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           +APE+      +   DV+++G +L EV+  R+P +    P   I            A+  
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----------MWAVHN 219

Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
              P L     +     +  L   C +     RP+M ++V+ + 
Sbjct: 220 GTRPPLIKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  184 bits (470), Expect = 1e-53
 Identities = 69/315 (21%), Positives = 127/315 (40%), Gaps = 61/315 (19%)

Query: 322 ESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK 381
               L          E++        ++ +G GGFG V+KG L    + VA+K +     
Sbjct: 12  RLPTLA-------DNEIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57

Query: 382 QG-------LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE 434
           +G        +EF  E+  +  L H N+V+L G         +V +F+P G L   L D 
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD- 114

Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR-----LGDF 489
           +   + W  + R++  +A G+ Y+       ++HRD+++ N+ L S          + DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 490 GLAKLYERGTNPSTTRVVGTLGYLAPE-LTRTGKP-TTSSDVYAFGALLLEVVCGRRP-- 545
           GL+    + +  S + ++G   ++APE +    +  T  +D Y+F  +L  ++ G  P  
Sbjct: 174 GLS----QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

Query: 546 -IEPKALPEELILVDWVWDRWKAGA---ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDA 601
                        + ++    + G    I E   PRL              +  +C +  
Sbjct: 230 EYSYGK-------IKFINMIREEGLRPTIPEDCPPRL------------RNVIELCWSGD 270

Query: 602 AEARPTMRQVVRYLE 616
            + RP    +V+ L 
Sbjct: 271 PKKRPHFSYIVKELS 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  184 bits (470), Expect = 4e-53
 Identities = 74/322 (22%), Positives = 135/322 (41%), Gaps = 58/322 (18%)

Query: 313 KKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVA 372
           K  + +  L+ W++        +E+L+         EL+G G FG+VY G     + +VA
Sbjct: 17  KASQTSIFLQEWDIP-------FEQLE-------IGELIGKGRFGQVYHGRW---HGEVA 59

Query: 373 VK--RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKC 430
           ++   +  +++  L+ F  E+ +  + RH N+V  +G C     L ++       +L   
Sbjct: 60  IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119

Query: 431 LFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL--GD 488
           + D  K +L   +  +I + +  G+ YLH    + ++H+D+K+ NV  D   NG++   D
Sbjct: 120 VRD-AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD---NGKVVITD 172

Query: 489 FGLAKL----YERGTNPSTTRVVGTLGYLAPELTRTGKP---------TTSSDVYAFGAL 535
           FGL  +                 G L +LAPE+ R   P         +  SDV+A G +
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232

Query: 536 LLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEA-LDVVKLG 594
             E+     P                +    A AI+  +   +    ++I    ++  + 
Sbjct: 233 WYELHAREWP----------------FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDIL 276

Query: 595 LMCSNDAAEARPTMRQVVRYLE 616
           L C     E RPT  +++  LE
Sbjct: 277 LFCWAFEQEERPTFTKLMDMLE 298

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  182 bits (465), Expect = 5e-53
 Identities = 77/308 (25%), Positives = 125/308 (40%), Gaps = 55/308 (17%)

Query: 324 WELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV----SNE 379
            E+D       + EL         +E++G GGFG+VY+        +VAVK        +
Sbjct: 2   LEID-------FAELT-------LEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDED 45

Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
             Q +     E      L+H N++ L G C +  +L LV +F   G L++ L       +
Sbjct: 46  ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRI 102

Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR--------LGDFGL 491
             +        +A G+ YLH+E    +IHRD+K+ N+L+  ++           + DFGL
Sbjct: 103 PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162

Query: 492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP---IEP 548
           A+ + R T        G   ++APE+ R    +  SDV+++G LL E++ G  P   I+ 
Sbjct: 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219

Query: 549 KALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTM 608
            A      +   V     A  I                     KL   C N    +RP+ 
Sbjct: 220 LA------VAYGVAMNKLALPIPSTCPEPF------------AKLMEDCWNPDPHSRPSF 261

Query: 609 RQVVRYLE 616
             ++  L 
Sbjct: 262 TNILDQLT 269

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  181 bits (461), Expect = 4e-52
 Identities = 73/307 (23%), Positives = 134/307 (43%), Gaps = 41/307 (13%)

Query: 317 NADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK-- 374
           + D  + WE+          ++          + +G G FG VYKG     +  VAVK  
Sbjct: 12  SRDAADDWEIP-------DGQIT-------VGQRIGSGSFGTVYKGKW---HGDVAVKML 54

Query: 375 RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE 434
            V+  + Q L+ F +E+  + + RH N++  +G+      L +V  +    SL   L   
Sbjct: 55  NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHA- 112

Query: 435 QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL 494
            +     ++   I +  A G+ YLH    +++IHRD+K+ N+ L  +   ++GDFGLA  
Sbjct: 113 SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169

Query: 495 YERGTNPST-TRVVGTLGYLAPELTRTGKP---TTSSDVYAFGALLLEVVCGRRPIEPKA 550
             R +      ++ G++ ++APE+ R       +  SDVYAFG +L E++ G+ P     
Sbjct: 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

Query: 551 LPEELI-LVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMR 609
             +++I +V           +      R+             +L   C     + RP+  
Sbjct: 230 NRDQIIEMVGRGSLSPDLSKVRSNCPKRM------------KRLMAECLKKKRDERPSFP 277

Query: 610 QVVRYLE 616
           +++  +E
Sbjct: 278 RILAEIE 284

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  181 bits (461), Expect = 5e-52
 Identities = 74/294 (25%), Positives = 121/294 (41%), Gaps = 35/294 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQLLG 407
           E +G G +G V++G+       VAVK  S+  ++   RE   E+ +   LRH N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRET--ELYNTVMLRHENILGFIA 69

Query: 408 WCRR----RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
                      L L+  +   GSL   L   Q   L      RI+  +ASGL +LH E  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 464 QT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGTLGYLAP 515
            T     + HRD+K+ N+L+       + D GLA ++ + TN         VGT  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 516 ELTRTGKPTTS-------SDVYAFGALLLEVVCGRRP---IEPKALP-EELILVDWVWDR 564
           E+                 D++AFG +L EV         +E    P  +++  D  ++ 
Sbjct: 187 EVLD-ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245

Query: 565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLM--CSNDAAEARPTMRQVVRYLE 616
            +    ++   P +   +     L  +   LM  C      AR T  ++ + L 
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARLTALRIKKTLT 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  178 bits (453), Expect = 1e-50
 Identities = 72/293 (24%), Positives = 120/293 (40%), Gaps = 33/293 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQLLG 407
           + +G G +G V+ G       +VAVK      +    RE  +EI     +RH N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIA 98

Query: 408 WCRRRGD----LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
              +       L L+ D+  NGSL   L   +   L  +   ++     SGL +LH E  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 464 QT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGTLGYLAP 515
            T     + HRD+K+ N+L+       + D GLA  +   TN         VGT  Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 516 EL------TRTGKPTTSSDVYAFGALLLEVVCGRRP---IEPKALP-EELILVDWVWDRW 565
           E+          +    +D+Y+FG +L EV         +E   LP  +L+  D  ++  
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275

Query: 566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLM--CSNDAAEARPTMRQVVRYLE 616
           +    ++ + P     ++  E L  +   LM  C      +R T  +V + L 
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMG-KLMTECWAHNPASRLTALRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  178 bits (453), Expect = 1e-50
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 41/297 (13%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQLLG 407
           E +G G FG V++G       +VAVK  S+  ++   RE  +EI     LRH N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIA 103

Query: 408 WCRRRGD----LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
              +       L LV D+  +GSL   L    +  +T E   ++    ASGL +LH E  
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 464 QT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST---TRVVGTLGYLAP 515
            T     + HRD+K+ N+L+       + D GLA  ++  T+         VGT  Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 516 EL------TRTGKPTTSSDVYAFGALLLEVVCGRRP---IEPKALPEELILVDWVWDRWK 566
           E+       +  +    +D+YA G +  E+          E   LP      D V     
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY----DLVPSDPS 276

Query: 567 AGAILEVVD-----PRLNGEFNEIEALDVVKLGLM--CSNDAAEARPTMRQVVRYLE 616
              + +VV      P +   +   EAL V+   +M  C      AR T  ++ + L 
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMA-KIMRECWYANGAARLTALRIKKTLS 332

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  174 bits (444), Expect = 5e-50
 Identities = 60/306 (19%), Positives = 115/306 (37%), Gaps = 53/306 (17%)

Query: 322 ESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNE 379
           +   +D       +++L            L     G ++KG        + VK  +V + 
Sbjct: 3   KHSGID-------FKQLN-------FLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDW 46

Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKA 437
           S +  R+F  E   +    H N++ +LG C+        L+  +MP GSL   L +    
Sbjct: 47  STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106

Query: 438 ILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER 497
           ++   Q  +    +A G+ +LH   E  +    + + +V++D ++  R+    +   +  
Sbjct: 107 VVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-- 163

Query: 498 GTNPSTTRVVGTLGYLAPELTRTGKP----TTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                +   +    ++APE  +  KP      S+D+++F  LL E+V    P        
Sbjct: 164 ----QSPGRMYAPAWVAPEALQ-KKPEDTNRRSADMWSFAVLLWELVTREVPF------A 212

Query: 554 ELILVDWVWDRWKAG---AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQ 610
           +L  ++        G    I   + P +             KL  +C N+    RP    
Sbjct: 213 DLSNMEIGMKVALEGLRPTIPPGISPHV------------SKLMKICMNEDPAKRPKFDM 260

Query: 611 VVRYLE 616
           +V  LE
Sbjct: 261 IVPILE 266

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181

 Score =  169 bits (428), Expect = 5e-49
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 19/199 (9%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTR 80
           ++   F  + F    +  N+   G        KL LT      +G A YSSPI   +   
Sbjct: 1   TETTSFLITKFSP--DQQNLIFQGDGYTT-KEKLTLTKAVKNTVGRALYSSPIHIWDRE- 56

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
                +F T F F I    +     GF F I A  +        YLG+ NS++  + T  
Sbjct: 57  TGNVANFVTSFTFVINAPNSYNVADGFTFFI-APVDTKPQTGGGYLGVFNSAE-YDKTTQ 114

Query: 141 IFAVEFDTVKDFEFGDIN-DNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQA 199
             AVEFDT  +  +   N D H+GID+NS++S  ++               L++GE    
Sbjct: 115 TVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKS------------WKLQNGEEANV 162

Query: 200 WIDYDSSKNHLEVRLAPSS 218
            I ++++ N L V L   +
Sbjct: 163 VIAFNAATNVLTVSLTYPN 181

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  157 bits (400), Expect = 9e-43
 Identities = 68/277 (24%), Positives = 111/277 (40%), Gaps = 33/277 (11%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLVQLL 406
            E +G G FG V+ G L + NT VAVK            +F  E   + +  H N+V+L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
           G C ++  + +V + +  G     L  E    L  +   +++   A+G+ YL     +  
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLE---SKCC 234

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY----LAPELTRTGK 522
           IHRD+ A N L+  +   ++ DFG+++    G         G         APE    G+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEALNYGR 291

Query: 523 PTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP--RLN 579
            ++ SDV++FG LL E    G  P                +         E V+   RL 
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP----------------YPNLSNQQTREFVEKGGRL- 334

Query: 580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
               E+    V +L   C       RP+   + + L+
Sbjct: 335 -PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  151 bits (384), Expect = 2e-41
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 10/205 (4%)

Query: 346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQL 405
            D+ +LG G +G VY G   S   ++A+K +     +  +    EI+    L+H+N+VQ 
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRII-KGVASGLLYLHEEWEQ 464
           LG     G + +  + +P GSL   L  +   +   EQ      K +  GL YLH   + 
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DN 141

Query: 465 TVIHRDIKAGNVLLDSELNGR--LGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            ++HRDIK  NVL+++  +G   + DFG +K    G NP T    GTL Y+APE+   G 
Sbjct: 142 QIVHRDIKGDNVLINTY-SGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGP 199

Query: 523 P--TTSSDVYAFGALLLEVVCGRRP 545
                ++D+++ G  ++E+  G+ P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133

 Score =  145 bits (366), Expect = 5e-41
 Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 14/132 (10%)

Query: 139 NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQ 198
           +++ AVEFDT  + ++GD N  H+GID+NS+RS  +    +            ++G++  
Sbjct: 1   SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDW------------QNGKIAT 48

Query: 199 AWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYIL 258
           A I Y+S    L V    +    +   LS+D++L  ++ E + VG S+STG     + + 
Sbjct: 49  AHISYNSVSKRLSVTSYYAG--SKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVH 106

Query: 259 GWSFNMSGDAKS 270
            WSF  S     
Sbjct: 107 SWSFTSSLWTNV 118

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (378), Expect = 5e-40
 Identities = 55/231 (23%), Positives = 106/231 (45%), Gaps = 12/231 (5%)

Query: 326 LDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQG 383
           +D+G     ++ ++K    +   + +G G FG+           Q  +K +  S  S + 
Sbjct: 11  VDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 384 LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ 443
             E   E++ +  ++H N+VQ        G L +V D+   G L K +  ++  +   +Q
Sbjct: 67  REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ 126

Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
                  +   L ++H+   + ++HRDIK+ N+ L  +   +LGDFG+A++       + 
Sbjct: 127 ILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183

Query: 504 TRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
              +GT  YL+PE+    KP    SD++A G +L E+   +   E  ++  
Sbjct: 184 A-CIGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  147 bits (373), Expect = 6e-40
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 16/211 (7%)

Query: 343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS--NESKQGLREFASEISSIGRLRHR 400
           R  +    +G G F  VYKG    T  +VA   +     +K   + F  E   +  L+H 
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85

Query: 401 NLVQLLG----WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           N+V+         + +  ++LV + M +G+L   L   +   +  +      + +  GL 
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQ 143

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGR--LGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           +LH      +IHRD+K  N+ +     G   +GD GLA L       +   V+GT  ++A
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKRASFAKA---VIGTPEFMA 198

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           PE+        S DVYAFG  +LE+     P
Sbjct: 199 PEMYEEKY-DESVDVYAFGMCMLEMATSEYP 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  151 bits (382), Expect = 2e-39
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 25/271 (9%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
             LG G +G VY+G     +  VAVK    E    + EF  E + +  ++H NLVQLLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
           C R     ++ +FM  G+L   L +  +  ++      +   ++S + YL    ++  IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341

Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
           R++ A N L+      ++ DFGL++L    T  +       + + APE     K +  SD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 529 VYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD--PRLNGEFNEI 585
           V+AFG LL E+   G  P     L +       V++  +    +E  +  P         
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPE-------- 446

Query: 586 EALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
               V +L   C       RP+  ++ +  E
Sbjct: 447 ---KVYELMRACWQWNPSDRPSFAEIHQAFE 474

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  141 bits (358), Expect = 6e-38
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 9/201 (4%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           K  LG G +G VY+G     +  VAVK +  E    + EF  E + +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C R     ++ +FM  G+L   L +  +  ++      +   ++S + YL    ++  I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY--LAPELTRTGKPTT 525
           HRD+ A N L+      ++ DFGL++L     +  T            APE     K + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191

Query: 526 SSDVYAFGALLLEVV-CGRRP 545
            SDV+AFG LL E+   G  P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  140 bits (356), Expect = 2e-37
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 25/214 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV---SNESKQGLREFASEISSIGRLRHRN 401
           FR ++ +G G F  VY+         VA+K+V        +   +   EI  + +L H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL---------DKCLFDEQKAILTWEQRYRIIKGVA 452
           +++         +L +V +    G L          K L  E+  +  +         + 
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT-VWKY------FVQLC 146

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           S L ++H    + V+HRDIK  NV + +    +LGD GL + +   T  + + +VGT  Y
Sbjct: 147 SALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYY 202

Query: 513 LAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
           ++PE           SD+++ G LL E+   + P
Sbjct: 203 MSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSP 235

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  140 bits (354), Expect = 3e-37
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 19/225 (8%)

Query: 334 SYEELKKATRGFRDKEL------LGFGGFGRVYKGTL--PSTNTQVAVK--RVSNESKQG 383
           + EE++        K L      LG G FG V KG          VAVK  +        
Sbjct: 2   ALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 61

Query: 384 LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQ 443
             E  +E + + +L +  +V+++G C      +LV +    G L+K L   +   +  + 
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKN 118

Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
              ++  V+ G+ YL  E E   +HRD+ A NVLL ++   ++ DFGL+K      N   
Sbjct: 119 IIELVHQVSMGMKYL--E-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175

Query: 504 TRVVGTL--GYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
            +  G     + APE     K ++ SDV++FG L+ E    G++P
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  139 bits (353), Expect = 6e-37
 Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 20/230 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           +   + LG GGF  V            A+KR+    +Q   E   E        H N+++
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 405 LLGWCRRRGD----LLLVYDFMPNGSLDKCL--FDEQKAILTWEQRYRIIKGVASGLLYL 458
           L+ +C R         L+  F   G+L   +    ++   LT +Q   ++ G+  GL  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV--------VGTL 510
           H    +   HRD+K  N+LL  E    L D G           S   +          T+
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 511 GYLAPEL--TRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELIL 557
            Y APEL   ++       +DV++ G +L  ++ G  P +      + + 
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  138 bits (351), Expect = 7e-37
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 348 KELLGFGGFGRVYKGTL--PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLVQ 404
              LG G FG V +G          VA+K +     K    E   E   + +L +  +V+
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L+G C+    L+LV +    G L K L  +++  +       ++  V+ G+ YL E   +
Sbjct: 75  LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEE---K 129

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYLAPELTRTGK 522
             +HRD+ A NVLL +    ++ DFGL+K      +  T R  G     + APE     K
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189

Query: 523 PTTSSDVYAFGALLLEVV-CGRRP 545
            ++ SDV+++G  + E +  G++P
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP 213

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score =  136 bits (343), Expect = 1e-36
 Identities = 43/127 (33%), Positives = 65/127 (51%), Gaps = 14/127 (11%)

Query: 139 NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQ 198
           + I AVE DT  + + GD +  H+GIDI S+RS  +               N+++G+V  
Sbjct: 2   DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQNGKVGT 49

Query: 199 AWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYIL 258
           A I Y+S    L   ++       S  +S+DVDL  ++ E + VG S+STGL   ++ IL
Sbjct: 50  AHIIYNSVDKRLSAVVSYP--NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTIL 107

Query: 259 GWSFNMS 265
            WSF   
Sbjct: 108 SWSFTSK 114

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score = 74.9 bits (183), Expect = 3e-15
 Identities = 26/130 (20%), Positives = 46/130 (35%), Gaps = 10/130 (7%)

Query: 11  LFIFLANPVFSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVL------ 64
               L +    +     F   + + +  ++ L G A    +G L LT  +          
Sbjct: 111 FTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSV 170

Query: 65  GHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTI-SASKELPGTLPS 123
           G A + +P+    S+  +   SF   F F I    +     G AF I +    +P     
Sbjct: 171 GRALFYAPVHIWESS--AVVASFEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTG 227

Query: 124 QYLGLLNSSD 133
           + LGL   ++
Sbjct: 228 RLLGLFPDAN 237

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  137 bits (348), Expect = 1e-36
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 27/218 (12%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           F++ EL+G GGFG+V+K           +KRV   +++  RE    + ++ +L H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68

Query: 405 LLG----------------WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRII 448
             G                   +   L +  +F   G+L++ +   +   L       + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG 508
           + +  G+ Y+H    + +I+RD+K  N+ L      ++GDFGL    +     + +   G
Sbjct: 129 EQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--KG 183

Query: 509 TLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
           TL Y++PE     +      D+YA G +L E++     
Sbjct: 184 TLRYMSPEQIS-SQDYGKEVDLYALGLILAELLHVCDT 220

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  144 bits (365), Expect = 2e-36
 Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 12/277 (4%)

Query: 275 SLPSLPGPKEKHLGLIVGVTVSAFFVMFLAIAVGCYLVKKIRNADVLESWELDVGPHRFS 334
           +LP+ P         I  +    +      I           +  V ES   D    +  
Sbjct: 269 TLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDK 328

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTN--TQVAVKRV-SNESKQGLREFASEI 391
              LK+      D EL G G FG V +G          VA+K +     K    E   E 
Sbjct: 329 KLFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 387

Query: 392 SSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV 451
             + +L +  +V+L+G C+    L+LV +    G L K L  +++  +       ++  V
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 445

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG 511
           + G+ YL E   +  +HR++ A NVLL +    ++ DFGL+K      +  T R  G   
Sbjct: 446 SMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502

Query: 512 Y--LAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
               APE     K ++ SDV+++G  + E +  G++P
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  141 bits (358), Expect = 2e-36
 Identities = 78/273 (28%), Positives = 115/273 (42%), Gaps = 31/273 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
             LG G FG V+ GT  +  T+VA+K  +    S +    F  E   + +LRH  LVQL 
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLY 245

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                   + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 301

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRD++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 527 SDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD--PRLNGEFN 583
           SDV++FG LL E+   GR P       E       V D+ + G  +      P       
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPCPPECPE------ 408

Query: 584 EIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
                 +  L   C     E RPT   +  +LE
Sbjct: 409 -----SLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  138 bits (351), Expect = 2e-36
 Identities = 65/205 (31%), Positives = 111/205 (54%), Gaps = 11/205 (5%)

Query: 348 KELLGFGGFGRVYKGTL---PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLV 403
           ++++G G  G V  G L      +  VA+K + +  +++  R+F SE S +G+  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L G   R    ++V ++M NGSLD  L        T  Q   +++GV +G+ YL    +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLS---D 169

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL--APELTRTG 521
              +HRD+ A NVL+DS L  ++ DFGL+++ E   + + T   G +     APE     
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229

Query: 522 KPTTSSDVYAFGALLLEVV-CGRRP 545
             +++SDV++FG ++ EV+  G RP
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP 254

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  138 bits (349), Expect = 2e-36
 Identities = 77/296 (26%), Positives = 117/296 (39%), Gaps = 52/296 (17%)

Query: 348 KELLGFGGFGRVYKGTL----PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNL 402
              LG G FG+V           T   VAVK + ++   Q    +  EI  +  L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 403 VQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           ++  G C   G   L LV +++P GSL   L    +  +   Q     + +  G+ YLH 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYLAPELT 518
              Q  IHRD+ A NVLLD++   ++GDFGLAK    G      R  G     + APE  
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 519 RTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR 577
           +  K   +SDV++FG  L E++        P     ELI +                  +
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ---------------GQ 254

Query: 578 LNGEFNEIEALDVVKLG---------------LM--CSNDAAEARPTMRQVVRYLE 616
           +          ++++ G               LM  C    A  RPT   ++  L+
Sbjct: 255 MTVL----RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (352), Expect = 3e-36
 Identities = 83/322 (25%), Positives = 140/322 (43%), Gaps = 51/322 (15%)

Query: 348 KELLGFGGFGRVYKGTLPST---NTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNL 402
            +++G G FG V  G L         VA+K  +V    KQ  R+F  E S +G+  H N+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNI 108

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           ++L G   +   +++V ++M NGSLD  L  +  A  T  Q   +++G+ASG+ YL    
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLS--- 164

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL--APELTRT 520
           +   +HRD+ A N+L++S L  ++ DFGL ++ E     + T   G +     +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 521 GKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD---- 575
            K T++SDV+++G +L EV+  G RP                +       +++ VD    
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIKAVDEGYR 268

Query: 576 -------PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAP 628
                  P             + +L L C       RP   Q+V  L+  +  P ++   
Sbjct: 269 LPPPMDCPA-----------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

Query: 629 DACDGKKEKTSGGGAGVDGPEF 650
            +   +        + VD   F
Sbjct: 318 TSAAARPSNLLLDQSNVDITTF 339

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  142 bits (359), Expect = 3e-36
 Identities = 78/273 (28%), Positives = 115/273 (42%), Gaps = 31/273 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQLL 406
             LG G FG V+ GT  +  T+VA+K  +    S +    F  E   + +LRH  LVQL 
Sbjct: 273 VKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLY 328

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                   + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+        
Sbjct: 329 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 384

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTS 526
           +HRD++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T  
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

Query: 527 SDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD--PRLNGEFN 583
           SDV++FG LL E+   GR P       E       V D+ + G  +      P       
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPCPPECPE------ 491

Query: 584 EIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
                 +  L   C     E RPT   +  +LE
Sbjct: 492 -----SLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  137 bits (348), Expect = 4e-36
 Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 29/221 (13%)

Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR 396
           E ++       +  +G G FG V++     T  Q AVK+V  E  +       E+ +   
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAG 106

Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGV 451
           L    +V L G  R    + +  + +  GSL + +       E +A+         +   
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY-------YLGQA 159

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAKLYERGTNPSTTR--- 505
             GL YLH    + ++H D+KA NVLL S  +G    L DFG A   +      +     
Sbjct: 160 LEGLEYLH---TRRILHGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGD 214

Query: 506 -VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            + GT  ++APE+          D+++   ++L ++ G  P
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  136 bits (344), Expect = 7e-36
 Identities = 71/244 (29%), Positives = 110/244 (45%), Gaps = 23/244 (9%)

Query: 323 SWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTL----PSTNTQVAVKRV-S 377
           + E+D  P  F    LK+          LG G FG+V          +T  QVAVK +  
Sbjct: 10  ATEVD--PTHFEKRFLKR-------IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60

Query: 378 NESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQ 435
                 + +   EI  +  L H N+V+  G C   G   + L+ +F+P+GSL + L    
Sbjct: 61  ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN- 119

Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
           K  +  +Q+ +    +  G+ YL     +  +HRD+ A NVL++SE   ++GDFGL K  
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176

Query: 496 ERGTNPSTTRVVGTL--GYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALP 552
           E      T +        + APE     K   +SDV++FG  L E++        P AL 
Sbjct: 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236

Query: 553 EELI 556
            ++I
Sbjct: 237 LKMI 240

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  137 bits (346), Expect = 7e-36
 Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 49/295 (16%)

Query: 348 KELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
              LG G FG V          +T   VAVK++ +      R+F  EI  +  L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 404 QLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +  G     G   L LV +++P+G L   L    +A L   +       +  G+ YL   
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG-- 144

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYLAPELTR 519
             +  +HRD+ A N+L++SE + ++ DFGLAKL     +    R  G     + APE   
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203

Query: 520 TGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL 578
               +  SDV++FG +L E+     +   P A    ++  +                   
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE------------------- 244

Query: 579 NGEFNEIEALDVVKLG---------------LM--CSNDAAEARPTMRQVVRYLE 616
                    L++++ G               LM  C   + + RP+   +   L+
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  135 bits (341), Expect = 1e-35
 Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 25/206 (12%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
            + +G G FG V  G       +VAVK + N++    + F +E S + +LRH NLVQLLG
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81

Query: 408 WC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                +G L +V ++M  GSL   L    +++L  +   +    V   + YL        
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 138

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYL-----APELTRT 520
           +HRD+ A NVL+  +   ++ DFGL K                  G L     APE  R 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----------GKLPVKWTAPEALRE 188

Query: 521 GKPTTSSDVYAFGALLLEVV-CGRRP 545
            K +T SDV++FG LL E+   GR P
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVP 214

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  136 bits (344), Expect = 1e-35
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 349 ELLGFGGFGRVYKGTL----PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLV 403
           ++LG G FG VYKG            VA+K +    S +  +E   E   +  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +LLG C     + L+   MP G L   +  E K  +  +        +A G+ YL +   
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLED--- 135

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT---LGYLAPELTRT 520
           + ++HRD+ A NVL+ +  + ++ DFGLAKL             G    + ++A E    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILH 193

Query: 521 GKPTTSSDVYAFGALLLEVV-CGRRP 545
              T  SDV+++G  + E++  G +P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  134 bits (340), Expect = 2e-35
 Identities = 67/284 (23%), Positives = 125/284 (44%), Gaps = 26/284 (9%)

Query: 348 KELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + LG G FG V          +T   VAVK++ + +++ LR+F  EI  +  L+H N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 404 QLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +  G C   G   L L+ +++P GSL   L  + K  +   +  +    +  G+ YL   
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG-- 131

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYLAPELTR 519
             +  IHRD+   N+L+++E   ++GDFGL K+  +       +  G     + APE   
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP--R 577
             K + +SDV++FG +L E+       +        ++ +    +     ++E++    R
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250

Query: 578 LNGEFNEIEA-----LDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
           L               ++  +   C N+    RP+ R +   ++
Sbjct: 251 L-------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  133 bits (338), Expect = 2e-35
 Identities = 62/202 (30%), Positives = 91/202 (45%), Gaps = 13/202 (6%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
            + LG G FG V  G        VAVK +  E      EF  E  ++ +L H  LV+  G
Sbjct: 13  LKELGSGQFGVVKLGKW-KGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
            C +   + +V +++ NG L   L    K  L   Q   +   V  G+ +L        I
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLE---SHQFI 126

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL---GYLAPELTRTGKPT 524
           HRD+ A N L+D +L  ++ DFG+ +             VGT     + APE+    K +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYS 183

Query: 525 TSSDVYAFGALLLEVV-CGRRP 545
           + SDV+AFG L+ EV   G+ P
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP 205

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (342), Expect = 3e-35
 Identities = 63/206 (30%), Positives = 114/206 (55%), Gaps = 12/206 (5%)

Query: 348 KELLGFGGFGRVYKGTL----PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNL 402
           ++++G G FG VYKG L          VA+K + +  +++   +F  E   +G+  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           ++L G   +   ++++ ++M NG+LDK L  E+    +  Q   +++G+A+G+ YL    
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLA--- 164

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY--LAPELTRT 520
               +HRD+ A N+L++S L  ++ DFGL+++ E     + T   G +     APE    
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224

Query: 521 GKPTTSSDVYAFGALLLEVV-CGRRP 545
            K T++SDV++FG ++ EV+  G RP
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP 250

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  137 bits (348), Expect = 3e-35
 Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 17/202 (8%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
            + +G G FG V  G       +VAVK + N++    + F +E S + +LRH NLVQLLG
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253

Query: 408 WC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                +G L +V ++M  GSL   L    +++L  +   +    V   + YL        
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY--LAPELTRTGKPT 524
           +HRD+ A NVL+  +   ++ DFGL K         +T+  G L     APE  R  K +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFS 364

Query: 525 TSSDVYAFGALLLEVV-CGRRP 545
           T SDV++FG LL E+   GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  133 bits (337), Expect = 4e-35
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 11/218 (5%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRNL 402
           +     +G G +GR  K    S    +  K +   + ++   +   SE++ +  L+H N+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 403 VQLLGW--CRRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQRYRIIKGVASGLLYL 458
           V+       R    L +V ++   G L   +    +++  L  E   R++  +   L   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 459 HE--EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           H   +   TV+HRD+K  NV LD + N +LGDFGLA++    T+ + T  VGT  Y++PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPE 186

Query: 517 LTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                      SD+++ G LL E+     P    +  E
Sbjct: 187 QMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  133 bits (337), Expect = 4e-35
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQL 405
            + LG G FG V  G        VA+K  +  + S+    EF  E   +  L H  LVQL
Sbjct: 29  LKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQL 84

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
            G C ++  + ++ ++M NG L   L  E +     +Q   + K V   + YL     + 
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQ 140

Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL---GYLAPELTRTGK 522
            +HRD+ A N L++ +   ++ DFGL++          T  VG+     +  PE+    K
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK 197

Query: 523 PTTSSDVYAFGALLLEVV-CGRRP 545
            ++ SD++AFG L+ E+   G+ P
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMP 221

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  134 bits (340), Expect = 4e-35
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 33/223 (14%)

Query: 348 KELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL 402
           K  LG G FG+V+               VAVK +   S+   ++F  E   +  L+H+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCL-------------FDEQKAILTWEQRYRIIK 449
           V+  G C     LL+V+++M +G L++ L              D     L   Q   +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVG 508
            VA+G++YL        +HRD+   N L+   L  ++GDFG+++ +Y         R VG
Sbjct: 166 QVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYYR-VG 217

Query: 509 TLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
               L      PE     K TT SDV++FG +L E+   G++P
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  133 bits (337), Expect = 5e-35
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 14/207 (6%)

Query: 348 KELLGFGGFGRVYKGTL---PSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
            E LG G FG V +G           VAVK +  +     + + +F  E++++  L HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L++L G       + +V +  P GSL   L  + +         R    VA G+ YL   
Sbjct: 83  LIRLYGVVLTPP-MKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLES- 139

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY--LAPELTR 519
             +  IHRD+ A N+LL +    ++GDFGL +   +  +    +    + +   APE  +
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197

Query: 520 TGKPTTSSDVYAFGALLLEVV-CGRRP 545
           T   + +SD + FG  L E+   G+ P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  133 bits (336), Expect = 5e-35
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQL 405
            + +G G FG V+ G       +VA+K  R    S++   +F  E   + +L H  LVQL
Sbjct: 13  VQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQL 68

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
            G C  +  + LV +FM +G L   L   Q+ +   E    +   V  G+ YL    E  
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 124

Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL---GYLAPELTRTGK 522
           VIHRD+ A N L+      ++ DFG+ +          T   GT     + +PE+    +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSR 181

Query: 523 PTTSSDVYAFGALLLEVV-CGRRP 545
            ++ SDV++FG L+ EV   G+ P
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP 205

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (336), Expect = 5e-35
 Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
            E LG G FG V+ G   + +T+VAVK +  +       F +E + + +L+H+ LV+L  
Sbjct: 18  VERLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVI 467
              +   + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +  I
Sbjct: 76  VVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131

Query: 468 HRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY--LAPELTRTGKPTT 525
           HRD++A N+L+   L+ ++ DFGLA+L E      T R          APE    G  T 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTI 189

Query: 526 SSDVYAFGALLLEVV-CGRRP 545
            SDV++FG LL E+V  GR P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  134 bits (339), Expect = 6e-35
 Identities = 67/284 (23%), Positives = 124/284 (43%), Gaps = 26/284 (9%)

Query: 348 KELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLV 403
            + LG G FG V          +T   VAVK++ + +++ LR+F  EI  +  L+H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 404 QLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +  G C   G   L L+ +++P GSL   L    K  +   +  +    +  G+ YL   
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLG-- 162

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL--GYLAPELTR 519
             +  IHRD+   N+L+++E   ++GDFGL K+  +       +  G     + APE   
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP--R 577
             K + +SDV++FG +L E+       +        ++ +    +     ++E++    R
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281

Query: 578 LNGEFNEIEA-----LDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
           L               ++  +   C N+    RP+ R +   ++
Sbjct: 282 L-------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  133 bits (336), Expect = 7e-35
 Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 13/206 (6%)

Query: 349 ELLGFGGFGRVYKGTL---PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL          AVK +        + +F +E   +    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           LLG C R  G  L+V  +M +G L   + +E     T +        VA G+ YL     
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLAS--- 146

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPELTRT 520
           +  +HRD+ A N +LD +   ++ DFGLA+ +Y++       +    L   ++A E  +T
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206

Query: 521 GKPTTSSDVYAFGALLLEVVC-GRRP 545
            K TT SDV++FG LL E++  G  P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPP 232

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  132 bits (335), Expect = 1e-34
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 15/211 (7%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLRE-FASEISSIGRLRHRNLVQL 405
             LG GGF + ++ +   T    A K V      K   RE  + EIS    L H+++V  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLLYLHEEW 462
            G+      + +V +     SL     +    +KA+   E RY  ++ +  G  YLH   
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR-- 133

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              VIHRD+K GN+ L+ +L  ++GDFGLA   E         + GT  Y+APE+     
Sbjct: 134 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 191

Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
            +   DV++ G ++  ++ G+ P E   L E
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  139 bits (351), Expect = 1e-34
 Identities = 70/219 (31%), Positives = 97/219 (44%), Gaps = 16/219 (7%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
           KE LG GGFG V +     T  QVA+K+   E     RE +  EI  + +L H N+V   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 407 ------GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKA-ILTWEQRYRIIKGVASGLLYLH 459
                          LL  ++   G L K L   +    L       ++  ++S L YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           E     +IHRD+K  N++L          + D G AK  ++G   +    VGTL YLAPE
Sbjct: 139 E---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPE 193

Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL 555
           L    K T + D ++FG L  E + G RP  P   P + 
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  136 bits (344), Expect = 1e-34
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 11/200 (5%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           + LG G FG V+  T  + +T+VAVK +       +  F +E + +  L+H  LV+L   
Sbjct: 194 KKLGAGQFGEVWMATY-NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH 468
             +   + ++ +FM  GSL   L  ++ +     +       +A G+ ++ +   +  IH
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIH 307

Query: 469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY--LAPELTRTGKPTTS 526
           RD++A N+L+ + L  ++ DFGLA++ E   N  T R          APE    G  T  
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIK 365

Query: 527 SDVYAFGALLLEVV-CGRRP 545
           SDV++FG LL+E+V  GR P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  131 bits (333), Expect = 1e-34
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 10/208 (4%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLRE-FASEISSIGRLRHRNLVQLL 406
           LLG G F  VY+     T  +VA+K +  ++  K G+ +   +E+    +L+H ++++L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
            +      + LV +   NG +++ L +  K     E R   +  + +G+LYLH      +
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHS---HGI 133

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP-TT 525
           +HRD+   N+LL   +N ++ DFGLA   +       T + GT  Y++PE+  T      
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIA-TRSAHGL 191

Query: 526 SSDVYAFGALLLEVVCGRRPIEPKALPE 553
            SDV++ G +   ++ GR P +   +  
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKN 219

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  133 bits (336), Expect = 2e-34
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 15/211 (7%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLRE-FASEISSIGRLRHRNLVQL 405
             LG GGF + ++ +   T    A K V      K   RE  + EIS    L H+++V  
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLLYLHEEW 462
            G+      + +V +     SL     +    +KA+   E RY  ++ +  G  YLH   
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR-- 159

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              VIHRD+K GN+ L+ +L  ++GDFGLA   E         + GT  Y+APE+     
Sbjct: 160 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 217

Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
            +   DV++ G ++  ++ G+ P E   L E
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  130 bits (330), Expect = 4e-34
 Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 40/222 (18%)

Query: 348 KELLGFGGFGRVYKGTL-------PSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHR 400
            E LG G F +++KG             T+V +K +    +     F    S + +L H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           +LV   G C    + +LV +F+  GSLD  L   +   +    +  + K +A+ + +L  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLE- 130

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGR--------LGDFGLAKLYERGTNPSTTRVVGTLGY 512
             E T+IH ++ A N+LL  E + +        L D G++              V     
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------------ITVLPKDI 176

Query: 513 L-------APELTRTGKP-TTSSDVYAFGALLLEVV-CGRRP 545
           L        PE     K    ++D ++FG  L E+   G +P
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  130 bits (330), Expect = 5e-34
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 34/224 (15%)

Query: 348 KELLGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL 402
           K  LG G FG+V+     +         VAVK + + +    ++F  E   +  L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCL--------------FDEQKAILTWEQRYRII 448
           V+  G C     L++V+++M +G L+K L                + K  L   Q   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVV 507
             +ASG++YL     Q  +HRD+   N L+ + L  ++GDFG+++ +Y         R V
Sbjct: 140 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST----DYYR-V 191

Query: 508 GTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
           G    L      PE     K TT SDV++FG +L E+   G++P
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  132 bits (333), Expect = 5e-34
 Identities = 49/245 (20%), Positives = 95/245 (38%), Gaps = 36/245 (14%)

Query: 326 LDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR 385
           +++G  R      +          +L  GGF  VY+     +  + A+KR+ +  ++  R
Sbjct: 23  VELGELR--LRVRR----------VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR 70

Query: 386 EFASEISSIGRLR-HRNLVQLLGWCRRRGD--------LLLVYDFMPNGSLDKCLFDEQK 436
               E+  + +L  H N+VQ         +         LL+ +      ++     E +
Sbjct: 71  AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR 130

Query: 437 AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE 496
             L+ +   +I       + ++H + +  +IHRD+K  N+LL ++   +L DFG A    
Sbjct: 131 GPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

Query: 497 RGTNPSTTR-----------VVGTLGYLAPEL--TRTGKP-TTSSDVYAFGALLLEVVCG 542
              + S +               T  Y  PE+    +  P     D++A G +L  +   
Sbjct: 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249

Query: 543 RRPIE 547
           + P E
Sbjct: 250 QHPFE 254

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  132 bits (335), Expect = 5e-34
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 13/206 (6%)

Query: 349 ELLGFGGFGRVYKGTL---PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLVQ 404
           E++G G FG VY GTL          AVK +        + +F +E   +    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           LLG C R  G  L+V  +M +G L   + +E     T +        VA G+ +L     
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLAS--- 210

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPELTRT 520
           +  +HRD+ A N +LD +   ++ DFGLA+ +Y++  +    +    L   ++A E  +T
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270

Query: 521 GKPTTSSDVYAFGALLLEVVC-GRRP 545
            K TT SDV++FG LL E++  G  P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPP 296

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  130 bits (330), Expect = 7e-34
 Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 14/218 (6%)

Query: 334 SYEELKKATRG---FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFA 388
            Y+  +  +     F+    LG G +G V+K          AVKR        +      
Sbjct: 45  GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL 104

Query: 389 SEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRI 447
           +E+ S  ++ +H   V+L       G L L  +     SL +   +   A L   Q +  
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGY 162

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
           ++     L +LH    Q ++H D+K  N+ L      +LGDFGL                
Sbjct: 163 LRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QE 217

Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           G   Y+APEL + G   T++DV++ G  +LEV C    
Sbjct: 218 GDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMEL 254

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  131 bits (331), Expect = 8e-34
 Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 54/256 (21%)

Query: 317 NADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTL--PSTNTQVAVK 374
           N D      LD   +   ++++            +G G FG+V K  +         A+K
Sbjct: 13  NPDPTIYPVLD--WNDIKFQDV------------IGEGNFGQVLKARIKKDGLRMDAAIK 58

Query: 375 RV-SNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL- 431
           R+    SK   R+FA E+  + +L  H N++ LLG C  RG L L  ++ P+G+L   L 
Sbjct: 59  RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118

Query: 432 -------------FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL 478
                         +   + L+ +Q       VA G+ YL    ++  IHRD+ A N+L+
Sbjct: 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV 175

Query: 479 DSELNGRLGDFGLAK---LYERGTNPSTTRVVGTLGYL-----APELTRTGKPTTSSDVY 530
                 ++ DFGL++   +Y + T           G L     A E       TT+SDV+
Sbjct: 176 GENYVAKIADFGLSRGQEVYVKKTM----------GRLPVRWMAIESLNYSVYTTNSDVW 225

Query: 531 AFGALLLEVV-CGRRP 545
           ++G LL E+V  G  P
Sbjct: 226 SYGVLLWEIVSLGGTP 241

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (329), Expect = 8e-34
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 38/228 (16%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           F +  +LG G FG+V K      +   A+K++ +  ++ L    SE+  +  L H+ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66

Query: 405 LLG-WCRRRGD------------LLLVYDFMPNGSLDKCLFD---EQKAILTWEQRYRII 448
               W  RR              L +  ++  NG+L    +D    +      ++ +R+ 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYWRLF 122

Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST----- 503
           + +   L Y+H    Q +IHRD+K  N+ +D   N ++GDFGLAK   R  +        
Sbjct: 123 RQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 504 --------TRVVGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVVCG 542
                   T  +GT  Y+A E L  TG      D+Y+ G +  E++  
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  129 bits (327), Expect = 8e-34
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 16/206 (7%)

Query: 348 KELLGFGGFGRVYKGTLPSTN---TQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLV 403
             +LG G FG VY+G   +       VAVK    + +     +F SE   +  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +L+G         ++ +  P G L   L +  K  L           +   + YL     
Sbjct: 77  KLIGIIEEE-PTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLES--- 131

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL---GYLAPELTRT 520
              +HRDI   N+L+ S    +LGDFGL++  E   +    +   T     +++PE    
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPESINF 188

Query: 521 GKPTTSSDVYAFGALLLEVV-CGRRP 545
            + TT+SDV+ F   + E++  G++P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (329), Expect = 1e-33
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 349 ELLGFGGFGRVYKGTL----PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLV 403
           ++LG G FG VYKG            VA+K +    S +  +E   E   +  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +LLG C     + L+   MP G L   +  E K  +  +        +A G+ YL +   
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLED--- 135

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT---LGYLAPELTRT 520
           + ++HRD+ A NVL+ +  + ++ DFGLAKL             G    + ++A E    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILH 193

Query: 521 GKPTTSSDVYAFGALLLEVV-CGRRP 545
              T  SDV+++G  + E++  G +P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  130 bits (329), Expect = 1e-33
 Identities = 66/219 (30%), Positives = 94/219 (42%), Gaps = 29/219 (13%)

Query: 348 KELLGFGGFGRVYKGTLP-----STNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRN 401
              LG G FG VY+G +       +  QVAVK +    S+Q   +F  E   I +  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           +V+ +G   +     ++ + M  G L   L        Q + L       + + +A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRL---GDFGLAK-LYERGTNPSTTRVVGTLGY 512
           YL    E   IHRDI A N LL     GR+   GDFG+A+ +Y      S  R  G    
Sbjct: 155 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYR-KGGCAM 206

Query: 513 L-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
           L      PE    G  T+ +D ++FG LL E+   G  P
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  129 bits (327), Expect = 1e-33
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 13/209 (6%)

Query: 346 RDKELLGFGGFGRVYKGTL---PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRN 401
               ++G G FG VY G          Q A+K +      Q +  F  E   +  L H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 402 LVQLLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           ++ L+G      G   ++  +M +G L + +   Q+   T +        VA G+ YL E
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYLAE 142

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTL--GYLAPEL 517
              Q  +HRD+ A N +LD     ++ DFGLA+ + +R            L   + A E 
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 518 TRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
            +T + TT SDV++FG LL E++  G  P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  130 bits (330), Expect = 2e-33
 Identities = 76/291 (26%), Positives = 115/291 (39%), Gaps = 47/291 (16%)

Query: 348 KELLGFGGFGRVYKGTLP-----STNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRN 401
              LG G FG VY+G +       +  QVAVK +    S+Q   +F  E   I +  H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLL 456
           +V+ +G   +     ++ + M  G L   L        Q + L       + + +A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRL---GDFGLAK-LYERGTNPSTTRVVGTLGY 512
           YL    E   IHRDI A N LL     GR+   GDFG+A+ +Y      +     G    
Sbjct: 196 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-----AGYYRKGGCAM 247

Query: 513 L-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWK 566
           L      PE    G  T+ +D ++FG LL E+   G  P   K+  E L  V        
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------T 300

Query: 567 AGAILEVVDPRLNGEFNEIEALDVV-KLGLMCSNDAAEARPTMRQVVRYLE 616
           +G  ++   P+             V ++   C     E RP    ++  +E
Sbjct: 301 SGGRMDP--PK--------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (324), Expect = 3e-33
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 35/225 (15%)

Query: 348 KELLGFGGFGRVYKGTLP-----STNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRN 401
            E LG   FG+VYKG L           VA+K +          EF  E     RL+H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--------------FDEQKAILTWEQRYRI 447
           +V LLG   +   L +++ +  +G L + L                  K+ L       +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRV 506
           +  +A+G+ YL       V+H+D+   NVL+  +LN ++ D GL  ++Y      +    
Sbjct: 134 VAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA-----ADYYK 185

Query: 507 VGTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
           +     L     APE    GK +  SD++++G +L EV   G +P
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  128 bits (325), Expect = 3e-33
 Identities = 50/242 (20%), Positives = 98/242 (40%), Gaps = 38/242 (15%)

Query: 327 DVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS--NESKQGL 384
           D+G     ++ +    R +   + +G GG  +V++  L       A+K V+      Q L
Sbjct: 12  DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTL 70

Query: 385 REFASEISSIGRLRHRNL--VQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKA 437
             + +EI+ + +L+  +   ++L  +      + +V +   N  L+  L      D  + 
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER 129

Query: 438 ILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR--LGDFGLAKLY 495
              W+        +   +  +H+     ++H D+K  N L+    +G   L DFG+A   
Sbjct: 130 KSYWKN-------MLEAVHTIHQ---HGIVHSDLKPANFLIV---DGMLKLIDFGIANQM 176

Query: 496 ERGT-NPSTTRVVGTLGYLAPEL-----------TRTGKPTTSSDVYAFGALLLEVVCGR 543
           +  T +      VGT+ Y+ PE                K +  SDV++ G +L  +  G+
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

Query: 544 RP 545
            P
Sbjct: 237 TP 238

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  128 bits (324), Expect = 3e-33
 Identities = 45/224 (20%), Positives = 88/224 (39%), Gaps = 32/224 (14%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLV 403
           F   + LG GGFG V++      +   A+KR+     +    +   E+ ++ +L H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 404 QLLG---------WCRRRGDLLLVY---DFMPNGSLDKCLFDEQKAILTWEQRY--RIIK 449
           +              +     + +Y         +L     + +  I   E+     I  
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLHIFL 125

Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV--- 506
            +A  + +LH    + ++HRD+K  N+    +   ++GDFGL    ++     T      
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 507 --------VGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVC 541
                   VGT  Y++PE    G   +   D+++ G +L E++ 
Sbjct: 183 AYARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELLY 225

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  128 bits (324), Expect = 4e-33
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 39/224 (17%)

Query: 348 KELLGFGGFGRVYKGTL---PSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNL 402
            ++LG G FG V +G L     T+ +VAVK  ++ N S++ + EF SE + +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 403 VQLLGWC-----RRRGDLLLVYDFMPNGSLD----KCLFDEQKAILTWEQRYRIIKGVAS 453
           ++LLG C     +     +++  FM  G L         +     +  +   + +  +A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL------YERGTNPSTTRVV 507
           G+ YL     +  +HRD+ A N +L  ++   + DFGL+K       Y +G         
Sbjct: 159 GMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI------- 208

Query: 508 GTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
                +     A E       T+ SDV+AFG  + E+   G  P
Sbjct: 209 ---AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  127 bits (322), Expect = 5e-33
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 16/205 (7%)

Query: 349 ELLGFGGFGRVYKGTL---PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLVQ 404
             +G G FG V++G      +    VA+K   +  S     +F  E  ++ +  H ++V+
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L+G       + ++ +    G L   L   +K  L           +++ L YL     +
Sbjct: 81  LIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---K 135

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTL---GYLAPELTRTG 521
             +HRDI A NVL+ S    +LGDFGL++  E  T     +         ++APE     
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFR 192

Query: 522 KPTTSSDVYAFGALLLEVV-CGRRP 545
           + T++SDV+ FG  + E++  G +P
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP 217

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  128 bits (323), Expect = 7e-33
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 30/231 (12%)

Query: 324 WELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTL----PSTNTQVAVKRV-SN 378
                        EL+K        ++LG G FG V+KG       S    V +K +   
Sbjct: 8   RIFKE-------TELRK-------LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK 53

Query: 379 ESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI 438
             +Q  +     + +IG L H ++V+LLG C     L LV  ++P GSL   +  + +  
Sbjct: 54  SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHV-RQHRGA 111

Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           L  +        +A G+ YL E     ++HR++ A NVLL S    ++ DFG+A L    
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP- 167

Query: 499 TNPSTTRVVGT---LGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
            +            + ++A E    GK T  SDV+++G  + E++  G  P
Sbjct: 168 -DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  129 bits (325), Expect = 7e-33
 Identities = 36/318 (11%), Positives = 73/318 (22%), Gaps = 62/318 (19%)

Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV---SNESKQGLREFASEISS 393
            L +  R  +  E L  G    V+           A+K     +  S+  L        +
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 394 IGRLRHRNLVQLLGWCR--------------------------RRGDLLLVYDFMPNGSL 427
             RL   +  +     R                             + LL+     +  L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDL 174

Query: 428 DKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL 482
           +            +        + +   +      L  +    ++H      N+ +  + 
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDG 231

Query: 483 NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT--RTGKPTTSSDVYAFGALLLEVV 540
              LGD                     + Y   E     T   T + + +  G  +  V 
Sbjct: 232 RLMLGDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

Query: 541 CGRRPIE-----PKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGL 595
           C   P        K   +   L     D    G+   + D              ++    
Sbjct: 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD----------FVKTLIG-RF 336

Query: 596 MCSNDAAEARPTMRQVVR 613
           +  +     R    + + 
Sbjct: 337 LNFD--RRRRLLPLEAME 352

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (321), Expect = 2e-32
 Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 38/220 (17%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVS--NESKQGLREFASEISSIGRLRHRNL--VQ 404
           + +G GG  +V++  L       A+K V+      Q L  + +EI+ + +L+  +   ++
Sbjct: 15  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLH 459
           L  +      + +V +   N  L+  L      D  +    W+        +   +  +H
Sbjct: 74  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN-------MLEAVHTIH 125

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR--LGDFGLAKLYERGT-NPSTTRVVGTLGYLAPE 516
           +     ++H D+K  N L+    +G   L DFG+A   +  T +      VGT+ Y+ PE
Sbjct: 126 Q---HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 517 L-----------TRTGKPTTSSDVYAFGALLLEVVCGRRP 545
                           K +  SDV++ G +L  +  G+ P
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  126 bits (319), Expect = 2e-32
 Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 35/231 (15%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
            ++LG G    V++G    T    A+K  +N S     +    E   + +L H+N+V+L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 407 G--WCRRRGDLLLVYDFMPNGSL--------DKCLFDEQKAILTWEQRYRIIKGVASGLL 456
                      +L+ +F P GSL        +     E + +        +++ V  G+ 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-------IVLRDVVGGMN 126

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGR----LGDFGLAKLYERGTNPSTTRVVGTLGY 512
           +L    E  ++HR+IK GN++     +G+    L DFG A+  E      +  + GT  Y
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEY 181

Query: 513 LAPEL-------TRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEEL 555
           L P++           K    + D+++ G        G  P  P   P   
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  128 bits (322), Expect = 3e-32
 Identities = 46/220 (20%), Positives = 89/220 (40%), Gaps = 38/220 (17%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVS--NESKQGLREFASEISSIGRLRHRNL--VQ 404
           + +G GG  +V++  L       A+K V+      Q L  + +EI+ + +L+  +   ++
Sbjct: 62  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLH 459
           L  +      + +V +   N  L+  L      D  +    W+        +   +  +H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN-------MLEAVHTIH 172

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGR--LGDFGLAKLYERGT-NPSTTRVVGTLGYLAPE 516
           +     ++H D+K  N L+    +G   L DFG+A   +  T +      VG + Y+ PE
Sbjct: 173 Q---HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 517 L-----------TRTGKPTTSSDVYAFGALLLEVVCGRRP 545
                           K +  SDV++ G +L  +  G+ P
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  126 bits (318), Expect = 4e-32
 Identities = 70/292 (23%), Positives = 120/292 (41%), Gaps = 49/292 (16%)

Query: 348 KELLGFGGFGRVYKGTLPST-----NTQVAVKRV-SNESKQGLREFASEISSIGRLRHRN 401
              LG G FG VY+G           T+VA+K V    S +   EF +E S +      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--------FDEQKAILTWEQRYRIIKGVAS 453
           +V+LLG   +    L++ + M  G L   L         +   A  +  +  ++   +A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGY 512
           G+ YL+       +HRD+ A N ++  +   ++GDFG+   +YE     +     G  G 
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-----TDYYRKGGKGL 201

Query: 513 L-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWK 566
           L     +PE  + G  TT SDV++FG +L E+     +P       E+      V     
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQ------VLRFVM 254

Query: 567 AGAILEVVD--PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
            G +L+  D  P             + +L  MC     + RP+  +++  ++
Sbjct: 255 EGGLLDKPDNCPD-----------MLFELMRMCWQYNPKMRPSFLEIISSIK 295

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  125 bits (317), Expect = 6e-32
 Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 28/219 (12%)

Query: 348 KELLGFGGFGRVYKGTL---PSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNL 402
             +LG G FG V +  L     +  +VAVK  +    +   + EF  E + +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 403 VQLLGWC------RRRGDLLLVYDFMPNGSLD----KCLFDEQKAILTWEQRYRIIKGVA 452
            +L+G         R    +++  FM +G L          E    L  +   R +  +A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
            G+ YL     +  IHRD+ A N +L  ++   + DFGL+    R          G    
Sbjct: 148 CGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLS----RKIYSGDYYRQGCASK 200

Query: 513 L-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
           L     A E       T  SDV+AFG  + E++  G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  124 bits (314), Expect = 7e-32
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 8/200 (4%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           + LG GG   VY       N +VA+K +       ++ L+ F  E+ +  +L H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
           +          LV +++   +L + +  E    L+ +        +  G+ + H+     
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHD---MR 131

Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTT 525
           ++HRDIK  N+L+DS    ++ DFG+AK     +   T  V+GT+ Y +PE  +      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 526 SSDVYAFGALLLEVVCGRRP 545
            +D+Y+ G +L E++ G  P
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP 211

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (317), Expect = 2e-31
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 21/224 (9%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
            ++LG G    V++G    T    A+K  +N S     +    E   + +L H+N+V+L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 407 GW--CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR-IIKGVASGLLYLHEEWE 463
                      +L+ +F P GSL   L +   A    E  +  +++ V  G+ +L    E
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130

Query: 464 QTVIHRDIKAGNVLLDSELNGR----LGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL-- 517
             ++HR+IK GN++     +G+    L DFG A+  E      +  + GT  YL P++  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYE 188

Query: 518 -----TRTGKPTTSS-DVYAFGALLLEVVCGRRPIEPKALPEEL 555
                    K   ++ D+++ G        G  P  P   P   
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  123 bits (310), Expect = 2e-31
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 25/214 (11%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLRE-FASEISSIGRLRHRNLVQLL 406
            LG G FG VY      +   +A+K +      K G+      E+     LRH N+++L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           G+      + L+ ++ P G++ + L     FDEQ+        Y  I  +A+ L Y H  
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT-----ATY--ITELANALSYCHS- 127

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPELTR 519
             + VIHRDIK  N+LL S    ++ DFG +        PS+ R  + GTL YL PE+  
Sbjct: 128 --KRVIHRDIKPENLLLGSAGELKIADFGWSVH-----APSSRRTDLCGTLDYLPPEMIE 180

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
                   D+++ G L  E + G+ P E     E
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (312), Expect = 2e-31
 Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 8/205 (3%)

Query: 344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLRE-FASEISSIGRLRHR 400
            +R + L+G GG G VY+         VA+K +S    S    R     E  + GRL+  
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           ++V +  +    G L +    +    L   L   ++  L   +   I++ + S L   H 
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHA 152

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
                  HRD+K  N+L+ ++    L DFG+A              VGTL Y+APE    
Sbjct: 153 ---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE 209

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRP 545
              T  +D+YA   +L E + G  P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  129 bits (325), Expect = 2e-31
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 10/202 (4%)

Query: 349 ELLGFGGFGRVYKGTL---PSTNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRNLVQ 404
             +G G FG V++G      +    VA+K   +  S     +F  E  ++ +  H ++V+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L+G       + ++ +    G L   L   +K  L           +++ L YL     +
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLES---K 510

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
             +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE     + T
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570

Query: 525 TSSDVYAFGALLLEVV-CGRRP 545
           ++SDV+ FG  + E++  G +P
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP 592

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  125 bits (316), Expect = 3e-31
 Identities = 33/248 (13%), Positives = 62/248 (25%), Gaps = 42/248 (16%)

Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK---RVSNESKQGLREFASEISS 393
           EL +  R      +LG        + T   T     V             +++   E+  
Sbjct: 72  ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 131

Query: 394 IGRLRH------------------------RNLVQLLGWCRRRGDLLLVYDFMP-----N 424
           +  LR                         +  +  +    R   +L  +   P      
Sbjct: 132 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 191

Query: 425 GSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL 482
            +  + L         L    R ++   V   L  LH      ++H  ++  +++LD   
Sbjct: 192 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRG 248

Query: 483 NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLL 537
              L  F               R        A  +           T + D +  G  + 
Sbjct: 249 GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308

Query: 538 EVVCGRRP 545
            + C   P
Sbjct: 309 WIWCADLP 316

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  121 bits (305), Expect = 1e-30
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 13/212 (6%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           +   E +G G  G VY     +T  +VA+++++ + +       +EI  +   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
            L       +L +V +++  GSL   +    +  +   Q   + +     L +LH     
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---SN 135

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
            VIHRDIK+ N+LL  + + +L DFG  A++    +  ST  +VGT  ++APE+      
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 193

Query: 524 TTSSDVYAFGALLLEVVCGRRP---IEP-KAL 551
               D+++ G + +E++ G  P     P +AL
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (304), Expect = 2e-30
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 14/216 (6%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           +     LG G FG+VYK     T    A K +  +S++ L ++  EI  +    H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           LLG     G L ++ +F P G++D  +  E    LT  Q   + + +   L +LH    +
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH---SK 136

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
            +IHRD+KAGNVL+  E + RL DFG++    +      +  +GT  ++APE+       
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMK 195

Query: 525 TSS-----DVYAFGALLLEVVCGRRP---IEP-KAL 551
            +      D+++ G  L+E+     P   + P + L
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (304), Expect = 3e-30
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 13/212 (6%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
                 +G G  G V       +  QVAVK +    +Q      +E+  +   +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           +        +L ++ +F+  G+L   +    +  L  EQ   + + V   L YLH    Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLH---AQ 160

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
            VIHRDIK+ ++LL  +   +L DFG  A++ +      +  +VGT  ++APE+      
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLY 218

Query: 524 TTSSDVYAFGALLLEVVCGRRP---IEP-KAL 551
            T  D+++ G +++E+V G  P     P +A+
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  120 bits (302), Expect = 4e-30
 Identities = 70/306 (22%), Positives = 109/306 (35%), Gaps = 67/306 (21%)

Query: 348 KELLGFGGFGRVYKGTLP-----STNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHR 400
            + LG G FG+V + T            VAVK +  +          SE+  +  L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL----------------FDEQKAILTWEQR 444
           N+V LLG C   G  L++ ++   G L   L                 ++ +  L  E  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL------YERG 498
                 VA G+ +L     +  IHRD+ A N+LL      ++ DFGLA+       Y   
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 499 TNPSTTRVVGTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALP 552
            N            L     APE       T  SDV+++G  L E+   G  P     + 
Sbjct: 205 GN----------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 553 EELILVDWVWDRWKAGAILEVVD--PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQ 610
            +           K G  +   +  P            ++  +   C +     RPT +Q
Sbjct: 255 SKFY------KMIKEGFRMLSPEHAPA-----------EMYDIMKTCWDADPLKRPTFKQ 297

Query: 611 VVRYLE 616
           +V+ +E
Sbjct: 298 IVQLIE 303

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  119 bits (300), Expect = 4e-30
 Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 28/233 (12%)

Query: 334 SYEELKKATRGFRDKEL---LGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLRE-F 387
           +  E+ K      D ++   LG G FG VY          +A+K +      K+G+    
Sbjct: 2   ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61

Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAILTWE 442
             EI     LRH N++++  +   R  + L+ +F P G L K L     FDEQ++     
Sbjct: 62  RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS----- 116

Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS 502
             +  ++ +A  L Y HE   + VIHRDIK  N+L+  +   ++ DFG +        PS
Sbjct: 117 ATF--MEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVH-----APS 166

Query: 503 TTR--VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
             R  + GTL YL PE+          D++  G L  E + G  P +  +  E
Sbjct: 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  120 bits (304), Expect = 4e-30
 Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 53/238 (22%)

Query: 348 KELLGFGGFGRVYKGTLP-----STNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRN 401
              +G G FGRV++   P        T VAVK +    S     +F  E + +    + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL----------------------DKCLFDEQKAIL 439
           +V+LLG C     + L++++M  G L                         +       L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL----- 494
           +  ++  I + VA+G+ YL    E+  +HRD+   N L+   +  ++ DFGL++      
Sbjct: 172 SCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 495 -YERGTNPSTTRVVGTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
            Y+   N            +      PE     + TT SDV+A+G +L E+   G +P
Sbjct: 229 YYKADGN----------DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  120 bits (302), Expect = 6e-30
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 47/227 (20%)

Query: 348 KELLGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-R 398
            + LG G FG+V            P     VAVK +  + +++ L +  SE+  +  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL--------------DKCLFDEQKAILTWEQR 444
           H+N++ LLG C + G L ++ ++   G+L                 +    +  +T++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL------YERG 498
                 +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ 
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 499 TNPSTTRVVGTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV 540
           TN          G L     APE       T  SDV++FG L+ E+ 
Sbjct: 217 TN----------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  119 bits (301), Expect = 7e-30
 Identities = 78/299 (26%), Positives = 114/299 (38%), Gaps = 54/299 (18%)

Query: 348 KELLGFGGFGRVYKGTLP-----STNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHR 400
            + LG G FG+V +         +T   VAVK +    +    R   SE+  +  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 401 NLVQLLGWCRRRGD-LLLVYDFMPNGSL--------------DKCLFDEQKAILTWEQRY 445
           N+V LLG C + G  L+++ +F   G+L                   D  K  LT E   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
                VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA    R        
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA----RDIYKDPDY 204

Query: 506 VVGTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVD 559
           V      L     APE       T  SDV++FG LL E+   G  P     + EE     
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--- 261

Query: 560 WVWDRWKAGAILEVVD--PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
               R K G  +   D               ++ +  L C +     RPT  ++V +L 
Sbjct: 262 ---RRLKEGTRMRAPDYTTP-----------EMYQTMLDCWHGEPSQRPTFSELVEHLG 306

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  119 bits (301), Expect = 1e-29
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 48/233 (20%)

Query: 348 KELLGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-R 398
            + LG G FG+V            P     VAVK +  + +++ L +  SE+  +  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL--------------DKCLFDEQKAILTWEQR 444
           H+N++ LLG C + G L ++ ++   G+L                 +    +  +T++  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL------YERG 498
                 +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y++ 
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 499 TNPSTTRVVGTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           TN          G L     APE       T  SDV++FG L+ E+   G  P
Sbjct: 263 TN----------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  118 bits (297), Expect = 1e-29
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 12/212 (5%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLV 403
           F   E +G G FG V+KG    T   VA+K +  E  +  + +   EI+ + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +  G   +   L ++ +++  GS    L   +   L   Q   I++ +  GL YLH    
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHS--- 137

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
           +  IHRDIKA NVLL      +L DFG+A           T  VGT  ++APE+ +    
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAY 196

Query: 524 TTSSDVYAFGALLLEVVCGRRP---IEP-KAL 551
            + +D+++ G   +E+  G  P   + P K L
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVL 228

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (296), Expect = 2e-29
 Identities = 51/294 (17%), Positives = 107/294 (36%), Gaps = 52/294 (17%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRL-RHRN 401
           F + E +G G FG V+K          A+KR           +    E+ +   L +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQRYRIIKGVASGLLYLH 459
           +V+          +L+  ++   GSL   +       +     +   ++  V  GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 460 EEWEQTVIHRDIKAGNVLLD-------------------SELNGRLGDFGLAKLYERGTN 500
                +++H DIK  N+ +                    +++  ++GD G      R ++
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISS 186

Query: 501 PSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD 559
           P      G   +LA E+ +        +D++A    ++          P+   +      
Sbjct: 187 PQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--PRNGDQ------ 236

Query: 560 WVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
             W   + G +     PR+    ++ E  +++K   +  +   E RP+   +V+
Sbjct: 237 --WHEIRQGRL-----PRIPQVLSQ-EFTELLK---VMIHPDPERRPSAMALVK 279

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  118 bits (297), Expect = 2e-29
 Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 11/211 (5%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           F   E LG G +G VYK     T   VA+K+V  ES   L+E   EIS + +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
             G   +  DL +V ++   GS+   +   +   LT ++   I++    GL YLH     
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHF---M 144

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
             IHRDIKAGN+LL++E + +L DFG+A           T V+GT  ++APE+ +     
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 203

Query: 525 TSSDVYAFGALLLEVVCGRRP---IEP-KAL 551
             +D+++ G   +E+  G+ P   I P +A+
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAI 234

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  118 bits (297), Expect = 2e-29
 Identities = 64/238 (26%), Positives = 100/238 (42%), Gaps = 53/238 (22%)

Query: 348 KELLGFGGFGRVYKGTLP-----STNTQVAVKRV-SNESKQGLREFASEISSIGRLRHRN 401
            + LG G FG+V K T       +  T VAVK +  N S   LR+  SE + + ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL----------------------DKCLFDEQKAIL 439
           +++L G C + G LLL+ ++   GSL                         L    +  L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL----- 494
           T          ++ G+ YL E     ++HRD+ A N+L+      ++ DFGL++      
Sbjct: 148 TMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 495 -YERGTNPSTTRVVGTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
            Y + +           G +     A E       TT SDV++FG LL E+V  G  P
Sbjct: 205 SYVKRSQ----------GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  120 bits (302), Expect = 3e-29
 Identities = 57/279 (20%), Positives = 115/279 (41%), Gaps = 35/279 (12%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLV 403
           F  K++LG G  G +    +   N  VAVKR+     +       E+  +     H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVI 81

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +     + R    +  +     +L +   +++       +   +++   SGL +LH    
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQE-YVEQKDFAHLGLEPITLLQQTTSGLAHLHS--- 136

Query: 464 QTVIHRDIKAGNVLL-----DSELNGRLGDFGLAKLYERGTNPSTTR--VVGTLGYLAPE 516
             ++HRD+K  N+L+       ++   + DFGL K    G +  + R  V GT G++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 517 L---TRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           +        PT + D+++ G +   V+  G  P       +  IL             L+
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--------LGACSLD 248

Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQV 611
            + P  + +     A ++++  ++  +   + RP+ + V
Sbjct: 249 CLHPEKHEDV---IARELIE-KMIAMD--PQKRPSAKHV 281

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  119 bits (299), Expect = 3e-29
 Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 48/233 (20%)

Query: 348 KELLGFGGFGRVYKGTL-------PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-R 398
            + LG G FG+V            P+  T+VAVK + S+ +++ L +  SE+  +  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL--------------DKCLFDEQKAILTWEQR 444
           H+N++ LLG C + G L ++ ++   G+L                      +  L+ +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL------YERG 498
                 VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+       Y++ 
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 499 TNPSTTRVVGTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
           TN          G L     APE       T  SDV++FG LL E+   G  P
Sbjct: 251 TN----------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  117 bits (296), Expect = 4e-29
 Identities = 62/229 (27%), Positives = 90/229 (39%), Gaps = 44/229 (19%)

Query: 348 KELLGFGGFGRVYKGTLP-----STNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHR 400
            + LG G FG+V + T           +VAVK + S           SE+  +  L +H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSL------------DKCLFDEQKAILTWEQRYRII 448
           N+V LLG C   G +L++ ++   G L                F    +  +        
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL------YERGTNPS 502
             VA G+ +L     +  IHRD+ A NVLL +    ++GDFGLA+       Y    N  
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN-- 225

Query: 503 TTRVVGTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
                     L     APE       T  SDV+++G LL E+   G  P
Sbjct: 226 --------ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  117 bits (294), Expect = 4e-29
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 15/213 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLV 403
           +  +E++G G    V          +VA+KR++ E  Q  + E   EI ++ +  H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSL------DKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
                   + +L LV   +  GS+           + +  +L       I++ V  GL Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTR---VVGTLGYL 513
           LH+      IHRD+KAGN+LL  + + ++ DFG+ A L   G           VGT  ++
Sbjct: 137 LHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 514 APELTRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
           APE+    +     +D+++FG   +E+  G  P
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  117 bits (295), Expect = 5e-29
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 15/176 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS---NESKQGLREFASEISSIGRLRHRN 401
           F D   +G G FG VY       +  VA+K++S    +S +  ++   E+  + +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
            +Q  G   R     LV ++    + D  L +  K  L   +   +  G   GL YLH  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 172

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGYLAPE 516
               +IHRD+KAGN+LL      +LGDFG  + +    +       VGT  ++APE
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPE 220

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  117 bits (295), Expect = 7e-29
 Identities = 63/238 (26%), Positives = 95/238 (39%), Gaps = 53/238 (22%)

Query: 348 KELLGFGGFGRVYKGTL-----PSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHR 400
            ++LG G FG+V   T         + QVAVK +             SE+  + +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSL---------------------DKCLFDEQKAIL 439
           N+V LLG C   G + L++++   G L                      +   +E   +L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL----- 494
           T+E        VA G+ +L     ++ +HRD+ A NVL+      ++ DFGLA+      
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 495 -YERGTNPSTTRVVGTLGYL-----APELTRTGKPTTSSDVYAFGALLLEVV-CGRRP 545
            Y    N            L     APE    G  T  SDV+++G LL E+   G  P
Sbjct: 227 NYVVRGN----------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (293), Expect = 7e-29
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 14/206 (6%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQL 405
           E+LGFGG   V+       +  VAVK +  +          F  E  +   L H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 406 L--GWCRRRGDLL--LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
              G        L  +V +++   +L   +    +  +T ++   +I      L + H+ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQ- 134

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELTR 519
               +IHRD+K  N+++ +    ++ DFG+A+      N    T  V+GT  YL+PE  R
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                  SDVY+ G +L EV+ G  P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  116 bits (292), Expect = 2e-28
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 14/208 (6%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLV 403
           F     LG G  G V+K +   +   +A K +  E K     +   E+  +       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY--RIIKGVASGLLYLHEE 461
              G     G++ +  + M  GSLD+ L    K      ++   ++   V  GL YL E+
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLA-KLYERGTNPSTTRVVGTLGYLAPELTRT 520
               ++HRD+K  N+L++S    +L DFG++ +L     +      VGT  Y++PE  + 
Sbjct: 151 --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQG 204

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEP 548
              +  SD+++ G  L+E+  GR PI P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  116 bits (293), Expect = 2e-28
 Identities = 44/213 (20%), Positives = 75/213 (35%), Gaps = 15/213 (7%)

Query: 345 FRDKELLGFG--GFGRVYKGTLPSTNTQVAVKRVS--NESKQGLREFASEISSIGRLRHR 400
           +    ++G G      V       T   V V+R++    S + +     E+       H 
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           N+V          +L +V  FM  GS    +       +       I++GV   L Y+H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFG-LAKLYERGTNPST-----TRVVGTLGYLA 514
                 +HR +KA ++L+  +    L        +   G             V  L +L+
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 515 PE-LTRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
           PE L +  +     SD+Y+ G    E+  G  P
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  115 bits (290), Expect = 2e-28
 Identities = 45/230 (19%), Positives = 80/230 (34%), Gaps = 32/230 (13%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS-----------------EISS 393
           L  G F ++        N   A+K+      +  R+F                   E+  
Sbjct: 39  LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY------RI 447
           I  +++   +   G      ++ ++Y++M N S+ K           +           I
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV 507
           IK V +   Y+H E  + + HRD+K  N+L+D     +L DFG ++              
Sbjct: 157 IKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK---IKGSR 211

Query: 508 GTLGYLAPELTRTGKPT--TSSDVYAFGALLLEVVCGRRPIEPKALPEEL 555
           GT  ++ PE             D+++ G  L  +     P   K    EL
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  118 bits (298), Expect = 6e-28
 Identities = 43/225 (19%), Positives = 78/225 (34%), Gaps = 42/225 (18%)

Query: 349 ELLGFGGFGRVYKGT-LPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLL 406
             +  GG G +Y           V +K + +      +    +E   +  + H ++VQ  
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ-- 143

Query: 407 GWCRRRGDLLLVYDF--MPNGSLDKCLF------------DEQKAILTWEQRYRIIKGVA 452
                      +++F    +   D   +              +   L   +    +  + 
Sbjct: 144 -----------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEIL 192

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
             L YLH      +++ D+K  N++L  E   +L D G      R    S   + GT G+
Sbjct: 193 PALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS---RIN--SFGYLYGTPGF 243

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE---PKALPEE 554
            APE+ R   PT ++D+Y  G  L  +              LPE+
Sbjct: 244 QAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED 287

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  115 bits (288), Expect = 7e-28
 Identities = 37/254 (14%), Positives = 70/254 (27%), Gaps = 53/254 (20%)

Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG---LREFASEISS 393
           EL +  R      +LG        + T   T     V       +     +++   E+  
Sbjct: 67  ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126

Query: 394 IGRLR-------------------------HRNLVQLLGWCRRRGDLLLVYDFMPNGSLD 428
           +  LR                          + ++++    R    L   + +    S  
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 429 KCLFDE------QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL 482
           +   +           L    R ++   V   L  LH      ++H  ++  +++LD   
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRG 243

Query: 483 NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT-----------RTGKPTTSSDVYA 531
              L  F                   + G+  PEL            R    T S D +A
Sbjct: 244 GVFLTGFEHLVRDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298

Query: 532 FGALLLEVVCGRRP 545
            G ++  + C   P
Sbjct: 299 LGLVIYWIWCADLP 312

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  113 bits (285), Expect = 1e-27
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 18/202 (8%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-----LREFASEISSIGRLRHRNLV 403
           + LG G +  VYKG    T+  VA+K +  E ++G     +RE    +S +  L+H N+V
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLD-KCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
            L         L LV++++     D K   D+   I+        +  +  GL Y H + 
Sbjct: 64  TLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              V+HRD+K  N+L++     +L DFGLA+     T      VV TL Y  P++     
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGST 176

Query: 523 P-TTSSDVYAFGALLLEVVCGR 543
             +T  D++  G +  E+  GR
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR 198

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (284), Expect = 1e-27
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 16/222 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRL-RHRNL 402
            +D   +G G +G V K     +   +AVKR+ +    +  ++   ++  + R      +
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCL---FDEQKAILTWEQRYRIIKGVASGLLYLH 459
           VQ  G   R GD  +  + M + S DK     +     ++  E   +I       L +L 
Sbjct: 84  VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL-AKLYERGTNPSTTRVVGTLGYLAPE-- 516
           E     +IHRDIK  N+LLD   N +L DFG+  +L +       TR  G   Y+APE  
Sbjct: 143 EN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERI 197

Query: 517 -LTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELI 556
             + + +     SDV++ G  L E+  GR P        + +
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  111 bits (280), Expect = 2e-27
 Identities = 62/277 (22%), Positives = 110/277 (39%), Gaps = 33/277 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV-----SNESKQGLREFASEISSIGRLRH 399
                 LG G +G V K     +   +AVKR+     S E K+ L +    + +   +  
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT---VDC 65

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY--RIIKGVASGLLY 457
              V   G   R GD+ +  + M + SLDK          T  +    +I   +   L +
Sbjct: 66  PFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE- 516
           LH +   +VIHRD+K  NVL+++    ++ DFG++       + +     G   Y+APE 
Sbjct: 125 LHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPER 180

Query: 517 ---LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV 573
                     +  SD+++ G  ++E+   R P +    P + +             ++E 
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK-----------QVVEE 229

Query: 574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQ 610
             P+L  +    E +D       C    ++ RPT  +
Sbjct: 230 PSPQLPADKFSAEFVDFTSQ---CLKKNSKERPTYPE 263

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  111 bits (280), Expect = 4e-27
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 19/203 (9%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES------KQGLREFASEISSIGRLRHRNL 402
            L+G G +G V K     T   VA+K+           K  +RE    I  + +LRH NL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE----IKLLKQLRHENL 86

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLD-KCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           V LL  C+++    LV++F+           +     L ++   + +  + +G+ + H  
Sbjct: 87  VNLLEVCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRT 520
               +IHRDIK  N+L+      +L DFG A+            V  T  Y APE L   
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGD 199

Query: 521 GKPTTSSDVYAFGALLLEVVCGR 543
            K   + DV+A G L+ E+  G 
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGE 222

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  111 bits (279), Expect = 7e-27
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 21/209 (10%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK--------RVSNESKQGLREFASEISSIGRLRHR 400
             LG G FG V+       N +V VK                 L +   EI+ + R+ H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYL 458
           N++++L     +G   LV +   +G     LF   ++   L       I + + S + YL
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
                + +IHRDIK  N+++  +   +L DFG A   ERG    T    GT+ Y APE+ 
Sbjct: 147 RL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPEV- 200

Query: 519 RTGKPTT--SSDVYAFGALLLEVVCGRRP 545
             G P      ++++ G  L  +V    P
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (283), Expect = 8e-27
 Identities = 64/303 (21%), Positives = 110/303 (36%), Gaps = 62/303 (20%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLV 403
              +++LG+G  G V           VAVKR+             EI  +     H N++
Sbjct: 17  VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVI 72

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLD-----KCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
           +          L +  +   N +L      K + DE   +        +++ +ASG+ +L
Sbjct: 73  RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGR-------------LGDFGLAKLYERGTNPSTTR 505
           H      +IHRD+K  N+L+ +                  + DFGL K  + G +   T 
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 506 ---VVGTLGYLAPEL-------TRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEE 554
                GT G+ APEL           + T S D+++ G +   ++  G+ P   K   E 
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248

Query: 555 LIL------VDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTM 608
            I+       +      +      ++           EA D++    M  +D    RPT 
Sbjct: 249 NIIRGIFSLDEMKCLHDR-----SLIA----------EATDLIS--QMIDHD-PLKRPTA 290

Query: 609 RQV 611
            +V
Sbjct: 291 MKV 293

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 1e-26
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 17/213 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLV 403
           F   EL+G G +G+VYKG    T    A+K +         E   EI+ + +   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84

Query: 404 QLLG------WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
              G             L LV +F   GS+   + + +   L  E    I + +  GL +
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
           LH+     VIHRDIK  NVLL      +L DFG++   +R      T  +GT  ++APE+
Sbjct: 145 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 200

Query: 518 TRTGKPTTSS-----DVYAFGALLLEVVCGRRP 545
               +   ++     D+++ G   +E+  G  P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  110 bits (278), Expect = 1e-26
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 31/225 (13%)

Query: 336 EELKKATRGFRD----KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEI 391
           ++L + +  F D    KE +G G +    +    +TN + AVK +    +        EI
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EI 66

Query: 392 SSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRY 445
             + R  +H N++ L         + +V + M  G L      +  F E++A        
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA-------S 119

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG----RLGDFGLAKLYERGTNP 501
            ++  +   + YLH    Q V+HRD+K  N+L   E       R+ DFG AK        
Sbjct: 120 AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176

Query: 502 STTRVVGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
             T    T  ++APE L R G    + D+++ G LL  ++ G  P
Sbjct: 177 LMT-PCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTP 219

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (272), Expect = 2e-26
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 32/221 (14%)

Query: 342 TRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLREFASEIS 392
           +  F D     E LG G F  V +    +T  + A K     ++S    Q L     E  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REAR 57

Query: 393 SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKG 450
              +L+H N+V+L    +      LV+D +  G     LF++   +   +       I+ 
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQ 113

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVV 507
           +   + Y H      ++HR++K  N+LL S+  G   +L DFGLA               
Sbjct: 114 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FA 168

Query: 508 GTLGYLAPE-LTRT--GKPTTSSDVYAFGALLLEVVCGRRP 545
           GT GYL+PE L +    KP    D++A G +L  ++ G  P
Sbjct: 169 GTPGYLSPEVLKKDPYSKP---VDIWACGVILYILLVGYPP 206

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  109 bits (274), Expect = 2e-26
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 21/213 (9%)

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFAS-EIS 392
           YE++ K          +G G +G V+K     T   VA+K+         +++ A  EI 
Sbjct: 5   YEKIGK----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR 54

Query: 393 SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLD-KCLFDEQKAILTWEQRYRIIKGV 451
            + +L+H NLV LL   RR+  L LV+++            D  +  +       I    
Sbjct: 55  MLKQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQT 111

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG 511
              + + H+      IHRD+K  N+L+      +L DFG A+L    ++     V  T  
Sbjct: 112 LQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRW 167

Query: 512 YLAPE-LTRTGKPTTSSDVYAFGALLLEVVCGR 543
           Y +PE L    +     DV+A G +  E++ G 
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  110 bits (276), Expect = 3e-26
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 32/227 (14%)

Query: 336 EELKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLRE 386
           E +  A+  F D     E LG G F  V +    +T  + A K     ++S    Q L  
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE- 76

Query: 387 FASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQR 444
              E     +L+H N+V+L    +      LV+D +  G     LF++   +   +    
Sbjct: 77  --REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADA 130

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNP 501
              I+ +   + Y H      ++HR++K  N+LL S+  G   +L DFGLA         
Sbjct: 131 SHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187

Query: 502 STTRVVGTLGYLAPE-LTRT--GKPTTSSDVYAFGALLLEVVCGRRP 545
                 GT GYL+PE L +    KP    D++A G +L  ++ G  P
Sbjct: 188 HG--FAGTPGYLSPEVLKKDPYSKP---VDIWACGVILYILLVGYPP 229

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  108 bits (272), Expect = 3e-26
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQG-----LREFASEISSIGRLRHRNL 402
           E +G G +G V+K     T+  VA+KRV  +   +G     LRE    I  +  L+H+N+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELKHKNI 63

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLD-KCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           V+L         L LV++F      D K  FD     L  E     +  +  GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
               V+HRD+K  N+L++     +L +FGLA+ +       +  VV TL Y  P++    
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 176

Query: 522 KP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           K  +TS D+++ G +  E+    RP+ P
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFP 204

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (275), Expect = 4e-26
 Identities = 54/231 (23%), Positives = 100/231 (43%), Gaps = 28/231 (12%)

Query: 330 PHRFSYEELKKATRGFRD------KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG 383
           P  F +  +                E+LG G FG+V+K    +T  ++A K +     + 
Sbjct: 70  PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129

Query: 384 LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL------DKCLFDEQKA 437
             E  +EIS + +L H NL+QL      + D++LV +++  G L      +     E   
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189

Query: 438 ILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL--GDFGLAKLY 495
           I         +K +  G+ ++H   +  ++H D+K  N+L  +    ++   DFGLA+ Y
Sbjct: 190 I-------LFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239

Query: 496 ERGTNPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
           +           GT  +LAPE+       +  +D+++ G +   ++ G  P
Sbjct: 240 KPREKLKV--NFGTPEFLAPEVVN-YDFVSFPTDMWSVGVIAYMLLSGLSP 287

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (278), Expect = 5e-26
 Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 28/223 (12%)

Query: 338 LKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGLREFASE 390
           ++ +T  F D+     +LG G FG V       T  + AVK +S    + K        E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCL----FDEQKAILTWEQRY 445
           +  + +L H N+++L  +   +G   LV +    G L D+ +    F E  A        
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------- 129

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPS 502
           RII+ V SG+ Y+H   +  ++HRD+K  N+LL+S+      R+ DFGL+  +E      
Sbjct: 130 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK 186

Query: 503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
               +GT  Y+APE+   G      DV++ G +L  ++ G  P
Sbjct: 187 D--KIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  108 bits (271), Expect = 6e-26
 Identities = 62/213 (29%), Positives = 90/213 (42%), Gaps = 29/213 (13%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS---------EISSIGRLRH 399
            LLG GGFG VY G   S N  VA+K V    K  + ++           E+  + ++  
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHV---EKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 400 R--NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGL 455
               +++LL W  R    +L+ +  P    D  LFD   ++  L  E        V   +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAV 162

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
            + H      V+HRDIK  N+L+D      +L DFG   L +      T    GT  Y  
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTD-FDGTRVYSP 216

Query: 515 PELTRTGKP--TTSSDVYAFGALLLEVVCGRRP 545
           PE  R        S+ V++ G LL ++VCG  P
Sbjct: 217 PEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIP 248

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  109 bits (275), Expect = 6e-26
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 29/218 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           + D +++G G FG VY+  L  +   VA+K+V  + +   R    E+  + +L H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111

Query: 405 LL------GWCRRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQ----RYRIIKGVA 452
           L       G  +    L LV D++P  ++ +    +   K  L         Y++ + +A
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLG 511
               Y+H      + HRDIK  N+LLD +    +L DFG AK   RG  P+ + +  +  
Sbjct: 171 ----YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYIC-SRY 221

Query: 512 YLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           Y APEL       T+S DV++ G +L E++   +PI P
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFP 258

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (278), Expect = 7e-26
 Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 37/240 (15%)

Query: 323 SWELDVGPHRFSYEELKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVK---- 374
             +L   P  F    +        +     + LG G +G V       T+ + A+K    
Sbjct: 17  QGDLQATPGMF----ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK 72

Query: 375 -RVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCL- 431
             VS  S   L     E++ +  L H N+++L  +   + +  LV +    G L D+ + 
Sbjct: 73  TSVSTSSNSKLL---EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129

Query: 432 ---FDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---R 485
              F+E  A         IIK V SG+ YLH   +  ++HRD+K  N+LL+S+      +
Sbjct: 130 RMKFNEVDAA-------VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIK 179

Query: 486 LGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           + DFGL+ ++E          +GT  Y+APE+ R  K     DV++ G +L  ++ G  P
Sbjct: 180 IVDFGLSAVFENQKKMKE--RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  108 bits (272), Expect = 7e-26
 Identities = 62/230 (26%), Positives = 95/230 (41%), Gaps = 32/230 (13%)

Query: 337 ELKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLREF 387
           ++      F D     E++G G F  V +     T  Q AVK     + ++       + 
Sbjct: 14  DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73

Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY-- 445
             E S    L+H ++V+LL      G L +V++FM        L  E          Y  
Sbjct: 74  KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSE 129

Query: 446 ----RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERG 498
                 ++ +   L Y H   +  +IHRD+K   VLL S+ N    +LG FG+A      
Sbjct: 130 AVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186

Query: 499 TNPSTTRVVGTLGYLAPE-LTRT--GKPTTSSDVYAFGALLLEVVCGRRP 545
              +  R VGT  ++APE + R   GKP    DV+  G +L  ++ G  P
Sbjct: 187 GLVAGGR-VGTPHFMAPEVVKREPYGKP---VDVWGCGVILFILLSGCLP 232

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  107 bits (270), Expect = 7e-26
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 31/221 (14%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-----LREFA 388
            +++L+K          LG G +  VYKG   +T   VA+K V  +S++G     +RE  
Sbjct: 6   QFKQLEK----------LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE-- 53

Query: 389 SEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN---GSLDKCLFDEQKAILTWEQRY 445
             IS +  L+H N+V+L         L LV++FM N     +D          L      
Sbjct: 54  --ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
                +  GL + HE     ++HRD+K  N+L++     +LGDFGLA+ +    N  ++ 
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168

Query: 506 VVGTLGYLAPEL---TRTGKPTTSSDVYAFGALLLEVVCGR 543
           VV TL Y AP++   +RT   +TS D+++ G +L E++ G+
Sbjct: 169 VV-TLWYRAPDVLMGSRT--YSTSIDIWSCGCILAEMITGK 206

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (270), Expect = 8e-26
 Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 13/211 (6%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV-SNESKQGLREFASEISSIGRL-RHRNL 402
             +   +G G  G+V+K     T   +AVK++  + +K+  +    ++  + +      +
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           VQ  G      D+ +  + M     +K L    +  +      ++   +   L YL E+ 
Sbjct: 87  VQCFGTFITNTDVFIAMELM-GTCAEK-LKKRMQGPIPERILGKMTVAIVKALYYLKEK- 143

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              VIHRD+K  N+LLD     +L DFG++       + +  R  G   Y+APE      
Sbjct: 144 -HGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 523 P-----TTSSDVYAFGALLLEVVCGRRPIEP 548
           P        +DV++ G  L+E+  G+ P + 
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKN 231

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  108 bits (271), Expect = 9e-26
 Identities = 65/194 (33%), Positives = 92/194 (47%), Gaps = 31/194 (15%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV----SNESKQG-----L 384
            YE+L            LG G F  VYK    +TN  VA+K++     +E+K G     L
Sbjct: 11  RYEKLDF----------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60

Query: 385 REFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLD-KCLFDEQKAILTWEQ 443
           RE    I  +  L H N++ LL     + ++ LV+DFM     D + +  +   +LT   
Sbjct: 61  RE----IKLLQELSHPNIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSH 113

Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
               +     GL YLH+ W   ++HRD+K  N+LLD     +L DFGLAK +       T
Sbjct: 114 IKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170

Query: 504 TRVVGTLGYLAPEL 517
            +VV T  Y APEL
Sbjct: 171 HQVV-TRWYRAPEL 183

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  108 bits (271), Expect = 1e-25
 Identities = 72/232 (31%), Positives = 108/232 (46%), Gaps = 40/232 (17%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFAS-EI 391
            YE+L K          +G G FG V+K     T  +VA+K+V  E+ K+G    A  EI
Sbjct: 18  KYEKLAK----------IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 67

Query: 392 SSIGRLRHRNLVQLLG--------WCRRRGDLLLVYDFMPNGSLD-KCLFDEQKAILTWE 442
             +  L+H N+V L+         + R +G + LV+DF      D   L        T  
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLS 124

Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY----ERG 498
           +  R+++ + +GL Y+H      ++HRD+KA NVL+  +   +L DFGLA+ +       
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181

Query: 499 TNPSTTRVVGTLGYLAPEL----TRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
            N  T RVV TL Y  PEL       G      D++  G ++ E+   R PI
Sbjct: 182 PNRYTNRVV-TLWYRPPELLLGERDYG---PPIDLWGAGCIMAEMWT-RSPI 228

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (278), Expect = 1e-25
 Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 24/228 (10%)

Query: 330 PHRFSYEELKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR 385
             ++  + ++       D     E LG G FG V++ T  +T    A K V    +    
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199

Query: 386 EFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL------DKCLFDEQKAIL 439
               EI ++  LRH  LV L        +++++Y+FM  G L      +     E +A+ 
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV- 258

Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL--GDFGLAKLYER 497
                   ++ V  GL ++H   E   +H D+K  N++  ++ +  L   DFGL    + 
Sbjct: 259 ------EYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309

Query: 498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
             +       GT  + APE+         +D+++ G L   ++ G  P
Sbjct: 310 KQSVKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  106 bits (268), Expect = 1e-25
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 27/209 (12%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
            E+LG G F  V+      T    A+K +            +EI+ + +++H N+V L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 408 WCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
                    LV   +  G L     ++ ++ E+ A         +I+ V S + YLH   
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLSAVKYLH--- 123

Query: 463 EQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LT 518
           E  ++HRD+K  N+L  +        + DFGL+K+ + G     +   GT GY+APE L 
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVLA 180

Query: 519 RT--GKPTTSSDVYAFGALLLEVVCGRRP 545
           +    K     D ++ G +   ++CG  P
Sbjct: 181 QKPYSKA---VDCWSIGVITYILLCGYPP 206

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  107 bits (268), Expect = 1e-25
 Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 29/214 (13%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE------SKQGLREFASEISSIGRLR---- 398
            LLG GGFG V+ G   +   QVA+K +                   E++ + ++     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLL 456
           H  +++LL W   +   +LV +        + LFD   +K  L           V + + 
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           + H    + V+HRDIK  N+L+D      +L DFG   L      P T    GT  Y  P
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTD-FDGTRVYSPP 207

Query: 516 ELTR----TGKPTTSSDVYAFGALLLEVVCGRRP 545
           E          P   + V++ G LL ++VCG  P
Sbjct: 208 EWISRHQYHALP---ATVWSLGILLYDMVCGDIP 238

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  108 bits (272), Expect = 1e-25
 Identities = 48/227 (21%), Positives = 92/227 (40%), Gaps = 26/227 (11%)

Query: 332 RFSYEELKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREF 387
           ++  + ++       D     E LG G FG V++    +T      K ++          
Sbjct: 36  KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV 95

Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL------DKCLFDEQKAILTW 441
            +EIS + +L H  L+ L      + +++L+ +F+  G L      +     E + I   
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI--- 152

Query: 442 EQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL--GDFGLAKLYERGT 499
                 ++    GL ++H   E +++H DIK  N++ +++    +   DFGLA       
Sbjct: 153 ----NYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205

Query: 500 NPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
                    T  + APE+    +P    +D++A G L   ++ G  P
Sbjct: 206 IVKV--TTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSP 249

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  109 bits (274), Expect = 1e-25
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 27/211 (12%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLREFASEISSIGRLRHRNL 402
            E LG G F  V +        + A       ++S    Q L     E      L+H N+
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNI 72

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHE 460
           V+L       G   L++D +  G     LF++   +   +       I+ +   +L+ H 
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCH- 127

Query: 461 EWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE- 516
             +  V+HR++K  N+LL S+L G   +L DFGLA   E           GT GYL+PE 
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEV 184

Query: 517 LTRT--GKPTTSSDVYAFGALLLEVVCGRRP 545
           L +   GKP    D++A G +L  ++ G  P
Sbjct: 185 LRKDPYGKP---VDLWACGVILYILLVGYPP 212

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  106 bits (266), Expect = 2e-25
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 31/229 (13%)

Query: 339 KKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVK--------RVSNESKQGLRE 386
             +T GF +     E+LG G    V +     T  + AVK          S E  Q LRE
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 387 -FASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWE 442
               E+  + ++  H N++QL           LV+D M  G L    FD   +K  L+ +
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK 124

Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS 502
           +  +I++ +   +  LH+     ++HRD+K  N+LLD ++N +L DFG +   + G    
Sbjct: 125 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181

Query: 503 TTRVVGTLGYLAPELTRTGKPTTSS------DVYAFGALLLEVVCGRRP 545
              V GT  YLAPE+                D+++ G ++  ++ G  P
Sbjct: 182 E--VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  109 bits (274), Expect = 2e-25
 Identities = 57/233 (24%), Positives = 105/233 (45%), Gaps = 38/233 (16%)

Query: 338 LKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVKRVS-------------NES 380
           ++K      +       LG G +G V      + +++ A+K +                 
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 381 KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-DKCL----FDEQ 435
           ++   E  +EIS +  L H N+++L      +    LV +F   G L ++ +    FDE 
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146

Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLA 492
            A         I+K + SG+ YLH   +  ++HRDIK  N+LL+++ +    ++ DFGL+
Sbjct: 147 DAA-------NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196

Query: 493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
             + +         +GT  Y+APE+ +  K     DV++ G ++  ++CG  P
Sbjct: 197 SFFSKDYKLRD--RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  107 bits (270), Expect = 3e-25
 Identities = 54/236 (22%), Positives = 90/236 (38%), Gaps = 36/236 (15%)

Query: 333 FSYEELKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVKRVS--------NES 380
            + ++     +  RD+    + LG G  G V       T  +VA++ +S           
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180

Query: 381 KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQ 435
                   +EI  + +L H  ++++  +     D  +V + M  G L           E 
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEA 239

Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLA 492
                          +   + YLH   E  +IHRD+K  NVLL S+      ++ DFG +
Sbjct: 240 TC-------KLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289

Query: 493 KLYERGTNPSTTRVVGTLGYLAPE-LTRTGKP--TTSSDVYAFGALLLEVVCGRRP 545
           K+    +   T  + GT  YLAPE L   G      + D ++ G +L   + G  P
Sbjct: 290 KILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  106 bits (266), Expect = 5e-25
 Identities = 49/285 (17%), Positives = 93/285 (32%), Gaps = 39/285 (13%)

Query: 336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQ-----VAVKRVSNESKQGLREFASE 390
            E +  ++      LLG G F +VY+ T    N         +K     +          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 391 ISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL---FDEQKAILTWEQRYRI 447
           +  +        ++       +   +LV +    G+L   +    +  + ++        
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLL-----------DSELNGRLGDFGLA---K 493
              +   +  +H   +  +IH DIK  N +L           D      L D G +   K
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 494 LYERGTNPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRP----IEP 548
           L+ +GT  +      T G+   E+  + KP     D +   A +  ++ G          
Sbjct: 235 LFPKGTIFTA--KCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291

Query: 549 KALPEELILVDWVWDRWKAGAILEVVDPRLNGE-FNEIEALDVVK 592
           +  PE L       D W      E     LN    + + +LD+++
Sbjct: 292 ECKPEGLFRRLPHLDMWN-----EFFHVMLNIPDCHHLPSLDLLR 331

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  105 bits (264), Expect = 5e-25
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 27/209 (12%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLL 406
            + LG G F    K     +N   AVK +S   +   ++   EI+++     H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72

Query: 407 GWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
                +    LV + +  G L      K  F E +A         I++ + S + ++H  
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA-------SYIMRKLVSAVSHMH-- 123

Query: 462 WEQTVIHRDIKAGNVLL-----DSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
            +  V+HRD+K  N+L      + E+  ++ DFG A+L      P  T    TL Y APE
Sbjct: 124 -DVGVVHRDLKPENLLFTDENDNLEI--KIIDFGFARLKPPDNQPLKT-PCFTLHYAAPE 179

Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           L        S D+++ G +L  ++ G+ P
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  106 bits (267), Expect = 7e-25
 Identities = 56/218 (25%), Positives = 109/218 (50%), Gaps = 30/218 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           + + +++G G FG V++  L  ++ +VA+K+V  + +   RE    +  +  ++H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNRE----LQIMRIVKHPNVVD 96

Query: 405 LL------GWCRRRGDLLLVYDFMPNGSLDKCL--FDEQKAILTWEQ----RYRIIKGVA 452
           L       G  +    L LV +++P  ++ +    + + K  +         Y++++ +A
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLG 511
               Y+H      + HRDIK  N+LLD      +L DFG AK+   G  P+ + +  +  
Sbjct: 156 ----YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYIC-SRY 206

Query: 512 YLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           Y APEL       TT+ D+++ G ++ E++ G +P+ P
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLFP 243

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  105 bits (264), Expect = 7e-25
 Identities = 50/262 (19%), Positives = 88/262 (33%), Gaps = 57/262 (21%)

Query: 338 LKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLREFA 388
              +    + K      +G G +G V       T    A+K     ++   + + +    
Sbjct: 17  QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76

Query: 389 SEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL--------------------- 427
           +E+  + +L H N+ +L         + LV +    G L                     
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136

Query: 428 -----------DKCLFDEQKAILTWEQRY------RIIKGVASGLLYLHEEWEQTVIHRD 470
                      +           + +          I++ + S L YLH    Q + HRD
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRD 193

Query: 471 IKAGNVLLDSELNGRL--GDFGLAKLYERGTNPSTTR---VVGTLGYLAPE-LTRTGKP- 523
           IK  N L  +  +  +   DFGL+K + +  N          GT  ++APE L  T +  
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253

Query: 524 TTSSDVYAFGALLLEVVCGRRP 545
               D ++ G LL  ++ G  P
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAVP 275

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  103 bits (260), Expect = 7e-25
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 15/203 (7%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           +  +G G +G V       T  + A K++     + +  F  EI  +  L H N+++L  
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQT 465
                 D+ LV +    G     LF+    K +       RI+K V S + Y H   +  
Sbjct: 74  TFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLN 126

Query: 466 VIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
           V HRD+K  N L  ++      +L DFGLA  ++ G    T   VGT  Y++P++   G 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLE-GL 183

Query: 523 PTTSSDVYAFGALLLEVVCGRRP 545
                D ++ G ++  ++CG  P
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPP 206

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  105 bits (263), Expect = 8e-25
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 16/209 (7%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGW 408
           +G G F +V       T  +VA+K +     +   L++   E+  +  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 409 CRRRGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTV 466
                 L L+ ++   G +    FD       +  ++     + + S + Y H+   + +
Sbjct: 83  IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRI 135

Query: 467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTT- 525
           +HRD+KA N+LLD+++N ++ DFG +  +  G         G   Y APEL + GK    
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ-GKKYDG 192

Query: 526 -SSDVYAFGALLLEVVCGRRPIEPKALPE 553
              DV++ G +L  +V G  P + + L E
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (259), Expect = 1e-24
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 29/211 (13%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLREFASEISSIGRLRHRNL 402
             +LG G FG V K     T  + AVK        N+    +     E+  + +L H N+
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNI 83

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSL-DKCL----FDEQKAILTWEQRYRIIKGVASGLLY 457
           ++L           +V +    G L D+ +    F E  A        RIIK V SG+ Y
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITY 136

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           +H   +  ++HRD+K  N+LL+S+      ++ DFGL+  +++ T       +GT  Y+A
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIA 191

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           PE+ R G      DV++ G +L  ++ G  P
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  103 bits (258), Expect = 1e-24
 Identities = 46/208 (22%), Positives = 94/208 (45%), Gaps = 20/208 (9%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEISSIGRLRHRNLVQLL 406
           K  LG G FG V+     S+  +  +K ++ + S+  + +  +EI  +  L H N++++ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRY------RIIKGVASGLLYLHE 460
                  ++ +V +    G     L +   +     +         ++K + + L Y H 
Sbjct: 87  EVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMNALAYFH- 141

Query: 461 EWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
              Q V+H+D+K  N+L          ++ DFGLA+L++   + +     GT  Y+APE+
Sbjct: 142 --SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEV 197

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            +    T   D+++ G ++  ++ G  P
Sbjct: 198 FK-RDVTFKCDIWSAGVVMYFLLTGCLP 224

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (260), Expect = 2e-24
 Identities = 44/209 (21%), Positives = 93/209 (44%), Gaps = 27/209 (12%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNLVQL 405
            E LG G FG V++    S+      K  +V    +  +++   EIS +   RHRN++ L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHL 66

Query: 406 LGWCRRRGDLLLVYDFMPNGSL-DKCL-----FDEQKAILTWEQRYRIIKGVASGLLYLH 459
                   +L+++++F+    + ++        +E++ +         +  V   L +LH
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV-------SYVHQVCEALQFLH 119

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRL--GDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
                 + H DI+  N++  +  +  +   +FG A+  + G N     +     Y APE+
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEV 174

Query: 518 TRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
            +     +T++D+++ G L+  ++ G  P
Sbjct: 175 HQ-HDVVSTATDMWSLGTLVYVLLSGINP 202

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  104 bits (262), Expect = 2e-24
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 30/228 (13%)

Query: 339 KKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVK-------RVSNESKQGLRE- 386
             A + F  K    +++G G    V +    +T  + AVK       R+S E  + +RE 
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145

Query: 387 FASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQ 443
              E   + ++  H +++ L+        + LV+D M  G L    FD   +K  L+ ++
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKE 201

Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST 503
              I++ +   + +LH      ++HRD+K  N+LLD  +  RL DFG +   E G     
Sbjct: 202 TRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258

Query: 504 TRVVGTLGYLAPE-LTRTGKPTTSS-----DVYAFGALLLEVVCGRRP 545
             + GT GYLAPE L  +   T        D++A G +L  ++ G  P
Sbjct: 259 --LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  103 bits (258), Expect = 2e-24
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 30/218 (13%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQG-----LREF 387
            Y++L+K          +G G +G VYK    S    VA+KR+  ++  +G     +RE 
Sbjct: 22  KYQKLEK----------VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIRE- 69

Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLD-KCLFDEQKAILTWEQRYR 446
              IS +  L H N+V L+        L LV++FM     D K + DE K  L   Q   
Sbjct: 70  ---ISLLKELHHPNIVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKI 123

Query: 447 IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV 506
            +  +  G+ + H+     ++HRD+K  N+L++S+   +L DFGLA+ +       T  V
Sbjct: 124 YLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180

Query: 507 VGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGR 543
           V TL Y AP++    K  +TS D+++ G +  E++ G+
Sbjct: 181 V-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  101 bits (255), Expect = 4e-24
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 20/203 (9%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQG-----LREFASEISSIGRLRHRNL 402
           E +G G +G VYK    +     A+K++  E   +G     +RE    IS +  L+H N+
Sbjct: 8   EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKELKHSNI 62

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLD-KCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           V+L      +  L+LV++ +     D K L D  +  L        +  + +G+ Y H+ 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
               V+HRD+K  N+L++ E   ++ DFGLA+ +       T  +V TL Y AP++    
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGS 175

Query: 522 KP-TTSSDVYAFGALLLEVVCGR 543
           K  +T+ D+++ G +  E+V G 
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  102 bits (256), Expect = 4e-24
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 30/218 (13%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLL 406
           +++LG G   RV       T+ + AVK +  +          E+  + + + HRN+++L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 407 GWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
            +        LV++ M  GS+      +  F+E +A         +++ VAS L +LH  
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA-------SVVVQDVASALDFLH-- 128

Query: 462 WEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERG------TNPSTTRVVGTLGY 512
             + + HRD+K  N+L +        ++ DF L    +        + P      G+  Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 513 LAPELTRTGKPTTSS-----DVYAFGALLLEVVCGRRP 545
           +APE+        S      D+++ G +L  ++ G  P
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (263), Expect = 4e-24
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 29/211 (13%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLREFASEISSIGRLRHRNL 402
             +LG G FG V K     T  + AVK        N+    +     E+  + +L H N+
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNI 83

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSL-DKCL----FDEQKAILTWEQRYRIIKGVASGLLY 457
           ++L           +V +    G L D+ +    F E  A        RIIK V SG+ Y
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITY 136

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           +H   +  ++HRD+K  N+LL+S+      ++ DFGL+  +++ T       +GT  Y+A
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIA 191

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           PE+ R G      DV++ G +L  ++ G  P
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (257), Expect = 6e-24
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 28/221 (12%)

Query: 338 LKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVKRVS-NESKQGLREFASEIS 392
                    D       LG G    VY+     T    A+K +     K+ +R   +EI 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIG 100

Query: 393 SIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKG 450
            + RL H N+++L        ++ LV + +  G     LFD   +K   +       +K 
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERDAADAVKQ 156

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVV 507
           +   + YLH   E  ++HRD+K  N+L  +       ++ DFGL+K+ E      T  V 
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VC 211

Query: 508 GTLGYLAPE-LTRT--GKPTTSSDVYAFGALLLEVVCGRRP 545
           GT GY APE L     G      D+++ G +   ++CG  P
Sbjct: 212 GTPGYCAPEILRGCAYGPE---VDMWSVGIITYILLCGFEP 249

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  101 bits (255), Expect = 8e-24
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 27/213 (12%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLRE-FASEISSIGRLRHRN 401
            E LG G F  V K    ST  + A K     +     +   RE    E+S + ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL-DKCL----FDEQKAILTWEQRYRIIKGVASGLL 456
           ++ L      R D++L+ + +  G L D         E++A          IK +  G+ 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVN 129

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG----RLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           YLH    + + H D+K  N++L  +       +L DFGLA   E G       + GT  +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEF 184

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +APE+         +D+++ G +   ++ G  P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  102 bits (256), Expect = 9e-24
 Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 27/231 (11%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISS 393
           + E  +K    F+ + + G G FG V  G   ST   VA+K+V  + +   RE    +  
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQD 72

Query: 394 IGRLRHRNLVQLLGWCRRRGD-------LLLVYDFMPNGSLDKCL--FDEQKAILTWEQ- 443
           +  L H N+VQL  +    G+       L +V +++P+ +L +C   +  ++        
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILI 131

Query: 444 ---RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL--GDFGLAKLYERG 498
               +++I+ +      LH      V HRDIK  NVL++   +G L   DFG AK     
Sbjct: 132 KVFLFQLIRSIG----CLHLP-SVNVCHRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPS 185

Query: 499 TNPSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEP 548
             P+   +  +  Y APEL    +  TT+ D+++ G +  E++    PI  
Sbjct: 186 -EPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM-LGEPIFR 233

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  102 bits (256), Expect = 1e-23
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 27/204 (13%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLRE-FASEISSIGRLRHRN 401
            E LG G F  V K    ST  + A K     +     +   RE    E+S + ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL-DKCL----FDEQKAILTWEQRYRIIKGVASGLL 456
           ++ L      R D++L+ + +  G L D         E++A          IK +  G+ 
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVN 129

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG----RLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           YLH    + + H D+K  N++L  +       +L DFGLA   E G       + GT  +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEF 184

Query: 513 LAPELTRTGKPTTSSDVYAFGALL 536
           +APE+         +D+++ G + 
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  101 bits (254), Expect = 1e-23
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 25/208 (12%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQG-----LREFASEISSIGRLRHRNL 402
             LG G +G VYK     TN  VA+KR+  E  ++G     +RE    +S +  L+HRN+
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKELQHRNI 95

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLD-KCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           ++L         L L++++      D K   D+   +     +   +  + +G+ + H  
Sbjct: 96  IELKSVIHHNHRLHLIFEYA---ENDLKKYMDKNPDVSMRVIKS-FLYQLINGVNFCHSR 151

Query: 462 WEQTVIHRDIKAGNVLLDSELNGR-----LGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
                +HRD+K  N+LL            +GDFGLA+ +       T  ++ TL Y  PE
Sbjct: 152 R---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE 207

Query: 517 LTRTGKP-TTSSDVYAFGALLLEVVCGR 543
           +    +  +TS D+++   +  E++   
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  100 bits (251), Expect = 1e-23
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLRE-FASEISSIGRLRHRN 401
            E LG G F  V K     T  + A K     R+S+  +   RE    E++ +  +RH N
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL-DKCL----FDEQKAILTWEQRYRIIKGVASGLL 456
           ++ L      + D++L+ + +  G L D         E +A        + +K +  G+ 
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQILDGVH 122

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG----RLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           YLH    + + H D+K  N++L  +       +L DFG+A   E G       + GT  +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEF 177

Query: 513 LAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
           +APE+    +P    +D+++ G +   ++ G  P
Sbjct: 178 VAPEIVN-YEPLGLEADMWSIGVITYILLSGASP 210

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  101 bits (253), Expect = 2e-23
 Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 42/238 (17%)

Query: 330 PHRFSYEELKKATRGFRD-----KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL 384
                ++  +       D     K++LG G  G+V +     T  + A+K + +  K   
Sbjct: 11  GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK--A 68

Query: 385 REFASEISSIGRL-RHRNLVQLLGWC----RRRGDLLLVYDFMPNGSL-------DKCLF 432
           R+   E+    +     ++V +L         +  LL++ + M  G L           F
Sbjct: 69  RQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF 125

Query: 433 DEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL-----DSELNGRLG 487
            E++A         I++ + + + +LH      + HRD+K  N+L      D+ L  +L 
Sbjct: 126 TEREA-------AEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVL--KLT 173

Query: 488 DFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           DFG AK        +      T  Y+APE+    K   S D+++ G ++  ++CG  P
Sbjct: 174 DFGFAKETT---QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  100 bits (250), Expect = 4e-23
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 29/214 (13%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVK-----RVSNESKQGLRE-FASEISSIGRLRHRN 401
            E LG G F  V K    ST  Q A K     R  +  +   RE    E+S +  ++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL-DKCL----FDEQKAILTWEQRYRIIKGVASGLL 456
           ++ L      + D++L+ + +  G L D         E++A          +K + +G+ 
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQILNGVY 128

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG----RLGDFGLAKLYERGTNPSTTRVVGTLGY 512
           YLH      + H D+K  N++L          ++ DFGLA   + G       + GT  +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183

Query: 513 LAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
           +APE+    +P    +D+++ G +   ++ G  P
Sbjct: 184 VAPEIVN-YEPLGLEADMWSIGVITYILLSGASP 216

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 98.0 bits (245), Expect = 7e-23
 Identities = 62/210 (29%), Positives = 88/210 (41%), Gaps = 28/210 (13%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 408 WCRRRGDLLLVYDFMPNGSL-DKCL----FDEQKAILTWEQRY--RIIKGVASGLLYLHE 460
             R      L  ++   G L D+        E  A     QR+  +++ GV     YLH 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMAGVV----YLHG 123

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS---TTRVVGTLGYLAPEL 517
                + HRDIK  N+LLD   N ++ DFGLA ++               GTL Y+APEL
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPEL 178

Query: 518 TRTGKP--TTSSDVYAFGALLLEVVCGRRP 545
            +  +       DV++ G +L  ++ G  P
Sbjct: 179 LK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 99.3 bits (248), Expect = 7e-23
 Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 30/228 (13%)

Query: 338 LKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVKRVS--------NESKQGLR 385
           +    +  RD+    + LG G  G V       T  +VA+K +S                
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60

Query: 386 EFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQ 443
              +EI  + +L H  ++++  +     D  +V + M  G     LFD+      L    
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE----LFDKVVGNKRLKEAT 115

Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLAKLYERGTN 500
                  +   + YLH   E  +IHRD+K  NVLL S   +   ++ DFG +K+    + 
Sbjct: 116 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

Query: 501 PSTTRVVGTLGYLAPE-LTRTGKP--TTSSDVYAFGALLLEVVCGRRP 545
             T  + GT  YLAPE L   G      + D ++ G +L   + G  P
Sbjct: 173 MRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 98.3 bits (245), Expect = 7e-23
 Identities = 35/290 (12%), Positives = 85/290 (29%), Gaps = 48/290 (16%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV---SNESKQGLREFASEISSIGRLRHRN 401
           +R     G     + ++    + + QVA+  V          L+E  S    + R+    
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           + ++L     R   L+V +++  GSL     +      +     R ++ +A+     H  
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQ----EVADTSPSPVGAIRAMQSLAAAADAAHRA 148

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
               V         V +  +  G +                   V+     +        
Sbjct: 149 G---VALSIDHPSRVRVSID--GDV-------------------VLAYPATMPDA----- 179

Query: 522 KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR-LNG 580
                 D+   GA L  ++  R P+    +   L   +            + ++P  ++ 
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEPADIDR 230

Query: 581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPDA 630
           +      +  V    +  +    +  T+  +++         + +   D 
Sbjct: 231 DIP--FQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDE 278

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 98.8 bits (247), Expect = 7e-23
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 21/211 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA---SEISSIGRLRHRN 401
           F+  ++LG G F  V      +T+ + A+K +         +      E   + RL H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCL-----FDEQKAIL-TWEQRYRIIKGVASGL 455
            V+L    +    L     +  NG L K +     FDE      T E        + S L
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSAL 143

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLA 514
            YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  +     VGT  Y++
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           PEL        SSD++A G ++ ++V G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (255), Expect = 9e-23
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 23/224 (10%)

Query: 333 FSYEELKKATRG-FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFA 388
           + + E +  T+  FR   +LG GGFG V    + +T    A K++  +    ++G     
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232

Query: 389 SEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL-------DKCLFDEQKAILTW 441
           +E   + ++  R +V L      +  L LV   M  G L        +  F E +A+   
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-- 290

Query: 442 EQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP 501
              Y     +  GL  LH    + +++RD+K  N+LLD   + R+ D GLA         
Sbjct: 291 ---Y--AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQ 340

Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +    VGT+GY+APE+ +  + T S D +A G LL E++ G+ P
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  102 bits (255), Expect = 9e-23
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 25/213 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASE---ISSIGRLR 398
           F    ++G GGFG VY      T    A+K +  +    KQG     +E   +S +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVAS 453
              +V +         L  + D M  G L        +F E          Y     +  
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-----Y--AAEIIL 303

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL 513
           GL ++H    + V++RD+K  N+LLD   + R+ D GLA  + +         VGT GY+
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYM 357

Query: 514 APELTRTGKP-TTSSDVYAFGALLLEVVCGRRP 545
           APE+ + G    +S+D ++ G +L +++ G  P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 98.4 bits (246), Expect = 9e-23
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 30/228 (13%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFAS--- 389
            YE + +          +G G +G VYK   P +   VA+K V   +   G         
Sbjct: 10  RYEPVAE----------IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV 59

Query: 390 -EISSIGRLR---HRNLVQLL-----GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILT 440
            E++ + RL    H N+V+L+         R   + LV++ +    L   L       L 
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118

Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN 500
            E    +++    GL +LH      ++HRD+K  N+L+ S    +L DFGLA++Y     
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQ 173

Query: 501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
            + T VV TL Y APE+       T  D+++ G +  E+   R+P+  
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFC 220

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 29/214 (13%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS----EISSIGRLRHRNLVQ 404
           +LLG G +G+V +     T  + AVK +  +  + +    +    EI  + RLRH+N++Q
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 405 LLG--WCRRRGDLLLVYDFMPNGSLDKCLFD--------EQKAILTWEQRYRIIKGVASG 454
           L+   +   +  + +V ++   G  +  + D          +A   + Q   +I G+   
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQ---LIDGLE-- 123

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV-GTLGYL 513
             YLH    Q ++H+DIK GN+LL +    ++   G+A+         T R   G+  + 
Sbjct: 124 --YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 514 APELTRTGKP--TTSSDVYAFGALLLEVVCGRRP 545
            PE+            D+++ G  L  +  G  P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113

 Score = 92.3 bits (229), Expect = 1e-22
 Identities = 27/114 (23%), Positives = 42/114 (36%), Gaps = 12/114 (10%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRV------LGHAFYSSPIKFKNST 79
           F F+ F    N  ++   G A    N  L +T             G   YS+P++    +
Sbjct: 6   FSFTKFDP--NQEDLIFQGHATS-TNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWEDS 62

Query: 80  RNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSD 133
                 SF T   F I   YT+    G AF I+    +       +LGL  +++
Sbjct: 63  AVL--TSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISY-HGGFLGLFPNAN 113

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 63/214 (29%), Positives = 88/214 (41%), Gaps = 36/214 (16%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLVQLLG 407
           + LG G +G V       T   VAVK V  +      E    EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 408 WCRRRGDLLLVYDFMPNGSLDKCLFD---------EQKAILTWEQRY--RIIKGVASGLL 456
             R      L  ++   G L    FD         E  A     QR+  +++ GV     
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDA-----QRFFHQLMAGVV---- 119

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS---TTRVVGTLGYL 513
           YLH      + HRDIK  N+LLD   N ++ DFGLA ++               GTL Y+
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYV 174

Query: 514 APELTRTGKP--TTSSDVYAFGALLLEVVCGRRP 545
           APEL +  +       DV++ G +L  ++ G  P
Sbjct: 175 APELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 31/219 (14%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLRE-FASEISSIGRLRHRNLVQL 405
           + LG G FG+V  G    T  +VAVK ++ +      +      EI ++   RH ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFD---------EQKAILTWEQRYRIIKGVASGLL 456
                   D  +V +++  G     LFD         E +A   ++Q   I+  V     
Sbjct: 77  YQVISTPTDFFMVMEYVSGG----ELFDYICKHGRVEEMEARRLFQQ---ILSAVD---- 125

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           Y H      V+HRD+K  NVLLD+ +N ++ DFGL+ +   G    T+   G+  Y APE
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE 180

Query: 517 LTRTGKP--TTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           +   G+       D+++ G +L  ++CG  P + + +P 
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.3 bits (245), Expect = 4e-22
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 32/214 (14%)

Query: 347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQL 405
             ++LG G  G+V +     T  + A+K + +  K   R    E+    R  +  ++V++
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--ARR---EVELHWRASQCPHIVRI 120

Query: 406 LGWC----RRRGDLLLVYDFMPNGSL-------DKCLFDEQKAILTWEQRYRIIKGVASG 454
           +         R  LL+V + +  G L           F E++A         I+K +   
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA-------SEIMKSIGEA 173

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLG 511
           + YLH      + HRD+K  N+L  S+      +L DFG AK      + +T     T  
Sbjct: 174 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPY 228

Query: 512 YLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           Y+APE+    K   S D+++ G ++  ++CG  P
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 46/233 (19%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------------------ 389
           K+ +G G +G V      + NT  A+K +   SK+ L   A                   
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVL---SKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 390 -----------EISSIGRLRHRNLVQLLG--WCRRRGDLLLVYDFMPNGSLDKCLFD-EQ 435
                      EI+ + +L H N+V+L+          L +V++ +  G     + +   
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG----PVMEVPT 130

Query: 436 KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY 495
              L+ +Q     + +  G+ YLH    Q +IHRDIK  N+L+  + + ++ DFG++  +
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 496 ERGTNPSTTRVVGTLGYLAPELTRTGKPT---TSSDVYAFGALLLEVVCGRRP 545
           +      +   VGT  ++APE     +      + DV+A G  L   V G+ P
Sbjct: 188 KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 96.5 bits (240), Expect = 6e-22
 Identities = 45/254 (17%), Positives = 85/254 (33%), Gaps = 44/254 (17%)

Query: 310 YLVKKIRNADVLESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNT 369
           Y +K+IR                      +K  R  +    L   G  R +   L +   
Sbjct: 34  YAIKRIR--------------LPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79

Query: 370 QVAVKRV-----------SNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV 418
           +   +                S   +   + +I  +     +N V  L     +  L + 
Sbjct: 80  KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQ 139

Query: 419 YDFMPNGSLDKCLFDEQKAILTWEQR--YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNV 476
                  +L     + + ++   E      I   +A  + +LH    + ++HRD+K  N+
Sbjct: 140 MQLCRKENLKD-WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNI 195

Query: 477 LLDSELNGRLGDFGLAKLYERGTNPST-----------TRVVGTLGYLAPELTRTGKP-T 524
               +   ++GDFGL    ++     T           T  VGT  Y++PE    G   +
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ-IHGNNYS 254

Query: 525 TSSDVYAFGALLLE 538
              D+++ G +L E
Sbjct: 255 HKVDIFSLGLILFE 268

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 16/61 (26%), Positives = 32/61 (52%), Gaps = 1/61 (1%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA-SEISSIGRLRHRNLV 403
           F   + +G GGFG V++      +   A+KR+   +++  RE    E+ ++ +L H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 404 Q 404
           +
Sbjct: 68  R 68

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 97.0 bits (242), Expect = 6e-22
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 38/224 (16%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIG 395
            + +     +G G +G V       +  +VA+K++S        +K+  RE    +  + 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE----LLLLK 78

Query: 396 RLRHRNLVQLL------GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----Y 445
            ++H N++ LL         R   D  LV  FM    L K +        + E+     Y
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----GLKFSEEKIQYLVY 133

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
           +++KG    L Y+H      V+HRD+K GN+ ++ +   ++ DFGLA    R  +   T 
Sbjct: 134 QMLKG----LKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTG 182

Query: 506 VVGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
            V T  Y APE +        + D+++ G ++ E++   + +  
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFK 225

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 33/216 (15%)

Query: 347 DKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHR-NLV 403
             + LG G F  V +    ST  + A K  +     +    E   EI+ +   +    ++
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSL-DKCL------FDEQKAILTWEQRYRIIKGVASGLL 456
            L        +++L+ ++   G +   CL        E   I       R+IK +  G+ 
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI-------RLIKQILEGVY 145

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYL 513
           YLH   +  ++H D+K  N+LL S       ++ DFG+++            ++GT  YL
Sbjct: 146 YLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYL 200

Query: 514 APELTRTGKP-TTSSDVYAFGAL---LLEVVCGRRP 545
           APE+     P TT++D++  G +   LL       P
Sbjct: 201 APEILN-YDPITTATDMWNIGIIAYMLL---THTSP 232

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 98.7 bits (246), Expect = 7e-22
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 24/227 (10%)

Query: 332 RFSYEELKKATRG-FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREF 387
           ++ + E +      F D  +LG GGFG V+   + +T    A K+++ +    ++G +  
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232

Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL---------DKCLFDEQKAI 438
             E   + ++  R +V L      + DL LV   M  G +         D   F E +AI
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292

Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
                 Y     + SGL +LH+   + +I+RD+K  NVLLD + N R+ D GLA   + G
Sbjct: 293 F-----Y--TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342

Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
              +     GT G++APEL    +   S D +A G  L E++  R P
Sbjct: 343 QTKTKGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 96.8 bits (241), Expect = 1e-21
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 37/220 (16%)

Query: 351 LGFGGFGRVYKGT--LPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLL 406
           +G G +G VYK        +   A+K++     S    RE    I+ +  L+H N++ L 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84

Query: 407 GWCRRRGD--LLLVYDFMPNGSLD-KCLFDEQKAILTWEQRYRI----IKGVA----SGL 455
                  D  + L++D+      D   +    +A    ++  ++    +K +      G+
Sbjct: 85  KVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGR----LGDFGLAKLYERGTNPST--TRVVGT 509
            YLH  W   V+HRD+K  N+L+  E   R    + D G A+L+     P      VV T
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198

Query: 510 LGYLAPEL---TRTGKPTTSSDVYAFGALLLEVVCGRRPI 546
             Y APEL    R    T + D++A G +  E++    PI
Sbjct: 199 FWYRAPELLLGARH--YTKAIDIWAIGCIFAELL-TSEPI 235

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 58/214 (27%), Positives = 87/214 (40%), Gaps = 23/214 (10%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGW 408
           + +G G FG         T   VAVK               EI +   LRH N+V+    
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 409 CRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
                 L ++ ++   G L     +   F E +A   ++Q   ++ GV+    Y H    
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ---LLSGVS----YCHS--- 134

Query: 464 QTVIHRDIKAGNVLLDSELNGRL--GDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
             + HRD+K  N LLD     RL   DFG +K     + P +T  VGT  Y+APE+    
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL-R 191

Query: 522 KP--TTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           +      +DV++ G  L  ++ G  P E    P 
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 96.0 bits (239), Expect = 5e-21
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 37/222 (16%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS------EISSIGRLRHRNL 402
           + LG G FG+V  G    T  +VAVK ++   +Q +R          EI ++   RH ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFRHPHI 78

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD---------EQKAILTWEQRYRIIKGVAS 453
           ++L        D+ +V +++  G L    FD         E+++   ++Q   I+ GV  
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQ---ILSGVD- 130

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL 513
              Y H      V+HRD+K  NVLLD+ +N ++ DFGL+ +   G    T+   G+  Y 
Sbjct: 131 ---YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYA 182

Query: 514 APELTRTGKP--TTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           APE+   G+       D+++ G +L  ++CG  P +   +P 
Sbjct: 183 APEVIS-GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 95.7 bits (238), Expect = 5e-21
 Identities = 52/222 (23%), Positives = 100/222 (45%), Gaps = 33/222 (14%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIG 395
            + +++ + +G G  G V        +  VA+K++S        +K+  RE    +  + 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE----LVLMK 116

Query: 396 RLRHRNLVQLL------GWCRRRGDLLLVYDFMP---NGSLDKCLFDEQKAILTWEQRYR 446
            + H+N++ LL             D+ LV + M       +   L  E+ + L     Y+
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL----YQ 172

Query: 447 IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV 506
           ++ G    + +LH      +IHRD+K  N+++ S+   ++ DFGLA+    GT+   T  
Sbjct: 173 MLCG----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY 223

Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
           V T  Y APE+        + D+++ G ++ E+V   + + P
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 264

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 93.0 bits (232), Expect = 8e-21
 Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 36/230 (15%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGT-LPSTNTQVAVKRVSNES-KQG-----LRE 386
            YE + +          +G G +G+V+K   L +    VA+KRV  ++ ++G     +RE
Sbjct: 12  QYECVAE----------IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61

Query: 387 FASEISSIGRLR---HRNLVQLL-----GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI 438
               ++ +  L    H N+V+L          R   L LV++ +    L   L    +  
Sbjct: 62  ----VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116

Query: 439 LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG 498
           +  E    ++  +  GL +LH      V+HRD+K  N+L+ S    +L DFGLA++Y   
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--S 171

Query: 499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
              + T VV TL Y APE+       T  D+++ G +  E+   R+P+  
Sbjct: 172 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFR 220

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 32/219 (14%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLRE-FASEISSIGRLRHRNLVQL 405
           E LG G FG+V   T   T  +VA+K +S +   K  +      EIS +  LRH ++++L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 406 LGWCRRRGDLLLVYDFMPNGSLDKCLFD---------EQKAILTWEQRYRIIKGVASGLL 456
                   D+++V ++   G L    FD         E +    ++Q   II  +     
Sbjct: 75  YDVITTPTDIVMVIEYA-GGEL----FDYIVEKKRMTEDEGRRFFQQ---IICAIE---- 122

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           Y H      ++HRD+K  N+LLD  LN ++ DFGL+ +   G    T+   G+  Y APE
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177

Query: 517 LTRTGKP--TTSSDVYAFGALLLEVVCGRRPIEPKALPE 553
           +   GK       DV++ G +L  ++ GR P + + +P 
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 47/246 (19%), Positives = 88/246 (35%), Gaps = 53/246 (21%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           +   + LG G FG V +     +  + A+K+V  + +   RE    +  +  L H N+++
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIK 64

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR-------------------- 444
           L+ +    GD        P+        +                               
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124

Query: 445 YRIIKGVAS-------------------GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR 485
           ++++K                        + ++H      + HRDIK  N+L++S+ +  
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK-DNT 180

Query: 486 L--GDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCG 542
           L   DFG AK       PS   +  +  Y APEL     + T S D+++ G +  E +  
Sbjct: 181 LKLCDFGSAKKLIPS-EPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGE-LIL 237

Query: 543 RRPIEP 548
            +P+  
Sbjct: 238 GKPLFS 243

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 37/224 (16%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIG 395
              +RD + +G G +G V       T  +VA+K++         +K+  RE    +  + 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLK 79

Query: 396 RLRHRNLVQLL------GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----Y 445
            +RH N++ LL             D  LV  FM    L K +   +   L  ++     Y
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM---KHEKLGEDRIQFLVY 135

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
           +++KG    L Y+H      +IHRD+K GN+ ++ +   ++ DFGLA    R  +   T 
Sbjct: 136 QMLKG----LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMTG 184

Query: 506 VVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
            V T  Y APE+       T + D+++ G ++ E++   + +  
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFK 227

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 49/223 (21%), Positives = 99/223 (44%), Gaps = 35/223 (15%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIG 395
            + +++ + +G G  G V           VA+K++S        +K+  RE    +  + 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE----LVLMK 79

Query: 396 RLRHRNLVQLL------GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----Y 445
            + H+N++ LL             D+ +V + M   +L + +    +  L  E+     Y
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSYLLY 134

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
           +++ G    + +LH      +IHRD+K  N+++ S+   ++ DFGLA+     T+   T 
Sbjct: 135 QMLCG----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTP 185

Query: 506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
            V T  Y APE+        + D+++ G ++ E++     + P
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFP 227

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLL 406
            +G G FG+V       T    A+K ++ +    +  +R    E+  +  L H  LV L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 407 GWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
              +   D+ +V D +  G L         F E+   L     +  I  +   L YL   
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-----F--ICELVMALDYLQN- 133

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE-LTRT 520
             Q +IHRD+K  N+LLD   +  + DF +A +  R T  +T  + GT  Y+APE  +  
Sbjct: 134 --QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSR 189

Query: 521 GKP--TTSSDVYAFGALLLEVVCGRRP 545
                + + D ++ G    E++ GRRP
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRP 216

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 37/224 (16%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIG 395
              +++   +G G +G V       T  +VAVK++S        +K+  RE    +  + 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE----LRLLK 83

Query: 396 RLRHRNLVQLL------GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----Y 445
            ++H N++ LL             D+ LV   M    L+  +   +   LT +      Y
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV---KCQKLTDDHVQFLIY 139

Query: 446 RIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR 505
           +I++G    L Y+H      +IHRD+K  N+ ++ +   ++ DFGLA    R T    T 
Sbjct: 140 QILRG----LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEMTG 188

Query: 506 VVGTLGYLAPE-LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEP 548
            V T  Y APE +        + D+++ G ++ E++   R + P
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFP 231

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 33/224 (14%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-----ESKQGLREFASEISSIGR 396
              + +   +G G +G V          +VA+K++S        ++ LRE    I  + R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILLR 81

Query: 397 LRHRNLVQLL-----GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----YRI 447
            RH N++ +          +  D+ +V D M    L K L   +   L+ +      Y+I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQI 137

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY--ERGTNPSTTR 505
           ++G    L Y+H      V+HRD+K  N+LL++  + ++ DFGLA++   +       T 
Sbjct: 138 LRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 506 VVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
            V T  Y APE+    K  T S D+++ G +L E++   RPI P
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFP 233

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 42/230 (18%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES----KQGLREFASEISSIGRLRHR 400
           + D + LG GG G V+       + +VA+K++        K  LRE    I  I RL H 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRLDHD 68

Query: 401 NLVQLL--------------GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR-- 444
           N+V++               G       + +V ++M    L   L   ++  L  E    
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARL 124

Query: 445 --YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLY--ERGT 499
             Y++++G    L Y+H      V+HRD+K  N+ +++E L  ++GDFGLA++       
Sbjct: 125 FMYQLLRG----LKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

Query: 500 NPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
               +  + T  Y +P L  +    T + D++A G +  E++   + +  
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTLFA 226

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA---SEISSIGRLRHRN 401
           F   + LG G FGRV       +    A+K +  +    L++     +E   +  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKG-VASGL 455
           LV+L    +   +L +V +++  G +         F E  A        R     +    
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--------RFYAAQIVLTF 154

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
            YLH      +I+RD+K  N+L+D +   ++ DFG AK  +  T   T  + GT   LAP
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--T--LCGTPEALAP 207

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           E+  +     + D +A G L+ E+  G  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 36/223 (16%)

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-LREFASEISS 393
           Y+ ++K          LG G +  V++    + N +V VK +    K+   RE    I  
Sbjct: 38  YQLVRK----------LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE----IKI 83

Query: 394 IGRLR-HRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKC---LFDEQKAILTWEQRYRI 447
           +  LR   N++ L    +        LV++ + N    +    L D           Y I
Sbjct: 84  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM----YEI 139

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRV 506
           +K     L Y H      ++HRD+K  NV++D E    RL D+GLA+ Y  G      RV
Sbjct: 140 LKA----LDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRV 191

Query: 507 VGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
             +  +  PEL    +    S D+++ G +L  ++  + P   
Sbjct: 192 A-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 34/228 (14%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN--ESKQGLREFAS---------E 390
              +  +  +  G +G V  G + S    VA+KRV N     + +   +          E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 391 ISSIGRLRHRNLVQLL-----GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR- 444
           I  +    H N++ L              L LV + M    L + + D++  +++ +   
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR-IVISPQHIQ 137

Query: 445 ---YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP 501
              Y I+ G    L  LHE     V+HRD+  GN+LL    +  + DF LA+      + 
Sbjct: 138 YFMYHILLG----LHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT--ADA 188

Query: 502 STTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
           + T  V    Y APEL    K  T   D+++ G ++ E+   R+ +  
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFR 235

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 52/216 (24%), Positives = 80/216 (37%), Gaps = 29/216 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
           +   +++G G FG V      ST    A+K +S      +     F  E   +       
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVA--------S 453
           +VQL    +    L +V ++MP G L           +     Y + +  A         
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDL-----------VNLMSNYDVPEKWARFYTAEVVL 179

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYL 513
            L  +H       IHRD+K  N+LLD   + +L DFG      +         VGT  Y+
Sbjct: 180 ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236

Query: 514 APE-LTRTGKP---TTSSDVYAFGALLLEVVCGRRP 545
           +PE L   G         D ++ G  L E++ G  P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 24/215 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE---FASEISSIGRLRHRN 401
           F   +++G G FG V    L + +   A+K ++        E   F  E   +     + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSL------DKCLFDEQKAILTWEQRYRIIKGVASGL 455
           +  L    +   +L LV D+   G L       +    E+ A     + Y  +  +   +
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-----RFY--LAEMVIAI 188

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
             +H+      +HRDIK  N+L+D   + RL DFG            ++  VGT  Y++P
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245

Query: 516 ELTRTGKP-----TTSSDVYAFGALLLEVVCGRRP 545
           E+ +  +          D ++ G  + E++ G  P
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 12/201 (5%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS---EISSIGRLRHRNLVQLL 406
           LLG G FG+V      +T    A+K +  E      E A    E   +   RH  L  L 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQT 465
              +    L  V ++   G L    F   +  +  E R R     + S L YLH E  + 
Sbjct: 215 YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KN 269

Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV-GTLGYLAPELTRTGKPT 524
           V++RD+K  N++LD + + ++ DFGL K  E   + +T +   GT  YLAPE+       
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327

Query: 525 TSSDVYAFGALLLEVVCGRRP 545
            + D +  G ++ E++CGR P
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLP 348

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 81.4 bits (202), Expect = 6e-17
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFA---SEISSIGRLRHRN 401
           F+    LG G FGRV+           A+K +  E    L++      E   +  + H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGS----LDKC-LFDEQKAILTWEQRYRIIKGVASGLL 456
           ++++ G  +    + ++ D++  G     L K   F    A       Y     V   L 
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-----Y--AAEVCLALE 120

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           YLH    + +I+RD+K  N+LLD   + ++ DFG AK     T   T  + GT  Y+APE
Sbjct: 121 YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--T--LCGTPDYIAPE 173

Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           +  T     S D ++FG L+ E++ G  P
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 81.9 bits (203), Expect = 7e-17
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 40/231 (17%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN-----ESKQGLREFASEISSIGR 396
           +  F+ K LLG G +G V   T   T   VA+K++        + + LRE    I  +  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKILKH 65

Query: 397 LRHRNLVQLL-----GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----YRI 447
            +H N++ +             ++ ++ + M    L + +      +L+ +      Y+ 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI---STQMLSDDHIQYFIYQT 121

Query: 448 IKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPST---- 503
           ++     +  LH      VIHRD+K  N+L++S  + ++ DFGLA++ +     ++    
Sbjct: 122 LRA----VKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

Query: 504 -----TRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEP 548
                   V T  Y APE+  T    + + DV++ G +L E+   RRPI P
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFP 224

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 83.1 bits (205), Expect = 1e-16
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSI--------GRLRHRN 401
           +LG G FG+V       T+   AVK +    K  + +   ++              +   
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQ-DDDVECTMVEKRVLALPGKPPF 403

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHE 460
           L QL    +    L  V +++  G L   ++  Q+     E         +A GL +L  
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV-GTLGYLAPELTR 519
              + +I+RD+K  NV+LDSE + ++ DFG+ K  E   +  TT+   GT  Y+APE+  
Sbjct: 461 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIA 515

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                 S D +AFG LL E++ G+ P
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 39/203 (19%), Positives = 77/203 (37%), Gaps = 33/203 (16%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE------SKQGLREFASEISSIGRLR 398
           +  + L+G G +G V +         VA+K++          K+ LRE    I+ + RL 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE----IAILNRLN 110

Query: 399 HRNLVQLL-----GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----YRIIK 449
           H ++V++L         +  +L +V +   +    K         LT        Y ++ 
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY--LTELHIKTLLYNLLV 167

Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT 509
           G    + Y+H      ++HRD+K  N L++ + + ++ DFGLA    R  +         
Sbjct: 168 G----VKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA----RTVDYPENGNSQL 216

Query: 510 LGYLAPELTRTGKPTTSSDVYAF 532
                 +         + ++   
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQ 239

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.1 bits (196), Expect = 3e-16
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 29/211 (13%)

Query: 350 LLGFGGFGRVY---KGTLPSTNTQVAVKRVSNESKQGLREFASEISSI-------GRLRH 399
           +LG GG+G+V+   K T  +T    A+K +    K  +   A + +           ++H
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK---KAMIVRNAKDTAHTKAERNILEEVKH 80

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASG 454
             +V L+   +  G L L+ +++  G L      + +F E  A       Y  +  ++  
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-----Y--LAEISMA 133

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           L +LH+   + +I+RD+K  N++L+ + + +L DFGL K        + T   GT+ Y+A
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMA 189

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
           PE+        + D ++ GAL+ +++ G  P
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 52/230 (22%), Positives = 81/230 (35%), Gaps = 29/230 (12%)

Query: 335 YEELKKATRGFRDKELL---GFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFA 388
              LK+      D E+L   G G F  V    +  T    A+K ++      +  +  F 
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109

Query: 389 SEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSL------DKCLFDEQKAILTWE 442
            E   +     R + QL    +    L LV ++   G L             + A     
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA----- 164

Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS 502
           + Y  +  +   +  +H       +HRDIK  N+LLD   + RL DFG            
Sbjct: 165 RFY--LAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219

Query: 503 TTRVVGTLGYLAPELTRTGKPTTSSDVY-------AFGALLLEVVCGRRP 545
           +   VGT  YL+PE+ +       +  Y       A G    E+  G+ P
Sbjct: 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 11/200 (5%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS---EISSIGRLRHRNLVQLL 406
           LLG G FG+V      +T    A+K +  E      E A    E   +   RH  L  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQT 465
              +    L  V ++   G L    F   +  +  E+R R     + S L YLH    + 
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS---RD 125

Query: 466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTT 525
           V++RDIK  N++LD + + ++ DFGL K          T   GT  YLAPE+        
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGR 184

Query: 526 SSDVYAFGALLLEVVCGRRP 545
           + D +  G ++ E++CGR P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLP 204

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 35/184 (19%)

Query: 329 GPHRFSYEELKKATRGFRD----KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL 384
           GPH  S  ++KK      D     ++LG G  G+V +     T  + A+K + +  K   
Sbjct: 1   GPHVKSGLQIKK-NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--A 57

Query: 385 REFASEISSIGRL-RHRNLVQLLGWC----RRRGDLLLVYDFMPNGSL-------DKCLF 432
           R    E+    R  +  ++V+++         R  LL+V + +  G L           F
Sbjct: 58  RR---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114

Query: 433 DEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG---RLGDF 489
            E++A         I+K +   + YLH      + HRD+K  N+L  S+      +L DF
Sbjct: 115 TEREA-------SEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 164

Query: 490 GLAK 493
           G AK
Sbjct: 165 GFAK 168

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 21/206 (10%)

Query: 350 LLGFGGFGRVY---KGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQ 404
           +LG G FG+V+   K +        A+K +   +   +       E   +  + H  +V+
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 405 LLGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
           L    +  G L L+ DF+  G L      + +F E+         Y  +  +A  L +LH
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----Y--LAELALALDHLH 143

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR 519
                 +I+RD+K  N+LLD E + +L DFGL+K        + +   GT+ Y+APE+  
Sbjct: 144 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVN 199

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
               T S+D ++FG L+ E++ G  P
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLP 225

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVS-------NESKQGLRE---FASEISSIGRLRH 399
           +LG G FG+V+      TN   A+K +        ++ +  + E    +          H
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW------EH 77

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYL 458
             L  +    + + +L  V +++  G L   ++  Q        R       +  GL +L
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFL 134

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLAPEL 517
           H    + +++RD+K  N+LLD + + ++ DFG+ K  E     + T    GT  Y+APE+
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEI 189

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRP 545
               K   S D ++FG LL E++ G+ P
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 9/136 (6%)

Query: 413 GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRI-IKGVASGLLYLHEEWEQTVIHRDI 471
             L L+ D++  G L        +     E   +I +  +   L +LH+     +I+RDI
Sbjct: 132 TKLHLILDYINGGEL---FTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDI 185

Query: 472 KAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP--TTSSDV 529
           K  N+LLDS  +  L DFGL+K +            GT+ Y+AP++ R G      + D 
Sbjct: 186 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 245

Query: 530 YAFGALLLEVVCGRRP 545
           ++ G L+ E++ G  P
Sbjct: 246 WSLGVLMYELLTGASP 261

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 20/205 (9%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISS----IGRLRHRNLVQL 405
           ++G G FG+V      +     AVK +  ++    +E    +S     +  ++H  LV L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 406 LGWCRRRGDLLLVYDFMPNGSL-----DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
               +    L  V D++  G L      +  F E +A       Y     +AS L YLH 
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-----Y--AAEIASALGYLHS 157

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
                +++RD+K  N+LLDS+ +  L DFGL K      + ++T   GT  YLAPE+   
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHK 213

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRP 545
                + D +  GA+L E++ G  P
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPP 238

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.7 bits (189), Expect = 6e-15
 Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 29/199 (14%)

Query: 342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIG 395
              +  K L+G G +G VY     +T   VA+K+V+       + K+ LRE    I+ + 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITILN 80

Query: 396 RLRHRNLVQLL-----GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----YR 446
           RL+   +++L          +  +L +V +   +  L K         LT E      Y 
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF--LTEEHIKTILYN 137

Query: 447 IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV 506
           ++ G      ++HE     +IHRD+K  N LL+ + + ++ DFGLA+      + +    
Sbjct: 138 LLLG----ENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 507 VGTLGYLAPELTRTGKPTT 525
           +       P      K  T
Sbjct: 191 LEENEEPGPHNKNLKKQLT 209

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.3 bits (186), Expect = 8e-15
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 350 LLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSI--------GRLRHRN 401
           +LG G FG+V    +  T    AVK +    K  + +   ++               H  
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQ-DDDVECTMTEKRILSLARNHPF 85

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHE 460
           L QL    +    L  V +F+  G L   +F  QK+    E R R     + S L++LH+
Sbjct: 86  LTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMFLHD 142

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLAPELTR 519
              + +I+RD+K  NVLLD E + +L DFG+ K  E   N  TT    GT  Y+APE+ +
Sbjct: 143 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQ 197

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRP 545
                 + D +A G LL E++CG  P
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAP 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.3 bits (186), Expect = 9e-15
 Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 8/134 (5%)

Query: 413 GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQTVIHRDI 471
             L  V +++  G L   ++  Q+     E         +A GL +L     + +I+RD+
Sbjct: 94  DRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDL 147

Query: 472 KAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYA 531
           K  NV+LDSE + ++ DFG+ K        + T   GT  Y+APE+        S D +A
Sbjct: 148 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWA 206

Query: 532 FGALLLEVVCGRRP 545
           FG LL E++ G+ P
Sbjct: 207 FGVLLYEMLAGQAP 220

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 47/133 (35%), Positives = 69/133 (51%), Gaps = 10/133 (7%)

Query: 415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQTVIHRDIKA 473
           L  V +++  G L   +F  Q+     E+  R     ++  L YLHE   + +I+RD+K 
Sbjct: 85  LFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKL 138

Query: 474 GNVLLDSELNGRLGDFGLAKLYERGTNPSTTR-VVGTLGYLAPELTRTGKPTTSSDVYAF 532
            NVLLDSE + +L D+G+ K  E      TT    GT  Y+APE+ R      S D +A 
Sbjct: 139 DNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196

Query: 533 GALLLEVVCGRRP 545
           G L+ E++ GR P
Sbjct: 197 GVLMFEMMAGRSP 209

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.8 bits (180), Expect = 2e-14
 Identities = 40/217 (18%), Positives = 64/217 (29%), Gaps = 55/217 (25%)

Query: 329 GPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--------SNES 380
           GP  FS+      T   +  E +G G FG V++      +T VA+K +        +   
Sbjct: 9   GPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSH 63

Query: 381 KQGLREFASEI---------SSIGRLRHRNLVQLLGWCRRRGD----LLLVYD------- 420
           ++   E   EI         S     R    + L      +G     LL  +D       
Sbjct: 64  QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123

Query: 421 ------------------FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
                                 G +D  L   +  + +      I+  + + L       
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASL 181

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
                HRD+  GNVLL      +L      K     +
Sbjct: 182 R--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPS 216

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 47/135 (34%), Positives = 69/135 (51%), Gaps = 10/135 (7%)

Query: 413 GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKG-VASGLLYLHEEWEQTVIHRDI 471
             L  V +++  G L   +F  Q+     E+  R     ++  L YLHE   + +I+RD+
Sbjct: 126 SRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDL 179

Query: 472 KAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVV-GTLGYLAPELTRTGKPTTSSDVY 530
           K  NVLLDSE + +L D+G+ K  E      TT    GT  Y+APE+ R      S D +
Sbjct: 180 KLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 237

Query: 531 AFGALLLEVVCGRRP 545
           A G L+ E++ GR P
Sbjct: 238 ALGVLMFEMMAGRSP 252

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 56/241 (23%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN------ESKQGLREFASEISSIGRLR 398
           +   + LG G +G V+K     T   VAVK++ +      ++++  RE       I  L 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE-------IMILT 63

Query: 399 ----HRNLVQLLGWCR--RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR----YRII 448
               H N+V LL   R     D+ LV+D+M    L   +   +  IL    +    Y++I
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI---RANILEPVHKQYVVYQLI 119

Query: 449 KGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV-- 506
           K     + YLH      ++HRD+K  N+LL++E + ++ DFGL++ +      +      
Sbjct: 120 KV----IKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 507 ------------------VGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIE 547
                             V T  Y APE+       T   D+++ G +L E++   +PI 
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPIF 231

Query: 548 P 548
           P
Sbjct: 232 P 232

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52

 Score = 61.8 bits (150), Expect = 1e-12
 Identities = 19/50 (38%), Positives = 28/50 (56%)

Query: 223 SPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSGDAKSLS 272
           S  LS  V L  +V E + +GFS++TG   ++H +L WSF+      S S
Sbjct: 3   SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELSGTSSS 52

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260

 Score = 67.2 bits (163), Expect = 2e-12
 Identities = 34/229 (14%), Positives = 76/229 (33%), Gaps = 29/229 (12%)

Query: 37  NNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV 96
               +  G A      ++ +  +     G  +  +   F+N         +     F + 
Sbjct: 48  VPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAFEN---------WEVEVTFRVT 97

Query: 97  PEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGD 156
                +G  G A   + ++ L G        +  S+D+ N       + FD+  +    +
Sbjct: 98  GR-GRIGADGLAIWYTENQGLDG-------PVFGSADMWN----GVGIFFDSFDNDGKKN 145

Query: 157 INDNHVGI-DINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLA 215
                V   +      + ++ A   L +  +   N      ++A I Y   +  L V + 
Sbjct: 146 NPAIVVVGNNGQINYDHQNDGATQALASCQRDFRN--KPYPVRAKITYY--QKTLTVMIN 201

Query: 216 PSSVKPRSP-ILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFN 263
                 ++       V+ + ++    + G S++TG LA  H +L +   
Sbjct: 202 NGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSFLTF 249

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 20/191 (10%)

Query: 428 DKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG 487
           ++   D  K  LT E        VA G+ +L     +  IHRD+ A N+LL  +   ++ 
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKIC 235

Query: 488 DFGLAK-LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRP 545
           DFGLA+ +Y+             L ++APE       T  SDV++FG LL E+   G  P
Sbjct: 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

Query: 546 IEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEAR 605
                + EE         R K G  +    P            ++ +  L C +     R
Sbjct: 296 YPGVKIDEEFC------RRLKEGTRMR--APDYTTP-------EMYQTMLDCWHGEPSQR 340

Query: 606 PTMRQVVRYLE 616
           PT  ++V +L 
Sbjct: 341 PTFSELVEHLG 351

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 12/95 (12%)

Query: 345 FRDK----ELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESKQG-LREFASEISSI 394
            RD+    + LG G FG+V +         +T   VAVK +   +     R   SE+  +
Sbjct: 20  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 79

Query: 395 GRL-RHRNLVQLLGWC-RRRGDLLLVYDFMPNGSL 427
             +  H N+V LLG C +  G L+++ +F   G+L
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.5 bits (156), Expect = 8e-11
 Identities = 67/453 (14%), Positives = 120/453 (26%), Gaps = 136/453 (30%)

Query: 269 KSLSLDSLPSLPGPKEKHLGLIVGV------TVSAFFVMFLAIAVGCYLVKKIRNADVLE 322
               +D +          L L   +       V  F    L I    +L+  I+      
Sbjct: 47  SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK-FLMSPIKTEQRQP 105

Query: 323 SWELDV----------GPHRFS---------YEELKKATRGFRDKELL---GFGGFGRVY 360
           S    +              F+         Y +L++A    R  + +   G  G G   
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG--- 162

Query: 361 KGTLPSTNTQVAVKRVSNESKQGLREFASEIS--SIGRLRHRNLVQLLGWCRRRGDLL-- 416
           K  +       A+    +   Q   +   +I   ++              C     +L  
Sbjct: 163 KTWV-------ALDVCLSYKVQ--CKMDFKIFWLNLKN------------CNSPETVLEM 201

Query: 417 ---LVYDFMPNG-SLDKCLFDEQKAILTWEQRYRII---KGVASGLLYLHEEWEQTVIHR 469
              L+Y   PN  S      + +  I + +   R +   K   + LL L         + 
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA 261

Query: 470 -DIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSD 528
            ++    +LL +                R      T  +         L       T  +
Sbjct: 262 FNLSC-KILLTT----------------R--FKQVTDFLSAATTTHISLDHHSMTLTPDE 302

Query: 529 VYAFGALLLEVVCGRRPIEPKALPEE----------LI---LVDWV--WDRWKAGAILEV 573
           V +     L+         P+ LP E          +I   + D +  WD WK       
Sbjct: 303 VKSLLLKYLD-------CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK------- 348

Query: 574 VDPRLNGE-FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQAVAAPDACD 632
               +N +    I    +  L      + AE R    ++  +      +P  + +    D
Sbjct: 349 ---HVNCDKLTTIIESSLNVL------EPAEYRKMFDRLSVFPPS-AHIPTILLSLIWFD 398

Query: 633 GKKEKTSGGGAGVDGPEFEDFVYSYPNSSLLEK 665
             K             +    V      SL+EK
Sbjct: 399 VIKS------------DVMVVVNKLHKYSLVEK 419

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.2 bits (124), Expect = 6e-07
 Identities = 57/391 (14%), Positives = 120/391 (30%), Gaps = 89/391 (22%)

Query: 325 ELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGL 384
           + + G H++ Y+++      F D            +             K V +  K  L
Sbjct: 8   DFETGEHQYQYKDILSV---FEDA-----------FVDNFD-------CKDVQDMPKSIL 46

Query: 385 REFASEISSIGRLRHR-NLVQLLGWCRRR----------GDLLLV-YDFM-------PNG 425
            +   EI  I   +   +    L W               ++L + Y F+          
Sbjct: 47  SK--EEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ 104

Query: 426 -SLDKCLFDEQKAILTWE----------QRYRIIKGVASGLLYLHEEWEQTVIHRDI--- 471
            S+   ++ EQ+  L +            R +    +   LL L    +  +I   +   
Sbjct: 105 PSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQALLELRPA-KNVLIDGVLGSG 162

Query: 472 K---AGNVLLDSELNGRLGDFGL--AKLYERGTNPSTTRVVGTLGY-LAPELTRTGKPTT 525
           K   A +V L  ++  ++ DF +    L    +  +   ++  L Y + P  T     + 
Sbjct: 163 KTWVALDVCLSYKVQCKM-DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS- 220

Query: 526 SSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP--------R 577
           S+      ++  E+   RR ++ K     L+++  V +           +         R
Sbjct: 221 SNIKLRIHSIQAEL---RRLLKSKPYENCLLVLLNVQNAK----AWNAFNLSCKILLTTR 273

Query: 578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP-LPQAVAAPDACDGKKE 636
                + + A     + L   +           +++YL+     LP      +       
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP-----REVLTTNPR 328

Query: 637 KTSGGGAGV-DGPEFEDFVYSYPNSSLLEKV 666
           + S     + DG    D  + + N   L  +
Sbjct: 329 RLSIIAESIRDGLATWDN-WKHVNCDKLTTI 358

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 37/174 (21%), Positives = 67/174 (38%), Gaps = 29/174 (16%)

Query: 345 FRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNESKQGLREF-----ASEISSI 394
           ++    +G GGFG +Y   + S     ++    VK   +++     E      A++   I
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 395 GRLRHRNLVQLLG-----WCRRRGDLLLVYDFM------PNGSLDKCLFDEQKAILTWEQ 443
            +      ++ LG                Y FM          L K +++      + + 
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQK-IYEANAKRFSRKT 153

Query: 444 RYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR--LGDFGLAKLY 495
             ++   +   L Y+HE      +H DIKA N+LL+ +   +  L D+GLA  Y
Sbjct: 154 VLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 45/219 (20%), Positives = 85/219 (38%), Gaps = 35/219 (15%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREF-------ASEISSIGRLR 398
             LG+G F  V+       NT VA+K V  +         E         ++ +    + 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 399 HRNLVQLLGWCRRRGD----LLLVYDFMPNGSLDKCLFDEQKAI----LTWEQRYRIIKG 450
             ++++LL     +G     +++V++      L + L    K      +      +I K 
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSE------LNGRLGDFGLAKLYERGTNPSTT 504
           +  GL Y+H      +IH DIK  NVL++        +  ++ D G A       +   T
Sbjct: 140 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYT 193

Query: 505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGR 543
             + T  Y +PE+         +D+++   L+ E++ G 
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253

 Score = 60.7 bits (146), Expect = 3e-10
 Identities = 32/241 (13%), Positives = 67/241 (27%), Gaps = 30/241 (12%)

Query: 27  FFSGFRDAANNN--NMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKS 84
               ++   +++       G+  +      +  +   +  G  +   P   K+       
Sbjct: 12  LIKPYQGVGSSSMPLWDFQGSTILTSQYVRLTPDERSKE-GSIWNHQPCFLKD------- 63

Query: 85  LSFSTCFAFAIV-PEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFA 143
             +     F +       L G G A   +  + +PG        +  S D  +      A
Sbjct: 64  --WEMHVHFKVHGTGKKNLHGDGIALWYTRDRLVPG-------PVFGSKDNFH----GLA 110

Query: 144 VEFDTVKDFEFGDINDNHVGIDIN-SLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWID 202
           +  DT  + E  +    ++ + +N    S        + E +                + 
Sbjct: 111 IFLDTYPNDETTERVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRNRDHDTFLAVR 170

Query: 203 YDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSF 262
           Y   +  L V             +       P      Y G S+ TG L+ +H I+    
Sbjct: 171 YS--RGRLTVMTDLEDKNEWKNCIDITGVRLP---TGYYFGASAGTGDLSDNHDIISMKL 225

Query: 263 N 263
            
Sbjct: 226 F 226

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 42/206 (20%), Positives = 82/206 (39%), Gaps = 23/206 (11%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFA--SEISSIGRLRHRNLV 403
           +++G G FG+V K      +  VA+K V NE +   Q   E      +    +    N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI----LTWEQRYRIIKGVASGLLYLH 459
            +L     R  + + ++      L   L++  K       +     +    +   L  LH
Sbjct: 163 HMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNG--RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL 517
              +  +IH D+K  N+LL  +     ++ DFG +       +      + +  Y APE+
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQSRFYRAPEV 270

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGR 543
               +     D+++ G +L E++ G 
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 37/177 (20%), Positives = 62/177 (35%), Gaps = 38/177 (21%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREF-----ASEISSIGR 396
           +   + +G GGFG +Y     +   + A   V  E +       E       ++   I +
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 397 LRHRNLVQLLG-----WCRRRGDLLLVYDFM------PNGSLDKCLFDE-----QKAILT 440
              R  +  LG                Y FM          L K +  +     +  +L 
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI--DLQK-ISGQNGTFKKSTVL- 154

Query: 441 WEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR--LGDFGLAKLY 495
                ++   +   L Y+HE      +H DIKA N+LL  +   +  L D+GL+  Y
Sbjct: 155 -----QLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 44/214 (20%), Positives = 85/214 (39%), Gaps = 29/214 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHR- 400
           +    L+G G FG+V K         VA+K + N+     Q       E+  +  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMNKHD 111

Query: 401 -----NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI----LTWEQRYRIIKGV 451
                 +V L      R  L LV++      L   L+D  +      ++     +  + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG--RLGDFGLAKLYERGTNPSTTRVVGT 509
            + LL+L    E ++IH D+K  N+LL +      ++ DFG +            + + +
Sbjct: 167 CTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQS 221

Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGR 543
             Y +PE+        + D+++ G +L+E+  G 
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 41/167 (24%), Positives = 63/167 (37%), Gaps = 33/167 (19%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           FR  + +G G FG +  G    TN  VA+K    +S+                 ++ L  
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-------YKQLGS 63

Query: 405 LLG-----WCRRRGDLLLVYDFM------PNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
             G     +    G     Y+ M      P  SL+  LFD      + +    I   + S
Sbjct: 64  GDGIPQVYYFGPCGK----YNAMVLELLGP--SLED-LFDLCDRTFSLKTVLMIAIQLIS 116

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR-----LGDFGLAKLY 495
            + Y+H +    +I+RD+K  N L+    N       + DF LAK Y
Sbjct: 117 RMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 42/160 (26%), Positives = 67/160 (41%), Gaps = 21/160 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           +R    +G G FG +Y GT  +   +VA+K    ++K        E      ++    + 
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIP 68

Query: 405 LLGWCRRRGDLLLVYDFM------PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
            + WC   GD    Y+ M      P  SL+  LF+      + +    +   + S + Y+
Sbjct: 69  TIRWCGAEGD----YNVMVMELLGP--SLED-LFNFCSRKFSLKTVLLLADQMISRIEYI 121

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLY 495
           H    +  IHRD+K  N L+     G    + DFGLAK Y
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 24/168 (14%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           FR    +G G FG +Y GT   TN +VA+K  + ++K     +  E      L+    + 
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIP 66

Query: 405 LLGWCRRRGDLLLVYDFM------PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
            + W    GD    Y+ +      P  SL+  LF+     L+ +    +   + + + ++
Sbjct: 67  NVRWFGVEGD----YNVLVMDLLGP--SLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGR---LGDFGLAKLYERGTNPST 503
           H    ++ +HRDIK  N L+          + DFGLAK Y    + ST
Sbjct: 120 H---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY---RDTST 161

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 34/178 (19%), Positives = 61/178 (34%), Gaps = 37/178 (20%)

Query: 345 FRDKELLGFGGFGRVYKGTLPST--------NTQVAVK------RVSNESKQGLREFASE 390
           ++ K        G +Y+    ST          + ++K      R+ NE     R  A++
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR--AAK 101

Query: 391 ISSIGRLRHRNLVQLLG-----WCRRRGDLLLVYDFM------PNGSLDKCLFDEQKAIL 439
              + + +      LL            D    Y F+         SL   L    K +L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDK---YRFLVLPSLGR--SLQSALDVSPKHVL 156

Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR--LGDFGLAKLY 495
           +     ++   +   L +LHE      +H ++ A N+ +D E   +  L  +G A  Y
Sbjct: 157 SERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 37/163 (22%), Positives = 66/163 (40%), Gaps = 25/163 (15%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           ++    +G G FG +++GT    N QVA+K     S                  ++ L  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-------YKLLAG 64

Query: 405 LLG-----WCRRRGDL-LLVYDFMPNG-SLDKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
             G     +  + G   +LV D +  G SL+  L D      + +      K + + +  
Sbjct: 65  CTGIPNVYYFGQEGLHNVLVIDLL--GPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGR-----LGDFGLAKLY 495
           +HE   +++++RDIK  N L+    +       + DFG+ K Y
Sbjct: 122 IHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 52/263 (19%), Positives = 85/263 (32%), Gaps = 73/263 (27%)

Query: 351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS-EISSIGRLR--------HRN 401
           LG+G F  V+          VA+K V +       E A  EI  +  +R           
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY--TETALDEIRLLKSVRNSDPNDPNREM 102

Query: 402 LVQLLGWCRRRGD----LLLVYDFM-PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           +VQLL   +  G     + +V++ +  +        + Q   L      +II+ V  GL 
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGLD 160

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSE----------------------------------- 481
           YLH +    +IH DIK  N+LL                                      
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 482 --------------LNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSS 527
                         L  ++ D G A       +   T  + T  Y + E+       T +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274

Query: 528 DVYAFGALLLEVVCGRRPIEPKA 550
           D+++   +  E+  G    EP +
Sbjct: 275 DIWSTACMAFELATGDYLFEPHS 297

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 30/144 (20%), Positives = 50/144 (34%), Gaps = 24/144 (16%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHR----- 400
             +G G FGRV            AVK V N  K       E       + ++++      
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNN 96

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI----LTWEQRYRIIKGVASGLL 456
           N+V+  G       + L+++      L   L++            E        +   L 
Sbjct: 97  NIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDS 480
           YL +    ++ H D+K  N+LLD 
Sbjct: 152 YLRKM---SLTHTDLKPENILLDD 172

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.3 bits (113), Expect = 9e-06
 Identities = 46/222 (20%), Positives = 73/222 (32%), Gaps = 39/222 (17%)

Query: 349 ELLGFGGFGRVYKGT-LPSTNTQVAVKRVSNESK---QGLREFA--SEISSIGRLRHRNL 402
             LG G FG+V +        +QVA+K + N  K       E     +I    +      
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI----LTWEQRYRIIKGVASGLLYL 458
           V +  W    G + + ++      L K  F+  K              +   +   L +L
Sbjct: 85  VLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--------STT------ 504
           HE     + H D+K  N+L  +     L +   +   +   N         S T      
Sbjct: 140 HEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196

Query: 505 -RVVGTLGYLAPE--LTRTGKP-TTSSDVYAFGALLLEVVCG 542
             +V T  Y  PE  L           DV++ G +L E   G
Sbjct: 197 TTIVATRHYRPPEVIL---ELGWAQPCDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 45.3 bits (108), Expect = 4e-05
 Identities = 46/222 (20%), Positives = 78/222 (35%), Gaps = 39/222 (17%)

Query: 349 ELLGFGGFGRVYKGT-LPSTNTQVAVKRVSNESK---QGLREFA--SEISSIGRLRHRNL 402
           + LG G FG+V +     +    VAVK V N  +       E      +++         
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI----LTWEQRYRIIKGVASGLLYL 458
           VQ+L W    G + +V++      L    +D  K         +   ++   +   + +L
Sbjct: 80  VQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--------STT------ 504
           H      + H D+K  N+L          +  + +      NP        S T      
Sbjct: 135 HSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191

Query: 505 -RVVGTLGYLAPE--LTRTGKP-TTSSDVYAFGALLLEVVCG 542
             +V T  Y APE  L       +   DV++ G +L+E   G
Sbjct: 192 STLVSTRHYRAPEVIL---ALGWSQPCDVWSIGCILIEYYLG 230

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	687
3ujo_A	281	Legume lectin; carbohydrate-binding, galactose, ad	100.0
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	100.0
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	100.0
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	100.0
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	100.0
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	100.0
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	100.0
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	100.0
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	100.0
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	100.0
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	100.0
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	100.0
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	100.0
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	100.0
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	100.0
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	100.0
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	100.0
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	100.0
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	100.0
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	100.0
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	100.0
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	100.0
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	100.0
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.98
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
2a6y_A	256	EMP47P (FORM1); beta sandwich, carbohydrate bindin	99.92
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
2a6z_A	222	EMP47P (FORM2); beta sandwich, carbohydrate bindin	99.74
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	99.46
2a6v_A	226	EMP46P; beta sandwich, carbohydrate binding protei	99.43
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.01
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.92
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.67
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.53
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.43
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.34
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.07
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.96
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.77
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.55
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.4
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.34
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.14
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.07
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.07
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.04
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.02
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.89
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.47
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.06
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.53
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.46
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.64
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.03
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.36

>3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A*

Probab=100.00  E-value=2.3e-62  Score=494.38  Aligned_cols=234  Identities=35%  Similarity=0.542  Sum_probs=202.3

Q ss_pred             HHHHHHhccCCC-cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCCC------eeEEEEecCCeecccCCCCC
Q 005621           10 VLFIFLANPVFS-QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLR------VLGHAFYSSPIKFKNSTRNS   82 (687)
Q Consensus        10 ~~~~~l~~~~~~-~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~~------~~Gr~~y~~p~~l~~~~~~~   82 (687)
                      .+||+|++++.+ ...+|+|++|..    .||+|+|+|++. +|.|+||+...+      ++|||+|++||+|||++ ++
T Consensus        12 ~~fl~l~~~~~sa~~~sF~f~~F~~----~nL~l~GdA~i~-~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d~~-tg   85 (281)
T 3ujo_A           12 VLFLILLTKAASANLISFTFKKFNE----TNLILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDNT-TG   85 (281)
T ss_dssp             ------------CEEEEEEESSCCS----TTEEECSSCCCB-TTBEECSCCCSSCCCCSSCEEEEEESSCEECBCSS-SC
T ss_pred             HHHHHHHcccCcCCcceEEcCCCCc----cCEEEecceEEe-CCEEEeCCCCCCCcccCCceEEEEECCCEEcccCC-CC
Confidence            345555555443 457999999974    689999999998 999999998765      89999999999999987 88


Q ss_pred             ceeeEEEEEEEEEeecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCee
Q 005621           83 KSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHV  162 (687)
Q Consensus        83 ~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hv  162 (687)
                      +++||+|+|+|.|.+++...+||||||||+|....|. .+||||||+|.+++ ++.+|+|||||||++|.+| ||++|||
T Consensus        86 ~vaSFsTsFsF~I~~~~~~~~gdGlAF~laP~~~~p~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N~e~-Dp~~nHV  162 (281)
T 3ujo_A           86 TVASWATSFTFNLQAPNAASPADGLAFALVPVGSQPK-DKGGFLGLFDSKNY-ASSNQTVAVEFDTFYNGGW-DPTERHI  162 (281)
T ss_dssp             CBEEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCSSC-CTTSCCEEEEECCSCCCSS-CCSSSEE
T ss_pred             CceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC-CCcceeeeccccCC-CccCcEEEEEEeccccccC-CCCCCeE
Confidence            9999999999999988778899999999999876665 68999999998766 7789999999999999887 9999999


Q ss_pred             eEEeCCCCcccccccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCcccccccee
Q 005621          163 GIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYV  242 (687)
Q Consensus       163 gi~~ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~v  242 (687)
                      ||||||+.|.++++|            .+.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.|||+++|||+|||
T Consensus       163 GIDvNSi~S~~t~~~------------~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~-~~~~~lS~~vDL~~~L~e~v~V  229 (281)
T 3ujo_A          163 GIDVNSIKSIKTTSW------------DFANGENAEVLITYDSSTNLLVASLVHPSQ-KTSFIVSERVDLTSVLPEWVSV  229 (281)
T ss_dssp             EEEESSSCCSCEEEC------------CCCSSCCEEEEEEECTTTCEEEEEEECTTT-CCCEEEEEECCSTTTSCSEEEE
T ss_pred             EEEcCCCCccccccc------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCCceEEEEechHHhccCcEEE
Confidence            999999999888764            466999999999999999999999998763 5588999999999999999999


Q ss_pred             eeeccCCc---ccceeEEEEeeeccC
Q 005621          243 GFSSSTGL---LASSHYILGWSFNMS  265 (687)
Q Consensus       243 GFsastG~---~~~~~~i~sWsf~~~  265 (687)
                      |||||||.   ..|.|+|++|+|++.
T Consensus       230 GFSAsTG~~~~~~e~H~IlsWSFss~  255 (281)
T 3ujo_A          230 GFSATTGLSKGYVETNEVLSWSFASK  255 (281)
T ss_dssp             EEEEEECSSTTSCCCCEEEEEEEEEE
T ss_pred             EEEeecCCCCcccceeEEEEEEEEEE
Confidence            99999996   689999999999864

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A*

Probab=100.00  E-value=1.8e-61  Score=483.02  Aligned_cols=225  Identities=35%  Similarity=0.481  Sum_probs=204.5

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCCC------eeEEEEecCCeecccCCCCCceeeEEEEEEEEEe
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLR------VLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV   96 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~~------~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~   96 (687)
                      ..+|+|++|.++  ..||+|+|+|.+.++|.|+||+...+      ++|||+|++||+||+++ +++++||+|+|+|.|.
T Consensus         3 ~~sF~f~~F~~~--~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~-tg~vaSFsT~F~F~I~   79 (251)
T 3ipv_A            3 ETSFVFSKFKPL--EPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSA-TGLVASFATSFRFTIY   79 (251)
T ss_dssp             EEEEEESSCCSS--CTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEECC
T ss_pred             ceEEEeCCCCCC--CCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCC-CCceeeEEEEEEEEEe
Confidence            468999999853  36899999999977999999997765      89999999999999987 8899999999999999


Q ss_pred             ecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccc
Q 005621           97 PEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEP  176 (687)
Q Consensus        97 ~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~  176 (687)
                      +++...+||||||||+|....|. .+||||||+|..++ +..+|+|||||||++|.+|+||++|||||||||+.|.++++
T Consensus        80 ~~~~~~~gdGlAF~lap~~~~~~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~  157 (251)
T 3ipv_A           80 APNIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK  157 (251)
T ss_dssp             CSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE
T ss_pred             CCCCCCCCCceEEEEecCCCCCC-CCCceeeeccccCC-CccCcEEEEEEecccccccCCCCCCeEEEEcCCCcccccce
Confidence            88778899999999999876665 57999999998766 67899999999999998889999999999999999988765


Q ss_pred             cccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc---cc
Q 005621          177 AAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL---AS  253 (687)
Q Consensus       177 ~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~---~~  253 (687)
                      +            .+.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.|||+++|||+||||||||||..   .|
T Consensus       158 ~------------~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~e  224 (251)
T 3ipv_A          158 W------------SLANGEAAKVLITYNSAVKLLVASLVYPSS-KTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIE  224 (251)
T ss_dssp             C------------CCCTTCEEEEEEEEETTTTEEEEEEECTTT-CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCC
T ss_pred             e------------EecCCCEEEEEEEEeCCCCEEEEEEecCCC-CccceEEEEechHHhCCCcEEEEEEEecCCCccccc
Confidence            3            578999999999999999999999997663 6678999999999999999999999999998   99


Q ss_pred             eeEEEEeeeccC
Q 005621          254 SHYILGWSFNMS  265 (687)
Q Consensus       254 ~~~i~sWsf~~~  265 (687)
                      .|+|++|+|++.
T Consensus       225 ~h~IlsWsF~s~  236 (251)
T 3ipv_A          225 THDVFSWSFASK  236 (251)
T ss_dssp             CCEEEEEEEEEE
T ss_pred             eeEEEEEEEEEE
Confidence            999999999864

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ...

Probab=100.00  E-value=5.4e-61  Score=480.84  Aligned_cols=227  Identities=28%  Similarity=0.443  Sum_probs=204.1

Q ss_pred             CCcccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCC------CeeEEEEecCCeecccCCCCCceeeEEEEEEE
Q 005621           20 FSQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL------RVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAF   93 (687)
Q Consensus        20 ~~~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~------~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f   93 (687)
                      .+...+|+|++|.++  ..+|+|+|+|.+.++|.|+||+...      +++|||+|++||+||++. +++++||+|+|+|
T Consensus         8 sa~~~sF~f~~F~~~--~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~-tg~vaSFsT~F~F   84 (261)
T 3zyr_A            8 STDSLSFSFINFDRD--ERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKS-TNRVANLQTQFSF   84 (261)
T ss_dssp             CCEEEEEEESSCCSC--CTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTT-TCCBEEEEEEEEE
T ss_pred             cCcccEEEcCCCCCC--CCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCC-CCCceeEEEEEEE
Confidence            345679999999853  3689999999997799999998765      799999999999999988 8899999999999


Q ss_pred             EEeecCCCCCCcceEEEEccCCC-CCCCCCCccccccccCCCCC-CcceEEEEEeecc---cCCCCCCCCCCeeeEEeCC
Q 005621           94 AIVPEYTALGGHGFAFTISASKE-LPGTLPSQYLGLLNSSDLGN-LTNHIFAVEFDTV---KDFEFGDINDNHVGIDINS  168 (687)
Q Consensus        94 ~i~~~~~~~~g~G~aF~l~~~~~-~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~---~n~~~~d~~~~Hvgi~~ns  168 (687)
                      .|.+. ...+||||||||+|... +|.+++||||||+|.+++++ ..||+|||||||+   +|.+| ||++|||||||||
T Consensus        85 ~I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~-Dp~~nHVGIdvNs  162 (261)
T 3zyr_A           85 FLSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTW-DPNYQHIGIDVNS  162 (261)
T ss_dssp             EEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTT-SCSSCEEEEEESS
T ss_pred             EEecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCC-CCCCCeEEEEcCC
Confidence            99886 67789999999999875 48888999999999887644 5689999999999   99887 9999999999999


Q ss_pred             CCcccccccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccC
Q 005621          169 LRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSST  248 (687)
Q Consensus       169 ~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsast  248 (687)
                      +.|.++++|            .+.+|+.++|||+||+.+++|+|+|++.+.  ..|+|++.+||+++|||+|||||||||
T Consensus       163 i~S~~s~~~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~e~v~VGFSAsT  228 (261)
T 3zyr_A          163 IRSSKVVRW------------ERREGKTLNVLVTYNPSTRTIDVVATYPDG--QRYQLSHVVDLTTILPEWVRVGFSAAS  228 (261)
T ss_dssp             SSCSEEEEC------------CCCTTCCEEEEEEEETTTTEEEEEEECTTC--CEEEEEEECCGGGTSCSEEEEEEEEEE
T ss_pred             CCccccccc------------cccCCceEEEEEEEcCCCCEEEEEEEcCCC--CCeEEEEEechHHhCcCcEEEEEEecC
Confidence            999888764            567999999999999999999999998753  388999999999999999999999999


Q ss_pred             CcccceeEEEEeeeccC
Q 005621          249 GLLASSHYILGWSFNMS  265 (687)
Q Consensus       249 G~~~~~~~i~sWsf~~~  265 (687)
                      |...|.|+|++|+|++.
T Consensus       229 G~~~e~h~IlsWsF~s~  245 (261)
T 3zyr_A          229 GEQFQTHNLESWSFTST  245 (261)
T ss_dssp             SSSCCEEEEEEEEEEEE
T ss_pred             CCccceEEEEEEEEEEE
Confidence            99999999999999864

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1

Probab=100.00  E-value=1.3e-59  Score=469.12  Aligned_cols=225  Identities=31%  Similarity=0.482  Sum_probs=203.6

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC-----CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEe
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT-----LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV   96 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~-----~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~   96 (687)
                      ...+|+|++|..+  ..+|+|+|+|.+.++|.|+||+..     .+++|||+|++||+||++. +++++||+|+|+|.|.
T Consensus         2 ~~~~F~f~~F~~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~-tg~vaSFsT~F~F~I~   78 (239)
T 1dbn_A            2 DELSFTINNFVPN--EADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNT-TGSVASFSTSFTFVVK   78 (239)
T ss_dssp             CEEEEEESSCCTT--CTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEECC
T ss_pred             cceEEEcCCCCCC--CCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCC-CCCccceEEEEEEEEe
Confidence            3568999999864  269999999999878999999876     6799999999999999987 8899999999999999


Q ss_pred             ecCCCCCCcceEEEEccCCC-CCCCCCCccccccccCCCCCCcceEEEEEeecccC---CCCCCCCCCeeeEEeCCCCcc
Q 005621           97 PEYTALGGHGFAFTISASKE-LPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKD---FEFGDINDNHVGIDINSLRSN  172 (687)
Q Consensus        97 ~~~~~~~g~G~aF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n---~~~~d~~~~Hvgi~~ns~~s~  172 (687)
                      +++...+||||||||+|... +|.+++||+|||+|..+ +++.+|+|||||||++|   .+ +||++|||||||||++|.
T Consensus        79 ~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdvNs~~S~  156 (239)
T 1dbn_A           79 APNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDVNGIESI  156 (239)
T ss_dssp             CSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEESSSSCS
T ss_pred             CCCCCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEEeccccCcccc-cCCCCCcEEEecCCcccc
Confidence            87777899999999999875 67788999999999764 46789999999999999   77 599999999999999998


Q ss_pred             cccccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc-
Q 005621          173 ASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL-  251 (687)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~-  251 (687)
                      +++++            ++.+|+.++|||+||+.+++|+|+|++.+ .|..|+|++.+||+++|||+||||||||||.. 
T Consensus       157 ~~~~~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~  223 (239)
T 1dbn_A          157 KTVQW------------DWINGGVAFATITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPT  223 (239)
T ss_dssp             EEEEC------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGG
T ss_pred             ceEcc------------cccCCCEEEEEEEEeCCCcEEEEEEccCC-CCCcceEEEEechHHhCCccEEEEEEeccCCCc
Confidence            87654            47899999999999999999999999875 45678999999999999999999999999999 


Q ss_pred             -cceeEEEEeeecc
Q 005621          252 -ASSHYILGWSFNM  264 (687)
Q Consensus       252 -~~~~~i~sWsf~~  264 (687)
                       .|.|+|++|+|++
T Consensus       224 ~~~~h~IlsWsF~s  237 (239)
T 1dbn_A          224 EVETHDVLSWSFTS  237 (239)
T ss_dssp             GCCCCEEEEEEEEE
T ss_pred             cceeeEEEEEEeEe
Confidence             9999999999985

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A*

Probab=100.00  E-value=2e-59  Score=466.71  Aligned_cols=224  Identities=32%  Similarity=0.465  Sum_probs=200.5

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC-----CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEee
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT-----LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVP   97 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~-----~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~   97 (687)
                      ..+|+|++|..+  ..+|+|+|+|.+.++|.|+||+..     .+++|||+|++||+||++. +++++||+|+|+|.|.+
T Consensus         3 ~~~F~f~~F~~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~-tg~vaSFsT~F~F~I~~   79 (237)
T 1fny_A            3 SLSFSFPKFAPN--QPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDST-TGNVASFVTSFTFIIQA   79 (237)
T ss_dssp             EEEEEESSCCTT--CTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEECCC
T ss_pred             ceEEEcCCCCCC--CCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCC-CCCccceEEEEEEEEeC
Confidence            468999999864  269999999999878999999876     6799999999999999987 88999999999999998


Q ss_pred             cCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccccc
Q 005621           98 EYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPA  177 (687)
Q Consensus        98 ~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~  177 (687)
                      ++...+||||||||+|....|. .+||+|||+|..+ +++.+|+|||||||++|.+ +||++|||||||||+.|.+++++
T Consensus        80 ~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~-~Dp~~nHVGIdvNsi~S~~~~~~  156 (237)
T 1fny_A           80 PNPATTADGLAFFLAPVDTQPL-DLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGD-WDPKGRHLGINVNSIESIKTVPW  156 (237)
T ss_dssp             SSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCC----CCTTSCCEEEEEECSCCTT-TCCSSSEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCCCCEEEEeccCCCCCC-CCCCcccccccCC-CCccccEEEEEeecccCcc-cCCCCCceEEecCCccccccccc
Confidence            7777899999999999876554 7899999999764 4778999999999999988 49999999999999999887764


Q ss_pred             ccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc---cce
Q 005621          178 AYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL---ASS  254 (687)
Q Consensus       178 ~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~---~~~  254 (687)
                                  ++.+|+.++|||+||+.+++|+|+|++.+ .|..|+|++.+||+++|||+||||||||||..   .|.
T Consensus       157 ------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~  223 (237)
T 1fny_A          157 ------------NWTNGEVANVFISYEASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQT  223 (237)
T ss_dssp             ------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCC
T ss_pred             ------------cccCCCEEEEEEEEeCCCcEEEEEEecCC-CCCcceEEEEechHHhCCCcEEEEEEEeeCCCCcccce
Confidence                        47899999999999999999999999875 46678999999999999999999999999998   999


Q ss_pred             eEEEEeeeccC
Q 005621          255 HYILGWSFNMS  265 (687)
Q Consensus       255 ~~i~sWsf~~~  265 (687)
                      |+|++|+|++.
T Consensus       224 h~IlsWsF~s~  234 (237)
T 1fny_A          224 NDVLSWSFESN  234 (237)
T ss_dssp             CEEEEEEEEEE
T ss_pred             eEEEEEEEEEe
Confidence            99999999863

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A*

Probab=100.00  E-value=5.2e-59  Score=469.33  Aligned_cols=243  Identities=30%  Similarity=0.426  Sum_probs=203.0

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      ...+|+|++|.... ..+|+|+|+|.+. +|.|+||+..      .+++|||+|++||+||++. +++++||+|+|+|.|
T Consensus         3 ~~~~F~f~~F~~~~-~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~-tg~vasFsT~F~F~I   79 (257)
T 1hql_A            3 DSVSFTFPNFWSDV-EDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNK-TESVASFYTEFTFFL   79 (257)
T ss_dssp             -CCEEEESCSCSCG-GGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCST-TCCCCEEEEEEEEEE
T ss_pred             cceEEEcCCCCCCC-CCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEecccCC-CCCeeceEEEEEEEE
Confidence            35689999998211 2689999999998 9999999875      5799999999999999987 889999999999999


Q ss_pred             eecCCCCCCcceEEEEccCCCCCCCCCCccccccccCC-CCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccc
Q 005621           96 VPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSD-LGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNAS  174 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~  174 (687)
                      .++ ...+||||||||+|....| +++|++|||+|.++ +++..+|+|||||||++|.+|+||++|||||||||+.|..+
T Consensus        80 ~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s  157 (257)
T 1hql_A           80 KIT-GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVAT  157 (257)
T ss_dssp             EEC-SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEE
T ss_pred             ecC-CCCCCCcEEEEEecCCCCC-CCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCccccce
Confidence            987 6778999999999987555 47899999999765 36778999999999999999999999999999999999988


Q ss_pred             ccccccccccccccc-ccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCC-ccc
Q 005621          175 EPAAYFLENSTKQVL-NLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTG-LLA  252 (687)
Q Consensus       175 ~~~~~~~~~~~~~~~-~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG-~~~  252 (687)
                      +++.          + +|.+|+.++|||+||+.+++|+|+|++.+.  ..|+|++.+||+.+|||+|||||||||| ...
T Consensus       158 ~~~~----------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~  225 (257)
T 1hql_A          158 KRWE----------DSDIFSGKIATARISYDGSAEILTVVLSYPDG--SDYILSHSVDMRQNLPESVRVGISASTGNNQF  225 (257)
T ss_dssp             EECC----------HHHHTSCSCEEEEEEEETTTTEEEEEEEETTT--EEEEEEEECCGGGTSCSEEEEEEEEECCSCCC
T ss_pred             eccC----------cccccCCceEEEEEEEeCCCCEEEEEEecCCC--CceeeEEeechHHhcCCceEEEEEeccCCCcc
Confidence            7752          2 366799999999999999999999998654  4689999999999999999999999999 999


Q ss_pred             ceeEEEEeeeccCCCCCcccCCCCCCCCC
Q 005621          253 SSHYILGWSFNMSGDAKSLSLDSLPSLPG  281 (687)
Q Consensus       253 ~~~~i~sWsf~~~~~~~~l~~~~lP~~p~  281 (687)
                      |.|+|++|+|++.+.++.++.+.+|..|+
T Consensus       226 ~~H~IlsWsF~s~~~~~~~~~~~~p~~~~  254 (257)
T 1hql_A          226 LTVYILSWRFSSNLQSTSVKAAMEPEITR  254 (257)
T ss_dssp             EEEEEEEEEEEEEC---------------
T ss_pred             ceeEEEEEEeEecCCCCCcccccCCCCCc
Confidence            99999999999888877888777777764

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A*

Probab=100.00  E-value=9.9e-59  Score=463.14  Aligned_cols=225  Identities=29%  Similarity=0.414  Sum_probs=202.8

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC---CCeeEE-EEecCCeecccCCCCCceeeEEEEEEEEEee
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT---LRVLGH-AFYSSPIKFKNSTRNSKSLSFSTCFAFAIVP   97 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~---~~~~Gr-~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~   97 (687)
                      ...+|+|++|..+  ..+|+|+|+|.+.++|.|+||+..   .+++|| |+|++||+||++. +++++||+|+|+|.|.+
T Consensus         2 ~~~~F~f~~F~~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~~~-tg~vaSFsT~F~F~I~~   78 (242)
T 1fx5_A            2 DDLSFKFKNFSQN--GKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCN-TGELASFITSFSFFMET   78 (242)
T ss_dssp             CEEEEEESSCCTT--CSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETT-TTEECEEEEEEEEEEEE
T ss_pred             cceEEEcCCCCCC--CCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeecCC-CCCccceEEEEEEEEec
Confidence            3568999999863  269999999999878999999876   789999 9999999999987 88999999999999998


Q ss_pred             c-CCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCC-CCCCCCeeeEEeCCCCccccc
Q 005621           98 E-YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEF-GDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        98 ~-~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      + +...+||||||||+|....|. .+||||||+|.++ +++.+|+|||||||++|.++ +||++|||||||||+.|.+++
T Consensus        79 ~~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~  156 (242)
T 1fx5_A           79 SANPKAATDGLTFFLAPPDSPLR-RAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAE  156 (242)
T ss_dssp             SSCGGGCCCEEEEEEECTTCCCC-BCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCCCeEEEecCCcccccee
Confidence            7 567789999999999876554 7899999999765 47789999999999999986 799999999999999998876


Q ss_pred             ccccccccccccccccCCC--CeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccC--Ccc
Q 005621          176 PAAYFLENSTKQVLNLKSG--EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSST--GLL  251 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g--~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsast--G~~  251 (687)
                      ++            ++.+|  +.++|||+||+.+++|+|+|++.+ .|..|+|++.+||+++|||+|||||||+|  |..
T Consensus       157 ~~------------~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~  223 (242)
T 1fx5_A          157 RW------------NKRYGLNNVANVEIIYEASSKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ  223 (242)
T ss_dssp             EC------------CCCCSGGGCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSC
T ss_pred             cc------------cccCCCceeEEEEEEEeCCCCEEEEEEecCC-CCccceeeEEechHHhCCccEEEEEEecccCCCc
Confidence            53            47799  999999999999999999999876 35678999999999999999999999999  999


Q ss_pred             cceeEEEEeeeccC
Q 005621          252 ASSHYILGWSFNMS  265 (687)
Q Consensus       252 ~~~~~i~sWsf~~~  265 (687)
                       |.|+|++|+|++.
T Consensus       224 -~~h~IlsWsF~s~  236 (242)
T 1fx5_A          224 -ATHEVLNWYFTST  236 (242)
T ss_dssp             -EEEEEEEEEEEEE
T ss_pred             -ceeEEEEEEeEee
Confidence             9999999999874

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ...

Probab=100.00  E-value=6.1e-59  Score=461.74  Aligned_cols=221  Identities=29%  Similarity=0.476  Sum_probs=202.1

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCC-CCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCC
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT-TLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTA  101 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~-~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~  101 (687)
                      ..+|+|++|..+  ..+|+|+|+|.+.++|.|+||++ ..+++|||+|++||+||++. +++++||+|+|+|.|.+++..
T Consensus         3 ~~~F~f~~F~~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~Gra~y~~Pi~l~~~~-tg~vaSFsT~F~F~I~~~~~~   79 (232)
T 1v6i_A            3 TVSFNFNSFSEG--NPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSA-TGNVASFLTSFSFEMKDIKDY   79 (232)
T ss_dssp             EEEEEESSCCTT--CTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTT-TCCBCEEEEEEEEEEECCSSS
T ss_pred             ceEEEcCCCCCC--CCCeEEcccEEEccCCcEEeCCCCCCCceEEEEeCCCEEeecCC-CCCccceEEEEEEEEecCCCC
Confidence            468999999864  26999999999987899999998 88899999999999999987 889999999999999988777


Q ss_pred             CCCcceEEEEccCC-CCCCCC-CCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccccccc
Q 005621          102 LGGHGFAFTISASK-ELPGTL-PSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAY  179 (687)
Q Consensus       102 ~~g~G~aF~l~~~~-~~~~~~-~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~  179 (687)
                      .+||||||||+|.. ..|.++ +||+|||+|.    ++.+|+|||||||++|.+++||++|||||||||++|.+++++  
T Consensus        80 ~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~~--  153 (232)
T 1v6i_A           80 DPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW--  153 (232)
T ss_dssp             BCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC--
T ss_pred             CCCCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEeecccccccCCCCCCeEEEEcCCccccccccc--
Confidence            89999999999986 467777 8999999986    567899999999999999889999999999999999887653  


Q ss_pred             ccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCc--ccceeEE
Q 005621          180 FLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL--LASSHYI  257 (687)
Q Consensus       180 ~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~--~~~~~~i  257 (687)
                                ++.+|+.++|||+||+.+++|+|+|++ + +|..|+|++.+||+++|||+|||||| |||.  ..|.|+|
T Consensus       154 ----------~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~-~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~I  220 (232)
T 1v6i_A          154 ----------NSVSGAVVKVTVIYDSSTKTLSVAVTN-D-NGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHLI  220 (232)
T ss_dssp             ----------CCCTTCEEEEEEEEETTTTEEEEEEEC-T-TSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEEE
T ss_pred             ----------cccCCCEEEEEEEEeCCCcEEEEEEec-C-CCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEEEE
Confidence                      478999999999999999999999998 5 57789999999999999999999999 9998  6999999


Q ss_pred             EEeeeccC
Q 005621          258 LGWSFNMS  265 (687)
Q Consensus       258 ~sWsf~~~  265 (687)
                      ++|+|++.
T Consensus       221 lsWsF~s~  228 (232)
T 1v6i_A          221 RSWSFTST  228 (232)
T ss_dssp             EEEEEEEE
T ss_pred             EEEEEEee
Confidence            99999864

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A*

Probab=100.00  E-value=1.4e-58  Score=461.87  Aligned_cols=224  Identities=33%  Similarity=0.532  Sum_probs=200.8

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEe
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV   96 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~   96 (687)
                      ..+|+|++|..+  ..+|+|+|+|.+.++|.|+||+..      .+++|||+|++||+||++. +++++||+|+|+|.|.
T Consensus         3 ~~~F~f~~F~~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~-tg~vaSFsT~F~F~I~   79 (239)
T 1gzc_A            3 TISFSFSEFEPG--NDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDST-TGTVASFETRFSFSIE   79 (239)
T ss_dssp             EEEEEESSCCTT--CTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEECC
T ss_pred             eEEEEeCCCCCC--CCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCC-CCCccceEEEEEEEEe
Confidence            468999999864  269999999999878999999865      5799999999999999987 8899999999999998


Q ss_pred             ecC-CCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           97 PEY-TALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        97 ~~~-~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      +++ ...+||||||||+|....|. .+||+|||+|..+ +++.+|+|||||||++|. |+||++|||||||||+.|.+++
T Consensus        80 ~~~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns~~S~~~~  156 (239)
T 1gzc_A           80 QPYTRPLPADGLVFFMGPTKSKPA-QGYGYLGVFNNSK-QDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQ  156 (239)
T ss_dssp             CCCSSSCCCEEEEEEEECSSCCCC-CCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEE
T ss_pred             CCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCC-CCccccEEEEEEeccccc-CCCCCCCeEEEecCCccccccc
Confidence            876 67789999999999876554 7899999999764 477899999999999998 8779999999999999998876


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCc---cc
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LA  252 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~---~~  252 (687)
                      ++            ++.+|+.++|||+||+.+++|+|+|++.+ .|..|+|++.+||+++|||+||||||||||.   ..
T Consensus       157 ~~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~  223 (239)
T 1gzc_A          157 PF------------QLDNGQVANVVIKYDAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAA  223 (239)
T ss_dssp             EC------------CCCTTCEEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCC
T ss_pred             cc------------cccCCCEEEEEEEEeCCCcEEEEEEecCC-CCccceEEEEechHHhCCCceEEEEEeccCCCcccc
Confidence            53            57899999999999999999999999765 4667899999999999999999999999997   49


Q ss_pred             ceeEEEEeeeccC
Q 005621          253 SSHYILGWSFNMS  265 (687)
Q Consensus       253 ~~~~i~sWsf~~~  265 (687)
                      |.|+|++|+|++.
T Consensus       224 ~~h~IlsWsF~s~  236 (239)
T 1gzc_A          224 ETHDVYSWSFQAS  236 (239)
T ss_dssp             CCCEEEEEEEEEE
T ss_pred             ceEEEEEEEeEEe
Confidence            9999999999863

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus}

Probab=100.00  E-value=6.7e-58  Score=454.27  Aligned_cols=217  Identities=31%  Similarity=0.488  Sum_probs=198.5

Q ss_pred             ceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCC--CCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCC
Q 005621           25 EFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT--TLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTAL  102 (687)
Q Consensus        25 ~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~--~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~  102 (687)
                      +|+|++|..   ..+|+|+|+|.+.++|.|+||+.  ..+++|||+|++||+||++. +++++||+|+|+|.|.+++...
T Consensus         2 sF~f~~F~~---~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~Gra~y~~Pv~l~~~~-tg~vaSFsT~F~F~I~~~~~~~   77 (234)
T 2eig_A            2 SFNYTRFKD---DGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSA-TGNVASFITSFSFIVSNVQRYP   77 (234)
T ss_dssp             EEEESSCCS---SSSEEEEETCEEEGGGEEESSSCGGGSSEEEEEEESSCEECBCTT-TCCBCEEEEEEEEEEEECTTSC
T ss_pred             eEEcCCCCC---CCCeEEcccEEEcCCCCeeeCCCCCccCceEEEEeCCCEEeecCC-CCCccceEEEEEEEEeCCCCCC
Confidence            699999982   26999999999987899999998  78899999999999999987 8899999999999999887778


Q ss_pred             CCcceEEEEccCC-CCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCC---CeeeEEeCCCCcccccccc
Q 005621          103 GGHGFAFTISASK-ELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDIND---NHVGIDINSLRSNASEPAA  178 (687)
Q Consensus       103 ~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~---~Hvgi~~ns~~s~~~~~~~  178 (687)
                      +||||||||+|.. ..|.+.+||+|||+|..   ++.+|+|||||||++|.  +||++   |||||||||+.|.+++++ 
T Consensus        78 ~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~--~Dp~~~~~nHVGIdvNsi~S~~~~~~-  151 (234)
T 2eig_A           78 PTDGVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPNV--WDPKSLRSSHIGIDVNSIMSLKAVNW-  151 (234)
T ss_dssp             CCCEEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCCT--TSCTTTCSSEEEEEESSSSCSEEEEC-
T ss_pred             CCCcEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEeccccCc--cCCCCCCCCceEEecCCccccceecc-
Confidence            9999999999986 46778899999999865   56899999999999997  59999   999999999999887653 


Q ss_pred             cccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccC--CcccceeE
Q 005621          179 YFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSST--GLLASSHY  256 (687)
Q Consensus       179 ~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsast--G~~~~~~~  256 (687)
                                 ++.+|+.++|||+||+.+++|+|+|++ + +|..|+|++.+||+++|||+|||||||+|  |.. |.|+
T Consensus       152 -----------~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~  217 (234)
T 2eig_A          152 -----------NRVSGSLEKATIIYDSDTKILTVVMTH-Q-NGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ERHD  217 (234)
T ss_dssp             -----------CCCTTCCEEEEEEEETTTTEEEEEEEE-T-TSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EEEE
T ss_pred             -----------cccCCCEEEEEEEEeCCCcEEEEEEec-C-CCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ceeE
Confidence                       477999999999999999999999999 5 57789999999999999999999999999  999 9999


Q ss_pred             EEEeeeccC
Q 005621          257 ILGWSFNMS  265 (687)
Q Consensus       257 i~sWsf~~~  265 (687)
                      |++|+|++.
T Consensus       218 IlsWsF~s~  226 (234)
T 2eig_A          218 IYSWSFTST  226 (234)
T ss_dssp             EEEEEEEEE
T ss_pred             EEEEEEEec
Confidence            999999874

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A*

Probab=100.00  E-value=5.3e-58  Score=457.92  Aligned_cols=224  Identities=32%  Similarity=0.525  Sum_probs=202.9

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC---CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeec
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT---LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPE   98 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~---~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~   98 (687)
                      ...+|+|++|..+  ..+|+|+|+|.+.++|.|+||+..   .+++|||+|++||+||++. +++++||+|+|+|.|.++
T Consensus         4 ~~~~F~f~~F~~~--~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~-tg~vasFsT~F~F~I~~~   80 (242)
T 1qnw_A            4 DDLSFNFDKFVPN--QKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSI-TGKVASFATSFSFVVKAD   80 (242)
T ss_dssp             CSEEEEESSCCTT--CTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTT-TCCBCEEEEEEEEECCBS
T ss_pred             cceEEEcCCCCCC--CCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeecCC-CCCcccEEEEEEEEEecC
Confidence            4578999999863  269999999999878999999876   7899999999999999987 889999999999999887


Q ss_pred             CCCCCCcceEEEEccCC-CCCCCCCCccccccccCCCCCCcceEEEEEeecc----cCCCCCCCCCCeeeEEeCCCCccc
Q 005621           99 YTALGGHGFAFTISASK-ELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTV----KDFEFGDINDNHVGIDINSLRSNA  173 (687)
Q Consensus        99 ~~~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~----~n~~~~d~~~~Hvgi~~ns~~s~~  173 (687)
                       ...+||||||||+|.. ..|.+++||+|||+|..+ +++.+|+|||||||+    +|.  +||++|||||||||+.|.+
T Consensus        81 -~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~--~Dp~~nHVGIdvNs~~S~~  156 (242)
T 1qnw_A           81 -KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNP--WDPDFKHIGIDVNSIKSIK  156 (242)
T ss_dssp             -SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCT--TSCSSCEEEEEESSSSCSE
T ss_pred             -CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEeecccccccCC--CCCCCCcEEEecCCccccc
Confidence             6778999999999986 468788999999999764 467899999999999    997  5999999999999999988


Q ss_pred             ccccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc--
Q 005621          174 SEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL--  251 (687)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~--  251 (687)
                      ++++            ++.+|+.++|||+||+.+++|+|+|.+.+ .|..|+|++.+||+++|||+|||||||+||..  
T Consensus       157 ~~~~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~  223 (242)
T 1qnw_A          157 TVKW------------DWRNGEVADVVITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAE  223 (242)
T ss_dssp             EEEC------------CCCTTCCEEEEEEEEGGGTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGG
T ss_pred             eecc------------cccCCCEEEEEEEEeCCCcEEEEEEecCC-CCcceeEEEeechHHhcCCceEEEEEeccCCCcc
Confidence            7653            47799999999999999999999999765 46678999999999999999999999999999  


Q ss_pred             cceeEEEEeeeccC
Q 005621          252 ASSHYILGWSFNMS  265 (687)
Q Consensus       252 ~~~~~i~sWsf~~~  265 (687)
                      .|.|+|++|+|++.
T Consensus       224 ~~~h~IlsWsF~s~  237 (242)
T 1qnw_A          224 FETHDVLSWYFTSN  237 (242)
T ss_dssp             CBCCEEEEEEEEEE
T ss_pred             ceEEEEEEEEeEee
Confidence            99999999999874

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A*

Probab=100.00  E-value=1.5e-57  Score=457.07  Aligned_cols=221  Identities=34%  Similarity=0.506  Sum_probs=199.7

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEe
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV   96 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~   96 (687)
                      ..+|+|++|..+  ..+|+|+|+|.+.++|.|+||+..      .+++|||+|++||+||++. +++++||+|+|+|.|.
T Consensus         3 ~~~F~f~~F~~~--~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~-tg~vaSFsT~F~F~I~   79 (253)
T 1sbf_A            3 TVSFSWNKFVPK--QPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKE-TGSVASFAASFNFTFY   79 (253)
T ss_dssp             EEEEEESSCCTT--CTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTT-TCCBCEEEEEEEEEEE
T ss_pred             ceEEEcCCCCCC--CCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCC-CCcccceEEEEEEEEe
Confidence            468999999864  269999999999878999999865      5799999999999999987 8899999999999999


Q ss_pred             ecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccc
Q 005621           97 PEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEP  176 (687)
Q Consensus        97 ~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~  176 (687)
                      +++...+||||||||+|....|. ++||+|||+|..   ++.+|+|||||||++|.  +||++|||||||||+.|.++++
T Consensus        80 ~~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~t~~  153 (253)
T 1sbf_A           80 APDTKRLADGLAFFLAPIDTKPQ-THAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTS  153 (253)
T ss_dssp             CSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCCTT---SCCCSCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE
T ss_pred             CCCCCCCCCcEEEEEecCCCCCC-CCCCccccccCC---CcccceEEEEeccccCC--CCCCCCcEEEEcCCccccceec
Confidence            88777899999999999876554 789999999865   56899999999999997  5999999999999999988765


Q ss_pred             cccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc--cce
Q 005621          177 AAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL--ASS  254 (687)
Q Consensus       177 ~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~--~~~  254 (687)
                      +            ++.+|+.++|||+||+.+++|+|+|++.+ .|..|+|++.+||+.+|||+||||||||||..  .|.
T Consensus       154 ~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~  220 (253)
T 1sbf_A          154 W------------DLANNKVAKVLITYDASTSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGES  220 (253)
T ss_dssp             C------------CCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCCE
T ss_pred             c------------cccCCCeeEEEEEEeCCCcEEEEEEecCC-CCCcceEEEEechHHhCCCceEEEEEeccCCCcccee
Confidence            3            47799999999999999999999999875 45678999999999999999999999999999  999


Q ss_pred             eEEEEeeeccC
Q 005621          255 HYILGWSFNMS  265 (687)
Q Consensus       255 ~~i~sWsf~~~  265 (687)
                      |+|++|+|++.
T Consensus       221 H~IlsWsF~s~  231 (253)
T 1sbf_A          221 HDVLSWSFASN  231 (253)
T ss_dssp             EEEEEEEEEEE
T ss_pred             eEEEEEEeEee
Confidence            99999999874

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A*

Probab=100.00  E-value=1.2e-57  Score=458.37  Aligned_cols=222  Identities=32%  Similarity=0.508  Sum_probs=200.8

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      ...+|+|++|..    .+|+|+|+|.+. +|.|+||+..      .+++|||+|++||+||++. +++++||+|+|+|.|
T Consensus         2 ~~~~F~f~~F~~----~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~-tg~vaSFsT~F~F~I   75 (253)
T 1g7y_A            2 DIQSFSFKNFNS----SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKS-TGAVASWATSFTANI   75 (253)
T ss_dssp             EEEEEEESSCCS----SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEEC
T ss_pred             cceEEEcCCCCc----CCEEEecceEEe-CCEEEeCCCCCCCccccCCeEEEEECCCEEeecCC-CCCccceEEEEEEEE
Confidence            356899999985    689999999998 9999999876      5799999999999999987 889999999999999


Q ss_pred             eecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           96 VPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      .+++...+||||||||+|....| +++|++|||+|.++ ++..+|+|||||||++|.+ +||++||||||+||+.|.+++
T Consensus        76 ~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~-~Dp~~nHVGIdvns~~S~~t~  152 (253)
T 1g7y_A           76 FAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTA  152 (253)
T ss_dssp             CCSSGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEE
T ss_pred             ecCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCceEEEEecceeccC-cCCCCCcEeeccCCcccccee
Confidence            98766778999999999987655 47899999999764 4678999999999999988 599999999999999998876


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc---c
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL---A  252 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~---~  252 (687)
                      ++            ++.+|+.++|||+||+.+++|+|+|++.+ .|..|+|++.+||+.+|||+||||||||||..   .
T Consensus       153 ~~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~  219 (253)
T 1g7y_A          153 SW------------GLANGQNAEILITYNAATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYT  219 (253)
T ss_dssp             EC------------CCCTTSEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCC
T ss_pred             cc------------ccCCCCeEEEEEEEeCCCCEEEEEEecCC-CCCcceEEEEechHHhCCCceEEEEEeCcCCCCccc
Confidence            53            47799999999999999999999999875 45678999999999999999999999999999   9


Q ss_pred             ceeEEEEeeeccC
Q 005621          253 SSHYILGWSFNMS  265 (687)
Q Consensus       253 ~~~~i~sWsf~~~  265 (687)
                      |.|+|++|+|++.
T Consensus       220 ~~H~IlsWsF~s~  232 (253)
T 1g7y_A          220 ETHDVLSWSFASK  232 (253)
T ss_dssp             CCCEEEEEEEEEE
T ss_pred             ceeEEEEEEEEee
Confidence            9999999999874

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii}

Probab=100.00  E-value=6.1e-57  Score=451.29  Aligned_cols=225  Identities=32%  Similarity=0.516  Sum_probs=200.4

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCC------CeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL------RVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~------~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      ...+|+|++|..+  ..+|+|+|+|.+.++|.|+||++..      ++.|||+|++||+||++  +++++||+|+|+|.|
T Consensus         2 ~~~~F~f~~F~~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~--~g~~~sFst~F~F~I   77 (240)
T 2fmd_A            2 NSVCFTFTDFESG--QQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS--SSLVASFETTFTFSI   77 (240)
T ss_dssp             CEEEEEESSCCTT--CTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCT--TCSEEEEEEEEEEEC
T ss_pred             cceEEEcCCCCCC--CCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCC--CCCcCcEEEEEEEEE
Confidence            3568999999863  2689999999998789999998875      79999999999999998  678999999999999


Q ss_pred             eecCCCCCCcceEEEEccCCCCCCC-CCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccc
Q 005621           96 VPEYTALGGHGFAFTISASKELPGT-LPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNAS  174 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~~~~~~-~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~  174 (687)
                      .++ ...+||||||+|+|....|.. ++|++|||+|.+++++..+++|||||||++|.+++||++||||||+|++.|..+
T Consensus        78 ~~~-~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s  156 (240)
T 2fmd_A           78 SQG-SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAA  156 (240)
T ss_dssp             CBS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEE
T ss_pred             ecC-CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeeccccccccce
Confidence            987 677899999999998766665 889999999987767788999999999999998789999999999999999887


Q ss_pred             cccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcccce
Q 005621          175 EPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASS  254 (687)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~  254 (687)
                      .++            ++.+|+.++|||+||+.+++|+|+|++.+.  ..|+|++.+||+.+||++|||||||+||...|.
T Consensus       157 ~~~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~  222 (240)
T 2fmd_A          157 SKW------------DWQNGKTATAHISYNSASKRLSVVSSYPNS--SPVVVSFDVELNNVBPBWVRVGFSATTGQYTQT  222 (240)
T ss_dssp             EEC------------CCCSSCEEEEEEEEETTTTEEEEEEECTTS--CCEEEEEECCGGGTSCSEEEEEEEEECCSSCBC
T ss_pred             eEE------------EeeCCCEEEEEEEEeCCCCEEEEEEecCCC--CceEEEEEechHHhCCCceEEEEEeccCCcccc
Confidence            653            467999999999999999999999998664  578999999999999999999999999999999


Q ss_pred             eEEEEeeeccC
Q 005621          255 HYILGWSFNMS  265 (687)
Q Consensus       255 ~~i~sWsf~~~  265 (687)
                      |+|++|+|++.
T Consensus       223 H~IlsWsF~s~  233 (240)
T 2fmd_A          223 NNILAWSFRSS  233 (240)
T ss_dssp             CEEEEEEEEEE
T ss_pred             EEEEEEEeEec
Confidence            99999999864

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A*

Probab=100.00  E-value=1.8e-57  Score=456.82  Aligned_cols=221  Identities=36%  Similarity=0.538  Sum_probs=200.1

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      ...+|+|++|..    .+|+|+|+|.+.++|.|+||+..      .+++|||+|++||+||++. +++++||+|+|+|.|
T Consensus         2 ~~~~F~f~~F~~----~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~-tg~vaSFsT~F~F~I   76 (252)
T 1fat_A            2 NDIYFNFQRFNE----TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNT-TGTVASFATSFTFNI   76 (252)
T ss_dssp             CCEEEEESSCCG----GGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETT-TTEEEEEEEEEEEEC
T ss_pred             cceEEEcCCCCc----CCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCC-CCcccceEEEEEEEE
Confidence            356899999985    58999999999878999999875      5799999999999999987 889999999999999


Q ss_pred             eecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           96 VPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      .+++...+||||||||+|....| +++||+|||+|..   ++.+|+|||||||++|.+ +||++||||||+||+.|.++.
T Consensus        77 ~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~-~Dp~~nHVGIdvNs~~S~~~~  151 (252)
T 1fat_A           77 QVPNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKTT  151 (252)
T ss_dssp             CCCSSCBCCEEEEEEEEETTCCC-CCSGGGTTTCCSS---CCCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEE
T ss_pred             eCCCCCCCCCcEEEEEccCCCCC-CCCCccccccccC---CccCcEEEEEeecccCCC-CCCCCCeEEEecCCcccccee
Confidence            98767778999999999987655 4789999999865   568999999999999988 599999999999999998876


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc---c
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL---A  252 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~---~  252 (687)
                      ++            ++.+|+.++|||+||+.+++|+|+|++.+ .|..|+|++.+||+.+|||+||||||||||..   .
T Consensus       152 ~~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~  218 (252)
T 1fat_A          152 RW------------DFVNGENAEVLITYDSSTNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNV  218 (252)
T ss_dssp             EC------------CCCTTCEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBC
T ss_pred             cc------------cccCCCEEEEEEEEeCCCCEEEEEEecCC-CCCcceEEEEechHHhCCCceEEEEEeccCCCCccc
Confidence            53            47799999999999999999999999875 45678999999999999999999999999999   9


Q ss_pred             ceeEEEEeeeccC
Q 005621          253 SSHYILGWSFNMS  265 (687)
Q Consensus       253 ~~~~i~sWsf~~~  265 (687)
                      |.|+|++|+|++.
T Consensus       219 ~~H~IlsWsF~s~  231 (252)
T 1fat_A          219 ETNDVLSWSFASK  231 (252)
T ss_dssp             CCCEEEEEEEEEE
T ss_pred             ceEEEEEEEEEee
Confidence            9999999999874

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1

Probab=100.00  E-value=4e-57  Score=450.05  Aligned_cols=221  Identities=33%  Similarity=0.510  Sum_probs=198.2

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC-----CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEe
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT-----LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV   96 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~-----~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~   96 (687)
                      ...+|+|++|..+  ..+|+|+|+|.+.++|.|+||+..     .+++|||+|++||+||++. +  ++||+|+|+|.|.
T Consensus         2 ~~~~F~f~~F~~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~-~--~~sFsT~F~F~I~   76 (233)
T 1n47_A            2 ESTSFSFTNFNPN--QNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT-T--LASFTTSFSFVMA   76 (233)
T ss_dssp             EEEEEEESSCCTT--CTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSS-C--BCEEEEEEEEECC
T ss_pred             cceEEEcCCCCCC--CCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCC-C--cCCEEEEEEEEEe
Confidence            3568999999863  269999999999878999999876     4799999999999999986 4  8999999999999


Q ss_pred             ecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccc
Q 005621           97 PEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEP  176 (687)
Q Consensus        97 ~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~  176 (687)
                      +++...+||||||||+|....|. ++|++|||+|.++ ++..+|+|||||||++|.  +||++||||||+||+.|.++++
T Consensus        77 ~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~--~Dp~~nHvGIdvns~~S~~~~~  152 (233)
T 1n47_A           77 APAAAAVADGLAFFLAPPDTQPQ-ARGGFLGLFADRA-HDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP  152 (233)
T ss_dssp             CSSTTSCCEEEEEEEECTTCCCC-CCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEE
T ss_pred             CCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCC-CCccCceEEEEeccccCC--CCCCCCcEEEccCCcccccccc
Confidence            87777789999999999876665 7899999999764 577899999999999997  5999999999999999988765


Q ss_pred             cccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc---cc
Q 005621          177 AAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL---AS  253 (687)
Q Consensus       177 ~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~---~~  253 (687)
                      +            ++.+|+.++|||+||+.+++|+|+|++.+. +..|+|++.+||+.+|||+||||||||||..   .|
T Consensus       153 ~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~  219 (233)
T 1n47_A          153 F------------DMVYGEKANIVITYQASTKALAASLVFPVS-QTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVE  219 (233)
T ss_dssp             C------------CCCTTSCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCC
T ss_pred             c------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeccCCCccccc
Confidence            3            577999999999999999999999998653 3578999999999999999999999999998   99


Q ss_pred             eeEEEEeeecc
Q 005621          254 SHYILGWSFNM  264 (687)
Q Consensus       254 ~~~i~sWsf~~  264 (687)
                      .|+|++|+|++
T Consensus       220 ~h~IlsWsF~s  230 (233)
T 1n47_A          220 THDIVSWSFAV  230 (233)
T ss_dssp             CCEEEEEEEEE
T ss_pred             eeEEEEEEEEe
Confidence            99999999986

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A*

Probab=100.00  E-value=3.9e-57  Score=452.46  Aligned_cols=221  Identities=30%  Similarity=0.433  Sum_probs=198.3

Q ss_pred             ccceEeCCC----CCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEE
Q 005621           23 QEEFFFSGF----RDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFA   92 (687)
Q Consensus        23 ~~~f~~~~F----~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~   92 (687)
                      ..+|+|++|    ..+  ..+|+|+|+|.+. +|.|+||+..      .+++|||+|++||+||+ . +++++||+|+|+
T Consensus         3 ~~~F~f~~F~~~~~~~--~~~l~l~GdA~i~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~-~-tg~vasFsT~F~   77 (243)
T 1gsl_A            3 TVNFTYPDFWSYSLKN--GTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWD-S-TGKAASFYTSFT   77 (243)
T ss_dssp             CCEEEESCCCCTTCCT--TSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECBC-T-TSCBCEEEEEEE
T ss_pred             ceEEEcCCCccccCCC--CCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEEccC-C-CCCcCceEEEEE
Confidence            468999999    532  3689999999998 9999999876      57999999999999999 6 889999999999


Q ss_pred             EEEeecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCC-CCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCc
Q 005621           93 FAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDL-GNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRS  171 (687)
Q Consensus        93 f~i~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s  171 (687)
                      |.|.++ ...+||||||||+|....|. ++|++|||++.+++ +++.+|+|||||||++|.+|+||++||||||+||+.|
T Consensus        78 F~I~~~-~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S  155 (243)
T 1gsl_A           78 FLLKNY-GAPTADGLAFFLAPVDSSVK-DYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVS  155 (243)
T ss_dssp             EEEEES-SSSCBCEEEEEEEETTCCCC-CCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSC
T ss_pred             EEEecC-CCCCCCCEEEEEecCCCCCC-CCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCCccc
Confidence            999987 66789999999999876554 78999999997764 6778999999999999999999999999999999999


Q ss_pred             ccccccccccccccccccccCC---CCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccC
Q 005621          172 NASEPAAYFLENSTKQVLNLKS---GEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSST  248 (687)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~---g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsast  248 (687)
                      .++.++            ++.+   |+.++|||+||+.+++|+|+|++...  ..|+|++.+||+.+|||+|||||||||
T Consensus       156 ~~~~~~------------~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~~~~~vGFSAsT  221 (243)
T 1gsl_A          156 VATTRW------------ENDDAYGSSIATAHITYDARSKILTVLLSYEHG--RDYILSHVVDLAKVLPQKVRIGFSAGV  221 (243)
T ss_dssp             SEEEEC------------CHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS--CEEEEEEECCHHHHSCSEEEEEEEEEE
T ss_pred             cceeee------------EEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC--CceeEEEEechHHhCCCceEEEEEecc
Confidence            887764            3556   99999999999999999999998664  468999999999999999999999999


Q ss_pred             CcccceeEEEEeeeccC
Q 005621          249 GLLASSHYILGWSFNMS  265 (687)
Q Consensus       249 G~~~~~~~i~sWsf~~~  265 (687)
                      | ..|.|+|++|+|++.
T Consensus       222 G-~~~~h~IlsWsF~s~  237 (243)
T 1gsl_A          222 G-YDEVTYILSWHFFST  237 (243)
T ss_dssp             C-BSEEEEEEEEEEEEE
T ss_pred             C-CcceeEEEEEEEEee
Confidence            9 999999999999874

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A*

Probab=100.00  E-value=5.3e-57  Score=450.68  Aligned_cols=220  Identities=32%  Similarity=0.473  Sum_probs=197.9

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC-----CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEee
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT-----LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVP   97 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~-----~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~   97 (687)
                      ..+|+|++|..+  ..+|+|+|+|.+.++|.|+||+..     .+++|||+|++||+||++. +++++||+|+|+|.|.+
T Consensus         3 ~~~F~f~~F~~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~-tg~vaSFsT~F~F~I~~   79 (242)
T 1wbf_A            3 TISFNFNQFHQN--EEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDST-TGNVASFETRFSFSIRQ   79 (242)
T ss_dssp             EEEEEESSCCTT--CTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEECCC
T ss_pred             ceEEEcCCCCCC--CCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCC-CCCeeeEEEEEEEEEeC
Confidence            468999999864  269999999999878999999876     6799999999999999987 88999999999999988


Q ss_pred             c-CCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccc
Q 005621           98 E-YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEP  176 (687)
Q Consensus        98 ~-~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~  176 (687)
                      + +...+||||||||+|....|. .+||+|||+|..    +.+|+|||||||++|.  +||++|||||||||+.|.++.+
T Consensus        80 ~~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~----~~~~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~~~~  152 (242)
T 1wbf_A           80 PFPRPHPADGLVFFIAPPNTQTG-EGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVP  152 (242)
T ss_dssp             SCCSSCCCEEEEEEEECSSCCCC-CCGGGTTTCCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE
T ss_pred             CCCCCCCCCcEEEEEecCCCCCC-CCCCccccccCC----CcCcEEEEEeccccCC--CCCCCCeEEEECCCccccceee
Confidence            6 567789999999999876554 789999999864    6789999999999997  5999999999999999988765


Q ss_pred             cccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccC----Ccc-
Q 005621          177 AAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSST----GLL-  251 (687)
Q Consensus       177 ~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsast----G~~-  251 (687)
                      +            ++.+|+.++|||+||+.+++|+|+|++.+ .|..|+|++.+||+++|||+|||||||||    |.. 
T Consensus       153 ~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~~~  219 (242)
T 1wbf_A          153 F------------TLDNGGIANVVIKYDASTKILHVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQR  219 (242)
T ss_dssp             C------------CCCTTSCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCT
T ss_pred             e------------EecCCCEEEEEEEEeCCCCEEEEEEccCC-CCCcceEEEEechHHhcCCceEEEEEEeecCcCCccc
Confidence            3            57899999999999999999999999875 35578999999999999999999999999    888 


Q ss_pred             --cceeEEEEeeeccC
Q 005621          252 --ASSHYILGWSFNMS  265 (687)
Q Consensus       252 --~~~~~i~sWsf~~~  265 (687)
                        .|.|+|++|+|++.
T Consensus       220 ~~~~~h~IlsWsF~s~  235 (242)
T 1wbf_A          220 NATETHDILSWSFSAS  235 (242)
T ss_dssp             TCCCCCEEEEEEEEEE
T ss_pred             cccceEEEEEEEeEec
Confidence              99999999999874

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A*

Probab=100.00  E-value=9.8e-57  Score=448.72  Aligned_cols=220  Identities=33%  Similarity=0.459  Sum_probs=198.1

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEe
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV   96 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~   96 (687)
                      +.+|+|++|..+  ..+|+|+|+|.+.++|.|+||+..      .+++|||+|++||+||++. +++++||+|+|+|.|.
T Consensus         2 ~~~F~f~~F~~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~-~g~vasFsT~F~F~I~   78 (238)
T 1f9k_A            2 TQSFNFDHFEEN--SKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDST-TGNVASFETRFSFNIT   78 (238)
T ss_dssp             EEEEEESSCCSS--CTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEEEE
T ss_pred             CeEEEcCCCCCC--CCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCC-CCCeeeEEEEEEEEEe
Confidence            458999999864  269999999999878999999876      5799999999999999987 8899999999999999


Q ss_pred             ec-CCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           97 PE-YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        97 ~~-~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      ++ +...+||||||||+|....| +++|++|||+|..   ++ +|+|||||||++|.  +||++|||||||||+.|..+.
T Consensus        79 ~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~--~Dp~~nHVgIdvns~~S~~s~  151 (238)
T 1f9k_A           79 QPYAYPEPADGLTFFMVPPNSPQ-GEDGGNLGVFKPP---EG-DNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTL  151 (238)
T ss_dssp             CCCSSSCCCEEEEEEEECTTCCC-CCSGGGTTTCCSS---CC-SCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEE
T ss_pred             cCCCCCCCCCcEEEEEccCCCCC-CCCCCcccccccC---CC-CcEEEEEEecccCC--CCCCCCeEEEecCCccccceE
Confidence            87 67778999999999987655 4789999999865   45 99999999999997  599999999999999998876


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccc--cceeeeeccCCcc--
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKE--TMYVGFSSSTGLL--  251 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~--~~~vGFsastG~~--  251 (687)
                      ++            ++.+|+.++|||+||+.+++|+|+|++.+ .|..|+|++.+||+.+|||  +||||||||||..  
T Consensus       152 ~~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~~  218 (238)
T 1f9k_A          152 HF------------QLENGGVANVVIKYDSPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKN  218 (238)
T ss_dssp             EC------------CCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTT
T ss_pred             ee------------cccCCCEEEEEEEEeCCCCEEEEEEecCC-CCCceeEEEEechHHhCCCCceEEEEEEeCcCCCCc
Confidence            53            57899999999999999999999999876 4567899999999999999  9999999999999  


Q ss_pred             -cceeEEEEeeeccC
Q 005621          252 -ASSHYILGWSFNMS  265 (687)
Q Consensus       252 -~~~~~i~sWsf~~~  265 (687)
                       .|.|+|++|+|++.
T Consensus       219 ~~~~h~IlsWsF~s~  233 (238)
T 1f9k_A          219 AVETHEIISWSFTSS  233 (238)
T ss_dssp             CCCEEEEEEEEEEEE
T ss_pred             ccceEEEEEeEeEee
Confidence             99999999999874

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1

Probab=100.00  E-value=1.6e-56  Score=446.94  Aligned_cols=224  Identities=32%  Similarity=0.484  Sum_probs=201.6

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCC
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTA  101 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~  101 (687)
                      ...+|+|++|..+  ..+|+|+|+|. .++|.|+||++..+++|||+|++||+||++. +++++||+|+|+|.|.+++..
T Consensus         2 ~~~~F~f~~F~~~--~~~l~l~G~A~-~~~g~l~LT~~~~~~~G~a~y~~Pv~l~~~~-~~~~~sFst~F~F~I~~~~~~   77 (234)
T 2bqp_A            2 ETTSFLITKFSPD--QQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRE-TGNVANFVTSFTFVINAPNSY   77 (234)
T ss_dssp             EEEEEEESSBCTT--CTTEEEEETCE-EETBEEEEECSCTTCEEEEEESSCEECBCTT-TCCBCEEEEEEEEEEECSSTT
T ss_pred             cceEEEcCCCCCC--CCCEEEeecee-cCCCEEEeCCCCCCCEEEEEECCCEEcccCC-CCceeeEEEEEEEEEeCCCCC
Confidence            3568999999863  26999999999 5689999999999999999999999999987 889999999999999987777


Q ss_pred             CCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCC--CCeeeEEeCCCCccccccccc
Q 005621          102 LGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDIN--DNHVGIDINSLRSNASEPAAY  179 (687)
Q Consensus       102 ~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgi~~ns~~s~~~~~~~~  179 (687)
                      .+||||||+|+|....|. ++|++|||+|.++ ++..+++|||||||++|.+ +||+  +||||||||++.|..+.++  
T Consensus        78 ~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~N~~-~Dp~~~~nHVgIdvns~~S~~s~~~--  152 (234)
T 2bqp_A           78 NVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW--  152 (234)
T ss_dssp             SCCCEEEEEEEETTCCCC-CCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCcEEEEEecCCCCCC-CCCCccccccccC-CCCCCcEEEEEEecccCcc-cCCCCCCCceeEeeCCccccceEee--
Confidence            899999999999876666 7899999999764 5678999999999999988 5999  9999999999999887653  


Q ss_pred             ccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCC----CCCCcceeeeecCCccccccceeeeeccCCccccee
Q 005621          180 FLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSV----KPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSH  255 (687)
Q Consensus       180 ~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~----~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~  255 (687)
                                ++.+|+.++|||+||+.+++|+|+|++.+.    ||..|+|++.+||+.+|||+||||||||||...|.|
T Consensus       153 ----------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H  222 (234)
T 2bqp_A          153 ----------KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAH  222 (234)
T ss_dssp             ----------CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCEE
T ss_pred             ----------EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcccE
Confidence                      467999999999999999999999988653    457889999999999999999999999999999999


Q ss_pred             EEEEeeecc
Q 005621          256 YILGWSFNM  264 (687)
Q Consensus       256 ~i~sWsf~~  264 (687)
                      +|++|+|++
T Consensus       223 ~IlsWsF~s  231 (234)
T 2bqp_A          223 EVLSWSFHS  231 (234)
T ss_dssp             EEEEEEEEE
T ss_pred             EEEEEEEEe
Confidence            999999986

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=9.3e-57  Score=444.84  Aligned_cols=215  Identities=36%  Similarity=0.545  Sum_probs=195.3

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCC---CCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecC
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT---TLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEY   99 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~---~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~   99 (687)
                      ..+|+|++|..    .||+|+|+|.+.++|.|+||++   ..+++|||+|++||++|++. +++++||+|+|+|.|.+++
T Consensus         3 ~~~F~f~~F~~----~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~-~g~vaSFsT~F~F~I~~~~   77 (226)
T 1avb_A            3 DASFNVETFNK----TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRT-IDNLASFSTNFTFRINAKN   77 (226)
T ss_dssp             EEEEEESSCCG----GGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGG-GTEEEEEEEEEEEEEEESS
T ss_pred             ceEEEcCCCCc----cCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEeecCC-CCCcccEEEEEEEEEeCCC
Confidence            46899999985    5899999999977899999988   77899999999999999987 8899999999999999887


Q ss_pred             CCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccccccc
Q 005621          100 TALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAY  179 (687)
Q Consensus       100 ~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~  179 (687)
                      ...+||||||||+|....|+ ++||+|||+|.. ++++.+|+|||||||+         +|||||||||+.|.+++++  
T Consensus        78 ~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~--  144 (226)
T 1avb_A           78 IENSAYGLAFALVPVGSRPK-LKGRYLGLFNTT-NYDRDAHTVAVVFDTV---------SNRIEIDVNSIRPIATESC--  144 (226)
T ss_dssp             TTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcccEEEEEecCc---------CCccceeecCcccCccccC--
Confidence            77899999999999876676 889999999975 4467899999999999         5999999999999988775  


Q ss_pred             ccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc---cceeE
Q 005621          180 FLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL---ASSHY  256 (687)
Q Consensus       180 ~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~---~~~~~  256 (687)
                              +..+.+|+.++|||+||+.+++|+|+|++.+. +..|+|++.+||+++|||+|||||||+||..   .|.|+
T Consensus       145 --------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h~  215 (226)
T 1avb_A          145 --------NFGHNNGEKAEVRITYDSPKNDLRVSLLYPSS-EEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHN  215 (226)
T ss_dssp             --------CSGGGTTCEEEEEEEEEGGGTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEE
T ss_pred             --------CccccCCCeEEEEEEEeCCCcEEEEEEeecCC-CccceEEEEechHHhCCCceEEEEEeccCCCCcccceeE
Confidence                    35677999999999999999999999998753 3478999999999999999999999999999   99999


Q ss_pred             EEEeeecc
Q 005621          257 ILGWSFNM  264 (687)
Q Consensus       257 i~sWsf~~  264 (687)
                      |++|+|++
T Consensus       216 IlsWsF~s  223 (226)
T 1avb_A          216 VLSWSFSS  223 (226)
T ss_dssp             EEEEEEEE
T ss_pred             EEEEEEEe
Confidence            99999985

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=8.5e-56  Score=441.44  Aligned_cols=214  Identities=32%  Similarity=0.510  Sum_probs=193.0

Q ss_pred             ccceEeCCCCCCCCCCC-eEEeeceEEccCCcEEecCCCC------CeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           23 QEEFFFSGFRDAANNNN-MSLNGAAEIEKNGKLMLTNTTL------RVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~-l~~~g~a~~~~~~~i~lt~~~~------~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      ..+|+|++|..    .| |+|+|+|.+.++|.|+||++..      +++|||+|++||+||++.   +++||+|+|+|.|
T Consensus         3 ~~~F~f~~F~~----~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~---~vaSFsT~F~F~I   75 (240)
T 1ioa_A            3 ETSFNFPNFHT----DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN---NVASFNTNFTFII   75 (240)
T ss_dssp             CCEEEESSCCT----TSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS---CBEEEEEEEEEEC
T ss_pred             ceEEEcCCCCC----CCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC---ccccEEEEEEEEE
Confidence            56899999985    58 9999999997789999998765      799999999999999974   7899999999999


Q ss_pred             eecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           96 VPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      .+++...+||||||||+|....|. ++||+|||+|.. ++++.+|+|||||||+         +|||||||||+.|.+++
T Consensus        76 ~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~  144 (240)
T 1ioa_A           76 RAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTN-NPEPNARTVAVVFNTF---------KNRIDFDKNFIKPYVNE  144 (240)
T ss_dssp             CBSCTTSCCEEEEEEEEETTCCCC-CCGGGTTTCCCS-SCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEE
T ss_pred             eCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcCcEEEEEecCc---------CCceeeeeCCccccccc
Confidence            988777899999999999876676 889999999975 4467899999999999         59999999999999887


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc---c
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL---A  252 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~---~  252 (687)
                      ++          +..+.+|+.++|||+||+.+++|+|+|++.+ .+..|+|++.+||+++|||+||||||||||..   .
T Consensus       145 ~~----------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~  213 (240)
T 1ioa_A          145 NC----------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTT  213 (240)
T ss_dssp             EC----------CHHHHCSSCEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTC
T ss_pred             cC----------CccccCCCEEEEEEEEeCCCcEEEEEEecCC-CCccceeEEEechHHhCCCceEEEEEeccCCCCccc
Confidence            75          3567799999999999999999999999875 34578999999999999999999999999999   9


Q ss_pred             ceeEEEEeeeccC
Q 005621          253 SSHYILGWSFNMS  265 (687)
Q Consensus       253 ~~~~i~sWsf~~~  265 (687)
                      |.|+|++|+|++.
T Consensus       214 ~~H~IlsWsF~s~  226 (240)
T 1ioa_A          214 ETHDVLSWSFSSK  226 (240)
T ss_dssp             BCCEEEEEEEEEE
T ss_pred             ceeEEEEEEEEee
Confidence            9999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.1e-54  Score=457.89  Aligned_cols=260  Identities=26%  Similarity=0.392  Sum_probs=210.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|...++||+|+||+||+|++.     .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677889999999999999874     3578999999988777778899999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchh-------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          418 VYDFMPNGSLDKCLFDEQ-------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      |||||++|+|.++|+...             ..+++|.++++|+.|||.||.|||+   ++|+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence            999999999999996532             2469999999999999999999998   999999999999999999999


Q ss_pred             EEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 005621          485 RLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVW  562 (687)
Q Consensus       485 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~  562 (687)
                      ||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+   +    .
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~----~  270 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---A----I  270 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---H----H
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---H----H
Confidence            9999999987644332 23345679999999999999999999999999999999999 899998654321   1    1


Q ss_pred             HHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCC
Q 005621          563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPL  621 (687)
Q Consensus       563 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  621 (687)
                      ..+..+..     +.    .+..++.++.+|+.+||+.||++||||.||++.|+...+.
T Consensus       271 ~~i~~g~~-----~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          271 DCITQGRE-----LE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHTCC-----CC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHcCCC-----CC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            22222221     11    2223344788999999999999999999999999886543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-54  Score=452.55  Aligned_cols=258  Identities=26%  Similarity=0.424  Sum_probs=214.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|...+.||+|+||+||+|++.     .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46788899999999999999874     3578899999988777778899999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchh-----------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEE
Q 005621          418 VYDFMPNGSLDKCLFDEQ-----------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL  486 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl  486 (687)
                      |||||++|+|.++|+...           ...++|.++++|+.|||.||.|||+   ++|+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence            999999999999996532           2469999999999999999999998   99999999999999999999999


Q ss_pred             cccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 005621          487 GDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       487 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      +|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||......+       +...
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence            999999865443222 2233579999999999999999999999999999999999 899998654321       1222


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      +..+...         ..+..++.++.+|+.+||+.||++||||+||+++|++..
T Consensus       243 i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          243 ITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2222221         122233457889999999999999999999999998753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.4e-54  Score=449.09  Aligned_cols=256  Identities=26%  Similarity=0.393  Sum_probs=211.6

Q ss_pred             CcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++..++||+|+||+||+|++.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+.++|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999974     356889999997653 3345789999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          418 VYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                      |||||++|+|.++|....              ...++|.++++|+.|||.||+|||+   ++|+||||||+||||+++++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence            999999999999995432              3469999999999999999999999   99999999999999999999


Q ss_pred             EEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 005621          484 GRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWV  561 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v  561 (687)
                      +||+|||+++....... .......||++|||||++.++.++.++|||||||+||||+| |+.||......+   +    
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~----  256 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V----  256 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H----
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H----
Confidence            99999999987644322 23345679999999999999999999999999999999998 899997654321   1    


Q ss_pred             HHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          562 WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       562 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .+....+...         ..+..++..+.+|+.+||+.||++||||.||++.|+..
T Consensus       257 ~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 VEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2222222221         12233445788999999999999999999999999854

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B*

Probab=100.00  E-value=3.5e-52  Score=409.69  Aligned_cols=199  Identities=30%  Similarity=0.459  Sum_probs=174.6

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCC
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTAL  102 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~  102 (687)
                      ..+|+|++|..    .||+|+|+|.+.++|.|+||++..+++|||+|++||++|++. +++++||+|+|+|.|.+++...
T Consensus         3 ~~~F~f~~F~~----~~l~l~G~A~v~~~g~l~LT~~~~~~~Gra~y~~Pi~l~~~~-~g~vaSFsT~F~F~I~~~~~~~   77 (223)
T 1dhk_B            3 ETSFIIDAFNK----TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDST-TGNVASFDTNFTMNIRTHRQAN   77 (223)
T ss_dssp             CCEEEESSCCG----GGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETT-TTEECEEEEEEEEEEECCC---
T ss_pred             ceEEEcCCCCc----CCEEEeccEEECCCCEEEcCCCCCCCEEEEEECCCEEeecCC-CCCccceEEEEEEEEeCCCCCC
Confidence            46899999985    589999999997789999999999999999999999999987 8899999999999999887778


Q ss_pred             CCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccccccccc
Q 005621          103 GGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLE  182 (687)
Q Consensus       103 ~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~~~  182 (687)
                      +||||||||+|....|+                   +++|||||||+         +||||||+||+ |.+++++     
T Consensus        78 ~gdGlAF~l~p~~~~p~-------------------~~~vAVEFDT~---------~nHVGIdvNsi-S~~~~~~-----  123 (223)
T 1dhk_B           78 SAVGLDFVLVPVQPESK-------------------GDTVTVEFDTF---------LSRISIDVNNN-DIKSVPW-----  123 (223)
T ss_dssp             CCSEEEEEEEEC-------------------------CCEEEEEETT---------TTEEEEEETTE-EEEEEEC-----
T ss_pred             CCCceEEEEecCCCCCC-------------------ccEEEEEecCC---------CCcccccCCcc-ccccccC-----
Confidence            99999999999764332                   35899999999         59999999999 9887765     


Q ss_pred             cccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc---cceeEEEE
Q 005621          183 NSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL---ASSHYILG  259 (687)
Q Consensus       183 ~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~---~~~~~i~s  259 (687)
                           +..+.+|+.++|||+||+.+++|+|+|++.+ .+..|+|++.+||+++|||+|||||||+||..   .|.|+|++
T Consensus       124 -----~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~Ils  197 (223)
T 1dhk_B          124 -----DVHDYDGQNAEVRITYNSSTKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLS  197 (223)
T ss_dssp             -----CGGGTTTSCEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEE
T ss_pred             -----CccccCCCEEEEEEEEeCCCCEEEEEEecCC-CCccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEE
Confidence                 3577799999999999999999999999865 34478999999999999999999999999999   99999999


Q ss_pred             eeeccCC
Q 005621          260 WSFNMSG  266 (687)
Q Consensus       260 Wsf~~~~  266 (687)
                      |+|++.+
T Consensus       198 WsF~s~~  204 (223)
T 1dhk_B          198 WSFSSKF  204 (223)
T ss_dssp             EEEEEEC
T ss_pred             EEEEecc
Confidence            9998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=438.96  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=204.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      +++...++||+|+||+||+|++..   .||||+++..  ..+..++|.+|+.++++++|||||+++|+|.+ +.++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            567788999999999999999843   5999998643  34556889999999999999999999999865 56899999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      ||++|+|.++|+.. ...++|.++++|+.|||.||+|||+   ++|+||||||+||||++++.+||+|||+|+.......
T Consensus       112 y~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999999643 3469999999999999999999998   9999999999999999999999999999987654322


Q ss_pred             -CceeeeecCCCCCchhhccC---CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          501 -PSTTRVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       501 -~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                       .......||+.|||||++.+   +.++.++|||||||+||||+||+.||.........      ......+    ...|
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~----~~~p  257 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRG----YASP  257 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTT----CCCC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC----CCCC
Confidence             23445689999999999964   46899999999999999999999999865532211      1111111    1112


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .+. ..+..++..+.+|+.+||+.||++||||.||++.|+.+
T Consensus       258 ~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          258 DLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             CST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             Ccc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            211 22233445788999999999999999999999988754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.5e-52  Score=441.57  Aligned_cols=251  Identities=22%  Similarity=0.389  Sum_probs=207.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..+.||+|+||+||+|+++.+|+.||||++...  .....+++.+|+++|++++|||||++++++.+.+.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999999999999999999764  34456789999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      ||+||+|.++|.......+++.++..|+.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+.+.... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            9999999999976666678999999999999999999999   999999999999999999999999999998654321 


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                      ...+..+||+.|||||++.+..++.++|||||||++|||+||+.||......+.      + .....+..     +.+..
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~-~~i~~~~~-----~~~~~  247 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------V-LKIISGSF-----PPVSL  247 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------H-HHHHHTCC-----CCCCT
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------H-HHHHcCCC-----CCCCc
Confidence            122346799999999999999999999999999999999999999986543211      1 11111211     12222


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+    ..++.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          248 HY----SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             TS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            23    347889999999999999999999987

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-51  Score=437.11  Aligned_cols=255  Identities=23%  Similarity=0.307  Sum_probs=214.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      +.|+..++||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46889999999999999999999999999999997765555667889999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++|+|.+++.   +..+++.++..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+.+..... .
T Consensus       154 ~gg~L~~~l~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  226 (346)
T 4fih_A          154 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  226 (346)
T ss_dssp             TTEEHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred             CCCcHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence            9999999884   3469999999999999999999999   9999999999999999999999999999997754332 3


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .+..+||+.|||||++.+..|+.++|||||||++|||++|+.||......+   ...    .+..+     ..+.+.  .
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~----~i~~~-----~~~~~~--~  292 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----MIRDN-----LPPRLK--N  292 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH----HHHHS-----SCCCCS--C
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH----HHHcC-----CCCCCC--c
Confidence            345789999999999999999999999999999999999999997654221   111    11111     111111  1


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                      ......++.+|+.+||+.||++|||+.|+++  ++.+.
T Consensus       293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence            1222347889999999999999999999987  45543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2e-51  Score=433.80  Aligned_cols=253  Identities=22%  Similarity=0.228  Sum_probs=207.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .+.|...++||+|+||+||+|+++.+|+.||||+++....     ..+|+.++++++|||||++++++.+.+.+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            3568888999999999999999999999999999976432     24699999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-cEEEcccccceeccCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-NGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~~~  500 (687)
                      |+||+|.++|.  ..+.+++.++..++.||+.||+|||+   ++|+||||||+||||+.++ .+||+|||+|+.+.....
T Consensus       132 ~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIK--QMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999994  34579999999999999999999998   9999999999999999987 699999999997754322


Q ss_pred             C----ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          501 P----STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       501 ~----~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      .    .....+||+.|||||++.+..++.++|||||||++|||+||+.||......+....   +.    .+..      
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---i~----~~~~------  273 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK---IA----SEPP------  273 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH---HH----HSCC------
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---HH----cCCC------
Confidence            1    12335799999999999999999999999999999999999999987654332211   11    1110      


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .+ .+++......+.+++.+||+.||++|||+.|+++.|...
T Consensus       274 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          274 PI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             GG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Cc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            00 112222334788999999999999999999999887653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.7e-51  Score=422.09  Aligned_cols=245  Identities=25%  Similarity=0.417  Sum_probs=200.9

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeec----CCeeEEEE
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRR----RGDLLLVY  419 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~  419 (687)
                      +..++||+|+||+||+|.+..++..||+|++...  .....++|.+|++++++++|||||+++++|..    .+.++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5667899999999999999999999999998654  34456789999999999999999999999864    35689999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCe--EEeeccCCCcEEecc-CCcEEEcccccceecc
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT--VIHRDIKAGNVLLDS-ELNGRLGDFGLAKLYE  496 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~  496 (687)
                      |||++|+|.++|.  +...+++.++..|+.||+.||+|||+   ++  |+||||||+||||+. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999995  34579999999999999999999998   66  999999999999985 7899999999998543


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      .   ......+||+.|||||++.+ .++.++|||||||++|||+||+.||........      +......+...    +
T Consensus       184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~~~~i~~~~~~----~  249 (290)
T 3fpq_A          184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKP----A  249 (290)
T ss_dssp             T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCC----G
T ss_pred             C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------HHHHHHcCCCC----C
Confidence            2   23445789999999999875 699999999999999999999999976443221      12222222111    1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+....    ..++.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111122    236889999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.7e-51  Score=436.60  Aligned_cols=266  Identities=28%  Similarity=0.401  Sum_probs=217.6

Q ss_pred             HHHHHHhcCcccceeeeeeCeEEEEEEEeCCC-----CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcC-CCceeeeee
Q 005621          336 EELKKATRGFRDKELLGFGGFGRVYKGTLPST-----NTQVAVKRVSNES-KQGLREFASEISSIGRLRH-RNLVQLLGW  408 (687)
Q Consensus       336 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~~~  408 (687)
                      .+++.-.++|+..+.||+|+||+||+|.+...     ++.||||++.... ....++|.+|+++|++++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            34445567899999999999999999997543     3689999997654 3446789999999999965 899999999


Q ss_pred             eecC-CeeEEEEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCC
Q 005621          409 CRRR-GDLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKA  473 (687)
Q Consensus       409 ~~~~-~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  473 (687)
                      |.+. +.++||||||++|+|.++|+...              ...++|.+++.|+.|||.||.|||+   ++||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCc
Confidence            9764 57899999999999999996532              2358999999999999999999999   9999999999


Q ss_pred             CcEEeccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCC
Q 005621          474 GNVLLDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKAL  551 (687)
Q Consensus       474 ~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~  551 (687)
                      +||||++++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||.....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999976544332 3345689999999999999999999999999999999998 9999987554


Q ss_pred             cchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          552 PEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       552 ~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .+.      +...+..+..     +..    +..++.++.+++.+||+.||++|||+.||++.|+...
T Consensus       294 ~~~------~~~~i~~g~~-----~~~----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          294 DEE------FCRRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             SHH------HHHHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH------HHHHHHcCCC-----CCC----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            322      1222222221     112    2223347889999999999999999999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3e-51  Score=430.00  Aligned_cols=266  Identities=26%  Similarity=0.308  Sum_probs=203.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC----eeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG----DLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV  418 (687)
                      ++|...++||+|+||+||+|++  +|+.||||+++..... ...+..|+..+.+++|||||+++++|.+.+    .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            4677889999999999999998  5899999999765332 223445777778899999999999998654    57999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccc-----cCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW-----EQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ||||++|+|.++|+   ...++|.++.+|+.|++.||+|||+.+     .++|+||||||+||||+.++++||+|||+++
T Consensus        80 ~Ey~~~gsL~~~l~---~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           80 SDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHH---HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCCCcHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999994   346999999999999999999999732     3499999999999999999999999999999


Q ss_pred             eccCCCCC---ceeeeecCCCCCchhhccCC------CCCCccceehhhHHHHHHHhCCCCCCCCCCcch----h----h
Q 005621          494 LYERGTNP---STTRVVGTLGYLAPELTRTG------KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE----L----I  556 (687)
Q Consensus       494 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~----~----~  556 (687)
                      ........   .....+||+.|||||++.+.      .++.++|||||||+||||+||+.|+........    .    .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            77554322   22346799999999999764      367799999999999999999887654322110    0    0


Q ss_pred             HHHHHHHHhcccccccccCCcCCCCC-CHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          557 LVDWVWDRWKAGAILEVVDPRLNGEF-NEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       557 ~~~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ..+.+.....    .+..+|.+.... ..+....+.+|+.+||+.||++||||.||++.|++.
T Consensus       237 ~~~~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          237 SVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CHHHHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            1111111111    122333333222 234566789999999999999999999999999764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.9e-51  Score=426.67  Aligned_cols=248  Identities=23%  Similarity=0.310  Sum_probs=211.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|+++.+++.||||++.+..   ....+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999997642   334578999999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |||+||+|.+++.  +.+.+++.++..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus       112 Ey~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999994  34579999999999999999999999   999999999999999999999999999999875433


Q ss_pred             -CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 -NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                       .......+||+.|||||++.+..++.++||||+||++|||+||+.||......+       +.+.+..+.      ..+
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~------~~~  253 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------IFAKIIKLE------YDF  253 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTC------CCC
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC------CCC
Confidence             233456789999999999999999999999999999999999999997654221       111121221      112


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV  612 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  612 (687)
                      ...+    ..++.+|+.+||+.||++|||++|++
T Consensus       254 p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 PEKF----FPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             Cccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence            2223    33688999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=438.20  Aligned_cols=254  Identities=23%  Similarity=0.315  Sum_probs=214.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      +.|+..++||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999999999999999998766555677899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++|+|.+++.   ...+++.++..|+.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+.+..... .
T Consensus       231 ~gG~L~~~i~---~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  303 (423)
T 4fie_A          231 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  303 (423)
T ss_dssp             TTEEHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred             CCCcHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence            9999999883   3469999999999999999999999   9999999999999999999999999999997654332 3


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+.   ..    .+..+     ..+.+..  
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~----~i~~~-----~~~~~~~--  369 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK----MIRDN-----LPPRLKN--  369 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH----HHHHS-----CCCCCSC--
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HH----HHHcC-----CCCCCcc--
Confidence            3457899999999999999999999999999999999999999976543211   11    11111     1111111  


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      .......+.+|+.+||+.||++|||+.|+++  +|.+
T Consensus       370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence            1112347889999999999999999999987  5654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.7e-50  Score=410.33  Aligned_cols=250  Identities=22%  Similarity=0.406  Sum_probs=197.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|+++.+++.||||++++..   ....+.+.+|++++++++|||||++++++.+.+.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999997642   233567899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+ +|+|.+++.  +.+.+++.++..++.||+.||+|||+   ++|+||||||+|||+++++++||+|||+|+......
T Consensus        93 Ey~-~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIV--QRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHH--HSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 689999984  34579999999999999999999999   999999999999999999999999999998654332


Q ss_pred             CCceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                        .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.......       +.+....+.      +.+
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-------~~~~i~~~~------~~~  231 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-------LFKNISNGV------YTL  231 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTC------CCC
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCC------CCC
Confidence              2334689999999999998776 579999999999999999999997653211       112222221      112


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ...+    ..++.+|+.+||+.||++|||+.|+++  +++.
T Consensus       232 p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          232 PKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             CTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             CCCC----CHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            2222    346889999999999999999999998  5654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.1e-50  Score=418.04  Aligned_cols=248  Identities=25%  Similarity=0.315  Sum_probs=199.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeC---CCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLP---STNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|+..+.||+|+||+||+|+..   .+++.||||++++..  .....++.+|+++|++++|||||++++++.+.+.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999873   457899999997653  2234568899999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      |||||+||+|.++|.  +.+.+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999994  34579999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .. ......+||+.|||||++.+..++.++|||||||++|||+||+.||......+.   .    ..+..+.      +.
T Consensus       179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~----~~i~~~~------~~  244 (304)
T 3ubd_A          179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET---M----TMILKAK------LG  244 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHCC------CC
T ss_pred             CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH---H----HHHHcCC------CC
Confidence            32 223446899999999999999999999999999999999999999986543221   1    1111111      11


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                      +...    .+.++.+|+.+||+.||++|||     ++|+++
T Consensus       245 ~p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 MPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            1222    2347889999999999999998     467775

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A*

Probab=100.00  E-value=2.1e-47  Score=363.14  Aligned_cols=176  Identities=31%  Similarity=0.483  Sum_probs=158.8

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCC
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTAL  102 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~  102 (687)
                      ..+|+|++|..+  ..+|+|+|+|. .++|.|+||+...+++|||+|++||+||++. +++++||+|+|+|.|.+.+...
T Consensus         3 ~~sF~f~~F~~~--~~~l~l~G~A~-~~~g~l~LT~~~~~~~Gra~y~~Pv~l~d~~-tg~vaSFsT~F~F~I~~~~~~~   78 (181)
T 2ltn_A            3 TTSFLITKFSPD--QQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRE-TGNVANFVTSFTFVINAPNSYN   78 (181)
T ss_dssp             EEEEEESSCCSS--CTTEEEEETCE-ECSSSEEEECSCSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEEEECSSTTS
T ss_pred             ceEEEcCCCCCC--CCCEEEecccc-CCCCCeEcCCCCCCCEEEEEECCCEEeecCC-CCCccceEEEEEEEEecCCCCC
Confidence            468999999864  26899999999 6689999999988999999999999999987 8899999999999999877778


Q ss_pred             CCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCC--CCeeeEEeCCCCcccccccccc
Q 005621          103 GGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDIN--DNHVGIDINSLRSNASEPAAYF  180 (687)
Q Consensus       103 ~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgi~~ns~~s~~~~~~~~~  180 (687)
                      +||||||||+|....|. ++||+|||+|.++ ++..+|+|||||||++|.+ +||+  +|||||||||+.|.++++|   
T Consensus        79 ~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~~-~~~~n~~vAVEFDT~~n~~-~Dp~~~~nHVGIdvNs~~S~~t~~~---  152 (181)
T 2ltn_A           79 VADGFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW---  152 (181)
T ss_dssp             CCCEEEEEEEETTCCCC-CCGGGTTTCSCSS-CCTTSCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC---
T ss_pred             CCCceEEEEecCCCCCC-CCCccccccccCC-CCccccEEEEEeccccccc-cCCCCCCCEEEEEcCCccccceecc---
Confidence            99999999999876666 8899999999763 5778999999999999988 5999  9999999999999888764   


Q ss_pred             cccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeC
Q 005621          181 LENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPS  217 (687)
Q Consensus       181 ~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~  217 (687)
                               ++.+|+.++|||+||+.+++|+|+|++.
T Consensus       153 ---------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~  180 (181)
T 2ltn_A          153 ---------KLQNGEEANVVIAFNAATNVLTVSLTYP  180 (181)
T ss_dssp             ---------CCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred             ---------ccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence                     4679999999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.3e-48  Score=406.53  Aligned_cols=250  Identities=18%  Similarity=0.313  Sum_probs=190.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC--------
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG--------  413 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------  413 (687)
                      ++|+..+.||+|+||+||+|+++.+++.||||+++... ....+++.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45889999999999999999999999999999987554 334567999999999999999999999886544        


Q ss_pred             ----eeEEEEecCCCCCchhhhhchh-hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcc
Q 005621          414 ----DLLLVYDFMPNGSLDKCLFDEQ-KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGD  488 (687)
Q Consensus       414 ----~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  488 (687)
                          .+|+|||||++|+|.+++.... .....+..++.|+.||+.||+|||+   ++|+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence                3799999999999999996432 2345677889999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCCCC-----------ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhH
Q 005621          489 FGLAKLYERGTNP-----------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELIL  557 (687)
Q Consensus       489 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~  557 (687)
                      ||+|+.+......           ..+..+||+.|||||++.+..++.++|||||||++|||++   ||....  +..  
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~--  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERV--  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH--
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHH--
Confidence            9999876543321           1234579999999999999999999999999999999996   765321  111  


Q ss_pred             HHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          558 VDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       558 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       . .........        .. .........+.+|+.+||+.||++|||+.|+++
T Consensus       235 -~-~~~~~~~~~--------~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 -R-TLTDVRNLK--------FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -H-HHHHHHTTC--------CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -H-HHHHHhcCC--------CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1 011111111        10 001122235678999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-46  Score=396.38  Aligned_cols=286  Identities=37%  Similarity=0.662  Sum_probs=251.4

Q ss_pred             CccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeee
Q 005621          331 HRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR  410 (687)
Q Consensus       331 ~~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  410 (687)
                      .++++.++..++++|+..+.||+|+||+||+|++. +++.||||++........+++.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            45666777788999999999999999999999974 68899999998777667788999999999999999999999999


Q ss_pred             cCCeeEEEEecCCCCCchhhhhchh--hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcc
Q 005621          411 RRGDLLLVYDFMPNGSLDKCLFDEQ--KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGD  488 (687)
Q Consensus       411 ~~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  488 (687)
                      ..+..++||||+++|+|.+++....  ...+++.+++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEee
Confidence            9999999999999999999996543  2358999999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          489 FGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       489 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      ||+++....... .......||+.|+|||++.++.++.++||||||+++|||++|+.||......+.....+|.......
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            999986543222 2233456899999999999899999999999999999999999999887766666677787777777


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       568 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      +.+.+.+++.+...........+.+++.+||+.||++||++.||++.|+....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            77888888888888888899999999999999999999999999999987653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=401.04  Aligned_cols=266  Identities=23%  Similarity=0.315  Sum_probs=206.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeec------CCe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRR------RGD  414 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~  414 (687)
                      ++|+..+.||+|+||+||+|++..+|+.||||++....  ....+++.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999997542  3445678899999999999999999998753      367


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      +|||||||+ |+|.+++..  .+.+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999995 789998853  4579999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCC---CCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          495 YERGT---NPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       495 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      +....   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+....+   .........
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p~~  284 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTPSP  284 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCCCG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCCCh
Confidence            64322   2233457899999999998875 5699999999999999999999999876533222111   111100000


Q ss_pred             --------------ccccCCcCCCCC---CHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          571 --------------LEVVDPRLNGEF---NEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       571 --------------~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                                    .....+.....+   ......++.+|+.+||+.||++|||+.|+++  ++.+
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  350 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK  350 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence                          000000000000   0011246789999999999999999999987  4543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.5e-46  Score=392.12  Aligned_cols=289  Identities=42%  Similarity=0.746  Sum_probs=250.7

Q ss_pred             CCccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-hHHHHHHHHHHHhhhcCCCceeeeee
Q 005621          330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-GLREFASEISSIGRLRHRNLVQLLGW  408 (687)
Q Consensus       330 ~~~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~  408 (687)
                      ...|+++++..++++|+..+.||+|+||+||+|.+. +++.||||++...... ...++.+|++++++++||||++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            467999999999999999999999999999999874 5889999998765432 23478999999999999999999999


Q ss_pred             eecCCeeEEEEecCCCCCchhhhhchh--hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEE
Q 005621          409 CRRRGDLLLVYDFMPNGSLDKCLFDEQ--KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL  486 (687)
Q Consensus       409 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl  486 (687)
                      +...+..++||||+++|+|.+++....  ...+++..+..|+.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999996533  335999999999999999999999933339999999999999999999999


Q ss_pred             cccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCC--CcchhhHHHHHHHH
Q 005621          487 GDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKA--LPEELILVDWVWDR  564 (687)
Q Consensus       487 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~--~~~~~~~~~~v~~~  564 (687)
                      +|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||+...  ........+|+...
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            9999999876555555555679999999999998899999999999999999999999996321  22334567788777


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ..........+..+...+...+...+.+++.+||+.||++|||+.||+++|++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            7777788888888888899999999999999999999999999999999998753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.1e-45  Score=390.25  Aligned_cols=204  Identities=22%  Similarity=0.353  Sum_probs=174.8

Q ss_pred             HHHHhcCcccceeeeeeCeEEEEEEEeC---CCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCC
Q 005621          338 LKKATRGFRDKELLGFGGFGRVYKGTLP---STNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRG  413 (687)
Q Consensus       338 l~~at~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  413 (687)
                      +....++|+..++||+|+||+||+|+++   .+++.||||++.....  ..++.+|+++|+.+ +||||+++++++.+.+
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            3445688999999999999999999864   4578999999876533  35678999999998 6999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-CcEEEcccccc
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLA  492 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla  492 (687)
                      .++||||||++|+|.+++.     .+++.++..++.||+.||.|||+   ++|+||||||+|||++.+ +.+||+|||+|
T Consensus        94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            9999999999999999882     48999999999999999999999   999999999999999887 79999999999


Q ss_pred             eeccCCCC---------------------------CceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCC
Q 005621          493 KLYERGTN---------------------------PSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRR  544 (687)
Q Consensus       493 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~  544 (687)
                      +.......                           ...+..+||+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            86543211                           112345799999999999775 58999999999999999999999


Q ss_pred             CCCCCCC
Q 005621          545 PIEPKAL  551 (687)
Q Consensus       545 p~~~~~~  551 (687)
                      ||.....
T Consensus       246 Pf~~~~~  252 (361)
T 4f9c_A          246 PFYKASD  252 (361)
T ss_dssp             SSSCCSS
T ss_pred             CCCCCCC
Confidence            9976543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8e-45  Score=412.78  Aligned_cols=253  Identities=24%  Similarity=0.321  Sum_probs=213.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|...+.||+|+||+||+|+++.+|+.||+|++........+.+.+|+.+|++++|||||++++++.+.+.++|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            36899999999999999999999999999999999877666677889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC--CcEEEcccccceeccCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE--LNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DFGla~~~~~~~  499 (687)
                      |+||+|.++|... ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.+  +.+||+|||+++.+... 
T Consensus       236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-  310 (573)
T 3uto_A          236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  310 (573)
T ss_dssp             CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred             cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence            9999999998543 3469999999999999999999999   999999999999999865  88999999999987543 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       ......+||+.|||||++.+..++.++||||+||++|||++|+.||......+..       ..+..+..  ...+...
T Consensus       311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~-------~~i~~~~~--~~~~~~~  380 (573)
T 3uto_A          311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-------RNVKSCDW--NMDDSAF  380 (573)
T ss_dssp             -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHTTCC--CCCSGGG
T ss_pred             -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------HHHHhCCC--CCCcccc
Confidence             3344568999999999999999999999999999999999999999865432211       11111111  0111111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+    ...+.+|+.+||+.||++||++.|+++
T Consensus       381 ~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          381 SGI----SEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            122    346789999999999999999999988

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.4e-44  Score=407.14  Aligned_cols=249  Identities=23%  Similarity=0.311  Sum_probs=203.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHH---HHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLR---EFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~---~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ++|+..++||+|+||+||+|+++.+|+.||||++.+..   .....   +...++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999999999999999997542   11222   3344567778889999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      ||||||+||+|.++|.  +.+.+++..+..++.||+.||.|||+   ++||||||||+||||+.++.+||+|||+|+.+.
T Consensus       269 lVmEy~~GGdL~~~l~--~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEECCCCSCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999994  34679999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ...   ....+||+.|||||++.. ..|+.++|+|||||++|||++|+.||..........+..    .....      .
T Consensus       344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~----~i~~~------~  410 (689)
T 3v5w_A          344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTM------A  410 (689)
T ss_dssp             SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH----HHHHC------C
T ss_pred             CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hhcCC------C
Confidence            432   334689999999999975 579999999999999999999999997654332221111    11111      1


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                      ..+...+    ..++.+|+.+||+.||++|++     +.||++
T Consensus       411 ~~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1122223    347889999999999999998     688876

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=369.84  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=214.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|...++||+|+||+||+|.+..+++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            35788999999999999999999989999999999877777788999999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++|+|.+++... ...+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999543 3469999999999999999999999   99999999999999999999999999999876443221


Q ss_pred             c-------------eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc
Q 005621          502 S-------------TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG  568 (687)
Q Consensus       502 ~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~  568 (687)
                      .             .....||+.|+|||++.+..++.++||||||+++|||++|..|+............          
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~----------  234 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------  234 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------
Confidence            1             11457999999999999999999999999999999999999998764432211000          


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          569 AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       569 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ......++.....+    +..+.+++.+||+.||++||++.++++.|+..
T Consensus       235 ~~~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          235 NVRGFLDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             CHHHHHHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhccccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00000111111122    23688999999999999999999999998865

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.4e-43  Score=367.23  Aligned_cols=256  Identities=22%  Similarity=0.339  Sum_probs=213.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|+..+.||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999999889999999999876655667889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++|+|.+++..   ..+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        99 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            999999999843   368999999999999999999999   8999999999999999999999999999987654332 


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........      .....+      .+.+  .
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~~~------~~~~--~  237 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNG------TPEL--Q  237 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHC------SCCC--S
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCC------CCCC--C
Confidence            2334679999999999999999999999999999999999999997654322111      111111      0111  1


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                      .+......+.+++.+||+.||++||++.|+++  +++..
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            11223346889999999999999999999997  44443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.5e-43  Score=365.93  Aligned_cols=262  Identities=21%  Similarity=0.380  Sum_probs=210.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++...   .....+++.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46799999999999999999999889999999998543   334467899999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++.  ....+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 ~e~~~g~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999994  34579999999999999999999998   99999999999999999999999999999876544


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      .........||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ........ .     +..
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~-----~~~  232 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-V-----PNV  232 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-C-----CCH
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-C-----CCc
Confidence            43444456799999999999999999999999999999999999999976543211      11111111 0     111


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCC-CHHHHHHHHhcCCC
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARP-TMRQVVRYLEGEVP  620 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~  620 (687)
                      ........+..+.+++.+||+.||++|| ++.++.+.|+....
T Consensus       233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            0111112234788999999999999999 99999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5e-43  Score=369.04  Aligned_cols=265  Identities=26%  Similarity=0.406  Sum_probs=206.7

Q ss_pred             HHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC
Q 005621          336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG  413 (687)
Q Consensus       336 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  413 (687)
                      .++....++|+..+.||+|+||+||+|++  .++.||||++....  ....+++.+|++++++++||||+++++++...+
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            33344457899999999999999999988  58899999987653  444678999999999999999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchh-hccCCHHHHHHHHHHHHhhhhhhcccccCe--EEeeccCCCcEEeccCCcEEEcccc
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQ-KAILTWEQRYRIIKGVASGLLYLHEEWEQT--VIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                      ..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   .+  |+||||||+|||++.++.+||+|||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            9999999999999999996533 3359999999999999999999998   78  9999999999999999999999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      +++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..   ..+..   ..  
T Consensus       185 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~~---~~--  255 (309)
T 3p86_A          185 LSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVGF---KC--  255 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---HHHHH---SC--
T ss_pred             CCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---cC--
Confidence            998543322 2233457999999999999999999999999999999999999999765432211   11100   00  


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCC
Q 005621          571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPL  621 (687)
Q Consensus       571 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  621 (687)
                         ....+    +......+.+++.+||+.+|++||++.++++.|+.....
T Consensus       256 ---~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          256 ---KRLEI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ---CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ---CCCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence               01111    222234788999999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-42  Score=367.46  Aligned_cols=263  Identities=24%  Similarity=0.323  Sum_probs=219.3

Q ss_pred             CCccCHHHHHHHhcC----------cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC
Q 005621          330 PHRFSYEELKKATRG----------FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH  399 (687)
Q Consensus       330 ~~~~~~~el~~at~~----------f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H  399 (687)
                      +..+++++++.+++.          |...+.||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            456899999999875          6777899999999999999988899999999987666667789999999999999


Q ss_pred             CCceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec
Q 005621          400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD  479 (687)
Q Consensus       400 ~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  479 (687)
                      |||+++++++...+..++||||+++++|.+++.   ...+++.++..++.|++.||.|||+   .+|+||||||+|||++
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT  175 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence            999999999999999999999999999999884   3469999999999999999999999   8999999999999999


Q ss_pred             cCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005621          480 SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD  559 (687)
Q Consensus       480 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~  559 (687)
                      .++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......   ...
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~  251 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK  251 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH
T ss_pred             CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence            999999999999987654322 2334579999999999999999999999999999999999999997654211   111


Q ss_pred             HHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          560 WVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       560 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                          .....     ..+.+..  .......+.+++.+||+.||++||++.|+++
T Consensus       252 ----~~~~~-----~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          252 ----RLRDS-----PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ----HHHHS-----SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----HHhcC-----CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                11111     1111111  1112336889999999999999999999997

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.9e-42  Score=359.64  Aligned_cols=282  Identities=36%  Similarity=0.619  Sum_probs=232.0

Q ss_pred             CCCccCHHHHHHHhcCcccc------eeeeeeCeEEEEEEEeCCCCeEEEEEEecCc----chhhHHHHHHHHHHHhhhc
Q 005621          329 GPHRFSYEELKKATRGFRDK------ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE----SKQGLREFASEISSIGRLR  398 (687)
Q Consensus       329 ~~~~~~~~el~~at~~f~~~------~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~  398 (687)
                      ..+.|++.++..++++|...      +.||+|+||+||+|.+  .++.||||++...    .....+.+.+|+.++++++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            35679999999999999887      8999999999999997  5789999998653    2334578999999999999


Q ss_pred             CCCceeeeeeeecCCeeEEEEecCCCCCchhhhhchh-hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEE
Q 005621          399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQ-KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL  477 (687)
Q Consensus       399 H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  477 (687)
                      ||||+++++++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+   .+|+||||||+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence            9999999999999999999999999999999986432 3469999999999999999999998   99999999999999


Q ss_pred             eccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhh
Q 005621          478 LDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELI  556 (687)
Q Consensus       478 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~  556 (687)
                      ++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......... 
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-  243 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-  243 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-
Confidence            999999999999999876543322 1233578999999998865 5889999999999999999999999876543322 


Q ss_pred             HHHHHHHHhcc-cccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          557 LVDWVWDRWKA-GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       557 ~~~~v~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                       ..+....... ..+.+.+++.+ ...+......+.+++.+||+.+|++||++.+|++.|++..
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          244 -LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             -THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             -HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence             1222221111 12233444444 3456677788999999999999999999999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=372.62  Aligned_cols=261  Identities=29%  Similarity=0.439  Sum_probs=211.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|+..+.||+|+||+||+|.+..+   +..||||++... .....++|.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            5678889999999999999999744   456999999865 344567899999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++|+|.+++... ...+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       129 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             eeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            9999999999999543 3469999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCCc--eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          499 TNPS--TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       499 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ....  .....+|..|+|||++.+..++.++||||||+++|||++ |+.||......+.       ......+.     .
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~~-----~  272 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-------ISSVEEGY-----R  272 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTC-----C
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHcCC-----C
Confidence            3222  222346778999999998999999999999999999999 9999976543211       11111111     1


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCCCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQ  623 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~  623 (687)
                      .    ..+......+.+++.+||+.||++||++.+|++.|+.....+.
T Consensus       273 ~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          273 L----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             C----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            1    1122233478899999999999999999999999998765444

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.9e-43  Score=371.15  Aligned_cols=268  Identities=29%  Similarity=0.390  Sum_probs=208.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC----eeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG----DLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l  417 (687)
                      .++|+..++||+|+||+||+|++.  ++.||||++...... ..++..|+.++++++||||+++++++....    .+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            468999999999999999999984  799999999765433 345567999999999999999999998754    4799


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccC----------eEEeeccCCCcEEeccCCcEEEc
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ----------TVIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~----------~ivHrDlk~~NIll~~~~~~kl~  487 (687)
                      ||||+++|+|.+++..   ..+++..+..++.|++.||.|||+   .          +|+||||||+|||++.++.+||+
T Consensus       100 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999943   459999999999999999999998   6          99999999999999999999999


Q ss_pred             ccccceeccCCCCC-ceeeeecCCCCCchhhccCC-----CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 005621          488 DFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTG-----KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV  561 (687)
Q Consensus       488 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v  561 (687)
                      |||+++........ ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||...............
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999876544322 23335799999999999863     4566889999999999999999999875443222111110


Q ss_pred             HHHhccc-----ccccccCCcCCCCC-CHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          562 WDRWKAG-----AILEVVDPRLNGEF-NEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       562 ~~~~~~~-----~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .......     .......+.+...+ .......+.+++.+||+.||++|||+.||++.|+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0000000     00111122222211 224556799999999999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.2e-43  Score=368.60  Aligned_cols=264  Identities=25%  Similarity=0.378  Sum_probs=208.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEE----eCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--Cee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGT----LPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  415 (687)
                      .++|+..+.||+|+||+||+|+    ...+++.||||++........+++.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            3678999999999999999998    4567899999999887777778899999999999999999999998553  568


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++|+|.+++... ...+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999999554 3359999999999999999999998   99999999999999999999999999999876


Q ss_pred             cCCCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCc---------chhhHHHHHHHH
Q 005621          496 ERGTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP---------EELILVDWVWDR  564 (687)
Q Consensus       496 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~~~~~v~~~  564 (687)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++|..|+......         ........+.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            443221  122234677899999999999999999999999999999999998643210         011111111222


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ...+         .....+...+..+.+++.+||+.||++||++.|+++.|+..
T Consensus       245 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          245 LKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             Hhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1111         11122223345788999999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-42  Score=375.54  Aligned_cols=259  Identities=26%  Similarity=0.397  Sum_probs=212.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeC-------CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecC
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLP-------STNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRR  412 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  412 (687)
                      .++|...+.||+|+||+||+|.+.       ..+..||||++.... ....+++.+|+.+++++ +||||++++++|...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467889999999999999999863       345689999997653 34567899999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                      +.+++||||+++|+|.+++....              ...+++.+++.++.||+.||.|||+   ++|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence            99999999999999999996532              2358999999999999999999998   999999999999999


Q ss_pred             ccCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhh
Q 005621          479 DSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELI  556 (687)
Q Consensus       479 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  556 (687)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence            9999999999999987654332 22233457889999999999999999999999999999999 99999765432211 


Q ss_pred             HHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          557 LVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       557 ~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                            .....+..     +    ..+......+.+++.+||+.+|++||++.|+++.|+...
T Consensus       316 ------~~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          316 ------KLLKEGHR-----M----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             ------HHHHTTCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHhcCCC-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  11111111     1    112223347889999999999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-42  Score=368.40  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=209.7

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ..++|...+.||+|+||.||+|++..+++.||||++...  .....+++.+|++++++++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            346899999999999999999999889999999998764  344567789999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++|+|.+++..  .+.+++.++..++.|++.||.|||+   .+|+||||||+|||++.++++||+|||+++.....
T Consensus        93 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           93 MEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             ECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999999943  4569999999999999999999999   99999999999999999999999999999865433


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCC-CccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPT-TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .  ......||+.|+|||++.+..+. .++|||||||++|||++|+.||......+       +.+....+..      .
T Consensus       168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~------~  232 (328)
T 3fe3_A          168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRGKY------R  232 (328)
T ss_dssp             C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------C
T ss_pred             C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC------C
Confidence            2  23446799999999999988765 79999999999999999999998654321       1111111111      1


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +...    ....+.+++.+||+.||++|||+.|+++
T Consensus       233 ~p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          233 IPFY----MSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CCTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1112    2336789999999999999999999987

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4e-43  Score=379.60  Aligned_cols=259  Identities=28%  Similarity=0.457  Sum_probs=200.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeC---CCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLP---STNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++|...+.||+|+||+||+|++.   ..+..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357889999999999999999986   45678999999765 34456789999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999999543 3469999999999999999999998   8999999999999999999999999999987654


Q ss_pred             CCCCc--eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          498 GTNPS--TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       498 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      .....  .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+   ..    .....+.     
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~----~~i~~~~-----  267 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VI----KAVDEGY-----  267 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HH----HHHHTTE-----
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCC-----
Confidence            33221  122345778999999999999999999999999999998 999997654221   11    1111111     


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                          ....+...+..+.+++.+||+.+|++||++.+|++.|+....
T Consensus       268 ----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          268 ----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             ----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                111122233478899999999999999999999999987643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.7e-43  Score=378.02  Aligned_cols=257  Identities=26%  Similarity=0.383  Sum_probs=211.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|...+.||+|+||+||+|.+..+++.||||++.... ....++|.+|++++++++||||++++++|...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888999999999999999998889999999987653 3344678899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++|+|.+++... ...+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999999643 3469999999999999999999999   9999999999999999999999999999986433211


Q ss_pred             C-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          501 P-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       501 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      . ......++..|+|||.+.++.++.++|||||||++|||++ |+.||......+       +.+....+..        
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~--------  333 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGR--------  333 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCC--------
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence            1 1112235778999999998899999999999999999998 999987654321       1111212111        


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                       ...+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus       334 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          334 -LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence             111222334788999999999999999999999999764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7e-43  Score=391.71  Aligned_cols=258  Identities=27%  Similarity=0.388  Sum_probs=216.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ..+|...+.||+|+||.||+|.+..++..||||++..... ..++|.+|+.++++++||||++++++|...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4678889999999999999999988899999999976543 357899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++|+|.+++.......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++........
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  374 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT  374 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence            999999999976555679999999999999999999999   99999999999999999999999999999876443222


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                      ......++..|+|||++..+.++.++|||||||++|||++ |+.||......+.   .    +....+         ...
T Consensus       375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~----~~~~~~---------~~~  438 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y----ELLEKD---------YRM  438 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H----HHHHTT---------CCC
T ss_pred             ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcC---------CCC
Confidence            2223346788999999999999999999999999999999 9999976553221   1    111111         111


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ..+..++..+.+|+.+||+.+|++||++.+|++.|+...
T Consensus       439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            222233457889999999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-42  Score=371.45  Aligned_cols=269  Identities=28%  Similarity=0.402  Sum_probs=218.0

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEE-----eCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCcee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGT-----LPSTNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQ  404 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~  404 (687)
                      .+...+++...++|...+.||+|+||.||+|.     ...+++.||||++.... ....+.+.+|++++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            34556666778899999999999999999998     45567899999997653 34457899999999999 7999999


Q ss_pred             eeeeeecCC-eeEEEEecCCCCCchhhhhchhh-----------------------------------------------
Q 005621          405 LLGWCRRRG-DLLLVYDFMPNGSLDKCLFDEQK-----------------------------------------------  436 (687)
Q Consensus       405 l~~~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~-----------------------------------------------  436 (687)
                      +++++.+.+ ..++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999988755 48999999999999999965432                                               


Q ss_pred             -----------------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          437 -----------------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       437 -----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                                       ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                             128999999999999999999999   899999999999999999999999999998664433


Q ss_pred             CC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          500 NP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       500 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .. ......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+..      ......+..     +.
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~~~-----~~  316 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTR-----MR  316 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHTCC-----CC
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcCCC-----CC
Confidence            22 2334578999999999999999999999999999999998 99999776543321      111111111     11


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ....    ....+.+++.+||+.||++||++.|+++.|+..
T Consensus       317 ~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          317 APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            1122    233688999999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=356.35  Aligned_cols=273  Identities=22%  Similarity=0.288  Sum_probs=217.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC--eeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG--DLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV  418 (687)
                      .++|...++||+|+||+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367899999999999999999999889999999997653 334577889999999999999999999987655  78999


Q ss_pred             EecCCCCCchhhhhchhh-ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe----ccCCcEEEcccccce
Q 005621          419 YDFMPNGSLDKCLFDEQK-AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL----DSELNGRLGDFGLAK  493 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGla~  493 (687)
                      |||+++++|.+++..... ..+++.+++.++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999965432 239999999999999999999999   999999999999999    778889999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhcc--------CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHH
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTR--------TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELI-LVDWVWDR  564 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~-~~~~v~~~  564 (687)
                      ......  ......||..|+|||++.        +..++.++|||||||++|||++|+.||.......... ....+...
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            765433  223457999999999986        5788999999999999999999999997655433221 11111111


Q ss_pred             hcccccccc---------c--CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          565 WKAGAILEV---------V--DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       565 ~~~~~~~~~---------~--d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .........         .  +..............+.+++.+||+.||++||++.|+++...+..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            111100000         0  111223455677778999999999999999999999999987654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.9e-42  Score=351.91  Aligned_cols=256  Identities=27%  Similarity=0.367  Sum_probs=211.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|+..+.||+|+||.||+|.+. ++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            467899999999999999999885 577899999976543 346789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++... ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++........
T Consensus        85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            9999999999543 3469999999999999999999999   99999999999999999999999999999876544322


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                      ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+..       .....+.     ......
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~-----~~~~~~  228 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-------LKVSQGH-----RLYRPH  228 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHHHTTC-----CCCCCT
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-------HHHHcCC-----CCCCCC
Confidence            2233456778999999998899999999999999999999 99999765432211       1111111     011111


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .    ....+.+++.+||+.+|++||++.++++.|+...
T Consensus       229 ~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          229 L----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             T----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             c----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1    2236889999999999999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.1e-42  Score=362.54  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=205.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|+..+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            3689999999999999999999998999999999865432 234668899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++|+|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        86 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           86 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999999999943  4469999999999999999999998   9999999999999999999999999999986643321


Q ss_pred             -CceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          501 -PSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       501 -~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                       .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...|.     ....  ..    
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~-----~~~~--~~----  228 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-----EKKT--YL----  228 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH-----TTCT--TS----
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh-----cccc--cC----
Confidence             22334679999999999987765 77899999999999999999999865543211 11111     1100  00    


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                        .........+.+|+.+||+.||++||++.|+++.
T Consensus       229 --~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              0011223467899999999999999999999873

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.4e-42  Score=383.44  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=213.2

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      +...++|...+.||+|+||+||+|.+. .+..||||+++... ...++|.+|+.++++++||||+++++++. .+..++|
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            344578889999999999999999995 47889999998654 34678999999999999999999999987 5678999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++|+|.+++.......+++.++++++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            999999999999976655679999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .........+|..|+|||++..+.++.++|||||||++|||++ |+.||......+.   .    ..+..+..       
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~----~~i~~~~~-------  403 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---I----RALERGYR-------  403 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---H----HHHHHTCC-------
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcCCC-------
Confidence            2111222346788999999999999999999999999999999 9999976543221   1    11111111       


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                        ...+...+..+.+++.+||+.||++||++.+|++.|+...
T Consensus       404 --~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          404 --MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence              1112223447889999999999999999999999999765

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-41  Score=360.66  Aligned_cols=248  Identities=25%  Similarity=0.320  Sum_probs=208.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|+.+.+++.||+|++++..   ......+.+|+.++++++||||+++++++...+.+++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57899999999999999999999899999999997642   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++.  ....+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        85 E~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           85 EYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            9999999999884  34569999999999999999999998   999999999999999999999999999998543222


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......       +.+....+.      ..+.
T Consensus       160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~------~~~p  225 (337)
T 1o6l_A          160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEE------IRFP  225 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------CCCC
T ss_pred             -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC------CCCC
Confidence             23345689999999999999999999999999999999999999997654211       111111111      1122


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ..+    ...+.+++.+||+.||++||     ++.|+++
T Consensus       226 ~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          226 RTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             TTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            222    34788999999999999999     8999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1e-42  Score=361.80  Aligned_cols=259  Identities=27%  Similarity=0.391  Sum_probs=218.3

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ...++|...+.||+|+||+||+|.+..++..||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            34678999999999999999999998889999999997653 34578899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++.......+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999999976556679999999999999999999998   899999999999999999999999999998765444


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.........   +.    ...+         .
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~---~~----~~~~---------~  229 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---EL----LEKD---------Y  229 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HH----HHTT---------C
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----Hhcc---------C
Confidence            333444567889999999999999999999999999999999 99998765433211   11    1111         1


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            1111222234788999999999999999999999998764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.5e-42  Score=380.23  Aligned_cols=258  Identities=30%  Similarity=0.430  Sum_probs=207.5

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ..++|...+.||+|+||+||+|.+.. +..||||+++.... ..++|.+|+.++++++||||+++++++.+ +..++|||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            34678899999999999999999964 57799999976542 34689999999999999999999999976 67899999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++|+|.+++.......+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999999976555679999999999999999999998   9999999999999999999999999999987654333


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      .......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+       +......+.         .
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~---------~  399 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY---------R  399 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---------C
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------C
Confidence            23333457889999999999999999999999999999999 999997654321       111111211         1


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      ...+...+..+.+++.+||+.+|++||++.+|++.|+....
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            11222334478899999999999999999999999998653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.6e-42  Score=364.49  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=203.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeE----EEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQ----VAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|+..++||+|+||+||+|++..+++.    ||+|.+.... ....+++.+|+.++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            5788999999999999999998766654    5888876543 345678999999999999999999999998754 789


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      |+||+++|+|.+++... ...+++..++.|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999653 3469999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      .... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||......+..   .    ....+.      
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~----~~~~~~------  236 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---S----ILEKGE------  236 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H----HHHTTC------
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH---H----HHHcCC------
Confidence            3322 2233456889999999999999999999999999999999 99999865433211   1    111111      


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                         ....+......+.+++.+||+.+|++||++.++++.|+....
T Consensus       237 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence               111122233478899999999999999999999999987543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=363.46  Aligned_cols=245  Identities=24%  Similarity=0.329  Sum_probs=197.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..++||+|+||+||+|.+..+++.||||++....  .....++..|+..+.++ +||||++++++|.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999999899999999986542  33344566677666666 8999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+ +++|.+++... ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            999 77999988543 3469999999999999999999998   899999999999999999999999999998764332


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                        ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....          +..+..+...    +.+.
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~----~~~~  274 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLP----PEFT  274 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCC----HHHH
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCC----cccc
Confidence              2334568999999999875 789999999999999999999877643210          1111111111    1111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..    ....+.+++.+||+.||++||++.|+++
T Consensus       275 ~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 AG----LSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11    2347889999999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-42  Score=354.64  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=209.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||+|+||+||+|.+. ++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            57888999999999999999986 578899999976543 2367899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.........
T Consensus        88 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             TTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            999999999543 3468999999999999999999998   999999999999999999999999999998654322222


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ......+     ..+..   
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-------~~~~~~~-----~~~~~---  228 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTG-----FRLYK---  228 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTT-----CCCCC---
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHhcC-----ccCCC---
Confidence            223356778999999999999999999999999999999 9999976543211       1111111     11111   


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                       +......+.+++.+||+.+|++||++.++++.|++.
T Consensus       229 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          229 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence             111234688999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-41  Score=376.77  Aligned_cols=250  Identities=30%  Similarity=0.416  Sum_probs=208.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC-eeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG-DLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E  420 (687)
                      .++|...+.||+|+||.||+|.+  .++.||||+++...  ..++|.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            46788899999999999999998  47899999998654  4578999999999999999999999987655 7999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++|+|.+++.......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            9999999999976555558999999999999999999999   999999999999999999999999999998543221 


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..       .....+.         .
T Consensus       344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~---------~  404 (450)
T 1k9a_A          344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGY---------K  404 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-------HHHHTTC---------C
T ss_pred             ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC---------C
Confidence               22357889999999999999999999999999999998 99999876543321       1111221         1


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ...+..++..+.+++.+||+.||++||++.++++.|+..
T Consensus       405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            112223345788999999999999999999999999764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=360.90  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=207.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh------hHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      .++|...+.||+|+||.||+|.+..+++.||+|++......      ..+++.+|+.++++++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            35689999999999999999999989999999998764321      357789999999999999999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC----cEEEccccc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL----NGRLGDFGL  491 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGl  491 (687)
                      ++||||+++++|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999999943  4569999999999999999999998   9999999999999999887    799999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...       ......  
T Consensus       165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~~~~~~--  233 (326)
T 2y0a_A          165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NVSAVN--  233 (326)
T ss_dssp             CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHHTC--
T ss_pred             CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------HHHhcC--
Confidence            98765432  2234579999999999999999999999999999999999999997654221111       111100  


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                          ..............+.+++.+||+.||++|||+.|+++
T Consensus       234 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          234 ----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                00100000112236789999999999999999999997

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-41  Score=365.94  Aligned_cols=253  Identities=24%  Similarity=0.313  Sum_probs=209.0

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh------hHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      ..++|...+.||+|+||+||+|.+..+|+.||+|++......      ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            346799999999999999999999999999999998765322      34678999999999999999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC----cEEEcccc
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL----NGRLGDFG  490 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFG  490 (687)
                      .++||||+++|+|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999999943  4569999999999999999999998   9999999999999998876    79999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||++|..||......+.       ...+..+..
T Consensus       165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-------~~~i~~~~~  235 (361)
T 2yab_A          165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITAVSY  235 (361)
T ss_dssp             SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCC
T ss_pred             CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcCC
Confidence            998765432  23345799999999999999999999999999999999999999976542211       111111110


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .  .++.....    ....+.+++.+||+.||++||++.|+++
T Consensus       236 ~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 D--FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             C--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C--CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  00000011    2336889999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-42  Score=381.36  Aligned_cols=266  Identities=19%  Similarity=0.242  Sum_probs=215.9

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhhcCCCceeeeee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHRNLVQLLGW  408 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~  408 (687)
                      .+.+++++..+++|+..++||+|+||+||+|+++.+++.||+|++.+...   .....+.+|..++..++||||++++++
T Consensus        63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  142 (437)
T 4aw2_A           63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA  142 (437)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            34566777778999999999999999999999999999999999976422   223348899999999999999999999


Q ss_pred             eecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcc
Q 005621          409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGD  488 (687)
Q Consensus       409 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  488 (687)
                      |.+.+.+++|||||++|+|.+++... ...+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|
T Consensus       143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          143 FQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcc
Confidence            99999999999999999999999542 3569999999999999999999998   9999999999999999999999999


Q ss_pred             cccceeccCCCCCceeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 005621          489 FGLAKLYERGTNPSTTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       489 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      ||+++.............+||+.|+|||++.     .+.++.++|||||||++|||++|+.||......+..   ..+..
T Consensus       219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~---~~i~~  295 (437)
T 4aw2_A          219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---GKIMN  295 (437)
T ss_dssp             CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHT
T ss_pred             hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH---Hhhhh
Confidence            9999876544433344468999999999987     567899999999999999999999999865432211   11110


Q ss_pred             HhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCc--CCCHHHHHH
Q 005621          564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEA--RPTMRQVVR  613 (687)
Q Consensus       564 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~  613 (687)
                         ...  ...-|.....+    ...+.+|+.+||+.+|++  ||+++|+++
T Consensus       296 ---~~~--~~~~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          296 ---HKE--RFQFPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ---HHH--HCCCCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ---ccc--cccCCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence               000  00111111122    236788999999888888  999999997

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-41  Score=354.24  Aligned_cols=263  Identities=26%  Similarity=0.348  Sum_probs=203.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhh--hcCCCceeeeeeeec----CCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR--LRHRNLVQLLGWCRR----RGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~----~~~~  415 (687)
                      .++|...+.||+|+||+||+|++  +++.||||++....   ...+..|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46899999999999999999998  68999999987543   3455566666666  799999999998654    3568


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccc-----cCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW-----EQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                      ++||||+++|+|.+++.   ...+++..+++++.|++.||.|||...     .++|+||||||+|||++.++.+||+|||
T Consensus        82 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            99999999999999993   346999999999999999999999211     2999999999999999999999999999


Q ss_pred             cceeccCCCCCc---eeeeecCCCCCchhhccCC------CCCCccceehhhHHHHHHHhC----------CCCCCCCCC
Q 005621          491 LAKLYERGTNPS---TTRVVGTLGYLAPELTRTG------KPTTSSDVYAFGALLLEVVCG----------RRPIEPKAL  551 (687)
Q Consensus       491 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDV~S~Gvvl~elltG----------~~p~~~~~~  551 (687)
                      +++.........   .....||+.|+|||++.+.      .++.++||||||+++|||++|          +.||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            998765443321   2234799999999999876      445799999999999999999          778765433


Q ss_pred             cchhhHHHHHHHHhcccccccccCCcCC-CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          552 PEELILVDWVWDRWKAGAILEVVDPRLN-GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       552 ~~~~~~~~~v~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .....  .........    ....+.+. ..........+.+++.+||+.||++|||+.+|++.|+++
T Consensus       239 ~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          239 NDPSF--EDMRKVVCV----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SSCCH--HHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcch--hhhhHHHhc----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            22111  111111111    11112221 112345667899999999999999999999999999753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-42  Score=365.56  Aligned_cols=262  Identities=27%  Similarity=0.424  Sum_probs=214.3

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG  413 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  413 (687)
                      ...++|...+.||+|+||.||+|++..     +++.||||++.... ....+++.+|+.++++++||||+++++++...+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            346789999999999999999999863     45899999998653 344678999999999999999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchh----------------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeecc
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQ----------------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDI  471 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  471 (687)
                      ..++||||+++|+|.+++....                      ...+++.+++.++.||+.||.|||+   ++|+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence            9999999999999999996532                      1569999999999999999999998   99999999


Q ss_pred             CCCcEEeccCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCC
Q 005621          472 KAGNVLLDSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPK  549 (687)
Q Consensus       472 k~~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~  549 (687)
                      ||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999986543221 22234567899999999999999999999999999999999 99999765


Q ss_pred             CCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          550 ALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       550 ~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      ...+       +......+...     ..    +...+..+.+++.+||+.+|++||++.++++.|++...
T Consensus       281 ~~~~-------~~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          281 AHEE-------VIYYVRDGNIL-----AC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             CHHH-------HHHHHHTTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ChHH-------HHHHHhCCCcC-----CC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            4211       11122222211     11    12223478899999999999999999999999998653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.3e-42  Score=366.38  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=207.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeE----EEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQ----VAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|+..++||+|+||+||+|.+..+++.    ||+|.+.... .....++.+|+.++++++||||++++++|. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            5788999999999999999998777664    7888775442 333456788999999999999999999986 466899


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999654 3479999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      .... ......||..|+|||++.++.++.++||||||+++|||++ |+.||......+...       ....+...    
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~----  236 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-------LLEKGERL----  236 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-------HHHTTCBC----
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-------HHHcCCCC----
Confidence            4322 2344567889999999999999999999999999999999 999998765432211       11111111    


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPL  621 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  621 (687)
                       .    .+......+.+++.+||+.||++||++.++++.|+.....
T Consensus       237 -~----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          237 -A----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             -C----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             -C----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             0    1111222577899999999999999999999999876543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9e-42  Score=370.29  Aligned_cols=260  Identities=27%  Similarity=0.404  Sum_probs=213.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC-------CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecC
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS-------TNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRR  412 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  412 (687)
                      .++|...+.||+|+||+||+|++..       .+..||||++.... ....+++.+|+++++++ +||||++++++|...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4688999999999999999999642       34689999997653 44567899999999999 999999999999999


Q ss_pred             CeeEEEEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                      +..++||||+++|+|.+++....              ...+++.+++.|+.||+.||.|||+   .+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence            99999999999999999996533              2359999999999999999999998   899999999999999


Q ss_pred             ccCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhh
Q 005621          479 DSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELI  556 (687)
Q Consensus       479 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  556 (687)
                      +.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||......+   
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999986654322 22333467889999999999999999999999999999999 999987654221   


Q ss_pred             HHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          557 LVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       557 ~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                          +.+....+..     +.....    ....+.+++.+||+.+|++||++.||++.|+....
T Consensus       302 ----~~~~~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          302 ----LFKLLKEGHR-----MDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             ----HHHHHHTTCC-----CCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHHcCCC-----CCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                1122222211     111122    23478899999999999999999999999987653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-41  Score=361.37  Aligned_cols=264  Identities=25%  Similarity=0.397  Sum_probs=213.1

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEe-----CCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeec
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRR  411 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  411 (687)
                      +...++|...+.||+|+||+||+|.+     ...+..||||++.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            33457899999999999999999997     3456789999997643 33457899999999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCCchhhhhchhh---------------------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeec
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDEQK---------------------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD  470 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  470 (687)
                      .+..++||||+++|+|.+++.....                     ..+++.+++.++.||+.||.|||+   ++|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence            9999999999999999999965432                     348999999999999999999999   9999999


Q ss_pred             cCCCcEEeccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCC
Q 005621          471 IKAGNVLLDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEP  548 (687)
Q Consensus       471 lk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~  548 (687)
                      |||+|||++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++||||||+++|||+| |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999999999999999999876544332 2234567889999999999999999999999999999998 9999987


Q ss_pred             CCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          549 KALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       549 ~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      .......      ......+.     .+    ..+......+.+++.+||+.||++||++.++++.|+....
T Consensus       278 ~~~~~~~------~~~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          278 IPVDANF------YKLIQNGF-----KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CCCSHHH------HHHHHTTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCcHHHH------HHHHhcCC-----CC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            6543221      11111111     11    1112223478899999999999999999999999987653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=371.41  Aligned_cols=258  Identities=26%  Similarity=0.396  Sum_probs=209.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEe-----CCCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ++|...+.||+|+||+||+|++     ..+++.||||++... ......++.+|+.++++++||||+++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            5788999999999999999995     345778999999754 3445668899999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchh-----hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC---cEEEcc
Q 005621          417 LVYDFMPNGSLDKCLFDEQ-----KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL---NGRLGD  488 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~D  488 (687)
                      +||||+++|+|.+++....     ...+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999996532     2458999999999999999999999   9999999999999999554   599999


Q ss_pred             cccceeccCCC-CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhc
Q 005621          489 FGLAKLYERGT-NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWK  566 (687)
Q Consensus       489 FGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~  566 (687)
                      ||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||......+   +.    ....
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~----~~i~  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL----EFVT  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH----HHHH
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHH
Confidence            99998553322 222334567899999999999999999999999999999998 999997654321   11    1111


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       567 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .+..     +    ..+......+.+|+.+||+.+|++||++.+|++.|+...
T Consensus       301 ~~~~-----~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          301 SGGR-----M----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCC-----C----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            1111     1    111222346889999999999999999999999997654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-41  Score=357.88  Aligned_cols=259  Identities=27%  Similarity=0.405  Sum_probs=212.9

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEe-----CCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      ..++|...+.||+|+||.||+|.+     ..+++.||||++.... ....+++.+|++++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            357899999999999999999987     3455899999997653 4456789999999999999999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhh----------------------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccC
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQK----------------------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIK  472 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~----------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  472 (687)
                      .++||||+++++|.+++.....                      ..+++.+++.++.||+.||.|||+   ++|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence            9999999999999999965322                      358999999999999999999998   899999999


Q ss_pred             CCcEEeccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCC
Q 005621          473 AGNVLLDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKA  550 (687)
Q Consensus       473 ~~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~  550 (687)
                      |+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876443221 1223456788999999998889999999999999999999 999997655


Q ss_pred             CcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          551 LPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       551 ~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .....       .....+.     .+..    +......+.+++.+||+.||++||++.++++.|+..
T Consensus       258 ~~~~~-------~~~~~~~-----~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          258 PERLF-------NLLKTGH-----RMER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             GGGHH-------HHHHTTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHH-------HHhhcCC-----cCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            32211       1111111     1111    122234788999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-41  Score=358.09  Aligned_cols=256  Identities=19%  Similarity=0.283  Sum_probs=210.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|...+.||+|+||+||+|.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            478999999999999999999999999999999987543 3446788999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc--CCcEEEcccccceeccCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS--ELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFGla~~~~~~~  499 (687)
                      +++|+|.+++... ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.  ++.+||+|||+++..... 
T Consensus        83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-  157 (321)
T 1tki_A           83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence            9999999998543 3469999999999999999999998   99999999999999987  789999999999876543 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ...    .+..+...  .++...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----~i~~~~~~--~~~~~~  227 (321)
T 1tki_A          158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIE----NIMNAEYT--FDEEAF  227 (321)
T ss_dssp             -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH----HHHHTCCC--CCHHHH
T ss_pred             -CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHH----HHHcCCCC--CChhhh
Confidence             23445679999999999998888999999999999999999999997654321   111    11111100  000000


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ..    ....+.+++.+||+.||++|||+.|+++  ++.+
T Consensus       228 ~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          228 KE----ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             cc----CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence            11    2346889999999999999999999998  4543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.4e-42  Score=360.14  Aligned_cols=258  Identities=23%  Similarity=0.340  Sum_probs=199.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe----
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD----  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----  414 (687)
                      .++|+..+.||+|+||+||+|++..+++.||||++....   ......+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            468999999999999999999998899999999997652   3345678999999999999999999999876553    


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++||||+++++|.+++..  ...+++.++..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            4999999999999999953  4569999999999999999999998   8999999999999999999999999999986


Q ss_pred             ccCCCC--CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          495 YERGTN--PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       495 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      ......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+      ...+.........
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~  239 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPP  239 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCH
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCCc
Confidence            654322  22334578999999999999999999999999999999999999997654321      1111111111100


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH-HHhc
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR-YLEG  617 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~-~L~~  617 (687)
                      .   .....    ....+.+++.+||+.||++||+..++++ .|..
T Consensus       240 ~---~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          240 S---ARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             H---HHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             c---cccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            0   00111    2336889999999999999997776654 4433

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-41  Score=349.02  Aligned_cols=250  Identities=27%  Similarity=0.458  Sum_probs=196.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch----hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK----QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++|+..+.||+|+||+||+|.+  .++.||||++.....    ...+.+.+|++++++++||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            36789999999999999999998  478999999876432    235678999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCe---EEeeccCCCcEEecc--------CCcEEE
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT---VIHRDIKAGNVLLDS--------ELNGRL  486 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~---ivHrDlk~~NIll~~--------~~~~kl  486 (687)
                      ||||+++++|.+++.   ...+++.++..++.|++.||.|||+   .+   |+||||||+|||++.        ++.+||
T Consensus        84 v~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             EEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             EEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            999999999999883   3469999999999999999999999   66   999999999999986        678999


Q ss_pred             cccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 005621          487 GDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK  566 (687)
Q Consensus       487 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~  566 (687)
                      +|||+++......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ......
T Consensus       158 ~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~  228 (271)
T 3dtc_A          158 TDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAM  228 (271)
T ss_dssp             CCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHT
T ss_pred             ccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhc
Confidence            9999998654332   2235689999999999999999999999999999999999999976542111      111111


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       567 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                               .......+......+.+++.+||+.+|++||++.|+++.|+.
T Consensus       229 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          229 ---------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ---------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                     111111222233478899999999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.5e-41  Score=362.88  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=209.2

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ...++|...+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3457899999999999999999999989999999999754  33455778999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC---cEEEccccccee
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL---NGRLGDFGLAKL  494 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGla~~  494 (687)
                      ||||+++|+|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++   .+||+|||+++.
T Consensus       106 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             EECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999998853  3568999999999999999999999   8999999999999998654   599999999987


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+       +...+..+...   
T Consensus       181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~---  248 (362)
T 2bdw_A          181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYD---  248 (362)
T ss_dssp             CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC---
T ss_pred             ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC---
Confidence            65332  2234579999999999999999999999999999999999999997654211       11112222110   


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         ............+.+++.+||+.||++||++.|+++
T Consensus       249 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          249 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             ---CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               000001112346889999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.6e-41  Score=348.88  Aligned_cols=262  Identities=19%  Similarity=0.231  Sum_probs=213.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|...+.||+|+||+||+|.+..+++.||||++....  ..+++.+|+.+++++ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            467999999999999999999998899999999986543  234678899999999 89999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc-----EEEcccccceec
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN-----GRLGDFGLAKLY  495 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~DFGla~~~  495 (687)
                      |+ +++|.+++... ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.     +||+|||+++..
T Consensus        87 ~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           87 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99 99999999543 3469999999999999999999998   99999999999999987776     999999999876


Q ss_pred             cCCCCC------ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          496 ERGTNP------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       496 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      ......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+........
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            554321      23446799999999999999999999999999999999999999987654333222222221111111


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ..     .+...+    +..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       242 ~~-----~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          242 LR-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             HH-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HH-----HHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            11     111122    237889999999999999999999999998653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.3e-42  Score=362.84  Aligned_cols=263  Identities=24%  Similarity=0.358  Sum_probs=197.2

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCe---EEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNT---QVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG  413 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  413 (687)
                      ....++|+..+.||+|+||+||+|.+..++.   .||||++...  .....+++.+|++++++++||||+++++++...+
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3445789999999999999999999876654   7999998765  3445678999999999999999999999998776


Q ss_pred             ee------EEEEecCCCCCchhhhhchhh----ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc
Q 005621          414 DL------LLVYDFMPNGSLDKCLFDEQK----AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN  483 (687)
Q Consensus       414 ~~------~lV~Ey~~~gsL~~~L~~~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~  483 (687)
                      ..      ++||||+++|+|.+++.....    ..+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCC
Confidence            55      999999999999999954321    258999999999999999999999   89999999999999999999


Q ss_pred             EEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 005621          484 GRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWV  561 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v  561 (687)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..   .  
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~--  250 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---N--  250 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H--
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---H--
Confidence            99999999986644332 22233456789999999999999999999999999999999 99999865533211   1  


Q ss_pred             HHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          562 WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       562 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                        ....+..     ...    +......+.+++.+||+.||++||++.++++.|++...
T Consensus       251 --~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          251 --YLIGGNR-----LKQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             --HHHTTCC-----CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHhcCCC-----CCC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              1111111     111    12223478899999999999999999999999987654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.7e-42  Score=354.14  Aligned_cols=257  Identities=29%  Similarity=0.443  Sum_probs=210.7

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ..++|+..+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|++++++++||||+++++++.. +..++|||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            4578999999999999999999985 578899999976532 35788999999999999999999999874 56899999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++.......+++.+++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.......
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            9999999999976555579999999999999999999998   9999999999999999999999999999987654332


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      .......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+   .    .+....+.     .+.. 
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~~-----~~~~-  231 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V----IQNLERGY-----RMVR-  231 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTTC-----CCCC-
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---H----HHHHhccc-----CCCC-
Confidence            22233456789999999998889999999999999999999 899987654321   1    11111111     1111 


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                         +......+.+++.+||+.+|++||++.++++.|+...
T Consensus       232 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence               1122347889999999999999999999999998653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.9e-41  Score=366.03  Aligned_cols=273  Identities=18%  Similarity=0.245  Sum_probs=211.3

Q ss_pred             HhcCcccceeeeee--CeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          341 ATRGFRDKELLGFG--GFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       341 at~~f~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ..++|+..++||+|  +||+||+|++..+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            35789999999999  99999999999899999999997653  444577889999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +||||+++|+|.+++.......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999999976555679999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCC------CceeeeecCCCCCchhhccC--CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc--
Q 005621          497 RGTN------PSTTRVVGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK--  566 (687)
Q Consensus       497 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~--  566 (687)
                      ....      .......||..|+|||++.+  ..++.++|||||||++|||++|+.||..........  ........  
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~  257 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPCL  257 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC--------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCcc
Confidence            2211      11122468899999999987  578999999999999999999999997654432211  00000000  


Q ss_pred             --------------------cccccccc---CCc------CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HH
Q 005621          567 --------------------AGAILEVV---DPR------LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YL  615 (687)
Q Consensus       567 --------------------~~~~~~~~---d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L  615 (687)
                                          .....+..   .++      ....+.......+.+|+.+||+.||++|||+.|+++  ++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence                                00000000   000      000112223346889999999999999999999997  35


Q ss_pred             hcC
Q 005621          616 EGE  618 (687)
Q Consensus       616 ~~~  618 (687)
                      +..
T Consensus       338 ~~~  340 (389)
T 3gni_B          338 KQI  340 (389)
T ss_dssp             GGC
T ss_pred             HHH
Confidence            543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-41  Score=363.56  Aligned_cols=253  Identities=20%  Similarity=0.261  Sum_probs=211.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|...+.||+|+||+||+|.+..+++.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46899999999999999999999989999999999877666667899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc--CCcEEEcccccceeccCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS--ELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFGla~~~~~~~  499 (687)
                      +++|+|.+++... ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.  ++.+||+|||+++......
T Consensus       130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            9999999998543 3469999999999999999999998   99999999999999974  4779999999998765432


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ....+    .....  ..++...
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~i----~~~~~--~~~~~~~  274 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNV----KRCDW--EFDEDAF  274 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH----HHCCC--CCCSSTT
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHHHH----HhCCC--CCCcccc
Confidence              2334579999999999999999999999999999999999999998654211   11111    11110  0111111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+    ...+.+++.+||+.||++||++.|+++
T Consensus       275 ~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          275 SSV----SPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccC----CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            222    347889999999999999999999997

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.6e-41  Score=350.34  Aligned_cols=255  Identities=23%  Similarity=0.348  Sum_probs=207.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCC-------eEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTN-------TQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      .++|...+.||+|+||+||+|.+..++       ..||+|++........+++.+|+.++++++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            357889999999999999999987655       5799999987777777889999999999999999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc--------EEE
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN--------GRL  486 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--------~kl  486 (687)
                      .++||||+++|+|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999543 3349999999999999999999999   99999999999999999887        999


Q ss_pred             cccccceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 005621          487 GDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       487 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      +|||++.....     .....||..|+|||++.+ ..++.++||||||+++|||++|..|+.........  ..    ..
T Consensus       163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~~----~~  231 (289)
T 4fvq_A          163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--LQ----FY  231 (289)
T ss_dssp             CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HH----HH
T ss_pred             ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--HH----Hh
Confidence            99999864322     223468999999999987 67899999999999999999966555443322111  11    11


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCCC
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLP  622 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  622 (687)
                      ..       .+.+....    ...+.+++.+||+.||++||++.++++.|+......
T Consensus       232 ~~-------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          232 ED-------RHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             HT-------TCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             hc-------cCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            11       01111111    225788999999999999999999999999876533

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=353.84  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=199.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--------------------------hhHHHHHHHHHHHh
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--------------------------QGLREFASEISSIG  395 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  395 (687)
                      .++|...+.||+|+||.||+|++..+++.||||++.....                          ...+++.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3689999999999999999999999999999999865431                          12356889999999


Q ss_pred             hhcCCCceeeeeeeec--CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCC
Q 005621          396 RLRHRNLVQLLGWCRR--RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKA  473 (687)
Q Consensus       396 ~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  473 (687)
                      +++||||+++++++.+  .+..++||||+++++|.+++.   ...+++.++..++.||+.||.|||+   .+|+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence            9999999999999986  568999999999999998763   3469999999999999999999999   8999999999


Q ss_pred             CcEEeccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCC---CCCccceehhhHHHHHHHhCCCCCCCCC
Q 005621          474 GNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK---PTTSSDVYAFGALLLEVVCGRRPIEPKA  550 (687)
Q Consensus       474 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvvl~elltG~~p~~~~~  550 (687)
                      +|||++.++.+||+|||+++...... .......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||....
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999998765432 2233457999999999998765   3778999999999999999999997643


Q ss_pred             CcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          551 LPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       551 ~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ...   +    .........    .......+    ...+.+++.+||+.||++||++.|+++
T Consensus       245 ~~~---~----~~~~~~~~~----~~~~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IMC---L----HSKIKSQAL----EFPDQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHH---H----HHHHHHCCC----CCCSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHH---H----HHHHhcccC----CCCCcccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            211   1    111111111    00111122    236889999999999999999999975

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.3e-41  Score=357.28  Aligned_cols=260  Identities=19%  Similarity=0.190  Sum_probs=211.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|...+.||+|+||+||+|++..+++.||||++.....  .+++..|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            4679999999999999999999988999999999875432  24678999999999 99999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc-----EEEcccccceec
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN-----GRLGDFGLAKLY  495 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~DFGla~~~  495 (687)
                      |+ +++|.+++... ...+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.     +||+|||+++.+
T Consensus        86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99 99999998543 4579999999999999999999998   89999999999999998887     999999999876


Q ss_pred             cCCCCC------ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          496 ERGTNP------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       496 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      ......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            543321      12356799999999999999999999999999999999999999987654333222221111100000


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                       .+    .+...    .+ .+.+++..||+.+|.+||++.+|++.|+..
T Consensus       241 -~~----~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          241 -IE----VLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             -HH----HHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             -HH----HHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence             00    00111    12 788999999999999999999999988754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=364.88  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=203.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++|+..++||+|+||+||+|+++.+++.||||++.+..   ....+.+..|..+++.+ +||||+++++++...+.+++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999999999999999997642   33456788999999988 79999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       102 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999943  4569999999999999999999999   9999999999999999999999999999985332


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+       +.+.+..+.      ..
T Consensus       177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~------~~  242 (353)
T 3txo_A          177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDE------VV  242 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------CC
T ss_pred             CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC------CC
Confidence            22 23345689999999999998899999999999999999999999998654321       111111111      11


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCH------HHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTM------RQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~  613 (687)
                      .    +......+.+++.+||+.||++||++      .|+++
T Consensus       243 ~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 Y----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             C----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             C----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1    12223468899999999999999998      77776

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.7e-41  Score=355.27  Aligned_cols=261  Identities=26%  Similarity=0.386  Sum_probs=214.1

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEe-----CCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhh-cCCCceeeeeeeecCC
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNESK-QGLREFASEISSIGRL-RHRNLVQLLGWCRRRG  413 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  413 (687)
                      ..++|...+.||+|+||+||+|++     ..+++.||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            356899999999999999999985     45678999999976543 3457899999999999 9999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchhh----------------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEE
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQK----------------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL  477 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  477 (687)
                      ..++||||+++|+|.+++.....                ..+++.+++.++.|++.||.|||+   ++|+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence            99999999999999999965432                248999999999999999999999   99999999999999


Q ss_pred             eccCCcEEEcccccceeccCCCCCc-eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchh
Q 005621          478 LDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEEL  555 (687)
Q Consensus       478 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  555 (687)
                      ++.++.+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            9999999999999998765443321 223457889999999999999999999999999999999 99999776543221


Q ss_pred             hHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       556 ~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                        .    .....+     ..+...    ......+.+++.+||+.||++||++.|+++.|++..
T Consensus       258 --~----~~~~~~-----~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          258 --Y----KMIKEG-----FRMLSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             --H----HHHHHT-----CCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --H----HHhccC-----CCCCCc----ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence              1    111111     111111    122347889999999999999999999999998653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.9e-42  Score=353.65  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=207.1

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ..++|+..+.||+|+||+||+|.+. ++..||||++..... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            3568899999999999999999985 578899999976533 24678999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++... ...+++.++..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++.......
T Consensus       100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          100 YMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             ccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999999999653 3469999999999999999999998   9999999999999999999999999999986543221


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..       .....+     ..... 
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~-----~~~~~-  242 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-------EHIAQG-----LRLYR-  242 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHHHTT-----CCCCC-
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-------HHHhcc-----cCCCC-
Confidence            11222346778999999998999999999999999999998 99999765432111       111111     11111 


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                         +......+.+++.+||+.+|++||++.++++.|+..
T Consensus       243 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          243 ---PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence               111234788999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-41  Score=352.35  Aligned_cols=257  Identities=23%  Similarity=0.325  Sum_probs=198.4

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ..++|+..+.||+|+||+||+|.+..+   +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            346889999999999999999998543   4679999987643 344578999999999999999999999985 46789


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +||||+++++|.+++... ...+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence            999999999999999543 3469999999999999999999998   999999999999999999999999999998765


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ...........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+.   ...    ...+..     
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~----i~~~~~-----  235 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR----IENGER-----  235 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH----HHTTCC-----
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHH----HHcCCC-----
Confidence            544333344567889999999998999999999999999999997 9999986543221   111    111111     


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      +.+..    ..+..+.+++.+||+.||++||++.++++.|+..
T Consensus       236 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          236 LPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11122    2334788999999999999999999999999764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.5e-41  Score=350.21  Aligned_cols=253  Identities=25%  Similarity=0.482  Sum_probs=206.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-------hHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-------GLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      .++|+..+.||+|+||+||+|++..+++.||+|++......       ..+++.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46899999999999999999999989999999998654321       1267899999999999999999999997655 


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCe--EEeeccCCCcEEeccCCc-----EEEc
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT--VIHRDIKAGNVLLDSELN-----GRLG  487 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlk~~NIll~~~~~-----~kl~  487 (687)
                       ++||||+++|+|.+++... ...+++..++.++.|++.||.|||+   .+  |+||||||+|||++.++.     +||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             7999999999999988654 3469999999999999999999998   78  999999999999988776     9999


Q ss_pred             ccccceeccCCCCCceeeeecCCCCCchhhcc--CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 005621          488 DFGLAKLYERGTNPSTTRVVGTLGYLAPELTR--TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       488 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      |||+++....    ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||.......... ...+..  
T Consensus       172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~--  244 (287)
T 4f0f_A          172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-INMIRE--  244 (287)
T ss_dssp             CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HHHHHH--
T ss_pred             CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HHHHhc--
Confidence            9999974332    234467899999999984  4567889999999999999999999998765433211 111111  


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                       .     ...+.+.    ......+.+++.+||+.||++||++.++++.|++
T Consensus       245 -~-----~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          245 -E-----GLRPTIP----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             -S-----CCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -c-----CCCCCCC----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             0     1112222    2233478899999999999999999999999975

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.5e-42  Score=361.78  Aligned_cols=273  Identities=24%  Similarity=0.303  Sum_probs=213.7

Q ss_pred             cCcccceeeeeeCeEEEEEEE----eCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeee--cCCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGT----LPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR--RRGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~  416 (687)
                      ++|+..+.||+|+||.||+|+    ...+++.||||++........+.+.+|++++++++||||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            578899999999999999999    45678999999998877777788999999999999999999999886  456789


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +||||+++++|.+++... ...+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999999999543 3469999999999999999999998   999999999999999999999999999998765


Q ss_pred             CCCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          497 RGTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       497 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      .....  ......||..|+|||++.+..++.++||||||+++|||++|+.||.......... ..+.........+.+.+
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPALSRLLELL  257 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccccccHHHHHHHh
Confidence            43321  1223457888999999999889999999999999999999999986432110000 00000000000011111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      ........+......+.+++.+||+.||++||++.|+++.|+....
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1112222233344578899999999999999999999999987653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.6e-41  Score=347.35  Aligned_cols=251  Identities=22%  Similarity=0.347  Sum_probs=206.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--CeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV  418 (687)
                      ++|...+.||+|+||+||+|++  .++.||||++...  .....+++.+|+.++++++||||+++++++...  +..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            5788999999999999999998  4889999998765  344567899999999999999999999999877  788999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCe--EEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT--VIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      |||+++|+|.+++.......+++.+++.++.|++.||.|||+   ++  |+||||||+||+++.++.++|+|||+.....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999976555569999999999999999999998   77  9999999999999999999999998875432


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCC---ccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTT---SSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      .      ....||+.|+|||.+.+...+.   ++||||||+++|||++|+.||......+.      .......+     
T Consensus       165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-----  227 (271)
T 3kmu_A          165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEG-----  227 (271)
T ss_dssp             C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSC-----
T ss_pred             c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcC-----
Confidence            2      2246899999999998765554   79999999999999999999976543211      11111111     


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ..+.+...    ....+.+++.+||+.||++||++.++++.|+...
T Consensus       228 ~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          228 LRPTIPPG----ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            11222222    3347889999999999999999999999998653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6e-41  Score=364.38  Aligned_cols=256  Identities=24%  Similarity=0.321  Sum_probs=206.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++|+..++||+|+||+||+|+++.+++.||+|++++..   ....+.+..|..++.++ +||||+++++++...+.+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999999999999999997653   23345678899999887 89999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|..++..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       131 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999999853  4579999999999999999999999   9999999999999999999999999999985322


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcch--hhHHHHHHHHhcccccccccC
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE--LILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~--~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      . .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  ....+++.+....+.      
T Consensus       206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------  278 (396)
T 4dc2_A          206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------  278 (396)
T ss_dssp             T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC------
T ss_pred             C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc------
Confidence            2 2234456899999999999999999999999999999999999999975432211  111122222222211      


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCH------HHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTM------RQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~  613 (687)
                      ..+...    ....+.+|+.+||+.||++||++      .||++
T Consensus       279 ~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          279 IRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             CCCCTT----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             cCCCCc----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            112222    23478899999999999999985      66665

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.1e-41  Score=360.60  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=207.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||+||+|.+..+++.||||++....   ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            68999999999999999999999999999999987542   222457889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+ +|+|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        89 E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             CCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             ECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            999 7899998843  4569999999999999999999998   899999999999999999999999999998654432


Q ss_pred             CCceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      .  .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.........                +.+... 
T Consensus       163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~~-  223 (336)
T 3h4j_B          163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNSC-  223 (336)
T ss_dssp             T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCSS-
T ss_pred             c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHcC-
Confidence            2  234579999999999988765 68999999999999999999999765432211                001000 


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ....+......+.+++.+||+.||++|||+.|+++  ++..
T Consensus       224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            01112223346889999999999999999999997  4544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.4e-41  Score=360.64  Aligned_cols=254  Identities=24%  Similarity=0.303  Sum_probs=206.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-----hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-----KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      .++|+..+.||+|+||+||+|.++.+++.||||++....     ....+++.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357999999999999999999999999999999986432     123577899999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchh--hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc---EEEccccc
Q 005621          417 LVYDFMPNGSLDKCLFDEQ--KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN---GRLGDFGL  491 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFGl  491 (687)
                      +||||+++++|.+++....  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999998885432  2358999999999999999999998   99999999999999987655   99999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....    .    .......+...
T Consensus       180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~----~~~~i~~~~~~  250 (351)
T 3c0i_A          180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----R----LFEGIIKGKYK  250 (351)
T ss_dssp             CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----H----HHHHHHHTCCC
T ss_pred             eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----H----HHHHHHcCCCC
Confidence            98765432 223345799999999999999999999999999999999999999976321    1    11111111110


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        ..+.....+    ...+.+++.+||+.||++||++.|+++
T Consensus       251 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 --MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             --CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              000000112    236889999999999999999999987

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7e-41  Score=349.19  Aligned_cols=263  Identities=22%  Similarity=0.281  Sum_probs=205.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..+.||+|+||+||+|.+..+++.||||++....  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999999999999999987543  3345778899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++ +|.+++.. ....+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            9975 56555533 24569999999999999999999999   8999999999999999999999999999987643322


Q ss_pred             CceeeeecCCCCCchhhccCCC-CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc------ccc
Q 005621          501 PSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI------LEV  573 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~------~~~  573 (687)
                       ......||+.|+|||++.+.. ++.++|||||||++|||++|..|+........  ....+.+.......      ...
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccc
Confidence             233457899999999998765 89999999999999999999988654433221  11222221111000      000


Q ss_pred             cC---------CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VD---------PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+         ..............+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00         00001111223347889999999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.7e-41  Score=364.63  Aligned_cols=275  Identities=22%  Similarity=0.244  Sum_probs=216.0

Q ss_pred             CCccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-----CCCcee
Q 005621          330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-----HRNLVQ  404 (687)
Q Consensus       330 ~~~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~  404 (687)
                      ...+++++.....++|...++||+|+||+||+|++..+++.||||++... ....+.+..|+.+++++.     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34566777777789999999999999999999999989999999999753 334466788999999986     999999


Q ss_pred             eeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc----
Q 005621          405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS----  480 (687)
Q Consensus       405 l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~----  480 (687)
                      +++++...+..++||||+ +++|.+++.......+++.++..++.||+.||.|||+   ++|+||||||+|||++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 9999999976655679999999999999999999998   99999999999999975    


Q ss_pred             ---------------------CCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHH
Q 005621          481 ---------------------ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEV  539 (687)
Q Consensus       481 ---------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~el  539 (687)
                                           ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                 788999999999865432    2245789999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCcchhhHHHHH---------HHHhcccccccccCCcCCCCCC--------------------HHHHHHH
Q 005621          540 VCGRRPIEPKALPEELILVDWV---------WDRWKAGAILEVVDPRLNGEFN--------------------EIEALDV  590 (687)
Q Consensus       540 ltG~~p~~~~~~~~~~~~~~~v---------~~~~~~~~~~~~~d~~l~~~~~--------------------~~~~~~l  590 (687)
                      ++|+.||......+........         ................+...++                    ......+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            9999999865433222111110         0000000000000000000000                    0011467


Q ss_pred             HHHHHhccccCcCcCCCHHHHHH
Q 005621          591 VKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       591 ~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+++.+||+.||++|||+.|+++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            79999999999999999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.5e-41  Score=369.92  Aligned_cols=255  Identities=23%  Similarity=0.317  Sum_probs=208.6

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ...++|+..+.||+|+||+||+|.+..+++.+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34578999999999999999999999999999999987643  3445678999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc---CCcEEEccccccee
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLAKL  494 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla~~  494 (687)
                      ||||+++|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.   ++.+||+|||+++.
T Consensus        88 v~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999999998853  4569999999999999999999999   99999999999999984   57899999999986


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+       +.+.+..+.. ...
T Consensus       163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~-~~~  233 (444)
T 3soa_A          163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAY-DFP  233 (444)
T ss_dssp             CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCC-CCC
T ss_pred             ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCC-CCC
Confidence            65432 22334679999999999999999999999999999999999999997654211       1112222211 111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+. ...    ....+.+++.+||+.||++||++.|+++
T Consensus       234 ~~~-~~~----~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          234 SPE-WDT----VTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TTT-TTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccc-ccc----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111 111    2346889999999999999999999997

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=349.53  Aligned_cols=253  Identities=26%  Similarity=0.457  Sum_probs=200.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|+..+.||+|+||+||+|++  .++.||||++...  ...+.|.+|++++++++||||+++++++.+  ..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            5788899999999999999998  4789999998754  345788999999999999999999999874  489999999


Q ss_pred             CCCCchhhhhchhh-ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc-EEEcccccceeccCCCC
Q 005621          423 PNGSLDKCLFDEQK-AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN-GRLGDFGLAKLYERGTN  500 (687)
Q Consensus       423 ~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-~kl~DFGla~~~~~~~~  500 (687)
                      ++|+|.+++..... ..+++..++.++.|+++||.|||+...++|+||||||+|||++.++. +||+|||+++.....  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999965432 34789999999999999999999854478999999999999998886 799999999755332  


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                        .....||..|+|||++.+..++.++||||||+++|||++|+.||.........  .  .+... .+.     .+.+..
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~--~~~~~-~~~-----~~~~~~  227 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--I--MWAVH-NGT-----RPPLIK  227 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--H--HHHHH-TTC-----CCCCBT
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--H--HHHHh-cCC-----CCCccc
Confidence              22346899999999999999999999999999999999999999765432211  1  11111 111     112222


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .++    ..+.+++.+||+.||++||++.++++.|+...
T Consensus       228 ~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          228 NLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             ccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            233    36889999999999999999999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-40  Score=356.87  Aligned_cols=255  Identities=25%  Similarity=0.326  Sum_probs=207.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|...+.||+|+||.||+|+++.+++.||+|++.+.   .....+.+..|..++.++ +||||+++++++...+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            5789999999999999999999999999999999765   234456788999999988 899999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++|+|.+++..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999843  4569999999999999999999999   99999999999999999999999999999854322


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchh--hHHHHHHHHhcccccccccCC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL--ILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~--~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ...+.+.+....+.      .
T Consensus       164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------~  236 (345)
T 3a8x_A          164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------I  236 (345)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------C
T ss_pred             C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------C
Confidence            2 2334568999999999999999999999999999999999999999754322110  11122222222211      1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCH------HHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTM------RQVVR  613 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~  613 (687)
                      .+...    ....+.+++.+||+.||++||++      .|+++
T Consensus       237 ~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          237 RIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             CCCTT----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             CCCCC----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            12222    23478899999999999999995      66665

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.9e-41  Score=362.06  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=202.8

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCCC
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      ...+.||+|+||.||+|.+..+++.||+|++........+++.+|++++++++||||+++++++...+..++||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            34678999999999999998899999999998876666788999999999999999999999999999999999999999


Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe--ccCCcEEEcccccceeccCCCCCce
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL--DSELNGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll--~~~~~~kl~DFGla~~~~~~~~~~~  503 (687)
                      +|.+++... ...+++.++..++.||+.||.|||+   .+|+||||||+|||+  +.++.+||+|||+++.......  .
T Consensus       172 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~  245 (373)
T 2x4f_A          172 ELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L  245 (373)
T ss_dssp             EEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred             cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence            999988543 3469999999999999999999998   999999999999999  5668899999999987654332  2


Q ss_pred             eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN  583 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~  583 (687)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  +.....     ... . ..+.....+ 
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~-----~~~-~-~~~~~~~~~-  315 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILA-----CRW-D-LEDEEFQDI-  315 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH-----TCC-C-SCSGGGTTS-
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh-----ccC-C-CChhhhccC-
Confidence            334699999999999988999999999999999999999999976543211  111111     100 0 001111122 


Q ss_pred             HHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHh
Q 005621          584 EIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLE  616 (687)
Q Consensus       584 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~  616 (687)
                         ...+.+++.+||+.||++||++.|+++  ++.
T Consensus       316 ---~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          316 ---SEEAKEFISKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             ---CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ---CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence               337889999999999999999999998  554

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.2e-41  Score=357.50  Aligned_cols=264  Identities=25%  Similarity=0.389  Sum_probs=214.9

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCC-----eEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeee
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTN-----TQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWC  409 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~  409 (687)
                      +++...++|...+.||+|+||+||+|.+...+     ..||+|++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            34455688999999999999999999986654     379999997653 34457789999999999 899999999999


Q ss_pred             ecCCeeEEEEecCCCCCchhhhhchh------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEE
Q 005621          410 RRRGDLLLVYDFMPNGSLDKCLFDEQ------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL  477 (687)
Q Consensus       410 ~~~~~~~lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  477 (687)
                      ...+..++||||+++|+|.+++....            ...+++..++.++.||+.||.|||+   .+|+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEE
Confidence            99999999999999999999996543            2357999999999999999999998   89999999999999


Q ss_pred             eccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchh
Q 005621          478 LDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEEL  555 (687)
Q Consensus       478 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  555 (687)
                      ++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            999999999999999866543322 1223467889999999999999999999999999999999 99999765543221


Q ss_pred             hHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       556 ~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                        .    .....+.     .+..    +...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus       277 --~----~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          277 --Y----KLVKDGY-----QMAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             --H----HHHHHTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --H----HHHhcCC-----CCCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence              1    1111111     1111    111234788999999999999999999999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.2e-41  Score=369.76  Aligned_cols=260  Identities=22%  Similarity=0.271  Sum_probs=211.3

Q ss_pred             HHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeec
Q 005621          335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRR  411 (687)
Q Consensus       335 ~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  411 (687)
                      .++++...++|...++||+|+||+||+|+++.+++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3455566789999999999999999999999999999999997532   1223457899999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                      .+.+++||||+++|+|.+++.   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999999884   3468999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCCC----CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGK----PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      ++.............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||......+..   .    .+..
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~----~i~~  287 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---S----KIMN  287 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H----HHHT
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH---H----HHHh
Confidence            9876544332334568999999999998765    789999999999999999999999865432111   1    1111


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCc--CCCHHHHHH
Q 005621          568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEA--RPTMRQVVR  613 (687)
Q Consensus       568 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~  613 (687)
                      +.. ...-|. ...+    ...+.+|+.+||+.+|++  ||++.||++
T Consensus       288 ~~~-~~~~p~-~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          288 HKN-SLTFPD-DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHH-HCCCCT-TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ccc-cccCCC-cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            100 000010 0112    236889999999999988  999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-41  Score=359.26  Aligned_cols=265  Identities=22%  Similarity=0.264  Sum_probs=208.7

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-----chhhHHHHHHHHHHHhhhcCCCceeeeeeeec
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-----SKQGLREFASEISSIGRLRHRNLVQLLGWCRR  411 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  411 (687)
                      ++....++|...+.||+|+||+||+|.+..+++.||+|++...     .....+++.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            4567778999999999999999999999999999999998654     23445789999999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCchhhhhch--------------------------------------hhccCCHHHHHHHHHHHHh
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDE--------------------------------------QKAILTWEQRYRIIKGVAS  453 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~--------------------------------------~~~~l~~~~~~~i~~~ia~  453 (687)
                      .+..++||||+++|+|.+++...                                      ....+++..+..++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999988420                                      0223467788899999999


Q ss_pred             hhhhhcccccCeEEeeccCCCcEEeccCC--cEEEcccccceeccCCCC---CceeeeecCCCCCchhhccC--CCCCCc
Q 005621          454 GLLYLHEEWEQTVIHRDIKAGNVLLDSEL--NGRLGDFGLAKLYERGTN---PSTTRVVGTLGYLAPELTRT--GKPTTS  526 (687)
Q Consensus       454 ~L~yLH~~~~~~ivHrDlk~~NIll~~~~--~~kl~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~  526 (687)
                      ||.|||+   .+|+||||||+|||++.++  .+||+|||+++.+.....   .......||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            9999999   8999999999999998776  899999999987644222   12344679999999999975  678999


Q ss_pred             cceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCC
Q 005621          527 SDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARP  606 (687)
Q Consensus       527 sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  606 (687)
                      +||||||+++|||++|+.||......+.      .........  ....+     ........+.+++.+||+.+|++||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKL--CFENP-----NYNVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC--CTTSG-----GGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhccc--ccCCc-----ccccCCHHHHHHHHHHcCCChhHCC
Confidence            9999999999999999999976543221      111111110  00001     0111234688999999999999999


Q ss_pred             CHHHHHH--HHhc
Q 005621          607 TMRQVVR--YLEG  617 (687)
Q Consensus       607 s~~evl~--~L~~  617 (687)
                      ++.++++  ++++
T Consensus       324 s~~~~l~hp~~~~  336 (345)
T 3hko_A          324 DAMRALQHPWISQ  336 (345)
T ss_dssp             CHHHHHHSHHHHT
T ss_pred             CHHHHhcChhhcc
Confidence            9999998  4544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-40  Score=352.42  Aligned_cols=264  Identities=27%  Similarity=0.373  Sum_probs=194.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|+..+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            4678999999999999999999988999999999876543 234678899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchh----hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          421 FMPNGSLDKCLFDEQ----KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       421 y~~~gsL~~~L~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      |++ |+|.+++....    ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 69999885432    2358999999999999999999998   999999999999999999999999999998765


Q ss_pred             CCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc--c---
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA--I---  570 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~--~---  570 (687)
                      .... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..   ..+.+......  .   
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCGG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhhh
Confidence            3322 2233578999999999976 46899999999999999999999999865432221   11211111000  0   


Q ss_pred             ---ccccCCcCC------------CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 ---LEVVDPRLN------------GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 ---~~~~d~~l~------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         .....+.+.            ..........+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence               000000000            0001112347889999999999999999999987

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.5e-41  Score=359.64  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=193.6

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ..++|...+.||+|+||+||+|++..+++.||||++....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4578999999999999999999999889999999997653  33568899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc---CCcEEEcccccceeccC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLAKLYER  497 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla~~~~~  497 (687)
                      |+++++|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       129 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          129 LVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            9999999999854  3468999999999999999999998   89999999999999975   88999999999986543


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........      ....+..+..      .
T Consensus       204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~------~  269 (349)
T 2w4o_A          204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEY------Y  269 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCC------C
T ss_pred             cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCC------c
Confidence            22  22345789999999999999999999999999999999999999976543221      1111111111      0


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ............+.+++.+||+.||++||++.|+++
T Consensus       270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111222347889999999999999999999987

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=351.88  Aligned_cols=245  Identities=24%  Similarity=0.313  Sum_probs=207.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||+||+++...+++.||+|++.+..   ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57899999999999999999999899999999997653   234567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        86 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           86 DYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             CCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999953  4568999999999999999999998   99999999999999999999999999999875432 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.       ......+.      ..+.
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~------~~~p  223 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKILNAE------LRFP  223 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHCC------CCCC
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCC------CCCC
Confidence               2345799999999999999999999999999999999999999976542111       11111111      1122


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ..+    ...+.+++.+||+.||++||     ++.++++
T Consensus       224 ~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          224 PFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            222    33788999999999999999     8999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.2e-41  Score=358.92  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=208.2

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCe
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  414 (687)
                      ....++|...+.||+|+||+||+|+++.+++.||||++++..   ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            445678999999999999999999999999999999997642   23456778899999987 99999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      +++||||+++|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999999943  3569999999999999999999999   9999999999999999999999999999985


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+       +.+.+..+      
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~------  233 (345)
T 1xjd_A          168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMD------  233 (345)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC------
T ss_pred             cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhC------
Confidence            43222 22345689999999999999999999999999999999999999997654221       11111111      


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHH-HHHH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMR-QVVR  613 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~  613 (687)
                      .+.+...+    ...+.+++.+||+.||++||++. +|++
T Consensus       234 ~~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          234 NPFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             CCCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            11122222    34788999999999999999997 7764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.6e-41  Score=361.89  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=208.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||.||++.+..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67899999999999999999999999999999987542   334577889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        95 e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             CCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            99999999999943  4569999999999999999999999   99999999999999999999999999999876433 


Q ss_pred             CCceeeeecCCCCCchhhccC---CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                       .......||+.|+|||++..   ..++.++|||||||++|||++|+.||...............    ...      ..
T Consensus       169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~~~------~~  237 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF----ETT------VV  237 (384)
T ss_dssp             -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH----HHC------CC
T ss_pred             -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hhc------cc
Confidence             23345679999999999874   45899999999999999999999999865443322222111    111      11


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCC-HHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPT-MRQVVR  613 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~  613 (687)
                      .....    ....+.+|+.+||+.||++||+ +.++++
T Consensus       238 ~~p~~----~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 TYPSA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCCTT----SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCCCc----CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            11122    2347889999999999999998 777775

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-41  Score=357.86  Aligned_cols=256  Identities=23%  Similarity=0.285  Sum_probs=185.6

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEEEecCCCCC
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVYDFMPNGS  426 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gs  426 (687)
                      .+.||+|+||+||+|.+..+++.||||++...   ....+.+|+.+++++. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            47899999999999999989999999999654   3456778999999997 9999999999999999999999999999


Q ss_pred             chhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC---cEEEcccccceeccCCCCCce
Q 005621          427 LDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL---NGRLGDFGLAKLYERGTNPST  503 (687)
Q Consensus       427 L~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGla~~~~~~~~~~~  503 (687)
                      |.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++   .+||+|||+++....... ..
T Consensus        93 L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~  166 (325)
T 3kn6_A           93 LFERIKK--KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL  166 (325)
T ss_dssp             HHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence            9999954  4579999999999999999999998   9999999999999997765   899999999986544322 23


Q ss_pred             eeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCC
Q 005621          504 TRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN  583 (687)
Q Consensus       504 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~  583 (687)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||..............+...+..+..      ....+..
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~  240 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEAW  240 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcccc
Confidence            3457899999999999999999999999999999999999999865432211111222222222221      0111111


Q ss_pred             HHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          584 EIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       584 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                      ......+.+|+.+||+.||++||++.|+++  ++++.
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            112347889999999999999999999985  45443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=369.23  Aligned_cols=265  Identities=21%  Similarity=0.222  Sum_probs=213.5

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGW  408 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~  408 (687)
                      .+.+++++...++|+..++||+|+||+||+++++.+++.||||++++..   ....+.+.+|..++.+++||||++++++
T Consensus        50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  129 (412)
T 2vd5_A           50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA  129 (412)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            3456666777899999999999999999999999899999999997642   2234558899999999999999999999


Q ss_pred             eecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcc
Q 005621          409 CRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGD  488 (687)
Q Consensus       409 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  488 (687)
                      +.+.+.+++||||+++|+|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEee
Confidence            99999999999999999999999543 2369999999999999999999998   9999999999999999999999999


Q ss_pred             cccceeccCCCCCceeeeecCCCCCchhhcc-------CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 005621          489 FGLAKLYERGTNPSTTRVVGTLGYLAPELTR-------TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV  561 (687)
Q Consensus       489 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v  561 (687)
                      ||+++.............+||+.|+|||++.       .+.++.++|||||||++|||++|+.||......+...   .+
T Consensus       206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~---~i  282 (412)
T 2vd5_A          206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG---KI  282 (412)
T ss_dssp             CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HH
T ss_pred             chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH---HH
Confidence            9999876544332333468999999999987       4578999999999999999999999998654322111   11


Q ss_pred             HHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcC---CCHHHHHH
Q 005621          562 WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEAR---PTMRQVVR  613 (687)
Q Consensus       562 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~  613 (687)
                      .   ....  ...-|.+...+    ...+.+++.+||+ +|++|   |+++|+++
T Consensus       283 ~---~~~~--~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          283 V---HYKE--HLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             H---THHH--HCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             H---hccc--CcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            1   0000  00011111222    3378899999999 99998   68999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-40  Score=348.65  Aligned_cols=263  Identities=22%  Similarity=0.271  Sum_probs=203.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999998899999999987653   23357789999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++..  ...+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus       113 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999953  3569999999999999999999999   89999999999999999999999999999876544


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      .........|+..|+|||.+.+..++.++||||||+++|||++|+.||......       .+......... .  ....
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-~--~~~~  257 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP-R--PSTV  257 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-C--GGGT
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-C--cccc
Confidence            333334557899999999999999999999999999999999999999764321       11111111100 0  0011


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCC-CHHHHHHHHhcCCCCCC
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARP-TMRQVVRYLEGEVPLPQ  623 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~~~~  623 (687)
                      ...+    +..+.+++.+||+.||++|| ++.++++.|+.......
T Consensus       258 ~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          258 RPGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             STTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CCCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            1222    23688999999999999999 99999999998654433

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.7e-41  Score=358.58  Aligned_cols=269  Identities=24%  Similarity=0.390  Sum_probs=218.4

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQL  405 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  405 (687)
                      .+..++++...++|...+.||+|+||.||+|++.     ..++.||||++.... .....++.+|+.++++++||||+++
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            3455566677889999999999999999999875     346789999997653 3445678999999999999999999


Q ss_pred             eeeeecCCeeEEEEecCCCCCchhhhhchhh--------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEE
Q 005621          406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQK--------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL  477 (687)
Q Consensus       406 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~--------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  477 (687)
                      ++++.+.+..++||||+++|+|.+++.....        ..+++..+++++.||+.||.|||+   ++|+||||||+||+
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIl  170 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCM  170 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEE
Confidence            9999999999999999999999999965332        357999999999999999999999   89999999999999


Q ss_pred             eccCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchh
Q 005621          478 LDSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEEL  555 (687)
Q Consensus       478 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  555 (687)
                      ++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......  
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--  248 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--  248 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--
Confidence            99999999999999986543221 12223467889999999999999999999999999999999 888987654211  


Q ss_pred             hHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       556 ~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                           +......+...     ..    +......+.+++.+||+.+|++||++.|+++.|+...
T Consensus       249 -----~~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          249 -----VLRFVMEGGLL-----DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             -----HHHHHHTTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             -----HHHHHHcCCcC-----CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence                 11111122111     11    1122346889999999999999999999999998764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.3e-40  Score=342.16  Aligned_cols=258  Identities=23%  Similarity=0.352  Sum_probs=211.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999999989999999998654  3445577889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc---EEEcccccceecc
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN---GRLGDFGLAKLYE  496 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFGla~~~~  496 (687)
                      ||+++++|.+++..  ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999988843  4569999999999999999999998   99999999999999987655   9999999998665


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........       ......+.. ....+
T Consensus       160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~-~~~~~  229 (284)
T 3kk8_A          160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YAQIKAGAY-DYPSP  229 (284)
T ss_dssp             SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC-CCCTT
T ss_pred             cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-------HHHHHhccc-cCCch
Confidence            432  22345789999999999999999999999999999999999999976542211       111111111 00111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCC
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEV  619 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~  619 (687)
                      . ...+    ...+.+++.+||+.||++||++.|+++  ++.+..
T Consensus       230 ~-~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          230 E-WDTV----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             T-TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             h-hccc----CHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            0 1122    236889999999999999999999998  565543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-40  Score=355.80  Aligned_cols=246  Identities=22%  Similarity=0.279  Sum_probs=208.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|...+.||+|+||.||++++..+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367999999999999999999999899999999997643   23456788999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999953  3569999999999999999999998   99999999999999999999999999999876432


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+       +.+.+..+.      ..+
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~------~~~  257 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGK------VRF  257 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------CCC
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCC------CCC
Confidence                234579999999999999999999999999999999999999997654211       111122221      112


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                      ...+    ...+.+++.+||+.||++||+     +.+|++
T Consensus       258 p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          258 PSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            2222    347889999999999999998     888886

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.8e-40  Score=348.25  Aligned_cols=267  Identities=25%  Similarity=0.311  Sum_probs=205.4

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ..++|+..++||+|+||+||+|++. +++.||+|++....  ......+.+|++++++++||||+++++++...+..++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            3478999999999999999999995 58999999987543  22346788999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++ +|.+++... ...+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           98 FEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             EcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            999974 888877543 3459999999999999999999998   99999999999999999999999999999876533


Q ss_pred             CCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc---cccc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI---LEVV  574 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~---~~~~  574 (687)
                      .. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....   +.........   ....
T Consensus       173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGT
T ss_pred             cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhhh
Confidence            22 2334578999999999876 5689999999999999999999999987654433221   1111111000   0000


Q ss_pred             ------CCcC--CCC-----CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          575 ------DPRL--NGE-----FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       575 ------d~~l--~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                            +...  ...     .......++.+|+.+||+.||++|||++|+++  ++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  306 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD  306 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence                  0000  000     00112246789999999999999999999997  4443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-40  Score=345.12  Aligned_cols=252  Identities=25%  Similarity=0.393  Sum_probs=206.8

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      +.++|+..+.||+|+||+||+|.+..+++.||||++....   ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3468999999999999999999999999999999986542   2235678899999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999999843  3569999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .   ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+..       .....      ....
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~------~~~~  225 (279)
T 3fdn_A          162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRISR------VEFT  225 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHH------TCCC
T ss_pred             c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-------HHHHh------CCCC
Confidence            2   223457899999999999999999999999999999999999999865432111       11111      1111


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      +...    ....+.+++.+||+.+|++||++.|+++  ++..
T Consensus       226 ~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          226 FPDF----VTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             CCTT----SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             CCCc----CCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence            1122    2346889999999999999999999997  4443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.5e-41  Score=382.62  Aligned_cols=260  Identities=30%  Similarity=0.422  Sum_probs=212.4

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      +...++|...++||+|+||.||+|.+.. +..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..+||
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            3445678899999999999999999964 57899999976542 34689999999999999999999999976 678999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++|+|.++|.......+++.+++.|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            999999999999976555679999999999999999999998   99999999999999999999999999999865422


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .........++..|+|||++..+.++.++|||||||+||||++ |+.||......+       +.+....+..       
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~-------  482 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR-------  482 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCC-------
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence            1111122346788999999999999999999999999999999 999997654321       1111112211       


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                        ...+..+...+.+|+.+||+.||++||++.+|++.|+....
T Consensus       483 --~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence              11122234478899999999999999999999999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1e-40  Score=344.91  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=210.4

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ..++|+..+.||+|+||+||+|.+..++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            34679999999999999999999999999999999987766667889999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe---ccCCcEEEcccccceeccC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL---DSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~~~  497 (687)
                      |+++++|.+++..  ...+++.++..++.|++.||.|||+   .+|+||||||+||++   +.++.+||+|||++.....
T Consensus        87 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           87 LCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999999998843  4569999999999999999999998   999999999999999   7889999999999987654


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      ..  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+.       ......+....  ...
T Consensus       162 ~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~--~~~  229 (277)
T 3f3z_A          162 GK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-------MLKIREGTFTF--PEK  229 (277)
T ss_dssp             TS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCC--CHH
T ss_pred             cc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCCCCC--Cch
Confidence            32  2234578999999999865 489999999999999999999999976542211       11111111100  000


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ....    ....+.+++.+||+.||++||++.++++  ++++
T Consensus       230 ~~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          230 DWLN----VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             HHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             hhhc----CCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            0001    2347889999999999999999999986  4443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.8e-41  Score=356.73  Aligned_cols=251  Identities=17%  Similarity=0.286  Sum_probs=199.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC-------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG-------  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-------  413 (687)
                      .++|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467899999999999999999999899999999997543 334578999999999999999999999885543       


Q ss_pred             --------------------------------------------------eeEEEEecCCCCCchhhhhchh-hccCCHH
Q 005621          414 --------------------------------------------------DLLLVYDFMPNGSLDKCLFDEQ-KAILTWE  442 (687)
Q Consensus       414 --------------------------------------------------~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~  442 (687)
                                                                        ..++||||+++++|.+++.... .....+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3799999999999999996532 3346778


Q ss_pred             HHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC-----------CceeeeecCCC
Q 005621          443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN-----------PSTTRVVGTLG  511 (687)
Q Consensus       443 ~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~  511 (687)
                      .++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            899999999999999998   9999999999999999999999999999987655421           11233569999


Q ss_pred             CCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHH
Q 005621          512 YLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVV  591 (687)
Q Consensus       512 y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  591 (687)
                      |+|||++.+..++.++||||||+++|||++|..|+..     ..   . .........        . ..........+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~---~-~~~~~~~~~--------~-~~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RV---R-IITDVRNLK--------F-PLLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HH---H-HHHHHHTTC--------C-CHHHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HH---H-HHHHhhccC--------C-CcccccCChhHH
Confidence            9999999999999999999999999999998765321     00   0 111111110        0 011122334678


Q ss_pred             HHHHhccccCcCcCCCHHHHHH
Q 005621          592 KLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       592 ~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +++.+||+.||++||++.|+++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            9999999999999999999987

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=350.33  Aligned_cols=265  Identities=23%  Similarity=0.280  Sum_probs=203.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..+.||+|+||+||+|.+..+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67999999999999999999999889999999986553  2335678899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++.  ....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           83 YCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             CCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            999999998874  34569999999999999999999998   9999999999999999999999999999987653322


Q ss_pred             CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhcccccc
Q 005621          501 PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV--------WDRWKAGAIL  571 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v--------~~~~~~~~~~  571 (687)
                       ......||..|+|||++.+ ..++.++||||||+++|||++|+.||......+........        ...+......
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence             2234578999999999876 67899999999999999999999999776543322211111        0001111100


Q ss_pred             ---cccCCcCCCCC---CHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 ---EVVDPRLNGEF---NEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ---~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         ...++.-....   .......+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence               00111000000   0112336889999999999999999999997

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4e-41  Score=345.61  Aligned_cols=254  Identities=26%  Similarity=0.424  Sum_probs=208.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|...+.||+|+||.||+|.+. ++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            57888999999999999999986 578899999976543 2367899999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.........
T Consensus        86 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             TTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            999999999543 3468999999999999999999998   999999999999999999999999999998653321111


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   .    ......+.     .+..   
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~i~~~~-----~~~~---  226 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---V----VEDISTGF-----RLYK---  226 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HHHHHTTC-----CCCC---
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---H----HHHHhcCC-----cCCC---
Confidence            222356778999999998899999999999999999999 899987654221   1    11111111     1111   


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                       +......+.+++.+||+.+|++||++.++++.|+..
T Consensus       227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          227 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             111234688999999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.4e-41  Score=352.51  Aligned_cols=263  Identities=22%  Similarity=0.249  Sum_probs=208.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeee----cCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR----RRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~~~~~~l  417 (687)
                      .++|+..+.||+|+||.||++....+++.||||++........+.+.+|+.++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            468999999999999999999998899999999997766667788999999999999999999999986    3457899


Q ss_pred             EEecCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          418 VYDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ||||+++|+|.+++...  ....+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999999643  34579999999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCC--------ceeeeecCCCCCchhhccCCC---CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 005621          496 ERGTNP--------STTRVVGTLGYLAPELTRTGK---PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       496 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      ......        ......||+.|+|||.+....   ++.++||||||+++|||++|+.||......... ..    ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~----~~  259 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VA----LA  259 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HH----HH
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hh----HH
Confidence            321111        011235799999999987553   688999999999999999999998532111000 00    00


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCC
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPL  621 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  621 (687)
                      ...         .............+.+++.+||+.||++||++.++++.|+...+.
T Consensus       260 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          260 VQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            000         000011112234788999999999999999999999999986543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.3e-41  Score=346.49  Aligned_cols=257  Identities=24%  Similarity=0.333  Sum_probs=205.7

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCC---CCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPS---TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ..++|...+.||+|+||+||+|.+..   .+..||+|++... .....+++.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            35789999999999999999998643   3456999998765 34456789999999999999999999999875 4578


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +||||+++++|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999999543 3458999999999999999999998   999999999999999999999999999998765


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   ..    ...+..     
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~----~~~~~~-----  232 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GV----LEKGDR-----  232 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HH----HHHTCC-----
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HH----HhcCCC-----
Confidence            443333334567889999999998999999999999999999998 99999765433211   11    111111     


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ......    ....+.+++.+||+.+|++||++.|+++.|+..
T Consensus       233 ~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          233 LPKPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            111112    234688999999999999999999999999764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.3e-41  Score=352.91  Aligned_cols=270  Identities=28%  Similarity=0.401  Sum_probs=217.7

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEEe-----CCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCcee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQ  404 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~  404 (687)
                      .+...++....++|...+.||+|+||+||+|.+     ..+++.||||++.... ....+.+.+|+.++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            345556666778999999999999999999985     3467899999997653 34456889999999999 7999999


Q ss_pred             eeeeeecCC-eeEEEEecCCCCCchhhhhchhh--------------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEee
Q 005621          405 LLGWCRRRG-DLLLVYDFMPNGSLDKCLFDEQK--------------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHR  469 (687)
Q Consensus       405 l~~~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  469 (687)
                      +++++...+ ..++||||+++++|.+++.....              ..+++.++..++.|++.||.|||+   .+|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccc
Confidence            999987654 58999999999999999965432              128999999999999999999999   899999


Q ss_pred             ccCCCcEEeccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCC
Q 005621          470 DIKAGNVLLDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIE  547 (687)
Q Consensus       470 Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~  547 (687)
                      ||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999999866443322 2234567899999999999999999999999999999998 999997


Q ss_pred             CCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          548 PKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       548 ~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ........      ......+..     .......    ...+.+++.+||+.||++||++.++++.|+...
T Consensus       253 ~~~~~~~~------~~~~~~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          253 GVKIDEEF------CRRLKEGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             TCCCSHHH------HHHHHHTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhHHH------HHHhccCcc-----CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            65543221      111111111     1111222    336889999999999999999999999998653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.8e-40  Score=352.15  Aligned_cols=266  Identities=19%  Similarity=0.283  Sum_probs=213.4

Q ss_pred             CCccCHHHHHHHhcCcccc-eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhh-cCCCceee
Q 005621          330 PHRFSYEELKKATRGFRDK-ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRL-RHRNLVQL  405 (687)
Q Consensus       330 ~~~~~~~el~~at~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l  405 (687)
                      ...+.++..+...++|... +.||+|+||+||+|.+..+++.||+|++.....  ....++.+|+.++.++ +||||+++
T Consensus        15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~   94 (327)
T 3lm5_A           15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL   94 (327)
T ss_dssp             -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            3445556667777888887 899999999999999998999999999876532  3357889999999999 56999999


Q ss_pred             eeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc---CC
Q 005621          406 LGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---EL  482 (687)
Q Consensus       406 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~  482 (687)
                      ++++...+..++||||+++|+|.+++.......+++.+++.++.|++.||.|||+   .+|+||||||+|||++.   ++
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBC
T ss_pred             EEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCC
Confidence            9999999999999999999999999976656779999999999999999999998   89999999999999988   78


Q ss_pred             cEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 005621          483 NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVW  562 (687)
Q Consensus       483 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~  562 (687)
                      .+||+|||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+...      
T Consensus       172 ~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------  243 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL------  243 (327)
T ss_dssp             CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------
T ss_pred             cEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH------
Confidence            99999999998765432  2234579999999999999999999999999999999999999997654322111      


Q ss_pred             HHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       563 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       ......      ..............+.+++.+||+.||++||++.++++
T Consensus       244 -~i~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          244 -NISQVN------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -HHHHTC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -HHHhcc------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence             010100      01111111122346889999999999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=349.26  Aligned_cols=264  Identities=25%  Similarity=0.319  Sum_probs=203.2

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-----hhhHHHHHHHHHHHhhhc---CCCceeeeeeeecC
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-----KQGLREFASEISSIGRLR---HRNLVQLLGWCRRR  412 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~  412 (687)
                      .+++|+..++||+|+||+||+|++..+++.||||++....     ......+.+|+.++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4679999999999999999999998899999999986432     112345667777777665   99999999999765


Q ss_pred             C-----eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEc
Q 005621          413 G-----DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       413 ~-----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~  487 (687)
                      .     ..++||||+. ++|.+++.......+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     5899999996 699999976655569999999999999999999999   899999999999999999999999


Q ss_pred             ccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          488 DFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       488 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      |||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   ..+.+....
T Consensus       163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~  237 (308)
T 3g33_A          163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGL  237 (308)
T ss_dssp             SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred             eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCC
Confidence            999998654332  233457899999999999999999999999999999999999999765432221   112221111


Q ss_pred             cccccc----------cCCcCCC---CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          568 GAILEV----------VDPRLNG---EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       568 ~~~~~~----------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ......          ..+....   .........+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            000000          0000000   000112347889999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.2e-40  Score=350.20  Aligned_cols=262  Identities=23%  Similarity=0.358  Sum_probs=202.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|+..+.||+|+||.||+|.+..+++.||||++...   ......++.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46799999999999999999999888999999998753   344567889999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          419 YDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      |||+++++|.+++...  ....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998542  34568999999999999999999998   999999999999999999999999999998654


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      .... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ .+.    .....+....    
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~~~~~~~~----  257 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC----KKIEQCDYPP----  257 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHH----HHHHTTCSCC----
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHH----HHhhcccCCC----
Confidence            3322 22335689999999999999999999999999999999999999976543211 111    1111111111    


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      .....+    ...+.+++.+||+.||++||++.+|++.|++..+
T Consensus       258 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          258 LPSDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             CCTTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Cccccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            011122    3368899999999999999999999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9e-41  Score=359.63  Aligned_cols=253  Identities=21%  Similarity=0.255  Sum_probs=196.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|...+.||+|+||+||++++..+++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            4689999999999999999999998999999999976432 236688999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc--EEEcccccceeccCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN--GRLGDFGLAKLYERGT  499 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DFGla~~~~~~~  499 (687)
                      +++|+|.+++..  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.  +||+|||+++......
T Consensus        98 ~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           98 ASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            999999999843  4569999999999999999999998   99999999999999987765  9999999997433222


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCc-cceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTS-SDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                        ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||..........  ..+.... ....      .+
T Consensus       173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~~~~-~~~~------~~  241 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQRIL-SVKY------SI  241 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHHHHH-TTCC------CC
T ss_pred             --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHHHHh-cCCC------CC
Confidence              2234579999999999988877665 899999999999999999998755433221  1111111 1100      01


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..  .......+.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          242 PD--DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            00  0112236889999999999999999999997

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-40  Score=357.17  Aligned_cols=250  Identities=24%  Similarity=0.299  Sum_probs=207.0

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  416 (687)
                      ..++|...+.||+|+||+||+|++..+++.||||++.+..   ....+.+..|..++..+ +||||+++++++...+.++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3468999999999999999999998889999999997652   23456788999999988 8999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +||||+++|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999943  3569999999999999999999999   999999999999999999999999999998543


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +    .+.+..+.      .
T Consensus       173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~----~~~i~~~~------~  238 (353)
T 2i0e_A          173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L----FQSIMEHN------V  238 (353)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCC------C
T ss_pred             cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---H----HHHHHhCC------C
Confidence            222 23345679999999999999999999999999999999999999997654211   1    11111111      1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                      .+...    ....+.+++.+||+.||++||+     ++++++
T Consensus       239 ~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 AYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCCTT----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            11122    2347889999999999999995     577775

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.8e-40  Score=342.28  Aligned_cols=253  Identities=24%  Similarity=0.405  Sum_probs=209.2

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeec---------
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRR---------  411 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------  411 (687)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++....    ..+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567999999999999999999998889999999997654    346789999999999999999998854         


Q ss_pred             -------CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          412 -------RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       412 -------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                             ....++||||+++++|.+++.......+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence                   4568999999999999999976656679999999999999999999998   899999999999999999999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      ||+|||+++.......  .....|++.|+|||.+.+..++.++||||||+++|||++|..|+...         ......
T Consensus       162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~~  230 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFTD  230 (284)
T ss_dssp             EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHHH
T ss_pred             EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHHH
Confidence            9999999987654322  23356899999999999999999999999999999999999886321         011111


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCCCC
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQ  623 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~  623 (687)
                      ...+        .+...++    ..+.+++.+||+.||++||++.|+++.|+.....+.
T Consensus       231 ~~~~--------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          231 LRDG--------IISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHTT--------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             hhcc--------cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            1111        1222233    367889999999999999999999999987654443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.6e-40  Score=351.48  Aligned_cols=252  Identities=24%  Similarity=0.323  Sum_probs=208.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh------hHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      .++|...+.||+|+||.||+|.+..+++.||+|++......      ..+++.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            46799999999999999999999989999999998764321      357789999999999999999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC----cEEEccccc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL----NGRLGDFGL  491 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGl  491 (687)
                      ++||||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            999999999999999943  4568999999999999999999998   9999999999999999887    799999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ++.......  .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+..       ..+..... 
T Consensus       166 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~~-  235 (321)
T 2a2a_A          166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------ANITSVSY-  235 (321)
T ss_dssp             CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHTTCC-
T ss_pred             ceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhccc-
Confidence            987654322  23456899999999999999999999999999999999999999765422111       11111110 


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       ..++.....    ....+.+++.+||+.||++||++.|+++
T Consensus       236 -~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 -DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             001111111    2236889999999999999999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.6e-41  Score=355.23  Aligned_cols=259  Identities=26%  Similarity=0.411  Sum_probs=210.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeC-------CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecC
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLP-------STNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRR  412 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  412 (687)
                      .++|...+.||+|+||+||+|.+.       .++..||||++.... ....+++.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999975       356789999997653 34567899999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                      +..++||||+++|+|.+++....              ...+++.+++.++.||+.||.|||+   .+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence            99999999999999999996532              2348999999999999999999998   999999999999999


Q ss_pred             ccCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhh
Q 005621          479 DSELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELI  556 (687)
Q Consensus       479 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  556 (687)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+   
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence            9999999999999987654322 11223456789999999998889999999999999999999 999997654221   


Q ss_pred             HHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          557 LVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       557 ~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                          +......+..     +.....    ....+.+++.+||+.+|++||++.|+++.|+...
T Consensus       268 ----~~~~~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          268 ----LFKLLKEGHR-----MDKPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             ----HHHHHHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHhcCCC-----CCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                1111111111     111122    2347889999999999999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=356.24  Aligned_cols=259  Identities=25%  Similarity=0.372  Sum_probs=203.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeE----EEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQ----VAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      .++|+..++||+|+||+||+|.+..+++.    ||+|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            36799999999999999999998777654    577777544 3345678999999999999999999999998754 78


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +|+||+++|+|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999999998643 3469999999999999999999998   999999999999999999999999999998764


Q ss_pred             CCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          497 RGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       497 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ..... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   .    ....+.     
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~----~~~~~~-----  236 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---S----ILEKGE-----  236 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H----HHHTTC-----
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---H----HHHcCC-----
Confidence            43221 2223456788999999999999999999999999999999 99999875543211   1    111111     


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCC
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPL  621 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  621 (687)
                          ....+......+.+++.+||+.||++||++.|+++.|+.....
T Consensus       237 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 ----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                1111222334688999999999999999999999999876543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.3e-40  Score=344.88  Aligned_cols=259  Identities=27%  Similarity=0.476  Sum_probs=197.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .++|+..++||+|+||+||+|++..   .||||++...  .....+.+.+|+.++++++||||+++++++. ....++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence            5689999999999999999998743   5999998754  3445678999999999999999999999764 55689999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++... ...+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        99 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           99 QWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999998543 3469999999999999999999998   999999999999999999999999999998654322


Q ss_pred             -CCceeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          500 -NPSTTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       500 -~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                       ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||......+.  ..    +....+...    
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~~~~----  244 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--II----EMVGRGSLS----  244 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HH----HHHHHTSCC----
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HH----HHhcccccC----
Confidence             22233457899999999986   56788899999999999999999999986554321  11    111122111    


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      +.+ .......+..+.+++.+||+.+|++||++.++++.|+...
T Consensus       245 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          245 PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            111 1111223347889999999999999999999999998764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=346.15  Aligned_cols=274  Identities=23%  Similarity=0.318  Sum_probs=206.4

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh--cCCCceeeeeee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL--RHRNLVQLLGWC  409 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~  409 (687)
                      ......-....++|+..+.||+|+||.||+|++  .++.||||++.....   ..+..|.+++..+  +||||+++++++
T Consensus        26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             CCCcccccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            344444555668999999999999999999998  489999999865432   3444555555554  999999999999


Q ss_pred             ecC----CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccc-----cCeEEeeccCCCcEEecc
Q 005621          410 RRR----GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW-----EQTVIHRDIKAGNVLLDS  480 (687)
Q Consensus       410 ~~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlk~~NIll~~  480 (687)
                      ...    ...++||||+++|+|.+++.   ...+++.+++.++.|++.||.|||+.+     .++|+||||||+|||++.
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK  177 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHH---HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence            877    68999999999999999993   346999999999999999999999821     129999999999999999


Q ss_pred             CCcEEEcccccceeccCCCCCc---eeeeecCCCCCchhhccCCCCCCc------cceehhhHHHHHHHhC---------
Q 005621          481 ELNGRLGDFGLAKLYERGTNPS---TTRVVGTLGYLAPELTRTGKPTTS------SDVYAFGALLLEVVCG---------  542 (687)
Q Consensus       481 ~~~~kl~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDV~S~Gvvl~elltG---------  542 (687)
                      ++.+||+|||+++.+.......   .....||+.|+|||++.+.....+      +|||||||++|||++|         
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            9999999999998664433221   123579999999999988776665      9999999999999999         


Q ss_pred             -CCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC-CHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          543 -RRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF-NEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       543 -~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                       +.||..........  ........    .....+.+...+ ...+...+.+++.+||+.||++||++.+|++.|+...
T Consensus       258 ~~~p~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          258 YQLPYHDLVPSDPSY--EDMREIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CCCTTTTTSCSSCCH--HHHHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccHhhhcCCCCch--hhhHHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence             56665433222111  11111111    111122222211 2356778999999999999999999999999998754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-40  Score=346.82  Aligned_cols=263  Identities=27%  Similarity=0.359  Sum_probs=207.2

Q ss_pred             cCcccceeeeeeCeEEEEEEE----eCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--Cee
Q 005621          343 RGFRDKELLGFGGFGRVYKGT----LPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDL  415 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  415 (687)
                      ++|+..+.||+|+||.||+|+    ...+++.||||++.... ....+++.+|+.++++++||||+++++++...  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            568899999999999999999    45678999999997553 33457889999999999999999999999876  668


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++++|.+++... ...+++.+++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            9999999999999998543 3469999999999999999999998   99999999999999999999999999999876


Q ss_pred             cCCCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCC--------cchhhHHHHHHHHh
Q 005621          496 ERGTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKAL--------PEELILVDWVWDRW  565 (687)
Q Consensus       496 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~--------~~~~~~~~~v~~~~  565 (687)
                      ......  ......||..|+|||.+.+..++.++||||||+++|||++|+.|+.....        .........+....
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            544321  12234578889999999998999999999999999999999988643210        00000111111111


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ..+         .....+......+.+++.+||+.||++||++.++++.|+..
T Consensus       257 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          257 KEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            111         11112223334788999999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.6e-40  Score=358.07  Aligned_cols=267  Identities=18%  Similarity=0.220  Sum_probs=207.2

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCC-----CeEEEEEEecCcchhhH-----------HHHHHHHHHHhhhcCCCcee
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPST-----NTQVAVKRVSNESKQGL-----------REFASEISSIGRLRHRNLVQ  404 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~  404 (687)
                      ..++|...+.||+|+||+||+|.+..+     ++.||||++........           ..+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            456899999999999999999998654     47899999876542211           12445667778889999999


Q ss_pred             eeeeeecC----CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec-
Q 005621          405 LLGWCRRR----GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD-  479 (687)
Q Consensus       405 l~~~~~~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~-  479 (687)
                      +++++...    ...+|||||+ +++|.+++... ...+++.+++.|+.||+.||.|||+   .+|+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence            99998764    4589999999 99999998542 3569999999999999999999999   8999999999999999 


Q ss_pred             -cCCcEEEcccccceeccCCCCC------ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCc
Q 005621          480 -SELNGRLGDFGLAKLYERGTNP------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALP  552 (687)
Q Consensus       480 -~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~  552 (687)
                       .++.+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999876433211      123356999999999999999999999999999999999999999864332


Q ss_pred             chhhHHHHHHHHhcccccccccCCcCC-CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          553 EELILVDWVWDRWKAGAILEVVDPRLN-GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       553 ~~~~~~~~v~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ...  ..+....+. ..+.+.+++.+. ..+    +..+.+++..||+.+|++||++.+|++.|+...
T Consensus       268 ~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          268 PKY--VRDSKIRYR-ENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             HHH--HHHHHHHHH-HCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHH--HHHHHHHhh-hhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            221  112221111 122233333322 122    237889999999999999999999999987653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.7e-40  Score=358.21  Aligned_cols=257  Identities=23%  Similarity=0.289  Sum_probs=196.7

Q ss_pred             cCcccc-eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhh-hcCCCceeeeeeeec----CCeeE
Q 005621          343 RGFRDK-ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR-LRHRNLVQLLGWCRR----RGDLL  416 (687)
Q Consensus       343 ~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~~~  416 (687)
                      ++|... ++||+|+||+||++.+..+++.||||++...     ..+.+|+.++.+ .+||||+++++++..    .+.++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 7899999999999999999999999999643     356678888755 489999999998865    56789


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc---CCcEEEcccccce
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLAK  493 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla~  493 (687)
                      +||||+++|+|.+++.......+++.++..|+.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            99999999999999976555679999999999999999999998   99999999999999998   7889999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........   ....+..+.. ..
T Consensus       213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~-~~  286 (400)
T 1nxk_A          213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQY-EF  286 (400)
T ss_dssp             ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCC-CC
T ss_pred             ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCcc-cC
Confidence            654322  23446789999999999999999999999999999999999999976543221100   0111111111 00


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                      ..+     ........+.+|+.+||+.||++||++.|+++  ++...
T Consensus       287 ~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          287 PNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             CTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            001     01112346889999999999999999999998  45443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-40  Score=344.22  Aligned_cols=250  Identities=30%  Similarity=0.423  Sum_probs=200.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-CeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRR-GDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~E  420 (687)
                      .++|+..+.||+|+||+||+|.+  .++.||||++....  ..+++.+|+.++++++||||+++++++.+. +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            46889999999999999999998  48899999997653  456789999999999999999999987544 57899999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++.......+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++...... 
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            9999999999976555568999999999999999999998   999999999999999999999999999997543321 


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..       .....+.     .+.. 
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-------~~~~~~~-----~~~~-  235 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGY-----KMDA-  235 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-------HHHTTTC-----CCCC-
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCC-----CCCC-
Confidence               23357889999999999999999999999999999998 99999765432211       1111111     1111 


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                         +...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          236 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence               222334788999999999999999999999999764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.1e-40  Score=344.92  Aligned_cols=261  Identities=24%  Similarity=0.325  Sum_probs=201.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..+.||+|+||+||+|++ .+++.||+|++.....  ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5789999999999999999998 5689999999865432  234678899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++ +|.+++... ...+++.++..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            9975 898888543 3468999999999999999999998   999999999999999999999999999998654322 


Q ss_pred             CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc--------cc
Q 005621          501 PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA--------IL  571 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~--------~~  571 (687)
                      .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..   ..+.+......        ..
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGS
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhhhcc
Confidence            12234578999999999876 45899999999999999999999999765432211   11111111100        00


Q ss_pred             cccCCcCC-------CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLN-------GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ...++...       ..+.......+.+++.+||+.||++||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            01111111       0111123347889999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-39  Score=340.21  Aligned_cols=261  Identities=18%  Similarity=0.258  Sum_probs=209.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeee-ecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWC-RRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~E  420 (687)
                      .++|+..+.||+|+||+||+|++..+++.||||++.....  .+++.+|+.++++++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            5789999999999999999999988999999999876533  24688999999999998877766665 56678899999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe---ccCCcEEEcccccceeccC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL---DSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~~~  497 (687)
                      |+ +++|.+++... ...+++.++..++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++....
T Consensus        86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            99 99999998533 3469999999999999999999998   999999999999999   5889999999999987655


Q ss_pred             CCCC------ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          498 GTNP------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       498 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ....      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.+....... 
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  239 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-  239 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-
Confidence            4321      123457999999999999999999999999999999999999999875443322222211111100000 


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                          +.+...++    ..+.+++.+||+.||++||++.+|++.|+..
T Consensus       240 ----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          240 ----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             ----HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             ----HHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence                01112222    3688999999999999999999999999865

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5e-40  Score=339.93  Aligned_cols=250  Identities=22%  Similarity=0.421  Sum_probs=187.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|...+.||+|+||.||+|++..+++.||||++.....   ...+++.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            3678999999999999999999988899999999865432   2346789999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++... ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999998543 3468999999999999999999998   89999999999999999999999999999876433


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      .. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........       ...      ..+..+
T Consensus       166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~------~~~~~~  231 (278)
T 3cok_A          166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------KVV------LADYEM  231 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CC------SSCCCC
T ss_pred             CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------HHh------hcccCC
Confidence            22 2233578999999999998899999999999999999999999998654322110       000      001111


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ...    ....+.+++.+||+.||++||++.++++
T Consensus       232 ~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          232 PSF----LSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccc----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            222    2347889999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-41  Score=355.70  Aligned_cols=258  Identities=27%  Similarity=0.464  Sum_probs=203.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCC----CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPST----NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ++|...+.||+|+||+||+|.+..+    +..||||++.... .....++.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            4677789999999999999988644    3469999997653 3445678999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++++|.+++... ...+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            99999999999998543 3469999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          498 GTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       498 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ....  ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+       +.+....+..    
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~----  268 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFR----  268 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC----
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCCCc----
Confidence            3221  1222346788999999999999999999999999999999 999997654211       1111111111    


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                       ..    .+......+.+++.+||+.+|++||++.++++.|+....
T Consensus       269 -~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          269 -LP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             -CC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             11    112233478899999999999999999999999987543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6e-40  Score=341.93  Aligned_cols=263  Identities=18%  Similarity=0.256  Sum_probs=206.7

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeee-ecCCeeEEEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWC-RRRGDLLLVY  419 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~  419 (687)
                      ..++|...+.||+|+||+||+|++..+++.||||++.....  ..++..|+.++++++|++++..++++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            45789999999999999999999988999999998765432  24578899999999988887777766 6667889999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe---ccCCcEEEcccccceecc
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL---DSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~~  496 (687)
                      ||+ +++|.+++... ...+++.++..++.||+.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 99999998532 3469999999999999999999999   999999999999999   788999999999998765


Q ss_pred             CCCC------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          497 RGTN------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       497 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      ....      .......||..|+|||.+.+..++.++|||||||++|||++|+.||..............+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            5432      1223467899999999999999999999999999999999999999875543322222211111110000


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       571 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                           +.+...++    ..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       240 -----~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          240 -----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             -----HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             -----hhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence                 00111222    37889999999999999999999999998653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.3e-40  Score=348.70  Aligned_cols=249  Identities=22%  Similarity=0.322  Sum_probs=196.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeC---CCCeEEEEEEecCcc----hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLP---STNTQVAVKRVSNES----KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      .++|...+.||+|+||.||+++..   .+++.||+|++....    ......+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            367999999999999999999984   578999999997652    2334567899999999999999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++||||+++++|.+++..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            9999999999999999843  4568999999999999999999998   8999999999999999999999999999975


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+   ....+    ..+.     
T Consensus       171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i----~~~~-----  237 (327)
T 3a62_A          171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TIDKI----LKCK-----  237 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH----HHTC-----
T ss_pred             cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HhCC-----
Confidence            43222 12234578999999999999999999999999999999999999998654221   11111    1111     


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                       ..+...+    ...+.+++.+||+.||++||     ++.|+++
T Consensus       238 -~~~p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 -LNLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -CCCCTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -CCCCCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence             1112222    34788999999999999999     7888886

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=359.15  Aligned_cols=271  Identities=21%  Similarity=0.287  Sum_probs=215.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC--eeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG--DLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV  418 (687)
                      .++|...++||+|+||+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            367899999999999999999999889999999997653 334577889999999999999999999988655  78999


Q ss_pred             EecCCCCCchhhhhchhh-ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe----ccCCcEEEcccccce
Q 005621          419 YDFMPNGSLDKCLFDEQK-AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL----DSELNGRLGDFGLAK  493 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGla~  493 (687)
                      |||+++|+|.+++..... ..+++.+++.++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999965432 239999999999999999999999   899999999999999    777889999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccC--------CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRT--------GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      ......  ......||..|+|||++..        ..++.++|||||||++|||++|+.||..........  +.+....
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~~  240 (396)
T 4eut_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKII  240 (396)
T ss_dssp             ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHHH
T ss_pred             EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHHh
Confidence            764432  2233568999999999865        467789999999999999999999997654332211  1111111


Q ss_pred             cccc---cccc-----------cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          566 KAGA---ILEV-----------VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       566 ~~~~---~~~~-----------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ....   ....           -+..............+.+++.+||+.||++||++.|+++.++...
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            1110   0000           0111123455677778999999999999999999999999887653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3e-40  Score=342.26  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=204.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch------hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK------QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ++|+..+.||+|+||+||+|.+..+++.||+|++.....      ...+.+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            578999999999999999999988899999999875421      13578899999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC----cEEEcccccc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL----NGRLGDFGLA  492 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGla  492 (687)
                      +||||+++++|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+||+++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999943  4569999999999999999999998   9999999999999998877    8999999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      +......  ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+.       ...+.....  
T Consensus       160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~--  228 (283)
T 3bhy_A          160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-------LTNISAVNY--  228 (283)
T ss_dssp             EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC--
T ss_pred             eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-------HHHhHhccc--
Confidence            8764432  22345689999999999999999999999999999999999999976542211       111111110  


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..++.....    ....+.+++.+||+.||++||++.|+++
T Consensus       229 ~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 DFDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CCCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCcchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            000000011    2236889999999999999999999997

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.3e-41  Score=348.43  Aligned_cols=256  Identities=27%  Similarity=0.364  Sum_probs=205.8

Q ss_pred             HhcCcccce-eeeeeCeEEEEEEEe--CCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          341 ATRGFRDKE-LLGFGGFGRVYKGTL--PSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       341 at~~f~~~~-~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      ..++|...+ .||+|+||+||+|.+  ...++.||||++....  ....+++.+|+.++++++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346777777 999999999999954  5567899999997653  23357899999999999999999999999 56778


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++++|.+++..  ...+++.+++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus        93 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            999999999999999954  3469999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCc--eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          496 ERGTNPS--TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       496 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       +......+..  
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~--  238 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER--  238 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC--
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC--
Confidence            5433211  122346788999999998889999999999999999999 999997654321       1111222211  


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                         +..    +...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       239 ---~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          239 ---MGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             ---CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               111    222334788999999999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=352.55  Aligned_cols=266  Identities=18%  Similarity=0.211  Sum_probs=202.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC---CCeEEEEEEecCcchh-----------hHHHHHHHHHHHhhhcCCCceeeee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS---TNTQVAVKRVSNESKQ-----------GLREFASEISSIGRLRHRNLVQLLG  407 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~  407 (687)
                      .++|...+.||+|+||+||+|.+..   .+..+|||++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3679999999999999999999976   6788999998765321           1234678889999999999999999


Q ss_pred             eeec----CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-
Q 005621          408 WCRR----RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-  482 (687)
Q Consensus       408 ~~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-  482 (687)
                      ++..    ....++||||+ +++|.+++...  ..+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence            9987    67899999999 99999999543  379999999999999999999998   8999999999999999887 


Q ss_pred             -cEEEcccccceeccCCCC------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchh
Q 005621          483 -NGRLGDFGLAKLYERGTN------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL  555 (687)
Q Consensus       483 -~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~  555 (687)
                       .+||+|||+++.+.....      .......||..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             999999999987643221      1123457999999999999999999999999999999999999999653322211


Q ss_pred             hHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       556 ~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .  ......... .+...+.....   ....+..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       270 ~--~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          270 V--QTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             H--HHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             H--HHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            1  111111110 00000000000   0012237889999999999999999999999998753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.7e-40  Score=370.39  Aligned_cols=254  Identities=26%  Similarity=0.360  Sum_probs=211.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|...++||+|+||.||+|++..+++.||||++....   ......+.+|+.++++++||||+++++++.+.+.+++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999999899999999997642   23456788999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++|+|.+++.......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            999999999999976555569999999999999999999999   89999999999999999999999999999876443


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........   +.+.....      ...+
T Consensus       340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~~~------~~~~  408 (576)
T 2acx_A          340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEV------PEEY  408 (576)
T ss_dssp             C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHHHC------CCCC
T ss_pred             c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhhcc------cccC
Confidence            2  23345899999999999998999999999999999999999999987543221111   11111111      1111


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ...+    ...+.+|+.+||+.||++||     ++.||++
T Consensus       409 p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          409 SERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             CccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            2222    34788999999999999999     7889886

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=355.17  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=199.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcC--CCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRH--RNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~l  417 (687)
                      .++|+..+.||+|+||+||++.+. +++.||||++...  .....+.+.+|+.++++++|  |||+++++++...+..++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            467999999999999999999984 5889999998754  34456789999999999976  999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||| +.+++|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++....
T Consensus        87 v~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEe-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            999 568899999953  4579999999999999999999998   8999999999999997 67899999999987654


Q ss_pred             CCCC-ceeeeecCCCCCchhhccC-----------CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 005621          498 GTNP-STTRVVGTLGYLAPELTRT-----------GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       498 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      .... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......     ...    
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~----  230 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKL----  230 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHH----
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHH----
Confidence            3322 2334679999999999865           678899999999999999999999997543211     111    


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                           ...+++.....++......+.+++.+||+.||++||++.|+++.
T Consensus       231 -----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 -----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                 11222222223333333478899999999999999999999973

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.6e-40  Score=367.89  Aligned_cols=250  Identities=23%  Similarity=0.310  Sum_probs=198.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|+..++||+|+||.||+|.+..+++.||||++...   .......+.+|+.++++++||||+++++++...+.+++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36799999999999999999999999999999999764   233456788999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++|+|.+++..  ...+++..+..++.||+.||.|||+  .++|+||||||+|||++.++.+||+|||+++.....
T Consensus       227 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            999999999999843  4579999999999999999999996  278999999999999999999999999999854322


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||........   .+    ....+      ...+
T Consensus       303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~----~i~~~------~~~~  368 (446)
T 4ejn_A          303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FE----LILME------EIRF  368 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHC------CCCC
T ss_pred             C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH----HHHhC------CCCC
Confidence            2 223346799999999999999999999999999999999999999976543211   11    11111      1112


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ...+    ...+.+++.+||+.||++||     +++|+++
T Consensus       369 p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          369 PRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            2222    34788999999999999999     9999987

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.2e-41  Score=355.34  Aligned_cols=257  Identities=23%  Similarity=0.290  Sum_probs=192.5

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeeeee--------
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWCR--------  410 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~--------  410 (687)
                      ....+|+..++||+|+||.||+|++..+++.||||++........+.+.+|+.++.++. ||||+++++++.        
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            34468999999999999999999998899999999997776667788999999999996 999999999983        


Q ss_pred             cCCeeEEEEecCCCCCchhhhhc-hhhccCCHHHHHHHHHHHHhhhhhhcccccCe--EEeeccCCCcEEeccCCcEEEc
Q 005621          411 RRGDLLLVYDFMPNGSLDKCLFD-EQKAILTWEQRYRIIKGVASGLLYLHEEWEQT--VIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       411 ~~~~~~lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlk~~NIll~~~~~~kl~  487 (687)
                      .....++||||+. |+|.+++.. .....+++.+++.++.||+.||.|||+   .+  |+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEe
Confidence            4456899999995 799998854 234569999999999999999999998   77  9999999999999999999999


Q ss_pred             ccccceeccCCCCC-----------ceeeeecCCCCCchhhc---cCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcc
Q 005621          488 DFGLAKLYERGTNP-----------STTRVVGTLGYLAPELT---RTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE  553 (687)
Q Consensus       488 DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~  553 (687)
                      |||+++........           ......||+.|+|||++   .+..++.++||||||+++|||++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            99999876543221           11134689999999998   56678899999999999999999999997543211


Q ss_pred             hhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          554 ELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       554 ~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .      .     .+..    ........    ...+.+++.+||+.||++||++.|+++.|+...
T Consensus       261 ~------~-----~~~~----~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          261 I------V-----NGKY----SIPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             ----------------C----CCCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             h------h-----cCcc----cCCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0      0     0000    00001111    124778999999999999999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-40  Score=355.02  Aligned_cols=245  Identities=28%  Similarity=0.420  Sum_probs=203.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      +.|...+.||+|+||+||+|++..+++.||||++....   ....+++.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45888999999999999999998899999999987542   334567899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||++ |+|.+++... ...+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            9997 6888877433 4579999999999999999999999   89999999999999999999999999999865432 


Q ss_pred             CCceeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          500 NPSTTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                          ....||+.|+|||++.   .+.++.++|||||||++|||++|+.||.......      .+.......      .+
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~------~~  271 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE------SP  271 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC------CC
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC------CC
Confidence                2357899999999984   5678999999999999999999999997654211      111111111      11


Q ss_pred             cC-CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          577 RL-NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       577 ~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+ ...+    ...+.+++.+||+.+|++||++.++++
T Consensus       272 ~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          272 ALQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCC----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            11 1122    236789999999999999999999987

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-39  Score=340.59  Aligned_cols=249  Identities=26%  Similarity=0.400  Sum_probs=209.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|...+.||+|+||+||++.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            46789999999999999999999989999999998654   234457788999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++.  ....+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        94 ~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999999884  34569999999999999999999999   89999999999999999999999999999876433


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      .. ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+..       .....+.      ..+
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~------~~~  234 (294)
T 2rku_A          169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------LRIKKNE------YSI  234 (294)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTC------CCC
T ss_pred             cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhhcc------CCC
Confidence            22 223457899999999999988999999999999999999999999765432111       1111111      111


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....    ...+.+++.+||+.||++||++.|+++
T Consensus       235 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          235 PKHI----NPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccc----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            2222    236889999999999999999999997

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.5e-41  Score=347.10  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=207.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeee--cCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCR--RRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~l  417 (687)
                      .++|+..+.||+|+||.||++.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46899999999999999999999989999999998754  3345677899999999999999999999874  4678999


Q ss_pred             EEecCCCCCchhhhhchh--hccCCHHHHHHHHHHHHhhhhhhcccccCe-----EEeeccCCCcEEeccCCcEEEcccc
Q 005621          418 VYDFMPNGSLDKCLFDEQ--KAILTWEQRYRIIKGVASGLLYLHEEWEQT-----VIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                      ||||+++++|.+++....  ...+++.+++.++.|++.||.|||+   .+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999996532  2349999999999999999999998   66     9999999999999999999999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      +++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......   .    +......+..
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~i~~~~~  233 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---E----LAGKIREGKF  233 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHTCC
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---H----HHHHHhhccc
Confidence            9986543221 122346899999999999989999999999999999999999999765421   1    1112222221


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       571 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                           +.+...+    ...+.+++.+||+.+|++||++.||++.+..
T Consensus       234 -----~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          234 -----RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             -----CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----ccCCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                 1122222    3478899999999999999999999987654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.2e-40  Score=365.25  Aligned_cols=253  Identities=24%  Similarity=0.435  Sum_probs=211.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch---hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK---QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||.||+|++..+|+.||||++.....   .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            678999999999999999999998999999999976432   23567899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        96 E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           96 EYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             ECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999953  4569999999999999999999998   999999999999999999999999999998765432


Q ss_pred             CCceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                        ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........       ...+..+..      ..
T Consensus       171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~------~~  235 (476)
T 2y94_A          171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-------FKKICDGIF------YT  235 (476)
T ss_dssp             --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-------HHHHHTTCC------CC
T ss_pred             --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCc------CC
Confidence              2334579999999999988765 6899999999999999999999986543221       111112211      11


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCC
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEV  619 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~  619 (687)
                      ....    ...+.+++.+||+.||++|||+.|+++  ++....
T Consensus       236 p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          236 PQYL----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             CTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             CccC----CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            1122    236889999999999999999999997  566543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-40  Score=343.05  Aligned_cols=256  Identities=25%  Similarity=0.375  Sum_probs=208.0

Q ss_pred             cCcccce-eeeeeCeEEEEEEEeC--CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKE-LLGFGGFGRVYKGTLP--STNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|...+ .||+|+||.||+|.+.  ..+..||||++.... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566665 9999999999999864  457889999998753 44567899999999999999999999999 45678999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++... ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999998543 3469999999999999999999998   99999999999999999999999999999876543


Q ss_pred             CCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          499 TNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       499 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ...  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.   .    .....+..     
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----~~i~~~~~-----  231 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M----AFIEQGKR-----  231 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---H----HHHHTTCC-----
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---H----HHHhcCCc-----
Confidence            321  1222356889999999998889999999999999999998 9999977554221   1    11111111     


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      +.    .+...+..+.+++.+||+.+|++||++.++++.|+...
T Consensus       232 ~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          232 ME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11    12223347889999999999999999999999998653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.6e-39  Score=346.18  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=211.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|...+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            36788999999999999999999989999999998754   234457789999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            999999999998843  4579999999999999999999998   89999999999999999999999999999876533


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      .. ......||..|+|||++.+..++.++||||||+++|||++|+.||......+..       .....+.      ..+
T Consensus       195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~------~~~  260 (335)
T 2owb_A          195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------LRIKKNE------YSI  260 (335)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHTC------CCC
T ss_pred             cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-------HHHhcCC------CCC
Confidence            22 223457899999999999989999999999999999999999999765422111       1111111      112


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ...++    ..+.+++.+||+.||++||++.|+++  ++..
T Consensus       261 ~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          261 PKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             CTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             CccCC----HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            22222    36788999999999999999999997  4544

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.9e-40  Score=341.45  Aligned_cols=246  Identities=20%  Similarity=0.337  Sum_probs=202.4

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  417 (687)
                      ..++|+..+.||+|+||+||+|.+..+++.||||++...  ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            356799999999999999999999889999999998764  234457788999999999 99999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhh--ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC--------------
Q 005621          418 VYDFMPNGSLDKCLFDEQK--AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE--------------  481 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~--------------  481 (687)
                      ||||+++++|.+++.....  ..+++.++..++.||+.||.|||+   ++|+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999965432  568999999999999999999999   999999999999999844              


Q ss_pred             -----CcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchh
Q 005621          482 -----LNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL  555 (687)
Q Consensus       482 -----~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~  555 (687)
                           ..+||+|||++.......     ...||..|+|||.+.+. .++.++||||||+++|||++|..++.....    
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence                 479999999998765432     23589999999999865 566899999999999999999887643210    


Q ss_pred             hHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       556 ~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                            +.....+..     +.+...++    ..+.+++.+||+.||++||++.|+++
T Consensus       237 ------~~~~~~~~~-----~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 ------WHEIRQGRL-----PRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ------HHHHHTTCC-----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHcCCC-----CCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                  111112211     22222333    37889999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-39  Score=346.96  Aligned_cols=275  Identities=24%  Similarity=0.329  Sum_probs=213.8

Q ss_pred             CccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhh--hcCCCceeeeee
Q 005621          331 HRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR--LRHRNLVQLLGW  408 (687)
Q Consensus       331 ~~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~  408 (687)
                      .......-....++|...+.||+|+||+||+|++  +++.||||++....   ...+..|.+++..  ++||||++++++
T Consensus        30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~  104 (342)
T 1b6c_B           30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAA  104 (342)
T ss_dssp             SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred             CCCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence            3445555566678999999999999999999998  58999999996543   3567788888887  799999999999


Q ss_pred             eecCC----eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccc-----cCeEEeeccCCCcEEec
Q 005621          409 CRRRG----DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW-----EQTVIHRDIKAGNVLLD  479 (687)
Q Consensus       409 ~~~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlk~~NIll~  479 (687)
                      +....    ..++||||+++|+|.+++.   ...+++.+++.++.|++.||.|||...     ..+|+||||||+|||++
T Consensus       105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  181 (342)
T ss_dssp             EECCCSSCCCEEEEECCCTTCBHHHHHH---HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred             ecccCCccceeEEEEeecCCCcHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence            98776    7899999999999999994   346999999999999999999999210     18999999999999999


Q ss_pred             cCCcEEEcccccceeccCCCCC---ceeeeecCCCCCchhhccCCC------CCCccceehhhHHHHHHHhC--------
Q 005621          480 SELNGRLGDFGLAKLYERGTNP---STTRVVGTLGYLAPELTRTGK------PTTSSDVYAFGALLLEVVCG--------  542 (687)
Q Consensus       480 ~~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDV~S~Gvvl~elltG--------  542 (687)
                      .++++||+|||+++........   ......||+.|+|||++.+..      ++.++||||||+++|||++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            9999999999999876544322   123457899999999998753      33689999999999999999        


Q ss_pred             --CCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC-CHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          543 --RRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF-NEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       543 --~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                        +.||......... ... +......    ....+.+...+ .......+.+|+.+||+.||++||++.+|++.|+...
T Consensus       262 ~~~~p~~~~~~~~~~-~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPS-VEE-MRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CCCCTTTTTSCSSCC-HHH-HHHHHTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccCccccCcCccc-HHH-HHHHHHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence              6777654332211 111 1111111    11222222221 2356668999999999999999999999999998653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-39  Score=337.28  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=209.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57899999999999999999999899999999986542   223467899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus        94 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           94 EFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            99999999999853  3469999999999999999999998   999999999999999999999999999997654322


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.       .......      +..+.
T Consensus       169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~------~~~~~  232 (284)
T 2vgo_A          169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------HRRIVNV------DLKFP  232 (284)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTT------CCCCC
T ss_pred             ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-------HHHHhcc------ccCCC
Confidence               2335689999999999999999999999999999999999999976542111       1111111      11122


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ..+    ...+.+++.+||+.||++||++.++++  +++.
T Consensus       233 ~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~  268 (284)
T 2vgo_A          233 PFL----SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA  268 (284)
T ss_dssp             TTS----CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred             CcC----CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence            222    346889999999999999999999997  5554

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=356.36  Aligned_cols=264  Identities=25%  Similarity=0.395  Sum_probs=210.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEe----CCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC--ee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG--DL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~  415 (687)
                      .++|+..+.||+|+||.||++.+    ..+++.||||++........+++.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688999999999999999984    5678999999998877777788999999999999999999999986644  78


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++++|.+++... ...+++.+++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            9999999999999999543 3459999999999999999999998   99999999999999999999999999999876


Q ss_pred             cCCCCCc--eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCC---------cchhhHHHHHHHH
Q 005621          496 ERGTNPS--TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKAL---------PEELILVDWVWDR  564 (687)
Q Consensus       496 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~---------~~~~~~~~~v~~~  564 (687)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||++|..|+.....         .........+.+.
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            5433211  1223567789999999988899999999999999999999998764210         0001111111111


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ...+.         ....+...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus       276 ~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          276 LKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111         1111222344788999999999999999999999999764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-40  Score=352.09  Aligned_cols=256  Identities=29%  Similarity=0.455  Sum_probs=206.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEE--EEEEecCc-chhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQV--AVKRVSNE-SKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|...+.||+|+||.||+|++..++..+  |+|++... .....+++.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67899999999999999999998788755  99988754 233456789999999999 999999999999999999999


Q ss_pred             EecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          419 YDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      |||+++++|.+++....              ...+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence            99999999999996532              2368999999999999999999998   999999999999999999999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      ||+|||+++......  ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+       ..+
T Consensus       182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE  252 (327)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred             EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHH
Confidence            999999997433211  2223457889999999998889999999999999999998 999997654211       112


Q ss_pred             HhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       564 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ....+.     .+.....    ....+.+++.+||+.+|++||++.++++.|+...
T Consensus       253 ~~~~~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          253 KLPQGY-----RLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             HGGGTC-----CCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhhcCC-----CCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            222211     1111122    2347889999999999999999999999988653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.9e-41  Score=354.46  Aligned_cols=268  Identities=26%  Similarity=0.345  Sum_probs=206.6

Q ss_pred             cccceeeeeeCeEEEEEEEe----CCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC--CeeEE
Q 005621          345 FRDKELLGFGGFGRVYKGTL----PSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRR--GDLLL  417 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  417 (687)
                      |+..+.||+|+||+||++.+    ..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.  ..+++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48999999999999988864    3468899999998654 34467799999999999999999999999874  67899


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++..   ..+++.+++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            9999999999999943   349999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ....  ......+|..|+|||.+.+..++.++||||||+++|||++|+.||........ ....+.........+.+.++
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHHh
Confidence            3321  12234578889999999998999999999999999999999999865321100 00000000000001111111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .......+......+.+++.+||+.||++||++.|+++.|+...
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            12222223333457899999999999999999999999998653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.3e-40  Score=341.51  Aligned_cols=252  Identities=23%  Similarity=0.357  Sum_probs=201.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|...+.||+|+||+||++.+..++..||+|++.... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            367899999999999999999999899999999987654 3346788999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe---ccCCcEEEcccccceec
Q 005621          421 FMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL---DSELNGRLGDFGLAKLY  495 (687)
Q Consensus       421 y~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~  495 (687)
                      |+++|+|.+++...  ....+++..+..++.|++.||.|||+   .+|+||||||+||++   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999998653  23579999999999999999999998   999999999999999   45678999999999865


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ....  ......||+.|+|||.+. +.++.++||||||+++|||++|+.||......+..       ......      .
T Consensus       178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~-------~~~~~~------~  241 (285)
T 3is5_A          178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ-------QKATYK------E  241 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHC------C
T ss_pred             CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH-------hhhccC------C
Confidence            4432  233457899999999986 56899999999999999999999999865422111       111000      0


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +...... ......+.+++.+||+.||++||++.|+++
T Consensus       242 ~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 PNYAVEC-RPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccccc-CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111000 001236789999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-40  Score=343.30  Aligned_cols=256  Identities=27%  Similarity=0.333  Sum_probs=204.0

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCC---eEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee-EEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL-LLV  418 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lV  418 (687)
                      .|...++||+|+||+||+|.+..++   ..||+|++.... ....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4556789999999999999975443   379999997653 34567899999999999999999999999776655 999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+.+|+|.+++... ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999553 4568999999999999999999999   89999999999999999999999999999855332


Q ss_pred             C---CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          499 T---NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       499 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      .   ........+|..|+|||.+.+..++.++||||||+++|||++|..|+........  ....+    ..+.     .
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~----~~~~-----~  246 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFL----AQGR-----R  246 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHH----HTTC-----C
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHh----hcCC-----C
Confidence            1   1222334678899999999999999999999999999999997666544333222  11111    1111     1


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ...    +......+.+++.+||+.+|++|||+.++++.|++.
T Consensus       247 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          247 LPQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111    112234788999999999999999999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.5e-40  Score=359.93  Aligned_cols=249  Identities=22%  Similarity=0.357  Sum_probs=198.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhc--CCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLR--HRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|...+.||+|+||+||++.+.. ++.||||++...  .....+.+.+|+.++++++  ||||+++++++...+.+++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            459999999999999999999865 889999998654  3445678999999999996  59999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      || +.+++|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++.+...
T Consensus       135 ~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             Ee-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            99 568899999954  3478999999999999999999998   8999999999999995 589999999999876543


Q ss_pred             CCC-ceeeeecCCCCCchhhccC-----------CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 005621          499 TNP-STTRVVGTLGYLAPELTRT-----------GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK  566 (687)
Q Consensus       499 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~  566 (687)
                      ... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......     ..+.    
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~----  278 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH----  278 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHH----
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHH----
Confidence            321 2334579999999999865           468899999999999999999999997543211     1111    


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       567 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                           ..+++.....++......+.+++.+||+.||++||++.|+++
T Consensus       279 -----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          279 -----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             -----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                 112222222222222347889999999999999999999997

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-40  Score=358.21  Aligned_cols=265  Identities=24%  Similarity=0.334  Sum_probs=196.1

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCC--e
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLR-HRNLVQLLGWCRRRG--D  414 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~  414 (687)
                      ...++|...+.||+|+||+||+|.+..+++.||||++...  .....+++.+|+.+++++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3467899999999999999999999999999999998654  3445677889999999997 999999999997543  7


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      +++|||||+ ++|.+++.   ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIR---ANILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCS-EEHHHHHH---HTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccC-cCHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            899999997 68988884   3469999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCC--------------------CCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcc
Q 005621          495 YERGT--------------------NPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE  553 (687)
Q Consensus       495 ~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~  553 (687)
                      +....                    ....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            54311                    112234579999999999976 678999999999999999999999998654322


Q ss_pred             hhhHHHHHHHHhcccccc---cc------------------cCCcCCCCCC------------HHHHHHHHHHHHhcccc
Q 005621          554 ELILVDWVWDRWKAGAIL---EV------------------VDPRLNGEFN------------EIEALDVVKLGLMCSND  600 (687)
Q Consensus       554 ~~~~~~~v~~~~~~~~~~---~~------------------~d~~l~~~~~------------~~~~~~l~~l~~~Cl~~  600 (687)
                      ....   +..........   ..                  ........++            ......+.+|+.+||+.
T Consensus       239 ~~~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          239 QLER---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHH---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHH---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            2111   11111000000   00                  0000000000            01133688999999999


Q ss_pred             CcCcCCCHHHHHHH
Q 005621          601 AAEARPTMRQVVRY  614 (687)
Q Consensus       601 dP~~RPs~~evl~~  614 (687)
                      ||++|||+.|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.2e-40  Score=352.59  Aligned_cols=253  Identities=23%  Similarity=0.319  Sum_probs=204.4

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ..++|...+.||+|+||+||++.++.+++.||||++.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            35679999999999999999999999999999999976543    234688888888 7999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC----CcEEEcccccceec
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE----LNGRLGDFGLAKLY  495 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGla~~~  495 (687)
                      ||+++|+|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||+..+    +.+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999999854  3469999999999999999999999   999999999999998543    35999999999876


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........    +...+..+...    
T Consensus       171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~~~----  241 (342)
T 2qr7_A          171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILARIGSGKFS----  241 (342)
T ss_dssp             BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH----HHHHHHHCCCC----
T ss_pred             cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH----HHHHHccCCcc----
Confidence            54332 2334578999999999988788999999999999999999999998643222211    12222222211    


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        +...........+.+++.+||+.||++||++.++++
T Consensus       242 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 --LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              111111223347889999999999999999999997

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-40  Score=351.06  Aligned_cols=256  Identities=21%  Similarity=0.311  Sum_probs=201.5

Q ss_pred             cCcccc-eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDK-ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      +.|... +.||+|+||+||+|.+..+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567774 7899999999999999889999999999876655667899999999995 79999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc---EEEcccccceeccC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN---GRLGDFGLAKLYER  497 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFGla~~~~~  497 (687)
                      |+++++|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.   +||+|||+++....
T Consensus        92 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           92 KMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             cCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999954  3569999999999999999999999   89999999999999998776   99999999976532


Q ss_pred             CCC------CceeeeecCCCCCchhhccC-----CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchh--------hHH
Q 005621          498 GTN------PSTTRVVGTLGYLAPELTRT-----GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL--------ILV  558 (687)
Q Consensus       498 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~--------~~~  558 (687)
                      ...      .......||+.|+|||++..     ..++.++|||||||++|||++|+.||......+..        ...
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            211      11223468999999999875     56889999999999999999999999875432210        000


Q ss_pred             HHHHHHhcccccccccCCcCCCCCCH----HHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          559 DWVWDRWKAGAILEVVDPRLNGEFNE----IEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       559 ~~v~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+.+....+..          .++.    .....+.+++.+||+.||++||++.|+++
T Consensus       247 ~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            111122211111          1111    12346889999999999999999999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=339.30  Aligned_cols=258  Identities=21%  Similarity=0.329  Sum_probs=206.3

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc----hhhHHHHHHHHHHHhhhcCCCceeeeeee--ecCCe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES----KQGLREFASEISSIGRLRHRNLVQLLGWC--RRRGD  414 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~--~~~~~  414 (687)
                      ..++|...+.||+|+||.||++.+..+++.||+|++....    ....+.+.+|+.++++++||||+++++++  .+.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3478999999999999999999999899999999997643    23457899999999999999999999998  45568


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++||||++++ |.+++.......+++.++..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999876 7777765556679999999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCC-CceeeeecCCCCCchhhccCCC--CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          495 YERGTN-PSTTRVVGTLGYLAPELTRTGK--PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       495 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ...... .......||..|+|||++.+..  .+.++||||||+++|||++|+.||......+       ..+.+..+.  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~--  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-------LFENIGKGS--  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCC--
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-------HHHHHhcCC--
Confidence            653322 2233456899999999987644  3779999999999999999999998654211       111111111  


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCC
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEV  619 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~  619 (687)
                          ..+...++    ..+.+++.+||+.||++||++.|+++  ++++..
T Consensus       230 ----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          230 ----YAIPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             ----CCCCSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             ----CCCCCccC----HHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence                11222233    36789999999999999999999997  565543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=349.92  Aligned_cols=266  Identities=27%  Similarity=0.408  Sum_probs=197.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHH--HHHHHhhhcCCCceeeeeeee-----cCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS--EISSIGRLRHRNLVQLLGWCR-----RRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~~~~~-----~~~~  414 (687)
                      .++|...+.||+|+||+||+|++  +++.||||++.....   ..+..  |+..+..++||||+++++++.     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            46899999999999999999987  689999999975443   33333  444455689999999998543     3346


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccc------cCeEEeeccCCCcEEeccCCcEEEcc
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW------EQTVIHRDIKAGNVLLDSELNGRLGD  488 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivHrDlk~~NIll~~~~~~kl~D  488 (687)
                      +++||||+++|+|.+++.   ....++..+.+++.||+.||.|||+.+      .++|+||||||+|||++.++.+||+|
T Consensus        87 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLS---LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEEECCCTTCBHHHHHH---HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEEecCCCCcHHHHHh---hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            799999999999999993   334689999999999999999999821      11999999999999999999999999


Q ss_pred             cccceeccCCCC-------CceeeeecCCCCCchhhccC-------CCCCCccceehhhHHHHHHHhCCCCCCCCCCcch
Q 005621          489 FGLAKLYERGTN-------PSTTRVVGTLGYLAPELTRT-------GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE  554 (687)
Q Consensus       489 FGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~  554 (687)
                      ||+++.+.....       .......||+.|+|||++.+       ..++.++|||||||++|||++|+.|+........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999987654321       11223468999999999986       3566789999999999999999887754432211


Q ss_pred             hh--HH---------HHHHHHhcccccccccCCcCCCCC--CHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          555 LI--LV---------DWVWDRWKAGAILEVVDPRLNGEF--NEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       555 ~~--~~---------~~v~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ..  ..         +........    ....+.+...+  .......+.+++.+||+.||++|||+.|+++.|+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSR----EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTT----SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhhcccCCCchHHHHHhhhcc----cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            10  00         000000110    11112222111  2345667999999999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-39  Score=339.16  Aligned_cols=248  Identities=25%  Similarity=0.413  Sum_probs=201.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeec----CCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRR----RGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~  416 (687)
                      +.|...+.||+|+||+||+|.+..++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ...++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            3477888999999999999999999999999998754  34456788999999999999999999998865    45689


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCe--EEeeccCCCcEEec-cCCcEEEcccccce
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT--VIHRDIKAGNVLLD-SELNGRLGDFGLAK  493 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlk~~NIll~-~~~~~kl~DFGla~  493 (687)
                      +||||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+  |+||||||+|||++ .++.+||+|||++.
T Consensus       106 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999999943  3569999999999999999999998   77  99999999999998 78999999999997


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      .....   ......||+.|+|||++. +.++.++||||||+++|||++|+.||.........      ......+.... 
T Consensus       181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~-  249 (290)
T 1t4h_A          181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPA-  249 (290)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCCG-
T ss_pred             ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH------HHHHhccCCcc-
Confidence            54322   233457899999999887 46899999999999999999999999765432211      11111111111 


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         .....    ....+.+++.+||+.||++||++.++++
T Consensus       250 ---~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 ---SFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---GGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---ccCCC----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               11111    1236889999999999999999999987

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.4e-39  Score=340.96  Aligned_cols=249  Identities=26%  Similarity=0.400  Sum_probs=209.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .+.|...+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356899999999999999999998889999999987653 3456789999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++.   ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus       101 ~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          101 YLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             eCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            999999999984   3569999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                       ......|+..|+|||++.+..++.++||||||+++|||++|+.||........   ...    ...+     ..+.+..
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~~~-----~~~~~~~  241 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LFL----IPKN-----NPPTLEG  241 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH----HHHS-----CCCCCCS
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HHH----hhcC-----CCCCCcc
Confidence             22345789999999999999999999999999999999999999976432111   111    1111     1122223


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .++    ..+.+++.+||+.+|++||++.++++
T Consensus       242 ~~~----~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          242 NYS----KPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             SCC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccC----HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            333    36889999999999999999999987

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.2e-39  Score=364.57  Aligned_cols=254  Identities=26%  Similarity=0.346  Sum_probs=209.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|...++||+|+||+||+|+++.+++.||+|++.+..   ......+..|+.++++++||||+++++++...+.+++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67889999999999999999999899999999997643   233567889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchh--hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          420 DFMPNGSLDKCLFDEQ--KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||+++|+|.+++....  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999986532  4469999999999999999999998   9999999999999999999999999999987654


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........  + +.+....+.      ..
T Consensus       342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~-~~~~i~~~~------~~  411 (543)
T 3c4z_A          342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E-LKQRVLEQA------VT  411 (543)
T ss_dssp             TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--H-HHHHHHHCC------CC
T ss_pred             CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--H-HHHHHhhcc------cC
Confidence            332 2334589999999999999999999999999999999999999998754321111  1 111111111      11


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCH-----HHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTM-----RQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  613 (687)
                      .    +......+.+++.+||+.||++||++     .+|++
T Consensus       412 ~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          412 Y----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             C----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             C----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            1    22223478899999999999999975     66764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2e-39  Score=352.48  Aligned_cols=263  Identities=23%  Similarity=0.272  Sum_probs=208.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc--------CCCceeeeeeee---
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR--------HRNLVQLLGWCR---  410 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~---  410 (687)
                      .++|...++||+|+||+||+|++..+++.||||++... ....+.+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999999999999999999754 334567889999999996        788999999987   


Q ss_pred             -cCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccC-eEEeeccCCCcEEeccCC------
Q 005621          411 -RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ-TVIHRDIKAGNVLLDSEL------  482 (687)
Q Consensus       411 -~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlk~~NIll~~~~------  482 (687)
                       .....++||||+ +++|.+++.......+++.++..++.||+.||.|||+   + +|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence             566899999999 6677777765555679999999999999999999998   7 999999999999998765      


Q ss_pred             -------------------------------------------cEEEcccccceeccCCCCCceeeeecCCCCCchhhcc
Q 005621          483 -------------------------------------------NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR  519 (687)
Q Consensus       483 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  519 (687)
                                                                 .+||+|||+++.....    .....||..|+|||++.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence                                                       7999999999876433    23347899999999999


Q ss_pred             CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchh---hHHHHHHHHhcc--------cccc-cccCC--cC-------
Q 005621          520 TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL---ILVDWVWDRWKA--------GAIL-EVVDP--RL-------  578 (687)
Q Consensus       520 ~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~---~~~~~v~~~~~~--------~~~~-~~~d~--~l-------  578 (687)
                      +..++.++|||||||++|||++|+.||......+..   .....+.+....        +... +....  .+       
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            999999999999999999999999999876543211   111111111110        0000 00000  00       


Q ss_pred             ----------CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          579 ----------NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       579 ----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                                ...++......+.+|+.+||+.||++|||+.|+++
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                      11345666778999999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.1e-40  Score=339.07  Aligned_cols=253  Identities=25%  Similarity=0.342  Sum_probs=207.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467899999999999999999998889999999987543 3345788999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+++++|.+++..  ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        86 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           86 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999843  3469999999999999999999998   9999999999999999999999999999986543221


Q ss_pred             -CceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          501 -PSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       501 -~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                       .......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....|     .....  ...   
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-----~~~~~--~~~---  229 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-----KEKKT--YLN---  229 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH-----HTTCT--TST---
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh-----hhccc--ccC---
Confidence             22334578999999999987664 7799999999999999999999987553221 11111     11100  000   


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         ........+.+++.+||+.||++||++.|+++
T Consensus       230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               01112336789999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=353.90  Aligned_cols=244  Identities=24%  Similarity=0.339  Sum_probs=204.7

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--------hhHHHHHHHHHHHhhhcCCCceeeeeeeecC
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--------QGLREFASEISSIGRLRHRNLVQLLGWCRRR  412 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  412 (687)
                      ..++|...+.||+|+||+||+|.+..+++.||||++.....        .....+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            35689999999999999999999999999999999876531        1334677899999999999999999999999


Q ss_pred             CeeEEEEecCCCC-CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          413 GDLLLVYDFMPNG-SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       413 ~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                      +..++||||+.+| +|.+++..  ...+++..+..|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999777 99998843  4469999999999999999999999   8999999999999999999999999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      ++......  ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......                 .
T Consensus       177 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~  237 (335)
T 3dls_A          177 AAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------V  237 (335)
T ss_dssp             CEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------T
T ss_pred             ceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------H
Confidence            98765433  2334679999999999988776 78999999999999999999999642110                 0


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          571 LEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       571 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .....+  ...+    ...+.+++.+||+.||++||++.++++.
T Consensus       238 ~~~~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 EAAIHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TTCCCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hhccCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000000  1112    2368899999999999999999999984

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.1e-40  Score=350.75  Aligned_cols=266  Identities=21%  Similarity=0.315  Sum_probs=197.3

Q ss_pred             HHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          338 LKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       338 l~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      -....++|...++||+|+||+||+|.+..+++.||||++.....  ...+.+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            34456789999999999999999999999999999999976532  2345678999999999999999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec-----cCCcEEEcccc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD-----SELNGRLGDFG  490 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~-----~~~~~kl~DFG  490 (687)
                      ++||||++ |+|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++     .++.+||+|||
T Consensus       109 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999997 599998843  3469999999999999999999999   8999999999999994     45569999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      +++....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||......+...  . +.+......
T Consensus       183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~-~~~~~~~~~  258 (329)
T 3gbz_A          183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF--K-IFEVLGLPD  258 (329)
T ss_dssp             HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-HHHHHCCCC
T ss_pred             CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH--H-HHHHhCCCc
Confidence            9987643322 23345789999999999874 58999999999999999999999997654322111  1 111110000


Q ss_pred             ---cccc--------cCCcCCCC-----CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          570 ---ILEV--------VDPRLNGE-----FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       570 ---~~~~--------~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         ....        ..+.....     ........+.+|+.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence               0000        00000000     00112346789999999999999999999987

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.9e-40  Score=344.81  Aligned_cols=258  Identities=23%  Similarity=0.390  Sum_probs=209.1

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ..++|...+.||+|+||+||++++..+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            34679999999999999999999988999999999987655555678899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe---ccCCcEEEcccccceeccC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL---DSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~~~  497 (687)
                      |+++++|.+++..  ...+++.++..++.|++.||.|||+   .+|+||||||+||++   +.++.+||+|||+++....
T Consensus        87 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           87 LVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             cCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999998843  4568999999999999999999998   899999999999999   7789999999999975432


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   +    .+.+..+...      
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~----~~~i~~~~~~------  225 (304)
T 2jam_A          162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---L----FEKIKEGYYE------  225 (304)
T ss_dssp             B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H----HHHHHHCCCC------
T ss_pred             C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H----HHHHHcCCCC------
Confidence            2   2233468999999999999999999999999999999999999997654211   1    1111111110      


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEV  619 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~  619 (687)
                      ............+.+++.+||+.||++||++.|+++  ++++..
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            111111222347889999999999999999999997  565543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=348.40  Aligned_cols=267  Identities=24%  Similarity=0.347  Sum_probs=200.7

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhh-HHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|...+.||+|+||+||+|.+..+++.||||++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999999899999999987653322 22456799999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      ++ |+|.+++... ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  155 (324)
T ss_dssp             CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence            97 5898888543 3469999999999999999999998   9999999999999999999999999999986543222 


Q ss_pred             ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc---ccccc---
Q 005621          502 STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA---ILEVV---  574 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~---~~~~~---  574 (687)
                      ......||..|+|||++.+ ..++.++|||||||++|||++|+.||......+..   ..+.+......   .....   
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcch
Confidence            2233578999999999876 56899999999999999999999999876533222   12222111100   00000   


Q ss_pred             ------CCcCCCC----CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          575 ------DPRLNGE----FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       575 ------d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                            .+.....    ........+.+++.+||+.||++|||++|+++  ++.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                  0000000    00112346789999999999999999999998  55544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=378.86  Aligned_cols=255  Identities=25%  Similarity=0.370  Sum_probs=203.9

Q ss_pred             cCcccce-eeeeeCeEEEEEEEeC--CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKE-LLGFGGFGRVYKGTLP--STNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      +++...+ .||+|+||.||+|.+.  .++..||||+++... ....++|.+|++++++++||||++++++|.. +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999875  346789999998653 3456889999999999999999999999976 568999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++|+|.+++... ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       414 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            9999999999999643 4469999999999999999999999   99999999999999999999999999999876433


Q ss_pred             CCCc--eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          499 TNPS--TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       499 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ....  .....+|+.|+|||++.++.++.++|||||||++|||++ |+.||......+.       ...+..+..     
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~~-----  557 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKR-----  557 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH-------HHHHHTTCC-----
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCC-----
Confidence            2211  122345689999999999999999999999999999998 9999987654321       122222221     


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                          ...+..++..+.+|+.+||+.+|++||++.+|++.|+..
T Consensus       558 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          558 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                112223345788999999999999999999999998864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.2e-40  Score=354.79  Aligned_cols=246  Identities=25%  Similarity=0.315  Sum_probs=195.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHH-HhhhcCCCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISS-IGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++|+..+.||+|+||+||+|+++.+++.||||++.+..   ......+..|..+ ++.++||||+++++++...+.+++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357899999999999999999999999999999997653   2234556677776 577899999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999843  4568999999999999999999998   9999999999999999999999999999985432


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+       +.+.+..+.      ..
T Consensus       192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~------~~  257 (373)
T 2r5t_A          192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKP------LQ  257 (373)
T ss_dssp             CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-------HHHHHHHSC------CC
T ss_pred             CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcc------cC
Confidence            22 23345689999999999999999999999999999999999999997654221       111111111      11


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQ  610 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  610 (687)
                      +...++    ..+.+++.+||+.||++||++.+
T Consensus       258 ~~~~~~----~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          258 LKPNIT----NSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             CCSSSC----HHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CCCCCC----HHHHHHHHHHcccCHHhCCCCCC
Confidence            122233    36889999999999999999853

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.2e-41  Score=362.04  Aligned_cols=242  Identities=17%  Similarity=0.130  Sum_probs=191.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc---chhhHHHHHHHH---HHHhhhcCCCceeee-------ee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEI---SSIGRLRHRNLVQLL-------GW  408 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~  408 (687)
                      .++|...+.||+|+||+||+|++..+++.||||++...   .....+.+.+|+   +.+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999999888999999998743   334567889999   555666899999998       55


Q ss_pred             eecCC-----------------eeEEEEecCCCCCchhhhhchh-----hccCCHHHHHHHHHHHHhhhhhhcccccCeE
Q 005621          409 CRRRG-----------------DLLLVYDFMPNGSLDKCLFDEQ-----KAILTWEQRYRIIKGVASGLLYLHEEWEQTV  466 (687)
Q Consensus       409 ~~~~~-----------------~~~lV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  466 (687)
                      +...+                 ..++||||+ +|+|.+++....     ...+++..++.|+.||+.||.|||+   ++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            55443                 278999999 689999996432     1234468899999999999999999   899


Q ss_pred             EeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCC-----------CCCCccceehhhHH
Q 005621          467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG-----------KPTTSSDVYAFGAL  535 (687)
Q Consensus       467 vHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDV~S~Gvv  535 (687)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999985322    3344567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          536 LLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       536 l~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +|||++|+.||..........               ... +. ...++    ..+.+++.+||+.||++||++.|+++
T Consensus       303 l~elltg~~Pf~~~~~~~~~~---------------~~~-~~-~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSE---------------WIF-RS-CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CCSG---------------GGG-SS-CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccchh---------------hhh-hh-ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999997654322110               000 00 01222    36889999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-40  Score=348.94  Aligned_cols=264  Identities=25%  Similarity=0.374  Sum_probs=201.9

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCC---CCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeec
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPS---TNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRR  411 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  411 (687)
                      ++....++|...+.||+|+||+||+|.+..   ++..||+|++...  .....+++.+|+.++++++||||+++++++..
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            334456788999999999999999998754   4568999998754  34456789999999999999999999999976


Q ss_pred             CC-----eeEEEEecCCCCCchhhhhc----hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC
Q 005621          412 RG-----DLLLVYDFMPNGSLDKCLFD----EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL  482 (687)
Q Consensus       412 ~~-----~~~lV~Ey~~~gsL~~~L~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~  482 (687)
                      .+     ..++||||+++++|.+++..    .....+++.+++.++.||+.||.|||+   ++|+||||||+||+++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCC
Confidence            55     35999999999999999843    233569999999999999999999998   8999999999999999999


Q ss_pred             cEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 005621          483 NGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDW  560 (687)
Q Consensus       483 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~  560 (687)
                      .+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||........   .+.
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~  261 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YDY  261 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHH
Confidence            999999999986544322 22233457889999999999999999999999999999999 8888876543221   111


Q ss_pred             HHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       561 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                          ...+.     .+.....    ....+.+++.+||+.+|++||++.++++.|+...
T Consensus       262 ----~~~~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          262 ----LLHGH-----RLKQPED----CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             ----HHTTC-----CCCCBTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHcCC-----CCCCCcc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                11111     1111122    2347889999999999999999999999998653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=352.58  Aligned_cols=262  Identities=19%  Similarity=0.211  Sum_probs=206.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC--------CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCcee---------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS--------TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ---------  404 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------  404 (687)
                      .++|...+.||+|+||+||+|++..        .++.||||++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999976        4789999998754     46788999999999999988         


Q ss_pred             ------eeeeeec-CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEE
Q 005621          405 ------LLGWCRR-RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL  477 (687)
Q Consensus       405 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  477 (687)
                            +++++.. .+..++||||+ +++|.+++.......+++.+++.++.||+.||.|||+   ++|+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence                  5667665 67899999999 9999999976545789999999999999999999999   89999999999999


Q ss_pred             eccCC--cEEEcccccceeccCCCCC------ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCC
Q 005621          478 LDSEL--NGRLGDFGLAKLYERGTNP------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPK  549 (687)
Q Consensus       478 l~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~  549 (687)
                      ++.++  .+||+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  8999999999866432211      123347899999999999999999999999999999999999999875


Q ss_pred             CCcchhhHHHHHHHHhcccccccccCCcCC-CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          550 ALPEELILVDWVWDRWKAGAILEVVDPRLN-GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       550 ~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ...... ..... ..+.. ......++... ..+    ...+.+++.+||+.||++||++.+|++.|+...
T Consensus       272 ~~~~~~-~~~~~-~~~~~-~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          272 LPNTED-IMKQK-QKFVD-KPGPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             TTCHHH-HHHHH-HHHHH-SCCCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CcCHHH-HHHHH-HhccC-ChhhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            432211 11111 11111 11111111111 112    247889999999999999999999999998753

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.5e-40  Score=379.77  Aligned_cols=247  Identities=28%  Similarity=0.393  Sum_probs=199.6

Q ss_pred             eeeeeeCeEEEEEEEe--CCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTL--PSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      +.||+|+||+||+|.+  ...++.||||+++...  ....+++.+|++++++++||||++++++|.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            5799999999999955  4556899999997653  3346789999999999999999999999964 568999999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC--Cc
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN--PS  502 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~--~~  502 (687)
                      |+|.+++.  ....+++.+++.|+.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++.+.....  ..
T Consensus       454 g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999994  34569999999999999999999998   9999999999999999999999999999987654332  22


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....+|..|+|||++.+..++.++|||||||++|||++ |+.||......+       +.+....+..         ..
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~---------~~  592 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER---------MG  592 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC---------CC
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---------CC
Confidence            233456889999999999999999999999999999998 999997654322       1222222211         11


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      .+...+..+.+|+.+||+.||++||++.+|++.|+.
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            222334578899999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.7e-40  Score=342.04  Aligned_cols=257  Identities=27%  Similarity=0.368  Sum_probs=202.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeee-cCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCR-RRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~l  417 (687)
                      .+|...++||+|+||+||+|++..+   ...+|+|.+.... ....+++.+|+.++++++||||++++++|. ..+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4678889999999999999997543   3469999987643 345678999999999999999999999864 5568899


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++... ...+++.+++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++....
T Consensus       105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999543 3468999999999999999999998   9999999999999999999999999999986543


Q ss_pred             CCC---CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          498 GTN---PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCG-RRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       498 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG-~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      ...   .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||......+..   ..+    ..+.    
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~----~~~~----  249 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYL----LQGR----  249 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHH----HTTC----
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHH----hcCC----
Confidence            221   122334678899999999999999999999999999999995 4555443322211   111    1111    


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                       .+.....+    +..+.+++.+||+.+|++||++.|+++.|+...
T Consensus       250 -~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          250 -RLLQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             -CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             01111122    236889999999999999999999999998753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.7e-40  Score=351.44  Aligned_cols=264  Identities=24%  Similarity=0.338  Sum_probs=206.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|...+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357899999999999999999999899999999997653 3445788999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccC-eEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ-TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++......
T Consensus       112 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  186 (360)
T 3eqc_A          112 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  186 (360)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999999943  3469999999999999999999998   5 89999999999999999999999999997553321


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHH-------------------
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW-------------------  560 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~-------------------  560 (687)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.......                   
T Consensus       187 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          187 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             -------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             ---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence               2235789999999999999999999999999999999999999976543211100000                   


Q ss_pred             ----HHHHhcccccccc----cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          561 ----VWDRWKAGAILEV----VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       561 ----v~~~~~~~~~~~~----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                          ...........+.    ................+.+++.+||+.||++|||+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                0000000000000    0000000001112346889999999999999999999997

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=349.11  Aligned_cols=264  Identities=26%  Similarity=0.398  Sum_probs=206.5

Q ss_pred             ccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeee
Q 005621          332 RFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCR  410 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~  410 (687)
                      .+.+.++....++|+..+.||+|+||.||+|.+..+++.||||++..... ..+++.+|+.+++++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            34555666678899999999999999999999988999999999875432 346788999999999 8999999999997


Q ss_pred             c------CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          411 R------RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       411 ~------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      .      .+..++||||+++++|.+++.......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence            6      4678999999999999999976555679999999999999999999999   899999999999999999999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD  559 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~  559 (687)
                      ||+|||++........ ......||..|+|||++.     +..++.++||||||+++|||++|+.||.........    
T Consensus       169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----  243 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----  243 (326)
T ss_dssp             EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----
T ss_pred             EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH----
Confidence            9999999986543221 223357899999999987     567899999999999999999999999764422111    


Q ss_pred             HHHHHhcccccccccCCcC-CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHh
Q 005621          560 WVWDRWKAGAILEVVDPRL-NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLE  616 (687)
Q Consensus       560 ~v~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~  616 (687)
                        .... ...     .+.+ ...++    ..+.+++.+||+.||++||++.++++  ++.
T Consensus       244 --~~~~-~~~-----~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          244 --FLIP-RNP-----APRLKSKKWS----KKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             --HHHH-HSC-----CCCCSCSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             --HHhh-cCc-----cccCCccccC----HHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence              1111 111     1111 12222    36889999999999999999999997  454

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-40  Score=352.09  Aligned_cols=255  Identities=22%  Similarity=0.287  Sum_probs=205.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeC---CCCeEEEEEEecCcc----hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCC
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLP---STNTQVAVKRVSNES----KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRG  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  413 (687)
                      .++|...+.||+|+||+||++++.   .+++.||||+++...    ....+.+..|+.+++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            367999999999999999999984   478999999987542    22345677899999999 6999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++||||+++++|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999953  3469999999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccC--CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      .+............||+.|+|||++.+  ..++.++|||||||++|||++|+.||..........  ........     
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~-----  280 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILK-----  280 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHH-----
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhc-----
Confidence            764433333344679999999999986  347899999999999999999999997654332211  11111111     


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHHH
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVRY  614 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  614 (687)
                        ..+.....+    ...+.+++.+||+.||++||     ++.|+++.
T Consensus       281 --~~~~~~~~~----~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          281 --SEPPYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             --CCCCCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             --cCCCCCccc----CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence              112222222    34678999999999999999     99999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.8e-39  Score=360.83  Aligned_cols=259  Identities=20%  Similarity=0.266  Sum_probs=198.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC------C
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR------G  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~  413 (687)
                      .++|+..+.||+|+||+||+|.+..+++.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999999999999999999764  344567889999999999999999999998654      4


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++||||+++ +|.+.+.    ..+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            57999999976 4655552    248999999999999999999999   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc------
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA------  567 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~------  567 (687)
                      .....  ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....   +.+....      
T Consensus       213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~---i~~~lg~p~~~~~  287 (464)
T 3ttj_A          213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---VIEQLGTPCPEFM  287 (464)
T ss_dssp             ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCSCCHHHH
T ss_pred             ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCCHHHH
Confidence            76443  223456899999999999999999999999999999999999999987543221111   1111000      


Q ss_pred             -------------cc------cccccCCcCC---CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          568 -------------GA------ILEVVDPRLN---GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       568 -------------~~------~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                                   ..      ........+.   .+........+.+|+.+||+.||++|||+.|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                         00      0000000000   0011122557899999999999999999999998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=338.82  Aligned_cols=252  Identities=26%  Similarity=0.421  Sum_probs=202.6

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCC
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMP  423 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~  423 (687)
                      +|....+||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            45556799999999999999988999999999987766667889999999999999999999999999999999999999


Q ss_pred             CCCchhhhhchh-hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-CCcEEEcccccceeccCCCCC
Q 005621          424 NGSLDKCLFDEQ-KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-ELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       424 ~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++|.+++.... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++. ++.+||+|||+++...... .
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence            999999996532 2356789999999999999999998   89999999999999988 8999999999998764322 2


Q ss_pred             ceeeeecCCCCCchhhccCCC--CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          502 STTRVVGTLGYLAPELTRTGK--PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      ......|+..|+|||++.+..  ++.++||||||+++|||++|+.||...........   ....       ....+.+.
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~-------~~~~~~~~  248 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGM-------FKVHPEIP  248 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH---HHHH-------HCCCCCCC
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH---hhcc-------cccccccc
Confidence            223457899999999987643  78999999999999999999999975433221110   0000       01122222


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+    ...+.+++.+||+.||++||++.++++
T Consensus       249 ~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          249 ESM----SAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            233    347889999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.5e-40  Score=361.26  Aligned_cols=254  Identities=23%  Similarity=0.308  Sum_probs=195.6

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--------hhhHHHHHHHHHHHhhhcCCCceeeeeeeec
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--------KQGLREFASEISSIGRLRHRNLVQLLGWCRR  411 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  411 (687)
                      ...++|...+.||+|+||+||+|.+..+++.||||++....        ......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45678999999999999999999999999999999987542        1122357899999999999999999999864


Q ss_pred             CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC---CcEEEcc
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE---LNGRLGD  488 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~D  488 (687)
                       +..++||||+++|+|.+++..  ...+++.++..++.|++.||.|||+   ++|+||||||+|||++.+   ..+||+|
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             -CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence             558999999999999998853  4569999999999999999999998   899999999999999754   4599999


Q ss_pred             cccceeccCCCCCceeeeecCCCCCchhhccC---CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 005621          489 FGLAKLYERGTNPSTTRVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       489 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      ||+++.....  .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.........  .+    ..
T Consensus       286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~----~i  357 (419)
T 3i6u_A          286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KD----QI  357 (419)
T ss_dssp             SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HH----HH
T ss_pred             cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HH----HH
Confidence            9999876432  22344679999999999853   57788999999999999999999999765432221  11    11


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+....  .+.....    ....+.+++.+||+.||++||++.|+++
T Consensus       358 ~~~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          358 TSGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HTTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1111100  0000011    2346889999999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.1e-39  Score=333.46  Aligned_cols=253  Identities=23%  Similarity=0.433  Sum_probs=201.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            368999999999999999999998889999999987543   23356789999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++..  ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           90 MEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999999943  3468999999999999999999998   89999999999999999999999999999865433


Q ss_pred             CCCceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .  ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.......       ..+....+.      ..
T Consensus       165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~------~~  229 (276)
T 2h6d_A          165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRGGV------FY  229 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------CC
T ss_pred             c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcCc------cc
Confidence            2  2233568999999999987765 689999999999999999999997643211       111111111      11


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                      +....    ...+.+++.+||+.||++||++.++++  ++++.
T Consensus       230 ~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          230 IPEYL----NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             Cchhc----CHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            11222    236889999999999999999999998  45543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.7e-40  Score=350.62  Aligned_cols=259  Identities=26%  Similarity=0.400  Sum_probs=205.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEe-----CCCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTL-----PSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      .++|...+.||+|+||.||+|++     ..+++.||||++... ......++.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            47899999999999999999994     456778999999754 344567899999999999999999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhh-----ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc---CCcEEEc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQK-----AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLG  487 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~  487 (687)
                      ++||||+++++|.+++.....     ..+++.+++.++.|++.||.|||+   .+|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999965321     458999999999999999999998   89999999999999984   4569999


Q ss_pred             ccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHh
Q 005621          488 DFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       488 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      |||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+   ..+    ..
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE----FV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH----HH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHH----HH
Confidence            9999986543322 22233467889999999999999999999999999999998 999987654211   111    11


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ..+..     +.....    ....+.+++.+||+.||++||++.++++.|+...
T Consensus       259 ~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          259 TSGGR-----MDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HTTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCCC-----CCCCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            11111     111122    2347889999999999999999999999988654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=349.03  Aligned_cols=255  Identities=16%  Similarity=0.110  Sum_probs=204.1

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEE-----eCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc---CCCceeeeee
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGT-----LPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR---HRNLVQLLGW  408 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~  408 (687)
                      +++...++|...++||+|+||+||+|.     ....++.||||++.....   .++..|++++.+++   |+|+++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            334456789999999999999999994     556788999999976643   45666777776665   9999999999


Q ss_pred             eecCCeeEEEEecCCCCCchhhhhch---hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-----
Q 005621          409 CRRRGDLLLVYDFMPNGSLDKCLFDE---QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-----  480 (687)
Q Consensus       409 ~~~~~~~~lV~Ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-----  480 (687)
                      +...+..++||||+++|+|.+++...   ....+++.+++.|+.||+.||.|||+   ++|+||||||+|||++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCc
Confidence            99999999999999999999999643   24569999999999999999999998   89999999999999998     


Q ss_pred             ------CCcEEEcccccceeccCCC-CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcc
Q 005621          481 ------ELNGRLGDFGLAKLYERGT-NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE  553 (687)
Q Consensus       481 ------~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~  553 (687)
                            ++.+||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  8999999999998654322 223345679999999999999999999999999999999999999986432211


Q ss_pred             hhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcC-CCHHHHHHHHhcC
Q 005621          554 ELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEAR-PTMRQVVRYLEGE  618 (687)
Q Consensus       554 ~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~  618 (687)
                                        ..+...+.....   ...+.+++..|++.+|.+| |+++++.+.|+..
T Consensus       293 ------------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 ------------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ------------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ------------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                              011112222222   3356688889999999998 6788888777654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.6e-40  Score=339.93  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=190.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .++|+..+.||+|+||+||+|.+..+++.||||++....  ....+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            468999999999999999999999899999999997653  222334455566688889999999999999999999999


Q ss_pred             ecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccC-eEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          420 DFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ-TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       420 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      ||++ |+|.+++..  .....+++..+..++.|++.||.|||+   + +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 588888754  234579999999999999999999998   7 99999999999999999999999999998664


Q ss_pred             CCCCCceeeeecCCCCCchhhc----cCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          497 RGTNPSTTRVVGTLGYLAPELT----RTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      ....  .....||+.|+|||++    .+..++.++||||||+++|||++|+.||.........     +.......    
T Consensus       162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~----  230 (290)
T 3fme_A          162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-----LKQVVEEP----  230 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-----HHHHHHSC----
T ss_pred             cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-----HHHHhccC----
Confidence            4322  2234689999999996    5567899999999999999999999999764432211     11111111    


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        .+...   .......+.+++.+||+.||++|||+.|+++
T Consensus       231 --~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 --SPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --CCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence              11111   1112336889999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-39  Score=349.47  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=208.7

Q ss_pred             HHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--------hhHHHHHHHHHHHhhh-cCCCceeee
Q 005621          336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--------QGLREFASEISSIGRL-RHRNLVQLL  406 (687)
Q Consensus       336 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~  406 (687)
                      .......++|...+.||+|+||.||+|++..+|+.||||++.....        ...+.+.+|+.+++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            3445566789999999999999999999988899999999875431        2245678999999999 799999999


Q ss_pred             eeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEE
Q 005621          407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRL  486 (687)
Q Consensus       407 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl  486 (687)
                      +++...+..++||||+++++|.+++..  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999853  4569999999999999999999998   89999999999999999999999


Q ss_pred             cccccceeccCCCCCceeeeecCCCCCchhhccC------CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 005621          487 GDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT------GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW  560 (687)
Q Consensus       487 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~  560 (687)
                      +|||++.......  ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||.......   ... 
T Consensus       242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~-  315 (365)
T 2y7j_A          242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLR-  315 (365)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH-
T ss_pred             EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHH-
Confidence            9999998765432  2334679999999999863      357889999999999999999999997643211   111 


Q ss_pred             HHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       561 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         ....+... ...+.. ..    ....+.+++.+||+.||++||++.++++
T Consensus       316 ---~i~~~~~~-~~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 ---MIMEGQYQ-FSSPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ---HHHHTCCC-CCHHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHHhCCCC-CCCccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               11111110 000000 11    1236889999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-40  Score=356.11  Aligned_cols=256  Identities=28%  Similarity=0.386  Sum_probs=195.4

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeec-CCeeEEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRR-RGDLLLV  418 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV  418 (687)
                      .|...++||+|+||+||+|.+...   +..||||.+.... ....++|.+|+.++++++||||++++++|.+ .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            466778999999999999987432   2468999987543 3456789999999999999999999998754 5688999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++|+|.+++... ...+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999543 3468999999999999999999999   99999999999999999999999999999865433


Q ss_pred             CCC---ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          499 TNP---STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       499 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ...   ......+|..|+|||.+.+..++.++||||||+++|||++ |..||......+..   ..+    ..+..    
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~~~----~~~~~----  314 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYL----LQGRR----  314 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---HHH----HTTCC----
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---HHH----HcCCC----
Confidence            211   1233457889999999999999999999999999999999 66677654432211   111    11111    


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                       +..    +...+..+.+++.+||+.+|++||++.|+++.|+...
T Consensus       315 -~~~----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          315 -LLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             -CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             111    1122347889999999999999999999999998754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.2e-39  Score=336.25  Aligned_cols=254  Identities=23%  Similarity=0.314  Sum_probs=207.1

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---------hhhHHHHHHHHHHHhhhc-CCCceeeeeee
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---------KQGLREFASEISSIGRLR-HRNLVQLLGWC  409 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~  409 (687)
                      ...++|...+.||+|+||.||+|.+..+++.||||++....         ....+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999999899999999986542         123457889999999995 99999999999


Q ss_pred             ecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccc
Q 005621          410 RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDF  489 (687)
Q Consensus       410 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF  489 (687)
                      ...+..++||||+++++|.+++..  ...+++.++..++.||+.||.|||+   .+++||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999999943  4579999999999999999999998   99999999999999999999999999


Q ss_pred             ccceeccCCCCCceeeeecCCCCCchhhcc------CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 005621          490 GLAKLYERGTNPSTTRVVGTLGYLAPELTR------TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       490 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      |++.......  ......|++.|+|||++.      ...++.++||||||+++|||++|+.||.......   ..    .
T Consensus       169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~----~  239 (298)
T 1phk_A          169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---ML----R  239 (298)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----H
T ss_pred             cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HH----H
Confidence            9998765432  233457899999999985      4568899999999999999999999997643211   11    1


Q ss_pred             HhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       564 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....+...      ............+.+++.+||+.||++||++.|+++
T Consensus       240 ~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11111110      000111122347889999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3e-40  Score=345.45  Aligned_cols=264  Identities=24%  Similarity=0.392  Sum_probs=188.7

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ...++|...+.||+|+||.||+|.+..+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999998889999999987543 33456788999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhch------hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccc
Q 005621          419 YDFMPNGSLDKCLFDE------QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA  492 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla  492 (687)
                      |||+++++|.+++...      ....+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999998542      23468999999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCC----CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          493 KLYERGTN----PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       493 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      +.......    .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..........   ........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~  245 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQNDPP  245 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHHTSSCC
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---HHhccCCC
Confidence            76543221    11234578999999999876 568999999999999999999999998754322111   00000000


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       568 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .......++.....++    ..+.+++.+||+.||++||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          246 SLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000111112222233    36889999999999999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-39  Score=353.24  Aligned_cols=263  Identities=21%  Similarity=0.265  Sum_probs=200.2

Q ss_pred             HHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeec------
Q 005621          338 LKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRR------  411 (687)
Q Consensus       338 l~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------  411 (687)
                      ++...++|...+.||+|+||+||+|++..+++.||||++......    ..+|+++++.++||||+++++++..      
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            345678999999999999999999999999999999998755322    2369999999999999999999843      


Q ss_pred             --------------------------------CCeeEEEEecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhh
Q 005621          412 --------------------------------RGDLLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLY  457 (687)
Q Consensus       412 --------------------------------~~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~y  457 (687)
                                                      ....++||||++ |+|.+.+..  .....+++..+..++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            334889999997 588887754  335679999999999999999999


Q ss_pred             hcccccCeEEeeccCCCcEEec-cCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHH
Q 005621          458 LHEEWEQTVIHRDIKAGNVLLD-SELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGAL  535 (687)
Q Consensus       458 LH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvv  535 (687)
                      ||+   .+|+||||||+|||++ .++.+||+|||+++.......  .....||..|+|||++.+. .++.++|||||||+
T Consensus       157 LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            998   9999999999999998 678999999999987644332  2345689999999998765 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc----------ccccccCCcC-----CCCCCHHHHHHHHHHHHhcccc
Q 005621          536 LLEVVCGRRPIEPKALPEELILVDWVWDRWKAG----------AILEVVDPRL-----NGEFNEIEALDVVKLGLMCSND  600 (687)
Q Consensus       536 l~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~----------~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~  600 (687)
                      +|||++|+.||......+...  ..+ +.....          ...+..-+.+     ...++......+.+|+.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~--~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLV--RII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHH--HHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHHHHH--HHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            999999999998754322211  111 111000          0000000111     1112222344688999999999


Q ss_pred             CcCcCCCHHHHHH
Q 005621          601 AAEARPTMRQVVR  613 (687)
Q Consensus       601 dP~~RPs~~evl~  613 (687)
                      ||++|||+.|+++
T Consensus       309 dP~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EPDLRINPYEAMA  321 (383)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999996

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.6e-40  Score=350.32  Aligned_cols=266  Identities=25%  Similarity=0.341  Sum_probs=203.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .++|+..+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            367899999999999999999999889999999986543  334566889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       104 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          104 EFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             ECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            99999999887632  3469999999999999999999999   999999999999999999999999999998654332


Q ss_pred             CCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH--------HHHHHhccccc
Q 005621          500 NPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD--------WVWDRWKAGAI  570 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~v~~~~~~~~~  570 (687)
                      . ......||..|+|||++.+. .++.++||||||+++|||++|+.||......+......        .....+.....
T Consensus       179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            2 22335689999999999875 78999999999999999999999998765322211110        00011111110


Q ss_pred             -ccccCCcCCCCCCH-----HHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 -LEVVDPRLNGEFNE-----IEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 -~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       .....+.+....+.     .....+.+++.+||+.||++||++.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             11111111111111     12347889999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-39  Score=361.11  Aligned_cols=195  Identities=25%  Similarity=0.379  Sum_probs=157.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeec-----CCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRR-----RGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~  414 (687)
                      .++|...++||+|+||+||+|.+..+++.||||++...  .....+++.+|+.++++++||||+++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36899999999999999999999989999999998654  34456789999999999999999999999843     357


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      +|+||||+ +++|.+++..  ...+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            89999998 5789988843  4569999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCC--------------------------CceeeeecCCCCCchhhc-cCCCCCCccceehhhHHHHHHHhC
Q 005621          495 YERGTN--------------------------PSTTRVVGTLGYLAPELT-RTGKPTTSSDVYAFGALLLEVVCG  542 (687)
Q Consensus       495 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDV~S~Gvvl~elltG  542 (687)
                      ......                          ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            643221                          123345789999999986 556799999999999999999994

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.8e-39  Score=356.05  Aligned_cols=201  Identities=21%  Similarity=0.299  Sum_probs=177.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh------cCCCceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL------RHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~  415 (687)
                      ..+|+..++||+|+||+||+|.+..+++.||||++.... ...+++..|+.+++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999999999999999997643 3346777888888887      467999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc--EEEcccccce
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN--GRLGDFGLAK  493 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DFGla~  493 (687)
                      ++||||+. ++|.+++.......+++..+..|+.||+.||.|||+   .+|+||||||+|||++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999995 699999876655669999999999999999999998   89999999999999999987  9999999997


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCC
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKAL  551 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~  551 (687)
                      .....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            65332    2335789999999999999999999999999999999999999977643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.5e-39  Score=363.09  Aligned_cols=252  Identities=24%  Similarity=0.360  Sum_probs=202.2

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ..++|...+.||+|+||+||+|++..++..||+|++....  ......+.+|+.++++++||||++++++|...+..++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3457999999999999999999999899999999987653  33457789999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC---CcEEEcccccceec
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE---LNGRLGDFGLAKLY  495 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGla~~~  495 (687)
                      |||+++|+|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++..   +.+||+|||+++..
T Consensus       115 ~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          115 MECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999999998843  4569999999999999999999998   999999999999999764   45999999999876


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ....  ......||+.|+|||++. +.++.++|||||||++|+|++|+.||......+.       ......+... ...
T Consensus       190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~-~~~  258 (494)
T 3lij_A          190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-------LRKVEKGKYT-FDS  258 (494)
T ss_dssp             BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCC-CCS
T ss_pred             CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC-CCc
Confidence            5432  233457999999999986 5689999999999999999999999986543211       1111111110 001


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +. ...    ....+.+++.+||+.+|++|||+.|+++
T Consensus       259 ~~-~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          259 PE-WKN----VSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             GG-GTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hh-ccc----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            11 111    2236889999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-39  Score=346.24  Aligned_cols=267  Identities=26%  Similarity=0.313  Sum_probs=200.5

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-----hHHHHHHHHHHHhhhcCCCceeeeeeeecCC
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-----GLREFASEISSIGRLRHRNLVQLLGWCRRRG  413 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  413 (687)
                      ....++|...+.||+|+||.||+|++..+++.||||++......     ..+.+.+|+.++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            44567899999999999999999999888999999998754221     1346889999999999999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++||||+++ +|.+++... ...+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            99999999976 888887543 3468999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      ...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......+.   ...+.+.........
T Consensus       161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTT
T ss_pred             eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhh
Confidence            764332 223345789999999999764 588999999999999999999999876543221   111222111100000


Q ss_pred             c------cCC---cCCCCCC-----HHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          573 V------VDP---RLNGEFN-----EIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       573 ~------~d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .      .+.   ......+     ......+.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0      000   0000011     1123478899999999999999999999983

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-39  Score=343.33  Aligned_cols=253  Identities=24%  Similarity=0.313  Sum_probs=199.9

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--------hhHHHHHHHHHHHhhhcCCCceeeeeeeecC
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--------QGLREFASEISSIGRLRHRNLVQLLGWCRRR  412 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  412 (687)
                      ..++|...+.||+|+||.||+|.+..+++.||||++.....        .....+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            45689999999999999999999999999999999875421        2234588999999999999999999998765


Q ss_pred             CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc---EEEccc
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN---GRLGDF  489 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DF  489 (687)
                      + .++||||+++++|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            5 8999999999999998853  4569999999999999999999998   99999999999999987654   999999


Q ss_pred             ccceeccCCCCCceeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 005621          490 GLAKLYERGTNPSTTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK  566 (687)
Q Consensus       490 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~  566 (687)
                      |+++.....  .......||+.|+|||++.   ...++.++||||||+++|||++|+.||.........  ...+    .
T Consensus       162 g~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~----~  233 (322)
T 2ycf_A          162 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQI----T  233 (322)
T ss_dssp             TTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHH----H
T ss_pred             ccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHH----H
Confidence            999876432  1223356899999999974   567899999999999999999999999765433221  1111    1


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       567 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+...  ..+.....    ....+.+++.+||+.||++||++.++++
T Consensus       234 ~~~~~--~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 SGKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HTCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCccc--cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11110  00011111    2347889999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.4e-39  Score=339.13  Aligned_cols=257  Identities=21%  Similarity=0.284  Sum_probs=202.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeeeeec--CCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWCRR--RGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|++..+++.||||++....   .+.+.+|+.++++++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            67899999999999999999998899999999997543   367889999999997 9999999999987  66789999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-cEEEcccccceeccCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-NGRLGDFGLAKLYERG  498 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~  498 (687)
                      ||+++++|.+++.     .+++.++..++.||+.||.|||+   .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus       113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999999998872     48999999999999999999998   9999999999999999776 8999999999876543


Q ss_pred             CCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhcccc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV--------WDRWKAGA  569 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v--------~~~~~~~~  569 (687)
                      ..  .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......... +....        .+.+....
T Consensus       185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTT
T ss_pred             Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhc
Confidence            32  233578999999999887 67899999999999999999999999655432211 11100        00000000


Q ss_pred             c------ccc--------cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          570 I------LEV--------VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       570 ~------~~~--------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .      .+.        ................+.+++.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0      000        0000111111123457889999999999999999999997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1e-39  Score=352.66  Aligned_cols=255  Identities=13%  Similarity=0.037  Sum_probs=186.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh--cCCCceeee-------eee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL--RHRNLVQLL-------GWC  409 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~  409 (687)
                      ..+|...+.||+|+||+||+|++..+++.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345889999999999999999998899999999998754   23456677886555555  599988755       333


Q ss_pred             ecC-----------------CeeEEEEecCCCCCchhhhhchhhccCCHHHH------HHHHHHHHhhhhhhcccccCeE
Q 005621          410 RRR-----------------GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQR------YRIIKGVASGLLYLHEEWEQTV  466 (687)
Q Consensus       410 ~~~-----------------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~i  466 (687)
                      ...                 ..+++||||++ |+|.+++.... ..+.+..+      ..++.||+.||+|||+   ++|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~i  215 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS---KGL  215 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCC
Confidence            322                 34899999998 89999996543 34566666      7888999999999998   999


Q ss_pred             EeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccC--CCCCCccceehhhHHHHHHHhCCC
Q 005621          467 IHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRR  544 (687)
Q Consensus       467 vHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~  544 (687)
                      +||||||+|||++.++.+||+|||+++....    ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999986532    2223457799999999987  679999999999999999999999


Q ss_pred             CCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          545 PIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       545 p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ||..........        +............+...........+.+++.+||+.||++||++.++++
T Consensus       292 Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            998764321110        0000000111111111111123447889999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.6e-39  Score=354.05  Aligned_cols=200  Identities=27%  Similarity=0.383  Sum_probs=170.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----Ce
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----GD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  414 (687)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+++.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999999999999999999764  334567889999999999999999999998766     57


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++||||+. ++|.+++..  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999996 699998843  4569999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCC---------------------CceeeeecCCCCCchhhc-cCCCCCCccceehhhHHHHHHHhCCCCCC
Q 005621          495 YERGTN---------------------PSTTRVVGTLGYLAPELT-RTGKPTTSSDVYAFGALLLEVVCGRRPIE  547 (687)
Q Consensus       495 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDV~S~Gvvl~elltG~~p~~  547 (687)
                      ......                     ...+..+||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            654321                     123456899999999986 55679999999999999999998655543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=349.76  Aligned_cols=264  Identities=24%  Similarity=0.327  Sum_probs=200.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG------  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  413 (687)
                      .++|...+.||+|+||.||+|.+..+|+.||||++...  .....+++.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46899999999999999999999989999999998653  3344577899999999999999999999987653      


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++||||+ +++|.+++..   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 8899998843   469999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHH--------HHHH
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW--------VWDR  564 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------v~~~  564 (687)
                      .....    .+...||..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+..        .++.
T Consensus       177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            75432    234578999999999887 6899999999999999999999999986543221111100        0000


Q ss_pred             hcccc-------cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          565 WKAGA-------ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       565 ~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      +....       +.......+. .........+.+|+.+||+.||++|||+.|+++  +++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~  313 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  313 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence            00000       0000001111 111122346889999999999999999999998  4554

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.5e-39  Score=348.27  Aligned_cols=267  Identities=24%  Similarity=0.324  Sum_probs=203.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeec--------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRR--------  411 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------  411 (687)
                      .++|+..+.||+|+||+||+|++..+++.||||++....  ......+.+|+.++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            368999999999999999999999899999999986543  2234678899999999999999999999876        


Q ss_pred             CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                      .+..++||||+++ +|.+.+... ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            4568999999975 777777443 3469999999999999999999998   9999999999999999999999999999


Q ss_pred             ceeccCCCC---CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          492 AKLYERGTN---PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       492 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      ++.+.....   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            987653222   22334578999999999876 45899999999999999999999999875533222211111111000


Q ss_pred             cccccc--------cCCcCCCCCCH-H------HHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          568 GAILEV--------VDPRLNGEFNE-I------EALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       568 ~~~~~~--------~d~~l~~~~~~-~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ......        ........... .      ....+.+|+.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            000000        00000000000 0      1235789999999999999999999997

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.1e-39  Score=340.04  Aligned_cols=263  Identities=21%  Similarity=0.300  Sum_probs=208.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEe-CCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCC------ceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTL-PSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN------LVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~  414 (687)
                      .++|+..+.||+|+||+||+|.+ ..+++.||||++.... ...+.+.+|+.++++++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999998 5578999999997543 34567889999999997665      9999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc--------------
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS--------------  480 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~--------------  480 (687)
                      .++||||+ +++|.+++.......+++.++..++.||+.||.|||+   ++|+||||||+|||++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 8999999966555578999999999999999999998   99999999999999987              


Q ss_pred             -----CCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchh
Q 005621          481 -----ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL  555 (687)
Q Consensus       481 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~  555 (687)
                           ++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+..
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                 668999999999865432    23357899999999999999999999999999999999999999865533222


Q ss_pred             hHHHHHH--------HHhcccccc------------------cccCCcC-CCCCCHHHHHHHHHHHHhccccCcCcCCCH
Q 005621          556 ILVDWVW--------DRWKAGAIL------------------EVVDPRL-NGEFNEIEALDVVKLGLMCSNDAAEARPTM  608 (687)
Q Consensus       556 ~~~~~v~--------~~~~~~~~~------------------~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  608 (687)
                      .......        +........                  ....+.. ...........+.+++.+||+.||++|||+
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            1111110        000000000                  0000000 011233456789999999999999999999


Q ss_pred             HHHHH
Q 005621          609 RQVVR  613 (687)
Q Consensus       609 ~evl~  613 (687)
                      .|+++
T Consensus       324 ~ell~  328 (339)
T 1z57_A          324 REALK  328 (339)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.7e-40  Score=340.06  Aligned_cols=259  Identities=27%  Similarity=0.390  Sum_probs=199.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC-CC--eEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS-TN--TQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      .++|+..+.||+|+||+||+|++.. ++  ..||||++...   .....+++.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3678999999999999999998632 22  36999998754   2345678999999999999999999999998765 8


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++||||+++++|.+++... ...+++.++..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            9999999999999999653 3569999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          496 ERGTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       496 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      ......  ......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+   .   .......+.   
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~~~~~---  242 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---I---LHKIDKEGE---  242 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHHHTSCC---
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---H---HHHHHccCC---
Confidence            543321  1223457888999999998889999999999999999999 999997654221   1   111111110   


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                        ....    +......+.+++.+||+.+|++||++.++++.|++..+
T Consensus       243 --~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          243 --RLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             --CCCC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence              0111    12233478899999999999999999999999987653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.9e-39  Score=362.36  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=206.4

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-------------hhHHHHHHHHHHHhhhcCCCceeeee
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-------------QGLREFASEISSIGRLRHRNLVQLLG  407 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~  407 (687)
                      ..++|...++||+|+||+||+|.+..+++.||||++.....             ...+++.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            46789999999999999999999999999999999875431             23567899999999999999999999


Q ss_pred             eeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC---cE
Q 005621          408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL---NG  484 (687)
Q Consensus       408 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~  484 (687)
                      ++.+.+..++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence            99999999999999999999998843  4569999999999999999999999   9999999999999998775   69


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      ||+|||+++......  ......||+.|+|||++. +.++.++|||||||++|+|++|+.||......+.       ...
T Consensus       189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~  258 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-------IKK  258 (504)
T ss_dssp             EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHH
T ss_pred             EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH
Confidence            999999998765432  233457999999999987 5689999999999999999999999986543221       111


Q ss_pred             hcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          565 WKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       565 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ...+....  +......    ....+.+++.+||+.||++|||+.|+++  ++++
T Consensus       259 i~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          259 VEKGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             HHHCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             HHcCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence            11221100  0000011    1246889999999999999999999997  4554

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-39  Score=363.33  Aligned_cols=256  Identities=23%  Similarity=0.374  Sum_probs=209.4

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      ..++|+..++||+|+||+||+|++..+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3467999999999999999999999899999999986542   3446788999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe---ccCCcEEEccccccee
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL---DSELNGRLGDFGLAKL  494 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~  494 (687)
                      ||||+++|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++.
T Consensus       104 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999998853  4569999999999999999999999   899999999999999   5678999999999987


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      +....  ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+   ..    ..+..+...   
T Consensus       179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~----~~i~~~~~~---  245 (484)
T 3nyv_A          179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---IL----KKVEKGKYT---  245 (484)
T ss_dssp             BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCCCC---
T ss_pred             ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HH----HHHHcCCCC---
Confidence            64432  2334579999999999876 68999999999999999999999998654321   11    111122111   


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                         ............+.+++.+||+.+|++|||+.|+++  +++.
T Consensus       246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence               000001122346889999999999999999999997  4543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.4e-39  Score=345.47  Aligned_cols=268  Identities=24%  Similarity=0.305  Sum_probs=207.4

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----C
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----G  413 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~  413 (687)
                      ...++|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++...     .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            34578999999999999999999999899999999997543 33457889999999999999999999998654     4


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++||||+. |+|.+++.   ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~iv~e~~~-~~L~~~l~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEcccC-cCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            6899999996 58998883   3469999999999999999999998   999999999999999999999999999998


Q ss_pred             eccCCCC--CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          494 LYERGTN--PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       494 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      .......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+   .........
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~  253 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQ  253 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCH
Confidence            7643322  11234579999999998754 45899999999999999999999999876543322211   111100000


Q ss_pred             ---------------ccccCCcCC--CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          571 ---------------LEVVDPRLN--GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       571 ---------------~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                                     .....+.-.  ..........+.+|+.+||+.||++|||+.|+++  +++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  319 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  319 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence                           000000000  0000112346889999999999999999999997  4444

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-38  Score=344.11  Aligned_cols=212  Identities=22%  Similarity=0.285  Sum_probs=181.3

Q ss_pred             cCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CC-----Cceeee
Q 005621          333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HR-----NLVQLL  406 (687)
Q Consensus       333 ~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~  406 (687)
                      +...+.....++|...+.||+|+||+||+|.+..+++.||||++... .....++..|+.+++.++ |+     ++++++
T Consensus        44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            33444455678999999999999999999999989999999999754 334567788999998885 55     499999


Q ss_pred             eeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec--cCCcE
Q 005621          407 GWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD--SELNG  484 (687)
Q Consensus       407 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~~~  484 (687)
                      +++...+..++||||++ ++|.+++.......+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.+
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence            99999999999999996 5999999765556799999999999999999999941 27899999999999994  47889


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCC
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKAL  551 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~  551 (687)
                      ||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       201 kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             EECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999876432    2345789999999999999999999999999999999999999987543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.9e-39  Score=361.86  Aligned_cols=256  Identities=24%  Similarity=0.352  Sum_probs=207.1

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ..++|...++||+|+||+||+|.+..+++.||||++....  ......+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999999899999999986542  23457889999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec---cCCcEEEcccccceec
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLY  495 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGla~~~  495 (687)
                      |||+++|+|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            999999999998843  3569999999999999999999999   9999999999999995   4567999999999866


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.       ...+..+....   
T Consensus       175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~---  241 (486)
T 3mwu_A          175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-------LKRVETGKYAF---  241 (486)
T ss_dssp             CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCS---
T ss_pred             CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCC---
Confidence            4432  2334579999999999875 589999999999999999999999976543211       11111111110   


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                         ...........+.+++.+||+.+|++|||+.|+++  ++++
T Consensus       242 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          242 ---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             ---CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             ---CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence               00001112346889999999999999999999998  4554

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-38  Score=355.03  Aligned_cols=261  Identities=20%  Similarity=0.255  Sum_probs=209.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC-CCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH-RNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|...++||+|+||.||+|++..+++.||||++......  .++..|+++++.++| +++..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999999888999999988654332  457889999999987 555566666777888999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe---ccCCcEEEcccccceeccC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL---DSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~~~  497 (687)
                      |+ +++|.+++... ...+++.+++.|+.||+.||.|||+   ++|+||||||+||||   +.++.+||+|||+++.+..
T Consensus        84 ~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99 99999998532 4469999999999999999999998   999999999999999   6889999999999987655


Q ss_pred             CCCC------ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          498 GTNP------STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       498 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ....      ......||..|+|||++.+..++.++|||||||+||||++|+.||..............+........+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            4321      1235679999999999999999999999999999999999999998765543333222222221111111


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      .     +...+    ..++.+++..||+.+|++||++.+|++.|+..
T Consensus       239 ~-----l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          239 A-----LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             H-----HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             H-----HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1     11122    23788999999999999999999999988653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=337.81  Aligned_cols=257  Identities=28%  Similarity=0.410  Sum_probs=205.1

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ...++|...+.||+|+||.||+|.+..+++.||||++....  ..+++.+|+.++++++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34568999999999999999999998889999999997643  3467889999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++++|.+++.. ....+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          104 EYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             ECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             ecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999999999853 34579999999999999999999998   999999999999999999999999999998765432


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      . ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.........      ... ....     .+.+ 
T Consensus       180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~-~~~~-----~~~~-  245 (314)
T 3com_A          180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMI-PTNP-----PPTF-  245 (314)
T ss_dssp             S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHH-HHSC-----CCCC-
T ss_pred             c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHH-hcCC-----Cccc-
Confidence            2 223456899999999999999999999999999999999999999765421111      110 0110     1111 


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                       ..+......+.+++.+||+.||++||++.++++  ++..
T Consensus       246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence             111122347889999999999999999999987  4443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.3e-39  Score=336.20  Aligned_cols=254  Identities=24%  Similarity=0.430  Sum_probs=197.6

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeec---------
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRR---------  411 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------  411 (687)
                      ..++|+..+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            356799999999999999999999889999999999653 3445788999999999999999999998754         


Q ss_pred             ----CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEc
Q 005621          412 ----RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       412 ----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~  487 (687)
                          .+..++||||+++++|.+++... ...+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence                45789999999999999999643 3468899999999999999999999   899999999999999999999999


Q ss_pred             ccccceeccCCC-------------CCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcc
Q 005621          488 DFGLAKLYERGT-------------NPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPE  553 (687)
Q Consensus       488 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~  553 (687)
                      |||+++......             ........||..|+|||.+.+. .++.++||||||+++|||++   |+....  .
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h
Confidence            999998654321             1122345689999999999864 78999999999999999998   443211  1


Q ss_pred             hhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          554 ELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       554 ~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      .   .+ ........      ...+...++......+.+++.+||+.||++||++.++++.
T Consensus       234 ~---~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 R---VN-ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             H---HH-HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             H---HH-HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            1   11 11111111      1122233334444578899999999999999999999873

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-38  Score=344.44  Aligned_cols=263  Identities=21%  Similarity=0.273  Sum_probs=197.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG------  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  413 (687)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+++.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999999989999999998754  3344577889999999999999999999987654      


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++||||++ ++|.+++.    ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            7899999996 47877773    358999999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH---------
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR---------  564 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~---------  564 (687)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   ..+.+.         
T Consensus       176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---NKVIEQLGTPCPEFM  250 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHC-CCCCCHHHH
T ss_pred             cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHH
Confidence            654322  233457899999999999999999999999999999999999999765432111   001000         


Q ss_pred             ----------hcccc------cccccCCcCC---CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          565 ----------WKAGA------ILEVVDPRLN---GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       565 ----------~~~~~------~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                                .....      ..+.......   .+........+.+|+.+||+.||++|||++|+++  +++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                      00000      0000000000   0011223567899999999999999999999998  4543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.4e-39  Score=340.66  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=201.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++........+++.+|+.++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            46899999999999999999999988999999999877666778899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++++|.+++... ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... .
T Consensus        98 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q  172 (302)
T ss_dssp             CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred             CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence            9999999988543 3469999999999999999999998   899999999999999999999999999976432111 1


Q ss_pred             ceeeeecCCCCCchhhc-----cCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          502 STTRVVGTLGYLAPELT-----RTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~-----~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      ......||..|+|||++     ....++.++||||||+++|||++|+.||........      ..... .+..     +
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~~-----~  240 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIA-KSDP-----P  240 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH-HSCC-----C
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHh-ccCC-----c
Confidence            11234689999999998     366789999999999999999999999976542111      11111 1111     1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+  ..+......+.+++.+||+.||++||++.++++
T Consensus       241 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          241 TL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00  011122346889999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=340.08  Aligned_cols=266  Identities=22%  Similarity=0.334  Sum_probs=199.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeee-----------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR-----------  410 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-----------  410 (687)
                      .++|...+.||+|+||.||+|.+..+++.||||++........+++.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999999889999999998777777788999999999999999999999873           


Q ss_pred             ---cCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec-cCCcEEE
Q 005621          411 ---RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD-SELNGRL  486 (687)
Q Consensus       411 ---~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl  486 (687)
                         +.+..++||||++ |+|.+++.   ...+++..+..++.|++.||.|||+   ++|+||||||+||+++ +++.+||
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence               4467899999997 69999884   3568999999999999999999998   9999999999999997 5679999


Q ss_pred             cccccceeccCCCC--CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 005621          487 GDFGLAKLYERGTN--PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       487 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      +|||+++.......  .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..   ..+.+
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~  239 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILE  239 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHH
Confidence            99999987643221  12233457899999998865 67899999999999999999999999875432211   11111


Q ss_pred             Hhcc---ccccc------------ccCCcCC-CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          564 RWKA---GAILE------------VVDPRLN-GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       564 ~~~~---~~~~~------------~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ....   ....+            ...+... ..........+.+++.+||+.||++||++.|+++  ++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence            1000   00000            0000000 0000112347889999999999999999999987  5553

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.8e-38  Score=339.77  Aligned_cols=270  Identities=20%  Similarity=0.282  Sum_probs=208.1

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-----------CCCceeeeeeee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-----------HRNLVQLLGWCR  410 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~  410 (687)
                      .++|...+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            368999999999999999999998899999999997543 33467888999999886           899999999987


Q ss_pred             cCC----eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccC-eEEeeccCCCcEEecc-----
Q 005621          411 RRG----DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ-TVIHRDIKAGNVLLDS-----  480 (687)
Q Consensus       411 ~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlk~~NIll~~-----  480 (687)
                      ..+    ..++||||+ +++|.+++.......+++..+..++.||+.||.|||+   + +|+||||||+|||++.     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 9999999976556679999999999999999999998   7 9999999999999954     


Q ss_pred             -CCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcch---hh
Q 005621          481 -ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEE---LI  556 (687)
Q Consensus       481 -~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~---~~  556 (687)
                       .+.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence             347999999999876543    2234789999999999999999999999999999999999999986543211   11


Q ss_pred             HHHHHHHHhcc------------------cccccccCC-c---------CCCCCCHHHHHHHHHHHHhccccCcCcCCCH
Q 005621          557 LVDWVWDRWKA------------------GAILEVVDP-R---------LNGEFNEIEALDVVKLGLMCSNDAAEARPTM  608 (687)
Q Consensus       557 ~~~~v~~~~~~------------------~~~~~~~d~-~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  608 (687)
                      ....+.+....                  ......+.. .         -...++......+.+|+.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            11111111100                  000000000 0         0123456677889999999999999999999


Q ss_pred             HHHHH--HHhcCCC
Q 005621          609 RQVVR--YLEGEVP  620 (687)
Q Consensus       609 ~evl~--~L~~~~~  620 (687)
                      .|+++  ++.+...
T Consensus       329 ~ell~hp~f~~~~~  342 (373)
T 1q8y_A          329 GGLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHHTCGGGTTCTT
T ss_pred             HHHhhChhhhcccC
Confidence            99998  5555433

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.4e-39  Score=348.20  Aligned_cols=270  Identities=21%  Similarity=0.262  Sum_probs=201.7

Q ss_pred             cCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-----------hhhHHHHHHHHHHHhhhcCCC
Q 005621          333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-----------KQGLREFASEISSIGRLRHRN  401 (687)
Q Consensus       333 ~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~H~n  401 (687)
                      ...+++....++|...+.||+|+||.||+|.+.. ++.||||++....           ....+++.+|++++++++|||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            3467888999999999999999999999999864 8999999986532           122478899999999999999


Q ss_pred             ceeeeeeeec-----CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcE
Q 005621          402 LVQLLGWCRR-----RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNV  476 (687)
Q Consensus       402 iv~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  476 (687)
                      |+++++++..     ....++||||++ |+|.+++... ...+++..+..++.||+.||.|||+   .+|+||||||+||
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI  165 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence            9999999843     346899999997 6888888543 3469999999999999999999999   8999999999999


Q ss_pred             EeccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchh
Q 005621          477 LLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL  555 (687)
Q Consensus       477 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~  555 (687)
                      |++.++.+||+|||+++......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999997543322  2334578999999999877 67899999999999999999999999875432211


Q ss_pred             hHHHHHHHHhcccc-----------cccccCCcCCC-------CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          556 ILVDWVWDRWKAGA-----------ILEVVDPRLNG-------EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       556 ~~~~~v~~~~~~~~-----------~~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         ..+.+......           ..+.+...+..       .........+.+++.+||+.||++|||+.|+++
T Consensus       244 ---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          244 ---NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             ---HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence               11111111000           00000000000       001112346889999999999999999999997

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.6e-38  Score=340.35  Aligned_cols=267  Identities=23%  Similarity=0.328  Sum_probs=204.3

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----Ce
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----GD  414 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  414 (687)
                      ..++|...+.||+|+||+||+|.+..+++.||||++.... .....++.+|+.++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3578999999999999999999998889999999997543 33456788999999999999999999988654     67


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++||||+. ++|.+++.   ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIS---TQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCS-EEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeccC-ccHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            899999996 68988884   3469999999999999999999998   9999999999999999999999999999987


Q ss_pred             ccCCCCC---------ceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 005621          495 YERGTNP---------STTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR  564 (687)
Q Consensus       495 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~  564 (687)
                      .......         ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........   .+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~  238 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGI  238 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHH
Confidence            6532211         1223468999999998765 678999999999999999999999998754322111   11111


Q ss_pred             hcccc---cc---------cccC--CcCCC----CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          565 WKAGA---IL---------EVVD--PRLNG----EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       565 ~~~~~---~~---------~~~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      .....   ..         +.+.  +....    .........+.+++.+||+.||++||++.|+++  +++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            10000   00         0000  00000    000112346789999999999999999999997  4544

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.2e-39  Score=347.32  Aligned_cols=258  Identities=22%  Similarity=0.291  Sum_probs=187.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecC------C
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRR------G  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~  413 (687)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+++.+|+.++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999999999999999998654  334567888999999999999999999998654      5


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++|+||+ +++|.+++..   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            689999999 7899998843   469999999999999999999998   999999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc----
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG----  568 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~----  568 (687)
                      .....    .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+...   .+.+.....    
T Consensus       181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~p~~~~  253 (367)
T 2fst_X          181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPGAEL  253 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHHH
T ss_pred             ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHH
Confidence            65432    334578999999999887 678999999999999999999999997654322211   111111000    


Q ss_pred             -------ccccccC--CcCC-CCCC---HHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          569 -------AILEVVD--PRLN-GEFN---EIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       569 -------~~~~~~d--~~l~-~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                             .....+.  +... ..+.   ......+.+|+.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                   0000000  0000 0000   011246889999999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7e-39  Score=338.99  Aligned_cols=265  Identities=24%  Similarity=0.303  Sum_probs=204.9

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeC-CCCeEEEEEEecCcch--hhHHHHHHHHHHHhhh---cCCCceeeeeeee---
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLP-STNTQVAVKRVSNESK--QGLREFASEISSIGRL---RHRNLVQLLGWCR---  410 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~---  410 (687)
                      .+.++|+..+.||+|+||+||+|.+. .+++.||+|++.....  .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            45688999999999999999999985 6789999999865432  2223566777777776   8999999999987   


Q ss_pred             --cCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcc
Q 005621          411 --RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGD  488 (687)
Q Consensus       411 --~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D  488 (687)
                        .....++||||++ |+|.+++.......+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEec
Confidence              5678899999997 699999966555569999999999999999999999   8999999999999999999999999


Q ss_pred             cccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc
Q 005621          489 FGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG  568 (687)
Q Consensus       489 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~  568 (687)
                      ||+++......  ......||..|+|||++.+..++.++||||||+++|||++|+.||......+.   ...+.......
T Consensus       164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~  238 (326)
T 1blx_A          164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLP  238 (326)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred             CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCC
Confidence            99998654322  22345789999999999999999999999999999999999999986543221   11122111100


Q ss_pred             c---ccc-------ccC---CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          569 A---ILE-------VVD---PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       569 ~---~~~-------~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .   ...       ...   ......+.......+.+++.+||+.||++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0   000       000   00001111223347889999999999999999999996

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.2e-39  Score=372.52  Aligned_cols=250  Identities=24%  Similarity=0.305  Sum_probs=208.9

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeE
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  416 (687)
                      ..++|...++||+|+||+||+|++..+++.||||++.+..   ....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3568999999999999999999999999999999997642   33456788899999988 7999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      |||||+++|+|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus       419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999953  3569999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+       +.+.+..+.      .
T Consensus       494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~------~  559 (674)
T 3pfq_A          494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHN------V  559 (674)
T ss_dssp             CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHSSC------C
T ss_pred             cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCC------C
Confidence            322 23445689999999999999999999999999999999999999998654321       111111111      1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCH-----HHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTM-----RQVVR  613 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  613 (687)
                          .++.....++.+|+.+||+.||++||++     +||++
T Consensus       560 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 ----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                1222233478899999999999999997     77775

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.1e-39  Score=342.32  Aligned_cols=259  Identities=20%  Similarity=0.304  Sum_probs=207.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhh-----------------HHHHHHHHHHHhhhcCCCcee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-----------------LREFASEISSIGRLRHRNLVQ  404 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~  404 (687)
                      .++|...+.||+|+||.||+|.+  +++.||||++.......                 .+.+.+|+.++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999999  78999999987543221                 178999999999999999999


Q ss_pred             eeeeeecCCeeEEEEecCCCCCchhh------hhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          405 LLGWCRRRGDLLLVYDFMPNGSLDKC------LFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       405 l~~~~~~~~~~~lV~Ey~~~gsL~~~------L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                      +++++.+.+..++||||+++++|.++      +.......+++..+..++.|++.||.|||+  .++|+||||||+||++
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM  185 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence            99999999999999999999999999      654446679999999999999999999996  3799999999999999


Q ss_pred             ccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCC-CCCC-ccceehhhHHHHHHHhCCCCCCCCCCcchhh
Q 005621          479 DSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG-KPTT-SSDVYAFGALLLEVVCGRRPIEPKALPEELI  556 (687)
Q Consensus       479 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~  556 (687)
                      +.++.+||+|||+++.....   ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||........  
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE--  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH--
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--
Confidence            99999999999999876433   33445789999999999877 5666 99999999999999999999987654211  


Q ss_pred             HHHHHHHHhcccccccccC------CcC---CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          557 LVDWVWDRWKAGAILEVVD------PRL---NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       557 ~~~~v~~~~~~~~~~~~~d------~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                          ..+.+..+......+      +..   ...........+.+++.+||+.||++||++.|+++
T Consensus       261 ----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 ----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ----HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                111122221110000      000   00000223347889999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.5e-39  Score=351.26  Aligned_cols=259  Identities=26%  Similarity=0.327  Sum_probs=196.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecC------CeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRR------GDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~  416 (687)
                      .+|...+.||+|+||+||+|++..+++.||||++.....    .+.+|++++++++||||+++++++...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            468889999999999999999988899999999865432    234699999999999999999988532      2367


Q ss_pred             EEEecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-CcEEEcccccce
Q 005621          417 LVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAK  493 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla~  493 (687)
                      +||||+++ +|.+.+..  .....+++..+..++.||+.||.|||+   ++|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999975 66666543  234579999999999999999999998   999999999999999965 568999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH-------h
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDR-------W  565 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~-------~  565 (687)
                      .+.....  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.  +.+.+...       +
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHH
Confidence            7644322  2345789999999998764 789999999999999999999999987543222  11111110       0


Q ss_pred             c--ccccccccCCcCCC-----CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          566 K--AGAILEVVDPRLNG-----EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       566 ~--~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .  .....+...+.+..     .+.......+.+|+.+||+.||++||++.|+++
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0  00001111111110     011222357889999999999999999999997

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.2e-39  Score=343.05  Aligned_cols=274  Identities=23%  Similarity=0.309  Sum_probs=198.0

Q ss_pred             HHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       335 ~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      ..+.....++|...+.||+|+||+||+|++..+++.||||++..... ...++.+|++.++.++||||+++++++...+.
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            35567778999999999999999999999998999999999865432 23456788888999999999999999865443


Q ss_pred             -------eEEEEecCCCCCchhhhhc--hhhccCCHHHHHHHHHHHHhhhhhhc--ccccCeEEeeccCCCcEEecc-CC
Q 005621          415 -------LLLVYDFMPNGSLDKCLFD--EQKAILTWEQRYRIIKGVASGLLYLH--EEWEQTVIHRDIKAGNVLLDS-EL  482 (687)
Q Consensus       415 -------~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivHrDlk~~NIll~~-~~  482 (687)
                             .++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||  +   ++|+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCC
Confidence                   7899999976 55554432  23456899999999999999999999  7   99999999999999997 89


Q ss_pred             cEEEcccccceeccCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 005621          483 NGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV  561 (687)
Q Consensus       483 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v  561 (687)
                      .+||+|||+++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..........  ..+
T Consensus       170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~~~  245 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH--EIV  245 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHH
T ss_pred             cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH--HHH
Confidence            999999999987654332  2335689999999998765 48999999999999999999999998755322211  111


Q ss_pred             HHHhccc--ccccccCCc----------------CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          562 WDRWKAG--AILEVVDPR----------------LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       562 ~~~~~~~--~~~~~~d~~----------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                       +.....  .....+++.                ............+.+|+.+||+.||++|||+.|+++  ++++.
T Consensus       246 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          246 -RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             -HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             -HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence             110000  000000000                001111223557899999999999999999999997  45443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-38  Score=337.32  Aligned_cols=255  Identities=24%  Similarity=0.346  Sum_probs=182.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHH-HHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEIS-SIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .++|...+.||+|+||.||+|.+..+++.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367889999999999999999998899999999997653 333455666665 777789999999999999999999999


Q ss_pred             ecCCCCCchhhhhc---hhhccCCHHHHHHHHHHHHhhhhhhcccccC-eEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          420 DFMPNGSLDKCLFD---EQKAILTWEQRYRIIKGVASGLLYLHEEWEQ-TVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       420 Ey~~~gsL~~~L~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ||+++ +|.+++..   .....+++..+.+++.|++.||.|||+   . +|+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88877743   224578999999999999999999998   7 9999999999999999999999999999866


Q ss_pred             cCCCCCceeeeecCCCCCchhhc----cCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELT----RTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ....  ......||..|+|||++    .+..++.++||||||+++|||++|+.||.........     +      ....
T Consensus       177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~------~~~~  243 (327)
T 3aln_A          177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----L------TQVV  243 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCC
T ss_pred             cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----H------HHHh
Confidence            4332  22334689999999998    4567899999999999999999999999764321110     0      0011


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....+.+...........+.+++.+||+.||++||++.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            111112221111223347889999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-38  Score=339.52  Aligned_cols=263  Identities=21%  Similarity=0.278  Sum_probs=180.9

Q ss_pred             HhcCcccc-eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeec----CCee
Q 005621          341 ATRGFRDK-ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRR----RGDL  415 (687)
Q Consensus       341 at~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~  415 (687)
                      ..++|... ++||+|+||+||+|.+..+++.||||++.....    ...+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            45788885 469999999999999998999999999976422    11222334566799999999999876    4568


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC---CcEEEcccccc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE---LNGRLGDFGLA  492 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGla  492 (687)
                      ++||||+++|+|.+++.......+++.+++.++.||+.||.|||+   .+|+||||||+|||++.+   +.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999999976655679999999999999999999999   899999999999999764   55999999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      +.....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........   ........+.   
T Consensus       179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~---  249 (336)
T 3fhr_A          179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQ---  249 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccc---
Confidence            865432   2234578999999999988889999999999999999999999997654321100   0000000000   


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCCCCC
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVPLP  622 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~~  622 (687)
                         ..+...........+.+++.+||+.||++||++.|+++  ++......+
T Consensus       250 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  298 (336)
T 3fhr_A          250 ---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP  298 (336)
T ss_dssp             ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred             ---cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence               01111111122347889999999999999999999998  666544333

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.7e-39  Score=339.59  Aligned_cols=263  Identities=22%  Similarity=0.358  Sum_probs=202.2

Q ss_pred             CCCccCHHHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhc--CCCcee
Q 005621          329 GPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLR--HRNLVQ  404 (687)
Q Consensus       329 ~~~~~~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~  404 (687)
                      ....+.++.+....++|+..+.||+|+||.||++.+. +++.||||++...  .....+.+.+|+.++++++  ||||++
T Consensus        14 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             ------CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             CCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence            3445556666667788999999999999999999985 4889999998654  3445678999999999997  599999


Q ss_pred             eeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       405 l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      +++++...+..++||| +.+++|.+++..  ...+++.++..++.|++.||.|||+   .+|+||||||+|||++ ++.+
T Consensus        93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~-~~~~  165 (313)
T 3cek_A           93 LYDYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGML  165 (313)
T ss_dssp             EEEEEECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEE
T ss_pred             EEEEeecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEE-CCeE
Confidence            9999999999999999 568899999953  3568999999999999999999998   8999999999999996 4899


Q ss_pred             EEcccccceeccCCCCC-ceeeeecCCCCCchhhccC-----------CCCCCccceehhhHHHHHHHhCCCCCCCCCCc
Q 005621          485 RLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRT-----------GKPTTSSDVYAFGALLLEVVCGRRPIEPKALP  552 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~  552 (687)
                      ||+|||+++........ ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||......
T Consensus       166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (313)
T 3cek_A          166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  245 (313)
T ss_dssp             EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence            99999999866443221 2234578999999999875           46888999999999999999999999764321


Q ss_pred             chhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          553 EELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       553 ~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..     ....         .+++.....++......+.+++.+||+.||++||++.|+++
T Consensus       246 ~~-----~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          246 IS-----KLHA---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HH-----HHHH---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH-----HHHH---------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            11     1111         11222222222222347889999999999999999999997

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.7e-38  Score=336.91  Aligned_cols=267  Identities=20%  Similarity=0.298  Sum_probs=207.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCC-eEEEEEEecCcchhhHHHHHHHHHHHhhhcCCC------ceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTN-TQVAVKRVSNESKQGLREFASEISSIGRLRHRN------LVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~  414 (687)
                      .++|...+.||+|+||+||+|.+..++ +.||+|++.... ...+.+..|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            478999999999999999999997666 799999997543 34567888999999998766      8999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe----------------
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL----------------  478 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll----------------  478 (687)
                      .++||||+ +++|.+++.......+++.++..++.||+.||.|||+   ++|+||||||+|||+                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 6778787765555679999999999999999999998   899999999999999                


Q ss_pred             ---ccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchh
Q 005621          479 ---DSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL  555 (687)
Q Consensus       479 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~  555 (687)
                         +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence               66789999999999864332    23357899999999999999999999999999999999999999875533222


Q ss_pred             hHHHHHHH--------Hhcccccc------------------cccCC-cCCCCCCHHHHHHHHHHHHhccccCcCcCCCH
Q 005621          556 ILVDWVWD--------RWKAGAIL------------------EVVDP-RLNGEFNEIEALDVVKLGLMCSNDAAEARPTM  608 (687)
Q Consensus       556 ~~~~~v~~--------~~~~~~~~------------------~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  608 (687)
                      ........        ........                  +...+ .........+...+.+|+.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            11111100        00000000                  00000 00011223445678999999999999999999


Q ss_pred             HHHHH--HHhc
Q 005621          609 RQVVR--YLEG  617 (687)
Q Consensus       609 ~evl~--~L~~  617 (687)
                      .|+++  ++.+
T Consensus       329 ~e~l~hp~f~~  339 (355)
T 2eu9_A          329 AEALLHPFFAG  339 (355)
T ss_dssp             HHHTTSGGGGG
T ss_pred             HHHhcChhhcC
Confidence            99986  4443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.3e-38  Score=329.25  Aligned_cols=254  Identities=25%  Similarity=0.364  Sum_probs=206.2

Q ss_pred             HHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       339 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ....++|+..+.||+|+||+||+|++..+++.||||++....  ....+.+.+|++++++++||||+++++++...+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            344578999999999999999999998889999999986543  234678899999999999999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC---CcEEEcccccce
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE---LNGRLGDFGLAK  493 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGla~  493 (687)
                      +||||+++++|.+++..  ...+++.++..++.||+.||.|||+   .+++||||||+||+++.+   +.+||+|||++.
T Consensus        98 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999999998853  3469999999999999999999998   899999999999999764   469999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      .......  .....|+..|+|||.+.+ .++.++||||||+++|+|++|+.||......+       +...+..+.... 
T Consensus       173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~-  241 (287)
T 2wei_A          173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAF-  241 (287)
T ss_dssp             TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC-
T ss_pred             eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCC-
Confidence            6544322  223468899999999875 58999999999999999999999997654211       111122221110 


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       +......+    ...+.+++.+||+.+|++||++.|+++
T Consensus       242 -~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 -DLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -CSGGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -Cchhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence             00000122    236889999999999999999999997

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=338.07  Aligned_cols=256  Identities=21%  Similarity=0.302  Sum_probs=199.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe-----
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD-----  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  414 (687)
                      .++|...+.||+|+||+||+|.+..+|+.||||++...  .....+++.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36789999999999999999999989999999999764  23345778999999999999999999999977654     


Q ss_pred             -eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          415 -LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       415 -~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                       .++||||++ ++|.+++.    ..+++.++..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999997 68888773    348999999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc------
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK------  566 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~------  566 (687)
                      .....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+..   ..+.....      
T Consensus       175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~  247 (353)
T 3coi_A          175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGTEF  247 (353)
T ss_dssp             C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHH---HHHHHHHCBCCHHH
T ss_pred             CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHH
Confidence            65332    234578999999999887 67899999999999999999999999865432211   11111000      


Q ss_pred             -----cc-------ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          567 -----AG-------AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       567 -----~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                           ..       .+.....+.+. .........+.+++.+||+.||++||++.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 00       00000011111 111223447889999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.5e-38  Score=340.71  Aligned_cols=257  Identities=22%  Similarity=0.309  Sum_probs=199.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee----
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL----  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~----  415 (687)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+++.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46889999999999999999999999999999999764  333457889999999999999999999999877654    


Q ss_pred             --EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          416 --LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       416 --~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                        ++||||+. ++|.+++    ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999997 6888777    2349999999999999999999999   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc----
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG----  568 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~----  568 (687)
                      .....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...   .+.......    
T Consensus       193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~  265 (371)
T 4exu_A          193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPGTEF  265 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCHHH
T ss_pred             ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCcHHH
Confidence            65432    233568999999999987 688999999999999999999999998654322111   111100000    


Q ss_pred             -------c---cccccCCcCCCC---CCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          569 -------A---ILEVVDPRLNGE---FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       569 -------~---~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                             .   ..+.+.......   ........+.+|+.+||+.||++||++.|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                   0   000000000000   00112347889999999999999999999997

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-38  Score=368.63  Aligned_cols=260  Identities=23%  Similarity=0.333  Sum_probs=206.9

Q ss_pred             HHHHhcCcccceeeeeeCeEEEEEEEeCC---CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC
Q 005621          338 LKKATRGFRDKELLGFGGFGRVYKGTLPS---TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG  413 (687)
Q Consensus       338 l~~at~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  413 (687)
                      .....++|...+.||+|+||+||+|.+..   .+..||||++.... ....++|.+|+.++++++||||+++++++. .+
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            33445778899999999999999999854   35679999987643 344578999999999999999999999985 45


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            689999999999999999543 3468999999999999999999999   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      ..............+|+.|+|||++.+..++.++||||||+++|||++ |..||......+   ...    .+..+..  
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~----~i~~~~~--  610 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGER--  610 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH----HHHHTCC--
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH----HHHcCCC--
Confidence            765444333344567889999999998999999999999999999997 999997654321   111    1111111  


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                         +.+..    ..+..+.+++.+||+.||++||++.++++.|+..
T Consensus       611 ---~~~~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          611 ---LPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ---CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               11122    2234788999999999999999999999998764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3e-38  Score=343.94  Aligned_cols=262  Identities=23%  Similarity=0.325  Sum_probs=195.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC------eeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG------DLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~  416 (687)
                      .+|...++||+|+||+||+|++..+++ ||+|++......    ..+|+++++.++||||+++++++...+      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            468899999999999999999976554 899887654322    236999999999999999999985543      378


Q ss_pred             EEEecCCCCCchhhhh-chhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec-cCCcEEEccccccee
Q 005621          417 LVYDFMPNGSLDKCLF-DEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD-SELNGRLGDFGLAKL  494 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGla~~  494 (687)
                      +||||++++.+..... ......+++..+..++.||+.||.|||+   .+|+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999997754433322 1234579999999999999999999998   9999999999999999 789999999999987


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc------
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA------  567 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~------  567 (687)
                      ......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+...  ..+. ....      
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~--~i~~-~~g~p~~~~~  266 (394)
T 4e7w_A          192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV--EIIK-VLGTPSREQI  266 (394)
T ss_dssp             CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH-HHCCCCHHHH
T ss_pred             ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHH-HhCCCCHHHH
Confidence            644332  2345789999999998764 58999999999999999999999998765322211  1111 1000      


Q ss_pred             ----cccccccCCcCC-----CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          568 ----GAILEVVDPRLN-----GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       568 ----~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                          ....+..-+...     ..+.......+.+|+.+||+.||++||++.|+++  ++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE  327 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence                000000001100     1111123347899999999999999999999997  3544

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=344.72  Aligned_cols=264  Identities=20%  Similarity=0.253  Sum_probs=183.8

Q ss_pred             Cccc-ceeeeeeCeEEEEEEEeC--CCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeee--cCCeeEEE
Q 005621          344 GFRD-KELLGFGGFGRVYKGTLP--STNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCR--RRGDLLLV  418 (687)
Q Consensus       344 ~f~~-~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV  418 (687)
                      .|.. .++||+|+||+||+|++.  .+++.||||++.....  ...+.+|+.++++++||||+++++++.  .....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3554 468999999999999975  4678999999975432  246789999999999999999999994  46789999


Q ss_pred             EecCCCCCchhhhhchh-------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe----ccCCcEEEc
Q 005621          419 YDFMPNGSLDKCLFDEQ-------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL----DSELNGRLG  487 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~  487 (687)
                      |||+. ++|.+++....       ...+++..+..|+.||+.||.|||+   .+|+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99996 58888774322       1249999999999999999999999   999999999999999    677899999


Q ss_pred             ccccceeccCCCC--CceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcc------hhhHH
Q 005621          488 DFGLAKLYERGTN--PSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPE------ELILV  558 (687)
Q Consensus       488 DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~------~~~~~  558 (687)
                      |||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......      .....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            9999987654322  223346789999999999874 58999999999999999999999997654311      11111


Q ss_pred             HHHHHHhcccc---cccc------------cCCcCCCCCCH---------HHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          559 DWVWDRWKAGA---ILEV------------VDPRLNGEFNE---------IEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       559 ~~v~~~~~~~~---~~~~------------~d~~l~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..+...+....   ....            ...........         .....+.+|+.+||+.||++|||+.|+++
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111111000   0000            00000000000         01236789999999999999999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=334.43  Aligned_cols=246  Identities=25%  Similarity=0.406  Sum_probs=193.9

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh------hHHHHHHHHHHHhhh----cCCCceeee
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRL----RHRNLVQLL  406 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~  406 (687)
                      +.+...++|...+.||+|+||.||+|.+..+++.||||++......      ....+..|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3445568899999999999999999999889999999999765321      223456799999999    899999999


Q ss_pred             eeeecCCeeEEEEec-CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec-cCCcE
Q 005621          407 GWCRRRGDLLLVYDF-MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD-SELNG  484 (687)
Q Consensus       407 ~~~~~~~~~~lV~Ey-~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~  484 (687)
                      +++...+..++|||| +++++|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+||+++ .++.+
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeE
Confidence            999999999999999 789999999954  4469999999999999999999998   8999999999999999 78999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCC-CccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT-TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWD  563 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~  563 (687)
                      ||+|||+++......   .....|+..|+|||++.+..+. .++||||||+++|||++|+.||....        +..  
T Consensus       180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~--  246 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EIL--  246 (312)
T ss_dssp             EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH--
T ss_pred             EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHh--
Confidence            999999998765432   2345689999999998876654 58999999999999999999986421        000  


Q ss_pred             HhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       564 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                         ..      ...+...+    ...+.+++.+||+.+|++||++.|+++
T Consensus       247 ---~~------~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          247 ---EA------ELHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---HT------CCCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---hh------ccCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00      01111222    336889999999999999999999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.4e-39  Score=337.32  Aligned_cols=261  Identities=26%  Similarity=0.406  Sum_probs=202.9

Q ss_pred             HHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC
Q 005621          336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG  413 (687)
Q Consensus       336 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  413 (687)
                      ++.....++|...+.||+|+||.||+|.+..   .+|+|++....  ....+.+.+|+.++++++||||+++++++...+
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            3444456789999999999999999999853   49999987542  233456788999999999999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ..++||||+++++|.+++... ...+++.+++.++.||+.||.|||+   .+|+||||||+||+++ ++.+||+|||+++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            999999999999999999543 3468999999999999999999999   8999999999999998 6799999999987


Q ss_pred             eccCCC----CCceeeeecCCCCCchhhccC---------CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 005621          494 LYERGT----NPSTTRVVGTLGYLAPELTRT---------GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW  560 (687)
Q Consensus       494 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~  560 (687)
                      ......    ........|+..|+|||.+..         ..++.++||||||+++|||++|+.||........      
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------  251 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------  251 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH------
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------
Confidence            543211    122233468999999999874         4578899999999999999999999976542211      


Q ss_pred             HHHHhcccccccccCCcCC-CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          561 VWDRWKAGAILEVVDPRLN-GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       561 v~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      . .....+.     .+.+. ..++    ..+.+++.+||+.+|++||++.++++.|+....
T Consensus       252 ~-~~~~~~~-----~~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          252 I-WQMGTGM-----KPNLSQIGMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             H-HHHHTTC-----CCCCCCSSCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             H-HHhccCC-----CCCCCcCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            1 1111111     11111 1122    257899999999999999999999999998654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=328.60  Aligned_cols=252  Identities=22%  Similarity=0.307  Sum_probs=183.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hh-HHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QG-LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .++|...+.||+|+||.||+|.+..+++.||||++..... .. .+.+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            4678899999999999999999988899999999976532 22 234445556788889999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccC-eEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ-TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      ||+ + .+...+.......+++..+..++.|++.||.|||+   . +|+||||||+||+++.++.+||+|||+++.....
T Consensus       104 e~~-~-~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          104 ELM-G-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CCC-S-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecc-C-CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999 4 44444544445679999999999999999999998   5 9999999999999999999999999999765433


Q ss_pred             CCCceeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          499 TNPSTTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      .  ......||+.|+|||++.     ...++.++||||||+++|||++|+.||.........     ...... +.    
T Consensus       179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~-~~----  246 (318)
T 2dyl_A          179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-----LTKVLQ-EE----  246 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHHH-SC----
T ss_pred             c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-----HHHHhc-cC----
Confidence            2  223456899999999984     457889999999999999999999999864432111     111111 11    


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       .+.+...  ......+.+++.+||+.||++||++.++++
T Consensus       247 -~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 -PPLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -CCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CCCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             1111110  012236889999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.3e-38  Score=333.78  Aligned_cols=246  Identities=26%  Similarity=0.390  Sum_probs=202.1

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh------hHHHHHHHHHHHhhhc--CCCceeeeee
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ------GLREFASEISSIGRLR--HRNLVQLLGW  408 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~  408 (687)
                      +.....++|...+.||+|+||.||+|++..+++.||||++......      ..+.+..|+.++++++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3344567899999999999999999999999999999998765321      2245678999999996  5999999999


Q ss_pred             eecCCeeEEEEecCCC-CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec-cCCcEEE
Q 005621          409 CRRRGDLLLVYDFMPN-GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD-SELNGRL  486 (687)
Q Consensus       409 ~~~~~~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl  486 (687)
                      +...+..++||||+.+ ++|.+++..  ...+++.++..++.||+.||.|||+   .+|+||||||+|||++ .++.+||
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEE
Confidence            9999999999999976 899999843  4579999999999999999999998   9999999999999999 7799999


Q ss_pred             cccccceeccCCCCCceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 005621          487 GDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       487 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      +|||+++......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....        ..    
T Consensus       192 ~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~----  256 (320)
T 3a99_A          192 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------II----  256 (320)
T ss_dssp             CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HH----
T ss_pred             eeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hh----
Confidence            9999998765322   233568999999999987665 6789999999999999999999864210        00    


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                       .+.      ..+...++    ..+.+++.+||+.||++||++.|+++
T Consensus       257 -~~~------~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 -RGQ------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -HCC------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -ccc------ccccccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence             010      01112222    36889999999999999999999997

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.1e-37  Score=338.54  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=188.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      +.|...++||+|+||+||.+.. .+|+.||||++....   .+.+.+|+.+++++ +||||+++++++...+..++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            3455678999999999976544 468999999986543   34678899999987 899999999999999999999999


Q ss_pred             CCCCCchhhhhchhhc-----cCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-------------Cc
Q 005621          422 MPNGSLDKCLFDEQKA-----ILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-------------LN  483 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-------------~~  483 (687)
                      +. |+|.+++......     ..++..++.++.||+.||.|||+   ++|+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceE
Confidence            95 6999999543221     11333567899999999999998   999999999999999754             48


Q ss_pred             EEEcccccceeccCCCCC---ceeeeecCCCCCchhhccC-------CCCCCccceehhhHHHHHHHh-CCCCCCCCCCc
Q 005621          484 GRLGDFGLAKLYERGTNP---STTRVVGTLGYLAPELTRT-------GKPTTSSDVYAFGALLLEVVC-GRRPIEPKALP  552 (687)
Q Consensus       484 ~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~  552 (687)
                      +||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            999999999976543321   1234579999999999975       678999999999999999999 99999755432


Q ss_pred             chhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          553 EELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       553 ~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..    ....     +..   ..+.+....+......+.+++.+||+.||++||++.+|++
T Consensus       247 ~~----~i~~-----~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 ES----NIIR-----GIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HH----HHHH-----TCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH----HHhc-----CCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11    1111     100   0011122224455678999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.3e-36  Score=315.12  Aligned_cols=235  Identities=21%  Similarity=0.290  Sum_probs=185.1

Q ss_pred             hcCcccc-eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHH-hhhcCCCceeeeeeeec----CCee
Q 005621          342 TRGFRDK-ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSI-GRLRHRNLVQLLGWCRR----RGDL  415 (687)
Q Consensus       342 t~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~  415 (687)
                      .++|... +.||+|+||.||+|.+..+++.||+|++...     ..+.+|+.++ +.++||||+++++++..    .+..
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567776 7899999999999999989999999998643     4567788888 55599999999999876    6789


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc---CCcEEEcccccc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLA  492 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla  492 (687)
                      ++||||+++|+|.+++.......+++.++..++.|++.||.|||+   .+|+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999976555679999999999999999999998   99999999999999998   788999999998


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      ....                       +..++.++|||||||++|||++|+.||.........           ......
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~  213 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTR  213 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHH
Confidence            7532                       134678999999999999999999999765421100           000000


Q ss_pred             ccCCcCCCCCCH----HHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCCC
Q 005621          573 VVDPRLNGEFNE----IEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVP  620 (687)
Q Consensus       573 ~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~  620 (687)
                      .....  ..++.    .....+.+++.+||+.||++||++.|+++  ++.+...
T Consensus       214 ~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          214 IRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             SCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             Hhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence            00000  01111    12347889999999999999999999998  5655443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-36  Score=316.87  Aligned_cols=230  Identities=13%  Similarity=0.125  Sum_probs=186.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      .++|+..+.||+|+||.||+|.+..+++.||||++....   ....+++.+|+.++++++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999998889999999997653   33457899999999999999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      |||+++++|.+++..   + ....++.+|+.|++.||.|||+   ++|+||||||+|||++.++.+||++++        
T Consensus       110 ~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            999999999999832   2 4566789999999999999999   999999999999999999999998443        


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                                   |++|       ++.++|||||||++|||++|+.||......+....            ....+....
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~  222 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQP  222 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCB
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCC
Confidence                         3333       68899999999999999999999987654221100            000000000


Q ss_pred             C--CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          579 N--GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       579 ~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      .  ..........+.+++.+||+.||++| |+.|+++.|+...
T Consensus       223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            0  00111123468899999999999999 9999999998754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-36  Score=351.56  Aligned_cols=239  Identities=19%  Similarity=0.268  Sum_probs=193.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC-CCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe-----
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS-TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD-----  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  414 (687)
                      .++|+..+.||+|+||+||+|.+.. +++.||||++... .......+.+|+.++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3789999999999999999999865 6899999998654 33455678999999999999999999999987665     


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .||||||+++++|.+++..    .+++.+++.|+.||+.||.|||+   ++|+||||||+|||++.+ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            7999999999999987732    69999999999999999999998   999999999999999986 999999999987


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      ....     ....||+.|+|||++.++. +.++|||||||++|||++|..|+.......                    +
T Consensus       231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------~  284 (681)
T 2pzi_A          231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------L  284 (681)
T ss_dssp             TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------C
T ss_pred             cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------c
Confidence            6433     3457999999999987654 889999999999999999988876421100                    0


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC-HHHHHHHHhc
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT-MRQVVRYLEG  617 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~  617 (687)
                      .   ...........+.+++.+||+.||++||+ +.++.+.|.+
T Consensus       285 ~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          285 P---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             C---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             c---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            0   00001112346889999999999999995 5555555543

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=100.00  E-value=1.6e-36  Score=271.38  Aligned_cols=113  Identities=35%  Similarity=0.570  Sum_probs=104.8

Q ss_pred             ceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCC
Q 005621          139 NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSS  218 (687)
Q Consensus       139 ~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~  218 (687)
                      ||+|||||||++|.+++||++|||||||||+.|.+++++            ++.+|+.++|||+||+.+++|+|+|++.+
T Consensus         1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~------------~l~sG~~~~v~I~Yd~~~~~L~V~l~~~~   68 (133)
T 1qmo_E            1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW------------DWQNGKIATAHISYNSVSKRLSVTSYYAG   68 (133)
T ss_dssp             CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC------------CCCTTSCEEEEEEEETTTTEEEEEEECSS
T ss_pred             CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeee------------EEcCCCEEEEEEEEeCCCcEEEEEEccCC
Confidence            589999999999999889999999999999999887754            47799999999999999999999999865


Q ss_pred             CCCCCcceeeeecCCccccccceeeeeccCCcccceeEEEEeeeccC
Q 005621          219 VKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMS  265 (687)
Q Consensus       219 ~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sWsf~~~  265 (687)
                      .+  .|+|++.+||+++|||+||||||||||...|.|+|++|+|++.
T Consensus        69 ~~--~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~  113 (133)
T 1qmo_E           69 SK--PATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSS  113 (133)
T ss_dssp             SC--CEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred             Cc--cceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEee
Confidence            43  7899999999999999999999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=333.88  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=186.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ..+|...++||+|+||+||.... .+++.||||++.....   ..+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            45688899999999998553333 3688999999976432   2346799999999 79999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-----CCcEEEcccccceec
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-----ELNGRLGDFGLAKLY  495 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-----~~~~kl~DFGla~~~  495 (687)
                      |+. |+|.+++.... ..+.+.++..++.||+.||.|||+   .+|+||||||+|||++.     ...+||+|||+++..
T Consensus        99 ~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           99 LCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            996 69999986543 234555678999999999999999   99999999999999943     346889999999876


Q ss_pred             cCCCC--CceeeeecCCCCCchhhcc---CCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          496 ERGTN--PSTTRVVGTLGYLAPELTR---TGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       496 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      .....  .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.........       ... ...
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~-~~~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILL-GAC  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHT-TCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHh-ccC
Confidence            54322  2234467999999999997   4567889999999999999999 99998654321110       001 000


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ....      ..........+.+|+.+||+.||++||++.+|++
T Consensus       246 ~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLDC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCTT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Cccc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0010      1112234456789999999999999999999995

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.4e-37  Score=351.27  Aligned_cols=260  Identities=29%  Similarity=0.361  Sum_probs=201.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeec------CCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRR------RGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~  414 (687)
                      .++|...+.||+|+||+||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            37899999999999999999999888999999998765 34456789999999999999999999998765      677


Q ss_pred             eEEEEecCCCCCchhhhhchh-hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc---EEEcccc
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQ-KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN---GRLGDFG  490 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFG  490 (687)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999996532 2368999999999999999999999   99999999999999997665   9999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      +++.......  .....||..|+|||.+.+..++.++||||||+++|||++|+.||.....+.     .|.......+..
T Consensus       170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~  242 (676)
T 3qa8_A          170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNE  242 (676)
T ss_dssp             CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC-----
T ss_pred             cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccch
Confidence            9987654332  234578999999999999999999999999999999999999997643211     111000000000


Q ss_pred             ----cccc--------CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHH
Q 005621          571 ----LEVV--------DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQV  611 (687)
Q Consensus       571 ----~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  611 (687)
                          .+..        ...............+.+++.+||+.||++||++.++
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence                0000        0011223444566789999999999999999999763

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-36  Score=333.04  Aligned_cols=243  Identities=17%  Similarity=0.112  Sum_probs=185.3

Q ss_pred             HhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcC-CCceeee----------
Q 005621          341 ATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRH-RNLVQLL----------  406 (687)
Q Consensus       341 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~----------  406 (687)
                      .+++|...++||+|+||+||+|++..+++.||||++....   ....+.+.+|+.+++.++| +|...+.          
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3456778899999999999999998899999999987433   2336789999999999987 3222111          


Q ss_pred             -----------eeeec-----CCeeEEEEecCCCCCchhhhh-----chhhccCCHHHHHHHHHHHHhhhhhhcccccCe
Q 005621          407 -----------GWCRR-----RGDLLLVYDFMPNGSLDKCLF-----DEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT  465 (687)
Q Consensus       407 -----------~~~~~-----~~~~~lV~Ey~~~gsL~~~L~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  465 (687)
                                 .++..     ....+++|+++ +++|.+++.     ......+++..++.++.||+.||.|||+   ++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence                       11111     22457777765 789999884     2234568899999999999999999998   99


Q ss_pred             EEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhc----------cCCCCCCccceehhhHH
Q 005621          466 VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT----------RTGKPTTSSDVYAFGAL  535 (687)
Q Consensus       466 ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDV~S~Gvv  535 (687)
                      |+||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          .+..++.++|||||||+
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999999999865432    334567 999999999          55568889999999999


Q ss_pred             HHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          536 LLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       536 l~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +|||++|+.||......+...               ..+..  ...++    ..+.+|+.+||+.||++||++.++++
T Consensus       307 l~elltg~~Pf~~~~~~~~~~---------------~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSE---------------WIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSG---------------GGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHCCCCCCCcchhhhHH---------------HHHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999999997654321110               11110  01222    46889999999999999999877653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.7e-35  Score=315.03  Aligned_cols=242  Identities=18%  Similarity=0.193  Sum_probs=184.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--------hhhHHHHHHHHHHHhhhc---------CCCcee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--------KQGLREFASEISSIGRLR---------HRNLVQ  404 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~  404 (687)
                      .++|...+.||+|+||+||+|++  +++.||||++....        ....+.+.+|+.++++++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46788999999999999999998  67999999987642        223477889999999986         666655


Q ss_pred             eeee-----------------eec-------------CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhh
Q 005621          405 LLGW-----------------CRR-------------RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG  454 (687)
Q Consensus       405 l~~~-----------------~~~-------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~  454 (687)
                      +.+.                 +..             .+..++||||+++|++.+.+..   ..+++.++..++.||+.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence            5554                 333             6789999999999987777732   468999999999999999


Q ss_pred             hhhhc-ccccCeEEeeccCCCcEEeccCC--------------------cEEEcccccceeccCCCCCceeeeecCCCCC
Q 005621          455 LLYLH-EEWEQTVIHRDIKAGNVLLDSEL--------------------NGRLGDFGLAKLYERGTNPSTTRVVGTLGYL  513 (687)
Q Consensus       455 L~yLH-~~~~~~ivHrDlk~~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~  513 (687)
                      |.||| +   ++|+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+
T Consensus       174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~  244 (336)
T 2vuw_A          174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM  244 (336)
T ss_dssp             HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred             HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence            99999 7   8999999999999999987                    8999999999876532      357999999


Q ss_pred             chhhccCCCCCCccceehhhHH-HHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHH
Q 005621          514 APELTRTGKPTTSSDVYAFGAL-LLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVK  592 (687)
Q Consensus       514 aPE~~~~~~~~~~sDV~S~Gvv-l~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  592 (687)
                      |||++.+.. +.++||||++++ .+++++|..||...      .......+......   ................++.+
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhh---ccCcccchhhhhhcCHHHHH
Confidence            999998766 889999998777 77788898887321      00000111111000   01111111223346678999


Q ss_pred             HHHhccccCcCcCCCHHHHH
Q 005621          593 LGLMCSNDAAEARPTMRQVV  612 (687)
Q Consensus       593 l~~~Cl~~dP~~RPs~~evl  612 (687)
                      |+.+||+.|     |++|++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999966     999888

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A*

Probab=100.00  E-value=2.4e-34  Score=291.31  Aligned_cols=196  Identities=17%  Similarity=0.168  Sum_probs=147.5

Q ss_pred             CCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCC-CCCCcceEEEEccCCC
Q 005621           38 NNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYT-ALGGHGFAFTISASKE  116 (687)
Q Consensus        38 ~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~-~~~g~G~aF~l~~~~~  116 (687)
                      .++.++|+|.+. +|.|+||++..++.|||||+.|+++         +||+|+|+|.|.+.+. ..+||||||+|+|...
T Consensus        25 ~~~~l~G~a~i~-~g~l~LT~~~~~~~G~~w~~~pi~~---------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~~~   94 (253)
T 2dur_A           25 PLWDFQGSTILT-SQYVRLTPDERSKEGSIWNHQPCFL---------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRL   94 (253)
T ss_dssp             CSEEEEETCEEC-SSCEEEECSSSSEEEEEEESSCBCC---------SSEEEEEEEEEECCCCTTCCCCEEEEEEESCCS
T ss_pred             CCEEEccceEEE-CCEEEECCCCCCCEEEEEeCCCCcc---------CcEEEEEEEEEecCCCCCcCCCcEEEEEECCCC
Confidence            589999999995 9999999999999999999999987         3799999999988755 5689999999999754


Q ss_pred             CCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccccccccccc-----ccccccc
Q 005621          117 LPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENS-----TKQVLNL  191 (687)
Q Consensus       117 ~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~~~~~-----~~~~~~~  191 (687)
                          ..|++||+.+       .++.|||||||++|.++.|    |++++|+++.+..+..+.... ++     ......+
T Consensus        95 ----~~G~~lG~~~-------~~~gvAVefDT~~n~~~~~----~~~~~I~~~~n~gs~~~d~~~-dg~~~~~~~c~~~~  158 (253)
T 2dur_A           95 ----VPGPVFGSKD-------NFHGLAIFLDTYPNDETTE----RVFPYISVMVNNGSLSYDHSK-DGRWTELAGCTADF  158 (253)
T ss_dssp             ----CEETBTEECS-------SCEEEEEEEECSCCCTTCC----SCSSEEEEEEEESCCCCCGGG-TTGGGCCEEEECCC
T ss_pred             ----CCCcccCcCC-------CCCEEEEEEECCCCCCCCC----CCCcEEEEEecCCceeeeccC-CCcccccccccHhh
Confidence                2578999732       3578999999999975433    444444444443333211000 11     1112233


Q ss_pred             -CCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcccceeEEEEeeecc
Q 005621          192 -KSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNM  264 (687)
Q Consensus       192 -~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sWsf~~  264 (687)
                       +.|+.++|||+||+.  +|+|++++.+..+..++  ..++ ..+||+++||||||+||...+.|+|++|+|..
T Consensus       159 ~n~g~~~~v~I~Y~~~--~L~V~l~~~~~~~~~~~--~~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~s  227 (253)
T 2dur_A          159 RNRDHDTFLAVRYSRG--RLTVMTDLEDKNEWKNC--IDIT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQ  227 (253)
T ss_dssp             BTCSSCEEEEEEEETT--EEEEEEECSSSSCCEEE--EEEC-CEECCSSBEEEEEEEESSSCCEEEEEEEEEEE
T ss_pred             ccCCCCeEEEEEEECC--EEEEEEeCCCCCCceEE--EEeC-CcccCCCcEEEEEeccCCCcceEEEEEEEEEe
Confidence             458999999999975  89999997653333333  3344 34599999999999999999999999999974

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A

Probab=100.00  E-value=9.8e-34  Score=287.54  Aligned_cols=205  Identities=15%  Similarity=0.147  Sum_probs=153.2

Q ss_pred             cceEeCCCCCCC-CCCCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCC
Q 005621           24 EEFFFSGFRDAA-NNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTAL  102 (687)
Q Consensus        24 ~~f~~~~F~~~~-~~~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~  102 (687)
                      .+|..+....+. .-.++.++|+|.+. +|.|+||++..++.||+||+.|+++         ++|+|+|+|.|...+ ..
T Consensus        34 ~Sf~~P~~~~~~~~i~~w~~~G~a~i~-~~~IrLT~~~~~~~G~~w~~~p~~~---------~sF~t~F~F~I~~~~-~~  102 (260)
T 1gv9_A           34 YSFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAF---------ENWEVEVTFRVTGRG-RI  102 (260)
T ss_dssp             GCEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCC---------SSEEEEEEEEEECSS-SC
T ss_pred             eeEcCccccCCCCccCCeEEcccEEee-CCEEEeCCCCCCCEEEEEECCCccc---------cCEEEEEEEEEecCC-CC
Confidence            355544443221 23589999999984 8999999999999999999999954         489999999998764 36


Q ss_pred             CCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCC-CC------CCCeeeEEeCC-CCcccc
Q 005621          103 GGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFG-DI------NDNHVGIDINS-LRSNAS  174 (687)
Q Consensus       103 ~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~------~~~Hvgi~~ns-~~s~~~  174 (687)
                      +||||||+|+|...    ..|++||+.       ..++.|||||||+.|.++. +|      +++|||||+|+ +.|...
T Consensus       103 ~gdGlAF~l~~~~~----~~g~~~G~~-------~~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~~~  171 (260)
T 1gv9_A          103 GADGLAIWYTENQG----LDGPVFGSA-------DMWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQAL  171 (260)
T ss_dssp             CCCEEEEEEESSCC----CEEEETTEC-------SCCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHHCS
T ss_pred             CCCeEEEEEecCCC----CCCCccCCC-------CCCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCccccee
Confidence            89999999999753    257888983       2457899999999997531 22      35677777764 433332


Q ss_pred             ccccccccccccccccc-CCCCeEEEEEEEeCCCCeEEEEEeeCCC-CCCCcceeeeecCCccccccceeeeeccCCccc
Q 005621          175 EPAAYFLENSTKQVLNL-KSGEVIQAWIDYDSSKNHLEVRLAPSSV-KPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA  252 (687)
Q Consensus       175 ~~~~~~~~~~~~~~~~~-~~g~~~~~~I~Yd~~~~~l~V~~~~~~~-~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~  252 (687)
                      ..+          .... ++|+.++|||+|++.  +|+|.+.+... ......++..+| ..+||+++||||||+||...
T Consensus       172 ~~c----------~~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaTG~~~  238 (260)
T 1gv9_A          172 ASC----------QRDFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLA  238 (260)
T ss_dssp             EEE----------CCCCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSC
T ss_pred             ecc----------ChhhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccccCCCcEEEEEEeCCCCc
Confidence            221          1222 358999999999986  89999987421 111235788888 67799999999999999999


Q ss_pred             ceeEEEEeeec
Q 005621          253 SSHYILGWSFN  263 (687)
Q Consensus       253 ~~~~i~sWsf~  263 (687)
                      |.|+|+||+|.
T Consensus       239 e~hdIlsw~~~  249 (260)
T 1gv9_A          239 DDHDVLSFLTF  249 (260)
T ss_dssp             CEEEEEEEEEE
T ss_pred             ceEEEEEEEEE
Confidence            99999999996

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.98  E-value=9.2e-33  Score=273.75  Aligned_cols=115  Identities=37%  Similarity=0.563  Sum_probs=106.2

Q ss_pred             cceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeC
Q 005621          138 TNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPS  217 (687)
Q Consensus       138 ~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~  217 (687)
                      .||+|||||||++|.+|+||++|||||||||+.|.+++++            ++.+|+.++|||+||+.+++|+|+|++.
T Consensus         1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~   68 (237)
T 1nls_A            1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW------------NMQNGKVGTAHIIYNSVDKRLSAVVSYP   68 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC------------CCCTTCEEEEEEEEETTTTEEEEEEECT
T ss_pred             CCCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccc------------cccCCCEEEEEEEEeCCCCEEEEEEecC
Confidence            3689999999999999999999999999999999888764            4679999999999999999999999876


Q ss_pred             CCCCCCcceeeeecCCccccccceeeeeccCCcccceeEEEEeeeccCC
Q 005621          218 SVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSG  266 (687)
Q Consensus       218 ~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sWsf~~~~  266 (687)
                      +.  ..|+|++.+||+++|+|+||||||||||...|.|+|++|+|++..
T Consensus        69 ~~--~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~  115 (237)
T 1nls_A           69 NA--DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL  115 (237)
T ss_dssp             TS--CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred             CC--CcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecc
Confidence            53  678999999999999999999999999999999999999998753

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=9.2e-30  Score=288.98  Aligned_cols=184  Identities=16%  Similarity=0.091  Sum_probs=131.5

Q ss_pred             eeeeCeEEEEEEEeCCCCeEEEEEEecCcc----------hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEEE
Q 005621          351 LGFGGFGRVYKGTLPSTNTQVAVKRVSNES----------KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       351 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .+.|+.|.+..+.....|+.+|+|++....          ....++|.+|+++|+++ .|+||+++++++++.+..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            556666666666655568889999986541          23356799999999999 7999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||++|++|.++|..  .++++..   +|+.||+.||+|||+   ++||||||||+||||++++++||+|||+|+......
T Consensus       322 Eyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             ECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999943  4556654   589999999999999   999999999999999999999999999998765433


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRR  544 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~  544 (687)
                      . .....+||+.|||||++.+ .+..++|+|++|++++++.++..
T Consensus       394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            2 2344689999999999875 56778999999999888766543

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=99.94  E-value=3.8e-27  Score=205.88  Aligned_cols=104  Identities=24%  Similarity=0.420  Sum_probs=92.7

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCC------CeeEEEEecCCeecccCCCCCceeeEEEEEEEEEe
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL------RVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV   96 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~------~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~   96 (687)
                      +.+|+|++|..+  ..||+|+|+|.+.+ |.|+||+...      +++|||+|++||+|||+  +++++||+|+|+|.|.
T Consensus         3 ~~~F~f~~F~~~--~~nl~l~G~A~v~~-g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~--tg~vaSFsT~F~F~I~   77 (113)
T 1qmo_A            3 SLSFSFTKFDPN--QEDLIFQGHATSTN-NVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED--SAVLTSFDTIINFEIS   77 (113)
T ss_dssp             EEEEEESSCCSS--CTTEEEEETCEEET-TEEECSCBCTTSCBCSSCEEEEEESSCEECCCT--TEEEEEEEEEEEEEEE
T ss_pred             ceEEEcCCCCCC--CCCeEEecceEcCC-CceEeCCCCCCCcccCCcEEEEEeCCCEEeeCC--CCCEEeeEEEEEEEEe
Confidence            468999999864  26999999999985 9999998765      79999999999999997  6789999999999999


Q ss_pred             ecCCCCCCcceEEEEccCCCCCCCCCCccccccccC
Q 005621           97 PEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSS  132 (687)
Q Consensus        97 ~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~  132 (687)
                      +++...+||||||||+|....|. ++||||||+|.+
T Consensus        78 ~~~~~~~gdGlAF~lap~~~~p~-s~g~~LGL~n~~  112 (113)
T 1qmo_A           78 TPYTSRIADGLAFFIAPPDSVIS-YHGGFLGLFPNA  112 (113)
T ss_dssp             CSSSSCCCCEEEEEEECTTCCCC-CCGGGTTTCSSC
T ss_pred             cCCCCCCCCeEEEEecCCCCCCC-CCccccccccCC
Confidence            88777899999999999877777 899999999864

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.3e-26  Score=261.75  Aligned_cols=188  Identities=15%  Similarity=0.155  Sum_probs=146.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--------hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--------KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  414 (687)
                      ..+...++||+|+||+||+|..  .+..+++|+.....        ....+++.+|++++++++||||+++..++...+.
T Consensus       336 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~  413 (540)
T 3en9_A          336 KRKIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN  413 (540)
T ss_dssp             ------------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT
T ss_pred             ccCCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc
Confidence            3335567999999999999965  57889999864321        1123568999999999999999977777777788


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .+|||||+++++|.+++..          +..++.|++.||.|||+   ++|+||||||+|||++.  ++||+|||+++.
T Consensus       414 ~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~  478 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKI  478 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred             cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence            8999999999999999953          56899999999999998   99999999999999998  999999999997


Q ss_pred             ccCCCCCc------eeeeecCCCCCchhhccC--CCCCCccceehhhHHHHHHHhCCCCCC
Q 005621          495 YERGTNPS------TTRVVGTLGYLAPELTRT--GKPTTSSDVYAFGALLLEVVCGRRPIE  547 (687)
Q Consensus       495 ~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~  547 (687)
                      ........      .....||+.|||||++..  ..|+..+|+|+..+-.++-+.++.+|.
T Consensus       479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            64422111      134679999999999986  567888999999998888888777663

>2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13

Probab=99.92  E-value=1.5e-24  Score=218.93  Aligned_cols=185  Identities=17%  Similarity=0.217  Sum_probs=141.6

Q ss_pred             CCCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCC
Q 005621           37 NNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKE  116 (687)
Q Consensus        37 ~~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~  116 (687)
                      ..++.++|+|.+. ++.|+||++ .++.|++|.+.|+++.        ++|+++|+|.|.... ..+||||||++++...
T Consensus        30 i~~w~~~G~a~v~-~~~IrLTp~-~~s~G~iW~~~p~~~~--------~~f~~~f~FrI~g~~-~~~gdGlAfwlt~~~~   98 (256)
T 2a6y_A           30 PNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK--------DSFTMEWTFRSVGYS-GQTDGGISFWFVQDSN   98 (256)
T ss_dssp             CTTEEEEETCEEE-TBEEECCCS-TTCEEEEEESSCEEES--------SCEEEEEEEEEESCC-SCCSCEEEEEEEECSS
T ss_pred             cCCeEEccceEEe-CCEEEECCC-CCceEEEeeCCCCccc--------CCEEEEEEEEEecCC-CCCCCeEEEEEeCCCC
Confidence            4689999999995 999999998 6789999999999752        379999999998653 3389999999999754


Q ss_pred             CCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCC------CCeeeEEeCCCCcccccccccccccccccccc
Q 005621          117 LPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDIN------DNHVGIDINSLRSNASEPAAYFLENSTKQVLN  190 (687)
Q Consensus       117 ~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~------~~Hvgi~~ns~~s~~~~~~~~~~~~~~~~~~~  190 (687)
                      .|  ..|+.+|..+       ...-+||||||+.|.   .|.      +.|+++|.++..+.....+          ...
T Consensus        99 ~~--~~g~~~G~~~-------~f~GlaV~fDT~~n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~c----------~~~  156 (256)
T 2a6y_A           99 IP--RDKQLYNGPV-------NYDGLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFASC----------LMG  156 (256)
T ss_dssp             SC--CCCTBTTBCT-------TCEEEEEEEESCSTT---CSEEEEEEEESSSCCCGGGHHHHCSEEE----------ECC
T ss_pred             cc--cCCcccCcCC-------CCCEEEEEEECCCCC---CceEEEEECCCceecccCCCcccceecc----------eee
Confidence            33  4678888863       234589999999873   343      5667776665323222221          111


Q ss_pred             c-CCCCeEEEEEEEe-CCCCeEEEEEeeCCCCCCCcceeeeecCCcc-ccccc-eeeeeccCC---cccceeEEEEeeec
Q 005621          191 L-KSGEVIQAWIDYD-SSKNHLEVRLAPSSVKPRSPILSFDVDLSPI-VKETM-YVGFSSSTG---LLASSHYILGWSFN  263 (687)
Q Consensus       191 ~-~~g~~~~~~I~Yd-~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~-l~~~~-~vGFsastG---~~~~~~~i~sWsf~  263 (687)
                      . ++|..+++||+|+ +..+.|+|.+.+          ...+++..+ ||+++ ||||||+||   ...+.|.|++|+|.
T Consensus       157 ~rn~~~~~~v~I~Y~~~~~~~L~V~i~~----------~~c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~  226 (256)
T 2a6y_A          157 YQDSSVPSTIRVTYDLEDDNLLKVQVDN----------KVCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFF  226 (256)
T ss_dssp             CTTCSSCEEEEEEEEGGGTSEEEEEETT----------EEEEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEEE
T ss_pred             cccCCCcEEEEEEEecCCCcEEEEEEcC----------EEEEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEEE
Confidence            1 4789999999999 888999999874          134455555 89997 699999999   88999999999998


Q ss_pred             c
Q 005621          264 M  264 (687)
Q Consensus       264 ~  264 (687)
                      .
T Consensus       227 ~  227 (256)
T 2a6y_A          227 N  227 (256)
T ss_dssp             E
T ss_pred             e
Confidence            5

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.89  E-value=2.4e-23  Score=206.29  Aligned_cols=106  Identities=26%  Similarity=0.478  Sum_probs=92.6

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCC------CeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL------RVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~------~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      ...+|.|++|..+  ..||+|+|+|.+.++|.|+||+...      +++|||+|++||+||++  +++++||+|+|+|.|
T Consensus       124 ~~~~F~~~~F~~~--~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~--~~~vaSFsT~F~F~I  199 (237)
T 1nls_A          124 NALHFMFNQFSKD--QKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES--SAVVASFEATFTFLI  199 (237)
T ss_dssp             EEEEEEESCCCTT--CTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT--TEEEEEEEEEEEEEC
T ss_pred             ccchhhhcccccc--CCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecC--CCCEeeeEEEEEEEE
Confidence            3468999999974  2589999999998789999998653      68999999999999996  568999999999999


Q ss_pred             eecCCCCCCcceEEEEccCC-CCCCCCCCccccccccC
Q 005621           96 VPEYTALGGHGFAFTISASK-ELPGTLPSQYLGLLNSS  132 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~  132 (687)
                      .+. ...+||||||||+|.. .+|.+++||||||+|.+
T Consensus       200 ~~~-~~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~  236 (237)
T 1nls_A          200 KSP-DSHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA  236 (237)
T ss_dssp             CCS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred             ecC-CCCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence            876 4458999999999987 57888999999999864

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=2.7e-23  Score=215.22  Aligned_cols=151  Identities=14%  Similarity=0.101  Sum_probs=123.1

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch------------------hhHHHHHHHHHHHhhhc
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK------------------QGLREFASEISSIGRLR  398 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  398 (687)
                      .+......|...+.||+|+||.||+|.+ .+|+.||||+++....                  .....+.+|+.++++++
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            4444556677789999999999999999 7899999999864321                  13467899999999999


Q ss_pred             CCCceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       399 H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                        | +++.+++.. +..++||||+++++|.+ +..        .....++.|++.||.|||+   .+|+||||||+|||+
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl  226 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLV  226 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEE
Confidence              5 666665543 56799999999999998 521        2244799999999999998   999999999999999


Q ss_pred             ccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhcc
Q 005621          479 DSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTR  519 (687)
Q Consensus       479 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  519 (687)
                      + ++.+||+|||+++.              +..|+|||++.
T Consensus       227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9 99999999999963              34689999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=3.5e-19  Score=181.85  Aligned_cols=137  Identities=17%  Similarity=0.130  Sum_probs=107.1

Q ss_pred             cccceeeeeeCeEEEEEEEeCCCCeE--EEEEEecCcchh------------------------hHHHHHHHHHHHhhhc
Q 005621          345 FRDKELLGFGGFGRVYKGTLPSTNTQ--VAVKRVSNESKQ------------------------GLREFASEISSIGRLR  398 (687)
Q Consensus       345 f~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  398 (687)
                      |...+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999998667888  999987543111                        1236789999999999


Q ss_pred             CCCc--eeeeeeeecCCeeEEEEecCCC-C----CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhc-ccccCeEEeec
Q 005621          399 HRNL--VQLLGWCRRRGDLLLVYDFMPN-G----SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLH-EEWEQTVIHRD  470 (687)
Q Consensus       399 H~ni--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivHrD  470 (687)
                      |+++  ..++++    +..+|||||+.+ |    +|.++...     .++..+..++.|++.+|.||| +   .+|+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence            8864  444442    357899999942 5    44444311     234567889999999999999 7   9999999


Q ss_pred             cCCCcEEeccCCcEEEcccccceec
Q 005621          471 IKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       471 lk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      |||+|||++.  .++|+|||++...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999754

>2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A

Probab=99.74  E-value=1.2e-16  Score=157.56  Aligned_cols=190  Identities=17%  Similarity=0.208  Sum_probs=129.4

Q ss_pred             CCCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCC
Q 005621           37 NNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKE  116 (687)
Q Consensus        37 ~~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~  116 (687)
                      ..+..+.|+|.+. ++.|+||++ .++.|.+|.+.|+++.+        +|+++|+|+|.... ..+||||||.+++...
T Consensus        23 ~~~W~~~G~a~i~-~~~IrLTp~-~~~~G~iWs~~p~~~~~--------~weie~~Fri~g~~-~~~gdGlA~W~t~~~~   91 (222)
T 2a6z_A           23 PNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLKD--------SFTMEWTFRSVGYS-GQTDGGISFWFVQDSN   91 (222)
T ss_dssp             CTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECCS--------CEEEEEEEEEESCC-SCCSCEEEEEEEECSS
T ss_pred             cCCcEEcccEEEc-CCEEEECCC-CCCeEEEEeCCCCCCCC--------CEEEEEEEEEeCCC-CCCCCEEEEEEECCCc
Confidence            3589999999996 899999999 57899999999998632        69999999998653 3479999999998753


Q ss_pred             CCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCC-CCcccccccccccccccccccc-cCCC
Q 005621          117 LPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINS-LRSNASEPAAYFLENSTKQVLN-LKSG  194 (687)
Q Consensus       117 ~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns-~~s~~~~~~~~~~~~~~~~~~~-~~~g  194 (687)
                      .+  ..|..+|..+.       -.=+||+|||+.|.      ..+|.+.+|. ..+..... +....-+. .... .+.+
T Consensus        92 ~~--~~g~~~G~~~~-------f~GL~I~~Dt~~n~------~p~i~~~~ndG~~~yd~~~-~~~~~~~~-C~~~~rn~~  154 (222)
T 2a6z_A           92 IP--RDKQLYNGPVN-------YDGLQLLVDNNGPL------GPTLRGQLNDGQKPVDKTK-IYDQSFAS-CLMGYQDSS  154 (222)
T ss_dssp             SC--CCCTBTTBCTT-------CEEEEEEEESCSTT------SSEEEEEEEESSSCCCGGG-HHHHCSEE-EECCCTTEE
T ss_pred             cc--CCCcccCCCCC-------CCEEEEEEECCCCC------CceEEEEECCCCeeeccCC-Cccccccc-cceeccCCC
Confidence            21  34555666321       23369999999873      3567766642 22211110 00000000 1111 2467


Q ss_pred             CeEEEEEEEe-CCCCeEEEEEeeCCCCCCCcceeeeecCCcccccc-ceeeeeccCC---cccceeEEEEeeec
Q 005621          195 EVIQAWIDYD-SSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKET-MYVGFSSSTG---LLASSHYILGWSFN  263 (687)
Q Consensus       195 ~~~~~~I~Yd-~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~-~~vGFsastG---~~~~~~~i~sWsf~  263 (687)
                      ...+++|.|+ ...+.|+|.++..     .-+-...|+    ||+. .|+||||+||   ...+.|.|++|++.
T Consensus       155 ~~~~~rI~Y~~~~~~~l~v~id~~-----~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~hdil~~~~~  219 (222)
T 2a6z_A          155 VPSTIRVTYDLEDDNLLKVQVDNK-----VCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESFEIFKMQFF  219 (222)
T ss_dssp             EEEEEEEEEEGGGTSEEEEEETTE-----EEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEEEEEEEEEE
T ss_pred             CcEEEEEEEEcCCCcEEEEEEcCe-----EEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccEEEEEEEEE
Confidence            7899999999 6678899988641     001112233    5655 4799999999   88999999999985

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=1.6e-16  Score=169.35  Aligned_cols=142  Identities=12%  Similarity=0.093  Sum_probs=100.9

Q ss_pred             HHHHhcC---cccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch--------------hhHHHH--------HHHHH
Q 005621          338 LKKATRG---FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK--------------QGLREF--------ASEIS  392 (687)
Q Consensus       338 l~~at~~---f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~  392 (687)
                      |....++   |++.+.||+|++|.||+|... +|+.||||+++....              ......        ..|..
T Consensus        87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           87 LHTHAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            3444444   889999999999999999985 589999998753210              001112        23555


Q ss_pred             HHhhhcCCCce--eeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeec
Q 005621          393 SIGRLRHRNLV--QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRD  470 (687)
Q Consensus       393 ~l~~l~H~niv--~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  470 (687)
                      .|.++.+.++.  ..+++    ...+|||||+++++|.++...        .....++.|++.+|.|||.   .+|||||
T Consensus       166 nL~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~---~gIVHrD  230 (397)
T 4gyi_A          166 FMKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAK---HGLIHGD  230 (397)
T ss_dssp             HHHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHH---TTEECSC
T ss_pred             HHHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHH---CCCcCCC
Confidence            55555443332  12221    233799999999988765421        1335688999999999998   8999999


Q ss_pred             cCCCcEEeccCC----------cEEEcccccceec
Q 005621          471 IKAGNVLLDSEL----------NGRLGDFGLAKLY  495 (687)
Q Consensus       471 lk~~NIll~~~~----------~~kl~DFGla~~~  495 (687)
                      |||.|||+++++          .+.|+||+-+...
T Consensus       231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            999999998876          3899999987643

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B

Probab=99.46  E-value=8.4e-15  Score=107.87  Aligned_cols=44  Identities=39%  Similarity=0.507  Sum_probs=41.2

Q ss_pred             CcceeeeecCCccccccceeeeeccCCcccceeEEEEeeeccCC
Q 005621          223 SPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMSG  266 (687)
Q Consensus       223 ~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sWsf~~~~  266 (687)
                      .|+|++.+||+++|+|+|||||||+||...|.|+|++|+|++.+
T Consensus         3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~   46 (52)
T 2ltn_B            3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL   46 (52)
T ss_dssp             EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEE
T ss_pred             eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeec
Confidence            47899999999999999999999999999999999999998753

>2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A

Probab=99.43  E-value=7.6e-12  Score=122.79  Aligned_cols=187  Identities=12%  Similarity=0.111  Sum_probs=123.0

Q ss_pred             CCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCCC
Q 005621           38 NNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKEL  117 (687)
Q Consensus        38 ~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~  117 (687)
                      .+..+.|+|.+. ++.|+||++ +++.|.+|-+.|+.+  ..      .|+.+|+|+|..... .+||||||.++.....
T Consensus        27 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~lWs~~p~~~--~~------~weiev~Fri~G~~~-~~gdGlA~Wyt~~~~~   95 (226)
T 2a6v_A           27 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSI--KD------AMTIEWTFRSFGFRG-STKGGLAFWLKQGNEG   95 (226)
T ss_dssp             TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCC--SS------CEEEEEEEEEESCCS-CCSCEEEEEEECSCCC
T ss_pred             CCcEEcCCeEEe-CCEEEECCC-CCceEEEeeCCCCCC--CC------CeEEEEEEEEecCCC-CCCCEEEEEEECCCCC
Confidence            478999999997 778999999 999999999999986  12      699999999986532 3799999999875431


Q ss_pred             CCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEe-CCCCcccccccccccccccccccccCCCCe
Q 005621          118 PGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDI-NSLRSNASEPAAYFLENSTKQVLNLKSGEV  196 (687)
Q Consensus       118 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~-ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~  196 (687)
                         ..|..+|-...      .-.=+||.|||+.|.      ...|-+-+ |+..+..... .  ..-+.+..--.+.+..
T Consensus        96 ---~~g~vfGg~~d------~f~GlgI~~Dt~~n~------~p~i~~~~NDGt~~yd~~~-~--~~~g~C~~~~rn~~~~  157 (226)
T 2a6v_A           96 ---DSTELFGGSSK------KFNGLMILLRLDDKL------GESVTAYLNDGTKDLDIES-S--PYFASCLFQYQDSMVP  157 (226)
T ss_dssp             ---CCCTBTTTBCS------SCEEEEEEEEEETTT------EEEEEEEEEESSSCCCTTT-S--CCSEEEECCCSSCSSC
T ss_pred             ---CCcccccccCC------CccEEEEEEECCCCC------CceEEEEECCCCcccCCCC-C--cccceEeEeccCCCCC
Confidence               23333332110      112379999999762      12233322 3333222111 0  0001111112346678


Q ss_pred             EEEEEEEe-CCCCeEEEEEeeCCCCCCCcceeeeecCCcc-ccccc--eeeeeccCCcccceeEEEEeeec
Q 005621          197 IQAWIDYD-SSKNHLEVRLAPSSVKPRSPILSFDVDLSPI-VKETM--YVGFSSSTGLLASSHYILGWSFN  263 (687)
Q Consensus       197 ~~~~I~Yd-~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~-l~~~~--~vGFsastG~~~~~~~i~sWsf~  263 (687)
                      .+++|.|. ...+.|+|.++.      .    ..++..++ ||..-  |+||||+||...+.|.|++-.+-
T Consensus       158 t~~ri~Y~~~~~~~l~v~id~------~----~Cf~~~~v~LP~g~~~yfGiSAaTg~~~D~hdils~~~~  218 (226)
T 2a6v_A          158 STLRLTYNPLDNHLLKLQMDN------R----VCFQTRKVKFMGSSPFRIGTSAINDASKESFEILKMKLY  218 (226)
T ss_dssp             EEEEEEEEGGGTSEEEEEETT------E----EEEEESCCCGGGTSCBEEEEEEECCTTCCEEEEEEEEEE
T ss_pred             EEEEEEEEccCCCEEEEEEcC------C----eeEEECCeecCCCCccEEEEEEcCCCCcccEEEEEEEEE
Confidence            89999997 456899998863      1    12222222 56544  99999999999999999998764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.31  E-value=4.6e-12  Score=128.93  Aligned_cols=148  Identities=18%  Similarity=0.095  Sum_probs=116.0

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCee
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~  415 (687)
                      .+.....+|.....++.|+.+.||++..  .+..+++|+...........+.+|+.+++.+. +.++.++++++...+..
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            4455667888888888888999999986  36789999987532223346888999999984 67788999999988899


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhccc----------------------------------
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE----------------------------------  461 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------  461 (687)
                      ++||||++|.+|.+.+.       +..+...++.+++++|..||+-                                  
T Consensus        86 ~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            99999999999877531       1122346788899999999971                                  


Q ss_pred             ----------------------ccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          462 ----------------------WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       462 ----------------------~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                                            ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  11569999999999999876556799999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=5.7e-11  Score=120.15  Aligned_cols=141  Identities=16%  Similarity=0.108  Sum_probs=100.8

Q ss_pred             HHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCC--ceeeeeeeecCCeeEE
Q 005621          340 KATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--LVQLLGWCRRRGDLLL  417 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~l  417 (687)
                      ....++....+.+.|..+.||++.. .+|..+++|+....   ....+..|+.+++.+.+.+  +.+++++....+..++
T Consensus        17 ~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           17 ERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             HhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            3344555543334555699999976 45678999997654   2245778999999986545  5568998888888999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccc-----------------------------------
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW-----------------------------------  462 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----------------------------------  462 (687)
                      ||||++|.+|.  ...     .+   ...++.+++..|..||+..                                   
T Consensus        93 v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           93 LLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            99999999884  211     11   1245667777777777521                                   


Q ss_pred             --------------------cCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          463 --------------------EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       463 --------------------~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                                          ...++|+|++|.|||++++..+.|+||+.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                13499999999999998776677999999763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.01  E-value=1e-09  Score=117.03  Aligned_cols=142  Identities=13%  Similarity=0.186  Sum_probs=108.0

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEEEEec--Ccc-hhhHHHHHHHHHHHhhhc--CCCceeeeeeeecC---CeeEEE
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVS--NES-KQGLREFASEISSIGRLR--HRNLVQLLGWCRRR---GDLLLV  418 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV  418 (687)
                      ..+.|+.|.++.||+....  +..+++|+..  ... ......+.+|+.+++.+.  +.++.+++.++.+.   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4578899999999999873  4678899876  332 122356788999999997  45688999998776   458999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhccc-------------------------------------
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE-------------------------------------  461 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------  461 (687)
                      |||++|..+.+..    ...++..++..++.+++..|..||..                                     
T Consensus       120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999998885422    12367888899999999999999962                                     


Q ss_pred             ------------------ccCeEEeeccCCCcEEeccCCc--EEEccccccee
Q 005621          462 ------------------WEQTVIHRDIKAGNVLLDSELN--GRLGDFGLAKL  494 (687)
Q Consensus       462 ------------------~~~~ivHrDlk~~NIll~~~~~--~kl~DFGla~~  494 (687)
                                        ....++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              0267999999999999997753  68999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.92  E-value=5.8e-10  Score=116.07  Aligned_cols=183  Identities=15%  Similarity=0.176  Sum_probs=122.9

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCC--ceeeeeeeecCC---eeEEEEec
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRN--LVQLLGWCRRRG---DLLLVYDF  421 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lV~Ey  421 (687)
                      .+.++.|....||+..     ..+++|+....  .....+..|+.+++.+. +..  +.+++......+   ..|+|||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999863     35889986543  34567889999999883 332  445665554333   34899999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhccc----------------------------------------
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE----------------------------------------  461 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------  461 (687)
                      ++|.+|.+...    ..++..++..++.+++..|..||.-                                        
T Consensus        98 i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           98 IKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99998875431    3467777788888888888888851                                        


Q ss_pred             ---------------ccCeEEeeccCCCcEEecc--CCcEEEcccccceeccCCCCCceeeeecCCCC---CchhhccC-
Q 005621          462 ---------------WEQTVIHRDIKAGNVLLDS--ELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY---LAPELTRT-  520 (687)
Q Consensus       462 ---------------~~~~ivHrDlk~~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-  520 (687)
                                     ....++|+|+++.||++++  ...+.|+||+.+..-+....     ......+   ..|+.... 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHH
Confidence                           1246899999999999998  45678999999875432110     0001111   22332110 


Q ss_pred             ----CCC---------CCccceehhhHHHHHHHhCCCCC
Q 005621          521 ----GKP---------TTSSDVYAFGALLLEVVCGRRPI  546 (687)
Q Consensus       521 ----~~~---------~~~sDV~S~Gvvl~elltG~~p~  546 (687)
                          +..         ....+.|+++.++|++.+|..++
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                111         12358999999999999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.43  E-value=1.2e-06  Score=88.98  Aligned_cols=145  Identities=18%  Similarity=0.175  Sum_probs=98.5

Q ss_pred             HHhcCcccceeeeeeCeE-EEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEE
Q 005621          340 KATRGFRDKELLGFGGFG-RVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       340 ~at~~f~~~~~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l  417 (687)
                      ....+|+. +.+..|..| .||+.....++..+++|+-...   ...++..|...|+.+. +-.+.++++++.+.+..++
T Consensus        22 ~~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~l   97 (272)
T 4gkh_A           22 ADLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWL   97 (272)
T ss_dssp             HHHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             ccccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEE
Confidence            33344443 345556555 6999888777788999986543   3456778999998884 3347789999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcc-------------------------------------
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE-------------------------------------  460 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-------------------------------------  460 (687)
                      |||+++|.++.+....      .......+..+++..|..||.                                     
T Consensus        98 vme~l~G~~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (272)
T 4gkh_A           98 LTTAIPGKTAFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER  171 (272)
T ss_dssp             EEECCCSEEHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred             EEEeeCCccccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence            9999999887654311      011122333444444444442                                     


Q ss_pred             ------------------cccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          461 ------------------EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       461 ------------------~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                                        .....++|+|+.+.|||++.+..+-|+||+.+..
T Consensus       172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              0123489999999999999877677999998863

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.41  E-value=1.5e-06  Score=90.33  Aligned_cols=136  Identities=21%  Similarity=0.188  Sum_probs=92.6

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCC---Cceeeeeeee-cCCeeEEEEecCC
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHR---NLVQLLGWCR-RRGDLLLVYDFMP  423 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~Ey~~  423 (687)
                      .+.++.|....||+.     +..+++|+...  ......+..|..+|+.+.+.   .+.+++.++. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            467888999999988     35688888532  23456788999999999753   3567777764 4556789999999


Q ss_pred             CCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhccc------------------------------------------
Q 005621          424 NGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE------------------------------------------  461 (687)
Q Consensus       424 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------  461 (687)
                      |.+|.+...    ..++..++..++.+++..|..||.-                                          
T Consensus        97 G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           97 GQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             SEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             CeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            988875321    1123333334444444444433321                                          


Q ss_pred             ---------------ccCeEEeeccCCCcEEecc---CCc-EEEccccccee
Q 005621          462 ---------------WEQTVIHRDIKAGNVLLDS---ELN-GRLGDFGLAKL  494 (687)
Q Consensus       462 ---------------~~~~ivHrDlk~~NIll~~---~~~-~kl~DFGla~~  494 (687)
                                     ....++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2346899999999999987   455 48999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.27  E-value=2.2e-06  Score=90.82  Aligned_cols=82  Identities=6%  Similarity=-0.025  Sum_probs=57.8

Q ss_pred             ceee-eeeCeEEEEEEEeC--C----CCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhc-C--CCceeeeeeeecC--
Q 005621          348 KELL-GFGGFGRVYKGTLP--S----TNTQVAVKRVSNES---KQGLREFASEISSIGRLR-H--RNLVQLLGWCRRR--  412 (687)
Q Consensus       348 ~~~l-G~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~--  412 (687)
                      .+.| +.|....+|+....  .    ++..+++|+.....   ......+..|+.+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 78889999998763  0    15678899865432   101245678888888884 3  3577888887665  


Q ss_pred             -CeeEEEEecCCCCCchh
Q 005621          413 -GDLLLVYDFMPNGSLDK  429 (687)
Q Consensus       413 -~~~~lV~Ey~~~gsL~~  429 (687)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             45789999999988764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.07  E-value=9.8e-06  Score=87.21  Aligned_cols=76  Identities=12%  Similarity=0.030  Sum_probs=50.5

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-------hhHHHHHHHHHHHhhhcC--C-CceeeeeeeecCCeeEE
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-------QGLREFASEISSIGRLRH--R-NLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~l~~~~~~~~~~~l  417 (687)
                      .+.||.|..+.||++....+++.++||.......       ....++..|.++++.+..  + .+.+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            5679999999999998755677899998654321       123456778889888743  3 344566543  345689


Q ss_pred             EEecCCCC
Q 005621          418 VYDFMPNG  425 (687)
Q Consensus       418 V~Ey~~~g  425 (687)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.96  E-value=7.9e-05  Score=77.91  Aligned_cols=139  Identities=17%  Similarity=0.236  Sum_probs=80.8

Q ss_pred             eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC--CCceeeee------eeecCCeeEEEEe
Q 005621          349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH--RNLVQLLG------WCRRRGDLLLVYD  420 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~------~~~~~~~~~lV~E  420 (687)
                      +.|+.|..+.||+....  +..+++|+.....    .+...|..+++.|..  -.+.+++.      +....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            45655678899999873  3458999987632    233345555555531  13344443      1234567899999


Q ss_pred             cCCCCCchh-----------h---hhchhh------------ccCCHHHHH-----------------------------
Q 005621          421 FMPNGSLDK-----------C---LFDEQK------------AILTWEQRY-----------------------------  445 (687)
Q Consensus       421 y~~~gsL~~-----------~---L~~~~~------------~~l~~~~~~-----------------------------  445 (687)
                      |++|..+..           .   |+....            ..-.|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            999876531           1   111100            001232210                             


Q ss_pred             --HHHHHHHhhhhhhcc----------cccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          446 --RIIKGVASGLLYLHE----------EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       446 --~i~~~ia~~L~yLH~----------~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                        .+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              111223345666653          134789999999999999888899999999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.78  E-value=0.00016  Score=73.89  Aligned_cols=81  Identities=19%  Similarity=0.230  Sum_probs=59.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC---CCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH---RNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~lV~  419 (687)
                      ......+.+|.|..+.||+.+.. +|+.+.+|+...........|..|+..|+.|.-   -.+.+++++.    .-++||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            35666788999999999999984 688999998765444334567889999988842   2345666553    347899


Q ss_pred             ecCCCCCch
Q 005621          420 DFMPNGSLD  428 (687)
Q Consensus       420 Ey~~~gsL~  428 (687)
                      ||++++...
T Consensus        90 e~l~~~~~~   98 (288)
T 3f7w_A           90 EWVDERPPT   98 (288)
T ss_dssp             ECCCCCCCC
T ss_pred             EeecccCCC
Confidence            999877643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.77  E-value=0.00014  Score=75.34  Aligned_cols=139  Identities=16%  Similarity=0.145  Sum_probs=93.2

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc---CCCceeeeeeeecCCeeEEEEecC
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR---HRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ...+.|+.|....+|+...  ++..+++|+....   ....+..|...|+.|.   ...+.+++.++...+..++||||+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            3456789999999999986  4667889987643   2456788999998884   356888999988888899999999


Q ss_pred             CCCCchhh-----------hhchhh------------c--------cCCHHHHH---HHHH----------------HHH
Q 005621          423 PNGSLDKC-----------LFDEQK------------A--------ILTWEQRY---RIIK----------------GVA  452 (687)
Q Consensus       423 ~~gsL~~~-----------L~~~~~------------~--------~l~~~~~~---~i~~----------------~ia  452 (687)
                      ++..+..-           |+....            +        .-+|....   ++..                .++
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            99876321           111100            0        12454322   1111                111


Q ss_pred             hhh-hhhcc-cccCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          453 SGL-LYLHE-EWEQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       453 ~~L-~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                      ..+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            111 22321 2247899999999999999887 8899973

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.55  E-value=0.00036  Score=72.40  Aligned_cols=158  Identities=14%  Similarity=0.125  Sum_probs=89.3

Q ss_pred             ccCHHHHHHHhcCccc-----ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCC--cee
Q 005621          332 RFSYEELKKATRGFRD-----KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN--LVQ  404 (687)
Q Consensus       332 ~~~~~el~~at~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~  404 (687)
                      .++.+++.....+|..     .+.|+.|....+|+....+ + .+++|+.....  ...++..|+.+++.+....  +.+
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence            3566777777777754     2446668788999998742 3 68899887631  1234556777777774222  334


Q ss_pred             eeee------eecCCeeEEEEecCCCCCchhh--------------hhchhh----------ccCCHHHHHHHH------
Q 005621          405 LLGW------CRRRGDLLLVYDFMPNGSLDKC--------------LFDEQK----------AILTWEQRYRII------  448 (687)
Q Consensus       405 l~~~------~~~~~~~~lV~Ey~~~gsL~~~--------------L~~~~~----------~~l~~~~~~~i~------  448 (687)
                      ++..      ....+..+++|||++|..+...              ++....          ....|...+.-.      
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            4422      1223567899999998765321              111000          001232211100      


Q ss_pred             ------HHHHhhhhhhcc----cccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          449 ------KGVASGLLYLHE----EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       449 ------~~ia~~L~yLH~----~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                            ..+...+..++.    .....++|+|+++.|||++.+..+.|+||+.+.
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                  012223333332    124689999999999999887556899999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.40  E-value=0.0005  Score=74.44  Aligned_cols=77  Identities=16%  Similarity=0.173  Sum_probs=47.2

Q ss_pred             cCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceeeeec--CCCCCchhhccCC---CCCCccceehhhHHHH
Q 005621          463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVG--TLGYLAPELTRTG---KPTTSSDVYAFGALLL  537 (687)
Q Consensus       463 ~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDV~S~Gvvl~  537 (687)
                      ...++|+|+++.|||++.++ ++|+||+.+..-+....-  .....  ...|++|+.....   ......++......+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            37899999999999998876 999999988753211100  00000  1345666654311   1112345557777777


Q ss_pred             HHHhC
Q 005621          538 EVVCG  542 (687)
Q Consensus       538 elltG  542 (687)
                      +..++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77664

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.34  E-value=0.0006  Score=74.01  Aligned_cols=75  Identities=16%  Similarity=0.162  Sum_probs=52.0

Q ss_pred             ceeeeeeCeEEEEEEEeCC-------CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc-eeeeeeeecCCeeEEEE
Q 005621          348 KELLGFGGFGRVYKGTLPS-------TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL-VQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~  419 (687)
                      .+.|+.|....+|+.....       .+..+++|+.....  ....+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4568888889999998753       24689999885421  11455679999988854444 667776643    3899


Q ss_pred             ecCCCCCch
Q 005621          420 DFMPNGSLD  428 (687)
Q Consensus       420 Ey~~~gsL~  428 (687)
                      ||++|.+|.
T Consensus       152 e~l~G~~l~  160 (429)
T 1nw1_A          152 EYIPSRPLS  160 (429)
T ss_dssp             CCCCEEECC
T ss_pred             EEeCCcccC
Confidence            999875653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.14  E-value=0.00055  Score=70.41  Aligned_cols=138  Identities=10%  Similarity=0.015  Sum_probs=77.1

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc-eeeeeeeecCCeeEEEEecC-CC
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL-VQLLGWCRRRGDLLLVYDFM-PN  424 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~-~~  424 (687)
                      ..+.|+.|....+|+.      ..+++|+........ .....|+.+++.+...++ .++++++.+  .-++++||+ ++
T Consensus        22 ~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g   92 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGA   92 (301)
T ss_dssp             SCEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTC
T ss_pred             ceeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCC
Confidence            3678999999999998      348889876542221 123468888877753333 466665433  347899999 66


Q ss_pred             CCchhhh------------------hchhh---ccCC-HHHHHHHHHHH--------------Hhhhh----hhc-cccc
Q 005621          425 GSLDKCL------------------FDEQK---AILT-WEQRYRIIKGV--------------ASGLL----YLH-EEWE  463 (687)
Q Consensus       425 gsL~~~L------------------~~~~~---~~l~-~~~~~~i~~~i--------------a~~L~----yLH-~~~~  463 (687)
                      .+|....                  +....   .... +.....+...+              ...+.    .|. ....
T Consensus        93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~  172 (301)
T 3dxq_A           93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP  172 (301)
T ss_dssp             EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence            5554210                  00000   0001 11111111110              00011    110 1123


Q ss_pred             CeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       464 ~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      ..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            56999999999999 5667889999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.07  E-value=0.005  Score=63.80  Aligned_cols=158  Identities=13%  Similarity=0.119  Sum_probs=90.0

Q ss_pred             ccCHHHHHHHhcCccc-----ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCC--Ccee
Q 005621          332 RFSYEELKKATRGFRD-----KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHR--NLVQ  404 (687)
Q Consensus       332 ~~~~~el~~at~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~  404 (687)
                      .++.+++..+...|..     .+.++ |....||+.... +|+.+++|+...... ...++..|..+++.+...  .+++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecc
Confidence            4556666666555432     34566 777899988763 466799999864321 234566788888877422  2444


Q ss_pred             eeee-----eecCCeeEEEEecCCCCCchh----hh----------hchh-------hccCCHHHH--------------
Q 005621          405 LLGW-----CRRRGDLLLVYDFMPNGSLDK----CL----------FDEQ-------KAILTWEQR--------------  444 (687)
Q Consensus       405 l~~~-----~~~~~~~~lV~Ey~~~gsL~~----~L----------~~~~-------~~~l~~~~~--------------  444 (687)
                      ++..     ....+..+++|||++|..+..    .+          +...       ....++...              
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            4443     122456688999998866531    01          1100       011222211              


Q ss_pred             --------HHHHHHHHhhhhhhc-ccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          445 --------YRIIKGVASGLLYLH-EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       445 --------~~i~~~ia~~L~yLH-~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                              ...+..++..+.-+- ......++|+|+++.|||++ + .+.|+||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                    011111111121111 11246799999999999999 5 899999988753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.07  E-value=0.0025  Score=66.33  Aligned_cols=140  Identities=21%  Similarity=0.157  Sum_probs=72.1

Q ss_pred             eeeeeeCeEE-EEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC--CCceeeeeeeecCCeeEEEEecCCCC
Q 005621          349 ELLGFGGFGR-VYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH--RNLVQLLGWCRRRGDLLLVYDFMPNG  425 (687)
Q Consensus       349 ~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~g  425 (687)
                      +.|+.|+... +|+.... ++..+++|.......   .++..|+.+++.+..  -.+.+++.+..+.+  +++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            4566665554 6677642 256677776544321   233456666666642  23566777654444  7899999776


Q ss_pred             Cchhhhhchhh------------------------ccCCHHHHH-------HHH-------------HHHHhhhhhhc--
Q 005621          426 SLDKCLFDEQK------------------------AILTWEQRY-------RII-------------KGVASGLLYLH--  459 (687)
Q Consensus       426 sL~~~L~~~~~------------------------~~l~~~~~~-------~i~-------------~~ia~~L~yLH--  459 (687)
                      .+.+++.....                        ..++.....       .+.             ..+...+..|.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            66544321100                        001111000       000             00111111221  


Q ss_pred             -ccccCeEEeeccCCCcEEeccC----CcEEEccccccee
Q 005621          460 -EEWEQTVIHRDIKAGNVLLDSE----LNGRLGDFGLAKL  494 (687)
Q Consensus       460 -~~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGla~~  494 (687)
                       ......++|||+.+.|||++.+    ..+.|+||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1123689999999999999874    6789999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.04  E-value=0.0023  Score=68.03  Aligned_cols=142  Identities=20%  Similarity=0.180  Sum_probs=86.0

Q ss_pred             ceeeeeeCeEEEEEEEeCC-------CCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCeeEEEE
Q 005621          348 KELLGFGGFGRVYKGTLPS-------TNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .+.|..|-...+|+.....       .+..+++|+..... .......+|..+++.+. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            3567777788899998742       34689999864322 23455668999998884 3333667777654    2999


Q ss_pred             ecCCCCCchhh-h----------------hchh---hccC--CHHHHHHHHHHHHhh-------------------hhhh
Q 005621          420 DFMPNGSLDKC-L----------------FDEQ---KAIL--TWEQRYRIIKGVASG-------------------LLYL  458 (687)
Q Consensus       420 Ey~~~gsL~~~-L----------------~~~~---~~~l--~~~~~~~i~~~ia~~-------------------L~yL  458 (687)
                      ||++|.+|..- +                +...   ....  -|.++.++..++...                   +..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998776421 1                0000   0111  245566665554322                   1222


Q ss_pred             cc-----cccCeEEeeccCCCcEEeccC----CcEEEccccccee
Q 005621          459 HE-----EWEQTVIHRDIKAGNVLLDSE----LNGRLGDFGLAKL  494 (687)
Q Consensus       459 H~-----~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGla~~  494 (687)
                      ..     .....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            11     123679999999999999876    6899999998863

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.02  E-value=0.0043  Score=67.75  Aligned_cols=76  Identities=12%  Similarity=0.045  Sum_probs=50.4

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc-eeeeeeeecCCeeEEEEecCCCCC
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL-VQLLGWCRRRGDLLLVYDFMPNGS  426 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gs  426 (687)
                      .+.|+.|-...+|+......+..+++|+........ -+...|..+++.|...++ .++++.+..    .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            467888888999999985445789999875432211 112578888988865545 567777632    25999999866


Q ss_pred             ch
Q 005621          427 LD  428 (687)
Q Consensus       427 L~  428 (687)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.89  E-value=0.003  Score=66.89  Aligned_cols=75  Identities=15%  Similarity=0.097  Sum_probs=45.9

Q ss_pred             ceeeeeeCeEEEEEEEeCC--------CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCC-ceeeeeeeecCCeeEEE
Q 005621          348 KELLGFGGFGRVYKGTLPS--------TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRN-LVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV  418 (687)
                      .+.|+.|....+|+.....        .+..+++|+....... ..+...|..+++.+...+ ..++++...    -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence            3567778888999998743        1267888987654322 122357888888875434 346665442    3789


Q ss_pred             EecCCCCCc
Q 005621          419 YDFMPNGSL  427 (687)
Q Consensus       419 ~Ey~~~gsL  427 (687)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999998655

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.06  E-value=0.039  Score=57.52  Aligned_cols=32  Identities=34%  Similarity=0.423  Sum_probs=28.5

Q ss_pred             cCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       463 ~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            46899999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.53  E-value=0.063  Score=57.79  Aligned_cols=141  Identities=11%  Similarity=0.140  Sum_probs=84.8

Q ss_pred             ceeeeeeCeEEEEEEEeCCC-------CeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCC-ceeeeeeeecCCeeEEEE
Q 005621          348 KELLGFGGFGRVYKGTLPST-------NTQVAVKRVSNESKQGLREFASEISSIGRLRHRN-LVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~  419 (687)
                      .+.|..|-...+|+......       +..+++|+....... .-+..+|..+++.+.-.+ ..++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            45676777889999987521       567999986543322 122357888888874323 455665432    27899


Q ss_pred             ecCCCCCchhh-h----------------hchhh-----------ccCCHHHHHHHHHHHHh------------------
Q 005621          420 DFMPNGSLDKC-L----------------FDEQK-----------AILTWEQRYRIIKGVAS------------------  453 (687)
Q Consensus       420 Ey~~~gsL~~~-L----------------~~~~~-----------~~l~~~~~~~i~~~ia~------------------  453 (687)
                      ||++|.+|..- +                +....           .+.-|.++.++..++-.                  
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998765321 1                11000           11124444444333211                  


Q ss_pred             -hhhhhc---------------------ccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          454 -GLLYLH---------------------EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       454 -~L~yLH---------------------~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                       .+..|.                     ......++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence             122221                     122357999999999999 7788999999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.46  E-value=0.014  Score=56.23  Aligned_cols=98  Identities=14%  Similarity=0.093  Sum_probs=63.0

Q ss_pred             CchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCceee
Q 005621          426 SLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTR  505 (687)
Q Consensus       426 sL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  505 (687)
                      ||.+.|.. .+.++++++++.++.|.+.+|.-+-..  ..-..+=+.|..|++..+|.+.+.+ ..+.            
T Consensus        34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            78887743 456899999999999999998776110  0101233456999999999998764 1110            


Q ss_pred             eecCCCCCchhhccCCCCCCccceehhhHHHHHHHh
Q 005621          506 VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC  541 (687)
Q Consensus       506 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt  541 (687)
                       .....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence             1122456888764 345678889999999998876

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.64  E-value=0.58  Score=49.74  Aligned_cols=31  Identities=29%  Similarity=0.399  Sum_probs=25.8

Q ss_pred             CeEEeeccCCCcEEe------ccCCcEEEccccccee
Q 005621          464 QTVIHRDIKAGNVLL------DSELNGRLGDFGLAKL  494 (687)
Q Consensus       464 ~~ivHrDlk~~NIll------~~~~~~kl~DFGla~~  494 (687)
                      ..++|+|+.+.|||+      +++..++++||..|..
T Consensus       244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            357899999999999      3456799999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.03  E-value=5.5  Score=38.13  Aligned_cols=116  Identities=8%  Similarity=0.044  Sum_probs=78.4

Q ss_pred             cCCCceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEE
Q 005621          398 RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVL  477 (687)
Q Consensus       398 ~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  477 (687)
                      .||++++. .+-...+.+.+.|+.-+  +...+-   .-..++...+++++.+|+....+++.     -+|--|.|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~---~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD---NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG---GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH---HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence            68888866 45566666666666543  222222   23457889999999999998877764     357789999999


Q ss_pred             eccCCcEEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCC
Q 005621          478 LDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIE  547 (687)
Q Consensus       478 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~  547 (687)
                      ++.++.+++.=.|+...+...             =+.+|-+          .-.+=+++..+++++..|+
T Consensus       112 f~~~~~p~i~~RGik~~l~P~-------------~~~ee~f----------L~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVVDPL-------------PVSEAEF----------LTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTBSCC-------------CCCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCCCCC-------------CCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            999999999887764322110             0122221          2356678888888888775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.36  E-value=0.12  Score=56.33  Aligned_cols=61  Identities=8%  Similarity=0.077  Sum_probs=17.7

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEE------EEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeee
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAV------KRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCR  410 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  410 (687)
                      ..+.||   ||.||+|.+.....+|||      |.....  ..+....|.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345566   999999999655568888      766542  2334457888999999999999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	687
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-67
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	1e-65
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-65
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-65
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	2e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-64
d1hqla_	236	b.29.1.1 (A:) Legume lectin {Griffonia simplicifol	9e-64
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	4e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-61
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	1e-61
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	1e-61
d1leda_	243	b.29.1.1 (A:) Legume lectin {West-central african	8e-61
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	9e-61
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	2e-60
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	2e-60
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	3e-60
g1qmo.1	230	b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich	7e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-60
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	8e-60
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	2e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-59
d1ukga_	241	b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero	1e-58
g2ltn.1	229	b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum	6e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-57
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	2e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-57
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-57
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	3e-57
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-57
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-53
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	2e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-51
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-48
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	3e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-43
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	2e-43
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	1e-22
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-36
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-28
d1gv9a_	228	b.29.1.13 (A:) Carbohydrate-recognition domain of	3e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-19
d2a6za1	221	b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake	3e-08
d2a6va1	218	b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake	9e-08

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 6e-67
 Identities = 76/301 (25%), Positives = 133/301 (44%), Gaps = 39/301 (12%)

Query: 322 ESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNE 379
           + WE+  G         ++          +G G FG VYKG     +  VAVK   V+  
Sbjct: 1   DDWEIPDG----QITVGQR----------IGSGSFGTVYKGKW---HGDVAVKMLNVTAP 43

Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
           + Q L+ F +E+  + + RH N++  +G+      L +V  +    SL   L   +    
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-F 101

Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
              +   I +  A G+ YLH    +++IHRD+K+ N+ L  +L  ++GDFGLA +  R +
Sbjct: 102 EMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158

Query: 500 NP-STTRVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL 555
                 ++ G++ ++APE+ R       +  SDVYAFG +L E++ G+ P         +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNI 212

Query: 556 ILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYL 615
              D +      G     + P L+ +        + +L   C     + RP   Q++  +
Sbjct: 213 NNRDQIIFMVGRG----YLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

Query: 616 E 616
           E
Sbjct: 268 E 268

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score =  214 bits (546), Expect = 1e-65
 Identities = 77/251 (30%), Positives = 112/251 (44%), Gaps = 29/251 (11%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNST 79
           F FS F     N+N++L GAA I ++G L LT             G   Y+ P+   +ST
Sbjct: 6   FSFSEFEP--GNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDST 63

Query: 80  RNSKSLSFSTCFAFAIVPEYT-ALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLT 138
                 SF T F+F+I   YT  L   G  F +  +K  P      YLG+ N+S   N +
Sbjct: 64  -TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGVFNNSKQDN-S 120

Query: 139 NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQ 198
               AVEFDT  +  +      H+GID+NS+RS  ++P              L +G+V  
Sbjct: 121 YQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQPF------------QLDNGQVAN 167

Query: 199 AWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSH 255
             I YD+    L V L   S       ++  VD+  ++ + + VG S +TG     A +H
Sbjct: 168 VVIKYDAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETH 226

Query: 256 YILGWSFNMSG 266
            +  WSF  S 
Sbjct: 227 DVYSWSFQASL 237

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 1e-65
 Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 21/272 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
            +  E LG G FG V+ G     +T+VAVK +  +       F +E + + +L+H+ LV+
Sbjct: 15  LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L     +   + ++ ++M NGSL   L       LT  +   +   +A G+ ++ E   +
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---R 128

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
             IHRD++A N+L+   L+ ++ DFGLA+L E     +       + + APE    G  T
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 525 TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE 584
             SDV++FG LL E+V   R   P     E+I             +             E
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ-----------NLERGYRMVRPDNCPE 237

Query: 585 IEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
               ++ +L  +C  +  E RPT   +   LE
Sbjct: 238 ----ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  214 bits (545), Expect = 7e-65
 Identities = 70/287 (24%), Positives = 122/287 (42%), Gaps = 19/287 (6%)

Query: 330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS 389
           P   +Y++ +        K  LG G +G VY+G     +  VAVK +  ++ + + EF  
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62

Query: 390 EISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIK 449
           E + +  ++H NLVQLLG C R     ++ +FM  G+L   L +  +  ++      +  
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122

Query: 450 GVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGT 509
            ++S + YL +   +  IHRD+ A N L+      ++ DFGL++L    T  +       
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA 569
           + + APE     K +  SDV+AFG LL E+                      +       
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQ 224

Query: 570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
           + E+++     E  E     V +L   C       RP+  ++ +  E
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  214 bits (546), Expect = 8e-65
 Identities = 80/313 (25%), Positives = 146/313 (46%), Gaps = 38/313 (12%)

Query: 333 FSYEELKKATRGF---------RDKELLGFGGFGRVYKGTLPSTNTQ---VAVKRV-SNE 379
           F++E+  +A R F         + ++++G G FG V  G L     +   VA+K + S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAIL 439
           +++  R+F SE S +G+  H N++ L G   +   ++++ +FM NGSLD  L        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 440 TWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT 499
           T  Q   +++G+A+G+ YL +      +HRD+ A N+L++S L  ++ DFGL++  E  T
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 500 NPSTTR----VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEE 554
           +  T          + + APE  +  K T++SDV+++G ++ EV+  G RP         
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--------- 233

Query: 555 LILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY 614
                  +       ++  ++              + +L L C       RP   Q+V  
Sbjct: 234 -------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 615 LEGEVPLPQAVAA 627
           L+  +  P ++ A
Sbjct: 287 LDKMIRNPNSLKA 299

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score =  211 bits (538), Expect = 2e-64
 Identities = 73/252 (28%), Positives = 112/252 (44%), Gaps = 24/252 (9%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRV---LGHAFYSSPIKFKN 77
           S    F F  F    N  N+   G A +   G L +T  +      +G A Y++PI+  +
Sbjct: 1   SDDLSFNFDKFVP--NQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD 58

Query: 78  STRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNL 137
           S    K  SF+T F+F +  + +        F   A+ ++P    +   GL +SSD    
Sbjct: 59  SI-TGKVASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKS 116

Query: 138 TNHIFAVEFDTVKDFEFG--DINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGE 195
           +N I AVEFDT     +   D +  H+GID+NS++S  +               + ++GE
Sbjct: 117 SNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK------------WDWRNGE 164

Query: 196 VIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA--S 253
           V    I Y +    L V L+  S    S I++  VDL  I+ E + VGFS   G  A   
Sbjct: 165 VADVVITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFE 223

Query: 254 SHYILGWSFNMS 265
           +H +L W F  +
Sbjct: 224 THDVLSWYFTSN 235

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 3e-64
 Identities = 71/292 (24%), Positives = 123/292 (42%), Gaps = 29/292 (9%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
           +E +G G FG V++G       +VAVK  S+  ++      +EI     LRH N++  + 
Sbjct: 8   QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIA 64

Query: 408 WCRRRGD----LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
              +       L LV D+  +GSL   L    +  +T E   ++    ASGL +LH E  
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 464 QT-----VIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGTLGYLAP 515
            T     + HRD+K+ N+L+       + D GLA  ++  T+    +    VGT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 516 EL------TRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPE----ELILVDWVWDRW 565
           E+       +  +    +D+YA G +  E+             +    +L+  D   +  
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 566 KAGAILEVVDPRLNGEFNEIEALD-VVKLGLMCSNDAAEARPTMRQVVRYLE 616
           +     + + P +   +   EAL  + K+   C      AR T  ++ + L 
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

 Score =  209 bits (533), Expect = 9e-64
 Identities = 70/248 (28%), Positives = 106/248 (42%), Gaps = 24/248 (9%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRV------LGHAFYSSPIKFKNST 79
           F F  F  +   +++   G A     G L L  T           G A YS P++  ++ 
Sbjct: 4   FTFPNF-WSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNK 61

Query: 80  RNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLT- 138
                 SF T F F +          G AF ++           +YLGL N S     + 
Sbjct: 62  -TESVASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKD-AGEYLGLFNKSTATQPSK 118

Query: 139 NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQ 198
           N + AVEFDT  +  F + +  H+GI++NS+ S A++              ++ SG++  
Sbjct: 119 NQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDS---------DIFSGKIAT 169

Query: 199 AWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLAS-SHYI 257
           A I YD S   L V L+         ILS  VD+   + E++ VG S+STG     + YI
Sbjct: 170 ARISYDGSAEILTVVLSYP--DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYI 227

Query: 258 LGWSFNMS 265
           L W F+ +
Sbjct: 228 LSWRFSSN 235

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score =  208 bits (529), Expect = 4e-63
 Identities = 76/259 (29%), Positives = 113/259 (43%), Gaps = 30/259 (11%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNST 79
           F ++ F       NM L G A +  +GKL L             LG A YS+PI   +  
Sbjct: 6   FSWNKF--VPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKE 63

Query: 80  RNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTN 139
                 SF+  F F      T     G AF ++       T P  + G L   +     +
Sbjct: 64  -TGSVASFAASFNFTFYAPDTKRLADGLAFFLAPI----DTKPQTHAGYLGLFNENESGD 118

Query: 140 HIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQA 199
            + AVEFDT ++    D  + H+GI++NS+RS  +               +L + +V + 
Sbjct: 119 QVVAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTTS------------WDLANNKVAKV 164

Query: 200 WIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL--ASSHYI 257
            I YD+S + L   L   S +  S ILS  VDL   + E + +GFS++TGL     SH +
Sbjct: 165 LITYDASTSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDV 223

Query: 258 LGWSFNMSGDAKSLSLDSL 276
           L WSF  +    S ++D L
Sbjct: 224 LSWSFASNLPHASSNIDPL 242

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 1e-62
 Identities = 76/272 (27%), Positives = 113/272 (41%), Gaps = 21/272 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
            R +  LG G FG V+ GT   T T+VA+K +          F  E   + +LRH  LVQ
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L         + +V ++M  GSL   L  E    L   Q   +   +ASG+ Y+      
Sbjct: 77  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---M 132

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
             +HRD++A N+L+   L  ++ DFGLA+L E     +       + + APE    G+ T
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 525 TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE 584
             SDV++FG LL E+    R   P  +  E               +L+ V+         
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQVERGYRMPCPP 237

Query: 585 IEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
                +  L   C     E RPT   +  +LE
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 3e-62
 Identities = 65/272 (23%), Positives = 110/272 (40%), Gaps = 21/272 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
               + +G G FG V+ G       +VA+K +  E      +F  E   + +L H  LVQ
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L G C  +  + LV++FM +G L       Q+ +   E    +   V  G+       E 
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGM---AYLEEA 120

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
            VIHRD+ A N L+      ++ DFG+ +        S+T     + + +PE+    + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 525 TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE 584
           + SDV++FG L+ EV    +         E++                +  PRL      
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--------EDISTGFRLYKPRLAST--- 229

Query: 585 IEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
                V ++   C  +  E RP   +++R L 
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 7e-62
 Identities = 64/273 (23%), Positives = 115/273 (42%), Gaps = 23/273 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
               + LG G FG V  G        VA+K +  E      EF  E   +  L H  LVQ
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L G C ++  + ++ ++M NG L   L + +      +Q   + K V   + YL     +
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLES---K 119

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
             +HRD+ A N L++ +   ++ DFGL++        S+      + +  PE+    K +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 525 TSSDVYAFGALLLEVV-CGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN 583
           + SD++AFG L+ E+   G+ P                ++R+      E +   L     
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP----------------YERFTNSETAEHIAQGLRLYRP 223

Query: 584 EIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
            + +  V  +   C ++ A+ RPT + ++  + 
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 1e-61
 Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 41/300 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLV 403
           F     LG G  G V+K +   +   +A K +  E K  +R     E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
              G     G++ +  + M  GSLD+ L    +  +  +   ++   V  GL YL E+  
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK-- 123

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
             ++HRD+K  N+L++S    +L DFG++              VGT  Y++PE  +    
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHY 180

Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALPEELI-----------------------LVDW 560
           +  SD+++ G  L+E+  GR PI P    E  +                       L  +
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240

Query: 561 VWDRWKAGAILEVVDPRLNGEFNEI-------EALDVVKLGLMCSNDAAEARPTMRQVVR 613
             D     AI E++D  +N    ++       E  D V        + AE R  ++Q++ 
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN--KCLIKNPAE-RADLKQLMV 297

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score =  203 bits (517), Expect = 1e-61
 Identities = 64/240 (26%), Positives = 95/240 (39%), Gaps = 21/240 (8%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTN-TTLRVLGHAFYSSPIKFKNSTRNSKS 84
           F F+ F +   N  ++  G   +  NG + LTN   +  +G   Y+ P++  +S      
Sbjct: 6   FNFNSFSE--GNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSA-TGNV 62

Query: 85  LSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAV 144
            SF T F+F +          G  F I+              G            H   V
Sbjct: 63  ASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIP--AGSIGGGTLGVSDTKGAGHFVGV 120

Query: 145 EFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYD 204
           EFDT  + E+ D   +HVGID+NS+ S  + P             N  SG V++  + YD
Sbjct: 121 EFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP------------WNSVSGAVVKVTVIYD 168

Query: 205 SSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASS-HYILGWSFN 263
           SS   L V    ++       ++  VDL   + E +  GFS+S  L     H I  WSF 
Sbjct: 169 SSTKTLSVA--VTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFT 226

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  203 bits (517), Expect = 1e-61
 Identities = 82/252 (32%), Positives = 117/252 (46%), Gaps = 32/252 (12%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRV------LGHAFYSSPIK 74
           S    F F  F    N  N+ L   A +  +G+L LTN           LG AFYS+PI+
Sbjct: 1   SNDIYFNFQRF----NETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQ 56

Query: 75  FKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDL 134
             ++T      SF+T F F I     A    G AF +      P      +LGL + S  
Sbjct: 57  IWDNT-TGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD-KGGFLGLFDGS-- 112

Query: 135 GNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSG 194
            N   H  AVEFDT+ + ++ D  + H+GID+NS+RS  +               +  +G
Sbjct: 113 -NSNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRW------------DFVNG 158

Query: 195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA-- 252
           E  +  I YDSS N L   L   S +  S I+S  VDL  ++ E + VGFS++TG+    
Sbjct: 159 ENAEVLITYDSSTNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGN 217

Query: 253 -SSHYILGWSFN 263
             ++ +L WSF 
Sbjct: 218 VETNDVLSWSFA 229

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

 Score =  201 bits (513), Expect = 8e-61
 Identities = 70/247 (28%), Positives = 103/247 (41%), Gaps = 26/247 (10%)

Query: 26  FFFSGFRDAA--NNNNMSLNGAAEIEKNGKLMLT------NTTLRVLGHAFYSSPIKFKN 77
           F +  F   +  N   ++  G A     G L LT      N      G A YS P+   +
Sbjct: 6   FTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWD 64

Query: 78  STRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNL 137
           ST   K+ SF T F F ++  Y A    G AF ++            +LGL       + 
Sbjct: 65  ST--GKAASFYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKD-YGGFLGLFRHETAADP 120

Query: 138 T-NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEV 196
           + N + AVEFDT  + ++ D    H+GID+NS+ S A+               +     +
Sbjct: 121 SKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWEND---------DAYGSSI 171

Query: 197 IQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHY 256
             A I YD+    L V L+      R  ILS  VDL+ ++ + + +GFS+  G      Y
Sbjct: 172 ATAHITYDARSKILTVLLSYE--HGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTY 228

Query: 257 ILGWSFN 263
           IL W F 
Sbjct: 229 ILSWHFF 235

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score =  201 bits (512), Expect = 9e-61
 Identities = 68/250 (27%), Positives = 96/250 (38%), Gaps = 23/250 (9%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLT----NTTLRVLGHAFYSSPIKFK 76
           S    F F  F    N  ++S  G A + + G L L     N      G A Y +PI   
Sbjct: 1   SDDLSFKFKNFSQ--NGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIW 58

Query: 77  NSTRNSKSLSFSTCFAFA-IVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLG 135
           N     +  SF T F+F             G  F ++     P      Y GL N +   
Sbjct: 59  NCN-TGELASFITSFSFFMETSANPKAATDGLTFFLAPPD-SPLRRAGGYFGLFNDTK-C 115

Query: 136 NLTNHIFAVEFDTVK-DFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSG 194
           + +    AVEFDT+     F D    H+GID+N ++S  +E                   
Sbjct: 116 DSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNK----------RYGLN 165

Query: 195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL-LAS 253
            V    I Y++S   L   L   S    S  ++  VDL  I+ E + VGFS ST +   +
Sbjct: 166 NVANVEIIYEASSKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQA 224

Query: 254 SHYILGWSFN 263
           +H +L W F 
Sbjct: 225 THEVLNWYFT 234

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score =  200 bits (509), Expect = 2e-60
 Identities = 74/253 (29%), Positives = 108/253 (42%), Gaps = 30/253 (11%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRV-----LGHAFYSSPIKF 75
           ++   F F+ F    N NN+ L   A +   G L LT           LG A Y++PI  
Sbjct: 1   TESTSFSFTNF--NPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHI 58

Query: 76  KNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLG 135
            ++T  +   SF+T F+F +     A    G AF ++     P      +LGL       
Sbjct: 59  HDNTTLA---SFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFADRA-H 113

Query: 136 NLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGE 195
           + +    AVEFDT  +    D N  H+GID N + S  + P             ++  GE
Sbjct: 114 DASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP------------FDMVYGE 159

Query: 196 VIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LA 252
                I Y +S   L   L        S  +S  VDL  I+ E + VGFS++TGL   + 
Sbjct: 160 KANIVITYQASTKALAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVV 218

Query: 253 SSHYILGWSFNMS 265
            +H I+ WSF +S
Sbjct: 219 ETHDIVSWSFAVS 231

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  199 bits (508), Expect = 2e-60
 Identities = 75/251 (29%), Positives = 106/251 (42%), Gaps = 33/251 (13%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL---RVLGHAFYSSPIKFKN 77
           S    F    F    N  N+ L G A +   G L+LTN        +G AFYS+PI+  +
Sbjct: 1   SNDASFNVETF----NKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIND 56

Query: 78  STRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNL 137
            T      SFST F F I  +      +G AF +      P  L  +YLGL N++     
Sbjct: 57  RT-IDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTT----- 109

Query: 138 TNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVI 197
                  + D        D   N + ID+NS+R  A+E   +   N          GE  
Sbjct: 110 -----NYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFGHNN----------GEKA 154

Query: 198 QAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL---ASS 254
           +  I YDS KN L V L   S       +S  V L   V++ + VGFS+++G       +
Sbjct: 155 EVRITYDSPKNDLRVSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTET 213

Query: 255 HYILGWSFNMS 265
           H +L WSF+ +
Sbjct: 214 HNVLSWSFSSN 224

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score =  199 bits (508), Expect = 3e-60
 Identities = 76/250 (30%), Positives = 102/250 (40%), Gaps = 35/250 (14%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNST 79
           F F  F +  N+  ++L   A I+ NG L LT  T       +  G A Y+ PIK  +ST
Sbjct: 5   FNFDHFEE--NSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDST 62

Query: 80  RNSKSLSFSTCFAFAIVPEY-TALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLT 138
                 SF T F+F I   Y       G  F +      P   P    G           
Sbjct: 63  -TGNVASFETRFSFNITQPYAYPEPADGLTFFMV-----PPNSPQGEDGGNLGVFKPPEG 116

Query: 139 NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQ 198
           ++ FAVEFDT ++    D    H+GID+NS+ S+ +                L++G V  
Sbjct: 117 DNAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKTLH------------FQLENGGVAN 162

Query: 199 AWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIV--KETMYVGFSSSTGL---LAS 253
             I YDS    L V LA  S       LS  VDL       E + VG S++TG       
Sbjct: 163 VVIKYDSPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVE 221

Query: 254 SHYILGWSFN 263
           +H I+ WSF 
Sbjct: 222 THEIISWSFT 231

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 7e-60
 Identities = 75/273 (27%), Positives = 123/273 (45%), Gaps = 27/273 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
            +  + +G G FG V  G       +VAVK + N++    + F +E S + +LRH NLVQ
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64

Query: 405 LLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           LLG     +G L +V ++M  GSL   L    +++L  +   +    V   + YL     
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---G 121

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
              +HRD+ A NVL+  +   ++ DFGL K      + +       + + APE  R  K 
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKF 177

Query: 524 TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFN 583
           +T SDV++FG LL E+    R   P+   ++++       R + G  ++  D        
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKGYKMDAPDGCPP---- 227

Query: 584 EIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
                 V ++   C +  A  RP+  Q+   LE
Sbjct: 228 -----AVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score =  199 bits (507), Expect = 8e-60
 Identities = 73/251 (29%), Positives = 117/251 (46%), Gaps = 31/251 (12%)

Query: 24  EEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT------TLRVLGHAFYSSPIKFKN 77
           + F F  F    N+++  L G A +  + KL LT        TL  LG AFYSSPI+  +
Sbjct: 4   QSFSFKNF----NSSSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYD 58

Query: 78  STRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNL 137
            +      S++T F   I     +    G AF +      P +  S +LG+ +S    N 
Sbjct: 59  KS-TGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGVFDSDVYDN- 115

Query: 138 TNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVI 197
           +    AVEFDT  + ++ D    H+GID+NS++S  +                L +G+  
Sbjct: 116 SAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASW------------GLANGQNA 162

Query: 198 QAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASS 254
           +  I Y+++ + L   L   S +  S I+S  VD++  + E + +GFS++TGL      +
Sbjct: 163 EILITYNAATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTET 221

Query: 255 HYILGWSFNMS 265
           H +L WSF   
Sbjct: 222 HDVLSWSFASK 232

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score =  197 bits (502), Expect = 2e-59
 Identities = 70/253 (27%), Positives = 99/253 (39%), Gaps = 34/253 (13%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKFKNSTR 80
           F F+ F    N   + L   A I  N  L LT       T    G A Y+ P++  +ST 
Sbjct: 5   FNFNQFHQ--NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDST- 61

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
                SF T F+F+I   +             A           Y G+ N          
Sbjct: 62  TGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLS----PYP 117

Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
             AVEFDT ++    D    H+GID+NS+ S  + P              L +G +    
Sbjct: 118 FVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVP------------FTLDNGGIANVV 163

Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL-------LAS 253
           I YD+S   L V L   S       ++  VDL  ++ E++ VGFS++TG           
Sbjct: 164 IKYDASTKILHVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATE 222

Query: 254 SHYILGWSFNMSG 266
           +H IL WSF+ S 
Sbjct: 223 THDILSWSFSASL 235

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 4e-59
 Identities = 67/285 (23%), Positives = 132/285 (46%), Gaps = 26/285 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQ----VAVKRVSNESKQGLR-EFASEISSIGRLRH 399
              ++++G G FG VYKG L +++ +    VA+K +     +  R +F  E   +G+  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
            N+++L G   +   ++++ ++M NG+LDK    E+    +  Q   +++G+A+G+ YL 
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMKYLA 127

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV--VGTLGYLAPEL 517
                  +HRD+ A N+L++S L  ++ DFGL+++ E     + T       + + APE 
Sbjct: 128 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 518 TRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR 577
               K T++SDV++FG ++ EV+        +    E               +++ ++  
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKAINDG 229

Query: 578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLP 622
                       + +L + C       RP    +V  L+  +  P
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 6e-59
 Identities = 66/298 (22%), Positives = 122/298 (40%), Gaps = 38/298 (12%)

Query: 325 ELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQ--VAVKRVSNESKQ 382
           +L +        +++           LG G FG V +G       Q  VA+K +   +++
Sbjct: 2   KLFLKRDNLLIADIE-----------LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK 50

Query: 383 G-LREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTW 441
               E   E   + +L +  +V+L+G C+    L+LV +    G L K L  +++  +  
Sbjct: 51  ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE-IPV 108

Query: 442 EQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP 501
                ++  V+ G+ YL E   +  +HRD+ A NVLL +    ++ DFGL+K      + 
Sbjct: 109 SNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165

Query: 502 STTR--VVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVV-CGRRPIEPKALPEELILV 558
            T R      L + APE     K ++ SDV+++G  + E +  G++P             
Sbjct: 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP------------- 212

Query: 559 DWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
              + + K   ++  ++     E       ++  L   C     E RP    V + + 
Sbjct: 213 ---YKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 6e-59
 Identities = 65/299 (21%), Positives = 109/299 (36%), Gaps = 41/299 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQGLRE-FASEISSIGRL- 397
               + LG G FG+V + T            VAVK +   +    RE   SE+  +  L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 398 RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL----------------FDEQKAILTW 441
            H N+V LLG C   G  L++ ++   G L   L                 ++ +  L  
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 442 EQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTN 500
           E        VA G+ +L  +     IHRD+ A N+LL      ++ DFGLA+ +      
Sbjct: 145 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW 560
                    + ++APE       T  SDV+++G  L E+                     
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------P 247

Query: 561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
                      +++         E    ++  +   C +     RPT +Q+V+ +E ++
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

 Score =  195 bits (497), Expect = 1e-58
 Identities = 60/247 (24%), Positives = 105/247 (42%), Gaps = 27/247 (10%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT------TLRVLGHAFYSSPIKFKNST 79
           F F  F    +  N+   G A+I KN  + LT T          +G   +S+ +     +
Sbjct: 6   FGFPTFPS--DQKNLIFQGDAQI-KNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKS 62

Query: 80  RNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLT- 138
            +S+  +F + F+F++    +        F       +P       LGL       N + 
Sbjct: 63  -SSRVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSA 121

Query: 139 NHIFAVEFDTVK--DFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEV 196
           N + AVEFDT    D    D N  H+GID+NS+RS  +               + + G+ 
Sbjct: 122 NQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVK------------WDRRDGQS 169

Query: 197 IQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHY 256
           +   + ++ S  +L+V    S        +S++VD+  ++ E + VGFS+++G    +H 
Sbjct: 170 LNVLVTFNPSTRNLDVVATYS--DGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHT 227

Query: 257 ILGWSFN 263
           +  WSF 
Sbjct: 228 LESWSFT 234

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (497), Expect = 1e-57
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 31/275 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG---LREFASEISSIGRLRHRN 401
           F D   +G G FG VY       +  VA+K++S   KQ     ++   E+  + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
            +Q  G   R     LV ++    + D     ++   L   +   +  G   GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH-- 132

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPEL---T 518
               +IHRD+KAGN+LL      +LGDFG A +            VGT  ++APE+    
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAM 186

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL 578
             G+     DV++ G   +E+   + P+        L              I +   P L
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQNESPAL 234

Query: 579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
                     + V     C     + RPT   +++
Sbjct: 235 QSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score =  192 bits (489), Expect = 2e-57
 Identities = 73/249 (29%), Positives = 109/249 (43%), Gaps = 27/249 (10%)

Query: 26  FFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKFKNSTR 80
           F F  F  A N   +   G A +   G L LTN      + + LG A Y++P +  +ST 
Sbjct: 6   FSFPKF--APNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDST- 62

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
                SF T F F I     A    G AF ++     P  L    LG+         +N 
Sbjct: 63  TGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDL-GGMLGIFKDGYFNK-SNQ 120

Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
           I AVEFDT  + ++ D    H+GI++NS+ S  + P             N  +GEV   +
Sbjct: 121 IVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPW------------NWTNGEVANVF 167

Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSHYI 257
           I Y++S   L   L   S    S I+   VD+  ++ E +  GFS++TG+      ++ +
Sbjct: 168 ISYEASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDV 226

Query: 258 LGWSFNMSG 266
           L WSF  + 
Sbjct: 227 LSWSFESNL 235

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 2e-57
 Identities = 70/304 (23%), Positives = 130/304 (42%), Gaps = 31/304 (10%)

Query: 335 YEELKKATRG---FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEI 391
           YE + +       +     LG G FG+VYK     T+   A K +  +S++ L ++  EI
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 392 SSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGV 451
             +    H N+V+LL       +L ++ +F   G++D  + + ++  LT  Q   + K  
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQT 119

Query: 452 ASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLG 511
              L YLH   +  +IHRD+KAGN+L   + + +L DFG++    R      +  +GT  
Sbjct: 120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPY 175

Query: 512 YLAPEL-----TRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK 566
           ++APE+     ++       +DV++ G  L+E+     P         L+          
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL---------- 225

Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY----LEGEVPLP 622
              I +   P L        + +       C     +AR T  Q++++    ++   P+ 
Sbjct: 226 --KIAKSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 281

Query: 623 QAVA 626
           + +A
Sbjct: 282 ELIA 285

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 3e-57
 Identities = 70/277 (25%), Positives = 116/277 (41%), Gaps = 30/277 (10%)

Query: 347 DKELLGFGGFGRVYKGTLPSTNT--QVAVKRVSNESKQG--LREFASEISSIGRLRHRNL 402
           DKEL G G FG V KG          VAVK + NE+       E  +E + + +L +  +
Sbjct: 12  DKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V+++G C      +LV +    G L+K L   +   +  +    ++  V+ G+ YL E  
Sbjct: 71  VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEE-- 125

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAPELTRT 520
               +HRD+ A NVLL ++   ++ DFGL+K      N   + T     + + APE    
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 521 GKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN 579
            K ++ SDV++FG L+ E    G++P                +   K   +  +++    
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKP----------------YRGMKGSEVTAMLEKGER 228

Query: 580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
                    ++  L  +C     E RP    V   L 
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score =  191 bits (487), Expect = 3e-57
 Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 27/253 (10%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNT-----TLRVLGHAFYSSPIKF 75
           S +  F  + F    N  ++   G A +   G L LT           +G A Y++P++ 
Sbjct: 1   SDELSFTINNFVP--NEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRI 58

Query: 76  KNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLG 135
             +T      SFST F F +      +   G AF ++       +        L ++   
Sbjct: 59  WGNT-TGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNS 117

Query: 136 NLTNHIFAVEFDTVKDFEF--GDINDNHVGIDINSLRSNASEPAAYFL-ENSTKQVLNLK 192
           + +N I AVEFDT     +   D N  H+GID+N + S  +    +     +   +  L 
Sbjct: 118 DSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLA 177

Query: 193 SGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL- 251
             + + A + Y                   +  ++  VDL  I+ E + VGFS++TG   
Sbjct: 178 PNKTLIASLVYP--------------SNQTTFSVAASVDLKEILPEWVRVGFSAATGYPT 223

Query: 252 -ASSHYILGWSFN 263
              +H +L WSF 
Sbjct: 224 EVETHDVLSWSFT 236

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  193 bits (492), Expect = 4e-57
 Identities = 70/312 (22%), Positives = 124/312 (39%), Gaps = 47/312 (15%)

Query: 334 SYEELKKATRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNESKQGLR-EF 387
               L+           +G G FGRV++   P        T VAVK +  E+   ++ +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 388 ASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI--------- 438
             E + +    + N+V+LLG C     + L++++M  G L++ L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 439 -------------LTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR 485
                        L+  ++  I + VA+G+ YL E      +HRD+   N L+   +  +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180

Query: 486 LGDFGLAK-LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRR 544
           + DFGL++ +Y      +       + ++ PE     + TT SDV+A+G +L E+     
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 545 PIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEA 604
                   EE+I         + G IL            E   L++  L  +C +     
Sbjct: 241 QPYYGMAHEEVI------YYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPAD 285

Query: 605 RPTMRQVVRYLE 616
           RP+   + R L+
Sbjct: 286 RPSFCSIHRILQ 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 4e-57
 Identities = 65/277 (23%), Positives = 116/277 (41%), Gaps = 25/277 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRNL 402
           +     +G G +GR  K    S    +  K +   + ++   +   SE++ +  L+H N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 403 VQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKA--ILTWEQRYRIIKGVASGLLYL 458
           V+       R +  L +V ++   G L   +    K    L  E   R++  +   L   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 459 HE--EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           H   +   TV+HRD+K  NV LD + N +LGDFGLA++    T+ +    VGT  Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPE 184

Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP 576
                     SD+++ G LL E+     P    +  E              G I E    
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------------GKIREGKFR 232

Query: 577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
           R+   +++ E  +++       N     RP++ +++ 
Sbjct: 233 RIPYRYSD-ELNEIIT---RMLNLKDYHRPSVEEILE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 4e-57
 Identities = 62/278 (22%), Positives = 112/278 (40%), Gaps = 28/278 (10%)

Query: 343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHR 400
           R  +    +G G F  VYKG    T  +VA   + +   +K   + F  E   +  L+H 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 401 NLVQLLGWC----RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           N+V+         + +  ++LV + M +G+L   L   +   +  +      + +  GL 
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQ 126

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           +LH      +IHRD+K  N+ +       ++GD GLA L           V+GT  ++AP
Sbjct: 127 FLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAP 182

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD 575
           E+    K   S DVYAFG  +LE+     P        ++                 V  
Sbjct: 183 EMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--------------VTS 227

Query: 576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
                 F+++   +V ++   C     + R +++ ++ 
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-56
 Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 27/277 (9%)

Query: 348 KELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQG-LREFASEISSIGRLRHRNLV 403
            E++G G FG VY GTL   +      AVK ++  +  G + +F +E   +    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 404 QLLGWC-RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
            LLG C R  G  L+V  +M +G L       +    T +        VA G+       
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY---ERGTNPSTTRVVGTLGYLAPELTR 519
            +  +HRD+ A N +LD +   ++ DFGLA+     E  +  + T     + ++A E  +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 520 TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN 579
           T K TT SDV++FG LL E++    P  P     ++ +      R        ++ P   
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------LLQPEYC 259

Query: 580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
            +        + ++ L C +  AE RP+  ++V  + 
Sbjct: 260 PD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 4e-56
 Identities = 68/323 (21%), Positives = 123/323 (38%), Gaps = 47/323 (14%)

Query: 326 LDVGPHRFSYEELKKATRG-FRDKELLGFGGFGRVYKGTLPSTN-----TQVAVKRVSNE 379
             V    + Y+   +  R      ++LG G FG+V   T    +      QVAVK +  +
Sbjct: 19  FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 78

Query: 380 SKQGLRE-FASEISSIGRL-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQK- 436
           +    RE   SE+  + +L  H N+V LLG C   G + L++++   G L   L  +++ 
Sbjct: 79  ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 138

Query: 437 --------------------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNV 476
                                +LT+E        VA G+ +L     ++ +HRD+ A NV
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNV 195

Query: 477 LLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGAL 535
           L+      ++ DFGLA+ +               + ++APE    G  T  SDV+++G L
Sbjct: 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255

Query: 536 LLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGL 595
           L E+        P    +                  +++      +       ++  +  
Sbjct: 256 LWEIFSLGVNPYPGIPVDAN--------------FYKLIQNGFKMDQPFYATEEIYIIMQ 301

Query: 596 MCSNDAAEARPTMRQVVRYLEGE 618
            C    +  RP+   +  +L  +
Sbjct: 302 SCWAFDSRKRPSFPNLTSFLGCQ 324

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 7e-56
 Identities = 71/290 (24%), Positives = 121/290 (41%), Gaps = 38/290 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQ--VAVKRVSNE-SKQGLREFASEISSIGRL-RHR 400
            + ++++G G FG+V K  +     +   A+KR+    SK   R+FA E+  + +L  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCL--------------FDEQKAILTWEQRYR 446
           N++ LLG C  RG L L  ++ P+G+L   L               +   + L+ +Q   
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 447 IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRV 506
               VA G+ YL    ++  IHRD+ A N+L+      ++ DFGL++  E       T  
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--VYVKKTMG 186

Query: 507 VGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK 566
              + ++A E       TT+SDV+++G LL E+V                     +    
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---------------YCGMT 231

Query: 567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
              + E +      E       +V  L   C  +    RP+  Q++  L 
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 8e-56
 Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 26/285 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQ----VAVKRVSNE-SKQGLREFASEISSIGRLRH 399
           F+  ++LG G FG VYKG       +    VA+K +    S +  +E   E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 400 RNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLH 459
            ++ +LLG C     + L+   MP G L      E K  +  +        +A G+ YL 
Sbjct: 71  PHVCRLLGICLT-STVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYL- 127

Query: 460 EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGTLGYLAPELT 518
              ++ ++HRD+ A NVL+ +  + ++ DFGLAK L               + ++A E  
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 519 RTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL 578
                T  SDV+++G  + E++                     +D   A  I  +++   
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKGE 230

Query: 579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPLPQ 623
                 I  +DV  + + C    A++RP  R+++         PQ
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 1e-55
 Identities = 68/272 (25%), Positives = 110/272 (40%), Gaps = 28/272 (10%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSN---ESKQGLREFASEISSIGRLRHRN 401
           F     LG G FG VY      +   +A+K +     E      +   E+     LRH N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           +++L G+      + L+ ++ P G++ + L    K     ++    I  +A+ L Y H  
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS- 124

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
             + VIHRDIK  N+LL S    ++ DFG +       +   T + GTL YL PE+    
Sbjct: 125 --KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGR 179

Query: 522 KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE 581
                 D+++ G L  E + G+ P E     E    +               V+      
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------------VEFTFPDF 226

Query: 582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
             E  A D++   L+  N     RP +R+V+ 
Sbjct: 227 VTE-GARDLIS-RLLKHN--PSQRPMLREVLE 254

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 3e-54
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 22/272 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLV 403
           +   + LG G +G V       T   VAVK V  +      E    EI     L H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
           +  G  R      L  ++   G L   +  +    +      R    + +G++YLH    
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG- 123

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS-TTRVVGTLGYLAPELTRTGK 522
             + HRDIK  N+LLD   N ++ DFGLA ++          ++ GTL Y+APEL +  +
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 523 P-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE 581
                 DV++ G +L  ++ G  P +  +   +          WK          +++  
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS------DWKEKKTYLNPWKKIDS- 234

Query: 582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
                 L ++   ++  N    AR T+  + +
Sbjct: 235 ----APLALLH-KILVEN--PSARITIPDIKK 259

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  186 bits (473), Expect = 9e-54
 Identities = 59/269 (21%), Positives = 110/269 (40%), Gaps = 21/269 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           +   E LG G FG V++ T  +T    A K V    +        EI ++  LRH  LV 
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L        +++++Y+FM  G L + + DE    ++ ++    ++ V  GL ++H   E 
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH---EN 143

Query: 465 TVIHRDIKAGNVLLDSELNGR--LGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
             +H D+K  N++  ++ +    L DFGL    +   +   T   GT  + APE+     
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKP 201

Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF 582
               +D+++ G L   ++ G  P   +   E L  V     +     + +     ++ + 
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNMDDSAFSGISEDG 256

Query: 583 NEIEALDVVKLGLMCSNDAAEARPTMRQV 611
            +        +  +   D    R T+ Q 
Sbjct: 257 KDF-------IRKLLLADPNT-RMTIHQA 277

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-53
 Identities = 59/281 (20%), Positives = 115/281 (40%), Gaps = 23/281 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           +   E +G G  G VY     +T  +VA+++++ + +       +EI  +   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
            L       +L +V +++  GSL   + +         Q   + +     L +LH     
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLH---SN 135

Query: 465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPT 524
            VIHRDIK+ N+LL  + + +L DFG         +  +T +VGT  ++APE+       
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYG 194

Query: 525 TSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNE 584
              D+++ G + +E++ G  P   +     L L+                    N E   
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-----------ATNGTPELQNPEKLS 243

Query: 585 IEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVPLPQ 623
               D +        D  + R + +++++  +L+   PL  
Sbjct: 244 AIFRDFLN--RCLDMDVEK-RGSAKELLQHQFLKIAKPLSS 281

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score =  181 bits (459), Expect = 2e-53
 Identities = 69/252 (27%), Positives = 106/252 (42%), Gaps = 37/252 (14%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIK 74
           + +  F F  F     ++ + L G A I   G+L LT         +  LG AFYS PI+
Sbjct: 1   ATETSFNFPNFHT---DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQ 57

Query: 75  FKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDL 134
            K+S   +   SF+T F F I  +  ++  +G AF +      P     ++LG+ N+++ 
Sbjct: 58  IKDSNNVA---SFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQK-KQEFLGIFNTNN- 112

Query: 135 GNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSG 194
                   AV F+T K+    D + N +   +N                      +  +G
Sbjct: 113 PEPNARTVAVVFNTFKNRI--DFDKNFIKPYVNENCDF-----------------HKYNG 153

Query: 195 EVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA-- 252
           E     I YDSS N L V L  +        +S  V L   V E + VGFS ++GL    
Sbjct: 154 EKTDVQITYDSSNNDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDT 212

Query: 253 -SSHYILGWSFN 263
             +H +L WSF+
Sbjct: 213 TETHDVLSWSFS 224

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 2e-53
 Identities = 66/280 (23%), Positives = 110/280 (39%), Gaps = 27/280 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNE---SKQGLREFASEISSIGRLR 398
            R  E LG G FG V +G   + +     VAVK +  +     + + +F  E++++  L 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
           HRNL++L G       + +V +  P GSL   L   Q          R    VA G+ YL
Sbjct: 70  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYL 127

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--TTRVVGTLGYLAPE 516
                +  IHRD+ A N+LL +    ++GDFGL +   +  +             + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 517 LTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP 576
             +T   + +SD + FG  L E+    +         ++              + ++   
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKIDKE 230

Query: 577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
                  E    D+  + + C     E RPT   +  +L 
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 4e-53
 Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 24/276 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNESKQGLRE-FASEISSIGRLRHR 400
                 +G G FG V++G   S       VA+K   N +   +RE F  E  ++ +  H 
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
           ++V+L+G       + ++ +    G L   L   + + L           +++ L YL  
Sbjct: 69  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES 126

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
              +  +HRDI A NVL+ S    +LGDFGL++  E  T    ++    + ++APE    
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG 580
            + T++SDV+ FG  + E++             ++I           G I       +  
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----------GRIENGERLPMPP 232

Query: 581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
                    +  L   C       RP   ++   L 
Sbjct: 233 NCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-51
 Identities = 66/290 (22%), Positives = 125/290 (43%), Gaps = 33/290 (11%)

Query: 345 FRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNE-SKQGLREFASEISSIGRLR 398
                 LG G FG VY+G           T+VA+K V+   S +   EF +E S +    
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAI--------LTWEQRYRIIKG 450
             ++V+LLG   +    L++ + M  G L   L   + A+         +  +  ++   
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNPSTTRVVGT 509
           +A G+ YL        +HRD+ A N ++  +   ++GDFG+ + +YE        + +  
Sbjct: 142 IADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 510 LGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA 569
           + +++PE  + G  TT SDV++FG +L E+            P + +  + V      G 
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------PYQGLSNEQVLRFVMEGG 252

Query: 570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV 619
           +L+  D   +          + +L  MC     + RP+  +++  ++ E+
Sbjct: 253 LLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 5e-51
 Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 26/282 (9%)

Query: 339 KKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIG 395
           KK    F+  ++LG G F  V      +T+ + A+K +       +  +     E   + 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 396 RLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGL 455
           RL H   V+L    +    L     +  NG L K +                   + S L
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSAL 121

Query: 456 LYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER-GTNPSTTRVVGTLGYLA 514
            YLH +    +IHRD+K  N+LL+ +++ ++ DFG AK+             VGT  Y++
Sbjct: 122 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 515 PELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV 574
           PEL        SSD++A G ++ ++V G  P                        I++ +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ------------KIIK-L 225

Query: 575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
           +     +F   +A D+V+  L+  +  A  R    ++  Y  
Sbjct: 226 EYDFPEKFFP-KARDLVE-KLLVLD--ATKRLGCEEMEGYGP 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  176 bits (447), Expect = 5e-50
 Identities = 57/280 (20%), Positives = 110/280 (39%), Gaps = 27/280 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           +   E LG G FG V++    +T      K ++           +EIS + +L H  L+ 
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L      + +++L+ +F+  G L   +  E    ++  +    ++    GL ++H   E 
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH---EH 146

Query: 465 TVIHRDIKAGNVLLDSELNGR--LGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
           +++H DIK  N++ +++      + DFGLA       +        T  + APE+     
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREP 204

Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF 582
               +D++A G L   ++ G  P   +   E L              +           F
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDAF 252

Query: 583 NEI--EALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE 618
           + +  EA D +K  L+        R T+   +   +L+G+
Sbjct: 253 SSVSPEAKDFIK-NLLQKE--PRKRLTVHDALEHPWLKGD 289

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 5e-50
 Identities = 70/301 (23%), Positives = 125/301 (41%), Gaps = 42/301 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTN-------TQVAVKRVSNE-SKQGLREFASEISSIGR 396
               + LG G FG+V        +       T+VAVK + ++ +++ L +  SE+  +  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 397 L-RHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFD--------------EQKAILTW 441
           + +H+N++ LLG C + G L ++ ++   G+L + L                  +  L+ 
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134

Query: 442 EQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP 501
           +        VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLA+        
Sbjct: 135 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 502 STTRVV-GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW 560
             T      + ++APE       T  SDV++FG LL E+            P   + V+ 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------PYPGVPVEE 245

Query: 561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP 620
           ++   K G  +         +       ++  +   C +     RPT +Q+V  L+  V 
Sbjct: 246 LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

Query: 621 L 621
           L
Sbjct: 297 L 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-48
 Identities = 74/295 (25%), Positives = 119/295 (40%), Gaps = 40/295 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNESKQG-LREFASEISSIGR-L 397
            +  + LG G FG+V +         +T   VAVK +   +     R   SE+  +    
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 398 RHRNLVQLLGWCRRRGD-LLLVYDFMPNGSLDKCLFDEQ--------------KAILTWE 442
            H N+V LLG C + G  L+++ +F   G+L   L  ++              K  LT E
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK-LYERGTNP 501
                   VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLA+ +Y+     
Sbjct: 135 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV 561
                   L ++APE       T  SDV++FG LL E+        P      + + +  
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKIDEEF 246

Query: 562 WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
             R K G  +   D             ++ +  L C +     RPT  ++V +L 
Sbjct: 247 CRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (431), Expect = 2e-48
 Identities = 67/297 (22%), Positives = 131/297 (44%), Gaps = 30/297 (10%)

Query: 335 YEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISS 393
           +++ +     +  +++LG G F  V       T   VA+K ++ ++ +G      +EI+ 
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 394 IGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVAS 453
           + +++H N+V L       G L L+   +  G L   +   +K   T     R+I  V  
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLD 118

Query: 454 GLLYLHEEWEQTVIHRDIKAGNVLL---DSELNGRLGDFGLAKLYERGTNPSTTRVVGTL 510
            + YLH+     ++HRD+K  N+L    D +    + DFGL+K+ + G+    +   GT 
Sbjct: 119 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTP 173

Query: 511 GYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI 570
           GY+APE+      + + D ++ G +   ++CG  P   +   +                I
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------------QI 221

Query: 571 LEVVDPRLNGEFNEI--EALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVPLPQ 623
           L+      +  +++I   A D ++  LM  +   E R T  Q ++  ++ G+  L +
Sbjct: 222 LKAEYEFDSPYWDDISDSAKDFIR-HLMEKD--PEKRFTCEQALQHPWIAGDTALDK 275

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  163 bits (414), Expect = 3e-47
 Identities = 60/248 (24%), Positives = 92/248 (37%), Gaps = 48/248 (19%)

Query: 21  SQQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTR 80
           + +  F    F    N  N+ L G A +  NG L L+  +   +  AFYS+PI+ ++ST 
Sbjct: 1   ATETSFIIDAF----NKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDST- 55

Query: 81  NSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNH 140
                SF T F   I     A    G  F +   +                         
Sbjct: 56  TGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESK-------------------GD 96

Query: 141 IFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAW 200
              VEFDT       D+N+N +                     S    ++   G+  +  
Sbjct: 97  TVTVEFDTFLSRISIDVNNNDI--------------------KSVPWDVHDYDGQNAEVR 136

Query: 201 IDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASS---HYI 257
           I Y+SS     V L+  S   +S  +S  V+L   V + + VGFS+++G    S   H +
Sbjct: 137 ITYNSSTKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDV 195

Query: 258 LGWSFNMS 265
           L WSF+  
Sbjct: 196 LSWSFSSK 203

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 3e-46
 Identities = 53/271 (19%), Positives = 108/271 (39%), Gaps = 22/271 (8%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           +   E LG G FG V++    S+      K V  +          EIS +   RHRN++ 
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65

Query: 405 LLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQ 464
           L        +L+++++F+    + + + +     L   +    +  V   L +LH     
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHS---H 121

Query: 465 TVIHRDIKAGNVLLDSELNGR--LGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + H DI+  N++  +  +    + +FG A+  + G N           Y APE+ +   
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDV 179

Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF 582
            +T++D+++ G L+  ++ G  P   +   +       + +           D     E 
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEY--TFDEEAFKEI 230

Query: 583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVR 613
           +  EA+D V   L+      ++R T  + ++
Sbjct: 231 SI-EAMDFVD-RLLVKE--RKSRMTASEALQ 257

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  161 bits (409), Expect = 1e-45
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 14/220 (6%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
           +   E+LGFGG   V+       +  VAVK +  +          F  E  +   L H  
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 402 LVQLLGWCRRRGD----LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLY 457
           +V +               +V +++   +L   +  E    +T ++   +I      L +
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNF 126

Query: 458 LHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP--STTRVVGTLGYLAP 515
                +  +IHRD+K  N+++ +    ++ DFG+A+      N    T  V+GT  YL+P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 516 ELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL 555
           E  R       SDVY+ G +L EV+ G  P    +     
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 223

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  163 bits (414), Expect = 2e-45
 Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 15/226 (6%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASE---ISSIGRLR 398
           F    ++G GGFG VY      T    A+K +  +    KQG     +E   +S +    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
              +V +         L  + D M  G L   L   Q  + +          +  GL ++
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHM 123

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELT 518
           H    + V++RD+K  N+LLD   + R+ D GLA  + +         VGT GY+APE+ 
Sbjct: 124 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVL 177

Query: 519 RTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWD 563
           + G    +S+D ++ G +L +++ G  P       ++  +      
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  158 bits (401), Expect = 1e-44
 Identities = 61/285 (21%), Positives = 112/285 (39%), Gaps = 40/285 (14%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVS---------NESKQGLREFASEISSIG 395
           +  KE+LG G    V +     T  + AVK +           E ++       E+  + 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 396 RLR-HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
           ++  H N++QL           LV+D M  G L   L   +K  L+ ++  +I++ +   
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEV 122

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLA 514
           +  LH   +  ++HRD+K  N+LLD ++N +L DFG +   + G       V GT  YLA
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLA 177

Query: 515 PELTRTG------KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG 568
           PE+                D+++ G ++  ++ G  P   +     L             
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML------------R 225

Query: 569 AILEVVDPRLNGEFNEI--EALDVVKLGLMCSNDAAEARPTMRQV 611
            I+       + E+++      D+V    +      + R T  + 
Sbjct: 226 MIMSGNYQFGSPEWDDYSDTVKDLVS-RFLVVQ--PQKRYTAEEA 267

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-44
 Identities = 61/299 (20%), Positives = 115/299 (38%), Gaps = 27/299 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVK--RVSNESKQGLREFASEISSIGRLRHRNL 402
           F+  E +G G +G VYK     T   VA+K  R+  E++        EIS +  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V+LL        L LV++F+ +  L K +       +        +  +  GL + H   
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV         L     
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 523 PTTSSDVYAFGALLLEVVCGRRP-------------IEPKALPEELILVDWVWDRWKAGA 569
            +T+ D+++ G +  E+V  R                     P+E++            +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 570 ILEVVDPRLNGEFNEI--EALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG-EVPLPQ 623
             +      +     +  +   ++   ++  +     R + +  +   + +    P+P 
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLS-QMLHYD--PNKRISAKAALAHPFFQDVTKPVPH 295

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 7e-44
 Identities = 78/337 (23%), Positives = 131/337 (38%), Gaps = 46/337 (13%)

Query: 330 PHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFAS 389
           P   SY + K          ++G G FG VY+  L  +   VA+K+V  + +   R    
Sbjct: 17  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 62

Query: 390 EISSIGRLRHRNLVQLLGWCRRRGD------LLLVYDFMPNGSLDKCL-FDEQKAILTWE 442
           E+  + +L H N+V+L  +    G+      L LV D++P         +   K  L   
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122

Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLYERGTNP 501
                +  +   L Y+H      + HRDIK  N+LLD +    +L DFG AK   RG   
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179

Query: 502 STTRVVGTLGYLAP-ELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDW 560
            +   + +  Y AP  +      T+S DV++ G +L E++ G+      +  ++L+ +  
Sbjct: 180 VSY--ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

Query: 561 VWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAA------------EARPTM 608
           V        I E+       +F +I+A    K+    +   A             AR T 
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297

Query: 609 RQVVR------YLEGEVPLPQAVAAPDACDGKKEKTS 639
            +           +  V LP     P   +   ++ S
Sbjct: 298 LEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS 334

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 10/205 (4%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGR-LRHR 400
           F   ++LG G FG+V+      TN   A+K +  +       +     E   +     H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 401 NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE 460
            L  +    + + +L  V +++  G L   +    K      +       +  GL +L  
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL-- 119

Query: 461 EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
              + +++RD+K  N+LLD + + ++ DFG+ K    G   + T   GT  Y+APE+   
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRP 545
            K   S D ++FG LL E++ G+ P
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score =  153 bits (389), Expect = 2e-43
 Identities = 43/125 (34%), Positives = 65/125 (52%), Gaps = 14/125 (11%)

Query: 139 NHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQ 198
           + I AVE DT  + + GD +  H+GIDI S+RS  +               N+++G+V  
Sbjct: 2   DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQNGKVGT 49

Query: 199 AWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYIL 258
           A I Y+S    L   ++       S  +S+DVDL  ++ E + VG S+STGL   ++ IL
Sbjct: 50  AHIIYNSVDKRLSAVVSYP--NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTIL 107

Query: 259 GWSFN 263
            WSF 
Sbjct: 108 SWSFT 112

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 95.0 bits (236), Expect = 1e-22
 Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 10/105 (9%)

Query: 36  NNNNMSLNGAAEIEKNGKLMLTNTTLRV------LGHAFYSSPIKFKNSTRNSKSLSFST 89
           +  ++ L G A    +G L LT  +         +G A + +P+    S+  +   SF  
Sbjct: 136 DQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESS--AVVASFEA 193

Query: 90  CFAFAIVPEYTALGGHGFAFTIS-ASKELPGTLPSQYLGLLNSSD 133
            F F I    +     G AF IS     +P     + LGL   ++
Sbjct: 194 TFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 5e-43
 Identities = 58/288 (20%), Positives = 115/288 (39%), Gaps = 22/288 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE-FASEISSIGRLRHRNLV 403
           + +   +G G +G V          +VA+K++S    Q   +    EI  + R RH N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKA-ILTWEQRYRIIKGVASGLLYLHEEW 462
            +    R      +   ++    +   L+   K   L+ +     +  +  GL Y+H   
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 126

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY--ERGTNPSTTRVVGTLGYLAPELTRT 520
              V+HRD+K  N+LL++  + ++ DFGLA++   +       T  V T  Y APE+   
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186

Query: 521 GKPTTSS-DVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN 579
            K  T S D+++ G +L E++  R     K   ++L  +  +        +  +++ +  
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 580 GEFNEIEALDVVKLGLMCSNDAAEA--------------RPTMRQVVR 613
                +   + V    +  N  ++A              R  + Q + 
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 5e-43
 Identities = 72/293 (24%), Positives = 116/293 (39%), Gaps = 26/293 (8%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQG-----LREFASEISSIGRLRHRNLV 403
           + LG G F  VYK    +TN  VA+K++    +        R    EI  +  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 404 QLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            LL     + ++ LV+DFM        +  +   +LT       +     GL YLH+ W 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120

Query: 464 QTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKP 523
             ++HRD+K  N+LLD     +L DFGLAK +    N + T  V T  Y APEL    + 
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARM 177

Query: 524 -TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF 582
                D++A G +L E++     +   +  ++L  +             ++        F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 583 NEIEALDVVKLGLMCSNDAA-----------EARPTMRQVVR--YLEGEVPLP 622
                + +  +     +D              AR T  Q ++  Y     P P
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR-PGP 289

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (387), Expect = 2e-42
 Identities = 55/289 (19%), Positives = 105/289 (36%), Gaps = 25/289 (8%)

Query: 337 ELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGR 396
           EL+   R +R    +G G FG +Y GT  +   +VA+K    ++K    +   E      
Sbjct: 2   ELRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58

Query: 397 LRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           ++    +  + WC   GD  ++   +   SL+  LF+      + +    +   + S + 
Sbjct: 59  MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIE 117

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRL---GDFGLAKLYERGTN------PSTTRVV 507
           Y+H    +  IHRD+K  N L+     G L    DFGLAK Y                + 
Sbjct: 118 YIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 508 GTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA 567
           GT  Y +       + +   D+ + G +L+    G  P +      +    + + ++   
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-- 232

Query: 568 GAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
              +      L   +   E    +     C +   + +P    + +   
Sbjct: 233 ---MSTPIEVLCKGYPS-EFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-42
 Identities = 60/285 (21%), Positives = 115/285 (40%), Gaps = 27/285 (9%)

Query: 348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLG 407
            ++LG G  G+V +     T  + A+K +  +  +  RE      +    +  ++V+++ 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWRA---SQCPHIVRIVD 72

Query: 408 WCR----RRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
                   R  LL+V + +  G L   + D      T  +   I+K +   + YLH    
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 129

Query: 464 QTVIHRDIKAGNVLLDSELNG---RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRT 520
             + HRD+K  N+L  S+      +L DFG AK      + +T     T  Y+APE+   
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187

Query: 521 GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG 580
            K   S D+++ G ++  ++CG  P         L +   +  R + G   +   P    
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAISPGMKTRIRMG---QYEFPNPEW 241

Query: 581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVPLPQ 623
                E   +++  L+ +      R T+ + +   ++     +PQ
Sbjct: 242 SEVSEEVKMLIR-NLLKTE--PTQRMTITEFMNHPWIMQSTKVPQ 283

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-42
 Identities = 62/293 (21%), Positives = 117/293 (39%), Gaps = 37/293 (12%)

Query: 333 FSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV------SNESKQGLRE 386
           F  E +      +   E LG G F  V K    ST  Q A K +      S+       +
Sbjct: 3   FRQENVDD---YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 387 FASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYR 446
              E+S +  ++H N++ L      + D++L+ + +  G L   L +++   LT E+   
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATE 117

Query: 447 IIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGR----LGDFGLAKLYERGTNPS 502
            +K + +G+ YLH      + H D+K  N++L      +    + DFGLA   + G    
Sbjct: 118 FLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--E 172

Query: 503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVW 562
              + GT  ++APE+         +D+++ G +   ++ G  P       E L       
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------- 225

Query: 563 DRWKAGAILEVVDPRLNGEFNEI--EALDVVKLGLMCSNDAAEARPTMRQVVR 613
                  +  V     +  F+     A D ++  L+  +   + R T++  ++
Sbjct: 226 -----ANVSAVNYEFEDEYFSNTSALAKDFIR-RLLVKD--PKKRMTIQDSLQ 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  151 bits (382), Expect = 6e-42
 Identities = 59/283 (20%), Positives = 112/283 (39%), Gaps = 20/283 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRNL 402
           +   E +G G +G VYK          A+K++    E +        EIS +  L+H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V+L      +  L+LV++ +        L D  +  L        +  + +G+ Y H+  
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-- 118

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
            + V+HRD+K  N+L++ E   ++ DFGLA+ +       T  +V         L  + K
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD-PRLNGE 581
            +T+ D+++ G +  E+V G       +  ++L+ +  +     +     V + P+ +  
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 582 FNEIEALDVVKLGLMCSNDAA-----------EARPTMRQVVR 613
           F   E L                           R T +Q + 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  151 bits (382), Expect = 2e-41
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 12/204 (5%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
           F+    LG G FGRV+           A+K +  E     + +     E   +  + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           ++++ G  +    + ++ D++  G L   L   Q+      + Y      A   L L   
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALEYL 120

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
             + +I+RD+K  N+LLD   + ++ DFG AK         T  + GT  Y+APE+  T 
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYTLCGTPDYIAPEVVSTK 176

Query: 522 KPTTSSDVYAFGALLLEVVCGRRP 545
               S D ++FG L+ E++ G  P
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTP 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-41
 Identities = 72/294 (24%), Positives = 116/294 (39%), Gaps = 43/294 (14%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLRE------FASEISSIGRLR 398
           ++   LLG GGFG VY G   S N  VA+K V  +      E         E+  + ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 399 --HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
                +++LL W  R    +L+ +             E+ A L  E        V   + 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVR 124

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNG-RLGDFGLAKLYERGTNPSTTRVVGTLGYLAP 515
           +        V+HRDIK  N+L+D      +L DFG   L +   +   T   GT  Y  P
Sbjct: 125 HC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPP 178

Query: 516 ELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV 574
           E  R  +    S+ V++ G LL ++VCG  P E     EE+I     + +         V
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQR--------V 227

Query: 575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVPLPQAVA 626
                      E   +++     +   ++ RPT  ++    +++ +V LPQ  A
Sbjct: 228 SS---------ECQHLIR--WCLALRPSD-RPTFEEIQNHPWMQ-DVLLPQETA 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 2e-40
 Identities = 63/289 (21%), Positives = 110/289 (38%), Gaps = 29/289 (10%)

Query: 345 FRDKELLGFGGFGRVYKGT-LPSTNTQVAVKRVSNES------KQGLREFASEISSIGRL 397
           +     +G G +G+V+K   L +    VA+KRV  ++         +RE  + +  +   
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETF 67

Query: 398 RHRNLVQLLGWC-----RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVA 452
            H N+V+L   C      R   L LV++ +            +   +  E    ++  + 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQLL 126

Query: 453 SGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGY 512
            GL +LH      V+HRD+K  N+L+ S    +L DFGLA++Y      ++  VV TL Y
Sbjct: 127 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWY 181

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV----------DWVW 562
            APE+       T  D+++ G +  E+   +      +  ++L  +          DW  
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241

Query: 563 DRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQV 611
           D             +   +F          L L C       R +    
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 3e-40
 Identities = 73/312 (23%), Positives = 124/312 (39%), Gaps = 43/312 (13%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRNL 402
           +     +G G FG V+K     T  +VA+K+V   NE +        EI  +  L+H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 403 VQLLGWC--------RRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASG 454
           V L+  C        R +G + LV+DF  +           K   T  +  R+++ + +G
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNG 129

Query: 455 LLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP---STTRVVGTLG 511
           L   +      ++HRD+KA NVL+  +   +L DFGLA+ +    N      T  V TL 
Sbjct: 130 L---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 512 YLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV--------DWVW 562
           Y  PEL    +      D++  G ++ E+      ++      +L L+          VW
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 563 DRWKAGAILEVVD----------PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVV 612
                  + E ++           RL     +  ALD++    +   D A+ R      +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID--KLLVLDPAQ-RIDSDDAL 303

Query: 613 R--YLEGEVPLP 622
              +     P+P
Sbjct: 304 NHDFFW-SDPMP 314

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 5e-40
 Identities = 57/301 (18%), Positives = 110/301 (36%), Gaps = 28/301 (9%)

Query: 333 FSYEELKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLRE 386
           F  +E+ K     R      + +G G +G V       T  +VA+K++     S+   + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 387 FASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDE--QKAILTWEQR 444
              E+  +  +RH N++ LL        L    DF            +  +   L  ++ 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 445 YRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTT 504
             ++  +  GL Y+H        HRD+K GN+ ++ +   ++ DFGLA+  +   +  T 
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTG 177

Query: 505 RVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP---IEPKALPEELILVDWV 561
            VV         +    + T + D+++ G ++ E++ G+      +     +E++ V   
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 562 WDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDA-----------AEARPTMRQ 610
                   +             E+E  D   +    S  A           AE R T  +
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 611 V 611
            
Sbjct: 298 A 298

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 51/284 (17%), Positives = 98/284 (34%), Gaps = 28/284 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           ++    +G G FG +++GT    N QVA+K     S     +   E  +   L     + 
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIP 64

Query: 405 LLGWCRRRGD-LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWE 463
            + +  + G   +LV D +  G   + L D      + +      K + + +  +HE   
Sbjct: 65  NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--- 119

Query: 464 QTVIHRDIKAGNVLLDSELNG-----RLGDFGLAKLYERGTN------PSTTRVVGTLGY 512
           +++++RDIK  N L+    +       + DFG+ K Y                + GT  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 513 LAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE 572
           ++       + +   D+ A G + +  + G  P +           + +    K    L 
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-GEKKQSTPLR 238

Query: 573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE 616
            +      EF +              N A +A P    +     
Sbjct: 239 ELCAGFPEEFYKYM--------HYARNLAFDATPDYDYLQGLFS 274

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-38
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 9/204 (4%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
           F   +LLG G FG+V      +T    A+K +  E   +K  +    +E   +   RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           L  L    +    L  V ++   G L   L   ++ + T E+       + S    L   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSA---LEYL 121

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
             + V++RDIK  N++LD + + ++ DFGL K        +     GT  YLAPE+    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPEVLEDN 180

Query: 522 KPTTSSDVYAFGALLLEVVCGRRP 545
               + D +  G ++ E++CGR P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-38
 Identities = 61/287 (21%), Positives = 111/287 (38%), Gaps = 26/287 (9%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRV--SNESKQGLREFASEISSIGRLRHRNL 402
           +   E +G G +G V+K     T+  VA+KRV   ++ +        EI  +  L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 403 VQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW 462
           V+L         L LV++F          FD     L  E     +  +  GL + H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 463 EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGK 522
              V+HRD+K  N+L++     +L +FGLA+ +       +  VV         L     
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 523 PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELI------LVDWVWDRWKAGAILEVVDP 576
            +TS D+++ G +  E+    RP+ P    ++ +      L     ++W +   L    P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 577 RLNGEFNEI----------EALDVVKLGLMCSNDAAEARPTMRQVVR 613
                                 D+++  L+  N     R +  + ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQ-NLLKCN--PVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (345), Expect = 3e-36
 Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 12/204 (5%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRN 401
           F   + LG G FGRV       +    A+K +  +     + +    +E   +  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 402 LVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEE 461
           LV+L    +   +L +V +++  G +   L    +   +          +     YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH-- 158

Query: 462 WEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTG 521
               +I+RD+K  N+L+D +   ++ DFG AK         T  + GT   LAPE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEALAPEIILSK 213

Query: 522 KPTTSSDVYAFGALLLEVVCGRRP 545
               + D +A G L+ E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 8e-34
 Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 24/232 (10%)

Query: 322 ESWELDVGPHRFSYEELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE-- 379
           + + ++VG   F    LK+    +++ + +G G  G V        +  VA+K++S    
Sbjct: 2   QFYSVEVGDSTF--TVLKR----YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 55

Query: 380 SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG------DLLLVYDFMPNGSLDKCLFD 433
           ++   +    E+  +  + H+N++ LL     +       D+ LV + M          +
Sbjct: 56  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 115

Query: 434 EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK 493
                   E+   ++  +  G+ +LH      +IHRD+K  N+++ S+   ++ DFGLA+
Sbjct: 116 L-----DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Query: 494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
               GT+   T  V T  Y APE+        + D+++ G ++ E+V  +  
Sbjct: 168 TA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (321), Expect = 4e-33
 Identities = 50/236 (21%), Positives = 90/236 (38%), Gaps = 21/236 (8%)

Query: 329 GPHRFSYEELKKATRG---FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLR 385
               + YE           ++    LG G +  V++    + N +V VK +    K+   
Sbjct: 18  PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--- 74

Query: 386 EFASEISSIGRLR-HRNLVQLLGWCRRRGD--LLLVYDFMPNGSLDKCLFDEQKAILTWE 442
           +   EI  +  LR   N++ L    +        LV++ + N    +         LT  
Sbjct: 75  KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDY 129

Query: 443 QRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLYERGTNP 501
                +  +   L Y H      ++HRD+K  NV++D E    RL D+GLA+ Y  G   
Sbjct: 130 DIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 184

Query: 502 STTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELI 556
                V +  +  PEL    +    S D+++ G +L  ++  + P        + +
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-32
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 15/211 (7%)

Query: 345 FRDKELLGFGGFGRVYKG---TLPSTNTQVAVKRVS----NESKQGLREFASEISSIGRL 397
           F   ++LG G +G+V+     +   T    A+K +      +  +      +E   +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 398 RHR-NLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLL 456
           R    LV L    +    L L+ D++  G L   L   ++   T  +    +  +   L 
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALE 143

Query: 457 YLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPE 516
           +LH+     +I+RDIK  N+LLDS  +  L DFGL+K +            GT+ Y+AP+
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 517 LTRTGK--PTTSSDVYAFGALLLEVVCGRRP 545
           + R G      + D ++ G L+ E++ G  P
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 5e-31
 Identities = 46/224 (20%), Positives = 91/224 (40%), Gaps = 20/224 (8%)

Query: 333 FSYEELKKATRGFRDK----ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLRE 386
           F  +EL K      ++      +G G +G V       T  +VAVK++S    S    + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 387 FASEISSIGRLRHRNLVQLLGWCRRR-----GDLLLVYDFMPNGSLDKCLFDEQKAILTW 441
              E+  +  ++H N++ LL            + + +   +    L+      +   LT 
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTD 120

Query: 442 EQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP 501
           +    +I  +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLA+  +   + 
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD---DE 174

Query: 502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP 545
            T  V          +        + D+++ G ++ E++ GR  
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (283), Expect = 6e-28
 Identities = 47/238 (19%), Positives = 82/238 (34%), Gaps = 19/238 (7%)

Query: 345 FRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQ 404
           +     LG+G F  V+       NT VA+K V  + K        EI  + R+   +  +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTK 73

Query: 405 LLGWCRRRG-DLLLVYDFMPNGSLDKCLFDE-------------QKAILTWEQRYRIIKG 450
                      LL  ++      +   +  E             +   +      +I K 
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 451 VASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLAKLYE-RGTNPSTTRVVG 508
           +  GL Y+H      +IH DIK  NVL++       L    +A L      +   T  + 
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 509 TLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK 566
           T  Y +PE+         +D+++   L+ E++ G    EP          D +    +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (255), Expect = 3e-25
 Identities = 30/241 (12%), Positives = 72/241 (29%), Gaps = 28/241 (11%)

Query: 25  EFFFSGFRDAANNNNM---SLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRN 81
           ++ F G     ++  +   +  G A      ++ +  +     G  +  +   F+N    
Sbjct: 8   KYSFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAFEN---- 62

Query: 82  SKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHI 141
                +        V     +G  G A   + ++ L G       G  +         + 
Sbjct: 63  -----WEVEV-TFRVTGRGRIGADGLAIWYTENQGLDG----PVFGSADM-------WNG 105

Query: 142 FAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWI 201
             + FD+  +   G  N+  + +  N+ + N           +          +      
Sbjct: 106 VGIFFDSFDND--GKKNNPAIVVVGNNGQINYD-HQNDGATQALASCQRDFRNKPYPVRA 162

Query: 202 DYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWS 261
                +  L V +       ++         + ++    + G S++TG LA  H +L + 
Sbjct: 163 KITYYQKTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFL 222

Query: 262 F 262
            
Sbjct: 223 T 223

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.7 bits (206), Expect = 4e-19
 Identities = 27/155 (17%), Positives = 53/155 (34%), Gaps = 20/155 (12%)

Query: 349 ELLGFGGFGRVYKGTLPSTNTQVAVK----------RVSNESKQGLREFASEISSIGRLR 398
           +L+G G    V+         +  VK          +V  +   G   F+       R  
Sbjct: 6   KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYL 458
            R L +L G       +  VY +  N  L + +  ++   +  E    ++  +   +   
Sbjct: 65  FRALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 459 HEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK 493
           +      ++H D+   NVL+  E    + DF  + 
Sbjct: 120 YHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 29/219 (13%), Positives = 57/219 (26%), Gaps = 33/219 (15%)

Query: 37  NNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV 96
            NN      A +E  G+++LT+      G  +       K+S        F+  + F  V
Sbjct: 22  PNNWQTGEQASLE-EGRIVLTSNQNSK-GSLWLKQGFDLKDS--------FTMEWTFRSV 71

Query: 97  PEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGD 156
             Y+     G +F       +P         +               +  D         
Sbjct: 72  -GYSGQTDGGISFWFVQDSNIPRDKQLYNGPVNYDG---------LQLLVDNNGPLGPTL 121

Query: 157 INDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAP 216
               + G           +  A  L           S       + YD   ++L      
Sbjct: 122 RGQLNDGQKPVDKTKIYDQSFASCLMG------YQDSSVPSTIRVTYDLEDDNL----LK 171

Query: 217 SSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSH 255
             V  +   + F          +  +G ++  G + ++ 
Sbjct: 172 VQVDNK---VCFQTRKVRFPSGSYRIGVTAQNGAVNNNA 207

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 51.1 bits (122), Expect = 9e-08
 Identities = 29/230 (12%), Positives = 58/230 (25%), Gaps = 42/230 (18%)

Query: 37  NNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV 96
            +  +L    ++E  G+ +LT       G  +       K++         +  + F   
Sbjct: 21  LSQWTLGDKVKLE-EGRFVLTPGKNTK-GSLWLKPEYSIKDA--------MTIEWTFRSF 70

Query: 97  PEYTALGGHGFAFTISASKELPGTLPS-QYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFG 155
             +      G AF +    E   T          N             +           
Sbjct: 71  G-FRGSTKGGLAFWLKQGNEGDSTELFGGSSKKFNG----------LMILLRL------- 112

Query: 156 DINDNHVGIDINSLRSNASEPAAYFLENSTKQVL--NLKSGEVIQAWIDYDSSKNH-LEV 212
             +D   G  + +  ++ ++             L     S       + Y+   NH L++
Sbjct: 113 --DDKL-GESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPSTLRLTYNPLDNHLLKL 169

Query: 213 RLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSF 262
                 +  R    +  V           +G S+       S  IL    
Sbjct: 170 -----QMDNRVCFQTRKVKFMGS--SPFRIGTSAINDASKESFEILKMKL 212

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	687
d1hqla_	236	Legume lectin {Griffonia simplicifolia, lectin I-b	100.0
d1leda_	243	Legume lectin {West-central african legume (Griffo	100.0
d1fx5a_	240	Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI	100.0
d1qnwa_	237	Legume lectin {Furze (Ulex europaeus), UEA-II [Tax	100.0
d1gzca_	239	Legume lectin {Cockspur coral tree (Erythrina cris	100.0
d2d3sa1	237	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1g9fa_	251	Legume lectin {Soybean (Glycine max) [TaxId: 3847]	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1f9ka_	234	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1dbna_	239	Legume lectin {Maackia amurensis, leukoagglutinin	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1g8wa_	233	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1g7ya_	253	Legume lectin {Horse gram (Dolichos biflorus), dif	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1v6ia_	232	Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1n47a_	233	Legume lectin {Hairy vetch (Vicia villosa), isolec	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fnya_	237	Legume lectin {Black locust (Robinia pseudoacacia)	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
g1qmo.1	230	Legume lectin {Field bean (Dolichos lablab), Fril	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ukga_	241	Legume lectin {Bloodwood tree (Pterocarpus angolen	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
g2ltn.1	229	Legume lectin {Garden pea (Pisum sativum) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ioaa_	228	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1avba_	226	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1dhkb_	204	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.96
d1gv9a_	228	Carbohydrate-recognition domain of P58/ERGIC-53 {R	99.94
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.89
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d2a6za1	221	Emp47p N-terminal domain {Baker's yeast (Saccharom	99.82
d2a6va1	218	Emp46p N-terminal domain {Baker's yeast (Saccharom	99.81
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.56
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.86
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.7
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.86
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.74
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.61

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

Probab=100.00  E-value=9.2e-55  Score=432.94  Aligned_cols=226  Identities=31%  Similarity=0.448  Sum_probs=198.2

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEe
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV   96 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~   96 (687)
                      +++|+|++|.++. .++|+|+|+|.+. +|.|+||+..      ..++|||+|++||+||++. +++++||+|+|+|.|.
T Consensus         1 ~~sF~f~~F~~~~-~~~l~l~G~A~~~-~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~-t~~~asFsT~F~F~i~   77 (236)
T d1hqla_           1 SVSFTFPNFWSDV-EDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNK-TESVASFYTEFTFFLK   77 (236)
T ss_dssp             CCEEEESCSCSCG-GGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCST-TCCCCEEEEEEEEEEE
T ss_pred             CEEEEeCCCCCCC-cCCEEEeccEEec-CCEEEEecCCCCCcccccceEEEEECCCEEeecCC-CCceeEEEEEEEEEEe
Confidence            3689999998643 3689999999986 8999999753      4578999999999999987 8899999999999998


Q ss_pred             ecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCC-CCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           97 PEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLG-NLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        97 ~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~-~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      +. ...+||||||||+|....+ +..|++||+++..+.+ ...+++|||||||++|.+++||++||||||+||+.|..+.
T Consensus        78 ~~-~~~~gDGlAFvl~p~~~~~-~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~  155 (236)
T d1hqla_          78 IT-GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATK  155 (236)
T ss_dssp             EC-SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEE
T ss_pred             CC-CCCCCceEEEEEeCCCCCC-CCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCccccccc
Confidence            74 5568999999999976444 4689999999877654 3578999999999999999999999999999999998776


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc-cce
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL-ASS  254 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~-~~~  254 (687)
                      ++         ...++.+|+.++|||+||+.+++|+|+|++.  +|..|+|++.|||+++|+++||||||||||.. .+.
T Consensus       156 ~~---------~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~--~~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~  224 (236)
T d1hqla_         156 RW---------EDSDIFSGKIATARISYDGSAEILTVVLSYP--DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLT  224 (236)
T ss_dssp             EC---------CHHHHTSCSCEEEEEEEETTTTEEEEEEEET--TTEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEE
T ss_pred             cc---------ccccccCCCEEEEEEEEeCCCcEEEEEEecC--CCCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCceE
Confidence            54         2467889999999999999999999999875  46678999999999999999999999999974 688


Q ss_pred             eEEEEeeecc
Q 005621          255 HYILGWSFNM  264 (687)
Q Consensus       255 ~~i~sWsf~~  264 (687)
                      |+|++|+|++
T Consensus       225 h~I~sWsF~s  234 (236)
T d1hqla_         225 VYILSWRFSS  234 (236)
T ss_dssp             EEEEEEEEEE
T ss_pred             EEEEEeEeEe
Confidence            9999999986

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

Probab=100.00  E-value=6.4e-54  Score=428.26  Aligned_cols=227  Identities=30%  Similarity=0.431  Sum_probs=197.8

Q ss_pred             cccceEeCCCCCCC--CCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEE
Q 005621           22 QQEEFFFSGFRDAA--NNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAF   93 (687)
Q Consensus        22 ~~~~f~~~~F~~~~--~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f   93 (687)
                      .+++|+|++|.+..  +..||+|+|+|++. +|.|+||+..      .+++|||+|++||+||++  +++++||+|+|+|
T Consensus         2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~-~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~--t~~~asFsT~F~f   78 (243)
T d1leda_           2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS--TGKAASFYTSFTF   78 (243)
T ss_dssp             CCCEEEESCBCCTTSCTTTSEEEEETCEEE-TBEEECSCBCTTSCBCSSEEEEEEESSCEECBCT--TSCBCEEEEEEEE
T ss_pred             CceEEEcCCCCCCCCCCCCcEEEeeeeEEc-CCEEEeccCCCCCCccccceEEEEeCCCeEecCC--CCcEeeEEEEEEE
Confidence            36789999998643  24689999999997 8999999643      458999999999999995  5789999999999


Q ss_pred             EEeecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCC-CcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcc
Q 005621           94 AIVPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGN-LTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSN  172 (687)
Q Consensus        94 ~i~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~  172 (687)
                      .|.+. ...+||||||||+|....+ +..|++||+++..+.++ ..+++|||||||++|.+++||++||||||+|++.|.
T Consensus        79 ~i~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s~  156 (243)
T d1leda_          79 LLKNY-GAPTADGLAFFLAPVDSSV-KDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSV  156 (243)
T ss_dssp             EEEES-SSSCBCEEEEEEEETTCCC-CCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCS
T ss_pred             EcCCC-CCCCCCceEEEEcCCCCCC-CCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCcccc
Confidence            88765 4568999999999976544 56899999998776544 578999999999999999999999999999999998


Q ss_pred             cccccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCccc
Q 005621          173 ASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA  252 (687)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~  252 (687)
                      .+.++.         ..++.+|+.++|||+||+.+++|+|+|++.  +|..|+|++.|||+++|+++||||||||||. .
T Consensus       157 ~~~~~~---------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~--~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~-~  224 (243)
T d1leda_         157 ATTRWE---------NDDAYGSSIATAHITYDARSKILTVLLSYE--HGRDYILSHVVDLAKVLPQKVRIGFSAGVGY-D  224 (243)
T ss_dssp             EEEECC---------HHHHTSCCEEEEEEEEETTTTEEEEEEEET--TSCEEEEEEECCHHHHSCSEEEEEEEEEECB-S
T ss_pred             cccccc---------cCCcccCceeEEEEEEECCCCEEEEEEeeC--CCCCceEEEecCHHHhcCCcEEEEEEcccCC-c
Confidence            877653         357889999999999999999999999875  5678899999999999999999999999995 6


Q ss_pred             ceeEEEEeeeccC
Q 005621          253 SSHYILGWSFNMS  265 (687)
Q Consensus       253 ~~~~i~sWsf~~~  265 (687)
                      |.|+|++|+|++.
T Consensus       225 ~~h~I~sWsF~s~  237 (243)
T d1leda_         225 EVTYILSWHFFST  237 (243)
T ss_dssp             EEEEEEEEEEEEE
T ss_pred             ceeeEEEEEEEee
Confidence            9999999999864

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

Probab=100.00  E-value=7.1e-53  Score=421.95  Aligned_cols=228  Identities=29%  Similarity=0.400  Sum_probs=199.7

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC----CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEee
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT----LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVP   97 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~----~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~   97 (687)
                      .+++|+|++|.++  ++||+|+|+|.+.++|.|+||+..    .+++|||+|++||+||++. ++.++||+|+|+|.|..
T Consensus         2 ~~~sF~f~~F~~~--~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~~~-t~~~~sF~t~F~f~i~~   78 (240)
T d1fx5a_           2 DDLSFKFKNFSQN--GKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCN-TGELASFITSFSFFMET   78 (240)
T ss_dssp             CEEEEEESSCCTT--CSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETT-TTEECEEEEEEEEEEEE
T ss_pred             CceEEECCCCCCC--CCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeecCC-CCceeeeEEEEEEEEeC
Confidence            4678999999864  368999999999888999999765    3478999999999999987 88999999999999965


Q ss_pred             c-CCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCC-CCCCCCCCeeeEEeCCCCccccc
Q 005621           98 E-YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDF-EFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        98 ~-~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~-~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      . ++..+||||||+|+|.. .|.+.+|++||+++..+ +++.+++|||||||++|. +++||++||||||+||+.+..+.
T Consensus        79 ~~~~~~ggdG~AFvl~p~~-~~~~~~g~~lGl~~~~~-~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~  156 (240)
T d1fx5a_          79 SANPKAATDGLTFFLAPPD-SPLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAE  156 (240)
T ss_dssp             SSCGGGCCCEEEEEEECTT-CCCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCCCcEEEEECCCC-CCCCCCCccccccccCC-CCccCceEEEEeeccccccccCCCCCCceEEccCCccccccc
Confidence            4 44568999999999975 46678999999998654 456789999999999985 67899999999999999987766


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCc-ccce
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL-LASS  254 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~-~~~~  254 (687)
                      ++          +..+.+|+.++|||+||+.+++|+|+|.+.. +|..|+|+..|||+++|+++||||||||||. ..|.
T Consensus       157 ~~----------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~~  225 (240)
T d1fx5a_         157 RW----------NKRYGLNNVANVEIIYEASSKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQAT  225 (240)
T ss_dssp             EC----------CCCCSGGGCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCEE
T ss_pred             cc----------ccccCCCCeEEEEEEEcCCCCEEEEEEecCC-CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCce
Confidence            54          3567789999999999999999999998765 7778999999999999999999999999995 6799


Q ss_pred             eEEEEeeeccC
Q 005621          255 HYILGWSFNMS  265 (687)
Q Consensus       255 ~~i~sWsf~~~  265 (687)
                      |+|++|+|++.
T Consensus       226 H~I~sWsFsst  236 (240)
T d1fx5a_         226 HEVLNWYFTST  236 (240)
T ss_dssp             EEEEEEEEEEE
T ss_pred             EEEEEEEeEEe
Confidence            99999999863

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

Probab=100.00  E-value=3.9e-52  Score=416.09  Aligned_cols=225  Identities=32%  Similarity=0.529  Sum_probs=197.7

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC---CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeec
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT---LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPE   98 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~---~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~   98 (687)
                      .+++|+|++|.++  ..||+|+|+|.+.++|.|+||+..   .+++|||+|++||+||++. +++++||+|+|+|.|.++
T Consensus         2 ~~lsF~f~~F~~~--~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~~~-~~~~~sF~t~F~f~i~~~   78 (237)
T d1qnwa_           2 DDLSFNFDKFVPN--QKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSI-TGKVASFATSFSFVVKAD   78 (237)
T ss_dssp             CSEEEEESSCCTT--CTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTT-TCCBCEEEEEEEEECCBS
T ss_pred             CcEEEEcCCCCCC--CCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecCCC-CcceeeEEEEEEEEEecC
Confidence            4678999999875  368999999999888999999754   4689999999999999987 889999999999999765


Q ss_pred             CCCCCCcceEEEEccCC-CCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCC--CCCCCeeeEEeCCCCccccc
Q 005621           99 YTALGGHGFAFTISASK-ELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFG--DINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        99 ~~~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgi~~ns~~s~~~~  175 (687)
                       ...+||||||+|+|.. ..|.+..++++|+.+.. ++.+.+++|||||||++|.+++  ||++||||||+|++.|..++
T Consensus        79 -~~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~-~~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~  156 (237)
T d1qnwa_          79 -KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSS-DSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTV  156 (237)
T ss_dssp             -SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSS-SCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred             -CCCCcceeEEEEeCCCCCCCCCCccccccccCCC-CCCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCccccc
Confidence             4558999999999976 45677888889998754 3467889999999999998765  58999999999999887665


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCccc--c
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA--S  253 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~--~  253 (687)
                      +            .++.+|+.++|||+||+.+++|+|+|++.. +|..|+|++.|||+++|+++||||||||||...  |
T Consensus       157 ~------------~~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q  223 (237)
T d1qnwa_         157 K------------WDWRNGEVADVVITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFE  223 (237)
T ss_dssp             E------------CCCCTTCCEEEEEEEEGGGTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCB
T ss_pred             c------------cccCCCcEEEEEEEEcCCCcEEEEEEecCC-CCccceEEEEEChHHhCCCcEEEEEEeECCCCCCcc
Confidence            4            467799999999999999999999999765 888999999999999999999999999999764  8


Q ss_pred             eeEEEEeeecc
Q 005621          254 SHYILGWSFNM  264 (687)
Q Consensus       254 ~~~i~sWsf~~  264 (687)
                      .|+|++|+|++
T Consensus       224 ~h~I~sWsF~s  234 (237)
T d1qnwa_         224 THDVLSWYFTS  234 (237)
T ss_dssp             CCEEEEEEEEE
T ss_pred             EeEEEEeEeEE
Confidence            99999999986

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

Probab=100.00  E-value=3.5e-52  Score=416.65  Aligned_cols=225  Identities=32%  Similarity=0.516  Sum_probs=196.8

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCC------CeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL------RVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~------~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      .+++|+|++|+++.  .||+|+|+|.+.++|.|+||+...      +++|||+|++||+||++. +++++||+|+|+|.|
T Consensus         2 ~~~sF~f~~F~~~~--~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~-~~~~~sFst~F~f~i   78 (239)
T d1gzca_           2 ETISFSFSEFEPGN--DNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDST-TGTVASFETRFSFSI   78 (239)
T ss_dssp             EEEEEEESSCCTTC--TTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEEC
T ss_pred             eeEEEEeCCCCCCC--CCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCC-CCceeeEEEEEEEEE
Confidence            35789999999652  589999999998889999998643      488999999999999987 889999999999999


Q ss_pred             eec-CCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccc
Q 005621           96 VPE-YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNAS  174 (687)
Q Consensus        96 ~~~-~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~  174 (687)
                      ... ....+||||||+|+|....+ ...+++||+++..+. ...++.|||||||++|. ++||++||||||+|++.|..+
T Consensus        79 ~~~~~~~~g~dG~aF~l~p~~~~~-~~~~g~lg~~~~~~~-~~~~~~vaVEFDT~~n~-~~d~~~~HvgI~vn~~~s~~t  155 (239)
T d1gzca_          79 EQPYTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFNNSKQ-DNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKT  155 (239)
T ss_dssp             CCCCSSSCCCEEEEEEEECSSCCC-CCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEE
T ss_pred             ecCCCCCCCCCeEEEEECCCCCCC-CCCcccccccccCCC-CCccceEEEEEEccccC-CCCCCCCEEEEEECCcccccc
Confidence            754 34568999999999987544 467889999876544 35778999999999994 789999999999999998776


Q ss_pred             cccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCc---c
Q 005621          175 EPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---L  251 (687)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~---~  251 (687)
                      .+            .++.+|+.++|||+||+.+++|+|+|++.. +|..|+|++.|||+++|+++|||||||+||.   .
T Consensus       156 ~~------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~  222 (239)
T d1gzca_         156 QP------------FQLDNGQVANVVIKYDAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDA  222 (239)
T ss_dssp             EE------------CCCCTTCEEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTC
T ss_pred             CC------------ccccCCCEEEEEEEEeCCCcEEEEEEecCC-CCcceeeeeEechHHhcCCcEEEEEEEEcCCCCCC
Confidence            54            468899999999999999999999998765 8889999999999999999999999999994   6


Q ss_pred             cceeEEEEeeeccC
Q 005621          252 ASSHYILGWSFNMS  265 (687)
Q Consensus       252 ~~~~~i~sWsf~~~  265 (687)
                      .|.|+|++|+|++.
T Consensus       223 ~~~H~V~sWsF~s~  236 (239)
T d1gzca_         223 AETHDVYSWSFQAS  236 (239)
T ss_dssp             CCCCEEEEEEEEEE
T ss_pred             ceeeEEEEEEeEee
Confidence            79999999999864

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

Probab=100.00  E-value=1.8e-51  Score=410.54  Aligned_cols=220  Identities=31%  Similarity=0.452  Sum_probs=192.4

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC-----CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEee
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT-----LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVP   97 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~-----~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~   97 (687)
                      +++|+|++|..+  .++|+|+|+|.+.++|.|+||+..     .+++|||+|++||+||++. +++++||+|+|+|.|..
T Consensus         2 t~sF~f~~F~~~--~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~-~~~~~sF~t~F~f~i~~   78 (237)
T d2d3sa1           2 TISFNFNQFHQN--EEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDST-TGNVASFETRFSFSIRQ   78 (237)
T ss_dssp             EEEEEESSCCSS--CTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEECCC
T ss_pred             eEEEEeCCCCCC--CCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCC-CCceeeEEEEEEEEeec
Confidence            568999999864  368999999999878899999753     4699999999999999987 88999999999999965


Q ss_pred             c-CCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccc
Q 005621           98 E-YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEP  176 (687)
Q Consensus        98 ~-~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~  176 (687)
                      . +...+||||||+|+|... +.+..|++||+++..    ..+++|||||||++|.  +||++||||||+|++.|.++. 
T Consensus        79 ~~~~~~g~dGlaFvl~p~~~-~~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n~--~d~~~nHvgI~vns~~s~~~~-  150 (237)
T d2d3sa1          79 PFPRPHPADGLVFFIAPPNT-QTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTV-  150 (237)
T ss_dssp             SCCSSCCCEEEEEEEECSSC-CCCBCGGGTTTBCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEE-
T ss_pred             CCCCCCCCCeEEEEeCCCCc-cCCccccccccccCC----CcCceEEEEEEeecCC--CCCCCCcEEEEcCCCcccccc-
Confidence            4 345678999999999764 445689999998753    4578999999999996  599999999999999887654 


Q ss_pred             cccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCc------
Q 005621          177 AAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL------  250 (687)
Q Consensus       177 ~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~------  250 (687)
                                 .+.+.+|+.++|||+||+.+++|+|+|.+.+ +|..|+++..|||+.+|+++||||||||||.      
T Consensus       151 -----------~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~~  218 (237)
T d2d3sa1         151 -----------PFTLDNGGIANVVIKYDASTKILHVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQR  218 (237)
T ss_dssp             -----------ECCCCTTCEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCT
T ss_pred             -----------ceeecCCCEEEEEEEEECCCCEEEEEEEcCC-CCcccceeeEechHHhCCCcEEEEEEeECCCCccCcc
Confidence                       3568899999999999999999999999866 6778899999999999999999999999994      


Q ss_pred             -ccceeEEEEeeeccC
Q 005621          251 -LASSHYILGWSFNMS  265 (687)
Q Consensus       251 -~~~~~~i~sWsf~~~  265 (687)
                       +.|.|+|++|+|++.
T Consensus       219 ~~~e~h~I~sWsFss~  234 (237)
T d2d3sa1         219 NATETHDILSWSFSAS  234 (237)
T ss_dssp             TCCCCCEEEEEEEEEE
T ss_pred             ccceeeEEEEeEeEee
Confidence             579999999999863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-52  Score=434.77  Aligned_cols=265  Identities=26%  Similarity=0.368  Sum_probs=222.0

Q ss_pred             HHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       336 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      ++++...++|+..+.||+|+||+||+|++..+++.||||+++.... ..++|.+|+.+|++++|||||+++++|.+.+.+
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            3333445688999999999999999999988899999999876543 457899999999999999999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceec
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLY  495 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~  495 (687)
                      ++|||||++|+|.+++.......+++..+..|+.||+.||.|||+   ++|+||||||+||||++++++||+|||+++..
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeec
Confidence            999999999999999977666789999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ............|++.|+|||++.++.++.++|||||||++|||++|..|+........      +.+....+       
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~~~-------  232 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKD-------  232 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTT-------
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHhcC-------
Confidence            55444444445789999999999999999999999999999999998877655433221      11222221       


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                        .....+...+..+.+|+.+||+.||++|||+.||++.|+...
T Consensus       233 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         233 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence              111222333447889999999999999999999999998654

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

Probab=100.00  E-value=6e-51  Score=410.66  Aligned_cols=227  Identities=33%  Similarity=0.493  Sum_probs=191.5

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      .+.+|+|++|.++  ..+|+|+|+|.+.++|.|+||+..      ..++|||+|++||+||++. ++.+++|+|+|+|.|
T Consensus         2 ~~~sF~f~~F~~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~-~~~~~sf~t~f~F~i   78 (251)
T d1g9fa_           2 ETVSFSWNKFVPK--QPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKE-TGSVASFAASFNFTF   78 (251)
T ss_dssp             EEEEEEESSCCC---CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC--CCCBCEEEEEEEEEE
T ss_pred             ceEEEEeCCCCCC--CCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCC-CccceeeEEEEEEEE
Confidence            4678999999864  258999999999888999999754      3588999999999999987 788999999999999


Q ss_pred             eecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           96 VPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      ...+...+||||||+|+|....+ +..+|+||+++..   ...++.|||||||++|.  +||++||||||+|++.|..+.
T Consensus        79 ~~~~~~~~gDGlAFvl~p~~~~~-~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n~--~D~~~~Hvgi~~n~~~s~~~~  152 (251)
T d1g9fa_          79 YAPDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTT  152 (251)
T ss_dssp             ECSCC--CCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEECC-CT--TSCSSSEEEEEESSSSCSEEE
T ss_pred             ecCCCCCCCCceEEEEecCCCCC-CCccCccCccccc---CCCcceEEEEEecccCC--CCCCCCcEeEEecCccccccc
Confidence            88878889999999999977544 5678899998753   34578999999999996  599999999999999887654


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCccc--c
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLA--S  253 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~--~  253 (687)
                      .            +++.+|+.++|||+||+..++|+|++.+.. +|..|++++.|||+.+|+++||||||||||...  |
T Consensus       153 ~------------~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~  219 (251)
T d1g9fa_         153 S------------WDLANNKVAKVLITYDASTSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGE  219 (251)
T ss_dssp             E------------CCCCTTCCEEEEEEEETTTTEEEEEEEEGG-GTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCCC
T ss_pred             c------------eEecCCCEEEEEEEEECCccEEEEEEecCC-CCcceeEEEEecchhhCCCcEEEEEEeecCCCCCCc
Confidence            3            578899999999999999999999998654 788899999999999999999999999999755  8


Q ss_pred             eeEEEEeeeccCCCCCc
Q 005621          254 SHYILGWSFNMSGDAKS  270 (687)
Q Consensus       254 ~~~i~sWsf~~~~~~~~  270 (687)
                      .|+|++|+|+++.+++.
T Consensus       220 ~h~I~sWsF~s~~~~~~  236 (251)
T d1g9fa_         220 SHDVLSWSFASNLPHAS  236 (251)
T ss_dssp             EEEEEEEEEEEEECC--
T ss_pred             eeEEEEeEeECCCCCCC
Confidence            99999999998655443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.9e-52  Score=432.70  Aligned_cols=270  Identities=28%  Similarity=0.464  Sum_probs=208.0

Q ss_pred             ccCHHHHHHHhcCc---------ccceeeeeeCeEEEEEEEeCCCCe---EEEEEEecCc-chhhHHHHHHHHHHHhhhc
Q 005621          332 RFSYEELKKATRGF---------RDKELLGFGGFGRVYKGTLPSTNT---QVAVKRVSNE-SKQGLREFASEISSIGRLR  398 (687)
Q Consensus       332 ~~~~~el~~at~~f---------~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~  398 (687)
                      .++|+++.+++++|         +..++||+|+||+||+|+++.+++   .||||++... .....++|.+|+++|++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            35667777776554         456899999999999999876553   6999998764 4455678999999999999


Q ss_pred             CCCceeeeeeeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          399 HRNLVQLLGWCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       399 H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                      |||||+++|+|...+..++|||||++|+|.+++... ...++|.++++|+.|||.||.|||+   ++|+||||||+||||
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl  161 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILV  161 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEE
Confidence            999999999999999999999999999999988543 3469999999999999999999998   999999999999999


Q ss_pred             ccCCcEEEcccccceeccCCCCCc----eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcc
Q 005621          479 DSELNGRLGDFGLAKLYERGTNPS----TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPE  553 (687)
Q Consensus       479 ~~~~~~kl~DFGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~  553 (687)
                      +.++.+||+|||+++.........    .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......+
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~  241 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD  241 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999998765433221    222457899999999999999999999999999999998 899997654321


Q ss_pred             hhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCC
Q 005621          554 ELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPL  621 (687)
Q Consensus       554 ~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  621 (687)
                         +...    ...+.         ....+...+..+.+|+.+||+.||++||||.||++.|++...-
T Consensus       242 ---~~~~----i~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         242 ---VINA----IEQDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ---HHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---HHHH----HHcCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence               1111    11111         1112223345788999999999999999999999999876543

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

Probab=100.00  E-value=2e-50  Score=402.52  Aligned_cols=219  Identities=34%  Similarity=0.481  Sum_probs=190.6

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEe
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV   96 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~   96 (687)
                      +.+|+|++|..+  ..+|+|+|+|++.++|.|+||+..      .+++|||+|++||+||++. +++++||+|+|+|.|.
T Consensus         2 ~~SF~f~~F~~~--~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~-~~~~~sFsT~F~f~i~   78 (234)
T d1f9ka_           2 TQSFNFDHFEEN--SKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDST-TGNVASFETRFSFNIT   78 (234)
T ss_dssp             EEEEEESSCCSS--CTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEEEE
T ss_pred             ceEEEeCCCCCC--CCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCC-CCcCcceEEEEEEEEE
Confidence            468999999864  368999999999888999999864      3588999999999999987 8899999999999997


Q ss_pred             ec-CCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           97 PE-YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        97 ~~-~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      +. ....+||||||+|+|... |.+..|+++|+++..    ..++.|||||||++|.  +||++||||||+|++.|..+.
T Consensus        79 ~~~~~~~g~dG~aF~i~p~~~-~~~~~g~~~g~~~~~----~~~~~vaVEFDT~~n~--~Dp~~nHvgi~~ns~~s~~~~  151 (234)
T d1f9ka_          79 QPYAYPEPADGLTFFMVPPNS-PQGEDGGNLGVFKPP----EGDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTL  151 (234)
T ss_dssp             CCCSSSCCCEEEEEEEECTTC-CCCCSGGGTTTCCSS----CCSCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEE
T ss_pred             CCCCCCCccceEEEEECCCCC-CcccccccccccCCC----CccceEEEEEeccccC--CCCCCCcEeEecCCccccccc
Confidence            54 345678999999999764 556688899997653    3567899999999996  699999999999999887654


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCcccc--ccceeeeeccCCc---
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVK--ETMYVGFSSSTGL---  250 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~--~~~~vGFsastG~---  250 (687)
                                  .+++.+|+.++|||+||+.+++|+|++++.. +|..|+|++.|||+++|+  |+||||||||||.   
T Consensus       152 ------------~~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~-~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~~  218 (234)
T d1f9ka_         152 ------------HFQLENGGVANVVIKYDSPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKN  218 (234)
T ss_dssp             ------------ECCCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTT
T ss_pred             ------------cccccCCCEEEEEEEEcCCCcEEEEEEEeCC-CCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCCC
Confidence                        3578899999999999999999999999866 667789999999999997  6799999999994   


Q ss_pred             ccceeEEEEeeecc
Q 005621          251 LASSHYILGWSFNM  264 (687)
Q Consensus       251 ~~~~~~i~sWsf~~  264 (687)
                      ..|.|+|++|+|++
T Consensus       219 ~~~~h~I~sWsF~s  232 (234)
T d1f9ka_         219 AVETHEIISWSFTS  232 (234)
T ss_dssp             CCCEEEEEEEEEEE
T ss_pred             ceeeeEEEEEEeEE
Confidence            57899999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=420.29  Aligned_cols=255  Identities=29%  Similarity=0.427  Sum_probs=211.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|+..+.||+|+||+||+|+++ +++.||||+++... ...++|.+|++++++++|||||+++|+|.+ +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            357888999999999999999985 57899999997653 334689999999999999999999998865 567999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++|+|.+++.......++|.++++|+.||++||.|||+   ++|+||||||+||||++++.+||+|||+|+........
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            999999999877766779999999999999999999998   99999999999999999999999999999987654433


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+........      +.+....+.     .+..   
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~------~~~~i~~~~-----~~~~---  231 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGY-----RMVR---  231 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTC-----CCCC---
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcC-----CCCC---
Confidence            34446789999999999999999999999999999999997776654433221      111222211     1111   


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                       +...+..+.+|+.+||+.||++||||.||++.|+.
T Consensus       232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence             22233478899999999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=418.72  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=199.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|+..+.||+|+||+||+|.+. +++.||||+++... ...++|.+|++++++++||||++++|+|...+..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            46888999999999999999986 57889999997643 33478999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++|+|.+++... ...+++..+++|+.|||.||.|||+   ++|+||||||+|||+++++++||+|||+++.........
T Consensus        83 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          83 EHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999998643 3568999999999999999999998   999999999999999999999999999998775544444


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....||+.|+|||++.+..++.++|||||||++|||+|+..|+........  +.+    ....+.  ..       ..
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~~----~i~~~~--~~-------~~  223 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE----DISTGF--RL-------YK  223 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HHH----HHHHTC--CC-------CC
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHhcC--CC-------CC
Confidence            4456789999999999999999999999999999999996555443332211  111    111111  11       11


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      +..++.++.+++.+||+.||++||||+||++.|+++
T Consensus       224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            222334788999999999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=418.73  Aligned_cols=254  Identities=22%  Similarity=0.346  Sum_probs=213.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|+..+.||+|+||+||+|++..+|+.||||++........+.+.+|++++++++||||+++++++.+.+.+|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999999999999999998766556678999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++|+|.+++.   +..+++.++..++.||+.||.|||+   ++|+||||||+|||++.++++||+|||+++.+..... .
T Consensus       100 ~gg~L~~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~  172 (293)
T d1yhwa1         100 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (293)
T ss_dssp             TTCBHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             CCCcHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence            9999998773   3469999999999999999999998   9999999999999999999999999999997654332 3


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....||+.|+|||++.++.++.++|||||||++|||++|+.||......+.      +......+.      +.+  ..
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~------~~~--~~  238 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT------PEL--QN  238 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCS------CCC--SS
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCCC------CCC--CC
Confidence            3456799999999999999999999999999999999999999976542211      111111111      111  11


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      +......+.+++.+||+.||++|||+.|+++  +++.
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            2223347889999999999999999999986  4543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=415.02  Aligned_cols=252  Identities=25%  Similarity=0.333  Sum_probs=206.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ++|+..+.||+|+||+||+|+++.+++.||||+++... ....+++.+|++++++++||||+++++++.+.+..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57899999999999999999999999999999997653 23446789999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC-
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN-  500 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~-  500 (687)
                      +++|+|.+++.  ....+++.++..++.||+.||.|||+   ++|+||||||+|||+++++++||+|||+|+....... 
T Consensus        85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999994  34579999999999999999999998   9999999999999999999999999999997654332 


Q ss_pred             CceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                      ...+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......... ..     ......        .
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~-----~~~~~~--------~  225 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD-----WKEKKT--------Y  225 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HH-----HHTTCT--------T
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HH-----HhcCCC--------C
Confidence            23445689999999999988775 578999999999999999999997654322111 10     111100        0


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..........+.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0011112346788999999999999999999976

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

Probab=100.00  E-value=1e-49  Score=400.53  Aligned_cols=226  Identities=31%  Similarity=0.502  Sum_probs=198.2

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC-----CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEe
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT-----LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIV   96 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~-----~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~   96 (687)
                      .+++|+|++|.++.  .||+|+|+|.+.++|.|+||+..     .+++|||+|++||+||++. ++.++||+|+|+|.|.
T Consensus         2 ~~~sF~f~~F~~~~--~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~-~~~~~sFst~F~F~i~   78 (239)
T d1dbna_           2 DELSFTINNFVPNE--ADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNT-TGSVASFSTSFTFVVK   78 (239)
T ss_dssp             CEEEEEESSCCTTC--TTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEECC
T ss_pred             CceEEEeCCCCCCC--CCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCC-CccceEEEEEEEEEEE
Confidence            46799999998752  58999999999888999999753     4578999999999999987 7899999999999998


Q ss_pred             ecCCCCCCcceEEEEccCC-CCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCC--CCCCCeeeEEeCCCCccc
Q 005621           97 PEYTALGGHGFAFTISASK-ELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFG--DINDNHVGIDINSLRSNA  173 (687)
Q Consensus        97 ~~~~~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgi~~ns~~s~~  173 (687)
                      +.....+||||||+|+|.. ..+.+..|++||+++..+ +++.++.+||||||++|.+++  ||+.+|||||+|++.|..
T Consensus        79 ~~~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~  157 (239)
T d1dbna_          79 APNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIK  157 (239)
T ss_dssp             CSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSE
T ss_pred             CCCCCCCCCCEEEEEeCCCccCCcccCccccccccccC-CCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCccccc
Confidence            8877789999999999876 456678899999998654 456789999999999998764  788999999999998877


Q ss_pred             ccccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc--
Q 005621          174 SEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL--  251 (687)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~--  251 (687)
                      +.+.            .+.+|+.+.|||+||+..+.|.|++.+.. +|..|.|+..+||+++|+++||||||||||..  
T Consensus       158 ~~~~------------~~~~g~~~~~~i~y~~~~~~l~v~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~  224 (239)
T d1dbna_         158 TVQW------------DWINGGVAFATITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTE  224 (239)
T ss_dssp             EEEC------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGG
T ss_pred             cccc------------eEeCCceeEEEEEEcCCCCEEEEEEEecC-CCccEEEEEecchHHhcCCcEEEEEEEeCCCCCC
Confidence            6543            45689999999999999999999998755 77788999999999999999999999999964  


Q ss_pred             cceeEEEEeeecc
Q 005621          252 ASSHYILGWSFNM  264 (687)
Q Consensus       252 ~~~~~i~sWsf~~  264 (687)
                      .|.|+|++|||++
T Consensus       225 ~~~H~I~sWsFss  237 (239)
T d1dbna_         225 VETHDVLSWSFTS  237 (239)
T ss_dssp             CCCCEEEEEEEEE
T ss_pred             cceeEEEEEEeEE
Confidence            5789999999986

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=411.86  Aligned_cols=246  Identities=25%  Similarity=0.386  Sum_probs=209.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|+++.+++.||+|++.+..   ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999999999999999987542   233567899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |||++|+|.+++.  ....+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        86 Ey~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          86 EYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             ECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             eecCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence            9999999999994  34579999999999999999999998   99999999999999999999999999999865432 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                        ......||+.|||||++.+..++.++|||||||++|||++|+.||......+       .......+.      +.+.
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~------~~~p  224 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVE------FTFP  224 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTC------CCCC
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC------CCCC
Confidence              2344679999999999999999999999999999999999999997654221       111111111      1122


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ..    .+.++.+++.+||+.||++|||++|+++
T Consensus       225 ~~----~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 DF----VTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            22    2347889999999999999999999987

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.5e-49  Score=396.34  Aligned_cols=220  Identities=36%  Similarity=0.556  Sum_probs=194.4

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      .+++|+|++|..    .||+|+|||.+.++|.|+||+..      .+++|||+|++||+||++. ++.++||+|+|+|.|
T Consensus         2 ~~~sF~f~~F~~----~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~-~~~~~sF~t~f~f~i   76 (233)
T d1g8wa_           2 NDIYFNFQRFNE----TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNT-TGTVASFATSFTFNI   76 (233)
T ss_dssp             EEEEEEESSCCG----GGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTT-TCCBEEEEEEEEEEC
T ss_pred             CceEEECCCCCc----CcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCC-CCceeeEEEEEEEEE
Confidence            467999999987    58999999999888999999753      3489999999999999987 888999999999999


Q ss_pred             eecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           96 VPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      .+.+...+||||||+|+|....+ +..|++||+++..   +..++.|||||||++|.++ ||+.+||||++|+..|..+.
T Consensus        77 ~~~~~~~~gDGlAF~l~~~~~~~-g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N~~~-d~~~~Hvgi~~n~~~s~~~~  151 (233)
T d1g8wa_          77 QVPNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTT  151 (233)
T ss_dssp             CCCSSCBCCEEEEEEEEETTCCC-CCCGGGTTTCCSS---CCCCCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEE
T ss_pred             ecCCCCCCCCeEEEEEecCCCCC-CcccccCCccccC---CCcccEEEEEeecccCCCC-CCCCCeEEEECCCcceeeec
Confidence            88777778999999999987544 5688999998653   3457889999999999875 99999999999999887655


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCc---cc
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LA  252 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~---~~  252 (687)
                      +            .++.+|+.++|||+||+.+++|.|++.+.. +|..|+++..+||+.+||++|||||||+||.   ..
T Consensus       152 ~------------~~~~~g~~~~~~I~yd~~~~~l~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~  218 (233)
T d1g8wa_         152 R------------WDFVNGENAEVLITYDSSTNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNV  218 (233)
T ss_dssp             E------------CCCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBC
T ss_pred             c------------ccccCCcEEEEEEEEeCCCcEEEEEEEeCC-CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCc
Confidence            4            467799999999999999999999998766 7778899999999999999999999999994   56


Q ss_pred             ceeEEEEeeecc
Q 005621          253 SSHYILGWSFNM  264 (687)
Q Consensus       253 ~~~~i~sWsf~~  264 (687)
                      |.|+|++|+|++
T Consensus       219 ~~h~I~sWsFss  230 (233)
T d1g8wa_         219 ETNDVLSWSFAS  230 (233)
T ss_dssp             CCCEEEEEEEEE
T ss_pred             eeeEEEEEEEEE
Confidence            889999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=414.70  Aligned_cols=259  Identities=27%  Similarity=0.449  Sum_probs=204.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      .++|...++||+|+||+||+|++.   ..||||+++..  .....++|.+|+.++++++|||||++++++.+ +.+++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            367888999999999999999874   35999998654  34567889999999999999999999999865 5689999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |||++|+|.+++... +..+++.++.+|+.||++||+|||+   ++|+||||||+||||+.++.+||+|||+|+......
T Consensus        83 Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          83 QWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             ECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             ecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            999999999999643 3469999999999999999999998   899999999999999999999999999998765433


Q ss_pred             C-CceeeeecCCCCCchhhccC---CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          500 N-PSTTRVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       500 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      . .......||+.|||||++.+   +.++.++|||||||++|||+||+.||.........      ......+.    ..
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~~----~~  228 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGY----LS  228 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHTS----CC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCC----CC
Confidence            2 23345679999999999864   35789999999999999999999999875543221      11111111    11


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      |.+ ...+...+..+.+|+.+||+.||++|||++||++.|+...
T Consensus       229 p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         229 PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            111 1122223347889999999999999999999999998653

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

Probab=100.00  E-value=2.3e-49  Score=400.49  Aligned_cols=222  Identities=31%  Similarity=0.519  Sum_probs=195.4

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      ...+|+|++|+.    .+|+++|+|.+. ++.|+||+..      .+++|||+|++||+||++. ++.++||+|+|+|.|
T Consensus         2 ~~~sF~f~~F~~----~~l~l~GdA~~~-~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~-~~~~~sF~t~F~F~i   75 (253)
T d1g7ya_           2 DIQSFSFKNFNS----SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKS-TGAVASWATSFTANI   75 (253)
T ss_dssp             EEEEEEESSCCS----SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEEC
T ss_pred             cccEEecCCCCc----ccEEEEeeeEEc-CCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCC-CCceeeEEEEEEEEE
Confidence            346899999987    589999999996 8889999754      3488999999999999987 788999999999999


Q ss_pred             eecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           96 VPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      .+.....+||||||+|+|....++ ..+|++|+++..+. ...++.+||||||++|.++ ||+++|||||+|++.|..+.
T Consensus        76 ~~~~~~~ggDGlAF~l~~~~~~~~-~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~~~-d~~~~Hvgi~~ns~~s~~~~  152 (253)
T d1g7ya_          76 FAPNKSSSADGIAFALVPVGSEPK-SNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTA  152 (253)
T ss_dssp             CCSSGGGCCCEEEEEEEETTCCCC-CCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEE
T ss_pred             ecCCCCCCCCceEEEEeCCCCCCC-CCcccccccccCCC-CCcCceEEEEEeceecCCC-CCCCCcEEEeeCCccccccc
Confidence            887777899999999999876554 57889999986543 3567899999999999875 99999999999999987765


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCC---ccc
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTG---LLA  252 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG---~~~  252 (687)
                      +            ..+.+|+.++|||+||+.+++|+|++++.. +|..|++++.+||+.+||++|||||||+||   .+.
T Consensus       153 ~------------~~~~~g~~~~v~I~Yd~~~~~L~v~l~~~~-~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~  219 (253)
T d1g7ya_         153 S------------WGLANGQNAEILITYNAATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYT  219 (253)
T ss_dssp             E------------CCCCTTSEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCC
T ss_pred             C------------CCccCCCEEEEEEEEeCCcEEEEEEEecCC-CCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCcc
Confidence            4            467899999999999999999999998754 788899999999999999999999999999   568


Q ss_pred             ceeEEEEeeeccC
Q 005621          253 SSHYILGWSFNMS  265 (687)
Q Consensus       253 ~~~~i~sWsf~~~  265 (687)
                      |.|+|++|+|++.
T Consensus       220 ~~H~IlsWsF~s~  232 (253)
T d1g7ya_         220 ETHDVLSWSFASK  232 (253)
T ss_dssp             CCCEEEEEEEEEE
T ss_pred             cccEEEEEEeEEe
Confidence            9999999999863

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-50  Score=406.79  Aligned_cols=253  Identities=25%  Similarity=0.388  Sum_probs=214.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|+..++||+|+||+||+|+++ +++.||||+++.... ..++|.+|+.++++++||||++++|+|.+.+.+++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            57889999999999999999985 688999999987543 3468999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++|+|.+++... ...+++..+.+++.|+++||.|||+   ++|+||||||+|||+++++.+||+|||+++.........
T Consensus        82 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          82 ANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999987554 3468999999999999999999998   999999999999999999999999999998766554444


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.       ...+..+..         ..
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~~~i~~~~~---------~~  221 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGLR---------LY  221 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTCC---------CC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------HHHHHhCCC---------CC
Confidence            445678999999999999999999999999999999998 8999987653221       112222211         11


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      .+...+..+.+++.+||+.||++|||+++|++.|.+
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            122233478899999999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-50  Score=409.91  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=197.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeec--CCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRR--RGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV  418 (687)
                      ++|+..+.||+|+||+||+|+++.+|+.||||++....  ....+.+.+|++++++++||||+++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57899999999999999999999999999999987653  3445778999999999999999999998864  4568999


Q ss_pred             EecCCCCCchhhhhch--hhccCCHHHHHHHHHHHHhhhhhhcccc--cCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          419 YDFMPNGSLDKCLFDE--QKAILTWEQRYRIIKGVASGLLYLHEEW--EQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      ||||++|+|.+++...  ....+++.+++.++.||+.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998643  3457999999999999999999999821  23599999999999999999999999999987


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccccc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVV  574 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  574 (687)
                      +..... ......||+.|||||++.+..++.++|||||||++|||+||+.||......+       +...+..+...   
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~---  232 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFR---  232 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCC---
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCC---
Confidence            654332 2334689999999999999999999999999999999999999997644211       11222222221   


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          575 DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       575 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        .+...++    .++.+|+.+||+.||++|||+.|+++
T Consensus       233 --~~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 --RIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              1222233    36889999999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=415.18  Aligned_cols=260  Identities=26%  Similarity=0.431  Sum_probs=205.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCC----eEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTN----TQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      +.|+..++||+|+||+||+|.+..++    ..||||+++... .....+|.+|+.++++++|||||+++|+|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            56888999999999999999986544    479999997653 3445679999999999999999999999999999999


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+.+++|.+++... ...++|.++++++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++....
T Consensus        87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999999877543 3569999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ....  ......||+.|||||++.++.++.++|||||||++|||++|..|+........      +.+....+       
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~------~~~~i~~~-------  229 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDG-------  229 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTT-------
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH------HHHHHhcc-------
Confidence            3322  22335689999999999999999999999999999999997777655433221      11122222       


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVPL  621 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  621 (687)
                        .+...+...+..+.+|+.+||+.+|++||+|.||++.|++....
T Consensus       230 --~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         230 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence              11222233445788999999999999999999999999876543

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

Probab=100.00  E-value=1e-48  Score=390.76  Aligned_cols=225  Identities=28%  Similarity=0.420  Sum_probs=191.3

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC-CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCC
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT-LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYT  100 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~-~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~  100 (687)
                      .+++|+|++|.++  +.+|+|+|||.+.++|.|+||++. .+++|||+|++||+||++. ++.+++|+|+|+|.|.+.+.
T Consensus         2 ~~~sF~~~~F~~~--~~~l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~~~~-~~~~~sf~t~f~f~i~~~~~   78 (232)
T d1v6ia_           2 ETVSFNFNSFSEG--NPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSA-TGNVASFLTSFSFEMKDIKD   78 (232)
T ss_dssp             EEEEEEESSCCTT--CTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTT-TCCBCEEEEEEEEEEECCSS
T ss_pred             ccEEEECCCCCCC--CCCEEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEccCCC-CCccceeEEEEEEEeccCCC
Confidence            4679999999985  257999999999888999999864 5899999999999999987 88999999999999998877


Q ss_pred             CCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccccccc
Q 005621          101 ALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYF  180 (687)
Q Consensus       101 ~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~  180 (687)
                      ..+||||||+|+|.......  ++..|+.......+..++.|||||||++|.+++||+++|||||+|++.+.....    
T Consensus        79 ~~~gDG~AF~l~~~~~~~~~--~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~~----  152 (232)
T d1v6ia_          79 YDPADGIIFFIAPEDTQIPA--GSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP----  152 (232)
T ss_dssp             SBCCCEEEEEEEETTCCCCT--TCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEE----
T ss_pred             CCCCCeEEEEEECCCCCCCC--CccCCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCcccccccc----
Confidence            88999999999997643322  222222222233456789999999999999889999999999999988766543    


Q ss_pred             cccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCc-ccceeEEEE
Q 005621          181 LENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL-LASSHYILG  259 (687)
Q Consensus       181 ~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~-~~~~~~i~s  259 (687)
                              .++.+|+.++|||+||+.+++|+|++++.  ++..|.++..+||+.+||++||||||||||. ..|.|+|++
T Consensus       153 --------~~~~~g~~~~v~I~Yd~~~~~L~V~~~~~--~~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~s  222 (232)
T d1v6ia_         153 --------WNSVSGAVVKVTVIYDSSTKTLSVAVTND--NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRS  222 (232)
T ss_dssp             --------CCCCTTCEEEEEEEEETTTTEEEEEEECT--TSCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEEE
T ss_pred             --------cccCCCCEEEEEEEEeCCceEEEEEEecC--CCCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEEE
Confidence                    46789999999999999999999999864  4667889999999999999999999999996 469999999


Q ss_pred             eeeccC
Q 005621          260 WSFNMS  265 (687)
Q Consensus       260 Wsf~~~  265 (687)
                      |+|++.
T Consensus       223 WsFss~  228 (232)
T d1v6ia_         223 WSFTST  228 (232)
T ss_dssp             EEEEEE
T ss_pred             eEeEEe
Confidence            999863

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=411.22  Aligned_cols=257  Identities=30%  Similarity=0.423  Sum_probs=206.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      ++|+..+.||+|+||+||+|+++. +..||||+++... ...++|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            579999999999999999999964 5679999997553 334789999999999999999999999864 5689999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++|+|..++.......++|.+++.++.||+.||.|||+   .+|+||||||+||||+.++++||+|||+++.........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            99999999987777789999999999999999999998   899999999999999999999999999998775554444


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEF  582 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~  582 (687)
                      .....||+.|+|||++..+.++.++|||||||++|||+||..|+........  ...++.    .+     ..+    +.
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~----~~-----~~~----~~  235 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVE----RG-----YRM----PC  235 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHH----TT-----CCC----CC
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHH----hc-----CCC----CC
Confidence            4556799999999999999999999999999999999998777665543222  111111    11     111    22


Q ss_pred             CHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCCC
Q 005621          583 NEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEVP  620 (687)
Q Consensus       583 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  620 (687)
                      +...+.++.+++.+||+.||++||+|.+|+++|+....
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            22334478899999999999999999999999987553

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=409.14  Aligned_cols=254  Identities=25%  Similarity=0.390  Sum_probs=208.0

Q ss_pred             cCccccee-eeeeCeEEEEEEEeCC--CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKEL-LGFGGFGRVYKGTLPS--TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~-lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|...+. ||+|+||+||+|.++.  ++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +.++||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666664 9999999999998753  45689999997653 4456789999999999999999999999865 568999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      ||||++|+|.+++... +..+++.++.+++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++.+...
T Consensus        87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999999987543 3469999999999999999999999   99999999999999999999999999999977543


Q ss_pred             CC--CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          499 TN--PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       499 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ..  .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+.       ...+..+..     
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-------~~~i~~~~~-----  230 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKR-----  230 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTCC-----
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC-----
Confidence            32  12233568999999999999999999999999999999998 9999987654321       122222221     


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      +.    .+...+.++.+|+.+||+.+|++||+|.+|++.|+.
T Consensus       231 ~~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         231 ME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11    222333478899999999999999999999998875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=417.71  Aligned_cols=257  Identities=26%  Similarity=0.397  Sum_probs=209.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCC-----eEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTN-----TQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  414 (687)
                      .++|+..++||+|+||+||+|++...+     ..||+|++.... ......+.+|+.++.++ +|||||+++++|.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            357889999999999999999985443     379999986543 34456789999999999 89999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchh---------------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCC
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQ---------------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKA  473 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  473 (687)
                      +++|||||++|+|.++|....                     ...+++.+++.++.||+.||.|||+   ++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence            999999999999999996532                     2358999999999999999999998   9999999999


Q ss_pred             CcEEeccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCC
Q 005621          474 GNVLLDSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKAL  551 (687)
Q Consensus       474 ~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~  551 (687)
                      +|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876554432 2334678999999999999999999999999999999998 8999986554


Q ss_pred             cchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHh
Q 005621          552 PEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLE  616 (687)
Q Consensus       552 ~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  616 (687)
                      ....  .    +....+         .+.+.+...+..+.+|+.+||+.||++|||++||+++|.
T Consensus       273 ~~~~--~----~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANF--Y----KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHH--H----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHH--H----HHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3221  1    111111         111222233457889999999999999999999999985

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

Probab=100.00  E-value=1.8e-48  Score=389.18  Aligned_cols=220  Identities=32%  Similarity=0.513  Sum_probs=192.9

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCC-----CeeEEEEecCCeecccCCCCCceeeEEEEEEEEEee
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL-----RVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVP   97 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~-----~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~   97 (687)
                      +.+|+|++|.++.  .+|+|+|+|.+.++|.|+||++..     +++|||+|++||+||++.   .+++|+|+|+|.|..
T Consensus         3 ~~sF~f~~F~~~~--~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~~---~~~sF~t~f~f~i~~   77 (233)
T d1n47a_           3 STSFSFTNFNPNQ--NNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT---TLASFTTSFSFVMAA   77 (233)
T ss_dssp             EEEEEESSCCTTC--TTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSS---CBCEEEEEEEEECCC
T ss_pred             ceEEEeCCCCCCC--CCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCCC---eeeeEEEEEEEEEeC
Confidence            5789999998652  689999999998888999997543     589999999999999854   578999999999988


Q ss_pred             cCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccccc
Q 005621           98 EYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPA  177 (687)
Q Consensus        98 ~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~  177 (687)
                      .....+||||||+|+|....+ +..|++||+++..+. +..++.|||||||++|.  +||++||||||+|++.|..+.+ 
T Consensus        78 ~~~~~~gDGlAF~l~~~~~~~-~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n~--~d~~~~higi~~n~~~s~~~~~-  152 (233)
T d1n47a_          78 PAAAAVADGLAFFLAPPDTQP-QARGGFLGLFADRAH-DASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP-  152 (233)
T ss_dssp             SSTTSCCEEEEEEEECTTCCC-CCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEE-
T ss_pred             CCCCCCCCceEEEECCCCCCC-CCCCCccccccccCC-CCcCceEEEEEEeeecC--CCCCCCceeEccCCcccccccc-
Confidence            877889999999999977544 457889999976543 45678899999999997  5999999999999998876543 


Q ss_pred             ccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCC---cccce
Q 005621          178 AYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTG---LLASS  254 (687)
Q Consensus       178 ~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG---~~~~~  254 (687)
                                 +.+.+|+.++|||+||+.+++|.|++.+.. +|..|.|+..+||+++||++|||||||+||   ...|.
T Consensus       153 -----------~~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~  220 (233)
T d1n47a_         153 -----------FDMVYGEKANIVITYQASTKALAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVET  220 (233)
T ss_dssp             -----------CCCCTTSCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCC
T ss_pred             -----------ceecCCCEEEEEEEEcCCCeEEEEEEEeCC-CCccEEEEEEechHHhcCCcEEEEEEEecCCCCCcccc
Confidence                       567899999999999999999999998765 778889999999999999999999999999   46789


Q ss_pred             eEEEEeeecc
Q 005621          255 HYILGWSFNM  264 (687)
Q Consensus       255 ~~i~sWsf~~  264 (687)
                      |+|++|+|++
T Consensus       221 H~I~sWsFss  230 (233)
T d1n47a_         221 HDIVSWSFAV  230 (233)
T ss_dssp             CEEEEEEEEE
T ss_pred             cEEEEEEeEE
Confidence            9999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=411.65  Aligned_cols=252  Identities=26%  Similarity=0.368  Sum_probs=209.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFM  422 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~  422 (687)
                      +.|+..+.||+|+||+||+|+++.+++.||||++........+++.+|++++++++|||||++++++.+.+.+++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888999999999999999999999999999998777677788999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS  502 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  502 (687)
                      ++|+|.+++... ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++++||+|||+++...... ..
T Consensus        92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~  166 (288)
T d2jfla1          92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  166 (288)
T ss_dssp             TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred             CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence            999999987543 3469999999999999999999998   999999999999999999999999999997653321 11


Q ss_pred             eeeeecCCCCCchhhcc-----CCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          503 TTRVVGTLGYLAPELTR-----TGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      .....||+.|+|||++.     ...++.++|||||||++|||+||+.||......+...      . ...+..     +.
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~------~-i~~~~~-----~~  234 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL------K-IAKSEP-----PT  234 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------H-HHHSCC-----CC
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH------H-HHcCCC-----CC
Confidence            23457999999999984     4568899999999999999999999998765332111      1 111111     11


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      +  ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 L--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             C--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1  111223347889999999999999999999986

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

Probab=100.00  E-value=8.9e-49  Score=393.42  Aligned_cols=224  Identities=32%  Similarity=0.480  Sum_probs=196.1

Q ss_pred             ccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC-----CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEee
Q 005621           23 QEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT-----LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVP   97 (687)
Q Consensus        23 ~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~-----~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~   97 (687)
                      +++|+|++|.++  +.+++|+|+|.+.++|.|+||++.     .+++|||+|++||+||++. ++.++||+|+|+|.|..
T Consensus         3 ~~sF~f~~F~~~--~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~-~~~~~sF~t~F~F~i~~   79 (237)
T d1fnya_           3 SLSFSFPKFAPN--QPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDST-TGNVASFVTSFTFIIQA   79 (237)
T ss_dssp             EEEEEESSCCTT--CTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTT-TCCBCEEEEEEEEECCC
T ss_pred             eEEEEeCCCCCC--CCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCC-CCcceeeEEEEEEEEec
Confidence            578999999864  369999999999888999999853     4689999999999999988 88999999999999988


Q ss_pred             cCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccccc
Q 005621           98 EYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPA  177 (687)
Q Consensus        98 ~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~  177 (687)
                      .+...+||||||+|+|....+ +..+|++|+++..+ .+..++.+||||||++|.++ ||+++|||||+|+..|..+.+ 
T Consensus        80 ~~~~~~gDG~AF~l~~~~~~~-~~~gg~lg~~~~~~-~~~~~~~~aVefDT~~n~~~-d~~~~Higi~~n~~~s~~~~~-  155 (237)
T d1fnya_          80 PNPATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVP-  155 (237)
T ss_dssp             SSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEEE-
T ss_pred             CCCCCCCCeeEEEEcCCCCCc-ccccCcccccCCCC-ccCccceEEEEeccccccCC-CCCCceEEEecCCCccccccc-
Confidence            877889999999999987544 45788999987543 34678899999999999875 999999999999998876553 


Q ss_pred             ccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCC---cccce
Q 005621          178 AYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTG---LLASS  254 (687)
Q Consensus       178 ~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG---~~~~~  254 (687)
                                 .++.+|+.++|||+||+..++|.|++.+.. ++..|+++..+||+.+||++|||||||+||   ...|.
T Consensus       156 -----------~~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e~  223 (237)
T d1fnya_         156 -----------WNWTNGEVANVFISYEASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQT  223 (237)
T ss_dssp             -----------CCCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCC
T ss_pred             -----------ccccCCcEEEEEEEEeCCccEEEEEEEeCC-CCcceeEEEEechhhcCCCcEEEEEEEECCCCCCcccc
Confidence                       456799999999999999999999998766 677889999999999999999999999999   56789


Q ss_pred             eEEEEeeeccC
Q 005621          255 HYILGWSFNMS  265 (687)
Q Consensus       255 ~~i~sWsf~~~  265 (687)
                      |+|+||+|++.
T Consensus       224 H~I~sWsF~s~  234 (237)
T d1fnya_         224 NDVLSWSFESN  234 (237)
T ss_dssp             CEEEEEEEEEE
T ss_pred             cEEEEeEeEEe
Confidence            99999999863

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=409.42  Aligned_cols=247  Identities=28%  Similarity=0.385  Sum_probs=200.0

Q ss_pred             eeeeeeCeEEEEEEEeCC--CCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEecCCC
Q 005621          349 ELLGFGGFGRVYKGTLPS--TNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDFMPN  424 (687)
Q Consensus       349 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~  424 (687)
                      ++||+|+||+||+|.+..  .++.||||+++...  ....++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643  45789999997542  3345789999999999999999999999965 467899999999


Q ss_pred             CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCCc--
Q 005621          425 GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNPS--  502 (687)
Q Consensus       425 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~--  502 (687)
                      |+|.+++.  ....+++.++++|+.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++.+.......  
T Consensus        92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999984  34569999999999999999999998   899999999999999999999999999998765433322  


Q ss_pred             eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCCC
Q 005621          503 TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNGE  581 (687)
Q Consensus       503 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~  581 (687)
                      .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......+       +...+..+..     +    .
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~-----~----~  230 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER-----M----G  230 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC-----C----C
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCC-----C----C
Confidence            233568999999999999999999999999999999998 899998654221       1122222221     1    1


Q ss_pred             CCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          582 FNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       582 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                      .+...+.++.+|+.+||+.||++|||+++|++.|+.
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            222234478899999999999999999999988864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-49  Score=401.65  Aligned_cols=245  Identities=25%  Similarity=0.420  Sum_probs=199.9

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeec----CCeeEEEE
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRR----RGDLLLVY  419 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~  419 (687)
                      +..++||+|+||+||+|++..+++.||+|++...  .....++|.+|+++|++++|||||++++++..    ...+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            5667899999999999999999999999998654  34456789999999999999999999999864    35689999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCe--EEeeccCCCcEEec-cCCcEEEcccccceecc
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQT--VIHRDIKAGNVLLD-SELNGRLGDFGLAKLYE  496 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlk~~NIll~-~~~~~kl~DFGla~~~~  496 (687)
                      ||+++|+|.+++.  +...+++.++..++.||+.||+|||+   ++  |+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHh--ccccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999994  34579999999999999999999998   66  99999999999996 47899999999998543


Q ss_pred             CCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      .   .......||+.|||||++.+ .++.++|||||||++|||++|+.||........      +.+....+...    +
T Consensus       167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~----~  232 (270)
T d1t4ha_         167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKP----A  232 (270)
T ss_dssp             T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCC----G
T ss_pred             C---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCC----c
Confidence            2   22345689999999999875 699999999999999999999999976543221      12222222111    1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+...    ...++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 SFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcc----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            11112    2236789999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=409.80  Aligned_cols=249  Identities=23%  Similarity=0.307  Sum_probs=206.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|+++.+++.||||++....   ....+.+.+|++++++++||||+++++++.+.+.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46999999999999999999999899999999997542   234567899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+++|+|.+++.  ..+.+++.++..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.+....
T Consensus        88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999884  44579999999999999999999999   999999999999999999999999999999775433


Q ss_pred             C-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          500 N-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       500 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+       +.+....+.      ..+
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~------~~~  229 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLE------YDF  229 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTC------CCC
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-------HHHHHHcCC------CCC
Confidence            2 23345679999999999999999999999999999999999999998654211       111121211      112


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ...+    ..++.+|+.+||+.||++|||++|+++
T Consensus       230 p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 PEKF----FPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            2222    346889999999999999999998743

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=414.78  Aligned_cols=266  Identities=24%  Similarity=0.362  Sum_probs=209.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|+..++||+|+||+||+|++..+|+.||+|+++... ....+++.+|+.+|++++|||||+++++|.+.+.+++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            468999999999999999999999999999999997653 3345678999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      ||++|+|.+++..  .+.+++..+..++.|++.||.|||+  .++|+||||||+|||++.++++||+|||+|+...... 
T Consensus        85 y~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             CCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             cCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence            9999999999953  4569999999999999999999997  1489999999999999999999999999998664322 


Q ss_pred             CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHHhc--------ccc--
Q 005621          501 PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILV-DWVWDRWK--------AGA--  569 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~-~~v~~~~~--------~~~--  569 (687)
                        ....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+..... ........        .+.  
T Consensus       160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence              23468999999999999999999999999999999999999999875432211100 00000000        000  


Q ss_pred             ------------ccc-------ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          570 ------------ILE-------VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       570 ------------~~~-------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                                  ..+       ...+.+..   .....++.+++.+||+.||++|||++|+++  ++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                        000       00001100   011246889999999999999999999997  4543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.4e-48  Score=410.91  Aligned_cols=254  Identities=23%  Similarity=0.301  Sum_probs=213.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|+..+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.++|||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999999999999999999877666678899999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc--CCcEEEcccccceeccCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS--ELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFGla~~~~~~~  499 (687)
                      |++|+|.+++... .+.+++.++..|+.||+.||.|||+   ++|+||||||+|||++.  ++.+||+|||+++.+....
T Consensus       105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999999998543 3469999999999999999999999   99999999999999964  5789999999998765432


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                        ......||+.|||||++.+..++.++|||||||++|||++|+.||......+.       ...+..+..      ...
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~------~~~  245 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDW------NMD  245 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC------CSC
T ss_pred             --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC------CCC
Confidence              34456899999999999999999999999999999999999999976542211       111111111      111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                      ..........+.+|+.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11111223468899999999999999999999983

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.7e-49  Score=409.41  Aligned_cols=249  Identities=27%  Similarity=0.416  Sum_probs=206.6

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      +.|+..+.||+|+||+||+|++..+++.||||+++...   ....+++.+|++++++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35899999999999999999999999999999987653   344567999999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |||++|+|..++.  .+..+++.++..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++....  
T Consensus        95 E~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             ECCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            9999999976653  34579999999999999999999999   9999999999999999999999999999986533  


Q ss_pred             CCceeeeecCCCCCchhhccC---CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRT---GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                         .....||+.|||||++.+   +.++.++|||||||++|||++|+.||......+.      ..... .+.     .+
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~-~~~-----~~  232 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNE-----SP  232 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH-HSC-----CC
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-hCC-----CC
Confidence               233579999999999864   4689999999999999999999999976542211      11111 111     11


Q ss_pred             cCC-CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          577 RLN-GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       577 ~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      .+. ..+    +..+.+|+.+||+.||++|||+.|+++  ++.+
T Consensus       233 ~~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         233 ALQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             CCSCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCCCCCC----CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            111 122    337889999999999999999999987  4544

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-49  Score=411.16  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=193.8

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch-hhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK-QGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .+.|+..+.||+|+||+||+|+++.+++.||||++..... .....+.+|+.++++++||||+++++++.+.+.+|||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4679999999999999999999998999999999976542 334568899999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec---cCCcEEEcccccceeccC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYER  497 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGla~~~~~  497 (687)
                      ||++|+|.++|..  .+.+++.++..++.||+.||.|||+   ++|+||||||+|||+.   +++.+||+|||+++....
T Consensus        88 ~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            9999999999943  4579999999999999999999998   9999999999999994   578999999999986644


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCc
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPR  577 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~  577 (687)
                      ..  .....+||+.|||||++.+..++.++|||||||++|||++|+.||......+   +    ......+..      .
T Consensus       163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~----~~~i~~~~~------~  227 (307)
T d1a06a_         163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---L----FEQILKAEY------E  227 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H----HHHHHTTCC------C
T ss_pred             CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---H----HHHHhccCC------C
Confidence            32  2334679999999999999999999999999999999999999997654221   1    111111111      1


Q ss_pred             CCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          578 LNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       578 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .........+..+.+|+.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111111222347889999999999999999999988

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=397.53  Aligned_cols=249  Identities=31%  Similarity=0.435  Sum_probs=200.0

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeec-CCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRR-RGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey  421 (687)
                      ++|+..++||+|+||.||+|++  .|+.||||+++.+.  ..++|.+|++++++++||||++++|+|.+ .+.+++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            4677889999999999999999  47899999997653  34679999999999999999999999854 4678999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +++|+|.++|.......++|..+++|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            999999999977666679999999999999999999998   99999999999999999999999999999865432   


Q ss_pred             ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCCC
Q 005621          502 STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLNG  580 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~  580 (687)
                       .....+|..|+|||++.++.++.++||||||+++|||+| |+.|+......+   +..++    ..+     ..+.   
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----~~~-----~~~~---  220 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKG-----YKMD---  220 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTT-----CCCC---
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcC-----CCCC---
Confidence             223467899999999999999999999999999999998 677766543222   12221    111     1122   


Q ss_pred             CCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          581 EFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       581 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                       ++......+.+|+.+||+.||++||||.+|+++|+..
T Consensus       221 -~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         221 -APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence             2223334788999999999999999999999999764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-48  Score=400.58  Aligned_cols=252  Identities=22%  Similarity=0.314  Sum_probs=208.7

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc------hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES------KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      .++|+..+.||+|+||+||+|+++.+|+.||||++.+..      ....+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999999999999999986542      12357899999999999999999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC----cEEEccccc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL----NGRLGDFGL  491 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGl  491 (687)
                      +||||||++|+|.+++..  ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++    .+||+|||+
T Consensus        89 ~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence            999999999999999943  4579999999999999999999998   9999999999999998776    499999999


Q ss_pred             ceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          492 AKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       492 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      ++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.       ...+..+.. 
T Consensus       164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~~-  233 (293)
T d1jksa_         164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAVNY-  233 (293)
T ss_dssp             CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTTCC-
T ss_pred             hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-------HHHHHhcCC-
Confidence            98765433  23345789999999999999999999999999999999999999986543211       111111111 


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                           ..........+..+.+|+.+||+.||++|||++|+++
T Consensus       234 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 -----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 1110011112346789999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-47  Score=407.83  Aligned_cols=257  Identities=20%  Similarity=0.269  Sum_probs=214.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|+..+.||+|+||+||+|++..+|+.||||+++.......+.+.+|+.+|++++||||+++++++.+++.++|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999999989999999999877666667889999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec--cCCcEEEcccccceeccCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD--SELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DFGla~~~~~~~  499 (687)
                      |++|+|.+++... ...+++.++..|+.||+.||.|||+   ++|+||||||+||||+  .++.+||+|||+|+.+... 
T Consensus       108 ~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-  182 (352)
T d1koba_         108 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  182 (352)
T ss_dssp             CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             CCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence            9999998877443 3469999999999999999999998   9999999999999998  5689999999999977543 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+.   .    ..+..+.      ....
T Consensus       183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~----~~i~~~~------~~~~  248 (352)
T d1koba_         183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---L----QNVKRCD------WEFD  248 (352)
T ss_dssp             -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H----HHHHHCC------CCCC
T ss_pred             -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHhCC------CCCC
Confidence             234456899999999999999999999999999999999999999976543211   1    1111111      1111


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ..........+.+|+.+||+.||++|||+.|+++  ++++
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            1111222347889999999999999999999987  4554

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-48  Score=405.82  Aligned_cols=264  Identities=26%  Similarity=0.417  Sum_probs=213.5

Q ss_pred             HHHHHhcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeee
Q 005621          337 ELKKATRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCR  410 (687)
Q Consensus       337 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  410 (687)
                      +++.-.++|+..+.||+|+||+||+|+++.     +++.||||+++... ....++|.+|++++++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            344456789999999999999999999753     45789999997654 334678999999999999999999999999


Q ss_pred             cCCeeEEEEecCCCCCchhhhhchh----------------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEe
Q 005621          411 RRGDLLLVYDFMPNGSLDKCLFDEQ----------------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIH  468 (687)
Q Consensus       411 ~~~~~~lV~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  468 (687)
                      ..+..++||||+++|+|.++|+...                      ...+++.+++.|+.|++.||+|||+   ++|+|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEe
Confidence            9999999999999999999995421                      2248999999999999999999998   99999


Q ss_pred             eccCCCcEEeccCCcEEEcccccceeccCCC-CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCC-CC
Q 005621          469 RDIKAGNVLLDSELNGRLGDFGLAKLYERGT-NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRR-PI  546 (687)
Q Consensus       469 rDlk~~NIll~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~-p~  546 (687)
                      |||||+||||+.++.+||+|||+++...... ....+...||+.|+|||++.+..++.++|||||||++|||++|.. ||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999998654332 223344678999999999999999999999999999999999864 56


Q ss_pred             CCCCCcchhhHHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          547 EPKALPEELILVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       547 ~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ......+   +.    .....+...     .    .+...+.++.+|+.+||+.+|++||||.||+++|+++.
T Consensus       244 ~~~~~~e---~~----~~v~~~~~~-----~----~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHEE---VI----YYVRDGNIL-----A----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHHH---HH----HHHHTTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHHH---HH----HHHHcCCCC-----C----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            5543221   11    122222221     1    12223347889999999999999999999999998764

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

Probab=100.00  E-value=9.7e-47  Score=379.47  Aligned_cols=225  Identities=27%  Similarity=0.479  Sum_probs=194.7

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      .+++|+|++|.++  +.+|+|+|+|.+. ++.|+||++.      .+++|||+|++||+||++. ++.+++|+|+|+|.|
T Consensus         2 ~~~sF~f~~F~~~--~~~l~l~G~A~i~-~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~-~~~~~sF~t~F~f~i   77 (241)
T d1ukga_           2 DSLSFGFPTFPSD--QKNLIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKS-SSRVANFQSQFSFSL   77 (241)
T ss_dssp             CEEEEEESSCCSC--CSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECEETT-TTEEEEEEEEEEEEE
T ss_pred             ccEEEEeCCCCCC--CCCEEEeeeEEEe-CCEEEeCCCCCCCCccccceEEEEeCCCeecccCC-CCceeeeEEEEEEEE
Confidence            3578999999764  3689999999997 7899999754      4689999999999999987 789999999999999


Q ss_pred             eecCCCCCCcceEEEEccCC-CCCCCCCCccccccccCC-CCCCcceEEEEEeecccCCCCC--CCCCCeeeEEeCCCCc
Q 005621           96 VPEYTALGGHGFAFTISASK-ELPGTLPSQYLGLLNSSD-LGNLTNHIFAVEFDTVKDFEFG--DINDNHVGIDINSLRS  171 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgi~~ns~~s  171 (687)
                      ..+ ....|||+||++.|.. ..|...+|+++|+++... .+...++.+||||||++|.+.+  ||++||||||+|++.|
T Consensus        78 ~~~-~~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s  156 (241)
T d1ukga_          78 KSP-LSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRS  156 (241)
T ss_dssp             ECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSC
T ss_pred             ecC-CCCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCccc
Confidence            765 4457999999998754 557778888899887654 3456789999999999987544  4889999999999998


Q ss_pred             ccccccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc
Q 005621          172 NASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL  251 (687)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~  251 (687)
                      ..+.+            ..+.+|+.++|||+||+..++|+|++++.  ++..|.+++.|||+++|+++||||||||||..
T Consensus       157 ~~~~~------------~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~  222 (241)
T d1ukga_         157 VKTVK------------WDRRDGQSLNVLVTFNPSTRNLDVVATYS--DGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQ  222 (241)
T ss_dssp             SEEEE------------CCCCTTCCEEEEEEEETTTTEEEEEEEET--TCCEEEEEEECCGGGTSCSEEEEEEEEEESSS
T ss_pred             ccccc------------cccCCCcEEEEEEEEeCCCcEEEEEEccC--CCCceEEEEEEehHHhCCCcEEEEEEEecCCC
Confidence            76543            46789999999999999999999999874  56778899999999999999999999999999


Q ss_pred             cceeEEEEeeeccC
Q 005621          252 ASSHYILGWSFNMS  265 (687)
Q Consensus       252 ~~~~~i~sWsf~~~  265 (687)
                      .|.|+|++|+|++.
T Consensus       223 ~~~H~IlsWsFss~  236 (241)
T d1ukga_         223 YQTHTLESWSFTST  236 (241)
T ss_dssp             CCEEEEEEEEEEEE
T ss_pred             CceeEEEEeEEEEE
Confidence            99999999999863

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=396.84  Aligned_cols=256  Identities=24%  Similarity=0.336  Sum_probs=198.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .++|+..+.||+|+||+||+|++..+   +..||||.++... ....+.|.+|++++++++||||+++++++. .+.+++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            35788999999999999999998643   3579999987653 344577999999999999999999999996 467899


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||+++....
T Consensus        85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            99999999999987543 4569999999999999999999999   9999999999999999999999999999997765


Q ss_pred             CCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccCC
Q 005621          498 GTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVDP  576 (687)
Q Consensus       498 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~  576 (687)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |..||......+.   ..    ....+..     +
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~----~i~~~~~-----~  228 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG----RIENGER-----L  228 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTCC-----C
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HH----HHHcCCC-----C
Confidence            55445556778999999999999999999999999999999998 8888876554321   11    1122211     1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          577 RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       577 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ..    +...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus       229 ~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         229 PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            12    222334788999999999999999999999988754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-48  Score=403.90  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=204.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCe----EEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNT----QVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  417 (687)
                      .+|+..++||+|+||+||+|.+..+|+    +||+|+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            358999999999999999999877665    6899988654 344567899999999999999999999999865 5678


Q ss_pred             EEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccC
Q 005621          418 VYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYER  497 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~  497 (687)
                      ++||+.+|+|.+++... ...+++..+++++.|||.||.|||+   ++|+||||||+||||+.++.+||+|||+++....
T Consensus        88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            89999999999987543 4579999999999999999999999   8999999999999999999999999999997654


Q ss_pred             CCCCc-eeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          498 GTNPS-TTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       498 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ..... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+..       .....+..     
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-------~~i~~~~~-----  231 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGER-----  231 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-------HHHHHTCC-----
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCC-----
Confidence            43322 334568999999999999999999999999999999998 78888765432211       11112211     


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                          ...+...+..+.+|+.+||+.||++|||+.||++.|+...
T Consensus       232 ----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                1122233447889999999999999999999999887643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.8e-47  Score=389.77  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=204.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC----e
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG----D  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~  414 (687)
                      .++|+..+.||+|+||+||+|++..+++.||||+++...   ....++|.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999999999999999997643   334567999999999999999999999987654    4


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      +||||||+++++|.+++.  ..+.+++.++..++.||+.||.|||+   ++|+||||||+|||++.++..+|+|||.++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence            799999999999999884  44579999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCC--CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          495 YERGTN--PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       495 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+      ...+....+....
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~~  234 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPP  234 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCG
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCCCC
Confidence            543322  23345679999999999999999999999999999999999999997654221      1222222221110


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCC-CHHHHHHHHhc
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARP-TMRQVVRYLEG  617 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~  617 (687)
                         ......+    +..+.+++.+||+.||++|| +++++++.|.+
T Consensus       235 ---~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 ---SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ---GGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---chhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence               0111222    23788999999999999999 89999988765

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=396.52  Aligned_cols=248  Identities=25%  Similarity=0.318  Sum_probs=210.3

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|+++.+++.||||++++..   ....+++.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57999999999999999999999999999999997642   334677899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |||++|+|.+++.  ..+.+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+......
T Consensus        85 ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          85 EYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            9999999999884  44579999999999999999999999   999999999999999999999999999998654332


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+       +.+....+.      ..+.
T Consensus       160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~------~~~p  225 (337)
T d1o6la_         160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEE------IRFP  225 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------CCCC
T ss_pred             -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCC------CCCC
Confidence             23345789999999999999999999999999999999999999998765321       111221211      1122


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                      ..+    ..++.+|+.+||+.||++||+     +.|+++
T Consensus       226 ~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         226 RTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             TTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ccC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            223    346789999999999999995     788876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=392.32  Aligned_cols=255  Identities=27%  Similarity=0.390  Sum_probs=198.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCC---CeEEEEEEecCc---chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPST---NTQVAVKRVSNE---SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ++|+..+.||+|+||+||+|++...   ...||||++.+.   ..+..++|.+|+.++++++||||++++|+|.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            5688899999999999999986432   347999998754   33446789999999999999999999999976 4678


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +||||+++|+|.+++... ...+++..+++++.|||.||.|||+   ++|+||||||+||||+.++++||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            999999999999988653 4469999999999999999999998   999999999999999999999999999999875


Q ss_pred             CCCCC--ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcccccccc
Q 005621          497 RGTNP--STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELILVDWVWDRWKAGAILEV  573 (687)
Q Consensus       497 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~  573 (687)
                      .....  ......||..|+|||++.+..++.++|||||||++|||+| |+.||......+   ...++   ...+.    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i---~~~~~----  232 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKI---DKEGE----  232 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---HTSCC----
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHH---HhCCC----
Confidence            54332  2233567889999999999999999999999999999998 899997654322   11111   11111    


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhc
Q 005621          574 VDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEG  617 (687)
Q Consensus       574 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  617 (687)
                       .+    +.+...+..+.+|+.+||+.||++|||+.||+++|++
T Consensus       233 -~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         233 -RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             -CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence             11    1122223478899999999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.9e-47  Score=395.97  Aligned_cols=245  Identities=24%  Similarity=0.315  Sum_probs=207.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|+++.+|+.||||++++..   ....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56899999999999999999999999999999997542   334578899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      |||++|+|..++.  ....+++.++..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+..... 
T Consensus        84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            9999999998884  44568899999999999999999998   99999999999999999999999999999876432 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         .....||+.|||||++.+..++.++|||||||++|||++|+.||......+.       ......+.      ..+.
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~------~~~p  221 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKILNAE------LRFP  221 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHCC------CCCC
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-------HHHHHcCC------CCCC
Confidence               2346899999999999999999999999999999999999999986543211       11111111      1112


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ..+    ..++.+++.+||+.||.+||     +++++++
T Consensus       222 ~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 PFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             TTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            222    33688999999999999996     8999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=397.05  Aligned_cols=256  Identities=28%  Similarity=0.432  Sum_probs=205.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCe--EEEEEEecCc-chhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNT--QVAVKRVSNE-SKQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|+..++||+|+||+||+|+++.++.  .||||+++.. .....++|.+|+++|+++ +||||++++++|.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578888999999999999999987776  4788887654 344567899999999999 799999999999999999999


Q ss_pred             EecCCCCCchhhhhch--------------hhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcE
Q 005621          419 YDFMPNGSLDKCLFDE--------------QKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNG  484 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~  484 (687)
                      |||+++|+|.++|+..              ....+++.++.+++.|||.||.|||+   ++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence            9999999999999643              23569999999999999999999999   999999999999999999999


Q ss_pred             EEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCC-CCCCCCCcchhhHHHHHHH
Q 005621          485 RLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRR-PIEPKALPEELILVDWVWD  563 (687)
Q Consensus       485 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~-p~~~~~~~~~~~~~~~v~~  563 (687)
                      ||+|||+++.......  .....||..|+|||.+.++.++.++|||||||++|||++|.. ||......+       +.+
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE  237 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHH
Confidence            9999999986543222  233568999999999999999999999999999999999765 555433211       112


Q ss_pred             HhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          564 RWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       564 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ....+.     .+.    .+...+.++.+|+.+||+.||++||||.||++.|++..
T Consensus       238 ~i~~~~-----~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         238 KLPQGY-----RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             HGGGTC-----CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhcC-----CCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            222221     121    22223347889999999999999999999999988764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.4e-46  Score=384.89  Aligned_cols=251  Identities=23%  Similarity=0.318  Sum_probs=207.5

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---------hhhHHHHHHHHHHHhhhc-CCCceeeeeeeecC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---------KQGLREFASEISSIGRLR-HRNLVQLLGWCRRR  412 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~  412 (687)
                      ++|+..+.||+|+||+||+|++..+++.||||++....         ....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67999999999999999999999899999999986542         122346889999999997 99999999999999


Q ss_pred             CeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccc
Q 005621          413 GDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLA  492 (687)
Q Consensus       413 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla  492 (687)
                      +..|||||||++|+|.++|.  ..+.+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999995  34579999999999999999999998   99999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccC------CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRT------GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWK  566 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~  566 (687)
                      +......  ......||..|+|||++.+      ..++.++||||+||++|||++|+.||.......       ..+...
T Consensus       158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~  228 (277)
T d1phka_         158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIM  228 (277)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred             eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHH
Confidence            9775533  2344679999999999863      356889999999999999999999998654211       111122


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          567 AGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       567 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .+...      .........+.++.+++.+||+.||++||++.||++
T Consensus       229 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            22111      111111123347889999999999999999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-47  Score=394.25  Aligned_cols=259  Identities=29%  Similarity=0.404  Sum_probs=200.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecC-C
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRR-G  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~  413 (687)
                      .++|+..++||+|+||+||+|++..     +++.||||+++... ....+++..|...+.++ +|+||+++++++.+. +
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            3678999999999999999999743     34789999987643 44467788899888887 689999999988654 5


Q ss_pred             eeEEEEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD  479 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  479 (687)
                      .+++|||||++|+|.++|....              ...+++.++..++.||+.||.|||+   ++|+||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence            6899999999999999996532              2358999999999999999999998   9999999999999999


Q ss_pred             cCCcEEEcccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCC-CCCCCCCCcchhhH
Q 005621          480 SELNGRLGDFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGR-RPIEPKALPEELIL  557 (687)
Q Consensus       480 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~-~p~~~~~~~~~~~~  557 (687)
                      +++.+||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||+||. .||......+.   
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---  245 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---  245 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            999999999999986644332 2334467999999999999999999999999999999999975 56765443321   


Q ss_pred             HHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          558 VDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       558 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                         +......+..     +..    +...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus       246 ---~~~~~~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         246 ---FCRRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             ---HHHHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHhcCCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               1222222221     112    222234788999999999999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=393.48  Aligned_cols=253  Identities=28%  Similarity=0.407  Sum_probs=203.4

Q ss_pred             ceeeeeeCeEEEEEEEeCCCC---eEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeec-CCeeEEEEecC
Q 005621          348 KELLGFGGFGRVYKGTLPSTN---TQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRR-RGDLLLVYDFM  422 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~  422 (687)
                      .++||+|+||+||+|++..++   ..||||+++.. .....++|.+|++++++++||||++++|+|.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            468999999999999986543   46999999754 45566889999999999999999999999865 56899999999


Q ss_pred             CCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC-
Q 005621          423 PNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP-  501 (687)
Q Consensus       423 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-  501 (687)
                      ++|+|.+++... ...+++..+++++.|++.||.|||+   ++|+||||||+||||++++.+||+|||+++........ 
T Consensus       112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            999999988543 3457899999999999999999998   99999999999999999999999999999876543322 


Q ss_pred             --ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          502 --STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       502 --~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                        ......||..|+|||.+.++.++.++||||||+++|||+||+.||........  ...++    ..+..     +.  
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i----~~g~~-----~~--  254 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL----LQGRR-----LL--  254 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCC-----CC--
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCCC-----CC--
Confidence              22335689999999999999999999999999999999998888765443221  11111    12211     11  


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                        .+......+.+|+.+||+.||++||+|.||++.|++..
T Consensus       255 --~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         255 --QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence              11222347889999999999999999999999998763

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=392.79  Aligned_cols=266  Identities=25%  Similarity=0.292  Sum_probs=202.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC----eeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG----DLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV  418 (687)
                      +.|...+.||+|+||+||+|++  +|+.||||+++..... ...+..|+..+.+++||||++++++|.+.+    .+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            5677889999999999999998  6899999999754332 122344666667889999999999997654    68999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccc-----cCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEW-----EQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ||||++|+|.++|..   ..++|.++++++.|+|.||+|||+..     .++|+||||||+||||+.++.+||+|||+++
T Consensus        80 ~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999943   46999999999999999999999732     3799999999999999999999999999999


Q ss_pred             eccCCCCC---ceeeeecCCCCCchhhccCCC------CCCccceehhhHHHHHHHhCCCCCCCCCCcchh--------h
Q 005621          494 LYERGTNP---STTRVVGTLGYLAPELTRTGK------PTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL--------I  556 (687)
Q Consensus       494 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~--------~  556 (687)
                      ........   ......||+.|+|||++....      ++.++|||||||+||||+||..|+.........        .
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            77554321   233467999999999987642      567899999999999999999887543321110        0


Q ss_pred             HHHHHHHHhcccccccccCCcCCCCC-CHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          557 LVDWVWDRWKAGAILEVVDPRLNGEF-NEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       557 ~~~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ..+.......    .+..+|.+...+ .......+.+|+.+||+.||++|||+.||++.|+..
T Consensus       237 ~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         237 SVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            1111222111    112233332222 223556788999999999999999999999998753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-47  Score=393.72  Aligned_cols=258  Identities=27%  Similarity=0.398  Sum_probs=208.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCC-------eEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCC
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTN-------TQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRG  413 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  413 (687)
                      ++|...+.||+|+||.||+|+....+       ..||||+++... .....++.+|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            57888999999999999999875433       479999997764 34567899999999998 8999999999999999


Q ss_pred             eeEEEEecCCCCCchhhhhchh--------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQ--------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD  479 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  479 (687)
                      ..++||||+++|+|.++|....              ...+++.++++++.||+.||+|||+   ++|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence            9999999999999999996432              2458999999999999999999999   9999999999999999


Q ss_pred             cCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHh-CCCCCCCCCCcchhhH
Q 005621          480 SELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVC-GRRPIEPKALPEELIL  557 (687)
Q Consensus       480 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~  557 (687)
                      .++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||++ |..||......     
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-----  244 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-----  244 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-----
Confidence            9999999999999977554332 2344678999999999999999999999999999999998 67777654421     


Q ss_pred             HHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          558 VDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       558 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                        .+++.+..+..     +.....    .+.++.+|+.+||+.||++|||+.||++.|+++.
T Consensus       245 --~~~~~i~~~~~-----~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         245 --ELFKLLKEGHR-----MDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             --HHHHHHHTTCC-----CCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHHcCCC-----CCCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence              12222322221     112222    2347889999999999999999999999998764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=393.05  Aligned_cols=259  Identities=25%  Similarity=0.356  Sum_probs=211.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeC-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhh-cCCCceeeeeeeecCCe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLP-----STNTQVAVKRVSNES-KQGLREFASEISSIGRL-RHRNLVQLLGWCRRRGD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  414 (687)
                      .++|+..++||+|+||.||+|++.     ..++.||||+++... .....+|.+|+.+++++ +|||||+++++|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            468888999999999999999863     456789999998654 34456799999999999 69999999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchh----------------hccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEe
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQ----------------KAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLL  478 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  478 (687)
                      .++|||||++|+|.++++...                ...+++..+.+++.||+.||+|||+   ++++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence            999999999999999996432                2358999999999999999999999   999999999999999


Q ss_pred             ccCCcEEEcccccceeccCCCCC-ceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCC-CCCCCCcchhh
Q 005621          479 DSELNGRLGDFGLAKLYERGTNP-STTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRP-IEPKALPEELI  556 (687)
Q Consensus       479 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p-~~~~~~~~~~~  556 (687)
                      +.++.+|++|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+|++.| +......+.. 
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~-  257 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-  257 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence            99999999999999976554332 23346789999999999999999999999999999999995555 4443332211 


Q ss_pred             HHHHHHHHhcccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          557 LVDWVWDRWKAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       557 ~~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                       ...+    ..+.     .+    ..+...+..+.+|+.+||+.||++||||.||+++|++.
T Consensus       258 -~~~i----~~~~-----~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         258 -YKMI----KEGF-----RM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             -HHHH----HHTC-----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHH----hcCC-----CC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence             1111    1111     11    11222334788999999999999999999999999864

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

Probab=100.00  E-value=3e-46  Score=372.49  Aligned_cols=215  Identities=32%  Similarity=0.482  Sum_probs=184.8

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCC------CeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTL------RVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~------~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      +..+|+|++|+.+   ++|+|+|+|.+.++|.|+||+...      +++|||+|++||+||++   ++++||+|+|+|.|
T Consensus         2 ~~~sF~f~~F~~~---~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~~---~~~~sFst~F~f~i   75 (228)
T d1ioaa_           2 TETSFNFPNFHTD---DKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS---NNVASFNTNFTFII   75 (228)
T ss_dssp             CCCEEEESSCCTT---SSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCS---SCBEEEEEEEEEEC
T ss_pred             ccceEEcCCCCCC---CcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecCC---CceeeEEEEEEEEE
Confidence            4578999999874   579999999998789999998654      47899999999999984   56899999999999


Q ss_pred             eecCCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccc
Q 005621           96 VPEYTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASE  175 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~  175 (687)
                      .+.+...+||||||+|+|....+ +..|++||+++... ++..++.|||||||++|.  .|++.+||++++++..     
T Consensus        76 ~~~~~~~~gDGlAF~l~~~~~~~-~~~g~~lgl~~~~~-~~~~~~~vave~dt~~n~--~~~~~~~~~~~~~~~~-----  146 (228)
T d1ioaa_          76 RAKNQSISAYGLAFALVPVNSPP-QKKQEFLGIFNTNN-PEPNARTVAVVFNTFKNR--IDFDKNFIKPYVNENC-----  146 (228)
T ss_dssp             CBSCTTSCCEEEEEEEEETTCCC-CCCGGGTTTCCCSS-CCGGGCCEEEEEETTTTE--EEEEESSSSCSEEEEC-----
T ss_pred             ecCCCCCCCCEEEEEEeCCCCCC-CCCccccccccccC-CCCcceeEEEEecCcccc--ccCCCCccceeccccc-----
Confidence            98877789999999999987544 46788999988543 456788999999999885  4777788877776421     


Q ss_pred             ccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCC---ccc
Q 005621          176 PAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTG---LLA  252 (687)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG---~~~  252 (687)
                                  ...+.+|+.++|||+||+..++|+|+|.+.. +|..|.|++.+||+++|+++||||||||||   ...
T Consensus       147 ------------~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~  213 (228)
T d1ioaa_         147 ------------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTT  213 (228)
T ss_dssp             ------------CHHHHCSSCEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTC
T ss_pred             ------------ccccccCcEEEEEEEEcCCCCEEEEEEEeCC-CCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCc
Confidence                        2456789999999999999999999999765 788899999999999999999999999999   567


Q ss_pred             ceeEEEEeeecc
Q 005621          253 SSHYILGWSFNM  264 (687)
Q Consensus       253 ~~~~i~sWsf~~  264 (687)
                      |.|+|++|+|++
T Consensus       214 ~~h~I~sWsFss  225 (228)
T d1ioaa_         214 ETHDVLSWSFSS  225 (228)
T ss_dssp             BCCEEEEEEEEE
T ss_pred             eEEEEEEEEeEE
Confidence            999999999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.6e-46  Score=395.10  Aligned_cols=249  Identities=23%  Similarity=0.312  Sum_probs=203.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHH---HHHHHHHhhhcCCCceeeeeeeecCCeeE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREF---ASEISSIGRLRHRNLVQLLGWCRRRGDLL  416 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~~~~~~~~~~~  416 (687)
                      ++|+..++||+|+||+||+|++..+|+.||||++.+..   ......+   ..|+.+++.++||||+++++++.+.+.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999999999999999986532   1222333   34577777888999999999999999999


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      +|||||++|+|.++|.  ....+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        84 ivmE~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHH--hcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999999994  34578999999999999999999999   999999999999999999999999999999765


Q ss_pred             CCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC
Q 005621          497 RGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD  575 (687)
Q Consensus       497 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d  575 (687)
                      ...   .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..........+    ......      ..
T Consensus       159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~------~~  225 (364)
T d1omwa3         159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MA  225 (364)
T ss_dssp             SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSS------CC
T ss_pred             CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhccc------CC
Confidence            432   334579999999999975 4689999999999999999999999987654332211    111111      11


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          576 PRLNGEFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       576 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                      +.+...++    .++.+|+.+||+.||++||+     ++|+++
T Consensus       226 ~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11222233    36889999999999999999     688876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=392.74  Aligned_cols=259  Identities=24%  Similarity=0.393  Sum_probs=211.5

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCC-----CCeEEEEEEecCc-chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCee
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPS-----TNTQVAVKRVSNE-SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDL  415 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  415 (687)
                      .++|...+.||+|+||+||+|.+..     .++.||||+++.. .......|.+|++++++++||||++++++|...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            3678889999999999999998742     3578999999764 344556799999999999999999999999999999


Q ss_pred             EEEEecCCCCCchhhhhchhh--------ccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQK--------AILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~--------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~  487 (687)
                      ++||||+++|+|.+++.....        ..+++.++.+++.|+|+||.|||+   ++|+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence            999999999999999865332        247999999999999999999998   899999999999999999999999


Q ss_pred             ccccceeccCCCC-CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHHh
Q 005621          488 DFGLAKLYERGTN-PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGR-RPIEPKALPEELILVDWVWDRW  565 (687)
Q Consensus       488 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~~~v~~~~  565 (687)
                      |||+++....... .......||+.|+|||.+.++.++.++||||||+++|||+||. .|+......+       +.+..
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------~~~~i  248 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFV  248 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence            9999986644332 2233457899999999999999999999999999999999985 5565433211       11122


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcCC
Q 005621          566 KAGAILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGEV  619 (687)
Q Consensus       566 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  619 (687)
                      ..+....         .+...+..+.+++.+||+.+|++||||++|++.|++..
T Consensus       249 ~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         249 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            2222211         11222347899999999999999999999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-45  Score=390.16  Aligned_cols=245  Identities=22%  Similarity=0.285  Sum_probs=208.1

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~  419 (687)
                      ++|+..+.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+++|++++||||+++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999999999999999987542   234567899999999999999999999999999999999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~  499 (687)
                      ||+.+|+|.+++.  ..+.+++.++..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+..... 
T Consensus       121 e~~~~g~l~~~l~--~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccchhhhHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            9999999999984  34579999999999999999999998   99999999999999999999999999999976432 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                         .....||+.|||||++.+..++.++|||||||++|||+||+.||.......       +...+..+.      +...
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~------~~~p  258 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGK------VRFP  258 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC------CCCC
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-------HHHHHhcCC------CCCC
Confidence               234679999999999999999999999999999999999999997653211       111111111      1112


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCC-----CHHHHHH
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARP-----TMRQVVR  613 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  613 (687)
                      ..+    ..++.+++.+||+.||.+|+     +++++++
T Consensus       259 ~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 SHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             TTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            223    33688999999999999994     8999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=393.01  Aligned_cols=261  Identities=22%  Similarity=0.275  Sum_probs=205.5

Q ss_pred             hcCcccc-eeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhh-cCCCceeeeeeeec----CCee
Q 005621          342 TRGFRDK-ELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRL-RHRNLVQLLGWCRR----RGDL  415 (687)
Q Consensus       342 t~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~  415 (687)
                      .++|.+. +.||+|+||+||+|++..+++.||||+++..     ..+.+|+.++.++ +||||+++++++.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            3578876 4699999999999999989999999998653     4567899887665 89999999999865    4678


Q ss_pred             EEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc---CCcEEEcccccc
Q 005621          416 LLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS---ELNGRLGDFGLA  492 (687)
Q Consensus       416 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla  492 (687)
                      |+|||||+||+|.++|.......+++.++..|+.||+.||.|||+   ++|+||||||+|||++.   ++.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence            999999999999999976545579999999999999999999998   99999999999999986   457999999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      +......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||.........   ..+......+    
T Consensus       162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~----  232 (335)
T d2ozaa1         162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMG----  232 (335)
T ss_dssp             EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC----
T ss_pred             eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcC----
Confidence            8765433  234467999999999999999999999999999999999999999765432211   0011111100    


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCCCC
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEVPL  621 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~  621 (687)
                        ...+..........++.+|+.+||+.||++|||+.|+++  ++.+....
T Consensus       233 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  281 (335)
T d2ozaa1         233 --QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  281 (335)
T ss_dssp             --SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred             --CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence              001111111223457889999999999999999999998  45544433

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-46  Score=387.48  Aligned_cols=262  Identities=26%  Similarity=0.301  Sum_probs=200.5

Q ss_pred             cceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchh-----hHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          347 DKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQ-----GLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       347 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      ..++||+|+||+||+|+++.+|+.||||+++.....     ..+.+.+|+.++++++|||||++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999999999999999998654322     134688999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTNP  501 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  501 (687)
                      +.++++..++  .....+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          82 METDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             CSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             hcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            9988777655  334568999999999999999999998   9999999999999999999999999999986654332 


Q ss_pred             ceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccC-----
Q 005621          502 STTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVD-----  575 (687)
Q Consensus       502 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d-----  575 (687)
                      ......||+.|+|||++... .++.++|||||||++|||++|+.||......+..   ..+.+...........+     
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSST
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccc
Confidence            22345799999999998754 5799999999999999999999999765432221   11111111000000000     


Q ss_pred             -C-cC--CCCCC-----HHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          576 -P-RL--NGEFN-----EIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       576 -~-~l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                       . ..  ....+     .....++.+|+.+||+.||++|||++|+++  +++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence             0 00  00011     112347889999999999999999999997  5653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-46  Score=389.12  Aligned_cols=248  Identities=23%  Similarity=0.370  Sum_probs=206.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc---hhhHHHHHHHHHHHh-hhcCCCceeeeeeeecCCeeEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES---KQGLREFASEISSIG-RLRHRNLVQLLGWCRRRGDLLLV  418 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV  418 (687)
                      ++|...+.||+|+||+||+|+++.+++.||||++++..   ....+.+..|..++. .++||||+++++++.+++..|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999999999999999997542   234456777777765 68999999999999999999999


Q ss_pred             EecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCC
Q 005621          419 YDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       419 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~  498 (687)
                      ||||++|+|.+++.  ....+++.++..++.||+.||.|||+   ++|+||||||+|||+++++++||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999994  44568999999999999999999999   99999999999999999999999999999865443


Q ss_pred             CCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcC
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRL  578 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l  578 (687)
                      . ...+...||+.|+|||++.++.++.++|||||||++|||++|+.||......+       +......+      .+.+
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~------~~~~  222 (320)
T d1xjda_         157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMD------NPFY  222 (320)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC------CCCC
T ss_pred             c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC------CCCC
Confidence            3 23344679999999999999999999999999999999999999998654321       22222222      1222


Q ss_pred             CCCCCHHHHHHHHHHHHhccccCcCcCCCHH-HHHH
Q 005621          579 NGEFNEIEALDVVKLGLMCSNDAAEARPTMR-QVVR  613 (687)
Q Consensus       579 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~  613 (687)
                      ...+    ...+.+|+.+||+.||++||++. ++++
T Consensus       223 p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         223 PRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            2222    34688999999999999999996 6764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=387.98  Aligned_cols=256  Identities=19%  Similarity=0.271  Sum_probs=210.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEec
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYDF  421 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey  421 (687)
                      .++|...+.||+|+||+||+|.++.+++.||||+++..... ...+.+|+++|++++||||+++++++.+.+.+||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            46899999999999999999999999999999999775433 35688999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC--CcEEEcccccceeccCCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE--LNGRLGDFGLAKLYERGT  499 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DFGla~~~~~~~  499 (687)
                      |++|+|.+++... ...+++.++..|+.||+.||.|||+   ++|+||||||+|||++.+  ..+||+|||+++..... 
T Consensus        83 ~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-  157 (321)
T d1tkia_          83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence            9999999998543 3369999999999999999999998   999999999999999854  57999999999876432 


Q ss_pred             CCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccccccCCcCC
Q 005621          500 NPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILEVVDPRLN  579 (687)
Q Consensus       500 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~~~d~~l~  579 (687)
                       .......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+.       ...+..+...  .+....
T Consensus       158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-------~~~i~~~~~~--~~~~~~  227 (321)
T d1tkia_         158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-------IENIMNAEYT--FDEEAF  227 (321)
T ss_dssp             -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCC--CCHHHH
T ss_pred             -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC--CChhhc
Confidence             234456799999999999999999999999999999999999999987543211       1111111100  000000


Q ss_pred             CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          580 GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       580 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      ..    ...++.+|+.+||+.||++|||+.|+++  ++.+
T Consensus       228 ~~----~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         228 KE----ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             cC----CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            11    1236789999999999999999999998  4544

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.2e-45  Score=367.79  Aligned_cols=216  Identities=33%  Similarity=0.499  Sum_probs=191.4

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecC---CCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeec
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTN---TTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPE   98 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~---~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~   98 (687)
                      .+++|+|++|..    .||+|+|||.+.++|.|+||+   ...+++|||+|++||+||++. ++.++||+|+|+|.|.+.
T Consensus         2 ~~~sf~f~~F~~----~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~~~-~~~~~sF~t~f~f~i~~~   76 (226)
T d1avba_           2 NDASFNVETFNK----TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRT-IDNLASFSTNFTFRINAK   76 (226)
T ss_dssp             EEEEEEESSCCG----GGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGG-GTEEEEEEEEEEEEEEES
T ss_pred             CceEEECCCCCc----cceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcccCC-CCcccceEEEEEEEEecC
Confidence            467999999987    589999999998788999996   445689999999999999987 789999999999999988


Q ss_pred             CCCCCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccccc
Q 005621           99 YTALGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAA  178 (687)
Q Consensus        99 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~  178 (687)
                      +...+||||||+|+|....+ +..++++|+++.          ++|||||+.|...+|+..||||||+|+..+..+.+. 
T Consensus        77 ~~~~~gDG~aF~i~~~~~~~-g~~gg~~gl~~~----------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~-  144 (226)
T d1avba_          77 NIENSAYGLAFALVPVGSRP-KLKGRYLGLFNT----------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESC-  144 (226)
T ss_dssp             STTSCCEEEEEEEEETTCCC-CCCGGGTTTCSC----------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCceEEEEEccCCCCC-CCccccCCcccc----------ccccccceeccccccCCCCEEEEeCCCCcccccccc-
Confidence            78889999999999987554 457888999753          368999999987679999999999999988777654 


Q ss_pred             cccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCc---cccee
Q 005621          179 YFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGL---LASSH  255 (687)
Q Consensus       179 ~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~---~~~~~  255 (687)
                               ...+.+|+.++|||+||+.+++|+|++.+.. +|..|.++..+||+.+||++|||||||+||.   ..|.|
T Consensus       145 ---------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H  214 (226)
T d1avba_         145 ---------NFGHNNGEKAEVRITYDSPKNDLRVSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETH  214 (226)
T ss_dssp             ---------CSGGGTTCEEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEE
T ss_pred             ---------ccccCCCeEEEEEEEEcCCCcEEEEEEEeCC-CCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeee
Confidence                     3567799999999999999999999999876 7788889999999999999999999999995   56889


Q ss_pred             EEEEeeecc
Q 005621          256 YILGWSFNM  264 (687)
Q Consensus       256 ~i~sWsf~~  264 (687)
                      +|+||+|++
T Consensus       215 ~IlsWsF~s  223 (226)
T d1avba_         215 NVLSWSFSS  223 (226)
T ss_dssp             EEEEEEEEE
T ss_pred             EEEEEEeEE
Confidence            999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-45  Score=379.25  Aligned_cols=268  Identities=24%  Similarity=0.347  Sum_probs=205.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..+.||+|+||+||+|++..+++.||||+++...  ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999999999999999996543  2335788999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+.+ ++.+++.......+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9965 55555555555679999999999999999999998   9999999999999999999999999999986643322


Q ss_pred             CceeeeecCCCCCchhhccCCC-CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc------cccc
Q 005621          501 PSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA------ILEV  573 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~------~~~~  573 (687)
                       ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+...   .+........      ....
T Consensus       158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF---RIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGS
T ss_pred             -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH---HHHHhcCCCchhhccccccc
Confidence             233457999999999877655 5789999999999999999999998654322111   1111110000      0000


Q ss_pred             --cCCcCC----CCC---CHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          574 --VDPRLN----GEF---NEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       574 --~d~~l~----~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                        ..+...    ..+   .......+.+|+.+||+.||++|||+.|+++  ++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence              000000    000   0012246789999999999999999999998  46543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-45  Score=375.22  Aligned_cols=244  Identities=26%  Similarity=0.397  Sum_probs=200.4

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch------hhHHHHHHHHHHHhhhc--CCCceeeeeeeecCCe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK------QGLREFASEISSIGRLR--HRNLVQLLGWCRRRGD  414 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~  414 (687)
                      ++|+..++||+|+||+||+|++..+++.||||++.....      ....++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            679999999999999999999999999999999875421      12234678999999996  8999999999999999


Q ss_pred             eEEEEecCCC-CCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccC-CcEEEcccccc
Q 005621          415 LLLVYDFMPN-GSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSE-LNGRLGDFGLA  492 (687)
Q Consensus       415 ~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla  492 (687)
                      .++||||+.+ +++.+++.  ....+++.++..++.||+.||.|||+   ++|+||||||+|||++.+ +.+||+|||++
T Consensus        84 ~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 56667663  34579999999999999999999998   999999999999999855 79999999999


Q ss_pred             eeccCCCCCceeeeecCCCCCchhhccCCCC-CCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccccc
Q 005621          493 KLYERGTNPSTTRVVGTLGYLAPELTRTGKP-TTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAIL  571 (687)
Q Consensus       493 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~  571 (687)
                      +.....   ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....         +    ..+.  
T Consensus       159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i----~~~~--  220 (273)
T d1xwsa_         159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------I----IRGQ--  220 (273)
T ss_dssp             EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H----HHCC--
T ss_pred             eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------H----hhcc--
Confidence            865432   2334679999999999987665 5679999999999999999999975210         0    0111  


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          572 EVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       572 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                          ..+...++    .++.+++.+||+.||++|||++|+++  ++++
T Consensus       221 ----~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         221 ----VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             ----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             ----cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                11222233    36889999999999999999999987  4543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.1e-44  Score=371.53  Aligned_cols=261  Identities=23%  Similarity=0.321  Sum_probs=200.9

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|...++||+|+||+||+|+++ +++.||||+++...  ....+++.+|+.+|++++||||+++++++...+..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            58999999999999999999995 68999999997653  2335789999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      |+.++.+..+..  ....+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        81 ~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          81 HLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             eehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            998877666653  34579999999999999999999998   8999999999999999999999999999987644322


Q ss_pred             CceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc------cccc
Q 005621          501 PSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA------ILEV  573 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~------~~~~  573 (687)
                       ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+...   .+........      ..+.
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGS
T ss_pred             -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH---HHHHhhCCCChhhccchhhh
Confidence             23334689999999998754 57899999999999999999999997654322111   1111110000      0000


Q ss_pred             --cCCcC-------CCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          574 --VDPRL-------NGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       574 --~d~~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        .+...       ...+.......+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00000       01111122347889999999999999999999985

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.8e-43  Score=345.93  Aligned_cols=198  Identities=29%  Similarity=0.480  Sum_probs=165.7

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCC
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTA  101 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~  101 (687)
                      ...+|+|++|..    .||+|+|||.+.++|.|+||++..+++|||+|++||+||++. +++++||+|+|+|.|.+.+..
T Consensus         2 ~~~sF~~~~F~~----~~l~l~GdA~v~~~g~i~LT~~~~~~~G~~~y~~Pi~l~~~~-~~~~~sF~t~F~f~i~~~~~~   76 (204)
T d1dhkb_           2 TETSFIIDAFNK----TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDST-TGNVASFDTNFTMNIRTHRQA   76 (204)
T ss_dssp             CCCEEEESSCCG----GGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETT-TTEECEEEEEEEEEEECCC--
T ss_pred             ccceEECCCCCc----cCeeEecceEEcCCCeEEeCCCCCCCEEEEEeCCCEeccCCC-CcccccEEEEEEEEEecCCCC
Confidence            457899999976    589999999998889999999999999999999999999987 889999999999999988777


Q ss_pred             CCCcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccccccccc
Q 005621          102 LGGHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFL  181 (687)
Q Consensus       102 ~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~~  181 (687)
                      .+||||||+|+|...                   ...++.+||||||+.|         |+++|+++...... .     
T Consensus        77 ~~gdGlaf~~~~~~~-------------------~~~~~~~~vefDt~~n---------~~~~d~~~~~~~~~-~-----  122 (204)
T d1dhkb_          77 NSAVGLDFVLVPVQP-------------------ESKGDTVTVEFDTFLS---------RISIDVNNNDIKSV-P-----  122 (204)
T ss_dssp             -CCSEEEEEEEEC-------------------------CCEEEEEETTTT---------EEEEEETTEEEEEE-E-----
T ss_pred             CCCceEEEEecCCCC-------------------CCCCcEeeEeeEcccc---------cccCcccccccccc-c-----
Confidence            789999999998542                   1234789999999975         56666665332111 1     


Q ss_pred             ccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcc---cceeEEE
Q 005621          182 ENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLL---ASSHYIL  258 (687)
Q Consensus       182 ~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~---~~~~~i~  258 (687)
                           ....+.+|+.++|||+||+..++|+|++++.+ +|..+.|++.+||+++||++||||||||||..   .|+|+|+
T Consensus       123 -----~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~Il  196 (204)
T d1dhkb_         123 -----WDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVL  196 (204)
T ss_dssp             -----CCGGGTTTSCEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEE
T ss_pred             -----cccEecCCCEEEEEEEEcCCCEEEEEEEecCC-CCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEE
Confidence                 14577899999999999999999999999766 66778899999999999999999999999964   5889999


Q ss_pred             Eeeecc
Q 005621          259 GWSFNM  264 (687)
Q Consensus       259 sWsf~~  264 (687)
                      ||+|++
T Consensus       197 sWsFss  202 (204)
T d1dhkb_         197 SWSFSS  202 (204)
T ss_dssp             EEEEEE
T ss_pred             EEEEEe
Confidence            999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-44  Score=372.71  Aligned_cols=266  Identities=23%  Similarity=0.251  Sum_probs=199.0

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCC-CeEEEEEEecCcch--hhHHHHHHHHHHHhhh---cCCCceeeeeeeec----
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPST-NTQVAVKRVSNESK--QGLREFASEISSIGRL---RHRNLVQLLGWCRR----  411 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----  411 (687)
                      .++|+..+.||+|+||+||+|++..+ ++.||||+++....  .....+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999998654 67899999865422  2233556777777666   79999999998853    


Q ss_pred             -CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccc
Q 005621          412 -RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFG  490 (687)
Q Consensus       412 -~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG  490 (687)
                       ....+++|||++++.+.... ......+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence             35789999999887765433 3344568999999999999999999998   999999999999999999999999999


Q ss_pred             cceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc
Q 005621          491 LAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI  570 (687)
Q Consensus       491 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~  570 (687)
                      +++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+............
T Consensus       162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            98864332  2334567999999999999999999999999999999999999999866432222111111000000000


Q ss_pred             c------c-cc---CCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          571 L------E-VV---DPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       571 ~------~-~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .      . ..   .+.....+.......+.+|+.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0      0 00   000001111222346788999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=369.33  Aligned_cols=267  Identities=24%  Similarity=0.309  Sum_probs=199.9

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeec--------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRR--------  411 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------  411 (687)
                      -++|+..+.||+|+||+||+|++..+|+.||||++...  .....+++.+|+++|++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            37899999999999999999999999999999998654  23345778999999999999999999998754        


Q ss_pred             CCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccc
Q 005621          412 RGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGL  491 (687)
Q Consensus       412 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl  491 (687)
                      .+..++||||+.++.+..+.  .....++..++..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence            34689999999887776544  334568999999999999999999998   9999999999999999999999999999


Q ss_pred             ceeccCCCC---CceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 005621          492 AKLYERGTN---PSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKA  567 (687)
Q Consensus       492 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~  567 (687)
                      ++.......   .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....................
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            987653322   122335799999999998765 6899999999999999999999999765432222211111111100


Q ss_pred             cccccc--------cCCcCCCCCCHH-------HHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          568 GAILEV--------VDPRLNGEFNEI-------EALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       568 ~~~~~~--------~d~~l~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      ......        ............       ....+.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            000000        000000011111       1235678999999999999999999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-43  Score=371.80  Aligned_cols=266  Identities=24%  Similarity=0.306  Sum_probs=198.7

Q ss_pred             CcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceeeeeeeecC------CeeEE
Q 005621          344 GFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQLLGWCRRR------GDLLL  417 (687)
Q Consensus       344 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l  417 (687)
                      +|+..++||+|+||+||+|++..+++.||||++......    +.+|+++|++++||||+++++++...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            578889999999999999999999999999999765422    24699999999999999999998533      35799


Q ss_pred             EEecCCCCCchhhhhc-hhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-cEEEcccccceec
Q 005621          418 VYDFMPNGSLDKCLFD-EQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-NGRLGDFGLAKLY  495 (687)
Q Consensus       418 V~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~  495 (687)
                      |||||+++.+...... .....+++.++..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987644443322 334579999999999999999999998   9999999999999999875 8999999999876


Q ss_pred             cCCCCCceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhc
Q 005621          496 ERGTNPSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV--------WDRWK  566 (687)
Q Consensus       496 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v--------~~~~~  566 (687)
                      .....  .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+...        +....
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            54332  233579999999998765 57899999999999999999999999765532221111000        00000


Q ss_pred             cc----ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcC
Q 005621          567 AG----AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGE  618 (687)
Q Consensus       567 ~~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  618 (687)
                      ..    ....................++.+|+.+||+.||++|||+.|+++  ++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            00    000000000001111223346889999999999999999999997  45543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=367.72  Aligned_cols=266  Identities=24%  Similarity=0.329  Sum_probs=199.3

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC------
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRRRG------  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  413 (687)
                      .++|+..++||+|+||+||+|++..+|+.||||+++..  .....+++.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999999989999999999754  3344578899999999999999999999997654      


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      .+++||||+ +.+|..+.   ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~~lv~e~~-~~~l~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM---KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHH---HhccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence            579999999 55676655   34579999999999999999999998   999999999999999999999999999998


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHH
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWV--------WDR  564 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v--------~~~  564 (687)
                      .....    .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...............        ++.
T Consensus       170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            76432    2345789999999998764 5789999999999999999999999765432211111000        000


Q ss_pred             hccc-------ccccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhcCC
Q 005621          565 WKAG-------AILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEGEV  619 (687)
Q Consensus       565 ~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~  619 (687)
                      ....       ...+.....+. .........+.+|+.+||+.||++|||+.|+++  +++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0000       00000000010 111112336789999999999999999999998  466543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-42  Score=357.56  Aligned_cols=267  Identities=22%  Similarity=0.262  Sum_probs=209.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCCeeEEEEe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E  420 (687)
                      ++|+..++||+|+||+||+|++..+++.||||+++...  .....++.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999999999999999986543  3446789999999999999999999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceeccCCCC
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYERGTN  500 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~  500 (687)
                      ++.+++|..++.  ..+.+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||.++.......
T Consensus        82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            999998887763  44578999999999999999999998   9999999999999999999999999999987654332


Q ss_pred             CceeeeecCCCCCchhhccCCC-CCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccc---cc---ccc
Q 005621          501 PSTTRVVGTLGYLAPELTRTGK-PTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAG---AI---LEV  573 (687)
Q Consensus       501 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~---~~---~~~  573 (687)
                       ......++..|+|||.+.... ++.++|||||||++|||++|+.||.........  ...+.......   ..   ...
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhhhhc
Confidence             223345788999999987665 689999999999999999999998654432211  11111111110   00   000


Q ss_pred             cCC---------cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          574 VDP---------RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       574 ~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                      .+.         .-...........+.+|+.+||+.||++|||++|+++  ++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence            000         0001111222346788999999999999999999987  4543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-42  Score=358.48  Aligned_cols=260  Identities=17%  Similarity=0.201  Sum_probs=200.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCceee-eeeeecCCeeEEEEec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNLVQL-LGWCRRRGDLLLVYDF  421 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~~~~~~~~~~~lV~Ey  421 (687)
                      ++|+..+.||+|+||+||+|++..+++.||||++.....  ..++..|++++++++|+|++.. .++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            579999999999999999999998999999999876533  2457889999999987776555 4555777889999999


Q ss_pred             CCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEec---cCCcEEEcccccceeccCC
Q 005621          422 MPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLD---SELNGRLGDFGLAKLYERG  498 (687)
Q Consensus       422 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGla~~~~~~  498 (687)
                      + +++|.+.+.. ....+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+|+.+...
T Consensus        85 ~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          85 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             c-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            9 5666665533 34569999999999999999999999   9999999999999985   4567999999999977543


Q ss_pred             CC------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          499 TN------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       499 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      ..      .......||+.|||||.+.+..++.++|||||||++|||+||+.||......................    
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----  235 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----  235 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS----
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC----
Confidence            32      12345679999999999999999999999999999999999999998765433222111111110000    


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                       ..+.+...++    .++.+++..||+.+|++||++.++.+.|+..
T Consensus       236 -~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         236 -PIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             -CHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             -ChhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence             0011112222    3688999999999999999999998887753

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.8e-42  Score=355.51  Aligned_cols=261  Identities=19%  Similarity=0.226  Sum_probs=209.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC-CCceeeeeeeecCCeeEEEEe
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH-RNLVQLLGWCRRRGDLLLVYD  420 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  420 (687)
                      .++|++.++||+|+||+||+|++..+|+.||||++.....  ..++.+|++.++.+.| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            4689999999999999999999999999999999865432  2456788899999865 899999999999999999999


Q ss_pred             cCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEecc-----CCcEEEcccccceec
Q 005621          421 FMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDS-----ELNGRLGDFGLAKLY  495 (687)
Q Consensus       421 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-----~~~~kl~DFGla~~~  495 (687)
                      |+ +++|.+++.. ....+++.++..++.|++.||+|||+   ++|+||||||+|||++.     ++.+||+|||+|+.+
T Consensus        82 ~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          82 LL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            99 7899988753 34469999999999999999999999   99999999999999974     567999999999976


Q ss_pred             cCCCC------CceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc
Q 005621          496 ERGTN------PSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA  569 (687)
Q Consensus       496 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~  569 (687)
                      .....      .......||+.|||||++.+..++.++|||||||++|||+||+.||..............+...-....
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            54322      123346799999999999999999999999999999999999999987655433322222221111111


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHHHHhcC
Q 005621          570 ILEVVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVRYLEGE  618 (687)
Q Consensus       570 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  618 (687)
                      ..     .+...++    .++.+++..|++.+|++||+++.+.+.|++.
T Consensus       237 ~~-----~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         237 LR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hH-----HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11     1112233    3688899999999999999999988877654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-43  Score=370.24  Aligned_cols=266  Identities=21%  Similarity=0.257  Sum_probs=199.6

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-hhhHHHHHHHHHHHhhhcCCCceeeeeeeecCC----eeE
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-KQGLREFASEISSIGRLRHRNLVQLLGWCRRRG----DLL  416 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~  416 (687)
                      +.+|+..++||+|+||+||+|++..+|+.||||++.... ....+++++|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            467999999999999999999999999999999997653 344678899999999999999999999986543    234


Q ss_pred             EEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccceecc
Q 005621          417 LVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKLYE  496 (687)
Q Consensus       417 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~  496 (687)
                      ++++|+.+|+|.+++.   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~l~~~~~~g~L~~~l~---~~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLK---TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            5556677999999984   3469999999999999999999998   999999999999999999999999999998654


Q ss_pred             CCCC--CceeeeecCCCCCchhhccC-CCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccc---
Q 005621          497 RGTN--PSTTRVVGTLGYLAPELTRT-GKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAI---  570 (687)
Q Consensus       497 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~---  570 (687)
                      ....  .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.......+.........   
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            3322  22344679999999999854 56789999999999999999999999765432221111111000000000   


Q ss_pred             -----c--cccCCcCCCCCCH-----HHHHHHHHHHHhccccCcCcCCCHHHHHHH
Q 005621          571 -----L--EVVDPRLNGEFNE-----IEALDVVKLGLMCSNDAAEARPTMRQVVRY  614 (687)
Q Consensus       571 -----~--~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  614 (687)
                           .  ....+... ..+.     ....++.+|+.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKN-KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCC-CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccC-CCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0  00000000 0000     112367899999999999999999999973

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-42  Score=362.22  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=204.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEe---CCCCeEEEEEEecCcc----hhhHHHHHHHHHHHhhhcC-CCceeeeeeeecCCe
Q 005621          343 RGFRDKELLGFGGFGRVYKGTL---PSTNTQVAVKRVSNES----KQGLREFASEISSIGRLRH-RNLVQLLGWCRRRGD  414 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~  414 (687)
                      ++|+..+.||+|+||+||+|..   +.+|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999987   3468999999986542    2334678899999999977 899999999999999


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++||||+.+|+|.+++.  ....++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            999999999999999984  34467889999999999999999998   9999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCC--CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccccccc
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTG--KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGAILE  572 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~~~~  572 (687)
                      +............|++.|+|||.+...  .++.++|||||||+||||++|+.||...........   +.+.....    
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~----  251 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKS----  251 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHC----
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccC----
Confidence            654444334456799999999999764  468899999999999999999999987654432211   11111110    


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccccCcCcCCC-----HHHHHH
Q 005621          573 VVDPRLNGEFNEIEALDVVKLGLMCSNDAAEARPT-----MRQVVR  613 (687)
Q Consensus       573 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  613 (687)
                        .+.+.    .....++.+++.+||++||++||+     ++|+++
T Consensus       252 --~~~~~----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 --EPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --CCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --CCCCc----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence              11122    223347889999999999999994     789886

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2e-41  Score=357.37  Aligned_cols=258  Identities=20%  Similarity=0.272  Sum_probs=200.2

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeeeeec--CCeeEEEE
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWCRR--RGDLLLVY  419 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~  419 (687)
                      ++|+..++||+|+||+||+|+++.+++.||||+++...   .+++.+|+++|++++ ||||+++++++..  ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999999999999999997643   357889999999995 9999999999874  45689999


Q ss_pred             ecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCC-cEEEcccccceeccCC
Q 005621          420 DFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSEL-NGRLGDFGLAKLYERG  498 (687)
Q Consensus       420 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~  498 (687)
                      ||+++++|..+.     +.+++.++..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999999998764     358999999999999999999998   9999999999999998765 5899999999876543


Q ss_pred             CCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhH-----------HHHHHHHhc
Q 005621          499 TNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELIL-----------VDWVWDRWK  566 (687)
Q Consensus       499 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~-----------~~~v~~~~~  566 (687)
                      .  ......||+.|+|||.+.+. .++.++||||+||+++||++|+.||...........           .+|....-.
T Consensus       184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            3  23345789999999998765 479999999999999999999999987654321110           001000000


Q ss_pred             c--cccccccCC--------cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          567 A--GAILEVVDP--------RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       567 ~--~~~~~~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                      .  .........        ............++.+|+.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  000000000        0011111122346889999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-41  Score=356.80  Aligned_cols=262  Identities=20%  Similarity=0.247  Sum_probs=193.4

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCc--chhhHHHHHHHHHHHhhhcCCCceeeeeeeec------CC
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNE--SKQGLREFASEISSIGRLRHRNLVQLLGWCRR------RG  413 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~  413 (687)
                      .++|+..++||+|+||+||+|.+..+|+.||||++...  ......++.+|+.++++++||||+++++++..      .+
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            36799999999999999999999999999999999754  33445678999999999999999999999853      46


Q ss_pred             eeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          414 DLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       414 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      .+|+||||+.++.+. .+    ...+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+|++|||+++
T Consensus        96 ~~~iv~Ey~~~~l~~-~~----~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          96 DVYLVMELMDANLCQ-VI----QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEEECCSEEHHH-HH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eeEEEEeccchHHHH-hh----hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence            889999999765444 34    2458999999999999999999999   999999999999999999999999999988


Q ss_pred             eccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHH--------------
Q 005621          494 LYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVD--------------  559 (687)
Q Consensus       494 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------------  559 (687)
                      ......  ..+...||+.|+|||++.+..++.++||||+||+++||++|+.||...........+.              
T Consensus       168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            654432  3344578999999999999999999999999999999999999997654211110000              


Q ss_pred             --HHHHHhcccc------cccccCCcCC---CCCCHHHHHHHHHHHHhccccCcCcCCCHHHHHH
Q 005621          560 --WVWDRWKAGA------ILEVVDPRLN---GEFNEIEALDVVKLGLMCSNDAAEARPTMRQVVR  613 (687)
Q Consensus       560 --~v~~~~~~~~------~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  613 (687)
                        ..........      ..........   ..........+.+|+.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              0000000000      0000100111   1112234567899999999999999999999997

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-41  Score=356.55  Aligned_cols=263  Identities=21%  Similarity=0.261  Sum_probs=199.2

Q ss_pred             hcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc--hhhHHHHHHHHHHHhhhcCCCceeeeeeeecC-----Ce
Q 005621          342 TRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES--KQGLREFASEISSIGRLRHRNLVQLLGWCRRR-----GD  414 (687)
Q Consensus       342 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  414 (687)
                      .++|+..++||+|+||+||+|++..+|+.||||+++...  ....+++.+|+++|++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999999999999999997653  34456789999999999999999999998533     34


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      .++++||+.+|+|.+++.   .+.+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence            567778888999999884   3469999999999999999999998   9999999999999999999999999999975


Q ss_pred             ccCCCCCceeeeecCCCCCchhhccCC-CCCCccceehhhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcccc----
Q 005621          495 YERGTNPSTTRVVGTLGYLAPELTRTG-KPTTSSDVYAFGALLLEVVCGRRPIEPKALPEELILVDWVWDRWKAGA----  569 (687)
Q Consensus       495 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~v~~~~~~~~----  569 (687)
                      ...    ......|+..|+|||...+. .++.++|||||||++|||++|+.||..........   .+........    
T Consensus       171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~---~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPGAELL  243 (348)
T ss_dssp             CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCHHHH
T ss_pred             cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChHHh
Confidence            432    23345789999999987665 46889999999999999999999997654322111   1111110000    


Q ss_pred             -------cccccC--CcCC-CCC---CHHHHHHHHHHHHhccccCcCcCCCHHHHHH--HHhc
Q 005621          570 -------ILEVVD--PRLN-GEF---NEIEALDVVKLGLMCSNDAAEARPTMRQVVR--YLEG  617 (687)
Q Consensus       570 -------~~~~~d--~~l~-~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  617 (687)
                             ......  +... ..+   .......+.+|+.+||+.||++|||+.|+++  ++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                   000000  0000 000   0012236789999999999999999999998  5654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-36  Score=321.55  Aligned_cols=270  Identities=20%  Similarity=0.241  Sum_probs=197.8

Q ss_pred             cCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-----------CCCceeeeeeeec
Q 005621          343 RGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-----------HRNLVQLLGWCRR  411 (687)
Q Consensus       343 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~  411 (687)
                      ++|+..++||+|+||+||+|++..+|+.||||+++.... ..+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            359999999999999999999999999999999986543 3456788998888875           5789999998764


Q ss_pred             C--CeeEEEEecCCCCCchhh-hhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCc-----
Q 005621          412 R--GDLLLVYDFMPNGSLDKC-LFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELN-----  483 (687)
Q Consensus       412 ~--~~~~lV~Ey~~~gsL~~~-L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-----  483 (687)
                      .  ...+++++++..+..... ........+++..+..++.||+.||.|||+  ..+|+||||||+|||++.++.     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence            3  456777777766544333 333445678999999999999999999997  378999999999999987653     


Q ss_pred             -EEEcccccceeccCCCCCceeeeecCCCCCchhhccCCCCCCccceehhhHHHHHHHhCCCCCCCCCCcchh----hHH
Q 005621          484 -GRLGDFGLAKLYERGTNPSTTRVVGTLGYLAPELTRTGKPTTSSDVYAFGALLLEVVCGRRPIEPKALPEEL----ILV  558 (687)
Q Consensus       484 -~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~~~~----~~~  558 (687)
                       +|++|||.+.......    ....||+.|+|||++....++.++||||+||+++||++|+.||.........    .+.
T Consensus       170 ~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence             8999999998654322    3457999999999999999999999999999999999999999765432111    111


Q ss_pred             HHHHHH-------hcc----------cccccccCC----------cCCCCCCHHHHHHHHHHHHhccccCcCcCCCHHHH
Q 005621          559 DWVWDR-------WKA----------GAILEVVDP----------RLNGEFNEIEALDVVKLGLMCSNDAAEARPTMRQV  611 (687)
Q Consensus       559 ~~v~~~-------~~~----------~~~~~~~d~----------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  611 (687)
                      ..+.-.       ...          ......+..          .....+.......+.+|+.+||+.||++|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            111100       000          000000000          00123445667789999999999999999999999


Q ss_pred             HH--HHhcCC
Q 005621          612 VR--YLEGEV  619 (687)
Q Consensus       612 l~--~L~~~~  619 (687)
                      ++  ++++..
T Consensus       326 L~Hp~f~~~~  335 (362)
T d1q8ya_         326 VNHPWLKDTL  335 (362)
T ss_dssp             HTCGGGTTCT
T ss_pred             hcCcccCCCC
Confidence            98  466443

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.96  E-value=3.9e-30  Score=252.20  Aligned_cols=114  Identities=38%  Similarity=0.590  Sum_probs=104.9

Q ss_pred             cceEEEEEeecccCCCCCCCCCCeeeEEeCCCCcccccccccccccccccccccCCCCeEEEEEEEeCCCCeEEEEEeeC
Q 005621          138 TNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLENSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPS  217 (687)
Q Consensus       138 ~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~  217 (687)
                      .|++|||||||++|.+++||++||||||+|++.|.++.+            +++.+|+.++|||+||+.+++|+|++++.
T Consensus         1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~------------~~l~~G~~~~v~I~Yd~~~~~L~V~~~~~   68 (237)
T d1nlsa_           1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQNGKVGTAHIIYNSVDKRLSAVVSYP   68 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE------------CCCCTTCEEEEEEEEETTTTEEEEEEECT
T ss_pred             CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceec------------ccccCCCEEEEEEEEecCCcEEEEEEecC
Confidence            378999999999999889999999999999999876553            57889999999999999999999999864


Q ss_pred             CCCCCCcceeeeecCCccccccceeeeeccCCcccceeEEEEeeeccC
Q 005621          218 SVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFNMS  265 (687)
Q Consensus       218 ~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sWsf~~~  265 (687)
                        ++..|+|++.|||+++|+++||||||||||...|.|+|++|+|++.
T Consensus        69 --~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~  114 (237)
T d1nlsa_          69 --NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK  114 (237)
T ss_dssp             --TSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEE
T ss_pred             --CCCCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEee
Confidence              4677899999999999999999999999999999999999999864

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=2.1e-26  Score=228.79  Aligned_cols=213  Identities=14%  Similarity=0.103  Sum_probs=143.0

Q ss_pred             ceEeCCCCCCCC-CCCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCC
Q 005621           25 EFFFSGFRDAAN-NNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALG  103 (687)
Q Consensus        25 ~f~~~~F~~~~~-~~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~  103 (687)
                      +|..+.+..++. -.+..++|+|.+. ++.|+||++..+++|+++|++|+++.         +|+++|+|.+... ...+
T Consensus        10 sf~~P~~~~~~~~~~~w~~~G~a~i~-~~~i~LT~~~~~~~G~v~~~~p~~~~---------~F~~~f~f~~~~~-~~~g   78 (228)
T d1gv9a_          10 SFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAFE---------NWEVEVTFRVTGR-GRIG   78 (228)
T ss_dssp             CEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCCS---------SEEEEEEEEEECS-SSCC
T ss_pred             ccCCCcccCCCCCccceEEeeeEEEE-CCEEEECCCCCCCEEEEEeCCCcccc---------CcEEEEEEeccCC-CCCC
Confidence            455454443322 2367899999886 78899999999999999999999872         6999999999764 4568


Q ss_pred             CcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCc-ccccccccccc
Q 005621          104 GHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRS-NASEPAAYFLE  182 (687)
Q Consensus       104 g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s-~~~~~~~~~~~  182 (687)
                      ||||||+|++...    ..|+.+|..       ...+-+||||||+.|.  ++++.+|+.+++|.... .......+...
T Consensus        79 gdG~aF~i~~~~~----~~g~~~G~~-------~~~~glaVefDt~~n~--~~~~~~~~~~~~n~~~~~~~~~~~~~~~~  145 (228)
T d1gv9a_          79 ADGLAIWYTENQG----LDGPVFGSA-------DMWNGVGIFFDSFDND--GKKNNPAIVVVGNNGQINYDHQNDGATQA  145 (228)
T ss_dssp             CCEEEEEEESSCC----CEEEETTEC-------SCCEEEEEEEECCCC-------CCEEEEEEEESCCCCCHHHHHHHHC
T ss_pred             CCEEEEEEecCCC----CCCCccCcC-------CCCceEEEEEEccccc--CCCCCCcEEEEecCCcceeeecCCCcccc
Confidence            9999999998753    356666662       2345689999999996  47888888888774332 11111111100


Q ss_pred             cccccccccCCCCeEEEEEEEeCCCCeEEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcccceeEEEEeee
Q 005621          183 NSTKQVLNLKSGEVIQAWIDYDSSKNHLEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSF  262 (687)
Q Consensus       183 ~~~~~~~~~~~g~~~~~~I~Yd~~~~~l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sWsf  262 (687)
                      -..........+..+++|++|+  .+.|+|++.........+.+.........+++++|||||||||...+.|.|+||.+
T Consensus       146 ~~~~~~~~~~~~~~~~i~~~~~--~~~l~v~i~~~~~~~~~~~~~~~~~~~~~l~~~~y~GFTAsTG~~~~~H~I~s~~~  223 (228)
T d1gv9a_         146 LASCQRDFRNKPYPVRAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT  223 (228)
T ss_dssp             SEEECCCCBSCSSCEEEEEEEE--TTEEEEEEECSSCCCTTCCEEEEEETTCCCCSSBEEEEEEECCSSCCEEEEEEEEE
T ss_pred             ccceeeeecCCceEEEEEEEec--CCEEEEEEeccccCCCcceeEEEEecccccCCCEEEEEEEeCCCCcCeEEEEEEEE
Confidence            0001111123444566666665  68899999865543333333333333556899999999999999999999999987


Q ss_pred             c
Q 005621          263 N  263 (687)
Q Consensus       263 ~  263 (687)
                      .
T Consensus       224 ~  224 (228)
T d1gv9a_         224 F  224 (228)
T ss_dssp             E
T ss_pred             E
Confidence            5

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.89  E-value=1.8e-23  Score=204.59  Aligned_cols=106  Identities=26%  Similarity=0.462  Sum_probs=92.4

Q ss_pred             cccceEeCCCCCCCCCCCeEEeeceEEccCCcEEecCCC------CCeeEEEEecCCeecccCCCCCceeeEEEEEEEEE
Q 005621           22 QQEEFFFSGFRDAANNNNMSLNGAAEIEKNGKLMLTNTT------LRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAI   95 (687)
Q Consensus        22 ~~~~f~~~~F~~~~~~~~l~~~g~a~~~~~~~i~lt~~~------~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i   95 (687)
                      ...+|+|++|.++  ..||+|+|+|.+.++|.|+||+..      ..++|||+|++||+|||+  +++++||+|+|+|.|
T Consensus       124 n~~~F~f~~F~~~--~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~--t~~~~SFsT~F~F~I  199 (237)
T d1nlsa_         124 NALHFMFNQFSKD--QKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES--SAVVASFEATFTFLI  199 (237)
T ss_dssp             EEEEEEESCCCTT--CTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT--TEEEEEEEEEEEEEC
T ss_pred             ccceEEeeecCCC--CCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECC--CCcEeeEEEEEEEEE
Confidence            4579999999975  369999999999889999999744      458999999999999995  578999999999999


Q ss_pred             eecCCCCCCcceEEEEccCC-CCCCCCCCccccccccC
Q 005621           96 VPEYTALGGHGFAFTISASK-ELPGTLPSQYLGLLNSS  132 (687)
Q Consensus        96 ~~~~~~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~  132 (687)
                      .+.+ ..+||||||||+|.. .+|.++.||||||+|.+
T Consensus       200 ~~~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~  236 (237)
T d1nlsa_         200 KSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA  236 (237)
T ss_dssp             CCSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred             ecCC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCC
Confidence            8764 558999999999964 67888999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=1.8e-22  Score=194.40  Aligned_cols=163  Identities=14%  Similarity=0.142  Sum_probs=120.3

Q ss_pred             ccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcch------------------hhHHHHHHHHHHHhhhcCCCceeeee
Q 005621          346 RDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESK------------------QGLREFASEISSIGRLRHRNLVQLLG  407 (687)
Q Consensus       346 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~  407 (687)
                      ...++||+|+||+||+|++. +|+.||||+++....                  ........|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45789999999999999985 689999998753210                  11233456889999999999998886


Q ss_pred             eeecCCeeEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcccccCeEEeeccCCCcEEeccCCcEEEc
Q 005621          408 WCRRRGDLLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHEEWEQTVIHRDIKAGNVLLDSELNGRLG  487 (687)
Q Consensus       408 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~  487 (687)
                      +..    .+++|||+++..+.+         ++.....+++.|++.+|.|||+   ++|+||||||+|||++++ .++|+
T Consensus        82 ~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEEC
T ss_pred             ecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEE
Confidence            542    379999998765543         3344456799999999999998   999999999999999865 59999


Q ss_pred             ccccceeccCCCCCceeeeecCCCCCch------hhccCCCCCCccceehhhHHH
Q 005621          488 DFGLAKLYERGTNPSTTRVVGTLGYLAP------ELTRTGKPTTSSDVYAFGALL  536 (687)
Q Consensus       488 DFGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDV~S~Gvvl  536 (687)
                      |||+|....+....         .|...      |. ..+.+..++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            99999865432211         01111      11 235678899999975433

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.82  E-value=2.2e-19  Score=176.04  Aligned_cols=201  Identities=12%  Similarity=0.150  Sum_probs=129.8

Q ss_pred             ceEeCCCCCCC-CCCCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCC
Q 005621           25 EFFFSGFRDAA-NNNNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALG  103 (687)
Q Consensus        25 ~f~~~~F~~~~-~~~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~  103 (687)
                      .|+++.+-... ...+..+.|+|.+. +|.|+||++ .++.|.+++++|+++++        .|+++|+|+|... ...+
T Consensus         9 ~~s~p~~~~~~~~~~~W~~~g~a~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~~--------~f~~~~~F~i~g~-~~~g   77 (221)
T d2a6za1           9 DYSLPDLINTRKVPNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLKD--------SFTMEWTFRSVGY-SGQT   77 (221)
T ss_dssp             GGCBCCCTTCCSCCTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECCS--------CEEEEEEEEEESC-CSCC
T ss_pred             cccCCCccccccCCCccEEcceeEEE-CCEEEECCC-CCCceEEEECCccccCC--------CeEEEEEEEEeCC-CCCC
Confidence            47776653322 23589999999997 899999987 57889999999999864        5999999999764 3457


Q ss_pred             CcceEEEEccCCCCCCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCCccccccccccccc
Q 005621          104 GHGFAFTISASKELPGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLRSNASEPAAYFLEN  183 (687)
Q Consensus       104 g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~s~~~~~~~~~~~~  183 (687)
                      ||||||++++....  ...|+.+|..+       ...-+||||||+.|.    ....|+.++.++..-...... . . .
T Consensus        78 gdG~af~~~~~~~~--~~~g~~~G~~~-------~~~GlaV~fDt~~n~----~~~~~~~~ndgt~~~~~~~~~-~-~-~  141 (221)
T d2a6za1          78 DGGISFWFVQDSNI--PRDKQLYNGPV-------NYDGLQLLVDNNGPL----GPTLRGQLNDGQKPVDKTKIY-D-Q-S  141 (221)
T ss_dssp             SCEEEEEEEECSSS--CCCCTBTTBCT-------TCEEEEEEEESCSTT----SSEEEEEEEESSSCCCGGGHH-H-H-C
T ss_pred             CCcEEEEEEcCCCc--cccccccccCC-------CCceEEEEEECCCCC----CCceEEEecCCCccccccCCc-c-c-c
Confidence            99999999975422  23455555522       234589999999873    222334444433221111110 0 0 0


Q ss_pred             ccccccc-cCCCCeEEEEEEEeCCCCe-EEEEEeeCCCCCCCcceeeeecCCccccccceeeeeccCCcccceeEEEEe
Q 005621          184 STKQVLN-LKSGEVIQAWIDYDSSKNH-LEVRLAPSSVKPRSPILSFDVDLSPIVKETMYVGFSSSTGLLASSHYILGW  260 (687)
Q Consensus       184 ~~~~~~~-~~~g~~~~~~I~Yd~~~~~-l~V~~~~~~~~~~~~~ls~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sW  260 (687)
                      ....... ..++...+++|+|++..+. |.|.+....      .+  .++--.+.++++|+||||+||...+.|.++.+
T Consensus       142 ~~~~~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~~~------c~--~~~~v~lp~~~~~fG~SA~TG~~~~~hd~~~i  212 (221)
T d2a6za1         142 FASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNKV------CF--QTRKVRFPSGSYRIGVTAQNGAVNNNAESFEI  212 (221)
T ss_dssp             SEEEECCCTTEEEEEEEEEEEEGGGTSEEEEEETTEE------EE--EESCCCCCSSEEEEEEEEECCSGGGCCCEEEE
T ss_pred             cceeeecccCCCCCEEEEEEEecCccceEEEEecCcE------eE--EECCeecCCCCEEEEEEEccCCccCCCceEEE
Confidence            0011122 3467788999999976544 788775211      11  11211122467899999999999998887665

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.81  E-value=3.7e-19  Score=173.75  Aligned_cols=189  Identities=14%  Similarity=0.157  Sum_probs=127.0

Q ss_pred             CCeEEeeceEEccCCcEEecCCCCCeeEEEEecCCeecccCCCCCceeeEEEEEEEEEeecCCCCCCcceEEEEccCCCC
Q 005621           38 NNMSLNGAAEIEKNGKLMLTNTTLRVLGHAFYSSPIKFKNSTRNSKSLSFSTCFAFAIVPEYTALGGHGFAFTISASKEL  117 (687)
Q Consensus        38 ~~l~~~g~a~~~~~~~i~lt~~~~~~~Gr~~y~~p~~l~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~~~~~~  117 (687)
                      .+..+.|+|.+. +|.|+||++ .++.|+++++.|+++++        +|+++|+|.|... ...+||||||.+.+....
T Consensus        22 ~~W~~~G~~~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~~--------~f~i~~~F~i~g~-~~~~~dG~afw~~~~~~~   90 (218)
T d2a6va1          22 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIKD--------AMTIEWTFRSFGF-RGSTKGGLAFWLKQGNEG   90 (218)
T ss_dssp             TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCSS--------CEEEEEEEEEESC-CSCCSCEEEEEEECSCCC
T ss_pred             CccEECCCEEEE-CCEEEECCC-CCCeeEEEeCCcccccc--------cceEEEEEEEeCC-CCCCCCcEEEEEEcCCcc
Confidence            579999999997 899999987 56889999999999864        5999999999754 356799999999875432


Q ss_pred             CCCCCCccccccccCCCCCCcceEEEEEeecccCCCCCCCCCCeeeEEeCCCC-cccccccccccccccccccccCCCCe
Q 005621          118 PGTLPSQYLGLLNSSDLGNLTNHIFAVEFDTVKDFEFGDINDNHVGIDINSLR-SNASEPAAYFLENSTKQVLNLKSGEV  196 (687)
Q Consensus       118 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi~~ns~~-s~~~~~~~~~~~~~~~~~~~~~~g~~  196 (687)
                      ..  .+..+|..+.       -.-+||||||+.|.      .+||.+.+|.=. .....+-..   -+...--...++..
T Consensus        91 ~~--~~~~~G~~~~-------f~GlaV~fDt~~n~------~~~i~~~~ndGs~~~~~~~d~~---~g~c~~~~~~~~~~  152 (218)
T d2a6va1          91 DS--TELFGGSSKK-------FNGLMILLRLDDKL------GESVTAYLNDGTKDLDIESSPY---FASCLFQYQDSMVP  152 (218)
T ss_dssp             CC--CTBTTTBCSS-------CEEEEEEEEEETTT------EEEEEEEEEESSSCCCTTTSCC---SEEEECCCSSCSSC
T ss_pred             cC--CCcccccCCC-------cceEEEEEECCCCC------CCeEEEEeCCCCccccccCCcc---cceEEecccCCCCc
Confidence            11  1222222111       12379999999874      267877665311 111111000   01111112456788


Q ss_pred             EEEEEEEeCCCC-eEEEEEeeCCCCCCCcce-eeeecCCccccccceeeeeccCCcccceeEEEEeeec
Q 005621          197 IQAWIDYDSSKN-HLEVRLAPSSVKPRSPIL-SFDVDLSPIVKETMYVGFSSSTGLLASSHYILGWSFN  263 (687)
Q Consensus       197 ~~~~I~Yd~~~~-~l~V~~~~~~~~~~~~~l-s~~~dl~~~l~~~~~vGFsastG~~~~~~~i~sWsf~  263 (687)
                      .+++|.|+.... .++|.+...      ..+ ...|+|  ..++++|+||||+||...+.|.|++|++.
T Consensus       153 ~~~~i~Y~~~~~~~l~v~id~~------~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls~~~~  213 (218)
T d2a6va1         153 STLRLTYNPLDNHLLKLQMDNR------VCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILKMKLY  213 (218)
T ss_dssp             EEEEEEEEGGGTSEEEEEETTE------EEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEEEEEE
T ss_pred             EEEEEEEECcccceEEEEeCCc------EEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEEEEEE
Confidence            999999997554 467766421      111 122332  34577999999999999999999999985

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.56  E-value=9.2e-08  Score=94.32  Aligned_cols=150  Identities=20%  Similarity=0.129  Sum_probs=102.1

Q ss_pred             HHHHHHhcCcccceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhc-CCCceeeeeeeecCCe
Q 005621          336 EELKKATRGFRDKELLGFGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLR-HRNLVQLLGWCRRRGD  414 (687)
Q Consensus       336 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~  414 (687)
                      .|++.....|+..+..+.+....||+...  ++..++||+...........+.+|...++.+. +-.+.+++.++...+.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            46777778888776655555678999864  56678899887665545556778888888774 4446788888888889


Q ss_pred             eEEEEecCCCCCchhhhhchhhccCCHHHHHHHHHHHHhhhhhhcc----------------------------------
Q 005621          415 LLLVYDFMPNGSLDKCLFDEQKAILTWEQRYRIIKGVASGLLYLHE----------------------------------  460 (687)
Q Consensus       415 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~~L~yLH~----------------------------------  460 (687)
                      .++|||++++.++.+.....       .....++.+++..|..||+                                  
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             eEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            99999999998775443111       0111122333333333331                                  


Q ss_pred             ----------------------cccCeEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          461 ----------------------EWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       461 ----------------------~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                                            .....++|+|+.|.|||++++..+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  0123489999999999999876667999998863

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.86  E-value=2.2e-05  Score=76.18  Aligned_cols=76  Identities=16%  Similarity=0.129  Sum_probs=53.7

Q ss_pred             eeeeeCe-EEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcC--CCceeeeeeeecCCeeEEEEecCCCCC
Q 005621          350 LLGFGGF-GRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRH--RNLVQLLGWCRRRGDLLLVYDFMPNGS  426 (687)
Q Consensus       350 ~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gs  426 (687)
                      .+..|.. ..||+.... ++..+++|.......   ..+..|...++.+..  -.+.+++.++.+.+..++|||+++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3444543 579999874 466688898665433   245667777777743  346778888888889999999999877


Q ss_pred             chh
Q 005621          427 LDK  429 (687)
Q Consensus       427 L~~  429 (687)
                      +.+
T Consensus        93 ~~~   95 (255)
T d1nd4a_          93 LLS   95 (255)
T ss_dssp             TTT
T ss_pred             ccc
Confidence            654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.70  E-value=7.4e-05  Score=77.68  Aligned_cols=78  Identities=12%  Similarity=0.056  Sum_probs=50.2

Q ss_pred             ceeeeeeCeEEEEEEEeCCCCeEEEEEEecCcc-------hhhHHHHHHHHHHHhhhc-C--CCceeeeeeeecCCeeEE
Q 005621          348 KELLGFGGFGRVYKGTLPSTNTQVAVKRVSNES-------KQGLREFASEISSIGRLR-H--RNLVQLLGWCRRRGDLLL  417 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~l  417 (687)
                      .+.||.|....||+.....+++.++||.-....       .....+...|.+.|+.+. +  ..+.+++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            456899999999999987778889999754321       112334556888887663 2  3456666554  345689


Q ss_pred             EEecCCCCCc
Q 005621          418 VYDFMPNGSL  427 (687)
Q Consensus       418 V~Ey~~~gsL  427 (687)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.86  E-value=0.0076  Score=59.65  Aligned_cols=158  Identities=15%  Similarity=0.053  Sum_probs=86.8

Q ss_pred             ccCHHHHHHHhcCcccceeee-----eeCeEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc--ee
Q 005621          332 RFSYEELKKATRGFRDKELLG-----FGGFGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL--VQ  404 (687)
Q Consensus       332 ~~~~~el~~at~~f~~~~~lG-----~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~  404 (687)
                      .++.+|++....+|...+...     .|---+.|+.+..  +..+++|+.....  ..++...|++++..|...++  ..
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccc
Confidence            357789999999997754443     4555788999874  3358999986542  22344556777777643222  11


Q ss_pred             eee------eeecCCeeEEEEecCCCCCchhhhhch----------------------hhc-----------------cC
Q 005621          405 LLG------WCRRRGDLLLVYDFMPNGSLDKCLFDE----------------------QKA-----------------IL  439 (687)
Q Consensus       405 l~~------~~~~~~~~~lV~Ey~~~gsL~~~L~~~----------------------~~~-----------------~l  439 (687)
                      .+.      +....+....++.+..+......-...                      ...                 ..
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            111      122344567777777665432211000                      000                 00


Q ss_pred             CHHHHHHHHHHHHhhhhhhc-ccccCeEEeeccCCCcEEeccCCcEEEcccccce
Q 005621          440 TWEQRYRIIKGVASGLLYLH-EEWEQTVIHRDIKAGNVLLDSELNGRLGDFGLAK  493 (687)
Q Consensus       440 ~~~~~~~i~~~ia~~L~yLH-~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~  493 (687)
                      ........+..+...+.-.+ .....++||+|+.++||+++.+...-|.||+.+.
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            00011112222222222222 2345789999999999999988777899999886

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.74  E-value=0.0031  Score=64.99  Aligned_cols=75  Identities=16%  Similarity=0.175  Sum_probs=51.3

Q ss_pred             ceeeeeeCeEEEEEEEeCC-------CCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc-eeeeeeeecCCeeEEEE
Q 005621          348 KELLGFGGFGRVYKGTLPS-------TNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL-VQLLGWCRRRGDLLLVY  419 (687)
Q Consensus       348 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~  419 (687)
                      .+.|+.|-.-.+|+...+.       ..+.|.+++... ... .....+|..+++.+.-.++ .++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4578888889999998753       234577777653 222 2345678888888853344 578887754    6899


Q ss_pred             ecCCCCCch
Q 005621          420 DFMPNGSLD  428 (687)
Q Consensus       420 Ey~~~gsL~  428 (687)
                      ||+++.+|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999886654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.61  E-value=0.003  Score=63.25  Aligned_cols=135  Identities=14%  Similarity=0.151  Sum_probs=78.6

Q ss_pred             eEEEEEEEeCCCCeEEEEEEecCcchhhHHHHHHHHHHHhhhcCCCc--eeeee-----eeecCCeeEEEEecCCCCCch
Q 005621          356 FGRVYKGTLPSTNTQVAVKRVSNESKQGLREFASEISSIGRLRHRNL--VQLLG-----WCRRRGDLLLVYDFMPNGSLD  428 (687)
Q Consensus       356 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~-----~~~~~~~~~lV~Ey~~~gsL~  428 (687)
                      --.||+++. .+|+.+++|+.+... ...+++..|...+..|....+  +..+.     .....+..+.++++++|..+.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            348999988 468889999987642 234667788888888753322  11111     234456788999999875542


Q ss_pred             hh----h----------hch-------hhccCCHH----------------------HHHHHHHHHHhhhhh-hcccccC
Q 005621          429 KC----L----------FDE-------QKAILTWE----------------------QRYRIIKGVASGLLY-LHEEWEQ  464 (687)
Q Consensus       429 ~~----L----------~~~-------~~~~l~~~----------------------~~~~i~~~ia~~L~y-LH~~~~~  464 (687)
                      ..    +          +..       ....+++.                      .....+.++...+.- +.+....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            10    0          000       00111111                      112222333333222 2223356


Q ss_pred             eEEeeccCCCcEEeccCCcEEEccccccee
Q 005621          465 TVIHRDIKAGNVLLDSELNGRLGDFGLAKL  494 (687)
Q Consensus       465 ~ivHrDlk~~NIll~~~~~~kl~DFGla~~  494 (687)
                      +++|+|+.+.|||++++  ..++||+-++.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            89999999999999743  46899998763